PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brooks, SJ; Nilsson, EK; Jacobsson, JA; Stein, DJ; Fredriksson, R; Lind, L; Schioth, HB				Brooks, Samantha J.; Nilsson, Emil K.; Jacobsson, Josefin A.; Stein, Dan J.; Fredriksson, Robert; Lind, Lars; Schioth, Helgi B.			BDNF Polymorphisms Are Linked to Poorer Working Memory Performance, Reduced Cerebellar and Hippocampal Volumes and Differences in Prefrontal Cortex in a Swedish Elderly Population	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; VOXEL-BASED MORPHOMETRY; VAL66MET POLYMORPHISM; VAL(66)MET POLYMORPHISM; GENE; PLASTICITY; CONNECTIVITY; COGNITION; WOMEN	Background: Brain-derived neurotrophic factor (BDNF) links learning, memory and cognitive decline in elderly, but evidence linking BDNF allele variation, cognition and brain structural differences is lacking. Methods: 367 elderly Swedish men (n = 181) and women (n = 186) from Prospective Investigation of the Vasculature in Uppsala seniors (PIVUS) were genotyped and the BDNF functional rs6265 SNP was further examined in subjects who completed the Trail Making Task (TMT), verbal fluency task, and had a magnetic resonance imaging (MRI) scan. Voxel-based morphometry (VBM) examined brain structure, cognition and links with BDNF. Results: The functional BDNF SNP (rs6265,) predicted better working memory performance on the TMT with positive association of the Met rs6265, and was linked with greater cerebellar, precuneus, left superior frontal gyrus and bilateral hippocampal volume, and reduced brainstem and bilateral posterior cingulate volumes. Conclusions: The functional BDNF polymorphism influences brain volume in regions associated with memory and regulation of sensorimotor control, with the Met rs6265 allele potentially being more beneficial to these functions in the elderly.	[Brooks, Samantha J.; Nilsson, Emil K.; Jacobsson, Josefin A.; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Brooks, Samantha J.; Stein, Dan J.] Univ Cape Town, Fac Hlth Sci, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa	Uppsala University; Uppsala University; University of Cape Town	Brooks, SJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	samantha.brooks@neuro.uu.se	Nilsson, Emil/D-3662-2014; Schioth, Helgi/AAQ-7239-2020; Stein, Dan/A-1752-2008; Brooks, Samantha/AAJ-2159-2020; Fredriksson, Robert/AAH-3921-2019	Stein, Dan/0000-0001-7218-7810; Fredriksson, Robert/0000-0002-2810-3226; Brooks, Samantha/0000-0002-9146-6257	Swedish Research Council; Swedish Brain research foundation; Gunvor och Josef Aners foundation; Karlssons foundation; LR Akerhams foundation; Tore Nilsons foundation; Novo Nordisk Fonden [NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain research foundation; Gunvor och Josef Aners foundation; Karlssons foundation; LR Akerhams foundation; Tore Nilsons foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The studies were supported by the Swedish Research Council, the Swedish Brain research foundation, Gunvor och Josef Aners foundation, A Karlssons foundation, LR Akerhams foundation, and Tore Nilsons foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benedict C, 2012, DIABETES CARE, V35, P488, DOI 10.2337/dc11-2075; Bernard JA, 2013, NEUROIMAGE, V83, P103, DOI 10.1016/j.neuroimage.2013.06.042; Brooks SJ, 2012, INT J OBES LOND; Camicioli R, 2009, PARKINSONISM RELAT D, V15, P187, DOI 10.1016/j.parkreldis.2008.05.002; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Ding H, 2012, NEUROSCI LETT, V508, P47, DOI 10.1016/j.neulet.2011.12.016; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Foubert-Samier A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.023; Gajewski PD, 2012, NEUROPSYCHOLOGIA; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Gruber O, 2012, EUR ARCH PSY CLIN N, V262, P23, DOI 10.1007/s00406-011-0214-6; Hajcak G, 2009, GENES BRAIN BEHAV, V8, P80, DOI 10.1111/j.1601-183X.2008.00447.x; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Khabour OF, 2013, BRAIN RES BULL, V90, P19, DOI 10.1016/j.brainresbull.2012.08.005; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Laing KR, 2012, AGE, V34, P1011, DOI 10.1007/s11357-011-9275-8; Lee MC, 2012, J APPL PHYSIOL, V113, P1260, DOI 10.1152/japplphysiol.00869.2012; Lezak H, 2004, NEUROPSYCHOLOGICAL A; Li SC, 2010, J COGNITIVE NEUROSCI, V22, P2164, DOI 10.1162/jocn.2009.21374; Li W, 2012, HUMAN BRAIN MAPPING; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Long XJ, 2012, ACAD RADIOL, V19, P785, DOI 10.1016/j.acra.2012.03.006; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marais L, 2009, METAB BRAIN DIS, V24, P587, DOI 10.1007/s11011-009-9157-2; Mattson MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.005.2010; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; Nordenskjold R, 2013, NEUROIMAGE, V83, P355, DOI 10.1016/j.neuroimage.2013.06.068; Ofen N, 2012, J NEUROSCI, V32, P10012, DOI 10.1523/JNEUROSCI.1082-11.2012; Patel R, 2012, NEUROREHABILITATION; Radua J, 2013, BRAIN STRUCT FUNCT; Shugart YY, 2009, EUR J HUM GENET, V17, P1050, DOI 10.1038/ejhg.2008.272; Team RC, 2012, R LANG ENV STAT COMP; Wei SM, 2012, J NEUROSCI, V32, P7074, DOI 10.1523/JNEUROSCI.5375-11.2012; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037777	44	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e82707	10.1371/journal.pone.0082707	http://dx.doi.org/10.1371/journal.pone.0082707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465375	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000002
J	Sacristan-Reviriego, A; Madrid, M; Cansado, J; Martin, H; Molina, M				Sacristan-Reviriego, Almudena; Madrid, Marisa; Cansado, Jose; Martin, Humberto; Molina, Maria			A Conserved Non-Canonical Docking Mechanism Regulates the Binding of Dual Specificity Phosphatases to Cell Integrity Mitogen-Activated Protein Kinases (MAPKs) in Budding and Fission Yeasts	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASES; FUSION PROTEINS; PATHWAY; STRESS; MSG5; EXPRESSION; ENCODES; MODULATION	Dual-specificity MAPK phosphatases (MKPs) are essential for the negative regulation of MAPK pathways. Similar to other MAPK-interacting proteins, most MKPs bind MAPKs through specific docking domains known as D-motifs. However, we found that the Saccharomyces cerevisiae MKP Msg5 binds the MAPK Slt2 within the cell wall integrity (CWI) pathway through a distinct motif (IYT). Here, we demonstrate that the IYT motif mediates binding of the Msg5 paralogue Sdp1 to Slt2 as well as of the MKP Pmp1 to its CWI MAPK counterpart Pmk1 in the evolutionarily distant yeast Schizosaccharomyces pombe. As a consequence, removal of the IYT site in Msg5, Sdp1 and Pmp1 reduces MAPK trapping caused by the overexpression of catalytically inactive versions of these phosphatases. Accordingly, an intact IYT site is necessary for inactive Sdp1 to prevent nuclear accumulation of Slt2. We also show that both Ile and Tyr but not Thr are essential for the functionality of the IYT motif. These results provide mechanistic insight into MKP-MAPK interplay and stress the relevance of this conserved non-canonical docking site in the regulation of the CWI pathway in fungi.	[Sacristan-Reviriego, Almudena; Martin, Humberto; Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Sacristan-Reviriego, Almudena; Martin, Humberto; Molina, Maria] IRYCIS, Madrid, Spain; [Madrid, Marisa; Cansado, Jose] Univ Murcia, Dept Genet & Microbiol, Yeast Physiol Grp, Fac Biol, Murcia, Spain	Complutense University of Madrid; University of Murcia	Martin, H (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	humberto@ucm.es	Madrid, Marisa/AAV-2154-2020; Cansado, Jose/ABC-6872-2020; Cansado, Jose/K-5212-2014; Martín, Humberto/Z-3423-2019; Brieva, Humberto Martin/E-9254-2016; Molina, Maria/ABE-7186-2021; Madrid, Marisa/K-7755-2014	Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152; Martín, Humberto/0000-0002-6736-3602; Brieva, Humberto Martin/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309; Madrid, Marisa/0000-0002-7970-2587	Ministerio de Ciencia e Innovacion (Spain) [BIO2010-22369-C02-01, BFU2011-22517]; Comunidad Autonoma de Madrid (Spain) [S2011/BMD-2414]; Fundacion Seneca (Region de Murcia, Spain) European Regional Development Fund (ERDF); EU [15280/PI/10]; FPU fellowship from Ministerio de Educacion y Ciencia (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Fundacion Seneca (Region de Murcia, Spain) European Regional Development Fund (ERDF); EU(European Commission); FPU fellowship from Ministerio de Educacion y Ciencia (Spain)(German Research Foundation (DFG))	This work was supported by the Ministerio de Ciencia e Innovacion (Spain) [grant BIO2010-22369-C02-01] and Comunidad Autonoma de Madrid (Spain) [grant S2011/BMD-2414] to M.M. and by Ministerio de Ciencia e Innovacion (Spain) [grant BFU2011-22517] and Fundacion Seneca (Region de Murcia, Spain) European Regional Development Fund (ERDF) co-funding from the EU [grant 15280/PI/10] to J.C. A.S-R is recipient of a FPU fellowship from Ministerio de Educacion y Ciencia (Spain). M. Madrid is a postdoctoral researcher (Juan de la Cierva Program) from Ministerio de Economia y Competitividad (Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Jeong DG, 2006, ACTA CRYSTALLOGR D, V62, P582, DOI 10.1107/S0907444906010109; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Marin MJ, 2009, MOL GENET GENOMICS, V281, P345, DOI 10.1007/s00438-008-0415-5; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Palacios L, 2011, J BIOL CHEM, V286, P42037, DOI 10.1074/jbc.M111.286948; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85390	10.1371/journal.pone.0085390	http://dx.doi.org/10.1371/journal.pone.0085390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465549	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000330283100040
J	Li, Z; He, T; Du, K; Xing, YQ; Run, YM; Yan, Y; Shen, Y				Li, Zhi; He, Tao; Du, Ke; Xing, Yi-Qiao; Run, Yuan-Min; Yan, Ying; Shen, Yin			Inhibition of Oxygen-Induced Ischemic Retinal Neovascularization with Adenoviral 15-Lipoxygenase-1 Gene Transfer via Up-Regulation of PPAR-gamma and Down-Regulation of VEGFR-2 Expression	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; ACTIVATED-RECEPTOR-GAMMA; INDUCED RETINOPATHY; DIABETIC-RETINOPATHY; MESSENGER-RNA; LINOLEIC-ACID; FATTY-ACIDS; ANGIOGENESIS; LIGANDS; LIPOXYGENASE	15-lipoxygenase-1 (15-LOX-1) plays an important role in angiogenesis, but how it works still remains a controversial subject. The aims of our study are focused on determining whether or not 15-LOX-1 inhibiting oxygen-induced ischemic retinal neovascularization (RNV) and the underlying regulatory mechanism involving of 15-LOX-1, peroxisome proliferator-activated receptor gamma (PPAR-gamma) and vascular endothelial growth factor receptor 2 (VEGFR-2) in oxygen-induced retinopathy (OIR). Recombinant adenoviral vectors that expressing the 15-LOX-1 gene (Ad-15-LOX-1-GFP) or the green fluorescence protein gene (Ad-GFP) were intravitreous injected into the OIR mice at postnatal day 12 (P12), the mice were sacrificed 5 days later (P17). Retinal 15-LOX-1 expression was significantly increased at both mRNA and protein levels after 15-LOX-1 gene transfer. Immunofluorescence staining of retinal sections revealed 15-LOX-1 expression was primarily in the outer plexiform layer (OPL), inner nuclear layer (INL) and ganglion cell layer (GCL) retina. Meanwhile, RNV was significantly inhibited indicated by fluorescein retinal angiography and quantification of the pre-retinal neovascular cells. The expression levels of PPAR-gamma were significantly up-regulated while VEGFR-2 were significantly down-regulated both in mRNA and protein levels. Our results suggested 15-LOX-1 gene transfer inhibited RNV in OIR mouse model via up-regulation of PPAR-gamma and further down-regulation of VEGFR-2 expression. This could be a potentially important regulatory mechanism involving 15-LOX-1, PPAR-gamma and VEGFR-2 during RNV in OIR. In conclusion, 15-LOX-1 may be a new therapeutic target for treating neovascularization diseases.	[Li, Zhi; He, Tao; Xing, Yi-Qiao; Shen, Yin] Wuhan Univ, Inst Eye, Renmin Hosp, Ctr Eye, Wuhan 430072, Hubei, Peoples R China; [Li, Zhi] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Hosp Affiliated, Dept Ophthalmol, Xiangyang, Hubei, Peoples R China; [Du, Ke] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Hosp Affiliated, Dept Oncol, Xiangyang, Hubei, Peoples R China; [Run, Yuan-Min] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Hosp Affiliated, Clin Lab, Xiangyang, Hubei, Peoples R China; [Yan, Ying] Wuhan Gen Hosp Guangzhou Mil, Dept Ophthalmol, Wuhan, Hubei, Peoples R China	Wuhan University; Hubei University of Arts & Science; Hubei University of Arts & Science; Hubei University of Arts & Science	Xing, YQ (corresponding author), Wuhan Univ, Inst Eye, Renmin Hosp, Ctr Eye, Wuhan 430072, Hubei, Peoples R China.	xyqdr@yahoo.com.cn; yinshen@whu.edu.cn			National Natural Science Foundation of China [81000393, 81000395, 81270998, 302-164172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (81000393; 81000395; 81270998; 302-164172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Bradley John, 2007, Angiogenesis, V10, P141, DOI 10.1007/s10456-007-9069-x; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chu K, 2006, BRAIN RES, V1093, P208, DOI 10.1016/j.brainres.2006.03.114; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FLEMING J, 1989, GENE, V79, P181, DOI 10.1016/0378-1119(89)90103-0; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Harats D, 2005, CANCER LETT, V229, P127, DOI 10.1016/j.canlet.2005.02.017; Hernandez C, 2007, EXPERT OPIN INV DRUG, V16, P1209, DOI 10.1517/13543784.16.8.1209; Hsi LC, 2001, J BIOL CHEM, V276, P34545, DOI 10.1074/jbc.M100280200; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kuhn H, 2007, J CARDIOVASC PHARM, V50, P609, DOI 10.1097/FJC.0b013e318159f177; Liu LL, 2010, NEUROSCIENCE, V167, P1151, DOI 10.1016/j.neuroscience.2010.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Mochizuki N, 2008, CIRC RES, V102, P143, DOI 10.1161/CIRCRESAHA.107.170191; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Oshima Y, 2006, AM J OPHTHALMOL, V142, P155, DOI 10.1016/j.ajo.2006.02.015; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Park K, 2009, DIABETES, V58, P1902, DOI 10.2337/db08-1327; Peeters Louis L. H., 2005, Angiogenesis, V8, P373; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sarayba MA, 2005, EXP EYE RES, V80, P435, DOI 10.1016/j.exer.2004.10.009; Sasaki T, 2006, VIRCHOWS ARCH, V448, P422, DOI 10.1007/s00428-005-0110-4; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Shappell SB, 1999, AM J PATHOL, V155, P235, DOI 10.1016/S0002-9440(10)65117-6; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Stahl A, 2010, CIRC RES, V107, P495, DOI 10.1161/CIRCRESAHA.110.221317; Tawfik A, 2009, INVEST OPHTH VIS SCI, V50, P878, DOI 10.1167/iovs.08-2005; Viita H, 2008, CIRC RES, V102, P177, DOI 10.1161/CIRCRESAHA.107.155556; Viita H, 2009, HUM GENE THER, V20, P1679, DOI 10.1089/hum.2009.069; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zhang Q, 2009, GRAEF ARCH CLIN EXP, V247, P919, DOI 10.1007/s00417-009-1066-x; Zhong XF, 2011, MOL VIS, V17, P492; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	64	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85824	10.1371/journal.pone.0085824	http://dx.doi.org/10.1371/journal.pone.0085824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465728	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500120
J	Lindner, NM; Graser, A; Nosek, BA				Lindner, Nicole M.; Graser, Alexander; Nosek, Brian A.			Age-Based Hiring Discrimination as a Function of Equity Norms and Self-Perceived Objectivity	PLOS ONE			English	Article							JOB; BIAS; PERCEPTIONS; IMPACT	Participants completed a questionnaire priming them to perceive themselves as either objective or biased, either before or after evaluating a young or old job applicant for a position linked to youthful stereotypes. Participants agreed that they were objective and tended to disagree that they were biased. Extending past research, both the objective and bias priming conditions led to an increase in age discrimination compared to the control condition. We also investigated whether equity norms reduced age discrimination, by manipulating the presence or absence of an equity statement reminding decision-makers of the legal prohibitions against discrimination "on the basis of age, disability, national or ethnic origin, race, religion, or sex.'' The presence of equity norms increased enthusiasm for both young and old applicants when participants were not already primed to think of themselves as objective, but did not reduce age-based hiring discrimination. Equity norms had no effect when individuals thought of themselves as objective - they preferred the younger more than the older job applicant. However, the presence of equity norms did affect individuals' perceptions of which factors were important to their hiring decisions, increasing the perceived importance of applicants' expertise and decreasing the perceived importance of the applicants' age. The results suggest that interventions that rely exclusively on decision-makers' intentions to behave equitably may be ineffective.	[Lindner, Nicole M.] DataSong, Irvine, CA USA; [Graser, Alexander] Univ Regensburg, D-93053 Regensburg, Germany; [Nosek, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Nosek, Brian A.] Ctr Open Sci, Charlottesville, VA USA	University of Regensburg; University of Virginia	Nosek, BA (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	nosek@virginia.edu		Nosek, Brian/0000-0001-6797-5476	Max Planck International Network on Aging; National Institutes of Health [F31 AG034796]; Project Implicit; NATIONAL INSTITUTE ON AGING [F31AG034796] Funding Source: NIH RePORTER	Max Planck International Network on Aging(Max Planck Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project Implicit; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Max Planck International Network on Aging (http://www.maxnetaging.mpg.de/en/doctoralschool/overview.htm), National Institutes of Health (F31 AG034796), and Project Implicit (http://www.projectimplicit.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armor DA, 1999, THESIS U CALIF; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Brown DJ, 2006, J APPL SOC PSYCHOL, V36, P2048, DOI 10.1111/j.0021-9029.2006.00093.x; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; Cuddy AJC, 2005, J SOC ISSUES, V61, P267, DOI 10.1111/j.1540-4560.2005.00405.x; Diekman AB, 2007, PERS SOC PSYCHOL B, V33, P1353, DOI 10.1177/0146167207303019; Goldin C, 2000, AM ECON REV, V90, P715, DOI 10.1257/aer.90.4.715; Gordon RA, 2004, J APPL SOC PSYCHOL, V34, P468, DOI 10.1111/j.1559-1816.2004.tb02557.x; Kite ME, 2005, J SOC ISSUES, V61, P241, DOI 10.1111/j.1540-4560.2005.00404.x; Lahey J, 2008, J LAW ECON, V51, P433, DOI 10.1086/589670; Lahey JN, 2008, J HUM RESOUR, V43, P30; McNab SM, 2002, AUST J PSYCHOL, V54, P105, DOI 10.1080/00049530210001706573; Nelson T., 2002, AGEISM STEREOTYPES P; Ng TWH, 2008, J APPL PSYCHOL, V93, P392, DOI 10.1037/0021-9010.93.2.392; Norton MI, 2004, J PERS SOC PSYCHOL, V87, P817, DOI 10.1037/0022-3514.87.6.817; Pronin E, 2004, PSYCHOL REV, V111, P781, DOI 10.1037/0033-295X.111.3.781; Pronin E, 2007, J EXP SOC PSYCHOL, V43, P565, DOI 10.1016/j.jesp.2006.05.011; Pronin E, 2009, ADV EXP SOC PSYCHOL, V41, P1, DOI 10.1016/S0065-2601(08)00401-2; Rau BL, 2005, J ORGAN BEHAV, V26, P649, DOI 10.1002/job.330; Salthouse Timothy A., 1996, P353; Shea G. F., 2006, OLDER WORKER ADVANTA; Uhlmann EL, 2005, PSYCHOL SCI, V16, P474; Uhlmann EL, 2007, ORGAN BEHAV HUM DEC, V104, P207, DOI 10.1016/j.obhdp.2007.07.001; WILSON TD, 1994, PSYCHOL BULL, V116, P117, DOI 10.1037/0033-2909.116.1.117	24	8	8	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84752	10.1371/journal.pone.0084752	http://dx.doi.org/10.1371/journal.pone.0084752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465429	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500014
J	Lu, HY; Yang, LZ; Zhang, SQ; Wu, YH				Lu, Haiying; Yang, Linzhang; Zhang, Shanqing; Wu, Yonghong			The Behavior of Organic Phosphorus under Non-Point Source Wastewater in the Presence of Phototrophic Periphyton	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; NUTRIENT-REMOVAL; BIOFILMS; ADSORPTION; KINETICS; SOIL; EQUILIBRIUM; MECHANISMS; PATTERNS	To understand the role of ubiquitous phototrophic periphyton in aquatic ecosystem on the biogeochemical cycling of organic phosphorus, the conversion and removal kinetic characteristics of organic phosphorus (Porg) such as adenosine triphosphate (ATP) were investigated in the presence of the periphyton cultured in artificial non-point source wastewater. The preliminary results showed that the periphyton was very powerful in converting P-org evidenced by the fact that inorganic phosphorus (P-inorg) content in solution increased from about 0.7 to 14.3 mg P L-1 in 48 hours in the presence of 0.6 g L-1 periphyton. This was because the periphyton could produce abundant phosphatases that benefited the conversion of P-org to P-inrog. Moreover, this conversion process was described more suitable by the pseudo-first-order kinetic model. The periphyton was also effective in removing P-org, which showed that the P-org can be completely removed even when the initial P-org concentration was as high as 13 mg P L-1 in 48 hours in the presence of 1.6 g L-1 periphyton. Furthermore, it was found that biosorption dominated the P-org removal process and exhibited the characteristics of physical adsorption. However, this biosorption process by the periphyton was significantly influenced by biomass (absorbent dosage) and temperature. This work provides insights into P-org biogeochemical circulation of aquatic ecosystem that contained the periphyton or similar microbial aggregates.	[Lu, Haiying; Yang, Linzhang; Wu, Yonghong] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Yang, Linzhang] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Shanqing] Griffith Univ, Griffith Sch Environm, Ctr Clean Environm & Energy, Environm Futures Ctr, Nathan, Qld 4111, Australia	Chinese Academy of Sciences; Institute of Soil Science, CAS; Jiangsu Academy of Agricultural Sciences; Griffith University	Wu, YH (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	yhwu@issas.ac.cn	Zhang, Shanqing/M-3663-2019; Zhang, Shanqing/C-2590-2008; Wu, Yonghong/B-4501-2010	Zhang, Shanqing/0000-0001-5192-1844; Zhang, Shanqing/0000-0001-5192-1844; Wu, Yonghong/0000-0002-2985-219X	National Natural Science Foundation of China [41171363, 41030640]; Innovative Project of Chinese Academy of Sciences [KZCX2-EW-QN401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (41171363 and 41030640), and the Innovative Project of Chinese Academy of Sciences (KZCX2-EW-QN401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksakal O, 2010, J HAZARD MATER, V181, P666, DOI 10.1016/j.jhazmat.2010.05.064; Badawy MI, 2006, DESALINATION, V194, P166, DOI 10.1016/j.desal.2005.09.027; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; BENTZEN E, 1992, LIMNOL OCEANOGR, V37, P217, DOI 10.4319/lo.1992.37.2.0217; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; COTNER JB, 1992, LIMNOL OCEANOGR, V37, P232, DOI 10.4319/lo.1992.37.2.0232; Dawood S, 2012, WATER RES, V46, P1933, DOI 10.1016/j.watres.2012.01.009; De Beer D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P904, DOI 10.1007/0-387-30741-9_28; de los Rios A, 2004, APPL ENVIRON MICROB, V70, P569, DOI 10.1128/AEM.70.1.569-580.2004; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Dogan M, 2006, CHEM ENG J, V124, P89, DOI 10.1016/j.cej.2006.08.016; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Ellwood NTW, 2012, WATER RES, V46, P378, DOI 10.1016/j.watres.2011.10.057; Espeland EM, 2001, MICROBIAL ECOL, V42, P328, DOI 10.1007/s002480000117; Gatidou G, 2011, ENVIRON SCI POLLUT R, V18, P949, DOI 10.1007/s11356-011-0452-1; Guzzon A, 2008, WATER RES, V42, P4357, DOI 10.1016/j.watres.2008.07.029; Hameed BH, 2008, J HAZARD MATER, V153, P701, DOI 10.1016/j.jhazmat.2007.09.019; HERBES SE, 1975, SCIENCE, V187, P432, DOI 10.1126/science.187.4175.432; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Huang CT, 1998, APPL ENVIRON MICROB, V64, P1526; JAMES GA, 1995, J IND MICROBIOL, V15, P257, DOI 10.1007/BF01569978; KAY M, 1995, CHEM PHYS LETT, V245, P311, DOI 10.1016/0009-2614(95)00975-A; Matheson FE, 2012, FRESHWATER BIOL, V57, P1617, DOI 10.1111/j.1365-2427.2012.02822.x; McCormick PV, 2006, ECOL ENG, V27, P279, DOI 10.1016/j.ecoleng.2006.05.018; McCormick PV, 2001, AQUAT BOT, V71, P119, DOI 10.1016/S0304-3770(01)00175-9; McKelvie I. D., 2005, SEPARATION PRECONCEN; MINEAR RA, 1972, ENVIRON SCI TECHNOL, V6, P431, DOI 10.1021/es60064a007; Rittmann BE, 2011, CHEMOSPHERE, V84, P846, DOI 10.1016/j.chemosphere.2011.02.001; Roeselers G, 2008, J APPL PHYCOL, V20, P227, DOI 10.1007/s10811-007-9223-2; Sabater S, 2002, HYDROBIOLOGIA, V469, P149, DOI 10.1023/A:1015549404082; Saisho D, 2001, J PLANT PHYSIOL, V158, P241, DOI 10.1078/0176-1617-00193; Sanudo-Wilhelmy SA, 2006, NATURE, V439, P25, DOI 10.1038/439025a; Scinto LJ, 2003, AQUAT BOT, V77, P203, DOI 10.1016/S0304-3770(03)00106-2; Shilton AN, 2012, CURR OPIN BIOTECH, V23, P884, DOI 10.1016/j.copbio.2012.07.002; Sun QY, 2003, WATER RES, V37, P1535, DOI 10.1016/S0043-1354(02)00520-1; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Wu YH, 2012, BIORESOURCE TECHNOL, V107, P10, DOI 10.1016/j.biortech.2011.12.088; Wu YH, 2010, ENVIRON SCI TECHNOL, V44, P6319, DOI 10.1021/es903761y; Wu YH, 2010, ENVIRON POLLUT, V158, P2472, DOI 10.1016/j.envpol.2010.03.020	41	5	7	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85910	10.1371/journal.pone.0085910	http://dx.doi.org/10.1371/journal.pone.0085910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465782	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500142
J	Puig-Domingo, M; Luque, RM; Reverter, JL; Lopez-Sanchez, LM; Gahete, MD; Culler, MD; Diaz-Soto, G; Lomena, F; Squarcia, M; Mate, JL; Mora, M; Fernandez-Cruz, L; Vidal, O; Alastrue, A; Balibrea, J; Halperin, I; Mauricio, D; Castano, JP				Puig-Domingo, Manel; Luque, Raul M.; Reverter, Jordi L.; Lopez-Sanchez, Laura M.; Gahete, Manuel D.; Culler, Michael D.; Diaz-Soto, Gonzalo; Lomena, Francisco; Squarcia, Mattia; Luis Mate, Jose; Mora, Mireia; Fernandez-Cruz, Laureano; Vidal, Oscar; Alastrue, Antonio; Balibrea, Jose; Halperin, Irene; Mauricio, Didac; Castano, Justo P.			The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer	PLOS ONE			English	Article							SUBTYPE EXPRESSION; MEDICAL-TREATMENT; GENE-EXPRESSION; CARCINOMA; ANALOGS; PROLIFERATION; SCINTIGRAPHY; RATIONALE; THERAPIES; GROWTH	Somatostatin receptors (ssts) are expressed in thyroid cancer cells, but their biological significance is not well understood. The aim of this study was to assess ssts in well differentiated (WDTC) and poorly differentiated thyroid cancer (PDTC) by means of imaging and molecular tools and its relationship with the efficacy of somatostatin analog treatment. Thirty-nine cases of thyroid carcinoma were evaluated (20 PDTC and 19 WDTC). Depreotide scintigraphy and mRNA levels of sst-subtypes, including the truncated variant sst5TMD4, were carried out. Depreotide scans were positive in the recurrent tumor in the neck in 6 of 11 (54%) PDTC, and in those with lung metastases in 5/11 cases (45.4%); sst5TMD4 was present in 18/20 (90%) of PDTC, being the most densely expressed sst-subtype, with a 20-fold increase in relation to sst2. In WDTC, sst2 was the most represented, while sst5TMD4 was not found; sst2 was significantly increased in PDTC in comparison to WDTC. Five depreotide positive PDTC received octreotide for 3-6 months in a pilot study with no changes in the size of the lesions in 3 of them, and a significant increase in the pulmonary and cervical lesions in the other 2. All PDTC patients treated with octreotide showed high expression of sst5TMD4. ROC curve analysis demonstrated that only sst5TMD4 discriminates between PDTC and WDTC. We conclude that sst5TMD4 is overexpressed in PDTC and may be involved in the lack of response to somatostatin analogue treatment.	[Puig-Domingo, Manel; Reverter, Jordi L.; Mauricio, Didac] Univ Autonoma Barcelona, Dept Med, Serv Endocrinol & Nutr, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Luque, Raul M.; Lopez-Sanchez, Laura M.; Gahete, Manuel D.; Castano, Justo P.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC,CIBE, Cordoba, Spain; [Culler, Michael D.] IPSEN, Milford, MA USA; [Diaz-Soto, Gonzalo] IEN UVa, Hosp Clin Valladolid, Serv Endocrinol, Valladolid, Spain; [Lomena, Francisco] Hosp Clin Barcelona, Nucl Med Serv, Barcelona, Spain; [Squarcia, Mattia] Hosp Clin Barcelona, Serv Radiol, Barcelona, Spain; [Luis Mate, Jose] Univ Autonoma Barcelona, Dept Pathol, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Mora, Mireia; Halperin, Irene] Hosp Clin Barcelona, Serv Endocrinol & Nutr, Barcelona, Spain; [Fernandez-Cruz, Laureano; Vidal, Oscar] Hosp Clin Barcelona, Surg Serv, Barcelona, Spain; [Alastrue, Antonio; Balibrea, Jose] Univ Autonoma Barcelona, Serv Gen Surg, Dept Surg, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Balibrea, Jose] Univ Autonoma Barcelona, Serv Gen Surg, Dept Surg, Vall dHebron Res Inst & Hosp, Badalona, Spain	Autonomous University of Barcelona; Universidad de Cordoba; Ipsen; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Puig-Domingo, M (corresponding author), Univ Autonoma Barcelona, Dept Med, Serv Endocrinol & Nutr, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain.	mpuigd@gmail.com	Balibrea, Jose M/V-5007-2019; López-Sánchez, Laura María/E-3260-2018; SANZ, JOSE LUIS MATE/O-3158-2019; Puig-Domingo, Manel/S-2169-2019; Raul, Luque Huertas/M-6948-2018; Castaño, Justo P/A-7124-2010; Mauricio, Didac/B-7951-2009; Gahete, Manuel D./C-4969-2009; Mora, Mireia/R-6696-2018	Balibrea, Jose M/0000-0002-0764-7179; López-Sánchez, Laura María/0000-0002-0763-1804; SANZ, JOSE LUIS MATE/0000-0002-4829-3426; Puig-Domingo, Manel/0000-0002-6744-7195; Castaño, Justo P/0000-0002-3145-7287; Mauricio, Didac/0000-0002-2868-0250; Gahete, Manuel D./0000-0002-4578-2179; Culler, Michael D./0000-0001-5168-8739; Luque, Raul M./0000-0002-7585-1913; Halperin Rabinovich, Irene/0000-0003-3151-5990; Diaz-Soto, Gonzalo/0000-0001-9743-9412; Mora, Mireia/0000-0002-5887-5016	Novartis; Ipsen; CIBERobn; "Sara Borrell" program [CD11/00276]; "Juan de la Cierva" program [JCI-2009-05675]; Novartis Oncology Spain;  [BIO-0139];  [CTS-5051];  [PI-036-2012];  [BFU2010-19300]; European Foundation for the Study of Diabetes [BI 2014_6_clinical] Funding Source: researchfish	Novartis(Novartis); Ipsen(Ipsen); CIBERobn; "Sara Borrell" program; "Juan de la Cierva" program; Novartis Oncology Spain; ; ; ; ; European Foundation for the Study of Diabetes	M. Puig-Domingo, J.P. Castano, R. M. Luque and I. Halperin have received lectures fees from Novartis and Ipsen. M. Puig-Domingo has received honoraria for participation in Advisory boards from Genzyme. This work has been funded by the following grants: BIO-0139, CTS-5051, PI-036-2012, BFU2010-19300, CIBERobn, (to R. M. Luque and J.P. Castano); "Sara Borrell" program CD11/00276 (to M. D. Gahete) and "Juan de la Cierva" program JCI-2009-05675 (to L. M. Lopez-Sanchez). This work was partially supported by Novartis Oncology Spain (to M. Puig-Domingo and I. Halperin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain KB, 1997, J CLIN ENDOCR METAB, V82, P1857, DOI 10.1210/jcem.82.6.4013; Ambrosini V, 2011, J NUCL MED, V52, p42S, DOI 10.2967/jnumed.110.085753; Antonelli A, 2011, CURR GENOMICS, V12, P626, DOI 10.2174/138920211798120808; Atkinson H, 2013, INT J EXP PATHOL, V94, P226, DOI 10.1111/iep.12024; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Bousquet C, 2012, J CLIN ENDOCR METAB, V97, P727, DOI 10.1210/jc.2011-2088; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cordoba-Chacon J, 2011, ANN NY ACAD SCI, V1220, P6, DOI 10.1111/j.1749-6632.2011.05985.x; Csaba Z, 2012, J MOL ENDOCRINOL, V48, pR1, DOI 10.1530/JME-11-0121; Duran-Prado M, 2012, ONCOGENE, V31, P2049, DOI 10.1038/onc.2011.389; Duran-Prado M, 2010, J CLIN ENDOCR METAB, V95, P2497, DOI 10.1210/jc.2009-2247; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Fleseriu M, 2011, PITUITARY, V14, P184, DOI 10.1007/s11102-010-0282-z; Klagge A, 2010, HORM METAB RES, V42, P237, DOI 10.1055/s-0029-1243636; Kohlfuerst S, 2006, THYROID, V16, P1113, DOI 10.1089/thy.2006.16.1113; Leu FP, 2008, MOL CANCER RES, V6, P1029, DOI 10.1158/1541-7786.MCR-07-2073; Margulies DJ, 2010, THYROID, V20, P671, DOI 10.1089/thy.2009.0453; Naraev BG, 2012, ONCOLOGY-BASEL, V83, P117, DOI 10.1159/000339539; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Pazaitou-Panayiotou K, 2012, HORM-INT J ENDOCRINO, V11, P290, DOI 10.14310/horm.2002.1357; Pedroncelli AM, 2010, NEUROENDOCRINOLOGY, V92, P120, DOI 10.1159/000314352; Pisarek H, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-1; Reverter Jordi L, 2010, Endocrinol Nutr, V57, P364, DOI 10.1016/j.endonu.2010.06.004; Rodrigues M, 2006, J CLIN ENDOCR METAB, V91, P3997, DOI 10.1210/jc.2006-0825; Schlumberger M, 2012, J ENDOCRINOL INVEST, V35, P40; Schlumberger M, 2012, EUR J ENDOCRINOL, V166, P5, DOI 10.1530/EJE-11-0631; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Sorensen ES, 2003, EUR J BIOCHEM, V270, P3651, DOI 10.1046/j.1432-1033.2003.03755.x; Susini C, 2006, ANN ONCOL, V17, P1733, DOI 10.1093/annonc/mdl105; Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313; Tutuncu Y, 2012, PITUITARY, V15, P398, DOI 10.1007/s11102-011-0335-y; Unger N, 2012, EXP CLIN ENDOCR DIAB, V120, P482, DOI 10.1055/s-0032-1314859; Zatelli MC, 2006, J CLIN ENDOCR METAB, V91, P2218, DOI 10.1210/jc.2006-0334; Zatelli MC, 2001, J CLIN ENDOCR METAB, V86, P2161, DOI 10.1210/jc.86.5.2161	34	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85527	10.1371/journal.pone.0085527	http://dx.doi.org/10.1371/journal.pone.0085527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465589	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500071
J	Shikano, I; Cory, JS				Shikano, Ikkei; Cory, Jenny S.			Genetic Resistance to Bacillus thuringiensis Alters Feeding Behaviour in the Cabbage Looper, Trichoplusia ni	PLOS ONE			English	Article							FITNESS COSTS; DROSOPHILA-MELANOGASTER; INSECT RESISTANCE; PINK-BOLLWORM; TOXIN CRY1AC; HOST-PLANT; BT COTTON; TRADE-OFF; EVOLUTION; MOTH	Evolved resistance to xenobiotics and parasites is often associated with fitness costs when the selection pressure is absent. Resistance to the widely used microbial insecticide Bacillus thuringiensis (Bt) has evolved in several insect species through the modification of insect midgut binding sites for Bt toxins, and reports of costs associated with Bt resistance are common. Studies on the costs of Bt-resistance restrict the insect to a single artificial diet or host-plant. However, it is well documented that insects can self-select appropriate proportions of multiple nutritionally unbalanced foods to optimize life-history traits. Therefore, we examined whether Bt-resistant and susceptible cabbage loopers Trichoplusia ni differed in their nutrient intake and fitness costs when they were allowed to compose their own protein: carbohydrate diet. We found that Bt-resistant T. ni composed a higher ratio of protein to carbohydrate than susceptible T. ni. Bt-resistant males exhibited no fitness cost, while the fitness cost (reduced pupal weight) was present in resistant females. The absence of the fitness cost in resistant males was associated with increased carbohydrate consumption compared to females. We demonstrate a sex difference in a fitness cost and a new behavioural outcome associated with Bt resistance.	[Shikano, Ikkei; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Shikano, I (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	ishikano@sfu.ca		Shikano, Ikkei/0000-0003-4857-1294	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral; Pacific Century Graduate Entrance Scholarship from the government of BC; Targeted Special Graduate Entrance Scholarship from SFU	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral; Pacific Century Graduate Entrance Scholarship from the government of BC; Targeted Special Graduate Entrance Scholarship from SFU	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to J.S.C. and an NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral, the Pacific Century Graduate Entrance Scholarship from the government of BC and a Targeted Special Graduate Entrance Scholarship from SFU to I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Alyokhin AV, 1999, J ECON ENTOMOL, V92, P510, DOI 10.1093/jee/92.3.510; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2004, J ECON ENTOMOL, V97, P1710, DOI 10.1603/0022-0493-97.5.1710; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cory JS, 2012, EVOL APPL, V5, P455, DOI 10.1111/j.1752-4571.2012.00269.x; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Janmaat AF, 2011, J INVERTEBR PATHOL, V107, P27, DOI 10.1016/j.jip.2010.12.014; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Oppert B, 2000, ENTOMOL EXP APPL, V96, P281, DOI 10.1023/A:1004061222318; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Povey S, 2014, J ANIM ECOL, V83, P245, DOI 10.1111/1365-2656.12127; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Raymond B, 2011, HEREDITY, V106, P281, DOI 10.1038/hdy.2010.65; Raymond B, 2007, J APPL ECOL, V44, P768, DOI 10.1111/j.1365-2664.2007.01285.x; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Thompson SN, 2000, BBA-GEN SUBJECTS, V1523, P91, DOI 10.1016/S0304-4165(00)00102-1; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Zhang X., 2012, PLoS ONE, V7, pe35991, DOI 10.1371/journal.pone.0035991	30	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85709	10.1371/journal.pone.0085709	http://dx.doi.org/10.1371/journal.pone.0085709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465656	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500093
J	Alegre, A; Menard, F; Tafur, R; Espinoza, P; Arguelles, J; Maehara, V; Flores, O; Simier, M; Bertrand, A				Alegre, Ana; Menard, Frederic; Tafur, Ricardo; Espinoza, Pepe; Arguelles, Juan; Maehara, Victor; Flores, Oswaldo; Simier, Monique; Bertrand, Arnaud			Comprehensive Model of Jumbo Squid Dosidicus gigas Trophic Ecology in the Northern Humboldt Current System	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; CEPHALOPODA OMMASTREPHIDAE; METABOLIC SUPPRESSION; BEHAVIOR; FOOD; HYPOXIA; BIOLOGY; HABITS; FISHES; CHILE	The jumbo squid Dosidicus gigas plays an important role in marine food webs both as predator and prey. We investigated the ontogenetic and spatiotemporal variability of the diet composition of jumbo squid in the northern Humboldt Current system. For that purpose we applied several statistical methods to an extensive dataset of 3,618 jumbo squid non empty stomachs collected off Peru from 2004 to 2011. A total of 55 prey taxa was identified that we aggregated into eleven groups. Our results evidenced a large variability in prey composition as already observed in other systems. However, our data do not support the hypothesis that jumbo squids select the most abundant or energetic taxon in a prey assemblage, neglecting the other available prey. Indeed, multinomial model predictions showed that stomach fullness increased with the number of prey taxa, while most stomachs with low contents contained one or two prey taxa only. Our results therefore question the common hypothesis that predators seek locally dense aggregations of monospecific prey. In addition D. gigas consumes very few anchovy Engraulis ringens in Peru, whereas a tremendous biomass of anchovy is potentially available. It seems that D. gigas cannot reach the oxygen unsaturated waters very close to the coast, where the bulk of anchovy occurs. Indeed, even if jumbo squid can forage in hypoxic deep waters during the day, surface normoxic waters are then required to recover its maintenance respiration (or energy?). Oxygen concentration could thus limit the co-occurrence of both species and then preclude predator-prey interactions. Finally we propose a conceptual model illustrating the opportunistic foraging behaviour of jumbo squid impacted by ontogenetic migration and potentially constrained by oxygen saturation in surface waters.	[Alegre, Ana; Tafur, Ricardo; Espinoza, Pepe; Arguelles, Juan; Flores, Oswaldo] Inst Mar Peru IMARPE, Callao, Peru; [Alegre, Ana; Menard, Frederic; Simier, Monique; Bertrand, Arnaud] Inst Rech Dev, EME IFREMER IRD UM2 UMR212, Sete, France; [Maehara, Victor] Univ Nacl Agr La Molina, Lima, Peru	Instituto del Mar del Peru; Ifremer; Institut de Recherche pour le Developpement (IRD); University Nacional Agraria La Molina	Bertrand, A (corresponding author), Inst Rech Dev, EME IFREMER IRD UM2 UMR212, Sete, France.	Arnaud.Bertrand@ird.fr	Menard, Frederic/C-3913-2008; SIMIER, Monique/O-4797-2019; Bertrand, Arnaud/E-4251-2010	Menard, Frederic/0000-0003-1162-660X; Bertrand, Arnaud/0000-0003-4723-179X; ESPINOZA, Pepe/0000-0001-5149-8310; Arguelles, Juan/0000-0002-4227-0952; Simier, Monique/0000-0002-8436-5925; Espinoza, Pepe/0000-0001-8699-8411	ARTS grant from IRD	ARTS grant from IRD	This work is a contribution to the cooperative agreement between the Instituto del Mar del Peru (IMARPE), the Institut de Recherche pour le Developpement (IRD), and of the LMI DISCOH. A. Alegre was financially supported by an ARTS grant from IRD and managed by Campus France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo V, 1987, B I MAR PERU VOL EXT; Amaratunga T., 1983, FAO Fisheries Technical Paper, V231, P379; Arguelles J, 2012, MAR BIOL, V159, P2105, DOI 10.1007/s00227-012-1998-2; Arguelles J, 2001, FISH RES, V54, P51, DOI 10.1016/S0165-7836(01)00380-0; AUSTER PJ, 1992, ENVIRON BIOL FISH, V35, P133, DOI 10.1007/BF00002187; Ballon M, 2011, PROG OCEANOGR, V91, P360, DOI 10.1016/j.pocean.2011.03.001; Barbieri M.A, 2004, Gayana (Concepc.), V68, P29; Bard FX, 2002, COLL VOL SCI PAP ICC, V54, P33; Bazzino G, 2010, PROG OCEANOGR, V86, P59, DOI 10.1016/j.pocean.2010.04.017; Bertrand A, 2002, MAR BIOL, V140, P1023, DOI 10.1007/s00227-001-0776-3; Bertrand A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029558; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Breiman L., 2017, CLASSIFICATION REGRE; Budelmann BU, 1994, MAR FRESHW BEHAV PHY, V25, P13, DOI 10.1080/10236249409378905; Caddy JF, 1983, ADV ASSESSMENT WORLD, V231, P416; Chipps Steven R., 2007, P473; Chong Javier, 2005, Gayana (Concepc.), V69, P319; Cornejo R, 2006, MAR BIOL, V149, P1519, DOI 10.1007/s00227-006-0319-z; Cubillos LS, 2004, PESCA INVESTIGACION; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Field JC, 2013, DEEP-SEA RES PT II, V95, P37, DOI 10.1016/j.dsr2.2012.09.006; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Garcia-Godos I, 2001, B I MAR PERU, V20; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Gilly WF, 2013, ANNU REV MAR SCI, V5, P393, DOI 10.1146/annurev-marine-120710-100849; Gilly WF, 2012, J EXP BIOL, V215, P3175, DOI 10.1242/jeb.072538; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Ibanez CM, 2008, HELGOLAND MAR RES, V62, P331, DOI 10.1007/s10152-008-0120-0; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; Jereb P., 2010, FAO SPECIES CATALOGU, V2; Keyl F, 2011, ICES J MAR SCI, V68, P507, DOI 10.1093/icesjms/fsq167; Kuhnert PM, 2012, MAR BIOL, V159, P87, DOI 10.1007/s00227-011-1792-6; Lorrain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022194; Lundvall D, 1999, CAN J FISH AQUAT SCI, V56, P1285, DOI 10.1139/cjfas-56-7-1285; Markaida U, 2005, FISH B-NOAA, V103, P219; Markaida U, 2003, J MAR BIOL ASSOC UK, V83, P507, DOI 10.1017/S0025315403007434h; Markaida U, 2006, FISH RES, V79, P16, DOI 10.1016/j.fishres.2006.02.016; Markaida U, 2008, CAL COOP OCEAN FISH, V49, P90; Menard F, 2003, AQUAT LIVING RESOUR, V16, P231, DOI 10.1016/S0990-7440(03)00040-8; Mendez M, 1981, B I MAR PERU, V5; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nesis K.N., 1983, P215; NESIS KN, 1970, OCEANOLOGY-USSR, V10, P108; Newell G, 1963, HUTCHISON BIOL MONGR; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Potier M., 2004, Western Indian Ocean Journal of Marine Science, V3, P51; Potier M, 2008, AQUAT LIVING RESOUR, V21, P123, DOI 10.1051/alr:2008026; Rahm G, 1937, CR 12 C INT ZOOL LIS, V2, P1237; Rasero M, 1996, J MAR BIOL ASSOC UK, V76, P73, DOI 10.1017/S0025315400029027; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Roper C. F. E., 1984, FAO FISH SYNOP, V125, P1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2010, PROG OCEANOGR, V86, P72, DOI 10.1016/j.pocean.2010.04.004; Rosas-Luis R, 2007, THESIS CIBNOR MEXICO; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; Ruiz-Cooley RI, 2006, J MAR BIOL ASSOC UK, V86, P437, DOI 10.1017/S0025315406013324; Ruiz-Cooley RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059651; Sanchez J, 2011, THESIS U NCAL FEDERI; Seibel BA, 2013, DEEP-SEA RES PT II, V95, P139, DOI 10.1016/j.dsr2.2012.10.003; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Tafur R, 2001, FISH RES, V54, P33, DOI 10.1016/S0165-7836(01)00379-4; Trubenbach K, 2013, DEEP-SEA RES PT II, V95, P209, DOI 10.1016/j.dsr2.2012.10.001; Trubenbach K, 2013, J EXP BIOL, V216, P359, DOI 10.1242/jeb.072587; Venables WN., 2002, MODERN APPL STAT S, V4; Wolff C, 1984, NOAA TECHNICAL REPOR, V17, P1; Yatsu Akihiko, 1999, Bulletin of the National Research Institute of Far Seas Fisheries, V36, P55; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	70	34	45	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85919	10.1371/journal.pone.0085919	http://dx.doi.org/10.1371/journal.pone.0085919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465788	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500089
J	Alla, RK; Cairns, BR				Alla, Ravi K.; Cairns, Bradley R.			RNA Polymerase III Transcriptomes in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells, and Relationships with Pluripotency Transcription Factors	PLOS ONE			English	Article							GENOME-WIDE LOCALIZATION; SACCHAROMYCES-CEREVISIAE; POL II; CHROMATIN; MACHINERY; GENES; METHYLATION; SIGNATURES; COMPLEXES; LEUKEMIA	Recent genomic approaches have revealed that the repertoire of RNA Pol III-transcribed genes varies in different human cell types, and that this variation is likely determined by a combination of the chromatin landscape, cell-specific DNA-binding transcription factors, and collaboration with RNA Pol II. Although much is known about this regulation in differentiated human cells, there is presently little understanding of this aspect of the Pol III system in human ES cells. Here, we determine the occupancy profiles of Pol III components in human H1 ES cells, and also induced pluripotent cells, and compare to known profiles of chromatin, transcription factors, and RNA expression. We find a relatively large fraction of the Pol III repertoire occupied in human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). In ES cells we find clear correlations between Pol III occupancy and active chromatin. Interestingly, we find a highly significant fraction of Pol III-occupied genes with adjacent binding events by pluripotency factors in ES cells, especially NANOG. Notably, in human ES cells we find H3K27me3 adjacent to but not overlapping many active Pol III loci. We observe in all such cases, a peak of H3K4me3 and/or RNA Pol II, between the H3K27me3 and Pol III binding peaks, suggesting that H3K4me3 and Pol II activity may "insulate' Pol III from neighboring repressive H3K27me3. Further, we find iPSCs have a larger Pol III repertoire than their precursors. Finally, the active Pol III genome in iPSCs is not completely reprogrammed to a hESC like state and partially retains the transcriptional repertoire of the precursor. Together, our correlative results are consistent with Pol III binding and activity in human ES cells being enabled by active/permissive chromatin that is shaped in part by the pluripotency network of transcription factors and RNA Pol II activity.	[Alla, Ravi K.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Alla, Ravi K.; Cairns, Bradley R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute	Cairns, BR (corresponding author), Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu			Howard Hughes Medical Institute;  [CA24014]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); 	This work was supported by the Howard Hughes Medical Institute, and by CA24014 for core facilities. www.hhmi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gu TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-563; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Hu QD, 2012, NAT STRUCT MOL BIOL, V19, P1168, DOI 10.1038/nsmb.2400; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Martini A, 2002, CANCER RES, V62, P5408; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Morinobu M, 2005, J EXP MED, V201, P961, DOI 10.1084/jem.20041097; Nakamoto T, 2004, GENES CELLS, V9, P575, DOI 10.1111/j.1356-9597.2004.00746.x; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Nyquist KB, 2011, CANCER GENET-NY, V204, P147, DOI 10.1016/j.cancergen.2011.01.003; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Simms TA, 2008, EUKARYOT CELL, V7, P2078, DOI 10.1128/EC.00128-08; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010	39	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85648	10.1371/journal.pone.0085648	http://dx.doi.org/10.1371/journal.pone.0085648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465633	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500064
J	Allen, SJ; Mott, KR; Matsuura, Y; Moriishi, K; Kousoulas, KG; Ghiasi, H				Allen, Sariah J.; Mott, Kevin R.; Matsuura, Yoshiharu; Moriishi, Kohji; Kousoulas, Konstantin G.; Ghiasi, Homayon			Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INDUCED CELL-FUSION; STROMAL KERATITIS; GAMMA-SECRETASE; CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; AMINO-TERMINUS	Glycoprotein K (gK) is a virion envelope protein of herpes simplex virus types 1 (HSV-1) and 2 (HSV-2), which plays important roles in virion entry, morphogenesis and egress. Two-hybrid and pull-down assays were utilized to demonstrate that gK and no other HSV-1 genes specifically binds to signal peptide peptidase (SPP), also known as minor histocompatibility antigen H13. SPP dominant negative mutants, shRNA against SPP significantly reduced HSV-1 replication in vitro. SPP also affected lysosomes and ER responses to HSV-1 infection. Thus, in this study we have shown for the first time that gK, despite its role in fusion and egress, is also involved in binding the cytoplasmic protein SPP. These results also suggest that SPP plays an important role in viral replication and possibly virus pathogenesis. This makes SPP unique in that its function appears to be required by the virus as no other protein can compensate its loss in terms of viral replication.	[Allen, Sariah J.; Mott, Kevin R.; Ghiasi, Homayon] Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA USA; [Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Osaka, Japan; [Moriishi, Kohji] Yamanashi Univ, Fac Med, Dept Microbiol, Yamanashi, Japan; [Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA	Osaka University; University of Yamanashi; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Ghiasi, H (corresponding author), Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA USA.	ghiasih@CSHS.org	Moriishi, Kohji/I-4173-2019	Moriishi, Kohji/0000-0002-9542-5188; Allen, Sariah J./0000-0001-8118-2413; KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	National Institutes of Health (NIH) grant [1 RO1 EY13615]; NIH [AI43000]; NGMS [P20 GM103458]; NATIONAL EYE INSTITUTE [R01EY013615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103458] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NGMS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant 1 RO1 EY13615 to HG. KGK was supported by NIH AI43000 and NGMS P20 GM103458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARRON BA, 1994, OPHTHALMOLOGY, V101, P1871; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Binder P S, 1984, Cornea, V3, P178; Bolhuis A, 1999, J BIOL CHEM, V274, P24585, DOI 10.1074/jbc.274.35.24585; BOND VC, 1984, VIROLOGY, V132, P368, DOI 10.1016/0042-6822(84)90042-4; Branco BC, 2004, BRIT J OPHTHALMOL, V88, P1285, DOI 10.1136/bjo.2003.040162; Burnett HF, 2012, CELL STRESS CHAPERON, V17, P473, DOI 10.1007/s12192-012-0324-8; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; David AT, 2008, CURR EYE RES, V33, P455, DOI 10.1080/02713680802130362; Dawson C R, 1984, Clin Dermatol, V2, P56, DOI 10.1016/0738-081X(84)90066-X; DEBROY C, 1985, VIROLOGY, V145, P36, DOI 10.1016/0042-6822(85)90199-0; Dix R.D., 2002, PATHOGENESIS HERPES; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Foster TP, 2008, J VIROL, V82, P6310, DOI 10.1128/JVI.00147-08; Foster TP, 2003, VIROLOGY, V317, P237, DOI 10.1016/j.virol.2003.07.008; Foster TP, 2003, J VIROL, V77, P499, DOI 10.1128/JVI.77.1.499-510.2003; Foster TP, 1999, J VIROL, V73, P8457, DOI 10.1128/JVI.73.10.8457-8468.1999; Ghiasi H, 1997, INVEST OPHTH VIS SCI, V38, P1213; GHIASI H, 1994, J VIROL, V68, P2347, DOI 10.1128/JVI.68.4.2347-2354.1994; GHIASI H, 1994, J VIROL, V68, P2118, DOI 10.1128/JVI.68.4.2118-2126.1994; GHIASI H, 1995, INVEST OPHTH VIS SCI, V36, P1352; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HILL TJ, 1987, CURR EYE RES, V6, P1, DOI 10.3109/02713688709020060; HUTCHINSON L, 1995, J VIROL, V69, P5401, DOI 10.1128/JVI.69.9.5401-5413.1995; HUTCHINSON L, 1992, J VIROL, V66, P5603, DOI 10.1128/JVI.66.9.5603-5609.1992; HUTCHINSON L, 1995, J VIROL, V69, P4556, DOI 10.1128/JVI.69.7.4556-4563.1995; Jambunathan N, 2011, J VIROL, V85, P12910, DOI 10.1128/JVI.06268-11; Jayachandra S, 1997, J VIROL, V71, P5012, DOI 10.1128/JVI.71.7.5012-5024.1997; Jing LC, 2012, J CLIN INVEST, V122, P654, DOI 10.1172/JCI60556; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Liesegang TJ, 1999, CORNEA, V18, P127, DOI 10.1097/00003226-199903000-00001; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; LITTLE SP, 1981, VIROLOGY, V112, P686, DOI 10.1016/0042-6822(81)90314-7; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MCGEOCH DJ, 1991, J GEN VIROL, V72, P3057, DOI 10.1099/0022-1317-72-12-3057; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Melancon JM, 2005, J VIROL, V79, P299, DOI 10.1128/JVI.79.1.299-313.2005; Mo CJ, 1997, J BIOL CHEM, V272, P33305, DOI 10.1074/jbc.272.52.33305; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, INVEST OPHTH VIS SCI, V48, P2185, DOI 10.1167/iovs.06-1276; Mulvey M, 2007, J VIROL, V81, P3377, DOI 10.1128/JVI.02191-06; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; POGUEGEILE KL, 1987, VIROLOGY, V157, P67, DOI 10.1016/0042-6822(87)90314-X; RAMASWAMY R, 1992, VIROLOGY, V186, P579, DOI 10.1016/0042-6822(92)90024-J; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schenk D, 2000, NATURE, V407, P34, DOI 10.1038/35024194; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Sun HL, 2006, J MUSCLE RES CELL M, V27, P241, DOI 10.1007/s10974-006-9067-4; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Urny J, 2003, GENE EXPR PATTERNS, V3, P685, DOI 10.1016/S1567-133X(03)00094-2; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wilhelmus KR, 1996, BRIT J OPHTHALMOL, V80, P969, DOI 10.1136/bjo.80.11.969; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992	75	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85360	10.1371/journal.pone.0085360	http://dx.doi.org/10.1371/journal.pone.0085360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465545	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500044
J	Barcelo, A; Pierola, J; Esquinas, C; de la Pena, M; Arque, M; Alonso-Fernandez, A; Bauca, JM; Robles, J; Barcelo, B; Barbe, F				Barcelo, Antonia; Pierola, Javier; Esquinas, Cristina; de la Pena, Monica; Arque, Meritxell; Alonso-Fernandez, Alberto; Miquel Bauca, Josep; Robles, Juan; Barcelo, Bernardino; Barbe, Ferran			Relationship between Aldosterone and the Metabolic Syndrome in Patients with Obstructive Sleep Apnea Hypopnea Syndrome: Effect of Continuous Positive Airway Pressure Treatment	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; PLASMA-ALDOSTERONE; INSULIN-RESISTANCE; RISK-FACTORS; HYPERTENSION; OBESITY; SEVERITY; ASSOCIATION	Background: Metabolic syndrome (MS) occurs frequently in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). We hypothesized that aldosterone levels are elevated in OSAHS and associated with the presence of MS. Methods: We studied 66 patients with OSAHS (33 with MS and 33 without MS) and 35 controls. The occurrence of the MS was analyzed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) clinical criteria. Measurements of plasma renin activity (PRA), aldosterone, aldosterone: PRA ratio, creatinine, glucose, triglycerides, cholesterol and HDL cholesterol were obtained at baseline and after CPAP treatment. Results: Aldosterone levels were associated with the severity of OSAHS and higher than controls (p = 0.046). Significant differences in aldosterone levels were detected between OSAHS patients with and without MS (p = 0.041). A significant reduction was observed in the aldosterone levels in patients under CPAP treatment (p = 0.012). Conclusion: This study shows that aldosterone levels are elevated in OSAHS in comparison to controls, and that CPAP therapy reduces aldosterone levels. It also shows that aldosterone levels are associated with the presence of metabolic syndrome, suggesting that aldosterone excess might predispose or aggravate the metabolic and cardiovascular complications of OSAHS.	[Barcelo, Antonia; Miquel Bauca, Josep; Robles, Juan; Barcelo, Bernardino] Hosp Univ Son Espases, Serv Anal Clin, Serv Pneumol, Palma De Mallorca, Spain; [de la Pena, Monica; Alonso-Fernandez, Alberto] Hosp Univ Son Espases, Serv Pneumol, Palma De Mallorca, Spain; [Pierola, Javier; Arque, Meritxell] Hosp Univ Son Espases, Unitat Invest, Serv Pneumol, Palma De Mallorca, Spain; [Esquinas, Cristina; Barbe, Ferran] Hosp Arnau de Vilanova Santa Maria, Lleida, Spain; [Pierola, Javier; de la Pena, Monica; Arque, Meritxell; Alonso-Fernandez, Alberto; Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Mallorca, Illes Balears, Spain	Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Barcelo, A (corresponding author), Hosp Univ Son Espases, Serv Anal Clin, Serv Pneumol, Palma De Mallorca, Spain.	Antonia.barcelo@ssib.es	Barcelo, Bernardino/H-2806-2017; Pierola Lopetegui, Javier/U-6193-2017; Barbé, Ferran/A-5988-2010	Barcelo, Bernardino/0000-0002-6952-5994; Pierola Lopetegui, Javier/0000-0003-0759-5580; Barbé, Ferran/0000-0002-2340-8928; , Alonso-Fernandez/0000-0002-0802-8871; Bauca, Josep Miquel/0000-0001-8808-6870; Barcelo Bennasar, Antonia/0000-0002-3170-5439	Hospital Universitari Son Espases (Proyectos piloto HUSE)	Hospital Universitari Son Espases (Proyectos piloto HUSE)	This work was supported in part by a grant from the Hospital Universitari Son Espases (Proyectos piloto HUSE-2011. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acelajado MC, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/837817; Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; Bonsignore Maria Rosaria, 2008, Archives of Physiology and Biochemistry, V114, P255, DOI 10.1080/13813450802307451 ; Briet M, 2011, CURR HYPERTENS REP, V13, P163, DOI 10.1007/s11906-011-0182-2; Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Dudenbostel T, 2012, J HUM HYPERTENS, V26, P281, DOI 10.1038/jhh.2011.47; EGAN BM, 1994, AM J HYPERTENS, V7, P886, DOI 10.1093/ajh/7.10.886; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Gaddam K, 2010, J HUM HYPERTENS, V24, P532, DOI 10.1038/jhh.2009.96; Giordani I, 2013, ACTA DIABETOL, V50, P639, DOI 10.1007/s00592-013-0487-5; Gonzaga CC, 2010, J CLIN SLEEP MED, V6, P363; Goodfriend TL, 2008, CURR HYPERTENS REP, V10, P222, DOI 10.1007/s11906-008-0042-x; Goodfriend TL, 1999, OBES RES, V7, P355, DOI 10.1002/j.1550-8528.1999.tb00418.x; Goodfriend TL, 1999, PROSTAG LEUKOTR ESS, V60, P401, DOI 10.1016/S0952-3278(99)80020-9; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hannemann A, 2011, EUR J ENDOCRINOL, V164, P751, DOI 10.1530/EJE-10-1074; Ingelsson E, 2007, CIRCULATION, V116, P984, DOI 10.1161/CIRCULATIONAHA.107.708537; Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; Lam JCM, 2007, CURR OPIN PULM MED, V13, P484, DOI 10.1097/MCP.0b013e3282efae9c; Lastra-Lastra G, 2009, CLIN ENDOCRINOL, V71, P1, DOI 10.1111/j.1365-2265.2008.03498.x; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Marzolla V, 2012, MOL CELL ENDOCRINOL, V350, P281, DOI 10.1016/j.mce.2011.09.011; Pimenta E, 2009, PROG CARDIOVASC DIS, V51, P371, DOI 10.1016/j.pcad.2008.02.004; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Saarelainen S, 1996, J SLEEP RES, V5, P181, DOI 10.1046/j.1365-2869.1996.t01-1-00007.x; Sim JJ, 2011, J HYPERTENS, V29, P1553, DOI 10.1097/HJH.0b013e3283492219; Stewart PM, 1999, LANCET, V353, P1341, DOI 10.1016/S0140-6736(98)06102-9; Stiefel P, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/685238; Strazzullo P, 2004, CURR OPIN NEPHROL HY, V13, P325, DOI 10.1097/00041552-200405000-00010; Svatikova A, 2009, SLEEP, V32, P1589, DOI 10.1093/sleep/32.12.1589; Thethi T, 2012, CURR HYPERTENS REP, V14, P160, DOI 10.1007/s11906-012-0245-z; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Vaz M, 1997, CIRCULATION, V96, P3423; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391	37	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84362	10.1371/journal.pone.0084362	http://dx.doi.org/10.1371/journal.pone.0084362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465407	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500016
J	Mishra, SK; Lutman, ME				Mishra, Srikanta K.; Lutman, Mark E.			Top-Down Influences of the Medial Olivocochlear Efferent System in Speech Perception in Noise	PLOS ONE			English	Article							INTENSITY DISCRIMINATION; MOC REFLEX; RECOGNITION; SUPPRESSION; MODEL; INTELLIGIBILITY; ENHANCEMENT; EMISSIONS; LEVEL; AGE	One of the putative functions of the medial olivocochlear (MOC) system is to enhance signal detection in noise. The objective of this study was to elucidate the role of the MOC system in speech perception in noise. In normal-hearing human listeners, we examined (1) the association between magnitude of MOC inhibition and speech-in-noise performance, and (2) the association between MOC inhibition and the amount of contralateral acoustic stimulation (CAS)-induced shift in speech-in-noise acuity. MOC reflex measurements in this study considered critical measurement issues overlooked in past work by: recording relatively low-level, linear click-evoked otoacoustic emissions (CEOAEs), adopting 6 dB signal-to-noise ratio (SNR) criteria, and computing normalized CEOAE differences. We found normalized index to be a stable measure of MOC inhibition (mean = 17.21%). MOC inhibition was not related to speech-in-noise performance measured without CAS. However, CAS in a speech-in-noise task caused an SNRSP enhancement (mean = 2.45 dB), and this improvement in speech-in-noise acuity was directly related to their MOC reflex assayed by CEOAEs. Individuals do not necessarily use the available MOC-unmasking characteristic while listening to speech in noise, or do not utilize unmasking to the extent that can be shown by artificial MOC activation. It may be the case that the MOC is not actually used under natural listening conditions and the higher auditory centers recruit MOC-mediated mechanisms only in specific listening conditions-those conditions remain to be investigated.	[Mishra, Srikanta K.; Lutman, Mark E.] Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England; [Mishra, Srikanta K.] Butler Univ, Dept Commun Sci & Disorders, Indianapolis, IN 46208 USA	University of Southampton; Butler University	Mishra, SK (corresponding author), Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England.	skmishra@butler.edu			European Commission, Directorate-General for Health and Consumer Protection [2004127]; Institute of Sound and Vibration Research, University of Southampton, Southampton, UK	European Commission, Directorate-General for Health and Consumer Protection; Institute of Sound and Vibration Research, University of Southampton, Southampton, UK	This research was supported by a grant (EMFnEAR) from the European Commission, Directorate-General for Health and Consumer Protection (Grant No. 2004127) and a Rayleigh scholarship from the Institute of Sound and Vibration Research, University of Southampton, Southampton, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala C, 2009, J ACOUST SOC AM, V125, P1584, DOI 10.1121/1.3068442; Bhagat SP, 2010, NEUROSCI LETT, V485, P94, DOI 10.1016/j.neulet.2010.08.069; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brown GJ, 2010, J ACOUST SOC AM, V127, P943, DOI 10.1121/1.3273893; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Clark NR, 2012, J ACOUST SOC AM, V132, P1535, DOI 10.1121/1.4742745; Cooper NP, 2003, J PHYSIOL-LONDON, V548, P307, DOI 10.1113/jphysiol.2003.039081; De Boer J, 2007, HEARING RES, V107, P83; de Boer J, 2012, J NEUROPHYSIOL, V107, P1301, DOI 10.1152/jn.00222.2011; Deeter R, 2008, J ACOUST SOC AM, V126, P2413; Feeney MP, 2003, J SPEECH LANG HEAR R, V46, P128, DOI 10.1044/1092-4388(2003/010); FOSTER J R, 1987, British Journal of Audiology, V21, P165, DOI 10.3109/03005368709076402; Garinis A, 2011, HEARING RES, V282, P128, DOI 10.1016/j.heares.2011.08.007; Garinis AC, 2011, J SPEECH LANG HEAR R, V54, P1464, DOI 10.1044/1092-4388(2011/10-0223); Giraud AL, 1997, NEUROREPORT, V8, P1779, DOI 10.1097/00001756-199705060-00042; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Harkrider Ashley W, 2005, J Am Acad Audiol, V16, P530, DOI 10.3766/jaaa.16.8.2; Hartmann WM, 2002, J ACOUST SOC AM, V112, P1037, DOI 10.1121/1.1500759; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2519, DOI 10.1152/jn.1993.70.6.2519; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Keefe DH, 2010, HEARING RES, V263, P52, DOI 10.1016/j.heares.2009.09.008; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kim S, 2006, SPEECH COMMUN, V48, P855, DOI 10.1016/j.specom.2006.03.004; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Messing DP, 2009, SPEECH COMMUN, V51, P668, DOI 10.1016/j.specom.2009.02.002; MICHEYL C, 1995, ACTA OTO-LARYNGOL, V115, P178, DOI 10.3109/00016489509139286; Micheyl C, 1997, BEHAV NEUROSCI, V111, P801, DOI 10.1037/0735-7044.111.4.801; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; Mishra SK, 2013, EAR HEARING, V34, P789, DOI 10.1097/AUD.0b013e3182944c04; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mukari SZMS, 2008, AUDIOL NEURO-OTOL, V13, P328, DOI 10.1159/000128978; Tokgoz-Yilmaz S, 2007, J LARYNGOL OTOL, V121, P1029, DOI 10.1017/S0022215107006883; Wagner W, 2008, ACTA OTO-LARYNGOL, V128, P53, DOI 10.1080/00016480701361954; WINSLOW RL, 1988, HEARING RES, V35, P165, DOI 10.1016/0378-5955(88)90116-5; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; YOST WA, 1988, J ACOUST SOC AM, V83, P1517, DOI 10.1121/1.395907; Zeng FG, 2000, HEARING RES, V142, P102, DOI 10.1016/S0378-5955(00)00011-3; Zhao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018725	40	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85756	10.1371/journal.pone.0085756	http://dx.doi.org/10.1371/journal.pone.0085756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465686	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500069
J	Suzuki, M; Toyoda, N; Takagi, S				Suzuki, Motoshi; Toyoda, Naoya; Takagi, Shin			Pulsed Irradiation Improves Target Selectivity of Infrared Laser-Evoked Gene Operator for Single-Cell Gene Induction in the Nematode C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; EXPRESSION; SYSTEM; ZEBRAFISH; MIGRATION	Methods for turning on/off gene expression at the experimenter's discretion would be useful for various biological studies. Recently, we reported on a novel microscope system utilizing an infrared laser-evoked gene operator (IR-LEGO) designed for inducing heat shock response efficiently in targeted single cells in living organisms without cell damage, thereby driving expression of a transgene under the control of a heat shock promoter. Although the original IR-LEGO can be successfully used for gene induction, several limitations hinder its wider application. Here, using the nematode Caenorhabditis elegans (C. elegans) as a subject, we have made improvements in IR-LEGO. For better spatial control of heating, a pulsed irradiation method using an optical chopper was introduced. As a result, single cells of C. elegans embryos as early as the 2-cell stage and single neurons in ganglia can be induced to express genes selectively. In addition, the introduction of site-specific recombination systems to IR-LEGO enables the induction of gene expression controlled by constitutive and cell type-specific promoters. The strategies adopted here will be useful for future applications of IR-LEGO to other organisms.	[Suzuki, Motoshi; Toyoda, Naoya; Takagi, Shin] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Takagi, S (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan.	i45116a@nucc.cc.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22300126, 25111708] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S. T.). M. S. is a Doctoral Course (DC1) Research Fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Halfon MS, 1997, P NATL ACAD SCI USA, V94, P6255, DOI 10.1073/pnas.94.12.6255; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hoier EF, 2000, GENE DEV, V14, P874; Husson SJ, 2013, BIOL CELL, V105, P235, DOI [10.1111/boc.201200069, 10.1111/boc.201390011]; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kelly WG, 1997, GENETICS, V146, P227; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mello C, 1995, METHOD CELL BIOL, V48, P451; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Ramos DM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-55; Schmitt C, 2013, PLOS ONE, V8; Shioi G, 2001, GENETICS, V157, P1611; STRINGHAM EG, 1993, J EXP ZOOL, V266, P227, DOI 10.1002/jez.1402660309; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki M, 2013, DEV GROWTH DIFFER, V55, P454, DOI 10.1111/dgd.12061; Voutev R, 2008, GENETICS, V180, P103, DOI 10.1534/genetics.108.090274; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wimmer EA, 1997, DEVELOPMENT, V124, P1509; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhu JW, 1998, GENE DEV, V12, P3809, DOI 10.1101/gad.12.24.3809	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85783	10.1371/journal.pone.0085783	http://dx.doi.org/10.1371/journal.pone.0085783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465705	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500073
J	Wakai, N; Takemura, K; Morita, T; Kitao, A				Wakai, Nobuhiko; Takemura, Kazuhiro; Morita, Takami; Kitao, Akio			Mechanism of Deep-Sea Fish alpha-Actin Pressure Tolerance Investigated by Molecular Dynamics Simulations	PLOS ONE			English	Article							SKELETAL-MUSCLE ACTIN; CHARGE FORCE-FIELD; ATP HYDROLYSIS; ADAPTIVE DIFFERENCES; FILAMENT NUCLEATION; PHOSPHATE RELEASE; GLOBULAR-PROTEINS; STRUCTURAL BASIS; MARINE FISHES; RATTAIL FISH	The pressure tolerance of monomeric alpha-actin proteins from the deep-sea fish Coryphaenoides armatus and C. yaquinae was compared to that of non-deep-sea fish C. acrolepis, carp, and rabbit/human/chicken actins using molecular dynamics simulations at 0.1 and 60 MPa. The amino acid sequences of actins are highly conserved across a variety of species. The actins from C. armatus and C. yaquinae have the specific substitutions Q137K/V54A and Q137K/L67P, respectively, relative to C. acrolepis, and are pressure tolerant to depths of at least 6000 m. At high pressure, we observed significant changes in the salt bridge patterns in deep-sea fish actins, and these changes are expected to stabilize ATP binding and subdomain arrangement. Salt bridges between ATP and K137, formed in deep-sea fish actins, are expected to stabilize ATP binding even at high pressure. At high pressure, deep-sea fish actins also formed a greater total number of salt bridges than non-deep-sea fish actins owing to the formation of inter-helix/strand and inter-subdomain salt bridges. Free energy analysis suggests that deep-sea fish actins are stabilized to a greater degree by the conformational energy decrease associated with pressure effect.	[Wakai, Nobuhiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Tokyo, Japan; [Takemura, Kazuhiro; Kitao, Akio] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Morita, Takami] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Res Ctr Fisheries Oceanog & Marine Ecosyst, Fukuura, Kanagawa, Japan	University of Tokyo; University of Tokyo; Japan Fisheries Research & Education Agency (FRA)	Kitao, A (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	kitao@iam.u-tokyo.ac.jp	Kitao, Akio/B-8371-2008	Kitao, Akio/0000-0002-5221-0806; Wakai, Nobuhiko/0000-0001-5073-8984; Takemura, Kazuhiro/0000-0001-5946-4502	Theoretical and Computational Chemistry Initiative (TCCI) in Computational Material Science Initiative (CMSI); Ministry of Education, Culture, Sports, Science and Technology of Japan [23370066, 25104002]; Japan Society for the Promotion of Science	Theoretical and Computational Chemistry Initiative (TCCI) in Computational Material Science Initiative (CMSI); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Theoretical and Computational Chemistry Initiative (TCCI) in Computational Material Science Initiative (CMSI), Grants-inAid for Science Research B (23370066), and Grants-in-Aid for Science Research in Innovative Areas (25104002), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japan Society for the Promotion of Science to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200; Busa J, 2010, COMPUT PHYS COMMUN, V181, P2116, DOI 10.1016/j.cpc.2010.08.032; CARLIER MF, 1986, J BIOL CHEM, V261, P778; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Collins MD, 2005, P NATL ACAD SCI USA, V102, P16668, DOI 10.1073/pnas.0508224102; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FINE RA, 1973, J CHEM PHYS, V59, P5529, DOI 10.1063/1.1679903; Freedman H, 2012, J CHEM THEORY COMPUT, V8, P3373, DOI 10.1021/ct3003282; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Grigera JR, 2010, BIOPHYS J, V98, P1626, DOI 10.1016/j.bpj.2009.12.4298; Harrison CB, 2012, J CHEM THEORY COMPUT, V8, P2328, DOI 10.1021/ct200886j; Hirata K, 2006, J MOL BIOL, V356, P945, DOI 10.1016/j.jmb.2005.12.031; Hochachka P. W., 1984, BIOCH ADAPTATION; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikeuchi Y, 2002, EUR J BIOCHEM, V269, P364, DOI 10.1046/j.0014-2956.2001.02664.x; IKKAI T, 1966, BIOCHEMISTRY-US, V5, P1551, DOI 10.1021/bi00869a015; Imai T, 2010, J PHYS CHEM B, V114, P2281, DOI 10.1021/jp909701j; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee MS, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816641; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; McQuarrie DA, 2000, STAT MECH; Meinhold L, 2007, P NATL ACAD SCI USA, V104, P17261, DOI 10.1073/pnas.0708199104; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morita T, 2003, J BIOL CHEM, V278, P28060, DOI 10.1074/jbc.M302328200; Morita T, 2000, FISHERIES SCI, V66, P1150, DOI 10.1046/j.1444-2906.2000.00182.x; Morita T, 2008, J EXP BIOL, V211, P1362, DOI 10.1242/jeb.017137; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Patel S, 2004, J COMPUT CHEM, V25, P1, DOI 10.1002/jcc.10355; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RASHIN AA, 1984, BIOPOLYMERS, V23, P1605, DOI 10.1002/bip.360230813; Reutzel R, 2004, J STRUCT BIOL, V146, P291, DOI 10.1016/j.jsb.2003.12.006; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarupria S, 2010, PROTEINS, V78, P1641, DOI 10.1002/prot.22680; SARVAZYAN AP, 1979, BIOPOLYMERS, V18, P3015, DOI 10.1002/bip.1979.360181209; Saunders MG, 2011, J MOL BIOL, V413, P279, DOI 10.1016/j.jmb.2011.07.068; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; SIEBENALLER JF, 1984, J COMP PHYSIOL, V154, P443, DOI 10.1007/BF02515148; SIEBENALLER JF, 1979, J COMP PHYSIOL, V129, P295, DOI 10.1007/BF00686984; Takemura K, 2012, J PHYS CHEM B, V116, P6279, DOI 10.1021/jp301100g; VARGAFTIK NB, 1983, J PHYS CHEM REF DATA, V12, P817, DOI 10.1063/1.555688; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P387, DOI 10.1063/1.1461829; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N	62	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85852	10.1371/journal.pone.0085852	http://dx.doi.org/10.1371/journal.pone.0085852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465747	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500079
J	Faber, IR; Oosterveld, FGJ; Nijhuis-Van der Sanden, MWG				Faber, Irene R.; Oosterveld, Frits G. J.; Nijhuis-Van der Sanden, Maria W. G.			Does an Eye-Hand Coordination Test Have Added Value as Part of Talent Identification in Table Tennis? A Validity and Reproducibility Study	PLOS ONE			English	Article							PERFORMANCE; BRAIN; SPORT	This study investigated the added value, i.e. discriminative and concurrent validity and reproducibility, of an eye-hand coordination test relevant to table tennis as part of talent identification. Forty-three table tennis players (7-12 years) from national (n = 13), regional (n = 11) and local training centres (n = 19) participated. During the eye-hand coordination test, children needed to throw a ball against a vertical positioned table tennis table with one hand and to catch the ball correctly with the other hand as frequently as possible in 30 seconds. Four different test versions were assessed varying the distance to the table (1 or 2 meter) and using a tennis or table tennis ball. 'Within session' reproducibility was estimated for the two attempts of the initial tests and ten youngsters were retested after 4 weeks to estimate 'between sessions' reproducibility. Validity analyses using age as covariate showed that players from the national and regional centres scored significantly higher than players from the local centre in all test versions (p < 0.05). The tests at 1 meter demonstrated better discriminative ability than those at 2 meter. While all tests but one had a positive significant association with competition outcome, which were corrected for age influences, the version with a table tennis ball at 1 meter showed the highest association (r = 0.54; p = 0.001). Differences between the first and second attempts were comparable for all test versions (between -8 and +7 repetitions) with ICC's ranging from 0.72 to 0.87. The smallest differences were found for the test with a table tennis ball at 1 meter (between -3 and + 3 repetitions). Best test version as part of talent identification appears to be the version with a table tennis ball at 1 meter regarding the psychometric characteristics evaluated. Longitudinal studies are necessary to evaluate the predictive value of this test.	[Faber, Irene R.; Oosterveld, Frits G. J.] Sax Univ Appl Sci, Fac Phys Act & Hlth, Enschede, Netherlands; [Nijhuis-Van der Sanden, Maria W. G.] Radboud Univ Nijmegen Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands	Saxion University of Applied Sciences; Radboud University Nijmegen	Faber, IR (corresponding author), Sax Univ Appl Sci, Fac Phys Act & Hlth, Enschede, Netherlands.	i.r.faber@saxion.nl	Faber, Irene Renate/C-9699-2019; Oosterveld, Frits/D-4530-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012	Faber, Irene Renate/0000-0002-4994-0453; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877	Dutch Olympic Committee*Dutch Sports Federation (NOC*NSF)	Dutch Olympic Committee*Dutch Sports Federation (NOC*NSF)	The study was carried out in cooperation with the Netherlands Table Tennis Association (NTTA). Financial support was given by the Dutch Olympic Committee*Dutch Sports Federation (NOC*NSF) in the context of a national talent identification project in sports. The interest of both the NTTA and NOC*NSF interest was solely based on gaining more insight in talent identification in sports, there were no commercial purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2014, INTELLIGENCE, V45, P6, DOI 10.1016/j.intell.2013.04.009; ACKERMAN PL, 1988, J EXP PSYCHOL GEN, V117, P288, DOI 10.1037/0096-3445.117.3.288; Ak E, 2010, PERCEPT MOTOR SKILL, V110, P879, DOI 10.2466/PMS.110.3.879-887; Akpinar S, 2012, PERCEPT MOTOR SKILL, V115, P581, DOI 10.2466/30.25.27.PMS.115.5.581-593; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bootsma RJ, 2010, J EXP PSYCHOL HUMAN, V36, P1056, DOI 10.1037/a0019327; Chu C. Y., 2012, INT J TABLE TENNIS S, V7, P86; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Di Russo F, 2005, MED SCI SPORT EXER, V37, P1586, DOI 10.1249/01.mss.0000177458.71676.0d; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Faber IR, 2012, INT J TABLE TENNIS S, V7, P15; Gagne F, 2004, HIGH ABIL STUD, V15, P119, DOI 10.1080/1359813042000314682; Gentile A. M., 2000, MOV SCI FDN PHYS THE, V2nd, P111; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Horsch R, 1990, TISCHTENNIS SCHULE V; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Limoochi S., 2006, INT J TABLE TENNIS S, V6, P280; Liu WN, 2012, J HUM KINET, V33, P173, DOI 10.2478/v10078-012-0056-y; Lopez A., 2012, INT J TABLE TENNIS S, V7, P1; Morrow J.R., 2011, MEASUREMENT EVALUATI, V5th ed., P89; Muster M., 1986, TISCHTENNIS LERNEN T; Netherlands Table Tennis Association, 2011, TEST PROT NEW EYE HA; Netherlands Table Tennis Association, 2008, TEST PROT NAT DAY TA; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Raab M, 2005, HUM MOVEMENT SCI, V24, P326, DOI 10.1016/j.humov.2005.06.004; Regnier G, 1993, HDB RES SPORTS PSYCH, P290; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Schoemaker M. M., 2003, Neural Plasticity, V10, P155, DOI 10.1155/NP.2003.155; SThve Carole., 2002, COGNITIVE SYSTEMS RE, V3, P501, DOI [DOI 10.1016/S1389-0417(02)00054-2, 10.1016/S1389-0417(02)00054-2]; Streiner D. L., 2003, HLTH MEASUREMENT SCA; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Toriola AL, 2004, PERCEPT MOTOR SKILL, V98, P584; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Van Rossum JH., 1994, EUR J HIGH ABILITY, V5, P68, DOI DOI 10.1080/0937445940050107; Vandorpe B, 2012, J SPORT SCI, V30, P497, DOI 10.1080/02640414.2012.654399; Watanabe D, 2007, EXP BRAIN RES, V176, P332, DOI 10.1007/s00221-006-0619-z; Woollacott M, 2011, MOTOR CONTROL TRANSL	39	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85657	10.1371/journal.pone.0085657	http://dx.doi.org/10.1371/journal.pone.0085657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465638	gold, Green Submitted, Green Published			2022-12-27	WOS:000330237000050
J	Mosser, JF; Grant, LR; Millar, EV; Weatherholtz, RC; Jackson, DM; Beall, B; Craig, MJ; Reid, R; Santosham, M; O'Brien, KL				Mosser, Jonathan F.; Grant, Lindsay R.; Millar, Eugene V.; Weatherholtz, Robert C.; Jackson, Delois M.; Beall, Bernard; Craig, Mariddie J.; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L.			Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use	PLOS ONE			English	Article							CHANGING EPIDEMIOLOGY; HIGH-RISK; SEROTYPE; COLONIZATION; DISEASE; CHILDREN; PARAMETERS; RESPONSES; FAMILIES; NAVAJO	Background: Young children played a major role in pneumococcal nasopharyngeal carriage, acquisition, and transmission in the era before pneumococcal conjugate vaccine (PCV) use. Few studies document pneumococcal household dynamics in the routine-PCV7 era. Methods: We investigated age-specific acquisition, household introduction, carriage clearance, and intra-household transmission in a prospective, longitudinal, observational cohort study of pneumococcal nasopharyngeal carriage in 300 American Indian households comprising 1,072 participants between March 2006 and March 2008. Results: Pneumococcal acquisition rates were 2-6 times higher in children than adults. More household introductions of new pneumococcal strains were attributable to children <9 years than adults >= 17 years (p<0.001), and older children (2-8 years) than younger children (<2 years) (p<0.008). Compared to children <2 years, carriage clearance was more rapid in older children (2-4 years, HRclearance 1.53 [95% CI: 1.22, 1.91]; 5-8 years, HRclearance 1.71 [1.36, 2.15]) and adults (HRclearance 1.75 [1.16, 2.64]). Exposure to serotype-specific carriage in older children (2-8 years) most consistently increased the odds of subsequently acquiring that serotype for other household members. Conclusions: In this community with a high burden of pneumococcal colonization and disease and routine PCV7 use, children (particularly older children 2-8 years) drive intra-household pneumococcal transmission: first, by acquiring, introducing, and harboring pneumococcus within the household, and then by transmitting acquired serotypes more efficiently than household members of other ages.	[Mosser, Jonathan F.; Grant, Lindsay R.; Weatherholtz, Robert C.; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA; [Millar, Eugene V.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Jackson, Delois M.; Beall, Bernard] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Craig, Mariddie J.] White Mt Apache Tribe, Whiteriver, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Uniformed Services University of the Health Sciences - USA; Centers for Disease Control & Prevention - USA	Grant, LR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA.	lgrant@jhsph.edu; klobrien@jhsph.edu		Mosser, Jonathan/0000-0001-9093-3186; O'Brien, Katherine/0000-0002-0164-4030	PneumoCarr Consortium; Grand Challenges in Global Health initiative; Bill & Melinda Gates Foundation; Foundation for the National Institutes of Health (US); Wellcome Trust; Canadian Institutes of Health Research; Native American Research Centers for Health [U26IHS300013/03]; National Institutes of Health; Indian Health Service; Centers for Disease Control and Prevention National Vaccine Program Office; Thrasher Research Fund	PneumoCarr Consortium; Grand Challenges in Global Health initiative; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Foundation for the National Institutes of Health (US); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Native American Research Centers for Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Health Service(United States Department of Health & Human Services); Centers for Disease Control and Prevention National Vaccine Program Office(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Thrasher Research Fund	This work was supported by the PneumoCarr Consortium funded by the Grand Challenges in Global Health initiative which is supported by the Bill & Melinda Gates Foundation, the Foundation for the National Institutes of Health (US), the Wellcome Trust and the Canadian Institutes of Health Research. This study was additionally supported by The Native American Research Centers for Health [U26IHS300013/03], a joint initiative between the National Institutes of Health and Indian Health Service to reduce Native health disparities and build tribal autonomy in conducting health research. This study was also funded by the Centers for Disease Control and Prevention National Vaccine Program Office and the Thrasher Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auranen K, 2000, J AM STAT ASSOC, V95, P1044, DOI 10.2307/2669741; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; Grant LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074906; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; Leino T, 2001, PEDIATR INFECT DIS J, V20, P1022, DOI 10.1097/00006454-200111000-00004; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melnick N, 2010, J CLIN MICROBIOL, V48, P2311, DOI 10.1128/JCM.00410-10; Mercado E, 2011, J CLIN MICROBIOL, V49, P2080, DOI 10.1128/JCM.00153-11; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Millar EV, 2006, CLIN INFECT DIS, V43, P8, DOI 10.1086/504802; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Pinheiro JC, 2006, J COMPUT GRAPH STAT, V15, P58, DOI 10.1198/106186006X96962; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Shah SS, 2006, CLIN INFECT DIS, V42, DOI 10.1086/498745; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tigoi CC, 2012, CLIN INFECT DIS, V55, P180, DOI 10.1093/cid/cis371; Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680; World Health Organization, 2008, EST HIB PNEUM DEATHS	38	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e79578	10.1371/journal.pone.0079578	http://dx.doi.org/10.1371/journal.pone.0079578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465365	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000002
J	Yamashita, T; Uehara, S; Udagawa, N; Li, F; Kadota, S; Esumi, H; Kobayashi, Y; Takahashi, N				Yamashita, Teruhito; Uehara, Shunsuke; Udagawa, Nobuyuki; Li, Feng; Kadota, Shigetoshi; Esumi, Hiroyasu; Kobayashi, Yasuhiro; Takahashi, Naoyuki			Arctigenin Inhibits Osteoclast Differentiation and Function by Suppressing Both Calcineurin-Dependent and Osteoblastic Cell-Dependent NFATc1 Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR RECEPTOR; GENE-EXPRESSION; NUCLEAR-FACTOR; IN-VITRO; LIGAND; OSTEOPROTEGERIN; RANKL; IDENTIFICATION; MODULATION	Arctigenin, a lignan-derived compound, is a constituent of the seeds of Arctium lappa. Arctigenin was previously shown to inhibit osteoclastogenesis; however, this inhibitory mechanism has yet to be elucidated. Here, we showed that arctigenin inhibited the action of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), a key transcription factor for osteoclastogenesis. NFATc1 in osteoclast precursors was activated through two distinct pathways: the calcineurin-dependent and osteoblastic cell-dependent pathways. Among the several lignan-derived compounds examined, arctigenin most strongly inhibited receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclast-like cell formation in mouse bone marrow macrophage (BMM) cultures, in which the calcineurin-dependent NFATc1 pathway was activated. Arctigenin suppressed neither the activation of nuclear factor kappa B and mitogen-activated protein kinases nor the up-regulation of c-Fos expression in BMMs treated with RANKL. However, arctigenin suppressed RANKL-induced NFATc1 expression. Interestingly, the treatment of osteoclast-like cells with arctigenin converted NFATc1 into a lower molecular weight species, which was translocated into the nucleus even in the absence of RANKL. Nevertheless, arctigenin as well as cyclosporin A (CsA), a calcineurin inhibitor, suppressed the NFAT-luciferase reporter activity induced by ionomycin and phorbol 12-myristate 13-acetate in BMMs. Chromatin immunoprecipitation analysis confirmed that arctigenin inhibited the recruitment of NFATc1 to the promoter region of the NFATc1 target gene. Arctigenin, but not CsA suppressed osteoclastlike cell formation in co-cultures of osteoblastic cells and bone marrow cells, in which the osteoblastic cell-dependent NFATc1 pathway was activated. The forced expression of constitutively active NFATc1 rescued osteoclastogenesis in BMM cultures treated with CsA, but not that treated with arctigenin. Arctigenin also suppressed the pit-forming activity of osteoclast-like cells cultured on dentin slices. These results suggest that arctigenin induces a dominant negative species of NFATc1, which inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.	[Yamashita, Teruhito; Kobayashi, Yasuhiro; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan; [Uehara, Shunsuke; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Nagano, Japan; [Li, Feng; Kadota, Shigetoshi] Toyama Univ, Inst Nat Med, Toyama 930, Japan; [Esumi, Hiroyasu] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan	Matsumoto Dental University; Matsumoto Dental University; University of Toyama; National Cancer Center - Japan	Yamashita, T (corresponding author), Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan.	teru@po.mdu.ac.jp	KOBAYASHI, YASUHIRO/AAU-4931-2021	Kobayashi, Yasuhiro/0000-0002-0903-3226	Japan Society for the Promotion of Science [24592821, 21592378, 22390351]; Grants-in-Aid for Scientific Research [26462825, 23593054, 25670792] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (24592821, 21592378 and 22390351) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cho MK, 2004, INT IMMUNOPHARMACOL, V4, P1419, DOI 10.1016/j.intimp.2004.06.011; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang SL, 2012, DIABETOLOGIA, V55, P1469, DOI 10.1007/s00125-011-2366-3; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishida N, 2006, J BONE MINER RES, V21, P48, DOI 10.1359/JBMR.051001; Jeong JB, 2011, INT IMMUNOPHARMACOL, V11, P1573, DOI 10.1016/j.intimp.2011.05.016; Jimi E, 1999, J IMMUNOL, V163, P434; Kim AR, 2012, EUR J PHARMACOL, V682, P29, DOI 10.1016/j.ejphar.2012.02.026; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021781; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Koide M, 2009, J BONE MINER RES, V24, P1469, DOI [10.1359/JBMR.090302, 10.1359/jbmr.090302]; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kou XJ, 2011, INT IMMUNOPHARMACOL, V11, P1095, DOI 10.1016/j.intimp.2011.03.005; Kudou N, 2013, EUR J MED CHEM, V60, P76, DOI 10.1016/j.ejmech.2012.11.031; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Kuroda Y, 2012, MOL CELL BIOL, V32, P2954, DOI 10.1128/MCB.05611-11; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Patra AK, 2013, NAT IMMUNOL, V14, P127, DOI 10.1038/ni.2507; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takahashi Naoyuki, 2007, V135, P285; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Tang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024224; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	45	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85878	10.1371/journal.pone.0085878	http://dx.doi.org/10.1371/journal.pone.0085878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465763	Green Submitted, gold, Green Published			2022-12-27	WOS:000330237000071
J	Najjar, RP; Chiquet, C; Teikari, P; Cornut, PL; Claustrat, B; Denis, P; Cooper, HM; Gronfier, C				Najjar, Raymond P.; Chiquet, Christophe; Teikari, Petteri; Cornut, Pierre-Loic; Claustrat, Bruno; Denis, Philippe; Cooper, Howard M.; Gronfier, Claude			Aging of Non-Visual Spectral Sensitivity to Light in Humans: Compensatory Mechanisms?	PLOS ONE			English	Article							AGE-RELATED-CHANGES; RETINAL GANGLION-CELLS; INDUCED MELATONIN SUPPRESSION; HUMAN CIRCADIAN PACEMAKER; SHORT-WAVELENGTH LIGHT; CLOCK GENE-EXPRESSION; MESSENGER-RNA LEVELS; SUPRACHIASMATIC NUCLEUS; CATARACT-SURGERY; BRIGHT LIGHT	The deterioration of sleep in the older population is a prevalent feature that contributes to a decrease in quality of life. Inappropriate entrainment of the circadian clock by light is considered to contribute to the alteration of sleep structure and circadian rhythms in the elderly. The present study investigates the effects of aging on non -visual spectral sensitivity to light and tests the hypothesis that circadian disturbances are related to a decreased light transmittance. In a within-subject design, eight aged and five young subjects were exposed at night to 60 minute monochromatic light stimulations at 9 different wavelengths (420-620 nm). Individual sensitivity spectra were derived from measures of melatonin suppression. Lens density was assessed using a validated psychophysical technique. Although lens transmittance was decreased for short wavelength light in the older participants, melatonin suppression was not reduced. Peak of non-visual sensitivity was, however, shifted to longer wavelengths in the aged participants (494 nm) compared to young (484 nm). Our results indicate that increased lens filtering does not necessarily lead to a decreased non-visual sensitivity to light. The lack of age-related decrease in non-visual sensitivity to light may involve as yet undefined adaptive mechanisms.	[Najjar, Raymond P.; Chiquet, Christophe; Teikari, Petteri; Cornut, Pierre-Loic; Claustrat, Bruno; Denis, Philippe; Cooper, Howard M.; Gronfier, Claude] Stem Cell & Brain Res Inst, Inserm U846, Dept Chronobiol, Bron, France; [Najjar, Raymond P.; Teikari, Petteri; Cooper, Howard M.; Gronfier, Claude] Univ Lyon 1, F-69622 Villeurbanne, France; [Chiquet, Christophe] Univ Grenoble 1, Grenoble, France; [Chiquet, Christophe] CHU Grenoble, Dept Ophthalmol, F-38043 Grenoble, France; [Cornut, Pierre-Loic] Hop Edouard Herriot, CHU Lyon, Dept Ophthalmol, Lyon, France; [Claustrat, Bruno] Hormone Lab, Ctr Biol, Bron, France; [Denis, Philippe] Hop Croix Rousse, Dept Ophtalmol, F-69317 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Lyon; CHU Lyon	Gronfier, C (corresponding author), Stem Cell & Brain Res Inst, Inserm U846, Dept Chronobiol, Bron, France.	claude.gronfier@inserm.fr	Gronfier, Claude/C-1243-2008; Najjar, Raymond P./J-4979-2019; Teikari, Petteri/AFR-9306-2022; COOPER, HOWARD/M-7304-2014; Chiquet, Christophe/M-7426-2014	Gronfier, Claude/0000-0002-6549-799X; Najjar, Raymond P./0000-0002-3770-2300; Teikari, Petteri/0000-0003-1095-4185; Chiquet, Christophe/0000-0002-7601-4885	Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Fondation de France; FP6-EUCLOCK; ANR [12-TECS-0013-01]; GIS-Vieillissement; Rhone-Alpes Cible; Rhone-Alpes Cluster HVN; Retina France;  [ANR-09-MNPS-040]	Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Fondation de France(Fondation de France); FP6-EUCLOCK; ANR(French National Research Agency (ANR)); GIS-Vieillissement; Rhone-Alpes Cible(Region Auvergne-Rhone-Alpes); Rhone-Alpes Cluster HVN(Region Auvergne-Rhone-Alpes); Retina France; 	RPN was funded by "Ministere de l'Enseignement Superieur et de la Recherche Francais" and "Federation des Aveugles et Handicapes Visuels de France". CC was funded by Fondation de France (Berthe Fouassier grant). This work was supported by grants from FP6-EUCLOCK, ANR-09-MNPS-040, ANR 12-TECS-0013-01, GIS-Vieillissement, Rhone-Alpes Cible, Rhone-Alpes Cluster HVN, and Retina France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujard F, 2006, CHRONOBIOL INT, V23, P451, DOI 10.1080/07420520500482090; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Benloucif S, 2006, NEUROBIOL AGING, V27, P1870, DOI 10.1016/j.neurobiolaging.2005.10.011; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Brainard GC, 1997, J BIOL RHYTHM, V12, P537, DOI 10.1177/074873049701200608; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Carrier J, 2002, NEUROSCI LETT, V320, P1, DOI 10.1016/S0304-3940(02)00038-1; Cayetanot F, 2005, EUR J NEUROSCI, V22, P902, DOI 10.1111/j.1460-9568.2005.04268.x; Chang AM, 2012, J PHYSIOL-LONDON, V590, P3103, DOI 10.1113/jphysiol.2011.226555; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Charman WN, 2003, OPHTHAL PHYSL OPT, V23, P181, DOI 10.1046/j.1475-1313.2003.00105.x; CLAUSTRAT B, 1984, BIOL PSYCHIAT, V19, P1215; Claustrat F, 2005, PATHOL BIOL, V53, P257, DOI 10.1016/j.patbio.2004.12.028; Czeisler CA, 1999, LUNG BIOL HEALTH DIS, V133, P149; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Daneault V, 2012, J BIOL RHYTHM, V27, P257, DOI 10.1177/0748730412441172; Davidson AJ, 2008, NEUROBIOL AGING, V29, P471, DOI 10.1016/j.neurobiolaging.2006.10.018; DEACON S, 1994, NEUROSCI LETT, V167, P191, DOI 10.1016/0304-3940(94)91059-6; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Duffy JF, 2007, NEUROBIOL AGING, V28, P799, DOI 10.1016/j.neurobiolaging.2006.03.005; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Eliasieh K, 2007, INVEST OPHTH VIS SCI, V48, P2824, DOI 10.1167/iovs.06-1228; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; GADDY JR, 1993, J CLIN ENDOCR METAB, V77, P1398, DOI 10.1210/jc.77.5.1398; Gerth C, 2002, GRAEF ARCH CLIN EXP, V240, P202, DOI 10.1007/s00417-002-0442-6; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; Gimenez MC, 2010, J BIOL RHYTHM, V25, P123, DOI 10.1177/0748730409360888; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hannibal J, 2007, NEUROREPORT, V18, P81, DOI 10.1097/WNR.0b013e328010ff56; Hannibal L, 2005, J MOL NEUROSCI, V27, P147, DOI 10.1385/JMN:27:02:147; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Herljevic M, 2005, EXP GERONTOL, V40, P237, DOI 10.1016/j.exger.2004.12.001; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; Hofman MA, 2000, CHRONOBIOL INT, V17, P245, DOI 10.1081/CBI-100101047; HOFMAN MA, 1994, BRAIN RES, V651, P134, DOI 10.1016/0006-8993(94)90689-0; Jelsma Tony N., 1994, Current Opinion in Neurobiology, V4, P717, DOI 10.1016/0959-4388(94)90015-9; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Kawakami F, 1997, NEUROSCI LETT, V222, P99, DOI 10.1016/S0304-3940(97)13355-9; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Krajnak K, 2002, BRAIN RES, V950, P297, DOI 10.1016/S0006-8993(02)03075-5; Kunz D, 1999, NEUROPSYCHOPHARMACOL, V21, P765, DOI 10.1016/S0893-133X(99)00069-X; LI ZY, 1995, J NEUROSCI, V15, P5429; Liets LC, 2006, P NATL ACAD SCI USA, V103, P12156, DOI 10.1073/pnas.0605211103; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Niggemyer KA, 2004, SLEEP, V27, P1535, DOI 10.1093/sleep/27.8.1535; Norren D Van, 1974, VISION RES, V14, P1237; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; ROOZENDAAL B, 1987, BRAIN RES, V409, P259, DOI 10.1016/0006-8993(87)90710-4; SAID FS, 1959, GERONTOLOGY, V3, P213, DOI 10.1159/000210900; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; SAMPLE PA, 1988, INVEST OPHTH VIS SCI, V29, P1306; Schmoll C, 2011, BRIT J OPHTHALMOL, V95, P1656, DOI 10.1136/bjophthalmol-2011-300677; Sexton T, 2012, J BIOL CHEM, V287, P1649, DOI 10.1074/jbc.R111.301226; Sharpe LT, 1998, VISION RES, V38, P3233, DOI 10.1016/S0042-6989(97)00457-4; Sitzmann BD, 2010, NEUROBIOL AGING, V31, P696, DOI 10.1016/j.neurobiolaging.2008.05.024; Sletten TL, 2009, J BIOL RHYTHM, V24, P73, DOI 10.1177/0748730408328973; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; Stringham JM, 2007, OPHTHAL PHYSL OPT, V27, P232, DOI 10.1111/j.1475-1313.2007.00462.x; Tanaka M, 2010, J PHYSIOL ANTHROPOL, V29, P219, DOI 10.2114/jpa2.29.219; Teikari P, 2012, J OPT SOC AM A, V29, P2469, DOI 10.1364/JOSAA.29.002469; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; Weibel L, 1997, AM J PHYSIOL-REG I, V272, pR948, DOI 10.1152/ajpregu.1997.272.3.R948; WERNER JS, 1993, J OPT SOC AM A, V10, P1509, DOI 10.1364/JOSAA.10.001509; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wooten BR, 2007, OPHTHAL PHYSL OPT, V27, P321, DOI 10.1111/j.1475-1313.2007.00489.x; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wulff K, 2010, J SLEEP RES, V19, P54, DOI [10.1111/j.1365-2869.2010.00868.x, DOI 10.1111/J.1365-2869.2010.00868.X]; Yoon IY, 2003, J AM GERIATR SOC, V51, P1085, DOI 10.1046/j.1532-5415.2003.51356.x; Zeitzer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022078; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zeitzer JM, 2005, AM J PHYSIOL-REG I, V289, pR839, DOI 10.1152/ajpregu.00232.2005	84	74	76	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85837	10.1371/journal.pone.0085837	http://dx.doi.org/10.1371/journal.pone.0085837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465738	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000028
J	Prins, PA; Hill, MF; Airey, D; Nwosu, S; Perati, PR; Tavori, H; Linton, MF; Kon, V; Fazio, S; Sampson, UK				Prins, Petra A.; Hill, Michael F.; Airey, David; Nwosu, Sam; Perati, Prudhvidhar R.; Tavori, Hagai; Linton, MacRae F.; Kon, Valentina; Fazio, Sergio; Sampson, Uchechukwu K.			Angiotensin-Induced Abdominal Aortic Aneurysms in Hypercholesterolemic Mice: Role of Serum Cholesterol and Temporal Effects of Exposure	PLOS ONE			English	Article							E-DEFICIENT MICE; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; INFLAMMATION; CYCLOPHILIN; ATHEROSCLEROSIS; IDENTIFICATION; ATHEROGENESIS; PATHOGENESIS; BIOMARKERS	Objective: Understanding variations in size and pattern of development of angiotensin II (Ang II)-induced abdominal aortic aneurysms (AAA) may inform translational research strategies. Thus, we sought insight into the temporal evolution of AAA in apolipoprotein (apo) E-/- mice. Approach: A cohort of mice underwent a 4-week pump-mediated infusion of saline (n = 23) or 1500 ng/kg/min of Ang II (n = 85) and AAA development was tracked via in vivo ultrasound imaging. We adjusted for hemodynamic covariates in the regression models for AAA occurrence in relation to time. Results: The overall effect of time was statistically significant (p<0.001). Compared to day 7 of AngII infusion, there was no decrease in the log odds of AAA occurrence by day 14 (-0.234, p = 0.65), but compared to day 21 and 28, the log odds decreased by 9.07 (p<0.001) and 2.35 (p = 0.04), respectively. Hemodynamic parameters were not predictive of change in aortic diameter (Delta) (SBP, p = 0.66; DBP, p = 0.66). Mean total cholesterol (TC) was higher among mice with large versus small AAA (601 vs. 422 mg/ml, p<0.0001), and the difference was due to LDL. AngII exposure was associated with 0.43 mm (95% CI, 0.27 to 0.61, p<0.0001) increase in aortic diameter; and a 100 mg/dl increase in mean final cholesterol level was associated with a 12% (95% CI, 5.68 to 18.23, p<0.0001) increase in aortic diameter. Baseline cholesterol was not associated with change in aortic diameter (p = 0.86). Conclusions: These are the first formal estimates of a consistent pattern of Ang II-induced AAA development. The odds of AAA occurrence diminish after the second week of Ang II infusion, and TC is independently associated with AAA size.	[Prins, Petra A.; Hill, Michael F.; Tavori, Hagai; Linton, MacRae F.; Fazio, Sergio; Sampson, Uchechukwu K.] VUMC, Dept Med, Nashville, TN USA; [Airey, David; Nwosu, Sam] VUMC, Dept Biostat, Nashville, TN USA; [Perati, Prudhvidhar R.] NCI Informat Syst Inc, Nashville, TN USA; [Kon, Valentina] VUMC, Dept Pediat, Nashville, TN USA; [Fazio, Sergio; Sampson, Uchechukwu K.] VUMC, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Sampson, Uchechukwu K.] VUMC, Dept Radiol & Radiol Sci, Nashville, TN USA		Sampson, UK (corresponding author), VUMC, Dept Med, Nashville, TN USA.	u.sampson@vanderbilt.edu	Tavori, Hagai/AAS-9079-2021		Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; American College of Cardiology Foundation/General Electric Healthcare Career Development Award in Cardiovascular Imaging Technologies and Targeted Imaging Agents; NIH [HL057986, HL106845]; National Heart, Lung, and Blood Institute [R01 HL089385];  [5R01HL087061-05];  [U24 DK059637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057986, R01HL106845, R01HL089385, R01HL087061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637] Funding Source: NIH RePORTER	Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; American College of Cardiology Foundation/General Electric Healthcare Career Development Award in Cardiovascular Imaging Technologies and Targeted Imaging Agents; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support for Dr. Sampson was provided in part by the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation, the Vanderbilt Clinical and Translational Scholars Award, and the American College of Cardiology Foundation/General Electric Healthcare Career Development Award in Cardiovascular Imaging Technologies and Targeted Imaging Agents. Dr. Fazio was supported in part by NIH grants HL057986 and HL106845. Dr. Hill was supported in part by National Heart, Lung, and Blood Institute grant R01 HL089385. Dr Kon was supported in part by 5R01HL087061-05 The Vanderbilt Mouse Metabolic phenotyping Center (MMPC) is supported in part by grant U24 DK059637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe N, 2006, ATHEROSCLEROSIS, V184, P312, DOI 10.1016/j.atherosclerosis.2005.05.016; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cassis LA, 2004, REGUL PEPTIDES, V117, P107, DOI 10.1016/j.regpep.2003.09.008; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hellenthal FAMVI, 2009, CARDIOVASC PATHOL, V18, P286, DOI 10.1016/j.carpath.2008.06.014; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; JEANCLAUDE J, 1994, SURGERY, V116, P472; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Juvonen J, 1997, ARTERIOSCL THROM VAS, V17, P2843, DOI 10.1161/01.ATV.17.11.2843; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Martin-McNulty B, 2005, ULTRASOUND MED BIOL, V31, P745, DOI 10.1016/j.ultrasmedbio.2005.02.012; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; Nishimura K, 2003, INT ANGIOL, V22, P229; Prins PA, 2012, CELL PHYSIOL BIOCHEM, V29, P121, DOI 10.1159/000337593; R Development Core Team, 2010, R LANG ENV STAT COMP; Sampson UK, 2011, J ULTRAS MED, V30, P773, DOI 10.7863/jum.2011.30.6.773; Sampson UK, 2010, ARTERIOSCLER THROMB; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Wang YX, 2001, AM J PATHOL, V159, P1455, DOI 10.1016/S0002-9440(10)62532-1; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031	33	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84517	10.1371/journal.pone.0084517	http://dx.doi.org/10.1371/journal.pone.0084517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465413	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000004
J	Suzuki, Y; Morimoto, T; Miyakawa, H; Aonishi, T				Suzuki, Yoshinori; Morimoto, Takako; Miyakawa, Hiroyoshi; Aonishi, Toru			Cooperative Integration and Representation Underlying Bilateral Network of Fly Motion-Sensitive Neurons	PLOS ONE			English	Article							PLATE TANGENTIAL CELLS; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; FLOW-FIELD SELECTIVITY; LOBULA PLATE; RECEPTIVE-FIELDS; HORIZONTAL CELLS; MOVEMENT; SYSTEM; INTERNEURONS; ORGANIZATION	How is binocular motion information integrated in the bilateral network of wide-field motion-sensitive neurons, called lobula plate tangential cells (LPTCs), in the visual system of flies? It is possible to construct an accurate model of this network because a complete picture of synaptic interactions has been experimentally identified. We investigated the cooperative behavior of the network of horizontal LPTCs underlying the integration of binocular motion information and the information representation in the bilateral LPTC network through numerical simulations on the network model. First, we qualitatively reproduced rotational motion-sensitive response of the H2 cell previously reported in vivo experiments and ascertained that it could be accounted for by the cooperative behavior of the bilateral network mainly via interhemispheric electrical coupling. We demonstrated that the response properties of single H1 and Hu cells, unlike H2 cells, are not influenced by motion stimuli in the contralateral visual hemi-field, but that the correlations between these cell activities are enhanced by the rotational motion stimulus. We next examined the whole population activity by performing principal component analysis (PCA) on the population activities of simulated LPTCs. We showed that the two orthogonal patterns of correlated population activities given by the first two principal components represent the rotational and translational motions, respectively, and similar to the H2 cell, rotational motion produces a stronger response in the network than does translational motion. Furthermore, we found that these population-coding properties are strongly influenced by the interhemispheric electrical coupling. Finally, to test the generality of our conclusions, we used a more simplified model and verified that the numerical results are not specific to the network model we constructed.	[Suzuki, Yoshinori; Aonishi, Toru] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Morimoto, Takako; Miyakawa, Hiroyoshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan	Tokyo Institute of Technology; Tokyo University of Pharmacy & Life Sciences	Suzuki, Y (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan.	suzuki.y.bh@m.titech.ac.jp			Japanese Society for the Promotion of Science (JSPS) [23500375]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant (23500375 http://kaken.nii.ac.jp/d/p/23500375.en.html) from the Japanese Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonishi T, 1999, PHYS REV LETT, V82, P2800, DOI 10.1103/PhysRevLett.82.2800; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Borst A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016303; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; ECKERT H, 1983, J INSECT PHYSIOL, V29, P547, DOI 10.1016/0022-1910(83)90020-3; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Farrow K, 2003, J NEUROSCI, V23, P9805; Farrow K, 2006, NAT NEUROSCI, V9, P1312, DOI 10.1038/nn1769; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gauck V, 1997, J COMP NEUROL, V381, P489; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Haag J, 1997, J NEUROSCI, V17, P4809; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2008, J NEUROSCI, V28, P14435, DOI 10.1523/JNEUROSCI.3603-08.2008; HAUSEN K, 1990, J NEUROSCI, V10, P351; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Hennig P, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00004; Horstmann W, 2000, EUR J NEUROSCI, V12, P2157, DOI 10.1046/j.1460-9568.2000.00094.x; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; IBBOTSON MR, 1991, J COMP PHYSIOL A, V168, P91, DOI 10.1007/BF00217107; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Jolliffe IT, 1986, PRINCIPAL COMPONENT, V487; JONES F. R. HARDEN, 1963, JOUR EXPTL BIOL, V40, P437; Kern R, 1998, J COMP PHYSIOL A, V182, P225, DOI 10.1007/s003590050173; KERN R, 1993, VISUAL NEUROSCI, V10, P643, DOI 10.1017/S0952523800005344; Kimmerle B, 1996, NATURWISSENSCHAFTEN, V83, P380, DOI 10.1007/s001140050305; KIRCHNER WH, 1989, NATURWISSENSCHAFTEN, V76, P281, DOI 10.1007/BF00368643; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Lemus L, 2007, P NATL ACAD SCI USA, V104, P17174, DOI 10.1073/pnas.0707961104; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; RAUSCHECKER JP, 1987, J NEUROSCI, V7, P943; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Torben-Nielsen B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000932; WYLIE DR, 1990, VISUAL NEUROSCI, V5, P489, DOI 10.1017/S0952523800000614; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041	47	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85790	10.1371/journal.pone.0085790	http://dx.doi.org/10.1371/journal.pone.0085790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465711	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000025
J	Bucksch, A; Turk, G; Weitz, JS				Bucksch, Alexander; Turk, Greg; Weitz, Joshua S.			The Fiber Walk: A Model of Tip-Driven Growth with Lateral Expansion	PLOS ONE			English	Article							SELF-ORGANIZATION; ROOT; AUXIN; ARCHITECTURE; CONSTRAINTS; CYTOKININ	Tip-driven growth processes underlie the development of many plants. To date, tip-driven growth processes have been modeled as an elongating path or series of segments, without taking into account lateral expansion during elongation. Instead, models of growth often introduce an explicit thickness by expanding the area around the completed elongated path. Modeling expansion in this way can lead to contradictions in the physical plausibility of the resulting surface and to uncertainty about how the object reached certain regions of space. Here, we introduce fiber walks as a self-avoiding random walk model for tip-driven growth processes that includes lateral expansion. In 2D, the fiber walk takes place on a square lattice and the space occupied by the fiber is modeled as a lateral contraction of the lattice. This contraction influences the possible subsequent steps of the fiber walk. The boundary of the area consumed by the contraction is derived as the dual of the lattice faces adjacent to the fiber. We show that fiber walks generate fibers that have well-defined curvatures, and thus enable the identification of the process underlying the occupancy of physical space. Hence, fiber walks provide a base from which to model both the extension and expansion of physical biological objects with finite thickness.	[Bucksch, Alexander; Turk, Greg] Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA; [Bucksch, Alexander; Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Bucksch, A (corresponding author), Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA.	bucksch@gatech.edu	Bucksch, Alexander/A-6102-2009	Bucksch, Alexander/0000-0002-1071-5355	National Science Foundation, Plant Genome Research Program [0820624]; Scientific Interface from the Burroughs Wellcome Fund	National Science Foundation, Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Science Foundation, Plant Genome Research Program grant nos. 0820624 to J.S.W.) J.S.W. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Aloni R, 2006, ANN BOT-LONDON, V97, P883, DOI 10.1093/aob/mcl027; Aloni R, 2004, PLANTA, V220, P177, DOI 10.1007/s00425-004-1381-8; Bhattacharya A, 2013, COMPUT GRAPH FORUM, V32, P11, DOI 10.1111/cgf.12088; CATMULL E, 1978, COMPUT AIDED DESIGN, V10, P350, DOI 10.1016/0010-4485(78)90110-0; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Dey TK, 2013, COMPUTERS GRAPHICS; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hamarneh G, 2010, COMPUT MED IMAG GRAP, V34, P605, DOI 10.1016/j.compmedimag.2010.06.002; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hund A, 2009, PLANT SOIL, V325, P335, DOI 10.1007/s11104-009-9984-2; Karch R, 1999, COMPUT BIOL MED, V29, P19, DOI 10.1016/S0010-4825(98)00045-6; Landau D.P., 2009, GUIDE MONTE CARLO SI; Leitner D, 2010, PLANT SOIL, V332, P177, DOI 10.1007/s11104-010-0284-7; Lew RR, 2011, NAT REV MICROBIOL, V9, P509, DOI 10.1038/nrmicro2591; Leyser O, 2011, CURR BIOL, V21, pR331, DOI 10.1016/j.cub.2011.02.031; LYKLEMA JW, 1984, J PHYS A-MATH GEN, V17, pL691, DOI 10.1088/0305-4470/17/13/003; Lynch JP, 1997, PLANT SOIL, V188, P139, DOI 10.1023/A:1004276724310; Madras N, 1993, SELF AVOIDING WALK P, V49, P105; Overvoorde P, 2010, COLD SPRING HARBOR P, V2; Prusinkiewicz P, 2010, J EXP BOT, V61, P2117, DOI 10.1093/jxb/erq081; RENSHAW E, 1981, J APPL PROBAB, V18, P403, DOI 10.2307/3213286; Rounds CM, 2013, ANNU REV PLANT BIOL, V64, P243, DOI 10.1146/annurev-arplant-050312-120150; Sachs T, 2004, J THEOR BIOL, V230, P197, DOI 10.1016/j.jtbi.2004.05.006; Skiena S., 1991, IMPLEMENTING DISCRET; Webster J, 1980, INTRO FUNGI, V667; Wilson R. J., 1985, INTRO GRAPH THEORY	29	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85585	10.1371/journal.pone.0085585	http://dx.doi.org/10.1371/journal.pone.0085585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465607	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100047
J	Lan, NTN; Thu, NTN; Barrail-Tran, A; Duc, NH; Lan, NN; Laureillard, D; Lien, TTX; Borand, L; Quillet, C; Connolly, C; Lagarde, D; Pym, A; Lienhardt, C; Dung, NH; Taburet, AM; Harries, AD				Nguyen Thi Ngoc Lan; Nguyen Thi Nguyet Thu; Barrail-Tran, Aurelie; Nguyen Hong Duc; Nguyen Ngoc Lan; Laureillard, Didier; Truong Thi Xuan Lien; Borand, Laurence; Quillet, Catherine; Connolly, Catherine; Lagarde, Dominique; Pym, Alexander; Lienhardt, Christian; Nguyen Huy Dung; Taburet, Anne-Marie; Harries, Anthony D.			Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam	PLOS ONE			English	Article							INFECTED PATIENTS; RITONAVIR; PHARMACODYNAMICS; COMBINATION; RESISTANCE; RIFAMPIN	Background: Rifampicin and protease inhibitors are difficult to use concomitantly in patients with HIV-associated tuberculosis because of drug-drug interactions. Rifabutin has been proposed as an alternative rifamycin, but there is concern that the current recommended dose is suboptimal. The principal aim of this study was to compare bioavailability of two doses of rifabutin (150 mg three times per week and 150 mg daily) in patients with HIV-associated tuberculosis who initiated lopinavir/ritonavir-based antiretroviral therapy in Vietnam. Concentrations of lopinavir/ritonavir were also measured. Methods: This was a randomized, open-label, multi-dose, two-arm, cross-over trial, conducted in Vietnamese adults with HIV-associated tuberculosis in Ho Chi Minh City (Clinical trial registry number NCT00651066). Rifabutin pharmacokinetics were evaluated before and after the introduction of lopinavir/ritonavir -based antiretroviral therapy using patient randomization lists. Serial rifabutin and 25-O-desacetyl rifabutin concentrations were measured during a dose interval after 2 weeks of rifabutin 300 mg daily, after 3 weeks of rifabutin 150 mg daily with lopinavir/ritonavir and after 3 weeks of rifabutin 150 mg three times per week with lopinavir/ritonavir. Results: Sixteen and seventeen patients were respectively randomized to the two arms, and pharmacokinetic analysis carried out in 12 and 13 respectively. Rifabutin 150 mg daily with lopinavir/ritonavir was associated with a 32% mean increase in rifabutin average steady state concentration compared with rifabutin 300 mg alone. In contrast, the rifabutin average steady state concentration decreased by 44% when rifabutin was given at 150 mg three times per week with lopinavir/ritonavir. With both dosing regimens, 2 - 5 fold increases of the 25-O-desacetyl- rifabutin metabolite were observed when rifabutin was given with lopinavir/ritonavir compared with rifabutin alone. The different doses of rifabutin had no significant effect on lopinavir/ritonavir plasma concentrations. Conclusions: Based on these findings, rifabutin 150 mg daily may be preferred when co-administered with lopinavir/ritonavir in patients with HIV-associated tuberculosis.	[Nguyen Thi Ngoc Lan; Nguyen Hong Duc; Nguyen Ngoc Lan; Nguyen Huy Dung] Pham Ngoc Thach Hosp, Ho Chi Minh City, Vietnam; [Nguyen Thi Nguyet Thu; Truong Thi Xuan Lien] Inst Pasteur, Ho Chi Minh City, Vietnam; [Barrail-Tran, Aurelie; Taburet, Anne-Marie] Bicetre Hosp, AP HP, Dept Clin Pharm, Le Kremlin Bicetre, France; [Laureillard, Didier; Quillet, Catherine] ANRS, Ho Chi Minh City, Vietnam; [Borand, Laurence] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Connolly, Catherine] MRC, Biostat Unit, Durban, South Africa; [Lagarde, Dominique; Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Pym, Alexander] MRC, TB Res Unit, Durban, South Africa; [Pym, Alexander] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Lienhardt, Christian] World Hlth Org Stop TB Program, Geneva, Switzerland; [Barrail-Tran, Aurelie] Univ Paris 11, Clin Pharm & Pharmacokinet Dept EA4123, Chatenay Malabry, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; World Health Organization; UDICE-French Research Universities; Universite Paris Saclay; University of London; London School of Hygiene & Tropical Medicine	Harries, AD (corresponding author), Int Union TB & Lung Dis, Paris, France.	adharries@theunion.org	Barrail-Tran, Aurélie/ABC-5935-2020; Lienhardt, Christian/AAU-4969-2021	Barrail-Tran, Aurélie/0000-0002-6053-6275; Lienhardt, Christian/0000-0003-0233-893X; Pym, Alexander/0000-0002-6260-8180; Laureillard, Didier/0000-0002-0104-9047	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (INSERM-ANRS); Fondation Total	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (INSERM-ANRS); Fondation Total	The French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (INSERM-ANRS) was the Sponsor and Funder of the study. Fondation Total also provided a grant to support the study. Laboratoires SERB generously provided a donation of rifabutin and Pfizer (SA) generously provided a donation of rifabutin and 25-O-desacetyl rifabutin reference powder which was used for the preparation of standard curves and quality control of assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; [Anonymous], 2012, GLOB REP UNAIDS REP; Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulanger C, 2009, CLIN INFECT DIS, V49, P1305, DOI 10.1086/606056; Burman WJ, 2001, CLIN PHARMACOKINET, V40, P327, DOI 10.2165/00003088-200140050-00002; Ford SL, 2008, ANTIMICROB AGENTS CH, V52, P534, DOI 10.1128/AAC.00724-07; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jenny-Avital ER, 2009, CLIN INFECT DIS, V48, P1471, DOI 10.1086/598336; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Khachi H, 2009, J ANTIMICROB CHEMOTH, V64, P871, DOI 10.1093/jac/dkp263; Lan NTN, 2013, PUBLIC HEALTH ACTION, V3, P97, DOI 10.5588/pha.13.0017; Loeliger A, 2012, INT J TUBERC LUNG D, V16, P6, DOI 10.5588/ijtld.10.0626; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Matteelli A, 2012, J ANTIMICROB CHEMOTH, V67, P2470, DOI 10.1093/jac/dks218; Ministry of Health Vietnam, 2007, GUID TB HIV CONTR CO; MITCHISON DA, 1971, POSTGRAD MED J, V47, P737, DOI 10.1136/pgmj.47.553.737; Naiker S, 2012, C RETR OPP INF TUESD, P312; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Sekar V, 2010, ANTIMICROB AGENTS CH, V54, P4440, DOI 10.1128/AAC.01749-09; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Taburet AM, 2004, CLIN PHARMACOL THER, V75, P310, DOI 10.1016/j.clpt.2003.12.013; UNAIDS and WHO, 2012, TREATM 2 0 FRAM ACT; Verbist L, 1969, ACT TUBERC PNEUMOL B, V60, P391; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2010, WHOHTMTB2009420, DOI DOI 10.WH0/HTM/TB/2009.420; Zhang J, 2011, J ANTIMICROB CHEMOTH, V66, P2075, DOI 10.1093/jac/dkr266; Zhang XP, 2011, ANTIMICROB AGENTS CH, V55, P680, DOI 10.1128/AAC.00992-10	34	35	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84866	10.1371/journal.pone.0084866	http://dx.doi.org/10.1371/journal.pone.0084866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465443	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330283100014
J	Weitz, JS				Weitz, Joshua S.			Let My People Go (Home) to Spain: A Genealogical Model of Jewish Identities since 1492	PLOS ONE			English	Article							INDIVIDUALS; ANCESTRY	The Spanish government recently announced an official fast-track path to citizenship for any individual who is Jewish and whose ancestors were expelled from Spain during the inquisition-related dislocation of Spanish Jews in 1492. It would seem that this policy targets a small subset of the global Jewish population, that is, restricted to individuals who retain cultural practices associated with ancestral origins in Spain. However, the central contribution of this manuscript is to demonstrate how and why the policy is far more likely to apply to a very large fraction (i.e., the vast majority) of Jews. This claim is supported using a series of genealogical models that include transmissible "identities'' and preferential intra-group mating. Model analysis reveals that even when intra-group mating is strong and even if only a small subset of a present-day population retains cultural practices typically associated with that of an ancestral group, it is highly likely that nearly all members of that population have direct genealogical links to that ancestral group, given sufficient number of generations have elapsed. The basis for this conclusion is that not having a link to an ancestral group must be a property of all of an individual's ancestors, the probability of which declines (nearly) superexponentially with each successive generation. These findings highlight unexpected incongruities induced by genealogical dynamics between present-day and ancestral identities.	[Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	jsweitz@gatech.edu			Burroughs Wellcome Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	Joshua S. Weitz holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PAIS; Botticini M, 2007, J EUR ECON ASSOC, V5, P885, DOI 10.1162/JEEA.2007.5.5.885; Brunet E, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01006; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; DellaPergola S, 2012, AM JEWISH YB; Derrida B, 2000, J THEOR BIOL, V203, P303, DOI 10.1006/jtbi.2000.1095; Krich J., 2013, TIME; Manrubia SC, 2003, AM SCI, V91, P158, DOI 10.1511/2003.2.158; Minder R, 2013, NY TIMES; Minder Raphael, 2012, NY TIMES; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rohde DLT, 2004, NATURE, V431, P562, DOI 10.1038/nature02842; Rubinstein Y, 2013, PRIDE PREJU IN PRESS; Telushkin Joseph, 2008, JEWISH LITERACY MOST; Zangwill I, 1893, KING SCHNORRERS; Zohar Zion, 2005, SEPHARDIC MIZRAHI JE	16	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85673	10.1371/journal.pone.0085673	http://dx.doi.org/10.1371/journal.pone.0085673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	297VL	24465647	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100059
J	Xiong, LP; He, ZY; Qian, L; Mu, L; Chen, AX; Han, S; Qiu, JW; Fu, XS				Xiong Liping; He Zhongyi; Qian Liang; Mu Lin; Chen Aixi; Han Sheng; Qiu Jianwei; Fu Xisheng			Synthesis, Tribological and Hydrolysis Stability Study of Novel Benzotriazole Borate Derivative	PLOS ONE			English	Article							ANTIWEAR ADDITIVES; PHOSPHORUS; ESTERS; ASH	Benzotriazole and borate derivatives have long been used as multifunctional additives to lubricants. A novel, environmentally friendly additive borate ester (NHB), which contains boron, ethanolamine, and benzotriazole groups in one molecule, was synthesized by a multi-step reaction, and its tribological properties in rapeseed oil (RSO) were investigated by a four-ball tribometer. The hydrolysis stability of the additive was investigated by half-time and open observation methods, and the mechanism of hydrolysis stability was discussed through Gaussian calculation. The novel compound NHB showed excellent performance under extreme pressure, against wearing, and in reducing friction, and its hydrolysis time is more than 1,220 times, which is better than that of triethyl borate. The mass ratio of NHB is bigger than that of the mixed liquid of triethyl borate and ethanolamine. The lone electron of amino N atoms forms a coordination effect with the B atom to compensate for the shortage of electrons in the B atom and to improve the hydrolysis stability of NHB. The surface morphology and the traces of different elements in the tribofilms formed with 1.0 wt.% NHB in were detected with scanning electron microscopy(SEM), energy dispersive X-ray spectroscopy (EDX) and X-ray photoelectron spectroscopy(XPS). The results shown that the additive caused a tribochemical reaction with the steel ball surface during the lubricating process. A mixed boundary lubrication film that contains organic nitrogen and inorganic salts, such as BN, B2O3, FeOx, Fe-O-B, and FeB, was also formed, and the formation of the lubricating film improved the tribological properties of the base oil.	[Xiong Liping; He Zhongyi; Qian Liang; Mu Lin; Chen Aixi] East China Jiaotong Univ, Sch Basic Sci, Nanchang, Jiangxi, Peoples R China; [Han Sheng] Shanghai Inst Technol, Shanghai, Peoples R China; [He Zhongyi; Qiu Jianwei; Fu Xisheng] PetroChina Lanzhou Lubricating Oil R&D Inst, Lanzhou, Peoples R China	East China Jiaotong University; Shanghai Institute of Technology; China National Petroleum Corporation	Xiong, LP (corresponding author), East China Jiaotong Univ, Sch Basic Sci, Nanchang, Jiangxi, Peoples R China.	helijia666@163.com			Chinese Natural Science Foundation [21063007]; Jiangxi Provincial Natural Science Foundation [20122BAB203011]; Jiangxi Education Department Foundation of China [GJJ13358]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation; Jiangxi Education Department Foundation of China	The work reported here was sponsored by Chinese Natural Science Foundation (No: 21063007); Jiangxi Provincial Natural Science Foundation (No: 20122BAB203011); Jiangxi Education Department Foundation of China (Grant No: GJJ13358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	DIDZIULIS SV, 1995, LANGMUIR, V11, P917, DOI 10.1021/la00003a040; Erdemir A., 2008, NANOLUBRICANTS, P203, DOI DOI 10.1002/9780470987711.CH6; He ZY, 2005, CHINESE SCI BULL, V50, P1174, DOI 10.1360/04wb0103; [胡晓兰 Hu Xiaolan], 2002, 材料导报, V16, P58; Jia ZF, 2011, TRIBOL LETT, V41, P247, DOI 10.1007/s11249-010-9706-1; Jia ZF, 2011, TRIBOL LETT, V41, P425, DOI 10.1007/s11249-010-9728-8; Li JS, 2010, TRIBOL INT, V43, P1048, DOI 10.1016/j.triboint.2009.12.030; Liang P, 2010, P I MECH ENG J-J ENG, V224, P65, DOI 10.1243/13506501JET615; Philippon D, 2011, TRIBOL LETT, V41, P73, DOI 10.1007/s11249-010-9685-2; Shah FU, 2012, TRIBOL LETT, V45, P67, DOI 10.1007/s11249-011-9855-x; Shah FU, 2009, ACS APPL MATER INTER, V1, P2835, DOI 10.1021/am900572y; Spikes H, 2008, LUBR SCI, V20, P103, DOI 10.1002/ls.57; Wang Q, 2011, APPL MECH MATER, V84-85, P499, DOI 10.4028/www.scientific.net/AMM.84-85.499; Wang Y, 2008, P I MECH ENG J-J ENG, V222, P133, DOI 10.1243/13506501JET293; Xue RT, 2011, THESIS OCEAN U CHINA; Yao J. B., 2006, LUBR OIL CHINA, V21, P29; Zhang H, 2008, LUBRI ENG CHINA, V33, P94; Zheng Z, 1998, WEAR, V222, P135, DOI 10.1016/S0043-1648(98)00323-8; Zhou XD, 2007, TRIBOL INT, V40, P863, DOI 10.1016/j.triboint.2006.09.002	19	12	15	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83501	10.1371/journal.pone.0083501	http://dx.doi.org/10.1371/journal.pone.0083501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465382	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100005
J	Atlas, WI; Palen, WJ				Atlas, William I.; Palen, Wendy J.			Prey Vulnerability Limits Top-Down Control and Alters Reciprocal Feedbacks in a Subsidized Model Food Web	PLOS ONE			English	Article							LENGTH-MASS RELATIONSHIPS; TROUT SALMO-GAIRDNERI; TERRESTRIAL INVERTEBRATES; TROPHIC CASCADES; RAINBOW-TROUT; TRADE-OFF; PREDATION; STREAM; FOREST; FISH	Resource subsidies increase the productivity of recipient food webs and can affect ecosystem dynamics. Subsidies of prey often support elevated predator biomass which may intensify top-down control and reduce the flow of reciprocal subsidies into adjacent ecosystems. However, top-down control in subsidized food webs may be limited if primary consumers posses morphological or behavioral traits that limit vulnerability to predation. In forested streams, terrestrial prey support high predator biomass creating the potential for strong top-down control, however armored primary consumers often dominate the invertebrate assemblage. Using empirically based simulation models, we tested the response of stream food webs to variations in subsidy magnitude, prey vulnerability, and the presence of two top predators. While terrestrial prey inputs increased predator biomass (+12%), the presence of armored primary consumers inhibited top-down control, and diverted most aquatic energy (similar to 75%) into the riparian forest through aquatic insect emergence. Food webs without armored invertebrates experienced strong trophic cascades, resulting in higher algal (similar to 50%) and detrital (similar to 1600%) biomass, and reduced insect emergence (-90%). These results suggest prey vulnerability can mediate food web responses to subsidies, and that top-down control can be arrested even when predator-invulnerable consumers are uncommon (20%) regardless of the level of subsidy.	[Atlas, William I.; Palen, Wendy J.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Atlas, WI (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	watlas@sfu.ca	Atlas, William/AAW-2528-2021		National Science and Engineering Research Council of Canada; Canada Research Chairs program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	Funding was provided through the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), and the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas WI, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00366.1; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; BENKE AC, 1980, ECOLOGY, V61, P108, DOI 10.2307/1937161; Bishop MJ, 2007, OIKOS, V116, P427, DOI 10.1111/j.2006.0030-1299.15557.x; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Eberle LC, 2010, RIVER RES APPL, V26, P682, DOI 10.1002/rra.1270; Finlay JC, 2001, ECOLOGY, V82, P1052, DOI 10.2307/2679902; GALBRAIT.MG, 1967, T AM FISH SOC, V96, P1, DOI 10.1577/1548-8659(1967)96[1:SPODBR]2.0.CO;2; GRAFIUS E, 1979, ECOLOGY, V60, P433, DOI 10.2307/1937670; GUTIERREZ AP, 1984, CAN ENTOMOL, V116, P923, DOI 10.4039/Ent116923-7; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Henschel JR, 2001, OIKOS, V93, P429, DOI 10.1034/j.1600-0706.2001.930308.x; Hodar JA, 1996, ACTA OECOL, V17, P421; Holling C. S., 1959, Canadian Entomologist, V91, P385; Jennings S, 2002, MAR BIOL, V141, P1085, DOI 10.1007/s00227-002-0905-7; JOHNSON JH, 1980, CAN J ZOOL, V58, P553, DOI 10.1139/z80-077; JOHNSON MG, 1971, J FISH RES BOARD CAN, V28, P1699, DOI 10.1139/f71-253; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Limm MP, 2011, J N AM BENTHOL SOC, V30, P485, DOI 10.1899/10-028.1; Malmqvist B, 2002, FRESHWATER BIOL, V47, P679, DOI 10.1046/j.1365-2427.2002.00895.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McDiffett WF, 1970, ECOLOGY, V51, P976; McNeely C, 2007, ECOLOGY, V88, P391, DOI 10.1890/0012-9658(2007)88[391:GTCACS]2.0.CO;2; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; Murakami M, 2002, ECOL LETT, V5, P333, DOI 10.1046/j.1461-0248.2002.00321.x; Nakano S, 1999, ECOLOGY, V80, P2435; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Parker Michael S., 1994, Northwestern Naturalist, V74, P77, DOI 10.2307/3536601; PARKER MS, 1994, COPEIA, P705, DOI 10.2307/1447187; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POLIS GA, 1995, P NATL ACAD SCI USA, V92, P4382, DOI 10.1073/pnas.92.10.4382; Polis Gary A., 1996, P275; Power ME, 2002, ECOL RES, V17, P451, DOI 10.1046/j.1440-1703.2002.00503.x; RESETARITS WJ, 1995, OIKOS, V73, P188, DOI 10.2307/3545907; Ruetz CR, 2002, OECOLOGIA, V132, P307, DOI 10.1007/s00442-002-0953-1; Sabo JL, 2002, J N AM BENTHOL SOC, V21, P336, DOI 10.2307/1468420; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Schade JD, 2011, FRESHWATER BIOL, V56, P424, DOI 10.1111/j.1365-2427.2010.02509.x; van der Stap I, 2007, ECOLOGY, V88, P2474, DOI 10.1890/07-1731.1; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; WARE DM, 1972, J FISH RES BOARD CAN, V29, P1193, DOI 10.1139/f72-175; Wellborn GA, 2002, ECOLOGY, V83, P129, DOI 10.2307/2680126; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wesner JS, 2012, OIKOS, V121, P53, DOI 10.1111/j.1600-0706.2011.19413.x; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; WURTSBAUGH WA, 1977, J FISH BIOL, V11, P87, DOI 10.1111/j.1095-8649.1977.tb04101.x; Zhang YX, 2011, AQUAT SCI, V73, P53, DOI 10.1007/s00027-010-0159-2	53	11	12	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85830	10.1371/journal.pone.0085830	http://dx.doi.org/10.1371/journal.pone.0085830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465732	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500123
J	Breitenbuecher, F; Hoffarth, S; Worm, K; Cortes-Incio, D; Gauler, TC; Kohler, J; Herold, T; Schmid, KW; Freitag, L; Kasper, S; Schuler, M				Breitenbuecher, Frank; Hoffarth, Sandra; Worm, Karl; Cortes-Incio, Diana; Gauler, Thomas C.; Koehler, Jens; Herold, Thomas; Schmid, Kurt Werner; Freitag, Lutz; Kasper, Stefan; Schuler, Martin			Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; METASTATIC COLORECTAL-CANCER; RESISTANT PROSTATE-CANCER; PROGNOSTIC-SIGNIFICANCE; RARE MUTATIONS; BREAST-CANCER; EGFR; GEFITINIB; PROGRESSION; ERLOTINIB	Background: Oncogenic mutations are powerful predictive biomarkers for molecularly targeted cancer therapies. For mutation detection patients have to undergo invasive tumor biopsies. Alternatively, archival samples are used which may no longer reflect the actual tumor status. Circulating tumor cells (CTC) could serve as an alternative platform to detect somatic mutations in cancer patients. We sought to develop a sensitive and specific assay to detect mutations in the EGFR gene in CTC from lung cancer patients. Methods: We developed a novel assay based on real-time polymerase chain reaction (PCR) and melting curve analysis to detect activating EGFR mutations in blood cell fractions enriched in CTC. Non-small-cell lung cancer (NSCLC) was chosen as disease model with reportedly very low CTC counts. The assay was prospectively validated in samples from patients with EGFR-mutant and EGFR-wild type NSCLC treated within a randomized clinical trial. Sequential analyses were conducted to monitor CTC signals during therapy and correlate mutation detection in CTC with treatment outcome. Results: Assay sensitivity was optimized to enable detection of a single EGFR-mutant CTC/mL peripheral blood. CTC were detected in pretreatment blood samples from all 8 EGFR-mutant lung cancer patients studied. Loss of EGFR-mutant CTC signals correlated with treatment response, and its reoccurrence preceded relapse. Conclusions: Despite low abundance of CTC in NSCLC oncogenic mutations can be reproducibly detected by applying an unbiased CTC enrichment strategy and highly sensitive PCR and melting curve analysis. This strategy may enable non-invasive, specific biomarker diagnostics and monitoring in patients undergoing targeted cancer therapies.	[Breitenbuecher, Frank; Hoffarth, Sandra; Cortes-Incio, Diana; Gauler, Thomas C.; Koehler, Jens; Kasper, Stefan; Schuler, Martin] Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Univ Hosp Essen, Essen, Germany; [Worm, Karl; Herold, Thomas; Schmid, Kurt Werner] Univ Duisburg Essen, Inst Pathol, West German Canc Ctr, Univ Hosp Essen, Essen, Germany; [Gauler, Thomas C.; Schuler, Martin] Univ Duisburg Essen, Div Thorac Oncol, West German Lung Ctr, Ruhrlandklin, Essen, Germany; [Freitag, Lutz] Univ Duisburg Essen, Div Intervent Pneumol, West German Lung Ctr, Ruhrlandklin, Essen, Germany; [Herold, Thomas] German Canc Res Ctr, Heidelberg, Germany; [Herold, Thomas; Schuler, Martin] German Canc Consortium DKTK, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Breitenbuecher, F (corresponding author), Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Univ Hosp Essen, Essen, Germany.	Frank.Breitenbuecher@uk-essen.de	Köhler, Jens/AAK-1541-2021; Kasper, Stefan/I-4521-2015	Kasper, Stefan/0000-0002-5947-8733; Kohler (MD), Jens/0000-0002-9922-6469	Oncology Center of Excellence grant from the German Cancer Aid (Deutsche Krebshilfe); Medical Faculty of the University Duisburg-Essen (IFORES); Boehringer Ingelheim	Oncology Center of Excellence grant from the German Cancer Aid (Deutsche Krebshilfe); Medical Faculty of the University Duisburg-Essen (IFORES); Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported in part by an Oncology Center of Excellence grant from the German Cancer Aid (Deutsche Krebshilfe, www.krebshilfe.de) to the West German Cancer Center, intramural research funds of the Medical Faculty of the University Duisburg-Essen (IFORES to M. S.), and an institutional research grant from Boehringer Ingelheim (www.boehringer-ingelheim.com) to F. B. and M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/j.mrfmmm.2011.10.001, 10.1016/mrfmmm.2011.10.001]; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pailler E, 2013, J CLIN ONCOL, V31, P2273, DOI 10.1200/JCO.2012.44.5932; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	32	46	47	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85350	10.1371/journal.pone.0085350	http://dx.doi.org/10.1371/journal.pone.0085350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465542	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500058
J	Chen, LW; Zhang, JH; Chen, WN				Chen, Liwei; Zhang, Jianhua; Chen, Wei Ning			Engineering the Saccharomyces cerevisiae beta-Oxidation Pathway to Increase Medium Chain Fatty Acid Production as Potential Biofuel	PLOS ONE			English	Article							YEAST YARROWIA-LIPOLYTICA; ACYL-COA THIOESTERASES; CARNITINE ACYLTRANSFERASES; LIPID-ACCUMULATION; METABOLISM; COENZYME; OXIDASES; POLYHYDROXYALKANOATE; MICROORGANISMS; BIOSYNTHESIS	Fatty acid-derived biofuels and biochemicals can be produced in microbes using beta-oxidation pathway engineering. In this study, the beta-oxidation pathway of Saccharomyces cerevisiae was engineered to accumulate a higher ratio of medium chain fatty acids (MCFAs) when cells were grown on fatty acid-rich feedstock. For this purpose, the haploid deletion strain Delta pox1 was obtained, in which the sole acyl-CoA oxidase encoded by POX1 was deleted. Next, the POX2 gene from Yarrowia lipolytica, which encodes an acyl-CoA oxidase with a preference for long chain acyl-CoAs, was expressed in the Delta pox1 strain. The resulting Delta pox1 [pox2+] strain exhibited a growth defect because the beta-oxidation pathway was blocked in peroxisomes. To unblock the beta-oxidation pathway, the gene CROT, which encodes carnitine O-octanoyltransferase, was expressed in the Delta pox1 [pox2+] strain to transport the accumulated medium chain acyl-coAs out of the peroxisomes. The obtained Delta pox1 [pox2+, crot+] strain grew at a normal rate. The effect of these genetic modifications on fatty acid accumulation and profile was investigated when the strains were grown on oleic acids-containing medium. It was determined that the engineered strains Delta pox1 [pox2+] and Delta pox1 [pox2+, crot+] had increased fatty acid accumulation and an increased ratio of MCFAs. Compared to the wild-type (WT) strain, the total fatty acid production of the strains Delta pox1 [pox2+] and Delta pox1 [pox2+, crot+] were increased 29.5% and 15.6%, respectively. The intracellular level of MCFAs in Delta pox1 [pox2+] and Delta pox1 [pox2+, crot+] increased 2.26- and 1.87-fold compared to the WT strain, respectively. In addition, MCFAs in the culture medium increased 3.29-fold and 3.34-fold compared to the WT strain. These results suggested that fatty acids with an increased MCFAs ratio accumulate in the engineered strains with a modified beta-oxidation pathway. Our approach exhibits great potential for transforming low value fatty acid-rich feedstock into high value fatty acid-derived products.	[Chen, Liwei; Zhang, Jianhua; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	WNChen@ntu.edu.sg		, Yang/0000-0002-6620-8897; Chen, Liwei/0000-0002-4165-4102	National Research Foundation, Singapore	National Research Foundation, Singapore(National Research Foundation, Singapore)	National Research Foundation, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardi L, 1999, INT J FOOD MICROBIOL, V47, P133, DOI 10.1016/S0168-1605(98)00203-7; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Dellomonaco C, 2010, APPL ENVIRON MICROB, V76, P5067, DOI 10.1128/AEM.00046-10; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Haddouche R, 2010, FEMS YEAST RES, V10, P917, DOI 10.1111/j.1567-1364.2010.00670.x; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Horak T, 2009, J AGR FOOD CHEM, V57, P11081, DOI 10.1021/jf9028305; Hunt MC, 2008, PROG LIPID RES, V47, P405, DOI 10.1016/j.plipres.2008.05.001; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; KOPKA J, 1995, ANAL BIOCHEM, V224, P51, DOI 10.1006/abio.1995.1007; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Luo YS, 2002, ARCH BIOCHEM BIOPHYS, V407, P32, DOI 10.1016/S0003-9861(02)00466-6; Mal M, 2009, RAPID COMMUN MASS SP, V23, P487, DOI 10.1002/rcm.3898; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; Mlickova K, 2004, J MOL CATAL B-ENZYM, V28, P81, DOI 10.1016/j.molcatb.2004.01.007; MORTENSEN PB, 1992, BIOCHIM BIOPHYS ACTA, V1124, P71, DOI 10.1016/0005-2760(92)90128-I; Poirier Y, 2001, APPL ENVIRON MICROB, V67, P5254, DOI 10.1128/AEM.67.11.5254-5260.2001; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shockey J, 2011, APPL MICROBIOL BIOT, V92, P1207, DOI 10.1007/s00253-011-3505-y; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Torija MJ, 2003, INT J FOOD MICROBIOL, V85, P127, DOI 10.1016/S0168-1605(02)00506-8; van Roermund CWT, 2003, CELL MOL LIFE SCI, V60, P1838, DOI 10.1007/s00018-003-3076-x; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Wang HJJ, 1999, J BACTERIOL, V181, P5140, DOI 10.1128/JB.181.17.5140-5148.1999; Wang MX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015441; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6	31	30	33	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84853	10.1371/journal.pone.0084853	http://dx.doi.org/10.1371/journal.pone.0084853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465440	Green Published, gold			2022-12-27	WOS:000330244500019
J	Kannape, OA; Barre, A; Aminian, K; Blanke, O				Kannape, Oliver Alan; Barre, Arnaud; Aminian, Kamiar; Blanke, Olaf			Cognitive Loading Affects Motor Awareness and Movement Kinematics but Not Locomotor Trajectories during Goal-Directed Walking in a Virtual Reality Environment	PLOS ONE			English	Article							PARKINSONS-DISEASE; PSYCHOMETRIC FUNCTION; ORIENTED LOCOMOTION; EXECUTIVE FUNCTION; GAIT VARIABILITY; ELDERLY-PEOPLE; DUAL-TASKING; AGENCY; SELF; HUMANS	The primary purpose of this study was to investigate the effects of cognitive loading on movement kinematics and trajectory formation during goal-directed walking in a virtual reality (VR) environment. The secondary objective was to measure how participants corrected their trajectories for perturbed feedback and how participants' awareness of such perturbations changed under cognitive loading. We asked 14 healthy young adults to walk towards four different target locations in a VR environment while their movements were tracked and played back in real-time on a large projection screen. In 75% of all trials we introduced angular deviations of +/- 5 degrees to +/- 30 degrees between the veridical walking trajectory and the visual feedback. Participants performed a second experimental block under cognitive load (serial-7 subtraction, counterbalanced across participants). We measured walking kinematics (joint-angles, velocity profiles) and motor performance (end-point-compensation, trajectory-deviations). Motor awareness was determined by asking participants to rate the veracity of the feedback after every trial. In-line with previous findings in natural settings, participants displayed stereotypical walking trajectories in a VR environment. Our results extend these findings as they demonstrate that taxing cognitive resources did not affect trajectory formation and deviations although it interfered with the participants' movement kinematics, in particular walking velocity. Additionally, we report that motor awareness was selectively impaired by the secondary task in trials with high perceptual uncertainty. Compared with data on eye and arm movements our findings lend support to the hypothesis that the central nervous system (CNS) uses common mechanisms to govern goal-directed movements, including locomotion. We discuss our results with respect to the use of VR methods in gait control and rehabilitation.	[Kannape, Oliver Alan; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Barre, Arnaud; Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Inst Bioengn, Lausanne, Switzerland; [Blanke, Olaf] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Sch Life Sci, Lausanne, Switzerland; [Blanke, Olaf] Univ Hosp, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland.	olaf.blanke@epfl.ch	Aminian, Kamiar/H-4568-2011; Kannape, Oliver Alan/AGK-6351-2022	Aminian, Kamiar/0000-0002-6582-5375; Kannape, Oliver Alan/0000-0002-2930-4118; Barre, annick/0000-0002-1360-8491	Swiss National Science Foundation [CRSII1-125135]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	O. Blanke and O.A. Kannape were supported by the Swiss National Science Foundation (Sinergia Grant CRSII1-125135: Balancing Self and Body, http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Daprati E, 2002, NEUROPSYCHOLOGIA, V40, P1379, DOI 10.1016/S0028-3932(01)00203-2; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; Davis Iii RB, 1991, HUM MOVEMENT SCI, V10, P575; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Glasauer S, 1995, ACTA ASTRONAUT, V36, P423, DOI 10.1016/0094-5765(95)00127-1; Grasso R, 1996, NEUROREPORT, V7, P1170, DOI 10.1097/00001756-199604260-00015; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Helmholtz H, 1866, HDB PHYSL OPTIK; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Hollands KL, 2010, EXP BRAIN RES, V202, P591, DOI 10.1007/s00221-010-2162-1; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huxham F, 2008, MOVEMENT DISORD, V23, P1391, DOI 10.1002/mds.21943; IDE JS, 2010, NEUROIMAGE; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Kannape OA, 2013, J NEUROPHYSIOL, V110, P1837, DOI 10.1152/jn.01042.2012; Kannape OA, 2010, NEUROPSYCHOLOGIA, V48, P1628, DOI 10.1016/j.neuropsychologia.2010.02.005; Kannape O. A., 2012, INT J PSYCHOPHYSIOL; Knoblich G, 2004, PSYCHOL MED, V34, P1561, DOI 10.1017/S0033291704002454; Knoblich G, 2009, COGNITION, V111, P248, DOI 10.1016/j.cognition.2009.02.007; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Menzer F, 2010, COGN NEUROSCI-UK, V1, P184, DOI 10.1080/17588921003743581; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Nielsen T., 1963, SCAND J PSYCHOL, V4, P6; Nutt JG, 2011, MOVEMENT DISORD, V26, P1166, DOI 10.1002/mds.23588; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2007, J EXP PSYCHOL HUMAN, V33, P469, DOI 10.1037/0096-1523.33.2.469; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Team R. D. C, 2011, R LANG ENV STAT COMP; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; van Iersel MB, 2007, ARCH PHYS MED REHAB, V88, P187, DOI 10.1016/j.apmr.2006.10.031; von Holst E., 1950, NATURWISSENSCHAFTEN, V20, P13; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yang YR, 2007, GAIT POSTURE, V25, P185, DOI 10.1016/j.gaitpost.2006.03.007; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	65	14	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85560	10.1371/journal.pone.0085560	http://dx.doi.org/10.1371/journal.pone.0085560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465601	Green Published, gold, Green Accepted			2022-12-27	WOS:000330244500075
J	Wang, JZ; Wang, BJ; Huang, SM; Song, ZT; Wu, J; Zhang, EJ; Zhu, ZN; Zhu, B; Yin, Y; Lin, Y; Xu, Y; Zheng, X; Lu, MJ; Yang, DL				Wang, Junzhong; Wang, Baoju; Huang, Shunmei; Song, Zhitao; Wu, Jun; Zhang, Ejuan; Zhu, Zhenni; Zhu, Bin; Yin, Ying; Lin, Yong; Xu, Yang; Zheng, Xin; Lu, Mengji; Yang, Dongliang			Immunosuppressive Drugs Modulate the Replication of Hepatitis B Virus (HBV) in a Hydrodynamic Injection Mouse Model	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; MYCOPHENOLIC-ACID; LIVER-TRANSPLANTATION; IN-VITRO; INFECTION; TOLERANCE; IMMUNITY; CELL; IDENTIFICATION; LYMPHOCYTES	Hepatitis B virus (HBV) reactivation and recurrence are common in patients under immunosuppression and can be controlled by hepatitis B immunoglobulin, antivirals, and hepatitis B vaccine. However, the detailed analysis of HBV infection under immunosuppression is essential for the prophylaxis and therapy for HBV reactivation and recurrence. In this study, HBV replication and T cell responses were analyzed in a HBV-transfected mouse model under immunosuppressive therapy. During the treatment, HBV replication was at a high level in mice treated with dexamethasone, cyclosporine, and cyclophosphamide, whereas was terminated in mice treated with mycophenolate mofetil. After the withdrawal, HBV replication was at low or high levels in the dexamethasone-treated mice or in both cyclosporine-and cyclophosphamide-treated mice. The early withdrawal of cyclosporine allowed the recovery of suppressed T cell responses and led to subsequent HBV clearance, while the adoptive immune transfer to the mice with HBV persistence led to HBV suppression. Taken together, long-term HBV persistence under immunosuppression depends on the immunosuppressive drugs used and on the treatment duration and is mediated by the suppressed intrahepatic CD8 T cell response. These data may be helpful for individualized immunosuppressive therapy in patients with high risk of HBV reactivation and recurrence, and the mouse system is suitable for studying HBV reactivation and recurrence under immunosuppression.	[Wang, Junzhong; Wang, Baoju; Huang, Shunmei; Song, Zhitao; Wu, Jun; Zhu, Zhenni; Zhu, Bin; Zheng, Xin; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Zhang, Ejuan; Yin, Ying; Lin, Yong; Xu, Yang] Huazhong Univ Sci & Technol, Dept Microbiol, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; University of Duisburg Essen; Huazhong University of Science & Technology	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	mengji.lu@uni-due.de; dlyang@mail.hust.edu.cn	Wang, Junzhong/AAS-9767-2021; Lu, Mengji/ABF-9410-2020		National Major Science and Technology Project for Infectious Diseases of China [2008ZX10002011, 2012ZX10004503]; Major State Basic Research Program of China (973 Program) [2009CB522506]; National Natural Science Foundation of China [81001313, 81101248]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [TRR60]; Chinese Post-doctorial Science Foundation [20090460949]	National Major Science and Technology Project for Infectious Diseases of China; Major State Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Post-doctorial Science Foundation	This work was supported by grants from National Major Science and Technology Project for Infectious Diseases of China (2008ZX10002011, 2012ZX10004503, http://www.moh.gov.cn), The Major State Basic Research Program of China (973 Program, 2009CB522506, http://www.most.gov.cn), the National Natural Science Foundation of China (81001313. 81101248, http://www.nsfc.gov.cn), the International Science & Technology Cooperation Program of China (2011DFA31030, http://www.most.gov.cn), the Deutsche Forschungsgemeinschaft (Transregio TRR60, http://www.dfg.de) and Chinese Post-doctorial Science Foundation (20090460949, http://www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaha P, 2003, BLOOD, V101, P2886, DOI 10.1182/blood-2002-10-3014; Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Cholongitas E, 2013, AM J TRANSPLANT, V13, P353, DOI 10.1111/j.1600-6143.2012.04315.x; Cobleigh MA, 2010, J VIROL, V84, P7513, DOI 10.1128/JVI.00200-10; Dahmen U, 2004, TRANSPLANTATION, V77, P965, DOI 10.1097/01.TP.0000113804.35096.8E; Dell'Era L, 2011, RHEUMATOLOGY, V50, P1358, DOI 10.1093/rheumatology/ker102; Egli A, 2013, TRANSPLANTATION, V95, P448, DOI 10.1097/TP.0b013e318276a19f; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; Halford WP, 2000, J VIROL, V74, P5957, DOI 10.1128/JVI.74.13.5957-5967.2000; Hoppe-Seyler K, 2012, HEPATOLOGY, V56, P9, DOI 10.1002/hep.25602; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; KUNKL A, 1980, J IMMUNOL, V125, P2526; Lan PX, 2013, HEPATOLOGY, V58, P73, DOI 10.1002/hep.26339; Lau GKK, 1997, HEPATOLOGY, V25, P1497, DOI 10.1002/hep.510250631; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Lohr HF, 1998, LIVER, V18, P405; Londono MC, 2013, J HEPATOL; Luo Y, 2007, LIVER TRANSPLANT, V13, P71, DOI 10.1002/lt.20887; Pan QW, 2012, HEPATOLOGY, V56, P1586, DOI 10.1002/hep.25700; Pan QW, 2012, HEPATOLOGY, V55, P1673, DOI 10.1002/hep.25562; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Rahier JF, 2010, RHEUMATOLOGY, V49, P1815, DOI 10.1093/rheumatology/keq183; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Schaecher SR, 2008, VIROLOGY, V380, P312, DOI 10.1016/j.virol.2008.07.026; Wang BJ, 2011, J GEN VIROL, V92, P681, DOI 10.1099/vir.0.025023-0; Wursthorn K, 2010, GUT, V59, P1430, DOI 10.1136/gut.2009.195834; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524	33	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85832	10.1371/journal.pone.0085832	http://dx.doi.org/10.1371/journal.pone.0085832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465734	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500125
J	Chen, HY; Cheng, FC; Pan, HC; Hsu, JC; Wang, MF				Chen, Hsuan-Ying; Cheng, Fu-Chou; Pan, Huan-Chuan; Hsu, Jaw-Cheng; Wang, Ming-Fu			Magnesium Enhances Exercise Performance via Increasing Glucose Availability in the Blood, Muscle, and Brain during Exercise	PLOS ONE			English	Article							PROLONGED EXERCISE; IN-VIVO; SUBSTRATE UTILIZATION; SUBMAXIMAL EXERCISE; ENERGY-METABOLISM; SKELETAL-MUSCLE; PLASMA-GLUCOSE; LACTATE; TRANSPORTERS; EXPRESSION	Glucose mobilization and utilization in the periphery and central nervous system are important during exercise and are responsible for exercise efficacy. Magnesium (Mg) is involved in energy production and plays a role in exercise performance. This study aimed to explore the effects of Mg on the dynamic changes in glucose and lactate levels in the muscle, blood and brain of exercising rats using a combination of auto-blood sampling and microdialysis. Sprague-Dawley rats were pretreated with saline or magnesium sulfate (MgSO4, 90 mg/kg, i.p.) 30 min before treadmill exercise (20 m/min for 60 min). Our results indicated that the muscle, blood, and brain glucose levels immediately increased during exercise, and then gradually decreased to near basal levels in the recovery periods of both groups. These glucose levels were significantly enhanced to approximately two-fold (P<0.05) in the Mg group. Lactate levels in the muscle, blood, and brain rapidly and significantly increased in both groups during exercise, and brain lactate levels in the Mg group further elevated (P<0.05) than those in the control group during exercise. Lactate levels significantly decreased after exercise in both groups. In conclusion, Mg enhanced glucose availability in the peripheral and central systems, and increased lactate clearance in the muscle during exercise.	[Chen, Hsuan-Ying; Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chen, Hsuan-Ying; Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, Taichung, Taiwan; [Cheng, Fu-Chou] Providence Univ, Dept Appl Chem, Taichung 43309, Taiwan; [Pan, Huan-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Hsu, Jaw-Cheng] HungKuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Hsu, Jaw-Cheng] HungKuang Univ, Grad Inst Cosmet Sci, Taichung, Taiwan	Providence University - Taiwan; Taichung Veterans General Hospital; Providence University - Taiwan; Taichung Veterans General Hospital; Hungkuang University; Hungkuang University	Wang, MF (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	vc1035@gmail.com			Taichung Veterans General Hospital, Providence University [TCVGH-PU-1008107]; National Science Council, Taiwan, R.O.C. [NSC-100-2113-M-075A-001-MY2]	Taichung Veterans General Hospital, Providence University; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Taichung Veterans General Hospital, Providence University (TCVGH-PU-1008107), and the National Science Council (NSC-100-2113-M-075A-001-MY2), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG B, 1968, ACTA PHYSIOL SCAND, V74, P238, DOI 10.1111/j.1748-1716.1968.tb04231.x; AHLBORG G, 1972, SCAND J CLIN LAB INV, V29, P397, DOI 10.3109/00365517209080256; Bequet F, 2001, ACTA PHYSIOL SCAND, V173, P223, DOI 10.1046/j.1365-201X.2001.00859.x; Bohl CH, 2002, CRIT REV FOOD SCI, V42, P533, DOI 10.1080/20024091054247; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Chen IJ, 2009, INT J SPORT EXERCISE, V1, P75; Chen YJ, 2009, APPL PHYSIOL NUTR ME, V34, P1040, DOI 10.1139/H09-105; Cheng SM, 2007, EUR J APPL PHYSIOL, V99, P695, DOI 10.1007/s00421-006-0374-7; Cheng SM, 2010, EUR J APPL PHYSIOL, V108, P363, DOI 10.1007/s00421-009-1235-y; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Christensen SD, 2009, LAB ANIM-UK, V43, P65, DOI 10.1258/la.2008.007075; Clarkson PM, 1991, J SPORT SCI, V9, P91, DOI 10.1080/02640419108729869; COGGAN AR, 1991, SPORTS MED, V11, P102, DOI 10.2165/00007256-199111020-00003; Coker RH, 2005, SPORTS MED, V35, P575, DOI 10.2165/00007256-200535070-00003; CONSOLAZIO CF, 1963, J NUTR, V79, P407, DOI 10.1093/jn/79.4.407; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; FELIG P, 1982, NEW ENGL J MED, V306, P895, DOI 10.1056/NEJM198204153061503; GINSBERG MD, 1987, NEUROLOGY, V37, P11, DOI 10.1212/WNL.37.1.11; Golf SW, 1998, CARDIOVASC DRUG THER, V12, P197, DOI 10.1023/A:1007708918683; Gotoh M, 1998, BRAIN RES, V780, P74, DOI 10.1016/S0006-8993(97)01131-1; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Helge JW, 2010, ACTA PHYSIOL, V199, P519, DOI 10.1111/j.1748-1716.2010.02123.x; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; Hocher B, 2009, PHARMACOGENET GENOM, V19, P710, DOI 10.1097/FPC.0b013e328330bc7a; Holmang A, 2002, J APPL PHYSIOL, V92, P982, DOI 10.1152/japplphysiol.01194.2000; Huang CY, 2010, CELL BIOCHEM FUNCT, V28, P313, DOI 10.1002/cbf.1659; Ide K, 1999, J APPL PHYSIOL, V87, P1604, DOI 10.1152/jappl.1999.87.5.1604; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; KENNEDY C, 1976, P NATL ACAD SCI USA, V73, P4230, DOI 10.1073/pnas.73.11.4230; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kimura Y, 1996, J NUTR SCI VITAMINOL, V42, P407, DOI 10.3177/jnsv.42.407; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; KORF J, 1990, INT J BIOCHEM, V22, P1371, DOI 10.1016/0020-711X(90)90225-R; Lukaski HC, 2002, J NUTR, V132, P930, DOI 10.1093/jn/132.5.930; Lukaski HC, 2000, AM J CLIN NUTR, V72, p585S, DOI 10.1093/ajcn/72.2.585S; MacLean DA, 1999, J APPL PHYSIOL, V87, P1483, DOI 10.1152/jappl.1999.87.4.1483; Meeusen R, 1997, ACTA PHYSIOL SCAND, V159, P335, DOI 10.1046/j.1365-201X.1997.00118.x; Mooren FC, 2005, LIFE SCI, V77, P1211, DOI 10.1016/j.lfs.2004.12.040; Murphy E, 2000, CIRC RES, V86, P245, DOI 10.1161/01.RES.86.3.245; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; PAGES T, 1993, LAB ANIM, V27, P171, DOI 10.1258/002367793780810342; PERNOW B, 1971, J APPL PHYSIOL, V31, P416, DOI 10.1152/jappl.1971.31.3.416; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; ROLAND PE, 1985, HUM NEUROBIOL, V4, P155; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; STENDIGLINDBERG G, 1987, J AM COLL NUTR, V6, P35; Stuart CA, 2001, METABOLISM, V50, P771, DOI 10.1053/meta.2001.24202; Toft MF, 2006, LAB ANIM-UK, V40, P261, DOI 10.1258/002367706777611433; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; Zhang WW, 2009, CHINESE MED J-PEKING, V122, P1996, DOI 10.3760/cma.j.issn.0366-6999.2009.17.007; ZHAO YP, 1995, ANAL CHIM ACTA, V316, P403, DOI 10.1016/0003-2670(95)00379-E	61	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85486	10.1371/journal.pone.0085486	http://dx.doi.org/10.1371/journal.pone.0085486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465574	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500050
J	Kwasniewska, M; Jegier, A; Kostka, T; Dziankowska-Zaborszczyk, E; Rebowska, E; Kozinska, J; Drygas, W				Kwasniewska, Magdalena; Jegier, Anna; Kostka, Tomasz; Dziankowska-Zaborszczyk, Elzbieta; Rebowska, Ewa; Kozinska, Joanna; Drygas, Wojciech			Long-Term Effect of Different Physical Activity Levels on Subclinical Atherosclerosis in Middle-Aged Men: A 25-Year Prospective Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY CALCIUM; VASCULAR ENDOTHELIAL FUNCTION; CARDIOVASCULAR RISK-FACTORS; HEART-DISEASE; LEISURE-TIME; CAROTID ATHEROSCLEROSIS; WALL THICKNESS; EXERCISE; PREVENTION	Background: The purpose of the study was to investigate the influence of lifetime physical activity (PA) on selected indices of atherosclerosis in longitudinal observation of middle-aged men. Methods: The subject of the study was a cohort of 101 men (mean age 59,769,0 years), free of cardiovascular symptoms and treatment, participating in follow-up examinations in the years 1985/90-2011/12. Self-report PA was assessed by interviewer-administered Seven-Day PA Recall and Historical PA questionnaire. Subclinical atherosclerosis was measured by assessing the coronary artery calcification (CAC) according to Agatston's method using multi-slice computed tomography; the carotid intima-media thickness (IMT) using high-resolution B-mode ultrasound; and the reactive hyperemia index (RHI) using peripheral arterial tonometry (EndoPAT2000). The participants were initially divided into three groups according to tertiles of exercise-related energy expenditure (EE) in kcal/week at baseline, i.e. <2050 (low-to-moderate; n = 33), 2050-3840 (high; n = 34), >3840 (very high; n = 34). Results: The low-to-moderate, high and very high PA groups were comparable in terms of age and atherosclerosis risk factors at baseline. No linear relationship was found between PA and CAC, IMT and RHI. Men who maintained low-to-moderate (n = 26), high (n = 21) and very high (n = 15) PA level had the mean CAC of 286.1 +/- 361.9, 10.7 +/- 28.9, and 106.1 +/- 278.3 (p<0.001 for low-to moderate vs high; p<0.05 for low-to-moderate vs very high); the mean IMT of 0.751 +/- 0.19 mm, 0,641 +/- 0.26 mm, and 0.750 +/- 0.60 mm (p>0.05); and the mean RHI of 1.69 +/- 0.4, 2.00 +/- 0.4, and 2.13 +/- 0.5 (p for trend = 0.050), respectively. No cases of CAC>400, IMT >= 0.9 and RHI<1.67 were noted only among men with maintained high PA level. At final examination men with high and very high PA had more favorable cardiometabolic profile than men with lower PA. Conclusions: Maintaining regular high PA level through young and middle adulthood may protect against atherosclerosis as measured by CAC, IMT and RHI.	[Kwasniewska, Magdalena; Dziankowska-Zaborszczyk, Elzbieta; Rebowska, Ewa; Kozinska, Joanna; Drygas, Wojciech] Med Univ Lodz, Dept Social & Prevent Med, Lodz, Poland; [Jegier, Anna] Med Univ Lodz, Dept Sports Med, Lodz, Poland; [Kostka, Tomasz] Med Univ Lodz, Dept Geriatr, Lodz, Poland; [Drygas, Wojciech] Inst Cardiol, Dept Cardiovasc Epidemiol & Prevent, Warsaw, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Institute of Cardiology - Poland	Kwasniewska, M (corresponding author), Med Univ Lodz, Dept Social & Prevent Med, Lodz, Poland.	magdalena.kwasniewska@umed.lodz.pl	Drygas, Wojciech/GLR-9863-2022; Kwaśniewska, Magdalena/S-6655-2016	Drygas, Wojciech/0000-0002-4351-6459; Rebowska, Ewa/0000-0002-3620-588X; Kostka, Tomasz/0000-0003-0437-650X; Kwasniewska, Magdalena/0000-0003-4547-5627; Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606; Jegier, Anna/0000-0003-4737-2226	National Science Centre (Poland) [NN 404 258940]	National Science Centre (Poland)(National Science Centre, Poland)	The study was supported by the scientific grant NN 404 258940 from the National Science Centre (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Clarkson P, 1999, J AM COLL CARDIOL, V33, P1379, DOI 10.1016/S0735-1097(99)00036-4; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Desai MY, 2004, AM J CARDIOL, V94, P729, DOI 10.1016/j.amjcard.2004.06.004; Drygas W, 2000, INT J SPORTS MED, V21, P235, DOI 10.1055/s-2000-309; Drygas W, 2009, PUBLIC HEALTH, V123, P592, DOI 10.1016/j.puhe.2009.08.004; Drygas Wojciech, 2005, Przegl Lek, V62 Suppl 3, P8; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; FOLSOM AR, 1994, STROKE, V25, P66, DOI 10.1161/01.STR.25.1.66; Fox S M 3rd, 1972, Mod Concepts Cardiovasc Dis, V41, P25; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hamer M, 2010, HEART, V96, P380, DOI 10.1136/hrt.2009.183350; Han SH, 2010, ATHEROSCLEROSIS, V209, P197, DOI 10.1016/j.atherosclerosis.2009.08.027; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Kriska AM, 1997, MED SCI SPORTS EXERC, V29, pS43; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Laursen AH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001711; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luedemann J, 2002, STROKE, V33, P2929, DOI 10.1161/01.STR.0000038422.57919.7F; Moreau KL, 2002, AM J PHYSIOL-HEART C, V283, pH1409, DOI 10.1152/ajpheart.00035.2002; Nordstrom CK, 2003, AM J MED, V115, P19, DOI 10.1016/S0002-9343(03)00242-0; Paffenbarger Jr, 1997, Blood Press Monit, V2, P115; Pahkala K, 2011, CIRCULATION, V124, P1956, DOI 10.1161/CIRCULATIONAHA.111.043851; Popovic M, 2010, AM J MED SCI, V339, P332, DOI 10.1097/MAJ.0b013e3181cefbb9; Rauramaa R, 2004, ANN INTERN MED, V140, P1007, DOI 10.7326/0003-4819-140-12-200406150-00010; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Siscovick DS, 1997, AM J EPIDEMIOL, V145, P977; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Sung J, 2012, AM J CARDIOL, V109, P839, DOI 10.1016/j.amjcard.2011.11.009; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Tanaka H, 2002, J APPL PHYSIOL, V92, P1458, DOI 10.1152/japplphysiol.00824.2001; Taylor AJ, 2002, MED SCI SPORT EXER, V34, P228, DOI 10.1097/00005768-200202000-00008; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wannamethee SG, 2001, SPORTS MED, V31, P101, DOI 10.2165/00007256-200131020-00003; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; Wilund KR, 2008, METABOLISM, V57, P584, DOI 10.1016/j.metabol.2007.11.024	49	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85209	10.1371/journal.pone.0085209	http://dx.doi.org/10.1371/journal.pone.0085209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465505	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500038
J	Mwafi, N; Beretta, CA; Paolini, A; Carl, M				Mwafi, Nesrin; Beretta, Carlo A.; Paolini, Alessio; Carl, Matthias			Divergent Wnt8a Gene Expression in Teleosts	PLOS ONE			English	Article							ORYZIAS-LATIPES; ZEBRAFISH WNT8; SONIC-HEDGEHOG; MEDAKA; MOUSE; XWNT-8; COMPLEMENTARY; MESODERM; MUTATION; EMBRYO	The analysis of genes in evolutionarily distant but morphologically similar species is of major importance to unravel the changes in genomes over millions of years, which led to gene silencing and functional diversification. We report the analysis of Wnt8a gene expression in the medakafish and provide a detailed comparison to other vertebrates. In all teleosts analyzed there are two paralogous Wnt8a copies. These show largely overlapping expression in the early developing zebrafish embryo, an evolutionarily distant relative of medaka. In contrast to zebrafish, we find that both maternal and zygotic expression of particularly one Wnt8a paralog has diverged in medaka. While Wnt8a1 expression is mostly conserved at early embryonic stages, the expression of Wnt8a2 differs markedly. In addition, both genes are distinctly expressed during organogenesis unlike the zebrafish homologs, which may hint at the emergence of functional diversification of Wnt8a ligands during evolution.	[Mwafi, Nesrin; Beretta, Carlo A.; Paolini, Alessio; Carl, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Carl, M (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Mannheim, Germany.	matthias.carl@medma.uni-heidelberg.de		Paolini, Alessio/0000-0001-7002-7303; Carl, Matthias/0000-0002-9936-5813	German Academic Exchange Service [DAAD - 441-kl]; Medical Faculty Mannheim of the University Heidelberg; Biotechnology and Biological Sciences Research Council [BB/C51454X/1] Funding Source: researchfish	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Medical Faculty Mannheim of the University Heidelberg; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the German Academic Exchange Service (DAAD - 441-kl) to NM and the Medical Faculty Mannheim of the University Heidelberg to CB and MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beretta CA, 2011, GENE EXPR PATTERNS, V11, P277, DOI 10.1016/j.gep.2011.01.004; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Christian JL, 1993, DEV BIOL, V180, P22; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Force A, 1999, GENETICS, V151, P1531; Fujita M, 2006, DEV DYNAM, V235, P734, DOI 10.1002/dvdy.20696; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUME CR, 1993, DEVELOPMENT, V119, P1147; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Koster R, 1997, DEVELOPMENT, V124, P3147; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Martin A, 2012, EVOL DEV, V14, P178, DOI 10.1111/j.1525-142X.2012.00534.x; MCDONALD FJ, 1994, DEV GENET, V15, P148, DOI 10.1002/dvg.1020150205; McNabb A, 2012, ZEBRAFISH, V9, P120, DOI 10.1089/zeb.2012.0768; Narayanan A, 2012, DEV DYNAM, V241, P1062, DOI 10.1002/dvdy.23787; Narayanan A, 2011, DEV DYNAM, V240, P898, DOI 10.1002/dvdy.22599; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ramel MC, 2004, DEV DYNAM, V231, P441, DOI 10.1002/dvdy.20141; Rieden PMJID, 2010, DEV DYNAM, V239, P126, DOI 10.1002/dvdy.22020; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Tian Q, 1999, DEVELOPMENT, V126, P3371; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Winkler S, 2000, DEVELOPMENT, V127, P1911; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yokoi H, 2003, DEV GROWTH DIFFER, V45, P51, DOI 10.1046/j.1440-169X.2003.00674.x; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85303	10.1371/journal.pone.0085303	http://dx.doi.org/10.1371/journal.pone.0085303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465531	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500041
J	Mezzanotte, L; An, N; Mol, IM; Lowik, CWGM; Kaijzel, EL				Mezzanotte, Laura; An, Na; Mol, Isabel M.; Lowik, Clemens W. G. M.; Kaijzel, Eric L.			A New Multicolor Bioluminescence Imaging Platform to Investigate NF-kappa B Activity and Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; ACTIVATION; REPORTER; LUCIFERASE; SULFORAPHANE; CELASTROL; CURCUMIN; RED; PROLIFERATION; INHIBITION	Background: Evaluation of novel drugs for clinical development depends on screening technologies and informative preclinical models. Here we developed a multicolor bioluminescent imaging platform to simultaneously investigate transcription factor NF-kappa B signaling and apoptosis. Methods: The human breast cancer cell line (MDA-MB-231) was genetically modified to express green, red and blue light emitting luciferases to monitor cell number and viability, NF-kappa B promoter activity and to perform specific cell sorting and detection, respectively. The pro-luciferin substrate Z-DEVD-animoluciferin was employed to determine apoptotic caspase 3/7 activity. We used the cell line for the in vitro evaluation of natural compounds and in vivo optical imaging of tumor necrosis factor TNF alpha-induced NF-kappa B activation. Results: Celastrol, resveratrol, sulphoraphane and curcumin inhibited the NF-kappa B promoter activity significantly and in a dose dependent manner. All compounds except resveratrol induced caspase 3/7 dependent apoptosis. Multicolor bioluminescence in vivo imaging allowed the investigation of tumor growth and NF-kappa B induction in a mouse model of breast cancer. Conclusion: Our new method provides an imaging platform for the identification, validation, screening and optimization of compounds acting on NF-kappa B signaling and apoptosis both in vitro and in vivo.	[Mezzanotte, Laura; An, Na; Lowik, Clemens W. G. M.; Kaijzel, Eric L.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Mol, Isabel M.] Leiden Univ, Dept Endocrinol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kaijzel, EL (corresponding author), Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.	e.l.kaijzel@lumc.nl	Kaijzel, Eric/GZN-2333-2022	Mezzanotte, Laura/0000-0001-5592-8904; Kaijzel, Eric/0000-0003-3118-9910	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 130 partners; China Scholarship Council	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 130 partners; China Scholarship Council(China Scholarship Council)	This work is supported in part by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners and the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Bartfeld S., 2010, BMC CELL BIOL, V2010, P11; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; BRASIER AR, 1992, METHOD ENZYMOL, V216, P386; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Castillo-Pichardo L, 2009, CLIN EXP METASTAS, V26, P505, DOI 10.1007/s10585-009-9250-2; Chiu TL, 2009, INT J MOL MED, V23, P469, DOI 10.3892/ijmm_00000153; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Haefner B, 2006, CANC TREAT, V130, P219; Hosseinkhani S, 2011, CELL MOL LIFE SCI, V68, P1167, DOI 10.1007/s00018-010-0607-0; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Jacobsen, 2009, BIOTECHNIQUES, V47, P826, DOI 10.2144/000113254; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Katula KS, 2005, J MED FOOD, V8, P269, DOI 10.1089/jmf.2005.8.269; Kim SR, 2012, ENDOCRINOLOGY, V153, P554, DOI 10.1210/en.2011-1413; Kwon H, 2010, BIOTECHNIQUES, V48, P460, DOI 10.2144/000113419; Lampe JW, 2009, GUT, V58, P900, DOI 10.1136/gut.2008.166694; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Maddox Clinton B, 2008, JALA Charlottesv Va, V13, P168, DOI 10.1016/j.jala.2008.02.002; Meeran SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037748; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Na IK, 2010, BLOOD, V116, pE18, DOI 10.1182/blood-2009-12-259432; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nguyen TH, 2008, INT J ONCOL, V33, P81; Pozo-Guisado E, 2005, INT J CANCER, V116, P1004, DOI 10.1002/ijc.21209; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Ralhan Ranju, 2009, Front Biosci (Schol Ed), V1, P45; Robbins D, 2011, METHODS MOL BIOL, V716, P169, DOI 10.1007/978-1-61779-012-6_10; Scabini M, 2011, APOPTOSIS, V16, P198, DOI 10.1007/s10495-010-0553-1; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stell A, 2007, Q J NUCL MED MOL IM, V51, P127; Sun AM, 2009, BIOORG MED CHEM LETT, V19, P6627, DOI 10.1016/j.bmcl.2009.10.023; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tang HY, 2006, MOL CANCER THER, V5, P2034, DOI 10.1158/1535-7163.MCT-06-0216; Thamake SI, 2012, BIOMATERIALS, V33, P7164, DOI 10.1016/j.biomaterials.2012.06.026; WOOD KV, 1990, J BIOLUM CHEMILUM, V5, P107, DOI 10.1002/bio.1170050206; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031; Zong H, 2012, MOL BIOL REP, V39, P4803, DOI 10.1007/s11033-011-1273-5	61	28	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85550	10.1371/journal.pone.0085550	http://dx.doi.org/10.1371/journal.pone.0085550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465597	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000044
J	Samuels, BA; Leonardo, ED; Dranovsky, A; Williams, A; Wong, E; Nesbitt, AMI; McCurdy, RD; Hen, R; Alter, M				Samuels, Benjamin A.; Leonardo, E. David; Dranovsky, Alex; Williams, Amanda; Wong, Erik; Nesbitt, Addie May I.; McCurdy, Richard D.; Hen, Rene; Alter, Mark			Global State Measures of the Dentate Gyrus Gene Expression System Predict Antidepressant-Sensitive Behaviors	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; HISTONE DEACETYLASE INHIBITORS; VENTRAL HIPPOCAMPUS; REGULATORY NETWORKS; IMMUNE-RESPONSES; MICROARRAY DATA; DORSAL; FLUOXETINE; BDNF; RECEPTOR	Background: Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are the most common form of medication treatment for major depression. However, approximately 50% of depressed patients fail to achieve an effective treatment response. Understanding how gene expression systems respond to treatments may be critical for understanding antidepressant resistance. Methods: We take a novel approach to this problem by demonstrating that the gene expression system of the dentate gyrus responds to fluoxetine (FLX), a commonly used antidepressant medication, in a stereotyped-manner involving changes in the expression levels of thousands of genes. The aggregate behavior of this large-scale systemic response was quantified with principal components analysis (PCA) yielding a single quantitative measure of the global gene expression system state. Results: Quantitative measures of system state were highly correlated with variability in levels of antidepressant-sensitive behaviors in a mouse model of depression treated with fluoxetine. Analysis of dorsal and ventral dentate samples in the same mice indicated that system state co-varied across these regions despite their reported functional differences. Aggregate measures of gene expression system state were very robust and remained unchanged when different microarray data processing algorithms were used and even when completely different sets of gene expression levels were used for their calculation. Conclusions: System state measures provide a robust method to quantify and relate global gene expression system state variability to behavior and treatment. State variability also suggests that the diversity of reported changes in gene expression levels in response to treatments such as fluoxetine may represent different perspectives on unified but noisy global gene expression system state level responses. Studying regulation of gene expression systems at the state level may be useful in guiding new approaches to augmentation of traditional antidepressant treatments.	[Samuels, Benjamin A.; Leonardo, E. David; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Samuels, Benjamin A.; Leonardo, E. David; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Williams, Amanda; Wong, Erik] CNS Discovery, AstraZeneca Pharmaceut, Wilmington, DE USA; [Nesbitt, Addie May I.; McCurdy, Richard D.; Alter, Mark] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Columbia University; Columbia University; AstraZeneca; University of Pennsylvania; Pennsylvania Medicine	Hen, R (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	rh95@columbia.edu; markalter1968@gmail.com	Leonardo, Eduardo/AAH-1525-2020; Dranovsky, Alex/P-4357-2018	Leonardo, Eduardo/0000-0001-7426-0217; Dranovsky, Alex/0000-0001-7896-3243	NIMH [1K08MH080228-04, 1K01MH098188-01, 1R01MH091427, 1K08MH076083]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091844, K01MH098188, R01MH091427, K08MH080228, R37MH068542, T32MH014654, K08MH076083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043688] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MA is funded by 1K08MH080228-04 from NIMH. BS is funded by 1K01MH098188-01 from NIMH. EDL is funded by 1R01MH091427 and was previously funded from 1K08MH076083 from NIMH at the time of participation in this study. RH receives compensation as a consultant for Lundbeck and Roche. Lundbeck and Roche had no role in the study. AW and EW were full-time employees of Astra Zeneca at the time of their participation in this study. Astra Zeneca paid for the microarrays but had no role in the study design, analysis, or writing of the manuscript.	Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Alme Maria Nordheim, 2007, Neural Plast, V2007, P26496, DOI 10.1155/2007/26496; Alter MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061324; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Alter O, 2006, P NATL ACAD SCI USA, V103, P11828, DOI 10.1073/pnas.0604756103; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; Bock M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035077; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Branchi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062226; Branchi I, 2010, PSYCHONEUROENDOCRINO, V35, P743, DOI 10.1016/j.psyneuen.2009.10.016; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Diaz SL, 2012, MOL PSYCHIATR, V17, P154, DOI 10.1038/mp.2011.159; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Felice D, 2012, NEUROPHARMACOLOGY, V63, P1380, DOI 10.1016/j.neuropharm.2012.06.066; Gandal MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041215; Hodes GE, 2010, NEUROSCI LETT, V484, P12, DOI 10.1016/j.neulet.2010.07.084; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Karagiannis TC, 2006, ONCOGENE, V25, P3885, DOI 10.1038/sj.onc.1209417; Karagiannis Tom C, 2004, Hell J Nucl Med, V7, P184; Kim DH, 2007, EXP NEUROL, V204, P748, DOI 10.1016/j.expneurol.2007.01.008; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Klebanov L, 2007, NAT BIOTECHNOL, V25, P24, DOI 10.1038/nbt0107-25; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; McHugh SB, 2008, BEHAV NEUROSCI, V122, P1, DOI 10.1037/0735-7044.122.1.1; McHugh SB, 2011, EUR J NEUROSCI, V33, P322, DOI 10.1111/j.1460-9568.2010.07497.x; Molteni R, 2006, INT J NEUROPSYCHOPH, V9, P307, DOI 10.1017/S1461145705005766; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Peixoto L, 2012, NEUROPSYCHOPHARMACOL; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rogers JL, 2006, NEUROBIOL LEARN MEM; Royce SG, 2012, ANN CLIN LAB SCI, V42, P338; Royce SG, 2012, J ASTHMA, V49, P121, DOI 10.3109/02770903.2011.648298; Samuels BA, 2011, NEUROPHARMACOLOGY, V61, P408, DOI 10.1016/j.neuropharm.2011.02.017; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Tanaka KF, 2012, PHILOS T R SOC B, V367, P2395, DOI 10.1098/rstb.2012.0038; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Vinet J, 2004, NEUROPHARMACOLOGY, V47, P1062, DOI 10.1016/j.neuropharm.2004.07.035; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wall MichaelE., 2003, SINGULAR VALUE DECOM; Wang JW, 2008, BIOL PSYCHIAT, V63, P640, DOI 10.1016/j.biopsych.2008.01.008; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	54	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85136	10.1371/journal.pone.0085136	http://dx.doi.org/10.1371/journal.pone.0085136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465494	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000026
J	Raes, AK; De Houwer, J; De Schryver, M; Brass, M; Kalisch, R				Raes, An K.; De Houwer, Jan; De Schryver, Maarten; Brass, Marcel; Kalisch, Raffael			Do CS-US Pairings Actually Matter? A Within-Subject Comparison of Instructed Fear Conditioning with and without Actual CS-US Pairings	PLOS ONE			English	Article							VERBAL INFORMATION PATHWAY; SKIN-CONDUCTANCE; CHILDHOOD FEARS; ACQUISITION; CHILDREN; PHOBIAS; ORIGINS; PARADIGM; ETIOLOGY; ANXIETY	Previous research showed that instructions about CS-US pairings can lead to fear of the CS even when the pairings are never presented. In the present study, we examined whether the experience of CS-US pairings adds to the effect of instructions by comparing instructed conditioning with and without actual CS-US pairings in a within-subject design. Thirty-two participants saw three fractals as CSs (CS(+)1, CS(+)2, CS-) and received electric shocks as USs. Before the start of a so-called training phase, participants were instructed that both CS(+)1 and CS(+)2 would be followed by the US, but only CS(+)1 was actually paired with the US. The absence of the US after CS(+)2 was explained in such a way that participants would not doubt the instructions about the CS(+)2-US relation. After the training phase, a test phase was carried out. In this phase, participants expected the US after both CS+s but none of the CS(+)s was actually paired with the US. During test, self-reported fear was initially higher for CS(+)1 than for CS(+)2, which indicates that the experience of actual CS-US pairings adds to instructions about these pairings. On the other hand, the CS(+)s elicited similar skin conductance responses and US expectancies. Theoretical and clinical implications are discussed.	[Raes, An K.; De Houwer, Jan; De Schryver, Maarten; Brass, Marcel] Univ Ghent, B-9000 Ghent, Belgium; [Raes, An K.] Erasmus Univ, Rotterdam, Netherlands; [Kalisch, Raffael] Univ Med Ctr Hamburg Eppendorf UKE, Inst Syst Neurosci, Hamburg, Germany; [Kalisch, Raffael] Johannes Gutenberg Univ Mainz, Med Ctr, Focus Program Translat Neurosci FTN, Neuroimaging Ctr Mainz NIC, D-55122 Mainz, Germany	Ghent University; Erasmus University Rotterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	De Houwer, J (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.	Jan.DeHouwer@UGent.be	Brass, Marcel/J-7082-2012; De Houwer, Jan/ABF-6866-2021; Kalisch, Raffael/H-6624-2016; Kalisch, Raffael/A-9863-2018	Brass, Marcel/0000-0002-3364-4019; De Houwer, Jan/0000-0003-0488-5224; 	Belgian Science Policy Office [IUAPVII/33]; Ghent University [BOF09/01M00209]; Deutsche Forschungsgemeinschaft (DFG) [KA1623/3-1]; Special Research Fund (BOF) of Ghent University (Belgium)	Belgian Science Policy Office(Belgian Federal Science Policy Office); Ghent University(Ghent University); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Special Research Fund (BOF) of Ghent University (Belgium)(CGIAR)	The research reported in this paper was funded by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (IUAPVII/33), by Ghent University Methusalem Grant BOF09/01M00209 awarded to Jan De Houwer, and by the Deutsche Forschungsgemeinschaft (DFG grant KA1623/3-1) awarded to Raffael Kalisch. An K. Raes was supported by a postdoctoral grant from the Special Research Fund (BOF) of Ghent University (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew C, 2008, CLIN PSYCHOL REV, V28, P1249, DOI 10.1016/j.cpr.2008.05.003; Cook SW, 1937, J EXP PSYCHOL, V21, P202, DOI 10.1037/h0063197; Davey G. C. L, 1997, PHOBIAS HDB THEORY R, P301; DAVEY GCL, 1992, ADV BEHAV RES THER, V14, P29, DOI 10.1016/0146-6402(92)90010-L; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; De Clercq A, 2006, BEHAV RES METHODS, V38, P504, DOI 10.3758/BF03192805; De Houwer J, 2009, LEARN BEHAV, V37, P1, DOI 10.3758/LB.37.1.1; Dickinson A, 1996, Q J EXP PSYCHOL-B, V49, P60, DOI 10.1080/713932614; Field AP, 2008, COGNITION EMOTION, V22, P459, DOI 10.1080/02699930801886532; Field AP, 2007, BEHAV RES THER, V45, P3051, DOI 10.1016/j.brat.2007.09.001; Field AP, 2007, J CHILD PSYCHOL PSYC, V48, P1088, DOI 10.1111/j.1469-7610.2007.01772.x; Field AP, 2006, CLIN PSYCHOL REV, V26, P857, DOI 10.1016/j.cpr.2005.05.010; Field AP, 2003, BEHAV RES THER, V41, P1277, DOI 10.1016/S0005-7967(03)00034-2; Field AP, 2001, BEHAV RES THER, V39, P1259, DOI 10.1016/S0005-7967(00)00080-2; JONES T, 1990, BEHAV RES THER, V28, P159, DOI 10.1016/0005-7967(90)90028-H; King NJ, 1998, BEHAV RES THER, V36, P297, DOI 10.1016/S0005-7967(98)00015-1; Lawson J, 2007, BEHAV RES THER, V45, P21, DOI 10.1016/j.brat.2006.01.007; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Miller RR, 2001, CURR DIR PSYCHOL SCI, V10, P141, DOI 10.1111/1467-8721.00135; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Mitchell CJ, 2009, BEHAV BRAIN SCI, V32, P183, DOI 10.1017/S0140525X09000855; Muris P, 1997, BEHAV RES THER, V35, P929, DOI 10.1016/S0005-7967(97)00050-8; Muris P, 2008, J ANXIETY DISORD, V22, P1510, DOI 10.1016/j.janxdis.2008.03.004; Muris P, 2010, CLIN CHILD FAM PSYCH, V13, P129, DOI 10.1007/s10567-010-0064-1; OLLENDICK TH, 1991, BEHAV RES THER, V29, P117, DOI 10.1016/0005-7967(91)90039-6; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Pineles SL, 2009, PSYCHOPHYSIOLOGY, V46, P984, DOI 10.1111/j.1469-8986.2009.00852.x; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Ugland CCO, 2013, BIOL PSYCHOL, V92, P69, DOI 10.1016/j.biopsycho.2012.02.003; Van der Ploeg HM, 2000, HANDLEIDING BIJ ZELF; Wagner A.R., 1981, P5; West B. T., 2007, LINEAR MIXED MODELS; WHITE K, 1989, BEHAV RES THER, V27, P161, DOI 10.1016/0005-7967(89)90074-0	35	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84888	10.1371/journal.pone.0084888	http://dx.doi.org/10.1371/journal.pone.0084888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24465447	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000009
J	Coll, M; Carreras, M; Ciercoles, C; Cornax, MJ; Gorelli, G; Morote, E; Saez, R				Coll, Marta; Carreras, Marta; Ciercoles, Cristina; Cornax, Maria-Jose; Gorelli, Giulia; Morote, Elvira; Saez, Raquel			Assessing Fishing and Marine Biodiversity Changes Using Fishers' Perceptions: The Spanish Mediterranean and Gulf of Cadiz Case Study	PLOS ONE			English	Article							SMALL PELAGIC FISH; SOUTH CATALAN SEA; BALEARIC-ISLANDS; OF-CALIFORNIA; TROPHIC FLOWS; ECOSYSTEM; IMPACTS; CONSEQUENCES; MANAGEMENT; ANECDOTES	Background: The expansion of fishing activities has intensively transformed marine ecosystems worldwide. However, available time series do not frequently cover historical periods. Methodology: Fishers' perceptions were used to complement data and characterise changes in fishing activity and exploited ecosystems in the Spanish Mediterranean Sea and Gulf of Cadiz. Fishers' interviews were conducted in 27 fishing harbours of the area, and included 64 fishers from ages between 20 to > 70 years old to capture the experiences and memories of various generations. Results are discussed in comparison with available independent information using stock assessments and international convention lists. Principal Findings: According to fishers, fishing activity substantially evolved in the area with time, expanding towards deeper grounds and towards areas more distant from the coast. The maximum amount of catch ever caught and the weight of the largest species ever captured inversely declined with time. Fishers (70%) cited specific fishing grounds where depletion occurred. They documented ecological changes of marine biodiversity during the last half of the century: 94% reported the decline of commercially important fish and invertebrates and 61% listed species that could have been extirpated, with frequent mentions to cartilaginous fish. Declines and extirpations were in line with available quantitative evaluations from stock assessments and international conventions, and were likely linked to fishing impacts. Conversely, half of interviewed fishers claimed that several species had proliferated, such as cephalopods, jellyfish, and small-sized fish. These changes were likely related to trophic cascades due to fishing and due to climate change effects. The species composition of depletions, local extinctions and proliferations showed differences by region suggesting that regional dynamics are important when analysing biodiversity changes. Conclusions/Significance: Using fishers' perceptions, fishing and ecological changes in the study area were documented. The recovery of local ecological knowledge provides valuable information complementing quantitative monitoring and evaluation surveys.	[Coll, Marta; Gorelli, Giulia; Saez, Raquel] CSIC, ICM, Barcelona, Spain; [Coll, Marta] IFREMER, IRD, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, Sete, France; [Coll, Marta] Univ Montpellier 2, Sete, France; [Carreras, Marta; Cornax, Maria-Jose] OCEANA, Madrid, Spain; [Ciercoles, Cristina] Invest Planificac & Desarrollo SA, Madrid, Spain; [Morote, Elvira] Univ Almeria UAL, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Universidad de Almeria	Coll, M (corresponding author), CSIC, ICM, Barcelona, Spain.	mcoll@icm.csic.es	; Coll, Marta/A-9488-2012	morote, elvira/0000-0002-8707-2159; Coll, Marta/0000-0001-6235-5868	Marie Curie EC CIG grant; Spanish Research Program Ramon y Cajal; EC program Science in Society EC [266544-GAP2]	Marie Curie EC CIG grant; Spanish Research Program Ramon y Cajal(German Research Foundation (DFG)); EC program Science in Society EC	MC was supported by the Marie Curie EC CIG grant to BIOWEB and the Spanish Research Program Ramon y Cajal. GG was funded through the EC program Science in Society EC. FP7 (ref # 266544-GAP2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; Aldebert Y, 1997, VIE MILIEU, V47, P275; Alvarez Ereipa B, 2008, THESIS U BARCELONA; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Barcelona Convention, 1976, CONV PROT MED SEA PO; Bas C., 2003, VARIACIONS DEMOGRAFI; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bonn Convention, 1983, CONV CONS MIGR SPEC; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Boudreau SA, 2010, MAR ECOL PROG SER, V403, P181, DOI 10.3354/meps08473; Brown C., 2006, MARINE COASTAL ECOSY; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Carreras M, 2013, ESTIMATES TOTAL FISH; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chiara P, 2010, ECOL MODEL, V221, P1526, DOI 10.1016/j.ecolmodel.2010.03.002; CITES Convention, 1975, CONV INT TRAD END SP; Coll M, 2006, J MARINE SYST, V59, P63, DOI 10.1016/j.jmarsys.2005.09.001; Coll M, 2013, ESTIMATE TOTAL CATCH; Coll M, 2008, ECOL MODEL, V217, P95, DOI 10.1016/j.ecolmodel.2008.06.013; Coll M, 2006, ECOL MODEL, V198, P53, DOI 10.1016/j.ecolmodel.2006.04.009; Coll M, 2013, DEEP-SEA RES PT II, V95, P21, DOI 10.1016/j.dsr2.2012.08.020; Coll M, 2013, BIOL CONSERV, V157, P108, DOI 10.1016/j.biocon.2012.06.029; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Duran J, 2012, AQUAC RES, V43, P1777, DOI 10.1111/j.1365-2109.2011.02983.x; FAO, 2011, GFCM MED BLACK SEA C; FAO-GFCM, 2013, 1042 FAOGFCM, P96; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Froese R., 2013, FISHBASE GLOBAL INFO; Gorley C.K., 2006, GETTING STARTED PRIM; Guenette S, 2012, OCEAN COAST MANAGE, V70, P10, DOI 10.1016/j.ocecoaman.2012.06.010; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hidalgo M, 2009, CAN J FISH AQUAT SCI, V66, P1355, DOI 10.1139/F09-081; Hutchings JA, 2009, ENVIRON REV, V17, P53, DOI 10.1139/A09-003; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Martin P, 2001, 00009 DG FISH, P135; Martin-Vide J, 2006, INT J CLIMATOL, V26, P1455, DOI 10.1002/joc.1388; Massuti E, 2003, ICES J MAR SCI, V60, P753, DOI 10.1016/S1054-3139(03)00089-4; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; Mayol J., 2000, DOCUMENTS TECNICS CO, VII, P1; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Narayanaswamy BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058909; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Quetglas A, 2012, SCI MAR, V76, P17, DOI 10.3989/scimar.2012.76n1017; Roux JP, 2013, B MAR SCI, V89, P249, DOI 10.5343/bms.2011.1145; Sabates A, 2006, GLOBAL CHANGE BIOL, V12, P2209, DOI 10.1111/j.1365-2486.2006.01246.x; SAC-GFCM, 2011, GEN FISH COMM MED SE; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sea Around Us P, 2011, SEA US PROJ LARG MAR; STECF, 2013, 25309 STECF EUR; Swartz W, 2011, PLOS ONE, V5; Van Swaay C, 1998, CONVENTION CONSERVAT; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	74	57	59	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85670	10.1371/journal.pone.0085670	http://dx.doi.org/10.1371/journal.pone.0085670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465644	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100057
J	Gudur, MSR; Rao, RR; Peterson, AW; Caldwell, DJ; Stegemann, JP; Deng, CX				Gudur, Madhu Sudhan Reddy; Rao, Rameshwar R.; Peterson, Alexis W.; Caldwell, David J.; Stegemann, Jan P.; Deng, Cheri X.			Noninvasive Quantification of In Vitro Osteoblastic Differentiation in 3D Engineered Tissue Constructs Using Spectral Ultrasound Imaging	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; MESENCHYMAL STEM-CELLS; NONDESTRUCTIVE EVALUATION; BIOMATERIALS; PARAMETERS; MATRIX; LESION	Non-destructive monitoring of engineered tissues is needed for translation of these products from the lab to the clinic. In this study, non-invasive, high resolution spectral ultrasound imaging (SUSI) was used to monitor the differentiation of MC3T3 pre-osteoblasts seeded within collagen hydrogels. SUSI was used to measure the diameter, concentration and acoustic attenuation of scatterers within such constructs cultured in either control or osteogenic medium over 21 days. Conventional biochemical assays were used on parallel samples to determine DNA content and calcium deposition. Construct volume and morphology were accurately imaged using ultrasound. Cell diameter was estimated to be approximately 12.5-15.5 mm using SUSI, which corresponded well to measurements of fluorescently stained cells. The total number of cells per construct assessed by quantitation of DNA content decreased from 5.662.4610 4 at day 1 to 0.960.2610 4 at day 21. SUSI estimation of the equivalent number of acoustic scatters showed a similar decreasing trend, except at day 21 in the osteogenic samples, which showed a marked increase in both scatterer number and acoustic impedance, suggestive of mineral deposition by the differentiating MC3T3 cells. Estimation of calcium content by SUSI was 41.7611.4 mg/ml, which agreed well with the biochemical measurement of 38.7616.7 mg/ml. Color coded maps of parameter values were overlaid on B-mode images to show spatiotemporal changes in cell diameter and calcium deposition. This study demonstrates the use of non-destructive ultrasound imaging to provide quantitative information on the number and differentiated state of cells embedded within 3D engineered constructs, and therefore presents a valuable tool for longitudinal monitoring of engineered tissue development.	[Gudur, Madhu Sudhan Reddy; Rao, Rameshwar R.; Peterson, Alexis W.; Caldwell, David J.; Stegemann, Jan P.; Deng, Cheri X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Stegemann, JP (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jpsteg@umich.edu; cxdeng@umich.edu		Caldwell, David/0000-0002-3179-5171	National Science Foundation Graduate Research Fellowship [DGE 1256260]; National Institutes of Health [R21-AR064041]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Science Foundation Graduate Research Fellowship, Grant # DGE 1256260 (to RRR) http://www.nsfgrfp.org/, and by the National Institutes of Health through R21-AR064041 (to CXD and JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Czarnota GJ, 1999, BRIT J CANCER, V81, P520, DOI 10.1038/sj.bjc.6690724; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Feleppa EJ, 2008, CANCER BIOMARK, V4, P201, DOI 10.3233/CBM-2008-44-504; Fite BZ, 2011, TISSUE ENG PART C-ME, V17, P495, DOI 10.1089/ten.tec.2010.0368; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Gudur M, 2012, TISSUE ENG PART C-ME, V18, P935, DOI [10.1089/ten.tec.2012.0180, 10.1089/ten.TEC.2012.0180]; Gudur MSR, 2012, IEEE T ULTRASON FERR, V59, P1687, DOI 10.1109/TUFFC.2012.2374; Han JW, 2012, MACH VISION APPL, V23, P15, DOI 10.1007/s00138-010-0275-y; Ho KY, 2013, J MAGN RESON IMAGING, V37, P237, DOI 10.1002/jmri.23749; INSANA MF, 1990, J ACOUST SOC AM, V87, P179, DOI 10.1121/1.399283; Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI [10.1016/j.biomaterials.2004.01.047, 10.1016/j.biomatcrials.2004.01.047]; Kolios MC, 2002, ULTRASOUND MED BIOL, V28, P589, DOI 10.1016/S0301-5629(02)00492-1; Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.tec.2010.0669, 10.1089/ten.TEC.2010.0669]; Kumon RE, 2012, GASTROINTEST ENDOSC, V75, P1175, DOI 10.1016/j.gie.2012.01.039; Kumon RE, 2012, ULTRASOUND MED BIOL, V38, P626, DOI 10.1016/j.ultrasmedbio.2012.01.004; Kumon RE, 2011, ULTRASOUND MED BIOL, V37, P834, DOI 10.1016/j.ultrasmedbio.2011.01.012; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lizzi FL, 2003, PATTERN RECOGN LETT, V24, P637, DOI 10.1016/S0167-8655(02)00172-1; Lizzi FL, 1997, INT J IMAG SYST TECH, V8, P3, DOI 10.1002/(SICI)1098-1098(1997)8:1<3::AID-IMA2>3.0.CO;2-E; Lizzi FL, 1997, 1997 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 & 2, P1109, DOI 10.1109/ULTSYM.1997.661774; LIZZI FL, 1987, IEEE T ULTRASON FERR, V34, P319, DOI 10.1109/T-UFFC.1987.26950; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nazarian A, 2008, BONE, V43, P302, DOI 10.1016/j.bone.2008.04.009; Oe K, 2010, TISSUE ENG PART C-ME, V16, P347, DOI [10.1089/ten.tec.2008.0564, 10.1089/ten.TEC.2008.0564]; Oelze ML, 2004, IEEE T MED IMAGING, V23, P764, DOI 10.1109/TMI.2004.826953; OLIVER MH, 1989, J CELL SCI, V92, P513; Qian J, 2009, AM J CARDIOL, V103, P1210, DOI 10.1016/j.amjcard.2009.01.031; Rao RR, 2013, J BIOMED MATER RES A, V101, P1531, DOI 10.1002/jbm.a.34611; Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1; Siebers S, 2004, ULTRASON, P1804; Tunis AS, 2005, ULTRASOUND MED BIOL, V31, P1041, DOI 10.1016/j.ultrasmedbio.2005.04.020; Vlad RM, 2008, INT J RADIAT ONCOL, V72, P1236, DOI 10.1016/j.ijrobp.2008.07.027; Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3; Walker JM, 2011, ANN BIOMED ENG, V39, P2521, DOI 10.1007/s10439-011-0351-0; Yang SY, 2006, MEAS SCI TECHNOL, V17, P2001, DOI 10.1088/0957-0233/17/7/045; Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296	40	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85749	10.1371/journal.pone.0085749	http://dx.doi.org/10.1371/journal.pone.0085749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465680	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100069
J	Lecina-Diaz, J; Alvarez, A; Retana, J				Lecina-Diaz, Judit; Alvarez, Albert; Retana, Javier			Extreme Fire Severity Patterns in Topographic, Convective and Wind-Driven Historical Wildfires of Mediterranean Pine Forests	PLOS ONE			English	Article							NORMALIZED BURN RATIO; FUEL TYPES; HALEPENSIS FORESTS; CLIMATE; VEGETATION; REGENERATION; LANDSCAPE; BEHAVIOR; CLASSIFICATION; INTENSITY	Crown fires associated with extreme fire severity are extremely difficult to control. We have assessed fire severity using differenced Normalized Burn Ratio (dNBR) from Landsat imagery in 15 historical wildfires of Pinus halepensis Mill. We have considered a wide range of innovative topographic, fuel and fire behavior variables with the purposes of (1) determining the variables that influence fire severity patterns among fires (considering the 15 wildfires together) and (2) ascertaining whether different variables affect extreme fire severity within the three fire types (topographic, convective and wind-driven fires). The among-fires analysis showed that fires in less arid climates and with steeper slopes had more extreme severity. In less arid conditions there was more crown fuel accumulation and closer forest structures, promoting high vertical and horizontal fuel continuity and extreme fire severity. The analyses carried out for each fire separately (within fires) showed more extreme fire severity in areas in northern aspects, with steeper slopes, with high crown biomass and in climates with more water availability. In northern aspects solar radiation was lower and fuels had less water limitation to growth which, combined with steeper slopes, produced more extreme severity. In topographic fires there was more extreme severity in northern aspects with steeper slopes and in areas with more water availability and high crown biomass; in convection-dominated fires there was also more extreme fire severity in northern aspects with high biomass; while in wind-driven fires there was only a slight interaction between biomass and water availability. This latter pattern could be related to the fact that wind-driven fires spread with high wind speed, which could have minimized the effect of other variables. In the future, and as a consequence of climate change, new zones with high crown biomass accumulated in non-common drought areas will be available to burn as extreme severity wildfires.	[Lecina-Diaz, Judit; Alvarez, Albert; Retana, Javier] CREAF, Cerdanyola Del Valles, Catalonia, Spain; [Retana, Javier] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Catalonia, Spain	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Lecina-Diaz, J (corresponding author), CREAF, Cerdanyola Del Valles, Catalonia, Spain.	j.lecina@creaf.uab.es	Retana, Javier/L-1214-2014	Retana, Javier/0000-0002-7505-9467; Lecina-Diaz, Judit/0000-0002-6867-5886; Alvarez Nebot, Albert/0000-0002-7592-9944	project MONTES CONSOLIDER [CSD-2008-00040]	project MONTES CONSOLIDER	This study has been partially funded by the project MONTES CONSOLIDER CSD-2008-00040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Omary A, 2011, NEW FOREST, V42, P285, DOI 10.1007/s11056-011-9251-2; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Alexander JD, 2006, INT J WILDLAND FIRE, V15, P237, DOI 10.1071/WF05053; Alrababah MA, 2006, INT J REMOTE SENS, V27, P2703, DOI 10.1080/01431160500522700; Alvarez A, 2013, FOREST SCI, V59, P139, DOI 10.5849/forsci.10-140; Alvarez A, 2012, FOREST ECOL MANAG, V270, P282, DOI 10.1016/j.foreco.2011.01.039; Alvarez A, 2012, EUR J FOREST RES, V131, P463, DOI 10.1007/s10342-011-0520-6; [Anonymous], 2006, RMRSGTR164CD USDA FO; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Broncano MJ, 2004, INT J WILDLAND FIRE, V13, P209, DOI 10.1071/WF03036; Capel J.J., 2000, CLIMA PENINSULA IBER; Castellnou M, 2009, P 5 C FOR ESP AV SPA; Castellnou M, 2010, EUR FOR I RES REP, V23, P121; Chafer CJ, 2004, INT J WILDLAND FIRE, V13, P227, DOI 10.1071/WF03041; Chung Joo-Sang, 2002, [Journal of Korean Society of Forest Science, 한국산림과학회지], V91, P34; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Costa P., 2011, PREVENTION LARGE WIL; Covington WW, 2000, NATURE, V408, P135; Cruz MG, 2004, FOREST SCI, V50, P640; Cruz MG, 2003, INT J WILDLAND FIRE, V12, P39, DOI 10.1071/WF02024; de la Cueva AV, 2006, INT J WILDLAND FIRE, V15, P397, DOI 10.1071/WF05071; Dimitrakopoulos AP, 2001, FIRE TECHNOL, V37, P143, DOI 10.1023/A:1011641601076; Escuin S, 2008, INT J REMOTE SENS, V29, P1053, DOI 10.1080/01431160701281072; Fule PZ, 2002, FOREST ECOL MANAG, V170, P19, DOI 10.1016/S0378-1127(01)00759-9; Garcia-Martin A, 2008, IEEE J-STARS, V1, P254, DOI 10.1109/JSTARS.2008.2011623; Gong X, 2008, J ARID ENVIRON, V72, P483, DOI 10.1016/j.jaridenv.2007.07.001; Graham R.T., 2004, SCI BASIS CHANGING F; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Holden ZA, 2009, FOREST ECOL MANAG, V258, P2399, DOI 10.1016/j.foreco.2009.08.017; Ireland KB, 2012, LANDSCAPE ECOL, V27, P983, DOI 10.1007/s10980-012-9753-0; Kane VR, 2013, FOREST ECOL MANAG, V287, P17, DOI 10.1016/j.foreco.2012.08.044; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Lee B, 2008, J FOREST RES-JPN, V13, P197, DOI 10.1007/s10310-008-0072-x; Lee SW, 2009, FOREST ECOL MANAG, V258, P1594, DOI 10.1016/j.foreco.2009.07.017; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P557, DOI 10.1071/WF05096; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Martinson EJ, 2008, INT J WILDLAND FIRE, V17, P415, DOI 10.1071/WF06067; McArthur AG, 1968, 9 COMM FOR C; MCSC, 2005, MAP COB SOL CAT; Miller JD, 2012, ECOL APPL, V22, P184, DOI 10.1890/10-2108.1; Miller JD, 2007, REMOTE SENS ENVIRON, V109, P66, DOI 10.1016/j.rse.2006.12.006; Mitsopoulos ID, 2007, ANN FOREST SCI, V64, P287, DOI 10.1051/forest:2007006; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; Ninyerola M, 2005, ATLAS CLIMATICO PENI; Oliveras I, 2009, INT J WILDLAND FIRE, V18, P755, DOI 10.1071/WF08070; PALA V, 1995, PHOTOGRAMM ENG REM S, V61, P935; Pausas J., 1999, REMOTE SENSING LARGE, P3, DOI [10.1007/978-3-642-60164-4, DOI 10.1007/978-3-642-60164-4, 10.1007/978-3-642-60164-4_2, DOI 10.1007/978-3-642-60164-4_2]; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pflugmacher D, 2012, REMOTE SENS ENVIRON, V122, P146, DOI 10.1016/j.rse.2011.09.025; PONS X, 1994, REMOTE SENS ENVIRON, V48, P191, DOI 10.1016/0034-4257(94)90141-4; PONS X., 2000, MIRAMON SISTEMA INFO; PONS X, 1996, 7 C GEOGR CUANT SIST; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raz-Yaseef N, 2010, AGR FOREST METEOROL, V150, P454, DOI 10.1016/j.agrformet.2010.01.010; Retana J, 2002, ECOSCIENCE, V9, P89, DOI 10.1080/11956860.2002.11682694; Rodrigo A, 2004, ECOLOGY, V85, P716, DOI 10.1890/02-0492; Rothermel R.C., 1972, MATH MODEL PREDICTIN; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; Schwind B, 2010, PNWGTR802 USDA FOR S; Scott JH, 2001, RMRS29 USDA FOR SERV; Silva J. S., 2010, INTEGRATED FIRE MANA; Soverel NO, 2011, INT J WILDLAND FIRE, V20, P518, DOI 10.1071/WF10081; Stocks BJ, 2004, CAN J FOREST RES, V34, P1543, DOI [10.1139/x04-905, 10.1139/X04-905]; Stow D, 2007, GISCI REMOTE SENS, V44, P1, DOI 10.2747/1548-1603.44.1.1; Taylor SW, 2004, CAN J FOREST RES, V34, P1561, DOI 10.1139/X04-116; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Turner MG, 1999, INT J WILDLAND FIRE, V9, P21, DOI 10.1071/WF99003; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Van Wagner C, 1985, EQUATIONS FORTRAN PR, P1; Velez R., 2000, DEFENSA INCENDIOS FO; Vicente-Serrano SM, 2010, AGR FOREST METEOROL, V150, P614, DOI 10.1016/j.agrformet.2010.02.002; Villanueva J. A., 2005, TERCER INVENTARIO FO; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; WEATHERSPOON CP, 1995, FOREST SCI, V41, P430; Werth PA, 2011, PNW854 USDA FOR SERV; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	81	52	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85127	10.1371/journal.pone.0085127	http://dx.doi.org/10.1371/journal.pone.0085127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465492	gold, Green Published			2022-12-27	WOS:000330283100023
J	Ogawa, D; Eguchi, J; Wada, J; Terami, N; Hatanaka, T; Tachibana, H; Nakatsuka, A; Horiguchi, CS; Nishii, N; Makino, H				Ogawa, Daisuke; Eguchi, Jun; Wada, Jun; Terami, Naoto; Hatanaka, Takashi; Tachibana, Hiromi; Nakatsuka, Atsuko; Horiguchi, Chikage Sato; Nishii, Naoko; Makino, Hirofumi			Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines	PLOS ONE			English	Article							PPAR-ALPHA AGONIST; DIABETIC-NEPHROPATHY; ERR-ALPHA; INFLAMMATION; ACTIVATION; MICE; FENOFIBRATE; PROTEINURIA; METABOLISM; FIBROSIS	Nuclear hormone receptors (NHRs) are transcription factors that regulate carbohydrate and lipid metabolism, immune responses, and inflammation. Although several NHRs, including peroxisome proliferator-activated receptor-gamma (PPAR gamma) and PPAR alpha, demonstrate a renoprotective effect in the context of diabetic nephropathy (DN), the expression and role of other NHRs in the kidney are still unrecognized. To investigate potential roles of NHRs in the biology of the kidney, we used quantitative real-time polymerase chain reaction to profile the expression of all 49 members of the mouse NHR superfamily in mouse kidney tissue (C57BL/6 and db/m), and cell lines of mesangial (MES13), podocyte (MPC), proximal tubular epithelial (mProx24) and collecting duct (mIMCD3) origins in both normal and high-glucose conditions. In C57BL/6 mouse kidney cells, hepatocyte nuclear factor 4 alpha, chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and COUP-TFIII were highly expressed. During hyperglycemia, the expression of the NHR 4A subgroup including neuron-derived clone 77 (Nur77), nuclear receptor-related factor 1, and neuron-derived orphan receptor 1 significantly increased in diabetic C57BL/6 and db/db mice. In renal cell lines, PPAR delta was highly expressed in mesangial and proximal tubular epithelial cells, while COUP-TFs were highly expressed in podocytes, proximal tubular epithelial cells, and collecting duct cells. High-glucose conditions increased the expression of Nur77 in mesangial and collecting duct cells, and liver x receptor alpha in podocytes. These data demonstrate NHR expression in mouse kidney cells and cultured renal cell lines and suggest potential therapeutic targets in the kidney for the treatment of DN.	[Ogawa, Daisuke; Eguchi, Jun; Wada, Jun; Terami, Naoto; Hatanaka, Takashi; Tachibana, Hiromi; Nakatsuka, Atsuko; Horiguchi, Chikage Sato; Nishii, Naoko; Makino, Hirofumi] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan; [Ogawa, Daisuke; Nakatsuka, Atsuko] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Okayama, Japan	Okayama University; Okayama University	Ogawa, D (corresponding author), Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan.	daiogawa@md.okayama-u.ac.jp	Wada, Jun/B-2023-2011	Wada, Jun/0000-0003-1468-5170	Ministry of Education, Culture, Sports, Science and Technology, Japan [25461223, 24790927]; Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This study was supported in part by Grants-in-Aid for Scientific Research (C) to Dr. Ogawa (25461223) and for Young Scientists (B) to Horiguchi (24790927) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis from the Ministry of Health, Labour and Welfare of Japan. This work also received support from the Takeda Science Foundation and the Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Ansquer JC, 2009, CURR PHARM DESIGN, V15, P537, DOI 10.2174/138161209787315701; Auwerx J, 1999, CELL, V97, P161; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Catanuto P, 2009, KIDNEY INT, V75, P1194, DOI 10.1038/ki.2009.69; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Ji R, 2012, BRIT J PHARMACOL, V166, P1033, DOI 10.1111/j.1476-5381.2011.01817.x; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kitamura S, 2003, NEPHRON EXP NEPHROL, V95, pE79, DOI 10.1159/000073675; Levi M, 2011, BBA-MOL BASIS DIS, V1812, P1061, DOI 10.1016/j.bbadis.2011.04.003; Libby P, 2007, AM J CARDIOL, V99, p27B, DOI 10.1016/j.amjcard.2006.11.004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsushita Y, 2011, DIABETES, V60, P960, DOI 10.2337/db10-1361; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Ogawa D, 2011, EXP DIABETES RES, DOI 10.1155/2011/534872; Okada T, 2006, DIABETES, V55, P1666, DOI 10.2337/db05-1285; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pirih FQ, 2005, BIOCHEM BIOPH RES CO, V332, P494, DOI 10.1016/j.bbrc.2005.04.132; Pistrosch F, 2012, HORM METAB RES, V44, P914, DOI 10.1055/s-0032-1314836; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Susztak K, 2006, J AM SOC NEPHROL, V17, P361, DOI 10.1681/ASN.2005101109; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Teng CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026961; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; Wang LL, 2008, BIOCHEM J, V416, P407, DOI 10.1042/BJ20081085; Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010; Wang XXX, 2010, NAT REV NEPHROL, V6, P342, DOI 10.1038/nrneph.2010.56; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Wu J, 2004, AM J PHYSIOL-RENAL, V287, pF886, DOI 10.1152/ajprenal.00123.2004; Yang JC, 2012, CURR OPIN NEPHROL HY, V21, P97, DOI 10.1097/MNH.0b013e32834de526; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yasuhara A, 2008, CIRCULATION, V118, P2146, DOI 10.1161/CIRCULATIONAHA.108.787259; Yu CT, 2012, DEVELOPMENT, V139, P2330, DOI 10.1242/dev.076299	45	11	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85594	10.1371/journal.pone.0085594	http://dx.doi.org/10.1371/journal.pone.0085594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465611	Green Published, gold			2022-12-27	WOS:000330283100050
J	Radhakrishnan, VM; Kojs, P; Young, G; Ramalingam, R; Jagadish, B; Mash, EA; Martinez, JD; Ghishan, FK; Kiela, PR				Radhakrishnan, Vijayababu M.; Kojs, Pawel; Young, Gavin; Ramalingam, Rajalakshmy; Jagadish, Bhumasamudram; Mash, Eugene A.; Martinez, Jesse D.; Ghishan, Fayez K.; Kiela, Pawel R.			pTyr(421) Cortactin Is Overexpressed in Colon Cancer and Is Dephosphorylated by Curcumin: Involvement of Non-Receptor Type 1 Protein Tyrosine Phosphatase (PTPN1)	PLOS ONE			English	Article							CHROMOSOME 11Q13 AMPLIFICATION; TANDEM MASS-SPECTROMETRY; RHO-FAMILY GTPASES; HEPATOCELLULAR-CARCINOMA; PHOSPHORYLATION SITES; ACTIN CYTOSKELETON; CLINICAL-TRIALS; CELL-ADHESION; INVASION; GROWTH	Cortactin (CTTN), first identified as a major substrate of the Src tyrosine kinase, actively participates in branching F-actin assembly and in cell motility and invasion. CTTN gene is amplified and its protein is overexpressed in several types of cancer. The phosphorylated form of cortactin (pTyr(421)) is required for cancer cell motility and invasion. In this study, we demonstrate that a majority of the tested primary colorectal tumor specimens show greatly enhanced expression of pTyr(421)-CTTN, but no change at the mRNA level as compared to healthy subjects, thus suggesting post-translational activation rather than gene amplification in these tumors. Curcumin (diferulolylmethane), a natural compound with promising chemopreventive and chemosensitizing effects, reduced the indirect association of cortactin with the plasma membrane protein fraction in colon adenocarcinoma cells as measured by surface biotinylation, mass spectrometry, and Western blotting. Curcumin significantly decreased the pTyr(421)-CTTN in HCT116 cells and SW480 cells, but was ineffective in HT-29 cells. Curcumin physically interacted with PTPN1 tyrosine phosphatases to increase its activity and lead to dephosphorylation of pTyr(421)-CTTN. PTPN1 inhibition eliminated the effects of curcumin on pTyr(421)-CTTN. Transduction with adenovirally-encoded CTTN increased migration of HCT116, SW480, and HT-29. Curcumin decreased migration of HCT116 and SW480 cells which highly express PTPN1, but not of HT-29 cells with significantly reduced endogenous expression of PTPN1. Curcumin significantly reduced the physical interaction of CTTN and pTyr(421)-CTTN with p120 catenin (CTNND1). Collectively, these data suggest that curcumin is an activator of PTPN1 and can reduce cell motility in colon cancer via dephosphorylation of pTyr(421)-CTTN which could be exploited for novel therapeutic approaches in colon cancer therapy based on tumor pTyr(421)-CTTN expression.	[Radhakrishnan, Vijayababu M.; Ramalingam, Rajalakshmy; Ghishan, Fayez K.; Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA; [Kojs, Pawel] Dept Nutr Sci, Tucson, AZ USA; [Young, Gavin; Jagadish, Bhumasamudram; Mash, Eugene A.; Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ USA; [Jagadish, Bhumasamudram; Mash, Eugene A.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; Arizona Center Cancer Care; University of Arizona; University of Arizona; University of Arizona Health Sciences; University of Arizona	Kiela, PR (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA.	pkiela@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Kiela, Pawel/0000-0002-0014-3517	National Institutes of Health [5 R01 DK067286]; NIH [P30 CA 23074]; NIEHS [ES006694]; NIH/NCI [CA023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institutes of Health [5 R01 DK067286 to PRK and FKG]. NIH grant, P30 CA 23074 [EAM] NIEHS grant ES006694 to the Southwest Environmental Health Sciences Center (SWEHSC), NIH/NCI grant CA023074 to the Arizona Cancer Center and by the BIO5 Institute of the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Angelo LS, 2013, BIOORGAN MED CHEM, V21, P932, DOI 10.1016/j.bmc.2012.12.008; Basile V, 2009, BIOCHEM PHARMACOL, V78, P1305, DOI 10.1016/j.bcp.2009.06.105; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Bringuier PP, 1996, ONCOGENE, V12, P1747; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Donato RP, METHODS MOL BIOL, V763, P115; Grosheva I, 2001, J CELL SCI, V114, P695; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Hashimoto A, PLOS ONE, V6; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hofman P, 2008, BRIT J CANCER, V98, P956, DOI 10.1038/sj.bjc.6604245; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Ji JL, 2012, ANTI-CANCER AGENT ME, V12, P210, DOI 10.2174/187152012800228733; Kim JM, 2012, PHYTOMEDICINE, V19, P1085, DOI 10.1016/j.phymed.2012.07.002; Kim SY, 2005, BIOCHEM BIOPH RES CO, V337, P510, DOI 10.1016/j.bbrc.2005.09.079; Kuttan G, 2007, ADV EXP MED BIOL, V595, P173; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Larmonier CB, 2011, INFLAMM BOWEL DIS, V17, P503, DOI 10.1002/ibd.21391; Li YS, 2001, CANCER RES, V61, P6906; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; MacGrath SM, J CELL SCI, V125, P1621; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Midura-Kiela MT, AM J PHYSL GASTROINT, V302, pG85; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Mo N, 2012, ASIAN PAC J CANCER P, V13, P5709, DOI 10.7314/APJCP.2012.13.11.5709; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; SCHUURING E, 1992, ONCOGENE, V7, P355; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tsang RKY, 2012, CANCER INVEST, V30, P503, DOI 10.3109/07357907.2012.691192; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; Wang GC, 2009, WORLD J UROL, V27, P557, DOI 10.1007/s00345-009-0376-2; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wilbur DS, 1996, BIOCONJUGATE CHEM, V7, P689, DOI 10.1021/bc9600628; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Yuan BZ, 2003, J MOL DIAGN, V5, P48, DOI 10.1016/S1525-1578(10)60451-5; ZHAN X, 1993, J BIOL CHEM, V268, P24427; ZHAN X, 1994, J BIOL CHEM, V269, P20221; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	63	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85796	10.1371/journal.pone.0085796	http://dx.doi.org/10.1371/journal.pone.0085796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465712	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100074
J	Schabrun, SM; van den Hoorn, W; Moorcroft, A; Greenland, C; Hodges, PW				Schabrun, Siobhan M.; van den Hoorn, Wolbert; Moorcroft, Alison; Greenland, Cameron; Hodges, Paul W.			Texting and Walking: Strategies for Postural Control and Implications for Safety	PLOS ONE			English	Article							OLDER-ADULTS; EXECUTIVE CONTROL; GAIT; FALLS; PELVIS; STABILITY; HEAD; COORDINATION; TALKING; BALANCE	There are concerns about the safety of texting while walking. Although evidence of negative effects of mobile phone use on gait is scarce, cognitive distraction, altered mechanical demands, and the reduced visual field associated with texting are likely to have an impact. In 26 healthy individuals we examined the effect of mobile phone use on gait. Individuals walked at a comfortable pace in a straight line over a distance of similar to 8.5 m while; 1) walking without the use of a phone, 2) reading text on a mobile phone, or 3) typing text on a mobile phone. Gait performance was evaluated using a three-dimensional movement analysis system. In comparison with normal waking, when participants read or wrote text messages they walked with: greater absolute lateral foot position from one stride to the next; slower speed; greater rotation range of motion (ROM) of the head with respect to global space; the head held in a flexed position; more in-phase motion of the thorax and head in all planes, less motion between thorax and head (neck ROM); and more tightly organized coordination in lateral flexion and rotation directions. While writing text, participants walked slower, deviated more from a straight line and used less neck ROM than reading text. Although the arms and head moved with the thorax to reduce relative motion of the phone and facilitate reading and texting, movement of the head in global space increased and this could negatively impact the balance system. Texting, and to a lesser extent reading, modify gait performance. Texting or reading on a mobile phone may pose an additional risk to safety for pedestrians navigating obstacles or crossing the road.	[Schabrun, Siobhan M.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; NHMRC, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Schabrun, SM (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	s.schabrun@uq.edu.au	van den Hoorn, Wolbert/F-6894-2010; Hodges, Paul W/B-6578-2008	van den Hoorn, Wolbert/0000-0002-9658-2388; Hodges, Paul W/0000-0002-1206-9107; Greenland, Cameron/0000-0001-9206-616X; Schabrun, Siobhan/0000-0002-9083-3107	National Health and Medical Research Council of Australia [ID1002190, ID631612, ID631717]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	SM Schabrun is supported by a Clinical Research fellowship (ID631612) and PW Hodges by a Senior Principal Research fellowship (ID1002190) both from the National Health and Medical Research Council of Australia. Funding for the study was provided by the National Health and Medical Research Council of Australia (ID631717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberici E, 2011, AUSTR BROADCASTING C; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Demura S, 2009, EUR J SPORT SCI, V9, P303, DOI 10.1080/17461390902853069; Drews FA, 2009, HUM FACTORS, V51, P762, DOI 10.1177/0018720809353319; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Hosking SG, 2009, HUM FACTORS, V51, P582, DOI 10.1177/0018720809341575; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Newcombe A, 2012, AM BROADCASTING CORP; Nymark JR, 2005, J REHABIL RES DEV, V42, P523, DOI 10.1682/JRRD.2004.05.0059; Pijnappels M, 2001, GAIT POSTURE, V14, P11, DOI 10.1016/S0966-6362(01)00110-2; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Richtel M, 2010, NY TIMES, pA1; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Segev-Jacubovski O, 2011, EXPERT REV NEUROTHER, V11, P1057, DOI [10.1586/ern.11.69, 10.1586/ERN.11.69]; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; St George RJ, 2011, J PHYSIOL-LONDON, V589, P807, DOI 10.1113/jphysiol.2010.197665; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yizhar Z, 2009, INT J REHABIL RES, V32, P115, DOI 10.1097/MRR.0b013e32830d3675; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963	28	94	95	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84312	10.1371/journal.pone.0084312	http://dx.doi.org/10.1371/journal.pone.0084312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465402	Green Published, gold			2022-12-27	WOS:000330283100011
J	Tamim, S; Vo, DT; Uren, PJ; Qiao, M; Bindewald, E; Kasprzak, WK; Shapiro, BA; Nakaya, HI; Burns, SC; Araujo, PR; Nakano, I; Radek, AJ; Kuersten, S; Smith, AD; Penalva, LOF				Tamim, Saleh; Vo, Dat T.; Uren, Philip J.; Qiao, Mei; Bindewald, Eckart; Kasprzak, Wojciech K.; Shapiro, Bruce A.; Nakaya, Helder I.; Burns, Suzanne C.; Araujo, Patricia R.; Nakano, Ichiro; Radek, Agnes J.; Kuersten, Scott; Smith, Andrew D.; Penalva, Luiz O. F.			Genomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal Differentiation in Glioblastoma Cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; MICRORNA REPLACEMENT THERAPY; EMBRYONIC STEM-CELLS; MIB1 LABELING INDEX; DOUBLECORTIN-LIKE; GLIOMA-CELLS; MESSENGER-RNAS; INTEGRATIVE ANALYSIS; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE	miR-137 plays critical roles in the nervous system and tumor development; an increase in its expression is required for neuronal differentiation while its reduction is implicated in gliomagenesis. To evaluate the potential of miR-137 in glioblastoma therapy, we conducted genome-wide target mapping in glioblastoma cells by measuring the level of association between PABP and mRNAs in cells transfected with miR-137 mimics vs. controls via RIPSeq. Impact on mRNA levels was also measured by RNASeq. By combining the results of both experimental approaches, 1468 genes were found to be negatively impacted by miR-137 - among them, 595 (40%) contain miR-137 predicted sites. The most relevant targets include oncogenic proteins and key players in neurogenesis like c-KIT, YBX1, AKT2, CDC42, CDK6 and TGF beta 2. Interestingly, we observed that several identified miR-137 targets are also predicted to be regulated by miR-124, miR-128 and miR-7, which are equally implicated in neuronal differentiation and gliomagenesis. We suggest that the concomitant increase of these four miRNAs in neuronal stem cells or their repression in tumor cells could produce a robust regulatory effect with major consequences to neuronal differentiation and tumorigenesis.	[Tamim, Saleh; Vo, Dat T.; Qiao, Mei; Burns, Suzanne C.; Araujo, Patricia R.; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Uren, Philip J.; Smith, Andrew D.] Univ So Calif, Div Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA USA; [Bindewald, Eckart; Kasprzak, Wojciech K.] SAIC Frederick Inc, Basic Sci Program, Ctr Canc Res Nanobiol Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Shapiro, Bruce A.] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA; [Nakaya, Helder I.] Univ Sao Paulo, Inst Pharmaceut Sci, Dept Clin Anal & Toxicol, Sao Paulo, Brazil; [Nakano, Ichiro] Ohio State Univ, Dept Neurol Surg, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Radek, Agnes J.; Kuersten, Scott] Epicentre, Madison, WI USA; [Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade de Sao Paulo; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio	Penalva, LOF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA.	penalva@uthscsa.edu	Nakaya, Helder/AAF-1738-2020; Nakano, Ichiro/AAR-9562-2020; Tamim, Saleh/ABH-1777-2020; Nakano, Ichiro/F-2076-2014; Nakaya, Helder I/A-1397-2010; Smith, Andrew D./G-4104-2013	Nakaya, Helder/0000-0001-5297-9108; Nakano, Ichiro/0000-0002-0916-3207; Nakano, Ichiro/0000-0002-6734-3468; Nakaya, Helder I/0000-0001-5297-9108; Smith, Andrew D./0000-0002-3337-1970; Penalva, Luiz/0000-0003-4491-6769	National Institutes of Health [HG006015]; IIMS; CTSA (UTHSCSA); Center for Biomedical Neuroscience (CBN) (UTHSCSA); Max and Minnie Tomerlin Voelcker Fund; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008382, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IIMS; CTSA (UTHSCSA); Center for Biomedical Neuroscience (CBN) (UTHSCSA); Max and Minnie Tomerlin Voelcker Fund; Frederick National Laboratory for Cancer Research, National Institutes of Health; Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [HG006015 to A.D.S. and L.O.F.P.], IIMS and CTSA (UTHSCSA) [to L.O.F.P.], Center for Biomedical Neuroscience (CBN) (UTHSCSA) [to L.O.F.P.], and the Max and Minnie Tomerlin Voelcker Fund [to L.O.F.P.]. This project has been funded in whole or in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. This research was supported [in part] by the Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, Center for Cancer Research. Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P591, DOI 10.1007/s10549-010-1028-3; Althoff K, 2013, INT J CANCER, V133, P1064, DOI 10.1002/ijc.28091; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007; Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3; Chen XY, 2011, INVEST OPHTH VIS SCI, V52, P1193, DOI 10.1167/iovs.10-5272; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Costello JF, 1997, CANCER RES, V57, P1250; Cui Y, 2012, BRAIN RES, V1469, P1, DOI 10.1016/j.brainres.2012.06.043; Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Featherstone DE, 2011, GLIA, V59, P1351, DOI 10.1002/glia.21085; Fitzsimons CP, 2008, MOL ENDOCRINOL, V22, P248, DOI 10.1210/me.2007-0233; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Fotovati A, 2011, CANCER RES, V71, P5569, DOI 10.1158/0008-5472.CAN-10-2805; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Glazer RI, 2012, FRONT BIOSCI-LANDMRK, V17, P54, DOI 10.2741/3915; Gomes AL, 2007, CELL ONCOL, V29, P399; Gonzalez-Gomez P, 2011, MOL NEUROBIOL, V44, P235, DOI 10.1007/s12035-011-8196-y; Hau P, 2011, CURR PHARM BIOTECHNO, V12, P2150, DOI 10.2174/138920111798808347; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Henry JC, 2011, PHARM RES-DORDR, V28, P3030, DOI 10.1007/s11095-011-0548-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Kang K, 2012, J BIOL CHEM; Kelleher FC, 2012, CANCER J, V18, P132, DOI 10.1097/PPO.0b013e31824ba4df; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Kwon E., 2011, MOL PSYCHIAT; Lam PYP, 2000, BRIT J NEUROSURG, V14, P28; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, ONCOL REP, V28, P909, DOI 10.3892/or.2012.1884; Li K.K., 2012, BRAIN PATHOL; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Milano V, 2009, MOL CANCER THER, V8, P394, DOI 10.1158/1535-7163.MCT-08-0669; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Nagamine T, 2011, J BIOCHEM, V149, P619, DOI 10.1093/jb/mvr013; Nielsen S, 1997, J NEUROSCI, V17, P171; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; Penalva LOF, 2004, BIOTECHNIQUES, V37, P604, DOI 10.2144/04374ST05; Perruisseau-Carrier C, 2011, MOL NEUROBIOL, V43, P215, DOI 10.1007/s12035-011-8179-z; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Pittoni P, 2011, ONCOGENE, V30, P757, DOI 10.1038/onc.2010.494; Pu PY, 2004, TUMOR BIOL, V25, P172, DOI 10.1159/000081099; Quintero A, 2006, J CLIN PATHOL, V59, P83, DOI 10.1136/jcp.2004.022939; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schmitt A, 2006, HISTOPATHOLOGY, V49, P298, DOI 10.1111/j.1365-2559.2006.02505.x; Schneider T, 2006, J NEURO-ONCOL, V79, P61, DOI 10.1007/s11060-005-9116-7; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Sharma S, 2004, APPL IMMUNOHISTO M M, V12, P290, DOI 10.1097/00129039-200412000-00002; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041; Warth A, 2007, J NEUROSCI RES, V85, P1336, DOI 10.1002/jnr.21224; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314; Zhang DY, 2011, ONCOL REP, V26, P901, DOI 10.3892/or.2011.1362; Zhang JX, 2010, ONCOL REP, V24, P65, DOI 10.3892/or_00000829; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; ZHU X, 2012, FEBS LETT	104	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85591	10.1371/journal.pone.0085591	http://dx.doi.org/10.1371/journal.pone.0085591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465609	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100048
J	Khurelbaatar, N; Krueger, WS; Heil, GL; Darmaa, B; Ulziimaa, D; Tserennorov, D; Baterdene, A; Anderson, BD; Gray, GC				Khurelbaatar, Nyamdavaa; Krueger, Whitney S.; Heil, Gary L.; Darmaa, Badarchiin; Ulziimaa, Daramragchaa; Tserennorov, Damdindorj; Baterdene, Ariungerel; Anderson, Benjamin D.; Gray, Gregory C.			Little Evidence of Avian or Equine Influenza Virus Infection among a Cohort of Mongolian Adults with Animal Exposures, 2010-2011	PLOS ONE			English	Article							ANTIBODIES; WATERFOWL	Avian (AIV) and equine influenza virus (EIV) have been repeatedly shown to circulate among Mongolia's migrating birds or domestic horses. In 2009, 439 Mongolian adults, many with occupational exposure to animals, were enrolled in a prospective cohort study of zoonotic influenza transmission. Sera were drawn upon enrollment and again at 12 and 24 months. Participants were contacted monthly for 24 months and queried regarding episodes of acute influenza-like illnesses (ILI). Cohort members confirmed to have acute influenza A infections, permitted respiratory swab collections which were studied with rRT-PCR for influenza A. Serologic assays were performed against equine, avian, and human influenza viruses. Over the 2 yrs of follow-up, 100 ILI investigations in the cohort were conducted. Thirty-six ILI cases (36%) were identified as influenza A infections by rRT-PCR; none yielded evidence for AIV or EIV. Serological examination of 12 mo and 24 mo annual sera revealed 37 participants had detectable antibody titers (>= 1: 10) against studied viruses during the course of study follow-up: 21 against A/Equine/Mongolia/01/2008(H3N8);4 against an avian A/Teal/Hong Kong/w3129(H6N1), 11 against an avian-like A/Hong Kong/1073/1999(H9N2), and 1 against an avian A/Migrating duck/Hong Kong/MPD268/2007(H10N4) virus. However, all such titers were <1:80 and none were statistically associated with avian or horse exposures. A number of subjects had evidence of seroconversion to zoonotic viruses, but the 4-fold titer changes were again not associated with avian or horse exposures. As elevated antibodies against seasonal influenza viruses were high during the study period, it seems likely that cross-reacting antibodies against seasonal human influenza viruses were a cause of the low-level seroreactivity against AIV or EIV. Despite the presence of AIV and EIV circulating among wild birds and horses in Mongolia, there was little evidence of AIV or EIV infection in this prospective study of Mongolians with animal exposures.	[Khurelbaatar, Nyamdavaa] Mongolian Assoc Infect Dis Researchers, Ulaanbaatar, Mongolia; [Krueger, Whitney S.; Heil, Gary L.; Anderson, Benjamin D.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Krueger, Whitney S.; Heil, Gary L.; Anderson, Benjamin D.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Darmaa, Badarchiin; Ulziimaa, Daramragchaa; Baterdene, Ariungerel] Minist Hlth, Natl Ctr Communicable Dis, Natl Influenza Ctr, Ulaanbaatar, Mongolia; [Tserennorov, Damdindorj] Minist Hlth, Natl Ctr Zoonot Dis, Ulaanbaatar, Mongolia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ministry of Health Mongolia; National Center for Communicable Diseases of Mongolia; Ministry of Health Mongolia	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020	Gray, Gregory/0000-0002-4628-5908	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by multiple grants from the US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program (Dr. Gray, principal investigator) and an ARRA supplement grant from the National Institute of Allergy and Infectious Diseases (R01 AI068803-Dr. Gray) (http://www.afhsc.mil/geis, http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1967, AM J EPIDEMIOL, V86, P185, DOI 10.1093/oxfordjournals.aje.a120723; Blair PJ, 2013, J INFECT PUBLIC HEAL, V6, P69, DOI 10.1016/j.jiph.2012.11.005; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Burmaa A, 2012, INFLUENZA OTHER RESP, V6, pe97, DOI 10.1111/j.1750-2659.2012.00334.x; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2008, INFLUENZA OTHER RESP, V2, P61, DOI 10.1111/j.1750-2659.2008.00041.x; Ishtiaq F, 2012, J WILDLIFE DIS, V48, P768, DOI 10.7589/0090-3558-48.3.768; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Kang HM, 2011, POULTRY SCI, V90, P2229, DOI 10.3382/ps.2011-01524; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kendal AP, 1982, CONCEPTS PROCEDURES; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Khurelbaatar N, 2013, INFLUENZA R IN PRESS; Myers KP, 2007, CLIN INFECT DIS, V45, P4, DOI 10.1086/518579; Nukiwa-Souma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033046; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Yondon M, 2013, INFLUENZA OTHER RESP	20	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85616	10.1371/journal.pone.0085616	http://dx.doi.org/10.1371/journal.pone.0085616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465622	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500083
J	Petrie, JR; Shrestha, P; Belide, S; Kennedy, Y; Lester, G; Liu, Q; Divi, UK; Mulder, RJ; Mansour, MP; Nichols, PD; Singh, SP				Petrie, James R.; Shrestha, Pushkar; Belide, Srinivas; Kennedy, Yoko; Lester, Geraldine; Liu, Qing; Divi, Uday K.; Mulder, Roger J.; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.			Metabolic Engineering Camelina sativa with Fish Oil-Like Levels of DHA	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LONG-CHAIN; TRANSGENIC PLANTS; BIOSYNTHESIS; OMEGA-3; OMEGA-3-FATTY-ACIDS; ARABIDOPSIS; OILSEEDS	Background: Omega-3 long-chain (>= C20) polyunsaturated fatty acids (omega 3 LC-PUFA) such as eicosapentaenoic acid (EPA) and docosapentaenoic acid (DHA) are critical for human health and development. Numerous studies have indicated that deficiencies in these fatty acids can increase the risk or severity of cardiovascular, inflammatory and other diseases or disorders. EPA and DHA are predominantly sourced from marine fish although the primary producers are microalgae. Much work has been done to engineer a sustainable land-based source of EPA and DHA to reduce pressure on fish stocks in meeting future demand, with previous studies describing the production of fish oil-like levels of DHA in the model plant species, Arabidopsis thaliana. Principal Findings: In this study we describe the production of fish oil-like levels (>12%) of DHA in the oilseed crop species Camelina sativa achieving a high omega 3/omega 6 ratio. The construct previously transformed in Arabidopsis as well as two modified construct versions designed to increase DHA production were used. DHA was found to be stable to at least the T-5 generation and the EPA and DHA were found to be predominantly at the sn-1,3 positions of triacylglycerols. Transgenic and parental lines did not have different germination or seedling establishment rates. Conclusions: DHA can be produced at fish oil-like levels in industrially-relevant oilseed crop species using multi-gene construct designs which are stable over multiple generations. This study has implications for the future of sustainable EPA and DHA production from land-based sources.	[Petrie, James R.; Shrestha, Pushkar; Belide, Srinivas; Kennedy, Yoko; Lester, Geraldine; Liu, Qing; Divi, Uday K.; Singh, Surinder P.] CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Mansour, Maged P.; Nichols, Peter D.] CSIRO Food Futures Natl Res Flagship, Hobart, Tas, Australia; [Mulder, Roger J.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Singh, SP (corresponding author), CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia.	surinder.singh@csiro.au	Nichols, Peter D/C-5128-2011; singh, surinder/C-9528-2009; Divi, Uday/P-2581-2017; Shrestha, Pushkar/A-2728-2010; Liu, Qing/A-1395-2010; Divi, Uday K/H-8010-2012; Belide, Srinivas/H-5649-2012; Mulder, Roger J/F-4607-2011	singh, surinder/0000-0003-4488-8147; Divi, Uday/0000-0003-0905-7567; Shrestha, Pushkar/0000-0001-9642-6636; Liu, Qing/0000-0001-6617-6859; Mulder, Roger J/0000-0002-8740-802X; Belide, Srinivas/0000-0001-9536-8200	CSIRO Food Futures Flagship; Nuseed Pty Ltd; Australian Grains Research and Development Corporation	CSIRO Food Futures Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Nuseed Pty Ltd; Australian Grains Research and Development Corporation(Grains R&D Corp)	This research was funded by CSIRO Food Futures Flagship, Nuseed Pty Ltd and the Australian Grains Research and Development Corporation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors were granted permission to publish the manuscript by the funders.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; AURSAND M, 1995, J AM OIL CHEM SOC, V72, P293, DOI 10.1007/BF02541085; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; BREYNE P, 1992, MOL GEN GENET, V235, P389, DOI 10.1007/BF00279385; Cheng BF, 2010, TRANSGENIC RES, V19, P221, DOI 10.1007/s11248-009-9302-z; Liu XJ, 2012, IN VITRO CELL DEV-PL, V48, P462, DOI 10.1007/s11627-012-9459-7; Petrie JR, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr011; Petrie JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035214, 10.1371/journal.pone.0049165]; Petrie JR, 2012, TRANSGENIC RES, V21, P139, DOI 10.1007/s11248-011-9517-7; Putnam D.H., 1993, NEW CROPS; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Robert SS, 2005, FUNCT PLANT BIOL, V32, P473, DOI 10.1071/FP05084; Ruiz-Lopez N, 2013, METAB ENG, V17, P30, DOI 10.1016/j.ymben.2013.03.001; Ruiz-Lopez N, 2012, TRANSGENIC RES, V21, P1233, DOI 10.1007/s11248-012-9596-0; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Standal IB, 2009, J AM OIL CHEM SOC, V86, P401, DOI 10.1007/s11746-009-1370-y; Turchini GM, 2012, CRIT REV FOOD SCI, V52, P795, DOI 10.1080/10408398.2010.509553; Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018; Vollmann J, 2007, IND CROP PROD, V26, P270, DOI 10.1016/j.indcrop.2007.03.017; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Zar JH., 2010, BIOSTAT ANAL, V5th; Zubr J, 1997, IND CROP PROD, V6, P113, DOI 10.1016/S0926-6690(96)00203-8	22	106	124	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85061	10.1371/journal.pone.0085061	http://dx.doi.org/10.1371/journal.pone.0085061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465476	Green Published, gold			2022-12-27	WOS:000330244500032
J	Larkin, C; Di Blasi, Z; Arensman, E				Larkin, Celine; Di Blasi, Zelda; Arensman, Ella			Risk Factors for Repetition of Self-Harm: A Systematic Review of Prospective Hospital-Based Studies	PLOS ONE			English	Review							TERM-FOLLOW-UP; SUBSEQUENT SUICIDAL-BEHAVIOR; EMERGENCY-DEPARTMENT; PARASUICIDE REPETITION; MULTICENTER COHORT; PREDICTIVE SCALES; DELIBERATE; ATTEMPTERS; REPEAT; EPIDEMIOLOGY	Background: Self-harm entails high costs to individuals and society in terms of suicide risk, morbidity and healthcare expenditure. Repetition of self-harm confers yet higher risk of suicide and risk assessment of self-harm patients forms a key component of the health care management of self-harm patients. To date, there has been no systematic review published which synthesises the extensive evidence on risk factors for repetition. Objective: This review is intended to identify risk factors for prospective repetition of self-harm after an index self-harm presentation, irrespective of suicidal intent. Data sources: PubMed, PsychInfo and Scirus were used to search for relevant publications. We included cohort studies which examining factors associated with prospective repetition among those presenting with self-harm to emergency departments. Journal articles, abstracts, letters and theses in any language published up to June 2012 were considered. Studies were quality-assessed and synthesised in narrative form. Results: A total of 129 studies, including 329,001 participants, met our inclusion criteria. Some factors were studied extensively and were found to have a consistent association with repetition. These included previous self-harm, personality disorder, hopelessness, history of psychiatric treatment, schizophrenia, alcohol abuse/dependence, drug abuse/dependence, and living alone. However, the sensitivity values of these measures varied greatly across studies. Psychological risk factors and protective factors have been relatively under-researched but show emerging associations with repetition. Composite risk scales tended to have high sensitivity but poor specificity. Conclusions: Many risk factors for repetition of self-harm match risk factors for initiation of self-harm, but the most consistent evidence for increased risk of repetition comes from long-standing psychosocial vulnerabilities, rather than characteristics of an index episode. The current review will enhance prediction of self-harm and assist in the efficient allocation of intervention resources.	[Larkin, Celine; Arensman, Ella] Natl Suicide Res Fdn, Cork, Ireland; [Di Blasi, Zelda] Natl Univ Ireland Univ Coll Cork, Sch Appl Psychol, Cork, Ireland	University College Cork	Larkin, C (corresponding author), Natl Suicide Res Fdn, Cork, Ireland.	c.larkin@ucc.ie		Larkin, Celine/0000-0003-2961-0585; Arensman, Ella/0000-0003-0376-1203; Di Blasi, Zelda/0000-0001-8950-4958	Health Research Board PhD in Health Services Research; National Office for Suicide Prevention	Health Research Board PhD in Health Services Research; National Office for Suicide Prevention	CL was funded through the Health Research Board PhD in Health Services Research. The National Suicide Research Foundation is funded by the National Office for Suicide Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER RF, 1990, PSYCHOL REV, V97, P90, DOI 10.1037/0033-295X.97.1.90; Beautrais AL, 2004, SUICIDE LIFE-THREAT, V34, P1, DOI 10.1521/suli.34.1.1.27772; Bilen K, 2011, EMERG MED J, V28, P1019, DOI 10.1136/emj.2010.102616; BUGLASS D, 1974, BRIT J PSYCHIAT, V124, P573, DOI 10.1192/bjp.124.6.573; Cailhol L, 2007, ENCEPHALE, V33, P156; Carter GL, 2002, SUICIDE LIFE-THREAT, V32, P230, DOI 10.1521/suli.32.3.230.22175; Chandrasekaran R, 2008, HONG KONG J PSYCHIAT, V18, P131; Christiansen E, 2007, AUST NZ J PSYCHIAT, V41, P257, DOI 10.1080/00048670601172749; Collaboration RTC, 2011, REV MAN REVMAN COMP; Colman I, 2004, ACTA PSYCHIAT SCAND, V109, P306, DOI 10.1111/j.1600-0447.2003.00282.x; Colman I, 2000, THESIS U ALBERTA ALB; Cooper J, 2007, EMERG MED J, V24, P720, DOI 10.1136/emj.2007.048983; Cooper J, 2006, ANN EMERG MED, V48, P459, DOI 10.1016/j.annemergmed.2006.07.944; Corcoran P, 1997, ARCH SUICIDE RES, V3, P65, DOI 10.1080/13811119708258257; Evans J, 2000, PSYCHOL MED, V30, P1327, DOI 10.1017/S0033291799002822; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; GARZOTTO N, 1976, BRIT J PSYCHIAT, V128, P137, DOI 10.1192/bjp.128.2.137; Gibb SJ, 2005, AUST NZ J PSYCHIAT, V39, P95, DOI 10.1111/j.1440-1614.2005.01514.x; Gilbody S, 1997, J ROY COLL PHYS LOND, V31, P171; Groholt B, 2006, SUICIDE LIFE-THREAT, V36, P638, DOI 10.1521/suli.2006.36.6.638; Gunnell D, 2002, SOC PSYCH PSYCH EPID, V37, P599, DOI 10.1007/s00127-002-0592-1; Harriss L, 2005, J AFFECT DISORDERS, V86, P225, DOI 10.1016/j.jad.2005.02.009; Harriss L, 2005, BRIT J PSYCHIAT, V186, P60, DOI 10.1192/bjp.186.1.60; Haw C, 2007, SUICIDE LIFE-THREAT, V37, P379, DOI 10.1521/suli.2007.37.4.379; Hawton K, 2003, AM J PSYCHIAT, V160, P1494, DOI 10.1176/appi.ajp.160.8.1494; Hawton K, 1998, BRIT MED J, V317, P441; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Hawton K, 1999, J ADOLESCENCE, V22, P369, DOI 10.1006/jado.1999.0228; Hawton K, 1995, ARCH SUICIDE RES, V1, P261; Hegerl U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-428; Hjelmeland H, 1996, SUICIDE LIFE-THREAT, V26, P395; Horne O, 2009, QUAL HEALTH RES, V19, P655, DOI 10.1177/1049732309334249; Kapur N, 2006, J CLIN PSYCHIAT, V67, P1599, DOI 10.4088/JCP.v67n1016; Keeley HS, 2003, PSYCHIAT B, V27, P411; Klonsky ED, 2009, PSYCHIAT RES, V166, P260, DOI 10.1016/j.psychres.2008.02.008; KREITMAN N, 1991, BRIT J PSYCHIAT, V159, P185, DOI 10.1192/bjp.159.2.185; Links P, 2012, GEN HOSP PSYCHIAT, V34, P88, DOI 10.1016/j.genhosppsych.2011.08.016; Macaskill P, 2009, COCHRANE HDB SYSTEMA; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; MAYO JA, 1974, AM J PUBLIC HEALTH, V64, P616, DOI 10.2105/AJPH.64.6.616; McAuliffe C, 2008, BRIT J CLIN PSYCHOL, V47, P43, DOI 10.1348/014466507X230958; McEvedy CJB, 1997, J ROY SOC MED, V90, P496, DOI 10.1177/014107689709000908; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Morton M J, 1993, Int J Soc Psychiatry, V39, P87, DOI 10.1177/002076409303900202; Murphy E, 2012, BRIT J PSYCHIAT, V200, P399, DOI 10.1192/bjp.bp.111.094177; MYERS ED, 1988, ACTA PSYCHIAT SCAND, V77, P314, DOI 10.1111/j.1600-0447.1988.tb05127.x; National Institute for Clinical Excellence (NICE), 2004, SELF HARM SHORT TERM; Neeleman J, 2004, J AFFECT DISORDERS, V82, P43, DOI 10.1016/j.jad.2003.09.005; OConnor RC, 2003, ARCH SUICIDE RES, V7, P297, DOI DOI 10.1080/713848941; OJEHAGEN A, 1992, ACTA PSYCHIAT SCAND, V85, P370, DOI 10.1111/j.1600-0447.1992.tb10321.x; OWENS D, 1994, BRIT J PSYCHIAT, V165, P797, DOI 10.1192/bjp.165.6.797; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Payne RA, 2009, PUBLIC HEALTH, V123, P134, DOI 10.1016/j.puhe.2008.12.002; Perry IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031663; PETRIE K, 1988, BRIT J CLIN PSYCHOL, V27, P247, DOI 10.1111/j.2044-8260.1988.tb00781.x; PETRIE K, 1992, BRIT J CLIN PSYCHOL, V31, P293, DOI 10.1111/j.2044-8260.1992.tb00996.x; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Randall JR, 2012, CAN J PSYCHIAT, V57, P21, DOI 10.1177/070674371205700105; Randall JR, 2011, J AFFECT DISORDERS, V134, P348, DOI 10.1016/j.jad.2011.05.032; SAKINOFSKY I, 1990, BRIT J PSYCHIAT, V156, P399, DOI 10.1192/bjp.156.3.399; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Scoliers G, 2009, ARCH SUICIDE RES, V13, P201, DOI 10.1080/13811110902835130; Scott J, 1997, BRIT J MED PSYCHOL, V70, P387, DOI 10.1111/j.2044-8341.1997.tb01914.x; SIANI R, 1979, ACTA PSYCHIAT SCAND, V59, P17, DOI 10.1111/j.1600-0447.1979.tb06942.x; Sidley GL, 1999, BRIT J CLIN PSYCHOL, V38, P375, DOI 10.1348/014466599162971; Sinclair J, 2010, SOC PSYCH PSYCH EPID, P1; Sinclair JMA, 2006, PSYCHOL MED, V36, P1681, DOI 10.1017/S0033291706008683; Soderberg S, 2004, SOC PSYCH PSYCH EPID, V39, P916, DOI 10.1007/s00127-004-0839-0; Steeg S, 2012, PSYCHOL MED, V42, P2012, DOI 10.1017/S0033291712001389; Suleiman M A, 1989, Int J Soc Psychiatry, V35, P146, DOI 10.1177/002076408903500202; Taylor DM, 1998, J ACCID EMERG MED, V15, P257; Tejedor MC, 1999, ACTA PSYCHIAT SCAND, V100, P205, DOI 10.1111/j.1600-0447.1999.tb10847.x; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; Vajda J, 2000, AUST NZ J PSYCHIAT, V34, P437, DOI 10.1080/j.1440-1614.2000.00712.x; van Heeringen K., 2001, UNDERSTANDING SUICID, P136; VANAALST JA, 1992, J TRAUMA, V33, P457, DOI 10.1097/00005373-199209000-00021; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; von Elm E, 2007, INT J EPIDEMIOL, V36, P677, DOI 10.1093/ije/dym112; Waern M, 2010, EUR PSYCHIAT, V25, P421, DOI 10.1016/j.eurpsy.2010.03.014; Wiktorsson S, 2011, J AFFECT DISORDERS, V134, P333, DOI 10.1016/j.jad.2011.06.010; Williams J. M. G., 1997, CRY PAIN UNDERSTANDI; Yeh AWC, 2012, ASIA-PAC PSYCHIAT, V4, P20, DOI 10.1111/j.1758-5872.2011.00165.x; Yip PSF, 2011, CRISIS, V32, P217, DOI 10.1027/0227-5910/a000069; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70	86	97	97	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84282	10.1371/journal.pone.0084282	http://dx.doi.org/10.1371/journal.pone.0084282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465400	Green Published, gold			2022-12-27	WOS:000330240500013
J	Zhang, Y; Wei, C; Zhang, PF; Li, X; Liu, T; Pu, Y; Li, YS; Cao, ZB; Cao, HG; Liu, Y; Zhang, XR; Zhang, YH				Zhang, Yu; Wei, Chao; Zhang, Pengfei; Li, Xia; Liu, Tong; Pu, Yong; Li, Yunsheng; Cao, Zubing; Cao, Hongguo; Liu, Ya; Zhang, Xiaorong; Zhang, Yunhai			Efficient Reprogramming of Naive-Like Induced Pluripotent Stem Cells from Porcine Adipose-Derived Stem Cells with a Feeder-Independent and Serum-Free System	PLOS ONE			English	Article							GENERATION; ADULT; INDUCTION; DERIVATION; CULTURE; EPIBLAST; 5-HYDROXYMETHYLCYTOSINE; TISSUES; LAYER; LINES	Induced pluripotent stem cells (iPSCs) are somatic cells reprogrammed by ectopic expression of transcription factors or small molecule treatment, which resemble embryonic stem cells (ESCs). They hold great promise for improving the generation of genetically modified large animals. However, few porcine iPSCs (piPSCs) lines obtained currently can support development of cloned embryos. Here, we generated iPSCs from porcine adipose-derived stem cells (pADSCs), using drug-inducible expression of defined human factors (Oct4, Sox2, c-Myc and Klf4). Reprogramming of iPSCs from pADSCs was more efficient than from fibroblasts, regardless of using feeder-independent or feeder-dependent manners. By addition of Lif-2i medium containing mouse Lif, CHIR99021 and PD0325901 (Lif-2i), naive-like piPSCs were obtained under feeder-independent and serum-free conditions. These successfully reprogrammed piPSCs were characterized by short cell cycle intervals, alkaline phosphatase (AP) staining, expression of Oct4, Sox2, Nanog, SSEA3 and SSEA4, and normal karyotypes. The resemblance of piPSCs to naive ESCs was confirmed by their packed dome morphology, growth after single-cell dissociation, Lif-dependency, up-regulation of Stella and Eras, low expression levels of TRA-1-60, TRA-1-81 and MHC I and activation of both X chromosomes. Full reprogramming of naive-like piPSCs was evaluated by the significant up-regulation of Lin28, Esrrb, Utf1 and Dppa5, differentiating into cell types of all three germ layers in vitro and in vivo. Furthermore, nuclear transfer embryos from naive-like piPSCs could develop to blastocysts with improved quality. Thus, we provided an efficient protocol for generating naive-like piPSCs from pADSCs in a feeder-independent and serum-free system with controlled regulation of exogenous genes, which may facilitate optimization of culture media and the production of transgenic pigs.	[Zhang, Yu; Wei, Chao; Zhang, Pengfei; Li, Xia; Liu, Tong; Pu, Yong; Li, Yunsheng; Cao, Zubing; Cao, Hongguo; Liu, Ya; Zhang, Xiaorong; Zhang, Yunhai] Anhui Agr Univ, Anhui Prov Lab Local Livestock & Poultry Genet Re, Dept Anim Sci, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Zhang, XR (corresponding author), Anhui Agr Univ, Anhui Prov Lab Local Livestock & Poultry Genet Re, Dept Anim Sci, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China.	zxr@ahau.edu.cn; yunhaizhang@ahau.edu.cn	Zhang, Yu/M-4249-2017; liu, ya/AAI-1890-2020; Zhang, Yunhai/O-4453-2014; Pu, Yong/T-8450-2019	Zhang, Yu/0000-0002-5592-111X; Zhang, Yunhai/0000-0001-9721-5910; 	National Basic Research Program [2009CB941004]; National Natural Science Foundation of China [31272442, 31372309]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program (2009CB941004), National Natural Science Foundation of China (31272442, 31372309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REGEN MED, V6, P141, DOI 10.2217/rme.11.11; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Cooper GM, 2011, PLAST RECONSTR SURG, V127, P88, DOI 10.1097/PRS.0b013e3181fad311; De Sousa PA, 2006, REPRODUCTION, V132, P681, DOI 10.1530/rep.1.01080; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Ding Q, 2013, PHARM RES-DORDR, V30, P60, DOI 10.1007/s11095-012-0849-7; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gu Q, 2012, PROTEIN CELL, V3, P71, DOI 10.1007/s13238-012-2007-8; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Haffner MC, 2011, ONCOTARGET, V2, P627; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Havasi P, 2013, MOL BIOL REP, V40, P3023, DOI 10.1007/s11033-012-2376-3; Hirai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039022; Jahn KA, 2011, J PHARM SCI-US, V100, P3751, DOI 10.1002/jps.22418; Jang M, 2013, BIOMATERIALS, V34, P3571, DOI 10.1016/j.biomaterials.2013.01.073; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li YY, 2011, CELL RES, V21, P1148, DOI 10.1038/cr.2011.97; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Liu L, 2012, BIOTECHNOL LETT, V34, P1951, DOI 10.1007/s10529-012-0973-9; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Manton KJ, 2010, STEM CELLS DEV, V19, P1297, DOI 10.1089/scd.2009.0504; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park JK, 2013, PLOS ONE, P8; Paul A, 2011, CELL BIOCH BIOPHYS; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Riebeling C, 2011, TOXICOL IN VITRO, V25, P914, DOI 10.1016/j.tiv.2011.02.013; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rubin Bent, 2008, Cancer Immun, V8, P14; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Singh AM, 2012, CELL CYCLE, V11, P2991, DOI 10.4161/cc.21110; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Sugiyama H, 2008, J TISSUE ENG REGEN M, V2, P445, DOI 10.1002/term.111; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Taha MF, 2010, TISSUE CELL, V42, P211, DOI 10.1016/j.tice.2010.04.003; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tey SK, 2012, AUTOPHAGY, V8, P1839, DOI 10.4161/auto.21860; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Wang QH, 2012, PROTEIN CELL, V3, P51, DOI 10.1007/s13238-012-2002-0; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Williams KJ, 2011, METHODS MOL BIOL, V702, P77, DOI 10.1007/978-1-61737-960-4_7; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xie LQ, 2013, CHINESE MED J-PEKING, V126, P1138, DOI 10.3760/cma.j.issn.0366-6999.20122755; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	80	14	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85089	10.1371/journal.pone.0085089	http://dx.doi.org/10.1371/journal.pone.0085089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465482	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500031
J	Calderon-Perez, B; Xoconostle-Cazares, B; Lira-Carmona, R; Hernandez-Rivas, R; Ortega-Lopez, J; Ruiz-Medrano, R				Calderon-Perez, Berenice; Xoconostle-Cazares, Beatriz; Lira-Carmona, Rosalia; Hernandez-Rivas, Rosaura; Ortega-Lopez, Jaime; Ruiz-Medrano, Roberto			The Plasmodium falciparum Translationally Controlled Tumor Protein (TCTP) Is Incorporated More Efficiently into B Cells than Its Human Homologue	PLOS ONE			English	Article							HISTAMINE-RELEASING-FACTOR; MOLECULAR-IDENTIFICATION; MALARIA; GROWTH; SECRETION; EXCHANGE	Plasmodium falciparum secretes a homologue of the translationally controlled tumor protein (TCTP) into serum of infected individuals, although its role in pathogenesis or virulence is unknown. To determine the effect of P. falciparum TCTP on B cells as compared to human TCTP, fluorescently labeled proteins were incubated on primary cultures of mouse splenic B cells and analyzed by flow cytometry and confocal microscopy. Our results indicate that both recombinant proteins are incorporated into B cells, but differ significantly in their rate and percentage of incorporation, being significantly higher for P. falciparum TCTP. Furthermore, P. falciparum TCTP showed a lower B cell proliferative effect than human TCTP, suggesting a mechanism through which the former could interfere in the host's immune response.	[Calderon-Perez, Berenice; Xoconostle-Cazares, Beatriz; Ortega-Lopez, Jaime; Ruiz-Medrano, Roberto] Dept Biotechnol & Bioengn CINVESTAV IPN, Mexico City, DF, Mexico; [Lira-Carmona, Rosalia] CMN Siglo XXI IMSS, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City, DF, Mexico; [Hernandez-Rivas, Rosaura] CINVESTAV IPN, Dept Mol Biomed, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Ruiz-Medrano, R (corresponding author), Dept Biotechnol & Bioengn CINVESTAV IPN, Mexico City, DF, Mexico.	rmedrano@cinvestav.mx	Ortega-Lopez, Jaime/A-1364-2008	Ortega-Lopez, Jaime/0000-0001-9136-9994; Lira, Rosalia/0000-0002-6812-9471	CONACyT Mexico [50769, 105985]; CONACyT doctoral fellowship; ICyT-DF	CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT doctoral fellowship; ICyT-DF	This work was supported by CONACyT Mexico grants Nos. 50769 to RR-M and 105985 to BX-C. BC-P was supported by a CONACyT doctoral fellowship and an ICyT-DF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Asito AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-362; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Dong XC, 2009, J BIOL CHEM, V284, P23754, DOI 10.1074/jbc.M109.012823; Eichhorn T, 2013, BIOCHEM PHARMACOL, V85, P38, DOI 10.1016/j.bcp.2012.10.006; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Hinojosa-Moya J, 2008, J MOL EVOL, V66, P472, DOI 10.1007/s00239-008-9099-z; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Kim M, 2011, BIOMATERIALS, V32, P222, DOI 10.1016/j.biomaterials.2010.08.077; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Pelleau S, 2012, INFECT IMMUN, V80, P2963, DOI 10.1128/IAI.00072-12; R Core Team, 2012, R LANG ENV STAT COMP; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Schroeder JT, 1997, J IMMUNOL, V159, P447; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003	25	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85514	10.1371/journal.pone.0085514	http://dx.doi.org/10.1371/journal.pone.0085514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465583	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000040
J	Cornetti, L; Menegon, M; Giovine, G; Heulin, B; Vernesi, C				Cornetti, Luca; Menegon, Michele; Giovine, Giovanni; Heulin, Benoit; Vernesi, Cristiano			Mitochondrial and Nuclear DNA Survey of Zootoca vivipara across the Eastern Italian Alps: Evolutionary Relationships, Historical Demography and Conservation Implications	PLOS ONE			English	Article							OVIPAROUS POPULATIONS; BAYESIAN METHODS; PHYLOGEOGRAPHY; LACERTIDAE; LIKELIHOOD; SELECTION; SOFTWARE; SEQUENCE; DIVERGENCE; STRATEGIES	The European common lizard Zootoca vivipara exhibits reproductive bimodality, with populations being either viviparous or oviparous. In the central-eastern Italian Alps oviparous populations (Z. v. carniolica) and viviparous populations (Z. v. vivipara) partly overlap geographically. Studying the evolutionary relationship between these taxa presents an interesting opportunity to gain insight into the evolution of this trait. We aim to: i) test whether Z. v. carniolica, which is endangered, constitutes an ESU (Evolutionary Significant Unity); ii) infer mtDNA divergence time between the Z. v. carniolica clade and all the other Z. vivipara subspecies with the aid of an external calibration point; and iii) describe the phylogeographical and demographic scenarios in the area. To do so we sequenced about 200 individuals for mitochondrial variation; 64 of them were also analysed for three nuclear genes. Furthermore, we analysed the same nuclear markers in 17 individuals from the other oviparous subspecies Z. v. louislantzi and 11 individuals of Z. v. vivipara from widespread geographical origins. The mtDNA and nDNA loci that we examined supported the monophyly of Z. v. carniolica. The mtDNA-based estimate of divergence time between Z. v. carniolica and all the other subspecies indicated a separation at 4.5 Mya (95% CI 6.1-2.6), with about 5% of sequence divergence. Considering that Z. v. carniolica harbours higher genetic diversity, while Z. v. vivipara from central-eastern Alps shows a signature of recent population and spatial expansion, we argue that Z. v. carniolica represents a distinct evolutionary unit, with a presumably long-term evolutionary history of separation. Z. v. carniolica populations, occurring at higher latitudes and altitudes than insofar supposed, live in peat bogs, a seriously threatened habitat: taking into account also its evolutionary distinctness, specific conservation measures should be considered.	[Cornetti, Luca; Vernesi, Cristiano] Fdn Edmund Mach, Ctr Res & Innovat, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy; [Cornetti, Luca] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Menegon, Michele] Museo Sci, Trento, Italy; [Giovine, Giovanni] Stn Sperimentale Reg Studio & Conservaz Anfibi Lo, Bergamo, Italy; [Heulin, Benoit] CNRS, UMR 6553, Stn Biol, Paimpont, France	Fondazione Edmund Mach; University of Ferrara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Vernesi, C (corresponding author), Fdn Edmund Mach, Ctr Res & Innovat, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy.	cristiano.vernesi@fmach.it		Vernesi, Cristiano/0000-0001-7534-5669	Autonomous Province of Trento (Italy)	Autonomous Province of Trento (Italy)(Autonomous Province of Trento)	This research is part of the ACE-SAP (University and Scientific Research Service regulation number 23, June 12th 2008) project funded by Autonomous Province of Trento (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2006, MOL ECOL, V15, P3269, DOI 10.1111/j.1365-294X.2006.02980.x; Arribas Oscar J., 2009, HERPETOZOA, V21, P123; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barata M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-167; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Beerli P, 1996, EVOLUTION, V50, P1676, DOI 10.1111/j.1558-5646.1996.tb03939.x; BLACKBURN DG, 1994, HERPETOL J, V4, P65; Bragazza L, 2008, GLOBAL CHANGE BIOL, V14, P2688, DOI 10.1111/j.1365-2486.2008.01699.x; BRANA F., 1987, B SOC HERPETOL FR, V44, P1; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dely OG, 1984, HDB REPTILIEN AMPHIB, P362; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fu YX, 1997, GENETICS, V147, P915; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Ghielmi Samuele, 2006, Acta Herpetologica, V1, P29; Ghielmi Samuele, 2001, Bulletin de la Societe Herpetologique de France, V98, P19; Giovine G, 1989, B GRUPPO RANA, V1, P59; Hartl DL, 2006, PRINCIPLES POPULATIO; Haubrich K, 2007, MOL ECOL, V16, P3643, DOI 10.1111/j.1365-294X.2007.03424.x; Heulin B, 2000, CR ACAD SCI III-VIE, V323, P461, DOI 10.1016/S0764-4469(00)00155-4; HEULIN B, 1988, CR ACAD SCI III-VIE, V306, P63; Heulin B., 1993, BIOGEOGRAPHICA, V69, P1; Heulin B, 2011, ECOGRAPHY, V34, P436, DOI 10.1111/j.1600-0587.2010.06540.x; Kerner A., 1870, NATURLICHEN FLOREN G; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAC J, 1968, Zoologicke Listy, V17, P157; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindtke D, 2010, SALAMANDRA, V46, P73; Lymberakis P, 2008, SYST BIODIVERS, V6, P307, DOI 10.1017/S1477200008002727; Mayer W, 2007, MOL PHYLOGENET EVOL, V44, P1155, DOI 10.1016/j.ympev.2007.05.015; Mayer Werner, 2000, Herpetozoa, V13, P59; Mazzotti Stefano, 1993, Quaderni della Stazione di Ecologia del Civico Museo di Storia Naturale di Ferrara, V5, P1; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nei M., 1987, MOL EVOLUTIONARY GEN; Odierna G, 2001, ECOGRAPHY, V24, P332, DOI 10.1034/j.1600-0587.2001.240311.x; Pavlicev M, 2006, J EXP BIOL B, V360B, P539; Pinho C, 2010, CONSERV GENET RESOUR, V2, P181, DOI 10.1007/s12686-009-9126-4; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Rambaut A., 2007, TRACER V1 5; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Runemark A, 2012, MOL ECOL, V21, P117, DOI 10.1111/j.1365-294X.2011.05377.x; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; SLATKIN M, 1991, GENETICS, V129, P555; SMITH MF, 1991, MOL BIOL EVOL, V8, P85; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Surget-Groba Y, 2006, BIOL J LINN SOC, V87, P1, DOI 10.1111/j.1095-8312.2006.00552.x; Surget-Groba Y, 2002, BIOL CONSERV, V106, P365, DOI 10.1016/S0006-3207(01)00263-4; Surget-Groba Y, 2001, MOL PHYLOGENET EVOL, V18, P449, DOI 10.1006/mpev.2000.0896; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P585; Thiel-Egenter C, 2007, THESIS U ZURICH ZURI; Thiel-Egenter C, 2009, MOL ECOL, V18, P4495, DOI 10.1111/j.1365-294X.2009.04360.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557	62	25	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85912	10.1371/journal.pone.0085912	http://dx.doi.org/10.1371/journal.pone.0085912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465784	Green Published, gold			2022-12-27	WOS:000330237000075
J	Bluml, S; Wisnowski, JL; Nelson, MD; Paquette, L; Panigrahy, A				Blueml, Stefan; Wisnowski, Jessica L.; Nelson, Marvin D., Jr.; Paquette, Lisa; Panigrahy, Ashok			Metabolic Maturation of White Matter Is Altered in Preterm Infants	PLOS ONE			English	Article							NERVOUS-SYSTEM MYELINATION; HUMAN BRAIN; PERIVENTRICULAR LEUKOMALACIA; NEURODEVELOPMENTAL OUTCOMES; ABSOLUTE QUANTITATION; WATER; TERM; INJURY; RELAXOMETRY; RELAXATION	Significant physiological switches occur at birth such as the transition from fetal parallel blood flow to a two-circuit serial system with increased arterial oxygenation of blood delivered to all organs including the brain. In addition, the extra-uterine environment exposes premature infants to a host of stimuli. These events could conceivably alter the trajectory of brain development in premature infants. We used in vivo magnetic resonance spectroscopy to measure absolute brain metabolite concentrations in term and premature-born infants without evidence of brain injury at equivalent post-conceptional age. Prematurity altered the developmental time courses of N-acetyl-aspartate, a marker for axonal and neuronal development, creatine, an energy metabolite, and choline, a membrane metabolite, in parietal white matter. Specifically, at term-equivalency, metabolic maturation in preterm infants preceded development in term infants, but then progressed at a slower pace and trajectories merged at approximate to 340-370 post-conceptional days. In parieto/occipital grey matter similar trends were noticed but statistical significance was not reached. The timing of white matter development and synchronization of white matter and grey matter maturation in premature-born infants is disturbed. This may contribute to the greater risk of long-term neurological problems of premature infants and to their higher risk for white matter injury.	[Blueml, Stefan; Wisnowski, Jessica L.; Nelson, Marvin D., Jr.; Panigrahy, Ashok] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Paquette, Lisa] Childrens Hosp Los Angeles, Div Neonatol, Los Angeles, CA 90027 USA; [Wisnowski, Jessica L.] USC, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA USA; [Blueml, Stefan] Rudi Schulte Res Inst, Santa Barbara, CA USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California	Bluml, S (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.	sbluml@chla.usc.edu		Bluml, Stefan/0000-0003-2124-797X	Rudi Schulte Research Institute; National Institutes of Health [K23NS063371, 1UL1RR031986, P50NS019632]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS063371, P50NS019632] Funding Source: NIH RePORTER	Rudi Schulte Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Rudi Schulte Research Institute (SB), National Institutes of Health (K23NS063371 to AP, 1UL1RR031986 to AP, JLW, LP, and P50NS019632 to JLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Bluml S, 1999, MAGNET RESON MED, V42, P643, DOI 10.1002/(SICI)1522-2594(199910)42:4<643::AID-MRM5>3.0.CO;2-N; Bluml S, 2012, CEREB CORTEX; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Folkerth RD, 2004, J NEUROPATH EXP NEUR, V63, P990, DOI 10.1093/jnen/63.9.990; Gimenez M, 2008, NEUROIMAGE, V41, P728, DOI 10.1016/j.neuroimage.2008.02.029; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Huppi PS, 1996, PEDIATR RES, V39, P895; Huppi PS, 1998, PEDIATR RES, V44, P584; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lentner C, 1981, GEIGY SCI TABLES, p[220, 222, 223]; Leppert IR, 2009, J MAGN RESON IMAGING, V29, P258, DOI 10.1002/jmri.21646; Matsumae M, 2001, MECH AGEING DEV, V122, P1281, DOI 10.1016/S0047-6374(01)00265-2; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Ross BD, 1999, NEUROIMAGING, P727; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Shestov AA, 2007, J NEUROSCI RES, V85, P3294, DOI 10.1002/jnr.21269; Sulyok E, 2001, BIOL NEONATE, V79, P67, DOI 10.1159/000047068; Vinall J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004666; Viola A, 2011, AM J NEURORADIOL, V32, P1451, DOI 10.3174/ajnr.A2555; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Wisnowski JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056880; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	43	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85829	10.1371/journal.pone.0085829	http://dx.doi.org/10.1371/journal.pone.0085829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465731	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100079
J	Chen, L; Schrementi, ME; Ranzer, MJ; Wilgus, TA; DiPietro, LA				Chen, Lin; Schrementi, Megan E.; Ranzer, Matthew J.; Wilgus, Traci A.; DiPietro, Luisa A.			Blockade of Mast Cell Activation Reduces Cutaneous Scar Formation	PLOS ONE			English	Article							WOUND CONTRACTION; GROWTH-FACTOR; I COLLAGEN; SKIN; TRYPTASE; MICE; FIBROBLASTS; EXPRESSION; INJURY; MYOFIBROBLASTS	Damage to the skin initiates a cascade of well-orchestrated events that ultimately leads to repair of the wound. The inflammatory response is key to wound healing both through preventing infection and stimulating proliferation and remodeling of the skin. Mast cells within the tissue are one of the first immune cells to respond to trauma, and upon activation they release pro-inflammatory molecules to initiate recruitment of leukocytes and promote a vascular response in the tissue. Additionally, mast cells stimulate collagen synthesis by dermal fibroblasts, suggesting they may also influence scar formation. To examine the contribution of mast cells in tissue repair, we determined the effects the mast cell inhibitor, disodium cromoglycate (DSCG), on several parameters of dermal repair including, inflammation, re-epithelialization, collagen fiber organization, collagen ultrastructure, scar width and wound breaking strength. Mice treated with DSCG had significantly reduced levels of the inflammatory cytokines IL-1 alpha, IL-1 beta, and CXCL1. Although DSCG treatment reduced the production of inflammatory mediators, the rate of re-epithelialization was not affected. Compared to control, inhibition of mast cell activity caused a significant decrease in scar width along with accelerated collagen re-organization. Despite the reduced scar width, DSCG treatment did not affect the breaking strength of the healed tissue. Tryptase beta 1 exclusively produced by mast cells was found to increase significantly in the course of wound healing. However, DSCG treatment did not change its level in the wounds. These results indicate that blockade of mast cell activation reduces scar formation and inflammation without further weakening the healed wound.	[Chen, Lin; Schrementi, Megan E.; Ranzer, Matthew J.; Wilgus, Traci A.; DiPietro, Luisa A.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	DiPietro, LA (corresponding author), Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA.	Ldipiet@uic.edu			NIH [R01-GM55238, R01-GM50875, P20-GM078426, 5T32AA013527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055238, R01GM050875, P20GM078426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This publication was supported by NIH Grants R01-GM55238 (LAD), R01-GM50875 (LAD), P20-GM078426 (LAD), and 5T32AA013527 (MJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1998, CLIN EXP ALLERGY, V28, P1509; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x; Ferreira AM, 2006, J INVEST DERMATOL, V126, P1900, DOI 10.1038/sj.jid.5700302; Gailit J, 2001, J INVEST DERMATOL, V117, P1113, DOI 10.1046/j.1523-1747.2001.15211.x; Gallant-Behm CL, 2008, WOUND REPAIR REGEN, V16, P226, DOI 10.1111/j.1524-475X.2008.00363.x; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Gamelli RL, 2003, METH MOLEC MED, V78, P37; GEISSLER EN, 1983, EXP HEMATOL, V11, P461; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gruber BL, 1997, J IMMUNOL, V158, P2310; Huttunen M, 2000, EXP DERMATOL, V9, P258, DOI 10.1034/j.1600-0625.2000.009004258.x; IOFFREDA MD, 1993, J INVEST DERMATOL, V101, P150, DOI 10.1111/1523-1747.ep12363632; KLEIN LM, 1989, P NATL ACAD SCI USA, V86, P8972, DOI 10.1073/pnas.86.22.8972; Kolaczkowska E, 2001, J LEUKOCYTE BIOL, V69, P33; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; MAZUREK N, 1980, NATURE, V286, P722, DOI 10.1038/286722a0; MAZUREK N, 1980, FEBS LETT, V111, P194, DOI 10.1016/0014-5793(80)80791-5; Nagarsenker MS, 2003, INT J PHARMACEUT, V251, P49, DOI 10.1016/S0378-5173(02)00583-5; PERSINGER MA, 1983, BRIT J DERMATOL, V108, P179, DOI 10.1111/j.1365-2133.1983.tb00060.x; QU ZH, 1995, AM J PATHOL, V147, P564; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Szabo A, 1997, SHOCK, V8, P284, DOI 10.1097/00024382-199710000-00008; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; TRABUCCHI E, 1988, INT J TISSUE REACT, V10, P367; Tsai M, 2002, INT J HEMATOL, V75, P345, DOI 10.1007/BF02982122; VIDAL BD, 1988, ACTA HISTOCHEM, V83, P189; WEBER S, 1995, INT J DERMATOL, V34, P1, DOI 10.1111/j.1365-4362.1995.tb04366.x; Welker P, 2001, ARCH DERMATOL RES, V293, P249, DOI 10.1007/s004030100225; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wilgus TA, 2003, WOUND REPAIR REGEN, V11, P25, DOI 10.1046/j.1524-475X.2003.11106.x; Wulff BC, 2012, J INVEST DERMATOL, V132, P458, DOI 10.1038/jid.2011.324	38	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85226	10.1371/journal.pone.0085226	http://dx.doi.org/10.1371/journal.pone.0085226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465509	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100027
J	Chow, WZ; Takebe, Y; Syafina, NE; Prakasa, MS; Chan, KG; Al-Darraji, HAA; Koh, C; Kamarulzaman, A; Tee, KK				Chow, Wei Zhen; Takebe, Yutaka; Syafina, Nur Ezreen; Prakasa, Malarvelli Soorya; Chan, Kok Gan; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng			A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; KUALA-LUMPUR; MOLECULAR EPIDEMIOLOGY; RISK POPULATIONS; FORM CRF33-01B; IDENTIFICATION; SEROCONVERTERS; SEQUENCE; SUBTYPES	The HIV epidemic is primarily characterised by the circulation of HIV-1 group M (main) comprising of 11 subtypes and sub-subtypes (A1, A2, B-D, F1, F2, G, H, J, and K) and to date 55 circulating recombinant forms (CRFs). In Southeast Asia, active inter-subtype recombination involving three main circulating genotypes-subtype B (including subtype B', the Thai variant of subtype B), CRF01_AE, and CRF33_01B-have contributed to the emergence of novel unique recombinant forms. In the present study, we conducted the molecular epidemiological surveillance of HIV-1 gag-RT genes among 258 people who inject drugs (PWIDs) in Kuala Lumpur, Malaysia, between 2009 and 2011 whereby a novel CRF candidate was recently identified. The near full-length genome sequences obtained from six epidemiologically unlinked individuals showed identical mosaic structures consisting of subtype B' and CRF01_AE, with six unique recombination breakpoints in the gag-RT, pol, and env regions. Among the high-risk population of PWIDs in Malaysia, which was predominantly infected by CRF33_01B (>70%), CRF58_01B circulated at a low but significant prevalence (2.3%, 6/258). Interestingly, the CRF58_01B shared two unique recombination breakpoints with other established CRFs in the region: CRF33_01B, CRF48_01B, and CRF53_01B in the gag gene, and CRF15_01B (from Thailand) in the env gene. Extended Bayesian Markov chain Monte Carlo sampling analysis showed that CRF58_01B and other recently discovered CRFs were most likely to have originated in Malaysia, and that the recent spread of recombinant lineages in the country had little influence from neighbouring countries. The isolation, genetic characterization, and evolutionary features of CRF58_01B among PWIDs in Malaysia signify the increasingly complex HIV-1 diversity in Southeast Asia that may hold an implication on disease treatment, control, and prevention.	[Chow, Wei Zhen; Takebe, Yutaka; Syafina, Nur Ezreen; Prakasa, Malarvelli Soorya; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Dept Med, Ctr Excellence Res AIDS CERiA, Fac Med, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Chan, Kok Gan] Univ Malaya, Inst Biol Sci, Div Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; National Institute of Infectious Diseases (NIID); Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Dept Med, Ctr Excellence Res AIDS CERiA, Fac Med, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010; Chan, Kok Gan/B-8347-2010; Chow, Wei Zhen/L-8228-2013; Tee, Kok Keng/A-8148-2008	Chan, Kok Gan/0000-0002-1883-1115; Tee, Kok Keng/0000-0002-7923-5448	Ministry of Higher Education, Malaysia [E-000001-20001, H-500001-00-A000011-000001, H-500001-00-A000012-000001]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This work was supported in part by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to AK, and High Impact Research H-500001-00-A000011-000001 and H-500001-00-A000012-000001 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; [Anonymous], 2012, GLOB REP UNAIDS REP; Beyrer C, 1998, AIDS RES HUM RETROV, V14, P1687, DOI 10.1089/aid.1998.14.1687; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Brown TM, 1996, AIDS RES HUM RETROV, V12, P1655, DOI 10.1089/aid.1996.12.1655; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ministry of Health, 2012, GLOB AIDS RESP COUNT; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Saraswathy T. S., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P283; Schierup MH, 2000, GENETICS, V156, P879; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2005, AIDS RES HUM RETROV, V21, P1046, DOI 10.1089/aid.2005.21.1046; Tee KK, 2005, AIDS, V19, P119, DOI 10.1097/00002030-200501280-00003; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tovanabutra S, 2001, AIDS, V15, P1063, DOI 10.1097/00002030-200105250-00018; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Wang B, 2007, VIROLOGY, V367, P288, DOI 10.1016/j.virol.2007.05.033; WENIGER BG, 1994, AIDS, V8, pS13; Weniger BG, 1996, NEW ENGL J MED, V335, P343, DOI 10.1056/NEJM199608013350510	35	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85250	10.1371/journal.pone.0085250	http://dx.doi.org/10.1371/journal.pone.0085250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465513	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100029
J	Han, JE; Wui, SR; Kim, KS; Cho, YJ; Cho, WJ; Lee, NG				Han, Ji Eun; Wui, Seo Ri; Kim, Kwang Sung; Cho, Yang Je; Cho, Wan Je; Lee, Na Gyong			Characterization of the Structure and Immunostimulatory Activity of a Vaccine Adjuvant, De-O-Acylated Lipooligosaccharide	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; ANTHRACIS PROTECTIVE ANTIGEN; TOLL-LIKE RECEPTOR-4; COLI DNA FRAGMENTS; ESCHERICHIA-COLI; IMMUNE-RESPONSES; MODIFIED LIPOPOLYSACCHARIDES; HPV VACCINE; RECOGNITION; ACTIVATION	Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria. LPS elicits strong immunopathological responses during bacterial infection, and the lipid A moiety of LPS is responsible for this immunostimulatory activity. Lipid A exerts its biological activity by sending signals via TLR4 present on immune cells, and TLR4 agonists have been a target for vaccine adjuvant. Previously, we demonstrated an adjuvant activity of deacylated lipooligosaccharide (dLOS) to viral and bacterial antigens. In this study, we characterized the chemical structure of dLOS and evaluated its immunostimulatory activity on mouse and human immune cells in comparison with monophosphoryl lipid A (MPL). dLOS consists of a core oligosaccharide lacking the terminal glucose residue, a glucosamine disaccharide with two phosphate groups, and two N-linked acyl groups. dLOS was similar to MPL in induction of cytokine production in mouse peritoneal macrophages, but was a more potent activator in human monocytes and dendritic cells (DCs). Results of an analysis of allogeneic T cell responses revealed that dLOS induces Th1, Th2, and Th17-type immune responses in a dose-dependent manner. The immunostimulatory activities of dLOS were completely abrogated in TLR4(-/-) mice, which confirms its TLR4-dependency. These results suggest that in the presence of the core oligosaccharide, O-linked acyl groups of LPS are dispensable for activating the TLR4 signaling pathway. dLOS did not cause any pathological effects or death at 0.25, 0.5, or 1 mg per kg body weight in mice in the acute toxicity tests. This result suggests that dLOS has a low toxicity. dLOS should be considered for further development as a safe and effective adjuvant for human vaccines.	[Han, Ji Eun; Wui, Seo Ri; Lee, Na Gyong] Sejong Univ, Coll Biosci, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Kwang Sung; Cho, Yang Je] EyeGene, Ctr Res & Dev, Seoul, South Korea; [Cho, Wan Je] Yonsei Univ, Gangnam Severance Hosp, Seoul 120749, South Korea	Sejong University; Yonsei University; Yonsei University Health System	Lee, NG (corresponding author), Sejong Univ, Coll Biosci, Dept Biosci & Biotechnol, Seoul, South Korea.	nglee@sejong.ac.kr			Transgovernmental Enterprise for Pandemic Influenza of Korea (TEPIK) [A103001]; National Research Foundation; Ministry of Science, ICT & Future Planning of Korea [2009-0074568]; Korean Health Technology R&D Project, Ministry of Health Welfare [HI13C0826]	Transgovernmental Enterprise for Pandemic Influenza of Korea (TEPIK); National Research Foundation; Ministry of Science, ICT & Future Planning of Korea; Korean Health Technology R&D Project, Ministry of Health Welfare	This study was supported by the Transgovernmental Enterprise for Pandemic Influenza of Korea (TEPIK) (grant No. A103001), the National Research Foundation funded by the Ministry of Science, ICT & Future Planning of Korea (grant No. 2009-0074568), and the Korean Health Technology R&D Project, Ministry of Health & Welfare (grant No. HI13C0826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhattacharjee AK, 1996, J INFECT DIS, V173, P1157, DOI 10.1093/infdis/173.5.1157; Brandenburg K, 2000, EUR J BIOCHEM, V267, P3370, DOI 10.1046/j.1432-1327.2000.01370.x; Cho YJ, 2006, VACCINE, V24, P5862, DOI 10.1016/j.vaccine.2006.04.048; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Gomery K, 2012, P NATL ACAD SCI USA, V109, P20877, DOI 10.1073/pnas.1209253109; Han JE, 2012, VACCINE, V30, P4127, DOI 10.1016/j.vaccine.2012.04.079; Han JE, 2010, INT IMMUNOPHARMACOL, V10, P169, DOI 10.1016/j.intimp.2009.10.012; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Ishizaka ST, 2007, EXPERT REV VACCINES, V6, P773, DOI 10.1586/14760584.6.5.773; Johnson DA, 1999, BIOORG MED CHEM LETT, V9, P2273, DOI 10.1016/S0960-894X(99)00374-1; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; Kusumoto S, 2003, J ENDOTOXIN RES, V9, P361, DOI 10.1179/096805103225002737; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Muller-Loennies S, 2003, J BIOL CHEM, V278, P25618, DOI 10.1074/jbc.M302904200; Muller-Loennies S, 2002, EUR J BIOCHEM, V269, P5982, DOI 10.1046/j.1432-1033.2002.03322.x; Muroi M, 2002, INFECT IMMUN, V70, P6043, DOI 10.1128/IAI.70.11.6043-6047.2002; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Orr MT, 2013, EUR J IMMUN IN PRESS, DOI [10.1002/eji.201243124, DOI 10.1002/EJI.201243124.PUBMED:23716300]; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; QURESHI N, 1985, J BIOL CHEM, V260, P5271; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schromm AB, 1998, J IMMUNOL, V161, P5464; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Song ES, 2007, FEMS IMMUNOL MED MIC, V51, P496, DOI 10.1111/j.1574-695X.2007.00325.x; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; WILLIAMSON SI, 1984, J IMMUNOL, V133, P2294; Wui SR, 2013, ARCH PHARM RES, V36, P464, DOI 10.1007/s12272-013-0034-5; Wui SR, 2011, INT IMMUNOPHARMACOL, V11, P1195, DOI 10.1016/j.intimp.2011.03.020; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	48	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85838	10.1371/journal.pone.0085838	http://dx.doi.org/10.1371/journal.pone.0085838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465739	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100081
J	Lazarus, D; Barron, J; Renaudie, J; Diver, P; Turke, A				Lazarus, David; Barron, John; Renaudie, Johan; Diver, Patrick; Tuerke, Andreas			Cenozoic Planktonic Marine Diatom Diversity and Correlation to Climate Change	PLOS ONE			English	Article							MACROEVOLUTIONARY CHANGE; FOSSIL RECORD; OCEAN; EVOLUTION; PACIFIC; SILICA; IMPACT; CYCLE; PHYTOPLANKTON; FORAMINIFERA	Marine planktonic diatoms export carbon to the deep ocean, playing a key role in the global carbon cycle. Although commonly thought to have diversified over the Cenozoic as global oceans cooled, only two conflicting quantitative reconstructions exist, both from the Neptune deep-sea microfossil occurrences database. Total diversity shows Cenozoic increase but is sample size biased; conventional subsampling shows little net change. We calculate diversity from a separately compiled new diatom species range catalog, and recalculate Neptune subsampled-in-bin diversity using new methods to correct for increasing Cenozoic geographic endemism and decreasing Cenozoic evenness. We find coherent, substantial Cenozoic diversification in both datasets. Many living cold water species, including species important for export productivity, originate only in the latest Miocene or younger. We make a first quantitative comparison of diatom diversity to the global Cenozoic benthic delta O-18 (climate) and carbon cycle records (delta C-13, and 20-0 Ma pCO(2)). Warmer climates are strongly correlated with lower diatom diversity (raw: rho=.92, p<.001; detrended, r=.6, p=.01). Diatoms were 20% less diverse in the early late Miocene, when temperatures and pCO(2) were only moderately higher than today. Diversity is strongly correlated to both delta C-13 and pCO(2) over the last 15 my (for both: r>.9, detrended r>.6, all p<.001), but only weakly over the earlier Cenozoic, suggesting increasingly strong linkage of diatom and climate evolution in the Neogene. Our results suggest that many living marine planktonic diatom species may be at risk of extinction in future warm oceans, with an unknown but potentially substantial negative impact on the ocean biologic pump and oceanic carbon sequestration. We cannot however extrapolate our my-scale correlations with generic climate proxies to anthropogenic time-scales of warming without additional species-specific information on proximate ecologic controls.	[Lazarus, David; Renaudie, Johan; Tuerke, Andreas] Museum Naturkunde, Berlin, Germany; [Barron, John] US Geol Survey, Menlo Pk, CA 94025 USA; [Diver, Patrick] Divdat Consulting, Wesley, AR USA; [Tuerke, Andreas] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; United States Department of the Interior; United States Geological Survey; University of Bremen	Lazarus, D (corresponding author), Museum Naturkunde, Berlin, Germany.	david.lazarus@mfn-berlin.de	Renaudie, Johan/D-9077-2012	Renaudie, Johan/0000-0002-9107-1984; Barron, John/0000-0002-9309-1145	German Federal Research Agency [DFG LA1191/8]; Center for Ecological and Evolutionary Synthesis (CEES), Oslo	German Federal Research Agency; Center for Ecological and Evolutionary Synthesis (CEES), Oslo	German Federal Research Agency grant DFG LA1191/8; database porting partial support by Center for Ecological and Evolutionary Synthesis (CEES), Oslo. Both grants to senior author (DBL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2010, PALEONTOLOGICAL SOC, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Aze T, 2011, BIOL REV, DOI [10.1111/j.1469-185X.2011.00178.x, DOI 10.1111/J.1469-185X.2011.00178.X:]; BALDAUF JG, 1990, NATO ADV SCI I C-MAT, V308, P575; Barron J.A., 1995, SILICEOUS MICROFOSSI, V8, P107, DOI DOI 10.1017/S2475263000001446; Barron JA, 2003, DIATOM RES, V18, P203; BARRON JA, 1989, LIFE SCI R, V44, P341; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Beerling DJ, 2012, J ECOL, V100, P31, DOI 10.1111/j.1365-2745.2011.01905.x; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Berger WH, 2007, DEEP-SEA RES PT II, V54, P2399, DOI 10.1016/j.dsr2.2007.07.024; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Bradshaw CD, 2012, CLIM PAST, V8, P715, DOI DOI 10.5194/CPD-8-715-2012; BURCKLE LH, 1982, NATURE, V299, P435, DOI 10.1038/299435a0; Butzin M., 2011, PALEOCEANOGRAPHY, V26, P1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cervato C, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000805; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Cortese G, 2004, EARTH PLANET SC LETT, V224, P509, DOI 10.1016/j.epsl.2004.05.035; Dornelas M, 2012, P ROYAL SOC B, V280, P1; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; Egan KE, 2013, EARTH PLANET SC LETT, V375, P34, DOI 10.1016/j.epsl.2013.04.030; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Falkowski PG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P429; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Fils D, 2009, COMPUT GEOSCI-UK, V35, P774, DOI 10.1016/j.cageo.2008.02.035; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Goldner A., 2013, CLIMATE DISCUSSIONS, V9, P3489; Gradstein FM, 2004, GEOLOGIC TIME SCALE; Halpern Benjamin S., 2012, P285; Hannisdal B, 2011, GEOL SOC SPEC PUBL, V358, P19, DOI 10.1144/SP358.3; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Huber M, 2011, CLIM PAST DISCUSS, V7, P241, DOI DOI 10.5194/CPD-7-241-2011; IPCC Core Writing Team, 2007, CLIM CHANG 2007 SYNT; Kamikuri S, 2009, PALAEOGEOGR PALAEOCL, V280, P469, DOI 10.1016/j.palaeo.2009.06.034; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Kennett J., 1982, MARINE GEOLOGY; Kidder DL, 2005, PALAIOS, V20, P198, DOI 10.2110/palo.2003.p03-108; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; LAZARUS D, 1994, MATH GEOL, V26, P817, DOI 10.1007/BF02083119; Lazarus D, 2011, GEOB ENV SIL BIOM, P20; Lazarus D, 2006, SCI DRILL, V3, P46, DOI 10.5194/sd-3-46-2006; Lazarus D, 2012, PALEOBIOLOGY, V38, P144, DOI 10.1666/10067.1; Lazarus DB, 2011, GEOL SOC SPEC PUBL, V358, P141, DOI 10.1144/SP358.10; Lazarus DB, 2009, P NATL ACAD SCI USA, V106, P9333, DOI 10.1073/pnas.0812979106; Lazarus DB, 1995, REVISED CHRONOLOGY N; Lear CH, 2003, EARTH PLANET SC LETT, V208, P69, DOI 10.1016/S0012-821X(02)01156-1; Lear CH, 2003, EARTH PLANET SC LETT, V210, P425, DOI [10.1016/S0012-821X(03)00164-X, 10.1016/S0012-821X(03)-00164-X]; Lefebvre V, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002345; LEINEN M, 1979, GEOL SOC AM B 2, V90, P1310; Levy R, 2012, GLOBAL PLANET CHANGE, V80-81, P61, DOI 10.1016/j.gloplacha.2011.10.002; Lloyd GT, 2012, PALEOBIOLOGY, V38, P569, DOI 10.1666/11041.1; Lloyd GT, 2011, GEOL SOC SPEC PUBL, V358, P167, DOI 10.1144/SP358.11; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lunt DJ, 2012, EARTH PLANET SC LETT, V321, P128, DOI 10.1016/j.epsl.2011.12.042; Marshall CR, 2010, SCIENCE, V329, P1156, DOI 10.1126/science.1194924; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Mayhew PJ, 2012, P NATL ACAD SCI USA, V109, P15141, DOI 10.1073/pnas.1200844109; Micheels A, 2007, PALAEOGEOGR PALAEOCL, V253, P251, DOI 10.1016/j.palaeo.2007.03.042; Micheels A, 2011, PALAEOGEOGR PALAEOCL, V304, P337, DOI 10.1016/j.palaeo.2010.09.021; Muttoni G, 2007, PALAEOGEOGR PALAEOCL, V253, P348, DOI 10.1016/j.palaeo.2007.06.008; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; RAYMO ME, 1994, PALEOCEANOGRAPHY, V9, P399, DOI 10.1029/94PA00289; Renaudie J, 2013, PALEOBIOLOGY, V39, P491, DOI 10.1666/12016; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Sanderson BM, 2011, ENVIRON RES LETT, V6, P1; Scherer R.P., 2007, POND SCUM CARBON SIN, V13, P61; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SPENCERCERVATO C, 1994, PALEOCEANOGRAPHY, V9, P739, DOI 10.1029/94PA01456; SPENCERCERVATO C, 1999, PALAEONTOLOGICA ELEC, V2; STANLEY SM, 1988, PALEOBIOLOGY, V14, P235, DOI 10.1017/S0094837300011970; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; van de Wal RSW, 2011, CLIM PAST, V7, P1459, DOI 10.5194/cp-7-1459-2011; Wei KY, 1986, PALEOCEANOGRAPHY, V1, P67, DOI 10.1029/PA001i001p00067; Willenbring JK, 2010, NATURE, V465, P211, DOI 10.1038/nature09044; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	95	75	78	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84857	10.1371/journal.pone.0084857	http://dx.doi.org/10.1371/journal.pone.0084857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465441	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100013
J	Shariff, AF; Aknin, LB				Shariff, Azim F.; Aknin, Lara B.			The Emotional Toll of Hell: Cross-National and Experimental Evidence for the Negative Well-Being Effects of Hell Beliefs	PLOS ONE			English	Article							RELIGION; GOD; HAPPINESS; PEOPLE; HAPPY; LIFE; WORLD	Though beliefs in Heaven and Hell are related, they are associated with different personality characteristics and social phenomena. Here we present three studies measuring Heaven and Hell beliefs' associations with and impact on subjective well-being. We find that a belief in Heaven is consistently associated with greater happiness and life satisfaction while a belief in Hell is associated with lower happiness and life satisfaction at the national (Study 1) and individual (Study 2) level. An experimental priming study (Study 3) suggests that these differences are mainly driven by the negative emotional impact of Hell beliefs. Possible cultural evolutionary explanations for the persistence of such a distressing religious concept are discussed.	[Shariff, Azim F.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Aknin, Lara B.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	University of Oregon; Simon Fraser University	Shariff, AF (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	shariff@uoregon.edu		Shariff, Azim/0000-0003-4444-460X	John Templeton Foundation	John Templeton Foundation	The first author is a recipient of grant money from the John Templeton Foundation for other projects unrelated to this one. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Argyle M., 1989, RECENT ADV SOCIAL PS, p189?247, DOI DOI 10.1111/J.1758-0854.20.10.01032.X; Barro RJ, 2003, AM SOCIOL REV, V68, P760, DOI 10.2307/1519761; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BENSON P, 1973, J SCI STUD RELIG, V12, P297, DOI 10.2307/1384430; Branas-Garza P, 2010, J BEHAV DECIS MAKING, V23, P288, DOI 10.1002/bdm.657; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cantril H., 1965, PATTERN HUMAN CONCER; Central Intelligence Agency, 2011, WORLD FACTBOOK; CLARK AE, 2012, WORLD HAPPINESS REPO; Di Tella R, 2001, AM ECON REV, V91, P335, DOI 10.1257/aer.91.1.335; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Diener E, 2011, J PERS SOC PSYCHOL, V101, P1278, DOI 10.1037/a0024402; Francis LJ, 2003, PSYCHOL REP, V92, P51, DOI 10.2466/PR0.92.1.51-52; Francis LJ, 2000, J PSYCHOL CHRISTIANI, V19, P245; Ginges J, 2009, PSYCHOL SCI, V20, P224, DOI 10.1111/j.1467-9280.2009.02270.x; Helliwell J., 2013, WORLD HAPPINESS REPO; Johnson KA, 2013, PSYCHOL RELIG SPIRIT, V5, P15, DOI 10.1037/a0030138; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kaufmann D., 2009, WORLD BANK POLICY RE; Laurin K, 2012, P ROY SOC B-BIOL SCI, V279, P3272, DOI 10.1098/rspb.2012.0615; Lim C, 2010, AM SOCIOL REV, V75, P914, DOI 10.1177/0003122410386686; MYERS DG, 1995, PSYCHOL SCI, V6, P10, DOI 10.1111/j.1467-9280.1995.tb00298.x; Oishi S, 2011, PSYCHOL SCI, V22, P1095, DOI 10.1177/0956797611417262; Ooms JCL, 2009, WE INTERFACE R PACKA; PARGAMENT KI, 1986, J SCI STUD RELIG, V25, P193, DOI 10.2307/1385476; Robbins M., 1996, RES RELIG ED, P207; Shariff AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039048; Shariff AF, 2011, INT J PSYCHOL RELIG, V21, P85, DOI 10.1080/10508619.2011.556990; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Tay L, 2011, J PERS SOC PSYCHOL, V101, P354, DOI 10.1037/a0023779; World Values Survey, 2009, 1981 2005 OFF AGGR V	33	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85251	10.1371/journal.pone.0085251	http://dx.doi.org/10.1371/journal.pone.0085251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465514	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100030
J	De Boer, AA; Monk, JM; Robinson, LE				De Boer, Anna A.; Monk, Jennifer M.; Robinson, Lindsay E.			Docosahexaenoic Acid Decreases Pro-Inflammatory Mediators in an In Vitro Murine Adipocyte Macrophage Co-Culture Model	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE INFLAMMATION; POLYUNSATURATED FATTY-ACIDS; TNF-ALPHA EXPRESSION; PPAR-GAMMA; INSULIN ACTION; MESSENGER-RNA; ADIPONECTIN; CELLS; DIET	Paracrine interactions between adipocytes and macrophages contribute to chronic inflammation in obese adipose tissue. Dietary strategies to mitigate such inflammation include long-chain polyunsaturated fatty acids, docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids, which act through PPAR gamma-dependent and independent pathways. We utilized an in vitro co-culture model designed to mimic the ratio of macrophages: adipocytes in obese adipose tissue, whereby murine 3T3-L1 adipocytes were cultured with RAW 264.7 macrophages in direct contact, or separated by a trans-well membrane (contact-independent mechanism), with 125 mu M of albumin-complexed DHA, EPA, palmitic acid (PA), or albumin alone (control). Thus, we studied the effect of physical cell contact versus the presence of soluble factors, with or without a PPAR gamma antagonist (T0070907) in order to elucidate putative mechanisms. After 12 hr, DHA was the most anti-inflammatory, decreasing MCP1 and IL-6 secretion in the contact system (-57%, -63%, respectively, p <= 0.05)with similar effects in the trans-well system. The trans-well system allowed for isolation of cell types for inflammatory mediator analysis. DHA decreased mRNA expression (p<0.05) of Mcp1 (-7.1 fold) and increased expression of the negative regulator, Mcp1-IP (+1.5 fold). In macrophages, DHA decreased mRNA expression of pro-inflammatory M1 polarization markers (p <= 0.05), Nos2 (iNOS; -7 fold), Tnf alpha (-4.2 fold) and Nf kappa b (-2.3 fold), while increasing anti-inflammatory Tgf beta 1 (+1.7 fold). Interestingly, the PPAR gamma antagonist co-administered with DHA or EPA in co-culture reduced (p <= 0.05) adiponectin cellular protein, without modulating other cytokines (protein or mRNA). Overall, our findings suggest that DHA may lessen the degree of MCP1 and IL-6 secreted from adipocytes, and may reduce the degree of M1 polarization of macrophages recruited to adipose tissue, thereby decreasing the intensity of pro-inflammatory cross-talk between adipocytes and macrophages in obese adipose tissue.	[De Boer, Anna A.; Monk, Jennifer M.; Robinson, Lindsay E.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Robinson, LE (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	lrobinso@uoguelph.ca			Natural Science and Engineering Research Council of Canada [400536]; CBS PhD award from the College of Biological Sciences, University of Guelph	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CBS PhD award from the College of Biological Sciences, University of Guelph	This study was funded by the Natural Science and Engineering Research Council of Canada (LER; 400536). AAD was supported by the CBS PhD award from the College of Biological Sciences, University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chen CW, 2003, J IMMUNOL, V171, P979, DOI 10.4049/jimmunol.171.2.979; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Greene M. E., 1995, Gene Expression, V4, P281; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hsueh HW, 2011, J NUTR, V141, P1260, DOI 10.3945/jn.110.132571; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oliver E, 2012, J NUTR BIOCHEM, V23, P1192, DOI 10.1016/j.jnutbio.2011.06.014; Oster RT, 2010, APPL PHYSIOL NUTR ME, V35, P783, DOI 10.1139/H10-076; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Scheele C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039657; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Thieringer R, 2000, J IMMUNOL, V164, P1046, DOI 10.4049/jimmunol.164.2.1046; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Turk H. F., 2012, PROSTAGLANDINS LEUKO, V88, P43; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Wilson SAF, 2013, INT J OBESITY, V37, P350, DOI 10.1038/ijo.2012.50; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09	46	46	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85037	10.1371/journal.pone.0085037	http://dx.doi.org/10.1371/journal.pone.0085037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465472	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500029
J	Fernandez-Ponce, C; Dominguez-Villar, M; Aguado, E; Garcia-Cozar, F				Fernandez-Ponce, Cecilia; Dominguez-Villar, Margarita; Aguado, Enrique; Garcia-Cozar, Francisco			CD4+Primary T Cells Expressing HCV-Core Protein Upregulate Foxp3 and IL-10, Suppressing CD4 and CD8 T Cells	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; BLOOD MONONUCLEAR-CELLS; CELLULAR IMMUNE-RESPONSES; IN-VITRO PROLIFERATION; PERIPHERAL-BLOOD; INFECTED PATIENTS; PD-1 EXPRESSION; VIRAL CLEARANCE; HELPER-CELLS; LYMPHOCYTES	Adaptive T cell responses are critical for controlling HCV infection. While there is clinical evidence of a relevant role for regulatory T cells in chronic HCV-infected patients, based on their increased number and function; mechanisms underlying such a phenomena are still poorly understood. Accumulating evidence suggests that proteins from Hepatitis C virus can suppress host immune responses. We and others have shown that HCV is present in CD4+ lymphocytes from chronically infected patients and that HCV-core protein induces a state of unresponsiveness in the CD4+ tumor cell line Jurkat. Here we show that CD4+ primary T cells lentivirally transduced with HCV-core, not only acquire an anergic phenotype but also inhibit IL-2 production and proliferation of bystander CD4+ or CD8+ T cells in response to anti-CD3 plus anti-CD28 stimulation. Core-transduced CD4+ T cells show a phenotype characterized by an increased basal secretion of the regulatory cytokine IL-10, a decreased IFN-gamma production upon stimulation, as well as expression of regulatory T cell markers, CTLA-4, and Foxp3. A significant induction of CD4+CD25+CD127(low)PD-1(high)TIM-3(high) regulatory T cells with an exhausted phenotype was also observed. Moreover, CCR7 expression decreased in HCV-core expressing CD4+ T cells explaining their sequestration in inflamed tissues such as the infected liver. This work provides a new perspective on de novo generation of regulatory CD4+ T cells in the periphery, induced by the expression of a single viral protein.	[Garcia-Cozar, Francisco] Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth Immunol, Cadiz, Spain; Puerto Real Univ Hosp, Res Unit, Sch Med, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerto Real	Garcia-Cozar, F (corresponding author), Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth Immunol, Cadiz, Spain.	curro.garcia@uca.es	Garcia-Cozar, Francisco/A-6212-2013; Ponce, Cecilia Matilde Fernández/L-4752-2014; Aguado, Enrique/L-4908-2014	Garcia-Cozar, Francisco/0000-0003-3720-259X; Ponce, Cecilia Matilde Fernández/0000-0002-0027-1703; Aguado, Enrique/0000-0002-7232-2661; Dominguez-Villar, Margarita/0000-0002-9719-0028	Ministerio de Ciencia e Innovacion (Spain) [SAF2009-09449]; Consejeria de Salud, Junta de Andalucia [PI-0007/2007]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [P08-CTS-04348]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia)	This work was supported by grants (SAF2009-09449) from the Ministerio de Ciencia e Innovacion (Spain), PI-0007/2007 from Consejeria de Salud, Junta de Andalucia, and P08-CTS-04348 from Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia to FGC. MDV was a graduate fellow of the FIS program (Ministerio de Salud, Spain) and CFP is a graduate fellow of the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Aberle JH, 2006, J CLIN VIROL, V36, P24, DOI 10.1016/j.jcv.2005.12.010; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Andris F, 2004, J IMMUNOL, V173, P3201, DOI 10.4049/jimmunol.173.5.3201; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bergqvist A, 2001, J VIROL, V75, P772, DOI 10.1128/JVI.75.2.772-781.2001; Billerbeck E, 2009, J GEN VIROL, V90, P1692, DOI 10.1099/vir.0.009837-0; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bolacchi F, 2006, CLIN EXP IMMUNOL, V144, P188, DOI 10.1111/j.1365-2249.2006.03048.x; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carabaich A, 2005, J MED VIROL, V76, P55, DOI 10.1002/jmv.20322; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; CHEN A, 1994, J IMMUNOL, V153, P1430; Claassen MAA, 2011, J VIROL, V85, P5323, DOI 10.1128/JVI.02551-10; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Dehesa-Violante M, 2007, ARCH MED RES, V38, P606, DOI 10.1016/j.arcmed.2007.03.001; Dominguez-Villar M, 2007, J LEUKOCYTE BIOL, V82, P1301, DOI 10.1189/jlb.0507335; Dominguez-Villar M, 2012, SCAND J IMMUNOL, V75, P54, DOI 10.1111/j.1365-3083.2011.02624.x; Dominguez-Villar M, 2012, CLIN SCI, V123, P15, DOI 10.1042/CS20110631; Doumba PP, 2013, CELL MOL LIFE SCI; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Eckels DD, 1999, HUM IMMUNOL, V60, P187, DOI 10.1016/S0198-8859(98)00111-6; El-Awady MK, 2005, WORLD J GASTROENTERO, V11, P5203; Engelhardt JJ, 2006, J IMMUNOL, V177, P1052, DOI 10.4049/jimmunol.177.2.1052; Falcon V, 2005, BIOCHEM BIOPH RES CO, V329, P1320, DOI 10.1016/j.bbrc.2005.02.107; Falcon V, 2003, BIOCHEM BIOPH RES CO, V310, P54, DOI 10.1016/j.bbrc.2003.08.118; Ferri S, 2011, DIGEST LIVER DIS, V43, P807, DOI 10.1016/j.dld.2011.04.020; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Freeman AJ, 2001, IMMUNOL CELL BIOL, V79, P515, DOI 10.1046/j.1440-1711.2001.01036.x; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Gavin MA, 2007, NATURE; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Goutagny N, 2003, J INFECT DIS, V187, P1951, DOI 10.1086/375350; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hall CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012154; Hayashi RJ, 1998, J IMMUNOL, V160, P33; Hiroishi K, 2008, J GASTROEN HEPATOL, V23, P1473, DOI 10.1111/j.1440-1746.2008.05475.x; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Irshad M, 2006, MED PRIN PRACT, V15, P405, DOI 10.1159/000095485; Ji XJ, 2013, EUR J IMMUNOL, V43, P458, DOI 10.1002/eji.201242768; Kakumu S, 1997, CLIN EXP IMMUNOL, V108, P138, DOI 10.1046/j.1365-2249.1997.d01-987.x; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kondo Y, 2006, VIROLOGY; Kondo Y, 2011, J GASTROENTEROL, V46, P232, DOI 10.1007/s00535-010-0297-2; Koziel MJ, 2005, CLIN INFECT DIS, V41, pS25, DOI 10.1086/429492; Koziel MJ, 1999, SEMIN LIVER DIS, V19, P157, DOI 10.1055/s-2007-1007107; Krishnadas DK, 2010, VACCINE, V28, P2104, DOI 10.1016/j.vaccine.2009.12.037; Lange C, 2011, BRAIN BEHAV IMMUN, V25, P120, DOI 10.1016/j.bbi.2010.09.004; Langhans B, 2010, CLIN SCI, V119, P97, DOI 10.1042/CS20090661; Laskus T, 1998, J INFECT DIS, V178, P1189, DOI 10.1086/515682; Laskus T, 2007, J INFECT DIS, V195, P124, DOI 10.1086/509897; Lauer GM, 2006, CLIN INFECT DIS, V42, P953, DOI 10.1086/500944; Lee S, 2010, CLIN EXP IMMUNOL, V161, P118, DOI 10.1111/j.1365-2249.2010.04141.x; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li S, 2007, IMMUNOL CELL BIOL, V85, P197, DOI 10.1038/sj.icb.7100020; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Melen K, 2004, J MED VIROL, V73, P536, DOI 10.1002/jmv.20123; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162; Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TN, 2008, WORLD J GASTROENTERO, V14, P2789, DOI 10.3748/wjg.14.2789; Piazzolla G, 2000, J CLIN IMMUNOL, V20, P54, DOI 10.1023/A:1006694627907; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Quiroga JA, 2006, J VIROL, V80, P10972, DOI 10.1128/JVI.00852-06; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Radziewicz H, 2009, J CLIN INVEST, V119, P450, DOI 10.1172/JCI38661; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Rushbrook SM, 2007, EXPERT OPIN BIOL TH, V7, P1689, DOI 10.1517/14712598.7.11.1689; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sakthivel P, 2012, REV RECENT CLIN TRIA, V7, P10, DOI 10.2174/157488712799363262; Semmo N, 2005, HEPATOLOGY, V41, P1019, DOI 10.1002/hep.20669; Serti E, 2011, CELL MOL LIFE SCI, V68, P505, DOI 10.1007/s00018-010-0466-8; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Soguero C, 2002, J VIROL, V76, P9345, DOI 10.1128/JVI.76.18.9345-9354.2002; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Sundstrom S, 2005, J VIROL, V79, P2230, DOI 10.1128/JVI.79.4.2230-2239.2005; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tsai SL, 1997, HEPATOLOGY, V25, P449; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Tsitoura P, 2007, FEBS LETT, V581, P4049, DOI 10.1016/j.febslet.2007.07.032; Ulsenheimer A, 2003, HEPATOLOGY, V37, P1189, DOI 10.1053/jhep.2003.50194; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Woitas RP, 1997, J IMMUNOL, V159, P1012; Yao ZQ, 2003, VIROLOGY, V314, P271, DOI 10.1016/S0042-6822(03)00419-7; Zhao BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077008; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	124	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85191	10.1371/journal.pone.0085191	http://dx.doi.org/10.1371/journal.pone.0085191			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465502	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500037
J	Kumar, A; Mamidi, P; Das, I; Nayak, TK; Kumar, S; Chhatai, J; Chattopadhyay, S; Suryawanshi, AR; Chattopadhyay, S				Kumar, Abhishek; Mamidi, Prabhudutta; Das, Indrani; Nayak, Tapas K.; Kumar, Sameer; Chhatai, Jagamohan; Chattopadhyay, Subhasis; Suryawanshi, Amol R.; Chattopadhyay, Soma			A Novel 2006 Indian Outbreak Strain of Chikungunya Virus Exhibits Different Pattern of Infection as Compared to Prototype Strain	PLOS ONE			English	Article							REEMERGENCE; GENOTYPE	Background: The recent re-emergence of Chikungunya virus (CHIKV) in India after 32 years and its worldwide epidemics with unprecedented magnitude raised a great public health concern. Methods and Findings: In this study, a biological comparison was carried out between a novel 2006 Indian CHIKV outbreak strain, DRDE-06 and the prototype strain S-27 in mammalian cells in order to understand their differential infection pattern. Results showed that S-27 produced maximum number of progenies (2.43E+06 PFU/ml) at 20 to 24 hours post infection whereas DRDE-06 produced more than double number of progenies around 8 hours post infection in mammalian cells. Moreover, the observation of cytopathic effect, detection of viral proteins and viral proliferation assay confirmed the remarkably faster and significantly higher replication efficiency of DRDE-06. Moreover, our mutational analysis of whole genome of DRDE-06 revealed the presence of nineteen mutations as compared to S-27, whereas the analysis of 273 global isolates showed the consistent presence of fifteen out of nineteen mutations in almost all outbreak isolates. Further analysis revealed that similar to 46% of recent outbreak strains including DRDE-06 do not contain the E1-A226V mutation which was earlier shown to be associated with the adaptation of CHIKV in a new vector species, Aedes albopictus. Conclusions: A novel 2006 Indian CHIKV outbreak strain, DRDE-06 exhibits different pattern of infection as compared to prototype strain, S-27. This might be associated to some specific mutations observed in genome wide mutational analysis in DRDE-06 which emphasizes the need of future experimental investigation.	[Kumar, Abhishek; Mamidi, Prabhudutta; Das, Indrani; Kumar, Sameer; Chhatai, Jagamohan; Suryawanshi, Amol R.; Chattopadhyay, Soma] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India; [Nayak, Tapas K.; Chattopadhyay, Subhasis] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); National Institute of Science Education & Research (NISER)	Chattopadhyay, S (corresponding author), Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India.	sochat.ils@gmail.com	Kumar, Abhishek/AAO-1910-2020; Mamidi, Prabhudutta/GNM-5436-2022; Suryawanshi, Amol Ratnakar/AAM-5853-2020	Kumar, Abhishek/0000-0001-5880-8123; Suryawanshi, Amol/0000-0001-8519-2467	Department of Biotechnology, Ministry of Science and Technology, Govt. of India [BT/PR13118/GBD/27/186/2009, BT/PR15173/GBD/27/356/2011]; Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India [37(1542)/12/EMR-II]	Department of Biotechnology, Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Govt. of India vide grant no BT/PR13118/GBD/27/186/2009 and BT/PR15173/GBD/27/356/2011 and by Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India vide Project No. 37(1542)/12/EMR-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Anderson BD, 2012, J CLIN VIROL, V54, P265, DOI 10.1016/j.jcv.2012.03.006; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Brooks G.F., 2004, MED MICROBIOLOGY, P514; Chattopadhyay S, 2006, J VIROL, V80, P4491, DOI 10.1128/JVI.80.9.4491-4500.2006; Das B, 2012, INFECT GENET EVOL, V12, P1094, DOI 10.1016/j.meegid.2012.03.012; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; Dash PK, 2008, BIOCHEM BIOPH RES CO, V376, P718, DOI 10.1016/j.bbrc.2008.09.040; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Ray P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030025; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSS R. W., 1956, JOUR HYG, V54, P192; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; Schlesinger, 1986, TOGAVIRIDAE FLAVIVIR, P35, DOI 10.1007/978-1-4757-0785-4_3; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Singh RK, 2012, J VIROL METHODS; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Suryawanshi AR, 2011, J ANDROL, V32, P240, DOI 10.2164/jandrol.110.010967; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaikruea Lakkana, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P359; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Yang EX, 2012, SCI CHINA LIFE SCI, V55, P336, DOI 10.1007/s11427-012-4313-z; Yusof MA, 2011, J GEN MOL VIROLOGY, V3, P35; Zhang X, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-194, 10.1186/1743-422X-10-174]	32	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85714	10.1371/journal.pone.0085714	http://dx.doi.org/10.1371/journal.pone.0085714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465661	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500067
J	Lin, ZH; Zhang, C; Zhang, MF; Xu, DQ; Fang, YF; Zhou, Z; Chen, XL; Qin, N; Zhang, XW				Lin, Zhaohu; Zhang, Chao; Zhang, Meifang; Xu, Danqing; Fang, Yanfen; Zhou, Zheng; Chen, Xiaolong; Qin, Ning; Zhang, Xiongwen			Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer	PLOS ONE			English	Article							LIVER-INTESTINE-CADHERIN; LI-CADHERIN; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC MARKER; TUMOR-GROWTH; EXPRESSION; METASTASIS; PATHWAY; ADENOCARCINOMAS; INVASIVENESS	Cadherin-17 (CDH17), one member of 7D-cadherin superfamily, was overexpressed in gastric cancer (GC) and was associated with poor survival, tumor recurrence, metastasis, and advanced tumor stage. So far the cellular function and signaling mechanism of CDH17 in GC remains unclear. In this study, we showed that over 66% of GC cell lines (20/30) were CDH17 positive. Tissue microarray (TMA) assay showed that 73.6% Chinese GC tissues (159/216) were CDH17 positive, while 37% respective adjacent normal tissues were CDH17 positive. Knockdown of CDH17 inhibited cell proliferation, migration, adhesion and colony formation, and also induced a cell cycle arrest and apoptosis in AGS human GC cells. On the other side, overexpression of CDH17 facilitated MGC-803 GC tumor growth in nude mice. Antibody array and Western blotting assay demonstrated that knockdown of CDH17 in AGS cells down-regulated integrin beta series proteins, further inactivated the Ras/Raf/MEK/ERK pathway and led to p53 and p21 accumulation, which resulted in proliferation inhibition, cell-cycle arrest and apoptosis induction. Collectively, our data firstly demonstrate the capacity of CDH17 to regulate the activity of Ras/Raf/MEK/ERK pathway for cell proliferation in GC, and suggest that CDH17 can serve as an attractive therapeutic target for future research.	[Lin, Zhaohu; Zhang, Chao; Zhang, Meifang; Xu, Danqing; Zhou, Zheng; Chen, Xiaolong; Qin, Ning; Zhang, Xiongwen] Roche Pharma Res & Early Dev China, Dept Discovery Technol, Shanghai, Peoples R China; [Fang, Yanfen; Zhang, Xiongwen] E China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai 200062, Peoples R China	East China Normal University	Zhang, XW (corresponding author), Roche Pharma Res & Early Dev China, Dept Discovery Technol, Shanghai, Peoples R China.	xwzhang@sat.ecnu.edu.cn						Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bartolome R. A., 2013, ONCOGENE; Dong WG, 2008, DIGEST DIS SCI, V53, P1811, DOI 10.1007/s10620-007-0080-2; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Ge J, 2008, CLIN ONCOL-UK, V20, P275, DOI 10.1016/j.clon.2008.01.013; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; Hartgrink HH, 2009, GASTRIC CANCER, V12, P3, DOI 10.1007/s10120-009-0501-3; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hippo Y, 2002, CANCER RES, V62, P233; Ito R, 2005, VIRCHOWS ARCH, V447, P717, DOI 10.1007/s00428-005-0015-2; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Ko S, 2004, BIOCHEM BIOPH RES CO, V319, P562, DOI 10.1016/j.bbrc.2004.04.197; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Liu QS, 2010, CANCER SCI, V101, P1807, DOI 10.1111/j.1349-7006.2010.01600.x; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Park JH, 2011, HISTOPATHOLOGY, V58, P316, DOI 10.1111/j.1365-2559.2011.03746.x; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Takamura M, 2003, CANCER SCI, V94, P425, DOI 10.1111/j.1349-7006.2003.tb01459.x; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Wang J, 2013, CANCER BIOL THER, V14, P262, DOI 10.4161/cbt.23299; Wang XQ, 2005, CLIN CANCER RES, V11, P483; Wong BW, 2003, BIOCHEM BIOPH RES CO, V311, P618, DOI 10.1016/j.bbrc.2003.10.032; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Xu Y, 2012, WORLD J GASTROENTERO, V18, P3129, DOI 10.3748/wjg.v18.i24.3129; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Zhang J, 2011, MED ONCOL, V28, P494, DOI 10.1007/s12032-010-9489-0	31	27	37	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85296	10.1371/journal.pone.0085296	http://dx.doi.org/10.1371/journal.pone.0085296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465527	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500039
J	Retschnig, G; Williams, GR; Mehmann, MM; Yanez, O; de Miranda, JR; Neumann, P				Retschnig, Gina; Williams, Geoffrey R.; Mehmann, Marion M.; Yanez, Orlando; de Miranda, Joachim R.; Neumann, Peter			Sex-Specific Differences in Pathogen Susceptibility in Honey Bees (Apis mellifera)	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE-LARVAE; WING VIRUS-INFECTION; DRONE BROOD CELLS; NOSEMA-CERANAE; VARROA-JACOBSONI; AMERICAN FOULBROOD; IMMUNE-RESPONSE; PARALYSIS VIRUS; COLONIES; PCR	Sex-related differences in susceptibility to pathogens are a common phenomenon in animals. In the eusocial Hymenoptera the two female castes, workers and queens, are diploid and males are haploid. The haploid susceptibility hypothesis predicts that haploid males are more susceptible to pathogen infections compared to females. Here we test this hypothesis using adult male (drone) and female (worker) honey bees (Apis mellifera), inoculated with the gut endoparasite Nosema ceranae and/or black queen cell virus (BQCV). These pathogens were chosen due to previously reported synergistic interactions between Nosema apis and BQCV. Our data do not support synergistic interactions between N. ceranae and BQCV and also suggest that BQCV has limited effect on both drone and worker health, regardless of the infection level. However, the data clearly show that, despite lower levels of N. ceranae spores in drones than in workers, Nosema-infected drones had both a higher mortality and a lower body mass than non-infected drones, across all treatment groups, while the mortality and body mass of worker bees were largely unaffected by N. ceranae infection, suggesting that drones are more susceptible to this pathogen than workers. In conclusion, the data reveal considerable sex-specific differences in pathogen susceptibility in honey bees and highlight the importance of ultimate measures for determining susceptibility, such as mortality and body quality, rather than mere infection levels.	[Retschnig, Gina; Williams, Geoffrey R.; Mehmann, Marion M.; Yanez, Orlando; Neumann, Peter] Res Stn Agroscope Liebefeld Posieux ALP HARAS, Swiss Bee Res Ctr, Bern, Switzerland; [Retschnig, Gina; Williams, Geoffrey R.; Yanez, Orlando; Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Williams, Geoffrey R.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Neumann, Peter] Univ Pretoria, Dept Zool & Entomol, Social Insect Res Grp, ZA-0002 Pretoria, South Africa	Swiss Federal Research Station Agroscope; University of Bern; Dalhousie University; Swedish University of Agricultural Sciences; University of Pretoria	Retschnig, G (corresponding author), Res Stn Agroscope Liebefeld Posieux ALP HARAS, Swiss Bee Res Ctr, Bern, Switzerland.	gina.retschnig@gmail.com	Williams, Geoffrey/C-9637-2015; Yanez, Orlando/AAQ-8347-2020; Yanez, Orlando/I-2428-2016; Neumann, Peter/C-9964-2015	Williams, Geoffrey/0000-0002-0093-1126; Yanez, Orlando/0000-0001-8493-2726; Yanez, Orlando/0000-0001-8493-2726; Neumann, Peter/0000-0001-5163-5215; Retschnig, Gina/0000-0001-6249-9853; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	European Union [244956]; BEEDOC (BEes in Europe and the Decline Of Colonies); Vinetum, Swiss National Science and Ricola foundations	European Union(European Commission); BEEDOC (BEes in Europe and the Decline Of Colonies); Vinetum, Swiss National Science and Ricola foundations	The research has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. (244956 CPFP), BEEDOC (BEes in Europe and the Decline Of Colonies), as well as the Vinetum, Swiss National Science and Ricola foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson D., 1993, Australasian Beekeeper, V94, P292; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; BAILEY L, 1977, J GEN VIROL, V37, P175, DOI 10.1099/0022-1317-37-1-175; Bailey L., 1972, Journal apic Res, V11, P171; Bailey L, 1991, HONEYBEE PATHOLOGY; BOOT WJ, 1995, APIDOLOGIE, V26, P109, DOI 10.1051/apido:19950204; Brodsgaard CJ, 2000, APIDOLOGIE, V31, P543, DOI 10.1051/apido:2000145; Burgher-MacLellan KL, 2010, CAN ENTOMOL, V142, P271, DOI 10.4039/n10-010; CAMAZINE S, 1986, ANN ENTOMOL SOC AM, V79, P801, DOI 10.1093/aesa/79.5.801; Cantwell G. E., 1970, AM BEE J, V110, P222; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; DEMIRANDA JR, 2013, J APICULT RES, V52, DOI DOI 10.3896/IBRA.1.52.4.22; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Duay Pedro, 2002, Genetics and Molecular Research, V1, P227; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Evans JD, 2005, J APICULT RES, V44, P168; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; FUCHS S, 1990, APIDOLOGIE, V21, P193, DOI 10.1051/apido:19900304; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; GROSSMAN C, 1989, J STEROID BIOCHEM, V34, P241, DOI 10.1016/0022-4731(89)90088-5; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; KELLNER N, 1978, VLAAMS DIERGEN TIJDS, V47, P252; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koeniger G, 2005, APIDOLOGIE, V36, P143, DOI 10.1051/apido:2005017; Koeniger N, 2005, APIDOLOGIE, V36, P211, DOI 10.1051/apido:2005011; Kurtz J, 2000, DEV COMP IMMUNOL, V24, P1, DOI 10.1016/S0145-305X(99)00057-9; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; LOCKE SJ, 1993, PHYSIOL ENTOMOL, V18, P144, DOI 10.1111/j.1365-3032.1993.tb00461.x; Martin SJ, 2013, ENV MICROBIOL REP, V5, P506, DOI 10.1111/1758-2229.12052; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Morton A, 2013, J INVERTEBR PATHOL, V112, P203, DOI 10.1016/j.jip.2012.11.012; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; O'Donnell S, 2004, P ROY SOC B-BIOL SCI, V271, P979, DOI 10.1098/rspb.2004.2685; OERTEL E., 1953, ANN ENT SOC AMER, V46, P596; Otteni M, 2004, APIACTA, V39, P91; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Poulin R, 2007, EVOLUTIONARY ECOLOGY, P188; Rhodes JW, 2011, APIDOLOGIE, V42, P29, DOI 10.1051/apido/2010026; Ribiere M, 2008, VIROLOGY HONEY BEE, P29; RINDERER TE, 1969, J INVERTEBR PATHOL, V13, P81, DOI 10.1016/0022-2011(69)90241-9; Roff Derek A., 1992; Roman A, 2010, J APIC SCI, V54, P25; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ruiz-Gonzalez MX, 2006, BEHAV ECOL SOCIOBIOL, V60, P501, DOI 10.1007/s00265-006-0192-2; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Siede R, 2003, BERL MUNCH TIERARZTL, V116, P130; Soroker V, 2011, APIDOLOGIE, V42, P192, DOI 10.1051/apido/2010047; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Traver BE, 2011, J INVERTEBR PATHOL, V107, P234, DOI 10.1016/j.jip.2011.05.016; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; VERBEKE M, 1984, AM BEE J, V124, P468; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Wilson EO, 1971, INSECT SOC, P548; Winston M.L., 1991, BIOL HONEY BEE; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	90	41	41	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85261	10.1371/journal.pone.0085261	http://dx.doi.org/10.1371/journal.pone.0085261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465518	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330237000028
J	Pinzon, AM; Orkisz, M; Useche, CMR; Gonzalez, JST; Teillaud, S; Sanchez, JA; Hoyos, MH				Morales Pinzon, Alfredo; Orkisz, Maciej; Rodriguez Useche, Catalina Maria; Torres Gonzalez, Juan Sebastian; Teillaud, Stanislas; Armando Sanchez, Juan; Hernandez Hoyos, Marcela			A Semi-Automatic Method to Extract Canal Pathways in 3D Micro-CT Images of Octocorals	PLOS ONE			English	Article							GASTROVASCULAR SYSTEM; COLONIAL ORGANISMS; CORAL; CIRCULATION; NETWORKS; CNIDARIA	The long-term goal of our study is to understand the internal organization of the octocoral stem canals, as well as their physiological and functional role in the growth of the colonies, and finally to assess the influence of climatic changes on this species. Here we focus on imaging tools, namely acquisition and processing of three-dimensional high-resolution images, with emphasis on automated extraction of canal pathways. Our aim was to evaluate the feasibility of the whole process, to point out and solve - if possible - technical problems related to the specimen conditioning, to determine the best acquisition parameters and to develop necessary image-processing algorithms. The pathways extracted are expected to facilitate the structural analysis of the colonies, namely to help observing the distribution, formation and number of canals along the colony. Five volumetric images of Muricea muricata specimens were successfully acquired by X-ray computed tomography with spatial resolution ranging from 4.5 to 25 micrometers. The success mainly depended on specimen immobilization. More than 85% of the canals were successfully detected and tracked by the image-processing method developed. Thus obtained three-dimensional representation of the canal network was generated for the first time without the need of histological or other destructive methods. Several canal patterns were observed. Although most of them were simple, i.e. only followed the main branch or "turned" into a secondary branch, many others bifurcated or fused. A majority of bifurcations were observed at branching points. However, some canals appeared and/or ended anywhere along a branch. At the tip of a branch, all canals fused into a unique chamber. Three-dimensional high-resolution tomographic imaging gives a non-destructive insight to the coral ultrastructure and helps understanding the organization of the canal network. Advanced image-processing techniques greatly reduce human observer's effort and provide methods to both visualize and quantify the structures of interest.	[Morales Pinzon, Alfredo; Rodriguez Useche, Catalina Maria; Torres Gonzalez, Juan Sebastian; Hernandez Hoyos, Marcela] Univ Los Andes, Dept Ingn Sistemas & Computac, Grp Imagine, Bogota, Colombia; [Orkisz, Maciej] Univ Lyon 1, CNRS, UMR5220, CREATIS, F-69622 Villeurbanne, France; [Teillaud, Stanislas; Armando Sanchez, Juan] Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Lab Biol Mol Marina BIOMMAR, Bogota, Colombia	Universidad de los Andes (Colombia); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de los Andes (Colombia)	Pinzon, AM (corresponding author), Univ Los Andes, Dept Ingn Sistemas & Computac, Grp Imagine, Bogota, Colombia.	alf-mora@uniandes.edu.co	sanchez, juan/GSD-8167-2022; Orkisz, Maciej/H-3761-2013	Orkisz, Maciej/0000-0003-1709-5766; Sanchez, Juan Armando/0000-0001-7149-8369	French ANR Labex PRIMES [ANR-11-LABX-0063]; Colombian COLCIENCIAS doctoral grant; "Proyecto interfacultades" (Vicerrectoria de Investigaciones, Universidad de los Andes); COLCIENCIAS [1204-521-29002]	French ANR Labex PRIMES(French National Research Agency (ANR)); Colombian COLCIENCIAS doctoral grant; "Proyecto interfacultades" (Vicerrectoria de Investigaciones, Universidad de los Andes); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was done in the framework of the French ANR Labex PRIMES (ANR-11-LABX-0063). Alfredo Morales was supported by a Colombian COLCIENCIAS doctoral grant. Support from "Proyecto interfacultades" (Vicerrectoria de Investigaciones, Universidad de los Andes) and COLCIENCIAS (Grant No. 1204-521-29002) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer F.M., 1973, P69; Bayer FM, 1961, SHALLOW WATER OCTOCO, P31; Beuck L, 2007, FACIES, V53, P157, DOI 10.1007/s10347-006-0094-9; Brun F, 2010, NUCL INSTRUM METH A, V615, P326, DOI 10.1016/j.nima.2010.02.063; Gabay Y, 2013, ECOL EVOL, V3, P465, DOI 10.1002/ece3.351; Hameeteman K, 2011, MED IMAGE ANAL, V15, P477, DOI 10.1016/j.media.2011.02.004; Heim I, 2010, ZOOTAXA, P1; Hernandez-Hoyos M, 1999, INT CONGR SER, V1191, P189; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Cadena NJ, 2010, MAR BIOL, V157, P1003, DOI 10.1007/s00227-009-1380-1; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2001, VIRTUAL LAB, P1; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knackstedt MA, 2006, BIOMATERIALS, V27, P2776, DOI 10.1016/j.biomaterials.2005.12.016; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kruszynski K.J., 2006, P EUR IEEE VGTC S VI, P283, DOI [DOI 10.2312/VISSYM/EUROVIS06/283-290, 10.2312/VisSym/EuroVis06/283-290]; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; MURDOCK GR, 1978, B MAR SCI, V28, P363; Nishikawa T., 2009, J ORAL TISSUE ENG, V7, P121; Orkisz M., 2000, Machine Graphics & Vision, V9, P463; Orkisz Maciej, 2008, Machine Graphics & Vision, V17, P5; Orkisz MM, 1997, MAGNET RESON MED, V37, P914, DOI 10.1002/mrm.1910370617; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parrin AP, 2010, BIOL BULL-US, V219, P112, DOI 10.1086/BBLv219n2p112; Puce S, 2011, ZOOMORPHOLOGY, V130, P85, DOI 10.1007/s00435-011-0120-5; Roche RC, 2010, J EXP MAR BIOL ECOL, V396, P1, DOI 10.1016/j.jembe.2010.10.006; Sanchez JA, 2004, HYDROBIOLOGIA, V530, P283, DOI 10.1007/s10750-004-2684-2; Sanchez JA, 2004, AM NAT, V163, pE24, DOI 10.1086/382139; Sanchez JA, 2004, P ROY SOC B-BIOL SCI, V271, pS117, DOI 10.1098/rsbl.2003.0108; Sarwar A, 2008, RADIOLOGY, V249, P301, DOI 10.1148/radiol.2483072003; Schaap M, 2009, MED IMAGE ANAL, V13, P701, DOI 10.1016/j.media.2009.06.003; Shahzad R, 2013, ACAD RADIOL, V20, P1, DOI 10.1016/j.acra.2012.07.018; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Turcotte DL, 1996, P NATL ACAD SCI USA, V93, P14295, DOI 10.1073/pnas.93.25.14295; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Wu YC, 2009, J MATER SCI-MATER M, V20, P1273, DOI 10.1007/s10856-009-3695-3	41	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85557	10.1371/journal.pone.0085557	http://dx.doi.org/10.1371/journal.pone.0085557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465599	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000017
J	Ongkeko, WM; Burton, D; Kiang, A; Abhold, E; Kuo, SZ; Rahimy, E; Yang, M; Hoffman, RM; Wang-Rodriguez, J; Deftos, LJ				Ongkeko, Weg M.; Burton, Doug; Kiang, Alan; Abhold, Eric; Kuo, Selena Z.; Rahimy, Elham; Yang, Meng; Hoffman, Robert M.; Wang-Rodriguez, Jessica; Deftos, Leonard J.			Parathyroid Hormone Related-Protein Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer	PLOS ONE			English	Article							SIGNALING PATHWAYS; BONE METASTASES; BREAST-CANCER; STEM-CELLS; FLUORESCENT PROTEIN; PTH/PTHRP RECEPTOR; TUMOR PROGRESSION; INDIAN HEDGEHOG; E-CADHERIN; TGF-BETA	Parathyroid hormone-related protein (PTHrP) possesses a variety of physiological and developmental functions and is also known to facilitate the progression of many common cancers, notably their skeletal invasion, primarily by increasing bone resorption. The purpose of this study was to determine whether PTHrP could promote epithelial-to-mesenchymal transition (EMT), a process implicated in cancer stem cells that is critically involved in cancer invasion and metastasis. EMT was observed in DU 145 prostate cancer cells stably overexpressing either the 1-141 or 1-173 isoform of PTHrP, where there was upregulation of Snail and vimentin and downregulation of E-cadherin relative to parental DU 145. By contrast, the opposite effect was observed in PC-3 prostate cancer cells where high levels of PTHrP were knocked-down via lentiviral siRNA transduction. Increased tumor progression was observed in PTHrP-overexpressing DU 145 cells while decreased progression was observed in PTHrP-knockdown PC-3 cells. PTHrP-overexpressing DU 145 formed larger tumors when implanted orthoptopically into nude mice and in one case resulted in spinal metastasis, an effect not observed among mice injected with parental DU 145 cells. PTHrP-overexpressing DU 145 cells also caused significant bone destruction when injected into the tibiae of nude mice, while parental DU 145 cells caused little to no destruction of bone. Together, these results suggest that PTHrP may work through EMT to promote an aggressive and metastatic phenotype in prostate cancer, a pathway of importance in cancer stem cells. Thus, continued efforts to elucidate the pathways involved in PTHrP-induced EMT as well as to develop ways to specifically target PTHrP signaling may lead to more effective therapies for prostate cancer.	[Ongkeko, Weg M.; Kiang, Alan; Abhold, Eric; Kuo, Selena Z.; Rahimy, Elham] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA; [Burton, Doug; Deftos, Leonard J.] Univ Calif San Diego, Vet Adm San Diego Healthcare Syst, Dept Med, La Jolla, CA 92093 USA; [Yang, Meng; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Vet Adm San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Anti Cancer Inc; University of California System; University of California San Diego	Ongkeko, WM (corresponding author), Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA.	wongkeko@ucsd.edu		Rahimy, Elham/0000-0001-7356-3996	Veterans Administration Merit Award	Veterans Administration Merit Award	Veterans Administration Merit Award (LJ Deftos) supported this project (http://www.research.va.gov/services/csrd/merit_review.cfm#.UcI2KPY-uCg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, CARCINOGENESIS, V28, P1893, DOI 10.1093/carcin/bgm106; Aguilera Abelardo, 2005, Curr Opin Investig Drugs, V6, P262; Aklilu F, 1996, AM J PHYSIOL-ENDOC M, V271, pE277, DOI 10.1152/ajpendo.1996.271.2.E277; Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Bryden AAG, 2002, BRIT J CANCER, V86, P322, DOI 10.1038/sj/bjc/6600115; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; BURTON DW, 1994, ENDOCRINOLOGY, V135, P253, DOI 10.1210/en.135.1.253; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan GK, 2001, ENDOCRINOLOGY, V142, P4900, DOI 10.1210/en.142.11.4900; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Deftos Leonard J., 2000, Cancer, V88, P3002; Deftos LJ, 2005, BIOCHEM BIOPH RES CO, V327, P468, DOI 10.1016/j.bbrc.2004.11.162; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Ditmer LS, 1996, ENDOCRINOLOGY, V137, P1608, DOI 10.1210/en.137.5.1608; Downs TM, 2011, CANCER LETT, V306, P52, DOI 10.1016/j.canlet.2011.02.027; Duband JL, 1995, ACTA ANAT, V154, P63; Fortino V, 2002, CELL MOL LIFE SCI, V59, P2165, DOI 10.1007/s000180200015; Gleave Martin E., 1997, P367; Goltzman D, 1999, J BONE MINER RES, V14, P173, DOI 10.1359/jbmr.1999.14.2.173; Gonzalez-Moreno O, 2010, EXP CELL RES, V316, P554, DOI 10.1016/j.yexcr.2009.11.020; Greaves M, 2011, NAT MED, V17, P1046, DOI 10.1038/nm.2458; Grille SJ, 2003, CANCER RES, V63, P2172; Gujral A, 2001, CANCER RES, V61, P2282; Hajra KM, 2002, CANCER RES, V62, P1613; Hastings RH, 2010, CANCER BIOL THER, V10, P1068, DOI 10.4161/cbt.10.10.13374; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iddon J, 2000, J PATHOL, V191, P170; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Isohata N, 2009, INT J CANCER, V125, P1212, DOI 10.1002/ijc.24400; Isowa S, 2010, ANTICANCER RES, V30, P2755; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LI X, 1994, J BIOL CHEM, V269, P6263; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Nemeth JA, 1999, CANCER RES, V59, P1987; Rabbani SA, 1999, INT J CANCER, V80, P257, DOI 10.1002/(SICI)1097-0215(19990118)80:2<257::AID-IJC15>3.0.CO;2-3; Sepulveda VAT, 2002, REGUL PEPTIDES, V105, P109, DOI 10.1016/S0167-0115(02)00007-1; Shen XL, 2007, REGUL PEPTIDES, V141, P61, DOI 10.1016/j.regpep.2006.12.017; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Veltmaat JM, 2000, INT J DEV BIOL, V44, P297; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang M, 2006, CLIN CANCER RES, V12, P2602, DOI 10.1158/1078-0432.CCR-05-2050; Yang M, 2005, PROSTATE, V62, P374, DOI 10.1002/pros.20125; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	61	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85803	10.1371/journal.pone.0085803	http://dx.doi.org/10.1371/journal.pone.0085803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465715	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100076
J	Wong, SSW; Kao, RYT; Yuen, KY; Wang, Y; Yang, D; Samaranayake, LP; Seneviratne, CJ				Wong, Sarah Sze Wah; Kao, Richard Yi Tsun; Yuen, Kwok Yong; Wang, Yu; Yang, Dan; Samaranayake, Lakshman Perera; Seneviratne, Chaminda Jayampath			In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections	PLOS ONE			English	Article							DRUG-RESISTANCE MECHANISMS; BIOFILM FORMATION; DENTURE STOMATITIS; ECHINOCANDIN RESISTANCE; ORAL CANDIDIASIS; ALBICANS HYPHAE; AMPHOTERICIN-B; MURINE MODEL; EPIDEMIOLOGY; SUSCEPTIBILITY	Candida is the most common fungal pathogen of humans worldwide and has become a major clinical problem because of the growing number of immunocompromised patients, who are susceptible to infection. Moreover, the number of available antifungals is limited, and antifungal-resistant Candida strains are emerging. New and effective antifungals are therefore urgently needed. Here, we discovered a small molecule with activity against Candida spp. both in vitro and in vivo. We screened a library of 50,240 small molecules for inhibitors of yeast-to-hypha transition, a major virulence attribute of Candida albicans. This screening identified 20 active compounds. Further examination of the in vitro antifungal and anti-biofilm properties of these compounds, using a range of Candida spp., led to the discovery of SM21, a highly potent antifungal molecule (minimum inhibitory concentration (MIC) 0.2 - 1.6 mu g/ml). In vitro, SM21 was toxic to fungi but not to various human cell lines or bacterial species and was active against Candida isolates that are resistant to existing antifungal agents. Moreover, SM21 was relatively more effective against biofilms of Candida spp. than the current antifungal agents. In vivo, SM21 prevented the death of mice in a systemic candidiasis model and was also more effective than the common antifungal nystatin at reducing the extent of tongue lesions in a mouse model of oral candidiasis. Propidium iodide uptake assay showed that SM21 affected the integrity of the cell membrane. Taken together, our results indicate that SM21 has the potential to be developed as a novel antifungal agent for clinical use.	[Wong, Sarah Sze Wah; Samaranayake, Lakshman Perera; Seneviratne, Chaminda Jayampath] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Kao, Richard Yi Tsun; Yuen, Kwok Yong] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Yang, Dan] Univ Hong Kong, Fac Sci, Dept Chem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Kao, RYT (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	rytkao@hku.hk; jaya@hku.hk	Samaranayake, Lakshman/K-4947-2018; Wong, Sarah/DOH-8455-2022; YANG, Dan/HHD-2733-2022; Wong, Sarah/AAX-5103-2020	Samaranayake, Lakshman/0000-0002-9122-336X; Wong, Sarah/0000-0002-9440-1774; /0000-0003-0816-538X; Yuen, Kwok-yung/0000-0002-2083-1552; wang, yu/0000-0001-8697-2940	Health and Medical Research Fund; HKU; Tah-Wah Endowed Professorship fund	Health and Medical Research Fund; HKU(University of Hong Kong); Tah-Wah Endowed Professorship fund	This study was funded by Health and Medical Research Fund, HKU Research Output Prize and HKU Small project funding to CJS and Tah-Wah Endowed Professorship fund to LPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; Ali I, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-7; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandrasekar P, 2011, J ANTIMICROB CHEMOTH, V66, P457, DOI 10.1093/jac/dkq479; Clancy CJ, 2011, J INFECT DIS, V204, P499, DOI 10.1093/infdis/jir355; Silva Wander José da, 2008, Braz. Dent. J., V19, P364, DOI 10.1590/S0103-64402008000400014; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Ellepola ANB, 1998, ARCH ORAL BIOL, V43, P999, DOI 10.1016/S0003-9969(98)00075-2; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Grald A, 2012, J MED MICROBIOL, V61, P109, DOI 10.1099/jmm.0.034124-0; Hakki M, 2006, ANTIMICROB AGENTS CH, V50, P2522, DOI 10.1128/AAC.00148-06; Hawser S, 1999, J ANTIMICROB CHEMOTH, V43, P411, DOI 10.1093/jac/43.3.411; Ikeda F, 2000, ANTIMICROB AGENTS CH, V44, P614, DOI 10.1128/AAC.44.3.614-618.2000; Jarosz LM, 2011, APPL ENVIRON MICROB, V77, P8193, DOI 10.1128/AEM.06227-11; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; John H., 2008, M27A328 CLIN LAB STA; Kamagata-Kiyoura Yusuke, 2004, Journal of Infection and Chemotherapy, V10, P253; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kao RY, 2004, CHEM BIOL, V11, P1293, DOI 10.1016/j.chembiol.2004.07.013; Krcmery Vladimir, 2007, Recent Pat Antiinfect Drug Discov, V2, P182, DOI 10.2174/157489107782497317; LaFleur MD, 2011, J ANTIMICROB CHEMOTH, V66, P820, DOI 10.1093/jac/dkq530; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Louie A, 1998, ANTIMICROB AGENTS CH, V42, P1105, DOI 10.1128/AAC.42.5.1105; Midkiff J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025395; Miyazaki M, 2011, ANTIMICROB AGENTS CH, V55, P4652, DOI 10.1128/AAC.00291-11; ODDS FC, 1985, J GEN MICROBIOL, V131, P2581; Odds FC, 1988, CANDIDA CANDIDOSIS R; Ortega M, 2011, J HOSP INFECT, V77, P157, DOI 10.1016/j.jhin.2010.09.026; Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Persidis A, 1999, NAT BIOTECHNOL, V17, P1141, DOI 10.1038/15141; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002; Ramani R, 1997, J CLIN MICROBIOL, V35, P2320, DOI 10.1128/JCM.35.9.2320-2324.1997; REX JH, 1993, CLIN MICROBIOL REV, V6, P367, DOI 10.1128/CMR.6.4.367-381.1993; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; Seneviratne CJ, 2011, MYCOPATHOLOGIA, V172, P389, DOI 10.1007/s11046-011-9444-4; Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Takakura N, 2003, MICROBIOL IMMUNOL, V47, P321, DOI 10.1111/j.1348-0421.2003.tb03403.x; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; VANTWOUT JW, 1989, ANTIMICROB AGENTS CH, V33, P147, DOI 10.1128/AAC.33.2.147; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	58	72	75	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85836	10.1371/journal.pone.0085836	http://dx.doi.org/10.1371/journal.pone.0085836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465737	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100080
J	Byrne, MB; Kimura, Y; Kapoor, A; He, Y; Mattam, KS; Hasan, KM; Olson, LN; Wang, F; Kenis, PJA; Rao, CV				Byrne, Matthew B.; Kimura, Yuki; Kapoor, Ashish; He, Yuan; Mattam, Kewin S.; Hasan, Katherine M.; Olson, Luke N.; Wang, Fei; Kenis, Paul J. A.; Rao, Christopher V.			Oscillatory Behavior of Neutrophils under Opposing Chemoattractant Gradients Supports a Winner-Take-All Mechanism	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; MULTISTEP NAVIGATION; LEUKOCYTE ADHESION; ORDERED EXTENSION; LOCAL-EXCITATION; STOCHASTIC-MODEL; IN-VITRO; CELLS; MIGRATION; RECEPTOR	Neutrophils constitute the largest class of white blood cells and are the first responders in the innate immune response. They are able to sense and migrate up concentration gradients of chemoattractants in search of primary sites of infection and inflammation through a process known as chemotaxis. These chemoattractants include formylated peptides and various chemokines. While much is known about chemotaxis to individual chemoattractants, far less is known about chemotaxis towards many. Previous studies have shown that in opposing gradients of intermediate chemoattractants (interleukin-8 and leukotriene B-4), neutrophils preferentially migrate toward the more distant source. In this work, we investigated neutrophil chemotaxis in opposing gradients of chemoattractants using a microfluidic platform. We found that primary neutrophils exhibit oscillatory motion in opposing gradients of intermediate chemoattractants. To understand this behavior, we constructed a mathematical model of neutrophil chemotaxis. Our results suggest that sensory adaptation alone cannot explain the observed oscillatory motion. Rather, our model suggests that neutrophils employ a winner-take-all mechanism that enables them to transiently lock onto sensed targets and continuously switch between the intermediate attractant sources as they are encountered. These findings uncover a previously unseen behavior of neutrophils in opposing gradients of chemoattractants that will further aid in our understanding of neutrophil chemotaxis and the innate immune response. In addition, we propose a winner-take-all mechanism allows the cells to avoid stagnation near local chemical maxima when migrating through a network of chemoattractant sources.	[Byrne, Matthew B.; Kimura, Yuki; Kapoor, Ashish; Mattam, Kewin S.; Hasan, Katherine M.; Kenis, Paul J. A.; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Wang, Fei] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA; [Olson, Luke N.] Univ Illinois, Dept Comp Sci, Urbana, IL USA; [He, Yuan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	chris@scs.uiuc.edu	Kapoor, Ashish/ABE-8197-2021; Kenis, Paul J A/S-7229-2016	Kapoor, Ashish/0000-0002-4686-394X; Kenis, Paul J A/0000-0001-7348-0381	National Institutes of Health [GM083601]; University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083601, R01GM083812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this study was provided by National Institutes of Health Grant GM083601 and the University of Illinois at Urbana-Champaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; ALLAN RB, 1978, EXP CELL RES, V111, P191, DOI 10.1016/0014-4827(78)90249-5; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; [Anonymous], [No title captured]; BARNETT ML, 1993, BIOCHIM BIOPHYS ACTA, V1177, P275, DOI 10.1016/0167-4889(93)90123-7; Benard EL, 2012, JOVE-J VIS EXP, DOI 10.3791/3781; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; Billadeau DD, 2008, NAT IMMUNOL, V9, P716, DOI 10.1038/ni0708-716; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Campbell JJ, 1997, EUR J IMMUNOL, V27, P2571, DOI 10.1002/eji.1830271016; Cavicchioni G, 2009, EUR J MED CHEM, V44, P4926, DOI 10.1016/j.ejmech.2009.08.010; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Dimasi D, 2013, INT IMMUNOPHARMACOL; FERNANDEZ HN, 1978, J IMMUNOL, V120, P109; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; GALLIN JI, 1978, J CLIN INVEST, V62, P1364, DOI 10.1172/JCI109257; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kim DH, 2012, ANAL CHEM; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; KREISLE RA, 1983, J EXP MED, V157, P628, DOI 10.1084/jem.157.2.628; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; LEWIS MS, 1988, J CLIN INVEST, V82, P2045, DOI 10.1172/JCI113825; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, METHODS MOL BIOL, V571, P151, DOI 10.1007/978-1-60761-198-1_10; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Millius A, 2009, CURR BIOL, V19, P253, DOI 10.1016/j.cub.2008.12.044; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oelz D, 2005, MATH MED BIOL, V22, P291, DOI 10.1093/imammb/dqi009; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Porter JR, 2012, INTEGR BIOL-UK, V4, P310, DOI [10.1039/c2ib00114d, 10.1039/C2IB90009B]; REILLY IAG, 1988, J CLIN PATHOL, V41, P1163, DOI 10.1136/jcp.41.11.1163; SAGER R, 1991, ADV EXP MED BIOL, V305, P73; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; Van Haastert PJM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000874; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018805; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107	68	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85726	10.1371/journal.pone.0085726	http://dx.doi.org/10.1371/journal.pone.0085726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465668	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500099
J	Czyz, ZT; Hoffmann, M; Schlimok, G; Polzer, B; Klein, CA				Czyz, Zbigniew T.; Hoffmann, Martin; Schlimok, Guenter; Polzer, Bernhard; Klein, Christoph A.			Reliable Single Cell Array CGH for Clinical Samples	PLOS ONE			English	Article							DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER PATIENTS; MULTIPLE DISPLACEMENT AMPLIFICATION; CYTOKERATIN-POSITIVE CELLS; COPY NUMBER VARIATION; BONE-MARROW; GENETIC-ANALYSIS; ESOPHAGEAL CANCER; CLONAL EVOLUTION	Background: Disseminated cancer cells (DCCs) and circulating tumor cells (CTCs) are extremely rare, but comprise the precursors cells of distant metastases or therapy resistant cells. The detailed molecular analysis of these cells may help to identify key events of cancer cell dissemination, metastatic colony formation and systemic therapy escape. Methodology/Principal Findings: Using the Ampli1 (TM) whole genome amplification (WGA) technology and high-resolution oligonucleotide aCGH microarrays we optimized conditions for the analysis of structural copy number changes. The protocol presented here enables reliable detection of numerical genomic alterations as small as 0.1 Mb in a single cell. Analysis of single cells from well-characterized cell lines and single normal cells confirmed the stringent quantitative nature of the amplification and hybridization protocol. Importantly, fixation and staining procedures used to detect DCCs showed no significant impact on the outcome of the analysis, proving the clinical usability of our method. In a proof-of-principle study we tracked the chromosomal changes of single DCCs over a full course of high-dose chemotherapy treatment by isolating and analyzing DCCs of an individual breast cancer patient at four different time points. Conclusions/Significance: The protocol enables detailed genome analysis of DCCs and thereby assessment of the clonal evolution during the natural course of the disease and under selection pressures. The results from an exemplary patient provide evidence that DCCs surviving selective therapeutic conditions may be recruited from a pool of genomically less advanced cells, which display a stable subset of specific genomic alterations.	[Czyz, Zbigniew T.; Klein, Christoph A.] Univ Regensburg, D-93053 Regensburg, Germany; [Czyz, Zbigniew T.; Hoffmann, Martin; Polzer, Bernhard; Klein, Christoph A.] Fraunhofer Inst Toxicol & Expt Med ITEM, Project Grp Personalized Tumor Therapy, Regensburg, Germany; [Schlimok, Guenter] Hosp Augsburg, Med Ctr 2, Augsburg, Germany	University of Regensburg; Fraunhofer Gesellschaft; Klinikum Augsburg	Klein, CA (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	christoph.klein@klinik.uni-regensburg.de		Klein, Christoph A./0000-0001-7128-1725	German Cancer Aid (Deutsche Krebshilfe) [109753]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This study was funded by The German Cancer Aid (Deutsche Krebshilfe): grant number 109753. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson Nona, 2012, ISRN Oncol, V2012, P710692, DOI 10.5402/2012/710692; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Cheng JQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r80; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fehm T, 2006, CANCER-AM CANCER SOC, V107, P885, DOI 10.1002/cncr.22076; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gangnus R, 2004, CLIN CANCER RES, V10, P3457, DOI 10.1158/1078-0432.CCR-03-0818; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Hosch S, 2000, CANCER RES, V60, P6836; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iwamoto K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001306; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Klein CA, 2003, ADV CANCER RES, V89, P35, DOI 10.1016/S0065-230X(03)01002-9; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Konings P, 2012, NAT PROTOC, V7, P281, DOI 10.1038/nprot.2011.426; Kraus J, 2003, GENE CHROMOSOME CANC, V36, P159, DOI 10.1002/gcc.10160; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Ling JW, 2009, MOL HUM REPROD, V15, P739, DOI 10.1093/molehr/gap066; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Mathiesen RR, 2012, INT J CANCER, V131, pE405, DOI 10.1002/ijc.26444; Mohlendick B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067031; Munne S, 2010, REPROD BIOMED ONLINE, V20, P92, DOI 10.1016/j.rbmo.2009.10.015; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parkin B, 2013, BLOOD, V121, P369, DOI 10.1182/blood-2012-04-427039; Pierga JY, 2012, ANN ONCOL, V23, P618, DOI 10.1093/annonc/mdr263; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Traversa MV, 2010, MOL HUM REPROD, V16, P329, DOI 10.1093/molehr/gaq013; Treff NR, 2010, FERTIL STERIL, V94, P2017, DOI 10.1016/j.fertnstert.2010.01.052; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587; Zhong XB, 2001, P NATL ACAD SCI USA, V98, P3940, DOI 10.1073/pnas.061026198; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	49	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85907	10.1371/journal.pone.0085907	http://dx.doi.org/10.1371/journal.pone.0085907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465780	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500140
J	Gabhann, JN; Hams, E; Smith, S; Wynne, C; Byrne, JC; Brennan, K; Spence, S; Kissenpfennig, A; Johnston, JA; Fallon, PG; Jefferies, CA				Gabhann, Joan Ni; Hams, Emily; Smith, Siobhan; Wynne, Claire; Byrne, Jennifer C.; Brennan, Kiva; Spence, Shaun; Kissenpfennig, Adrien; Johnston, James A.; Fallon, Padraic G.; Jefferies, Caroline A.			Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; NF-KAPPA-B; X-LINKED AGAMMAGLOBULINEMIA; ALTERNATIVE ACTIVATION; CELL-DEVELOPMENT; GENE-EXPRESSION; DENDRITIC CELLS; PHOSPHORYLATION; SYSTEM; GAMMA	Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages to the classic inflammatory M1 population. Given the role of Btk as a critical signal transducer downstream of TLR4, we investigated its role in M1/M2 induction. In Btk deficient (Btk(-\-)) mice we observed markedly reduced recruitment of M1 macrophages following intraperitoneal administration of LPS. Ex vivo analysis demonstrated an impaired ability of Btk(-/-) macrophages to polarize into M1 macrophages, instead showing enhanced induction of immunosuppressive M2-associated markers in response to M1 polarizing stimuli, a finding accompanied by reduced phosphorylation of STAT1 and enhanced STAT6 phosphorylation. In addition to STAT activation, M1 and M2 polarizing signals modulate the expression of inflammatory genes via differential activation of transcription factors and regulatory proteins, including NF-kappa B and SHIP1. In keeping with a critical role for Btk in macrophage polarization, we observed reduced levels of NF-kappa B p65 and Akt phosphorylation, as well as reduced induction of the M1 associated marker iNOS in Btk(-/-) macrophages in response to M1 polarizing stimuli. Additionally enhanced expression of SHIP1, a key negative regulator of macrophage polarisation, was observed in Btk(-/-) macrophages in response to M2 polarizing stimuli. Employing classic models of allergic M2 inflammation, treatment of Btk(-/-) mice with either Schistosoma mansoni eggs or chitin resulted in increased recruitment of M2 macrophages and induction of M2-associated genes. This demonstrates an enhanced M2 skew in the absence of Btk, thus promoting the development of allergic inflammation.	[Gabhann, Joan Ni; Smith, Siobhan; Wynne, Claire; Byrne, Jennifer C.; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Gabhann, Joan Ni; Smith, Siobhan; Wynne, Claire; Byrne, Jennifer C.; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, RCSI Res Inst, Dublin 2, Ireland; [Hams, Emily; Brennan, Kiva; Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Wynne, Claire] Dublin Inst Technol, Sch Biol Sci, Dublin, Ireland; [Johnston, James A.] Univ Dublin Trinity Coll, St Jamess Hosp, Inst Mol Med, Dublin 2, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Spence, Shaun; Kissenpfennig, Adrien] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Johnston, James A.] Amgen Inc, Thousand Oaks, CA 91320 USA	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin; Technological University Dublin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Queens University Belfast; Amgen	Jefferies, CA (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	cjefferies@rcsi.ie	Jefferies, Caroline/AAI-1543-2021; Fallon, Padraic/Y-2711-2019	Jefferies, Caroline/0000-0002-8879-6722; Fallon, Padraic/0000-0002-8401-7293; Wynne, Claire/0000-0002-0481-8366; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; Hams, Emily/0000-0002-9745-3246; Kissenpfennig, Adrien/0000-0002-9633-3111; Brennan, Kiva/0000-0003-4960-7076	Health Research Board, Ireland [RP/2004/79, P/2006/121]; Science Foundation Ireland [08/IN.1/B2091]	Health Research Board, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Health Research Board, Ireland (RP/2004/79) and P/2006/121 www.hrb.ie) and Science Foundation Ireland (Grant 08/IN.1/B2091 www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amoras ALB, 2007, CLIN EXP IMMUNOL, V150, P422, DOI 10.1111/j.1365-2249.2007.03512.x; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Antignano F, 2010, J IMMUNOL, V184, P2805, DOI 10.4049/jimmunol.0903170; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Byrne JC, 2013, J IMMUNOL IN PRESS; Costa-Carvalho BT, 2011, ALLERGOL IMMUNOPATH, V39, P128, DOI 10.1016/j.aller.2010.12.003; D'Cruz OJ, 2013, ONCOTARGETS THER, V6, P161, DOI 10.2147/OTT.S33732; Dasgupta P, 2012, J INNATE IMMUN, V4, P478, DOI 10.1159/000336025; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Gagliardi MC, 2003, CLIN EXP IMMUNOL, V133, P115, DOI 10.1046/j.1365-2249.2003.t01-1-02178.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Jyonouchi H, 2008, EUR J PEDIATR, V167, P317, DOI 10.1007/s00431-007-0493-0; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangan NE, 2007, EUR J IMMUNOL, V37, P1302, DOI 10.1002/eji.200636520; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mohammad DK, 2013, MOL CELL BIOL, V33, P3214, DOI 10.1128/MCB.00247-13; Ni Gabhann J, 2011, CLIN IMMUNOL; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Orme J, 2012, DISCOV MED, V13, P151; Ostrand-Rosenberg S, 2000, J IMMUNOL, V165, P6015, DOI 10.4049/jimmunol.165.11.6015; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Shabestari MS, 2008, J INVEST ALLERG CLIN, V18, P300; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Smith Philip, 2009, V517, P401, DOI 10.1007/978-1-59745-541-1_24; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Taha RA, 1999, J ALLERGY CLIN IMMUN, V103, P476, DOI 10.1016/S0091-6749(99)70474-4; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Uckun F, 2007, BRIT J HAEMATOL, V136, P574, DOI 10.1111/j.1365-2141.2006.06468.x; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Xu F, 2013, J INFECT DIS, V208, P528, DOI 10.1093/infdis/jit177; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	70	61	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85834	10.1371/journal.pone.0085834	http://dx.doi.org/10.1371/journal.pone.0085834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465735	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500126
J	Kar, PK; Murmu, S; Saha, S; Tandon, V; Acharya, K				Kar, Pradip Kumar; Murmu, Sanatan; Saha, Saswati; Tandon, Veena; Acharya, Krishnendu			Anthelmintic Efficacy of Gold Nanoparticles Derived from a Phytopathogenic Fungus, Nigrospora oryzae	PLOS ONE			English	Article							ROOT-TUBER EXTRACT; IN-VITRO; SILVER NANOPARTICLES; HAEMONCHUS-CONTORTUS; FASCIOLA-HEPATICA; FLEMINGIA VESTITA; ACID-PHOSPHATASE; ESSENTIAL OIL; PLANT; BIOSYNTHESIS	Exploring a green chemistry approach, this study brings to the fore, the anthelmintic efficacy of gold nanoparticles, highlighting the plausible usage of myconanotechnology. Gold nanoparticles of similar to 6 to similar to 18 nm diameter were synthesized by treating the mycelia-free culture filtrate of the phytopathogenic fungus with gold chloride. Their size and morphology were confirmed by UV-Vis spectroscopy, DLS data, AFM and TEM images. The XRD studies reveal a crystalline nature of the nanoparticles, which are in cubic phase. The FTIR spectroscopic studies before and after the formation of nanoparticles show the presence of possible functional groups responsible for the bio-reduction and capping of the synthesized gold nanoparticles. The latter were tested as vermifugal agents against a model cestode Raillietina sp., an intestinal parasite of domestic fowl. Further, ultrastructural and biochemical parameters were used to corroborate the efficacy study.	[Kar, Pradip Kumar; Murmu, Sanatan] Jhargram Raj Coll, Parasitol Lab, Post Grad Dept Zool, West Midnapore, W Bengal, India; [Saha, Saswati; Acharya, Krishnendu] Univ Calcutta, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India; [Tandon, Veena] NE Hill Univ, Parasitol Lab, Shillong 793014, Meghalaya, India	University of Calcutta; North Eastern Hill University	Kar, PK (corresponding author), Jhargram Raj Coll, Parasitol Lab, Post Grad Dept Zool, West Midnapore, W Bengal, India.	karpradip@gmail.com; krish_paper@yahoo.com	Acharya, Krishnendu/G-2317-2012	Acharya, Krishnendu/0000-0003-1193-1823; Tandon, Veena/0000-0003-4315-2082; MURMU, SANATAN/0000-0001-7697-9604				Acharya K, 2009, ADV BIOTECHNOL, P204; Alawa CBI, 2003, VET PARASITOL, V113, P73, DOI 10.1016/S0304-4017(03)00040-2; ANDERSON HR, 1995, INT J PARASITOL, V25, P319, DOI 10.1016/0020-7519(94)00105-W; Bajaj S, 1998, INDIAN J MED RES, V108, P104; BHAKUNI DS, 1988, INDIAN J EXP BIOL, V26, P883; Biftu D, 2004, ETHIOP VET J, V8, P57; Bunitian HC, 1970, HDB NEUROCHEMISTRY; Chen PC, 2008, NANOTECHNOL SCI APPL, V1, P45; CHHABRA SC, 1990, J ETHNOPHARMACOL, V29, P295, DOI 10.1016/0378-8741(90)90041-Q; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; DEY S, 1989, J MICROSC-OXFORD, V156, P259, DOI 10.1111/j.1365-2818.1989.tb02925.x; Fetterer RH, 2000, J PARASITOL, V86, P1, DOI 10.1645/0022-3395(2000)086[0001:COAPAP]2.0.CO;2; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Hillyer JF, 2001, J PHARM SCI, V90, P1927, DOI 10.1002/jps.1143; Hordegen P, 2006, J ETHNOPHARMACOL, V108, P85, DOI 10.1016/j.jep.2006.04.013; Kamei H, 1998, CANCER BIOTHER RADIO, V13, P403, DOI 10.1089/cbr.1998.13.403; Kaplan C, 1957, J BIOL CHEM, VIII; Kar P. K., 2004, Journal of Parasitic Diseases, V28, P45; KAUSHIK RK, 1981, INDIAN J ANIM SCI, V51, P869; Ketzis JK, 2002, SMALL RUMINANT RES, V44, P193, DOI 10.1016/S0921-4488(02)00047-0; Khunkitti W, 2000, J HELMINTHOL, V74, P241, DOI 10.1017/S0022149X00000342; Kumar D., 1995, Indian Journal of Pharmacology, V27, P161; Kwak Kee-Hoon, 1996, Korean Journal of Parasitology, V34, P69, DOI 10.3347/kjp.1996.34.1.69; LEON P, 1989, VET PARASITOL, V30, P297, DOI 10.1016/0304-4017(89)90099-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luechinger NA, 2010, CHEM MATER, V22, P155, DOI 10.1021/cm902527n; Mohamed AM, 2005, MEM I OSWALDO CRUZ, V100, P205, DOI 10.1590/S0074-02762005000200016; Mohanpuria P, 2008, J NANOPART RES, V10, P507, DOI 10.1007/s11051-007-9275-x; Molgaard P, 2001, J ETHNOPHARMACOL, V74, P257, DOI 10.1016/S0378-8741(00)00377-9; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711; Pal Papri, 1998, Parasitology International, V47, P233, DOI 10.1016/S1383-5769(98)00025-7; PAPPAS PW, 1988, J CELL BIOCHEM, V37, P395, DOI 10.1002/jcb.240370407; PARVEEN N, 1991, Fitoterapia, V62, P163; PERRETT S, 1995, PHYTOTHER RES, V9, P401, DOI 10.1002/ptr.2650090603; Perry Lily M., 1980, MED PLANTS E SE ASIA; Pessoa LM, 2002, VET PARASITOL, V109, P59, DOI 10.1016/S0304-4017(02)00253-4; Plummer D. T., 1988, INTRO PRACTICAL BIOC; Richards DG, 2002, INT J NEUROSCI, V112, P31, DOI 10.1080/00207450212018; ROBINSON RD, 1990, W INDIAN MED J, V39, P213; Roy B, 1996, PARASITOL RES, V82, P248, DOI 10.1007/s004360050104; Roy B, 2008, PHARMACOGN MAG, V4, P20; Roy B, 2008, MICROSC RES TECHNIQ, V71, P810, DOI 10.1002/jemt.20623; Saha S, 2010, DIG J NANOMATER BIOS, V5, P887; Saha S, 2011, DIG J NANOMATER BIOS, V6, P1519; Sarkar J, 2011, MICRO NANO LETT, V6, P599, DOI 10.1049/mnl.2011.0227; Sarkar J, 2013, MATER LETT, V92, P313, DOI 10.1016/j.matlet.2012.10.130; Sarkar J, 2012, BIOPROC BIOSYST ENG, V35, P637, DOI 10.1007/s00449-011-0646-4; Sarkar J, 2011, DIG J NANOMATER BIOS, V6, P563; Shilaskar DV, 1989, INDIAN J INDIGENOUS, V6, P49; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Tandon V., 2004, Journal of Parasitic Diseases, V28, P37; Tandon V, 1997, PARASITOL RES, V83, P492, DOI 10.1007/s004360050286; Tangpu Temgenmogla V., 2006, Indian Journal of Pharmacology, V38, P29; Temjenmongla T., 2005, AFR J TRADIT COMPLEM, V2, P129, DOI [10.4314/ajtcam.v2i2.31111, DOI 10.4314/AJTCAM.V2I2.31111]; TERADA M, 1982, Folia Pharmacologica Japonica, V79, P93, DOI 10.1254/fpj.79.93; Tikariha S, 2012, INT J PHARM SCI RES, V3, P1603, DOI 10.13040/IJPSR.0975-8232.3(6).1603-15; Verma VC, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9743-6; Yadav AK, 2006, PHARM ONLINE, V3, P90	59	37	39	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84693	10.1371/journal.pone.0084693	http://dx.doi.org/10.1371/journal.pone.0084693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465424	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500011
J	Lei, Y; Lui, VWY; Grandis, JR; Egloff, AM				Lei, Yu; Lui, Vivian W. Y.; Grandis, Jennifer R.; Egloff, Ann Marie			Identification of Mutations in the PYRIN-Containing NLR Genes (NLRP) in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							COLON INFLAMMATION; I INTERFERON; INFLAMMASOMES; AUTOPHAGY; CYTOKINES; PROTEIN; DISEASE; TUFM	Head and Neck Squamous Cell Carcinoma (HNSCC) encompasses malignancies that arise in the mucosa of the upper aerodigestive tract. Recent high throughput DNA sequencing revealed HNSCC genes mutations that contribute to several cancer cell characteristics, including dysregulation of cell proliferation and death, intracellular proinflammatory signaling, and autophagy. The PYRIN-domain containing NLR (Nucleotide-binding domain, Leucine rich Repeats - containing) proteins have recently emerged as pivotal modulators of cell death, autophagy, inflammation, and metabolism. Their close physiologic association with cancer development prompted us to determine whether mutations within the NLRP (PYRIN-containing NLR) gene family were associated with HNSCC genome instability and their clinicopathologic correlations. Catastrophic mutational events underlie cancer cell genome instability and mark a point-of-no-return in cancer cell development and generation of heterogeneity. The mutation profiles of 62 patients with primary conventional type HNSCC excluding other histologic variants were analyzed. Associations were tested using Fisher's Exact test or Mann-Whitney U test. Mutations in NLRP were associated with elevated genome instability as characterized by higher mutation rates. Clinically, NLRP mutations were more frequently found in HNSCC arising in the floor of mouth (50.0%) in comparison with HNSCC at other head and neck locations (14.8%). These mutations were clustered at the leucine rich repeats region of NLRP proteins, and affected NLRP genes were mostly localized at chromosomes 11p15.4 and 19q13.42-19q13.43. Twenty novel NLRP mutations were identified in HNSCC, and mutations in this group of genes were correlated with increased cancer cell genome mutation rates, and such features could be a potential molecular biomarker of HNSCC genome instability.	[Lei, Yu] Univ Pittsburgh, Sch Dent Med, Dept Diagnost Sci, Pittsburgh, PA 15213 USA; [Lui, Vivian W. Y.; Grandis, Jennifer R.; Egloff, Ann Marie] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Lui, Vivian W. Y.; Grandis, Jennifer R.; Egloff, Ann Marie] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Grandis, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Egloff, Ann Marie] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lei, Y (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Diagnost Sci, Pittsburgh, PA 15213 USA.	leiyuleo@gmail.com	Lei, Yu Leo/ABF-1293-2020; Lui, Vivian W. Y./I-5458-2016	Lei, Yu Leo/0000-0002-9868-9824; Lui, Vivian W. Y./0000-0001-6918-1573	Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer neoplasm of the University of Pittsburgh [P50CA097190];  [K07CA137140]; NATIONAL CANCER INSTITUTE [K07CA137140, P50CA097190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023685] Funding Source: NIH RePORTER	Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer neoplasm of the University of Pittsburgh; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by P50CA097190 (JRG) the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer neoplasm of the University of Pittsburgh and K07CA137140 (AME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Brailo V, 2011, MED ORAL PATOL ORAL; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Collisson EA, 2012, NAT REV CLIN ONCOL; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Davis BK, 2011, ANN REV IMMUNOL; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jounai N, 2011, J IMMUNOL, V186, P1646, DOI 10.4049/jimmunol.1001654; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; MASHBERG A, 1995, CA-CANCER J CLIN, V45, P328, DOI 10.3322/canjclin.45.6.328; Meurman JH, 2010, J ORAL MICROBIOL, V10, P2; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; O'Rorke MA, 2012, ORAL ONCOL; Pries R, 2006, CYTOKINE GROWTH F R, V17, P141, DOI 10.1016/j.cytogfr.2006.02.001; Slim R, 2012, MOL HUM REPROD, V18, P52, DOI 10.1093/molehr/gar060; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Woods KV, 1998, CANCER RES, V58, P3132; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046	40	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85619	10.1371/journal.pone.0085619	http://dx.doi.org/10.1371/journal.pone.0085619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465623	Green Published, gold, Green Accepted			2022-12-27	WOS:000330244500084
J	Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N; Bonotti, A; Cristaudo, A; Foddis, R; Mutti, L; Barale, R; Gemignani, F; Giamas, G; Landi, S				Melaiu, Ombretta; Stebbing, Justin; Lombardo, Ylenia; Bracci, Elisa; Uehara, Norihisa; Bonotti, Alessandra; Cristaudo, Alfonso; Foddis, Rudy; Mutti, Luciano; Barale, Roberto; Gemignani, Federica; Giamas, Georgios; Landi, Stefano			MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma	PLOS ONE			English	Article							OVARIAN-CANCER; ANTITUMOR-ACTIVITY; SERUM MESOTHELIN; IMMUNOTHERAPY; CA125/MUC16; ACTIVATION; DIAGNOSIS; INVASION; THERAPY; BINDING	Genes involved in the carcinogenetic mechanisms underlying malignant pleural mesothelioma (MPM) are still poorly characterized. So far, mesothelin (MSLN) has aroused the most interest. It encodes for a membrane glycoprotein, frequently over-expressed in various malignancies such as MPM, and ovarian and pancreatic cancers. It has been proposed as a diagnostic and immunotherapeutic target with promising results. However, an alternative therapeutic approach seems to rise, whereby synthetic molecules, such as antisense oligonucleotides, could be used to inhibit MSLN activity. To date, such a gene-level inhibition has been attempted in two studies only, both on pancreatic and ovarian carcinoma cell lines, with the use of silencing RNA approaches. With regard to MPM, only one cell line (H2373) has been employed to study the effects of MSLN depletion. Indeed, the knowledge on the role of MSLN in MPM needs expanding. Accordingly, we investigated the expression of MSLN in a panel of three MPM cell lines, i.e. NCI-H28, Mero-14, and IstMes2; one non-MPM cell line was used as reference (Met5A). MSLN knock-down experiments on MSLN-overexpressing cells were also performed through silencing RNA (siRNA) to verify whether previous findings could be generalized to a different set of cell cultures. In agreement with previous studies, transient MSLN-silencing caused decreased proliferation rate and reduced invasive capacity and sphere formation in MSLN-overexpressing Mero-14 cells. Moreover, MSLN-siRNA combined with cisplatin, triggered a marked increase in apoptosis and a decrease in proliferation as compared to cells treated with each agent alone, thereby suggesting a sensitizing effect of siRNA towards cisplatin. In summary, our findings confirm that MSLN should be considered a key molecular target for novel gene-based targeted therapies of cancer.	[Melaiu, Ombretta; Bracci, Elisa; Barale, Roberto; Gemignani, Federica; Landi, Stefano] Univ Pisa, Dept Biol, Pisa, Italy; [Stebbing, Justin; Lombardo, Ylenia; Giamas, Georgios] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Uehara, Norihisa] Kansai Med Univ, Dept Pathol 2, Moriguchi, Osaka 570, Japan; [Bonotti, Alessandra; Cristaudo, Alfonso; Foddis, Rudy] Univ Pisa, Dept Endocrinol & Metab Orthoped & Traumatol, Pisa, Italy; [Mutti, Luciano] Vercelli Natl Hlth Trust, Lab Clin Oncol, Vercelli, Italy	University of Pisa; Imperial College London; Kansai Medical University; University of Pisa	Landi, S (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	slandi@biologia.unipi.it	Melaiu, Ombretta/Z-3461-2019; Giamas, Georgios/AAP-3487-2021; Mutti, Luciano/A-3545-2011; Uehara, Norihisa/ABB-8106-2020	Melaiu, Ombretta/0000-0001-7118-5186; GEMIGNANI, Federica/0000-0003-1297-0701; Mutti, Luciano/0000-0002-1578-2637; Stebbing, Justin/0000-0002-1117-6947; Landi, Stefano/0000-0001-8364-6357; Giamas, Georgios/0000-0002-4417-2707; BARALE, Roberto/0000-0003-4161-2241	University of Pisa; Fondazione Buzzi Unicem; Cancer Research UK [14549] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	University of Pisa; Fondazione Buzzi Unicem; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was funded by the University of Pisa (www.unipi.it) (regular badget, ex 60%), and by the Fondazione Buzzi Unicem (www.buzziunicem.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Breidenbach M, 2005, GENE THER, V12, P187, DOI 10.1038/sj.gt.3302404; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Hassan R, 2006, CLIN CANCER RES, V12, P447, DOI 10.1158/1078-0432.CCR-05-1477; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2000, J IMMUNOTHER, V23, P473, DOI 10.1097/00002371-200007000-00011; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Hung CF, 2007, VACCINE, V25, P127, DOI 10.1016/j.vaccine.2006.06.087; Imamura O, 2008, CANCER LETT, V268, P278, DOI 10.1016/j.canlet.2008.04.002; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Sapede C, 2008, CANCER SCI, V99, P590, DOI 10.1111/j.1349-7006.2007.00715.x; Tang ZW, 2013, MOL CANCER THER, V12, P416, DOI 10.1158/1535-7163.MCT-12-0731; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033214; YAMAGUCHI N, 1994, J BIOL CHEM, V269, P805; Yu LP, 2010, J CANCER, V1, P141; Zheng CN, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-84	31	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85935	10.1371/journal.pone.0085935	http://dx.doi.org/10.1371/journal.pone.0085935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465798	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000330244500148
J	Tkacik, G; Ghosh, A; Schneidman, E; Segev, R				Tkacik, Gasper; Ghosh, Anandamohan; Schneidman, Elad; Segev, Ronen			Adaptation to Changes in Higher-Order Stimulus Statistics in the Salamander Retina	PLOS ONE			English	Article							CONTRAST GAIN-CONTROL; RECEPTIVE-FIELDS; NEURAL RESPONSES; NATURAL SCENES; INFORMATION; MODEL; SPIKE; NEURONS; MECHANISM; SIGNALS	Adaptation in the retina is thought to optimize the encoding of natural light signals into sequences of spikes sent to the brain. While adaptive changes in retinal processing to the variations of the mean luminance level and second-order stimulus statistics have been documented before, no such measurements have been performed when higher-order moments of the light distribution change. We therefore measured the ganglion cell responses in the tiger salamander retina to controlled changes in the second (contrast), third (skew) and fourth (kurtosis) moments of the light intensity distribution of spatially uniform temporally independent stimuli. The skew and kurtosis of the stimuli were chosen to cover the range observed in natural scenes. We quantified adaptation in ganglion cells by studying linear-nonlinear models that capture well the retinal encoding properties across all stimuli. We found that the encoding properties of retinal ganglion cells change only marginally when higher-order statistics change, compared to the changes observed in response to the variation in contrast. By analyzing optimal coding in LN-type models, we showed that neurons can maintain a high information rate without large dynamic adaptation to changes in skew or kurtosis. This is because, for uncorrelated stimuli, spatio-temporal summation within the receptive field averages away non-gaussian aspects of the light intensity distribution.	[Tkacik, Gasper] IST Austria, Klosterneuburg, Austria; [Ghosh, Anandamohan] Indian Inst Sci Educ & Res Kolkata, Mohanpur, Nadia, India; [Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, Fac Nat Sci, IL-84105 Beer Sheva, Israel; [Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Institute of Science & Technology - Austria; Indian Institute of Science Education & Research (IISER) - Kolkata; Weizmann Institute of Science; Ben Gurion University; Ben Gurion University	Tkacik, G (corresponding author), IST Austria, Klosterneuburg, Austria.	gtkacik@ist.ac.at		Tkacik, Gasper/0000-0002-6699-1455; Segev, Ronen/0000-0002-8109-1076; schneidman, elad/0000-0001-8653-9848	Israel Science Foundation; Human Frontiers Science Program	Israel Science Foundation(Israel Science Foundation); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by The Israel Science Foundation and The Human Frontiers Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Adrian E.D., 1928, BASIS SENSATION; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Bialek W, 2005, FEATURES DIMENSIONS; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Chubb C, 2004, VISION RES, V44, P3223, DOI 10.1016/j.visres.2004.07.019; Cover T. M., 1991, ELEMENTS INFORM THEO; Fairhall AL, 2006, J NEUROPHYSIOL, V96, P2724, DOI 10.1152/jn.00995.2005; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gaudry KS, 2007, J NEUROSCI, V27, P8071, DOI 10.1523/JNEUROSCI.1093-07.2007; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003060; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Olveczky BP, 2007, NEURON, V56, P689, DOI 10.1016/j.neuron.2007.09.030; PARTRIDGE LD, 1976, J PHYSIOL-LONDON, V256, P315, DOI 10.1113/jphysiol.1976.sp011327; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Rajan K, 2013, NEURAL COMPUT, V25, P1661, DOI 10.1162/NECO_a_00463; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Sadeghi KS, 2009, THESIS PRINCETON U P; Schwartz G, 2008, J NEUROPHYSIOL, V99, P1787, DOI 10.1152/jn.01025.2007; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simmons K, 2009, FRONT SYST NEUR COS, DOI [10.3389/conf.neuro.06.2009.03.144, DOI 10.3389/C0NF.NEUR0.06.2009.03.144]; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tkacik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020409; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P18149, DOI 10.1073/pnas.0914916107; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Wallach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040029; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019	56	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85841	10.1371/journal.pone.0085841	http://dx.doi.org/10.1371/journal.pone.0085841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465742	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500130
J	Di Sabatino, D; Lorusso, A; Di Francesco, CE; Gentile, L; Di Pirro, V; Bellacicco, AL; Giovannini, A; Di Francesco, G; Marruchella, G; Marsilio, F; Savini, G				Di Sabatino, Daria; Lorusso, Alessio; Di Francesco, Cristina E.; Gentile, Leonardo; Di Pirro, Vincenza; Bellacicco, Anna Lucia; Giovannini, Armando; Di Francesco, Gabriella; Marruchella, Giuseppe; Marsilio, Fulvio; Savini, Giovanni			Arctic Lineage-Canine Distemper Virus as a Cause of Death in Apennine Wolves (Canis lupus) in Italy	PLOS ONE			English	Article							MORBILLIVIRUS INFECTIONS; GENETIC-CHARACTERIZATION; HEMAGGLUTININ GENES; VACCINATED DOGS; RED FOXES; CDV; PCR; EMERGENCE; STRAINS; DISEASE	Canine distemper virus (CDV) infection is a primary threat affecting a wide number of carnivore species, including wild animals. In January 2013, two carcasses of Apennine wolves (Canis lupus) were collected in Ortona dei Marsi (L'Aquila province, Italy) by the local Veterinary Services. CDV was immediately identified either by RT-PCR or immunohistochemistry in lung and central nervous tissue samples. At the same time, severe clinical signs consistent with CDV infection were identified and taped (Videos S1-S3) from three wolves rescued in the areas surrounding the National Parks of the Abruzzi region by the Veterinary Services. The samples collected from these symptomatic animals also turned out CDV positive by RT-PCR. So far, 30 carcasses of wolves were screened and CDV was detected in 20 of them. The sequencing of the haemagglutinin gene and subsequent phylogenetic analysis demonstrated that the identified virus belonged to the CDV Arctic lineage. Strains belonging to this lineage are known to circulate in Italy and in Eastern Europe amongst domestic dogs. To the best of our knowledge this is the first report of CDV Arctic lineage epidemics in the wild population in Europe.	[Di Sabatino, Daria; Lorusso, Alessio; Bellacicco, Anna Lucia; Giovannini, Armando; Di Francesco, Gabriella; Marruchella, Giuseppe; Savini, Giovanni] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy; [Di Francesco, Cristina E.; Marsilio, Fulvio] Fac Vet Med Teramo, Infect Dis Unit, Teramo, Italy; [Gentile, Leonardo; Di Pirro, Vincenza] Natl Pk Abruzzi Lazio & Molise, Vet Serv, Pescasseroli, AQ, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Lorusso, A (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy.	a.lorusso@izs.it	Di Francesco, Gabriella/D-8396-2016; Di Francesco, Cristina/AAE-8997-2019; Giovannini, Armando/B-9828-2013; Di Sabatino, Daria/I-2868-2016; Marsilio, Fulvio/AAS-3924-2020; Savini, Giovanni/AAT-7897-2020; Lorusso, Alessio/A-7311-2016; Savini, Giovanni/D-8416-2016	Di Francesco, Gabriella/0000-0001-5002-9969; Giovannini, Armando/0000-0001-5006-5564; Di Sabatino, Daria/0000-0003-0348-3709; Savini, Giovanni/0000-0001-7933-7367; Lorusso, Alessio/0000-0001-6156-8212; Savini, Giovanni/0000-0001-7933-7367; DI FRANCESCO, Cristina Esmeralda/0000-0002-0896-4539; MARSILIO, FULVIO/0000-0001-9552-1199	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding was provided by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altobello Giuseppe, 1921, FAUNA ABRUZZO MOLISE; Appel M.J.G., 1987, VIRUS INFECT CARNIVO, P133; Barrett T, 1999, VET MICROBIOL, V69, P3, DOI 10.1016/S0378-1135(99)00080-2; BLIXENKRONEMOLLER M, 1992, ARCH VIROL, V123, P279, DOI 10.1007/BF01317264; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Daoust PY, 2009, J WILDLIFE DIS, V45, P611, DOI 10.7589/0090-3558-45.3.611; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Demeter Z, 2007, VET MICROBIOL, V122, P258, DOI 10.1016/j.vetmic.2007.02.001; Di Francesco CE, 2012, J VET DIAGN INVEST, V24, P107, DOI 10.1177/1040638711425700; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Di Guardo G, 2013, RES VET SCI, V94, P132, DOI 10.1016/j.rvsc.2012.07.030; Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634, DOI 10.1128/JCM.37.11.3634-3643.1999; Gervasi V, 2012, BIOL CONSERV, V152, P10, DOI 10.1016/j.biocon.2012.04.005; Iwatsuki K, 2000, VET MICROBIOL, V71, P281, DOI 10.1016/S0378-1135(99)00172-8; Kapil S, 2011, VET CLIN N AM-SMALL, V41, P1069, DOI 10.1016/j.cvsm.2011.08.005; Kennedy S, 1998, J COMP PATHOL, V119, P201, DOI 10.1016/S0021-9975(98)80045-5; Marsilio F., 1999, Veterinaria (Cremona), V13, P39; Marsilio F, 1997, J WILDLIFE DIS, V33, P304, DOI 10.7589/0090-3558-33.2.304; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2002, MOL CELL PROBE, V16, P77, DOI 10.1006/mcpr.2001.0387; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Martella V, 2007, VET MICROBIOL, V122, P32, DOI 10.1016/j.vetmic.2007.01.005; Martella V, 2010, EMERG INFECT DIS, V16, P2007, DOI 10.3201/eid1612.100579; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Meli ML, 2010, VET MICROBIOL, V146, P132, DOI 10.1016/j.vetmic.2010.04.024; Mochizuki M, 1999, J CLIN MICROBIOL, V37, P2936, DOI 10.1128/JCM.37.9.2936-2942.1999; Monne I, 2011, VET MICROBIOL, V150, P63, DOI 10.1016/j.vetmic.2011.01.009; Murray DL, 1999, ANIM CONSERV, V2, P241, DOI 10.1111/j.1469-1795.1999.tb00070.x; Ohishi K, 2010, COMP IMMUNOL MICROB, V33, P227, DOI 10.1016/j.cimid.2008.10.003; Osterhaus A, 2001, PHILOS T ROY SOC B, V356, P791, DOI 10.1098/rstb.2001.0856; Pavlacik L, 2007, VET MED-CZECH, V52, P69, DOI 10.17221/2057-VETMED; RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Simon-Martinez J, 2008, VET J, V175, P423, DOI 10.1016/j.tvjl.2007.01.015; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; van de Bildt MWG, 1999, VET MICROBIOL, V69, P19, DOI 10.1016/S0378-1135(99)00082-6; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; Woma TY, 2010, VET MICROBIOL, V143, P126, DOI 10.1016/j.vetmic.2009.11.013; Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010	41	41	41	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e82356	10.1371/journal.pone.0082356	http://dx.doi.org/10.1371/journal.pone.0082356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465373	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500003
J	Martonfalvi, Z; Kellermayer, M				Martonfalvi, Zsolt; Kellermayer, Miklos			Individual Globular Domains and Domain Unfolding Visualized in Overstretched Titin Molecules with Atomic Force Microscopy	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE MODULES; M-BAND; ENTROPIC ELASTICITY; CARDIAC-MUSCLE; PROTEIN; EXTENSIBILITY; REGION; STABILITY; MYOMESIN; FLEXIBILITY	Titin is a giant elastomeric protein responsible for the generation of passive muscle force. Mechanical force unfolds titins globular domains, but the exact structure of the overstretched titin molecule is not known. Here we analyzed, by using high-resolution atomic force microscopy, the structure of titin molecules overstretched with receding meniscus. The axial contour of the molecules was interrupted by topographical gaps with a mean width of 27.7 nm that corresponds well to the length of an unfolded globular (immunoglobulin and fibronectin) domain. The wide gap-width distribution suggests, however, that additional mechanisms such as partial domain unfolding and the unfolding of neighboring domain multimers may also be present. In the folded regions we resolved globules with an average spacing of 5.9 nm, which is consistent with a titin chain composed globular domains with extended interdomain linker regions. Topographical analysis allowed us to allocate the most distal unfolded titin region to the kinase domain, suggesting that this domain systematically unfolds when the molecule is exposed to overstretching forces. The observations support the prediction that upon the action of stretching forces the N-terminal ss-sheet of the titin kinase unfolds, thus exposing the enzymes ATP-binding site and hence contributing to the molecules mechanosensory function.	[Martonfalvi, Zsolt; Kellermayer, Miklos] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Kellermayer, Miklos] Semmelweis Univ, MTA SE Mol Biophys Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University	Kellermayer, M (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary.	kellermayer.miklos@med.semmelweis-univ.hu			Hungarian Science Foundation [OTKA K84133, OTKA K109480]; European Union [HEALTH-F2-2011-278850]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission)	This work was supported by grants from the Hungarian Science Foundation (OTKA K84133, OTKA K109480). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2011-278850 (INMiND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Anderson BR, 2013, J BIOL CHEM, V288, P5303, DOI 10.1074/jbc.M112.401372; Anderson BR, 2012, PROG BIOPHYS MOL BIO, V110, P204, DOI 10.1016/j.pbiomolbio.2012.08.003; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Freiburg A, 2000, CIRC RES, V86, P1114; FUNATSU T, 1990, J CELL BIOL, V110, P53, DOI 10.1083/jcb.110.1.53; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Karsai A, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345102; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kiss B, 2011, J MOL RECOGNIT, V24, P1095, DOI 10.1002/jmr.1158; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1998, J CELL SCI, V111, P1567; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Linke WA, 1998, P NATL ACAD SCI USA, V95, P8052, DOI 10.1073/pnas.95.14.8052; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Lu H, 2000, ADV EXP MED BIOL, V481, P143; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NAVE R, 1989, J CELL BIOL, V109, P2177, DOI 10.1083/jcb.109.5.2177; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Pires RH, 2011, J MOL RECOGNIT, V24, P467, DOI 10.1002/jmr.1112; Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050; POLITOU AS, 1994, BIOCHEMISTRY-US, V33, P4730, DOI 10.1021/bi00181a604; Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; SOTERIOU A, 1993, J CELL SCI, V104, P119; Trombitas K, 2000, BIOPHYS J, V79, P3226, DOI 10.1016/S0006-3495(00)76555-6; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tskhovrebova L, 1997, J MOL BIOL, V265, P100, DOI 10.1006/jmbi.1996.0717; Tskhovrebova L, 2001, J MOL BIOL, V310, P755, DOI 10.1006/jmbi.2001.4700; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Wang K, 1996, ADV BIOPHYS, V33, P123	46	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85847	10.1371/journal.pone.0085847	http://dx.doi.org/10.1371/journal.pone.0085847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465745	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500077
J	Molina, L; Udaondo, Z; Duque, E; Fernandez, M; Molina-Santiago, C; Roca, A; Porcel, M; de la Torre, J; Segura, A; Plesiat, P; Jeannot, K; Ramos, JL				Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Fernandez, Matilde; Molina-Santiago, Carlos; Roca, Amalia; Porcel, Mario; de la Torre, Jesus; Segura, Ana; Plesiat, Patrick; Jeannot, Katy; Ramos, Juan-Luis			Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; QUINOLONE RESISTANCE; REGULATORY SYSTEM; SEQUENCE-ANALYSIS; ACTIVE EFFLUX; GENE; IDENTIFICATION; PLASMID	Environmental microbes harbor an enormous pool of antibiotic and biocide resistance genes that can impact the resistance profiles of animal and human pathogens via horizontal gene transfer. Pseudomonas putida strains are ubiquitous in soil and water but have been seldom isolated from humans. We have established a collection of P. putida strains isolated from inpatients in different hospitals in France. One of the isolated strains (HB3267) kills insects and is resistant to the majority of the antibiotics used in laboratories and hospitals, including aminoglycosides, beta-lactams, cationic peptides, chromoprotein enediyne antibiotics, dihydrofolate reductase inhibitors, fluoroquinolones and quinolones, glycopeptide antibiotics, macrolides, polyketides and sulfonamides. Similar to other P. putida clinical isolates the strain was sensitive to amikacin. To shed light on the broad pattern of antibiotic resistance, which is rarely found in clinical isolates of this species, the genome of this strain was sequenced and analysed. The study revealed that the determinants of multiple resistance are both chromosomally-borne as well as located on the pPC9 plasmid. Further analysis indicated that pPC9 has recruited antibiotic and biocide resistance genes from environmental microorganisms as well as from opportunistic and true human pathogens. The pPC9 plasmid is not self-transmissible, but can be mobilized by other bacterial plasmids making it capable of spreading antibiotic resistant determinants to new hosts.	[Molina, Lazaro] Univ Huelva, Lab Invest & Control Agroalimentario, Huelva, Spain; [Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Molina-Santiago, Carlos; Porcel, Mario; de la Torre, Jesus; Segura, Ana; Ramos, Juan-Luis] CSIC, Estn Expt Zaidin, Granada, Spain; [Molina, Lazaro] Univ Huelva, Ctr Invest Quim Sostenible, Huelva, Spain; [Fernandez, Matilde; Roca, Amalia] Bioiliberis Res & Dev, Peligros Granada, Spain; [Plesiat, Patrick; Jeannot, Katy] Ctr Hosp Reg Univ Hop Jean Minjoz, Besancon, France	Universidad de Huelva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad de Huelva; Universite de Franche-Comte; CHU Besancon	Ramos, JL (corresponding author), CSIC, Estn Expt Zaidin, Granada, Spain.	juanluis.ramos@eez.csic.es	Molina, Carlos/AAS-5053-2020; Roca, Amalia/AAB-9240-2021; Molina, Lazaro/K-9645-2014; Segura, Ana/F-9811-2016; Udaondo, Zulema/ABI-7810-2020; Fernandez, Matilde/F-5980-2013; Hernandez, Amalia Roca/AAD-3048-2019	Molina, Carlos/0000-0002-1131-8917; Molina, Lazaro/0000-0002-8483-9203; Segura, Ana/0000-0001-7985-5658; Fernandez, Matilde/0000-0002-7064-670X; Hernandez, Amalia Roca/0000-0003-2332-3112; Duque, Estrella/0000-0002-4857-8974; Ramos, Juan L./0000-0002-8731-7435; De la Torre Zuniga, Jesus/0000-0001-8111-6299; Udaondo, Zulema/0000-0003-3445-6842; Porcel, Mario/0000-0002-8445-5621; Fernandez, Matilde/0000-0002-5832-5161; Jeannot, katy/0000-0002-4634-8550	ERANET [BIO2008-04419-E, BIO2010-17227]	ERANET	Funds were recieved from ERANET BIO2008-04419-E and BIO2010-17227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Aranda-Olmedo I, 2002, NUCLEIC ACIDS RES, V30, P1826, DOI 10.1093/nar/30.8.1826; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bramucci M, 2006, APPL MICROBIOL BIOT, V71, P67, DOI 10.1007/s00253-005-0119-2; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Dahshan H, 2011, VET RES COMMUN, V35, P55, DOI 10.1007/s11259-010-9448-4; Pescaretti MD, 2011, MICROBIOL-SGM, V157, P2515, DOI 10.1099/mic.0.050088-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; Dogan NM, 2011, ENVIRON SCI TECHNOL, V45, P2278, DOI 10.1021/es102095t; Duque E, 2012, ENV MICROBI IN PRESS; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Espinosa-Urgel Manuel, 2002, Microbiology (Reading), V148, P341, DOI 10.1099/00221287-148-2-341; Fernandez M, 2012, ANTIMICROB AGENTS CH, V56, P1001, DOI 10.1128/AAC.05398-11; Fernandez M, 2009, MICROB BIOTECHNOL, V2, P287, DOI 10.1111/j.1751-7915.2009.00085.x; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Godoy P, 2010, MICROB BIOTECHNOL, V3, P691, DOI 10.1111/j.1751-7915.2010.00189.x; GOLDMAN RA, 1983, BIOCHEMISTRY-US, V22, P359, DOI 10.1021/bi00271a020; GRAEVENITZ AV, 1971, YALE J BIOL MED, V44, P265; Hainrichson M, 2007, ANTIMICROB AGENTS CH, V51, P774, DOI 10.1128/AAC.01034-06; Han HS, 2004, J MICROBIOL, V42, P365; HEDGES RW, 1985, ANTIMICROB AGENTS CH, V27, P479, DOI 10.1128/AAC.27.4.479; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Horii T, 2005, J ANTIMICROB CHEMOTH, V56, P643, DOI 10.1093/jac/dki254; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kamath R, 2004, ENVIRON SCI TECHNOL, V38, P1740, DOI 10.1021/es0306258; Kent M., 2000, ADV BIOL, P46; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Kumita W, 2009, J INFECT CHEMOTHER, V15, P6, DOI 10.1007/s10156-008-0661-9; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; LOISEAUMAROLLEAU ML, 1977, PATHOL BIOL, V25, P637; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Mendes RE, 2007, ANTIMICROB AGENTS CH, V51, P2611, DOI 10.1128/AAC.00838-06; Mine T, 1998, J BIOCHEM-TOKYO, V124, P187, DOI 10.1093/oxfordjournals.jbchem.a022078; Molina L, 2011, ENVIRON MICROBIOL, V13, P2315, DOI 10.1111/j.1462-2920.2011.02492.x; Moskowitz SM, 2012, ANTIMICROB AGENTS CH, V56, P1019, DOI 10.1128/AAC.05829-11; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Parameswaran GI, 2009, DRUG AGING, V26, P985, DOI 10.2165/11315700-000000000-00000; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000; RADSTROM P, 1988, ANTIMICROB AGENTS CH, V32, P1684, DOI 10.1128/AAC.32.11.1684; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rodriguez-Herva JJ, 2007, ENVIRON MICROBIOL, V9, P1550, DOI 10.1111/j.1462-2920.2007.01276.x; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Rolston KVI, 2005, DIAGN MICR INFEC DIS, V51, P215, DOI 10.1016/j.diagmicrobio.2004.11.002; Saha Rumpa, 2010, J Indian Med Assoc, V108, P344; Santos C, 2010, CLIN MICROBIOL INFEC, V16, P1558, DOI 10.1111/j.1469-0691.2010.03165.x; SCHMIDT FRJ, 1988, MOL MICROBIOL, V2, P709, DOI 10.1111/j.1365-2958.1988.tb00081.x; Steinmann J, 2011, EUROSURVEILLANCE, V16, P13; Struble JM, 2006, ANTIMICROB AGENTS CH, V50, P2506, DOI 10.1128/AAC.01640-05; Tang HZ, 2011, J BACTERIOL, V193, P6789, DOI 10.1128/JB.06201-11; Trevino M, 2010, J MED MICROBIOL, V59, P853, DOI 10.1099/jmm.0.018036-0; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; Vaziri F, 2011, CLINICS, V66, P1519, DOI 10.1590/S1807-59322011000900002; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wei Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029276; WILLIAMS PA, 1974, J BACTERIOL, V120, P416, DOI 10.1128/JB.120.1.416-423.1974; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yomoda S, 2003, J CLIN MICROBIOL, V41, P4246, DOI 10.1128/JCM.41.9.4246-4251.2003; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Zhao HB, 2005, MICROBIOL RES, V160, P307, DOI 10.1016/j.micres.2005.02.004	68	55	55	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e81604	10.1371/journal.pone.0081604	http://dx.doi.org/10.1371/journal.pone.0081604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465371	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000004
J	Beck, F; Guignard, R; Legleye, S				Beck, Francois; Guignard, Romain; Legleye, Stephane			Does Computer Survey Technology Improve Reports on Alcohol and Illicit Drug Use in the General Population? A Comparison Between Two Surveys with Different Data Collection Modes In France	PLOS ONE			English	Article							FACE-TO-FACE; ASSISTED SELF-INTERVIEWS; NATIONAL SURVEYS; SUBSTANCE USE; SEXUAL-BEHAVIOR; TELEPHONE INTERVIEWS; PREVALENCE; CONSUMPTION; IMPACT; BIAS	Background: Previous studies have shown that survey methodology can greatly influence prevalence estimates for alcohol and illicit drug use. The aim of this article is to assess the effect of data collection modes on alcohol misuse and drug use reports by comparing national estimates from computer-assisted telephone interviews (CATI) and audio-computer-assisted self interviews (A-CASI). Methods: Design: Two national representative surveys conducted in 2005 in France by CATI (n = 24,674) and A-CASI (n = 8,111). Participants: French-speaking individuals aged [18-64] years old. Measurements: Alcohol misuse according to the CAGE test, cannabis use (lifetime, last year, 10+ in last month) and experimentation with cocaine, LSD, heroin, amphetamines, ecstasy, were measured with the same questions and wordings in the two surveys. Multivariate logistic regressions controlling for sociodemographic characteristics (age, educational level, marital status and professional status) were performed. Analyses were conducted on the whole sample and stratified by age (18-29 and 30-44 years old) and gender. 45-64 years old data were not analysed due to limited numbers. Results: Overall national estimates were similar for 9 out of the 10 examined measures. However, after adjustment, A-CASI provided higher use for most types of illicit drugs among the youngest men (adjusted odds ratio, or OR, of 1.64 [1.08-2.49] for cocaine, 1.62 [1.10-2.38] for ecstasy, 1.99 [1.17-3.37] for LSD, 2.17 [1.07-4.43] for heroin, and 2.48 [1.41-4.35] for amphetamines), whereas use amongst women was similar in CATI and A-CASI, except for LSD in the 30-44 age group (OR = 3.60 [1.64-7.89]). Reported alcohol misuse was higher with A-CASI, for all ages and genders. Conclusions: Although differences in the results over the whole population were relatively small between the surveys, the effect of data collection mode seemed to vary according to age and gender.	[Beck, Francois; Guignard, Romain] INPES, St Denis, France; [Beck, Francois] Univ Paris 05, Sorbonne Paris Cite, EHESS,Res Ctr Med, CNRS UMR 8211,Inserm U988,Cesames Team Cermes3, Paris, France; [Legleye, Stephane] Inst Natl Etud Demog Ined, Paris, France; [Legleye, Stephane] Univ Paris Sud, INSERM, U669, Paris, France; [Legleye, Stephane] Univ Paris 05, UMR S0669, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Beck, F (corresponding author), INPES, St Denis, France.	francois.beck@inpes.sante.fr	Legleye, Stéphane/L-3546-2019	Legleye, Stéphane/0000-0002-1704-2499; Beck, Francois/0000-0002-4880-1638				[Anonymous], 1999, COMP GEN POPULATION; AQUILINO WS, 1994, PUBLIC OPIN QUART, V58, P210, DOI 10.1086/269419; AQUILINO WS, 1990, PUBLIC OPIN QUART, V54, P362, DOI 10.1086/269212; Aquilino WS, 1996, PUBLIC OPIN QUART, V60, P563, DOI 10.1086/297773; BABOR TF, 1989, ADDICT BEHAV, V14, P139, DOI 10.1016/0306-4603(89)90043-9; BAJOS N, 1992, AIDS, V6, P315; Beck F, 2000, PSYCHOTROPES REV INT, V6, P7; Beck F, 2002, POPULATION E, V57, P571; BECK F, 2004, EUROPEAN STUDIES DRU, P113; Beck F, 2005, DIFFERENCES GENRE US, P73; BECK F, 2007, BAROMETRE SANTE 2005; Beebe TJ, 2005, J CLIN EPIDEMIOL, V58, P421, DOI 10.1016/j.jclinepi.2004.10.007; Beebe TJ, 1998, PUBLIC OPIN QUART, V62, P623, DOI 10.1086/297863; Biemer P., 2001, J OFF STAT, V17, P295; Brittingham A, 1998, ANN EPIDEMIOL, V8, P393, DOI 10.1016/S1047-2797(97)00237-8; Brogger J, 2002, AM J EPIDEMIOL, V155, P572, DOI 10.1093/aje/155.6.572; Carpenter C, 2003, J STUD ALCOHOL, V64, P415, DOI 10.15288/jsa.2003.64.415; Cavalin C, 2009, VIOLENCES SANTE FRAN; COTTLER LB, 1987, AM J EPIDEMIOL, V125, P329, DOI 10.1093/oxfordjournals.aje.a114534; Czaja R, 1987, Int Q Community Health Educ, V8, P23, DOI 10.2190/XT6W-31CX-TD87-E643; DELEEUW ED, 1988, WILEY S PRO, P283; Diemel S, 1997, IMPROVING COMP GEN P; Dietze PM, 2008, MED J AUSTRALIA, V189, P479, DOI 10.5694/j.1326-5377.2008.tb02138.x; EMCDDA European Monitoring Centre for Drugs and Drug Addiction, 2011, 2011 ANN REP STAT DR; Fendrich M, 2000, J SUBST ABUSE, V11, P161, DOI 10.1016/S0899-3289(00)00018-3; Fendrich M, 2001, J DRUG ISSUES, V31, P615, DOI 10.1177/002204260103100303; Fowler FJ, 2001, J DRUG ISSUES, V31, P643, DOI 10.1177/002204260103100304; Gfroerer J, 1997, DRUG ALCOHOL DEPEN, V47, P19, DOI 10.1016/S0376-8716(97)00063-X; GFROERER JC, 1991, PUBLIC HEALTH REP, V106, P384; Gmel G, 2000, ADDICTION, V95, P123, DOI 10.1046/j.1360-0443.2000.95112313.x; Gmel G, 2007, J STUD ALCOHOL DRUGS, V68, P303, DOI 10.15288/jsad.2007.68.303; Greenfield TK, 2000, ADDICTION, V95, P277, DOI 10.1046/j.1360-0443.2000.95227714.x; Grucza RA, 2007, ADDICTION, V102, P623, DOI 10.1111/j.1360-0443.2007.01745.x; Guilbert P, 1999, REV EPIDEMIOL SANTE, V47, P129; Hallfors D, 2000, EVAL PROGRAM PLANN, V23, P149, DOI 10.1016/S0149-7189(00)00011-2; Harmon T, 2009, PUBLIC OPIN QUART, V73, P255, DOI 10.1093/poq/nfp020; Hjorthoj CR, 2012, ADDICT BEHAV, V37, P225, DOI 10.1016/j.addbeh.2011.11.025; HOCHSTIM JR, 1967, J AM STAT ASSOC, V62, P976, DOI 10.2307/2283686; Kann L, 2002, J ADOLESCENT HEALTH, V31, P327, DOI 10.1016/S1054-139X(02)00343-9; Kaskutas LA, 2000, J SUBST ABUSE, V12, P67, DOI 10.1016/S0899-3289(00)00042-0; Kraus L, 2001, ADDICTION, V96, P459, DOI 10.1046/j.1360-0443.2001.9634599.x; Makela P, 2010, ADDICTION, V105, P1935, DOI 10.1111/j.1360-0443.2010.03069.x; MANGIONE TW, 1982, SOCIOL METHOD RES, V10, P337, DOI 10.1177/0049124182010003006; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McAuliffe WE, 2002, J DRUG ISSUES, V32, P1139, DOI 10.1177/002204260203200409; Midanik LT, 2003, DRUG ALCOHOL DEPEN, V72, P209, DOI 10.1016/S0376-8716(03)00204-7; Miller JW, 2004, AM J PREV MED, V27, P197, DOI 10.1016/j.amepre.2004.05.004; Moskowitz JM, 2004, PUBLIC OPIN QUART, V68, P565, DOI 10.1093/poq/nfh040; NEEDLE R, 1983, INT J ADDICT, V18, P901, DOI 10.3109/10826088309033058; NEEDLE RH, 1989, AM J DRUG ALCOHOL AB, V15, P275, DOI 10.3109/00952998908993408; Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335; Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294; Rodgers SM, 1999, POPULATION, V54, P231; Rouse BA, 1985, SELF REPORT METHODS; SIEMIATYCKI J, 1984, AM J EPIDEMIOL, V120, P302, DOI 10.1093/oxfordjournals.aje.a113893; Smart RG, 1985, STUDYING DRUG ABUSE, P47; SYKES W, 1988, WILEY S PRO, P301; Thornberry O T Jr, 1987, Vital Health Stat 2, P1; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; Turner C. F., 1992, SURVEY MEASUREMENT D; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Turner CF, 2005, ADDICTION, V100, P1432, DOI 10.1111/j.1360-0443.2005.01196.x; Turner CF, 2009, INT J EPIDEMIOL, V38, P1118, DOI 10.1093/ije/dyp210; Vereecken CA, 2006, J ADOLESCENT HEALTH, V38, P426, DOI 10.1016/j.jadohealth.2004.10.010; Villarroel MA, 2008, SEX TRANSM DIS, V35, P499, DOI 10.1097/OLQ.0b013e318165925a; Webb PM, 1999, J ADOLESCENT HEALTH, V24, P383, DOI 10.1016/S1054-139X(99)00005-1; Weir E, 2003, CAN MED ASSOC J, V169, P1186; WISEMAN F, 1972, PUBLIC OPIN QUART, V36, P105, DOI 10.1086/267981	69	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85810	10.1371/journal.pone.0085810	http://dx.doi.org/10.1371/journal.pone.0085810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465720	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100077
J	Borg, C; Georgiadis, JR; Renken, RJ; Spoelstra, SK; Schultz, WW; de Jong, PJ				Borg, Charmaine; Georgiadis, Janniko R.; Renken, Remco J.; Spoelstra, Symen K.; Schultz, Willibrord Weijmar; de Jong, Peter J.			Brain Processing of Visual Stimuli Representing Sexual Penetration versus Core and Animal-Reminder Disgust in Women with Lifelong Vaginismus	PLOS ONE			English	Article							CONTAMINATION SENSITIVITY; AROUSAL; RESPONSES; FEAR; EXPOSURE; PICTURES; EMOTION; PHOBIA; SPIDER; FMRI	It has been proposed that disgust evolved to protect humans from contamination. Through eliciting the overwhelming urge to withdraw from the disgusting stimuli, it would facilitate avoidance of contact with pathogens. The physical proximity implied in sexual intercourse provides ample opportunity for contamination and may thus set the stage for eliciting pathogen disgust. Building on this, it has been argued that the involuntary muscle contraction characteristic of vaginismus (i.e., inability to have vaginal penetration) may be elicited by the prospect of penetration by potential contaminants. To further investigate this disgust-based interpretation of vaginismus (in DSM-5 classified as a Genito-Pelvic Pain/Penetration Disorder, GPPPD) we used functional magnetic resonance imaging (fMRI) to examine if women with vaginismus (n = 21) show relatively strong convergence in their brain responses towards sexual penetration- and disgust-related pictures compared to sexually asymptomatic women (n = 21) and women suffering from vulvar pain (dyspareunia/also classified as GPPPD in the DSM-5, n = 21). At the subjective level, both clinical groups rated penetration stimuli as more disgusting than asymptomatic women. However, the brain responses to penetration stimuli did not differ between groups. In addition, there was considerable conjoint brain activity in response to penetration and disgust pictures, which yield for both animal-reminder (e. g., mutilation) and core (e. g., rotten food) disgust domains. However, this overlap in brain activation was similar for all groups. A possible explanation for the lack of vaginismus-specific brain responses lies in the alleged female ambiguity (procreation/pleasure vs. contamination/disgust) toward penetration: generally in women a (default) disgust response tendency may prevail in the absence of sexual readiness. Accordingly, a critical next step would be to examine the processing of penetration stimuli following the induction of sexual arousal.	[Borg, Charmaine; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Georgiadis, Janniko R.] Univ Groningen, Univ Med Ctr Groningen, Sect Anat, Dept Neurosci, Groningen, Netherlands; [Renken, Remco J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr BCN NiC, Groningen, Netherlands; [Spoelstra, Symen K.; Schultz, Willibrord Weijmar] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Borg, C (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	C.borg@med.umcg.nl	de Jong, Peter/ABB-1750-2020; de Jong, Peter/E-9095-2014	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Borg, Charmaine/0000-0002-0122-1118; Renken, Remco Jan/0000-0002-7777-9484	Malta Government Scholarship Scheme [MGSS_PHD_2008-12]	Malta Government Scholarship Scheme	This work was supported by the Malta Government Scholarship Scheme Grant Number MGSS_PHD_2008-12, which partially funds the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Basson R, 2004, J PSYCHOSOMATIC OBST, V34, P221; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; Bianchi KN, 2012, J ANXIETY DISORD, V26, P753, DOI 10.1016/j.janxdis.2012.06.004; Binik YM, 2010, ARCH SEX BEHAV, V39, P278, DOI 10.1007/s10508-009-9560-0; Borg C, 2014, SOC COGN AFFECT NEUR, V9, P158, DOI 10.1093/scan/nss117; Borg C, 2013, SOC COGN AFFECT NEUR, V8, P351, DOI 10.1093/scan/nss006; Borg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044111; Borg C, 2010, J SEX MED, V7, P2149, DOI 10.1111/j.1743-6109.2010.01800.x; Brauer M, 2007, EUR J PAIN, V11, P788, DOI 10.1016/j.ejpain.2006.12.006; Cherner RA, 2013, J SEX MED, V10, P1291, DOI 10.1111/jsm.12102; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; de Jong PJ, 2013, J SEX RES, V50, P247, DOI 10.1080/00224499.2012.746280; de Jong PJ, 2010, INT J COGN THER, V3, P23, DOI 10.1521/ijct.2010.3.1.23; de Jong PJ, 2009, ARCH SEX BEHAV, V38, P244, DOI 10.1007/s10508-007-9240-x; de Jong PJ, 2002, J ANXIETY DISORD, V16, P51, DOI 10.1016/S0887-6185(01)00089-5; de Jong PJ, 1998, PERS INDIV DIFFER, V24, P153, DOI 10.1016/S0191-8869(97)00178-5; Engelhard IM, 2011, J ANXIETY DISORD, V25, P58, DOI 10.1016/j.janxdis.2010.08.003; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Goldstein A, 2009, PROVOKED VESTIBULODY, P43; Huijding J, 2011, J SEX MED, V8, P806, DOI 10.1111/j.1743-6109.2010.02083.x; Karama S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022343; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Leiblum SR, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P181; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2007, BEHAV RES THER, V45, P263, DOI 10.1016/j.brat.2006.03.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips ML, 1998, BRIT J PSYCHIAT, V172, P373, DOI 10.1192/bjp.172.5.373; ROZIN P, 1995, J RES PERS, V29, P318, DOI 10.1006/jrpe.1995.1019; Sarlo M, 2005, NEUROSCI LETT, V382, P330; Schienle A, 2006, NEUROSCI LETT, V393, P2347; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Stark R, 2005, BIOL PSYCHOL, V70, P19, DOI 10.1016/j.biopsycho.2004.11.014; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; ter Kuile MM, 2009, J CONSULT CLIN PSYCH, V77, P149, DOI 10.1037/a0014273; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; van der Velde J, 2001, INT UROGYNECOL J PEL, V12, P328, DOI 10.1007/s001920170035; van Overveld M, 2013, J SEX MED, V10, P396, DOI 10.1111/j.1743-6109.2012.02979.x; van Overveld WJM, 2009, BIOL PSYCHOL, V80, P149, DOI 10.1016/j.biopsycho.2008.08.002; Verwoerd J, 2013, BEHAV RES THER, V51, P122, DOI 10.1016/j.brat.2012.11.005; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Wright P, 2004, NEUROREPORT, V15, P2347, DOI 10.1097/00001756-200410250-00009; Yartz AR, 2002, BIOL PSYCHOL, V59, P55, DOI 10.1016/S0301-0511(01)00121-1; Young LJ, 2002, BIOL PSYCHIAT, V51, P18, DOI 10.1016/S0006-3223(01)01268-9	46	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84882	10.1371/journal.pone.0084882	http://dx.doi.org/10.1371/journal.pone.0084882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465445	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100016
J	Dancik, GM; Theodorescu, D				Dancik, Garrett M.; Theodorescu, Dan			Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes	PLOS ONE			English	Article							PREDICT SURVIVAL; PROGRESSION; CARCINOMA; PROFILES; MODULES; HEAD; TOOL	Few prognostic biomarkers are approved for clinical use primarily because their initial performance cannot be repeated in independent datasets. We posited that robust biomarkers could be obtained by identifying deregulated biological processes shared among tumor types having a common etiology. We performed a gene set enrichment analysis in 20 publicly available gene expression datasets comprising 1968 patients having one of the three most common tobacco-related cancers (lung, bladder, head and neck) and identified cell cycle related genes as the most consistently prognostic class of biomarkers in bladder (BL) and lung adenocarcinoma (LUAD). We also found the prognostic value of 13 of 14 published BL and LUAD signatures were dependent on cell cycle related genes, supporting the importance of cell cycle related biomarkers for prognosis. Interestingly, no prognostic gene classes were identified in squamous cell lung carcinoma or head and neck squamous cell carcinoma. Next, a specific 31 gene cell cycle proliferation (CCP) signature, previously derived in prostate tumors was evaluated and found predictive of outcome in BL and LUAD cohorts in univariate and multivariate analyses. Specifically, CCP score significantly enhanced the predictive ability of multivariate models based on standard clinical variables for progression in BL patients and survival in LUAD patients in multiple cohorts. We then generated random CCP signatures of various sizes and found sets of 10-15 genes had robust performance in these BL and LUAD cohorts, a finding that was confirmed in an independent cohort. Our work characterizes the importance of cell cycle related genes in prognostic signatures for BL and LUAD patients and identifies a specific signature likely to survive additional validation.	[Dancik, Garrett M.] Eastern Connecticut State Univ, Math & Comp Sci Dept, Willimantic, CT 06226 USA; [Theodorescu, Dan] Univ Colorado, Dept Surg, Aurora, CO 80045 USA; [Theodorescu, Dan] Univ Colorado, Dept Pharmacol, Aurora, CO USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	Connecticut State University System; Eastern Connecticut State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Theodorescu, D (corresponding author), Univ Colorado, Dept Surg, Aurora, CO 80045 USA.	dan.theodorescu@ucdenver.edu		Dancik, Garrett/0000-0002-1391-8641	National Institutes of Health [CA075115, CA104106]; NATIONAL CANCER INSTITUTE [R01CA075115, P01CA104106, R29CA075115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health grants CA075115 and CA104106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Colo AEL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-33; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Dyrskjot L, 2007, CLIN CANCER RES, V13, P3545, DOI 10.1158/1078-0432.CCR-06-2940; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kenfield SA, 2011, JAMA-J AM MED ASSOC, V305, P2548, DOI 10.1001/jama.2011.879; Lauss M, 2010, CLIN CANCER RES, V16, P4421, DOI 10.1158/1078-0432.CCR-10-0606; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	25	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85249	10.1371/journal.pone.0085249	http://dx.doi.org/10.1371/journal.pone.0085249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465512	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100028
J	Elliott, KH; Davis, M; Elliott, JE				Elliott, Kyle H.; Davis, Mikaela; Elliott, John E.			Equations for Lipid Normalization of Carbon Stable Isotope Ratios in Aquatic Bird Eggs	PLOS ONE			English	Article							FISH-TISSUES; EXTRACTION; DELTA-C-13; SEABIRDS; MERCURY; CONTAMINANTS; PREY; ACCUMULATION; CONSEQUENCES; REPRODUCTION	Stable isotope ratios are biogeochemical tracers that can be used to determine the source of nutrients and contaminants in avian eggs. However, the interpretation of stable carbon ratios in lipid-rich eggs is complicated because C-13 is depleted in lipids. Variation in C-13 abundance can therefore be obscured by variation in percent lipids. Past attempts to establish an algebraic equation to correct carbon isotope ratios for lipid content in eggs have been unsuccessful, possibly because they relied partly on data from coastal or migratory species that may obtain egg lipids from different habitats than egg protein. We measured carbon, nitrogen and sulphur stable isotope ratios in 175 eggs from eight species of aquatic birds. Carbon, nitrogen and sulphur isotopes were enriched in lipid-extracted egg samples compared with non extracted egg samples. A logarithmic equation using the C:N ratio and carbon isotope ratio from the non extracted egg tissue calculated 90% of the lipid-extracted carbon isotope ratios within +/- 0.5 parts per thousand. Calculating separate equations for eggs laid by species in different habitats (pelagic, offshore and terrestrial-influenced) improved the fit. A logarithmic equation, rather than a linear equation as often used for muscle, was necessary to accurately correct for lipid content because the relatively high lipid content of eggs compared with muscle meant that a linear relationship did not accurately approximate the relationship between percent lipids and the C: N ratio. Because lipid extraction alters sulphur and nitrogen isotope ratios (and cannot be corrected algebraically), we suggest that isotopic measurement on bulk tissue followed by algebraic lipid normalization of carbon stable isotope ratio is often a good solution for homogenated eggs, at least when it is not possible to complete separate chemical analyses for each isotope.	[Elliott, Kyle H.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Davis, Mikaela] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Elliott, John E.] Environm Canada, Sci & Technol Branch, Delta, BC, Canada	University of Manitoba; Simon Fraser University; Environment & Climate Change Canada	Elliott, KH (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	urialomvia@gmail.com	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993; Chiaradia, Andre/0000-0002-6178-4211	NSERC Vanier scholarship; ACUNS Garfield Weston Foundation Northern Studies Award; Jennifer Robinson Memorial Award (Arctic Institute of North America); Environment Canada's Chemical Management Plan	NSERC Vanier scholarship; ACUNS Garfield Weston Foundation Northern Studies Award; Jennifer Robinson Memorial Award (Arctic Institute of North America); Environment Canada's Chemical Management Plan	KHE received financial support via an NSERC Vanier scholarship, ACUNS Garfield Weston Foundation Northern Studies Award and Jennifer Robinson Memorial Award (Arctic Institute of North America). M. Davis and J. Elliott were funded by Environment Canada's Chemical Management Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodin N, 2007, J EXP MAR BIOL ECOL, V341, P168, DOI 10.1016/j.jembe.2006.09.008; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Braune BM, 2011, ENVIRON POLLUT, V159, P2891, DOI 10.1016/j.envpol.2011.04.036; Braune BM, 2005, SCI TOTAL ENVIRON, V346, P156, DOI 10.1016/j.scitotenv.2004.12.017; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Choy ES, 2010, SCI TOTAL ENVIRON, V408, P1858, DOI 10.1016/j.scitotenv.2010.01.014; Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003; Day RD, 2012, ENVIRON POLLUT, V166, P226, DOI 10.1016/j.envpol.2012.03.004; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Ehrich D, 2011, METHODS ECOL EVOL, V2, P66, DOI 10.1111/j.2041-210X.2010.00047.x; Elliott J.E., 1992, P181; Elliott JE, 2005, ENVIRON TOXICOL CHEM, V24, P3099, DOI 10.1897/04-474R.1; Elliott JE, 2005, ARCH ENVIRON CON TOX, V49, P89, DOI 10.1007/s00244-004-0180-3; Elliott JE, 1984, ENV SPECIMEN BANKING, P45; Elliott JE, 2007, ECOL APPL, V17, P1223, DOI 10.1890/06-1213; Elliott JE, 2013, SCIENCE, V340, P556, DOI 10.1126/science.1235197; Elliott JE, 2012, ENVIRON SCI TECHNOL, V46, P9681, DOI 10.1021/es301539b; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Elliott KH, 2009, SCI TOTAL ENVIRON, V407, P3867, DOI 10.1016/j.scitotenv.2009.02.027; Guigueno MF, 2012, ENVIRON INT, V40, P24, DOI 10.1016/j.envint.2011.11.004; Hebert CE, 2008, ECOLOGY, V89, P891, DOI 10.1890/07-1603.1; Hobson KA, 2005, J WILDLIFE MANAGE, V69, P1221, DOI 10.2193/0022-541X(2005)069[1221:TNATRI]2.0.CO;2; Hobson KA, 2010, J AVIAN BIOL, V41, P565, DOI 10.1111/j.1600-048X.2010.04980.x; Holmstrom KE, 2005, ENVIRON SCI TECHNOL, V39, P80, DOI 10.1021/es049257d; Hussey NE, 2012, J EXP MAR BIOL ECOL, V434, P7, DOI 10.1016/j.jembe.2012.07.012; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Ito M, 2012, ORNITHOL SCI, V11, P113, DOI 10.2326/osj.11.113; Jacobs SR, 2009, J AVIAN BIOL, V40, P327, DOI 10.1111/j.1600-048X.2008.04625.x; Jardine TD, 2006, ENVIRON SCI TECHNOL, V40, P7501, DOI 10.1021/es061263h; JO N, 1997, OIKOS, V78, P57, DOI DOI 10.2307/3545800); Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Lesage V, 2010, MAR ECOL PROG SER, V419, P249, DOI 10.3354/meps08825; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; Mallory ML, 2012, MAR POLLUT BULL, V64, P1475, DOI 10.1016/j.marpolbul.2012.05.012; Mintenbeck K, 2008, J FISH BIOL, V72, P815, DOI 10.1111/j.1095-8649.2007.01754.x; Morrissey CA, 2010, ENVIRON POLLUT, V158, P447, DOI 10.1016/j.envpol.2009.08.040; Oppel S, 2010, AUK, V127, P72, DOI 10.1525/auk.2009.09153; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Ricca MA, 2007, CAN J ZOOL, V85, P40, DOI 10.1139/Z06-187; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Schlechtriem C, 2003, ISOT ENVIRON HEALT S, V39, P135, DOI 10.1080/1025601031000113565; Sharp CM, 2009, CONDOR, V111, P361, DOI 10.1525/cond.2009.090011; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; Thomas VG, 1989, P INT ORN C, VXIX, P353; Vander Pol SS, 2004, ENVIRON SCI TECHNOL, V38, P1305, DOI 10.1021/es034987r; Vo ATE, 2011, P NATL ACAD SCI USA, V108, P7466, DOI 10.1073/pnas.1013865108; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Yohannes E, 2010, J AVIAN BIOL, V41, P580, DOI 10.1111/j.1600-048X.2010.04965.x	54	37	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83597	10.1371/journal.pone.0083597	http://dx.doi.org/10.1371/journal.pone.0083597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465384	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100006
J	Hrbek, T; da Silva, VMF; Dutra, N; Gravena, W; Martin, AR; Farias, IP				Hrbek, Tomas; Ferreira da Silva, Vera Maria; Dutra, Nicole; Gravena, Waleska; Martin, Anthony R.; Farias, Izeni Pires			A New Species of River Dolphin from Brazil or: How Little Do We Know Our Biodiversity	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MICROSATELLITE LOCI; BAYESIAN-INFERENCE; INIA-GEOFFRENSIS; POPULATION; EVOLUTION; DNA; PHYLOGENY; PHYLOGEOGRAPHY; PROBABILITIES	True river dolphins are some of the rarest and most endangered of all vertebrates. They comprise relict evolutionary lineages of high taxonomic distinctness and conservation value, but are afforded little protection. We report the discovery of a new species of a river dolphin from the Araguaia River basin of Brazil, the first such discovery in nearly 100 years. The species is diagnosable by a series of molecular and morphological characters and diverged from its Amazonian sister taxon 2.08 million years ago. The estimated time of divergence corresponds to the separation of the Araguaia-Tocantins basin from the Amazon basin. This discovery highlights the immensity of the deficit in our knowledge of Neotropical biodiversity, as well as vulnerability of biodiversity to anthropogenic actions in an increasingly threatened landscape. We anticipate that this study will provide an impetus for the taxonomic and conservation reanalysis of other taxa shared between the Araguaia and Amazon aquatic ecosystems, as well as stimulate historical biogeographical analyses of the two basins.	[Hrbek, Tomas; Dutra, Nicole; Gravena, Waleska; Farias, Izeni Pires] Fed Univ Amazonas UFAM, Inst Biol Sci, Dept Biol, Lab Evolut & Anim Genet LEGAL, Manaus, Amazonas, Brazil; [Ferreira da Silva, Vera Maria] Natl Res Inst Amazon INPA, LMA, Manaus, Amazonas, Brazil; [Martin, Anthony R.] Univ Dundee, Ctr Remote Environm, Dundee, Scotland	Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; University of Dundee	Hrbek, T (corresponding author), Fed Univ Amazonas UFAM, Inst Biol Sci, Dept Biol, Lab Evolut & Anim Genet LEGAL, Manaus, Amazonas, Brazil.	hrbek@evoamazon.net	Gravena, Waleska/AAJ-2875-2020; Farias, Izeni Pires/J-3069-2014; Hrbek, Tomas/J-6988-2012	Gravena, Waleska/0000-0002-1102-971X; Farias, Izeni Pires/0000-0002-1416-4351; Hrbek, Tomas/0000-0003-3239-7068	CNPq/CT [Amazonia-575603/2008-9]; CNPq/FAPEAM [SISBIOTA-563348/2010-0]; Scott Neotropical Fund; Society for Marine Mammalogy; Bolsa de Pesquisa scholarship from CNPq; CAPES fellowship; CNPq fellowship;  [CNPq-483408/2009-3];  [482253/2012-6]	CNPq/CT; CNPq/FAPEAM; Scott Neotropical Fund; Society for Marine Mammalogy; Bolsa de Pesquisa scholarship from CNPq(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; 	Financial support for fieldwork and laboratory analyses was provided by grants CNPq-483408/2009-3 and 482253/2012-6, CNPq/CT Amazonia-575603/2008-9 and CNPq/FAPEAM SISBIOTA-563348/2010-0 to IPF, and the Scott Neotropical Fund and the Society for Marine Mammalogy to WG. TH and IPF were supported by a Bolsa de Pesquisa scholarship from CNPq during the study, ND by a CAPES fellowship and WG by a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2006, POPULATION GENETICS; Araujo CC, 2010, DISTRIBUICAO ESTIMAT; Araujo CC, 2010, 14 REUN TRAB ESP MAM, P1; Araujo CC, 2012, AQUAT MAMM, V38, P435, DOI 10.1578/AM.38.4.2012.435; Banguera-Hinestroza E, 2002, J HERED, V93, P312, DOI 10.1093/jhered/93.5.312; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; BAUM DA, 1995, SYST BOT, V20, P560, DOI 10.2307/2419810; BERGGREN WA, 1992, EOCENE OLIGOCENE CLI, P29; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x; Carroll RL, 1988, VERTEBRATE PALEONTOL; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Castoe TA, 2004, SYST BIOL, V53, P448, DOI 10.1080/10635150490445797; Cracraft J., 1983, Current Ornithology, V1, P159; da Silva V. M. F., 2000, BIOL CONSERVATION FR, P121; da Silva VMF., 1994, ASPECTS BIOL AMAZONI; Da Silva VMF, 2009, ENCY MARINE MAMMALS, P18; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; De Muizon C, 1983, CR HEBD ACAD SCI, V296, P625; Drummond AJ, 2012, GENEIOUS V5 6 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDWARDS AWF, 1963, ANN HUM GENET, V27, P104; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Espurt N, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P89; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fordyce Ewan, 2001, P169; Gesai C, 2010, EIA SANTA ISABEL ENV; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Goulding M, 2003, SMITHSONIAN ATLAS AM; Gravena W, 2009, MOL ECOL RESOUR, V9, P600, DOI 10.1111/j.1755-0998.2008.02458.x; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HOLM S, 1979, SCAND J STAT, V6, P65; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Latrubesse EM, 2009, GEOMORPHOLOGY, V113, P239, DOI 10.1016/j.geomorph.2009.03.014; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mchedlidze GA, 1970, NEKOTORYE OBSHIE CHE; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller M.A., 2010, P GAT COMP ENV WORKS; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; Pericchi LR, 2005, HANDB STAT, V25, P115, DOI 10.1016/S0169-7161(05)25004-6; Pilleri G, 1977, INVESTIGATIONS CETAC, P11; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Reeves RR, 2006, CONSERV BIOL, V20, P626, DOI 10.1111/j.1523-1739.2006.00472.x; Renno JF, 2006, MOL PHYLOGENET EVOL, V41, P503, DOI 10.1016/j.ympev.2006.05.029; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4; Rosel PE, 2005, MOL ECOL NOTES, V5, P830, DOI 10.1111/j.1471-8286.2005.01078.x; ROSEN D E, 1979, Bulletin of the American Museum of Natural History, V162, P267; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossetti DF, 2007, CATENA, V70, P253, DOI 10.1016/j.catena.2006.08.009; Ruiz-Garcia M, 2008, POPULATION GENETICS, P177; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Trujillo F, 2010, ACTION PLAN S AM RIV, P167; Turvey S., 2008, WITNESS EXTINCTION W; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20	74	88	104	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83623	10.1371/journal.pone.0083623	http://dx.doi.org/10.1371/journal.pone.0083623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465386	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100007
J	Feng, ZM; Zhou, XL; Wu, F; Yao, K; Kong, XF; Li, TJ; Blachier, F; Yin, YL				Feng, Zemeng; Zhou, Xiaoli; Wu, Fei; Yao, Kang; Kong, Xiangfeng; Li, Tiejun; Blachier, Francois; Yin, Yulong			Both Dietary Supplementation with Monosodium L-Glutamate and Fat Modify Circulating and Tissue Amino Acid Pools in Growing Pigs, but with Little Interactive Effect	PLOS ONE			English	Article							GROWTH-PERFORMANCE; RENAL METABOLISM; GUT MICROBIOTA; PROTEIN; LEUCINE; AMMONIA; PLASMA; MUSCLE; KIDNEY; CARBOHYDRATE	Background: The Chinese population has undergone rapid transition to a high-fat diet. Furthermore, monosodium L-glutamate (MSG) is widely used as a daily food additive in China. Little information is available on the effects of oral MSG and dietary fat supplementation on the amino acid balance in tissues. The present study aimed to determine the effects of both dietary fat and MSG on amino acid metabolism in growing pigs, and to assess any possible interactions between these two nutrients. Methods and Results: Four iso-nitrogenous and iso-caloric diets (basal diet, high fat diet, basal diet with 3% MSG and high fat diet with 3% MSG) were provided to growing pigs. The dietary supplementation with fat and MSG used alone and in combination were found to modify circulating and tissue amino acid pools in growing pigs. Both dietary fat and MSG modified the expression of gene related to amino acid transport in jejunum. Conclusions: Both dietary fat and MSG clearly influenced amino acid content in tissues but in different ways. Both dietary fat and MSG enhance the absorption of amino acids in jejunum. However, there was little interaction between the effects of dietary fat and MSG.	[Feng, Zemeng; Wu, Fei; Yao, Kang; Kong, Xiangfeng; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Hunan Engn & Res Ctr Anim & Poultry Sci, Res Ctr Hlth Breeding Livestock & Poultry,Key Lab, Inst Subtrop Agr,Minist Agr,Sci Observat & Expt S, Changsha, Hunan, Peoples R China; [Zhou, Xiaoli] Guiyang Univ, Coll Food & Pharm Engn, Guiyang, Guizhou, Peoples R China; [Blachier, Francois] Paris Inst Technol Life Food & Environm Sci, Paris, France	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Guiyang University	Yin, YL (corresponding author), Chinese Acad Sci, Hunan Engn & Res Ctr Anim & Poultry Sci, Res Ctr Hlth Breeding Livestock & Poultry,Key Lab, Inst Subtrop Agr,Minist Agr,Sci Observat & Expt S, Changsha, Hunan, Peoples R China.	yinyulong@isa.ac.cn			Major Program for International Cooperation of the National Natural Science Foundation of China [31110103909]; Funds of the Chinese Academy of Sciences for Key Topics in Innovation Engineering [KZCX2-EW-412]; Funds of Institute of Subtropical Agriculture, the Chinese Academy of Sciences for field cutting- edge [Y151012100]	Major Program for International Cooperation of the National Natural Science Foundation of China; Funds of the Chinese Academy of Sciences for Key Topics in Innovation Engineering(Chinese Academy of Sciences); Funds of Institute of Subtropical Agriculture, the Chinese Academy of Sciences for field cutting- edge	This work was supported by the Major Program for International Cooperation of the National Natural Science Foundation of China (Grant No. 31110103909), Funds of the Chinese Academy of Sciences for Key Topics in Innovation Engineering (Grant No. KZCX2-EW-412) and Funds of Institute of Subtropical Agriculture, the Chinese Academy of Sciences for field cutting- edge (Grant No. Y151012100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauchart-Thevret C, 2013, J NUTR, V143, P563, DOI 10.3945/jn.112.167783; Blachier F, 1999, DIGESTION, V60, P349, DOI 10.1159/000007682; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Boutry C, 2011, AM J PHYSIOL-GASTR L, V300, pG137, DOI 10.1152/ajpgi.00299.2010; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; CHUA B, 1979, J BIOL CHEM, V254, P8358; Cui ZH, 2012, BRIT J NUTR, V108, P1292, DOI 10.1017/S0007114511006891; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Farombi EO, 2006, HUM EXP TOXICOL, V25, P251, DOI 10.1191/0960327106ht621oa; Friedman AN, 2004, AM J KIDNEY DIS, V44, P950, DOI 10.1053/j.ajkd.2004.08.020; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Go G, 2012, AMINO ACIDS, V43, P1713, DOI 10.1007/s00726-012-1255-5; Graham TE, 1998, MED SCI SPORT EXER, V30, P34, DOI 10.1097/00005768-199801000-00006; HARRIS CI, 1979, P NUTR SOC, V38, pA11; Janeczko MJ, 2007, J NUTR, V137, P2384, DOI 10.1093/jn/137.11.2384; Jinap S, 2010, APPETITE, V55, P1, DOI 10.1016/j.appet.2010.05.002; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Kopple JD, 2007, J NUTR, V137, p1586S, DOI 10.1093/jn/137.6.1586S; MELLINKOFF SM, 1965, AM J CLIN NUTR, V16, P232, DOI 10.1093/ajcn/16.2.232; Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001; Nakashima K, 2005, BIOCHEM BIOPH RES CO, V336, P660, DOI 10.1016/j.bbrc.2005.08.138; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Novak EM, 2012, AM J PHYSIOL-GASTR L, V302, pG250, DOI 10.1152/ajpgi.00189.2011; Oda H, 2006, J NUTR, V136, p1666S, DOI 10.1093/jn/136.6.1666S; OWEN EE, 1963, J CLIN INVEST, V42, P263, DOI 10.1172/JCI104713; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P205, DOI 10.1079/PHN2001295; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Schmid RD, 2002, TASCHENATLAS BIOTECH; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Tessari P, 2000, Curr Opin Clin Nutr Metab Care, V3, P51, DOI 10.1097/00075197-200001000-00009; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; Turnbaugh PJ, 2012, NATURE, V487, P47, DOI 10.1038/487047a; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; van der Laan JW, 2010, J PHARMACOL TOX MET, V62, P184, DOI 10.1016/j.vascn.2010.05.005; VAZQUEZ JA, 1985, J CLIN INVEST, V76, P737, DOI 10.1172/JCI112029; Wright Jacqueline D, 2010, NCHS Data Brief, P1; YOUNG GA, 1982, KIDNEY INT, V21, P492, DOI 10.1038/ki.1982.51; Zai H, 2009, AM J CLIN NUTR, V89, P431, DOI 10.3945/ajcn.2008.26180	42	22	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84533	10.1371/journal.pone.0084533	http://dx.doi.org/10.1371/journal.pone.0084533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465415	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500007
J	Fung, T; Keenan, K				Fung, Tak; Keenan, Kevin			Confidence Intervals for Population Allele Frequencies: The General Case of Sampling from a Finite Diploid Population of Any Size	PLOS ONE			English	Article							SELECTION; DISTRIBUTIONS; INDIVIDUALS; DIVERSITY; EVOLUTION; INSECT; POWER	The estimation of population allele frequencies using sample data forms a central component of studies in population genetics. These estimates can be used to test hypotheses on the evolutionary processes governing changes in genetic variation among populations. However, existing studies frequently do not account for sampling uncertainty in these estimates, thus compromising their utility. Incorporation of this uncertainty has been hindered by the lack of a method for constructing confidence intervals containing the population allele frequencies, for the general case of sampling from a finite diploid population of any size. In this study, we address this important knowledge gap by presenting a rigorous mathematical method to construct such confidence intervals. For a range of scenarios, the method is used to demonstrate that for a particular allele, in order to obtain accurate estimates within 0.05 of the population allele frequency with high probability (>= 95%), a sample size of >30 is often required. This analysis is augmented by an application of the method to empirical sample allele frequency data for two populations of the checkerspot butterfly (Melitaea cinxia L.), occupying meadows in Finland. For each population, the method is used to derive >= 98.3% confidence intervals for the population frequencies of three alleles. These intervals are then used to construct two joint >= 95% confidence regions, one for the set of three frequencies for each population. These regions are then used to derive a >= 95% confidence interval for Jost's D, a measure of genetic differentiation between the two populations. Overall, the results demonstrate the practical utility of the method with respect to informing sampling design and accounting for sampling uncertainty in studies of population genetics, important for scientific hypothesis-testing and also for risk-based natural resource management.	[Fung, Tak] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Fung, Tak] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Keenan, Kevin] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland	National University of Singapore; Queens University Belfast; Queens University Belfast	Fung, T (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	tfung01@qub.ac.uk			National University of Singapore [WBS R-154-000-551-133]; Beaufort Marine Research Award in Ecosystem Approach; Sea Change Strategy and the Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the Irish National Development Plan; Beaufort Marine Research Award in Fish Population Genetics; Irish Government under the Sea Change Strategy	National University of Singapore(National University of Singapore); Beaufort Marine Research Award in Ecosystem Approach; Sea Change Strategy and the Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the Irish National Development Plan; Beaufort Marine Research Award in Fish Population Genetics; Irish Government under the Sea Change Strategy	TF is being supported by the National University of Singapore start-up grant WBS R-154-000-551-133. In addition, TF acknowledges past funding support by a Ph.D. studentship from the Beaufort Marine Research Award in Ecosystem Approach to Fisheries Management, carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the Irish National Development Plan 2007-2013 (http://www.marine.ie/home/research/MIFunded/BeaufortAwards/). KK is being supported by a Ph.D. studentship from the Beaufort Marine Research Award in Fish Population Genetics, funded by the Irish Government under the Sea Change Strategy as above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; [Anonymous], 2012, MATLAB VERS 8 0; [Anonymous], 2010, R LANG ENV STAT COMP; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Cai Y, 2005, COMPUT STAT DATA AN, V48, P605, DOI 10.1016/j.csda.2004.03.008; CHAKRABORTY R, 1992, HUM BIOL, V64, P141; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cox DR, 1974, THEORETICAL STAT; De Kovel CGF, 2006, GENET SEL EVOL, V38, P3, DOI 10.1051/gse:2005024; DeGiorgio M, 2010, GENETICS, V186, P1367, DOI 10.1534/genetics.110.121756; DeGiorgio M, 2009, MOL BIOL EVOL, V26, P501, DOI 10.1093/molbev/msn254; EANES WF, 1978, EVOLUTION, V32, P784, DOI 10.1111/j.1558-5646.1978.tb04633.x; FORBES SH, 1995, MOL BIOL EVOL, V12, P1106; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Friedlander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052282; Gillespie J. H., 2004, POPULATION GENETICS; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; GREGORIUS HR, 1980, BIOMETRICS, V36, P643, DOI 10.2307/2556116; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hugnet C, 2004, J VET PHARMACOL THER, V27, P227, DOI 10.1111/j.1365-2885.2004.00585.x; Johnson N., 1997, DISCRETE MULTIVARIAT; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Laplace PS., 1820, THEORIE ANAL PROBABI; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Palo J, 1995, HEREDITAS, V123, P295, DOI 10.1111/j.1601-5223.1995.00295.x; Petrejcikova E, 2011, FORENSIC SCI INT-GEN, V5, pE53, DOI 10.1016/j.fsigen.2010.08.003; Rank NE, 2002, EVOLUTION, V56, P2278, DOI 10.1111/j.0014-3820.2002.tb00151.x; Rice J., 1995, MATH STAT DATA ANAL; Seider T, 2010, FORENSIC SCI INT-GEN, V4, pE159, DOI 10.1016/j.fsigen.2010.03.009; SJOGREN P, 1994, CONSERV BIOL, V8, P267, DOI 10.1046/j.1523-1739.1994.08010267.x; Talens E, 2005, STAT AUDITING AOQL M; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, METHODS DISCRETE POP; Wolfram Research Inc, 2003, MATH ED VERS 5 0	39	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85925	10.1371/journal.pone.0085925	http://dx.doi.org/10.1371/journal.pone.0085925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465792	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500147
J	Littlejohn, MD; Tiplady, K; Lopdell, T; Law, TA; Scott, A; Harland, C; Sherlock, R; Henty, K; Obolonkin, V; Lehnert, K; MacGibbon, A; Spelman, RJ; Davis, SR; Snell, RG				Littlejohn, Mathew D.; Tiplady, Kathryn; Lopdell, Thomas; Law, Tania A.; Scott, Andrew; Harland, Chad; Sherlock, Ric; Henty, Kristen; Obolonkin, Vlad; Lehnert, Klaus; MacGibbon, Alistair; Spelman, Richard J.; Davis, Stephen R.; Snell, Russell G.			Expression Variants of the Lipogenic AGPAT6 Gene Affect Diverse Milk Composition Phenotypes in Bos taurus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; DAIRY-CATTLE; FERTILITY TRAITS; DGAT1; CARCASS; HEALTH; SCAN; QTL; IDENTIFICATION	Milk is composed of a complex mixture of lipids, proteins, carbohydrates and various vitamins and minerals as a source of nutrition for young mammals. The composition of milk varies between individuals, with lipid composition in particular being highly heritable. Recent reports have highlighted a region of bovine chromosome 27 harbouring variants affecting milk fat percentage and fatty acid content. We aimed to further investigate this locus in two independent cattle populations, consisting of a Holstein-Friesian x Jersey crossbreed pedigree of 711 F2 cows, and a collection of 32,530 mixed ancestry Bos taurus cows. Bayesian genome-wide association mapping using markers imputed from the Illumina BovineHD chip revealed a large quantitative trait locus (QTL) for milk fat percentage on chromosome 27, present in both populations. We also investigated a range of other milk composition phenotypes, and report additional associations at this locus for fat yield, protein percentage and yield, lactose percentage and yield, milk volume, and the proportions of numerous milk fatty acids. We then used mammary RNA sequence data from 212 lactating cows to assess the transcript abundance of genes located in the milk fat percentage QTL interval. This analysis revealed a strong eQTL for AGPAT6, demonstrating that high milk fat percentage genotype is also additively associated with increased expression of the AGPAT6 gene. Finally, we used whole genome sequence data from six F1 sires to target a panel of novel AGPAT6 locus variants for genotyping in the F2 crossbreed population. Association analysis of 58 of these variants revealed highly significant association for polymorphisms mapping to the 5'UTR exons and intron 1 of AGPAT6. Taken together, these data suggest that variants affecting the expression of AGPAT6 are causally involved in differential milk fat synthesis, with pleiotropic consequences for a diverse range of other milk components.	[Littlejohn, Mathew D.; Tiplady, Kathryn; Lopdell, Thomas; Scott, Andrew; Harland, Chad; Sherlock, Ric; Henty, Kristen; Obolonkin, Vlad; Lehnert, Klaus; Spelman, Richard J.; Davis, Stephen R.] Livestock Improvement Corp, Res & Dev, Hamilton, New Zealand; [Law, Tania A.; Henty, Kristen; Lehnert, Klaus; Snell, Russell G.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [MacGibbon, Alistair] Fonterra Res Ctr, Palmerston North, New Zealand	Livestock Improvement Corporation; University of Auckland; Fonterra	Littlejohn, MD (corresponding author), Livestock Improvement Corp, Res & Dev, Hamilton, New Zealand.	mlittlejohn@lic.co.nz	MacGibbon, Alastair Kenneth Hugh/AAE-4692-2022; Lopdell, Thomas John/T-6661-2019	MacGibbon, Alastair Kenneth Hugh/0000-0002-1223-3501; Lopdell, Thomas John/0000-0002-7684-4870; Snell, Russell/0000-0002-8166-4014; Littlejohn, Mathew/0000-0001-9044-047X; Harland, Chad/0000-0002-6268-0107	Ministry for Primary Industries	Ministry for Primary Industries	This work was funded by the Ministry for Primary Industries through the Primary Growth Partnership. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2012, CURR OPIN LIPIDOL, V23, P290, DOI 10.1097/MOL.0b013e328354fcf4; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Berry SD, 2010, NEW ZEAL VET J, V58, P1, DOI 10.1080/00480169.2010.65053; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Berry S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057219; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Casas E, 2000, J ANIM SCI, V78, P560; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernando RL, 2010, GENSEL USER MANUAL P; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gilmour AR, 2009, ASREML USER GUIDE RE; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; *INT DAIR FED, 1987, MILK DET FAT CONT RO; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li X, 2013, MEAT SCI, V94, P153, DOI 10.1016/j.meatsci.2013.01.010; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; Mansson H.L., 2008, FOOD NUTR RES, V52; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Nalaila SM, 2012, J ANIM BREED GENET, V129, P107, DOI 10.1111/j.1439-0388.2011.00954.x; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROOK JAF, 1979, P NUTR SOC, V38, P309, DOI 10.1079/PNS19790053; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Spelman R. J., 2001, Proceedings of the Fourteenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Queenstown, New Zealand, 30 July-2 August 2001, P393; Strucken EM, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-108; Thaller G, 2003, ANIM GENET, V34, P354, DOI 10.1046/j.1365-2052.2003.01011.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Zhang Q, 1998, GENETICS, V149, P1959	45	46	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85757	10.1371/journal.pone.0085757	http://dx.doi.org/10.1371/journal.pone.0085757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465687	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500106
J	Simo, R; Hernandez, C; Saez-Lopez, C; Soldevila, B; Puig-Domingo, M; Selva, DM				Simo, Rafael; Hernandez, Cristina; Saez-Lopez, Cristina; Soldevila, Berta; Puig-Domingo, Manel; Selva, David M.			Thyroid Hormone Upregulates Zinc-alpha(2)-glycoprotein Production in the Liver but Not in Adipose Tissue	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; NECROSIS-FACTOR-ALPHA; ZINC-ALPHA-2-GLYCOPROTEIN; EXPRESSION; ZAG; INDUCTION; LIPOLYSIS; WEIGHT; MICE	Overproduction of zinc-alpha(2)-glycoprotein by adipose tissue is crucial in accounting for the lipolysis occurring in cancer cachexia of certain malignant tumors. The main aim of this study was to explore whether thyroid hormone could enhance zinc-alpha(2)-glycoprotein production in adipose tissue. In addition, the regulation of zinc-alpha(2)-glycoprotein by thyroid hormone in the liver was investigated. We performed in vitro (HepG2 cells and primary human adipocytes) and in vivo (C57BL6/mice) experiments addressed to examine the effect of thyroid hormone on zinc-alpha(2)-glycoprotein production (mRNA and protein levels) in liver and visceral adipose tissue. We also measured the zinc-alpha(2)-glycoprotein serum levels in a cohort of patients before and after controlling their hyperthyroidism. Our results showed that thyroid hormone up-regulates zinc-alpha(2)-glycoprotein production in HepG2 cells in a dose-dependent manner. In addition, the zinc-alpha(2)-glycoprotein proximal promoter contains functional thyroid hormone receptor binding sites that respond to thyroid hormone treatment in luciferase reporter gene assays in HepG2 cells. Furthermore, zinc-alpha(2)-glycoprotein induced lipolysis in HepG2 in a dose-dependent manner. Our in vivo experiments in mice confirmed the up-regulation of zinc-alpha(2)-glycoprotein induced by thyroid hormone in the liver, thus leading to a significant increase in zinc-alpha(2)-glycoprotein circulating levels. However, thyroid hormone did not regulate zinc-alpha(2)-glycoprotein production in either human or mouse adipocytes. Finally, in patients with hyperthyroidism a significant reduction of zinc-alpha(2)-glycoprotein serum levels was detected after treatment but was unrelated to body weight changes. We conclude that thyroid hormone up-regulates the production of zinc-alpha(2)-glycoprotein in the liver but not in the adipose tissue. The neutral effect of thyroid hormones on zinc-alpha(2)-glycoprotein expression in adipose tissue could be the reason why zinc-alpha(2)-glycoprotein is not related to weight loss in hyperthyroidism.	[Simo, Rafael; Hernandez, Cristina; Saez-Lopez, Cristina; Selva, David M.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, Diabet & Metab Res Unit, E-08193 Barcelona, Spain; [Simo, Rafael; Hernandez, Cristina; Saez-Lopez, Cristina; Selva, David M.] CIBERDEM ISCIII, Barcelona, Spain; [Soldevila, Berta; Puig-Domingo, Manel] Univ Autonoma Barcelona, Germans Trias & Pujol Hlth Sci Reseach Inst & Hos, Dept Med, Serv Endocrinol & Nutr, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Autonomous University of Barcelona	Selva, DM (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, Diabet & Metab Res Unit, E-08193 Barcelona, Spain.	david.martinez.selva@vhir.org	Puig-Domingo, Manel/S-2169-2019; Selva, David Martínez/O-6444-2016; Soldevila, Berta/GXV-0551-2022	Puig-Domingo, Manel/0000-0002-6744-7195; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	Instituto de Salud Carlos III [CP08/00058, PI09/144]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by two grants from the Instituto de Salud Carlos III (DMS): CP08/00058 and PI09/144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; Chen CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011270; Flik G, 2009, J CLIN ENDOCR METAB, V94, P4668, DOI 10.1210/jc.2009-2199; Gao D, 2010, MOL CELL ENDOCRINOL, V325, P135, DOI 10.1016/j.mce.2010.05.020; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Grasselli E, 2011, J HEPATOL, V54, P1230, DOI 10.1016/j.jhep.2010.09.027; Hirai K, 1998, CANCER RES, V58, P2359; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ittermann T, 2012, THYROID, V22, P568, DOI 10.1089/thy.2011.0279; Moreno-Navarrete JM, 2013, INT J OBESITY; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Philipp A, 2011, METABOLISM, V60, P669, DOI 10.1016/j.metabol.2010.06.019; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Russell ST, 2011, INT J OBESITY, V35, P658, DOI 10.1038/ijo.2010.193; Russell ST, 2005, PROSTAG LEUKOTR ESS, V72, P409, DOI 10.1016/j.plefa.2005.03.002; Russell ST, 2005, BRIT J CANCER, V92, P876, DOI 10.1038/sj.bjc.6602404; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Todorov PT, 1998, CANCER RES, V58, P2353; Viguerie N, 2002, J CLIN ENDOCR METAB, V87, P630, DOI 10.1210/jc.87.2.630; Yeung DCY, 2009, J CLIN ENDOCR METAB, V94, P2531, DOI 10.1210/jc.2009-0058	29	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85753	10.1371/journal.pone.0085753	http://dx.doi.org/10.1371/journal.pone.0085753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465683	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500104
J	Fan, AR; Wu, XF; Wu, HJ; Li, L; Huang, R; Zhu, YY; Qiu, Y; Fu, J; Ren, J; Zhu, CG				Fan, Angran; Wu, Xiaofeng; Wu, Huijuan; Li, Long; Huang, Rui; Zhu, Yueyong; Qiu, Yan; Fu, Jin; Ren, Jie; Zhu, Chenggang			Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; MUSCLE-CELL PROLIFERATION; CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA ACTIVATORS; BODY-WEIGHT; METABOLIC SYNDROME; NUCLEAR RECEPTORS; SMALL-INTESTINE	Dietary fat-derived lipid oleoylethanolamide (OEA) has shown to modulate lipid metabolism through a peroxisome proliferator-activated receptor-alpha (PPAR-alpha)-mediated mechanism. In our study, we further demonstrated that OEA, as an atheroprotective agent, modulated the atherosclerotic plaques development. In vitro studies showed that OEA antagonized oxidized LDL (ox-LDL)-induced vascular endothelial cell proliferation and vascular smooth muscle cell migration, and suppressed lipopolysaccharide (LPS)-induced LDL modification and inflammation. In vivo studies, atherosclerosis animals were established using balloon-aortic denudation (BAD) rats and ApoE(-/-) mice fed with high-caloric diet (HCD) for 17 or 14 weeks respectively, and atherosclerotic plaques were evaluated by oil red staining. The administration of OEA (5 mg/kg/day, intraperitoneal injection, i.p.) prevented or attenuated the formation of atherosclerotic plaques in HCD-BAD rats or HCD-ApoE(-/-) mice. Gene expression analysis of vessel tissues from these animals showed that OEA induced the mRNA expressions of PPAR-alpha and downregulated the expression of M-CFS, an atherosclerotic marker, and genes involved in oxidation and inflammation, including iNOS, COX-2, TNF-alpha and IL-6. Collectively, our results suggested that OEA exerted a pharmacological effect on modulating atherosclerotic plaque formation through the inhibition of LDL modification in vascular system and therefore be a potential candidate for anti-atherosclerosis drug.	[Fan, Angran; Wu, Xiaofeng; Wu, Huijuan; Li, Long; Huang, Rui; Qiu, Yan; Fu, Jin; Ren, Jie] Xiamen Univ, Dept Med Sci, Coll Med, Xiamen, Fujian, Peoples R China; [Zhu, Yueyong] Fujian Med Univ, Affiliated Hosp 1, Div Liver Dis, Fuzhou, Fujian, Peoples R China; [Zhu, Chenggang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Xiamen University; Fujian Medical University; Fudan University	Ren, J (corresponding author), Xiamen Univ, Dept Med Sci, Coll Med, Xiamen, Fujian, Peoples R China.	renjie_7912@xmu.edu.cn; chenggang.zhu@gmail.com			Fundamental Research Fund for China Universities [2011121059]; National Natural Science Foundation of China [91129722]; Xiamen Science and Technology Program, China [3502Z20113010]	Fundamental Research Fund for China Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology Program, China	This work was supported by the Fundamental Research Fund for China Universities (To JF, No. 2011121059); National Natural Science Foundation of China (To JF, 91129722) and Xiamen Science and Technology Program (To QY, 3502Z20113010), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita G, 2006, J PHARMACOL EXP THER, V318, P563, DOI 10.1124/jpet.106.105221; Babaev VR, 2007, CIRCULATION, V116, P1404, DOI 10.1161/CIRCULATIONAHA.106.684704; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bocher Virginie, 2002, Journal de la Societe de Biologie, V196, P47; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chinetti-Gbaguidi G, 2005, CURR OPIN PHARMACOL, V5, P177, DOI 10.1016/j.coph.2004.11.004; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Gizard F, 2008, CIRC RES, V103, P1155, DOI 10.1161/CIRCRESAHA.108.186205; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Keating GM, 2007, DRUGS, V67, P121, DOI 10.2165/00003495-200767010-00013; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Marx N, 2002, CIRC RES, V90, P703, DOI 10.1161/01.RES.0000014225.20727.8F; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Wagner JD, 2010, J PHARMACOL EXP THER, V333, P844, DOI 10.1124/jpet.110.166736; Yang YK, 2007, AM J PHYSIOL-REG I, V292, pR235, DOI 10.1152/ajpregu.00270.2006; Zahradka P, 2006, J PHARMACOL EXP THER, V317, P651, DOI 10.1124/jpet.105.096271; Zahradka P, 2003, MOL CELL BIOCHEM, V246, P105, DOI 10.1023/A:1023424500160	47	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85337	10.1371/journal.pone.0085337	http://dx.doi.org/10.1371/journal.pone.0085337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465540	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500043
J	Pedersen, BP; Ifrim, G; Liboriussen, P; Axelsen, KB; Palmgren, MG; Nissen, P; Wiuf, C; Pedersen, CNS				Pedersen, Bjorn P.; Ifrim, Georgiana; Liboriussen, Poul; Axelsen, Kristian B.; Palmgren, Michael G.; Nissen, Poul; Wiuf, Carsten; Pedersen, Christian N. S.			Large Scale Identification and Categorization of Protein Sequences Using Structured Logistic Regression	PLOS ONE			English	Article							P-TYPE ATPASES; CRYSTAL-STRUCTURE; TRANSPORT; ORGANIZATION; EVOLUTION; ALIGNMENT; TOPOLOGY; CALCIUM; NA+; CU+	Background: Structured Logistic Regression (SLR) is a newly developed machine learning tool first proposed in the context of text categorization. Current availability of extensive protein sequence databases calls for an automated method to reliably classify sequences and SLR seems well-suited for this task. The classification of P-type ATPases, a large family of ATP-driven membrane pumps transporting essential cations, was selected as a test-case that would generate important biological information as well as provide a proof-of-concept for the application of SLR to a large scale bioinformatics problem. Results: Using SLR, we have built classifiers to identify and automatically categorize P-type ATPases into one of 11 pre-defined classes. The SLR-classifiers are compared to a Hidden Markov Model approach and shown to be highly accurate and scalable. Representing the bulk of currently known sequences, we analysed 9.3 million sequences in the UniProtKB and attempted to classify a large number of P-type ATPases. To examine the distribution of pumps on organisms, we also applied SLR to 1,123 complete genomes from the Entrez genome database. Finally, we analysed the predicted membrane topology of the identified P-type ATPases. Conclusions: Using the SLR-based classification tool we are able to run a large scale study of P-type ATPases. This study provides proof-of-concept for the application of SLR to a bioinformatics problem and the analysis of P-type ATPases pinpoints new and interesting targets for further biochemical characterization and structural analysis.	[Pedersen, Bjorn P.; Liboriussen, Poul; Axelsen, Kristian B.; Palmgren, Michael G.; Nissen, Poul; Pedersen, Christian N. S.] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Aarhus C, Denmark; [Pedersen, Bjorn P.; Nissen, Poul] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Liboriussen, Poul; Pedersen, Christian N. S.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Axelsen, Kristian B.] CMU, Swiss Inst Bioinformat, Swiss Prot Grp, Geneva, Switzerland; [Palmgren, Michael G.] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Wiuf, Carsten] Univ Copenhagen, Dept Math Sci, Copenhagen O, Denmark; [Ifrim, Georgiana] Univ Coll Dublin, INSIGHT Ctr Data Analyt, Dublin 2, Ireland	Danmarks Grundforskningsfond; Aarhus University; Aarhus University; Swiss Institute of Bioinformatics; University of Geneva; University of Copenhagen; University of Copenhagen; University College Dublin	Pedersen, BP (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Aarhus C, Denmark.	bpp@mb.au.dk; cstorm@birc.au.dk	Axelsen, Kristian B/F-3449-2015; Pedersen, Bjørn/AAT-2409-2021; Palmgren, Michael/A-9808-2013; Ifrim, Georgiana/AAE-6438-2020; Pedersen, Bjørn/H-4128-2017; Wiuf, Carsten/H-6320-2011	Axelsen, Kristian B/0000-0003-3889-2879; Pedersen, Bjørn/0000-0001-7860-7230; Palmgren, Michael/0000-0002-9982-6114; Ifrim, Georgiana/0000-0002-8400-2972; Pedersen, Bjørn/0000-0001-7860-7230; Wiuf, Carsten/0000-0002-1302-4445; Nissen, Poul/0000-0003-0948-6628	Carlsberg Foundation; Danish Cancer Society; Science Foundation Ireland INSIGHT Centre for Data Analytics, Science Foundation Ireland grant [10/IN.1/I3032]; Novo Nordisk Foundation; BIOMEMOS advanced research program of the European Research Council	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Science Foundation Ireland INSIGHT Centre for Data Analytics, Science Foundation Ireland grant(Science Foundation Ireland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); BIOMEMOS advanced research program of the European Research Council	BPP was supported by a post-doctoral fellowship from the Carlsberg Foundation and by the Danish Cancer Society. CW was supported by the Danish Cancer Society. GI was supported by Science Foundation Ireland INSIGHT Centre for Data Analytics, Science Foundation Ireland grant 10/IN.1/I3032 and by the Danish Cancer Society. PN was supported by a Hallas-Moller stipend from the Novo Nordisk Foundation and by the BIOMEMOS advanced research program of the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chan H, 2010, J MOL MICROB BIOTECH, V19, P5, DOI 10.1159/000319588; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAGAN MJ, 1994, J MOL EVOL, V38, P57; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ifrim G, 2009, THESIS SAARLAND U GE; Ifrim G., 2008, P 14 ACM SIGKDD INT, P354, DOI [10.1145/1401890.1401936, DOI 10.1145/1401890.1401936]; Ifrim G., 2011, P 17 ACM SIGKDD INT, DOI [10.1145/2020408.2020519, DOI 10.1145/2020408.2020519]; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Ness LS, 1999, J BIOL CHEM, V274, P9524, DOI 10.1074/jbc.274.14.9524; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Rodriguez-Navarro A, 2010, BBA-BIOMEMBRANES, V1798, P1841, DOI 10.1016/j.bbamem.2010.07.009; Saez AG, 2009, GENETICA, V136, P479, DOI 10.1007/s10709-009-9356-0; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Simonsen M, 2011, COMM COM INF SC, V127, P334; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Stiles JK, 2003, ANN TROP MED PARASIT, V97, P351, DOI 10.1179/000349803235002362; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thever MD, 2009, J MEMBRANE BIOL, V229, P115, DOI 10.1007/s00232-009-9176-2; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025	47	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85139	10.1371/journal.pone.0085139	http://dx.doi.org/10.1371/journal.pone.0085139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465495	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500035
J	Vega, FE; Simpkins, A; Bauchan, G; Infante, F; Kramer, M; Land, MF				Vega, Fernando E.; Simpkins, Ann; Bauchan, Gary; Infante, Francisco; Kramer, Matthew; Land, Michael F.			On the Eyes of Male Coffee Berry Borers as Rudimentary Organs	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE SCOLYTINAE; XYLEBORUS-FERRUGINEUS; COMPOUND EYE; BEETLE; ULTRASTRUCTURE; INSECTS	The coffee berry borer, Hypothenemus hampei, is the most damaging insect pest of coffee worldwide. Like males in other species in the genus, male coffee berry borers have a lower number of facets in the compound eyes than females. The rudimentary eyes in male coffee berry borers could be an evolutionary response to their cryptic life habit, whereby they are born inside a coffee berry and never leave the berry. The main objective of the study was to determine if the differences in the number of facets translates into differences in visual acuity. We used low-temperature scanning electron microscopy to visualize and quantify the number of facets in the compound eyes. There was a significantly lower (p<0.0001) number of facets in males (19.1 +/- 4.10) than in females (127.5 +/- 3.88). To assess visual acuity, we conducted optomotor response experiments, which indicate that females respond to movement, while males did not respond under the conditions tested. The coffee berry borer is an example of an insect whereby disuse of an organ has led to a rudimentary compound eye. This is the first study that has experimentally tested responses to movement in bark beetles.	[Vega, Fernando E.; Simpkins, Ann] ARS, Sustainable Perennial Crops Lab, USDA, Beltsville, MD USA; [Bauchan, Gary] ARS, Electron & Confocal Microscopy Unit, USDA, Beltsville, MD USA; [Infante, Francisco] El Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Kramer, Matthew] ARS, Biometr Consulting Serv, USDA, Beltsville, MD USA; [Land, Michael F.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); El Colegio de la Frontera Sur (ECOSUR); United States Department of Agriculture (USDA); University of Sussex	Vega, FE (corresponding author), ARS, Sustainable Perennial Crops Lab, USDA, Beltsville, MD USA.	Fernando.Vega@ars.usda.gov	Bauchan, Gary/ABH-3800-2020; Vega, Fernando E./AAM-5536-2021	Vega, Fernando E./0000-0001-8103-5640; Infante, Francisco/0000-0002-7419-7606; Bauchan, Gary/0000-0003-3060-7666	U.S. Department of Agriculture	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by U.S. Department of Agriculture core funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW HB, 1952, J EXP BIOL, V29, P667; Bell G, 2008, SELECTION: THE MECHANISM OF EVOLUTION, 2ND EDITION, P1; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRIGHT D E, 1981, Coleopterists Bulletin, V35, P117; BROWNE F. G., 1961, MALAYAN FOREST REC, V22, P1; BYERS JA, 1989, J CHEM ECOL, V15, P749, DOI 10.1007/BF01014716; CHAPMAN JA, 1972, ANN ENTOMOL SOC AM, V65, P550, DOI 10.1093/aesa/65.3.550; CHU H, 1975, CELL TISSUE RES, V165, P23; CHU HM, 1976, CELL TISSUE RES, V168, P315; Constantino LM, 2011, REV COLOMB ENTOMOL, V37, P173; Darwin C, 1859, ORIGIN SPECIES MEANS; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hopkins AD, 1909, USDA BUR ENTOMOL TEC, V17, P1; HOULE D, 1992, GENETICS, V130, P195; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Land MF, 2012, OXF ANIMAL BIOL SER, P1; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oliveira CM, 2013, J APPL ENTOMOL, V137, P1, DOI 10.1111/jen.12018; RUSSO GIUSEPPE, 1926, BOLL LAB ZOOL GEN E AGRAR R SCUOLA SUP AGRIC PORTICI, V19, P103; SAS JMP, 2005, JMP STAT GRAPH GUID; Vega F.E., 2004, ENCY ENTOMOLOGY, V1, P575; Vega FE, 2011, J ECON ENTOMOL, V104, P87, DOI 10.1603/EC10353; Vega Fernando E., 2009, Terrestrial Arthropod Reviews, V2, P129; Wood S.L., 2007, BARK AMBROSIA BEETLE	24	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85860	10.1371/journal.pone.0085860	http://dx.doi.org/10.1371/journal.pone.0085860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465752	Green Published, gold			2022-12-27	WOS:000330240500081
J	Wang, J; Guo, XY; Lui, M; Chu, PJ; Yoo, J; Chang, M; Yen, Y				Wang, James; Guo, Xiaoyu; Lui, Monica; Chu, Pei-Ju; Yoo, Jennifer; Chang, Megan; Yen, Yun			Identification of a Distinct Small Cell Population from Human Bone Marrow Reveals Its Multipotency In Vivo and In Vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPORE-LIKE CELLS; ADIPOSE-TISSUE; STROMAL CELLS; SELF-RENEWAL; DIFFERENTIATION; PLURIPOTENCY; NANOG; TRANSPLANTATION; RECEPTORS	Small stem cells, such as spore-like cells, blastomere-like stem cells (BLSCs), and very-small embryonic-like stem cells (VSELs) have been described in recent studies, although their multipotency in human tissues has not yet been confirmed. Here, we report the discovery of adult multipotent stem cells derived from human bone marrow, which we call StemBios (SB) cells. These isolated SB cells are smaller than 6 im and are DAPI+ and Lgr5+ (Leucine-Rich Repeat Containing G Protein-Coupled Receptor 5). Because Lgr5 has been characterized as a stem cell marker in the intestine, we hypothesized that SB cells may have a similar function. In vivo cell tracking assays confirmed that SB cells give rise to three types of cells, and in vitro studies demonstrated that SB cells cultured in proprietary media are able to grow to 6-25 im in size. Once the SB cells have attached to the wells, they differentiate into different cell lineages upon exposure to specific differentiation media. We are the first to demonstrate that stem cells smaller than 6 im can differentiate both in vivo and in vitro. In the future, we hope that SB cells will be used therapeutically to cure degenerative diseases.	[Wang, James; Guo, Xiaoyu; Lui, Monica; Chu, Pei-Ju; Yoo, Jennifer; Chang, Megan] StemBios Technol Inc, Monterey Pk, CA USA		Wang, J (corresponding author), StemBios Technol Inc, Monterey Pk, CA USA.	jwang@stembios.com; yyen@stembios.com	Yen, Yun/H-9591-2016		TriMax SBT LLC of Los Angeles, a venture investment company	TriMax SBT LLC of Los Angeles, a venture investment company	This study was funded by TriMax SBT LLC of Los Angeles, a venture investment company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Danova-Alt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034899; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Frankel MS, 2000, SCIENCE, V287, P1397, DOI 10.1126/science.287.5457.1397; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Havens AM, 2013, STEM CELLS DEV, V22, P622, DOI 10.1089/scd.2012.0327; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Iglesias-Bartolome R, 2011, CURR OPIN CELL BIOL, V23, P716, DOI 10.1016/j.ceb.2011.08.002; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kassmer SH, 2013, MOL REPROD DEV; Katoh Y, 2006, INT J MOL MED, V18, P1019; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Mannon PJ, 2011, EXPERT OPIN BIOL TH, V11, P1249, DOI 10.1517/14712598.2011.602967; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanishi M, 2013, STEM CELL REP, V1, P198, DOI 10.1016/j.stemcr.2013.07.001; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ratajczak MZ, 2008, EXP HEMATOL, V36, P742, DOI 10.1016/j.exphem.2008.03.010; Ratajczak MZ, 2011, DIFFERENTIATION, V81, P153, DOI 10.1016/j.diff.2011.01.006; Sakata N, 2011, WORLD J GASTROENTERO, V17, P5150, DOI 10.3748/wjg.v17.i47.5150; Shin DM, 2012, STEM CELLS DEV, V21, P1639, DOI 10.1089/scd.2011.0389; Shmilovici A, 2007, MED HYPOTHESES, V68, P767, DOI 10.1016/j.mehy.2006.08.044; Slupsky JR, 1997, BRIT J HAEMATOL, V96, P275, DOI 10.1046/j.1365-2141.1997.d01-2011.x; Stout CL, 2007, AM SURGEON, V73, P1106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Vacanti MP, 2001, J CELL BIOCHEM, V80, P455, DOI 10.1002/1097-4644(20010301)80:3<455::AID-JCB180>3.0.CO;2-Z; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Wang J, 2013, US Patent, Patent No. [12391,581 50045-004001, 12391581]; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85112	10.1371/journal.pone.0085112	http://dx.doi.org/10.1371/journal.pone.0085112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465489	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000025
J	Smitson, CC; Tenna, A; Tsegaye, M; Alemu, AS; Fekade, D; Aseffa, A; Blumberg, HM; Kempker, RR				Smitson, Christopher C.; Tenna, Admasu; Tsegaye, Mulugeta; Alemu, Abere S.; Fekade, Daniel; Aseffa, Abraham; Blumberg, Henry M.; Kempker, Russell R.			No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SOUTH-AFRICA; MORTALITY; METAANALYSIS; INDIVIDUALS; GUIDELINES; MORBIDITY	Introduction: There are limited data on clinical outcomes of ART-experienced patients with cryptococcal antigenemia. We assessed clinical outcomes of a predominantly asymptomatic, ART-experienced cohort of HIV+ patients previously found to have a high (8.4%) prevalence of cryptococcal antigenemia. Methods: The study took place at All Africa Leprosy, Tuberculosis and Rehabilitative Training Centre and Black Lion Hospital HIV Clinics in Addis Ababa, Ethiopia. A retrospective study design was used to perform 12-month follow-up of 367 mostly asymptomatic HIV-infected patients (CD4<200 cells/mu l) with high levels of antiretroviral therapy use (74%) who were previously screened for cryptococcal antigenemia. Medical chart abstraction was performed approximately one year after initial screening to obtain data on clinic visit history, ART use, CD4 count, opportunistic infections, and patient outcome. We evaluated the association of cryptococcal antigenemia and a composite poor outcome of death and loss to follow-up using logistic regression. Results: Overall, 323 (88%) patients were alive, 8 (2%) dead, and 36 (10%) lost to follow-up. Among the 31 patients with a positive cryptococcal antigen test (titers >= 1:8) at baseline, 28 were alive (all titers <= 1:512), 1 dead and 2 lost to follow-up (titers >= 1:1024). In multivariate analysis, cryptococcal antigenemia was not predictive of a poor outcome (aOR = 1.3, 95% CI 0.3-4.8). A baseline CD4 count,100 cells/mu l was associated with an increased risk of a poor outcome (aOR 3.0, 95% CI 1.4-6.7) while an increasing CD4 count (aOR 0.1, 95% CI 0.1-0.3) and receiving antiretroviral therapy at last follow-up visit (aOR 0.1, 95% CI 0.02-0.2) were associated with a reduced risk of a poor outcome. Conclusions: Unlike prior ART-naive cohorts, we found that among persons receiving ART and with CD4 counts <200 cells/ml, asymptomatic cryptococcal antigenemia was not predictive of a poor outcome.	[Smitson, Christopher C.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Tenna, Admasu; Fekade, Daniel] Univ Addis Ababa, Dept Med, Div Infect Dis, Addis Ababa, Ethiopia; [Tsegaye, Mulugeta] All Africa Leprosy TB & Rehabil Training Ctr, Addis Ababa, Ethiopia; [Alemu, Abere S.] Haramya Univ, Harar, Ethiopia; [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Blumberg, Henry M.; Kempker, Russell R.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	University of California System; University of California San Francisco; Addis Ababa University; Haramaya University; Emory University	Smitson, CC (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA.	chrissmitson@gmail.com; kadmasen@gmail.com	Kempker, Russell/F-5776-2017; Aseffa, Abraham/J-3248-2016; Blumberg, Henry/W-2156-2019; hlupeni, admire/M-1539-2018	Aseffa, Abraham/0000-0002-8028-1150; Blumberg, Henry/0000-0002-3110-2443; Mamuye, Admasu Tenna/0000-0002-9882-9989	NIH NIAID [K23AI103044]; NIH Fogarty International Center [D43TW009127-01A1]; Infectious Diseases Society of America Medical Scholars Program; Emory University Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Infectious Diseases Society of America Medical Scholars Program; Emory University Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by NIH NIAID (K23AI103044), NIH Fogarty International Center (D43TW009127-01A1), Infectious Diseases Society of America Medical Scholars Program, and Emory University Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Beck EJ, 1999, AIDS, V13, P2157, DOI 10.1097/00002030-199910220-00020; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hosmer D. W., 2000, LOGISTIC REGRESSION; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Jordan R, 2002, BMJ-BRIT MED J, V324, P757, DOI 10.1136/bmj.324.7340.757; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	22	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85698	10.1371/journal.pone.0085698	http://dx.doi.org/10.1371/journal.pone.0085698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465651	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500092
J	Han, HY; Xu, DW; Liu, C; Claesson, HE; Bjorkholm, M; Sjoberg, J				Han, Hongya; Xu, Dawei; Liu, Cheng; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan			Interleukin-4-Mediated 15-Lipoxygenase-1 Trans-Activation Requires UTX Recruitment and H3K27me3 Demethylation at the Promoter in A549 Cells	PLOS ONE			English	Article							CLASSICAL HODGKIN LYMPHOMA; COLORECTAL-CANCER; MONOCYTE 15-LIPOXYGENASE; EPITHELIAL-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; METHYLATION; INDUCTION; POLYCOMB; APOPTOSIS	Arachidonate 15-lipoxygenase-1 (ALOX15) oxygenates polyunsaturated fatty acids and bio-membranes, generating multiple lipid signalling mediators involved in inflammation. Several lines of evidence indicate that ALOX15 activation in the respiratory tract contributes to asthma progression. Recent experimental data reveals that histone modification at the promoter plays a critical role in ALOX15 gene transcription. In the present study, we examined the status of histone H3 trimethyl-lysine 27 (H3K27me3) at the ALOX15 promoter by chromatin immunoprecipitation assay in human lung epithelial carcinoma A549 cells incubated with or without interleukin (IL)-4. We identified demethylation of H3K27me3 at the ALOX15 promoter after IL-4 treatment. Furthermore, we found that the H3K27me2/3-specific demethylase, ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX), mediates the H3K27me3 demethylation during ALOX15 transcriptional activation. When UTX expression was knocked down using siRNA, IL-4-mediated H3K27me3 demethylation and ALOX15 induction were significantly attenuated. The critical role of UTX in ALOX15 expression was confirmed in human monocytes and the Hodgkin lymphoma (HL) cell line L1236, but was in these cells not related to H3K27me3-demethylase activity. These results demonstrate that UTX is implicated in IL-4 mediated transcriptional activation of the ALOX15 gene.	[Han, Hongya; Xu, Dawei; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden; [Han, Hongya; Xu, Dawei; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Inst, Stockholm, Sweden; [Liu, Cheng] Shandong Univ, Dept Urol, Qilu Hosp, Jinan 250100, Peoples R China	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Shandong University	Han, HY (corresponding author), Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden.	Ya.Han@ki.se		Claesson, Hans-Erik/0000-0002-1960-6542; Xu, Dawei/0000-0003-3141-4524	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from the Swedish Cancer Society and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Bhattacharjee A, 2010, J IMMUNOL, V185, P5211, DOI 10.4049/jimmunol.1000514; Brinckmann R, 1996, BIOCHEM J, V318, P305, DOI 10.1042/bj3180305; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; Claesson HE, 2008, FEBS J, V275, P4222, DOI 10.1111/j.1742-4658.2008.06570.x; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Hennig R, 2007, NEOPLASIA, V9, P917, DOI 10.1593/neo.07565; Heslin MJ, 2005, ANN SURG, V241, P941, DOI 10.1097/01.sla.0000164177.95620.c1; Hsi LC, 2004, CANCER RES, V64, P8778, DOI 10.1158/0008-5472.CAN-04-1867; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kelavkar U, 1998, MOL BIOL REP, V25, P173, DOI 10.1023/A:1006813009006; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052703; Liu C, 2012, EXP CELL RES, V318, P169, DOI 10.1016/j.yexcr.2011.10.017; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Satoh Takeshi, 2013, Methods Mol Biol, V960, P401, DOI 10.1007/978-1-62703-218-6_30; Schewe T, 2002, BIOL CHEM, V383, P365, DOI 10.1515/BC.2002.041; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Shureiqi I, 2001, CANCER RES, V61, P4879; Skinnider BF, 2002, LEUKEMIA LYMPHOMA, V43, P1203, DOI 10.1080/10428190290026259; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Xu DW, 1998, BRIT J HAEMATOL, V102, P1367, DOI 10.1046/j.1365-2141.1998.00969.x; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhao JM, 2009, AM J RESP CRIT CARE, V179, P782, DOI 10.1164/rccm.200811-1744OC; Zuo XS, 2008, J BIOL CHEM, V283, P31341, DOI 10.1074/jbc.M803729200	43	13	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85085	10.1371/journal.pone.0085085	http://dx.doi.org/10.1371/journal.pone.0085085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465480	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500030
J	Lorente, G; Syriani, E; Morales, M				Lorente, Gisela; Syriani, Emilio; Morales, Miguel			Actin Filaments at the Leading Edge of Cancer Cells Are Characterized by a High Mobile Fraction and Turnover Regulation by Profilin I	PLOS ONE			English	Article							ENA/VASP PROTEINS; BINDING-SITE; MOTILITY; RICH; OVEREXPRESSION; MIGRATION; MICROFILAMENTS; IDENTIFICATION; LAMELLIPODIN; ACTIVATION	Cellular motility is the basis for cancer cell invasion and metastasis. In the case of breast cancer, the most common type of cancer among women, metastasis represents the most devastating stage of the disease. The central role of cellular motility in cancer development emphasizes the importance of understanding the specific mechanisms involved in this process. In this context, tumor development and metastasis would be the consequence of a loss or defect of the mechanisms that control cytoskeletal remodeling. Profilin I belongs to a family of small actin binding proteins that are thought to assist in actin filament elongation at the leading edge of migrating cells. Traditionally, Profilin I has been considered to be an essential control element for actin polymerization and cell migration. Expression of Profilin I is down-regulated in breast and various other cancer cells. In MDA-MB-231 cells, a breast cancer cell line, further inhibition of Profilin I expression promotes hypermotility and metastatic spread, a finding that contrasts with the proposed role of Profilin in enhancing polymerization. In this report, we have taken advantage of the fluorescence recovery after photobleaching (FRAP) of GFP-actin to quantify and compare actin dynamics at the leading edge level in both cancer and non-cancer cell models. Our results suggest that (i) a high level of actin dynamics (i. e., a large mobile fraction of actin filaments and a fast turnover) is a common characteristic of some cancer cells; (ii) actin polymerization shows a high degree of independence from the presence of extracellular growth factors; and (iii) our results also corroborate the role of Profilin I in regulating actin polymerization, as raising the intracellular levels of Profilin I decreased the mobile fraction ratio of actin filaments and slowed their polymerization rate; furthermore, increased Profilin levels also led to reduced individual cell velocity and directionality.	[Lorente, Gisela] Univ Barcelona, Neurophysiol Lab, Deptartment Physiol Sci 1, Sch Med, Barcelona, Spain; [Syriani, Emilio; Morales, Miguel] CIBIR Piqueras 98, Struct Synapt Plast Lab, Dept Neurodegenerat Dis, Logrono, La Rioja, Spain	University of Barcelona	Morales, M (corresponding author), CIBIR Piqueras 98, Struct Synapt Plast Lab, Dept Neurodegenerat Dis, Logrono, La Rioja, Spain.	miguelmorales@spineup.es	Morales, Miguel/G-8995-2014	Morales, Miguel/0000-0002-8885-2333	Spanish Ministry of Research [SAF2010-16024, BFU 2012-17537]; Fundacion Rioja funds; Universidad de Barcelona	Spanish Ministry of Research(Spanish Government); Fundacion Rioja funds; Universidad de Barcelona	This work was supported by grants from the Spanish Ministry of Research (SAF2010-16024; BFU 2012-17537; ONCE 2010 and 2011) and Fundacion Rioja funds. GL was fellowship holder of the Universidad de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bollig-Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017959; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; BUTTON E, 1995, CELL MOTIL CYTOSKEL, V30, P247, DOI 10.1002/cm.970300402; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Ding ZJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3433; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GEY GO, 1952, CANCER RES, V12, P264; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Ho A, 2001, CANCER RES, V61, P474; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Kovar DR, 2006, CURR BIOL, V16, pR535, DOI 10.1016/j.cub.2006.06.039; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; Miki H, 1999, J BIOL CHEM, V274, P27605, DOI 10.1074/jbc.274.39.27605; Mimuro H, 2000, J BIOL CHEM, V275, P28893, DOI 10.1074/jbc.M003882200; Moldovan NI, 1997, CURR BIOL, V7, P24, DOI 10.1016/S0960-9822(06)00024-8; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Neely MD, 1997, P ROY SOC B-BIOL SCI, V264, P1701, DOI 10.1098/rspb.1997.0236; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Yao W, 2013, CURR MOL MED, V13, P417; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038; Zou L, 2009, CELL MOTIL CYTOSKEL, V66, P1048, DOI 10.1002/cm.20407	63	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85817	10.1371/journal.pone.0085817	http://dx.doi.org/10.1371/journal.pone.0085817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465723	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000065
J	Worm, BS; Buch, SV				Worm, Bjarne Skjodt; Buch, Steen Vigh			Does Competition Work as a Motivating Factor in E-Learning? A Randomized Controlled Trial	PLOS ONE			English	Article								Background and Aims:Examinations today are often computerized and the primary motivation and curriculum is often based on the examinations. This study aims to test if competition widgets in e-learning quiz modules improve post-test and follow-up test results and self-evaluation. The secondary aim is to evaluate improvements during the training period comparing test-results and number of tests taken. Methods: Two groups were randomly assigned to either a quiz-module with competition widgets or a module without. Pre-, post-and follow up test-results were recorded. Time used within the modules was measured and students reported time studying. Students were able to choose questions from former examinations in the quiz-module. Results: Students from the competing group were significantly better at both post-and follow-up-test and had a significantly better overall learning efficiency than those from the non-competing group. They were also significantly better at guessing their post-test results. Conclusion: Quiz modules with competition widgets motivate students to become more active during the module and stimulate better total efficiency. They also generate improved self-awareness regarding post-test-results.	[Worm, Bjarne Skjodt] Univ Copenhagen, Bispebjerg Hosp, Dept Anesthesia & Intens Care, DK-1168 Copenhagen, Denmark; [Buch, Steen Vigh] Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen	Worm, BS (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Anesthesia & Intens Care, DK-1168 Copenhagen, Denmark.	bsworm@gmail.com						Chan TS, 1999, J EDUC COMPUT RES, V21, P151, DOI 10.2190/UJ04-T5YB-YFXE-0BG2; Charlier N, 2013, J SCHOOL HEALTH, V83, P493, DOI 10.1111/josh.12057; Coakley J.J., 1994, SPORT SOC ISSUES CON; Deci E. L., 2002, HDB SELF DETERMINATI; Dettmer JW, 2005, PSA J, V71, P36; Graham PJ, 1976, INT C PHYS ACT SCI; Johnson D, 1994, J PROFESSIONAL ISSUE, V25, P8; Johnson D.W., 1998, LEARNING TOGETHER AL; Kelly S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-32; Kim S, 2011, SENSORS-BASEL, V11, P7835, DOI 10.3390/s110807835; Kolb AY, 2005, ACAD MANAG LEARN EDU, V4, P193, DOI 10.5465/AMLE.2005.17268566; Malone T.W., 1987, APTITUDE LEARNING IN, V1st ed., P223, DOI [10.4324/9781003163244, DOI 10.4324/9781003163244]; MCNERGNEY RF, 1994, J TEACH EDUC, V45, P339, DOI 10.1177/0022487194045005006; Rabinowitz HK, 2001, ACAD MED, V76, P587, DOI 10.1097/00001888-200106000-00007; Smith R., 1982, LEARNING LEARN APPL; van Bruggen L, 2012, PERSPECT MED EDUC, V1, P162, DOI 10.1007/s40037-012-0024-1; White CB, 2010, ADV HEALTH SCI EDUC, V15, P469, DOI 10.1007/s10459-009-9211-1; Worm BS, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.21877; Worm BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073336; Yo FY, 2008, CYBERPSYCHOLOGY BEHA, V11, P511; Yousefy Alireza, 2012, J Educ Health Promot, V1, P4, DOI 10.4103/2277-9531.94412	21	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85434	10.1371/journal.pone.0085434	http://dx.doi.org/10.1371/journal.pone.0085434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465561	gold, Green Submitted, Green Published			2022-12-27	WOS:000330237000034
J	Zhu, HG; Russell, RA; Saunders, LJ; Ceccon, S; Garway-Heath, DF; Crabb, DP				Zhu, Haogang; Russell, Richard A.; Saunders, Luke J.; Ceccon, Stefano; Garway-Heath, David F.; Crabb, David P.			Detecting Changes in Retinal Function: Analysis with Non-Stationary Weibull Error Regression and Spatial Enhancement (ANSWERS)	PLOS ONE			English	Article							VISUAL-FIELD PROGRESSION; GLAUCOMA; VARIABILITY; SENSITIVITY; PERIMETRY; DISEASE; SERIES; TIME	Visual fields measured with standard automated perimetry are a benchmark test for determining retinal function in ocular pathologies such as glaucoma. Their monitoring over time is crucial in detecting change in disease course and, therefore, in prompting clinical intervention and defining endpoints in clinical trials of new therapies. However, conventional change detection methods do not take into account non-stationary measurement variability or spatial correlation present in these measures. An inferential statistical model, denoted 'analysis with Non-Stationary Weibull Error Regression and Spatial enhancement' (ANSWERS), was proposed. In contrast to commonly used ordinary linear regression models, which assume normally distributed errors, ANSWERS incorporates non-stationary variability modelled as a mixture of Weibull distributions. Spatial correlation of measurements was also included into the model using a Bayesian framework. It was evaluated using a large dataset of visual field measurements acquired from electronic health records, and was compared with other widely used methods for detecting deterioration in retinal function. ANSWERS was able to detect deterioration significantly earlier than conventional methods, at matched false positive rates. Statistical sensitivity in detecting deterioration was also significantly better, especially in short time series. Furthermore, the spatial correlation utilised in ANSWERS was shown to improve the ability to detect deterioration, compared to equivalent models without spatial correlation, especially in short follow-up series. ANSWERS is a new efficient method for detecting changes in retinal function. It allows for better detection of change, more efficient endpoints and can potentially shorten the time in clinical trials for new therapies.	[Zhu, Haogang; Russell, Richard A.; Saunders, Luke J.; Ceccon, Stefano; Crabb, David P.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Zhu, Haogang; Garway-Heath, David F.] UCL, Inst Ophthalmol, London, England; [Garway-Heath, David F.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr Ophthalmol, London, England; [Garway-Heath, David F.] UCL Inst Ophthalmol, London, England	City University London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Zhu, HG (corresponding author), City Univ London, Sch Hlth Sci, London EC1V 0HB, England.	haogangzhu@gmail.com		Crabb, David/0000-0001-8754-3902; Garway-Heath, David/0000-0003-2907-6992	National Institute for Health Research, National Health Service, United Kingdom; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-081, 11/129/245] Funding Source: researchfish	National Institute for Health Research, National Health Service, United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from a Research Fellow Award supported by the National Institute for Health Research, National Health Service, United Kingdom. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Artes PH, 2008, OPTOMETRY VISION SCI, V85, P380, DOI 10.1097/OPX.0b013e31817882ee; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Asaoka R, 2012, INVEST OPHTH VIS SCI, V53, P8396, DOI 10.1167/iovs.12-9794; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BIRCH MK, 1995, OPHTHALMOLOGY, V102, P1227, DOI 10.1016/S0161-6420(95)30885-8; BISHOP CM, 1996, NEURAL NETWORK PATTE; Bogachev MI, 2009, PHYSIOL MEAS, V30, P631, DOI 10.1088/0967-3334/30/7/008; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; CHAUHAN BC, 1990, INVEST OPHTH VIS SCI, V31, P512; Crabb DP, 1997, OPHTHALMOLOGY, V104, P517, DOI 10.1016/S0161-6420(97)30281-4; Cramer AO, 2013, CURR GENE THER, V13, P139; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Gardiner SK, 2002, INVEST OPHTH VIS SCI, V43, P1400; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P81, DOI 10.1001/archopht.1989.01070010083032; Heijl A, 2003, ACTA OPHTHALMOL SCAN, V81, P286, DOI 10.1034/j.1600-0420.2003.00070.x; Henson DB, 2000, INVEST OPHTH VIS SCI, V41, P417; Katz J, 1997, OPHTHALMOLOGY, V104, P1017, DOI 10.1016/S0161-6420(97)30192-4; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Malik R, 2006, VISION RES, V46, P2956, DOI 10.1016/j.visres.2006.03.004; McNeill A, 2013, MOL GENET METAB, V109, P221, DOI 10.1016/j.ymgme.2013.04.001; Morgan JE, 2012, CLIN EXP OPHTHALMOL, V40, P364, DOI 10.1111/j.1442-9071.2012.02789.x; Oliveira C, 2012, SEMIN OPHTHALMOL, V27, P187, DOI 10.3109/08820538.2012.708808; Patel PJ, 2011, INVEST OPHTH VIS SCI, V52, P3089, DOI 10.1167/iovs.10-6208; Patterson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1659, DOI 10.1167/iovs.04-0953; Pizzarello L, 2004, ARCH OPHTHALMOL-CHIC, V122, P615, DOI 10.1001/archopht.122.4.615; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Redmond T, 2010, INVEST OPHTH VIS SCI, V51, P6540, DOI 10.1167/iovs.10-5718; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; Smith SD, 1996, INVEST OPHTH VIS SCI, V37, P1419; Strouthidis NG, 2007, INVEST OPHTH VIS SCI, V48, P251, DOI 10.1167/iovs.06-0576; Strouthidis NG, 2006, INVEST OPHTH VIS SCI, V47, P5356, DOI 10.1167/iovs.05-1660; Swanson WH, 2000, OPHTHALMOLOGY, V107, P1950, DOI 10.1016/S0161-6420(00)00356-0; Swift S, 2002, ARTIF INTELL MED, V24, P5, DOI 10.1016/S0933-3657(01)00095-1; Tanna AP, 2011, OPHTHALMOLOGY, V118, P60, DOI 10.1016/j.ophtha.2010.04.038; TIERNEY L, 1986, J AM STAT ASSOC, V81, P82, DOI 10.2307/2287970; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Tucker A, 2005, ARTIF INTELL MED, V34, P163, DOI 10.1016/j.artmed.2004.07.004; Turin TC, 2011, CLIN J AM SOC NEPHRO, V6, P1805, DOI 10.2215/CJN.05950611; Viswanathan AC, 2003, BRIT J OPHTHALMOL, V87, P726, DOI 10.1136/bjo.87.6.726; Westcott MC, 2002, BRIT J OPHTHALMOL, V86, P761, DOI 10.1136/bjo.86.7.761; WILD JM, 1989, ACTA OPHTHALMOL, V67, P537	46	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85654	10.1371/journal.pone.0085654	http://dx.doi.org/10.1371/journal.pone.0085654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465636	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330237000049
J	Guo, RN; Lin, JY; Li, LH; Ke, CW; He, JF; Zhong, HJ; Zhou, HQ; Peng, ZQ; Yang, F; Liang, WJ				Guo, Ru-ning; Lin, Jin-yan; Li, Lin-hui; Ke, Chang-wen; He, Jian-feng; Zhong, Hao-jie; Zhou, Hui-qiong; Peng, Zhi-qiang; Yang, Fen; Liang, Wen-jia			The Prevalence and Endemic Nature of Dengue Infections in Guangdong, South China: An Epidemiological, Serological, and Etiological Study from 2005-2011	PLOS ONE			English	Article							VIRUS; SEROPREVALENCE; GUANGZHOU; FEVER; REEMERGENCE; CHILDREN	Objectives: Frequent outbreaks of dengue are considered to be associated with an increased risk for endemicity of the disease. The occurrence of a large number of indigenous dengue cases in consecutive years indicates the epidemic pattern in Guangdong, China. Methods: To have a clear understanding of the current dengue epidemic, a retrospective study of epidemiological profile, serological response, and virological features of dengue infections from 2005-2011 was conducted. Case data were collected from the National Notifiable Infectious Diseases Reporting Network. Serum samples were collected and prepared for serological verification and etiological confirmation. Incidence, temporal and spatial distribution, and the clinical manifestation of dengue infections were analyzed. Pearson's Chi-Square test was used to compare incidences between different age groups. A seroprevalence survey was implemented in local healthy inhabitants to obtain the overall positive rate for the specific immunoglobulin (Ig) G antibody against dengue virus (DENV). Results: The overall annual incidence rate was 1.87/100000. A significant difference was found in age-specific incidence (Pearson's Chi-Square value 498.008, P<0.001). Children under 5 years of age had the lowest incidence of 0.28/100000. The vast majority of cases presented with a mild manifestation typical to dengue fever. The overall seroprevalence of dengue IgG antibody in local populations was 2.43% (range 0.28%-5.42%). DENV-1 was the predominant serotype in circulation through the years, while all 4 serotypes were identified in indigenous patients from different outbreak localities since 2009. Conclusions: A gradual change in the epidemic pattern of dengue infection has been observed in recent years in Guangdong. With the endemic nature of dengue infections, the transition from a monotypic to a multitypic circulation of dengue virus in the last several years will have an important bearing on the prevention and control of dengue in the province and in the neighboring districts.	[Guo, Ru-ning; Li, Lin-hui] Ctr Dis Control & Prevent Guangdong Prov, Publ Hlth Emergency Management Off, Guangzhou, Guangdong, Peoples R China; [Lin, Jin-yan] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ke, Chang-wen; Zhou, Hui-qiong] Ctr Dis Control & Prevent Guangdong Prov, Inst Pathogen Microorganisms, Guangzhou, Guangdong, Peoples R China; [He, Jian-feng; Zhong, Hao-jie; Peng, Zhi-qiang; Yang, Fen; Liang, Wen-jia] Ctr Dis Control & Prevent Guangdong Prov, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China		He, JF (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China.	hjf_2003@163.com	Zhou, Huiqiong/S-1276-2016	Zhou, Huiqiong/0000-0003-2124-6563	Research Base of Key Laboratory of Surveillance and Early-warning on Infectious Disease in China CDC, Health department of Guangdong province [C2012017]; Public Health Emergency Management and Filed Epidemiology Training Program of key medical subjects of 'Twelfth Five Year Plan' in Guangdong, China	Research Base of Key Laboratory of Surveillance and Early-warning on Infectious Disease in China CDC, Health department of Guangdong province; Public Health Emergency Management and Filed Epidemiology Training Program of key medical subjects of 'Twelfth Five Year Plan' in Guangdong, China	The study was supported by Research Base of Key Laboratory of Surveillance and Early-warning on Infectious Disease in China CDC, Health department of Guangdong province (project number: C2012017), and also supported by Public Health Emergency Management and Filed Epidemiology Training Program of key medical subjects of 'Twelfth Five Year Plan' in Guangdong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Huang MT, 1981, ACTA MICROBIOLOGICA, V21, P239; Iturrino-Monge R, 2006, REV PANAM SALUD PUBL, V20, P39, DOI 10.1590/S1020-49892006000700005; Jian-Feng H., 2007, DENGUE B, P31; Jiang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-125; Jin Y, 2009, CHIN J MICROBIOL IMM, V29, P121; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lo CL, 2013, TROP MED INT HLTH; Luo Huiming, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P427; LUO L, 2002, ZHONGHUA LIU XING BI, V29, P203; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; McBride WJH, 2010, INTERN MED J, V40, P247, DOI 10.1111/j.1445-5994.2010.02196.x; Ocazionez Raquel E, 2007, Rev. salud pública, V9, P262, DOI 10.1590/S0124-00642007000200010; Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Siddiqui FJ, 2009, J INFECT DEV COUNTR, V3, P306; Vairo F, 2012, INT J INFECT DIS, V16, pE44, DOI 10.1016/j.ijid.2011.09.018; Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Yamashiro T, 2004, AM J TROP MED HYG, V71, P138, DOI 10.4269/ajtmh.2004.71.138; Yang F, 2007, 2006 S CHINA J PREVE, V33, P8; Zhang Fu-chun, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P421; Zhao H, 2012, J VIROL, V86, P7021, DOI 10.1128/JVI.00858-12; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617; Zheng Kui, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P382; Zhou HuiQiong, 2006, Chinese Journal of Zoonoses, V22, P665	33	47	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85596	10.1371/journal.pone.0085596	http://dx.doi.org/10.1371/journal.pone.0085596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465613	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000018
J	Cha, PH; Shin, W; Zahoor, M; Kim, HY; Min, DS; Choi, KY				Cha, Pu-Hyeon; Shin, Wookjin; Zahoor, Muhammad; Kim, Hyun-Yi; Min, Do Sik; Choi, Kang-Yell			Hovenia dulcis Thunb Extract and Its Ingredient Methyl Vanillate Activate Wnt/beta-Catenin Pathway and Increase Bone Mass in Growing or Ovariectomized Mice	PLOS ONE			English	Article							BETA-CATENIN; VERTEBRAL FRACTURES; OSTEOPOROSIS; CONSTITUENTS; TERIPARATIDE; GROWTH; BISPHOSPHONATES; DIFFERENTIATION; OSTEOSARCOMAS; ALENDRONATE	The Wnt/beta-catenin pathway is a potential target for development of anabolic agents to treat osteoporosis because of its role in osteoblast differentiation and bone formation. However, there is no clinically available anti-osteoporosis drug that targets this Wnt/beta-catenin pathway. In this study, we screened a library of aqueous extracts of 350 plants and identified Hovenia dulcis Thunb (HDT) extract as a Wnt/beta-catenin pathway activator. HDT extract induced osteogenic differentiation of calvarial osteoblasts without cytotoxicity. In addition, HDT extract increased femoral bone mass without inducing significant weight changes in normal mice. In addition, thickness and area of femoral cortical bone were also significantly increased by the HDT extract. Methyl vanillate (MV), one of the ingredients in HDT, also activated the Wnt/beta-catenin pathway and induced osteoblast differentiation in vitro. MV rescued trabecular or cortical femoral bone loss in the ovariectomized mice without inducing any significant weight changes or abnormality in liver tissue when administrated orally. Thus, natural HDT extract and its ingredient MV are potential anabolic agents for treating osteoporosis.	[Cha, Pu-Hyeon; Shin, Wookjin; Zahoor, Muhammad; Kim, Hyun-Yi; Min, Do Sik; Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Cha, Pu-Hyeon; Shin, Wookjin; Zahoor, Muhammad; Kim, Hyun-Yi; Choi, Kang-Yell] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea	Yonsei University; Yonsei University; Pusan National University	Choi, KY (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea.	kychoi@yonsei.ac.kr	cha, puhyeon/ABA-7719-2020		National Research Foundation (NRF); Ministry of Future Creation and Science (MFCS) of Korea; Mid-career Researcher Program [2012R1A2A1A01010285]; Translational Research Center for Protein Function Control; Stem Research Project [2010-0020235]; Ministry of Knowledge Economy through the Korea Research Institute of Chemical Technology [SI-095];  [2009-0083522]	National Research Foundation (NRF); Ministry of Future Creation and Science (MFCS) of Korea; Mid-career Researcher Program; Translational Research Center for Protein Function Control; Stem Research Project; Ministry of Knowledge Economy through the Korea Research Institute of Chemical Technology(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); 	This work was supported by grants from the National Research Foundation (NRF), funded by the Ministry of Future Creation and Science (MFCS) of Korea; Mid-career Researcher Program (2012R1A2A1A01010285), Translational Research Center for Protein Function Control; (2009-0083522), and Stem Research Project (2010-0020235). This work was also partly supported by a grant from the Ministry of Knowledge Economy through the Korea Research Institute of Chemical Technology (SI-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioka M, 2013, BIOCHEM BIOPH RES CO; Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/JBMR.090105, 10.1359/jbmr.090105]; Bouxsein ML, 2009, J BONE JOINT SURG AM, V91A, P1329, DOI 10.2106/JBJS.H.01030; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Chen Shao-hong, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1094; Cheng MJ, 2008, J CHIL CHEM SOC, V53, P1631, DOI 10.4067/S0717-97072008000300019; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Ding L. S., 1997, Yaoxue Xuebao, V32, P600; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Gadelha APR, 2005, PARASITOL RES, V97, P399, DOI 10.1007/s00436-005-1476-6; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; HUSSAIN RA, 1990, J ETHNOPHARMACOL, V28, P103, DOI 10.1016/0378-8741(90)90067-4; Hyun TK, 2010, PLANTA MED, V76, P943, DOI 10.1055/s-0030-1249776; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Khan AW, 2006, J OBSTET GYNAECOL CA, V28, P136, DOI 10.1016/S1701-2163(16)32063-1; Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009; Kloen P, 1997, CANCER, V80, P2230; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li G, 2005, ARCH PHARM RES, V28, P804, DOI 10.1007/BF02977346; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lories RJU, 2007, ARTHRITIS RHEUM-US, V56, P4095, DOI 10.1002/art.23137; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McGrath H, 1996, NEW ENGL J MED, V334, P734; Pei SJ, 2001, PHARM BIOL, V39, P74, DOI [10.1076/phbi.39.s1.74.0005, 10.1076/phbi.39.7.74.5869]; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Sawadogo WR, 2012, BIOCHEM PHARMACOL, V84, P1225, DOI 10.1016/j.bcp.2012.07.021; Seeman E, 2009, CRIT REV EUKAR GENE, V19, P219, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.40; Sibai T, 2011, CLIN ORTHOP RELAT R, V469, P2215, DOI 10.1007/s11999-010-1722-9; Tai A, 2012, BIOSCI BIOTECH BIOCH, V76, P314, DOI 10.1271/bbb.110700; Tang DZ, 2010, J BONE MINER RES, V25, P1234, DOI 10.1002/jbmr.21; Tashjian AH, 2006, J BONE MINER RES, V21, P354, DOI 10.1359/JBMR.051023; Trivedi R, 2008, MOL CELL ENDOCRINOL, V289, P85, DOI 10.1016/j.mce.2008.02.027; Vasudeva N, 2012, CHIN J INTEGR MED, V18, P473, DOI 10.1007/s11655-012-1120-0; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yang SP, 2012, ACTA PHARMACOL SIN, V33, P1147, DOI 10.1038/aps.2012.105; YOSHIKAWA K, 1993, PHYTOCHEMISTRY, V34, P1431, DOI 10.1016/0031-9422(91)80044-2; Yoshikawa M, 1997, YAKUGAKU ZASSHI, V117, P108, DOI 10.1248/yakushi1947.117.2_108; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; YUNCHOI HS, 1987, J NAT PROD, V50, P1059, DOI 10.1021/np50054a008; Zhang JH, 2012, COMPLEMENT THER MED, V20, P100, DOI 10.1016/j.ctim.2011.09.004	49	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85546	10.1371/journal.pone.0085546	http://dx.doi.org/10.1371/journal.pone.0085546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465596	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100046
J	Kwon, SK; Kim, HB; Song, JJ; Cho, CG; Park, SW; Choi, JS; Ryu, J; Oh, SH; Lee, JH				Kwon, Seong Keun; Kim, Hee-Bok; Song, Jae-Jun; Cho, Chang Gun; Park, Seok-Won; Choi, Jong-Sun; Ryu, Junsun; Oh, Se Heang; Lee, Jin Ho			Vocal Fold Augmentation with Injectable Polycaprolactone Microspheres/Pluronic F127 Hydrogel: Long-Term In Vivo Study for the Treatment of Glottal Insufficiency	PLOS ONE			English	Article							INJECTION LARYNGOPLASTY; INTRAPERITONEAL BARRIER; COLLAGEN INJECTION; CELL CARRIER; PREVENTION; PARALYSIS; SCAFFOLDS; VIBRATION; ADHESION; COMPLICATIONS	There is increasing demand for reconstruction of glottal insufficiency. Several injection materials have been examined for this purpose, but all had limitations, such as poor long-term durability, migration from the injection site, inflammation, granuloma formation, and interference with vocal fold vibration due to viscoelastic mismatch. Here, we developed a novel injection material, consisting of polycaprolactone (PCL) microspheres, which exhibits better viscoelasticity than conventional materials, and Pluronic F127 carrier, which decreases the migration of the injection materials. The material was injected into rabbits with glottal insufficiency and compared with the FDA-approved injection material, calcium hydroxylapatite (CaHA). Endoscopic and histological examinations indicated that PCL/Pluronic F127 remained at the injection site with no inflammatory response or granuloma formation, whereas CaHA leaked out and migrated from the injection site. Therefore, vocal fold augmentation was almost completely retained during the 12-month follow-up period in this study. Moreover, induced phonation and high-speed recording of vocal fold vibration showed decreased vocal fold gap area in the PCL/Pluronic F127 group. Our newly developed injection material, PCL/Pluronic F127, permits efficient augmentation of paralyzed vocal fold without complications, a concept that can be applied clinically, as demonstrated by the successful long-term follow-up.	[Kwon, Seong Keun] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul 110744, South Korea; [Kwon, Seong Keun] Canc Res Inst, Seoul, South Korea; [Kwon, Seong Keun] Seoul Natl Univ, Med Res Ctr, Seoul, South Korea; [Kim, Hee-Bok; Song, Jae-Jun; Cho, Chang Gun; Park, Seok-Won] Dongguk Univ, Ilsan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Goyang, South Korea; [Choi, Jong-Sun] Dongguk Univ, Ilsan Hosp, Dept Pathol, Goyang, South Korea; [Ryu, Junsun] Natl Canc Ctr, Head & Neck Oncol Clin, Goyang, South Korea; [Oh, Se Heang] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Oh, Se Heang] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Lee, Jin Ho] Hannam Univ, Dept Adv Mat, Taejon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Dongguk University; NHIS Ilsan Hospital; Dongguk University; NHIS Ilsan Hospital; National Cancer Center - Korea (NCC); Dankook University; Dankook University; Hannam University	Kwon, SK (corresponding author), Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul 110744, South Korea.	otolarynx@snuh.org		Ryu, Junsun/0000-0002-6730-6755	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2011-0014024]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0014024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TD, 2004, J VOICE, V18, P392, DOI 10.1016/j.jvoice.2002.04.001; BENNINGER MS, 1994, OTOLARYNG HEAD NECK, V111, P497; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; BLESS DM, 1987, EAR NOSE THROAT J, V66, P48; Bruening W, 1911, VERH DTSCH LARYNG, V18, P23; Carroll TL, 2011, LARYNGOSCOPE, V121, P313, DOI 10.1002/lary.21258; Chheda NN, 2008, LARYNGOSCOPE, V118, P2260, DOI 10.1097/MLG.0b013e318184e6ee; Chodara AM, 2012, LARYNGOSCOPE, V122, P58, DOI 10.1002/lary.22324; Courey MS, 2004, OTOLARYNG CLIN N AM, V37, P121, DOI 10.1016/j.otc.2003.12.002; DeFatta RA, 2012, J VOICE, V26, P614, DOI 10.1016/j.jvoice.2011.08.005; Deliyski DD, 2008, FOLIA PHONIATR LOGO, V60, P33, DOI 10.1159/000111802; Deliyski DD, 2010, CURR OPIN OTOLARYNGO, V18, P147, DOI 10.1097/MOO.0b013e3283395dd4; Dursun G, 2008, AM J OTOLARYNG, V29, P7, DOI 10.1016/j.amjoto.2006.12.001; Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002; FORD CN, 1995, LARYNGOSCOPE, V105, P944, DOI 10.1288/00005537-199509000-00014; Havas TE, 2003, ANZ J SURG, V73, P938, DOI 10.1046/j.1445-2197.2003.02824.x; HIRANO M, 1995, ACTA OTO-LARYNGOL, V115, P553, DOI 10.3109/00016489509139366; Katori Y, 2013, CLIN ANAT, V26, P204, DOI 10.1002/ca.22088; Kimura M, 2010, ANN OTO RHINOL LARYN, V119, P359, DOI 10.1177/000348941011900601; Kwon SK, 2013, LARYNGOSCOPE, V123, P1694, DOI 10.1002/lary.23879; Kwon TK, 2010, LARYNGOSCOPE, V120, P326, DOI 10.1002/lary.20749; LEACH RE, 1990, AM J OBSTET GYNECOL, V162, P1317, DOI 10.1016/0002-9378(90)90044-8; Lim JY, 2008, EUR ARCH OTO-RHINO-L, V265, P321, DOI 10.1007/s00405-007-0458-y; Lim SM, 2009, J BIOMED MATER RES B, V90B, P521, DOI 10.1002/jbm.b.31313; Liu GJ, 2011, OPT EXPRESS, V19, P11880, DOI 10.1364/OE.19.011880; Mallur PS, 2010, CLIN EXP OTORHINOLAR, V3, P177, DOI 10.3342/ceo.2010.3.4.177; Mau T, 2012, LARYNGOSCOPE, V122, P2005, DOI 10.1002/lary.23451; Mergell P, 2000, J ACOUST SOC AM, V108, P2996, DOI 10.1121/1.1314398; MIKUS JL, 1995, LARYNGOSCOPE, V105, P17, DOI 10.1288/00005537-199501000-00007; Oh SH, 2005, J BIOMED MATER RES A, V72A, P306, DOI 10.1002/jbm.a.30239; Patel R, 2008, ANN OTO RHINOL LARYN, V117, P413, DOI 10.1177/000348940811700603; Rana RS, 2011, RADIOL CLIN N AM, V49, P165, DOI 10.1016/j.rcl.2010.07.013; REICH AR, 1978, J SPEECH HEAR DISORD, V43, P496, DOI 10.1044/jshd.4304.496; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Rihkanen H, 2004, EUR ARCH OTO-RHINO-L, V261, P177, DOI 10.1007/s00405-003-0642-7; Rontal E, 2003, J VOICE, V17, P434, DOI 10.1067/S0892-1997(03)00020-1; Rosen CA, 2007, OTOLARYNG HEAD NECK, V136, P198, DOI 10.1016/j.otohns.2006.07.014; Schwarz R, 2006, IEEE T BIO-MED ENG, V53, P1099, DOI 10.1109/TBME.2006.873396; Senuma Y, 2000, BIOMATERIALS, V21, P1135, DOI 10.1016/S0142-9612(99)00276-8; Shaw HS, 2008, J VOICE, V22, P23, DOI 10.1016/j.jvoice.2006.08.006; STEINLEITNER A, 1991, OBSTET GYNECOL, V77, P48; STEINLEITNER A, 1992, FERTIL STERIL, V57, P305; Suckow MA BD, 2002, BIOL DIS RABBITS, P329; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Wittenberg T, 2000, J VOICE, V14, P422, DOI 10.1016/S0892-1997(00)80087-9; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; 권택균, 2006, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V49, P768	47	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85512	10.1371/journal.pone.0085512	http://dx.doi.org/10.1371/journal.pone.0085512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465582	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100044
J	Cobo, T; Jacobsson, B; Kacerovsky, M; Hougaard, DM; Skogstrand, K; Gratacos, E; Palacio, M				Cobo, Teresa; Jacobsson, Bo; Kacerovsky, Marian; Hougaard, David M.; Skogstrand, Kristin; Gratacos, Eduard; Palacio, Montse			Systemic and Local Inflammatory Response in Women with Preterm Prelabor Rupture of Membranes	PLOS ONE			English	Article							MICROBIAL INVASION; AMNIOTIC-FLUID; INTRAAMNIOTIC INFLAMMATION; CLINICAL-SIGNIFICANCE; SWEDISH POPULATION; CYTOKINE RESPONSE; PREMATURE RUPTURE; LABOR; IDENTIFICATION; INFECTION	Objective: To evaluate the inflammatory pattern in maternal circulation, amniotic cavity, cervix and vagina from women with preterm prelabor rupture of membranes (PPROM) considering the occurrence of microbial invasion of the amniotic cavity (MIAC). Methodology: A prospective study was performed in 58 women with PPROM before 34+0 weeks of gestational age. Twenty-six proteins were analyzed by a multiple immunoassay in samples of amniotic fluid, serum, cervix and vagina. Association of an inflammatory response in the invasive and non-invasive samples with MIAC was investigated. Results: The rate of MIAC was 36.2% (21/58). Both amniotic fluid IL-6 and cervical C-reactive protein (CRP) showed to be independent predictors of MIAC. A cut-off level of cervical CRP >= 1836 pg/mL showed a detection rate of 75%, false positive rate of 19% and positive and negative predictive values to predict MIAC of 67% and 87%, respectively. There were no independent biomarkers of MIAC either in the serum or vaginal compartment. Conclusion: A cervical inflammatory response mediated by CRP was observed in PPROM women with MIAC. Evaluation of serum or vaginal samples did not add valuable information regarding the outcome evaluated.	[Cobo, Teresa; Gratacos, Eduard; Palacio, Montse] Univ Barcelona, Maternal Fetal Med Dept, ICGON, Hosp Clin, Barcelona, Spain; [Cobo, Teresa; Gratacos, Eduard; Palacio, Montse] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Cobo, Teresa; Gratacos, Eduard; Palacio, Montse] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Oslo, Norway; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Hougaard, David M.; Skogstrand, Kristin] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Sahlgrenska University Hospital; University Hospital Hradec Kralove; Statens Serum Institut	Cobo, T (corresponding author), Univ Barcelona, Maternal Fetal Med Dept, ICGON, Hosp Clin, Barcelona, Spain.	tcobo@clinic.ub.es	Gratacos, Eduard/AAR-4939-2020; Kacerovsky, Marian/ABE-3437-2020; Hougaard, David/AAD-6368-2019; Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/A-7586-2011; Cobo, Teresa/K-2770-2017	Gratacos, Eduard/0000-0002-7405-7224; Jacobsson, Bo/0000-0001-5079-2374; Skogstrand, Kristin/0000-0002-0026-3711; Kacerovsky, Marian/0000-0001-9858-7900; Cobo, Teresa/0000-0003-3130-1829; Palacio, Montse/0000-0002-5869-4629	Instituto de Salud Carlos III in Spain [CM09/00213]; Spanish government [FIS PI10/01308]	Instituto de Salud Carlos III in Spain(Instituto de Salud Carlos III); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by a Rio Hortega grant from Instituto de Salud Carlos III in Spain (CM09/00213) and grants from Spanish government (FIS PI10/01308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins-Obstetrics, 2007, OBSTET GYNECOL, V109, P1007, DOI DOI 10.1097/01.AOG.0000263888.69178.1F; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Cobo T, 2013, ACTA OBSTET GYN SCAN, V92, P61, DOI 10.1111/aogs.12028; Cobo T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.050; Cobo T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.036; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Hitti J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.037; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; Rizzo G, 1996, AM J OBSTET GYNECOL, V175, P812, DOI 10.1016/S0002-9378(96)80004-4; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680	17	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85277	10.1371/journal.pone.0085277	http://dx.doi.org/10.1371/journal.pone.0085277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465522	Green Published, gold			2022-12-27	WOS:000330244500048
J	Cristaldo, PF; DeSouza, O; Krasulova, J; Jirosova, A; Kutalova, K; Lima, ER; Sobotnik, J; Sillam-Dusses, D				Cristaldo, Paulo Fellipe; DeSouza, Og; Krasulova, Jana; Jirosova, Anna; Kutalova, Katerina; Lima, Eraldo Rodrigues; Sobotnik, Jan; Sillam-Dusses, David			Mutual Use of Trail-Following Chemical Cues by a Termite Host and Its Inquiline	PLOS ONE			English	Article							CONSTRICTOTERMES-CYPHERGASTER TERMITIDAE; NORTHEASTERN BRAZIL; SOCIAL PARASITISM; ISOPTERA; NASUTITERMITINAE; PHEROMONE; RHINOTERMITIDAE; IDENTIFICATION; USURPATION; EVOLUTION	Termite nests are often secondarily inhabited by other termite species (= inquilines) that cohabit with the host. To understand this association, we studied the trail-following behaviour in two Neotropical species, Constrictotermes cyphergaster (Termitidae: Nasutitermitinae) and its obligatory inquiline, Inquilinitermes microcerus (Termitidae: Termitinae). Using behavioural experiments and chemical analyses, we determined that the trail-following pheromone of C. cyphergaster is made of neocembrene and (3Z, 6Z, 8E)-dodeca-3,6,8-trien-1-ol. Although no specific compound was identified in I. microcerus, workers were able to follow the above compounds in behavioural bioassays. Interestingly, in choice tests, C. cyphergaster prefers conspecific over heterospecific trails while I. microcerus shows the converse behaviour. In no-choice tests with whole body extracts, C. cyphergaster showed no preference for, while I. microcerus clearly avoided heterospecific trails. This seems to agree with the hypothesis that trail-following pheromones may shape the cohabitation of C. cyphergaster and I. microcerus and reinforce the idea that their cohabitation is based on conflict-avoiding strategies.	[Cristaldo, Paulo Fellipe; DeSouza, Og; Lima, Eraldo Rodrigues] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Cristaldo, Paulo Fellipe; Krasulova, Jana; Jirosova, Anna; Kutalova, Katerina; Sobotnik, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Krasulova, Jana; Kutalova, Katerina] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic; [Sillam-Dusses, David] Inst Rech Dev, Unite Mixte Rech Biogeochim & Ecol Milieux Contin, Bondy, France; [Sillam-Dusses, David] Univ Paris 13, Sorbonne Paris Cite, Equipe Accueil 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France	Universidade Federal de Vicosa; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague; Institut de Recherche pour le Developpement (IRD); Universite Paris 13	Krasulova, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	krasulova@uochb.cas.cz	Sillam-Dussès, David/AAI-5942-2021; DeSouza, Og/A-7140-2008; Lima, Eraldo R/B-6675-2008; Krasulova, Jana/G-8107-2014; Cristaldo, Paulo/A-1247-2013; Jirosova, Anna/G-5697-2014; Lima, Eraldo R/S-9585-2018	DeSouza, Og/0000-0002-7108-0242; Lima, Eraldo R/0000-0003-4446-5435; Cristaldo, Paulo/0000-0003-4939-0487; Jirosova, Anna/0000-0002-5054-5821; Sobotnik, Jan/0000-0002-8581-637X; Sillam-Dusses, David/0000-0001-5027-8703	Brazilian National Council for Research (CNPq) [140085/2010-6, 302486/2010-0, PQ-2, 200271/2010]; Coordination for the Improvement of Higher Education Personnel (CAPES) [PDSE 9669/11-6]; Minas Gerais State Foundation for Research Support (FAPEMIG) [CRA-APQ-02124-09, CRA-APQ-01519-11, BPV-00055-11]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [RVO: 61388963]; Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences) [20134359]	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Foundation for Research Support (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences)	The Brazilian National Council for Research (CNPq) provided financial support to the following coauthors: PFC (doctoral grant 140085/2010-6), ODS (fellowship 302486/2010-0, PQ-2 and grant 200271/2010). The Coordination for the Improvement of Higher Education Personnel (CAPES) supported PFC (PDSE 9669/11-6). The Minas Gerais State Foundation for Research Support (FAPEMIG) funded significant parts of field and lab work through grants CRA-APQ-02124-09, CRA-APQ-01519-11, and BPV-00055-11. This research was also supported by the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (RVO: 61388963). JS thanks to project 20134359 of Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1987, P125; Bordereau C, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P279, DOI 10.1007/978-90-481-3977-4_11; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; Crawley M.J., 2007, R BOOK; Cristaldo PF, 2012, INSECT SOC, V59, P541, DOI 10.1007/s00040-012-0249-3; da Cunha HF, 2003, SOCIOBIOLOGY, V42, P761; Moura FMD, 2006, SOCIOBIOLOGY, V48, P21; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dejean A, 1996, OECOLOGIA, V106, P57, DOI 10.1007/BF00334407; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Florencio DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066535; Grasse P.P., 1986, TERMITOLOGIA, VI; Grasse PP, 1951, ANN PSYCHOL, V50, P273; Hanus R, 2012, CHEM SENSES, V37, P55, DOI 10.1093/chemse/bjr065; HARRIS RN, 1995, ANIM BEHAV, V50, P1309, DOI 10.1016/0003-3472(95)80046-8; Hines HM, 2010, INSECT SOC, V57, P379, DOI 10.1007/s00040-010-0094-1; HOWARD RW, 1980, ANN ENTOMOL SOC AM, V73, P36, DOI 10.1093/aesa/73.1.36; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Jones Clara B., 2005, Mastozool. neotrop., V12, P19; Kilner RM, 2011, BIOL REV, V86, P836, DOI 10.1111/j.1469-185X.2010.00173.x; Kistner D.H., 1979, P339; Kotoklo EA, 2010, SOCIOBIOLOGY, V55, P579; Kronland WJ, 2007, WILSON J ORNITHOL, V119, P486, DOI 10.1676/05-139.1; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; LEONARDO AMC, 1990, INT J INSECT MORPHOL, V19, P61, DOI 10.1016/0020-7322(90)90030-S; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; Mathews A. G. A., 1977, STUDIES TERMITES MAT; Menzel F, 2010, ECOL ENTOMOL, V35, P495, DOI 10.1111/j.1365-2311.2010.01206.x; Moura FMS, 2006, INSECT SOC, V53, P472, DOI 10.1007/s00040-005-0899-0; Noirot C., 1970, P73; Ollerton J, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P411; Ortolani I, 2008, ETHOLOGY, V114, P782, DOI 10.1111/j.1439-0310.2008.01525.x; Pasteels Jacques M., 1998, P193; R Development Core Team, 2012, R LANG ENV STAT COMP; REDFORD KH, 1984, OECOLOGIA, V65, P145, DOI 10.1007/BF00384477; Rupf T, 2008, NATURWISSENSCHAFTEN, V95, P811, DOI 10.1007/s00114-008-0387-7; Shellman-Reeve Janet S., 1997, P52; Sillam-Dusses D, 2005, CHEMOECOLOGY, V15, P1, DOI 10.1007/s00049-005-0285-9; Sillam-Dusses D, 2007, J CHEM ECOL, V33, P1960, DOI 10.1007/s10886-007-9363-5; Sillam-Dusses D, 2010, BIOCHEM RES TRENDS, P39; Sillam-Dusses D, 2010, BIOL J LINN SOC, V99, P20, DOI 10.1111/j.1095-8312.2009.01348.x; Sillam-Dusses D, 2009, CHEMOECOLOGY, V19, P103, DOI 10.1007/s00049-009-0017-7; Sillam-Dusses D, 2009, J INSECT PHYSIOL, V55, P751, DOI 10.1016/j.jinsphys.2009.04.007; Sobotnik J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015761; Souto L, 2000, SOCIOBIOLOGY, V35, P367; STUART AM, 1961, NATURE, V189, P419, DOI 10.1038/189419a0; Traniello JFA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P141; Tsuneoka Y, 2008, J ETHOL, V26, P243, DOI 10.1007/s10164-007-0055-y; Vasconcellos A, 2007, NEOTROP ENTOMOL, V36, P693, DOI 10.1590/S1519-566X2007000500009; Wilson E.O., 1975, P1	53	32	33	3	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85315	10.1371/journal.pone.0085315	http://dx.doi.org/10.1371/journal.pone.0085315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465533	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500053
J	Fischer, V; Bardet, N; Guiomar, M; Godefroit, P				Fischer, Valentin; Bardet, Nathalie; Guiomar, Myette; Godefroit, Pascal			High Diversity in Cretaceous Ichthyosaurs from Europe Prior to Their Extinction	PLOS ONE			English	Article							JURASSIC MARINE REPTILES; DE-HAUTE-PROVENCE; NEUQUEN BASIN; PLATYPTERYGIUS-AUSTRALIS; LITHOGRAPHIC LIMESTONES; FRANCE; RECORD; GENUS; OPHTHALMOSAURIDAE; REDESCRIPTION	Background: Ichthyosaurs are reptiles that inhabited the marine realm during most of the Mesozoic. Their Cretaceous representatives have traditionally been considered as the last survivors of a group declining since the Jurassic. Recently, however, an unexpected diversity has been described in Upper Jurassic-Lower Cretaceous deposits, but is widely spread across time and space, giving small clues on the adaptive potential and ecosystem control of the last ichthyosaurs. The famous but little studied English Gault Formation and 'greensands' deposits (the Upper Greensand Formation and the Cambridge Greensand Member of the Lower Chalk Formation) offer an unprecedented opportunity to investigate this topic, containing thousands of ichthyosaur remains spanning the Early-Late Cretaceous boundary. Methodology/Principal Findings: To assess the diversity of the ichthyosaur assemblage from these sedimentary bodies, we recognized morphotypes within each type of bones. We grouped these morphotypes together, when possible, by using articulated specimens from the same formations and from new localities in the Vocontian Basin (France); a revised taxonomic scheme is proposed. We recognize the following taxa in the 'greensands': the platypterygiines 'Platypterygius' sp. and Sisteronia seeleyi gen. et sp. nov., indeterminate ophthalmosaurines and the rare incertae sedis Cetarthrosaurus walkeri. The taxonomic diversity of late Albian ichthyosaurs now matches that of older, well-known intervals such as the Toarcian or the Tithonian. Contrasting tooth shapes and wear patterns suggest that these ichthyosaurs colonized three distinct feeding guilds, despite the presence of numerous plesiosaur taxa. Conclusion/Significance: Western Europe was a diversity hot-spot for ichthyosaurs a few million years prior to their final extinction. By contrast, the low diversity in Australia and U.S.A. suggests strong geographical disparities in the diversity pattern of Albian-early Cenomanian ichthyosaurs. This provides a whole new context to investigate the extinction of these successful marine reptiles, at the end of the Cenomanian.	[Fischer, Valentin] Univ Liege, Dept Geol, Liege, Belgium; [Fischer, Valentin; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Bardet, Nathalie] Museum Natl Hist Nat, CNRS, UMR 7207, Dept Hist Terre, Paris, France; [Guiomar, Myette] Reserve Nat Geol Haute Provence, Digne Les Bains, France	University of Liege; Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Fischer, V (corresponding author), Univ Liege, Dept Geol, Liege, Belgium.	v.fischer@ulg.ac.be	BARDET, Nathalie/N-8670-2019; Bardet, Nathalie/I-3805-2015	Fischer, Valentin/0000-0002-8808-6747; Bardet, Nathalie/0000-0001-7881-7107	national research fund of Belgium	national research fund of Belgium	VF is an aspirant of the F.R.S.-FNRS. This a PhD thesis grant from the national research fund of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCARIE H, 1995, CR ACAD SCI II, V320, P327; Adams T.L., 2011, PALAEONTOL ELECTRON, V14; Amedro F, 2008, CARNETS GEOL, V02, P5; Amedro F, 2008, NOTEBOOKS GEOLOGY ME; Andrews C.W, 1910, DESCRIPTIVE CATALOGU; APPLEBY R. M., 1961, PROC ZOOL SOC LONDON, V137, P333; APPLEBY R. M., 1956, PROC ZOOL SOC LONDON, V126, P403; Araujo Ricardo, 2008, Irish Journal of Earth Sciences, V26, P17; Arkhangelsky M.S., 2000, PALEONTOL J, V34, P549; Arkhangelsky M.S., 2001, PALEONTOL J+, V35, P521; Arkhangelsky MS, 1997, PALEONTOL ZH, P87; Arkhangelsky MS., 1998, PALEONTOLOGICAL J, V32, P192; Arkhangelsky MS., 2001, PALEONTOL J, V35, P629; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1990, GEOBIOS-LYON, V23, P169, DOI 10.1016/S0016-6995(06)80049-5; BARDET N, 1992, TERRA NOVA, V4, P649, DOI 10.1111/j.1365-3121.1992.tb00614.x; Bardet N, 1989, MEMOIRES SOC ACAD BO, V6; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Bardet Nathalie, 1994, Historical Biology, V7, P313; Barrett PM, 2002, CRETACEOUS RES, V23, P231, DOI 10.1006/cres.2002.0312; Baur G., 1887, American Naturalist, Vxxi, P837; Benson RBJ, 2011, GEOL SOC SPEC PUBL, V358, P191, DOI 10.1144/SP358.13; Benson RBJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031838; Benson RBJ, 2011, PALAEONTOLOGY, V54, P547, DOI 10.1111/j.1475-4983.2011.01044.x; Billon-Bruyat JP, 2005, PALAEOGEOGR PALAEOCL, V216, P359, DOI 10.1016/j.palaeo.2004.11.011; Blain H-A, 2003, ECHOS FALAISES, V7, P35; Breheret J.-G., 1997, PUBL SOC GEOL NORD, V25, P614; Breton G, 2011, GEODIVERSITAS, V33, P279, DOI 10.5252/g2011n2a5; Broili Ferdinand, 1907, Palaeontographica Stuttgart, V54; Buchy Marie-Céline, 2009, Bol. Soc. Geol. Mex, V61, P233; Buchy MC, 2010, J PALEONTOL, V84, P149; Buffetaut Eric, 1994, Geobios Memoire Special (Villeurbanne), V16, P259; Butler RJ, 2012, EVOLUTION, V66, P147, DOI 10.1111/j.1558-5646.2011.01415.x; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Carter A. M., 1846, REPORTS BRIT ASS ADV, V15, P60; Carter J, 1846, LONDON GEOLOGICAL J, V1; Cookson I. C., 1964, Palaeontology, V1, P37; De Blainville H.D., 1835, NOUV ANN MUS HIST NA, V4, P233; Delair J.B., 1972, Wiltshire Archaeol Nat Hist Mag (Nat Hist), V67, P12; Delair JB, 1960, P DORSET NATURAL HIS, V81, P59; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Efimov, 1999, PALEONTOL J, V33, P174; Efimov V.M., 1999, Paleontologicheskii Zhurnal, V1, P92; Efimov V.M., 1997, PALEONTOL J+, V31, P422; Efimov VM, 1998, PALEONTOL ZH, P82; Ensom PC, 2009, CRETACEOUS RES, V30, P699, DOI 10.1016/j.cretres.2008.12.005; Fernandez M, 2005, J VERTEBR PALEONTOL, V25, P583, DOI 10.1671/0272-4634(2005)025[0583:ROPHVH]2.0.CO;2; Fernandez M, 2007, J PALEONTOL, V81, P368, DOI 10.1666/0022-3360(2007)81[368:RAPPOC]2.0.CO;2; Fernandez Marta, 2007, P271; Fernandez MS, 2012, GEOBIOS-LYON, V45, P535, DOI 10.1016/j.geobios.2012.02.001; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fischer V, 2011, CRETACEOUS RES, V32, P155, DOI 10.1016/j.cretres.2010.11.005; Fischer V, J VERTEBRATE PALEONT; Fischer V, 2013, ORIGIN BIODIVERSITY; Fischer V, GEOLOGICAL IN PRESS; Fischer V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0021; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Fischer V, 2012, ACTA PALAEONTOL POL, V57, P123, DOI 10.4202/app.2011.0007; Fischer V, 2011, NEUES JAHRB GEOL P-A, V261, P111, DOI 10.1127/0077-7749/2011/0155; Fv Huene, 1922, ICHTHYOSAURIER LIAS; Gasparini Z, 2005, GEOL SOC SPEC PUBL, V252, P279, DOI 10.1144/GSL.SP.2005.252.01.14; GASPARINI Z, 1988, Ameghiniana, V25, P3; Gasparini Z, 1995, 2 INT S LITH LIM LEI, P81; Godefroit P, 1996, B SOC BELG GEOL, V104, P67; Godefroit Pascal, 1993, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V63, P25; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Herrle JO, 2003, CRETACEOUS RES, V24, P1, DOI 10.1016/S0195-6671(03)00023-5; Hopson, 2005, BRIT GEOLOGICAL SURV; Hopson P.M., 2008, BRIT GEOLOGICAL SURV; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Juignet P., 1974, STRATOTYPE CENOMANIE, P810; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kear BP, 2003, P ROY SOC B-BIOL SCI, V270, pS206, DOI 10.1098/rsbl.2003.0050; Kear BP, 2001, ALCHERINGA, V25, P387, DOI 10.1080/03115510108619228; Kear BP, 2003, CRETACEOUS RES, V24, P277, DOI 10.1016/S0195-6671(03)00046-6; Kear BP, 2013, GEOLOGICAL IN PRESS; Kennedy WJ, 2000, CRETACEOUS RES, V21, P591, DOI 10.1006/cres.2000.0223; Kiprijanoff W., 1881, MEMOIRES ACAD IMPERI, V28, P1; Kirton A.M., 1983, REV BRIT UPPER JURAS; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; Kuhn O., 1946, Ber naturf Ges Ramburg, V29, P69; Kuhnt Wolfgang, 2007, Carnets de Geologie, P1; Lehmann J, 2009, CRETACEOUS RES, V30, P895, DOI 10.1016/j.cretres.2009.02.002; Lingham-Soliar T, 2003, NEUES JAHRB GEOL P-A, V228, P421; Lydekker R., 1888, GEOLOGICAL MAGAZINE, V5, P309, DOI DOI 10.1017/S0016756800181968; Lydekker R, 1889, CATALOGUE FOSSIL REP; Maisch Michael W., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V209, P47; Maisch Michael W., 2001, Geologica et Palaeontologica, V35, P145; Maisch Michael W., 2008, Palaeodiversity, P227; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mannion PD, 2011, PALAEOGEOGR PALAEOCL, V299, P529, DOI 10.1016/j.palaeo.2010.12.003; Martill DM, 2012, CRETACEOUS RES, V34, P1, DOI 10.1016/j.cretres.2011.09.003; Martin JE, 2012, PALAEONTOLOGY, V55, P995, DOI 10.1111/j.1475-4983.2012.01159.x; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 1997, P401, DOI 10.1016/B978-012155210-7/50021-1; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2006, CAN J EARTH SCI, V43, P1291, DOI 10.1139/E06-029; Maxwell EE, 2012, J PALEONTOL, V86, P105, DOI 10.1666/11-038.1; Maxwell EE, 2011, PALAEONTOL Z, V85, P457, DOI 10.1007/s12542-011-0106-0; Maxwell EE, 2011, J MORPHOL, V272, P129, DOI 10.1002/jmor.10898; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; McGowan C, 1997, J VERTEBR PALEONTOL, V17, P428, DOI 10.1080/02724634.1997.10010986; McGowan C., 1974, Life Sci Contr R Ont Mus, VNo. 100, P1; MCGOWAN C, 1989, PALAEONTOLOGY, V32, P409; MCGOWAN C, 1972, Contributions to Geology University of Wyoming, V11, P9; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; McGowan C., 1974, Life Sci Contr R Ont Mus, VNo. 97, P1; McGowan C., 1991, DINOSAURS SPITFIRES; McGowan C., 1973, B BRIT MUS NAT HIST, V24, P1; McGowan C., 2003, ICHTHYOPTERYGIA; Nace RL, 1941, AM J SCI, V239, P908, DOI 10.2475/ajs.239.12.908; Nace RL, 1939, AM J SCI, V237, P673, DOI 10.2475/ajs.237.9.673; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Owen HG, 2012, P GEOLOGIST ASSOC, V123, P742, DOI 10.1016/j.pgeola.2012.06.006; Owen R, 1851, MONOGRAPH FOSSIL REP; Paramo ME., 1997, REV INGEOMINAS, V6, P1; Pardo-Perez Judith, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P287, DOI 10.1007/s12549-012-0074-8; Robaszynskii F, 2008, B SOC GEOL FR, V179, P245, DOI 10.2113/gssgfbull.179.3.245; Ross MR, 2009, J VERTEBR PALEONTOL, V29, P409, DOI 10.1671/039.029.0212; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sauvage HE, 1882, MEMOIRES SOC GEOLOGI, V2, P21; Scheyer TM, 2011, SWISS J GEOSCI, V104, pS147, DOI 10.1007/s00015-011-0076-y; Schubert BW, 2005, ACTA PALAEONTOL POL, V50, P93; Scott Robert W., 2009, Carnets de Geologie, P1; Seeley, 1873, Q J GEOLOGICAL SOC, V29, P505; SEELEY H. G., 1869, INDEX FOSSIL REMAINS; Seeley HG, 1876, Q J GEOL SOC LOND, V32, P433, DOI DOI 10.1144/GSL.JGS.1876.032.01-04.48; Sirotti Achille, 2002, Bollettino della Societa Paleontologica Italiana, V41, P237; Smith AS, 2007, ANATOMY SYSTEMATICS; Spalletti LA, 1999, REV GEOL CHILE, V26, P109; TAYLOR MA, 1986, P DORSET NAT HIST AR, V107, P121; Thewissen JGM, 2011, PALEOBIOLOGY, V37, P655; Travassac F, 2004, STRATIGRAPHIE SEDIME; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Vincent P, 2008, PLESIOSAURIA REPTILI; Vincent P, 2013, ACTA PALAEONTOL POL, V58, P471, DOI 10.4202/app.2011.0113; Vincent P, 2012, J VERTEBR PALEONTOL, V32, P1049, DOI 10.1080/02724634.2012.686467; Von Huene F, 1927, CENTRALBLATT MINER B, V1, P22; WADE M, 1984, LETHAIA, V17, P99, DOI 10.1111/j.1502-3931.1984.tb01713.x; WADE M, 1990, Memoirs of the Queensland Museum, V28, P115; Wilpshaar M, 1997, CRETACEOUS RES, V18, P457, DOI 10.1006/cres.1997.0062; Woods MA, 2008, P GEOLOGIST ASSOC, V119, P229, DOI 10.1016/S0016-7878(08)80303-3; Young MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044985; Zammit M, 2011, AUSTR CRETACEOUS ICH; Zammit M, 2012, GEOSCIENCES, V2, P11, DOI 10.3390/geosciences2020011; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930; Zammit M, 2010, ALCHERINGA, V34, P281, DOI 10.1080/03115511003663939	150	50	53	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84709	10.1371/journal.pone.0084709	http://dx.doi.org/10.1371/journal.pone.0084709			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465427	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500013
J	Larsen, SB; Grove, EL; Hvas, AM; Kristensen, SD				Larsen, Sanne Bojet; Grove, Erik Lerkevang; Hvas, Anne-Mette; Kristensen, Steen Dalby			Platelet Turnover in Stable Coronary Artery Disease - Influence of Thrombopoietin and Low-Grade Inflammation	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; RETICULATED PLATELETS; MYOCARDIAL-INFARCTION; HEART-DISEASE; IMMATURE PLATELETS; SIZE HETEROGENEITY; WHOLE-BLOOD; VOLUME; INTERLEUKIN-6; ACTIVATION	Background: Newly formed platelets are associated with increased aggregation and adverse outcomes in patients with coronary artery disease (CAD). The mechanisms involved in the regulation of platelet turnover in patients with CAD are largely unknown. Aim: To investigate associations between platelet turnover parameters, thrombopoietin and markers of low-grade inflammation in patients with stable CAD. Furthermore, to explore the relationship between platelet turnover parameters and type 2 diabetes, prior myocardial infarction, smoking, age, gender and renal insufficiency. Methods: We studied 581 stable CAD patients. Platelet turnover parameters (immature platelet fraction, immature platelet count, mean platelet volume, platelet distribution width and platelet large cell-ratio) were determined using automated flow cytometry (Sysmex XE-2100). Furthermore, we measured thrombopoietin and evaluated low-grade inflammation by measurement of high-sensitive CRP and interleukin-6. Results: We found strong associations between the immature platelet fraction, immature platelet count, mean platelet volume, platelet distribution width and platelet large cell ratio (r = 0.61-0.99, p<0.0001). Thrombopoietin levels were inversely related to all of the platelet turnover parameters (r = -0.17--0.25, p<0.0001). Moreover, thrombopoietin levels were significantly increased in patients with diabetes (p = 0.03) and in smokers (p = 0.003). Low-grade inflammation evaluated by high-sensitive CRP correlated significantly, yet weakly, with immature platelet count (r = 0.10, p = 0.03) and thrombopoietin (r = 0.16, p<0.001). Also interleukin-6 correlated with thrombopoietin (r = 0.10, p = 0.02). Conclusion: In stable CAD patients, thrombopoietin was inversely associated with platelet turnover parameters. Furthermore, thrombopoietin levels were increased in patients with diabetes and in smokers. However, low-grade inflammation did not seem to have a substantial impact on platelet turnover parameters.	[Larsen, Sanne Bojet; Grove, Erik Lerkevang; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette; Kristensen, Steen Dalby] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, SD (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark.	steendk@dadlnet.dk		Grove, Erik/0000-0002-1466-0865	Danish Agency for Science Technology and Innovation [2101-05-0052]; Danish Heart Foundation; A. P. Moller Foundation; Department of Clinical Medicine, Aarhus University, Denmark,; Eva and Henry Fraenkel Foundation; Aase and Ejnar Danielsen Foundation; Korning Foundation; Physician's assurance association anno; Sophus Jacobsen and Spouse Astrid Jacobsen Foundation	Danish Agency for Science Technology and Innovation; Danish Heart Foundation; A. P. Moller Foundation; Department of Clinical Medicine, Aarhus University, Denmark,; Eva and Henry Fraenkel Foundation; Aase and Ejnar Danielsen Foundation; Korning Foundation(National Research Foundation of Korea); Physician's assurance association anno; Sophus Jacobsen and Spouse Astrid Jacobsen Foundation	The study was financially supported be the Danish Agency for Science Technology and Innovation (grant no. 2101-05-0052), The Danish Heart Foundation, A. P. Moller Foundation, Department of Clinical Medicine, Aarhus University, Denmark, The Eva and Henry Fraenkel Foundation, The Aase and Ejnar Danielsen Foundation, The Korning Foundation, The Physician's assurance association anno 1891 and The Sophus Jacobsen and Spouse Astrid Jacobsen Foundation. Carl and Ellen Hertz's legate to Danish medical and natural science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULT KA, 1992, AM J CLIN PATHOL, V98, P637, DOI 10.1093/ajcp/98.6.637; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; BROWN AS, 1994, EUR J CLIN INVEST, V24, P9, DOI 10.1111/j.1365-2362.1994.tb02419.x; Butkiewicz A M, 2006, Adv Med Sci, V51, P123; Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/THOS-01-0002, 10.1160/TH08-01-0002]; Cesari F, 2013, THROMB HAEMOSTASIS, V109, P846, DOI 10.1160/TH12-09-0709; Coban E, 2005, INT J CLIN PRACT, V59, P981, DOI 10.1111/j.1742-1241.2005.00500.x; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Deutsch VR, 2013, BRIT J HAEMATOL, V161, P778, DOI 10.1111/bjh.12328; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; Folman CC, 2000, THROMB HAEMOSTASIS, V83, P923, DOI 10.1055/s-0037-1613944; Freynhofer MK, 2011, THROMB HAEMOSTASIS, V106, P182, DOI 10.1160/TH11-01-0051; Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x; Grove EL, 2009, THROMB HAEMOSTASIS, V101, P151, DOI 10.1160/TH08-03-0186; Guthikonda S, 2008, J AM COLL CARDIOL, V52, P743, DOI 10.1016/j.jacc.2008.05.031; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; KARIO K, 1992, CLIN LAB HAEMATOL, V14, P281; Keating FK, 2003, AM J CARDIOL, V92, P1362, DOI 10.1016/j.amjcard.2003.08.033; Khode Vitthal, 2012, J Cardiovasc Dis Res, V3, P272, DOI 10.4103/0975-3583.102694; Klovaite J, 2011, J THROMB HAEMOST, V9, P49, DOI 10.1111/j.1538-7836.2010.04110.x; Koike Y, 1998, THROMB HAEMOSTASIS, V79, P1106; Larsen SB, 2012, THROMB HAEMOST, P108; LATERVEER L, 1993, EXP HEMATOL, V21, P1621; Lordkipanidze M, 2012, CURR PHARM DESIGN, V18, P5328, DOI 10.2174/138161212803251952; Lupia E, 2006, J AM COLL CARDIOL, V48, P2195, DOI 10.1016/j.jacc.2006.04.106; Lupia E, 2010, ATHEROSCLEROSIS, V210, P314, DOI 10.1016/j.atherosclerosis.2009.11.019; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; MARTIN JF, 1983, BRIT MED J, V287, P456, DOI 10.1136/bmj.287.6390.456; MARTIN JF, 1983, THROMB RES, V32, P443, DOI 10.1016/0049-3848(83)90255-4; Martin JF, 2012, NAT REV CARDIOL, V9, P658, DOI 10.1038/nrcardio.2012.131; Panasiuk A, 2004, HEPATO-GASTROENTEROL, V51, P1124; Gonzalez-Porras JR, 2010, THROMB HAEMOSTASIS, V103, P247, DOI 10.1160/TH09-02-0124; Ranjith MP, 2009, J CLIN PATHOL, V62, P830, DOI 10.1136/jcp.2009.066787; RITCHIE JL, 1977, AM J CARDIOL, V39, P595, DOI 10.1016/S0002-9149(77)80171-9; Sahin DY, 2012, CLIN APPL THROMB HEM; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Senaran H, 2001, CLIN CARDIOL, V24, P405, DOI 10.1002/clc.4960240511; Senchenkova EY, 2013, AM J PATHOL, V183, P173, DOI 10.1016/j.ajpath.2013.03.014; Sosman JA, 1997, CLIN CANCER RES, V3, P39; Takajo Y, 2001, J AM COLL CARDIOL, V38, P1320, DOI 10.1016/S0735-1097(01)01583-2; Tavil Y, 2010, PLATELETS, V21, P368, DOI 10.3109/09537101003628421; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; Ucar H, 2013, PLATELETS IN PRESS, DOI [10.3109/09537104.2013.805406, DOI 10.3109/09537104.2013.805406).IN]; Watala C, 1999, PLATELETS, V10, P52, DOI 10.1080/09537109976356; Wurtz M, 2010, JACC-CARDIOVASC INTE, V3, P828, DOI 10.1016/j.jcin.2010.05.014; Zhang L, 2013, ARTERIOSCL THROM VAS, V33, P1820, DOI 10.1161/ATVBAHA.113.301507	47	39	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85566	10.1371/journal.pone.0085566	http://dx.doi.org/10.1371/journal.pone.0085566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465602	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500076
J	Li, XC; Chen, SP; Xie, WW; Vogel, I; Choy, KW; Chen, F; Christensen, R; Zhang, CL; Ge, HJ; Jiang, HJ; Yu, C; Huang, F; Wang, W; Jiang, H; Zhang, XQ				Li, Xuchao; Chen, Shengpei; Xie, Weiwei; Vogel, Ida; Choy, Kwong Wai; Chen, Fang; Christensen, Rikke; Zhang, Chunlei; Ge, Huijuan; Jiang, Haojun; Yu, Chang; Huang, Fang; Wang, Wei; Jiang, Hui; Zhang, Xiuqing			PSCC: Sensitive and Reliable Population-Scale Copy Number Variation Detection Method Based on Low Coverage Sequencing	PLOS ONE			English	Article							ARRAY-CGH; VARIANTS; GENOME; IDENTIFICATION; AMPLIFICATION; ALGORITHM; CANCER; SEQ	Background: Copy number variations (CNVs) represent an important type of genetic variation that deeply impact phenotypic polymorphisms and human diseases. The advent of high-throughput sequencing technologies provides an opportunity to revolutionize the discovery of CNVs and to explore their relationship with diseases. However, most of the existing methods depend on sequencing depth and show instability with low sequence coverage. In this study, using low coverage whole-genome sequencing (LCS) we have developed an effective population-scale CNV calling (PSCC) method. Methodology/Principal Findings: In our novel method, two-step correction was used to remove biases caused by local GC content and complex genomic characteristics. We chose a binary segmentation method to locate CNV segments and designed combined statistics tests to ensure the stable performance of the false positive control. The simulation data showed that our PSCC method could achieve 99.7%/100% and 98.6%/100% sensitivity and specificity for over 300 kb CNV calling in the condition of LCS (similar to 2x) and ultra LCS (similar to 0.2x), respectively. Finally, we applied this novel method to analyze 34 clinical samples with an average of 2xLCS. In the final results, all the 31 pathogenic CNVs identified by aCGH were successfully detected. In addition, the performance comparison revealed that our method had significant advantages over existing methods using ultra LCS. Conclusions/Significance: Our study showed that PSCC can sensitively and reliably detect CNVs using low coverage or even ultra-low coverage data through population-scale sequencing.	[Li, Xuchao; Chen, Shengpei; Xie, Weiwei; Chen, Fang; Zhang, Chunlei; Ge, Huijuan; Jiang, Haojun; Yu, Chang; Wang, Wei; Jiang, Hui; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Peoples R China; [Vogel, Ida; Christensen, Rikke] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Chen, Shengpei; Jiang, Haojun] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Huang, Fang] Guangzhou Childrens Social Welf Home, Guangzhou, Guangdong, Peoples R China; [Wang, Wei] Clin Lab BGI Hlth, Shenzhen, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen, Peoples R China	Beijing Genomics Institute (BGI); Aarhus University; Chinese University of Hong Kong; Southeast University - China; Beijing Genomics Institute (BGI)	Jiang, H (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	jianghui@genomics.org.cn; zhangxq@genomics.org.cn	Choy, Richard/AAW-8230-2020; Vogel, Ida/AAD-1087-2019; Yu, Chang/AAE-8538-2019	Choy, Richard/0000-0002-3616-6200; Vogel, Ida/0000-0002-1125-0393; 	Key Laboratory Project in Shenzhen [CXB200903110066A, CXB201108250096A]	Key Laboratory Project in Shenzhen	This study was funded by Key Laboratory Project in Shenzhen (CXB200903110066A and CXB201108250096A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ballantyne KN, 2007, ANAL BIOCHEM, V368, P222, DOI 10.1016/j.ab.2007.05.017; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hormansdorfer C, 2009, ULTRASOUND OBST GYN, V33, P147, DOI 10.1002/uog.6250; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kim TM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-432; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Kusenda M, 2008, CYTOGENET GENOME RES, V123, P36, DOI 10.1159/000184690; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Magi A, 2010, BIOSTATISTICS, V11, P265, DOI 10.1093/biostatistics/kxp051; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ptacek T, 2008, CYTOGENET GENOME RES, V123, P142, DOI 10.1159/000184701; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Shen YP, 2009, J GENET GENOMICS, V36, P257, DOI 10.1016/S1673-8527(08)60113-7; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Takahashi N, 2008, CYTOGENET GENOME RES, V123, P224, DOI 10.1159/000184712; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	32	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85096	10.1371/journal.pone.0085096	http://dx.doi.org/10.1371/journal.pone.0085096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465483	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500035
J	Raymond, PA; Colvin, SM; Jabeen, Z; Nagashima, M; Barthel, LK; Hadidjojo, J; Popova, L; Pejaver, VR; Lubensky, DK				Raymond, Pamela A.; Colvin, Steven M.; Jabeen, Zahera; Nagashima, Mikiko; Barthel, Linda K.; Hadidjojo, Jeremy; Popova, Lilia; Pejaver, Vivek R.; Lubensky, David K.			Patterning the Cone Mosaic Array in Zebrafish Retina Requires Specification of Ultraviolet-Sensitive Cones	PLOS ONE			English	Article							LIVE CELL EXTRUSION; T-BOX GENES; PHOTORECEPTOR DEVELOPMENT; VISUAL PIGMENTS; TRANSGENIC ZEBRAFISH; EMBRYONIC ZEBRAFISH; TEMPORAL EXPRESSION; MAMMALIAN RETINA; GOLDFISH RETINA; TELEOST RETINA	Cone photoreceptors in teleost fish are organized in precise, crystalline arrays in the epithelial plane of the retina. In zebrafish, four distinct morphological/spectral cone types occupy specific, invariant positions within a regular lattice. The cone lattice is aligned orthogonal and parallel to circumference of the retinal hemisphere: it emerges as cones generated in a germinal zone at the retinal periphery are incorporated as single-cell columns into the cone lattice. Genetic disruption of the transcription factor Tbx2b eliminates most of the cone subtype maximally sensitive to ultraviolet (UV) wavelengths and also perturbs the long-range organization of the cone lattice. In the tbx2b mutant, the other three cone types (red, green, and blue cones) are specified in the correct proportion, differentiate normally, and acquire normal, planar polarized adhesive interactions mediated by Crumbs 2a and Crumbs 2b. Quantitative image analysis of cell adjacency revealed that the cones in the tbx2b mutant primarily have two nearest neighbors and align in single-cell-wide column fragments that are separated by rod photoreceptors. Some UV cones differentiate at the dorsal retinal margin in the tbx2b mutant, although they are severely dysmorphic and are eventually eliminated. Incorporating loss of UV cones during formation of cone columns at the margin into our previously published mathematical model of zebrafish cone mosaic formation (which uses bidirectional interactions between planar cell polarity proteins and anisotropic mechanical stresses in the plane of the retinal epithelium to generate regular columns of cones parallel to the margin) reproduces many features of the pattern disruptions seen in the tbx2b mutant.	[Raymond, Pamela A.; Colvin, Steven M.; Nagashima, Mikiko; Barthel, Linda K.; Popova, Lilia; Pejaver, Vivek R.] Univ Michigan, Coll Literature Sci & Arts, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jabeen, Zahera; Hadidjojo, Jeremy; Lubensky, David K.] Univ Michigan, Dept Phys, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raymond, PA (corresponding author), Univ Michigan, Coll Literature Sci & Arts, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	praymond@umich.edu; dkluben@umich.edu		Lubensky, David/0000-0002-4619-116X; Raymond, Pamela/0000-0003-1083-5530; Jabeen, Zahera/0000-0001-7813-3493	NSF IOS [0952873]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY015509] Funding Source: NIH RePORTER; Direct For Biological Sciences [0952873] Funding Source: National Science Foundation	NSF IOS(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF IOS 0952873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2008, BRAIN RES, V1192, P134, DOI 10.1016/j.brainres.2007.03.044; Albalat R, 2010, GENE EXPR PATTERNS, V10, P24, DOI 10.1016/j.gep.2009.11.003; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; BERGER ER, 1967, J ULTRA MOL STRUCT R, V17, P220, DOI 10.1016/S0022-5320(67)80044-3; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Chinen A, 2003, GENETICS, V163, P663; Dowling J. E., 1987, RETINA APPROACHABLE; Eisenhoffer GT, 2013, TRENDS CELL BIOL, V23, P185, DOI 10.1016/j.tcb.2012.11.006; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; ENGSTROM KJELL, 1963, ACTA ZOOL, V44, P179; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; Gu YP, 2012, CURR OPIN CELL BIOL, V24, P865, DOI 10.1016/j.ceb.2012.09.003; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; KLJAVIN IJ, 1987, J COMP NEUROL, V260, P461, DOI 10.1002/cne.902600311; KUNZ YW, 1983, CELL TISSUE RES, V230, P469, DOI 10.1007/BF00216193; KUNZ YW, 1994, VISION RES, V34, P1375, DOI 10.1016/0042-6989(94)90136-8; LARISON KD, 1990, DEVELOPMENT, V109, P567; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; Prabhudesai SN, 2005, DEV BIOL, V287, P157, DOI 10.1016/j.ydbio.2005.08.045; Ramsey M, 2013, J COMP NEUROL, V521, P1803, DOI 10.1002/cne.23260; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1985, TRENDS NEUROSCI, V8, P12; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; RAYMOND PA, 1985, J COMP NEUROL, V236, P90, DOI 10.1002/cne.902360108; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Salbreux G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002618; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Snelson CD, 2008, DEVELOPMENT, V135, P1693, DOI 10.1242/dev.016576; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Stenkamp DL, 2002, MOL VIS, V8, P280; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Stenkamp DL, 1996, INVEST OPHTH VIS SCI, V37, P363; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thompson BJ, 2013, NAT REV MOL CELL BIO, V14, P307, DOI 10.1038/nrm3568; Wallace VA, 1999, EXP EYE RES, V69, P617, DOI 10.1006/exer.1999.0741; Wei XY, 2006, EXP EYE RES, V83, P31, DOI 10.1016/j.exer.2005.10.030; Westerfield M, 1990, ZEBRAFISH BOOK GUIDE; WILLIAMS DS, 1990, J COMP NEUROL, V295, P155, DOI 10.1002/cne.902950113; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007; Zou J, 2010, INVEST OPHTH VIS SCI, V51, P1738, DOI 10.1167/iovs.09-4520	61	32	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85325	10.1371/journal.pone.0085325	http://dx.doi.org/10.1371/journal.pone.0085325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465536	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500054
J	Singh, A; Vaidya, B; Khatri, I; Srinivas, TNR; Subramanian, S; Korpole, S; Pinnaka, AK				Singh, Aditya; Vaidya, Bhumika; Khatri, Indu; Srinivas, T. N. R.; Subramanian, Srikrishna; Korpole, Suresh; Pinnaka, Anil Kumar			Grimontia indica AK16(T), sp nov., Isolated from a Seawater Sample Reports the Presence of Pathogenic Genes Similar to Vibrio Genus	PLOS ONE			English	Article							FINISHED GENOME SEQUENCE; IDENTIFICATION; HOLLISAE; KEGG	Grimontia indica strain AK16(T) sp. nov. is the type strain of G. indica sp. nov. a new species within the genus Grimontia. This strain, whose genome is described here, was isolated from seawater sample collected from southeast coast of Palk Bay, India. G. indica AK16(T) is a Gram-negative, facultative aerobic rod shaped bacterium. There are only two other strains in the genus Grimontia one of which, Grimontia hollisae CIP 101886(T), is a reported human pathogen isolated from human stool sample while the other, 'Grimontia marina IMCC5001(T)', was isolated from a seawater sample. As compared to the pathogenic strain Grimontia hollisae CIP 101886(T), the strain AK16(T) lacks some genes for pathogenesis like the accessory colonization factors AcfA and AcfD, which are required for the colonization of the bacterium in the host body. While it carries some pathogenesis genes like OmpU, which are related to pathogenesis of Vibrio strains. This suggests that the life cycle of AK16(T) may include some pathogenic interactions with marine animal(s), or it may be an opportunistic pathogen. Study of the Grimontia genus is important because of the severe pathogenic traits exhibited by a member of the genus with only three species reported in total. The study will provide some vital information which may be useful in future clinical studies on the genus.	[Singh, Aditya; Vaidya, Bhumika; Khatri, Indu; Subramanian, Srikrishna; Korpole, Suresh; Pinnaka, Anil Kumar] Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank, Chandigarh, India; [Srinivas, T. N. R.] Natl Inst Oceanog, Visakhapatnam, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Pinnaka, AK (corresponding author), Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank, Chandigarh, India.	apinnaka@imtech.res.in	Singh, Aditya/AAC-4183-2020; subramanian, srikrishna/N-3018-2019; Khatri, Indu/Y-2429-2018; TANUKU, SRINIVAS N R/F-1029-2013; Pinnaka, Anil Kumar/G-5063-2011	Singh, Aditya/0000-0003-0827-7429; subramanian, srikrishna/0000-0002-3263-1048; Khatri, Indu/0000-0002-7993-1953; TANUKU, SRINIVAS N R/0000-0003-3434-6993; 	CSIR-IMTECH	CSIR-IMTECH	This work was funded by CSIR-IMTECH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baharoglu Z, 2012, J BACTERIOL, V194, P1659, DOI 10.1128/JB.05982-11; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Choi A, 2012, J MICROBIOL, V50, P170, DOI 10.1007/s12275-012-1615-6; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Hinestrosa F, 2007, J CLIN MICROBIOL, V45, P3462, DOI 10.1128/JCM.01205-07; Jean-Christophe L, 2012, STAND GENOMIC SCI, V7, P343; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kokcha S, 2012, STAND GENOMIC SCI, V6, P346, DOI 10.4056/sigs.2776064; Lagier JC, 2012, STAND GENOMIC SCI, V6, P116, DOI 10.4056/sigs.2415480; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mishra AK, 2012, STAND GENOMIC SCI, V6, P304, DOI 10.4056/sigs.2625821; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Srinivas TNR, 2013, SYST APPL MICROBIOL, V36, P160, DOI 10.1016/j.syapm.2012.12.002; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P1615, DOI 10.1099/ijs.0.02660-0; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; van Kessel JC, 2013, J BACTERIOL, V195, P436, DOI 10.1128/JB.01998-12	24	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85590	10.1371/journal.pone.0085590	http://dx.doi.org/10.1371/journal.pone.0085590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465608	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500079
J	Barone, C; Pinto, C; Normanno, N; Capussotti, L; Cognetti, F; Falcone, A; Mantovani, L				Barone, Carlo; Pinto, Carmine; Normanno, Nicola; Capussotti, Lorenzo; Cognetti, Francesco; Falcone, Alfredo; Mantovani, Lorenzo			KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting	PLOS ONE			English	Article							QUALITY INDICATORS; 1ST-LINE TREATMENT; DELPHI SURVEY; CANCER; CETUXIMAB; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; SOCIETY; ISSUES	KRAS testing is relevant for the choice of the most appropriate first-line therapy of metastatic colorectal cancer (CRC). Strategies for preventing unequal access to the test should be implemented, but their relevance in the practice is related to economic sustainability. The study adopted the Delphi technique to reach a consensus on several topics. Issues related to execution of KRAS testing were identified by an experts board and proposed to 108 Italian oncologists and pathologists through two subsequent questionnaires. The emerging proposal was evaluated by decision analyses models employed by technology assessment agencies in order to assess cost-effectiveness. Alternative therapeutic strategies included most commonly used chemotherapy regimens alone or in combination with cetuximab or bevacizumab. The survey indicated that time interval for obtaining KRAS test should not exceed 15 days, 10 days being an optimal interval. To assure the access to proper treatment, a useful strategy should be to anticipate the test after radical resection in patients at high risk of relapse. Early KRAS testing in high risk CRC patients generates incremental cost-effectiveness ratios between 6,000 and 13,000 Euro per quality adjusted life year (QALY) gained. In extensive sensitivity analyses ICERs were always below 15,000 Euro per QALY gained, far within the threshold of 60,000 Euro/QALY gained accepted by regulatory institutions in Italy. In metastatic CRC a time interval higher than 15 days for result of KRAS testing limits access to therapeutic choices. Anticipating KRAS testing before the onset of metastatic disease in patients at high risk does not affect the sustainability and cost-effectiveness profile of cetuximab in first-line mCRC. Early KRAS testing may prevent this inequality in high-risk patients, whether they develop metastases, and is a cost-effective strategy. Based on these results, present joined recommendations of Italian societies of Oncology and Pathology should be updated including early KRAS testing.	[Barone, Carlo] Gemelli Hosp, Med Oncol Unit, Rome, Italy; [Pinto, Carmine] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy; [Normanno, Nicola] Pascale Fdn, Cellular Biol & Biotherapies Unit, Naples, Italy; [Capussotti, Lorenzo] Umberto I Hosp, Turin, Italy; [Cognetti, Francesco] Regina Elena Hosp, Dept Med Oncol, Rome, Italy; [Falcone, Alfredo] Santa Chiara Hosp, Oncol Transplantat & New Med Technol Dept, Pisa, Italy; [Mantovani, Lorenzo] Univ Naples Federico II, Clin Med & Surg Unit, Naples, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Fondazione Pascale; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Santa Chiara Hospital; University of Naples Federico II	Barone, C (corresponding author), Gemelli Hosp, Med Oncol Unit, Rome, Italy.	carlobarone@rm.unicatt.it	Cognetti, Francesco/AAC-2637-2019; Normanno, Nicola/AAT-1107-2021; Pinto, Carmine/AAC-2184-2020; Falcone, Alfredo/G-5217-2013; Mantovani, Lorenzo Giovanni/AAC-4263-2021	Pinto, Carmine/0000-0002-3159-5268; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199; Falcone, Alfredo/0000-0001-5840-2529; COGNETTI, FRANCESCO/0000-0003-2022-9446; Normanno, Nicola/0000-0002-7158-2605	Merck Serono S.p.A.	Merck Serono S.p.A.	Merck Serono S.p.A. (http://www.merckserono.com/it/index.html) has given support to the scientific committee to finance the development of field work for the Delphi survey part of the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2012, NICE TECHN APPR GUID; Asseburg C, 2011, CLIN THER, V33, P482, DOI 10.1016/j.clinthera.2011.04.010; Barone C, 2012, FARMECONOMIA S1, V13, P1; Behl AS, 2012, JNCI-J NATL CANCER I, V104, P1785, DOI 10.1093/jnci/djs433; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Chan A, 2009, CLIN THER, V31, P2379, DOI 10.1016/j.clinthera.2009.11.008; Danielson B, 2011, RADIOTHER ONCOL, V99, P29, DOI 10.1016/j.radonc.2011.02.013; Delva F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-5; Dempke WCM, 2010, ANTICANCER RES, V30, P4673; Exposito J, 2010, CLIN TRANSL ONCOL, V12, P493, DOI 10.1007/s12094-010-0542-4; Fehr A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-312; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Frank SJ, 2011, BRACHYTHERAPY, V10, P357, DOI 10.1016/j.brachy.2011.01.014; Gagliardi AR, 2005, CAN J SURG, V48, P441; Garcia-Foncillas J, 2012, J CLIN ONCOL S4, V30; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lievre A, 2013, EUR J CANCER, V49, P2126, DOI 10.1016/j.ejca.2013.02.016; Linstone HA, 1975, DELPHI METHOD TECHNI, P1; Loblaw DA, 2012, J CLIN ONCOL, V30, P3136, DOI 10.1200/JCO.2012.42.0489; Marchetti A, 2011, J CLIN ONCOL S, V29; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Mileshkin Linda, 2012, Chemother Res Pract, V2012, P838509, DOI 10.1155/2012/838509; Moss EL, 2010, INT J GYNECOL CANCER, V20, P488, DOI 10.1111/IGC.0b013e3181a835a3; Petrelli F, 2012, INT J COLORECTAL DIS, V27, P997, DOI 10.1007/s00384-012-1438-2; Raijmakers NJH, 2012, PALLIATIVE MED, V26, P947, DOI 10.1177/0269216311423794; Robson N, 2010, EJSO-EUR J SURG ONC, V36, P230, DOI 10.1016/j.ejso.2010.01.002; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Shankaran V, 2009, ASCO 2009 GASTR CANC; Speksnijder HT, 2011, INT J NURS TERMIN CL, V22, P77, DOI 10.1111/j.1744-618X.2011.01183.x; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; Vijayaraghavan A, 2012, INT J CANCER, V131, P438, DOI 10.1002/ijc.26400; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85897	10.1371/journal.pone.0085897	http://dx.doi.org/10.1371/journal.pone.0085897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465771	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500085
J	Douidah, L; De Zutter, L; Van Nieuwerburgh, F; Deforce, D; Ingmer, H; Vandenberg, O; Van den Abeele, AM; Houf, K				Douidah, Laid; De Zutter, Lieven; Van Nieuwerburgh, Filip; Deforce, Dieter; Ingmer, Hanne; Vandenberg, Olivier; Van den Abeele, Anne-Marie; Houf, Kurt			Presence and Analysis of Plasmids in Human and Animal Associated Arcobacter Species	PLOS ONE			English	Article							BUTZLERI BACTEREMIA; IV SECRETION; IDENTIFICATION; CAMPYLOBACTER; PATIENT; DNA; HELICOBACTER; RESISTANCE; DIVERSITY; SEQUENCE	In this study, we report the screening of four Arcobacter species for the presence of small and large plasmids. Plasmids were present in 9.9% of the 273 examined strains. One Arcobacter cryaerophilus and four Arcobacter butzleri plasmids were selected for further sequencing. The size of three small plasmids isolated from A. butzleri and the one from A. cryaerophilus strains ranged between 4.8 and 5.1 kb, and the size of the large plasmid, isolated from A. butzleri, was 27.4 kbp. The G+C content of all plasmids ranged between 25.4% and 26.2%. A total of 95% of the large plasmid sequence represents coding information, which contrasts to the 20 to 30% for the small plasmids. Some of the open reading frames showed a high homology to putative conserved domains found in other related organisms, such as replication, mobilization and genes involved in type IV secretion system. The large plasmid carried 35 coding sequences, including seven genes in a contiguous region of 11.6 kbp that encodes an orthologous type IV secretion system found in the Wolinella succinogenes genome, Helicobacter pylori and Campylobacter jejuni plasmids, which makes this plasmid interesting for further exploration.	[Douidah, Laid; De Zutter, Lieven; Houf, Kurt] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg, Denmark; [Vandenberg, Olivier] Brussels Publ Hosp Network, Natl Reference Ctr Campylobacter, Iris Lab, Dept Microbiol, Brussels, Belgium; [Van den Abeele, Anne-Marie] Sint Lucas Hosp, Microbiol Lab, Ghent, Belgium	Ghent University; Ghent University; University of Copenhagen; Ghent University	Houf, K (corresponding author), Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium.	Kurt.houf@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Houf, Kurt/AAC-4027-2019; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Houf, Kurt/0000-0002-0909-7756; Deforce, Dieter LD/0000-0002-0635-661X; Ingmer, Hanne/0000-0002-8350-5631				Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bacon DJ, 2002, INFECT IMMUN, V70, P6242, DOI 10.1128/IAI.70.11.6242-6250.2002; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Smet S, 2011, APPL ENVIRON MICROB, V77, P1732, DOI 10.1128/AEM.02409-10; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Douidah L, 2010, J MICROBIOL METH, V80, P281, DOI 10.1016/j.mimet.2010.01.009; Harrass B, 1998, J VET MED B, V45, P87, DOI 10.1111/j.1439-0450.1998.tb00770.x; Houf K, 2005, INT J SYST EVOL MICR, V55, P713, DOI 10.1099/ijs.0.63103-0; Houf K, 2002, APPL ENVIRON MICROB, V68, P2172, DOI 10.1128/AEM.68.5.2172-2178.2002; Houf K, 2001, INT J FOOD MICROBIOL, V71, P189, DOI 10.1016/S0168-1605(01)00605-5; Houf K, 2002, J FOOD PROTECT, V65, P1233, DOI 10.4315/0362-028X-65.8.1233; Houf K, 2007, J MICROBIOL METH, V68, P408, DOI 10.1016/j.mimet.2006.09.020; Hsueh PR, 1997, J CLIN MICROBIOL, V35, P489, DOI 10.1128/JCM.35.2.489-491.1997; International Commission on Microbiological Specifications for Foods (ICMSF), 2002, MICR FOODS MICR TEST; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Lau SKP, 2002, J CLIN PATHOL-MOL PA, V55, P182, DOI 10.1136/mp.55.3.182; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; ON SLW, 1995, J INFECTION, V31, P225, DOI 10.1016/S0163-4453(95)80031-X; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; Snyder L, 1997, MOL GENETICS BACTERI, P265; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; Tagliabue L, 2010, MICROBIOL-SGM, V156, P2901, DOI 10.1099/mic.0.041350-0; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Toh H, 2011, J BACTERIOL, V193, P6411, DOI 10.1128/JB.06084-11; TREVORS JT, 1985, FEMS MICROBIOL LETT, V32, P39, DOI 10.1016/0378-1097(85)90025-4; Van Driessche E, 2004, RES MICROBIOL, V155, P662, DOI 10.1016/j.resmic.2004.04.011; Van Driessche E, 2003, FEMS MICROBIOL LETT, V229, P243, DOI 10.1016/S0378-1097(03)00840-1; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0; Woo PCY, 2001, DIAGN MICR INFEC DIS, V40, P125, DOI 10.1016/S0732-8893(01)00261-9; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004; Yan JJ, 2000, J FORMOS MED ASSOC, V99, P166	38	19	20	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85487	10.1371/journal.pone.0085487	http://dx.doi.org/10.1371/journal.pone.0085487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465575	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500051
J	Schmidt, M; Neuner, B; Kindler, A; Scholtz, K; Eckardt, R; Neuhaus, P; Spies, C				Schmidt, Maren; Neuner, Bruno; Kindler, Andrea; Scholtz, Kathrin; Eckardt, Rahel; Neuhaus, Peter; Spies, Claudia			Prediction of Long-Term Mortality by Preoperative Health-Related Quality-of-Life in Elderly Onco-Surgical Patients	PLOS ONE			English	Article							EORTC QLQ-C30; COGNITIVE FUNCTION; PROGNOSTIC-SIGNIFICANCE; EUROPEAN-ORGANIZATION; CANCER-PATIENTS; SURVIVAL; SURGERY; CHEMOTHERAPY; COMPLICATIONS; DYSFUNCTION	Objective: Aim of this study was to evaluate the association between preoperative health-related quality of life (HRQoL) and mortality in a cohort of elderly patients (>65 years) with gastrointestinal, gynecological and genitourinary carcinomas. Design: Prospective cohort pilot study. Setting: Tertiary university hospital in Germany. Patients: Between June 2008 and July 2010 and after ethical committee approval and written informed consent, 126 patients scheduled for onco-surgery were included. Prior to surgery as well as 3 and 12 months postoperatively all participants completed the EORTC-QLQ-C30 questionnaire (measuring self-reported health-related quality of life). Additionally, demographic and clinical data including the Mini Mental State Examination (MMSE) were collected. Surgery and anesthesia were conducted according to the standard operating procedures. Primary endpoint was the cumulative mortality rate over 12 months after one year. Changes in Quality of life were considered as secondary outcome. Results: Mortality after one year was 28%. In univariable and multivariable logistic regression analysis baseline HRQoL self-reported cognitive function (OR per point: 0.98; CI 95% 0.96-0.99; p = 0.024) and higher symptom burden for appetite loss (per point: OR 1.02; CI 95% 1.00-1.03; p = 0.014) were predictive for long-term mortality. Additionally the MMSE as an objective measure of cognitive impairment (per point: OR 0.69; CI 95% 0.51-0.96; p = 0.026) as well as severity of surgery (OR 0.31; CI 95% 0.11-0.93; p = 0.036) were predictive for long-term mortality. Global health status 12 months after surgery was comparable to the baseline levels in survivors despite moderate impairments in other domains. Conclusion: This study showed that objective and self-reported cognitive functioning together with appetite loss were prognostic for mortality in elderly cancer patients. In addition, impaired cognitive dysfunction and severity of surgery were predictive for one-year mortality whereas in this selected population scheduled for surgery age, gender, cancer site and metastases were not.	[Schmidt, Maren; Neuner, Bruno; Kindler, Andrea; Scholtz, Kathrin; Spies, Claudia] Charite, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Schmidt, Maren; Neuner, Bruno; Kindler, Andrea; Scholtz, Kathrin; Spies, Claudia] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Eckardt, Rahel] Charite, Charite Res Grp Geriatr, D-13353 Berlin, Germany; [Neuhaus, Peter] Charite, Dept Gen Visceral & Transplantat Surg, Charite Campus Virchow, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spies, C (corresponding author), Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany.	claudia.spies@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495; Schmidt, Maren/0000-0002-7821-9577				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P295, DOI 10.1177/026921639500900404; Amemiya T, 2007, ANN SURG, V246, P222, DOI 10.1097/SLA.0b013e3180caa3fb; Benyamini Y, 2003, PSYCHO-ONCOLOGY, V12, P161, DOI 10.1002/pon.637; Blazeby JM, 2005, BRIT J SURG, V92, P1502, DOI 10.1002/bjs.5175; Bowling A, 2002, AGING MENT HEALTH, V6, P355, DOI 10.1080/1360786021000006983; Braun DP, 2013, PANCREAS, V42, P254, DOI 10.1097/MPA.0b013e31825b9f56; Camilleri-Brennan J, 2001, BRIT J SURG, V88, P1617, DOI 10.1046/j.0007-1323.2001.01933.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; COPELAND GP, 1991, BRIT J SURG, V78, P356; Correa DD, 2012, GYNECOL ONCOL, V124, P404, DOI 10.1016/j.ygyno.2011.11.005; de Graeff A, 2001, EUR J CANCER, V37, P332, DOI 10.1016/S0959-8049(00)00385-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Efficace F, 2009, EUR J HAEMATOL, V82, P484, DOI 10.1111/j.1600-0609.2009.01254.x; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fitzsimmons D, 2009, EUR J CANCER, V45, P19, DOI 10.1016/j.ejca.2008.07.036; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ME, 2001, QUAL LIFE RES, V10, P533, DOI 10.1023/A:1013003014340; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Hestad K, 1998, CLINICAL GEROPSYCHOLOGY, P259, DOI 10.1037/10295-022; Higginson I, 1993, Qual Health Care, V2, P112, DOI 10.1136/qshc.2.2.112; HISLOP TG, 1987, J CHRON DIS, V40, P729; Hjermstad MJ, 1998, EUR J CANCER, V34, P1381, DOI 10.1016/S0959-8049(98)00136-1; Iconomou G, 2004, CANCER-AM CANCER SOC, V101, P404, DOI 10.1002/cncr.20385; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Iwasa H, 2013, INT J GERIATR PSYCH, V28, P841, DOI 10.1002/gps.3890; Johnson C, 2010, EUR J CANCER, V46, P2242, DOI 10.1016/j.ejca.2010.04.014; Kaatsch P, 2012, HAUFIGKEITEN TRENDS, V8; KATZ S, 1987, J CHRON DIS, V40, P459, DOI 10.1016/0021-9681(87)90001-4; Lichtman SM, 2007, J CLIN ONCOL, V25, P1821, DOI 10.1200/JCO.2007.10.6567; Mastracci TM, 2006, DIS COLON RECTUM, V49, P1878, DOI 10.1007/s10350-006-0725-9; Minisini AM, 2008, CRIT REV ONCOL HEMAT, V67, P71, DOI 10.1016/j.critrevonc.2008.02.004; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Montazeri A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-102; Neuman HB, 2013, CANCER-AM CANCER SOC, V119, P639, DOI 10.1002/cncr.27765; O'Connell JB, 2004, ANN SURG ONCOL, V11, P962, DOI 10.1245/ASO.2004.03.052; Oates JE, 2007, ARCH OTOLARYNGOL, V133, P533, DOI 10.1001/archotol.133.6.533; Oberaigner W, 2012, ACTA ONCOL, V51, P441, DOI 10.3109/0284186X.2011.653437; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Osoba D, 2007, SUPPORT CARE CANCER, V15, P353, DOI 10.1007/s00520-006-0187-6; Park S, 2013, ANN ONCOL, V24, P1630, DOI 10.1093/annonc/mds649; PERRY EK, 1980, AGE AGEING, V9, P1, DOI 10.1093/ageing/9.1.1; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Repetto L, 2001, CRIT REV ONCOL HEMAT, V37, P147, DOI 10.1016/S1040-8428(00)00104-9; Robb C, 2010, CRIT REV ONCOL HEMAT, V74, P218, DOI 10.1016/j.critrevonc.2009.07.002; Robinson TN, 2012, J AM COLL SURGEONS, V215, P12, DOI 10.1016/j.jamcollsurg.2012.02.007; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Schwarz R, 2001, EUR J CANCER, V37, P1345, DOI 10.1016/S0959-8049(00)00447-0; Semple C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009441.pub2; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Spies C., 2013, SOPS AN STHESIOLOGIE; Story DA, 2008, CURR OPIN ANESTHESIO, V21, P375, DOI 10.1097/ACO.0b013e3282f889f8; van Heijl M, 2010, ANN SURG ONCOL, V17, P23, DOI 10.1245/s10434-009-0731-y; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	58	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85456	10.1371/journal.pone.0085456	http://dx.doi.org/10.1371/journal.pone.0085456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465568	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500049
J	Weiss, EM; Schulter, G; Fink, A; Reiser, EM; Mittenecker, E; Niederstatter, H; Nagl, S; Parson, W; Papousek, I				Weiss, Elisabeth M.; Schulter, Guenter; Fink, Andreas; Reiser, Eva M.; Mittenecker, Erich; Niederstaetter, Harald; Nagl, Simone; Parson, Walther; Papousek, Ilona			Influences of COMT and 5-HTTLPR Polymorphisms on Cognitive Flexibility in Healthy Women: Inhibition of Prepotent Responses and Memory Updating	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; CARD SORTING TEST; SEROTONIN TRANSPORTER POLYMORPHISM; ACUTE TRYPTOPHAN DEPLETION; RANDOM NUMBER GENERATION; WORKING-MEMORY; GENETIC-VARIATION; SCHIZOPHRENIC-PATIENTS; PARKINSONS-DISEASE; PREFRONTAL CORTEX	Understanding genetic factors that affect monoamine neurotransmitters flux in prefrontal cortex may help to further specify the complex neurobiological processes that underlie cognitive function and dysfunction in health and illness. The current study examined the associations between the polymorphisms of dopaminergic ( COMT Met158Val) and serotoninergic (5-HTTLPR) genes and the sequential pattern of responses in a motor random generation task providing well-established indexes for executive functioning in a large sample of 255 healthy women. Participants homozygous for the Met allele of the COMT polymorphism showed impaired inhibition of prepotent responses, whereas individuals homozygous for the s-allele of the 5-HTTLPR showed a restricted ability to update information in working memory. Taken together the results indicate differentiated influences of dopaminergic and serotonergic genes on important and definite executive sub-processes related to cognitive flexibility.	[Weiss, Elisabeth M.; Schulter, Guenter; Fink, Andreas; Reiser, Eva M.; Mittenecker, Erich; Papousek, Ilona] Graz Univ, Dept Psychol, Biol Psychol Unit, Graz, Austria; [Niederstaetter, Harald; Nagl, Simone; Parson, Walther] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria	University of Graz; Medical University of Innsbruck	Weiss, EM (corresponding author), Graz Univ, Dept Psychol, Biol Psychol Unit, Graz, Austria.	e.weiss@uni-graz.at	Parson, Walther/AAD-6845-2020; VARRECCHIA, TIWANA/AAJ-8712-2021; Papousek, Ilona/H-3043-2019	Papousek, Ilona/0000-0002-6620-0318; Parson, Walther/0000-0002-5692-2392; Fink, Andreas/0000-0001-7316-3140; Weiss, Elisabeth/0000-0003-1296-3448				Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Avons SE, 2003, PSYCHIAT RES, V120, P145, DOI 10.1016/S0165-1781(03)00174-4; AXMACHER I, 1970, ARZNEI-FORSCHUNG, V20, P919; Baddeley A. D, 1986, WORKING MEMORY; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Borg J, 2009, INT J NEUROPSYCHOPH, V12, P783, DOI 10.1017/S1461145708009759; Brown RG, 1998, NEUROPSYCHOLOGIA, V36, P1355, DOI 10.1016/S0028-3932(98)00015-3; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; DeYoung CG, 2012, DEV PSYCHOPATHOL, V24, P1307, DOI 10.1017/S0954579412000727; Diaz-Asper CM, 2008, BIOL PSYCHIAT, V63, P72, DOI 10.1016/j.biopsych.2007.03.031; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Enge S, 2011, NEUROPSYCHOLOGIA, V49, P3776, DOI 10.1016/j.neuropsychologia.2011.09.038; EVANS FJ, 1978, B PSYCHONOMIC SOC, V12, P35; Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Gonzalez-Burgos I, 2012, NEUROSCI RES, V73, P321, DOI 10.1016/j.neures.2012.05.003; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GUTTMANN G, 1966, Z EXP ANGEW PSYCHOL, V13, P19; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; HERZOG GR, 1989, Z EXP ANGEW PSYCHOL, V36, P199; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Izquierdo A, 2007, P NATL ACAD SCI USA, V104, P14128, DOI 10.1073/pnas.0706583104; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; KRUG R, 1994, PSYCHONEUROENDOCRINO, V19, P21, DOI 10.1016/0306-4530(94)90056-6; KUHL J, 1974, PSYCHOL RES-PSYCH FO, V37, P143, DOI 10.1007/BF00308418; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lamar M, 2009, NEUROBIOL AGING, V30, P1135, DOI 10.1016/j.neurobiolaging.2007.09.013; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Luciana M, 1998, CEREB CORTEX, V8, P218, DOI 10.1093/cercor/8.3.218; Ludewig K, 2003, PSYCHIAT RES, V119, P293, DOI 10.1016/S0165-1781(03)00103-3; LYON M, 1994, SCHIZOPHR RES, V13, P45, DOI 10.1016/0920-9964(94)90059-0; Madsen K, 2011, PSYCHOPHARMACOLOGY, V213, P573, DOI 10.1007/s00213-010-1926-4; Marini S, 2011, ARCH GERONTOL GERIAT, V52, pE71, DOI 10.1016/j.archger.2010.06.006; Mazei MS, 2002, BRAIN RES, V936, P58, DOI 10.1016/S0006-8993(02)02542-8; Mittenecker E, 1960, Z EXPT ANGEWANDTE PS, V7, P392; Mittenecker E, 1958, Z EXPT ANGEWANDTE PS, V5, P45; Mittenecker E, 1953, Z EXPT ANGEWANDTE PS, V1, P5; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morrens M, 2006, EUR NEUROPSYCHOPHARM, V16, pS392, DOI 10.1016/S0924-977X(06)70480-1; Morrens M, 2008, PSYCHIAT RES, V161, P121, DOI 10.1016/j.psychres.2008.01.017; Morrens M, 2006, SCHIZOPHR RES, V84, P397, DOI 10.1016/j.schres.2006.01.024; Murphy FC, 2002, PSYCHOPHARMACOLOGY, V163, P42, DOI 10.1007/s00213-002-1128-9; Naudon L, 2007, PSYCHOPHARMACOLOGY, V191, P353, DOI 10.1007/s00213-006-0660-4; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Hara R, 2007, MOL PSYCHIATR, V12, P544, DOI 10.1038/sj.mp.4001978; Oberacher H, 2006, ANAL BIOANAL CHEM, V386, P83, DOI 10.1007/s00216-006-0589-9; Pacheco J, 2012, NEUROPSYCHOLOGIA, V50, P2257, DOI 10.1016/j.neuropsychologia.2012.05.030; Paulus MP, 1999, SCHIZOPHR RES, V35, P69, DOI 10.1016/S0920-9964(98)00108-X; Paulus MP, 1999, BIOL PSYCHIAT, V46, P662, DOI 10.1016/S0006-3223(99)00086-4; Perras B, 2001, PSYCHONEUROENDOCRINO, V26, P1, DOI 10.1016/S0306-4530(00)00031-7; Price JS, 2013, BEHAV BRAIN RES, V242, P158, DOI 10.1016/j.bbr.2012.11.013; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; REMSCHMIDT H, 1970, FORTSCHR NEUROL P I, V38, P524; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Rosa A, 2004, AM J PSYCHIAT, V161, P1110, DOI 10.1176/appi.ajp.161.6.1110; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Rybakowski JK, 2006, PSYCHIAT RES, V143, P13, DOI 10.1016/j.psychres.2005.10.008; Rybakowski JK, 2005, J NEURAL TRANSM, V112, P1575, DOI 10.1007/s00702-005-0292-6; Schmitt JAJ, 2000, J PSYCHOPHARMACOL, V14, P21, DOI 10.1177/026988110001400102; Schmuck P, 1996, DIAGNOSTICA, V42, P47; Schulter G, 1987, PERSPEKTIVEN PSYCHOL, P77; Schulter G, 2010, BEHAV RES METHODS, V42, P333, DOI 10.3758/BRM.42.1.333; SCHWIBBE MH, 1985, Z KLIN PSYCHOL-FORSC, V14, P130; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Stoffers D, 2001, NEUROLOGY, V57, P2111, DOI 10.1212/WNL.57.11.2111; Stottenberg SF, 2010, NEUROPHARMACOLOGY, V58, P423, DOI 10.1016/j.neuropharm.2009.09.010; Strobel A, 2007, J COGNITIVE NEUROSCI, V19, P1923, DOI 10.1162/jocn.2007.19.12.1923; Towse JN, 1998, BRIT J PSYCHOL, V89, P77, DOI 10.1111/j.2044-8295.1998.tb02674.x; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4	92	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85506	10.1371/journal.pone.0085506	http://dx.doi.org/10.1371/journal.pone.0085506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465579	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500053
J	Baranski, M; Gopikrishna, G; Robinson, NA; Katneni, VK; Shekhar, MS; Shanmugakarthik, J; Jothivel, S; Gopal, C; Ravichandran, P; Kent, M; Arnyasi, M; Ponniah, AG				Baranski, Matthew; Gopikrishna, Gopalapillay; Robinson, Nicholas A.; Katneni, Vinaya Kumar; Shekhar, Mudagandur S.; Shanmugakarthik, Jayakani; Jothivel, Sarangapani; Gopal, Chavali; Ravichandran, Pitchaiyappan; Kent, Matthew; Arnyasi, Mariann; Ponniah, Alphis G.			The Development of a High Density Linkage Map for Black Tiger Shrimp (Penaeus monodon) Based on cSNPs	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; POLYMORPHIC MICROSATELLITE MARKERS; INFECTIOUS PANCREATIC NECROSIS; EXPRESSED SEQUENCE TAGS; SALMO-SALAR REVEALS; SYNDROME VIRUS WSSV; KURUMA PRAWN; LITOPENAEUS-VANNAMEI; GENE-EXPRESSION; GENOME	Transcriptome sequencing using Illumina RNA-seq was performed on populations of black tiger shrimp from India. Samples were collected from (i) four landing centres around the east coastline (EC) of India, (ii) survivors of a severe WSSV infection during pond culture (SUR) and (iii) the Andaman Islands (AI) in the Bay of Bengal. Equal quantities of purified total RNA from homogenates of hepatopancreas, muscle, nervous tissue, intestinal tract, heart, gonad, gills, pleopod and lymphoid organs were combined to create AI, EC and SUR pools for RNA sequencing. De novo transcriptome assembly resulted in 136,223 contigs (minimum size 100 base pairs, bp) with a total length 61 Mb, an average length of 446 bp and an average coverage of 163 x across all pools. Approximately 16% of contigs were annotated with BLAST hit information and gene ontology annotations. A total of 473,620 putative SNPs/indels were identified. An Illumina iSelect genotyping array containing 6,000 SNPs was developed and used to genotype 1024 offspring belonging to seven full-sibling families. A total of 3959 SNPs were mapped to 44 linkage groups. The linkage groups consisted of between 16-129 and 13-130 markers, of length between 139-10.8 and 109.1-10.5 cM and with intervals averaging between 1.2 and 0.9 cM for the female and male maps respectively. The female map was 28% longer than the male map (4060 and 2917 cM respectively) with a 1.6 higher recombination rate observed for female compared to male meioses. This approach has substantially increased expressed sequence and DNA marker resources for tiger shrimp and is a useful resource for QTL mapping and association studies for evolutionarily and commercially important traits.	[Baranski, Matthew; Robinson, Nicholas A.] Nofima, As, Norway; [Gopikrishna, Gopalapillay; Katneni, Vinaya Kumar; Shekhar, Mudagandur S.; Shanmugakarthik, Jayakani; Jothivel, Sarangapani; Gopal, Chavali; Ravichandran, Pitchaiyappan; Ponniah, Alphis G.] Cent Inst Brackishwater Aquaculture, Madras, Tamil Nadu, India; [Robinson, Nicholas A.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Kent, Matthew; Arnyasi, Mariann] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	Nofima; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute Brackishwater Aquaculture; Flinders University South Australia; Norwegian University of Life Sciences	Baranski, M (corresponding author), Nofima, As, Norway.	matthew.baranski@nofima.no	Robinson, Nicholas/H-2745-2017; Ponniah, A.G./AAI-5665-2020; Katneni, Vinaya/AGU-4127-2022; Robinson, Nicholas/P-2672-2019; Baranski, Matthew/I-7839-2018	Robinson, Nicholas/0000-0003-1724-2551; Baranski, Matthew/0000-0002-9138-071X	Norwegian Research Council; Department of Biotechnology of India; Indian Council of Agricultural Research of India [183833]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Department of Biotechnology of India; Indian Council of Agricultural Research of India	The authors are thankful to the Norwegian Research Council, Department of Biotechnology of India and Indian Council of Agricultural Research of India for funding this project (project 183833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andriantahina F, 2013, MAR BIOTECHNOL, V15, P399, DOI 10.1007/s10126-013-9500-9; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Ciobanu DC, 2010, ANIM GENET, V41, P39, DOI 10.1111/j.1365-2052.2009.01961.x; de Freitas PD, 2007, GENET MOL BIOL, V30, P1194, DOI 10.1590/S1415-47572007000600027; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fishman L, 2001, GENETICS, V159, P1701; Food and Agriculture Organisation of the United Nations, 2010, STAT WORLD FISH AQ; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Gitterle T, 2005, AQUACULTURE, V246, P139, DOI 10.1016/j.aquaculture.2005.02.011; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Hayes BJ, 2010, AQUAC RES, V41, pe872, DOI 10.1111/j.1365-2109.2010.02611.x; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Huang PY, 2008, FISH SHELLFISH IMMUN, V25, P250, DOI 10.1016/j.fsi.2008.06.002; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Ibarra AM, 2007, AQUACULTURE, V268, P23, DOI 10.1016/j.aquaculture.2007.04.028; Jeswin J, 2013, AQUACULTURE, V380, P84, DOI 10.1016/j.aquaculture.2012.12.004; Lehnert SA, 1999, MAR BIOTECHNOL, V1, P465, DOI 10.1007/PL00011803; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li YT, 2003, AQUACULTURE, V219, P143, DOI 10.1016/S0044-8486(02)00355-1; Li YT, 2006, AQUACULTURE, V258, P198, DOI 10.1016/j.aquaculture.2006.04.027; Li ZX, 2006, AQUACULTURE, V261, P463, DOI 10.1016/j.aquaculture.2006.07.002; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lyons RE, 2007, MAR BIOTECHNOL, V9, P712, DOI 10.1007/s10126-007-9022-4; Maneeruttanarungroj C, 2006, ANIM GENET, V37, P363, DOI 10.1111/j.1365-2052.2006.01493.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moen T, 2004, ANIM GENET, V35, P81, DOI 10.1111/j.1365-2052.2004.01097.x; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pan YW, 2004, MOL ECOL NOTES, V4, P345, DOI 10.1111/j.1471-8286.2004.00692.x; Perez F, 2004, AQUACULTURE, V242, P105, DOI 10.1016/j.aquaculture.2004.09.002; Qi HG, 2009, AQUAC RES, V40, P1661, DOI 10.1111/j.1365-2109.2009.02269.x; Robinson N, 2012, MAR BIOTECHNOL, V14, P620, DOI 10.1007/s10126-012-9433-8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Sun ZN, 2008, HYDROBIOLOGIA, V596, P133, DOI 10.1007/s10750-007-9063-8; Tassanakajon A, 1998, MOL MAR BIOL BIOTECH, V7, P55; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tian Y, 2008, CHINESE SCI BULL, V53, P1205, DOI 10.1007/s11434-008-0170-3; Tong J, 2002, AQUACULTURE, V208, P69, DOI 10.1016/S0044-8486(01)00706-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Whan VA, 2000, ANIM GENET, V31, P143; Whankaew S, 2008, MOL ECOL RESOUR, V8, P1494, DOI 10.1111/j.1755-0998.2008.02290.x; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Woram RA, 2004, GENOME, V47, P304, DOI [10.1139/G03-127, 10.1139/g03-127]; Wuthisuthimethavee S, 2003, AQUACULTURE, V224, P39, DOI 10.1016/S0044-8486(03)00222-9; Xu Z, 1999, ANIM GENET, V30, P150, DOI 10.1046/j.1365-2052.1999.00458.x; You E, 2009, PLANT AN GEN 17 C SA; You EM, 2010, ANIM GENET, V41, P365, DOI 10.1111/j.1365-2052.2009.02014.x; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8	59	52	55	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85413	10.1371/journal.pone.0085413	http://dx.doi.org/10.1371/journal.pone.0085413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465553	Green Published, gold, Green Accepted			2022-12-27	WOS:000330237000032
J	Bersten, DC; Bruning, JB; Peet, DJ; Whitelaw, ML				Bersten, David C.; Bruning, John B.; Peet, Daniel J.; Whitelaw, Murray L.			Human Variants in the Neuronal Basic Helix-Loop-Helix/Per-Arnt-Sim (bHLH/PAS) Transcription Factor Complex NPAS4/ARNT2 Disrupt Function	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDERS; PAS DOMAIN; RESPONSE ELEMENT; GENE-EXPRESSION; DNA-BINDING; CROSS-TALK; PROTEIN; OBESITY	Neuronal Per-Arnt-Sim homology (PAS) Factor 4 (NPAS4) is a neuronal activity-dependent transcription factor which heterodimerises with ARNT2 to regulate genes involved in inhibitory synapse formation. NPAS4 functions to maintain excitatory/inhibitory balance in neurons, while mouse models have shown it to play roles in memory formation, social interaction and neurodegeneration. NPAS4 has therefore been implicated in a number of neuropsychiatric or neurodegenerative diseases which are underpinned by defects in excitatory/inhibitory balance. Here we have explored a broad set of non-synonymous human variants in NPAS4 and ARNT2 for disruption of NPAS4 function. We found two variants in NPAS4 (F147S and E257K) and two variants in ARNT2 (R46W and R107H) which significantly reduced transcriptional activity of the heterodimer on a luciferase reporter gene. Furthermore, we found that NPAS4. F147S was unable to activate expression of the NPAS4 target gene BDNF due to reduced dimerisation with ARNT2. Homology modelling predicts F147 in NPAS4 to lie at the dimer interface, where it appears to directly contribute to protein/protein interaction. We also found that reduced transcriptional activation by ARNT2 R46W was due to disruption of nuclear localisation. These results provide insight into the mechanisms of NPAS4/ARNT dimerisation and transcriptional activation and have potential implications for cognitive phenotypic variation and diseases such as autism, schizophrenia and dementia.	[Whitelaw, Murray L.] Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia; Univ Adelaide, Australian Res Council Special Res Ctr Mol Genet, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Whitelaw, ML (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia.	murray.whitelaw@adelaide.edu.au	Peet, Daniel/AAE-6698-2020; Bruning, John/AAW-8567-2020	Peet, Daniel/0000-0002-6085-8936; Bruning, John/0000-0002-6919-1824	Australian Research Council	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chapman-Smith A, 2006, J BIOL CHEM, V281, P12535, DOI 10.1074/jbc.M512145200; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Farrall AL, 2009, ONCOGENE, V28, P3671, DOI 10.1038/onc.2009.228; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Floor K, 2012, EUR J MED GENET, V55, P695, DOI 10.1016/j.ejmg.2012.08.002; Fu W, 2012, NATURE; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hao N, 2011, NUCLEIC ACIDS RES, V39, P3695, DOI 10.1093/nar/gkq1336; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Olechnowicz SWZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044564; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, BBA-GENE REGUL MECH, V1789, P192, DOI 10.1016/j.bbagrm.2009.01.003; Ooe N, 2009, J BIOL CHEM, V284, P1057, DOI 10.1074/jbc.M805196200; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	65	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85768	10.1371/journal.pone.0085768	http://dx.doi.org/10.1371/journal.pone.0085768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465693	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000062
J	Byrne, L; Elson, R; Dallman, TJ; Perry, N; Ashton, P; Wain, J; Adak, GK; Grant, KA; Jenkins, C				Byrne, Lisa; Elson, Richard; Dallman, Timothy J.; Perry, Neil; Ashton, Philip; Wain, John; Adak, Goutam K.; Grant, Kathie A.; Jenkins, Claire			Evaluating the Use of Multilocus Variable Number Tandem Repeat Analysis of Shiga Toxin-Producing Escherichia coli O157 as a Routine Public Health Tool in England	PLOS ONE			English	Article							INFECTION; OUTBREAK; ELECTROPHORESIS; PROTOCOL; CONTACT; WALES	Multilocus variable number tandem repeat analysis (MLVA) provides microbiological support for investigations of clusters of cases of infection with Shiga toxin-producing E. coli (STEC) O157. All confirmed STEC O157 isolated in England and submitted to the Gastrointestinal Bacteria Reference Unit (GBRU) during a six month period were typed using MLVA, with the aim of assessing the impact of this approach on epidemiological investigations. Of 539 cases investigated, 341 (76%) had unique (>2 single locus variants) MLVA profiles, 12% of profiles occurred more than once due to known household transmission and 12% of profiles occurred as part of 41 clusters, 21 of which were previously identified through routine public health investigation of cases. The remaining 20 clusters were not previously detected and STEC enhanced surveillance data for associated cases were retrospectively reviewed for epidemiological links including shared exposures, geography and/or time. Additional evidence of a link between cases was found in twelve clusters. Compared to phage typing, the number of sporadic cases was reduced from 69% to 41% and the diversity index for MLVA was 0.996 versus 0.782 for phage typing. Using MLVA generates more data on the spatial and temporal dispersion of cases, better defining the epidemiology of STEC infection than phage typing. The increased detection of clusters through MLVA typing highlights the challenges to health protection practices, providing a forerunner to the advent of whole genome sequencing as a diagnostic tool.	[Byrne, Lisa; Elson, Richard; Adak, Goutam K.] Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, Hlth Protect Serv, Ctr Infect Dis Surveillance & Control, London, England; [Dallman, Timothy J.; Perry, Neil; Ashton, Philip; Grant, Kathie A.; Jenkins, Claire] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, Microbiol Serv,GBRU, Ctr Infect Dis Surveillance & Control, London, England; [Wain, John] Univ E Anglia, Fac Med & Hlth Serv, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; Public Health England; University of East Anglia	Byrne, L (corresponding author), Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, Hlth Protect Serv, Ctr Infect Dis Surveillance & Control, London, England.	lisa.byrne@phe.gov.uk	Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	Wain, John Richard/0000-0002-1257-1148	Public Health England Strategic Research and Development Fund [108061]	Public Health England Strategic Research and Development Fund	The MLVA component of this study, and the authors PA and NP were funded by the Public Health England Strategic Research and Development Fund: Grant #108061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Cowden JM, 2001, EPIDEMIOL INFECT, V126, P335, DOI 10.1017/S0950268801005520; Dyet KH, 2011, EPIDEMIOL INFECT, V139, P464, DOI 10.1017/S0950268810001068; Gillespie IA, 2005, EPIDEMIOL INFECT, V133, P803, DOI 10.1017/S0950268805004486; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Hyytia-Trees E, 2010, FOODBORNE PATHOG DIS, V7, P129, DOI 10.1089/fpd.2009.0371; Ihekweazu C, 2012, EPIDEMIOL INFECT, V140, P1400, DOI 10.1017/S0950268811002111; Jenkins C, 2012, J MED MICROBIOL, V61, P1082, DOI 10.1099/jmm.0.041517-0; KHAKHRIA R, 1990, EPIDEMIOL INFECT, V105, P511, DOI 10.1017/S0950268800048135; Locking ME, 2001, EPIDEMIOL INFECT, V127, P215, DOI 10.1017/S0950268801006045; Lynn RM, 2005, EMERG INFECT DIS, V11, P590, DOI 10.3201/eid1104.040833; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; Pei YX, 2008, JPN J INFECT DIS, V61, P58; Perry N, 2013, J APPL MICROBIOL, V10; Pritchard GC, 2009, VET REC, V164, P545, DOI 10.1136/vr.164.18.545; Salmon R, 2005, EUROSURVEILLANCE, V10; Underwood AP, 2013, J CLIN MICROBIOL, V51, P232, DOI 10.1128/JCM.01696-12	19	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85901	10.1371/journal.pone.0085901	http://dx.doi.org/10.1371/journal.pone.0085901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465775	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330237000073
J	Guaraldi, P; Poda, R; Calandra-Buonaura, G; Solieri, L; Sambati, L; Gallassi, R; Cortelli, P				Guaraldi, Pietro; Poda, Roberto; Calandra-Buonaura, Giovanna; Solieri, Laura; Sambati, Luisa; Gallassi, Roberto; Cortelli, Pietro			Cognitive Function in Peripheral Autonomic Disorders	PLOS ONE			English	Article							ORTHOSTATIC HYPOTENSION; FAILURE; DEFINITION	Objective: aims of the current study were 1) to evaluate global cognitive function in patients with autonomic failure (AF) of peripheral origin and 2) to investigate the effect of a documented fall in blood pressure (BP) fulfilling the criteria for orthostatic hypotension (OH) on cognitive performances. Methods: we assessed 12 consecutive patients (10 males, 68 +/- 7 years old) with pure AF (PAF) or autoimmune autonomic neuropathy (AAN) and 12 age-and gender-matched controls. All patients had no clinical signs of central nervous system involvement and normal brain CT/MRI scan. Cognitive function was assessed on two consecutive days in 3 conditions: on day 1, while sitting, by means of a comprehensive battery of neuropsychological tests; on day 2, while tilted (HUT) and during supine rest (supine) in a randomized manner. BP and heart rate (HR) were continuously recorded non-invasively for the whole duration of the examination. Results: patients with PAF or AAN displayed a preserved global cognitive function while sitting. However, compared to supine assessment, during HUT patients scored significantly worse during the Trail Making Test A and B, Barrage test, Analogies test, Immediate Visual Memory, Span Forward and Span Backward test. Pathological scores, with regard to Italian normative range values, were observed only during HUT in the Barrage test and in the Analogies test in 3 and 6 patients respectively. On the contrary, in healthy controls, results to neuropsychological tests were not significantly different, during HUT compared to supine rest. Conclusions: these data demonstrate that patients with PAF and AAN present a normal sitting global cognitive evaluation. However, their executive functions worsen significantly during the orthostatic challenge, possibly because of transient frontal lobes hypoperfusion.	[Guaraldi, Pietro; Poda, Roberto; Calandra-Buonaura, Giovanna; Solieri, Laura; Sambati, Luisa; Gallassi, Roberto; Cortelli, Pietro] IRCCS, Inst Neurol Sci Bologna, Bologna, Italy; [Guaraldi, Pietro; Poda, Roberto; Calandra-Buonaura, Giovanna; Solieri, Laura; Sambati, Luisa; Gallassi, Roberto; Cortelli, Pietro] Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, Bologna, Italy	IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna	Guaraldi, P (corresponding author), IRCCS, Inst Neurol Sci Bologna, Bologna, Italy.	pietro.guaraldi@unibo.it	Cortelli, Pietro/K-6063-2016; Buonaura, Giovanna Calandra/K-5281-2016; Guaraldi, Pietro/K-4558-2018; Poda, Roberto/AAB-9576-2020	Buonaura, Giovanna Calandra/0000-0002-9447-3532; Poda, Roberto/0000-0003-4055-6989; Cortelli, Pietro/0000-0002-3633-8818; , Luisa Sambati/0000-0002-5939-7933; Guaraldi, Pietro/0000-0003-0597-603X	RFO University of Bologna	RFO University of Bologna	Supported by by RFO 2012 University of Bologna. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elmstahl S, 1997, DEMENT GERIATR COGN, V8, P180, DOI 10.1159/000106629; Fanciulli A, 2013, EUR J NEUROL, V20, P231, DOI 10.1111/j.1468-1331.2012.03819.x; Fukuoka S, 1996, J NUCL MED, V37, P1824; GALLASSI R, 1986, ACTA PSYCHIAT SCAND, V74, P62, DOI 10.1111/j.1600-0447.1986.tb06228.x; Gallassi R, 2010, NEUROL SCI, V31, P327, DOI 10.1007/s10072-010-0224-6; Garland Emily M, 2013, Handb Clin Neurol, V117, P243, DOI 10.1016/B978-0-444-53491-0.00020-1; Gibbons CH, 2012, ARCH NEUROL-CHICAGO, V69, P461, DOI 10.1001/archneurol.2011.2372; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Heims HC, 2006, CLIN AUTON RES, V16, P113, DOI 10.1007/s10286-006-0318-7; Kim JS, 2012, NEUROLOGY, V79, P1323, DOI 10.1212/WNL.0b013e31826c1acd; Klein CM, 2003, ANN NEUROL, V53, P752, DOI 10.1002/ana.10556; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Poda R, 2012, NEUROL SCI, V33, P469, DOI 10.1007/s10072-011-0746-6; Rose KM, 2010, NEUROEPIDEMIOLOGY, V34, P1, DOI 10.1159/000255459; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470	17	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85020	10.1371/journal.pone.0085020	http://dx.doi.org/10.1371/journal.pone.0085020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465471	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000021
J	Scerbo, P; Markov, GV; Vivien, C; Kodjabachian, L; Demeneix, B; Coen, L; Girardot, F				Scerbo, Pierluigi; Markov, Gabriel V.; Vivien, Celine; Kodjabachian, Laurent; Demeneix, Barbara; Coen, Laurent; Girardot, Fabrice			On the Origin and Evolutionary History of NANOG	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; POU DOMAIN; PLURIPOTENCY; OCT4; GENE; SPECIFICATION; VERTEBRATES; ORTHOLOGS; ROLES; TRAIT	Though pluripotency is well characterized in mammals, many questions remain to be resolved regarding its evolutionary history. A necessary prerequisite for addressing this issue is to determine the phylogenetic distributions and orthology relationships of the transcription factor families sustaining or modulating this property. In mammals, the NANOG homeodomain transcription factor is one of the core players in the pluripotency network. However, its evolutionary history has not been thoroughly studied, hindering the interpretation of comparative studies. To date, the NANOG family was thought to be monogenic, with numerous pseudogenes described in mammals, including a tandem duplicate in Hominidae. By examining a wide-array of craniate genomes, we provide evidence that the NANOG family arose at the latest in the most recent common ancestor of osteichthyans and that NANOG genes are frequently found as tandem duplicates in sarcopterygians and as a single gene in actinopterygians. Their phylogenetic distribution is thus reminiscent of that recently shown for Class V POU paralogues, another key family of pluripotency-controlling factors. However, while a single ancestral duplication has been reported for the Class V POU family, we suggest that multiple independent duplication events took place during evolution of the NANOG family. These multiple duplications could have contributed to create a layer of complexity in the control of cell competence and pluripotency, which could explain the discrepancies relative to the functional evolution of this important gene family. Further, our analysis does not support the hypothesis that loss of NANOG and emergence of the preformation mode of primordial germ cell specification are causally linked. Our study therefore argues for the need of further functional comparisons between NANOG paralogues, notably regarding the novel duplicates identified in sauropsids and non-eutherian mammals.	[Scerbo, Pierluigi; Markov, Gabriel V.; Vivien, Celine; Demeneix, Barbara; Coen, Laurent; Girardot, Fabrice] Museum Natl Hist Nat, CNRS, Dept Regulat Dev & Diversite Mol, Paris, France; [Scerbo, Pierluigi; Kodjabachian, Laurent] Aix Marseille Univ, Inst Biol Dev Marseille, CNRS, Marseille, France; [Markov, Gabriel V.] Univ Lyon, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS, Lyon, France; [Markov, Gabriel V.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany; [Vivien, Celine] WatchFrog SA, Evry, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Max Planck Society	Girardot, F (corresponding author), Museum Natl Hist Nat, CNRS, Dept Regulat Dev & Diversite Mol, Paris, France.	girardot@mnhn.fr	Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020; Markov, Gabriel V./Y-5043-2019	Girardot, Fabrice/0000-0002-0916-877X; Markov, Gabriel V./0000-0002-8566-7482; Scerbo, Pierluigi/0000-0002-3360-4367; Kodjabachian, Laurent/0000-0002-4000-612X	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale [FDT20100920225, FDT20110922932]; Watchfrog S.A. (CIFRE Convention) [216/2011]; European Union [LSHM-CT-2005-018652 CRESCENDO, FP7-PEOPLE-2013-ITN DEVCOM]; Ministere de L'Ecologie et du Developpement Durable [2009 nu0007065]; l'Agence Nationale de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Watchfrog S.A. (CIFRE Convention); European Union(European Commission); Ministere de L'Ecologie et du Developpement Durable; l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Ministere de l'Enseignement Superieur et de la Recherche (PhD fellowships to PS and GVM); by Fondation pour la Recherche Medicale (PhD fellowships grant FDT20100920225 and FDT20110922932 to GVM and PS, respectively); by Watchfrog S.A. (CIFRE Convention 216/2011 Ph.D. fellowship to C. V.); by European Union (contracts LSHM-CT-2005-018652 CRESCENDO and FP7-PEOPLE-2013-ITN DEVCOM); by Ministere de L'Ecologie et du Developpement Durable (Programme National de Recherche sur les Perturbateurs Endocriniens contract 2009 nu0007065) and by l'Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Borrull A, 2012, J CANCER RES CLIN, V138, P1145, DOI 10.1007/s00432-012-1186-2; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fairbanks DJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-12; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Force A, 1999, GENETICS, V151, P1531; Frankenberg S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-56; Frankenberg S, 2013, DEVELOPMENT, V140, P965, DOI 10.1242/dev.091629; Frankenberg S, 2010, DEV BIOL, V337, P162, DOI 10.1016/j.ydbio.2009.10.017; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Gogarten JP, 1999, CURR OPIN GENET DEV, V9, P630, DOI 10.1016/S0959-437X(99)00029-5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Johnson AD, 2003, PHILOS T ROY SOC B, V358, P1371, DOI 10.1098/rstb.2003.1331; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Niwa H, 2008, EVOL DEV, V10, P671, DOI 10.1111/j.1525-142X.2008.00280.x; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Onichtchouk D, 2012, GENESIS, V50, P75, DOI 10.1002/dvg.20800; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robertson M, 2006, MAMM GENOME, V17, P732, DOI 10.1007/s00335-005-0131-y; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Saunders A, 2013, STEM CELLS; Scerbo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036855; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schuff M, 2012, STEM CELLS DEV, V21, P1225, DOI 10.1089/scd.2011.0285; Sommer RJ, 2008, BIOESSAYS, V30, P653, DOI 10.1002/bies.20776; TAKEDA H, 1994, GENE DEV, V8, P45, DOI 10.1101/gad.8.1.45; Tapia N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2229; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Sanchez-Sanchez AV, 2010, STEM CELLS, V28, P1457, DOI 10.1002/stem.469; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yang Y, 2004, ANIM GENET, V35, P411, DOI 10.1111/j.1365-2052.2004.01173.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhou Y, 2013, J MOL CELL BIOL	49	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85104	10.1371/journal.pone.0085104	http://dx.doi.org/10.1371/journal.pone.0085104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465486	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000024
J	Guo, HF; Qu, YF; Liu, XD; Zhong, WF; Fang, JC				Guo, Huifang; Qu, Yufeng; Liu, Xiangdong; Zhong, Wanfang; Fang, Jichao			Female-Biased Symbionts and Tomato Yellow Leaf Curl Virus Infections in Bemisia tabaci	PLOS ONE			English	Article							SECONDARY SYMBIONTS; ENDOSYMBIONTS; APHIDS; TRANSMISSION; WHITEFLIES; DIVERSITY; LOCALIZATION; ALEYRODIDAE; ACQUISITION; RICKETTSIA	The female-biased infection of facultative symbionts has been found in Bemisia tabaci; however, whether there are any differences in tomato yellow leaf curl virus (TYLCV) and obligate symbiont infection rates between females and males is unknown. Determining whether such differences exist would be very important for understanding the spread of the plant virus and of the symbionts. We compared both symbiont infection types, including obligate and facultative symbionts, and the rates of TYLCV infection in both sexes in five field populations from Jiangsu Province, China. The obligate symbiont Portiera aleyrodidarum was not found in every whitefly tested. In all tested populations, more females than males were found to harbor P. aleyrodidarum; and more females than males also harbored Hamiltonella defense, the most common facultative symbiont as well as Cardinium. In addition to female-biased symbiont infections, there were also female-biased TYLCV infections, and the infection frequencies of this plant virus in females were higher than those in males. Taken together, these results suggested that both the female-biased symbiont infections and female-biased TYLCV infections promoted the rapid spread of TYLCV in China.	[Guo, Huifang; Qu, Yufeng; Zhong, Wanfang; Fang, Jichao] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China; [Liu, Xiangdong] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Guo, HF (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	guohfjaas@163.com			Key Technology R&D Program of Jiangsu province, China [BE2010342]; Independent Innovation Fund of Agricultural Science and Technology in Jiangsu province [cx(11)2016]	Key Technology R&D Program of Jiangsu province, China; Independent Innovation Fund of Agricultural Science and Technology in Jiangsu province	This research was supported by grants from the Key Technology R&D Program of Jiangsu province, China (BE2010342) and the Independent Innovation Fund of Agricultural Science and Technology in Jiangsu province (cx(11)2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Byrne FJ, 1996, BIOCHEM GENET, V34, P93, DOI 10.1007/BF02396243; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Ghanim M, 2000, J VIROL, V74, P4738, DOI 10.1128/JVI.74.10.4738-4745.2000; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Muniyappa V, 2000, ARCH VIROL, V145, P1583, DOI 10.1007/s007050070078; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Pan Huipeng, 2012, Commun Integr Biol, V5, P337, DOI 10.4161/cib.20398; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Thierry M, 2011, MOL ECOL, V20, P2172, DOI 10.1111/j.1365-294X.2011.05087.x; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	35	16	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84538	10.1371/journal.pone.0084538	http://dx.doi.org/10.1371/journal.pone.0084538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465416	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100012
J	Qasim, M; Khan, ZH; Khan, WA; Shah, IA				Qasim, Muhammad; Khan, Zafar Hayat; Khan, Waqar Ahmad; Shah, Inayat Ali			MHD Boundary Layer Slip Flow and Heat Transfer of Ferrofluid along a Stretching Cylinder with Prescribed Heat Flux	PLOS ONE			English	Article							STAGNATION-POINT FLOW; GROUP TRANSFORMATION; NANOFLUID; SHEET	This study investigates the magnetohydrodynamic (MHD) flow of ferrofluid along a stretching cylinder. The velocity slip and prescribed surface heat flux boundary conditions are employed on the cylinder surface. Water as conventional base fluid containing nanoparticles of magnetite (Fe3O4) is used. Comparison between magnetic (Fe3O4) and non-magnetic (Al2O3) nanoparticles is also made. The governing non-linear partial differential equations are reduced to non-linear ordinary differential equations and then solved numerically using shooting method. Present results are compared with the available data in the limiting cases. The present results are found to be in an excellent agreement. It is observed that with an increase in the magnetic field strength, the percent difference in the heat transfer rate of magnetic nanoparticles with Al2O3 decreases. Surface shear stress and the heat transfer rate at the surface increase as the curvature parameter increases, i.e curvature helps to enhance the heat transfer.	[Qasim, Muhammad] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Khan, Zafar Hayat] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Khan, Waqar Ahmad] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Shah, Inayat Ali] Islamia Coll Peshawar CU, Dept Math, Khyber Pakhtunkhwa, Pakistan	COMSATS University Islamabad (CUI); Peking University; National University of Sciences & Technology - Pakistan	Qasim, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan.	mq_qau@yahoo.com	Khan, Waqar/H-3886-2013; QASIM, MUHAMMAD/D-5593-2011; Khan, Zafar Hayat/D-5542-2013	Khan, Waqar/0000-0002-8328-850X; QASIM, MUHAMMAD/0000-0001-6516-9809; Khan, Zafar Hayat/0000-0001-9412-2727				Abdel-Salam, 2011, MIDDLE E J SCI RES, V8, P764; Abdul-Kahar R, 2011, COMPUT FLUIDS, V52, P15, DOI 10.1016/j.compfluid.2011.08.003; Ashorynejad HR, 2013, HEAT MASS TRANSFER, V49, P427, DOI 10.1007/s00231-012-1087-6; Bachok N., 2010, MALAYS J MATH SCI, V4, P159; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; Hamad MAA, 2012, COMMUN NONLINEAR SCI, V17, P132, DOI 10.1016/j.cnsns.2011.02.024; Hamad MAA, 2011, INT COMMUN HEAT MASS, V38, P487, DOI 10.1016/j.icheatmasstransfer.2010.12.042; Hamad MAA, 2011, TRANSPORT POROUS MED, V87, P25, DOI 10.1007/s11242-010-9683-8; Ishak A., 2009, EUR J SCI RES, V36, P22; Kandasamy R, 2011, NUCL ENG DES, V241, P2053, DOI 10.1016/j.nucengdes.2011.04.011; Khan W, 2013, APPL NANOSCI, V1, P1; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Mukhopadhay S, 2013, INT J APPL MATH MECH, V9, P62; Mukhopadhyay S, 2013, AIN SHAMS ENG J, V4, P317, DOI 10.1016/j.asej.2012.07.003; Nadeem S, 2013, APPL NANOSCIENCE, P1; Ozerinc S, 2010, MICROFLUID NANOFLUID, V8, P145, DOI 10.1007/s10404-009-0524-4; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Rosmila AB, 2012, APPL MATH MECH-ENGL, V33, P593, DOI 10.1007/s10483-012-1573-9; Yacob NA, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-314	20	80	80	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83930	10.1371/journal.pone.0083930	http://dx.doi.org/10.1371/journal.pone.0083930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465388	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100009
J	Benzekry, S; Gandolfi, A; Hahnfeldt, P				Benzekry, Sebastien; Gandolfi, Alberto; Hahnfeldt, Philip			Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis	PLOS ONE			English	Article							PRIMARY TUMOR; BREAST-CANCER; SIZE DISTRIBUTION; GROWTH; MODEL; MECHANISMS; RESECTION; ANGIOSTATIN; SUPPRESSION; PREVALENCE	Autopsy studies of adults dying of non-cancer causes have shown that virtually all of us possess occult, cancerous lesions. This suggests that, for most individuals, cancer will become dormant and not progress, while only in some will it become symptomatic disease. Meanwhile, it was recently shown in animal models that a tumor can produce both stimulators and inhibitors of its own blood supply. To explain the autopsy findings in light of the preclinical research data, we propose a mathematical model of cancer development at the organism scale describing a growing population of metastases, which, together with the primary tumor, can exert a progressively greater level of systemic angiogenesis-inhibitory influence that eventually overcomes local angiogenesis stimulation to suppress the growth of all lesions. As a departure from modeling efforts to date, we look not just at signaling from and effects on the primary tumor, but integrate over this increasingly negative global signaling from all sources to track the development of total tumor burden. This in silico study of the dynamics of the tumor/metastasis system identifies ranges of parameter values where mutual angio-inhibitory interactions within a population of tumor lesions could yield global dormancy, i.e., an organism-level homeostatic steady state in total tumor burden. Given that mortality arises most often from metastatic disease rather than growth of the primary per se, this finding may have important therapeutic implications.	[Benzekry, Sebastien; Hahnfeldt, Philip] Tufts Univ, Sch Med, Ctr Canc Syst Biol, GRI, Boston, MA 02111 USA; [Benzekry, Sebastien] Inst Math Bordeaux, Inria Team MC2, Bordeaux, France; [Gandolfi, Alberto] Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy	Tufts University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Hahnfeldt, P (corresponding author), Tufts Univ, Sch Med, Ctr Canc Syst Biol, GRI, Boston, MA 02111 USA.	philip.hahnfeldt@tufts.edu	Benzekry, Sébastien/AAG-5164-2020	Benzekry, Sébastien/0000-0002-3749-8637	National Cancer Institute [U54CA149233]; NATIONAL CANCER INSTITUTE [U54CA149233] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute under Award Number U54CA149233 (to L. Hlatky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Albini A, 2012, NAT REV CLIN ONCOL, P1; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Barbolosi D, 2009, MATH BIOSCI, V218, P1, DOI 10.1016/j.mbs.2008.11.008; Benzekry S, 2012, MATH MODEL NAT PHENO, V7, P306, DOI 10.1051/mmnp/20127114; BENZEKRY S, 2011, J EVOL EQU, V11, P187; Benzekry S, 2012, J BIOL DYNAM, V6, P19, DOI 10.1080/17513758.2011.568071; Benzekry S, 2012, ESAIM-MATH MODEL NUM, V46, P207, DOI 10.1051/m2an/2011041; Bethge A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035689; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Chen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017933; Chiarella P, 2012, CANCER LETT, V324, P133, DOI 10.1016/j.canlet.2012.05.021; d'Onofrio A, 2004, MATH BIOSCI, V191, P159, DOI 10.1016/j.mbs.2004.06.003; Devys A, 2009, DISCRETE CONT DYN-B, V12, P731, DOI 10.3934/dcdsb.2009.12.731; DEWYS WD, 1972, CANCER RES, V32, P374; Ehrlich P, 1905, BERLINER KLIN WOCHEN, V42, P871; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FISHER B, 1983, CANCER RES, V43, P1488; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; FOLKMAN J, 1995, MOL MED, V1, P120, DOI 10.1007/BF03401559; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GORELIK E, 1983, CANCER RES, V43, P138; GUNDUZ N, 1979, CANCER RES, V39, P3861; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanin L, 2013, ADV EXP MED BIOL, V734, P261, DOI 10.1007/978-1-4614-1445-2_12; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Huang XJ, 2002, CANCER RES, V62, P5727; Iwata K, 2000, J THEOR BIOL, V203, P177, DOI 10.1006/jtbi.2000.1075; Levine HA, 2001, B MATH BIOL, V63, P801, DOI 10.1006/bulm.2001.0240; Li TS, 2001, EUR J CANCER, V37, P2283, DOI 10.1016/S0959-8049(01)00281-7; LIOTTA LA, 1976, BIOMETRICS, V32, P535, DOI 10.2307/2529743; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ossowski L, 2010, PIGM CELL MELANOMA R, V23, P41, DOI 10.1111/j.1755-148X.2009.00647.x; Peeters CFJM, 2008, ANN SURG ONCOL, V15, P3308, DOI 10.1245/s10434-008-0029-5; Peeters CFJM, 2006, INT J CANCER, V119, P1249, DOI 10.1002/ijc.21928; PREHN RT, 1993, CANCER RES, V53, P3266; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Retsky Michael, 2010, Cancers (Basel), V2, P305, DOI 10.3390/cancers2020305; Retsky MW, 1997, BREAST CANCER RES TR, V45, P193, DOI 10.1023/A:1005849301420; Rofstad EK, 2001, J INVEST DERMATOL, V117, P1042, DOI 10.1046/j.0022-202x.2001.01552.x; Sanchez-Chapado M, 2003, PROSTATE, V54, P238, DOI 10.1002/pros.10177; Sckell A, 1998, CANCER RES, V58, P5866; SUGARBAKER EV, 1971, ANN SURG, V174, P161, DOI 10.1097/00000658-197108000-00001; Tait CR, 2004, J PATHOL, V203, P515, DOI 10.1002/path.1544; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5; Volpert OV, 1998, P NATL ACAD SCI USA, V95, P6343, DOI 10.1073/pnas.95.11.6343; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Willis L, 2010, CANCER RES, V70, P4310, DOI 10.1158/0008-5472.CAN-09-3144	58	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84249	10.1371/journal.pone.0084249	http://dx.doi.org/10.1371/journal.pone.0084249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465399	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500002
J	Bitsikas, V; Riento, K; Howe, JD; Barry, NP; Nichols, BJ				Bitsikas, Vassilis; Riento, Kirsi; Howe, Jonathan D.; Barry, Nicholas P.; Nichols, Benjamin J.			The Role of Flotillins in Regulating A beta Production, Investigated Using Flotillin 1-/-, Flotillin 2-/- Double Knockout Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MEMBRANE MICRODOMAINS; TRAFFICKING; ENDOCYTOSIS; REGGIE-1/FLOTILLIN-2; CYTOSKELETON; REGGIE/FLOTILLIN; ACCUMULATION	Flotillin 1 and flotillin 2 associate in the plasma membrane to form microdomains that have roles in cell signaling, regulation of cell-cell contacts, membrane-cytoskeletal interactions, and endocytosis. They are thought to be involved in the trafficking and hence processing of the Amyloid Precursor Protein, APP. In this study we set out to obtain in vivo confirmation of a link between flotillins and cleavage of APP to release amyloidogenic A beta peptide, and to generate tools that would allow us to ask whether flotillins are functionally redundant. We used a mouse model for A beta-dependent cerebral amyloidosis, APPPS1 mice, combined with deletion of either flotillin 1 singly, or flotillin 1 and flotillin 2 together. There was a small but significant reduction in A beta levels, and the Abundance of congo-red stained plaques, in brains of 12 week old mice lacking flotillin 1. A similar reduction in A beta levels was observed in the flotillin 1-/-, flotillin 2-/-double knockouts. We did not observe large effects on the clustering or endocytosis of APP in flotillin 1-/-mouse embryonic fibroblasts. We conclude that flotillins are likely to play some role in APP trafficking or processing, but the relevant cellular mechanisms require more investigation. The availability of flotillin 1-/-, flotillin 2-/-mice, which have no overt phenotypes, will facilitate research into flotillin function in vivo.	[Bitsikas, Vassilis; Riento, Kirsi; Howe, Jonathan D.; Barry, Nicholas P.; Nichols, Benjamin J.] MRC, Mol Biol Lab, Cambridge, England	MRC Laboratory Molecular Biology	Nichols, BJ (corresponding author), MRC, Mol Biol Lab, Cambridge, England.	ben@mrc-lmb.cam.ac.uk		Bitsikas, Vassilis/0000-0002-1731-9910	Medical Research Council, UK; MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [MC_U105178778] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affentranger S, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-28; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen TY, 2006, BIOCHEM BIOPH RES CO, V342, P266, DOI 10.1016/j.bbrc.2006.01.156; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Guillaume E, 2013, J CELL SCI; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jensen M, 2000, MOL MED, V6, P291, DOI 10.1007/BF03401938; Koo EH, 1996, J CELL SCI, V109, P991; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Okabayashi S, 2010, NEUROREPORT, V21, P606, DOI 10.1097/WNR.0b013e3283383467; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200	34	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85217	10.1371/journal.pone.0085217	http://dx.doi.org/10.1371/journal.pone.0085217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465508	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500044
J	Carstensen, M; Wiza, C; Rohrig, K; Fahlbusch, P; Roden, M; Herder, C; Ouwens, DM				Carstensen, Maren; Wiza, Claudia; Roehrig, Karin; Fahlbusch, Pia; Roden, Michael; Herder, Christian; Ouwens, D. Margriet			Effect of Sfrp5 on Cytokine Release and Insulin Action in Primary Human Adipocytes and Skeletal Muscle Cells	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; OBESITY; RESISTANCE; PHOSPHORYLATION; INHIBITION; PATHWAY; PRAS40; GENE; AKT	Secreted frizzled-related protein 5 (Sfrp5) is an adipokine with anti-inflammatory and insulin-sensitizing properties in mice. However, the mechanism of Sfrp5 action, especially in humans, is largely unknown. Therefore, cytokine release and insulin signaling were analyzed to investigate the impact of Sfrp5 on inflammation and insulin signaling in primary human adipocytes and skeletal muscle cells (hSkMC). Sfrp5 neither affected interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1) and adiponectin release from human adipocytes, nor IL-6 and IL-8 release from hSkMC. In tumor necrosis factor (TNF) alpha-treated adipocytes, Sfrp5 reduced IL-6 release by 49% (p, 0.05), but did not affect MCP-1 and adiponectin release. In MCP-1-treated hSkMC, Sfrp5 did not affect cytokine secretion. In untreated adipocytes, Sfrp5 decreased the insulin-mediated phosphorylation of Akt-Ser473, Akt-Thr308, GSK3 alpha-Ser21 and PRAS40-Thr246 by 34% (p<0.01), 31% (p<0.05), 37% (p<0.05) and 34% (p<0.01), respectively, and the stimulation of glucose uptake by 25% (p<0.05). Incubation with TNF alpha increased the phosphorylation of JNK and NF kappa B, and impaired insulin signaling. When Sfrp5 and TNF alpha were combined, there was no additional effect on insulin signaling and JNK phosphorylation, but phosphorylation of NF kappa B was reversed to basal levels. Sfrp5 had no effect on insulin signaling in untreated or in MCP-1 treated hSkMC. Thus, Sfrp5 lowered IL-6 release and NF kappa B phosphorylation in cytokine-treated human adipocytes, but not under normal conditions, and decreased insulin signaling in untreated human adipocytes. Sfrp5 did not act on hSkMC. Therefore, the cellular actions of Sfrp5 seem to depend on the type of tissue as well as its inflammatory and metabolic state.	[Carstensen, Maren; Roehrig, Karin; Roden, Michael; Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Carstensen, Maren; Wiza, Claudia; Roehrig, Karin; Fahlbusch, Pia; Roden, Michael; Herder, Christian; Ouwens, D. Margriet] German Ctr Diabet Res DZD, Dusseldorf, Germany; [Wiza, Claudia; Fahlbusch, Pia; Ouwens, D. Margriet] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Ouwens, D. Margriet] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Ghent University; Ghent University Hospital	Herder, C (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	christian.herder@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019; Ouwens, Margriet/H-2442-2013	Fahlbusch, Pia/0000-0002-4912-1722; Ouwens, Margriet/0000-0001-6709-2702	German Diabetes Association (DDG Allgemeine Projektforderung); German Federal Ministry of Health; Ministry of Innovation, Science and Research of the state North Rhine-Westphalia; German Federal Ministry of Education and Research (BMBF)	German Diabetes Association (DDG Allgemeine Projektforderung); German Federal Ministry of Health; Ministry of Innovation, Science and Research of the state North Rhine-Westphalia; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant of the German Diabetes Association (DDG Allgemeine Projektforderung 2012) to Maren Carstensen. The German Diabetes Center was supported by the German Federal Ministry of Health and the Ministry of Innovation, Science and Research of the state North Rhine-Westphalia. This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Carstensen M, 2013, EUR J CLIN INVEST, V43, P350, DOI 10.1111/eci.12052; Ehrlund A, 2013, J CLIN ENDOCR METAB, V98, pE503, DOI 10.1210/jc.2012-3416; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Hu ZP, 2013, DIABETES RES CLIN PR, V99, P391, DOI 10.1016/j.diabres.2012.11.026; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lu YC, 2013, DIABETES-METAB RES, V29, P551, DOI 10.1002/dmrr.2426; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Oh DY, 2010, SCIENCE, V329, P397, DOI 10.1126/science.1193404; Okada Yuko, 2009, Kobe J Med Sci, V54, pE241; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Stuckenholz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062470; Wiza C, 2013, DIABETOLOGIA, V56, P1118, DOI 10.1007/s00125-013-2861-9; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011	23	32	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85906	10.1371/journal.pone.0085906	http://dx.doi.org/10.1371/journal.pone.0085906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465779	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500139
J	Ditlev, SB; Florea, R; Nielsen, MA; Theander, TG; Magez, S; Boeuf, P; Salanti, A				Ditlev, Sisse B.; Florea, Raluca; Nielsen, Morten A.; Theander, Thor G.; Magez, Stefan; Boeuf, Philippe; Salanti, Ali			Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; PREGNANCY-ASSOCIATED MALARIA; FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; INHIBITORY ANTIBODIES; MEMBRANE PROTEIN-1; EPITOPES; ADHESION; IMMUNOGLOBULINS; IDENTIFICATION	Placental malaria is a major health problem for both pregnant women and their fetuses in malaria endemic regions. It is triggered by the accumulation of Plasmodium falciparum-infected erythrocytes (IE) in the intervillous spaces of the placenta and is associated with foetal growth restriction and maternal anemia. IE accumulation is supported by the binding of the parasite-expressed protein VAR2CSA to placental chondroitin sulfate A (CSA). Defining specific CSA-binding epitopes of VAR2CSA, against which to target the immune response, is essential for the development of a vaccine aimed at blocking IE adhesion. However, the development of a VAR2CSA adhesion-blocking vaccine remains challenging due to (i) the large size of VAR2CSA and (ii) the extensive immune selection for polymorphisms and thereby non-neutralizing B-cell epitopes. Camelid heavy-chain-only antibodies (HcAbs) are known to target epitopes that are less immunogenic to classical IgG and, due to their small size and protruding antigen-binding loop, able to reach and recognize cryptic, conformational epitopes which are inaccessible to conventional antibodies. The variable heavy chain (VHH) domain is the antigen-binding site of camelid HcAbs, the so called Nanobody, which represents the smallest known (15 kDa) intact, native antigen-binding fragment. In this study, we have used the Nanobody technology, an approach new to malaria research, to generate small and functional antibody fragments recognizing unique epitopes broadly distributed on VAR2CSA.	[Ditlev, Sisse B.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Ditlev, Sisse B.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Florea, Raluca; Magez, Stefan] Vrije Univ Brussel, Cellular & Mol Immunol Res Unit, Brussels, Belgium; [Florea, Raluca; Magez, Stefan] VIB, Dept Biol Struct, Brussels, Belgium; [Boeuf, Philippe] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Boeuf, Philippe] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia	University of Copenhagen; Rigshospitalet; University of Copenhagen; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Melbourne; Royal Melbourne Hospital	Ditlev, SB (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	sditlev@sund.ku.dk	Magez, Stefan/D-9497-2014; Magez, Stefan/AAC-5682-2021; Theander, Thor/F-6714-2015	Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968; Theander, Thor/0000-0002-3509-7514; Boeuf, Philippe/0000-0002-5851-3373; Nielsen, Morten Agertoug/0000-0003-2668-4992; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711	Danish Research Council for Development Research (RUF); IWT (Agentschap voor Innovatie door Wetenschap en Technologie) Belgium; Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU; Novo Nordisk Fonden [1015627]; Australian NHMRC [1003384]	Danish Research Council for Development Research (RUF); IWT (Agentschap voor Innovatie door Wetenschap en Technologie) Belgium; Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU; Novo Nordisk Fonden(Novo Nordisk Foundation); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	SBD is supported by a PhD studentship from the Danish Research Council for Development Research (RUF). RF is supported by IWT (Agentschap voor Innovatie door Wetenschap en Technologie) Belgium. This study received funding from Danish National Advanced Technology Foundation and Proof of Concept Foundation DTU. The project also was supported by Novo Nordisk Fonden, Project number: 1015627 and also supported by a Project grant from the Australian NHMRC to Philippe Boeuf Grant # 1003384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Boeuf P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003153; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 2013, INFECT IMMUN, V81, P487, DOI 10.1128/IAI.01106-12; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Minaeian S, 2012, J MICROBIOL BIOTECHN, V22, P721, DOI 10.4014/jmb.1112.12001; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Obiakor H, 2013, CLIN VACCINE IMMUNOL, V20, P433, DOI 10.1128/CVI.00638-12; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7	37	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84981	10.1371/journal.pone.0084981	http://dx.doi.org/10.1371/journal.pone.0084981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465459	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500024
J	Herrera, VL; Decano, JL; Tan, GA; Moran, AM; Pasion, KA; Matsubara, Y; Ruiz-Opazo, N				Herrera, Victoria L.; Decano, Julius L.; Tan, Glaiza A.; Moran, Ann M.; Pasion, Khristine A.; Matsubara, Yuichi; Ruiz-Opazo, Nelson			DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A 'Common Receptor Coordinator' Paradigm	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER STEM-CELLS; EMBRYONIC LETHALITY; UBIQUITIN LIGASE; HYPOXIA; TRANSCRIPTION; EXPRESSION; GENE; SRC; NICHE	A priori, a common receptor induced in tumor microvessels, cancer cells and cancer stem-like cells (CSCs) that is involved in tumor angiogenesis, invasiveness, and CSC anoikis resistance and survival, could underlie contemporaneous coordination of these events rather than assume stochasticity. Here we show that functional analysis of the dual endothelin1/VEGFsignal peptide receptor, DEspR, (formerly named Dear, Chr.4q31.2) supports the putative common receptor paradigm in pancreatic ductal adenocarcinoma (PDAC) and glioblastoma (GBM) selected for their invasiveness, CD133+CSCs, and polar angiogenic features. Unlike normal tissue, DEspR is detected in PDAC and GBM microvessels, tumor cells, and CSCs isolated from PDAC-Panc1 and GBM-U87 cells. DEspR-inhibition decreased angiogenesis, invasiveness, CSC-survival and anoikis resistance in vitro, and decreased Panc1-CSC and U87-CSC xenograft tumor growth, vasculo-angiogenesis and invasiveness in nude nu/nu rats, suggesting that DEspR activation would coordinate these tumor progression events. As an accessible, cell-surface 'common receptor coordinator', DEspR-inhibition defines a novel targeted-therapy paradigm for pancreatic cancer and glioblastoma.	[Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University; Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	nruizo@bu.edu			Boston University (BU) Office of Technology; BU Clinical and Translational Science Institute, National Institutes of Health (NIH) [UL1RR025771]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER	Boston University (BU) Office of Technology; BU Clinical and Translational Science Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Phase-I and Phase-II Ignition Awards from the Boston University (BU) Office of Technology, and Phase-I and Phase-II Clinical and Translational Science Awards from BU Clinical and Translational Science Institute, National Institutes of Health (NIH) grant UL1RR025771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bao B, 2012, BBA-REV CANCER, V1826, P272, DOI 10.1016/j.bbcan.2012.04.008; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Basson MD, 2008, CANCER RES, V68, P2, DOI 10.1158/0008-5472.CAN-07-2992; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bunger S, 2012, EUR SURG RES, V49, P88, DOI 10.1159/000341669; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cheng YB, 2012, CANCER METAST REV, V31, P75, DOI 10.1007/s10555-011-9330-z; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Decano JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055222; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fox JC, 1998, BRIT J CANCER, V77, P1267, DOI 10.1038/bjc.1998.212; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He H, 2012, ONCOL REP, V27, P45, DOI 10.3892/or.2011.1484; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Herrera VLM, 2008, PHYSIOL GENOMICS, V35, P316, DOI 10.1152/physiolgenomics.00044.2008; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Hiscox S, 2008, EXPERT OPIN THER TAR, V12, P757, DOI [10.1517/14728222.12.6.757, 10.1517/14728222.12.6.757 ]; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang BH, 1997, CANCER RES, V57, P5328; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Li Y, 2012, CANC LETT; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Long BJ, 2004, JNCI-J NATL CANCER I, V96, P456, DOI 10.1093/jnci/djh076; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Narazaki M, 2006, JNCI-J NATL CANCER I, V98, P294, DOI 10.1093/jnci/djj099; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Rak Janusz, 1999, Neoplasia (New York), V1, P23, DOI 10.1038/sj.neo.7900001; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rowher N, 2008, CANCER RES, V68, P10113; Ruiz-Opazo N, 2002, MOL MED, V8, P24, DOI 10.1007/BF03402000; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Smalley M, 2013, CANCER LETT, V338, P57, DOI 10.1016/j.canlet.2012.04.023; Tan K, 2013, J CANCER RES CLIN, V139, P1795, DOI 10.1007/s00432-013-1482-5; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz; Zhao YG, 2010, AM J PATHOL, V176, P3032, DOI 10.2353/ajpath.2010.090571	62	12	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85821	10.1371/journal.pone.0085821	http://dx.doi.org/10.1371/journal.pone.0085821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465725	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500119
J	Liu, WJ; Shiung, HJ; Lo, CF; Leu, JH; Lai, YJ; Lee, TL; Huang, WT; Kou, GH; Chang, YS				Liu, Wang-Jing; Shiung, Hui-Jui; Lo, Chu-Fang; Leu, Jiann-Horng; Lai, Ying-Jang; Lee, Tai-Lin; Huang, Wei-Tung; Kou, Guang-Hsiung; Chang, Yun-Shiang			Characterization and Interactome Study of White Spot Syndrome Virus Envelope Protein VP11	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PENAEUS-MONODON; MAJOR ENVELOPE; STRUCTURAL PROTEINS; PROTEOMIC ANALYSIS; WSSV INFECTION; TIGER SHRIMP; VP26; IDENTIFICATION; ENTRY	White spot syndrome virus (WSSV) is a large enveloped virus. The WSSV viral particle consists of three structural layers that surround its core DNA: an outer envelope, a tegument and a nucleocapsid. Here we characterize the WSSV structural protein VP11 (WSSV394, GenBank accession number AF440570), and use an interactome approach to analyze the possible associations between this protein and an array of other WSSV and host proteins. Temporal transcription analysis showed that vp11 is an early gene. Western blot hybridization of the intact viral particles and fractionation of the viral components, and immunoelectron microscopy showed that VP11 is an envelope protein. Membrane topology software predicted VP11 to be a type of transmembrane protein with a highly hydrophobic transmembrane domain at its N-terminal. Based on an immunofluorescence assay performed on VP11-transfected Sf9 cells and a trypsin digestion analysis of the virion, we conclude that, contrary to topology software prediction, the C-terminal of this protein is in fact inside the virion. Yeast two-hybrid screening combined with co-immunoprecipitation assays found that VP11 directly interacted with at least 12 other WSSV structural proteins as well as itself. An oligomerization assay further showed that VP11 could form dimers. VP11 is also the first reported WSSV structural protein to interact with the major nucleocapsid protein VP664.	[Liu, Wang-Jing] Univ Taipei, Dept Earth & Life Sci, Taipei, Taiwan; [Shiung, Hui-Jui; Lee, Tai-Lin; Huang, Wei-Tung; Chang, Yun-Shiang] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Lo, Chu-Fang] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Leu, Jiann-Horng] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Leu, Jiann-Horng] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Lai, Ying-Jang] Natl Quemoy Univ, Dept Food Sci, Kinmen, Taiwan; [Kou, Guang-Hsiung] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	University of Taipei; Da Yeh University; National Cheng Kung University; National Taiwan Ocean University; National Taiwan Ocean University; Academia Sinica - Taiwan; National Taiwan University	Chang, YS (corresponding author), Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan.	yschang@mail.dyu.edu.tw	Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129	National Science Council [NSC99-2321-B-845-001-MY3, NSC100-2313-B-212-006]	National Science Council(Ministry of Science and Technology, Taiwan)	This investigation was supported financially by National Science Council (http://web1.nsc.gov.tw/) grants under grant numbers NSC99-2321-B-845-001-MY3 and NSC100-2313-B-212-006. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; Chang YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010718; Chang YS, 2008, J VIROL, V82, P12555, DOI 10.1128/JVI.01238-08; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen J, 2007, VIROLOGY, V364, P208, DOI 10.1016/j.virol.2007.02.030; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Herr W, 1998, COLD SPRING HARB SYM, V63, P599, DOI 10.1101/sqb.1998.63.599; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang R, 2005, J GEN VIROL, V86, P1357, DOI 10.1099/vir.0.80923-0; Jie ZL, 2008, ARCH VIROL, V153, P2103, DOI 10.1007/s00705-008-0221-8; Kang ST, 2009, VIROLOGY, V387, P353, DOI 10.1016/j.virol.2009.02.012; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar SR, 2008, FISH SHELLFISH IMMUN, V24, P467, DOI 10.1016/j.fsi.2008.01.004; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Li LJ, 2006, ARCH VIROL, V151, P1309, DOI 10.1007/s00705-005-0719-2; Li Q, 2012, ACTA VIROL, V56, P57, DOI 10.4149/av_2012_01_57; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Liang Y, 2005, DIS AQUAT ORGAN, V66, P81, DOI 10.3354/dao066081; Liu QH, 2009, DIS AQUAT ORGAN, V85, P23, DOI 10.3354/dao02050; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; Liu WJ, 2001, VIROLOGY, V289, P362, DOI 10.1006/viro.2001.1091; Lo C-F, 2005, DIS ASIAN AQUACULTUR, P421; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Rajcani J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P407, DOI 10.1556/AMicr.50.2003.4.8; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rout N, 2007, VACCINE, V25, P2778, DOI 10.1016/j.vaccine.2006.12.056; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tang XH, 2007, J VIROL, V81, P6709, DOI 10.1128/JVI.02505-06; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; Tsai MF, 1999, DIS AQUAT ORGAN, V38, P107, DOI 10.3354/dao038107; van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; Wan Q, 2008, J VIROL, V82, P12598, DOI 10.1128/JVI.01732-08; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu WL, 2005, VIROLOGY, V332, P578, DOI 10.1016/j.virol.2004.12.011; Xie XX, 2006, J VIROL, V80, P10615, DOI 10.1128/JVI.01452-06; Xie XX, 2006, J GEN VIROL, V87, P1903, DOI 10.1099/vir.0.81570-0; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Ye T, 2012, GENE, V505, P254, DOI 10.1016/j.gene.2012.06.015; Ye T, 2012, FISH SHELLFISH IMMUN, V33, P350, DOI 10.1016/j.fsi.2012.05.017; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; Zhan WB, 2013, FISH SHELLFISH IMMUN, V34, P228, DOI 10.1016/j.fsi.2012.10.019; Zhang XB, 2004, PROTEINS, V55, P229, DOI 10.1002/prot.10640; Zhou Q, 2009, J VIROL, V83, P4709, DOI 10.1128/JVI.02360-08; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003	54	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85779	10.1371/journal.pone.0085779	http://dx.doi.org/10.1371/journal.pone.0085779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465701	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500110
J	Prior, JC; Elliott, TG; Norman, E; Stajic, V; Hitchcock, CL				Prior, Jerilynn C.; Elliott, Thomas G.; Norman, Eric; Stajic, Vesna; Hitchcock, Christine L.			Progesterone Therapy, Endothelial Function and Cardiovascular Risk Factors: A 3-Month Randomized, Placebo-Controlled Trial in Healthy Early Postmenopausal Women	PLOS ONE			English	Article							SUBCLINICAL OVULATORY DISTURBANCES; COGNITIVE DIETARY RESTRAINT; CORONARY-HEART-DISEASE; HORMONE-THERAPY; MICRONIZED PROGESTERONE; EQUINE ESTROGEN; HYSTERECTOMY; COMPLEXITY; PREVENTION; MARKERS	Background: Progesterone is effective treatment for hot flushes/night sweats. The cardiovascular effects of progesterone therapy are unknown but evidence suggests that premenopausal normal estradiol with also normal progesterone levels may provide later cardiovascular protection. We compared the effects of progesterone to placebo on endothelial function, weight, blood pressure, metabolism, lipids, inflammation and coagulation. Methods and Results: We conducted a randomized, double-blind, 3-month placebo-controlled trial of progesterone (300 mg daily) among 133 healthy postmenopausal women in Vancouver, Canada from 2003-2009. Endothelial function by venous occlusion plethysmography was a planned primary outcome. Enrolled women were 1-11 y since last menstruation, not using hormones (for >6 months), non-smoking, without diabetes, hypertension, heart disease or their medications. Randomized (1:1) women (55 +/- 4 years, body mass index 25 +/- 3) initially had normal blood pressure, fasting lipid, glucose and electrocardiogram results. Endothelial function (% forearm blood flow above saline) was not changed with progesterone (487 +/- 189%, n = 18) compared with placebo (408 +/- 278%, n = 16) (95% CI diff [-74 to 232], P = 0.30). Progesterone (n = 65) and placebo (n = 47) groups had similar changes in systolic and diastolic blood pressure, resting heart rate, weight, body mass index, waist circumference, total cholesterol, low-density lipoprotein cholesterol and triglyceride levels. High-density lipoprotein was lower (-0.14 mmol/L, P = 0.001) on progesterone compared with placebo. Fasting glucose, hs-C-reactive protein, albumin and D-dimer changes were all comparable to placebo. Framingham General Cardiovascular Risk Profile scores were initially low and remained low with progesterone therapy and not statistically different from placebo. Conclusions: Results indicate that progesterone has short-term cardiovascular safety. Endothelial function, weight, blood pressure, waist circumference, inflammation and coagulation were unchanged as were lipids except for HDL-C. The statistically significant decrease in HDL-C levels was not clinically important (based on lack of Cardiovascular Risk Profile change).	[Prior, Jerilynn C.; Elliott, Thomas G.; Norman, Eric; Stajic, Vesna; Hitchcock, Christine L.] Univ British Columbia, Ctr Menstrual Cycle & Ovulat Res CeMCOR, Vancouver, BC V5Z 1M9, Canada; [Prior, Jerilynn C.; Elliott, Thomas G.] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada; [Prior, Jerilynn C.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Prior, Jerilynn C.] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Prior, JC (corresponding author), Univ British Columbia, Ctr Menstrual Cycle & Ovulat Res CeMCOR, Vancouver, BC V5Z 1M9, Canada.	jerilynn.prior@ubc.ca	Hitchcock, Chris/AAW-7607-2020					ADAMS MR, 1985, ARTERIOSCLEROSIS, V5, P192, DOI 10.1161/01.ATV.5.2.192; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8; Battistella E, 2010, J WOMENS HEALTH, V19, P1519, DOI 10.1089/jwh.2009.1751; Bedford JL, 2010, J CLIN ENDOCR METAB, V95, P3291, DOI 10.1210/jc.2009-2497; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Friess E, 1997, AM J PHYSIOL-ENDOC M, V272, pE885, DOI 10.1152/ajpendo.1997.272.5.E885; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Gorgels WJMJ, 1997, J CLIN EPIDEMIOL, V50, P275, DOI 10.1016/S0895-4356(96)00367-8; Grady D, 2005, AM J MED, V118, P1411, DOI 10.1016/j.amjmed.2005.10.028; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Hitchcock CL, 2012, MENOPAUSE, V19, P886, DOI 10.1097/gme.0b013e318247f07a; Hitchcock CL, 2012, MENOPAUSE, V19, P1208, DOI 10.1097/gme.0b013e31825541cc; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ikram Z, 1999, J WOMEN HEALTH GEN-B, V8, P973, DOI 10.1089/jwh.1.1999.8.973; Kalyan S, 2010, PHARMACOTHERAPY, V30, P442, DOI 10.1592/phco.30.5.442; KAPLAN JR, 1984, ATHEROSCLEROSIS, V53, P283, DOI 10.1016/0021-9150(84)90129-1; Kharazmi E, 2010, HEART, DOI [10.1136/hrt.2010.202226:1-6, DOI 10.1136/HRT.2010.202226:1-6]; Lawton B, 2003, BRIT MED J, V327, P845, DOI 10.1136/bmj.327.7419.845; Mather KJ, 2000, J CLIN ENDOCR METAB, V85, P4644, DOI 10.1210/jc.85.12.4644; Menon U, 2007, MENOPAUSE, V14, P462, DOI 10.1097/01.gme.0000243569.70946.9d; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Nath A, 2009, CLIMACTERIC, V12, P96, DOI 10.1080/13697130902905757; PRIOR JC, 1990, NEW ENGL J MED, V323, P1221, DOI 10.1056/NEJM199011013231801; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RYLANCE PB, 1985, BRIT MED J, V290, P13, DOI 10.1136/bmj.290.6461.13; Sathi P, 2013, CLIN ENDOCRINOL, V79, P282, DOI 10.1111/cen.12128; Schussler P, 2008, PSYCHONEUROENDOCRINO, V33, P1124, DOI 10.1016/j.psyneuen.2008.05.013; Simon JA, 1992, J CONTRACEPT FERTIL, V20, P13; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Turgeon JL, 2004, SCIENCE, V304, P1269, DOI 10.1126/science.1096725; Waugh EJ, 2007, AM J CLIN NUTR, V86, P1791	36	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84698	10.1371/journal.pone.0084698	http://dx.doi.org/10.1371/journal.pone.0084698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465425	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500012
J	Secatto, A; Soares, EM; Locachevic, GA; Assis, PA; Paula-Silva, FWG; Serezani, CH; de Medeiros, AI; Faccioli, LH				Secatto, Adriana; Soares, Elyara Maria; Locachevic, Gisele Aparecida; Assis, Patricia Aparecida; Garcia Paula-Silva, Francisco Wanderlei; Serezani, Carlos Henrique; de Medeiros, Alexandra Ivo; Faccioli, Lucia Helena			The Leukotriene B-4/BLT1 Axis Is a Key Determinant in Susceptibility and Resistance to Histoplasmosis	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; HOST CONTROL; B-4; PHAGOCYTOSIS; CAPSULATUM; MICE; MEDIATORS; INFECTION; PLAY; INHIBITION	The bioactive lipid mediator leukotriene B-4 (LTB4) greatly enhances phagocyte antimicrobial functions against a myriad of pathogens. In murine histoplasmosis, inhibition of the LT-generating enzyme 5-lypoxigenase (5-LO) increases the susceptibility of the host to infection. In this study, we investigated whether murine resistance or susceptibility to Histoplasma capsulatum infection is associated with leukotriene production and an enhancement of in vivo and/or in vitro antimicrobial effector function. We show that susceptible C57BL/6 mice exhibit a higher fungal burden in the lung and spleen, increased mortality, lower expression levels of 5-LO and leukotriene B-4 receptor 1 (BLT1) and decreased LTB4 production compared to the resistant 129/Sv mice. Moreover, we demonstrate that endogenous and exogenous LTs are required for the optimal phagocytosis of H. capsulatum by macrophages from both murine strains, although C57BL/6 macrophages are more sensitive to the effects of LTB4 than 129/Sv macrophages. Therefore, our results provide novel evidence that LTB4 production and BLT1 signaling are required for a histoplasmosis-resistant phenotype.	[Secatto, Adriana; Soares, Elyara Maria; Locachevic, Gisele Aparecida; Assis, Patricia Aparecida; Garcia Paula-Silva, Francisco Wanderlei; Faccioli, Lucia Helena] Univ Sao Paulo, Dept Anal Clin Toxicol & Bromatol, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Garcia Paula-Silva, Francisco Wanderlei] Univ Sao Paulo, Dept Odontopediat, Fac Odontol Ribeirao Preto, Sao Paulo, Brazil; [Serezani, Carlos Henrique] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [de Medeiros, Alexandra Ivo] Univ Estadual Paulista, Dept Ciencias Biol, Fac Ciencias Farmaceut, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Indiana University System; Indiana University Bloomington; Universidade Estadual Paulista	de Medeiros, AI (corresponding author), Univ Estadual Paulista, Dept Ciencias Biol, Fac Ciencias Farmaceut, Sao Paulo, Brazil.	medeirosai@fcfar.unesp.br; faccioli@fcfrp.usp.br	Faccioli, Lúcia Helena/AGH-5297-2022; de Paula e Silva, Francisco Wanderley Garcia Garcia/D-1712-2012; Lucia, Faccioli/G-8976-2015; Assis, Patricia/AAW-8642-2021; Medeiros, Alexandra I. AIM/J-6103-2012; serezani, C. Henrique/H-1675-2013	Faccioli, Lúcia Helena/0000-0002-4999-8305; de Paula e Silva, Francisco Wanderley Garcia Garcia/0000-0001-8559-532X; Lucia, Faccioli/0000-0002-4999-8305; Medeiros, Alexandra I. AIM/0000-0001-6048-3647; serezani, C. Henrique/0000-0002-5363-415X	Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [302097/2010-4]; National Institutes of Health (NIH) [HL103777-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 302097/2010-4 (CNPq, Brazil) and National Institutes of Health (NIH) HL103777-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailie MB, 1996, J IMMUNOL, V157, P5221; Campos MRM, 2009, MOL IMMUNOL, V46, P1204, DOI 10.1016/j.molimm.2008.11.024; Chen NN, 2001, J NEUROIMMUNOL, V120, P94, DOI 10.1016/S0165-5728(01)00415-5; Deepe GS, 2006, J INFECT DIS, V194, P855, DOI 10.1086/506946; Deepe GS, 2000, MED MYCOL, V38, P87, DOI 10.1080/744118735; Deepe GS, 2000, CURR OPIN MICROBIOL, V3, P359, DOI 10.1016/S1369-5274(00)00104-1; FACCIOLI LH, 1991, IMMUNOLOGY, V73, P222; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Funk CD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002040; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Heninger E, 2006, J IMMUNOL, V177, P3303, DOI 10.4049/jimmunol.177.5.3303; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Lynch KR, 1999, NATURE, V399, P789; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Medeiros AI, 1999, BRIT J PHARMACOL, V128, P1529, DOI 10.1038/sj.bjp.0702912; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Morato-Marques M, 2011, J BIOL CHEM, V286, P28902, DOI 10.1074/jbc.M111.235309; Newman SL, 2005, METH MOLEC MED, V118, P181; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Pina A, 2008, J LEUKOCYTE BIOL, V83, P1088, DOI 10.1189/jlb.1107738; Pina A, 2006, J LEUKOCYTE BIOL, V79, P1202, DOI 10.1189/jlb.0106052; Sa-Nunes A, 2007, MICROBES INFECT, V9, P1393, DOI 10.1016/j.micinf.2006.10.007; SAMUELSSON B, 1983, ADV PROSTAG THROMB L, V11, P1; Secatto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031701; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Talvani A, 2002, INFECT IMMUN, V70, P4247, DOI 10.1128/IAI.70.8.4247-4253.2002; Wan Kong-Sang, 2007, Acta Paediatrica Taiwanica, V48, P299; WUHSIEH B, 1989, INFECT IMMUN, V57, P3788, DOI 10.1128/IAI.57.12.3788-3792.1989; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; ZHOU P, 1995, J IMMUNOL, V155, P785	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85083	10.1371/journal.pone.0085083	http://dx.doi.org/10.1371/journal.pone.0085083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465479	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500034
J	Qiao, MY; Cheng, J; Bian, W; Tao, DC				Qiao, Maoying; Cheng, Jun; Bian, Wei; Tao, Dacheng			Biview Learning for Human Posture Segmentation from 3D Points Cloud	PLOS ONE			English	Article							POSE ESTIMATION; RECOGNITION; REGRESSION	Posture segmentation plays an essential role in human motion analysis. The state-of-the-art method extracts sufficiently high-dimensional features from 3D depth images for each 3D point and learns an efficient body part classifier. However, high-dimensional features are memory-consuming and difficult to handle on large-scale training dataset. In this paper, we propose an efficient two-stage dimension reduction scheme, termed biview learning, to encode two independent views which are depth-difference features (DDF) and relative position features (RPF). Biview learning explores the complementary property of DDF and RPF, and uses two stages to learn a compact yet comprehensive low-dimensional feature space for posture segmentation. In the first stage, discriminative locality alignment (DLA) is applied to the high-dimensional DDF to learn a discriminative low-dimensional representation. In the second stage, canonical correlation analysis (CCA) is used to explore the complementary property of RPF and the dimensionality reduced DDF. Finally, we train a support vector machine (SVM) over the output of CCA. We carefully validate the effectiveness of DLA and CCA utilized in the two-stage scheme on our 3D human points cloud dataset. Experimental results show that the proposed biview learning scheme significantly outperforms the state-of-the-art method for human posture segmentation.	[Qiao, Maoying; Bian, Wei; Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Cheng, Jun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Guangdong Prov Key Lab Robot & Intelligent Syst, Shenzhen, Guangdong, Peoples R China; [Cheng, Jun] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	University of Technology Sydney; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong	Cheng, J (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Guangdong Prov Key Lab Robot & Intelligent Syst, Shenzhen, Guangdong, Peoples R China.	jun.cheng@siat.ac.cn			CAS and Locality Cooperation Projects [ZNGZ-2011-012]; Guangdong-CAS Strategic Cooperation Program [2012B090400044]; Guangdong-Hongkong Technology Cooperation Funding [2011A091200001]; Shenzhen Technology Project [ZD201111040087A]; Australian Research Council [FT-130101457]	CAS and Locality Cooperation Projects; Guangdong-CAS Strategic Cooperation Program; Guangdong-Hongkong Technology Cooperation Funding; Shenzhen Technology Project; Australian Research Council(Australian Research Council)	This work is supported by five departments: CAS and Locality Cooperation Projects (Grand No. ZNGZ-2011-012), Guangdong-CAS Strategic Cooperation Program (Grand No. 2012B090400044), Guangdong-Hongkong Technology Cooperation Funding (Grand No. 2011A091200001), Shenzhen Technology Project (Grand No. ZD201111040087A), Australian Research Council (Grand No. FT-130101457). 1. CAS and Locality Cooperation Projects (ZNGZ-2011-012), http://www.cas.ac.cn/ 2. Guangdong-CAS Strategic Cooperation Program (2012B090400044), http://www.gdstc.gov.cn/ 3. Shenzhen Technology Project (ZD201111040087A), http://www.szsti.gov.cn/ 4. Guangdong-Hongkong Technology Cooperation Funding (2011A091200001), http://www.gdstc.gov.cn/ 5. Australian Research Council (FT-130101457), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Balla-Arabe S, 2012, NEUROCOMPUTING, V93, P106, DOI 10.1016/j.neucom.2012.04.019; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bregler C, 1998, PROC CVPR IEEE, P8, DOI 10.1109/CVPR.1998.698581; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaudhuri K., 2009, P ICML, P129, DOI DOI 10.1145/1553374.1553391; Cheng J, 2011, SIGNAL PROCESS, V91, P2204, DOI 10.1016/j.sigpro.2011.04.003; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Foster D., 2008, TR20084 TTI; Gao XB, 2008, NEUROCOMPUTING, V71, P1921, DOI 10.1016/j.neucom.2007.10.025; Girshick R, 2011, IEEE I CONF COMP VIS, P415, DOI 10.1109/ICCV.2011.6126270; Grest D, 2005, LECT NOTES COMPUT SC, V3663, P285; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Luo Y, 2013, 27 AAAI C ART INT; Luo Y, 2013, IEEE T NEUR NET LEAR, V24, P709, DOI 10.1109/TNNLS.2013.2238682; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mori G., 2002, P EUR C COMP VIS, P150; Moschini D, 2008, P THEMIS, P61; Pishchulin L, 2012, PROC CVPR IEEE, P3178, DOI 10.1109/CVPR.2012.6248052; Poppe R, 2007, COMPUT VIS IMAGE UND, V108, P4, DOI 10.1016/j.cviu.2006.10.016; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rupnik J, 2010, C DAT MIN DAT WARH L; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; SIMON DA, 1994, IEEE INT CONF ROBOT, P2235, DOI 10.1109/ROBOT.1994.350953; Sun M, 2012, PROC CVPR IEEE, P3394, DOI 10.1109/CVPR.2012.6248079; Tao DP, 2014, PATTERN RECOGN LETT, V35, P186, DOI 10.1016/j.patrec.2012.06.014; Tao DP, 2013, IEEE T CIRC SYST VID, V23, P1675, DOI 10.1109/TCSVT.2013.2255413; Tao DP, 2013, IEEE T CYBERNETICS, V43, P1406, DOI 10.1109/TCYB.2013.2264285; Tao DP, 2013, IEEE T MULTIMEDIA, V15, P833, DOI 10.1109/TMM.2013.2238909; Tao DP, 2012, NEUROCOMPUTING, V91, P11, DOI 10.1016/j.neucom.2012.02.024; Tu ZW, 2008, PROC CVPR IEEE, P735; TURK MA, 1991, 1991 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, P586; Vinzi V. E., 2010, HDB PARTIAL LEAST SQ, DOI [DOI 10.1007/978-3-540-32827-8_29, DOI 10.1007/978-3-540-32827-8]; Wang XC, 2013, IEEE T IMAGE PROCESS, V22, P2646, DOI 10.1109/TIP.2013.2255300; Wang XM, 2010, NEUROCOMPUTING, V73, P2186, DOI 10.1016/j.neucom.2010.01.021; Wen J, 2010, NEUROCOMPUTING, V73, P827, DOI 10.1016/j.neucom.2009.10.013; Xie B, 2011, IEEE T SYST MAN CY B, V41, P1088, DOI 10.1109/TSMCB.2011.2106208; Xu C, 2013, ARXIV13045634; Yu J, 2012, IEEE T IMAGE PROCESS, V21, P4636, DOI 10.1109/TIP.2012.2207395; Zhang TH, 2008, LECT NOTES COMPUT SC, V5302, P725, DOI 10.1007/978-3-540-88682-2_55	44	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85811	10.1371/journal.pone.0085811	http://dx.doi.org/10.1371/journal.pone.0085811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465721	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500076
J	Tiruvannamalai-Annamalai, R; Armant, DR; Matthew, HWT				Tiruvannamalai-Annamalai, Ramkumar; Armant, David Randall; Matthew, Howard W. T.			A Glycosaminoglycan Based, Modular Tissue Scaffold System for Rapid Assembly of Perfusable, High Cell Density, Engineered Tissues	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; VASCULAR ENDOTHELIAL-CELLS; HUMAN SKIN EQUIVALENT; ARTICULAR CHONDROCYTES; HEPARAN-SULFATE; BLOOD-VESSEL; IN-VITRO; ANGIOGENESIS; HEPATOCYTES	The limited ability to vascularize and perfuse thick, cell-laden tissue constructs has hindered efforts to engineer complex tissues and organs, including liver, heart and kidney. The emerging field of modular tissue engineering aims to address this limitation by fabricating constructs from the bottom up, with the objective of recreating native tissue architecture and promoting extensive vascularization. In this paper, we report the elements of a simple yet efficient method for fabricating vascularized tissue constructs by fusing biodegradable microcapsules with tunable interior environments. Parenchymal cells of various types, (i.e. trophoblasts, vascular smooth muscle cells, hepatocytes) were suspended in glycosaminoglycan (GAG) solutions (4%/1.5% chondroitin sulfate/carboxymethyl cellulose, or 1.5 wt% hyaluronan) and encapsulated by forming chitosan-GAG polyelectrolyte complex membranes around droplets of the cell suspension. The interior capsule environment could be further tuned by blending collagen with or suspending microcarriers in the GAG solution These capsule modules were seeded externally with vascular endothelial cells (VEC), and subsequently fused into tissue constructs possessing VEC-lined, inter-capsule channels. The microcapsules supported high density growth achieving clinically significant cell densities. Fusion of the endothelialized, capsules generated three dimensional constructs with an embedded network of interconnected channels that enabled long-term perfusion culture of the construct. A prototype, engineered liver tissue, formed by fusion of hepatocyte-containing capsules exhibited urea synthesis rates and albumin synthesis rates comparable to standard collagen sandwich hepatocyte cultures. The capsule based, modular approach described here has the potential to allow rapid assembly of tissue constructs with clinically significant cell densities, uniform cell distribution, and endothelialized, perfusable channels.	[Tiruvannamalai-Annamalai, Ramkumar; Matthew, Howard W. T.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Armant, David Randall] Wayne State Univ, Dept Obstet, Detroit, MI USA; [Armant, David Randall] Wayne State Univ, Dept Gynecol, Detroit, MI USA; [Armant, David Randall] NICHHD, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Matthew, Howard W. T.] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI USA	Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University	Matthew, HWT (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	hmatthew@wayne.edu	Annamalai, Ramkumar T./Q-7043-2019	Annamalai, Ramkumar T./0000-0002-9880-3973; Matthew, Howard/0000-0001-6033-9258; Armant, D. Randall/0000-0001-5904-9325	DRICTR award from Wayne State University; National Science Foundation [CBET-1067323]; National Institutes of Health [HD067629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071408] Funding Source: NIH RePORTER; Directorate For Engineering [1067323] Funding Source: National Science Foundation	DRICTR award from Wayne State University; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for these studies was provided by a DRICTR award from Wayne State University, and grant awards from the National Science Foundation (CBET-1067323) and the National Institutes of Health (HD067629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkadopoulos N, 1998, HEPATOLOGY, V28, P1365, DOI 10.1002/hep.510280527; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398; Butcher JT, 2004, J HEART VALVE DIS, V13, P478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang Q, 2011, BRAZ J MED BIOL RES, V44, P303, DOI 10.1590/S0100-879X2011007500026; Chang SC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/457971; Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039; Christen T, 1999, CIRC RES, V85, P99; Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7; CROOKS CA, 1990, J BIOMED MATER RES, V24, P1241, DOI 10.1002/jbm.820240908; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2113, DOI [10.1089/ten.TEA.2011.0019, 10.1089/ten.tea.2011.0019]; Ferretti A, 2003, LIFE SCI, V73, P1985, DOI 10.1016/S0024-3205(03)00541-1; Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Fuster MM, 2010, PROG MOL BIOL TRANSL, V93, P179, DOI 10.1016/S1877-1173(10)93009-3; Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003; Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m; Gallagher SR, 2001, QUANTITATION DNA RNA; Govers R, 2002, BIOCHEM J, V361, P193, DOI 10.1042/0264-6021:3610193; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045; Hammouche S, 2012, CURR STEM CELL RES T, V7, P134, DOI 10.2174/157488812799219018; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Kasuya J, 2011, TISSUE ENG PT A, V17, P361, DOI 10.1089/ten.TEA.2010.0033; Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084; Kobayashi N, 2000, TRANSPLANTATION, V69, P202, DOI 10.1097/00007890-200001270-00002; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002; Lavender MD, 2005, BIOMATERIALS, V26, P4642, DOI 10.1016/j.biomaterials.2004.11.045; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381; Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]; Lin SV, 2002, METHODS TISSUE ENG, P815; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Mathieu C, 2013, OSTEOARTHR CARTILAGE, V21, P849, DOI 10.1016/j.joca.2013.03.012; MATTHEW HW, 1993, BIOTECHNOL PROGR, V9, P510, DOI 10.1021/bp00023a010; Matthew HW, 1991, ASAIO T, V37, pM328; Matthew HWT, 1996, BIOTECHNOL BIOENG, V51, P100, DOI 10.1002/(SICI)1097-0290(19960705)51:1<100::AID-BIT12>3.0.CO;2-U; MATTHEW HWT, 1993, J PEDIATR SURG, V28, P1423, DOI 10.1016/0022-3468(93)90424-J; Meretoja VV, 2013, BIOMATERIALS, V34, P4266, DOI 10.1016/j.biomaterials.2013.02.064; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007; Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; Paquet C, 2010, ANN NY ACAD SCI, V1197, P166, DOI 10.1111/j.1749-6632.2009.05373.x; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Selwyn AP, 2003, AM J CARDIOL, V91, p3H, DOI 10.1016/S0002-9149(03)00428-4; Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41; Surapaneni S, 1997, ASAIO J, V43, pM848; Tao J, 2009, CELLS TISSUES ORGANS, V190, P185, DOI 10.1159/000218139; Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI [10.1089/ten.tea.2008.0405, 10.1089/ten.TEA.2008.0405]; van der Meer AD, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/823148; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205; WEST DC, 1989, CIBA F SYMP, V143, P187; WYBENGA DR, 1971, CLIN CHEM, V17, P891; Yagi H, 2009, TISSUE ENG PT A, V15, P3377, DOI [10.1089/ten.tea.2008.0681, 10.1089/ten.TEA.2008.0681]; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038; Zhao X, 2012, ANN PLAS SURG, V69, P91, DOI 10.1097/SAP.0b013e3182583eb9	72	45	47	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84287	10.1371/journal.pone.0084287	http://dx.doi.org/10.1371/journal.pone.0084287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465401	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500014
J	Vincze, S; Stamm, I; Kopp, PA; Hermes, J; Adlhoch, C; Semmler, T; Wieler, LH; Lubke-Becker, A; Walther, B				Vincze, Szilvia; Stamm, Ivonne; Kopp, Peter A.; Hermes, Julia; Adlhoch, Cornelia; Semmler, Torsten; Wieler, Lothar H.; Luebke-Becker, Antina; Walther, Birgit			Alarming Proportions of Methicillin-Resistant Staphylococcus aureus (MRSA) in Wound Samples from Companion Animals, Germany 2010-2012	PLOS ONE			English	Article							SKIN INFECTIONS; TRANSMISSION; STRAINS; HUMANS; SPREAD; ST398	Staphylococcus (S.) aureus is an important cause of wound infections in companion animals, and infections with methicillin-resistant S. aureus (MRSA) are of particular concern due to limited treatment options and their zoonotic potential. However, comparable epidemiological data on MRSA infections in dogs, cats and horses is scarce, also limiting the knowledge about possible links to MRSA isolates from human populations. To gain more knowledge about the occurrence and genotypic variation of MRSA among wound swabs of companion animal origin in Germany we performed a survey (2010-2012) including 5,229 samples from 1,170 veterinary practices. S. aureus was identified in 201 (5.8%) canine, 140 (12.2%) feline and 138 (22.8%) equine swabs from a total of 3,479 canine, 1,146 feline and 604 equine wounds, respectively. High MRSA rates were identified with 62.7%, 46.4% and 41.3% in S. aureus of canine, feline and equine origin, respectively. Further genotyping including spa typing and multilocus sequence typing (MLST) revealed a comparable distribution of spa types among canine and feline MRSA with CC22 (47.6%; 49.2%) and CC5 (30.2%; 29.2%) as predominant lineages followed by CC398 (13.5%; 7.7%) and CC8 (4.0%; 9.2%). In contrast, the majority of equine MRSA belonged to CC398 (87.7%). Our data highlight the importance of S. aureus and MRSA as a cause of wound infections, particularly in cats and horses in Germany. While ;"human-associated" MRSA lineages were most common in dogs and cats, a remarkable number of CC398-MRSA was detected in horses, indicating a replacement of CC8-MRSA as the predominant lineage within horses in Germany. These data enforce further longitudinal epidemiological approaches to examine the diversity and temporal relatedness of MRSA populations in humans and animals to assess probable sources of MRSA infections. This would enable a sound risk assessment and establishment of intervention strategies to limit the additional spread of MRSA.	[Vincze, Szilvia; Semmler, Torsten; Wieler, Lothar H.; Luebke-Becker, Antina; Walther, Birgit] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Stamm, Ivonne; Kopp, Peter A.] Vet Med Lab GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Hermes, Julia; Adlhoch, Cornelia] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany	Free University of Berlin; Robert Koch Institute	Vincze, S (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	szilvia.vincze@fu-berlin.de	Semmler, Torsten/O-9540-2019; Semmler, Torsten/Q-7716-2018; Adlhoch, Cornelia/AAH-5888-2021	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Adlhoch, Cornelia/0000-0002-8842-0469; Walther, Birgit/0000-0003-3112-5722; Wieler, Lothar H./0000-0003-4365-3717	Federal Ministry of Education and Research (BMBF); MedVet-Staph project [01KI1014A]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); MedVet-Staph project	This work was supported by the Federal Ministry of Education and Research (BMBF) and is part of the MedVet-Staph project (01KI1014A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axon JE, 2011, AUST VET J, V89, P221, DOI 10.1111/j.1751-0813.2011.00711.x; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Leonard FC, 2008, VET J, V175, P27, DOI 10.1016/j.tvjl.2006.11.008; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Malik S, 2006, J ANTIMICROB CHEMOTH, V58, P428, DOI 10.1093/jac/dkl253; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Nienhoff U, 2009, J ANTIMICROB CHEMOTH, V64, P660, DOI 10.1093/jac/dkp243; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Price LB, 2012, HOST ADAPTATION EMER, VCC398, P3, DOI DOI 10.1128/MBI0.00305-11; Rankin S, 2005, VET MICROBIOL, V108, P145, DOI 10.1016/j.vetmic.2005.02.013; Robert-Koch-Institut, 2011, EP B, P12; Rohde SM, 2013, J ANTIMICROB CHEMOTH; Sing A, 2008, NEW ENGL J MED, V358, P1200, DOI 10.1056/NEJMc0706805; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Duijkeren E, 2004, EMERG INFECT DIS, V10, P2235, DOI 10.3201/eid1012.040387; Vincze S, 2013, APPL ENVIRON MICROB, V79, P655, DOI 10.1128/AEM.02704-12; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Wayne P., 2010, CLIN LAB STANDARDS I; Wayne P., 2008, M31A3 CLSI, V28; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weese JS, 2006, VET MICROBIOL, V114, P160, DOI 10.1016/j.vetmic.2005.11.054; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Zhang Wanjiang, 2011, Vet J, V190, pe125, DOI 10.1016/j.tvjl.2011.02.006	40	84	86	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85656	10.1371/journal.pone.0085656	http://dx.doi.org/10.1371/journal.pone.0085656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465637	gold, Green Published			2022-12-27	WOS:000330240500065
J	Dong, R; Jia, DS; Xue, P; Cui, XM; Li, K; Zheng, S; He, XH; Dong, KR				Dong, Rui; Jia, Deshui; Xue, Ping; Cui, Ximao; Li, Kai; Zheng, Shan; He, Xianghuo; Dong, Kuiran			Genome-Wide Analysis of Long Noncoding RNA (lncRNA) Expression in Hepatoblastoma Tissues	PLOS ONE			English	Article							CELL-SPECIFIC MOLECULE-1; COLORECTAL-CANCER; GASTRIC-CANCER; RISK-FACTORS; MEG3; CARCINOMA; OVEREXPRESSION; PROFILE; ESM-1; PROLIFERATION	Long noncoding RNAs (lncRNAs) have crucial roles in cancer biology. We performed a genome-wide analysis of lncRNA expression in hepatoblastoma tissues to identify novel targets for further study of hepatoblastoma. Hepatoblastoma and normal liver tissue samples were obtained from hepatoblastoma patients. The genome-wide analysis of lncRNA expression in these tissues was performed using a 46180 K lncRNA microarray and Sureprint G3 Human lncRNA Chips. Quantitative RTPCR (qRT-PCR) was performed to confirm these results. The differential expressions of lncRNAs and mRNAs were identified through fold-change filtering. Gene Ontology (GO) and pathway analyses were performed using the standard enrichment computation method. Associations between lncRNAs and adjacent protein-coding genes were determined through complex transcriptional loci analysis. We found that 2736 lncRNAs were differentially expressed in hepatoblastoma tissues. Among these, 1757 lncRNAs were upregulated more than two-fold relative to normal tissues and 979 lncRNAs were downregulated. Moreover, in hepatoblastoma there were 420 matched lncRNA-mRNA pairs for 120 differentially expressed lncRNAs, and 167 differentially expressed mRNAs. The co-expression network analysis predicted 252 network nodes and 420 connections between 120 lncRNAs and 132 coding genes. Within this co-expression network, 369 pairs were positive, and 51 pairs were negative. Lastly, qRT-PCR data verified six upregulated and downregulated lncRNAs in hepatoblastoma, plus endothelial cell-specific molecule 1 (ESM1) mRNA. Our results demonstrated that expression of these aberrant lncRNAs could respond to hepatoblastoma development. Further study of these lncRNAs could provide useful insight into hepatoblastoma biology.	[Dong, Rui; Xue, Ping; Cui, Ximao; Li, Kai; Zheng, Shan; Dong, Kuiran] Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai 200433, Peoples R China; [Dong, Rui; Xue, Ping; Cui, Ximao; Li, Kai; Zheng, Shan; Dong, Kuiran] Chinese Minist Hlth, Key Lab Neonatal Dis, Shanghai, Peoples R China; [Jia, Deshui; He, Xianghuo] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Ren Ji Hosp,Sch Med, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Dong, KR (corresponding author), Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai 200433, Peoples R China.	kuirand@fudan.edu.cn	He, Xianghuo/I-1497-2014; Jia, Deshui/U-9732-2019	He, Xianghuo/0000-0001-8872-668X; Zheng, Shan/0000-0002-9712-4573	State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute [SKLORG 90-12-01]	State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute	This study received financial support from the grant from the State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute (SKLORG # 90-12-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balik V, 2013, J NEURO-ONCOL, V112, P1, DOI 10.1007/s11060-012-1038-6; BUCKLEY JD, 1989, CANCER, V64, P1169, DOI 10.1002/1097-0142(19890901)64:5<1169::AID-CNCR2820640534>3.0.CO;2-I; De Ioris M, 2008, EUR J CANCER, V44, P545, DOI 10.1016/j.ejca.2007.11.022; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Ge XS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0588-6; Haas JE, 2001, CANCER-AM CANCER SOC, V92, P3130, DOI 10.1002/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#; Han L, 2012, INT J ONCOL, V40, P2004, DOI 10.3892/ijo.2012.1413; Herzog C E, 2000, Oncologist, V5, P445, DOI 10.1634/theoncologist.5-6-445; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Ji NY, 2010, CANCER SCI, V101, P2248, DOI 10.1111/j.1349-7006.2010.01665.x; Kang YH, 2012, CELL SIGNAL, V24, P1940, DOI 10.1016/j.cellsig.2012.06.004; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Lee CT, 2013, HUM PATHOL, V44, P802, DOI 10.1016/j.humpath.2012.08.003; Leroy X, 2010, HISTOPATHOLOGY, V56, P180, DOI 10.1111/j.1365-2559.2009.03458.x; Li JP, 2013, BIOCHEM BIOPH RES CO, V433, P200, DOI 10.1016/j.bbrc.2013.02.083; Litten JB, 2008, ONCOLOGIST, V13, P812, DOI 10.1634/theoncologist.2008-0011; Liu N, 2010, ANN SURG ONCOL, V17, P2628, DOI 10.1245/s10434-010-1037-9; Magrelli A, 2009, TRANSL ONCOL, V2, P157, DOI 10.1593/tlo.09124; Massimi M, 2012, BBA-GEN SUBJECTS, V1820, P1, DOI 10.1016/j.bbagen.2011.10.005; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Pan YF, 2013, J HUAZHONG U SCI-MED, V33, P96, DOI 10.1007/s11596-013-1078-y; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Qin R, 2013, NEOPLASMA, V60, P486, DOI 10.4149/neo_2013_063; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Spector LG, 2008, BRIT J CANCER, V98, P1570, DOI 10.1038/sj.bjc.6604335; Sun WL, 2013, TUMOR BIOL, V34, P2697, DOI 10.1007/s13277-013-0821-0; Tomlinson GE, 2012, PEDIATR BLOOD CANCER, V59, P785, DOI 10.1002/pbc.24213; von Frowein J, 2011, HEPATOLOGY, V53, P833, DOI 10.1002/hep.24125; von Schweinitz D, 2012, SEMIN PEDIATR SURG, V21, P21, DOI 10.1053/j.sempedsurg.2011.10.011; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Yamamoto H, 2007, GENES CELLS, V12, P461, DOI 10.1111/j.1365-2443.2007.01065.x; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	38	61	64	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85599	10.1371/journal.pone.0085599	http://dx.doi.org/10.1371/journal.pone.0085599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465615	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000046
J	Herzen, J; Willner, MS; Fingerle, AA; Noel, PB; Kohler, T; Drecoll, E; Rummeny, EJ; Pfeiffer, F				Herzen, Julia; Willner, Marian S.; Fingerle, Alexander A.; Noel, Peter B.; Koehler, Thomas; Drecoll, Enken; Rummeny, Ernst J.; Pfeiffer, Franz			Imaging Liver Lesions Using Grating-Based Phase-Contrast Computed Tomography with Bi-Lateral Filter Post-Processing	PLOS ONE			English	Article							INCIDENTAL FINDINGS; HIGH-RESOLUTION; INTERFEROMETRY; SONOGRAPHY; FREQUENCY; MR	X-ray phase-contrast imaging shows improved soft-tissue contrast compared to standard absorption-based X-ray imaging. Especially the grating-based method seems to be one promising candidate for clinical implementation due to its extendibility to standard laboratory X-ray sources. Therefore the purpose of our study was to evaluate the potential of grating-based phase-contrast computed tomography in combination with a novel bi-lateral denoising method for imaging of focal liver lesions in an ex vivo feasibility study. Our study shows that grating-based phase-contrast CT ( PCCT) significantly increases the soft-tissue contrast in the ex vivo liver specimens. Combining the information of both signals - absorption and phase-contrast - the bi-lateral filtering leads to an improvement of lesion detectability and higher contrast-to-noise ratios. The normal and the pathological tissue can be clearly delineated and even internal structures of the pathological tissue can be visualized, being invisible in the absorption-based CT alone. Histopathology confirmed the presence of the corresponding findings in the analyzed tissue. The results give strong evidence for a sufficiently high contrast for different liver lesions using non-contrast-enhanced PCCT. Thus, ex vivo imaging of liver lesions is possible with a polychromatic X-ray source and at a spatial resolution of similar to 100 mu m. The post-processing with the novel bi-lateral denoising method improves the image quality by combining the information from the absorption and the phase-contrast images.	[Herzen, Julia] Helmholtz Zentrum Geesthacht, Inst Mat Sci, Geesthacht, Germany; [Herzen, Julia; Willner, Marian S.; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Garching, Germany; [Herzen, Julia; Willner, Marian S.; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Fingerle, Alexander A.; Noel, Peter B.; Rummeny, Ernst J.] Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany; [Koehler, Thomas] Philips Technol GmbH, Innovat Technol, Res Labs, Hamburg, Germany; [Drecoll, Enken] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Technical University of Munich; Technical University of Munich; Technical University of Munich; Philips; Philips Research; Technical University of Munich	Herzen, J (corresponding author), Helmholtz Zentrum Geesthacht, Inst Mat Sci, Geesthacht, Germany.	julia.herzen@hzg.de	Herzen, Julia/B-2368-2015	Herzen, Julia/0000-0002-9456-1591; Noel, Peter/0000-0002-9671-6171	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The Authors JH, MSW and FP acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech M, 2009, J SYNCHROTRON RADIAT, V16, P43, DOI 10.1107/S090904950803464X; Beckmann F, 1999, BIOPHYS J, V76, P98, DOI 10.1016/S0006-3495(99)77181-X; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; Bevins N, 2012, MED PHYS, V39, P424, DOI 10.1118/1.3672163; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cochran ST, 2001, AJR AM J ROENTGENOLO, V176; David C, 2007, MICROELECTRON ENG, V84, P1172, DOI 10.1016/j.mee.2007.01.151; DAVIS TJ, 1995, PHYS REV LETT, V74, P3173, DOI 10.1103/PhysRevLett.74.3173; Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Eiber M, 2012, EUR J RADIOL, V81, P683, DOI 10.1016/j.ejrad.2011.01.072; Ghetti C, 2008, MED PHYS, V35, P456, DOI 10.1118/1.2828185; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Jensen TH, 2010, PHYS MED BIOL, V55, P3317, DOI 10.1088/0031-9155/55/12/004; Koehler T, 2012, AIP CONF PROC, V1466, P78, DOI 10.1063/1.4742272; Kohler T, 2011, MED PHYS, V38, pS106, DOI 10.1118/1.3532396; Lanitis S, 2012, AM SURGEON, V78, P366; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Noel PB, 2013, Z MED PHYS; Oudkerk M, 2002, RADIOLOGY, V223, P517, DOI 10.1148/radiol.2232010318; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Raupach R, 2012, MED PHYS, V39, P4761, DOI 10.1118/1.4736529; Revol V, 2011, NUCL INSTRUM METH A, V648, pS302, DOI 10.1016/j.nima.2010.11.040; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Sahani DV, 2004, NURSING STANDARD OFF, V10, P55; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Seitz K, 2011, ULTRASCHALL MED, V32, P598, DOI 10.1055/s-0031-1281858; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Sztrokay A, 2012, EUROPEAN RADIOLOGY, P1; Thomsen HS, 2010, RADIOLOGY, V256, P672, DOI 10.1148/radiol.100566; van der Molen AJ, 2004, EUR RADIOL, V14, P902, DOI 10.1007/s00330-004-2238-z; Volk M, 2001, ACTA RADIOL, V42, P172, DOI 10.1034/j.1600-0455.2001.042002172.x; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2013, OPT EXPRESS, V21, P4155, DOI 10.1364/OE.21.004155; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zanette I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559849; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	39	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83369	10.1371/journal.pone.0083369	http://dx.doi.org/10.1371/journal.pone.0083369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465378	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000007
J	Sakamoto, T; Kobayashi, M; Tada, K; Shinohara, M; Io, K; Nagata, K; Iwai, F; Takiuchi, Y; Arai, Y; Yamashita, K; Shindo, K; Kadowaki, N; Koyanagi, Y; Takaori-Kondo, A				Sakamoto, Takashi; Kobayashi, Masayuki; Tada, Kohei; Shinohara, Masanobu; Io, Katsuhiro; Nagata, Kayoko; Iwai, Fumie; Takiuchi, Yoko; Arai, Yasuyuki; Yamashita, Kouhei; Shindo, Keisuke; Kadowaki, Norimitsu; Koyanagi, Yoshio; Takaori-Kondo, Akifumi			CKIP-1 Is an Intrinsic Negative Regulator of T-Cell Activation through an Interaction with CARMA1	PLOS ONE			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING PROTEIN; KINASE PKC-THETA; ADAPTER PROTEIN; IMMUNOLOGICAL SYNAPSE; UBIQUITIN LIGASE; SIGNALING PATHWAYS; C-THETA; CARD11; PHOSPHORYLATION	The transcription factor NF-kappa B plays a key regulatory role in lymphocyte activation and generation of immune response. Stimulation of T cell receptor (TCR) induces phosphorylation of CARMA1 by PKC theta, resulting in formation of CARMA1-Bcl10-MALT1 (CBM) complex at lipid rafts and subsequently leading to NF-kappa B activation. While many molecular events leading to NF-kappa B activation have been reported, it is less understood how this activation is negatively regulated. We performed a cell-based screening for negative regulators of TCR-mediated NF-kappa B activation, using mutagenesis and complementation cloning strategies. Here we show that casein kinase-2 interacting protein-1 (CKIP-1) suppresses PKCh-CBM-NF-kappa B signaling. We found that CKIP-1 interacts with CARMA1 and competes with PKC theta for association. We further confirmed that a PH domain of CKIP-1 is required for association with CARMA1 and its inhibitory effect. CKIP-1 represses NF-kappa B activity in unstimulated cells, and inhibits NF-kappa B activation induced by stimulation with PMA or constitutively active PKC theta, but not by stimulation with TNFa. Interestingly, CKIP-1 does not inhibit NF-kappa B activation induced by CD3/CD28 costimulation, which caused dissociation of CKIP-1 from lipid rafts. These data suggest that CKIP-1 contributes maintenance of a resting state on NF-kappa B activity or prevents T cells from being activated by inadequate signaling. In conclusion, we demonstrate that CKIP-1 interacts with CARMA1 and has an inhibitory effect on PKCh-CBM-NF-kappa B signaling.	[Sakamoto, Takashi; Kobayashi, Masayuki; Tada, Kohei; Shinohara, Masanobu; Io, Katsuhiro; Nagata, Kayoko; Iwai, Fumie; Takiuchi, Yoko; Arai, Yasuyuki; Yamashita, Kouhei; Shindo, Keisuke; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan; [Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto 606, Japan	Kyoto University; Kyoto University	Kobayashi, M (corresponding author), Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan.	mkobayas@kuhp.kyoto-u.ac.jp	Arai, Yasuyuki/AAF-6623-2020	Shindo, Keisuke/0000-0001-8793-8189; Arai, Yasuyuki/0000-0002-9662-5093	JSPS KAKENHI [23591383]; Grants-in-Aid for Scientific Research [24115004] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23591383. The URL is http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Cvijic ME, 2003, J IMMUNOL METHODS, V278, P293, DOI 10.1016/S0022-1759(03)00191-1; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kawano Y, 2004, J VIROL, V78, P11352, DOI 10.1128/JVI.78.20.11352-11359.2004; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Krishna S, 2012, J IMMUNOL, V189, P1209, DOI 10.4049/jimmunol.1102429; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Ling S, 2012, CIRCULATION; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nie J, 2013, AGEING RES REV, V12, P276, DOI 10.1016/j.arr.2012.07.002; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tokuda E, 2007, CANCER RES, V67, P9666, DOI 10.1158/0008-5472.CAN-07-1050; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang YF, 2012, EMBO REP, V13, P1004, DOI 10.1038/embor.2012.144; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Yoshida T, 2008, TRAFFIC, V9, P540, DOI [10.1111/j.1600-0854.2007.00700.x, 10.1111/j.1600-0854.2008.00700.x]; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85762	10.1371/journal.pone.0085762	http://dx.doi.org/10.1371/journal.pone.0085762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465689	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000060
J	Sirovich, L				Sirovich, Lawrence			Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)	PLOS ONE			English	Article							MELLITUS GENETICS FUSION; SUSCEPTIBILITY LOCI; WIDE ASSOCIATION; GENES; SCAN	A general approach is presented for the extraction of a classifier of disease risk that is latent in large scale disease/control databases. Novel features are the following: (1) a data reorganization into a regularized standard form that emphasizes individual alleles instead of the single nucleotide polymorphism (Snp) allele pair to which they belong; (2) from this a procedure that significantly enhances the discovery of high value genomic loci; (3) an investigative analysis based on the hypothesis that disease represents a very small signal (small signal-to-noise) that is latent in the data. The resulting analyses applied to the FUSION T2D database leads to the polling of thousands of genomic loci to classify disease. This large genomic kernel of loci is shared by non-diabetics at nearly the same high level; but a small well defined separation exists and it is speculated that this might be due to unconventional disease mechanisms. Another analysis demonstrates that the FUSION database size limits its disease predictability, and only one third of the resulting classifier loci are estimated to relate to T2D. The remainder is associated with hidden features that might contrast the disease and control populations and that more data would eliminate.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Sirovich, L (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	lsirovich@rockefeller.edu			Rockefeller University Committee for Clinical and Translational Science [UL1RR024143]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Rockefeller University Committee for Clinical and Translational Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	There were no external funding sources for this study. The high quality Fusion database was acquired from NIH at the request of the Rockefeller University Committee for Clinical and Translational Science, grant # UL1RR024143, National Center for Research Resources, National Institutes of Health.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Brookes AJ, 2000, NUCLEIC ACIDS RES, V28, P356, DOI 10.1093/nar/28.1.356; Chakravarti A, 2011, SCIENCE, V334, P15, DOI 10.1126/science.1214458; Dirac PAM, 1942, PROC R SOC LON SER-A, V180, P0001, DOI 10.1098/rspa.1942.0023; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Everson RM, 1998, P NATL ACAD SCI USA, V95, P8334, DOI 10.1073/pnas.95.14.8334; Feynman RP, 2000, MATH P CAMB PHIL SOC, V41, P71; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kolata G, 2012, NYTIMES         0402; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberts NJ, 2012, SCI TRANSL MED, V4; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silander K, 2004, DIABETES, V53, P821, DOI 10.2337/diabetes.53.3.821; Sirovich L, 1996, PHYSICA D, V96, P355, DOI 10.1016/0167-2789(96)00033-4; Sirovich L, 2002, METH NE FRO NEUROSCI, P43; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Wigner E, 1932, PHYS REV, V40, P0749, DOI 10.1103/PhysRev.40.749; Wolpert L, 2007, PRINCIPLES DEV; Wolpert L, 1969, THEOR BIOL, V25, P147; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85684	10.1371/journal.pone.0085684	http://dx.doi.org/10.1371/journal.pone.0085684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465649	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000051
J	Chakraborty, R; Bhullar, RP; Dakshinamurti, S; Hwa, J; Chelikani, P				Chakraborty, Raja; Bhullar, Rajinder P.; Dakshinamurti, Shyamala; Hwa, John; Chelikani, Prashen			Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor	PLOS ONE			English	Article							CONSTITUTIVELY ACTIVE MUTANT; PROTEIN-COUPLED RECEPTORS; A(2) RECEPTOR; P-SELECTIN; ANTAGONISTS; ACTIVATION; INSIGHTS; DISEASE; POTENT; CELLS	G protein-coupled receptors (GPCRs) show some level of basal activity even in the absence of an agonist, a phenomenon referred to as constitutive activity. Such constitutive activity in GPCRs is known to have important pathophysiological roles in human disease. The thromboxane A2 receptor (TP) is a GPCR that promotes thrombosis in response to binding of the prostanoid, thromboxane A2. TP dysfunction is widely implicated in pathophysiological conditions such as bleeding disorders, hypertension and cardiovascular disease. Recently, we reported the characterization of a few constitutively active mutants (CAMs) in TP, including a genetic variant A160T. Using these CAMs as reporters, we now test the inverse agonist properties of known antagonists of TP, SQ 29,548, Ramatroban, L-670596 and Diclofenac, in HEK293T cells. Interestingly, SQ 29,548 reduced the basal activity of both, WT-TP and the CAMs while Ramatroban was able to reduce the basal activity of only the CAMs. Diclofenac and L-670596 showed no statistically significant reduction in basal activity of WT-TP or CAMs. To investigate the role of these compounds on human platelet function, we tested their effects on human megakaryocyte based system for platelet activation. Both SQ 29,548 and Ramatroban reduced the platelet hyperactivity of the A160T genetic variant. Taken together, our results suggest that SQ 29,548 and Ramatroban are inverse agonists for TP, whereas, L-670596 and Diclofenac are neutral antagonists. Our findings have important therapeutic applications in the treatment of TP mediated pathophysiological conditions.	[Chakraborty, Raja; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada; [Hwa, John] Yale Univ, Sch Med, Dept Internal Med Cardiol, Cardiovasc Res Ctr, New Haven, CT USA	University of Manitoba; University of Manitoba; University of Manitoba; Yale University	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	chelikan@cc.umanitoba.ca	Mo, Xiulei/A-1616-2017; Chakraborty, Raja/L-6316-2017	Chelikani, Prashen/0000-0003-1129-7957	Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; MMSF Allen Rouse Career Award; Manitoba Health Research Council studentship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190, R01HL115247] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MMSF Allen Rouse Career Award; Manitoba Health Research Council studentship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada ((RGPIN 356285); and the MMSF Allen Rouse Career Award to PC, and a Manitoba Health Research Council studentship to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bylund DB, 2013, BIOCH PHARM IN PRESS; Cai GP, 1999, MOL PHARMACOL, V56, P989, DOI 10.1124/mol.56.5.989; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; COSTA T, 1992, MOL PHARMACOL, V41, P549; Davi Giovanni, 2012, Handb Exp Pharmacol, P261, DOI 10.1007/978-3-642-29423-5_11; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; Fontana P, 2011, J THROMB HAEMOST, V9, P2109, DOI 10.1111/j.1538-7836.2011.04446.x; FORDHUTCHINSON AW, 1989, CAN J PHYSIOL PHARM, V67, P989, DOI 10.1139/y89-155; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Gleim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067314; Gleim S, 2009, CURR ATHEROSCLER REP, V11, P227, DOI 10.1007/s11883-009-0035-5; HIRATA T, 1994, J CLIN INVEST, V94, P1662, DOI 10.1172/JCI117510; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Labrecque P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065767; Lesault PF, 2011, BRIT J CLIN PHARMACO, V71, P844, DOI 10.1111/j.1365-2125.2010.03858.x; Leytin V, 2000, BIOCHEM BIOPH RES CO, V273, P565, DOI 10.1006/bbrc.2000.2977; Li QL, 2007, J PHARMACOL EXP THER, V320, P637, DOI 10.1124/jpet.106.111203; Miggin SM, 2001, BBA-MOL CELL RES, V1539, P147, DOI 10.1016/S0167-4889(01)00103-3; Milligan G, 1997, TRENDS PHARMACOL SCI, V18, P468, DOI 10.1016/S0165-6147(97)90685-4; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Mo XL, 2013, BBA-MOL BASIS DIS, V1832, P1939, DOI 10.1016/j.bbadis.2013.06.006; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; Perzborn E, 1990, STROKE, V21, pIV143; Pydi SP, 2012, J NEUROCHEM, V122, P537, DOI 10.1111/j.1471-4159.2012.07808.x; Selg E, 2007, BRIT J PHARMACOL, V152, P1185, DOI 10.1038/sj.bjp.0707518; Shibata K, 1996, BRIT J PHARMACOL, V118, P1403, DOI 10.1111/j.1476-5381.1996.tb15552.x; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Wieland K, 2001, J PHARMACOL EXP THER, V299, P908	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85937	10.1371/journal.pone.0085937	http://dx.doi.org/10.1371/journal.pone.0085937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465800	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000033
J	Abd-Alhaseeb, MM; Zaitone, SA; Abou-El-Ela, SH; Moustafa, YM				Abd-Alhaseeb, Mohammad M.; Zaitone, Sawsan A.; Abou-El-Ela, Soad H.; Moustafa, Yasser M.			Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7)	PLOS ONE			English	Article							TYPE-1 RECEPTOR ANTAGONIST; ENDOTHELIAL GROWTH-FACTOR; HUMAN PANCREATIC-CANCER; I-CONVERTING-ENZYME; MICROVESSEL DENSITY; TUMOR ANGIOGENESIS; PROSTATE-CANCER; INHIBITS GROWTH; LUNG-CANCER; EXPRESSION	Local renin-angiotensin systems exist in various malignant tumor tissues; this suggests that the main effector peptide, angiotensin II, could act as a key factor in tumor growth. The underlying mechanisms for the anti-angiogenic effect of angiotensin II type 1 receptor blockers need to be further evaluated. The present study was carried out to investigate the anti-angiogenic effect of olmesartan alone or in combination with sorafenib, an angiotensin (1-7) agonist or an angiotensin (1-7) antagonist in Ehrlich's ascites carcinoma-bearing mice. The tumor was induced by intradermal injection of Ehrlich's ascites carcinoma cells into mice. Tumor discs were used to evaluate the microvessel density; the serum levels of vascular endothelial growth factor (VEGF) and serum insulin-like growth factor I (IGF-I); and their intratumoral receptors, VEGF receptor-2 and IGF-I receptor, respectively. All parameters were determined following the treatment course, which lasted for 21 days post-inoculation. Monotherapy with olmesartan and its combination with sorafenib resulted in a significant reduction in microvessel density and serum levels of VEGF and IGF-I, as well as their intratumoral receptors. In addition, the combination of olmesartan (30 mg/kg) with an angiotensin (1-7) agonist reduced the microvessel density, IGF-I serum levels and the levels of its intratumoral receptor. In conclusion, olmesartan reduced the levels of the angiogenesis markers IGF-I and VEGF and down-regulated the intratumoral expression of their receptors in a dose-dependent manner, and these effects were dependent on the angiotensin (1-7) receptor. These results suggest that olmesartan is a promising adjuvant to sorafenib in the treatment of cancer.	[Abd-Alhaseeb, Mohammad M.] Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Pharmacol & Toxicol, Arish, Egypt; [Zaitone, Sawsan A.; Moustafa, Yasser M.] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt; [Abou-El-Ela, Soad H.] Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Biochem, Arish, Egypt	Egyptian Knowledge Bank (EKB); Sinai University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Sinai University	Abd-Alhaseeb, MM (corresponding author), Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Pharmacol & Toxicol, Arish, Egypt.	m.abdelhasseb@su.edu.eg	Abd-Alhaseeb, Mohammad M/R-6176-2017; Zaitone, Sawsan A/G-8930-2017; Moustafa, Yasser/AAS-1212-2021	Abd-Alhaseeb, Mohammad M/0000-0001-5388-5250; Zaitone, Sawsan A/0000-0002-9688-7683; Moustafa, Yasser/0000-0001-5394-5559				Abali H, 2002, MED HYPOTHESES, V59, P344, DOI 10.1016/S0306-9877(02)00185-8; Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; AL Abdan M, 2012, SCI WORLD J, DOI 10.1100/2012/509838; Chen M, 2001, HYPERTENS RES, V24, P323, DOI 10.1291/hypres.24.323; Choi WWL, 2005, MODERN PATHOL, V18, P143, DOI 10.1038/modpathol.3800253; El-Azab M, 2011, EUR J PHARMACOL, V652, P7, DOI 10.1016/j.ejphar.2010.11.008; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535; Ferreira E, 2007, PATHOL RES PRACT, V203, P39, DOI 10.1016/j.prp.2006.09.005; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fraga-Silva RA, 2011, CLINICS, V66, P837, DOI 10.1590/S1807-59322011000500021; Fujimoto Y, 2001, FEBS LETT, V495, P197, DOI 10.1016/S0014-5793(01)02377-8; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; Gong QK, 2010, PANCREAS, V39, P581, DOI 10.1097/MPA.0b013e3181c314cd; Grunstein J, 1999, CANCER RES, V59, P1592; Habib SA., 2012, NAT SCI, V4, P808, DOI [10.4236/NS.2012.411108, DOI 10.4236/NS.2012.411108]; Hoff PM, 2012, CANCER TREAT REV, V38, P825, DOI 10.1016/j.ctrv.2012.04.006; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Huang W, 2008, DIGEST DIS SCI, V53, P1206, DOI 10.1007/s10620-007-0009-9; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Inwang ER, 1997, BRIT J CANCER, V75, P1279, DOI 10.1038/bjc.1997.217; Jawen J, 2012, J PHYSIOL PHARMACOL, V63, P77; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim S, 2000, PHARMACOL REV, V52, P11; Kosaka T, 2007, PROSTATE, V67, P41, DOI 10.1002/pros.20486; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Koukourakis MI, 2000, CANCER RES, V60, P3088; LAZARUS H., 1966, CANCER CHEMOTHERAP REP, V50, P543; Liu CY, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3457; Menon J, 2007, CANCER RES, V67, P2809, DOI 10.1158/0008-5472.CAN-06-3614; Miyajima A, 2002, CANCER RES, V62, P4176; Munzenmaier DH, 1996, HYPERTENSION, V27, P760, DOI 10.1161/01.HYP.27.3.760; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Ozaslan M, 2011, AFR J BIOTECHNOL, V10, P2375; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Rahbari-Oskoui F, 2011, AM J KIDNEY DIS, V57, P7, DOI 10.1053/j.ajkd.2010.09.012; Rakusan K, 2007, AM J PHYSIOL-HEART C, V292, pH1237, DOI 10.1152/ajpheart.00965.2006; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Schult C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-560; Schutz FAB, 2011, CRIT REV ONCOL HEMAT, V80, P291, DOI 10.1016/j.critrevonc.2010.11.007; Sica DA, 2006, J CLIN ONCOL, V24, P1329, DOI 10.1200/JCO.2005.04.5740; Siegelin MD, 2010, NEUROSCI LETT, V478, P165, DOI 10.1016/j.neulet.2010.05.009; Silva Alessandra Estrela da, 2004, Arq Bras Endocrinol Metabol, V48, P867; Soto-Pantoja DR, 2009, MOL CANCER THER, V8, P1676, DOI 10.1158/1535-7163.MCT-09-0161; Tallant EA, 1999, HYPERTENSION, V34, P950, DOI 10.1161/01.HYP.34.4.950; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Taskinen M, 2010, EUR J CANCER, V46, P2506, DOI 10.1016/j.ejca.2010.06.014; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Tsuda M, 2005, HYPERTENSION, V45, P545, DOI 10.1161/01.HYP.0000157409.88971.fc; Uemura Hiroji, 2005, Int J Clin Oncol, V10, P405, DOI 10.1007/s10147-005-0520-y; Ullrich RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019592; Walsh DA, 1997, BRIT J PHARMACOL, V120, P1302, DOI 10.1038/sj.bjp.0701062; Wang W, 2009, J INT MED RES, V37, P417, DOI 10.1177/147323000903700217; Wang YL, 2002, CURR CANCER DRUG TAR, V2, P191, DOI 10.2174/1568009023333863; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zaitone SA, 2012, EUR J PHARMACOL, V691, P134, DOI 10.1016/j.ejphar.2012.06.022	61	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85891	10.1371/journal.pone.0085891	http://dx.doi.org/10.1371/journal.pone.0085891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465768	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100086
J	Al-Qahtani, AA; Al-Anazi, MR; Abdo, AA; Sanai, FM; Al-Hamoudi, W; Alswat, KA; Al-Ashgar, HI; Khalaf, NZ; Eldali, AM; Viswan, NA; Al-Ahdal, MN				Al-Qahtani, Ahmed A.; Al-Anazi, Mashael R.; Abdo, Ayman A.; Sanai, Faisal M.; Al-Hamoudi, Waleed; Alswat, Khalid A.; Al-Ashgar, Hamad I.; Khalaf, Nisreen Z.; Eldali, Abdelmoneim M.; Viswan, Nisha A.; Al-Ahdal, Mohammed N.			Association between HLA Variations and Chronic Hepatitis B Virus Infection in Saudi Arabian Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEPATOCELLULAR-CARCINOMA; CLEARANCE; ALLELES; LOCUS; SUSCEPTIBILITY; EXPRESSION; VARIANTS; HLA-DPA1; DISEASES	Hepatitis B virus (HBV) infection is a leading cause of liver diseases including cirrhosis and hepatocellular carcinoma. Human leukocyte antigens (HLAs) play an important role in the regulation of immune response against infectious organisms, including HBV. Recently, several genome-wide association (GWAS) studies have shown that genetic variations in HLA genes influence disease progression in HBV infection. The aim of this study was to investigate the role of HLA genetic polymorphisms and their possible role in HBV infection in Saudi Arabian patients. Variations in HLA genes were screened in 1672 subjects who were divided according to their clinical status into six categories as follows; clearance group, inactive carriers, active carriers, cirrhosis, hepatocellular carcinoma (HCC) patients and uninfected healthy controls. Three single nucleotide polymorphisms (SNPs) belonged to HLA-DQ region (rs2856718, rs7453920 and rs9275572) and two SNPs belonged to HLA-DP (rs3077 and rs9277535) were studied. The SNPs were genotyped by PCR-based DNA sequencing (rs2856718) and allele specific TaqMan genotyping assays (rs3077, rs7453920, rs9277535 and rs9275572). The results showed that rs2856718, rs3077, rs9277535 and rs9275572 were associated with HBV infection (p = 0.0003, OR = 1.351, CI = 1.147-1.591; p = 0.041, OR = 1.20, CI = 1.007-1.43; p = 0.045, OR = 1.198, CI = 1.004-1.43 and p = 0.0018, OR = 0.776, CI = 0.662-0.910, respectively). However, allele frequency of rs2856718, rs7453920 and rs9275572 were found more in chronically infected patients when compared to clearance group infection (p = 0.0001, OR = 1.462, CI = 1.204-1.776; p = 0.0178, OR = 1.267, CI = 1.042-1.540 and p = 0.010, OR = 0.776, CI = 0.639-0.942, respectively). No association was found when polymorphisms in HLA genes were compared in active carriers versus cirrhosis/HCC patients. In conclusion, these results suggest that variations in HLA genes could affect susceptibility to and clearance of HBV infection in Saudi Arabian patients.	[Al-Qahtani, Ahmed A.; Al-Anazi, Mashael R.; Khalaf, Nisreen Z.; Viswan, Nisha A.; Al-Ahdal, Mohammed N.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Abdo, Ayman A.; Al-Hamoudi, Waleed; Alswat, Khalid A.] King Saud Univ, Coll Med, Dept Med, Gastroenterol Sect, Riyadh 11461, Saudi Arabia; [Sanai, Faisal M.] King Abdul Aziz Med City, Hepatobiliary Sci & Liver Transplantat, Riyadh, Saudi Arabia; [Al-Ashgar, Hamad I.] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia; [Eldali, Abdelmoneim M.] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Al-Qahtani, Ahmed A.; Abdo, Ayman A.; Sanai, Faisal M.; Al-Hamoudi, Waleed; Alswat, Khalid A.] King Saud Univ, Liver Dis Res Ctr, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Saud University; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University	Al-Qahtani, AA (corresponding author), King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	aqahtani@kfshrc.edu.sa		Alswat, Khalid/0000-0002-3521-8523; Al-Ahdal, Mohammed/0000-0002-8707-1594	King Abdulaziz City for Science and Technology, Saudi Arabia [ARP-27-18]	King Abdulaziz City for Science and Technology, Saudi Arabia	This study was supported in part by a grant from King Abdulaziz City for Science and Technology, Saudi Arabia [GRANT # ARP-27-18]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo AA, 2006, ANN SAUDI MED, V26, P261, DOI 10.5144/0256-4947.2006.261; Accolla RS, 2001, TRENDS IMMUNOL, V22, P560, DOI 10.1016/S1471-4906(01)02003-8; Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Jiang YG, 2003, WORLD J GASTROENTERO, V9, P2221; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Katsuyama Y, 1998, HUM HERED, V48, P126, DOI 10.1159/000022793; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lau KC, 2011, CLIN CHIM ACTA, V412, P952, DOI 10.1016/j.cca.2011.01.030; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Lu Liang-ping, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P427; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; PURCELL RH, 1993, GASTROENTEROLOGY, V104, P955, DOI 10.1016/0016-5085(93)90261-A; Thio CL, 1999, J INFECT DIS, V179, P1004, DOI 10.1086/314684; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Tseng TC, 2011, ANTIVIR THER, V16, P629, DOI 10.3851/IMP1841; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wu YF, 2004, J MED VIROL, V72, P17, DOI 10.1002/jmv.10557; Yan ZH, 2012, INFECT GENET EVOL, V12, P1222, DOI 10.1016/j.meegid.2012.03.026	30	48	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e80445	10.1371/journal.pone.0080445	http://dx.doi.org/10.1371/journal.pone.0080445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465366	Green Submitted, gold, Green Published			2022-12-27	WOS:000330283100001
J	Elia, N; Wager, E; Tramer, MR				Elia, Nadia; Wager, Elizabeth; Tramer, Martin R.			Fate of Articles That Warranted Retraction Due to Ethical Concerns: A Descriptive Cross-Sectional Study	PLOS ONE			English	Article							FRAUDULENT PUBLICATION; SCIENTIFIC LITERATURE; MISCONDUCT; JOURNALS; IMPACT	Objective: To study journals' responses to a request from the State Medical Association of Rheinland-Pfalz, Germany, to retract 88 articles due to ethical concerns, and to check whether the resulting retractions followed published guidelines. Design: Descriptive cross-sectional study. Population: 88 articles (18 journals) by the anaesthesiologist Dr. Boldt, that warranted retraction. Method: According to the recommendations of the Committee on Publication Ethics, we regarded a retraction as adequate when a retraction notice was published, linked to the retracted article, identified the title and authors of the retracted article in its heading, explained the reason and who took responsibility for the retraction, and when the retracted article was freely accessible and marked using a transparent watermark that preserved original content. Two authors extracted data independently (January 2013) and contacted editors-in-chief and publishers for clarification in cases of inadequate retraction. Results: Five articles (6%) fulfilled all criteria for adequate retraction. Nine (10%) were not retracted (no retraction notice published, full text article not marked). 79 (90%) retraction notices were published, 76 (86%) were freely accessible, but only 15 (17%) were complete. 73 (83%) full text articles were marked as retracted, of which 14 (16%) had an opaque watermark hiding parts of the original content, and 11 (13%) had all original content deleted. 59 (67%) retracted articles were freely accessible. One editor-in-chief stated personal problems as a reason for incomplete retractions, eight blamed their publishers. Two publishers cited legal threats from Dr. Boldt's co-authors which prevented them from retracting articles. Conclusion: Guidelines for retracting articles are incompletely followed. The role of publishers in the retraction process needs to be clarified and standards are needed on marking retracted articles. It remains unclear who should check that retractions are done properly. Legal safeguards are required to allow retraction of articles against the wishes of authors.	[Elia, Nadia; Tramer, Martin R.] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Elia, Nadia; Tramer, Martin R.] Univ Geneva, Fac Med, Geneva, Switzerland; [Elia, Nadia] Inst Social & Prevent Med, Fac Med, Geneva, Switzerland; [Wager, Elizabeth] Sideview, Princes Risborough, England	University of Geneva; University of Geneva; University of Geneva	Elia, N (corresponding author), Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland.	nadia.elia@hcuge.ch	Elia, Nadia/Y-6999-2019	Elia, Nadia/0000-0003-1787-9288; Wager, Elizabeth/0000-0002-4202-7813				Abbott A, 2002, NATURE, V418, P113, DOI 10.1038/418113a; Atlas MC, 2004, J MED LIBR ASSOC, V92, P242; Dyer C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1492; Fang FC, 2011, INFECT IMMUN, V79, P3855, DOI 10.1128/IAI.05661-11; FRIEDMAN PJ, 1990, JAMA-J AM MED ASSOC, V263, P1416; GARFIELD E, 1990, JAMA-J AM MED ASSOC, V263, P1424, DOI 10.1001/jama.263.10.1424; Knottnerus JA, 2012, J CLIN EPIDEMIOL, V65, P353, DOI 10.1016/j.jclinepi.2012.01.005; Marchant J, 2011, NATURE, V476, P263, DOI 10.1038/476263a; Newman M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6985; PFEIFER MP, 1990, JAMA-J AM MED ASSOC, V263, P1420, DOI 10.1001/jama.263.10.1420; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Tramer MR, 2013, EUR J ANAESTH, V30, P195, DOI 10.1097/EJA.0b013e328360a0db; Tramer MR, 2011, EUR J ANAESTH, V28, P393, DOI 10.1097/EJA.0b013e328347bdd1; Wager E, RETRACTIONS GUIDANCE; Wager E, 2011, J MED ETHICS, V37, P567, DOI 10.1136/jme.2010.040964; WHITELY WP, 1994, JAMA-J AM MED ASSOC, V272, P170, DOI 10.1001/jama.272.2.170	16	35	36	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85846	10.1371/journal.pone.0085846	http://dx.doi.org/10.1371/journal.pone.0085846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465744	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100082
J	Brodeur, MR; Bouvet, C; Bouchard, S; Moreau, S; Leblond, J; deBlois, D; Moreau, P				Brodeur, Mathieu R.; Bouvet, Celine; Bouchard, Sonia; Moreau, Simon; Leblond, Jeanne; deBlois, Denis; Moreau, Pierre			Reduction of Advanced-Glycation End Products Levels and Inhibition of RAGE Signaling Decreases Rat Vascular Calcification Induced by Diabetes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ISOLATED SYSTOLIC HYPERTENSION; MEDIAL ARTERIAL CALCIFICATION; CROSS-LINK BREAKER; OXIDATIVE STRESS; IN-VITRO; SUPEROXIDE-PRODUCTION; GENE-EXPRESSION; AGE; ACTIVATION	Advanced-glycation end products (AGEs) were recently implicated in vascular calcification, through a process mediated by RAGE (receptor for AGEs). Although a correlation between AGEs levels and vascular calcification was established, there is no evidence that reducing in vivo AGEs deposition or inhibiting AGEs-RAGE signaling pathways can decrease medial calcification. We evaluated the impact of inhibiting AGEs formation by pyridoxamine or elimination of AGEs by alagebrium on diabetic medial calcification. We also evaluated if the inhibition of AGEs-RAGE signaling pathways can prevent calcification. Rats were fed a high fat diet during 2 months before receiving a low dose of streptozotocin. Then, calcification was induced with warfarin. Pyridoxamine was administered at the beginning of warfarin treatment while alagebrium was administered 3 weeks after the beginning of warfarin treatment. Results demonstrate that AGEs inhibitors prevent the time-dependent accumulation of AGEs in femoral arteries of diabetic rats. This effect was accompanied by a reduced diabetes-accelerated calcification. Ex vivo experiments showed that N-methylpyridinium, an agonist of RAGE, induced calcification of diabetic femoral arteries, a process inhibited by antioxidants and different inhibitors of signaling pathways associated to RAGE activation. The physiological importance of oxidative stress was demonstrated by the reduction of femoral artery calcification in diabetic rats treated with apocynin, an inhibitor of reactive oxygen species production. We demonstrated that AGE inhibitors prevent or limit medial calcification. We also showed that diabetes-accelerated calcification is prevented by antioxidants. Thus, inhibiting the association of AGE-RAGE or the downstream signaling reduced medial calcification in diabetes.	[Brodeur, Mathieu R.; Bouvet, Celine; Bouchard, Sonia; Moreau, Simon; Leblond, Jeanne; deBlois, Denis; Moreau, Pierre] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Moreau, P (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	Pierre.moreau@umontreal.ca	Leblond, Jeanne/T-3453-2019	Chain Leblond, Jeanne/0000-0001-8390-4811; Moreau, Pierre/0000-0002-3604-721X	Pfizer Canada; Canadian Institutes for Health Research (CIHR); Rx D/CIHR; Fonds de la recherche en sante du Quebec (FRSQ)	Pfizer Canada(Pfizer); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Rx D/CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This project was supported by grants from Pfizer Canada and the Canadian Institutes for Health Research (CIHR). CB received a studentship from the Rx & D/CIHR and SM from the Fonds de la recherche en sante du Quebec (FRSQ). MRB was a fellow from Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baidoshvili A, 2004, ATHEROSCLEROSIS, V174, P287, DOI 10.1016/j.atherosclerosis.2004.02.012; Basta G, 2005, ARTERIOSCL THROM VAS, V25, P1401, DOI 10.1161/01.ATV.0000167522.48370.5e; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Bouvet C, 2007, CARDIOVASC RES, V73, P504, DOI 10.1016/j.cardiores.2006.11.001; Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Brodeur MR, 2013, J VASC RES, V50, P430, DOI 10.1159/000354235; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Cameron JD, 2003, DIABETES CARE, V26, P2133, DOI 10.2337/diacare.26.7.2133; CHANTELAU E, 1995, DIABETES RES CLIN PR, V29, P169, DOI 10.1016/0168-8227(95)01126-9; Conway B, 2010, DIABETES TECHNOL THE, V12, P339, DOI 10.1089/dia.2009.0152; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; Corman B, 1998, P NATL ACAD SCI USA, V95, P1301, DOI 10.1073/pnas.95.3.1301; Coughlan MT, 2007, KIDNEY INT, V72, pS54, DOI 10.1038/sj.ki.5002387; Dao HH, 2005, CARDIOVASC RES, V66, P307, DOI 10.1016/j.cardiores.2005.01.012; Edmonds ME, 2000, Z KARDIOL, V89, P101; EDMONDS ME, 1982, BRIT MED J, V284, P928, DOI 10.1136/bmj.284.6320.928; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; Farsang C, 2001, J HYPERTENS, V19, P2279, DOI 10.1097/00004872-200112000-00023; Gawdzik J, 2011, AM J NEPHROL, V33, P250, DOI 10.1159/000324693; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kass DA, 2001, CIRCULATION, V104, P1464, DOI 10.1161/hc3801.097806; Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Konova E, 2004, EXP GERONTOL, V39, P249, DOI 10.1016/j.exger.2003.10.003; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; MONNIER VM, 1986, NEW ENGL J MED, V314, P403, DOI 10.1056/NEJM198602133140702; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Nitenberg A, 2007, CARDIOVASC RES, V73, P450, DOI 10.1016/j.cardiores.2006.12.004; NUGENT LJ, 1984, CANCER RES, V44, P238; Qian MW, 1998, BIOCHEM BIOPH RES CO, V250, P385, DOI 10.1006/bbrc.1998.9326; Ren X, 2009, J INT MED RES, V37, P847, DOI 10.1177/147323000903700329; Sakata N, 2003, J VASC RES, V40, P567, DOI 10.1159/000075807; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Skatchkov MP, 1999, BIOCHEM BIOPH RES CO, V254, P319, DOI 10.1006/bbrc.1998.9942; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Suga T, 2011, J ATHEROSCLER THROMB, V18, P670, DOI 10.5551/jat.7120; Sun M, 1998, INT J EXP PATHOL, V79, P207; Sutra T, 2008, FREE RADICAL RES, V42, P789, DOI 10.1080/10715760802400766; Taki K, 2006, KIDNEY INT, V70, P218, DOI 10.1038/sj.ki.5000330; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Vasan S, 2003, ARCH BIOCHEM BIOPHYS, V419, P89, DOI 10.1016/j.abb.2003.08.016; Voziyan PA, 2003, J BIOL CHEM, V278, P46616, DOI 10.1074/jbc.M307155200; Voziyan PA, 2005, ANN NY ACAD SCI, V1043, P807, DOI 10.1196/annals.1333.093; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Winlove CP, 1996, DIABETOLOGIA, V39, P1131, DOI 10.1007/BF02658498; Wolffenbuttel BHR, 1998, P NATL ACAD SCI USA, V95, P4630, DOI 10.1073/pnas.95.8.4630; Zieman SJ, 2007, J HYPERTENS, V25, P577, DOI 10.1097/HJH.0b013e328013e7dd; Zill H, 2003, BIOCHEM BIOPH RES CO, V300, P311, DOI 10.1016/S0006-291X(02)02856-5	65	57	60	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85922	10.1371/journal.pone.0085922	http://dx.doi.org/10.1371/journal.pone.0085922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465790	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500145
J	Cao, H; Hu, XH; Zhang, Q; Li, J; Wang, JP; Shao, Y; Liu, B; Xin, SJ				Cao, Hui; Hu, Xinhua; Zhang, Qiang; Li, Jun; Wang, Junpeng; Shao, Yang; Liu, Bing; Xin, Shijie			Homocysteine Level and Risk of Abdominal Aortic Aneurysm: A Meta-Analysis	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PLASMA HOMOCYSTEINE; HEART-DISEASE; HYPERHOMOCYSTEINAEMIA; STROKE	Objectives: Previous studies have reported inconsistent findings regarding the association between elevated plasma homocysteine (Hcy) levels and abdominal aortic aneurysm (AAA). We investigated this association between Hcy levels in patients with AAA and unaffected controls by conducting a meta-analysis and systematic review. Methods: We conducted a systematic literature search (up to August 2013) of the PubMed database and Embase. We selected observational studies that evaluated Hcy levels in subjects with AAA compared to unaffected controls. Criteria for inclusion were the assessment of baseline Hcy and risk of AAA as an outcome. The results were presented as odd ratio (OR) and corresponding 95% confidence intervals (CI) comparing AAA patients to the control subjects. Results: 7 studies with 6,445 participants were identified and analyzed. Overall, elevated plasma Hcy was associated with an increased risk of AAA (3.29; 95% CI 1.66-6.51). The pooled adjusted OR from a random effect model of only men participants in the AAA compared with the control group was 2.36 (95% CI 0.63-8.82). Conclusion: This meta-analysis and systematic review suggested that Hcy significantly increased the risk of AAA.	[Cao, Hui; Hu, Xinhua; Zhang, Qiang; Li, Jun; Wang, Junpeng; Shao, Yang; Liu, Bing; Xin, Shijie] China Med Univ, Affiliated Hosp 1, Dept Vasc & Thyriod Surg, Shenyang, Peoples R China	China Medical University	Hu, XH (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Vasc & Thyriod Surg, Shenyang, Peoples R China.	xhhu@mail.cmu.edu.cn		Xin, Shijie/0000-0001-6278-8794	National Nature Science Foundation of China [81070254, 30872527, 30672048]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (81070254, 30872527 and 30672048). URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berti C, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/470656; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Brunelli T, 2000, J VASC SURG, V32, P531, DOI 10.1067/mva.2000.107563; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; den Heijer M, 2005, EUR J HUM GENET, V13, P753, DOI 10.1038/sj.ejhg.5201389; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng J, 2009, CARDIOVASC RES, V84, P155, DOI 10.1093/cvr/cvp182; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; Giusti B, 2008, J MED GENET, V45, P721, DOI 10.1136/jmg.2008.057851; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Harrison SC, 2013, EUR HEART J, V34, P3707, DOI 10.1093/eurheartj/ehs354; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Jee SH, 2002, HUM GENET, V111, P128, DOI 10.1007/s00439-002-0757-8; JourdheuilRahmani D, 1997, CARDIOVASC RES, V34, P597, DOI 10.1016/S0008-6363(97)00048-5; Ke XD, 2010, MOL CELL BIOCHEM, V335, P203, DOI 10.1007/s11010-009-0270-7; Krishna SM, 2013, ATHEROSCLEROSIS, V228, P295, DOI 10.1016/j.atherosclerosis.2013.02.019; Liu ZY, 2012, CIRC RES, V111, P1261, DOI [10.1161/CIRCRESAHA.112.270520, 10.1161/circresaha.112.270520]; Maegdefessel L, 2013, INT J MOL SCI, V14, P14374, DOI 10.3390/ijms140714374; Marti-Carvajal AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub3; Moroz P, 2007, ANZ J SURG, V77, P329, DOI 10.1111/j.1445-2197.2007.04052.x; Peeters AC, 2007, J VASC SURG, V45, P701, DOI 10.1016/j.jvs.2006.12.019; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Sofi F, 2005, THROMB HAEMOSTASIS, V94, P1094, DOI 10.1160/TH05-06-0431; Spark JI, 2003, EUR J VASC ENDOVASC, V26, P558, DOI 10.1016/S1078-5884(03)00381-2; van Wijngaarden JP, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/486186; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Warsi AA, 2004, EUR J VASC ENDOVASC, V27, P75, DOI 10.1016/j.ejvs.2003.09.001; Wells G., 2013, NEWCASTLE OTTAWA SCA; Wong YYE, 2013, J VASC SURG, V58, P364, DOI 10.1016/j.jvs.2013.01.046; Yang J, 2012, BONE, V51, P376, DOI 10.1016/j.bone.2012.05.024	35	29	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85831	10.1371/journal.pone.0085831	http://dx.doi.org/10.1371/journal.pone.0085831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465733	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500124
J	Malvindi, MA; De Matteis, V; Galeone, A; Brunetti, V; Anyfantis, GC; Athanassiou, A; Cingolani, R; Pompa, PP				Malvindi, Maria Ada; De Matteis, Valeria; Galeone, Antonio; Brunetti, Virgilio; Anyfantis, George C.; Athanassiou, Athanassia; Cingolani, Roberto; Pompa, Pier Paolo			Toxicity Assessment of Silica Coated Iron Oxide Nanoparticles and Biocompatibility Improvement by Surface Engineering	PLOS ONE			English	Article							IN-VIVO TOXICITY; CELLULAR UPTAKE; SIO2 NANOPARTICLES; CONTRAST AGENTS; CELLS; CYTOTOXICITY; VITRO; GENOTOXICITY; DELIVERY; DEXTRAN	We have studied in vitro toxicity of iron oxide nanoparticles (NPs) coated with a thin silica shell (Fe3O4/SiO2 NPs) on A549 and HeLa cells. We compared bare and surface passivated Fe3O4/SiO2 NPs to evaluate the effects of the coating on the particle stability and toxicity. NPs cytotoxicity was investigated by cell viability, membrane integrity, mitochondrial membrane potential (MMP), reactive oxygen species (ROS) assays, and their genotoxicity by comet assay. Our results show that NPs surface passivation reduces the oxidative stress and alteration of iron homeostasis and, consequently, the overall toxicity, despite bare and passivated NPs show similar cell internalization efficiency. We found that the higher toxicity of bare NPs is due to their stronger in-situ degradation, with larger intracellular release of iron ions, as compared to surface passivated NPs. Our results indicate that surface engineering of Fe3O4/SiO2 NPs plays a key role in improving particles stability in biological environments reducing both cytotoxic and genotoxic effects.	[Malvindi, Maria Ada; De Matteis, Valeria; Galeone, Antonio; Brunetti, Virgilio; Pompa, Pier Paolo] Ist Italiano Tecnol, UNILE, Ctr Biomol Nanotechnol, Arnesano, Italy; [Anyfantis, George C.; Athanassiou, Athanassia; Cingolani, Roberto] Ist Italiano Tecnol, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Pompa, PP (corresponding author), Ist Italiano Tecnol, UNILE, Ctr Biomol Nanotechnol, Arnesano, Italy.	pierpaolo.pompa@iit.it	Anyfantis, George C/K-9048-2017; ATHANASSIOU, ATHANASSIA/B-4197-2018; De Matteis, Valeria/J-4530-2019; Brunetti, Virgilio/AGZ-3500-2022	ATHANASSIOU, ATHANASSIA/0000-0002-6533-3231; De Matteis, Valeria/0000-0003-2204-8817; Galeone, Antonio/0000-0002-8678-7726; Brunetti, Virgilio/0000-0002-7615-1150				Apopa PL, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-1; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Bardi G, 2010, BIOMATERIALS, V31, P6555, DOI 10.1016/j.biomaterials.2010.04.063; Bartolozzi C, 1999, EUR RADIOL, V9, P1496, DOI 10.1007/s003300050876; Brunetti V, 2013, NANOSCALE, V5, P307, DOI 10.1039/c2nr33024e; Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972; Chen YC, 2010, TOXICOL APPL PHARM, V245, P272, DOI 10.1016/j.taap.2010.03.011; Davila-Ibanez AB, 2012, ACS NANO, V6, P747, DOI 10.1021/nn204231g; Dunford HB, 2002, COORDIN CHEM REV, V233, P311, DOI 10.1016/S0010-8545(02)00024-3; Gazeau F, 2008, NANOMEDICINE-UK, V3, P831, DOI 10.2217/17435889.3.6.831; Ge YQ, 2009, COLLOID SURFACE B, V73, P294, DOI 10.1016/j.colsurfb.2009.05.031; Gharagozloo M, 2008, EUR J PHARMACOL, V589, P1, DOI 10.1016/j.ejphar.2008.03.059; Hong SC, 2011, INT J NANOMED, V6, P3219, DOI 10.2147/IJN.S26355; Jarrett BR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035603; Juang JH, 2010, TRANSPL P, V42, P2104, DOI 10.1016/j.transproceed.2010.05.103; Kang K, 2009, J PHYS CHEM B, V113, P536, DOI 10.1021/jp807081b; Klostergaard J, 2012, NANOMED-NANOTECHNOL, V8, pS37, DOI 10.1016/j.nano.2012.05.010; Kunzmann A, 2011, TOXICOL APPL PHARM, V253, P81, DOI 10.1016/j.taap.2011.03.011; Laskar A, 2012, NANOMEDICINE-UK, V7, P705, DOI [10.2217/nnm.11.148, 10.2217/NNM.11.148]; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Levy M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395103; Lorenzo R, 2006, ATMOS ENVIRON, V40, P7831, DOI 10.1016/j.atmosenv.2006.07.026; Lunov O, 2010, BIOMATERIALS, V31, P9015, DOI 10.1016/j.biomaterials.2010.08.003; Mahmoudi M, 2012, CHEM REV, V112, P2323, DOI 10.1021/cr2002596; Mahmoudi M, 2011, ACS NANO, V5, P7263, DOI 10.1021/nn2021088; Mahon E, 2012, CHEM COMMUN, V48, P7970, DOI 10.1039/c2cc34023b; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Malvindi MA, 2012, NANOSCALE, V4, P486, DOI 10.1039/c1nr11269d; Malvindi MA, 2011, ADV FUNCT MATER, V21, P2548, DOI 10.1002/adfm.201100031; Manning T, 2009, CURR MED CHEM, V16, P2416, DOI 10.2174/092986709788682128; Murruni LG, 2009, ATMOS ENVIRON, V43, P4577, DOI 10.1016/j.atmosenv.2009.06.025; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Plank C, 2011, ADV DRUG DELIVER REV, V63, P1300, DOI 10.1016/j.addr.2011.08.002; Qhobosheane M, 2001, ANALYST, V126, P1274, DOI 10.1039/b101489g; Qiao RR, 2009, J MATER CHEM, V19, P6274, DOI 10.1039/b902394a; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Rivera-Gil P, 2013, ACCOUNTS CHEM RES, V46, P743, DOI 10.1021/ar300039j; Schroedter A, 2002, ANGEW CHEM INT EDIT, V41, P17; Singh N, 2012, BIOMATERIALS, V33, P163, DOI 10.1016/j.biomaterials.2011.09.087; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075; Soenen SJH, 2010, SMALL, V6, P832, DOI 10.1002/smll.200902084; Sowards JW, 2008, WELD J, V87, p106S; Wang FJ, 2013, NANOMED-NANOTECHNOL, V9, P1159, DOI 10.1016/j.nano.2013.04.010; Wei K, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-480; Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9; Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554; Zhu XM, 2012, INT J NANOMED, V7, P953, DOI 10.2147/IJN.S28316	48	159	161	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85835	10.1371/journal.pone.0085835	http://dx.doi.org/10.1371/journal.pone.0085835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465736	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500127
J	Pischke, S; Gisa, A; Suneetha, PV; Wiegand, SB; Taubert, R; Schlue, J; Wursthorn, K; Bantel, H; Raupach, R; Bremer, B; Zacher, BJ; Schmidt, RE; Manns, MP; Rifai, K; Witte, T; Wedemeyer, H				Pischke, Sven; Gisa, Anett; Suneetha, Pothakamuri Venkata; Wiegand, Steffen Bjoern; Taubert, Richard; Schlue, Jerome; Wursthorn, Karsten; Bantel, Heike; Raupach, Regina; Bremer, Birgit; Zacher, Behrend Johann; Schmidt, Reinhold Ernst; Manns, Michael Peter; Rifai, Kinan; Witte, Torsten; Wedemeyer, Heiner			Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis	PLOS ONE			English	Article							E VIRUS-INFECTION; TRANSPLANT RECIPIENTS; LIVER-DISEASE; ANTIBODIES	Background: Hepatitis E virus (HEV) infection takes a clinically silent, self-limited course in the far majority of cases. Chronic hepatitis E has been reported in some cohorts of immunocompromised individuals. The role of HEV infections in patients with autoimmune hepatitis (AIH) is unknown. Methods: 969 individuals were tested for anti-HEV antibodies (MP-diagnostics) including 208 patients with AIH, 537 healthy controls, 114 patients with another autoimmune disease, rheumatoid arthritis (RA), and 109 patients with chronic HCV- or HBV-infection (HBV/HCV). Patients with AIH, RA and HBV/HCV were tested for HEV RNA. HEV-specific proliferative T cell responses were investigated using CFSE staining and in vitro stimulation of PBMC with overlapping HEV peptides. Results: HEV-antibodies tested more frequently positive in patients with AIH (n = 16; 7.7%) than in healthy controls (n = 11; 2.0%; p = 0.0002), patients with RA (n = 4; 3.5%; p = 0.13) or patients with HBV/HCV infection (n = 2; 2.8%; p = 0.03). HEV-specific T cell responses could be detected in all anti-HEV-positive AIH patients. One AIH patient receiving immunosuppression with cyclosporin and prednisolone and elevated ALT levels had acute hepatitis E but HEV viremia resolved after reducing immunosuppressive medication. None of the RA or HBV/HCV patients tested HEV RNA positive. Conclusions: Patients with autoimmune hepatitis but not RA or HBV/HCV patients are more likely to test anti-HEV positive. HEV infection should been ruled out before the diagnosis of AIH is made. Testing for HEV RNA is also recommended in AIH patients not responding to immunosuppressive therapy.	[Pischke, Sven; Gisa, Anett; Suneetha, Pothakamuri Venkata; Wiegand, Steffen Bjoern; Taubert, Richard; Wursthorn, Karsten; Bantel, Heike; Raupach, Regina; Bremer, Birgit; Zacher, Behrend Johann; Manns, Michael Peter; Rifai, Kinan; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Schlue, Jerome] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Witte, Torsten] Hannover Med Sch, Dept Clin Immunol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Wedemeyer, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Wedemeyer.Heiner@mh-hannover.de	Witte, Torsten/B-5783-2016		German Federal Ministry of Education and Research [01EO0802]; Robert Koch Institute on hepatitis E [1362-1097];  [KFO 250 TP 03]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute on hepatitis E; 	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802), a grant from the Robert Koch Institute on hepatitis E to Sven Pischke and Heiner Wedemeyer (reference number 1362-1097), and by a grant to Torsten Witte and Reinhold E. Schmidt: KFO 250 TP 03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; [Anonymous], HEPATOLOGY; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Goens S. Denise, 2004, Animal Health Research Reviews, V5, P145, DOI 10.1079/AHR200495; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kammer AR, 1999, J EXP MED, V190, P169, DOI 10.1084/jem.190.2.169; LeCann P, 1997, SCAND J GASTROENTERO, V32, P387, DOI 10.3109/00365529709007689; Manns MP, 1997, J VIRAL HEPATITIS, V4, P7, DOI 10.1111/j.1365-2893.1997.tb00154.x; MANNS MP, 1993, INTERVIROLOGY, V35, P108, DOI 10.1159/000150301; Manns MP, 2001, GASTROENTEROLOGY, V120, P1502, DOI 10.1053/gast.2001.24227; Pischke S, 2012, AM J TRANSPLANT, V12, P3128, DOI 10.1111/j.1600-6143.2012.04200.x; Pischke S, 2010, J VIRAL HEPATITIS, V17, P598, DOI 10.1111/j.1365-2893.2009.01219.x; Pischke S, 2010, LIVER TRANSPLANT, V16, P74, DOI 10.1002/lt.21958; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Suneetha PV, 2012, HEPATOLOGY, V55, P695, DOI 10.1002/hep.24738; Suneetha PV, 2009, J IMMUNOL METHODS, V342, P33, DOI 10.1016/j.jim.2008.11.020; SYLVAN SPE, 1995, JAMA-J AM MED ASSOC, V273, P377, DOI 10.1001/jama.1995.03520290029022; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; Usui R, 2004, INFECTION, V32, P57, DOI 10.1007/s15010-004-3078-0; Vento S, 2004, AUTOIMMUN REV, V3, P61, DOI 10.1016/S1568-9972(03)00053-3; Vieira CL, 2013, WORLD J HEPATOL, V5, P152, DOI 10.4254/wjh.v5.i3.152; Wedemeyer H, 2013, SEMIN LIVER DIS, V33, P71, DOI 10.1055/s-0033-1338118; Wedemeyer H, 2012, GASTROENTEROLOGY, V142, P1388, DOI 10.1053/j.gastro.2012.02.014; Wenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688	27	52	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85330	10.1371/journal.pone.0085330	http://dx.doi.org/10.1371/journal.pone.0085330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465537	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500055
J	Smith, S; Tripathi, R; Goodings, C; Cleveland, S; Mathias, E; Hardaway, JA; Elliott, N; Yi, YJ; Chen, X; Downing, J; Mullighan, C; Swing, DA; Tessarollo, L; Li, LQ; Love, P; Jenkins, NA; Copeland, NG; Thompson, MA; Du, Y; Dave, UP				Smith, Stephen; Tripathi, Rati; Goodings, Charnise; Cleveland, Susan; Mathias, Elizabeth; Hardaway, J. Andrew; Elliott, Natalina; Yi, Yajun; Chen, Xi; Downing, James; Mullighan, Charles; Swing, Deborah A.; Tessarollo, Lino; Li, Liqi; Love, Paul; Jenkins, Nancy A.; Copeland, Neal G.; Thompson, Mary Ann; Du, Yang; Dave, Utpal P.			LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct Pathways	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENOME-WIDE ANALYSIS; LIM-PROTEIN LMO2; TRANSCRIPTION FACTOR; GENE-THERAPY; HEMATOPOIETIC STEM; ONLY PROTEINS; MOUSE MODEL; FORMS PART; EXPRESSION	The LMO2 oncogene is deregulated in the majority of human T-cell leukemia cases and in most gene therapy-induced T-cell leukemias. We made transgenic mice with enforced expression of Lmo2 in T-cells by the CD2 promoter/enhancer. These transgenic mice developed highly penetrant T-ALL by two distinct patterns of gene expression: one in which there was concordant activation of Lyl1, Hhex, and Mycn or alternatively, with Notch1 target gene activation. Most strikingly, this gene expression clustering was conserved in human Early T-cell Precursor ALL (ETP-ALL), where LMO2, HHEX, LYL1, and MYCN were most highly expressed. We discovered that HHEX is a direct transcriptional target of LMO2 consistent with its concordant gene expression. Furthermore, conditional inactivation of Hhex in CD2-Lmo2 transgenic mice markedly attenuated T-ALL development, demonstrating that Hhex is a crucial mediator of Lmo2's oncogenic function. The CD2-Lmo2 transgenic mice offer mechanistic insight into concordant oncogene expression and provide a model for the highly treatment-resistant ETP-ALL subtype.	[Smith, Stephen; Tripathi, Rati; Goodings, Charnise; Cleveland, Susan; Mathias, Elizabeth; Elliott, Natalina; Dave, Utpal P.] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN 37212 USA; [Smith, Stephen; Tripathi, Rati; Goodings, Charnise; Cleveland, Susan; Mathias, Elizabeth; Elliott, Natalina; Dave, Utpal P.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Hardaway, J. Andrew] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Yi, Yajun] Vanderbilt Univ, Med Ctr, Div Med Genet, Nashville, TN USA; [Chen, Xi] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Downing, James; Mullighan, Charles] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Swing, Deborah A.; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Li, Liqi; Love, Paul] NICHHD, NIH, Bethesda, MD 20892 USA; [Jenkins, Nancy A.; Copeland, Neal G.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Thompson, Mary Ann] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Du, Yang] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); The Methodist Hospital System; The Methodist Hospital - Houston; Vanderbilt University; Uniformed Services University of the Health Sciences - USA	Dave, UP (corresponding author), Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN 37212 USA.	utpal.dave@vanderbilt.edu	Goodings, Charnise/S-7372-2019; Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850; Goodings, Charnise/0000-0001-8189-0989; Elliott, Natalina/0000-0002-6713-7349	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX001799-01A1]; National Institutes of Health (NIH) [K08HL089403]; Leukemia & Lymphoma Society; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; Cancer Prevention Research Institute of Texas (CPRIT); American Society of Hematology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592, ZICBC011265, P30CA021765, ZICBC010903, P30CA068485, R01CA143193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001799] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; Cancer Prevention Research Institute of Texas (CPRIT); American Society of Hematology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a VA Merit award, BX001799-01A1 (UPD), by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development and the National Institutes of Health (NIH) grant K08HL089403, the Leukemia & Lymphoma Society, and the Vanderbilt Ingram Cancer Center (P30 CA68485) (UPD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the NIH. The VMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). NGC and NAJ are supported in part by the Cancer Prevention Research Institute of Texas (CPRIT). They are also both CPRIT Scholars in Cancer Research. This work was also supported by a Bridge Grant from the American Society of Hematology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnafi V, 2004, BLOOD, V104, P4173, DOI 10.1182/blood-2003-11-3944; Berquam-Vrieze KE, 2011, BLOOD, V118, P4646, DOI 10.1182/blood-2011-03-343947; Bogue CW, 2003, P NATL ACAD SCI USA, V100, P556, DOI 10.1073/pnas.0236979100; Cai Y, 2009, BIOCHEM BIOPH RES CO, V390, P295, DOI 10.1016/j.bbrc.2009.09.111; Calero-Nieto FJ, 2013, ONCOGENE; Cleveland SM, 2013, STEM CELLS, V31, P882, DOI 10.1002/stem.1345; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; Dave UP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000491; Deleuze V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040484; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drynan LF, 2001, ONCOGENE, V20, P4412, DOI 10.1038/sj.onc.1204538; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; George A, 2003, ONCOGENE, V22, P6764, DOI 10.1038/sj.onc.1206822; Giroux S, 2007, GENE EXPR PATTERNS, V7, P215, DOI 10.1016/j.modgep.2006.10.004; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; LARSON RC, 1994, ONCOGENE, V9, P3675; Li LQ, 2011, NAT IMMUNOL, V12, P129, DOI 10.1038/ni.1978; Lin YW, 2005, CANCER RES, V65, P7151, DOI 10.1158/0008-5472.CAN-05-1400; LOVE PE, 1994, J EXP MED, V179, P1485, DOI 10.1084/jem.179.5.1485; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; McCormack MP, SCIENCE NEW YORK NY, V327, P879; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Neumann M, 2013, BLOOD; O'Neil J, 2005, BLOOD; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tatarek J, 2011, BLOOD, V118, P1579, DOI 10.1182/blood-2010-08-300343; Treanor LM, 2011, BLOOD, V117, P5453, DOI 10.1182/blood-2010-09-309831; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu Chuanfeng, 2011, Front Med, V5, P356, DOI 10.1007/s11684-011-0159-1; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zohren F, 2012, NAT IMMUNOL, V13, P761, DOI 10.1038/ni.2365	56	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85883	10.1371/journal.pone.0085883	http://dx.doi.org/10.1371/journal.pone.0085883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465765	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500135
J	Unzu, C; Melero, I; Morales-Kastresana, A; Sampedro, A; Serrano-Mendioroz, I; Azpilikueta, A; Ochoa, MC; Dubrot, J; Martinez-Anso, E; Fontanellas, A				Unzu, Carmen; Melero, Ignacio; Morales-Kastresana, Aizea; Sampedro, Ana; Serrano-Mendioroz, Irantzu; Azpilikueta, Arantza; Carmen Ochoa, Maria; Dubrot, Juan; Martinez-Anso, Eduardo; Fontanellas, Antonio			Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus	PLOS ONE			English	Article							KUPFFER CELLS LEADS; IMMUNE-RESPONSE; COMPLEMENT ACTIVATION; TRANSGENE EXPRESSION; NATURAL ANTIBODIES; VECTORS; IGM; TRANSDUCTION; DEPLETION; DELIVERY	The immune system poses obstacles to viral vectors, even in the first administration to preimmunized hosts. We have observed that the livers of B cell-deficient mice were more effectively transduced by a helper-dependent adenovirus serotype-5 (HDA) vector than those of WT mice. This effect was T-cell independent as shown in athymic mice. Passive transfer of the serum from adenovirus-naive WT to Rag1KO mice resulted in a reduction in gene transfer that was traced to IgM purified from serum of adenovirus-naive mice. To ascribe the gene transfer inhibition activity to either adenoviral antigen-specific or antigen-unspecific functions of IgM, we used a monoclonal IgM antibody of unrelated specificity. Both the polyclonal and the irrelevant monoclonal IgM inhibited gene transfer by the HDA vector to either cultured hepatocellular carcinoma cells or to the liver of mice in vivo. Adsorption of polyclonal or monoclonal IgMs to viral capsids was revealed by ELISAs on adenovirus-coated plates. These observations indicate the existence of an inborn IgM mechanism deployed against a prevalent virus to reduce early post-infection viremia. In conclusion, innate IgM binding to adenovirus serotype-5 capsids restrains gene-transfer and offers a mechanism to be targeted for optimization of vector dosage in gene therapy with HDA vectors.	[Unzu, Carmen; Melero, Ignacio; Morales-Kastresana, Aizea; Sampedro, Ana; Serrano-Mendioroz, Irantzu; Azpilikueta, Arantza; Carmen Ochoa, Maria; Martinez-Anso, Eduardo; Fontanellas, Antonio] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain; [Dubrot, Juan] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland	University of Navarra; University of Geneva	Fontanellas, A (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain.	afontanellas@unav.es	Unzu, Carmen/ABC-2904-2021; Fontanellas, Antonio/AAD-8073-2022; Unzu, Carmen/M-1026-2019; Melero, Ignacio/T-7600-2019; Ochoa, Maria C./K-4508-2017; Azpilicueta, Arantza/K-2701-2017; Dubrot, Juan/ABI-1676-2020	Unzu, Carmen/0000-0002-1582-7196; Fontanellas, Antonio/0000-0001-9279-7990; Melero, Ignacio/0000-0002-1360-348X; Ochoa, Maria C./0000-0001-9920-2144; Azpilicueta, Arantza/0000-0001-8511-6050; Dubrot, Juan/0000-0002-8093-2208	UTE project of Centro de Investigacion Medica Aplicada; University of Navarra; Spanish Fondo de Investigacion Sanitaria [PS09/02639]; Spanish Fundacion Mutua Madrilena de Investigacion Medica [AP66712009]	UTE project of Centro de Investigacion Medica Aplicada; University of Navarra; Spanish Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Spanish Fundacion Mutua Madrilena de Investigacion Medica	This work was supported in part by grants from UTE project of Centro de Investigacion Medica Aplicada, University of Navarra, Spanish Fondo de Investigacion Sanitaria (PS09/02639) and Spanish Fundacion Mutua Madrilena de Investigacion Medica (AP66712009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2011, CURR GENE THER, V11, P307; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Brunetti-Pierri N, 2005, MOL THER, V12, P99, DOI 10.1016/j.ymthe.2005.03.001; Brunetti-Pierri N, 2007, MOL THER, V15, P732, DOI 10.1038/sj.mt.6300102; Brunetti-Pierri N, 2012, MOL THER, V20, P1863, DOI 10.1038/mt.2012.143; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, pR7, DOI 10.1093/hmg/ddr143; CAPEL PJA, 1980, J IMMUNOL METHODS, V36, P77, DOI 10.1016/0022-1759(80)90096-4; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Cerreto M, 2012, CURR GENE THER, V12, P48, DOI 10.2174/156652312799789280; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Crettaz J, 2008, J GENE MED, V10, P1092, DOI 10.1002/jgm.1236; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dimmock D, 2011, HUM GENE THER, V22, P483, DOI 10.1089/hum.2010.167; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; Fontanellas A, 2010, MOL THER, V18, P754, DOI 10.1038/mt.2009.312; Gau CL, 2009, MOL THER, V17, P1155, DOI 10.1038/mt.2009.65; Haegel-Kronenberger H, 2004, GENE THER, V11, P241, DOI 10.1038/sj.gt.3302152; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; Higgins R, 2010, THER APHER DIAL, V14, P392, DOI 10.1111/j.1744-9987.2010.00821.x; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Khare R, 2013, J VIROL, V87, P3678, DOI 10.1128/JVI.01392-12; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; MARTINEZANSO E, 1994, HEPATOLOGY, V19, P1400, DOI 10.1002/hep.1840190613; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Piccolo P, 2013, MOL THER, V21, P767, DOI 10.1038/mt.2012.287; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Schiedner G, 2003, MOL THER, V7, P35, DOI 10.1016/S1525-0016(02)00017-5; Seregin SS, 2009, MOL THER, V17, P685, DOI 10.1038/mt.2008.297; Smith JG, 2008, J VIROL, V82, P6492, DOI 10.1128/JVI.00557-08; Snoeys J, 2006, MOL THER, V13, P98, DOI 10.1016/j.ymthe.2005.06.477; Sokoloff AV, 2001, MOL THER, V3, P821, DOI 10.1006/mthe.2001.0340; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Thaci B, 2011, ONCOTARGET, V2, P113; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Unzu C, 2013, HUM MOL GENET; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Yamaguchi T, 2007, HUM GENE THER, V18, P753, DOI 10.1089/hum.2007.016; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06; Zong S, 2011, J GENE MED, V13, P670, DOI 10.1002/jgm.1627	46	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85432	10.1371/journal.pone.0085432	http://dx.doi.org/10.1371/journal.pone.0085432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465560	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500065
J	Wanless, AG; Lin, Y; Weiss, EL				Wanless, Antony G.; Lin, Yuan; Weiss, Eric L.			Cell Morphogenesis Proteins Are Translationally Controlled through UTRs by the Ndr/LATS Target Ssd1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE W303-1A; GREEN FLUORESCENT PROTEIN; RNA-BINDING PROTEIN; MESSENGER-RNA; GENETIC INTERACTIONS; MITOTIC EXIT; YEAST CBK1; KINASE; WALL; LOCALIZATION	Eukaryotic cells control their growth and morphogenesis to maintain integrity and viability. Free-living cells are further challenged by their direct interaction with the environment and in many cases maintain a resilient cell wall to stay alive under widely varying conditions. For these organisms, stringent and highly localized control of the cell wall's remodeling and expansion is crucial for cell growth and reproduction. In the budding yeast Saccharomyces cerevisiae the RNA binding protein Ssd1 helps control cell wall remodeling by repressing translation of proteins involved in wall expansion. Ssd1 is itself negatively regulated by the highly conserved Ndr/LATS protein kinase Cbk1. We sought to identify mRNA regions that confer Ssd1-mediated translational control. After validating a GFP reporter system as a readout of Ssd1 activity we found that 3' untranslated regions of the known Ssd1 targets CTS1, SIM1 and UTH1 are sufficient for Cbk1-regulated translational control. The 5' untranslated region of UTH1 also facilitated Ssd1-mediated translational control in a heterologous context. The CTS1 and SIM1 3' untranslated regions confer Ssd1 binding, and the SIM1 3' untranslated region improves Ssd1 immunoprecipitation of the endogenous SIM1 transcript. However, SIM1's 3' untranslated region is not essential for Ssd1-regulated control of the message's translation. We propose that Ssd1 regulates translation of its target message primarily through UTRs and the SIM1 message through multiple potential points of interaction, permitting fine translational control in various contexts.	[Wanless, Antony G.; Lin, Yuan; Weiss, Eric L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Weiss, EL (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	elweiss@northwestern.edu			National Institutes of Health - National Institue of General Medical Sciences (NIGMS) [R01 GM084223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084223] Funding Source: NIH RePORTER	National Institutes of Health - National Institue of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health - National Institue of General Medical Sciences (NIGMS). The relevant grant number is R01 GM084223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrahami-Moyal L, 2012, FEMS YEAST RES, V12, P521, DOI 10.1111/j.1567-1364.2012.00803.x; Avrahami-Moyal L, 2012, FEMS YEAST RES, V12, P447, DOI 10.1111/j.1567-1364.2012.00795.x; Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Evans DRH, 1997, GENETICS, V145, P227; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Ibeas JI, 2001, PLANT J, V25, P271, DOI 10.1046/j.1365-313x.2001.00967.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Jansen JM, 2009, CURR BIOL, V19, P2114, DOI 10.1016/j.cub.2009.10.071; Jorgensen P, 2002, GENETICS, V162, P1091; Kaeberlein M, 2004, GENETICS, V166, P1661, DOI 10.1534/genetics.166.4.1661; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kurischko C, 2011, MOL MICROBIOL, V81, P831, DOI 10.1111/j.1365-2958.2011.07731.x; Kurischko C, 2011, J CELL BIOL, V192, P583, DOI 10.1083/jcb.201011061; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Li LH, 2009, MOL BIOL CELL, V20, P3851, DOI 10.1091/mbc.E09-04-0347; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Moriya H, 1999, YEAST, V15, P481, DOI 10.1002/(SICI)1097-0061(199904)15:6<481::AID-YEA391>3.0.CO;2-M; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Natarajan A, 1998, J BIOTECHNOL, V62, P29, DOI 10.1016/S0168-1656(98)00040-6; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Ohyama Y, 2010, GENES CELLS, V15, P1169, DOI 10.1111/j.1365-2443.2010.01452.x; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Richardson R, 2012, MOL GENET GENOMICS, V287, P711, DOI 10.1007/s00438-012-0709-5; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uesono Y, 1997, J BIOL CHEM, V272, P16103, DOI 10.1074/jbc.272.26.16103; Vincent K, 2003, GENETICS, V164, P895; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	47	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85212	10.1371/journal.pone.0085212	http://dx.doi.org/10.1371/journal.pone.0085212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465507	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500043
J	Zhang, HH; Zhang, XQ; Xue, QS; Yan-Luo; Huang, JL; Zhang, S; Shao, HJ; Lu, H; Wang, WY; Yu, BW				Zhang, Hong-Hai; Zhang, Xiao-Qin; Xue, Qing-Sheng; Yan-Luo; Huang, Jin-Lu; Zhang, Su; Shao, Hai-Jun; Lu, Han; Wang, Wen-Yuan; Yu, Bu-Wei			The BDNF/TrkB Signaling Pathway Is Involved in Heat Hyperalgesia Mediated by Cdk5 in Rats	PLOS ONE			English	Article							INFLAMMATORY PAIN HYPERSENSITIVITY; PERIPHERAL-NERVE INJURY; DORSAL-HORN NEURONS; NEUROTROPHIC FACTOR; SPINAL-CORD; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; THERMAL NOCICEPTION; PERSISTENT PAIN; BDNF	Background: Cyclin-dependent kinase 5 (Cdk5) has been shown to play an important role in mediating inflammation-induced heat hyperalgesia. However, the underlying mechanism remains unclear. The aim of this study was to determine whether roscovitine, an inhibitor of Cdk5, could reverse the heat hyperalgesia induced by peripheral injection of complete Freund's adjuvant (CFA) via the brain-derived neurotrophic factor (BDNF)-tyrosine kinase B (TrkB) signaling pathway in the dorsal horn of the spinal cord in rats. Results: Heat hyperalgesia induced by peripheral injection of CFA was significantly reversed by roscovitine, TrkB-IgG, and the TrkB inhibitor K252a, respectively. Furthermore, BDNF was significantly increased from 0.5 h to 24 h after CFA injection in the spinal cord dorsal horn. Intrathecal adminstration of the Cdk5 inhibitor roscovitine had no obvious effects on BDNF levels. Increased TrkB protein level was significantly reversed by roscovitine between 0.5 h and 6 h after CFA injection. Cdk5 and TrkB co-immunoprecipitation results suggested Cdk5 mediates the heat hyperalgesia induced by CFA injection by binding with TrkB, and the binding between Cdk5 and TrkB was markedly blocked by intrathecal adminstration of roscovitine. Conclusion: Our data suggested that the BDNF-TrkB signaling pathway was involved in CFA-induced heat hyperalgesia mediated by Cdk5. Roscovitine reversed the heat hyperalgesia induced by peripheral injection of CFA by blocking BDNF/TrkB signaling pathway, suggesting that severing the close crosstalk between Cdk5 and the BDNF/TrkB signaling cascade may present a potential target for anti-inflammatory pain.	[Zhang, Hong-Hai; Zhang, Xiao-Qin; Xue, Qing-Sheng; Yan-Luo; Zhang, Su; Shao, Hai-Jun; Lu, Han; Wang, Wen-Yuan; Yu, Bu-Wei] Shanghai JiaoTong Univ Sch Med, Dept Anesthesiol, Ruijin Hosp, Shanghai, Peoples R China; [Zhang, Hong-Hai] Nan Jing Med Univ, Hang Zhou Peoples Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Huang, Jin-Lu] Shanghai JiaoTong Univ Sch Med, Dept Pharm, Affiliated Hosp 6, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, BW (corresponding author), Shanghai JiaoTong Univ Sch Med, Dept Anesthesiol, Ruijin Hosp, Shanghai, Peoples R China.	yubuwei_ruijin@163.com			National Natural Science Foundation, Beijing, P.R. China [81102513, 81072703]	National Natural Science Foundation, Beijing, P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation, Beijing, P. R. China, grant No. 81102513 to Dr. Han Lu and grant No. 81072703 to Dr. Buwei Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charlton E, 1995, Pain, V63, P277, DOI 10.1016/0304-3959(95)90040-3; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Garraway SM, 2003, EUR J NEUROSCI, V18, P2467, DOI 10.1046/j.1460-9568.2003.02982.x; Groth R, 2002, PAIN, V100, P171, DOI 10.1016/S0304-3959(02)00264-6; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang Y, 2012, EXP NEUROL, V233, P791, DOI 10.1016/j.expneurol.2011.11.043; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; Lin YT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-126; Malcangio M, 1997, J NEUROSCI, V17, P8459; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Obata K, 2006, NEUROSCI RES, V55, P1, DOI 10.1016/j.neures.2006.01.005; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8; Sandow SL, 2000, IMMUNOL CELL BIOL, V78, P430, DOI 10.1046/j.1440-1711.2000.00924.x; Santi S, 2006, EMBO J, V25, P4372, DOI 10.1038/sj.emboj.7601303; Shu XQ, 1999, PAIN, V80, P463, DOI 10.1016/S0304-3959(99)00042-1; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Utreras E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-49; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zhang HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046666; Zhang R, 2012, PHARMACOL BIOCHEM BE, V102, P139, DOI 10.1016/j.pbb.2012.03.025; Zhang W, 2008, NEUROSCIENCE, V152, P502, DOI 10.1016/j.neuroscience.2007.12.037; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	38	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85536	10.1371/journal.pone.0085536	http://dx.doi.org/10.1371/journal.pone.0085536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465591	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500072
J	Hessel, J; Heldrich, J; Fuller, J; Staudt, MR; Radisch, S; Hollmann, C; Harvey, BG; Kaner, RJ; Salit, J; Yee-Levin, J; Sridhar, S; Pillai, S; Hilton, H; Wolff, G; Bitter, H; Visvanathan, S; Fine, J; Stevenson, CS; Crystal, RG; Tilley, AE				Hessel, Justina; Heldrich, Jonna; Fuller, Jennifer; Staudt, Michelle R.; Radisch, Sharon; Hollmann, Charleen; Harvey, Ben-Gary; Kaner, Robert J.; Salit, Jacqueline; Yee-Levin, Jenny; Sridhar, Sriram; Pillai, Sreekumar; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay; Stevenson, Christopher S.; Crystal, Ronald G.; Tilley, Ann E.			Intraflagellar Transport Gene Expression Associated with Short Cilia in Smoking and COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ORGANELLE SIZE REGULATION; FLAGELLAR LENGTH CONTROL; SMALL AIRWAY EPITHELIUM; BRONCHIAL EPITHELIUM; CIGARETTE-SMOKING; MUCOCILIARY CLEARANCE; PROTEIN; ABNORMALITIES; SMOKERS	Smoking and COPD are associated with decreased mucociliary clearance, and healthy smokers have shorter cilia in the large airway than nonsmokers. We hypothesized that changes in cilia length are consistent throughout the airway, and we further hypothesized that smokers with COPD have shorter cilia than healthy smokers. Because intraflagellar transport (IFT) is the process by which cilia of normal length are produced and maintained, and alterations in IFT lead to short cilia in model organisms, we also hypothesized that smoking induces changes in the expression of IFT-related genes in the airway epithelium of smokers and smokers with COPD. To assess these hypotheses, airway epithelium was obtained via bronchoscopic brushing. Cilia length was assessed by measuring 100 cilia (10 cilia on each of 10 cells) per subject and Affymetrix microarrays were used to evaluate IFT gene expression in nonsmokers and healthy smokers in 2 independent data sets from large and small airway as well as in COPD smokers in a data set from the small airway. In the large and small airway epithelium, cilia were significantly shorter in healthy smokers than nonsmokers, and significantly shorter in COPD smokers than in both healthy smokers and nonsmokers. The gene expression data confirmed that a set of 8 IFT genes were down-regulated in smokers in both data sets; however, no differences were seen in COPD smokers compared to healthy smokers. These results support the concept that loss of cilia length contributes to defective mucociliary clearance in COPD, and that smoking-induced changes in expression of IFT genes may be one mechanism of abnormally short cilia in smokers. Strategies to normalize cilia length may be an important avenue for novel COPD therapies.	[Hessel, Justina; Harvey, Ben-Gary; Kaner, Robert J.; Yee-Levin, Jenny; Crystal, Ronald G.; Tilley, Ann E.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY 10065 USA; [Heldrich, Jonna; Fuller, Jennifer; Staudt, Michelle R.; Radisch, Sharon; Hollmann, Charleen; Salit, Jacqueline; Crystal, Ronald G.; Tilley, Ann E.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Sridhar, Sriram; Pillai, Sreekumar; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay; Stevenson, Christopher S.] Hoffmann La Roche Inc, Nutley, NJ 07110 USA	Cornell University; Cornell University; Roche Holding	Tilley, AE (corresponding author), Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Wolff MD|PhD, Gerhard/0000-0002-4458-0700; Staudt, Michelle/0000-0002-3364-0894	Hoffmann-La Roche, Inc, Nutley, NJ [1R01HL107882, P20 HL113443, 1 K23 HL103837, UL1- RR024996, UL1- RR024143, P50 HL084936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107882, K23HL103837, P50HL084936, P20HL113443] Funding Source: NIH RePORTER	Hoffmann-La Roche, Inc, Nutley, NJ(Hoffmann-La Roche); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by 1R01HL107882; P20 HL113443; 1 K23 HL103837; UL1- RR024996; UL1- RR024143; P50 HL084936; Hoffmann-La Roche, Inc, Nutley, NJ; and JP Smith Clinical Scholar (B.G Harvey and R. Kaner). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH O, 1979, NEW ENGL J MED, V300, P381, DOI 10.1056/NEJM197902223000801; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; BALLENGER JJ, 1960, NEW ENGL J MED, V263, P832, DOI 10.1056/NEJM196010272631704; Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.e03-03-0166; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; CHANG SC, 1957, CANCER-AM CANCER SOC, V10, P1246, DOI 10.1002/1097-0142(195711/12)10:6<1246::AID-CNCR2820100623>3.0.CO;2-Z; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Fowler VM, 2006, CURR BIOL, V16, pR18, DOI 10.1016/j.cub.2005.12.003; FOX B, 1983, EUR J RESPIR DIS, V64, P11; FOX B, 1981, CHEST, V80, P796, DOI 10.1378/chest.80.6.796; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Gower Adam C, 2011, Proc Am Thorac Soc, V8, P173, DOI 10.1513/pats.201011-066MS; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; NORRANDER JM, 1995, DEVELOPMENT, V121, P1615; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Rajagopalan V, 2009, MOL BIOL CELL, V20, P708, DOI 10.1091/mbc.E08-07-0746; Rosenbaum J, 2003, CURR BIOL, V13, pR506, DOI 10.1016/S0960-9822(03)00440-8; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; SERAFINI SM, 1977, B EUR PHYSIOPATH RES, V13, P551; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Tsao CC, 2008, MOL BIOL CELL, V19, P1450, DOI 10.1091/mbc.E07-05-0403; Veleri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034389; VERRA F, 1995, AM J RESP CRIT CARE, V151, P630; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; WAGENKNECHT T, 1975, BIOPOLYMERS, V14, P2297, DOI 10.1002/bip.1975.360141106; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wemmer KA, 2007, INT REV CYTOL, V260, P175, DOI 10.1016/S0074-7696(06)60004-1	47	50	51	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85453	10.1371/journal.pone.0085453	http://dx.doi.org/10.1371/journal.pone.0085453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465567	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500048
J	Laine, J; Lumio, J; Toikkanen, S; Virtanen, MJ; Uotila, T; Korpela, M; Kujansuu, E; Kuusi, M				Laine, Janne; Lumio, Jukka; Toikkanen, Salla; Virtanen, Mikko J.; Uotila, Terhi; Korpela, Markku; Kujansuu, Eila; Kuusi, Markku			The Duration of Gastrointestinal and Joint Symptoms after a Large Waterborne Outbreak of Gastroenteritis in Finland in 2007-A Questionnaire-Based 15-Month Follow-Up Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CONTAMINATED DRINKING-WATER; REACTIVE ARTHRITIS; BACTERIAL DYSENTERY; RISK; HYPERTENSION; POPULATION; PROGNOSIS	An extensive drinking water-associated gastroenteritis outbreak took place in the town of Nokia in Southern Finland in 2007. 53% of the exposed came down with gastroenteritis and 7% had arthritis-like symptoms (joint swelling, redness, warmth or pain in movement) according to a population-based questionnaire study at 8 weeks after the incident. Campylobacter and norovirus were the main pathogens. A follow-up questionnaire study was carried out 15 months after the outbreak to evaluate the duration of gastrointestinal and joint symptoms. 323 residents of the original contaminated area were included. The response rate was 53%. Participants were inquired about having gastroenteritis during the outbreak and the duration of symptoms. Of those with gastroenteritis, 43% reported loose stools and abdominal pain or distension after the acute disease. The prevalence of symptoms declined promptly during the first 3 months but at 15 months, 11% reported continuing symptoms. 32% of the respondents with gastroenteritis reported subsequent arthritis-like symptoms. The disappearance of arthritis-like symptoms was more gradual and they levelled off only after 5 months. 19% showed symptoms at 15 months. Prolonged gastrointestinal symptoms correlated to prolonged arthritis-like symptoms. High proportion of respondents continued to have arthritis-like symptoms at 15 months after the epidemic. The gastrointestinal symptoms, instead, had declined to a low level.	[Laine, Janne; Uotila, Terhi; Korpela, Markku] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Laine, Janne; Toikkanen, Salla; Virtanen, Mikko J.; Kuusi, Markku] Natl Inst Hlth & Welf, Epidemiol Surveillance & Response Unit, Helsinki, Finland; [Lumio, Jukka; Korpela, Markku] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kujansuu, Eila] Nokia Hlth Ctr, Nokia, Finland	Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; Tampere University; Nokia Corporation	Laine, J (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	janne.laine@pshp.fi		Uotila, Terhi/0000-0002-4625-3922	Competitive Research Funding of the Tampere University Hospital [9E129, 9M124]	Competitive Research Funding of the Tampere University Hospital	This study was financially supported by the Competitive Research Funding of the Tampere University Hospital (Grants 9E129 and 9M124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark WF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6020; DuPont AW, 2008, CLIN INFECT DIS, V46, P594, DOI 10.1086/526774; Garg AX, 2008, RHEUMATOLOGY, V47, P200, DOI 10.1093/rheumatology/kem339; Garg AX, 2005, CAN MED ASSOC J, V173, P261, DOI 10.1503/cmaj.050581; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Hillila MT, 2004, ALIMENT PHARM THERAP, V20, P339, DOI 10.1111/j.1365-2036.2004.02034.x; Laine J, 2011, EPIDEMIOL INFECT, P1; Laine J, 2012, RHEUMATOLOGY, V51, P513, DOI 10.1093/rheumatology/ker320; Leirisalo-Repo M, 2005, SCAND J RHEUMATOL, V34, P251, DOI 10.1080/03009740500202540; Lovell RM, 2012, CLIN GASTROENTEROL H; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; Marshall JK, 2009, KIDNEY INT, V75, pS42, DOI 10.1038/ki.2008.618; Maunula L, 2009, FOOD ENVIRON VIROL, V1, P31, DOI 10.1007/s12560-008-9004-3; Moist LM, 2009, KIDNEY INT, V75, pS47, DOI 10.1038/ki.2008.620; Morris D, 2012, CURR RHEUMATOL REP, V14, P390, DOI 10.1007/s11926-012-0280-4; Nielsen H, 2012, SCAND J IMMUNOL, V75, P449, DOI 10.1111/j.1365-3083.2012.02678.x; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Rasanen S, 2010, EPIDEMIOL INFECT, V138, P1227, DOI 10.1017/S0950268809991671; Rimhanen-Finne R, 2010, SCAND J INFECT DIS, V42, P613, DOI 10.3109/00365541003774608; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Uotila T, 2011, SCAND J RHEUMATOL, V40, P358, DOI 10.3109/03009742.2011.562533; Uotila TM, 2013, CLIN RHEUMATOL	24	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85457	10.1371/journal.pone.0085457	http://dx.doi.org/10.1371/journal.pone.0085457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465569	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000036
J	Padberg, I; Peter, E; Gonzalez-Maldonado, S; Witt, H; Mueller, M; Weis, T; Bethan, B; Liebenberg, V; Wiemer, J; Katus, HA; Rein, D; Schatz, P				Padberg, Inken; Peter, Erik; Gonzalez-Maldonado, Sandra; Witt, Henning; Mueller, Matthias; Weis, Tanja; Bethan, Bianca; Liebenberg, Volker; Wiemer, Jan; Katus, Hugo A.; Rein, Dietrich; Schatz, Philipp			A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology	PLOS ONE			English	Article							OXALATE; INSULIN; RISK	Objective: The objective of the current study was to find a metabolic signature associated with the early manifestations of type-2 diabetes mellitus. Research Design and Method: Modern metabolic profiling technology (MxP (TM) Broad Profiling) was applied to find early alterations in the plasma metabolome of type-2 diabetic patients. The results were validated in an independent study. Eicosanoid and single inon monitoring analysis (MxP (TM) Eicosanoid and MxP (TM) SIM analysis) were performed in subsets of samples. Results: A metabolic signature including significantly increased levels of glyoxylate as a potential novel marker for early detection of type-2 diabetes mellitus was identified in an initial study (Study1). The signature was significantly altered in fasted diabetic and pre-diabetic subjects and in non-fasted subjects up to three years prior to the diagnosis of type-2 diabetes; most alterations were also consistently found in an independent patient group (Study 2). In Study 2 diabetic and most control subjects suffered from heart failure. In Study 1 a subgroup of diabetic subjects, with a history of use of antihypertensive medication further showed a more pronounced increase of glyoxylate levels, compared to a non-diabetic control group when tested in a hyperglycemic state. In the context of a prior history of anti-hypertensive medication, alterations in hexosamine and eicosanoid levels were also found. Conclusion: A metabolic signature including glyoxylate was associated with type-2 diabetes mellitus, independent of the fasting status and of occurrence of another major disease. The same signature was also found to be associated with prediabetic subjects. Glyoxylate levels further showed a specifically strong increase in a subgroup of diabetic subjects. It could represent a new marker for the detection of medical subgroups of diabetic subjects.	[Padberg, Inken; Peter, Erik; Gonzalez-Maldonado, Sandra; Witt, Henning; Bethan, Bianca; Liebenberg, Volker; Wiemer, Jan; Rein, Dietrich; Schatz, Philipp] Metan Hlth GmbH, Berlin, Germany; [Padberg, Inken; Peter, Erik; Gonzalez-Maldonado, Sandra; Witt, Henning; Bethan, Bianca; Liebenberg, Volker; Wiemer, Jan; Rein, Dietrich; Schatz, Philipp] Metan GmbH, Biomarker Program, Berlin, Germany; [Mueller, Matthias; Weis, Tanja; Katus, Hugo A.] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Padberg, I (corresponding author), Metan Hlth GmbH, Berlin, Germany.	inken.padberg@metanomics.de; philipp.schatz@metanomics-health.de	Rein, Dietrich/AAN-3694-2020; Cerviño, Alejandro/L-5853-2014; Liebenberg, Volker/AAY-7687-2021	Rein, Dietrich/0000-0003-0076-1865; Cerviño, Alejandro/0000-0001-8014-3279; Padberg, Inken/0000-0002-3656-5682; Liebenberg, Volker/0000-0003-1936-1247	National Genome Research Network (NGFN); German Ministry of Education and Research (BMBF) [FKZ01GR0813, 01GR0812]; Bayrische Forschungsstiftung [AZ 773-707]	National Genome Research Network (NGFN); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bayrische Forschungsstiftung	Study II was supported by the National Genome Research Network (NGFN-transfer/http://www.ngfn.de/) and funding was provided by the German Ministry of Education and Research (BMBF) under the funding ID FKZ01GR0813 (University of Heidelberg) and 01GR0812 (metanomics GmbH, Berlin). Sample collection of study I was co-funded by the "Bayrische Forschungsstiftung" (http://www.forschungsstiftung.de/grant number: AZ 773-707). These funders had no role in sample collection, study design, data analysis, decision to publish, and preparation of the manuscript.	Adedayo A, 2012, SLEEP BREATH, V16; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BARNGROVER DA, 1981, BIOCHEM BIOPH RES CO, V102, P75, DOI 10.1016/0006-291X(81)91490-X; Begum N, 2002, DIABETES, V51, P2256, DOI 10.2337/diabetes.51.7.2256; Brownlee M, 2005, DIABETES; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Caplin B, 2012, ARTERIOSCLEROSIS THR; Dungan KM, 2006, DIABETES CARE, V29, P1214, DOI 10.2337/dc06-1910; Faure P, 2008, EUR RESPIR J, V31, P1046, DOI 10.1183/09031936.00062707; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Kim DH, 2011, BMB REP, V44, P415, DOI 10.5483/BMBRep.2011.44.6.415; Knight J, 2010, HORM METAB RES, V42, P868, DOI 10.1055/s-0030-1265145; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Nayak AU, 2013, DIABETES CARE; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Sathiyapriya V, 2007, ARCH MED RES, V38, P822, DOI 10.1016/j.arcmed.2007.05.008; SCHROR K, 1990, J CARDIOVASC PHARM, V15, pS60, DOI 10.1097/00005344-199015061-00012; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; VANPRAAG D, 1986, PROSTAG LEUKOTR ESS, V24, P227, DOI 10.1016/0262-1746(86)90130-7; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43	24	63	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85082	10.1371/journal.pone.0085082	http://dx.doi.org/10.1371/journal.pone.0085082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465478	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000022
J	Tang, XQ; Li, X; Li, PW; Zhang, Q; Li, R; Zhang, W; Ding, XX; Lei, JW; Zhang, ZW				Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Ding, Xiaoxia; Lei, Jiawen; Zhang, Zhaowei			Development and Application of an Immunoaffinity Column Enzyme Immunoassay for Mycotoxin Zearalenone in Complicated Samples	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PERFORMANCE LIQUID-CHROMATOGRAPHY; MONOCLONAL-ANTIBODY; T-2 TOXIN; CEREALS; CORN; OCHRATOXIN; CHINA; ELISA; CONTAMINATION	The zearalenone (ZEA) monoclonal antibody (mAb) 2D3, one of the highest sensitivity antibodies, was developed. Based on this mAb, it was established of an immunoaffinity column (IAC) coupled with an indirect competitive enzyme-linked immunosorbent assay (icELISA). After optimization, the icELISA allowed an IC50 against ZEA of 0.02 mu g L-1. The mAb 2D3 exhibited a high recognition of ZEA (100%) and beta-zearalenol (beta-ZOL, 88.2%). Its cross-reactivity with a-zearalenol (alpha-ZOL) and beta-zearalanol (beta-ZAL) were found to be 4.4% and 4.6%, respectively. The IAC-icELISA method was employed to analyze ZEA contamination in food samples, compared with high-performance liquid chromatography (HPLC). The spiked assay for ZEA demonstrated the considerable recoveries for IAC-icELISA (83-93%) and HPLC (94-108%) methods. Results showed that the mAb 2D3 and IAC-icELISA method posed potential applications in sensitively determination of ZEA in maize.	[Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Ding, Xiaoxia; Lei, Jiawen; Zhang, Zhaowei] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Lei, Jiawen; Zhang, Zhaowei] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China; [Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Lei, Jiawen; Zhang, Zhaowei] Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China; [Tang, Xiaoqian; Li, Xin; Li, Peiwu; Lei, Jiawen; Zhang, Zhaowei] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China; [Ding, Xiaoxia] Minist Agr, Qual Inspect & Test Ctr Oilseeds Prod, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Li, PW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	peiwuli@oilcrops.cn; zhangqi521x@yahoo.cn	li, ran/GPW-6786-2022	, Zhaowei/0000-0002-6686-2995	Project of National Science and Technology Pillar Plan [2012BAB19B09]; Special Fund for Agro-scientific Research in the Public Interest [201203094]; National Natural Science Foundation of China [21205133]; Key Project of the Ministry of Agriculture [2011-G5]	Project of National Science and Technology Pillar Plan; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Ministry of Agriculture	This work was supported by the Project of National Science and Technology Pillar Plan (2012BAB19B09), the Special Fund for Agro-scientific Research in the Public Interest (201203094), The National Natural Science Foundation of China (21205133) and the Key Project of the Ministry of Agriculture (2011-G5). We state the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayed-Boussema I, 2007, J BIOCHEM MOL TOXIC, V21, P136, DOI 10.1002/jbt.20171; Basova EY, 2010, ANAL BIOANAL CHEM, V397, P55, DOI 10.1007/s00216-009-3328-1; Bittencourt ABF, 2005, FOOD CONTROL, V16, P117, DOI 10.1016/j.foodcont.2003.12.005; Burkin AA, 2002, APPL BIOCHEM MICRO+, V38, P263, DOI 10.1023/A:1015479626475; Burmistrova NA, 2009, ANAL BIOANAL CHEM, V395, P1301, DOI 10.1007/s00216-009-2913-7; Cha SH, 2012, J VET SCI, V13, P119, DOI 10.4142/jvs.2012.13.2.119; Chilaka CA, 2012, J FOOD AGRIC ENVIRON, V10, P296; Chun HS, 2009, ANAL CHIM ACTA, V639, P83, DOI 10.1016/j.aca.2009.02.048; Dawlatana M, 1998, CHROMATOGRAPHIA, V47, P215, DOI 10.1007/BF02466584; Guan D, 2011, FOOD CHEM, V125, P1359, DOI 10.1016/j.foodchem.2010.10.006; Hamide Z, 2010, J CHROMATOGR B, V878, P115; Hervas M, 2009, ANALYST, V134, P2405, DOI 10.1039/b911839j; Hervas M, 2010, BIOSENS BIOELECTRON, V25, P1755, DOI 10.1016/j.bios.2009.12.031; Ibanez-Vea M, 2011, FOOD CONTROL, V22, P1949, DOI 10.1016/j.foodcont.2011.05.008; Liu G, 2012, FOOD CONTROL, V27, P200, DOI 10.1016/j.foodcont.2012.03.023; LIU MT, 1985, APPL ENVIRON MICROB, V50, P332, DOI 10.1128/AEM.50.2.332-336.1985; Park JW, 2003, FOOD AGR IMMUNOL, V15, P159, DOI 10.1080/09540100400013393; Pei SC, 2009, FOOD CONTROL, V20, P1080, DOI 10.1016/j.foodcont.2009.02.004; Pei SC, 2013, FOOD CONTROL, V31, P65, DOI 10.1016/j.foodcont.2012.09.006; RUSSO C, 1983, J IMMUNOL METHODS, V65, P269, DOI 10.1016/0022-1759(83)90324-1; Soleimany F, 2012, FOOD CONTROL, V25, P647, DOI 10.1016/j.foodcont.2011.11.012; Thongrussamee T, 2008, FOOD ADDIT CONTAM A, V25, P997, DOI 10.1080/02652030701823159; Visconti A, 1998, J CHROMATOGR A, V815, P133, DOI 10.1016/S0021-9673(98)00296-9; Wang YR, 2011, J CHROMATOGR B, V879, P3531, DOI 10.1016/j.jchromb.2011.09.037; Zeng HY, 2006, CHINESE J ANAL CHEM, V34, P351; Zhang AH, 2011, FOOD CONTROL, V22, P1723, DOI 10.1016/j.foodcont.2011.04.004; Zhang DH, 2009, ANAL CHIM ACTA, V636, P63, DOI 10.1016/j.aca.2009.01.010; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	28	25	25	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85606	10.1371/journal.pone.0085606	http://dx.doi.org/10.1371/journal.pone.0085606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465616	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000047
J	Kanda, R; Sutoh, Y; Kasamatsu, J; Maenaka, K; Kasahara, M; Ose, T				Kanda, Ryo; Sutoh, Yoichi; Kasamatsu, Jun; Maenaka, Katsumi; Kasahara, Masanori; Ose, Toyoyuki			Crystal Structure of the Lamprey Variable Lymphocyte Receptor C Reveals an Unusual Feature in Its N-Terminal Capping Module	PLOS ONE			English	Article							SOMATIC DIVERSIFICATION; ANTIGEN RECOGNITION; COMPLEX; GLYCOPROTEIN; DIVERSITY; EVOLUTION; ALIGNMENT	Jawless vertebrates represented by lampreys and hagfish use variable lymphocyte receptors (VLRs) as antigen receptors to mount adaptive immune responses. VLRs generate diversity that is comparable to immunoglobulins and T-cell receptors by a gene conversion-like mechanism, which is mediated by cytosine deaminases. Currently, three types of VLRs, VLRA, VLRB, and VLRC, have been identified in lampreys. Crystal structures of VLRA and VLRB in complex with antigens have been reported recently, but no structural information is available for VLRC. Here, we present the first crystal structure of VLRC from the Japanese lamprey (Lethenteron japonicum). Similar to VLRA and VLRB, VLRC forms a typical horseshoe-like solenoid structure with a variable concave surface. Strikingly, its N-terminal cap has a long loop with limited sequence variability that protrudes toward the concave surface, which is the putative antigen-binding surface. Furthermore, as predicted previously, its C-terminal cap lacks a highly variable protruding loop that plays an important role in antigen recognition by lamprey VLRA and VLRB. Recent work suggests that VLRC+ lymphocytes in jawless vertebrates might be akin to gamma delta T cells in jawed vertebrates. Structural features of lamprey VLRC described here suggest that it may recognize antigens in a unique manner.	[Kanda, Ryo] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Sutoh, Yoichi; Kasamatsu, Jun; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Maenaka, Katsumi; Ose, Toyoyuki] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kasahara, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	mkasaha@med.hokudai.ac.jp; ose@pharm.hokudai.ac.jp	Sutoh, Yoichi/AAA-5516-2020; Ose, Toyoyuki/AAW-7821-2020; Kasahara, Masanori/G-7651-2011	Sutoh, Yoichi/0000-0002-1607-9759; Ose, Toyoyuki/0000-0002-2001-9388; Sutoh, Yoichi/0000-0002-3470-0465	Japan Society for the Promotion of Science [JSPS: 22021001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS: 22021001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das S, 2013, P NATL ACAD SCI USA, V110, P6043, DOI 10.1073/pnas.1302500110; Das S, 2011, ADV IMMUNOL, V111, P143, DOI 10.1016/B978-0-12-385991-4.00004-0; Deng L, 2010, P NATL ACAD SCI USA, V107, P13408, DOI 10.1073/pnas.1005475107; Durbin R, 1988, BIOL SEQUENCE ANAL P; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Hirano M, 2013, NATURE IN PRESS; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kirchdoerfer RN, 2012, STRUCTURE, V20, P479, DOI 10.1016/j.str.2012.01.009; Kishishita N, 2010, EMBO REP, V11, P126, DOI 10.1038/embor.2009.274; Konigshofer Y, 2006, CURR OPIN IMMUNOL, V18, P527, DOI 10.1016/j.coi.2006.07.008; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li J, 2013, P NATL ACAD IN PRESS; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sprengart ML, 1996, EMBO J, V15, P665, DOI 10.1002/j.1460-2075.1996.tb00399.x; Takaba H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01716; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619	42	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85875	10.1371/journal.pone.0085875	http://dx.doi.org/10.1371/journal.pone.0085875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465760	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000029
J	Yamagata, Y; Nishino, K; Takaki, E; Sato, S; Maekawa, R; Nakai, A; Sugino, N				Yamagata, Yoshiaki; Nishino, Koichiro; Takaki, Eiichi; Sato, Shun; Maekawa, Ryo; Nakai, Akira; Sugino, Norihiro			Genome-Wide DNA Methylation Profiling in Cultured Eutopic and Ectopic Endometrial Stromal Cells	PLOS ONE			English	Article							STEROIDOGENIC-FACTOR-I; ABERRANT EXPRESSION; GENE-EXPRESSION; PROMOTER METHYLATION; AROMATASE GENE; HYPERMETHYLATION; ISLAND; PROGESTERONE; ESTROGEN	The objective of this study was to characterize the genome-wide DNA methylation profiles of isolated endometrial stromal cells obtained from eutopic endometria with (euESCa) and without endometriosis (euESCb) and ovarian endometrial cysts (choESC). Three samples were analyzed in each group. The infinium methylation array identified more hypermethylated and hypomethylated CpGs in choESC than in euESCa, and only a few genes were methylated differently in euESCa and euESCb. A functional analysis revealed that signal transduction, developmental processes, immunity, etc. were different in choESC and euESCa. A clustering analysis and a principal component analysis performed based on the methylation levels segregated choESC from euESC, while euESCa and euESCb were identical. A transcriptome analysis was then conducted and the results were compared with those of the DNA methylation analysis. Interestingly, the hierarchical clustering and principal component analyses showed that choESC were segregated from euESCa and euESCb in the DNA methylation analysis, while no segregation was recognized in the transcriptome analysis. The mRNA expression levels of the epigenetic modification enzymes, including DNA methyltransferases, obtained from the specimens were not significantly different between the groups. Some of the differentially methylated and/or expressed genes (NR5A1, STAR, STRA6 and HSD17B2), which are related with steroidogenesis, were validated by independent methods in a larger number of samples. Our findings indicate that different DNA methylation profiles exist in ectopic ESC, highlighting the benefits of genome wide DNA methylation analyses over transcriptome analyses in clarifying the development and characterization of endometriosis.	[Yamagata, Yoshiaki; Sato, Shun; Maekawa, Ryo; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan; [Nishino, Koichiro] Miyazaki Univ, Fac Agr, Lab Vet Biochem & Mol Biol, Miyazaki 88921, Japan; [Takaki, Eiichi; Nakai, Akira] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 755, Japan	Yamaguchi University; University of Miyazaki; Yamaguchi University	Yamagata, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan.	yymgt@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X	Ministry of Education, Science and Culture, Japan [21592099, 22591825, 23659781, 23791846, 23890140]; Yamaguchi University School of Medicine; Grants-in-Aid for Scientific Research [25462560] Funding Source: KAKEN	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid 21592099, 22591825, 23659781, 23791846 and 23890140 for Scientific Research from the Ministry of Education, Science and Culture, Japan and the New Frontier Project, Yamaguchi University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar E, 2009, J CLIN ENDOCR METAB, V94, P623, DOI 10.1210/jc.2008-1180; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Dimitrakopoulos L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-486; Eyster KM, 2007, FERTIL STERIL, V88, P1505, DOI 10.1016/j.fertnstert.2007.01.056; Gentilini D, 2010, FERTIL STERIL, V93, P706, DOI 10.1016/j.fertnstert.2008.10.014; Harada T, 2004, HUM REPROD UPDATE, V10, P29, DOI 10.1093/humupd/dmh007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwabe T, 2000, J CLIN ENDOCR METAB, V85, P824, DOI 10.1210/jc.85.2.824; Izawa M, 2008, FERTIL STERIL, V89, P1390, DOI 10.1016/j.fertnstert.2007.03.078; Izawa M, 2011, FERTIL STERIL, V95, P33, DOI 10.1016/j.fertnstert.2010.06.024; Lucki NC, 2012, MOL ENDOCRINOL, V26, P228, DOI 10.1210/me.2011-1150; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Pavone ME, 2011, HUM REPROD, V26, P2157, DOI 10.1093/humrep/der172; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sugino N, 2000, MOL HUM REPROD, V6, P178, DOI 10.1093/molehr/6.2.178; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Wu Y, 2005, AM J OBSTET GYNECOL, V193, P371, DOI 10.1016/j.ajog.2005.01.034; Wu Y, 2007, REPROD SCI, V14, P374, DOI 10.1177/1933719107302913; Wu Y, 2007, FERTIL STERIL, V87, P24, DOI 10.1016/j.fertnstert.2006.05.077; Wu Y, 2006, EPIGENETICS-US, V1, P106, DOI 10.4161/epi.1.2.2766; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Xue Q, 2011, REPROD SCI, V18, P1080, DOI 10.1177/1933719111404614; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015	27	48	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e83612	10.1371/journal.pone.0083612	http://dx.doi.org/10.1371/journal.pone.0083612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465385	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000003
J	Edgar, LT; Underwood, CJ; Guilkey, JE; Hoying, JB; Weiss, JA				Edgar, Lowell T.; Underwood, Clayton J.; Guilkey, James E.; Hoying, James B.; Weiss, Jeffrey A.			Extracellular Matrix Density Regulates the Rate of Neovessel Growth and Branching in Sprouting Angiogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO ANGIOGENESIS; MECHANICAL-PROPERTIES; CAPILLARY MORPHOGENESIS; MICROVESSEL FRAGMENTS; ENDOTHELIAL-CELLS; COLLAGEN; ORIENTATION; MAINTENANCE; INVOLVEMENT	Angiogenesis is regulated by the local microenvironment, including the mechanical interactions between neovessel sprouts and the extracellular matrix (ECM). However, the mechanisms controlling the relationship of mechanical and biophysical properties of the ECM to neovessel growth during sprouting angiogenesis are just beginning to be understood. In this research, we characterized the relationship between matrix density and microvascular topology in an in vitro 3D organ culture model of sprouting angiogenesis. We used these results to design and calibrate a computational growth model to demonstrate how changes in individual neovessel behavior produce the changes in vascular topology that were observed experimentally. Vascularized gels with higher collagen densities produced neovasculatures with shorter vessel lengths, less branch points, and reduced network interconnectivity. The computational model was able to predict these experimental results by scaling the rates of neovessel growth and branching according to local matrix density. As a final demonstration of utility of the modeling framework, we used our growth model to predict several scenarios of practical interest that could not be investigated experimentally using the organ culture model. Increasing the density of the ECM significantly reduced angiogenesis and network formation within a 3D organ culture model of angiogenesis. Increasing the density of the matrix increases the stiffness of the ECM, changing how neovessels are able to deform and remodel their surroundings. The computational framework outlined in this study was capable of predicting this observed experimental behavior by adjusting neovessel growth rate and branching probability according to local ECM density, demonstrating that altering the stiffness of the ECM via increasing matrix density affects neovessel behavior, thereby regulated vascular topology during angiogenesis.	[Edgar, Lowell T.; Underwood, Clayton J.; Weiss, Jeffrey A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Edgar, Lowell T.; Weiss, Jeffrey A.] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA; [Underwood, Clayton J.] WL Gore & Assoc Inc, Med Prod Div, Flagstaff, AZ USA; [Guilkey, James E.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Hoying, James B.] Univ Louisville, Cardiovasc Innovat Inst, Div Cardiovasc Therapeut, Louisville, KY 40292 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Louisville	Weiss, JA (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	jeff.weiss@utah.edu	Edgar, Lowell Taylor/L-3428-2019	Edgar, Lowell/0000-0002-8586-1605	National Institutes of Health [NIH R01HL077683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from the National Institutes of Health (NIH R01HL077683) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chang CC, 2006, CELL TRANSPLANT, V15, P533, DOI 10.3727/000000006783981693; Chang CC, 2010, TISSUE ENG PT A, V16, P795, DOI [10.1089/ten.tea.2009.0370, 10.1089/ten.TEA.2009.0370]; Chang CC, 2012, ARTERIOSCL THROM VAS, V32, P5, DOI 10.1161/ATVBAHA.111.238725; Edgar LT, 2013, COMPUT METHOD BIOMEC, V16, P790, DOI 10.1080/10255842.2012.662678; FISHER C, 1994, DEV BIOL, V162, P499, DOI 10.1006/dbio.1994.1104; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Hoying JB, 1996, IN VITRO CELL DEV-AN, V32, P409; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]; Kniazeva E, 2009, AM J PHYSIOL-CELL PH, V297, pC179, DOI 10.1152/ajpcell.00018.2009; Korff T, 1999, J CELL SCI, V112, P3249; Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880; Krishnan L, 2008, CARDIOVASC RES, V78, P324, DOI 10.1093/cvr/cvn055; Krishnan L, 2007, AM J PHYSIOL-HEART C, V293, pH3650, DOI 10.1152/ajpheart.00772.2007; Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; NICOSIA RF, 1990, LAB INVEST, V63, P115; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Nunes SS, 2010, MICROCIRCULATION, V17, P557, DOI 10.1111/j.1549-8719.2010.00052.x; Nunes SS, 2010, MICROVASC RES, V79, P10, DOI 10.1016/j.mvr.2009.10.001; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Richter SJ, 2012, QUAL ENG, V14, P375; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e; Shiu Yan-Ting, 2005, Critical Reviews in Biomedical Engineering, V33, P431, DOI 10.1615/CritRevBiomedEng.v33.i5.10; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Tranqui L, 2000, CR ACAD SCI III-VIE, V323, P31, DOI 10.1016/S0764-4469(00)00110-4; Underwood CJ, P ASME SUMM BIOENG C; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Vernon RB, 1996, J CELL BIOCHEM, V60, P185, DOI 10.1002/(SICI)1097-4644(19960201)60:2<185::AID-JCB3>3.0.CO;2-T; Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122; WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Yang MT, 2011, INTEGR BIOL-UK, V3, P663, DOI 10.1039/c0ib00156b	48	90	91	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85178	10.1371/journal.pone.0085178	http://dx.doi.org/10.1371/journal.pone.0085178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465500	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100024
J	Escobar, A; Aguirre, A; Guzman, MA; Gonzalez, R; Catalan, D; Acuna-Castillo, C; Larrondo, M; Lopez, M; Pesce, B; Rolland, J; O'Hehir, R; Aguillon, JC				Escobar, Alejandro; Aguirre, Adam; Guzman, Maria Antonieta; Gonzalez, Rodrigo; Catalan, Diego; Acuna-Castillo, Claudio; Larrondo, Milton; Lopez, Mercedes; Pesce, Barbara; Rolland, Jennifer; O'Hehir, Robyn; Aguillon, Juan Carlos			Tolerogenic Dendritic Cells Derived from Donors with Natural Rubber Latex Allergy Modulate Allergen-Specific T-Cell Responses and IgE Production	PLOS ONE			English	Article							HEALTH-CARE WORKERS; GRASS-POLLEN IMMUNOTHERAPY; HEV B 5; INTERLEUKIN-10 PRODUCTION; VENOM IMMUNOTHERAPY; IMMUNE-RESPONSES; REGULATORY CELLS; IN-VIVO; ANTIGEN; DIFFERENTIATION	Natural rubber latex (NRL; Hevea brasiliensis) allergy is an IgE-mediated reaction to latex proteins. When latex glove exposure is the main sensitizing agent, Hev b 5 is one of the major allergens. Dendritic cells (DC), the main antigen presenting cells, modulated with pharmacological agents can restore tolerance in several experimental models, including allergy. In the current study, we aimed to generate DC with tolerogenic properties from NRL-allergic patients and evaluate their ability to modulate allergen-specific T and B cell responses. Here we show that dexamethasone-treated DC (dxDC) differentiated into a subset of DC, characterized by low expression of MHC class II, CD40, CD80, CD86 and CD83 molecules. Compared with LPS-matured DC, dxDC secreted lower IL-12 and higher IL-10 after CD40L activation, and induced lower alloantigenic T cell proliferation. We also show that dxDC pulsed with the dominant Hev b 5 T-cell epitope peptide, Hev b 5(46-65), inhibited both proliferation of Hev b 5-specific T-cell lines and the production of Hev b 5-specific IgE. Additionally, dxDC induced a subpopulation of IL-10-producing regulatory T cells that suppressed proliferation of Hev b 5-primed T cells. In conclusion, dxDC generated from NRL-allergic patients can modulate allergen-specific T-cell responses and IgE production, supporting their potential use in allergen-specific immunotherapy.	[Escobar, Alejandro] Univ Chile, Fac Dent, Res Inst Dent Sci, Santiago, Chile; [Aguirre, Adam] Catholic Univ Chile, Fac Chem, Dept Pharm, Santiago, Chile; [Guzman, Maria Antonieta] Univ Chile, Clin Hosp Univ Chile, Allergy Ctr, Santiago, Chile; [Gonzalez, Rodrigo; Larrondo, Milton] Univ Chile, Blood Bank Clin Hosp Univ Chile, Santiago, Chile; [Catalan, Diego; Lopez, Mercedes; Pesce, Barbara; Aguillon, Juan Carlos] Univ Chile, Millennium Inst Immunol & Immunotherapy, Fac Med, Program Immunol, Santiago, Chile; [Acuna-Castillo, Claudio] Univ Santiago, Fac Chem & Biol, Dept Biol, Santiago, Chile; [Rolland, Jennifer; O'Hehir, Robyn] Monash Univ, AMREP, Dept Immunol, Melbourne, Vic 3004, Australia	Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Santiago de Chile; Monash University	Escobar, A (corresponding author), Univ Chile, Fac Dent, Res Inst Dent Sci, Santiago, Chile.	jano@med.uchile.cl; jaguillo@med.uchile.cl	Aguirre, Adam/GQQ-3265-2022; Lopez, Mercedes/CAF-4801-2022; O'Hehir, Robyn E/H-3627-2011; Catalán, Diego/AAN-3241-2020; Aguillon, Juan C/H-9234-2013; Catalán, Diego F/H-7983-2013; Acuña-Castillo, Claudio/AAI-7090-2021	O'Hehir, Robyn E/0000-0002-3489-7595; Catalán, Diego/0000-0002-4353-1229; Aguillon, Juan C/0000-0003-3148-6843; Catalán, Diego F/0000-0002-4353-1229; Acuña-Castillo, Claudio/0000-0003-3607-6077	Millennium Institute on Immunology and Immunotherapy [P09-016-F]; Research Support Office, Clinical Hospital of the University of Chile, Santiago; National Fund for Scientific and Technological Development, Chile [FONDECYT 1100102]	Millennium Institute on Immunology and Immunotherapy; Research Support Office, Clinical Hospital of the University of Chile, Santiago; National Fund for Scientific and Technological Development, Chile	This work was supported by grants from the Millennium Institute on Immunology and Immunotherapy P09-016-F, Research Support Office, Clinical Hospital of the University of Chile, Santiago and the National Fund for Scientific and Technological Development, Chile (FONDECYT 1100102). All authors have no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, TRANSPL IMMUNOL, V11, P357, DOI 10.1016/S0966-3274(03)00050-9; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Akdis CA, 2001, MICROBES INFECT, V3, P891, DOI 10.1016/S1286-4579(01)01449-6; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Beezhold DH, 2004, INT ARCH ALLERGY IMM, V134, P334, DOI 10.1159/000079537; Bellinghausen I, 1997, EUR J IMMUNOL, V27, P1131, DOI 10.1002/eji.1830270513; Bernstein DI, 2003, J ALLERGY CLIN IMMUN, V111, P610, DOI 10.1067/mai.2003.164; Bosma BM, 2008, IMMUNOLOGY, V125, P91, DOI 10.1111/j.1365-2567.2008.02824.x; Charous BL, 2002, J ALLERGY CLIN IMMUN, V109, P31, DOI 10.1067/mai.2002.120953; Ciesek S, 2005, TRANSPL P, V37, P20, DOI 10.1016/j.transproceed.2004.11.055; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; de Silva HD, 2000, J ALLERGY CLIN IMMUN, V105, P1017, DOI 10.1067/mai.2000.105806; Delgado M, 2006, ANN NY ACAD SCI, V1070, P226, DOI 10.1196/annals.1317.019; Drew AC, 2004, J IMMUNOL, V173, P5872, DOI 10.4049/jimmunol.173.9.5872; Escobar A, 2005, CLIN EXP IMMUNOL, V142, P555, DOI 10.1111/1365-2249.2005.02938.x; Francis JN, 2003, J ALLERGY CLIN IMMUN, V111, P1255, DOI 10.1067/mai.2003.1570; Gardner LM, 2004, CLIN EXP ALLERGY, V34, P1209, DOI 10.1111/j.1365-2222.2004.02009.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Henry E, 2008, J IMMUNOL, V181, P7230, DOI 10.4049/jimmunol.181.10.7230; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jugde F, 2005, TOXICOLOGY, V212, P227, DOI 10.1016/j.tox.2005.04.019; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kanjarawi R, 2011, INT ARCH ALLERGY IMM, V156, P387, DOI 10.1159/000323940; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Lyakh LA, 2005, J IMMUNOL, V174, P2061, DOI 10.4049/jimmunol.174.4.2061; Mahnke Karsten, 2008, V94, P29, DOI 10.1159/000154854; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Nasser SMS, 2001, EUR J IMMUNOL, V31, P3704, DOI 10.1002/1521-4141(200112)31:12<3704::AID-IMMU3704>3.0.CO;2-3; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Pacciani V, 2010, J ALLERGY CLIN IMMUN, V125, P727, DOI 10.1016/j.jaci.2009.12.004; Piemonti L, 1999, J IMMUNOL, V162, P6473; Ranta PM, 2004, CLIN INFECT DIS, V38, P252, DOI 10.1086/380789; Reunala T, 2004, CURR OPIN ALLERGY CL, V4, P397, DOI 10.1097/00130832-200410000-00011; Rihs HP, 2002, J ALLERGY CLIN IMMUN, V110, P507, DOI 10.1067/mai.2002.127282; Rolland JM, 2009, PHARMACOL THERAPEUT, V121, P273, DOI 10.1016/j.pharmthera.2008.11.007; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Slater JE, 1996, J BIOL CHEM, V271, P25394, DOI 10.1074/jbc.271.41.25394; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sutherland MF, 2002, CLIN EXP ALLERGY, V32, P583, DOI 10.1046/j.0954-7894.2002.01355.x; van der Merwe PA, 2000, NAT IMMUNOL, V1, P194, DOI 10.1038/79729; Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x; Xia CQ, 2003, SCAND J IMMUNOL, V58, P23, DOI 10.1046/j.1365-3083.2003.01268.x	52	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85930	10.1371/journal.pone.0085930	http://dx.doi.org/10.1371/journal.pone.0085930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465795	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100089
J	Garrett, SH; Somji, S; Sens, DA; Zhang, KK				Garrett, Scott H.; Somji, Seema; Sens, Donald A.; Zhang, Ke K.			Prediction of the Number of Activated Genes in Multiple Independent Cd+2- and As+3-Induced Malignant Transformations of Human Urothelial Cells (UROtsa)	PLOS ONE			English	Article							GENOMIC ANALYSES; BLADDER-CANCER; EXPRESSION; CADMIUM; CARCINOGENESIS; HETEROGENEITY; MUTATIONS; ALGORITHM; CARCINOMA; PATTERNS	Background: Many toxic environmental agents such as cadmium and arsenic are found to be epidemiologically linked to increasing rates of cancers. In vitro studies show that these toxic agents induced malignant transformation in human cells. It is not clear whether such malignant transformation induced by a single toxic agent is driven by a common set of genes. Although the advancement of high-throughput technology has facilitated the profiling of global gene expression, it remains a question whether the sample size is sufficient to identify this common driver gene set. Results: We have developed a statistical method, SOFLR, to predict the number of common activated genes using a limited number of microarray samples. We conducted two case studies, cadmium and arsenic transformed human urothelial cells. Our method is able to precisely predict the number of stably induced and repressed genes and the number of samples to identify the common activated genes. The number of independent transformed isolates required for identifying the common activated genes is also estimated. The simulation study further validated our method and identified the important parameters in this analysis. Conclusions: Our method predicts the degree of similarity and diversity during cell malignant transformation by a single toxic agent. The results of our case studies imply the existence of common driver and passenger gene sets in toxin-induced transformation. Using a pilot study with small sample size, this method also helps microarray experimental design by determining the number of samples required to identify the common activated gene	[Garrett, Scott H.; Somji, Seema; Sens, Donald A.; Zhang, Ke K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Zhang, KK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA.	ke.zhang@med.und.edu			National Center for Research Resources [5P20RR016471-12]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103442-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Center for Research Resources (5P20RR016471-12) and the National Institute of General Medical Sciences (8 P20 GM103442-12) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, J ENV HLTH, V64, p[36, 44]; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benbrahim-Tallaa L, 2009, ENVIRON HEALTH PERSP, V117, P1847, DOI 10.1289/ehp.0900999; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; Fujiwara K, 2004, CARCINOGENESIS, V25, P1495, DOI 10.1093/carcin/bgh155; Garrett SH, 2011, J TOXICOL ENV HEAL A, V74, P24, DOI 10.1080/15287394.2010.514230; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kellen E, 2007, CANCER DETECT PREV, V31, P77, DOI 10.1016/j.cdp.2006.12.001; Kitchin KT, 2010, CHEM RES TOXICOL, V23, P327, DOI 10.1021/tx900343d; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Li SYS, 2005, STAT MED, V24, P2267, DOI 10.1002/sim.2119; Lu X, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-23; Medeiros M, 2012, TOXICOLOGY, V291, P102, DOI 10.1016/j.tox.2011.11.002; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Petzoldt JL, 1995, UROL RES, V23, P337; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Posey T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-115; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Sjoblom T, 2008, CURR OPIN ONCOL, V20, P66; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somji S, 2010, CHEM RES TOXICOL, V23, P348, DOI 10.1021/tx900346q; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-36; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verma R, 2004, MOL CELL BIOCHEM, V255, P203, DOI 10.1023/B:MCBI.0000007276.94488.3d; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zhang K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S10; 1993, IARC MON EV CARC RIS, V58, P1	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85614	10.1371/journal.pone.0085614	http://dx.doi.org/10.1371/journal.pone.0085614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465620	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100053
J	Piombino, P; Genovese, A; Esposito, S; Moio, L; Cutolo, PP; Chambery, A; Severino, V; Moneta, E; Smith, DP; Owens, SM; Gilbert, JA; Ercolini, D				Piombino, Paola; Genovese, Alessandro; Esposito, Silvia; Moio, Luigi; Cutolo, Pier Paolo; Chambery, Angela; Severino, Valeria; Moneta, Elisabetta; Smith, Daniel P.; Owens, Sarah M.; Gilbert, Jack A.; Ercolini, Danilo			Saliva from Obese Individuals Suppresses the Release of Aroma Compounds from Wine	PLOS ONE			English	Article							VITIS-VINIFERA L.; VOLATILE COMPOUNDS; OXIDATIVE STRESS; RETRONASAL AROMA; FLAVOR COMPOUNDS; FOOD; HABITUATION; PERCEPTION; VARIABILITY; MASTICATION	Background: Recent evidence suggests that a lower extent of the retronasal aroma release correspond to a higher amount of ad libitum food intake. This has been regarded as one of the bases of behavioral choices towards food consumption in obese people. In this pilot study we investigated the hypothesis that saliva from obese individuals could be responsible for an alteration of the retro-nasal aroma release. We tested this hypothesis in vitro, by comparing the release of volatiles from a liquid food matrix (wine) after its interaction with saliva from 28 obese (O) and 28 normal-weight (N) individuals. Methods and Findings: Amplicon sequencing of the 16S rRNA V4 region indicated that Firmicutes and Actinobacteria were more abundant in O, while Proteobacteria and Fusobacteria dominated in N. Streptococcaceae were significantly more abundant in the O subjects and constituted 34% and 19% on average of the saliva microbiota of O and N subjects, respectively. The Total Antioxidant Capacity was higher in O vs N saliva samples. A model mouth system was used to test whether the in-mouth wine aroma release differs after the interaction with O or N saliva. In O samples, a 18% to 60% significant decrease in the mean concentration of wine volatiles was detected as a result of interaction with saliva, compared with N. This suppression was linked to biochemical differences in O and N saliva composition, which include protein content. Conclusion: Microbiological and biochemical differences were found in O vs N saliva samples. An impaired retronasal aroma release from white wine was detected in vitro and linked to compositional differences between saliva from obese and normal-weight subjects. Additional in vivo investigations on diverse food matrices could contribute to understanding whether a lower olfactory stimulation due to saliva composition can be a co-factor in the development/maintenance of obesity.	[Piombino, Paola; Genovese, Alessandro; Esposito, Silvia; Moio, Luigi; Ercolini, Danilo] Univ Naples Federico II, Dept Agr Sci, Portici, Italy; [Cutolo, Pier Paolo] S Giovanni Bosco Hosp, Gen & Laparoscop Surg Unit, Naples, Italy; [Chambery, Angela; Severino, Valeria] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Chambery, Angela] IRCCS, Milan, Italy; [Moneta, Elisabetta] Agr Res Council, Res Ctr Food & Nutr, Rome, Italy; [Smith, Daniel P.; Owens, Sarah M.; Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Piombino, P (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	paola.piombino@unina.it	Genovese, Alessandro/AAG-5396-2021; Smith, Daniel/L-6827-2019; Gilbert, Jack/AAF-3270-2019; Ercolini, Danilo/B-2431-2009	Genovese, Alessandro/0000-0002-9202-6122; Smith, Daniel/0000-0002-2479-2044; Ercolini, Danilo/0000-0003-3061-9560; Moneta, Elisabetta/0000-0002-7179-1570; Piombino, Paola/0000-0001-8705-9846; Chambery, Angela/0000-0002-5136-0941	"Premio Montana alla Ricerca Alimentare 2010''; Italian Ministry of University and Research (MIUR)	"Premio Montana alla Ricerca Alimentare 2010''; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by "Premio Montana alla Ricerca Alimentare 2010'' awarded to P. Piombino and D. Ercolini by Montana Alimentari S. p. A, Italy (www.montanafood.it). Microbiological investigations were partially supported by the Italian Ministry of University and Research (MIUR, programme PRIN 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bausenwein J, 2010, MOL HUM REPROD, V16, P117, DOI 10.1093/molehr/gap078; Bond DS, 2010, INT J OBESITY, V34, P593, DOI 10.1038/ijo.2009.267; Bond DS, 2009, OBES SURG, V19, P873, DOI 10.1007/s11695-009-9861-3; Buettner A, 2001, CHEM SENSES, V26, P1211, DOI 10.1093/chemse/26.9.1211; Burgen ASV, 1961, PHYSIOLOGY SALIVARY, P140; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; de Wijk RA, 2004, PHYSIOL BEHAV, V83, P81, DOI 10.1016/j.physbeh.2004.07.014; de Wijk RA, 2004, PHYSIOL BEHAV, V82, P397, DOI 10.1016/j.physbeh.2004.04.053; De Wijk RA, 2012, FLAVOUR, V1; Del Barrio-Galan R, 2012, EUR FOOD RES TECHNOL, V234, P231, DOI 10.1007/s00217-011-1633-3; del Caro A, 2012, S AFR J ENOL VITIC, V33, P115; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; EPSTEIN LH, 1992, PHYSIOL BEHAV, V51, P945, DOI 10.1016/0031-9384(92)90075-D; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Escudero A, 2007, J AGR FOOD CHEM, V55, P4501, DOI 10.1021/jf0636418; Fernandez-Real JM, 2010, OBESITY, V18, P482, DOI 10.1038/oby.2009.266; Ferreira V, 2002, J AGR FOOD CHEM, V50, P4048, DOI 10.1021/jf0115645; Ferreira V, 2002, MOL METHODS PLANT AN, P88; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Genovese A, 2009, FOOD CHEM, V114, P100, DOI 10.1016/j.foodchem.2008.09.022; Genovese A, 2007, FOOD CHEM, V103, P1228, DOI 10.1016/j.foodchem.2006.10.027; Gierczynski I, 2011, FLAVOUR FRAG J, V26, P141, DOI 10.1002/ffj.2036; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Guichard E, 2002, FOOD REV INT, V18, P49, DOI 10.1081/FRI-120003417; Harthoorn LF, 2008, FOOD QUAL PREFER, V19, P644, DOI 10.1016/j.foodqual.2008.05.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMANN EL, 1975, NONPARAMETRICS; LUBBERS S, 1994, AM J ENOL VITICULT, V45, P29; Ly MH, 2008, FOOD HYDROCOLLOID, V22, P211, DOI 10.1016/j.foodhyd.2006.11.001; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; MELA D, 2005, FOOD DIET OBESITY; Mishellany-Dutour A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041276; Moio L, 2004, AM J ENOL VITICULT, V55, P7; Moio L, 2004, J AGR FOOD CHEM, V52, P891, DOI 10.1021/jf034869n; Motoki M., 2000, FSTR, V6, P151, DOI [10.3136/fstr.6.151, DOI 10.3136/FSTR.6.151]; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Pepino MY, 2012, APPETITE, V58, P800, DOI 10.1016/j.appet.2012.01.026; Piombino P, 2010, INT J FOOD SCI TECH, V45, P234, DOI 10.1111/j.1365-2621.2009.02126.x; Repoux M, 2012, FLAVOUR FRAG J, V27, P40, DOI 10.1002/ffj.2077; Rocco M, 2011, J PROTEOME RES, V10, P4703, DOI 10.1021/pr200511f; Ruijschop RMAJ, 2009, J AGR FOOD CHEM, V57, P9888, DOI 10.1021/jf901445z; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salles C, 2011, CRIT REV FOOD SCI, V51, P67, DOI 10.1080/10408390903044693; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Severino V, 2011, J PROTEOME RES, V10, P3212, DOI 10.1021/pr200244f; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Tan Y, 2008, J FOOD SCI, V73, pS56, DOI 10.1111/j.1750-3841.2007.00591.x; Tehrani AB, 2012, NEUROGASTROENT MOTIL, V24, P305, DOI 10.1111/j.1365-2982.2012.01895.x; Temple JL, 2007, PHYSIOL BEHAV, V91, P250, DOI 10.1016/j.physbeh.2007.03.009; van Ruth SM, 2001, J AGR FOOD CHEM, V49, P2409, DOI 10.1021/jf001510f; van Ruth SM, 2000, FOOD CHEM, V71, P339, DOI 10.1016/S0308-8146(00)00186-2; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	63	69	74	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85611	10.1371/journal.pone.0085611	http://dx.doi.org/10.1371/journal.pone.0085611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465618	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100052
J	Alrifai, M; Marsh, LM; Dicke, T; Kilic, A; Conrad, ML; Renz, H; Garn, H				Alrifai, Mohammed; Marsh, Leigh M.; Dicke, Tanja; Kilic, Ayse; Conrad, Melanie L.; Renz, Harald; Garn, Holger			Compartmental and Temporal Dynamics of Chronic Inflammation and Airway Remodelling in a Chronic Asthma Mouse Model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ALLERGEN CHALLENGE; INHALED BUDESONIDE; CYCLOSPORINE-A; ANIMAL-MODELS; MURINE MODEL; MICE; RESOLUTION; CORTICOSTEROIDS; DEXAMETHASONE	Background: Allergic asthma is associated with chronic airway inflammation and progressive airway remodelling. However, the dynamics of the development of these features and their spontaneous and pharmacological reversibility are still poorly understood. We have therefore investigated the dynamics of airway remodelling and repair in an experimental asthma model and studied how pharmacological intervention affects these processes. Methods: Using BALB/c mice, the kinetics of chronic asthma progression and resolution were characterised in absence and presence of inhaled corticosteroid (ICS) treatment. Airway inflammation and remodelling was assessed by the analysis of bronchoalveolar and peribronichal inflammatory cell infiltrate, goblet cell hyperplasia, collagen deposition and smooth muscle thickening. Results: Chronic allergen exposure resulted in early (goblet cell hyperplasia) and late remodelling (collagen deposition and smooth muscle thickening). After four weeks of allergen cessation eosinophilic inflammation, goblet cell hyperplasia and collagen deposition were resolved, full resolution of lymphocyte inflammation and smooth muscle thickening was only observed after eight weeks. ICS therapy when started before the full establishment of chronic asthma reduced the development of lung inflammation, decreased goblet cell hyperplasia and collagen deposition, but did not affect smooth muscle thickening. These effects of ICS on airway remodelling were maintained for a further four weeks even when therapy was discontinued. Conclusions: Utilising a chronic model of experimental asthma we have shown that repeated allergen exposure induces reversible airway remodelling and inflammation in mice. Therapeutic intervention with ICS was partially effective in inhibiting the transition from acute to chronic asthma by reducing airway inflammation and remodelling but was ineffective in preventing smooth muscle hypertrophy.	[Alrifai, Mohammed; Marsh, Leigh M.; Dicke, Tanja; Kilic, Ayse; Conrad, Melanie L.; Renz, Harald; Garn, Holger] Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, UGMLC, Marburg, Germany; [Marsh, Leigh M.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Philipps University Marburg; Ludwig Boltzmann Institute	Garn, H (corresponding author), Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, UGMLC, Marburg, Germany.	garn@staff.uni-marburg.de	Marsh, Leigh/AAB-5125-2021; Conrad, Melanie/AAH-8431-2019	Marsh, Leigh/0000-0002-1754-9249; Conrad, Melanie Lynn/0000-0002-8811-5536; Garn, Holger/0000-0002-5178-4023	Deutsche Forschungsgemeinschaft (DFG) [SFB/TR22 Z2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grant SFB/TR22 Z2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAN D, 1987, BRIT J DIS CHEST, V81, P170, DOI 10.1016/0007-0971(87)90135-5; Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL401, DOI 10.1152/ajplung.00027.2009; Blyth DI, 2000, AM J RESP CELL MOL, V23, P241, DOI 10.1165/ajrcmb.23.2.3999; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Caramori Gaetano, 2008, J Occup Med Toxicol, V3 Suppl 1, pS6, DOI 10.1186/1745-6673-3-S1-S6; Chian CF, 2011, PULM PHARMACOL THER, V24, P256, DOI 10.1016/j.pupt.2010.07.001; Chu HW, 2006, MICROBES INFECT, V8, P1764, DOI 10.1016/j.micinf.2006.02.014; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Gauvreau GM, 2000, CLIN EXP ALLERGY, V30, P1235; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Hogan MB, 2008, ANN ALLERG ASTHMA IM, V101, P619, DOI 10.1016/S1081-1206(10)60225-6; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Karras JG, 2007, AM J RESP CELL MOL, V36, P276, DOI 10.1165/rcmb.2005-0456OC; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Kumar RK, 2004, CLIN EXP ALLERGY, V34, P1796, DOI 10.1111/j.1365-2222.2004.02097.x; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Lederlin M, 2010, EUR RADIOL, V20, P128, DOI 10.1007/s00330-009-1541-0; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Leung SY, 2004, CLIN EXP ALLERGY, V34, P213, DOI 10.1111/j.1365-2222.2004.01870.x; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Miller M, 2006, AM J PHYSIOL-LUNG C, V290, pL162, DOI 10.1152/ajplung.00252.2005; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Nygaard UC, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-11; Persson C, 2010, THORAX, V65, P1111, DOI 10.1136/thx.2009.133363; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Sakai K, 2001, INT ARCH ALLERGY IMM, V126, P126, DOI 10.1159/000049503; SCHMIDT J, 1994, EUR J PHARMACOL, V260, P247, DOI 10.1016/0014-2999(94)90345-X; Shen HH, 2002, AM J RESP CRIT CARE, V166, P146, DOI 10.1164/rccm.2008161; Southam DS, 2008, EUR RESPIR J, V32, P970, DOI 10.1183/09031936.00125307; Southam DS, 2008, AM J RESP CRIT CARE, V178, P1115, DOI 10.1164/rccm.200801-084OC; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x; WEIBEL ER, 1997, LUNG SCI FDN, P333; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	45	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85839	10.1371/journal.pone.0085839	http://dx.doi.org/10.1371/journal.pone.0085839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465740	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500128
J	Li, M; Du, XM; Jin, ZT; Peng, ZH; Ding, J; Li, L				Li, Min; Du, Xiang-min; Jin, Zhi-tao; Peng, Zhao-hui; Ding, Juan; Li, Li			The Diagnostic Performance of Coronary Artery Angiography with 64-MSCT and Post 64-MSCT: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DUAL-SOURCE CT; 64-SLICE COMPUTED-TOMOGRAPHY; FRACTIONAL FLOW RESERVE; HEART-RATE-VARIABILITY; 320-DETECTOR ROW CT; NONINVASIVE DETECTION; PRETEST PROBABILITY; IMAGE QUALITY; RADIATION-EXPOSURE; HIGH-PITCH	Purpose: To comprehensively investigate the diagnostic performance of coronary artery angiography with 64-MDCT and post 64-MDCT. Materials and Methods: PubMed was searched for all published studies that evaluated coronary arteries with 64-MDCT and post 64-MDCT. The clinical diagnostic role was evaluated by applying the likelihood ratios (LRs) to calculate the post-test probability based on Bayes' theorem. Results: 91 studies that met our inclusion criteria were ultimately included in the analysis. The pooled positive and negative LRs at patient level were 8.91 (95% CI, 7.53, 10.54) and 0.02 (CI, 0.01, 0.03), respectively. For studies that did not claim that non-evaluable segments were included, the pooled positive and negative LRs were 11.16 (CI, 8.90, 14.00) and 0.01 (CI, 0.01, 0.03), respectively. For studies including uninterruptable results, the diagnostic performance decreased, with the pooled positive LR 7.40 (CI, 6.00, 9.13) and negative LR 0.02 (CI, 0.01, 0.03). The areas under the summary ROC curve were 0.98 (CI, 0.97 to 0.99) for 64-MDCT and 0.96 (CI, 0.94 to 0.98) for post 64-MDCT, respectively. For references explicitly stating that the non-assessable segments were included during analysis, a post-test probability of negative results >95% and a positive post-test probability,95% could be obtained for patients with a pre-test probability of <73% for coronary artery disease (CAD). On the other hand, when the pre-test probability of CAD was >73%, the diagnostic role was reversed, with a positive post-test probability of CAD >95% and a negative post-test probability of CAD <95%. Conclusion: The diagnostic performance of post 64-MDCT does not increase as compared with 64-MDCT. CTA, overall, is a test of exclusion for patients with a pre-test probability of CAD<73%, while for patients with a pre-test probability of CAD>73%, CTA is a test used to confirm the presence of CAD.	[Li, Min; Peng, Zhao-hui; Ding, Juan; Li, Li] Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China; [Du, Xiang-min] Jinan Mil Gen Hosp, Dept Med Engn, Jinan, Shandong, Peoples R China; [Jin, Zhi-tao] Second Artillery, Gen Hosp, Dept Cardiol, Beijing, Peoples R China		Li, M (corresponding author), Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China.	liminyingxiang@163.com		Li, Min/0000-0002-7649-3900				Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Achenbach S, 2008, JACC-CARDIOVASC IMAG, V1, P177, DOI 10.1016/j.jcmg.2007.11.006; Alkadhi H, 2008, EUR HEART J, V29, P766, DOI 10.1093/eurheartj/ehn044; Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; Andreini D, 2012, JACC-CARDIOVASC IMAG, V5, P690, DOI 10.1016/j.jcmg.2012.03.009; Andreini D, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-80; Bamberg F, 2011, RADIOLOGY, V260, P689, DOI 10.1148/radiol.11110638; Brodoefel H, 2008, RADIOLOGY, V247, P346, DOI 10.1148/radiol.2472070906; Budaj A, 2006, EUROPEAN HEART J, P1; Cademartiri F, 2007, RADIOL MED, V112, P969, DOI 10.1007/s11547-007-0198-5; Cademartiri F, 2010, EUR RADIOL, V20, P846, DOI 10.1007/s00330-009-1612-2; Cademartiri F, 2010, EUR RADIOL, V20, P81, DOI 10.1007/s00330-009-1529-9; Carrascosa P, 2010, J CARDIOVASC COMPUT, V4, P197, DOI 10.1016/j.jcct.2010.04.001; Chen HW, 2010, CLIN IMAG, V34, P165, DOI 10.1016/j.clinimag.2009.05.012; Chen MY, 2013, RADIOLOGY, V267, P76, DOI 10.1148/radiol.13122621; Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Dharampal AS, 2012, EUR RADIOL, V22, P2415, DOI 10.1007/s00330-012-2503-5; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Donati OF, 2010, AM J ROENTGENOL, V194, P920, DOI 10.2214/AJR.09.3225; Ehara M, 2006, CIRC J, V70, P564, DOI 10.1253/circj.70.564; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Fang XM, 2010, INT J CARDIOVAS IMAG, V26, P323, DOI 10.1007/s10554-009-9527-1; Gang S, 2011, BRIT J RADIOL; Gaudio C, 2009, INT J CARDIOL, V135, P280, DOI 10.1016/j.ijcard.2008.03.091; Ghostine S, 2006, J AM COLL CARDIOL, V48, P1929, DOI 10.1016/j.jacc.2006.04.103; Gueret P, 2013, AM J CARDIOL, V111, P471, DOI 10.1016/j.amjcard.2012.10.029; Hamon M, 2007, RADIOLOGY, V245, P720, DOI 10.1148/radiol.2453061899; Han SC, 2008, J CHIN MED ASSOC, V71, P241, DOI 10.1016/S1726-4901(08)70114-X; Herzog BA, 2009, HEART, V95, P1656, DOI 10.1136/hrt.2008.162420; Herzog BA, 2008, EUR HEART J, V29, P3037, DOI 10.1093/eurheartj/ehn485; Herzog C, 2007, RADIOLOGY, V244, P112, DOI 10.1148/radiol.2441060332; Herzog C, 2007, RADIOLOGY, V244, P121, DOI 10.1148/radiol.2441060004; Heuschmid M, 2007, AM J CARDIOL, V100, P587, DOI 10.1016/j.amjcard.2007.03.066; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsiao Edward M, 2010, Curr Cardiol Rep, V12, P68, DOI 10.1007/s11886-009-0075-z; Husmann L, 2010, ACAD RADIOL, V17, P201, DOI 10.1016/j.acra.2009.09.007; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Kadokami T, 2012, NUCL MED COMMUN, V33, P60, DOI 10.1097/MNM.0b013e32834d3bde; Kajander S, 2010, CIRCULATION, V122, P603, DOI 10.1161/CIRCULATIONAHA.109.915009; Kerl JM, 2011, EUR RADIOL, V21, P1895, DOI 10.1007/s00330-011-2134-2; Kerl JM, 2012, J THORAC IMAG, V27, P29, DOI 10.1097/RTI.0b013e3181f82805; Ko BS, 2012, EUR HEART J, V33, P67, DOI 10.1093/eurheartj/ehr268; Leber AW, 2007, EUR HEART J, V28, P2354, DOI 10.1093/eurheartj/ehm294; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Leschka S, 2008, HEART, V94, P1154, DOI 10.1136/hrt.2007.124800; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Maffei E, 2012, RADIOL MED, V117, P725, DOI 10.1007/s11547-011-0754-x; Maffei E, 2012, RADIOL MED, V117, P6, DOI 10.1007/s11547-011-0693-6; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Meijboom WB, 2007, J AM COLL CARDIOL, V50, P1469, DOI 10.1016/j.jacc.2007.07.007; Meijboom WB, 2007, HEART, V93, P1386, DOI 10.1136/hrt.2006.112771; Meijboom WB, 2006, J AM COLL CARDIOL, V48, P1658, DOI 10.1016/j.jacc.2006.06.054; Meng LD, 2009, KOREAN J RADIOL, V10, P347, DOI 10.3348/kjr.2009.10.4.347; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Moon JH, 2011, KOREAN J RADIOL, V12, P308, DOI 10.3348/kjr.2011.12.3.308; Moscariello A, 2012, RADIOLOGY, V265, P385, DOI 10.1148/radiol.12112426; Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, P1; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nance JW, 2012, RADIOLOGY, V264, P679, DOI 10.1148/radiol.12112350; Nasis A, 2010, AM J CARDIOL, V106, P1429, DOI 10.1016/j.amjcard.2010.06.073; Nazeri I, 2010, ARCH IRAN MED, V13, P373, DOI 010135/AIM.003; Nikolaou K, 2006, AM J ROENTGENOL, V187, P111, DOI 10.2214/AJR.05.1697; Oncel D, 2007, EUR J RADIOL, V62, P394, DOI 10.1016/j.ejrad.2007.01.009; Ovrehus KA, 2010, J CARDIOVASC COMPUT, V4, P186, DOI 10.1016/j.jcct.2010.03.010; Pelliccia F, 2013, INT J CARDIOVAS IMAG, V29, P443, DOI 10.1007/s10554-012-0095-4; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Plass A, 2006, EUR J CARDIO-THORAC, V30, P109, DOI 10.1016/j.ejcts.2006.03.048; Pontone G, 2009, J AM COLL CARDIOL, V54, P346, DOI 10.1016/j.jacc.2009.04.027; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Pugliese F, 2005, EUROPEAN RADIOLOGY, V16, P575; Pugliese F, 2008, RADIOLOGY, V246, P384, DOI 10.1148/radiol.2462070113; Pundziute G, 2008, HEART, V94, P48, DOI 10.1136/hrt.2007.116715; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Ravipati G, 2008, AM J CARDIOL, V101, P774, DOI 10.1016/j.amjcard.2007.10.044; Reimann AJ, 2009, INT J CARDIOVAS IMAG, V25, P195, DOI 10.1007/s10554-008-9372-7; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rixe J, 2009, CIRC J, V73, P316, DOI 10.1253/circj.CJ-08-0534; Ropers D, 2006, AM J CARDIOL, V97, P343, DOI 10.1016/j.amjcard.2005.08.050; Ropers U, 2007, J AM COLL CARDIOL, V50, P2393, DOI 10.1016/j.jacc.2007.09.017; Salavati A, 2011, J CARDIOVASC COMPUT; Sato A, 2010, J NUCL CARDIOL, V17, P19, DOI 10.1007/s12350-009-9150-5; Scheffel H, 2008, HEART, V94, P1132, DOI 10.1136/hrt.2008.149971; Scheffel H, 2007, AM J CARDIOL, V100, P701, DOI 10.1016/j.amjcard.2007.03.087; Scheffel H, 2006, EUR RADIOL, V16, P2739, DOI 10.1007/s00330-006-0474-0; Scheffel H, 2010, INTERACT CARDIOV TH, V10, P513, DOI 10.1510/icvts.2009.227439; Scheffel H, 2010, INT J CARDIOVAS IMAG, V26, P579, DOI 10.1007/s10554-010-9595-2; Schlattmann P, 2011, EUR RADIOL, V21, P1904, DOI 10.1007/s00330-011-2142-2; Schlosser T, 2007, ACTA RADIOL, V48, P300, DOI 10.1080/02841850701203587; Schueler S, 2013, EUR RADIOL, V23, P1603, DOI 10.1007/s00330-012-2763-0; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Schuijf JD, 2006, AM J CARDIOL, V98, P145, DOI 10.1016/j.amjcard.2006.01.092; Sheikh M, 2009, MED PRIN PRACT, V18, P323, DOI 10.1159/000215732; Skupski DW, 2002, OBSTET GYNECOL, V100, P830, DOI 10.1016/S0029-7844(02)02210-X; Sohns C, 2012, EUR HEART J-CARD IMG, V13, P263, DOI [10.1093/ejechocard/jer277, 10.1093/ejechocard/Jer277]; Stengel D, 2003, J MED SCREEN, V10, P47, DOI 10.1258/096914103321610806; Stolzmann P, 2008, AM J ROENTGENOL, V191, P1684, DOI 10.2214/AJR.07.4040; Stolzmann P, 2011, EUR J RADIOL, V79, P85, DOI 10.1016/j.ejrad.2009.12.016; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Uehara M, 2012, INT J CARDIOL; van Velzen J, 2011, INT J CARDIOVAS IMAG, P1; van Velzen JE, 2012, INT J CARDIOVAS IMAG, V28, P865, DOI 10.1007/s10554-011-9889-z; van Velzen JE, 2011, EUR HEART J, V32, P637, DOI 10.1093/eurheartj/ehq395; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Weustink AC, 2011, NETH HEART J, V19, P336, DOI 10.1007/s12471-011-0096-2; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068; Weustink AC, 2009, RADIOLOGY, V252, P53, DOI 10.1148/radiol.2521082023; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Xu L, 2011, EUR RADIOL, V21, P936, DOI 10.1007/s00330-010-1987-0; Xu Y, 2010, INT J CARDIOVAS IMAG, V26, P75, DOI 10.1007/s10554-009-9568-5; Yang X, 2010, VASC HEALTH RISK MAN, V6, P935, DOI 10.2147/VHRM.S13879; Yoneyama K, 2012, HEART INT, V7, P51, DOI 10.4081/hi.2012.e11; Zhang LJ, 2010, ACTA RADIOL, V51, P727, DOI 10.3109/02841851.2010.492792; Zhang T, 2011, MINERVA MED, V102, P249	127	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84937	10.1371/journal.pone.0084937	http://dx.doi.org/10.1371/journal.pone.0084937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465453	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500022
J	Park, J; Yamaura, T; Kawamoto, J; Kurihara, T; Sato, SB				Park, Jungha; Yamaura, Takayuki; Kawamoto, Jun; Kurihara, Tatsuo; Sato, Satoshi B.			Reciprocal Modulation of Surface Expression of Annexin A2 in a Human Umbilical Vein Endothelial Cell-Derived Cell Line by Eicosapentaenoic Acid and Docosahexaenoic Acid	PLOS ONE			English	Article							N-3 FATTY-ACIDS; CARDIOVASCULAR HEALTH; CAVEOLAE; PLASMIN; INFLAMMATION; MECHANISM; RECEPTOR; DISEASE; CULTURE; SERUM	Background: Annexin A2 (ANXA2), a member of the annexin family of cytosolic Ca2+-binding proteins, plays a pivotal role in vascular biology. Small amounts of this protein and S100A10 protein are exposed on the surface of endothelial cells (ECs). They control fibrinolysis by recruiting tissue-type and urokinase-type plasminogen activators from the plasma. Nutritional studies indicate that two major long-chain polyunsaturated fatty acids (PUFAs), i.e., eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), provide benefits for EC functions. The effects of EPA and DHA on the plasminogen/plasmin system have not been characterized. Methodology/Principal Findings: Proteomic analysis of a cultured human umbilical vein EC-derived cell line, HUV-EC-C, showed that cell-associated ANXA2 decreased with EPA treatment and increased with DHA. A small fraction of ANXA2 was bound to the cell surface, which was also affected by these PUFAs following the same trends. Cell surface expression was negatively regulated by protein kinase C (PKC) alpha-mediated Ser-phosphorylation, which was up-and down-regulated by EPA and DHA, respectively. These PUFAs differentially affected a small fraction of caveolae/rafts-associated ANXA2. In addition to chymotrypsin-like activity in the serum, newly activated plasmin cleaved the ANXA2 on the cell surface at distinct sites in the N-terminal sequence. ANXA2 also bound to membranes released in the medium, which was similarly processed by these proteases. Both the PUFAs did not directly affect the release. Conclusion/Significance: These results suggest that EPA and DHA reciprocally control cell surface location of ANXA2. Moreover, cleavage of this protein by plasmin likely resulted in autodigestion of the platform for formation of this protease. In conjunction with termination of the proteolysis by rapid inactivation of plasmin by alpha-2-antiplasmin and other polypeptide inhibitors, this feedback mechanism may emphasize the benefits of these PUFA in regulation of the initiation of fibrinolysis on the surface of ECs.	[Park, Jungha; Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto, Japan; [Yamaura, Takayuki; Kawamoto, Jun; Kurihara, Tatsuo] Kyoto Univ, Inst Chem Res, Uji, Kyoto, Japan	Kyoto University; Kyoto University	Sato, SB (corresponding author), Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto, Japan.	sbsato@ltm.kyoto-u.ac.jp		Kawamoto, Jun/0000-0002-5025-5613				Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Balakumar P, 2012, FREE RADICAL BIO MED, V53, P271, DOI 10.1016/j.freeradbiomed.2012.05.005; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; Bruneel A, 2003, PROTEOMICS, V3, P714, DOI 10.1002/pmic.200300409; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Cockrell E, 2008, LUPUS, V17, P943, DOI 10.1177/0961203308095329; COLLINS T, 1993, LAB INVEST, V68, P499; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; Deckelbaum RJ, 2012, J NUTR, V142, p587S, DOI 10.3945/jn.111.148080; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Flood EC, 2011, VASC PHARMACOL, V54, P59, DOI 10.1016/j.vph.2011.03.003; GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gu Y, 2009, REPROD SCI, V16, P905, DOI 10.1177/1933719109337333; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; He KL, 2011, J BIOL CHEM, V286, P15428, DOI 10.1074/jbc.M110.185058; Hedhli N, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406273; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; HOSHI H, 1984, P NATL ACAD SCI-BIOL, V81, P6413, DOI 10.1073/pnas.81.20.6413; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kelley DS, 2012, P NUTR SOC, V71, P1; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Leung C, 2011, BIOCHEM BIOPH RES CO, V415, P263, DOI 10.1016/j.bbrc.2011.10.031; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; LOSKUTOFF DJ, 1978, J CELL PHYSIOL, V96, P361, DOI 10.1002/jcp.1040960312; Madureira PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050591; Madureira PA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/353687; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Matesanz N, 2010, INVEST OPHTH VIS SCI, V51, P6815, DOI 10.1167/iovs.10-5339; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Mozaffarian D, 2011, ANN INTERN MED, V155, P160, DOI 10.7326/0003-4819-155-3-201108020-00006; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Park J, 2012, EXTREMOPHILES, V16, P227, DOI 10.1007/s00792-011-0422-z; Ramadeen A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P978, DOI 10.1161/CIRCEP.112.971515; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Sato SB, 2013, BBA-MOL CELL BIOL L, V1831, P306, DOI 10.1016/j.bbalip.2012.10.004; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Tunica DG, 2009, PROTEOMICS, V9, P4991, DOI 10.1002/pmic.200900065; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308; Zoeller JJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-7	66	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85045	10.1371/journal.pone.0085045	http://dx.doi.org/10.1371/journal.pone.0085045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465474	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500031
J	Molina, LA; Skelin, I; Gruber, AJ				Molina, Leonardo A.; Skelin, Ivan; Gruber, Aaron J.			Acute NMDA Receptor Antagonism Disrupts Synchronization of Action Potential Firing in Rat Prefrontal Cortex	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GAMMA-OSCILLATIONS; WORKING-MEMORY; HEALTHY-VOLUNTEERS; PYRAMIDAL NEURONS; SCHIZOPHRENIA; INTERNEURONS; KETAMINE; PHENCYCLIDINE; PARVALBUMIN	Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are used to model schizophrenia in animals. We used high-density electrophysiological recordings to assess the effects of acute systemic injection of an NMDAR antagonist (MK-801) on ensemble neural processing in the medial prefrontal cortex of freely moving rats. Although MK-801 increased neuron firing rates and the amplitude of gamma-frequency oscillations in field potentials, the synchronization of action potential firing decreased and spike trains became more Poisson-like. This disorganization of action potential firing following MK-801 administration is consistent with changes in simulated cortical networks as the functional connections among pyramidal neurons become less clustered. Such loss of functional heterogeneity of the cortical microcircuit may disrupt information processing dependent on spike timing or the activation of discrete cortical neural ensembles, and thereby contribute to hallucinations and other features of psychosis induced by NMDAR antagonists.	[Molina, Leonardo A.; Skelin, Ivan; Gruber, Aaron J.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Gruber, AJ (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	aaron.gruber@uleth.ca		Gruber, Aaron/0000-0003-2700-5429	Canadian Natural Sciences and Engineering Research Council; Alberta Heritage Foundation for Medical Research; Alberta Innovates-Health Solutions	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Innovates-Health Solutions	This work has been supported by funding from the Canadian Natural Sciences and Engineering Research Council (AJG), Alberta Heritage Foundation for Medical Research (AJG), and Alberta Innovates-Health Solutions (AJG, IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; Ahn S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016201; Andine P, 1999, J PHARMACOL EXP THER, V290, P1393; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; Arvanov VL, 1997, BRAIN RES, V768, P361, DOI 10.1016/S0006-8993(97)00842-1; Barr MS, 2010, SCHIZOPHR RES, V121, P146, DOI 10.1016/j.schres.2010.05.023; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gallinat J, 2004, CLIN NEUROPHYSIOL, V115, P1863, DOI 10.1016/j.clinph.2004.03.013; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Gruber AJ, 2010, J NEUROSCI, V30, P17102, DOI 10.1523/JNEUROSCI.4623-10.2010; Haig AR, 2000, CLIN NEUROPHYSIOL, V111, P1461, DOI 10.1016/S1388-2457(00)00347-3; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Harris K, 2002, KLUSTAKWIK AUTOMATIC; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Insel N, 2012, J NEUROSCI, V32, P16331, DOI 10.1523/JNEUROSCI.1577-12.2012; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kloosterman F, 2009, J VISUALIZED EXPT JO; KOEK W, 1988, J PHARMACOL EXP THER, V245, P969; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kulikova SP, 2012, EUR J NEUROSCI, V36, P3407, DOI 10.1111/j.1460-9568.2012.08263.x; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Ma JY, 2007, PSYCHOPHARMACOLOGY, V191, P961, DOI 10.1007/s00213-006-0667-x; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Redish A, 2002, MCLUST SPIKE SORTING; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Rung JP, 2005, PROG NEURO-PSYCHOPH, V29, P833, DOI 10.1016/j.pnpbp.2005.03.003; Slewa-Younan S, 2001, INT J NEUROSCI, V107, P131, DOI 10.3109/00207450109149762; Spencer KM, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00190; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; STURGEON RD, 1979, EUR J PHARMACOL, V59, P169; STURGEON RD, 1981, EUR J PHARMACOL, V76, P37, DOI 10.1016/0014-2999(81)90007-8; TIEDTKE PI, 1990, J NEURAL TRANSM-GEN, V81, P173, DOI 10.1007/BF01245040; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANEDEN CG, 1992, EUR J NEUROSCI, V4, P77; Verma A, 1996, J NEUROSCI, V16, P373; Wang XJ, 1996, J NEUROSCI, V16, P6402; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Wood J, 2012, J NEUROSCI, V32, P3022, DOI 10.1523/JNEUROSCI.6377-11.2012; Xi D, 2009, INT J NEUROPSYCHOPH, V12, P1395, DOI 10.1017/S146114570900042X	75	39	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85842	10.1371/journal.pone.0085842	http://dx.doi.org/10.1371/journal.pone.0085842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465743	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000067
J	Vindas, MA; Sorensen, C; Johansen, IB; Folkedal, O; Hoglund, E; Khan, UW; Stien, LH; Kristiansen, TS; Braastad, BO; Overli, O				Vindas, Marco A.; Sorensen, Christina; Johansen, Ida B.; Folkedal, Ole; Hoglund, Erik; Khan, Uniza W.; Stien, Lars H.; Kristiansen, Tore S.; Braastad, Bjarne O.; Overli, Oyvind			Coping with Unpredictability: Dopaminergic and Neurotrophic Responses to Omission of Expected Reward in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							CHARR SALVELINUS-ALPINUS; SPATIAL WORKING-MEMORY; CELL-PROLIFERATION; ARCTIC-CHARR; AGONISTIC BEHAVIOR; PREFRONTAL CORTEX; NEURAL PLASTICITY; FACTOR EXPRESSION; SOCIAL-DOMINANCE; BRAIN MONOAMINES	Comparative studies are imperative for understanding the evolution of adaptive neurobiological processes such as neural plasticity, cognition, and emotion. Previously we have reported that prolonged omission of expected rewards (OER, or `frustrative nonreward') causes increased aggression in Atlantic salmon (Salmo salar). Here we report changes in brain monoaminergic activity and relative abundance of brain derived neurotrophic factor (BDNF) and dopamine receptor mRNA transcripts in the same paradigm. Groups of fish were initially conditioned to associate a flashing light with feeding. Subsequently, the expected food reward was delayed for 30 minutes during two out of three meals per day in the OER treatment, while the previously established routine was maintained in control groups. After 8 days there was no effect of OER on baseline brain stem serotonin (5-HT) or dopamine (DA) activity. Subsequent exposure to acute confinement stress led to increased plasma cortisol and elevated turnover of brain stem DA and 5-HT in all animals. The DA response was potentiated and DA receptor 1 (D1) mRNA abundance was reduced in the OER-exposed fish, indicating a sensitization of the DA system. In addition OER suppressed abundance of BDNF in the telencephalon of non-stressed fish. Regardless of OER treatment, a strong positive correlation between BDNF and D1 mRNA abundance was seen in non-stressed fish. This correlation was disrupted by acute stress, and replaced by a negative correlation between BDNF abundance and plasma cortisol concentration. These observations indicate a conserved link between DA, neurotrophin regulation, and corticosteroid-signaling pathways. The results also emphasize how fish models can be important tools in the study of neural plasticity and responsiveness to environmental unpredictability.	[Vindas, Marco A.; Khan, Uniza W.; Braastad, Bjarne O.; Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Sorensen, Christina; Johansen, Ida B.] Univ Oslo, Dept Biosci, Oslo, Norway; [Folkedal, Ole; Stien, Lars H.; Kristiansen, Tore S.] Inst Marine Res, Dept Anim Welf, Matredal, Norway; [Hoglund, Erik] Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, Hirtshals, Denmark	Norwegian University of Life Sciences; University of Oslo; Institute of Marine Research - Norway; Technical University of Denmark	Vindas, MA (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	marco.vindas@umb.no	Johansen, Ida Beitnes/W-3766-2019; Sørensen, Christina/E-7933-2012; Kristiansen, Tore/ABC-7142-2020	Sørensen, Christina/0000-0003-4009-1608; Kristiansen, Tore S/0000-0001-5904-0224	Research Council of Norway [119728]	Research Council of Norway(Research Council of Norway)	This study has been carried out with financial support from the Research Council of Norway, Project 119728 SALMOWA (www.imr.no/salmowa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2005, NEUROREPORT, V16, P669, DOI 10.1097/00001756-200505120-00003; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; AMSEL A, 1992, PSYCHOL BULL, V112, P396, DOI 10.1037/0033-2909.112.3.396; Bratland S, 2010, AQUACULT INT, V18, P991, DOI 10.1007/s10499-009-9317-8; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Butler A.B., 2005, COMP VERTEBRATE NEUR, Vsecond; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Calu DJ, 2010, NEURON, V68, P991, DOI 10.1016/j.neuron.2010.11.019; CARLSTEAD K, 1986, APPL ANIM BEHAV SCI, V16, P25, DOI 10.1016/0168-1591(86)90037-7; Chorley P, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00021; DANTZER R, 1980, PHYSIOL BEHAV, V24, P1, DOI 10.1016/0031-9384(80)90005-0; DUNCAN IJH, 1971, ANIM BEHAV, V19, P500, DOI 10.1016/S0003-3472(71)80104-5; Eisch AJ, 2007, CURR PHARM BIOTECHNO, V8, P147; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gray JD, 2013, NEUROSCIENCE, V239, P214, DOI 10.1016/j.neuroscience.2012.08.034; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hess U, 2009, AM PSYCHOL, V64, P120, DOI 10.1037/a0013386; Hoglund E, 2000, J EXP BIOL, V203, P1711; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Izquierdo A, 2012, BEHAV BRAIN RES, V233, P494, DOI 10.1016/j.bbr.2012.05.032; Johansen IB, 2012, COMP BIOCHEM PHYS D, V7, P161, DOI 10.1016/j.cbd.2012.01.002; Johansen IB, 2011, COMP BIOCHEM PHYS D, V6, P126, DOI 10.1016/j.cbd.2010.11.002; Johnson AW, 2008, EUR J NEUROSCI, V28, P997, DOI 10.1111/j.1460-9568.2008.06383.x; Kalueff AV, 2012, BEHAVIOUR, V149, P1019, DOI 10.1163/1568539X-00003030; Karakatsouli N, 2012, AQUACULTURE, V364, P48, DOI 10.1016/j.aquaculture.2012.07.033; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KEENLEYSIDE MILES H. A., 1962, BEHAVIOUR, V19, P139, DOI 10.1163/156853961X00231; Kino T, 2010, MOL ENDOCRINOL, V24, P941, DOI 10.1210/me.2009-0395; Kittilsen S, 2009, AQUACULTURE, V298, P146, DOI 10.1016/j.aquaculture.2009.10.009; Kohler T, 2005, HISTOCHEM CELL BIOL, V123, P315, DOI 10.1007/s00418-004-0730-9; Krause J., 2011, FISH COGNITION BEHAV, P10; Kuppers E, 2001, NEUROREPORT, V12, P1175; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Maximino C, 2010, ZEBRAFISH, V7, P359, DOI 10.1089/zeb.2010.0669; MAYER I, 1990, CAN J ZOOL, V68, P1360, DOI 10.1139/z90-203; MCINTYRE DC, 1979, BEHAV NEURAL BIOL, V25, P90, DOI 10.1016/S0163-1047(79)90807-0; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; O'Connell LA, 2013, J CHEM NEUROANAT, V47, P106, DOI 10.1016/j.jchemneu.2012.12.007; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; O'Connell LA, 2011, J COMP NEUROL, V519, P75, DOI 10.1002/cne.22506; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Papini M.R., 1997, REV GEN PSYCHOL, V1, P175, DOI [10.1037/1089-2680.1.2.175, DOI 10.1037/1089-2680.1.2.175]; Prunet P, 2012, FISH PHYSIOL BIOCHEM, V38, P43, DOI 10.1007/s10695-011-9522-z; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SHANNON NJ, 1986, J NEUROCHEM, V47, P958; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; Sorensen C, 2013, GEN COMP ENDOCR, V181, P25, DOI 10.1016/j.ygcen.2012.12.003; Sorensen C, 2012, BEHAV BRAIN RES, V227, P311, DOI 10.1016/j.bbr.2011.01.041; Sorensen C, 2011, PHYSIOL BEHAV, V102, P518, DOI 10.1016/j.physbeh.2010.12.023; Stien LH, 2013, REV AQUACULT, V5, P33, DOI 10.1111/j.1753-5131.2012.01083.x; Suri D, 2013, NEUROSCIENCE, V239, P196, DOI 10.1016/j.neuroscience.2012.08.065; Taylor SL, 2011, BEHAV NEUROSCI, V125, P911, DOI 10.1037/a0026172; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Vindas MA, 2012, ANIM COGN, V15, P903, DOI 10.1007/s10071-012-0517-7; von Krogh K, 2010, PHYSIOL BEHAV, V101, P32, DOI 10.1016/j.physbeh.2010.04.003; Williams SN, 2009, NEUROREPORT, V20, P606, DOI 10.1097/WNR.0b013e32832a0a98; WINBERG S, 1992, J COMP PHYSIOL A, V170, P93; WINBERG S, 1991, J COMP PHYSIOL A, V168, P241; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; WINBERG S, 1992, NEUROREPORT, V3, P243, DOI 10.1097/00001756-199203000-00006; Xing B, 2012, BEHAV BRAIN RES, V235, P36, DOI 10.1016/j.bbr.2012.06.035; Zimmerman PH, 1998, BEHAV PROCESS, V44, P73, DOI 10.1016/S0376-6357(98)00035-7; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2000, ETHOLOGY, V106, P467, DOI 10.1046/j.1439-0310.2000.00546.x	76	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85543	10.1371/journal.pone.0085543	http://dx.doi.org/10.1371/journal.pone.0085543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465595	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330237000043
J	Wu, S; Sun, QB				Wu, Song; Sun, Quanbin			Computer Simulation of Leadership, Consensus Decision Making and Collective Behaviour in Humans	PLOS ONE			English	Article							EVACUATION SIMULATION; MODELING CROWD; ANIMAL GROUPS; SPEED	The aim of this study is to evaluate the reliability of a crowd simulation model developed by the authors by reproducing Dyer et al.'s experiments (published in Philosophical Transactions in 2009) on human leadership and consensus decision making in a computer-based environment. The theoretical crowd model of the simulation environment is presented, and its results are compared and analysed against Dyer et al.'s original experiments. It is concluded that the simulation results are largely consistent with the experiments, which demonstrates the reliability of the crowd model. Furthermore, the simulation data also reveals several additional new findings, namely: 1) the phenomena of sacrificing accuracy to reach a quicker consensus decision found in ants colonies was also discovered in the simulation; 2) the ability of reaching consensus in groups has a direct impact on the time and accuracy of arriving at the target position; 3) the positions of the informed individuals or leaders in the crowd could have significant impact on the overall crowd movement; and 4) the simulation also confirmed Dyer et al.'s anecdotal evidence of the proportion of the leadership in large crowds and its effect on crowd movement. The potential applications of these findings are highlighted in the final discussion of this paper.	[Wu, Song; Sun, Quanbin] Univ Salford, Sch Built & Environm, Salford M5 4WT, Lancs, England	University of Salford	Sun, QB (corresponding author), Univ Salford, Sch Built & Environm, Salford M5 4WT, Lancs, England.	Sun52014@gmail.com		Wu, Song/0000-0002-5633-2229				Bandini S, 2007, CYBERNET SYST, V38, P729, DOI 10.1080/01969720701534141; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Braun A, 2003, COMP ANIM CONF PROC, P143, DOI 10.1109/CASA.2003.1199317; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dyer JRG, 2008, ANIM BEHAV, V75, P461, DOI 10.1016/j.anbehav.2007.05.010; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Heliovaara S, 2012, BUILD ENVIRON, V48, P89, DOI 10.1016/j.buildenv.2011.08.020; Kirchner A, 2002, PHYSICA A, V312, P260, DOI 10.1016/S0378-4371(02)00857-9; Lam WHK, 2003, TRANSPORT RES A-POL, V37, P789, DOI 10.1016/S0965-8564(03)00058-2; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Li J, 2005, PHYSICA A, V354, P619, DOI 10.1016/j.physa.2005.03.007; Macal CM, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P83; Moussa M.S., 2011, P INT C MICR ICM HAM, P1; Moussaid M, 2012, PLOS COMPUTATIONAL; Parisi DR, 2007, PHYSICA A, V385, P343, DOI 10.1016/j.physa.2007.06.033; Pelechano N, 2008, AUTOMAT CONSTR, V17, P377, DOI 10.1016/j.autcon.2007.06.005; Pelechano N, 2006, IEEE COMPUT GRAPH, V26, P80, DOI 10.1109/MCG.2006.133; Perez GJ, 2002, PHYSICA A, V312, P609, DOI 10.1016/S0378-4371(02)00987-1; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; Reynolds C., 1999, GAM DEV C; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Sakuma T, 2005, COMPUT ANIMAT VIRT W, V16, P343, DOI 10.1002/cav.105; Seeley TD, 1999, BEHAV ECOL SOCIOBIOL, V45, P19, DOI 10.1007/s002650050536; Seeley TD, 2004, APIDOLOGIE, V35, P101, DOI 10.1051/apido:2004004; Shendarkar A, 2008, SIMUL MODEL PRACT TH, V16, P1415, DOI 10.1016/j.simpat.2008.07.004; Sun Q, 2011, 2011 P 28 ISARC, P107; WOLFRAM S, 1986, THEORY APPL CELLULAR; Yu YF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046112; Yuan JP, 2009, FIRE SAFETY J, V44, P266, DOI 10.1016/j.firesaf.2008.07.004; Yue H, 2010, PHYSICA A, V389, P527, DOI 10.1016/j.physa.2009.09.035; Zheng XP, 2009, BUILD ENVIRON, V44, P437, DOI 10.1016/j.buildenv.2008.04.002	37	6	6	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e80680	10.1371/journal.pone.0080680	http://dx.doi.org/10.1371/journal.pone.0080680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465367	Green Published, gold, Green Accepted			2022-12-27	WOS:000330237000003
J	Balcha, TT; Sturegard, E; Winqvist, N; Skogmar, S; Reepalu, A; Jemal, ZH; Tibesso, G; Schon, T; Bjorkman, P				Balcha, Taye T.; Sturegard, Erik; Winqvist, Niclas; Skogmar, Sten; Reepalu, Anton; Jemal, Zelalem Habtamu; Tibesso, Gudeta; Schon, Thomas; Bjorkman, Per			Intensified Tuberculosis Case-Finding in HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB/RIF Compared with Smear Microscopy and Liquid Culture	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL TREATMENT; SUBCLINICAL TUBERCULOSIS; PREVALENCE; MORTALITY; THERAPY; COINFECTION; RESISTANCE; INFECTION; ACCURACY	Background: Detection of active tuberculosis (TB) before antiretroviral therapy (ART) initiation is important, but optimal diagnostic methods for use in resource-limited settings are lacking. We assessed the prevalence of TB, evaluated the diagnostic yield of Xpert MTB/RIF in comparison with smear microscopy and culture, and the impact of Xpert results on clinical management in HIV-positive adults eligible for ART at health centers in a region of Ethiopia. Methods: Participants were prospectively recruited and followed up at 5 health centers. Trained nurses collected data on socio-demographic characteristics, medical history and symptoms, and performed physical examination. Two paired morning sputum samples were obtained, and lymph node aspirates in case of lymphadenopathy. Diagnostic yield of Xpert MTB/RIF in sputum was compared with smear microscopy and liquid culture. Results: TB was diagnosed in 145/812 participants (17.9%), with bacteriological confirmation in 137 (16.9%). Among bacteriologically confirmed cases, 31 were smear-positive (22.6%), 96 were Xpert-positive (70.1%), and 123 were culture-positive (89.8%). Xpert MTB/RIF increased the TB detection rate by 64 cases (47.4%) compared with smear microscopy. The overall sensitivity of Xpert MTB/RIF was 66.4%, and was not significantly lower when testing one compared with two samples. While Xpert MTB/RIF was 46.7% sensitive among patients with CD4 cell counts >200 cells/mm(3), this increased to 82.9% in those with CD4 cell counts <= 100 cells/mm(3). Compared with Xpert-positive TB patients, Xpert-negative cases had less advanced HIV and TB disease characteristics. Conclusions: Previously undiagnosed TB is common among HIV-positive individuals managed in Ethiopian health centers. Xpert MTB/RIF increased TB case detection, especially in patients with advanced immunosuppression. An algorithm based on the use of a single morning sputum sample for individuals with negative sputum smear microscopy could be considered for intensified case finding in patients eligible for ART. However, technical and cost-effectiveness issues relevant for low-income countries warrant further study.	[Balcha, Taye T.; Winqvist, Niclas; Skogmar, Sten; Reepalu, Anton; Bjorkman, Per] Lund Univ, Dept Clin Sci Malmo, Infect Dis Res Unit, Malmo, Sweden; [Balcha, Taye T.] Minist Hlth, Addis Ababa, Ethiopia; [Sturegard, Erik] Clin Microbiol Reg & Univ Labs, Region Skane, Sweden; [Winqvist, Niclas] Reg Dept Infect Dis Control & Prevent, Malmo, Sweden; [Jemal, Zelalem Habtamu] Oromia Hlth Bur, Addis Ababa, Ethiopia; [Tibesso, Gudeta] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs Ethiopia, Addis Ababa, Ethiopia; [Schon, Thomas] Linkoping Univ, Fac Hlth Sci, Dept Med Microbiol, S-58183 Linkoping, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden	Lund University; Linkoping University	Balcha, TT (corresponding author), Lund Univ, Dept Clin Sci Malmo, Infect Dis Res Unit, Malmo, Sweden.	tayetolera@yahoo.com		Reepalu, Anton/0000-0003-1690-8921	Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingency Agency (MSB); Swedish Medical Society	Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingency Agency (MSB); Swedish Medical Society	The Swedish International Development Cooperation Agency (SIDA), the Swedish Civil Contingency Agency (MSB) and the Swedish Medical Society have provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, REV DEF REP FRAM TUB; [Anonymous], 2010, ROADM ROLL OUT XPERT; Aparna S, 2006, INT J TUBERC LUNG D, V10, P447; Assefa Y, 2012, J HEALTH SERV RES PO, V17, P24, DOI 10.1258/jhsrp.2011.010135; Balcha Taye T, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P318, DOI 10.1177/1545109710367518; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; BLAKEMORE R, 2010, J CLIN MICROBIOL; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Corbett EL, 2013, INT J TUBERC LUNG D, V17, P1125, DOI 10.5588/ijtld.13.0117; Datiko DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-266; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2012, CLIN INFECT DIS, P1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Ministry of Health, 2006, AIDS ETH; Ministry of Health of Ethiopia, 2012, GUID CLIN PROGR MAN; Ministry of Health of Ethiopia, 2008, GUID MAN OPP INF ANT; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Mugusi F, 2006, INT J TUBERC LUNG D, V10, P663; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO/International Union Against Tuberculosis and Lung Disease, 2000, TECHN GUID SPUT EX T; WHO/TDR/FIND, 2006, DIAGN TUB GLOB DEM M; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; World Health Organization, 2012, WHO POLICY COLLABORA	43	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85478	10.1371/journal.pone.0085478	http://dx.doi.org/10.1371/journal.pone.0085478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465572	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100042
J	Kottler, VA; Koch, I; Flotenmeyer, M; Hashimoto, H; Weigel, D; Dreyer, C				Kottler, Verena A.; Koch, Iris; Floetenmeyer, Matthias; Hashimoto, Hisashi; Weigel, Detlef; Dreyer, Christine			Multiple Pigment Cell Types Contribute to the Black, Blue, and Orange Ornaments of Male Guppies (Poecilia reticulata)	PLOS ONE			English	Article							FEMALE MATE PREFERENCE; LEBISTES-RETICULATUS; SEXUAL SELECTION; DICHROMATIC CHROMATOPHORES; COUNTERGRADIENT VARIATION; FISH CHROMATOPHORES; PATTERN-FORMATION; ORYZIAS-LATIPES; COLOR PATTERNS; PETERS PISCES	The fitness of male guppies (Poecilia reticulata) highly depends on the size and number of their black, blue, and orange ornaments. Recently, progress has been made regarding the genetic mechanisms underlying male guppy pigment pattern formation, but we still know little about the pigment cell organization within these ornaments. Here, we investigate the pigment cell distribution within the black, blue, and orange trunk spots and selected fin color patterns of guppy males from three genetically divergent strains using transmission electron microscopy. We identified three types of pigment cells and found that at least two of these contribute to each color trait. Further, two pigment cell layers, one in the dermis and the other in the hypodermis, contribute to each trunk spot. The pigment cell organization within the black and orange trunk spots was similar between strains. The presence of iridophores in each of the investigated color traits is consistent with a key role for this pigment cell type in guppy color pattern formation.	[Kottler, Verena A.; Weigel, Detlef; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Koch, Iris; Floetenmeyer, Matthias] Max Planck Inst Dev Biol, Tubingen, Germany; [Hashimoto, Hisashi] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Max Planck Society; Max Planck Society; Nagoya University	Kottler, VA (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	verena.kottler@tuebingen.mpg.de; christine.dreyer@tuebingen.mpg.de	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Floetenmeyer, Matthias/0000-0002-0133-1632	Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft; Max Planck Society; Grants-in-Aid for Scientific Research [26440121] Funding Source: KAKEN	Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft; Max Planck Society(Max Planck Society); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and funds from the Max Planck Society to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Brooks R, 1996, NATURWISSENSCHAFTEN, V83, P39, DOI 10.1007/BF01139310; Deere KA, 2012, P ROY SOC B-BIOL SCI, V279, P1684, DOI 10.1098/rspb.2011.2132; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; FARR JA, 1980, BEHAVIOUR, V74, P38, DOI 10.1163/156853980X00311; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; FUJII R, 1989, ZOOL SCI, V6, P477; FUJII R, 1993, INT REV CYTOL, V143, P191; Fujii R., 1966, Annotationes Zoologicae Japonenses, V39, P185; FUJII R, 1970, Annotationes Zoologicae Japonenses, V43, P123; Fujii Ryozo, 1993, P535; GODA M, 1994, ZOOL SCI, V11, P527; Goda M, 2001, ZOOL SCI, V18, P165, DOI 10.2108/zsj.18.165; Goda M, 2013, BIOL BULL-US, V224, P14, DOI 10.1086/BBLv224n1p14; Goda M, 2011, PIGM CELL MELANOMA R, V24, P614, DOI 10.1111/j.1755-148X.2011.00861.x; Goodrich HB, 1944, GENETICS, V29, P584; Goodrich HB, 1941, GENETICS, V26, P573; Grether GF, 2005, EVOLUTION, V59, P175, DOI 10.1111/j.0014-3820.2005.tb00904.x; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; GUNDERSEN RE, 1982, J MORPHOL, V172, P349, DOI 10.1002/jmor.1051720309; HAMA T, 1970, CHEM BIOL PTERIDINES, P391; Hama T., 1975, MEDAKA KILLIFISH BIO, P138; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Haskins CP, 1938, AM NAT, V72, P571, DOI 10.1086/280808; HAWKES JW, 1974, CELL TISSUE RES, V149, P159, DOI 10.1007/BF00222271; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Houde AE, 1987, EVOLUTION, P1; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; IGA T, 1978, J EXP ZOOL, V205, P413, DOI 10.1002/jez.1402050310; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; KODRICBROWN A, 1985, BEHAV ECOL SOCIOBIOL, V17, P199, DOI 10.1007/BF00300137; Kottler VA, 2013, GENETICS, V194, P631, DOI 10.1534/genetics.113.151738; Kuriyama T, 2006, ZOOL SCI, V23, P793, DOI 10.2108/zsj.23.793; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; MATSUMOTO J, 1965, J CELL BIOL, V27, P493, DOI 10.1083/jcb.27.3.493; MENTER DG, 1979, J MORPHOL, V160, P103, DOI 10.1002/jmor.1051600107; MORRISON RL, 1995, PIGM CELL RES, V8, P28, DOI 10.1111/j.1600-0749.1995.tb00771.x; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; OBIKA M, 1990, PIGM CELL RES, V3, P33, DOI 10.1111/j.1600-0749.1990.tb00259.x; OBIKA M, 1993, CELL TISSUE RES, V271, P81, DOI 10.1007/BF00297544; OLIPHANT LW, 1993, PIGM CELL RES, V6, P205, DOI 10.1111/j.1600-0749.1993.tb00603.x; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schmidt J, 1920, C R TRAV LABOR CARLS, V14; Sheets L, 2007, CURR BIOL, V17, P1721, DOI 10.1016/j.cub.2007.09.028; TAKEUCHI I K, 1975, Annotationes Zoologicae Japonenses, V48, P242; TAKEUCHI IK, 1976, CELL TISSUE RES, V173, P17; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Tripathi N, 2008, ZEBRAFISH, V5, P265, DOI 10.1089/zeb.2008.0548; WINGE O, 1947, HEREDITY, V1, P65, DOI 10.1038/hdy.1947.4; Winge O, 1927, J GENET, V18, P1, DOI 10.1007/BF03052599; Winge O, 1922, J GENET, V12, P145, DOI 10.1007/BF02983078	66	27	30	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85647	10.1371/journal.pone.0085647	http://dx.doi.org/10.1371/journal.pone.0085647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465632	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100055
J	Veldwijk, MR; Zhang, B; Wenz, F; Herskind, C				Veldwijk, Marlon R.; Zhang, Bo; Wenz, Frederik; Herskind, Carsten			The Biological Effect of Large Single Doses: A Possible Role for Non-Targeted Effects in Cell Inactivation	PLOS ONE			English	Article							NORMAL HUMAN FIBROBLASTS; LINEAR-QUADRATIC MODEL; BYSTANDER RESPONSES; GLIOMA-CELLS; INTRAOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; CYTOKINE RELEASE; RADIOSURGERY; CANCER; FRACTION	Background and Purpose: Novel radiotherapy techniques increasingly use very large dose fractions. It has been argued that the biological effect of large dose fractions may differ from that of conventional fraction sizes. The purpose was to study the biological effect of large single doses. Material and Methods: Clonogenic cell survival of MCF7 and MDA-MB-231 cells was determined after direct X-ray irradiation, irradiation of feeder cells, or transfer of conditioned medium (CM). Cell-cycle distributions and the apoptotic sub-G1 fraction were measured by flow cytometry. Cytokines in CM were quantified by a cytokine antibody array. gamma H2AX foci were detected by immunofluorescence microscopy. Results: The surviving fraction of MCF7 cells irradiated in vitro with 12 Gy showed an 8.5-fold decrease (95% c.i.: 4.4-16.3; P<0.0001) when the density of irradiated cells was increased from 10 to 50x10(3) cells per flask. Part of this effect was due to a dose-dependent transferrable factor as shown in CM experiments in the dose range 5-15 Gy. While no effect on apoptosis and cell cycle distribution was observed, and no differentially expressed cytokine could be identified, the transferable factor induced prolonged expression of gamma H2AX DNA repair foci at 1-12 h. Conclusions: A dose-dependent non-targeted effect on clonogenic cell survival was found in the dose range 5-15 Gy. The dependence of SF on cell numbers at high doses would represent a "cohort effect" in vivo. These results support the hypothesis that non-targeted effects may contribute to the efficacy of very large dose fractions in radiotherapy.	[Veldwijk, Marlon R.; Zhang, Bo; Wenz, Frederik; Herskind, Carsten] Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Univ Med Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg	Herskind, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Univ Med Mannheim, Mannheim, Germany.	Carsten.Herskind@medma.uni-heidelberg.de	Herskind, Carsten/J-2457-2019	Herskind, Carsten/0000-0001-6554-5907	Shanghai Mai-Ge Medical Technology Co. (Shanghai, China)	Shanghai Mai-Ge Medical Technology Co. (Shanghai, China)	BZ was supported by a fellowship from Shanghai Mai-Ge Medical Technology Co. (www.luluyang.ezhaobiao.com; Yanan Rd, 700 room 1102, 200001, Shanghai, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Brenner DJ, 2008, SEMIN RADIAT ONCOL, V18, P234, DOI 10.1016/j.semradonc.2008.04.004; Buonanno M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021540; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Facoetti A, 2009, INT J RADIAT BIOL, V85, P690, DOI 10.1080/09553000903020016; Flickinger JC, 2003, TECHNOL CANCER RES T, V2, P87, DOI 10.1177/153303460300200203; Garcia LM, 2007, INT J RADIAT ONCOL, V67, P587, DOI 10.1016/j.ijrobp.2006.10.017; Gerashchenko BI, 2003, CYTOM PART A, V54A, P1, DOI 10.1002/cyto.a.10049; Gomez-Millan J, 2012, RADIOTHER ONCOL, V102, P450, DOI 10.1016/j.radonc.2011.11.002; Gow MD, 2008, PHYS MED BIOL, V53, P119, DOI 10.1088/0031-9155/53/1/008; Gow MD, 2010, RADIAT RES, V173, P769, DOI 10.1667/RR1895.1; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Herskind C, 2009, INT J RADIAT ONCOL, V74, P976, DOI 10.1016/j.ijrobp.2009.02.042; Hof H, 2007, CANCER-AM CANCER SOC, V110, P148, DOI 10.1002/cncr.22763; Iyer R, 2000, CANCER RES, V60, P1290; Kirkpatrick JP, 2008, SEMIN RADIAT ONCOL, V18, P240, DOI 10.1016/j.semradonc.2008.04.005; Kondziolka D, 2012, PROG NEUROL SURG, V25, P115, DOI 10.1159/000331184; Liu Q, 2013, INT J RADIAT ONCOL, V85, P1127, DOI 10.1016/j.ijrobp.2012.08.005; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Maier P, 2006, RADIAT RES, V166, P463, DOI 10.1667/RR0550.1; Mariotti LG, 2012, INT J RADIAT BIOL, V88, P751, DOI 10.3109/09553002.2012.703365; McMahon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054526; Morton G, 2011, RADIOTHER ONCOL, V100, P463, DOI 10.1016/j.radonc.2011.08.022; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Mothersill Carmel, 2012, Frontiers in Genetics, V3, P74, DOI 10.3389/fgene.2012.00074; Nagasawa H, 2003, INT J RADIAT BIOL, V79, P35, DOI 10.1080/0955300021000019230; Pomp J, 1996, RADIOTHER ONCOL, V40, P121, DOI 10.1016/0167-8140(96)01767-7; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Timmerman RD, 2007, J CLIN ONCOL, V25, P947, DOI 10.1200/JCO.2006.09.7469; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Veronesi U, 2010, BREAST CANCER RES TR, V124, P141, DOI 10.1007/s10549-010-1115-5; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Zhou HN, 2008, CANCER RES, V68, P2233, DOI 10.1158/0008-5472.CAN-07-5278	38	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84991	10.1371/journal.pone.0084991	http://dx.doi.org/10.1371/journal.pone.0084991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465461	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100018
J	Lin, H; Yang, YN; Wang, Y; Wang, LH; Zhou, X; Liu, J; Peng, DZ				Lin, Heng; Yang, Yanni; Wang, Yong; Wang, Lihua; Zhou, Xin; Liu, Jing; Peng, Daizhi			Effect of Mixed Transplantation of Autologous and Allogeneic Microskin Grafts on Wound Healing in a Rat Model of Acute Skin Defect	PLOS ONE			English	Article							EPIDERMAL STEM-CELLS; SYNGENEIC KERATINOCYTES; INTEGRIN FUNCTION; CRUCIAL ROLE; IN-VITRO; ADHESION; DEDIFFERENTIATION; BETA-1-INTEGRIN; FIBROBLASTS; EXPRESSION	The treatment of extensive thermal injuries with insufficient autologous skin remains a great challenge to burn surgeons. In this study, we investigated the influence of the ratio of autologous and allogeneic tissue in mixed microskin grafts on wound healing in order to develop an effective method for using limited donor skin to cover a large open wound. Four different mixtures were tested: autologous microskin at an area expansion ratio of 10:1 with allogeneic microskin at an area expansion ratio of 10:1 or 10:3 and autologous microskin at an expansion ratio of 20:1 with allogeneic microskin at an expansion ratio of 20:3 or 20:6. Wound healing, wound contraction, and integrin beta 1 expression were measured. Mixed microskin grafting facilitated wound healing substantially. The mixture of autologous microskin at an expansion ratio of 10:1 with the same amount of allogeneic microskin achieved the most satisfactory wound healing among the 4 tested mixtures. Histological examination revealed the presence of obviously thickened epidermis and ectopic integrin beta 1 expression. Keratinocytes expressing integrin beta 1 were scattered in the suprabasal layer. Higher levels of integrin beta 1 expression were associated with faster wound healing, implying that ectopic expression of integrin beta 1 in keratinocytes may play a pivotal role in wound healing. In conclusion, this study proves that this new skin grafting technique may improve wound healing.	[Lin, Heng; Yang, Yanni; Wang, Yong; Wang, Lihua; Zhou, Xin; Liu, Jing; Peng, Daizhi] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China; [Lin, Heng; Peng, Daizhi] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Tissue Engn Res Unit, Chongqing, Peoples R China	Army Medical University; Army Medical University	Peng, DZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China.	dzpengpub@126.com			National Key Basic Research and Development Project of China (973 Project) [2005CB522605]; National High Technology Research and Development Project of China (863 Project) [2006AA02A121]; Independent Research Subject Project Type I of State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ200904]	National Key Basic Research and Development Project of China (973 Project)(National Basic Research Program of China); National High Technology Research and Development Project of China (863 Project); Independent Research Subject Project Type I of State Key Laboratory of Trauma, Burns and Combined Injury	This study was supported in part by grants from National Key Basic Research and Development Project of China (973 Project) (No. 2005CB522605), National High Technology Research and Development Project of China (863 Project) (No. 2006AA02A121) and Independent Research Subject Project Type I of State Key Laboratory of Trauma, Burns and Combined Injury (No. SKLZZ200904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brakebusch C, 1997, J CELL SCI, V110, P2895; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cao YP, 2003, TRANSPLANTATION, V75, P1390, DOI 10.1097/01.TP.0000061599.24682.EC; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Chen MK, 1999, J SURG RES, V84, P82, DOI 10.1006/jsre.1999.5614; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Fu XB, 2001, LANCET, V358, P1067, DOI 10.1016/S0140-6736(01)06202-X; Grose R, 2002, DEVELOPMENT, V129, P2303; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; JOHNSONWINT B, 1988, ANN NY ACAD SCI, V548, P167, DOI 10.1111/j.1749-6632.1988.tb18803.x; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kato A, 1997, CRIT REV ONCOL HEMAT, V26, P1, DOI 10.1016/S1040-8428(97)00011-5; KIM ZW, 1970, SURG GYNECOL OBSTETR, V131, P495; Larochelle F, 1998, LAB INVEST, V78, P1089; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li HH, 2007, CELL BIOL INT, V31, P1436, DOI 10.1016/j.cellbi.2007.05.016; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; McCarty JH, 2009, CELL ADHES MIGR, V3, P211, DOI 10.4161/cam.3.2.7767; Nowinski D, 2004, J INVEST DERMATOL, V122, P216, DOI 10.1046/j.0022-202X.2003.22112.x; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rouabhia M, 1996, TRANSPLANTATION, V61, P1290, DOI 10.1097/00007890-199605150-00002; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Weis SM, 2007, METHOD ENZYMOL, V426, P505, DOI 10.1016/S0076-6879(07)26021-5; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; YAMADA KM, 1996, MOL CELLULAR BIOL WO, P311; YANG CC, 1980, BURNS, V6, P141; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Zhang CP, 2010, J CELL MOL MED, V14, P1135, DOI 10.1111/j.1582-4934.2009.00765.x; Zhang M, 2001, Zhonghua Wai Ke Za Zhi, V39, P708; Zhang M L, 1986, Burns Incl Therm Inj, V12, P540; Zuo HB, 2012, J MATER SCI-MATER M, V23, P2933, DOI 10.1007/s10856-012-4745-9	37	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85672	10.1371/journal.pone.0085672	http://dx.doi.org/10.1371/journal.pone.0085672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465646	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500090
J	Thorolfsdottir, RB; Aspelund, T; Capewell, S; Critchley, J; Gudnason, V; Andersen, K				Thorolfsdottir, Rosa Bjoerk; Aspelund, Thor; Capewell, Simon; Critchley, Julia; Gudnason, Vilmundur; Andersen, Karl			Population Assessment of Future Trajectories in Coronary Heart Disease Mortality	PLOS ONE			English	Article							RISK-FACTORS; LIFE EXPECTANCY; YOUNG-ADULTS; DECLINE; ENGLAND; WALES; DECREASE; PROFILE; DEATHS; IMPACT	Background: Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s, largely reflecting improvements in cardiovascular risk factors. The purpose of this study was to predict future CHD mortality in Iceland based on potential risk factor trends. Methods and findings: The previously validated IMPACT model was used to predict changes in CHD mortality between 2010 and 2040 among the projected population of Iceland aged 25-74. Calculations were based on combining: i) data on population numbers and projections (Statistics Iceland), ii) population risk factor levels and projections (Refine Reykjavik study), and iii) effectiveness of specific risk factor reductions (published meta-analyses). Projections for three contrasting scenarios were compared: 1) If the historical risk factor trends of past 30 years were to continue, the declining death rates of past decades would level off, reflecting population ageing. 2) If recent trends in risk factors (past 5 years) continue, this would result in a death rate increasing from 49 to 70 per 100,000. This would reflect a recent plateau in previously falling cholesterol levels and recent rapid increases in obesity and diabetes prevalence. 3) Assuming that in 2040 the entire population enjoys optimal risk factor levels observed in low risk cohorts, this would prevent almost all premature CHD deaths before 2040. Conclusions: The potential increase in CHD deaths with recent trends in risk factor levels is alarming both for Iceland and probably for comparable Western populations. However, our results show considerable room for reducing CHD mortality. Achieving the best case scenario could eradicate premature CHD deaths by 2040. Public health policy interventions based on these predictions may provide a cost effective means of reducing CHD mortality in the future.	[Thorolfsdottir, Rosa Bjoerk; Aspelund, Thor; Gudnason, Vilmundur; Andersen, Karl] Iceland Heart Assoc, Kopavogur, Iceland; [Thorolfsdottir, Rosa Bjoerk; Aspelund, Thor; Gudnason, Vilmundur; Andersen, Karl] Univ Iceland, Reykjavik, Iceland; [Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Critchley, Julia] Univ London, Dept Populat Hlth Sci & Educ, London, England	Icelandic Heart Association; University of Iceland; University of Liverpool; University of London	Andersen, K (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	andersen@landspitali.is	Shao, Ruitai/AAU-7642-2021; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008	Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Critchley, Julia/0000-0002-5248-4188; Thorolfsdottir, Rosa B/0000-0001-7475-0398				Allender S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-148; Aspelund A, 2007, EUROPEAN SOC CARDIOL, V14, P761; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Bruthans J, 2014, EUR J PREV CARDIOL, V21, P829, DOI 10.1177/2047487312469476; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2006, HEART, V92, P521, DOI 10.1136/hrt.2004.053645; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, J EPIDEMIOL COMMUN H, V57, P243, DOI 10.1136/jech.57.4.243; Critchley JA, 2002, EUR HEART J, V23, P110, DOI 10.1053/euhj.2001.2681; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hughes J, 2013, EUR J PREV CARDIOL, V20, P310, DOI 10.1177/2047487312441725; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Statistics-Iceland, 2011, BIRTHS DEATHS; Thorsson B, 2013, EUR HEART J, V34, P1778, DOI 10.1093/eurheartj/ehs395; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; World Health Organization, 2012, REV WHO DISC PAP DEV; World Health Organization, 2011, LEAD CAUS DEATHS 200; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85800	10.1371/journal.pone.0085800	http://dx.doi.org/10.1371/journal.pone.0085800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465713	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500115
J	Francis, JH; Abramson, DH; Gobin, YP; Marr, BP; Dunkel, IJ; Riedel, ER; Brodie, SE				Francis, Jasmine H.; Abramson, David H.; Gobin, Y. Pierre; Marr, Brian P.; Dunkel, Ira J.; Riedel, Elyn R.; Brodie, Scott E.			Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review	PLOS ONE			English	Article							TRANSGENIC MURINE RETINOBLASTOMA; INTRAOCULAR RETINOBLASTOMA; INTRAARTERIAL CHEMOTHERAPY; SUBCONJUNCTIVAL CARBOPLATIN; RETINAL FUNCTION; PHARMACOKINETIC ANALYSIS; PRECLINICAL MODELS; FIBRIN SEALANT; INJECTION; TOPOTECAN	Purpose: To report electroretinogram responses of retinoblastoma children under anesthesia before and after treatment with chemotherapeutic drugs (melphalan, topotecan, carboplatin) delivery by ophthalmic artery chemosurgery (OAC). Methods: A cohort study of 81 patients with retinoblastoma treated with OAC. All patients treated with OAC at our center through May 2012 for whom the requisite ERG data were available are included in the analysis. This study recorded the ERG 30 Hz flicker amplitude response changes from baseline, at 3 and 12 months following OAC treatment completion. Both univariate and multivariate linear regression models were evaluated, with generalized estimating equations to correct for correlations within patients. Independent numerical variables included maximum doses and cumulative doses of melphalan, topotecan and carboplatin. Results: By univariate analysis, both melphalan and topotecan appear to be associated with changes in ERG amplitude at both 3 and 12 months; but for the most part, these changes are minimal and likely clinically insignificant. By multivariate analysis, maximum and cumulative melphalan have a modest, temporary effect on the ERG amplitude change, which is apparent at 3 months but no longer evident at 12 months after completing treatment. By multivariate analysis, topotecan and carboplatin do not appear to adversely effect the change in ERG response. Conclusion: Melphalan has the strongest, and carboplatin the weakest association with reduction in ERG response amplitudes; but for the most part, these changes are minimal and likely clinically insignificant. These conclusions apply only over the dose ranges used here, and should be applied with caution.	[Francis, Jasmine H.; Abramson, David H.; Marr, Brian P.; Brodie, Scott E.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Abramson, David H.; Marr, Brian P.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Neurosurg Neurol, Serv Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Radiol, Serv Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Riedel, Elyn R.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai	Brodie, SE (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	scott.brodie@mssm.edu		Francis, Jasmine/0000-0002-7637-3108; Brodie, Scott/0000-0002-3303-4552; Dunkel, Ira/0000-0001-8091-6067	Fund for Ophthalmic Knowledge, The New York Community Trust; Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, The New York Community Trust; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The Fund for Ophthalmic Knowledge, The New York Community Trust, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034120; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Bianciotto C, 2012, OPHTHALMOLOGY, V119, P843, DOI 10.1016/j.ophtha.2011.09.040; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Buitrago E, 2013, EXP EYE RES, V108, P103, DOI 10.1016/j.exer.2013.01.002; Friedrich S, 1997, CURR EYE RES, V16, P663, DOI 10.1076/ceyr.16.7.663.5061; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Harbour JW, 1996, INVEST OPHTH VIS SCI, V37, P1892; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Kirath H, 2007, J AAPOS, V11, P404, DOI 10.1016/j.jaapos.2006.11.005; Lee TC, 2003, OPHTHALMOLOGY, V110, P1989, DOI 10.1016/S0161-6420(03)00669-9; Liu CY, 2013, DOC OPHTHALMOL; Mallipatna AC, 2011, ARCH OPHTHALMOL-CHIC, V129, P738, DOI 10.1001/archophthalmol.2011.130; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Mulvihill A, 2003, ARCH OPHTHALMOL-CHIC, V121, P1120, DOI 10.1001/archopht.121.8.1120; Munier FL, 2012, BR J OPHTHALMOL, DOI [10.1136/bjophthalmol-2011-301450, DOI 10.1136/BJ0PHTHALM0L-2011-301450]; Munier FL, 2011, RETINA-J RET VIT DIS, V31, P566, DOI 10.1097/IAE.0b013e318203c101; Nemeth KM, 2011, CANCER-AM CANCER SOC, V117, P421, DOI 10.1002/cncr.25574; Palioura S, 2012, PEDIATR BLOOD CANCER, V59, P859, DOI 10.1002/pbc.24170; Pardue MT, 2004, RETINA-J RET VIT DIS, V24, P776, DOI 10.1097/00006982-200410000-00015; Peterson EC, 2011, J NEUROSURG, V114, P1603, DOI 10.3171/2011.1.JNS10466; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Schaiquevich P, 2012, RETINA-J RET VIT DIS, V32, P387, DOI 10.1097/IAE.0b013e31821e9f8a; Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1407, DOI 10.1001/archophthalmol.2011.151; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1399, DOI 10.1001/archophthalmol.2011.150; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Tse BC, 2013, JAMA OPHTHALMOL, P1, DOI [10.1001/jamaophthal-mol.2013.2065, DOI 10.1001/JAMA0PHTHAL-M0L.2013.2065]; Ueda Mitsuyuki, 1994, Nippon Ganka Gakkai Zasshi, V98, P352; Ueda Mitsuyuki, 1995, Nippon Ganka Gakkai Zasshi, V99, P1230; Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665; Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060; Venturi C, 2013, ACTA OPHTHALMOL, V91, P335, DOI 10.1111/j.1755-3768.2011.02296.x; Wilson MW, 2011, ARCH OPHTHALMOL-CHIC, V129, P1458, DOI 10.1001/archophthalmol.2011.330; ZLIOBA A, 1988, ANN OPHTHALMOL, V20, P71	38	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84247	10.1371/journal.pone.0084247	http://dx.doi.org/10.1371/journal.pone.0084247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465398	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500012
J	Garin, N; Olaya, B; Perales, J; Moneta, MV; Miret, M; Ayuso-Mateos, JL; Haro, JM				Garin, Noe; Olaya, Beatriz; Perales, Jaime; Victoria Moneta, Maria; Miret, Marta; Luis Ayuso-Mateos, Jose; Haro, Josep Maria			Multimorbidity Patterns in a National Representative Sample of the Spanish Adult Population	PLOS ONE			English	Article							CHRONIC PHYSICAL CONDITIONS; QUALITY-OF-LIFE; MENTAL-DISORDERS; HEALTH-CARE; COMORBIDITY; PREVALENCE; DEPRESSION; EPIDEMIOLOGY; ASSOCIATION; PAIN	Background: In the context of population aging, multimorbidity has emerged as a growing concern in public health. However, little is known about multimorbidity patterns and other issues surrounding chronic diseases. The aim of our study was to examine multimorbidity patterns, the relationship between physical and mental conditions and the distribution of multimorbidity in the Spanish adult population. Methods: Data from this cross-sectional study was collected from the COURAGE study. A total of 4,583 participants from Spain were included, 3,625 aged over 50. An exploratory factor analysis was conducted to detect multimorbidity patterns in the population over 50 years of age. Crude and adjusted binary logistic regressions were performed to identify individual associations between physical and mental conditions. Results: Three multimorbidity patterns rose: 'cardio-respiratory' (angina, asthma, chronic lung disease), 'mental-arthritis' (arthritis, depression, anxiety) and the 'aggregated pattern' (angina, hypertension, stroke, diabetes, cataracts, edentulism, arthritis). After adjusting for covariates, asthma, chronic lung disease, arthritis and the number of physical conditions were associated with depression. Angina and the number of physical conditions were associated with a higher risk of anxiety. With regard to multimorbidity distribution, women over 65 years suffered from the highest rate of multimorbidity (67.3%). Conclusion: Multimorbidity prevalence occurs in a high percentage of the Spanish population, especially in the elderly. There are specific multimorbidity patterns and individual associations between physical and mental conditions, which bring new insights into the complexity of chronic patients. There is need to implement patient-centered care which involves these interactions rather than merely paying attention to individual diseases.	[Garin, Noe; Olaya, Beatriz; Perales, Jaime; Victoria Moneta, Maria; Haro, Josep Maria] Univ Barcelona, Res Unit, St Boi De Llobregat, Spain; [Garin, Noe; Olaya, Beatriz; Perales, Jaime; Haro, Josep Maria] Fundacio St Joan de Deu, Esplugas de Llobregat, Spain; [Garin, Noe; Olaya, Beatriz; Miret, Marta; Luis Ayuso-Mateos, Jose; Haro, Josep Maria] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Inst Salud Carlos III, Madrid, Spain; [Miret, Marta; Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Luis Ayuso-Mateos, Jose] Inst Invest Sanitaria Princesa IP, Madrid, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Madrid	Haro, JM (corresponding author), Univ Barcelona, Res Unit, Parc Sanitari St Joan de Deu, St Boi De Llobregat, Spain.	jmharo@pssjd.org	Olaya, Beatriz/AAB-1952-2020; Miret, Marta/C-6103-2019; Haro, Josep Maria/D-1423-2011	Olaya, Beatriz/0000-0003-2046-3929; Miret, Marta/0000-0003-3252-854X; Haro, Josep Maria/0000-0002-3984-277X; Garin, Noe/0000-0002-1559-9453; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Perales-Puchalt, Jaime/0000-0003-1013-7847	European Community [223071]; Spanish Ministry of Education, Culture and Sport [FPU12/05661]; Instituto de Salud Carlos III-FIS [PS09/00295, PS09/01845]; Spanish Ministry of Science and Innovation's ACI-Promociona [ACI2009-1010]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM); Instituto de Salud Carlos III	European Community(European Commission); Spanish Ministry of Education, Culture and Sport; Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation's ACI-Promociona(Ministry of Science and Innovation, Spain (MICINN)); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe) and the Spanish Ministry of Education, Culture and Sport (FPU12/05661). Additional support was provided by funds from the Instituto de Salud Carlos III-FIS research grants number PS09/00295 and PS09/01845, from the Spanish Ministry of Science and Innovation's ACI-Promociona (ACI2009-1010). The study was supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. This article is part of a PhD programme developed in the Public Health Department of the Universitat de Barcelona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28; Alves L, 2010, ARQ BRAS CARDIOL, V95, P179, DOI 10.1590/S0066-782X2010005000075; American Optometric Association, 2004, OPT CLIN PRACT GUID; Andreas S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-62; [Anonymous], GLOB STRAT DIAGN MAN; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bonnewyn A, 2009, J AFFECT DISORDERS, V117, P193, DOI 10.1016/j.jad.2009.01.012; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Bruffaerts R, 2012, BRIT J PSYCHIAT, V200, P454, DOI 10.1192/bjp.bp.111.097519; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; Cataluna Juan Jose Soler, 2009, Arch Bronconeumol, V45 Suppl 4, P18, DOI 10.1016/S0300-2896(09)72859-5; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; European Union Health Policy Forum, 2012, ANSW DG SANCO CONS C; Falsarella GR, 2013, GERIATR GERONTOL INT, V13, P1043, DOI 10.1111/ggi.12052; Felton DA, 2009, J PROSTHODONT, V18, P88, DOI 10.1111/j.1532-849X.2009.00437.x; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Giordana J Y, 2010, Encephale, V36, P59, DOI 10.1016/S0013-7006(10)70018-X; Global Initiative for Asthma, 2012, GLOB STRAT ASTHM MAN; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; He Y, 2008, PSYCHOL MED, V38, P1639, DOI 10.1017/S0033291707002474; Hinton R, 2002, AM FAM PHYSICIAN, V65, P841; Instituto Nacional de Estadistica (Spanish Statistical Office), ENC NAC SAL ENSE 201; Kim KI, 2012, GENDER MED, V9, P309, DOI 10.1016/j.genm.2012.08.001; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; KNAUPER B, 1994, J PSYCHIATR RES, V28, P147, DOI 10.1016/0022-3956(94)90026-4; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kubinder K., 2003, PSYCHOL SCI, V45, P103; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Levinson D, 2008, GEN HOSP PSYCHIAT, V30, P226, DOI 10.1016/j.genhosppsych.2008.02.007; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007; Lobo-Escolar A, 2008, J PSYCHOSOM RES, V65, P347, DOI 10.1016/j.jpsychores.2008.03.002; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; Mannino DM, 2013, RESPIROLOGY, V18, P1083, DOI 10.1111/resp.12119; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mullerova H, 2013, CHEST, DOI [10.1378/chest.12-28478, DOI 10.1378/CHEST.12-28478]; Nagl A, 2012, Z GERONTOL GERIATR, V45, P146, DOI 10.1007/s00391-011-0266-2; National Collaboratoring Centre for Chronic Conditions, 2008, NICE CLIN GUID 68 ST; Olivera J, 2008, INT J GERIATR PSYCH, V23, P915, DOI 10.1002/gps.2004; Ormel J, 2007, GEN HOSP PSYCHIAT, V29, P325, DOI 10.1016/j.genhosppsych.2007.03.009; Ose D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-179; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Quintas R, 2012, MATURITAS, V71, P147, DOI 10.1016/j.maturitas.2011.11.014; Ritchie K, 2004, BRIT J PSYCHIAT, V184, P147, DOI 10.1192/bjp.184.2.147; Rodrigues SM, 2012, INT J ENV RES PUB HE, V9, P100, DOI 10.3390/ijerph9010100; Salive M.E., 2013, EPIDEMIOL REV; Schafer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045390; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Scott KM, 2007, GEN HOSP PSYCHIAT, V29, P123, DOI 10.1016/j.genhosppsych.2006.12.006; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Silver K, 2012, IS HHS ADDRESSING MU; Stegmann ME, 2010, J AFFECT DISORDERS, V124, P38, DOI 10.1016/j.jad.2009.10.026; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thomson WM, 2012, INT J DENT, V2012, DOI 10.1155/2012/375407; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; United Nations Department of Economic and Social Affairs Population Division, 2012, POP AG DEV 2012; Ustun T.B., 2005, HOUSEHOLD SAMPLE SUR, P199; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; van't Land H, 2010, J PSYCHOSOM RES, V68, P187, DOI 10.1016/j.jpsychores.2009.05.011; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; WHO, 2008, 2008 2013 ACT PLAN G; WHO, 2003, ACT AG POL FRAM; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, PROC TRANSL AD INSTR; Yorgancioglu A, 2012, TUBERK TORAK, V60, P81, DOI 10.5578/tt.2652	78	56	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84794	10.1371/journal.pone.0084794	http://dx.doi.org/10.1371/journal.pone.0084794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465433	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500023
J	Ma, K; Malhotra, P; Soni, V; Hedroug, O; Annaba, F; Dudeja, A; Shen, S; Turner, JR; Khramtsova, EA; Saksena, S; Dudeja, PK; Gill, RK; Alrefai, WA				Ma, Ke; Malhotra, Pooja; Soni, Vinay; Hedroug, Omar; Annaba, Fadi; Dudeja, Amish; Shen, Le; Turner, Jerrold R.; Khramtsova, Ekaterina A.; Saksena, Seema; Dudeja, Pradeep K.; Gill, Ravinder K.; Alrefai, Waddah A.			Overactivation of Intestinal SREBP2 in Mice Increases Serum Cholesterol	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-2; FATTY-ACID SYNTHESIS; LIPID HOMEOSTASIS; TRANSGENIC MICE; STEROL; GUT; LIVER; GENE; METABOLISM; NPC1L1	Sterol Response Element Binding Protein 2 (SREBP2) transcription factor is a master regulator of cholesterol homeostasis. Treatment with statins, inhibitors of cholesterol synthesis, activates intestinal SREBP2, which may hinder their cholesterol-lowering effects. Overactivation of SREBP2 in mouse liver was shown to have no effect on plasma cholesterol. However, the influence of activating intestinal SREBP2 on plasma cholesterol is not known. We have generated a novel transgenic mouse model with intestine specific overexpression of active SREBP2 (ISR2) driven by villin promoter. ISR2 mice showed overexpression of active SREBP2 specifically in the intestine. Microarray analysis of jejunal RNA from ISR2 mice showed a significant increase in genes involved in fatty acid and cholesterol synthesis. Cholesterol and triglyceride (TG) in jejunum and liver (mg/g protein) were significantly increased in ISR2 vs wild type mice. Serum Cholesterol was significantly increased in VLDL and LDL fractions whereas the level of serum triglycerides was decreased in ISR2 vs wild type mice. In conclusion, activation of intestinal SREBP2 alone seems to be sufficient to increase plasma cholesterol, highlighting the essential role of intestine in maintaining cholesterol homeostasis in the body.	[Alrefai, Waddah A.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA; [Ma, Ke; Malhotra, Pooja; Soni, Vinay; Hedroug, Omar; Annaba, Fadi; Dudeja, Amish; Saksena, Seema; Dudeja, Pradeep K.; Gill, Ravinder K.; Alrefai, Waddah A.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA; [Shen, Le] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Turner, Jerrold R.; Khramtsova, Ekaterina A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago	Alrefai, WA (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	walrefai@uic.edu	Turner, Jerrold/H-1502-2019	Gill, Ravinder/0000-0002-5337-2567	Department of Veterans Affairs; NIDDK [DK54016, DK81858, DK92441, DK96258, DK96245, DK71596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK067887, R01DK081858, R56DK094954, R01DK054016, R01DK071596, R01DK092441, R56DK071596, R03DK096258, R21DK096254, R24DK099803] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000152] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by the Department of Veterans Affairs (WAA, PKD) and the following NIDDK grants: DK54016, DK81858, DK92441 (PKD), DK96258 (RKG), DK96245 (SS), and DK71596 (WAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V292, pG369, DOI 10.1152/ajpgi.00306.2006; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Gahete MD, 2011, ENDOCRINOLOGY, V152, P4825, DOI 10.1210/en.2011-1447; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Im SS, 2009, MOL CELL BIOL, V29, P4864, DOI 10.1128/MCB.00553-09; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Iwayanagi Y, 2008, PHARM RES, V25, P1134, DOI 10.1007/s11095-007-9496-9; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Jeon TI, 2012, TRENDS ENDOCRINOL ME; Levy E, 2013, ATHEROSCLEROSIS, V227, P297, DOI 10.1016/j.atherosclerosis.2013.01.023; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Pramfalk C, 2010, J LIPID RES, V51, P1354, DOI [10.1194/jlr.M900274-JLR200, 10.1194/jlr.M900274]; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Tremblay AJ, 2011, J LIPID RES, V52, P558, DOI 10.1194/jlr.M011080; van der Wulp MY, 2013, MOL CELL ENDOCRINOL	28	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84221	10.1371/journal.pone.0084221	http://dx.doi.org/10.1371/journal.pone.0084221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465397	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500011
J	Morreale, M; Marchione, P; Giacomini, P; Pontecorvo, S; Marianetti, M; Vento, C; Tinelli, E; Francia, A				Morreale, Manuela; Marchione, Pasquale; Giacomini, Patrizia; Pontecorvo, Simona; Marianetti, Massimo; Vento, Claudio; Tinelli, Emanuele; Francia, Ada			Neurological Involvement in Primary Sjogren Syndrome: A Focus on Central Nervous System	PLOS ONE			English	Article							NEUROPSYCHIATRIC DYSFUNCTION; MANIFESTATIONS; ALEXITHYMIA; DIAGNOSIS; VALIDITY; SCALE	Objectives: Sjogren syndrome is an autoimmune disease involving mainly salivary and lacrimal glands. Beyond widely described PNS involvement, high variable prevalence of CNS manifestations ranging from 2.5 and 60% of all pSS patients has been reported, without specific syndrome definition. The aim of this cohort study was to evaluate the prevalence of CNS signs and symptoms in pSS patients and to identify possible biomarkers of CNS damage. Methods: 120 patients with pSS diagnosis according to the 2002 American-European Consensus Group criteria were enrolled after exclusion of secondary causes. All patients underwent to a wide neurological, neuropsychological, psychiatric, neuroradiological and ultrasonographic evaluation. Results: Central and peripheral nervous system involvement was observed in 81 patients with a prevalence of 67.5%. The prevalence of CNS involvement was significantly higher than PNS disease (p 0.001). 68 patients (84%) shown non-focal CNS symptoms and 64 (79%) focal CNS deficits with headache as the most common feature (46.9%), followed by cognitive (44.4%) and mood disorders (38.3%). Particularly, we observed a high prevalence of migraine without aura, subcortical frontal executive functions and verbal memory impairment and apathy/alexythimia. MR spectroscopy revealed a reduction of NAA levels or NAA/Cr ratio decrease in subcortical frontal and basal ganglia white matter, while ultrasonography showed an impairment of microvasculature response. At multivariate analysis, headache, cognitive disorders and psychiatric symptoms was significantly associated to serological markers (anti-SSA), MRS and ultrasonographic features. Conclusions: The higher prevalence of MWO-mimic headache, cognitive dys-esecutive syndrome and mood disorders observed in this series confirmed previous evidences of a higher diffused CNS compromission rather than focal involvement such as SM-like clinical course or NMO-like syndrome. The association with immunological biomarkers, metabolic cerebral dysfunction and microvascular damage suggests a possible endothelial dysfunction of the cerebral microcirculation or a potential inflammation-mediated shift of the neurovascular coupling.	[Morreale, Manuela; Pontecorvo, Simona; Francia, Ada] Univ Roma La Sapienza, Dept Neurol & Psychiat, Ctr Neuroimmunol, I-00185 Rome, Italy; [Morreale, Manuela; Marchione, Pasquale; Giacomini, Patrizia; Vento, Claudio] Univ Roma La Sapienza, Neurosonol Unit, Dept Med & Surg Sci & Biotechnol, Neurol Sect, I-00185 Rome, Italy; [Marchione, Pasquale; Tinelli, Emanuele] Inst Neurosci, Dept Clin Neurosci, Neurol Ctr Latium, Rome, Italy; [Giacomini, Patrizia; Marianetti, Massimo] Univ Roma La Sapienza, Neuropsychol Outpatients Serv, Dept Med & Surg Sci & Biotechnol, Neurol Sect, I-00185 Rome, Italy; [Tinelli, Emanuele] Univ Roma La Sapienza, Dept Neurol & Psychiat, Neuroradiol Unit, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Morreale, M (corresponding author), Univ Roma La Sapienza, Dept Neurol & Psychiat, Ctr Neuroimmunol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	manuelamorreale@yahoo.it	Tinelli, Emanuele/AAH-9176-2021; tinelli, emanuele/GSO-0025-2022	Tinelli, Emanuele/0000-0002-3007-4022; tinelli, emanuele/0000-0002-3007-4022; Francia, Ada/0000-0002-9550-9082; Marianetti, Massimo/0000-0002-1402-3831; Pontecorvo, Simona/0000-0002-4256-2568	no profit association SCAN-Onlus	no profit association SCAN-Onlus	This study has been supported by no profit association SCAN-Onlus. The supporters had no role in study design, data collection and statistical analysis. No funding has been received.	ALEXANDER GE, 1981, NEUROLOGY, V31, P1391, DOI 10.1212/WNL.31.11.1391; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDONOPOULOS AP, 1990, BRIT J RHEUMATOL, V29, P21; Belin C, 1999, ANN MED INTERNE, V150, P598; Belleville S, 1998, MEM COGNITION, V26, P572, DOI 10.3758/BF03201163; Birnbaum J, 2010, NEUROLOGIST, V16, P287, DOI 10.1097/NRL.0b013e3181ebe59f; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Carlesimo G. A., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P471; Castellino G, 2008, AUTOIMMUN REV, V7, P297, DOI 10.1016/j.autrev.2007.11.022; Colombo L., 2002, G ITAL PSICOL, V3, P613, DOI DOI 10.1421/1256; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; ESCUDERO D, 1995, ANN MED INTERNE, V146, P239; FABER RJ, 1992, J CONSUM RES, V19, P459, DOI 10.1086/209315; FANCELLO GS, 2006, TORRE LONDRA TEST VA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; Harboe E, 2009, BRAIN BEHAV IMMUN, V23, P1104, DOI 10.1016/j.bbi.2009.06.151; Harms L, 2012, Z RHEUMATOL, V71, P564, DOI 10.1007/s00393-012-0958-z; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Lafitte C, 2001, J NEUROL, V248, P577, DOI 10.1007/s004150170135; Le Guern V, 2010, ANN RHEUM DIS, V69, P132, DOI 10.1136/ard.2008.090811; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MALINOW KL, 1985, ANN INTERN MED, V103, P344, DOI 10.7326/0003-4819-103-3-344; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Martinez S, 2010, ACTA NEUROL SCAND, V122, P182, DOI 10.1111/j.1600-0404.2009.01293.x; Massara A, 2010, RHEUMATOLOGY, V49, P1540, DOI 10.1093/rheumatology/keq111; MAUCH E, 1994, ACTA NEUROL SCAND, V89, P31; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; Meyers J. E., 1995, REY COMPLEX FIGURE T; Nichelli P., 2002, NUOVA RIV NEUROLOGIA, V12, P37; Pavlakis PP, 2011, J NEUROL NEUROSUR PS, V82, P798, DOI 10.1136/jnnp.2010.222109; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Rabadi MH, 2010, J NEUROL NEUROSUR PS, V81, P213, DOI 10.1136/jnnp.2009.183913; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1958, MEMORISATION SERIE 1; Segal B, 2008, RHEUM DIS CLIN N AM, V34, P885, DOI 10.1016/j.rdc.2008.08.001; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Skopouli FN, 2000, SEMIN ARTHRITIS RHEU, V29, P296, DOI 10.1016/S0049-0172(00)80016-5; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vadacca M, 2008, REUMATISMO, V60, P50, DOI 10.4081/reumatismo.2008.50; van Leeuwen N, 2012, CLIN EXP RHEUMATOL, V30, P492; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	48	62	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84605	10.1371/journal.pone.0084605	http://dx.doi.org/10.1371/journal.pone.0084605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465419	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500019
J	Bouret, Y; Argentina, M; Counillon, L				Bouret, Yann; Argentina, Mederic; Counillon, Laurent			Capturing Intracellular pH Dynamics by Coupling Its Molecular Mechanisms within a Fully Tractable Mathematical Model	PLOS ONE			English	Article							CARBON-DIOXIDE HYDRATION; NA+/H+ EXCHANGER; NA/K PUMP; KINETICS; LACTATE; NHE-1; AE2; DISSOCIATION; GENERATION; TRANSPORT	We describe the construction of a fully tractable mathematical model for intracellular pH. This work is based on coupling the kinetic equations depicting the molecular mechanisms for pumps, transporters and chemical reactions, which determine this parameter in eukaryotic cells. Thus, our system also calculates the membrane potential and the cytosolic ionic composition. Such a model required the development of a novel algebraic method that couples differential equations for slow relaxation processes to steady-state equations for fast chemical reactions. Compared to classical heuristic approaches based on fitted curves and ad hoc constants, this yields significant improvements. This model is mathematically self-consistent and allows for the first time to establish analytical solutions for steady-state pH and a reduced differential equation for pH regulation. Because of its modular structure, it can integrate any additional mechanism that will directly or indirectly affect pH. In addition, it provides mathematical clarifications for widely observed biological phenomena such as overshooting in regulatory loops. Finally, instead of including a limited set of experimental results to fit our model, we show examples of numerical calculations that are extremely consistent with the wide body of intracellular pH experimental measurements gathered by different groups in many different cellular systems.	[Bouret, Yann] Univ Nice Sophia Antipolis, CNRS, LPMC, UMR 7336, F-06189 Nice, France; [Argentina, Mederic] Univ Nice Sophia Antipolis, CNRS, INLN, UMR 7335, Valbonne, France; [Argentina, Mederic] Minist Enseignement Super & Rech Sci, IUF, Paris, France; [Counillon, Laurent] Univ Nice Sophia Antipolis, CNRS, LP2M, FRE 3472, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Counillon, L (corresponding author), Univ Nice Sophia Antipolis, CNRS, LP2M, FRE 3472, F-06189 Nice, France.	laurent.counillon@unice.fr	Argentina, Mederic/AAR-8153-2021; Argentina, Mederic/AAQ-9236-2021; Argentina, Mederic/I-8741-2014	Argentina, Mederic/0000-0002-8926-7398; Argentina, Mederic/0000-0002-8926-7398	University of Nice-Sophia Antipolis; CNRS Bio Maths Info PEPS; INSERM "Physique-Cancer'' Program (H+ Cancer)	University of Nice-Sophia Antipolis; CNRS Bio Maths Info PEPS; INSERM "Physique-Cancer'' Program (H+ Cancer)	This work was supported by the University of Nice-Sophia Antipolis, the CNRS Bio Maths Info PEPS 2012 and the INSERM "Physique-Cancer'' Program (H+ Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boron WF, 2004, ADV PHYSIOL EDUC, V28, P128; Brett CL, 2006, FEBS LETT, V580, P717, DOI 10.1016/j.febslet.2005.12.103; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cavet ME, 1999, AM J PHYSL CELL PHYS, V277; Cha CY, 2009, BIOPHYS J, V97, P2674, DOI 10.1016/j.bpj.2009.08.053; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Eckhaus, 1979, ASYMPTOTIC ANAL SING; EIGEN M, 1958, PROC R SOC LON SER-A, V247, P505, DOI 10.1098/rspa.1958.0208; Falkenberg CV, 2010, BIOPHYS J, V98, P1476, DOI 10.1016/j.bpj.2009.11.045; GADSBY DC, 1989, J GEN PHYSIOL, V94, P511, DOI 10.1085/jgp.94.3.511; Haragus M, 2011, UNIVERSITEXT, P1, DOI 10.1007/978-0-85729-112-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JOHNSON KS, 1982, LIMNOL OCEANOGR, V27, P849, DOI 10.4319/lo.1982.27.5.0849; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; KHALIFAH RG, 1972, P NATL ACAD SCI USA, V69, P172, DOI 10.1073/pnas.69.1.172; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lacroix J, 2008, BIOCHEMISTRY-US, V47, P13674, DOI 10.1021/bi801368n; Marcinek DJ, 2010, J APPL PHYSIOL, V108, P1479, DOI 10.1152/japplphysiol.01189.2009; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Pattillo RE, 2005, J APPL PHYSIOL, V99, P822, DOI 10.1152/japplphysiol.00235.2005; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SCHWIENING CJ, 1992, J PHYSIOL-LONDON, V447, P693, DOI 10.1113/jphysiol.1992.sp019024; Sekler I, 1996, CELL, V86, P929, DOI 10.1016/S0092-8674(00)80168-3; Swietach P, 2005, BIOPHYS J, V88, P3018, DOI 10.1529/biophysj.104.051391; ten Hove M, 2003, MOL CELL BIOCHEM, V250, P47, DOI 10.1023/A:1024985931797; Touret N, 2003, EUR J PHARMACOL, V459, P151, DOI 10.1016/S0014-2999(02)02824-8; Webb SD, 1999, J THEOR BIOL, V196, P237, DOI 10.1006/jtbi.1998.0836; WU P, 1993, BIOTECHNOL PROGR, V9, P374, DOI 10.1021/bp00022a004; Yabuuchi H, 1998, PHARMACEUT RES, V15, P411, DOI 10.1023/A:1011920213991; Zaniboni M, 2003, AM J PHYSL HEART CIR, V285; Zhang Y, 1996, J BIOL CHEM, V271, P5741, DOI 10.1074/jbc.271.10.5741	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85449	10.1371/journal.pone.0085449	http://dx.doi.org/10.1371/journal.pone.0085449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465564	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000035
J	Chen, T; Zhou, T; He, B; Yu, HY; Guo, XJ; Song, XF; Sha, JH				Chen, Tong; Zhou, Tao; He, Bing; Yu, Haiyan; Guo, Xuejiang; Song, Xiaofeng; Sha, Jiahao			mUbiSiDa: A Comprehensive Database for Protein Ubiquitination Sites in Mammals	PLOS ONE			English	Article							PROTEOMICS APPROACH; IDENTIFICATION; SYSTEM; CELLS; DEGRADATION; CROSSTALK	Motivation: Protein ubiquitination is one of the important post-translational modifications by attaching ubiquitin to specific lysine (K) residues in target proteins, and plays important regulatory roles in many cell processes. Recent studies indicated that abnormal protein ubiquitination have been implicated in many diseases by degradation of many key regulatory proteins including tumor suppressor, oncoprotein, and cell cycle regulator. The detailed information of protein ubiquitination sites is useful for scientists to investigate the mechanism of many cell activities and related diseases. Results: In this study we established mUbiSida for mammalian Ubiquitination Site Database, which provides a scientific community with a comprehensive, freely and high-quality accessible resource of mammalian protein ubiquitination sites. In mUbiSida, we deposited about 35,494 experimentally validated ubiquitinated proteins with 110,976 ubiquitination sites from five species. The mUbiSiDa can also provide blast function to predict novel protein ubiquitination sites in other species by blast the query sequence in the deposit sequences in mUbiSiDa. The mUbiSiDa was designed to be a widely used tool for biologists and biomedical researchers with a user-friendly interface, and facilitate the further research of protein ubiquitination, biological networks and functional proteomics. The mUbiSiDa database is freely available at http://reprod.njmu.edu.cn/mUbiSiDa.	[Chen, Tong; He, Bing; Yu, Haiyan; Song, Xiaofeng] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China; [Zhou, Tao; Guo, Xuejiang; Sha, Jiahao] Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing Medical University	Guo, XJ (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China.	guo_xuejiang@njmu.edu.cn; xfsong@nuaa.edu.cn	Zhou, Tao/H-1094-2013; Guo, Xuejiang/J-9600-2014	Zhou, Tao/0000-0003-2219-6385; Guo, Xuejiang/0000-0002-0475-5705	National Key Basic Research Program Grant [2011CB944304]; National Natural Science Foundation of China [81222006, 61171191]; Natural Science Foundation of Jiangsu Province in China [BK2010500]	National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province in China(Natural Science Foundation of Jiangsu Province)	The study was supported by grants from National Key Basic Research Program Grant (2011CB944304), National Natural Science Foundation of China (81222006, 61171191) and Natural Science Foundation of Jiangsu Province in China (BK2010500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; Ciechanover A, 2000, J CELL BIOCHEM, P40; Denis NJ, 2007, PROTEOMICS, V7, P868, DOI 10.1002/pmic.200600410; Du YP, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar055; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Hagai T, 2012, MOL BIOSYST, V8, P1865, DOI 10.1039/c2mb25052g; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	27	47	48	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85744	10.1371/journal.pone.0085744	http://dx.doi.org/10.1371/journal.pone.0085744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465676	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000058
J	Ronsard, L; Lata, S; Singh, J; Ramachandran, VG; Das, S; Banerjea, AC				Ronsard, Larance; Lata, Sneh; Singh, Jyotsna; Ramachandran, Vishnampettai G.; Das, Shukla; Banerjea, Akhil C.			Molecular and Genetic Characterization of Natural HIV-1 Tat Exon-1 Variants from North India and Their Functional Implications	PLOS ONE			English	Article							SUBTYPE-C; TRANSACTIVATION ACTIVITY; VIRUS; PROTEIN; RNA; RECOMBINATION; EXPRESSION; INFECTION; SEQUENCE; TRIAL	Background: Designing an ideal vaccine against HIV-1 has been difficult due to enormous genetic variability as a result of high replication rate and lack of proofreading activity of reverse transcriptase leading to emergence of genetic variants and recombinants. Tat transactivates HIV-1 LTR, resulting in a remarkable increase in viral gene expression, and plays a vital role in pathogenesis. The aim of this study was to characterize the genetic variations of Tat exon-1 from HIV-1 infected patients from North India. Methods: Genomic DNA was isolated from PBMCs and Tat exon-1 was PCR amplified with specific primers followed by cloning, sequencing and sequence analyses using bioinformatic tools for predicting HIV-1 subtypes, recombination events, conservation of domains and phosphorylation sites, and LTR transactivation by luciferase assay. Results: Phylogenetic analysis of Tat exon-1 variants (n = 120) revealed sequence similarity with South African Tat C sequences and distinct geographical relationships were observed for B/C recombinants. Bootscan analysis of our variants showed 90% homology to Tat C and 10% to B/C recombinants with a precise breakpoint. Natural substitutions were observed with high allelic frequencies which may be beneficial for virus. High amino acid conservation was observed in Tat among Anti Retroviral Therapy (ART) recipients. Barring few changes, most of the functional domains, predicted motifs and phosphorylation sites were well conserved in most of Tat variants. dN/dS analysis revealed purifying selection, implying the importance of functional conservation of Tat exon-1. Our Indian Tat C variants and B/C recombinants showed differential LTR transactivation. Conclusions: The possible role of Tat exon-1 variants in shaping the current HIV-1 epidemic in North India was highlighted. Natural substitutions across conserved functional domains were observed and provided evidence for the emergence of B/C recombinants within the ORF of Tat exon-1. These events are likely to have implications for viral pathogenesis and vaccine formulations.	[Ronsard, Larance; Singh, Jyotsna; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi 110067, India; [Ronsard, Larance; Lata, Sneh; Singh, Jyotsna; Ramachandran, Vishnampettai G.; Das, Shukla] Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India; [Ronsard, Larance; Lata, Sneh; Singh, Jyotsna; Ramachandran, Vishnampettai G.; Das, Shukla] Guru Teg Bahadur Hosp, Delhi 110095, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences	Banerjea, AC (corresponding author), Natl Inst Immunol, Virol Lab, New Delhi 110067, India.	akhil@nii.res.in	Singh, Jaikaran/O-5363-2015; Ronsard, Larance/H-2731-2019	Singh, Jaikaran/0000-0002-9273-6765; Ronsard, Larance/0000-0002-5307-1940	Department of Biotechnology [BT/PR10599/Med/29/76/2008]; Indian Council of Medical Research, Government of India [HIV/50/142/9/2011-ECD-II]; National Institute of Immunology, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); National Institute of Immunology, New Delhi, India	This study was supported by the Department of Biotechnology (BT/PR10599/Med/29/76/2008) and the Indian Council of Medical Research (HIV/50/142/9/2011-ECD-II), Government of India, to the corresponding author, National Institute of Immunology, New Delhi, India, for the period of 3 years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BUONAGURO L, 1994, J VIROL, V68, P2677, DOI 10.1128/JVI.68.4.2677-2682.1994; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Campbell GR, 2004, J BIOL CHEM, V279, P48197, DOI 10.1074/jbc.M406195200; CHANG HK, 1994, GENE THER, V1, P208; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; Endo-Munoz L, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-17; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Goldstein G, 1996, NAT MED, V2, P960, DOI 10.1038/nm0996-960; Gupta N, 2009, AIDS, V23, P141, DOI 10.1097/QAD.0b013e32831c8b08; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Hinkula J, 1997, J VIROL, V71, P5528, DOI 10.1128/JVI.71.7.5528-5539.1997; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; JUNGHANS RP, 1982, CELL, V30, P53, DOI 10.1016/0092-8674(82)90011-3; Kim DT, 1997, J IMMUNOL, V159, P1666; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lakhashe S, 2008, J BIOSCIENCES, V33, P515, DOI 10.1007/s12038-008-0070-3; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lata S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082128; Li L, 2012, ADV VIROL, V2012, DOI 10.1155/2012/123605; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; Mohankumar K, 2013, CHEM BIOL INTERACT; Monaco DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017185; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Mullick R, 2010, VIRUS RES, V147, P195, DOI 10.1016/j.virusres.2009.10.024; Neogi U, 2011, INDIAN J MED RES, V134, P769, DOI 10.4103/0971-5916.92624; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reza SM, 2003, J VIROL, V77, P8602, DOI 10.1128/JVI.77.15.8602-8606.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rodriguez MA, 2009, VIROLOGY, V385, P416, DOI 10.1016/j.virol.2008.12.025; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Sood V, 2008, AIDS, V22, P1683, DOI 10.1097/QAD.0b013e3282f56114; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan RY, 1998, P NATL ACAD SCI USA, V95, P4247, DOI 10.1073/pnas.95.8.4247; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathy SP, 2005, AIDS RES HUM RETROV, V21, P152, DOI 10.1089/aid.2005.21.152; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059283; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zheng Lin, 2005, J Zhejiang Univ Sci B, V6, P668, DOI 10.1631/jzus.2005.B0668	70	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85452	10.1371/journal.pone.0085452	http://dx.doi.org/10.1371/journal.pone.0085452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465566	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000015
J	Li, L; Li, A; Hao, BB; Guan, ZD; Zhu, TS				Li, Lin; Li, Ang; Hao, Bibo; Guan, Zengda; Zhu, Tingshao			Predicting Active Users' Personality Based on Micro-Blogging Behaviors	PLOS ONE			English	Article							INTERNET; FACEBOOK	Because of its richness and availability, micro-blogging has become an ideal platform for conducting psychological research. In this paper, we proposed to predict active users' personality traits through micro-blogging behaviors. 547 Chinese active users of micro-blogging participated in this study. Their personality traits were measured by the Big Five Inventory, and digital records of micro-blogging behaviors were collected via web crawlers. After extracting 845 micro-blogging behavioral features, we first trained classification models utilizing Support Vector Machine (SVM), differentiating participants with high and low scores on each dimension of the Big Five Inventory. The classification accuracy ranged from 84% to 92%. We also built regression models utilizing PaceRegression methods, predicting participants' scores on each dimension of the Big Five Inventory. The Pearson correlation coefficients between predicted scores and actual scores ranged from 0.48 to 0.54. Results indicated that active users' personality traits could be predicted by micro-blogging behaviors.	[Li, Lin; Li, Ang; Hao, Bibo; Guan, Zengda; Zhu, Tingshao] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Li, Lin; Li, Ang; Hao, Bibo; Guan, Zengda] Univ Chinese Acad Sci, Sch Comp & Control, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, TS (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	tszhu@psych.ac.cn	Hao, Bibo/X-8485-2019; Hao, Bibo/I-2476-2013	Hao, Bibo/0000-0003-1138-8365; Hao, Bibo/0000-0003-1138-8365; Li, Ang/0000-0002-9222-3521; Zhu, Tingshao/0000-0003-0020-3812	Key Research Program of CAS [KJZD-EW-L04]; Strategic Priority Research Program [XDA06030800]; National Basic Research Program of China [2014CB744600]	Key Research Program of CAS; Strategic Priority Research Program(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by Key Research Program of CAS (KJZD-EW-L04), Strategic Priority Research Program (XDA06030800) and National Basic Research Program of China (2014CB744600). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichai-Hamburger Y, 2002, COMPUT HUM BEHAV, V18, P1, DOI 10.1016/S0747-5632(01)00034-6; Anastasi A., 1997, PSYCHOL TESTING; [Anonymous], 1992, J Pers, V60, P175; Blackman MC, 1998, J EXP SOC PSYCHOL, V34, P164, DOI 10.1006/jesp.1997.1347; BORKENAU P, 1992, J PERS SOC PSYCHOL, V62, P645, DOI 10.1037/0022-3514.62.4.645; Buchanan T, 1999, BRIT J PSYCHOL, V90, P125, DOI 10.1348/000712699161189; Burger J.M., 2008, PERSONALITY, V7th; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Cattell H.E.P., 2003, ESSENTIALS 16PF ASSE; Chen X., 2008, EMPIRICAL METHODS OR; Costa PT, 2007, REVISED NEO PERSONAL; Domino G., 2006, PSYCHOL TESTING INTR, V2nd ed; Egger O, 1996, AP0196 SWISS FED I T; Golbeck J, 2011, P CHI 11 HUM FACT CO; Golbeck J, 2011, P PRIV SEC RISK TRUS; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Gosling SD, 2011, CYBERPSYCH BEH SOC N, V14, P483, DOI 10.1089/cyber.2010.0087; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hamburger YA, 2000, COMPUT HUM BEHAV, V16, P441, DOI 10.1016/S0747-5632(00)00017-0; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Kwak N, 2002, IEEE T NEURAL NETWOR, V13, P143, DOI 10.1109/72.977291; LaValle SM, 2004, INT J ROBOT RES, V23, P673, DOI 10.1177/0278364904045481; Marcus B, 2006, J PERS SOC PSYCHOL, V90, P1014, DOI 10.1037/0022-3514.90.6.1014; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Mehdizadeh S, 2010, CYBERPSYCH BEH SOC N, V13, P357, DOI 10.1089/cyber.2009.0257; Nowson S, 2007, P INT C WEBL SOC; Orr ES, 2009, CYBERPSYCHOL BEHAV, V12, P337, DOI 10.1089/cpb.2008.0214; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; PARK SJ, 2013, ASIAN WOMEN, V29, P1; Qiu L, 2010, STUD HEALTH TECHNOL, V154, P140, DOI 10.3233/978-1-60750-561-7-140; Quercia D, 2011, 2011 IEEE 3 INT C 20; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Wang Y, 2000, THESIS U WAIKATO HAM; Yee N, 2011, SOC PSYCHOL PERS SCI, V2, P5, DOI 10.1177/1948550610379056; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	36	33	37	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84997	10.1371/journal.pone.0084997	http://dx.doi.org/10.1371/journal.pone.0084997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465462	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100019
J	Vleeschouwer, M; Schubart, CD; Henquet, C; Myin-Germeys, I; van Gastel, WA; Hillegers, MHJ; van Os, JJ; Boks, MPM; Derks, EM				Vleeschouwer, Marloes; Schubart, Chris D.; Henquet, Cecile; Myin-Germeys, Inez; van Gastel, Willemijn A.; Hillegers, Manon H. J.; van Os, Jim J.; Boks, Marco P. M.; Derks, Eske M.			Does Assessment Type Matter? A Measurement Invariance Analysis of Online and Paper and Pencil Assessment of the Community Assessment of Psychic Experiences (CAPE)	PLOS ONE			English	Article							PSYCHOTIC EXPERIENCES; PERSONALITY TESTS; SELF-ESTEEM; INTERNET; QUESTIONNAIRES; INDIVIDUALS; PERSISTENCE; INSTRUMENT; CONTINUUM; VERSIONS	Background: The psychometric properties of an online test are not necessarily identical to its paper and pencil original. The aim of this study is to test whether the factor structure of the Community Assessment of Psychic Experiences (CAPE) is measurement invariant with respect to online vs. paper and pencil assessment. Method: The factor structure of CAPE items assessed by paper and pencil (N = 796) was compared with the factor structure of CAPE items assessed by the Internet (N = 21,590) using formal tests for Measurement Invariance (MI). The effect size was calculated by estimating the Signed Item Difference in the Sample (SIDS) index and the Signed Test Difference in the Sample (STDS) for a hypothetical subject who scores 2 standard deviations above average on the latent dimensions. Results: The more restricted Metric Invariance model showed a significantly worse fit compared to the less restricted Configural Invariance model (chi(2)(23) = 152.75, p<0.001). However, the SIDS indices appear to be small, with an average of -0.11. A STDS of -4.80 indicates that Internet sample members who score 2 standard deviations above average would be expected to score 4.80 points lower on the CAPE total scale (ranging from 42 to 114 points) than would members of the Paper sample with the same latent trait score. Conclusions: Our findings did not support measurement invariance with respect to assessment method. Because of the small effect sizes, the measurement differences between the online assessed CAPE and its paper and pencil original can be neglected without major consequences for research purposes. However, a person with a high vulnerability for psychotic symptoms would score 4.80 points lower on the total scale if the CAPE is assessed online compared to paper and pencil assessment. Therefore, for clinical purposes, one should be cautious with online assessment of the CAPE.	[Vleeschouwer, Marloes; Schubart, Chris D.; van Gastel, Willemijn A.; Hillegers, Manon H. J.; Boks, Marco P. M.; Derks, Eske M.] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Derks, Eske M.] Acad Med Ctr Amsterdam, Dept Psychiat, Amsterdam, Netherlands; [Henquet, Cecile; Myin-Germeys, Inez; van Os, Jim J.] Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Vleeschouwer, M (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	M.Vleeschouwer@umcutrecht.nl	Derks, Eske M/A-1652-2017; Myin Germeys, Inez/HIR-3364-2022; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Myin-Germeys, Inez/L-5106-2014; hillegers, manon h.j./L-6794-2016; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Derks, Eske M/0000-0002-6292-6883; Myin Germeys, Inez/0000-0002-3731-4930; van Os, Jim/0000-0002-7245-1586; hillegers, manon h.j./0000-0003-4877-282X; Boks, Marco/0000-0001-6163-7484	Netherlands Scientific Organization (NWO) [451-080-010]	Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is supported by the Netherlands Scientific Organization (NWO; project number 451-080-010; PI E. M. Derks). No funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2003, J PSYCHOSOM RES, V55, P259, DOI 10.1016/S0022-3999(02)00575-5; Asparouhov T., 2006, MATRIX, V1, P1, DOI DOI 10.1177/0013164416683754; Bartram D, 2005, J APPL PSYCHOL, V90, P1185, DOI 10.1037/0021-9010.90.6.1185; Bartram D, 2006, COMPUTER-BASED TESTING AND THE INTERNET: ISSUES AND ADVANCES, P13; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bollen K. A., 1993, TESTING STRUCTURAL E; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Boonstra N, 2009, EARLY INTERV PSYCHIA, V3, P289, DOI 10.1111/j.1751-7893.2009.00147.x; Brenner K, 2007, SCHIZOPHR RES, V95, P86, DOI 10.1016/j.schres.2007.06.017; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buchanan T, 2005, BEHAV RES METHODS, V37, P148, DOI 10.3758/BF03206409; Buchanan Tom, 2003, Cognitive Behaviour Therapy, V32, P100, DOI 10.1080/16506070310000957; Buchanan T, 2010, BEHAV RES METHODS, V42, P709, DOI 10.3758/BRM.42.3.709; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Coles ME, 2007, BEHAV RES THER, V45, P2232, DOI 10.1016/j.brat.2006.12.009; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Cronk BC, 2002, BEHAV RES METH INS C, V34, P177, DOI 10.3758/BF03195440; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Hanssen M, 2003, SOC PSYCH PSYCH EPID, V38, P149, DOI 10.1007/s00127-003-0622-7; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Meade AW, 2007, ORGAN RES METHODS, V10, P322, DOI 10.1177/1094428106289393; Meade AW, 2010, J APPL PSYCHOL, V95, P728, DOI 10.1037/a0018966; Meade AW, 2004, STRUCT EQU MODELING, V11, P60, DOI 10.1207/S15328007SEM1101_5; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Meyerson P, 2003, BEHAV RES METH INS C, V35, P614, DOI 10.3758/BF03195541; Mossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008; Musch J., 2000, PSYCHOL EXPT INTERNE, P61, DOI [DOI 10.1016/B978-012099980-4/50004-6, 10.1016/B978-012099980-4/50004-6]; Muthen B., 2010, MPLUS USERS GUIDE; MuthUn B., 2002, MPLUS WEB NOTES, V4, P4, DOI DOI 10.1007/S10519-008-9237-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schubart CD, 2011, PSYCHOL MED, V41, P1301, DOI 10.1017/S003329171000187X; Schubart CD, 2011, ACTA PSYCHIAT SCAND, V123, P368, DOI 10.1111/j.1600-0447.2010.01640.x; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Spauwen J, 2003, SCHIZOPHR RES, V62, P45, DOI 10.1016/S0920-9964(03)00063-X; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Thewissen V, 2008, J ABNORM PSYCHOL, V117, P143, DOI 10.1037/0021-843X.117.1.143; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Vandenberg RJ, 2002, ORGAN RES METHODS, V5, P139, DOI 10.1177/1094428102005002001; Vecchione M, 2012, ASSESSMENT, V19, P243, DOI 10.1177/1073191111419091; Vispoel WP, 2001, EDUC PSYCHOL MEAS, V61, P461, DOI 10.1177/00131640121971329; Wu RC, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1106	47	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84011	10.1371/journal.pone.0084011	http://dx.doi.org/10.1371/journal.pone.0084011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465389	Green Submitted, gold, Green Published			2022-12-27	WOS:000330283100010
J	Zhao, J; Zhao, P; Weng, XC; Li, S				Zhao, Jing; Zhao, Pei; Weng, Xuchu; Li, Su			Do Preschool Children Learn to Read Words from Environmental Prints?	PLOS ONE			English	Article							HOME LITERACY ENVIRONMENT; CHINESE; INTERVENTION	Parents and teachers worldwide believe that a visual environment rich with print can contribute to young children's literacy. Children seem to recognize words in familiar logos at an early age. However, most of previous studies were carried out with alphabetic scripts. Alphabetic letters regularly correspond to phonological segments in a word and provide strong cues about the identity of the whole word. Thus it was not clear whether children can learn to read words by extracting visual word form information from environmental prints. To exclude the phonological-cue confound, this study tested children's knowledge of Chinese words embedded in familiar logos. The four environmental logos were employed and transformed into four versions with the contextual cues (i.e., something apart from the presentation of the words themselves in logo format like the color, logo and font type cues) gradually minimized. Children aged from 3 to 5 were tested. We observed that children of different ages all performed better when words were presented in highly familiar logos compared to when they were presented in a plain fashion, devoid of context. This advantage for familiar logos was also present when the contextual information was only partial. However, the role of various cues in learning words changed with age. The color and logo cues had a larger effect in 3- and 4-year-olds than in 5-year-olds, while the font type cue played a greater role in 5-year-olds than in the other two groups. Our findings demonstrated that young children did not easily learn words by extracting their visual form information even from familiar environmental prints. However, children aged 5 begin to pay more attention to the visual form information of words in highly familiar logos than those aged 3 and 4.	[Zhao, Jing; Zhao, Pei; Li, Su] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhao, Jing; Weng, Xuchu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zhao, Jing; Weng, Xuchu] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Hangzhou Normal University	Li, S (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	lis@psych.ac.cn	zhao, jing/B-3868-2019	li, su/0000-0002-8604-8181	National Science Foundation of China [31271109, 31070905]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (31271109, 31070905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, HDB READING RES; Burgess SR, 2002, READ RES QUART, V37, P408, DOI 10.1598/RRQ.37.4.4; BUS AG, 1995, REV EDUC RES, V65, P1, DOI 10.3102/00346543065001001; Cronin V, 1999, J RES READ, V22, P271, DOI DOI 10.1111/1467-9817; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; DeLoache JS, 2010, PSYCHOL SCI, V21, P1570, DOI 10.1177/0956797610384145; DUNNING DB, 1994, DEV REV, V14, P324, DOI 10.1006/drev.1994.1012; Evans MA, 2009, CHILD DEV, V80, P1824, DOI 10.1111/j.1467-8624.2009.01370.x; Ho CSH, 2007, J EXP CHILD PSYCHOL, V97, P61, DOI 10.1016/j.jecp.2007.01.002; Kuby P., 1994, READ PSYCHOL, V15, P1, DOI [10.1080/0270271940150101, DOI 10.1080/0270271940150101, https://doi.org/10.1080/0270271940150101]; Marulis LM, 2010, REV EDUC RES, V80, P300, DOI 10.3102/0034654310377087; MASONHEIMER PE, 1984, J READING BEHAV, V16, P257, DOI 10.1080/10862968409547520; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; MCGEE LM, 1988, J READING BEHAV, V20, P99, DOI 10.1080/10862968809547629; Oliver BR, 2005, PSYCHOL SCI, V16, P861, DOI 10.1111/j.1467-9280.2005.01627.x; PAYNE AC, 1994, EARLY CHILD RES Q, V9, P427, DOI 10.1016/0885-2006(94)90018-3; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Peterson C, 1999, J CHILD LANG, V26, P49, DOI 10.1017/S0305000998003651; SCARBOROUGH HS, 1994, DEV REV, V14, P245, DOI 10.1006/drev.1994.1010; Snow Catherine, 1968, EMERGENT LITERACY WR, P116; SULZBY E, 1985, READ RES QUART, V20, P458, DOI 10.1598/RRQ.20.4.4; Tan LH, 2005, P NATL ACAD SCI USA, V102, P8781, DOI 10.1073/pnas.0503523102; Treiman R, 1998, CHILD DEV, V69, P1524, DOI 10.1111/j.1467-8624.1998.tb06175.x; Whitehurst GJ, 1998, CHILD DEV, V69, P848, DOI 10.2307/1132208; WHITEHURST GJ, 1988, DEV PSYCHOL, V24, P552, DOI 10.1037/0012-1649.24.4.552; WHITEHURST GJ, 1994, J EDUC PSYCHOL, V86, P542, DOI 10.1037/0022-0663.86.4.542; Yeh SL, 2002, J EXP PSYCHOL HUMAN, V28, P933, DOI 10.1037//0096-1523.28.4.933; Yin L, 2013, J EXP CHILD PSYCHOL, V116, P199, DOI 10.1016/j.jecp.2013.05.010	28	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85745	10.1371/journal.pone.0085745	http://dx.doi.org/10.1371/journal.pone.0085745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465677	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100067
J	Misailidi, M; Tzatzarakis, MN; Kavvalakis, MP; Koutedakis, Y; Tsatsakis, AM; Flouris, AD				Misailidi, Maria; Tzatzarakis, Manolis N.; Kavvalakis, Mathaios P.; Koutedakis, Yiannis; Tsatsakis, Aristidis M.; Flouris, Andreas D.			Instruments to Assess Secondhand Smoke Exposure in Large Cohorts of Never Smokers: The Smoke Scales	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; HAIR NICOTINE; SEGMENTAL ANALYSIS; CIGARETTE-SMOKING; COTININE LEVELS; PREGNANT-WOMEN; SERUM COTININE; SELF-REPORT; CHILDREN; HEALTH	The objectives of this study were to: (i) to develop questionnaires that can identify never-smoking children and adults experiencing increased exposure to secondhand smoke (SHS+), (ii) to determine their validity against hair nicotine, and (iii) assess their reliability. A sample of 191 children (85 males; 106 females; 7-18 years) and 95 adult (23 males; 72 females; 1862 years) never-smokers consented to hair nicotine analysis and answered a large number of questions assessing all sources of SHS. A randomly-selected 30% answered the questions again after 20-30 days. Prevalence of SHS+ in children and adults was 0.52 +/- 0.07 and 0.67 +/- 0.10, respectively (p<0.05). The Smoke Scale for Children (SS-C) and the Smoke Scale for Adults (SS-A) were developed via factor analysis and included nine questions each. Positivity criteria for SS-C and SS-A via receiver operating characteristics curve analysis were identified at >16.5 and >16, respectively. Significant Kappa agreement (p<0.05) was confirmed when comparing the SS-C and SS-A to hair nicotine concentration. Reliability analyses demonstrated that the SS-C and SS-A scores obtained on two different days are highly correlated (p<0.001) and not significantly different (p>0.05). Area under the curve and McNemar's Chi-square showed no pair-wise differences in sensitivity and specificity at the cutoff point between the two different days for SS-C and SS-A (p>0.05). We conclude that the SS-C and the SS-A represent valid, reliable, practical, and inexpensive instruments to identify children and adult never-smokers exposed to increased SHS. Future research should aim to further increase the validity of the two questionnaires.	[Misailidi, Maria; Flouris, Andreas D.] Ctr Res & Technol Hellas, FAME Lab, Trikala, Greece; [Misailidi, Maria; Koutedakis, Yiannis] Univ Thessaly, Dept Exercise Sci, Trikala, Greece; [Misailidi, Maria] Reg Directorate Primary & Secondary Educ Western, Patras, Greece; [Tzatzarakis, Manolis N.; Kavvalakis, Mathaios P.; Tsatsakis, Aristidis M.] Univ Crete, Sch Med, Ctr Toxicol Sci & Res, Iraklion, Greece; [Koutedakis, Yiannis] Wolverhampton Univ, Sch Sports Performing Arts & Leisure, Walsall, W Midlands, England	Centre for Research & Technology Hellas; University of Thessaly; University of Crete; University of Wolverhampton	Flouris, AD (corresponding author), Ctr Res & Technol Hellas, FAME Lab, Trikala, Greece.	aflouris@ireteth.certh.gr	Tsatsakis, Aristidis M./H-2890-2013; Flouris, Andreas/GXG-4893-2022; Flouris, Andreas/I-5930-2014	Tsatsakis, Aristidis M./0000-0003-3824-2462; Flouris, Andreas/0000-0002-9823-3915; Koutedakis, Yiannis/0000-0002-7065-9447; Kavvalakis, Matthaios/0000-0003-3033-6165				Al-Delaimy W. K., 2002, Journal of Epidemiology and Community Health, V56, P66, DOI 10.1136/jech.56.1.66; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bernert JT, 2000, J ANAL TOXICOL, V24, P333, DOI 10.1093/jat/24.5.333; Boyd N R, 1998, Matern Child Health J, V2, P77, DOI 10.1023/A:1022936705438; Brajenovic N, 2013, ARCH ENVIRON OCCUP H, V68, P117, DOI 10.1080/19338244.2012.658121; Britton GRA, 2004, JOGNN-J OBST GYN NEO, V33, P306, DOI 10.1177/0884217504264866; Callais F, 2003, PREV MED, V36, P108, DOI 10.1006/pmed.2002.1132; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Carrillo Andres E., 2009, Inflammation & Allergy Drug Targets, V8, P359; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinas PC, 2011, INT J CARDIOL; Directorate General Health and Consumers, 2010, SPEC EUR 332 WAV 72; DWYER AJ, 1991, RADIOLOGY, V178, P328, DOI 10.1148/radiology.178.2.1987587; Eisner Mark D, 2005, Environ Health, V4, P7, DOI 10.1186/1476-069X-4-7; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; EMMONS KM, 1994, PREV MED, V23, P35, DOI 10.1006/pmed.1994.1005; Faught Brent E., 2009, Inflammation & Allergy Drug Targets, V8, P321; Florescu A, 2007, THER DRUG MONIT, V29, P437, DOI 10.1097/FTD.0b013e318074df6e; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Flouris AD, 2008, INT J OBESITY, V32, P1506, DOI 10.1038/ijo.2008.142; Flouris AD, 2005, BRIT J SPORT MED, V39, P166, DOI 10.1136/bjsm.2004.012500; Flouris AD, 2004, J SCI MED SPORT, V7, P197, DOI 10.1016/S1440-2440(04)80009-4; Flouris AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031880; Flouris AD, 2010, HEART, V96, P860, DOI 10.1136/hrt.2009.190744; Flouris Andreas D., 2009, Inflammation & Allergy Drug Targets, V8, P319; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Flouris AD, 2008, J CHILD HEALTH CARE, V12, P221, DOI 10.1177/1367493508092509; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gorsuch R., 1983, FACTOR ANAL; Jaakkola MS, 1997, EUR RESPIR J, V10, P2384, DOI 10.1183/09031936.97.10102384; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; Kidwell DA, 1995, NIDA RES MONOGRAPH H, P19; Kim SR, 2009, BIOMED CHROMATOGR, V23, P273, DOI 10.1002/bmc.1110; Koren G, 2008, THER DRUG MONIT, V30, P246, DOI 10.1097/FTD.0b013e318167d05b; Llaquet H, 2010, ANAL BIOANAL CHEM, V396, P379, DOI 10.1007/s00216-009-2831-8; Metsios GS, 2007, J CLIN ENDOCR METAB, V92, P208, DOI 10.1210/jc.2006-0762; Metsios GS, 2009, INFLAMM ALLERGY DRUG, V8; Misailidi M, 2012, ARCH HELL MED, V29, P174; NAFSTAD P, 1995, INT J EPIDEMIOL, V24, P88, DOI 10.1093/ije/24.1.88; Nondahl DM, 2005, ENVIRON RES, V97, P76, DOI 10.1016/j.envres.2004.02.005; Oberg M, 2010, GLOBAL ESTIMATE BURD; OConnor TZ, 1995, AM J EPIDEMIOL, V142, P1315, DOI 10.1093/oxfordjournals.aje.a117599; Olivieri M, 2002, ARCH ENVIRON HEALTH, V57, P355, DOI 10.1080/00039890209601421; Pichini S, 2003, J EXPO ANAL ENV EPID, V13, P144, DOI 10.1038/sj.jea.7500264; Pitsavos C, 2002, TOB CONTROL, V11, P220, DOI 10.1136/tc.11.3.220; Preacher K. J., 2003, UNDERSTANDING STAT, V2, P13, DOI DOI 10.1207/S15328031US0201_02; Sandhu S, 2004, ORAL ONCOL, V40, P576, DOI 10.1016/j.oraloncology.2003.11.006; Tzatzarakis MN, 2012, HUM EXP TOXICOL, V31, P258, DOI 10.1177/0960327111422401; U.S. Environmental Protection Agency, 1992, US EPA MON, V4, p[44, 270, 232]; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Webb David A, 2003, J Public Health Manag Pract, V9, P322; Woodruff SI, 2007, AM J HEALTH PROMOT, V22, P93, DOI 10.4278/0890-1171-22.2.93; World Health Organization, 2011, REP GLOB TOB EP WARN; Zhou X, 2002, STAT METHODS DIAGNOS, P185	56	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85809	10.1371/journal.pone.0085809	http://dx.doi.org/10.1371/journal.pone.0085809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465719	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500117
J	Potter, CS; Wang, Z; Silva, KA; Kennedy, VE; Stearns, TM; Burzenski, L; Shultz, LD; HogenEsch, H; Sundberg, JP				Potter, Christopher S.; Wang, Zhe; Silva, Kathleen A.; Kennedy, Victoria E.; Stearns, Timothy M.; Burzenski, Lisa; Shultz, Leonard D.; HogenEsch, Harm; Sundberg, John P.			Chronic Proliferative Dermatitis in Sharpin Null Mice: Development of an Autoinflammatory Disease in the Absence of B and T Lymphocytes and IL4/IL13 Signaling	PLOS ONE			English	Article							ATOPIC-DERMATITIS; INCREASED EXPRESSION; SKIN-DISEASE; IL-4; INFLAMMATION; CPDM/CPDM; APOPTOSIS; PHENOTYPE; COMPONENT; CYTOKINES	SHARPIN is a key regulator of NFKB and integrin signaling. Mice lacking Sharpin develop a phenotype known as chronic proliferative dermatitis (CPDM), typified by progressive epidermal hyperplasia, apoptosis of keratinocytes, cutaneous and systemic eosinophilic inflammation, and hypoplasia of secondary lymphoid organs. Rag1(-/-) mice, which lack mature B and T cells, were crossed with Sharpin(-/-) mice to examine the role of lymphocytes in CDPM. Although inflammation in the lungs, liver, and joints was reduced in these double mutant mice, dermatitis was not reduced in the absence of functional lymphocytes, suggesting that lymphocytes are not primary drivers of the inflammation in the skin. Type 2 cytokine expression is increased in CPDM. In an attempt to reduce this aspect of the phenotype, Il4ra(-/-) mice, unresponsive to both IL4 and IL13, were crossed with Sharpin(-/-) mice. Double homozygous Sharpin(-/-), Il4ra(-/-) mice developed an exacerbated granulocytic dermatitis, acute system inflammation, as well as hepatic necrosis and mineralization. High expression of CHI3L4, normally seen in CPDM skin, was abolished in Sharpin(-/-), Il4ra(-/-) double mutant mice indicating the crucial role of IL4 and IL13 in the expression of this protein. Cutaneous eosinophilia persisted in Sharpin(-/-), Il4ra(-/-) mice, although expression of Il5 mRNA was reduced and the expression of Ccl11 and Ccl24 was completely abolished. TSLP and IL33 were both increased in the skin of Sharpin(-/-) mice and this was maintained in Sharpin(-/-), Il4ra(-/-) mice suggesting a role for TSLP and IL33 in the eosinophilic dermatitis in SHARPIN-deficient mice. These studies indicate that cutaneous inflammation in SHARPIN-deficient mice is autoinflammatory in nature developing independently of B and T lymphocytes, while the systemic inflammation seen in CPDM has a strong lymphocyte-dependent component. Both the cutaneous and systemic inflammation is enhanced by loss of IL4 and IL13 signaling indicating that these cytokines normally play an anti-inflammatory role in SHARPIN-deficient mice.	[Potter, Christopher S.; Silva, Kathleen A.; Kennedy, Victoria E.; Stearns, Timothy M.; Burzenski, Lisa; Shultz, Leonard D.; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wang, Zhe; HogenEsch, Harm; Sundberg, John P.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Jackson Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org	Wang, Zhe/O-6663-2016; Wang, Zhe/N-6846-2015	Stearns, Timothy/0000-0002-5533-6076; HogenEsch, Harm/0000-0002-2738-9189	National Institutes of Health [AR49288]; National Cancer Institute [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institutes of Health (AR49288)(http://www.nih.gov/). Core facilities at The Jackson Laboratory were supported by the National Cancer Institute (CA034196)(http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Carey GB, 2007, CELL RES, V17, P942, DOI 10.1038/sj.cr.2007.90; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; GAUTAM S, 1992, J IMMUNOL, V148, P1725; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIJBELS MJJ, 1995, J INVEST DERMATOL, V105, P769, DOI 10.1111/1523-1747.ep12325599; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Hwang H, 2007, J BIOCHEM MOL BIOL, V40, P36; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Mikaelian I, 2004, TOXICOL PATHOL, V32, P181, DOI 10.1080/01926230490274335; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Renninger ML, 2005, EXP DERMATOL, V14, P906, DOI 10.1111/j.1600-0625.2005.00378.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Seymour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055224; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; Silva K, 2012, LAB MOUSE, P779; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sundberg JP, 2008, MAMM GENOME, V19, P413, DOI 10.1007/s00335-008-9123-z; TEVELDE AA, 1990, BLOOD, V76, P1392; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Wang Z, 2012, J CELL MOL MED, V16, P2271, DOI 10.1111/j.1582-4934.2012.01574.x; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031809; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Yagi R, 2002, J IMMUNOL, V168, P2020, DOI 10.4049/jimmunol.168.4.2020; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503	49	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85666	10.1371/journal.pone.0085666	http://dx.doi.org/10.1371/journal.pone.0085666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465642	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500088
J	Seki, T; Yuasa, S; Kusumoto, D; Kunitomi, A; Saito, Y; Tohyama, S; Yae, K; Kishino, Y; Okada, M; Hashimoto, H; Takei, M; Egashira, T; Kodaira, M; Kuroda, Y; Tanaka, A; Okata, S; Suzuki, T; Murata, M; Fujita, J; Fukuda, K				Seki, Tomohisa; Yuasa, Shinsuke; Kusumoto, Dai; Kunitomi, Akira; Saito, Yuki; Tohyama, Shugo; Yae, Kojiro; Kishino, Yoshikazu; Okada, Marina; Hashimoto, Hisayuki; Takei, Makoto; Egashira, Toru; Kodaira, Masaki; Kuroda, Yusuke; Tanaka, Atsushi; Okata, Shinichiro; Suzuki, Tomoyuki; Murata, Mitsushige; Fujita, Jun; Fukuda, Keiichi			Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DIFFERENTIATION; CALCIUM; MODELS	Induced pluripotent stem cells (iPSCs) have been proposed as novel cell sources for genetic disease models and revolutionary clinical therapies. Accordingly, human iPSC-derived cardiomyocytes are potential cell sources for cardiomyocyte transplantation therapy. We previously developed a novel generation method for human peripheral T cell-derived iPSCs (TiPSCs) that uses a minimally invasive approach to obtain patient cells. However, it remained unknown whether TiPSCs with genomic rearrangements in the T cell receptor (TCR) gene could differentiate into functional cardiomyocyte in vitro. To address this issue, we investigated the morphology, gene expression pattern, and electrophysiological properties of TiPSC-derived cardiomyocytes differentiated by floating culture. RT-PCR analysis and immunohistochemistry showed that the TiPSC-derived cardiomyocytes properly express cardiomyocyte markers and ion channels, and show the typical cardiomyocyte morphology. Multiple electrode arrays with application of ion channel inhibitors also revealed normal electrophysiological responses in the TiPSC-derived cardiomyocytes in terms of beating rate and the field potential waveform. In this report, we showed that TiPSCs successfully differentiated into cardiomyocytes with morphology, gene expression patterns, and electrophysiological features typical of native cardiomyocytes. TiPSCs-derived cardiomyocytes obtained from patients by a minimally invasive technique could therefore become disease models for understanding the mechanisms of cardiac disease and cell sources for revolutionary cardiomyocyte therapies.	[Seki, Tomohisa; Yuasa, Shinsuke; Kusumoto, Dai; Kunitomi, Akira; Saito, Yuki; Tohyama, Shugo; Yae, Kojiro; Kishino, Yoshikazu; Okada, Marina; Hashimoto, Hisayuki; Takei, Makoto; Egashira, Toru; Kodaira, Masaki; Kuroda, Yusuke; Tanaka, Atsushi; Okata, Shinichiro; Suzuki, Tomoyuki; Murata, Mitsushige; Fujita, Jun; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Seki, Tomohisa; Tohyama, Shugo] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Keio University; Japan Society for the Promotion of Science	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.	kfukuda@a2.keio.jp	Seki, Tomohisa/L-3524-2013; Fukuda, Keiichi/L-3777-2013; Hashimoto, Hisayuki/AAS-1938-2020	Hashimoto, Hisayuki/0000-0001-7367-4805; Yuasa, Shinsuke/0000-0001-5593-7552; Kishino, Yoshikazu/0000-0003-3291-2795; Saito, Yuki/0000-0003-2686-9604; Kodaira, Masaki/0000-0002-7293-617X; Seki, Tomohisa/0000-0002-4281-135X	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [25461117] Funding Source: KAKEN	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome, the Highway Program for the Realization of Regenerative Medicine, and a Grant-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Egashira T, 2013, BIOL PHARM BULL, V36, P182, DOI 10.1248/bpb.b12-00960; Egashira T, 2012, CARDIOVASC RES, V95, P419, DOI 10.1093/cvr/cvs206; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Knollmann BC, 2013, CIRC RES, V112, P969, DOI 10.1161/CIRCRESAHA.112.300567; Kunisato A, 2011, STEM CELLS DEV, V20, P159, DOI 10.1089/scd.2010.0063; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ma DR, 2013, EUR HEART J, V34, P1122, DOI 10.1093/eurheartj/ehs226; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schaub MC, 2006, J MOL CELL CARDIOL, V41, P183, DOI 10.1016/j.yjmcc.2006.04.005; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sinnecker D, 2013, CIRC RES, V112, P961, DOI 10.1161/CIRCRESAHA.112.268623; Smyth JW, 2012, HEART RHYTHM, V9, P151, DOI 10.1016/j.hrthm.2011.07.028; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yuasa Shinsuke, 2008, Expert Rev Cardiovasc Ther, V6, P803, DOI 10.1586/14779072.6.6.803; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885; Zwi-Dantsis L, 2013, EUR HEART J, V34, P1575, DOI 10.1093/eurheartj/ehs096	40	13	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85645	10.1371/journal.pone.0085645	http://dx.doi.org/10.1371/journal.pone.0085645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465630	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500087
J	Lacey, MG; Gooding-Williams, G; Prokic, EJ; Yamawaki, N; Hall, SD; Stanford, IM; Woodhall, GL				Lacey, Michael G.; Gooding-Williams, Gerard; Prokic, Emma J.; Yamawaki, Naoki; Hall, Stephen D.; Stanford, Ian M.; Woodhall, Gavin L.			Spike Firing and IPSPs in Layer V Pyramidal Neurons during Beta Oscillations in Rat Primary Motor Cortex (M1) In Vitro	PLOS ONE			English	Article							PARKINSONS-DISEASE; INHIBITORY INTERNEURONS; GAMMA-OSCILLATIONS; SOMATOSENSORY CORTEX; RECEPTOR ACTIVATION; SUBTHALAMIC NUCLEUS; MOUSE NEOCORTEX; CEREBRAL-CORTEX; 40 HZ; HIPPOCAMPUS	Beta frequency oscillations (10-35 Hz) in motor regions of cerebral cortex play an important role in stabilising and suppressing unwanted movements, and become intensified during the pathological akinesia of Parkinson's Disease. We have used a cortical slice preparation of rat brain, combined with concurrent intracellular and field recordings from the primary motor cortex (M1), to explore the cellular basis of the persistent beta frequency (27-30 Hz) oscillations manifest in local field potentials (LFP) in layers II and V of M1 produced by continuous perfusion of kainic acid (100 nM) and carbachol (5 mu M). Spontaneous depolarizing GABA-ergic IPSPs in layer V cells, intracellularly dialyzed with KCl and IEM1460 (to block glutamatergic EPSCs), were recorded at -80 mV. IPSPs showed a highly significant (P<0.01) beta frequency component, which was highly significantly coherent with both the Layer II and V LFP oscillation (which were in antiphase to each other). Both IPSPs and the LFP beta oscillations were abolished by the GABA(A) antagonist bicuculline. Layer V cells at rest fired spontaneous action potentials at sub-beta frequencies (mean of 7.1+1.2 Hz; n = 27) which were phase-locked to the layer V LFP beta oscillation, preceding the peak of the LFP beta oscillation by some 20 ms. We propose that M1 beta oscillations, in common with other oscillations in other brain regions, can arise from synchronous hyperpolarization of pyramidal cells driven by synaptic inputs from a GABA-ergic interneuronal network (or networks) entrained by recurrent excitation derived from pyramidal cells. This mechanism plays an important role in both the physiology and pathophysiology of control of voluntary movement generation.	[Lacey, Michael G.] Univ Birmingham, Sch Clin & Expt Med, Neuronal Networks Grp, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Gooding-Williams, Gerard; Prokic, Emma J.; Yamawaki, Naoki; Hall, Stephen D.; Stanford, Ian M.; Woodhall, Gavin L.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Birmingham; Aston University	Woodhall, GL (corresponding author), Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	G.L.woodhall@aston.ac.uk	Yamawaki, Naoki/AAD-5044-2022	Yamawaki, Naoki/0000-0001-8253-2059; Hall, Stephen/0000-0002-9274-6867; woodhall, gavin/0000-0003-1281-9008; Stanford, Ian M/0000-0002-5677-8538	BBSRC [BB/H003894/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003894/1] Funding Source: researchfish; Parkinson&quot;s UK [G-0711] Funding Source: researchfish; Parkinson&apos;s UK [G-0711] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Parkinson&quot;s UK(Parkinson&apos;s UK); Parkinson&apos;s UK(Parkinson&apos;s UK)		Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Canolty R, 2006, SCIENCE; Cauli B, 1997, J NEUROSCI, V17, P3894; Chen W, 1996, NEUROSCIENCE, V73, P39, DOI 10.1016/0306-4522(96)00009-7; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fell J, 2005, HIPPOCAMPUS; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisher NI, 1995, STAT ANAL CIRCULAR D; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hedrick T, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00001; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li XM, 2013, J NEUROPHYSIOL, V109, P2739, DOI 10.1152/jn.00397.2012; Mancilla JG, 2007, J NEUROSCI, V27, P2058, DOI 10.1523/JNEUROSCI.2715-06.2007; McAllister CJ, 2013, J NEUROSCI, V33, P7919, DOI 10.1523/JNEUROSCI.5624-12.2013; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Pakhotin PI, 1997, NEUROREPORT, V8, P1755, DOI 10.1097/00001756-199705060-00037; Pollok B, 2012, J PHYSIOL-LONDON, V590, P3203, DOI 10.1113/jphysiol.2012.231316; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Samoilova MV, 1999, NEUROSCIENCE, V94, P261, DOI 10.1016/S0306-4522(99)00326-7; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stein E, 2013, EXP NEUROL, V245, P52, DOI 10.1016/j.expneurol.2012.07.023; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021	49	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85109	10.1371/journal.pone.0085109	http://dx.doi.org/10.1371/journal.pone.0085109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465488	Green Published, gold, Green Accepted			2022-12-27	WOS:000330240500033
J	Millan-Ucles, A; Diaz-Castro, B; Garcia-Flores, P; Baez, A; Perez-Simon, JA; Lopez-Barneo, J; Piruat, JI				Millan-Ucles, Africa; Diaz-Castro, Blanca; Garcia-Flores, Paula; Baez, Alicia; Antonio Perez-Simon, Jose; Lopez-Barneo, Jose; Piruat, Jose I.			A Conditional Mouse Mutant in the Tumor Suppressor SdhD Gene Unveils a Link between p21(WAF1/Cip1) Induction and Mitochondrial Dysfunction	PLOS ONE			English	Article							COMPLEX-II; HIF-ALPHA; HYPOXIA; PHEOCHROMOCYTOMA; PARAGANGLIOMA; ACTIVATION; HIF1-ALPHA; SUCCINATE; APOPTOSIS; MUTATION	Mutations in mitochondrial complex II (MCII; succinate dehydrogenase, Sdh) genes cause familiar pheochromocytoma/paraganglioma tumors. Several mechanisms have been proposed to account for Sdh-mutation-induced tumorigenesis, the most accepted of which is based on the constitutive expression of the hypoxia-inducible factor 1 alpha (Hif1 alpha) at normal oxygen tension, a theory referred to as "pseudo-hypoxic drive". Other molecular processes, such as oxidative stress, apoptosis, or chromatin remodeling have been also proposed to play a causative role. Nevertheless, the actual contribution of each of these mechanisms has not been definitively established. Moreover, the biological factors that determine the tissue-specificity of these tumors have not been identified. In this work, we made use of the inducible SDHD-ESR mouse, a conditional mutant in the SdhD gene, which encodes the small subunit of MCII, and that acts as a tumor suppressor gene in humans. The analysis of the Hif1 alpha pathway in SDHD-ESR tissues and in two newly derived cell lines after complete SdhD loss -a requirement for hereditary paraganglioma type-1 tumor formation in humans-partially recapitulated the "pseudohypoxic" response and rendered inconsistent results. Therefore, we performed microarray analysis of adrenal medulla and kidney in order to identify other early gene expression changes elicited by SdhD deletion. Our results revealed that each mutant tissue displayed different variations in their gene expression profiles affecting to different biological processes. However, we found that the Cdkn1a gene was up-regulated in both tissues. This gene encodes the cyclin-dependent kinase inhibitor p21(WAF1/Cip1), a factor implicated in cell cycle, senescence, and cancer. The two SDHD-ESR cell lines also showed accumulation of this protein. This new and unprecedented evidence for a link between SdhD dysfunction and p21(WAF1/Cip1) will open new avenues for the study of the mechanisms that cause tumors in Sdh mutants. Finally, we discuss the actual role of Hif1 alpha in tumorigenesis.	[Millan-Ucles, Africa; Diaz-Castro, Blanca; Garcia-Flores, Paula; Baez, Alicia; Antonio Perez-Simon, Jose; Lopez-Barneo, Jose; Piruat, Jose I.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain; [Millan-Ucles, Africa; Baez, Alicia; Antonio Perez-Simon, Jose; Piruat, Jose I.] Hosp Univ Virgen del Rocio, Dept Hematol, Seville, Spain; [Diaz-Castro, Blanca; Garcia-Flores, Paula; Lopez-Barneo, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; CIBERNED	Piruat, JI (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain.	jpiruat-ibis@us.es	IBIS, NEUROBIOLOGIA/O-9922-2015	PEREZ-SIMON, JOSE-ANTONIO/0000-0002-0621-5809; Perez-Simon, Jose A/0000-0003-3616-6101	Spanish Ministry of Science and Innovation [SAF2009-06970, SAF2009-12409]; Andalusian Government [CTS-4589]; Botin Foundation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Government; Botin Foundation	This work was supported by grants SAF2009-06970 and SAF2009-12409 of the Plan Nacional I+D+I from The Spanish Ministry of Science and Innovation, and grant CTS-4589 from the Andalusian Government. Support was also provided by the Botin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bayley JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007987; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2013, BBA-BIOENERGETICS, V1827, P573, DOI 10.1016/j.bbabio.2012.12.005; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng XY, 2010, BIOCHEM BIOPH RES CO, V403, P103, DOI 10.1016/j.bbrc.2010.10.126; Dahia PLM, 2006, CURR OPIN ONCOL, V18, P1, DOI 10.1097/01.cco.0000198017.45982.06; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Diaz-Castro B, 2012, MOL CELL BIOL, V32, P3347, DOI 10.1128/MCB.00128-12; Favier J, 2010, BEST PRACT RES CL EN, V24, P957, DOI 10.1016/j.beem.2010.10.004; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gill AJ, 2011, PATHOLOGY, V43, P85, DOI 10.1097/PAT.0b013e3283410c9c; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hensen EF, 2004, ONCOGENE, V23, P4076, DOI 10.1038/sj.onc.1207591; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Ishii T, 2005, CANCER RES, V65, P203; Ishii T, 2011, MITOCHONDRION, V11, P155, DOI 10.1016/j.mito.2010.09.006; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Merlo A, 2012, J CLIN ENDOCR METAB, V97, pE2194, DOI 10.1210/jc.2012-2410; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nakamura E, 2006, ENDOCR PATHOL, V17, P97, DOI 10.1385/EP:17:2:97; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SMITH BW, 2011, MOUSE MODELS HUMAN F, P82248, DOI DOI 10.5772/25346; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	43	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85528	10.1371/journal.pone.0085528	http://dx.doi.org/10.1371/journal.pone.0085528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465590	Green Submitted, gold, Green Published			2022-12-27	WOS:000330240500056
J	Pitino, M; Hoffman, MT; Zhou, LJ; Hall, DG; Stocks, IC; Duan, YP				Pitino, Marco; Hoffman, Michele T.; Zhou, Lijuan; Hall, David G.; Stocks, Ian C.; Duan, Yongping			The Phloem-Sap Feeding Mealybug (Ferrisia virgata) Carries 'Candidatus Liberibacter asiaticus' Populations That Do Not Cause Disease in Host Plants	PLOS ONE			English	Article							REAL-TIME PCR; DIAPHORINA-CITRI; GREENING DISEASE; SWEET ORANGE; PAULO STATE; VECTOR; INSECT; HEMIPTERA; TRANSMISSION; PERIWINKLE	'Candidatus Liberibacter asiaticus' (Las) is the primary causal agent of huanglongbing (HLB), the most devastating disease of citrus worldwide. There are three known insect vectors of the HLB-associated bacteria, and all are members of the Hemiptera: Diaphorina citri (Psyllidae), Trioza erytreae (Triozidae), and Cacopsylla (Psylla) citrisuga (Psyllidae). In this study, we found that another hemipteran, the striped mealybug Ferrisia virgata (Cockerell) (Hemiptera: Pseudococcidae), was able to acquire and retain Las bacteria. The bacterial titers were positively correlated with the feeding acquisition time on Las-infected leaf discs, with a two-weeks feeding period resulting in Ct values ranging from 23.1 to 36.1 (8.24x10(7) to 1.07x10(4) Las cells per mealybug). We further discovered that the prophage/phage populations of Las in the mealybugs were different from those of Las in psyllids based on Las prophage-specific molecular markers: infected psyllids harbored the Las populations with prophage/phage FP1 and FP2, while infected mealybugs carried the Las populations with the iFP3 being the dominant prophage/phage. As in the psyllids, Las bacteria were shown to move through the insect gut wall to the salivary glands after being ingested by the mealybug based on a time-course quantitative polymerase chain reaction (qPCR) assay of the dissected digestive systems. However, Las populations transmitted by the mealybugs did not cause disease in host plants. This is the first evidence of genetic difference among Las populations harbored by different insect vectors and difference among Las populations with respect to whether or not they cause disease in host plants.	[Pitino, Marco; Hoffman, Michele T.; Zhou, Lijuan; Hall, David G.; Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA; [Zhou, Lijuan] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Stocks, Ian C.] Florida Dept Agr & Consumer Serv, Drug Policy Inst, Gainesville, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Duan, YP (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA.	yongping.duan@ars.usda.gov	Hoffman, Michele T/D-2537-2011; Zhou, Li/GSE-4531-2022		United States Department of Agriculture; Florida Department of Agriculture and Consumer Services-Specialty Crop Block Grant [18023]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Florida Department of Agriculture and Consumer Services-Specialty Crop Block Grant	Funding provided by United States Department of Agriculture and Florida Department of Agriculture and Consumer Services-Specialty Crop Block Grant #18023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar El Desouky, 1994, Advances in Disease Vector Research, V10, P289; Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Article Catalogues, 1997, J APPL ENTOMOL, V121, P559; Aubert B., 1988, P 10 C INT ORG CITR, P231; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Capoor S. P., 1974, Proceedings of the Sixth Conference of the International Organization of Citrus Virologists., P43; Cen YJ, 2012, FLA ENTOMOL, V95, P304, DOI 10.1653/024.095.0210; Cruz-Gonzalez AG, 2011, PHYTOPATHOLOGY, V101, pS276; Fletcher J, 1998, PHYTOPATHOLOGY, V88, P1351, DOI 10.1094/PHYTO.1998.88.12.1351; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; GARNIER M, 1983, PHYTOPATHOLOGY, V73, P1358, DOI 10.1094/Phyto-73-1358; Garnier M., 1991, P 11 C INT ORG CITR, P428; GHOSH S K, 1978, Annales de Phytopathologie, V9, P525; GILDOW FE, 1993, PHYTOPATHOLOGY, V83, P1293, DOI 10.1094/Phyto-83-1293; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Hoffman MT, 2011, PHYTOPATHOLOGY, V101, pS73; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Purcell A.H., 1991, P383; Skelley LH, 2004, BIOL CONTROL, V29, P14, DOI 10.1016/S1049-9644(03)00129-4; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082248; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	39	6	7	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85503	10.1371/journal.pone.0085503	http://dx.doi.org/10.1371/journal.pone.0085503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465578	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500052
J	Tomaru, A; Sasaki, R; Miyahara, H; Okino, A; Ogawa, N; Hamasaki, K				Tomaru, Akiko; Sasaki, Ryota; Miyahara, Hidekazu; Okino, Akitoshi; Ogawa, Nobuhiro; Hamasaki, Koji			Settlement of Planulae of the Moon Jellyfish Aurelia aurita onto Hydrophilic Polycarbonate Plates Modified by Atmospheric Plasma Treatment	PLOS ONE			English	Article							SURFACE MODIFICATION; PELAGIC CNIDARIANS; COMMON JELLYFISH; POLYIMIDE FILMS; WESTERN SWEDEN; GULLMAR FJORD; LIFE-HISTORY; SCYPHOZOA; LARVAE; PREFERENCES	It has been reported that planula larvae of some jellyfish prefer artificial substrates for settlement. This research focused on the relationship between the settlement of planulae and the wettability of artificial substrate surfaces. We used atmospheric plasmas to change the wettability of the surfaces of polycarbonate (PC) plates because plasma treatment has no chemical side effects. The treatment made the surfaces hydrophilic, as evidenced by the decrease of contact angle from 85 degrees to 35 degrees. X-ray photoelectron spectroscopy revealed that the change of wettability of the PC plates could be attributed to N-2, which was probably ionized in the air above the plates. Scanning electron microscopy revealed no difference in the surface morphology of the plates before and after plasma treatment. Results of bioassays using treated PC plates showed that planulae tended to preferentially settle on hydrophobic surfaces.	[Tomaru, Akiko; Ogawa, Nobuhiro; Hamasaki, Koji] Univ Tokyo, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Sasaki, Ryota; Miyahara, Hidekazu; Okino, Akitoshi] Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 227, Japan	University of Tokyo; Tokyo Institute of Technology	Tomaru, A (corresponding author), Fukushima Univ, Dept Environm Management, Fukushima, Japan.	akotoma@gmail.com	Okino, Akitoshi/O-1804-2013	Okino, Akitoshi/0000-0002-8949-294X; Hamasaki, Koji/0000-0002-8514-506X	Agriculture, Forestry and Fisheries Research Council	Agriculture, Forestry and Fisheries Research Council(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by the Agriculture, Forestry and Fisheries Research Council (POMAL-STOPJELLY Project) (http://www.s.affrc.go.jp/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI MN, 1988, CAN J ZOOL, V66, P1913, DOI 10.1139/z88-280; Arai MN, 1997, FUNCTIONAL BIOL SCYP; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; BREWER RH, 1984, BIOL BULL, V166, P11, DOI 10.2307/1541426; BREWER RH, 1978, ESTUARIES, V1, P120, DOI 10.2307/1351601; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Cui NY, 2002, APPL SURF SCI, V189, P31, DOI 10.1016/S0169-4332(01)01035-2; GRONDAHL F, 1989, MAR ECOL PROG SER, V56, P119, DOI 10.3354/meps056119; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; HERNROTH L, 1985, B MAR SCI, V37, P567; HERNROTH L, 1985, OPHELIA, V24, P37, DOI 10.1080/00785236.1985.10426617; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Japanese Industrial Standards Committee (JIS), 1999, R3257 JIS COMM; KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028; Kang SM, 2008, THIN SOLID FILMS, V516, P1405, DOI 10.1016/j.tsf.2007.07.176; KEEN SL, 1987, MAR ECOL PROG SER, V38, P151, DOI 10.3354/meps038151; Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5; Kramp P. L., 1968, Vidensk. Meddr dansk. naturh. Foren, V131, P67; Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038; Lin YS, 2006, SURF COAT TECH, V200, P3775, DOI 10.1016/j.surfcoat.2004.11.031; Lo WT, 2008, ICES J MAR SCI, V65, P453, DOI 10.1093/icesjms/fsm185; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; MAYER AG, 1910, MEDUSAE WORLD; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miyake H, 2002, J OCEANOGR, V58, P451, DOI 10.1023/A:1021628314041; Miyake H., 2004, MAR BIOTECHNOL, V6, pS174, DOI 10.1007/s10126-004-8366-2; Miyake Hiroshi, 1997, South Pacific Study, V17, P273; MOLLER H, 1980, MEERESFORSCHUNG, V28, P90; Noeske M, 2004, INT J ADHES ADHES, V24, P171, DOI 10.1016/j.ijadhadh.2003.09.006; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; PURCELL JE, 1985, B MAR SCI, V37, P739; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Rasmussen E., 1973, OPHELIA, V11, P41; Russell FS, 1970, MEDUSAE BRIT ISLES 2; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tanford C, 1973, CELLULAR MENBRANES D, P321; UNEP (United Nations Environmental Programme), 1991, MED ACT PLAN TECHN R, V47; Uye Shin-ichi, 2004, Bulletin of the Japanese Society of Fisheries Oceanography, V68, P9; WINSTON JE, 1982, MAR POLLUT BULL, V13, P348, DOI 10.1016/0025-326X(82)90038-8; Yaghoubi H, 2011, APPL SURF SCI, V257, P9836, DOI 10.1016/j.apsusc.2011.06.034; Yaghoubi H, 2010, SURF COAT TECH, V204, P1562, DOI 10.1016/j.surfcoat.2009.09.085; Zar JH, 2010, BIOSTAT ANAL, P286	45	4	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85569	10.1371/journal.pone.0085569	http://dx.doi.org/10.1371/journal.pone.0085569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465603	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500059
J	Usuf, E; Bottomley, C; Adegbola, RA; Hall, A				Usuf, Effua; Bottomley, Christian; Adegbola, Richard A.; Hall, Andrew			Pneumococcal Carriage in Sub-Saharan Africa-A Systematic Review	PLOS ONE			English	Review							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINE; HAEMOPHILUS-INFLUENZAE; CHANGING EPIDEMIOLOGY; SEROTYPE DISTRIBUTION; INVASIVE-DISEASE; CHILDREN; RESISTANCE; COMMUNITY	Background: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV) era. Methods: A search for pneumococcal carriage studies published before 2012 was conducted to describe carriage in sSA. The review also describes pneumococcal serotypes and assesses the impact of vaccination on carriage in this region. Results: Fifty-seven studies were included in this review with the majority (40.3%) from South Africa. There was considerable variability in the prevalence of carriage between studies (I-squared statistic = 99%). Carriage was higher in children and decreased with increasing age, 63.2% (95% CI: 55.6-70.8) in children less than 5 years, 42.6% (95% CI: 29.9-55.4) in children 5-15 years and 28.0% (95% CI: 19.0-37.0) in adults older than 15 years. There was no difference in the prevalence of carriage between males and females in 9/11 studies. Serotypes 19F, 6B, 6A, 14 and 23F were the five most common isolates. A meta-analysis of four randomized trials of PCV vaccination in children aged 9-24 months showed that carriage of vaccine type (VT) serotypes decreased with PCV vaccination; however, overall carriage remained the same because of a concomitant increase in non-vaccine type (NVT) serotypes. Conclusion: Pneumococcal carriage is generally high in the African continent, particularly in young children. The five most common serotypes in sSA are among the top seven serotypes that cause invasive pneumococcal disease in children globally. These serotypes are covered by the two PCVs recommended for routine childhood immunization by the WHO. The distribution of serotypes found in the nasopharynx is altered by PCV vaccination.	[Usuf, Effua] MRC, Gambia Unit, Fajara, Gambia; [Bottomley, Christian] Univ London London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1E 7HT, England; [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium; [Hall, Andrew] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine	Usuf, E (corresponding author), MRC, Gambia Unit, Fajara, Gambia.	effuau@gmail.com		Bottomley, Christian/0000-0002-5241-8412	Medical Research Council; MRC [MC_EX_MR/L100001/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/L100001/1, MR/K012126/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council PhD studentship awarded to EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2007, VALIDATION NASOPHARY; Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Adegbola RA, 2001, EVALUATION BINAX NOW; Antonio M., 2008, BMC Microbiology, V8; Batt SL, 2003, IMPACT AZITHROMYCIN; Bere Leonard C, 2009, Pak J Biol Sci, V12, P1282, DOI 10.3923/pjbs.2009.1282.1286; Blossom DB, 2006, OROPHARYNGEAL COLONI; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; CAPEDING MRZ, 1995, J CLIN MICROBIOL, V33, P3077, DOI 10.1128/JCM.33.11.3077-3079.1995; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Cotton MF, 2008, HIGH INCIDENCE ANTIM; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; Darboe MK, 2007, EFFECTIVENESS EARLY; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Denno DM, 2002, NASOPHARYNGEAL CARRI; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Feikin DR, 2003, ANTIBIOTIC RESISTANC; Feikin DR, 2000, INCREASED CARRIAGE T; Fenoll A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-239; Frederiksen B, 1988, THROAT CARRIAGE STRE; Gordon SB, 2003, POOR POTENTIAL COVER; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; GRAY BM, 1982, AM J EPIDEMIOL, V116, P692, DOI 10.1093/oxfordjournals.aje.a113452; Guevara M, 2009, CLIN MICROBIOL INFEC, V15, P1013, DOI 10.1111/j.1469-0691.2009.02904.x; Hansman D, 1978, LANCET, V1102; Haug S, 2010, CLIN INFECT DIS, V51, P571, DOI 10.1086/655697; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Ho PL, 2011, VACCINE, V29, P3270, DOI 10.1016/j.vaccine.2011.02.025; Huang SS, 2004, AM J EPIDEMIOL, V159, P645, DOI 10.1093/aje/kwh088; Huebner RE, 2000, S AFR MED J, V90, P1116; Huebner RE, 1998, NASOPHARYNGEAL CARRI; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jacobs MR, 1978, EMERGENCE MULTIPLY R; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Joloba ML, 2001, HIGH PREVALENCE CARR; Kacou-N'douba A, 2010, INDIAN J MED MICROBI, V28, P80, DOI 10.4103/0255-0857.58742; Kacou-N'Douba A, 2001, ANTIMICROBIAL RESIST; Kandakai-Olukemi YT, 2009, ANN AFR MED, V8, P10, DOI 10.4103/1596-3519.55757; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Klugman KP, 1998, AM J DIS CHILD, V140, P1186; Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69; LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Marcus L, 1996, S AFR MED J, V86, P1132; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McNally LM, 2006, J INFECT DIS, V194, P385, DOI 10.1086/505076; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; Mthwalo M, 1998, ANTIBIOTIC RESISTANC; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; Ndip RN, 2008, ANTIMICROBIAL RESIST; Nwachukwu NOA, 2008, AFRICAN J RESP M SEP, V16; Nyandiko WM, 2007, NASOPHARYNGEAL STREP; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Obaro SK, 2000, PEDIATR INFECT DIS J, V19, P463, DOI 10.1097/00006454-200005000-00014; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Oppenheim B, 1986, ANTIBIOTIC RESISTANT; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Pemba L, 2008, IMPACT COTRIMOXAZOLE; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Ringertz S, 1993, PREVALENCE POTENTIAL; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Robins-Browne RM, 1984, ANTIBIOTIC RESISTANT; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Roche PW, 2008, COMMUN DIS INTELL, V32, P18; Rowe AK, 2000, ANTIMICROBIAL RESIST; Rusen ID, 1997, NASOPHARYNGEAL PNEUM; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Scott JAG, 1998, CLIN INFECT DIS, V27, P1442, DOI 10.1086/515013; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377; Smith-Vaughan H, 2009, CLIN VACCINE IMMUNOL, V16, P218, DOI 10.1128/CVI.00283-08; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; Varon E, 2000, CLIN INFECT DIS, V31, P477, DOI 10.1086/313981; von Gottberg A, 2008, EMERGENCE LEVOFLOXAC; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Williams SR, 2011, MED J AUSTRALIA, V194, P116, DOI 10.5694/j.1326-5377.2011.tb04192.x; Woolfson A, 1997, NASOPHARYNGEAL CARRI; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005; Yomo A, 1997, CARRIAGE PENICILLIN	89	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85001	10.1371/journal.pone.0085001	http://dx.doi.org/10.1371/journal.pone.0085001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465464	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330240500028
J	Yuan, JB; Zhu, QM; Liu, B				Yuan, Jianbo; Zhu, Qingming; Liu, Bin			Phylogenetic and Biological Significance of Evolutionary Elements from Metazoan Mitochondrial Genomes	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; WHOLE-PROTEOME PHYLOGENY; FEATURE SUBSET-SELECTION; CONSERVED REGION; SEQUENCE ALIGNMENT; ANIMAL PHYLOGENY; RIBOSOMAL-RNA; TREE; CLASSIFICATION; GENE	The evolutionary history of living species is usually inferred through the phylogenetic analysis of molecular and morphological information using various mathematical models. New challenges in phylogenetic analysis are centered mostly on the search for accurate and efficient methods to handle the huge amounts of sequence data generated from newer genome sequencing. The next major challenge is the determination of relationships between the evolution of structural elements and their functional implementation, which is largely ignored in previous analyses. Here, we described the discovery of structural elements in metazoan mitochondrial genomes, termed key K-strings, that can serve as a basis for phylogenetic tree construction. Although comprising only a small fraction (0.73%) of all K-strings, these key K-strings are pivotal to the tree construction because they allow for a significant reduction in the computational time required to construct phylogenetic trees, and more importantly, they make significant improvement to the results of phylogenetic inference. The trees constructed from the key K-strings were consistent overall to our current view of metazoan phylogeny and exhibited a more rational topology than the trees constructed by using other conventional methods. Surprisingly, the key K-strings tended to accumulate in the conserved regions of the original sequences, which were most likely due to strong selection pressure. Furthermore, the special structural features of the key K-strings should have some potential applications in the study of the structures and functions relationship of proteins and in the determination of evolutionary trajectory of species. The novelty and potential importance of key K-strings lead us to believe that they are essential evolutionary elements. As such, they may play important roles in the process of species evolution and their physical existence. Further studies could lead to discoveries regarding the relationship between evolution and processes of speciation.	[Yuan, Jianbo; Liu, Bin] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Ctr Systemat Genom, Urumqi, Xinjiang, Peoples R China; [Yuan, Jianbo; Liu, Bin] Chinese Acad Sci, Inst Oceanol, CAS Key Lab Expt Marine Biol, Qingdao, Shandong, Peoples R China; [Yuan, Jianbo; Liu, Bin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhu, Qingming] GenomeSense Inst, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, B (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Ctr Systemat Genom, Urumqi, Xinjiang, Peoples R China.	bliu@ms.xjb.ac.cn			Innovation Grant from Xinjiang Institute of Ecology and Geography; Institute of Oceanology, Chinese Academy of Sciences	Innovation Grant from Xinjiang Institute of Ecology and Geography; Institute of Oceanology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Innovation Grant from Xinjiang Institute of Ecology and Geography, and the Bairen fund to BL of the Institute of Oceanology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Bayona-Bafaluy MP, 2005, MOL BIOL EVOL, V22, P716, DOI 10.1093/molbev/msi059; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S9; Chu KH, 2006, BIOINFORMATICS, V22, P1690, DOI 10.1093/bioinformatics/btl146; Cover T. M., 1991, ELEMENTS INFORM THEO; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EERNISSE DJ, 1992, SYST BIOL, V41, P305, DOI 10.1093/sysbio/41.3.305; Gardner AE, 2007, J VIROL, V81, P8303, DOI 10.1128/JVI.00366-07; Gaucher Eric A, 2010, COLD SPRING HARB PER, V2; Gimenez Gallego G, 2002, Nefrologia, V22 Suppl 5, P21; Giribet G, 1998, MOL PHYLOGENET EVOL, V9, P481, DOI 10.1006/mpev.1998.0494; Giribet G, 1999, MOL PHYLOGENET EVOL, V13, P619, DOI 10.1006/mpev.1999.0679; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Han B, 2006, BIOINFORMATICS, V22, P2136, DOI 10.1093/bioinformatics/btl350; Hao Bailin, 2004, J Bioinform Comput Biol, V2, P1; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Jelonek J, 1997, ARTIF INTELL MED, V9, P227, DOI 10.1016/S0933-3657(96)00375-2; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Kishore R, 2004, CURR PROTEIN PEPT SC, V5, P435, DOI 10.2174/1389203043379396; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Leo-Macias A, 2005, BIOPHYS J, V88, P1291, DOI 10.1529/biophysj.104.052449; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li QA, 2010, J BIOTECHNOL, V149, P115, DOI 10.1016/j.jbiotec.2009.12.015; Li ST, 2011, IEEE INT CONF FUZZY, P2583; Lim A, 1999, BIOINFORMATICS, V15, P1068, DOI 10.1093/bioinformatics/15.12.1068; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; LOCKE M, 1977, NATURE, V270, P341, DOI 10.1038/270341a0; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; McInerney JO, 2008, TRENDS ECOL EVOL, V23, P276, DOI 10.1016/j.tree.2008.01.008; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Morrison DA, 1996, INT J PARASITOL, V26, P589, DOI 10.1016/0020-7519(96)00044-6; Nielsen C, 1996, BIOL J LINN SOC, V57, P385; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Park YH, 2003, 2003 INTERNATIONAL CONFERENCE ON NATURAL LANGUAGE PROCESSING AND KNOWLEDGE ENGINEERING, PROCEEDINGS, P591; Pasyk EA, 1998, J BIOL CHEM, V273, P31759, DOI 10.1074/jbc.273.48.31759; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Qi ZH, 2009, J THEOR BIOL, V260, P104, DOI 10.1016/j.jtbi.2009.05.011; Saarikoski J, 2011, LECT NOTES COMPUT SC, V6593, P260, DOI 10.1007/978-3-642-20282-7_27; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schierwater Bernd, 2009, Communicative & Integrative Biology, V2, P403; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Snel B, 2005, ANNU REV MICROBIOL, V59, P191, DOI 10.1146/annurev.micro.59.030804.121233; Stenderup JT, 2006, MOL PHYLOGENET EVOL, V41, P182, DOI 10.1016/j.ympev.2006.06.006; Stuart GW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-204; Stuart GW, 2002, BIOINFORMATICS, V18, P100, DOI 10.1093/bioinformatics/18.1.100; Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111; SUZUKI Y, 1987, APPL MICROBIOL BIOT, V26, P546, DOI 10.1007/BF00253030; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Teichmann SA, 1999, NAT GENET, V21, P66, DOI 10.1038/5001; Tekaia F, 1999, GENOME RES, V9, P550; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tripathi N., 2011, INT J HYBRID INTELLI, V8, P99, DOI [10.3233/his-2011-0137, DOI 10.3233/HIS-2011-0137]; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wei HL, 2007, IEEE T PATTERN ANAL, V29, P162, DOI 10.1109/TPAMI.2007.250607; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; WRIGHT KA, 1992, MICROSC RES TECHNIQ, V22, P285, DOI 10.1002/jemt.1070220306; Wu GA, 2009, P NATL ACAD SCI USA, V106, P12826, DOI 10.1073/pnas.0905115106; Wu W, 2000, MOL PHYLOGENET EVOL, V17, P294, DOI 10.1006/mpev.2000.0833; Xie Q, 2011, PROTEIN CELL, V2, P161, DOI 10.1007/s13238-011-1017-2; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xiong H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027382; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yokobori S, 2008, MOL PHYLOGENET EVOL, V47, P612, DOI 10.1016/j.ympev.2008.02.013; Yu Z., 2007, P 11 WORLD MULT SYST, P206; Zhang C, 2011, EL MECH ENG INF TECH, P4639; Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; Zuo Guanghong, 2010, Genomics Proteomics & Bioinformatics, V8, P262, DOI 10.1016/S1672-0229(10)60028-9	87	6	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84330	10.1371/journal.pone.0084330	http://dx.doi.org/10.1371/journal.pone.0084330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465405	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500015
J	Kolpen, M; Kuhl, M; Bjarnsholt, T; Moser, C; Hansen, CR; Liengaard, L; Kharazmi, A; Pressler, T; Hoiby, N; Jensen, PO				Kolpen, Mette; Kuhl, Michael; Bjarnsholt, Thomas; Moser, Claus; Hansen, Christine Ronne; Liengaard, Lars; Kharazmi, Arsalan; Pressler, Tanja; Hoiby, Niels; Jensen, Peter Ostrup			Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection	PLOS ONE			English	Article							NITRIC-OXIDE; POLYMORPHONUCLEAR LEUKOCYTES; REDUCTASE; NITRATE; AIRWAY; OXYGEN; DENITRIFICATION; BACTERIAL; BIOFILMS; SURVIVAL	Chronic lung infection by Pseudomonas aeruginosa is the major severe complication in cystic fibrosis (CF) patients, where P. aeruginosa persists and grows in biofilms in the endobronchial mucus under hypoxic conditions. Numerous polymorphonuclear leukocytes (PMNs) surround the biofilms and create local anoxia by consuming the majority of O-2 for production of reactive oxygen species (ROS). We hypothesized that P. aeruginosa acquires energy for growth in anaerobic endobronchial mucus by denitrification, which can be demonstrated by production of nitrous oxide (N2O), an intermediate in the denitrification pathway. We measured N2O and O-2 with electrochemical microsensors in 8 freshly expectorated sputum samples from 7 CF patients with chronic P. aeruginosa infection. The concentrations of NO3- and NO2- in sputum were estimated by the Griess reagent. We found a maximum median concentration of 41.8 mu M N2O (range 1.4-157.9 mu M N2O). The concentration of N2O in the sputum was higher below the oxygenated layers. In 4 samples the N2O concentration increased during the initial 6 h of measurements before decreasing for approximately 6 h. Concomitantly, the concentration of NO3- decreased in sputum during 24 hours of incubation. We demonstrate for the first time production of N2O in clinical material from infected human airways indicating pathogenic metabolism based on denitrification. Therefore, P. aeruginosa may acquire energy for growth by denitrification in anoxic endobronchial mucus in CF patients. Such ability for anaerobic growth may be a hitherto ignored key aspect of chronic P. aeruginosa infections that can inform new strategies for treatment and prevention.	[Kolpen, Mette; Bjarnsholt, Thomas; Moser, Claus; Kharazmi, Arsalan; Hoiby, Niels; Jensen, Peter Ostrup] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Kolpen, Mette; Bjarnsholt, Thomas; Hoiby, Niels] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Kuhl, Michael; Liengaard, Lars] Univ Copenhagen, Marine Biol Sect, Dept Biol, Helsingor, Denmark; [Kuhl, Michael] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Kuhl, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [Hansen, Christine Ronne; Pressler, Tanja] Rigshosp, Copenhagen CF Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Technology Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Rigshospitalet; University of Copenhagen	Jensen, PO (corresponding author), Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark.	Peter.Oestrup.Jensen@regionh.dk	Kühl, Michael/A-1977-2009; Jensen, Peter Ostrup/HGD-7725-2022; Moser, Claus Ernst/N-5951-2017; Møller, Lars Liengård Holten/AAF-5048-2020; Moser, Claus Ernst/GPK-5546-2022; Bjarnsholt, Thomas/ABD-6178-2021	Kühl, Michael/0000-0002-1792-4790; Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Kolpen, Mette/0000-0001-5575-0384; Jensen, Peter Ostrup/0000-0003-1648-7186; Hoiby, Niels/0000-0002-1347-725X; Bjarnsholt, Thomas/0000-0002-8003-7414	Faculty of Health and Medical Sciences, University of Copenhagen	Faculty of Health and Medical Sciences, University of Copenhagen	This work was funded by Faculty of Health and Medical Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Andersen K, 2001, SENSOR ACTUAT B-CHEM, V81, P42, DOI 10.1016/S0925-4005(01)00924-8; ARAI H, 1995, BBA-GENE STRUCT EXPR, V1261, P279, DOI 10.1016/0167-4781(95)00018-C; Arai H, 2013, BIOSCI BIOTECH BIOCH, V77, P198, DOI 10.1271/bbb.120656; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Beckmann C, 2005, INFECT IMMUN, V73, P444, DOI 10.1128/IAI.73.1.444-452.2005; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; BROECKER WS, 1974, TELLUS, V26, P21, DOI 10.1111/j.2153-3490.1974.tb01948.x; De Beer D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P904, DOI 10.1007/0-387-30741-9_28; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, J AM CHEM SOC, V124, P11737, DOI 10.1021/ja0206487; Gaston B, 2002, AM J RESP CRIT CARE, V165, P387, DOI 10.1164/ajrccm.165.3.2106006; Grasemann H, 2005, EUR RESPIR J, V25, P62, DOI 10.1183/09031936.04.00086104; Grasemann H, 2013, J CYST FIBROS, V12, P468, DOI 10.1016/j.jcf.2012.12.008; Grasemann H, 1997, PEDIATR PULM, V24, P173, DOI 10.1002/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O; Gundersen JK, 1998, LIMNOL OCEANOGR, V43, P1932; Hampton T, 2000, ANAESTH INTENS CARE, V28, P540, DOI 10.1177/0310057X0002800510; Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Hoiby N., 2000, CYSTIC FIBROSIS, V2nd, P83; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Kakishima K, 2007, BIOCHEM BIOPH RES CO, V355, P587, DOI 10.1016/j.bbrc.2007.02.017; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koch C, 2000, RESPIRATION, V67, P239, DOI 10.1159/000029503; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x; Liengaard L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00433; Linnane SJ, 1998, AM J RESP CRIT CARE, V158, P207, DOI 10.1164/ajrccm.158.1.9707096; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; Markfoged R, 2013, EUROPEAN J SOIL SCI, V62, P541; Mitsui T, 2004, CLIN CHIM ACTA, V345, P129, DOI 10.1016/j.cccn.2004.03.011; Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07; PEDERSEN SS, 1992, APMIS, V100, P326, DOI 10.1111/j.1699-0463.1992.tb00879.x; Philippot L, 2005, TRENDS MICROBIOL, V13, P191, DOI 10.1016/j.tim.2005.03.001; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Planelles G, 2007, NEPHRON PHYSIOL, V105, P11, DOI 10.1159/000096979; Ratjen F, 1999, RESP MED, V93, P579, DOI 10.1016/S0954-6111(99)90158-0; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schreiber F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-24; SENETERRE E, 1994, EUR RESPIR J, V7, P596, DOI 10.1183/09031936.94.07030596; Shimizu T, 2012, MOL MICROBIOL, V85, P492, DOI 10.1111/j.1365-2958.2012.08122.x; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; SOOHOO CK, 1991, J BIOL CHEM, V266, P2203; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; THOMAS KL, 1994, FEMS MICROBIOL LETT, V118, P181, DOI 10.1016/0378-1097(94)90616-5; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; WILLIAMS DR, 1978, APPL ENVIRON MICROB, V36, P257, DOI 10.1128/AEM.36.2.257-263.1978; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	62	67	67	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84353	10.1371/journal.pone.0084353	http://dx.doi.org/10.1371/journal.pone.0084353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465406	Green Published, gold			2022-12-27	WOS:000330237000013
J	Mustafi, N; Grunberger, A; Mahr, R; Helfrich, S; Noh, K; Blombach, B; Kohlheyer, D; Frunzke, J				Mustafi, Nurije; Gruenberger, Alexander; Mahr, Regina; Helfrich, Stefan; Noeh, Katharina; Blombach, Bastian; Kohlheyer, Dietrich; Frunzke, Julia			Application of a Genetically Encoded Biosensor for Live Cell Imaging of L-Valine Production in Pyruvate Dehydrogenase Complex-Deficient Corynebacterium glutamicum Strains	PLOS ONE			English	Article							MOLECULAR ANALYSIS; MICROBIAL-POPULATIONS; EXPORT SYSTEM; L-METHIONINE; L-ISOLEUCINE; GENE; ENZYME; CHAIN; HETEROGENEITIES; INFORMATION	The majority of biotechnologically relevant metabolites do not impart a conspicuous phenotype to the producing cell. Consequently, the analysis of microbial metabolite production is still dominated by bulk techniques, which may obscure significant variation at the single-cell level. In this study, we have applied the recently developed Lrp-biosensor for monitoring of amino acid production in single cells of gradually engineered L-valine producing Corynebacterium glutamicum strains based on the pyruvate dehydrogenase complex-deficient (PDHC) strain C. glutamicum Delta aceE. Online monitoring of the sensor output (eYFP fluorescence) during batch cultivation proved the sensor's suitability for visualizing different production levels. In the following, we conducted live cell imaging studies on C. glutamicum sensor strains using microfluidic chip devices. As expected, the sensor output was higher in microcolonies of high-yield producers in comparison to the basic strain C. glutamicum Delta aceE. Microfluidic cultivation in minimal medium revealed a typical Gaussian distribution of single cell fluorescence during the production phase. Remarkably, low amounts of complex nutrients completely changed the observed phenotypic pattern of all strains, resulting in a phenotypic split of the population. Whereas some cells stopped growing and initiated L-valine production, others continued to grow or showed a delayed transition to production. Depending on the cultivation conditions, a considerable fraction of non-fluorescent cells was observed, suggesting a loss of metabolic activity. These studies demonstrate that genetically encoded biosensors are a valuable tool for monitoring single cell productivity and to study the phenotypic pattern of microbial production strains.	[Mustafi, Nurije; Gruenberger, Alexander; Mahr, Regina; Helfrich, Stefan; Noeh, Katharina; Kohlheyer, Dietrich; Frunzke, Julia] Forschungszentrum Julich, IBG Biotechnol 1, D-52425 Julich, Germany; [Blombach, Bastian] Univ Stuttgart, Inst Biochem Engn, D-70174 Stuttgart, Germany	Helmholtz Association; Research Center Julich; University of Stuttgart	Frunzke, J (corresponding author), Forschungszentrum Julich, IBG Biotechnol 1, D-52425 Julich, Germany.	j.frunzke@fz-juelich.de	Frunzke, Julia/A-9918-2012; Kohlheyer, Dietrich/A-9645-2012	Frunzke, Julia/0000-0001-6209-7950; Kohlheyer, Dietrich/0000-0001-6215-1857; Helfrich, Stefan/0000-0003-3549-8649; Blombach, Bastian/0000-0002-2996-2049; Grunberger, Alexander/0000-0002-7564-4957; Noh, Katharina/0000-0002-5407-2275	Helmholtz association [VH-NG-716]; German ministry of education and research [0315589A]; Deutsche Forschungsgemeinschaft [SPP1617]	Helmholtz association(Helmholtz Association); German ministry of education and research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grants of the Helmholtz association (VH-NG-716), the German ministry of education and research (0315589A) and the Deutsche Forschungsgemeinschaft (SPP1617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bartek T, 2011, APPL ENVIRON MICROB, V77, P6644, DOI 10.1128/AEM.00575-11; Binder S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r40; Blombach B, 2008, APPL MICROBIOL BIOT, V79, P471, DOI 10.1007/s00253-008-1444-z; Blombach B, 2007, APPL ENVIRON MICROB, V73, P2079, DOI 10.1128/AEM.02826-06; Buchholz J, 2013, APPL ENVIRON MICROB, V79, P5566, DOI 10.1128/AEM.01741-13; Carlquist M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-94; Delvigne F, 2011, BIOTECHNOL J, V6, P968, DOI 10.1002/biot.201000410; Dietrich JA, 2010, ANNU REV BIOCHEM, V79, P563, DOI 10.1146/annurev-biochem-062608-095938; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Eriksen DT, 2014, J STRUCT BIOL, V185, P234, DOI 10.1016/j.jsb.2013.03.011; Fernandes RL, 2011, BIOTECHNOL ADV, V29, P575, DOI 10.1016/j.biotechadv.2011.03.007; Gruenberger A, 2013, JOVE-J VIS EXP, DOI 10.3791/50560; Grunberger A, 2013, BIOTECHNOL BIOENG, V110, P220, DOI 10.1002/bit.24616; Grunberger A, 2012, LAB CHIP, V12, P2060, DOI [10.1039/c2lc40156h, 10.1039/c21c40156h]; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Haussmann U, 2012, J PROTEOMICS, V75, P2649, DOI 10.1016/j.jprot.2012.03.005; Heinemann M, 2011, CURR OPIN BIOTECH, V22, P26, DOI 10.1016/j.copbio.2010.09.008; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kensy F, 2009, MICROB CELL FACT, V8, DOI [10.1186/1475-2859-1188-1131, DOI 10.1186/1475-2859-1188-1131]; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lange C, 2012, J BIOTECHNOL, V158, P231, DOI 10.1016/j.jbiotec.2011.06.003; Lara AR, 2006, MOL BIOTECHNOL, V34, P355, DOI 10.1385/MB:34:3:355; Liden G, 2002, BIOPROC BIOSYST ENG, V24, P273, DOI 10.1007/s004490100263; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Litsanov B, 2012, MICROB BIOTECHNOL, V5, P116, DOI [10.1111/j.1751-7915.2011.00310.x, 10.1111/j.1751-7915.2012.00347.x]; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Muller S, 2010, CURR OPIN BIOTECH, V21, P100, DOI 10.1016/j.copbio.2010.01.002; Mustafi N, 2012, METAB ENG, V14, P449, DOI 10.1016/j.ymben.2012.02.002; Neumeyer A, 2013, MICROB BIOTECHNOL, V6, P157, DOI 10.1111/1751-7915.12018; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Radmacher E, 2002, APPL ENVIRON MICROB, V68, P2246, DOI 10.1128/AEM.68.5.2246-2250.2002; Sambrook J., 2001, MOL CLONING LAB MANU; Schafer A, 1997, GENE, V203, P95, DOI 10.1016/S0378-1119(97)00519-2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schreiner ME, 2006, J BACTERIOL, V188, P1341, DOI 10.1128/JB.188.4.1341-1350.2006; Schreiner ME, 2005, J BACTERIOL, V187, P6005, DOI 10.1128/JB.187.17.6005-6018.2005; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Strack RL, 2009, BIOCHEMISTRY-US, V48, P9704, DOI 10.1021/bi901587v; Takors R, 2012, J BIOTECHNOL, V160, P3, DOI 10.1016/j.jbiotec.2011.12.010; Trotschel C, 2005, J BACTERIOL, V187, P3786, DOI 10.1128/JB.187.11.3786-3794.2005; Unthan S, 2014, BIOTECHNOL BIOENG, V111, P359, DOI 10.1002/bit.25103; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wendisch V. F., 2007, AMINO ACID BIOSYNTHE; Yin L, 2013, J APPL MICROBIOL, V114, P1369, DOI 10.1111/jam.12141; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003	52	78	83	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85731	10.1371/journal.pone.0085731	http://dx.doi.org/10.1371/journal.pone.0085731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465669	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000056
J	Sun, Y; Yang, YX; Zeng, SC; Tan, YQ; Lu, GX; Lin, G				Sun, Yi; Yang, Yixuan; Zeng, Sicong; Tan, Yueqiu; Lu, Guangxiu; Lin, Ge			Identification of Proteins Related to Epigenetic Regulation in the Malignant Transformation of Aberrant Karyotypic Human Embryonic Stem Cells by Quantitative Proteomics	PLOS ONE			English	Article							CARCINOMA-CELLS; COPY NUMBER; DNA METHYLTRANSFERASES; PROMYELOCYTIC LEUKEMIA; HISTONE DEACETYLASES; GENOMIC INSTABILITY; EXPRESSED PROTEINS; GASTRIC-CANCER; SELF-RENEWAL; BETA-CATENIN	Previous reports have demonstrated that human embryonic stem cells (hESCs) tend to develop genomic alterations and progress to a malignant state during long-term in vitro culture. This raises concerns of the clinical safety in using cultured hESCs. However, transformed hESCs might serve as an excellent model to determine the process of embryonic stem cell transition. In this study, ITRAQ-based tandem mass spectrometry was used to quantify normal and aberrant karyotypic hESCs proteins from simple to more complex karyotypic abnormalities. We identified and quantified 2583 proteins, and found that the expression levels of 316 proteins that represented at least 23 functional molecular groups were significantly different in both normal and abnormal hESCs. Dysregulated protein expression in epigenetic regulation was further verified in six pairs of hESC lines in early and late passage. In summary, this study is the first large-scale quantitative proteomic analysis of the malignant transformation of aberrant karyotypic hESCs. The data generated should serve as a useful reference of stem cell-derived tumor progression. Increased expression of both HDAC2 and CTNNB1 are detected as early as the pre-neoplastic stage, and might serve as prognostic markers in the malignant transformation of hESCs.	[Sun, Yi; Zeng, Sicong; Tan, Yueqiu; Lu, Guangxiu; Lin, Ge] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Sun, Yi; Tan, Yueqiu; Lu, Guangxiu; Lin, Ge] Natl Engn & Res Ctr Human Stem Cells, Changsha, Hunan, Peoples R China; [Sun, Yi; Tan, Yueqiu; Lin, Ge] Minist Hlth, Key Lab Stem Cells & Reprod Engn, Changsha, Hunan, Peoples R China; [Yang, Yixuan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ China, Affiliated Hosp 2, Chongqing, Peoples R China	Central South University; Chongqing Medical University; Ministry of Education, China	Lu, GX (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China.	lugxdirector@aliyun.com; linggf@hotmail.com	yang, yx/GZM-0464-2022	Sun, Yi/0000-0001-9238-976X	National Basic Research Program of China (973 program) [2011CB964900]; National Natural Science Foundation of China [81101510]; Natural Science Foundation of Hunan Province [14JJ2004, 09JJ4009]; Research Fund for the Doctoral Program of Higher Education of China [200805331133]; National High Technology Research and Development Program of China (863 program) [2006AA02A102]; Fundamental Research Funds for the Central Universities [201012200219]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 program 2011CB964900), the National Natural Science Foundation of China (81101510), the Natural Science Foundation of Hunan Province (14JJ2004 and 09JJ4009), the Research Fund for the Doctoral Program of Higher Education of China (200805331133), National High Technology Research and Development Program of China (863 program 2006AA02A102), and the Fundamental Research Funds for the Central Universities (201012200219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; ANDREWS PW, 1984, LAB INVEST, V50, P147; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Chaerkady R, 2010, PROTEOMICS, V10, P1359, DOI 10.1002/pmic.200900483; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Geiman TM, 2004, BIOCHEM BIOPH RES CO, V318, P544, DOI 10.1016/j.bbrc.2004.04.058; Gerwe BA, 2011, PROTEOMICS, V11, P2515, DOI 10.1002/pmic.201000032; Giudice FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058672; Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/ol.2012.1057; Guo T, 2008, J PROTEOME RES, V7, P4831, DOI 10.1021/pr800403z; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Hatzimichael E, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/529312; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Rodriguez-Jimenez FJ, 2008, STEM CELLS, V26, P2052, DOI 10.1634/stemcells.2007-1016; Kim JK, 2013, MOL CANCER RES, V11, P62, DOI 10.1158/1541-7786.MCR-12-0332; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz P, 2003, PROTEOMICS, V3, P991, DOI 10.1002/pmic.200300412; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Martens-de Kemp SR, 2013, CLIN CANCER RES, V19, P1994, DOI 10.1158/1078-0432.CCR-12-2539; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Papachristou EK, 2013, J PROTEOME RES, V12, P2078, DOI 10.1021/pr301067r; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Sun Y, 2007, FEBS LETT, V581, P131, DOI 10.1016/j.febslet.2006.12.008; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Turner-Ivey B, 2013, ONCOGENE, DOI [10.1038/onc.2012.624, DOI 10.1038/0NC.2012.624]; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang DJ, 2004, J PROTEOME RES, V3, P627, DOI 10.1021/pr049976r; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Yang S, 2010, CELL PROLIFERAT, V43, P195, DOI 10.1111/j.1365-2184.2010.00669.x; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Yang YX, 2012, J PROTEOME RES, V11, P5736, DOI 10.1021/pr300555y; Yang YX, 2010, J PROTEOME RES, V9, P4767, DOI 10.1021/pr100492x; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zhou D, 2009, CELL BIOL INT, V33, P796, DOI 10.1016/j.cellbi.2009.04.008	60	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85823	10.1371/journal.pone.0085823	http://dx.doi.org/10.1371/journal.pone.0085823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465727	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000066
J	Zhang, CH; Zhang, J; Zhao, H; Liang, JM				Zhang, Chunhui; Zhang, Jun; Zhao, Heng; Liang, Jimin			A Part-Based Probabilistic Model for Object Detection with Occlusion	PLOS ONE			English	Article							CLASS RECOGNITION; FACE RECOGNITION; SPARSE	The part-based method has been a fast rising framework for object detection. It is attracting more and more attention for its detection precision and partial robustness to the occlusion. However, little research has been focused on the problem of occlusion overlapping of the part regions, which can reduce the performance of the system. This paper proposes a part-based probabilistic model and the corresponding inference algorithm for the problem of the part occlusion. The model is based on the Bayesian theory integrally and aims to be robust to the large occlusion. In the stage of the model construction, all of the parts constitute the vertex set of a fully connected graph, and a binary variable is assigned to each part to indicate its occlusion status. In addition, we introduce a penalty term to regularize the argument space of the objective function. Thus, the part detection is formulated as an optimization problem, which is divided into two alternative procedures: the outer inference and the inner inference. A stochastic tentative method is employed in the outer inference to determine the occlusion status for each part. In the inner inference, the gradient descent algorithm is employed to find the optimal positions of the parts, in term of the current occlusion status. Experiments were carried out on the Caltech database. The results demonstrated that the proposed method achieves a strong robustness to the occlusion.	[Zhang, Chunhui; Zhang, Jun; Zhao, Heng; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	Xidian University	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn	Liang, Jimin/B-5394-2014	Liang, Jimin/0000-0003-1428-5804	973 program [2011CB707702]; National Natural Science Foundation of China [81090272]	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the 973 program under Grant No. 2011CB707702 and the National Natural Science Foundation of China under Grant No. 81090272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, IEEE T PATTERN ANAL, V26, P1475, DOI 10.1109/TPAMI.2004.108; Amit Y., 2002, 2D OBJECT DETECTION; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; CHOU PB, 1990, INT J COMPUT VISION, V4, P185, DOI 10.1007/BF00054995; Crandall D, 2005, PROC CVPR IEEE, P10; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Fei-Fei L, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1134, DOI 10.1109/ICCV.2003.1238476; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; Felzenszwalb P., 2008, P 2008 IEEE C COMP V, P1; Felzenszwalb P.F., 2012, THEORY COMPUT, V8, P415, DOI DOI 10.4086/TOC.2012.V008A019; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Fergus R, 2005, PROC CVPR IEEE, P380; Fergus R, 2003, PROC CVPR IEEE, P264; FISCHLER MA, 1973, IEEE T COMPUT, VC 22, P67, DOI 10.1109/T-C.1973.223602; Frey BJ, 1998, ADV NEUR IN, V10, P479; Gross R, 2004, IEEE C COMP VIS PATT, V72; Jiang XY, 2011, PATTERN RECOGN, V44, P2008, DOI 10.1016/j.patcog.2011.03.010; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kolmogorov V, 2004, IEEE T PATTERN ANAL, V26, P147, DOI 10.1109/TPAMI.2004.1262177; Lazebnik S, 2005, IEEE I CONF COMP VIS, P832, DOI 10.1109/ICCV.2005.10; Li SF, 2012, PATTERN RECOGN, V45, P3402, DOI 10.1016/j.patcog.2012.03.011; Li Y, 2009, PROC CVPR IEEE, P2458; Mikolajczyk K, 2004, LECT NOTES COMPUT SC, V3021, P69; Moghaddam B, 1997, IEEE T PATTERN ANAL, V19, P696, DOI 10.1109/34.598227; Papandreou George, 2008, COMP VIS PATT REC 20, P1; Peng YG, 2010, PROC CVPR IEEE, P763, DOI 10.1109/CVPR.2010.5540138; Rowley HA, 1998, PROC CVPR IEEE, P38, DOI 10.1109/CVPR.1998.698585; Schneiderman H, 1998, PROC CVPR IEEE, P45, DOI 10.1109/CVPR.1998.698586; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Wagner A, 2009, PROC CVPR IEEE, P597, DOI 10.1109/CVPRW.2009.5206654; Wen M, 2007, LECT NOTES ARTIF INT, V4482, P526; Yang XW, 2012, PATTERN RECOGN, V45, P1927, DOI 10.1016/j.patcog.2011.11.010; Zhao XY, 2011, PATTERN RECOGN, V44, P1296, DOI 10.1016/j.patcog.2010.11.022; Zhou ZH, 2009, IEEE I CONF COMP VIS, P1050, DOI 10.1109/ICCV.2009.5459383	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84624	10.1371/journal.pone.0084624	http://dx.doi.org/10.1371/journal.pone.0084624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465420	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000015
J	Jami, E; White, BA; Mizrahi, I				Jami, Elie; White, Bryan A.; Mizrahi, Itzhak			Potential Role of the Bovine Rumen Microbiome in Modulating Milk Composition and Feed Efficiency	PLOS ONE			English	Article							GUT MICROBIOME; BACTERIAL; PREVOTELLA; COWS	Ruminants are completely dependent on their microbiota for feed digestion and consequently, their viability. It is therefore tempting to hypothesize a connection between the composition and abundance of resident rumen bacterial taxa and the physiological parameters of the host. Using a pyrosequencing approach, we characterized the rumen bacterial community composition in 15 dairy cows and their physiological parameters. We analyzed the degree of divergence between the different animals and found that some physiological parameters, such as milk yield and composition, are highly correlated with the abundance of various bacterial members of the rumen microbiome. One apparent finding was a strong correlation between the ratio of the phyla Firmicutes to Bacteroidetes and milk-fat yield. These findings paralleled human studies showing similar trends of increased adiposity with an increase in Bacteroidetes. This correlation remained evident at the genus level, where several genera showed correlations with the animals' physiological parameters. This suggests that the bacterial community has a role in shaping host physiological parameters. A deeper understanding of this process may allow us to modulate the rumen microbiome for better agricultural yield through bacterial community design.	[Jami, Elie; Mizrahi, Itzhak] Agr Res Org, Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel; [Jami, Elie] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Tel Aviv University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Mizrahi, I (corresponding author), Agr Res Org, Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel.	itzhakm@agri.gov.il		Jami, Elie/0000-0002-2839-0843	BARD the United States-Israel Binational Agricultural research development Fund [IS-4390-11]	BARD the United States-Israel Binational Agricultural research development Fund	This research was supported by Research Grant No. IS-4390-11 from BARD the United States-Israel Binational Agricultural research development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer JA, 1999, AUST J AGR RES, V50, P147, DOI 10.1071/A98075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiquette J, 2008, J DAIRY SCI, V91, P3536, DOI 10.3168/jds.2007-0849; DEHORITY BA, 1980, APPL ENVIRON MICROB, V39, P376, DOI 10.1128/AEM.39.2.376-381.1980; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hernandez-Sanabria E, 2010, APPL ENVIRON MICROB, V76, P6338, DOI 10.1128/AEM.01052-10; HURTAUD C, 1993, J DAIRY SCI, V76, P3011, DOI 10.3168/jds.S0022-0302(93)77640-7; Jami E, 2012, J DAIRY SCI, V95, P5996, DOI 10.3168/jds.2012-5537; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Mizrahi I, 2011, BENEFICIAL MICROORGA; Mizrahi I., 2013, PROKARYOTES PROKARYO, P533, DOI DOI 10.1007/978-3-642-30194-0_1; NATIONAL RESEARCH COUNCIL-NRC, 2001, NUTR REQ DAIR CATTL; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wei T., 2012, PACKAGE CORRPLOT VIS	30	299	316	7	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85423	10.1371/journal.pone.0085423	http://dx.doi.org/10.1371/journal.pone.0085423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465556	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100041
J	Kim, SH; Yoo, C; Choo, M; Paick, JS; Oh, SJ				Kim, Sung Han; Yoo, Changwon; Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June			Factors Affecting De Novo Urinary Retention after Holmium Laser Enucleation of the Prostate	PLOS ONE			English	Article							TRANSURETHRAL RESECTION; LEARNING-CURVE; HYPERPLASIA; COMPLICATIONS; EXPERIENCE; MANAGEMENT; ABLATION; EFFICACY	Objective: Patients can experience urinary retention (UR) after Holmium laser enucleation of the prostate (HoLEP) that requires bladder distension during the procedure. The aim of this retrospective study is to identify factors affecting the UR after HoLEP. Materials and Methods: 336 patients, which underwent HoLEP for a symptomatic benign prostatic hyperplasia between July 2008 and March 2012, were included in this study. Urethral catheters were routinely removed one or two days after surgery. UR was defined as the need for an indwelling catheter placement following a failure to void after catheter removal. Demographic and clinical parameters were compared between the UR (n = 37) and the non-urinary retention (non-UR; n = 299) groups. Results: The mean age of patients was 68.3 (+/- 6.5) years and the mean operative time was 75.3 (+/- 37.4) min. Thirty seven patients (11.0%) experienced a postoperative UR. UR patients voided catheter free an average of 1.9 (+/- 1.7) days after UR. With regard to the causes of UR, 24 (7.1%) and 13 (3.9%) patients experienced a blood clot-related UR and a non-clot related UR respectively. Using multivariate analysis (p<0.05), we found significant differences between the UR and the non-UR groups with regard to a morcellation efficiency (OR 0.701, 95% CI 0.498-0.988) and a bleeding-related complication, such as, a reoperation for bleeding (OR 0.039, 95% CI 0.004-0.383) or a transfusion (OR 0.144, 95% CI 0.027-0.877). Age, history of diabetes, prostate volume, pre-operative post-void residual, bladder contractility index, learning curve, and operative time wwere not significantly associated with the UR (p>0.05). Conclusions: De novo UR after HoLEP was found to be self-limited and it was not related to learning curve, patient age, diabetes, or operative time. Efficient morcellation and careful control of bleeding, which reduces clot formation, decrease the risk of UR after HoLEP.	[Kim, Sung Han] Natl Canc Ctr, Dept Urol, Goyang, Gyeonggi, South Korea; [Yoo, Changwon] Florida Int Univ, Dept Biostat, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	National Cancer Center - Korea (NCC); State University System of Florida; Florida International University; Seoul National University (SNU); Seoul National University Hospital	Oh, SJ (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	sjo@snu.ac.kr	; Oh, Seung-June/D-6015-2012	Yoo, Changwon/0000-0003-0969-7468; Oh, Seung-June/0000-0002-0322-3539; KIM, Sung Han/0000-0002-1689-5203				Bae Jungbum, 2011, Int Neurourol J, V15, P29, DOI 10.5213/inj.2011.15.1.29; Bae J, 2010, KOREAN J UROL, V51, P688, DOI 10.4111/kju.2010.51.10.688; Djavan B, 1997, J UROLOGY, V158, P1829, DOI 10.1016/S0022-5347(01)64139-9; Du CJ, 2008, J ENDOUROL, V22, P1031, DOI 10.1089/end.2007.0262; Dubey D, 2001, BJU INT, V88, P178, DOI 10.1046/j.1464-410x.2001.02273.x; Eltabey MA, 2010, CAN J UROL, V17, P5447; Elzayat EA, 2006, EUR UROL, V49, P87, DOI 10.1016/j.eururo.2005.08.015; Elzayat EA, 2005, UROLOGY, V66, P789, DOI 10.1016/j.urology.2005.04.049; Elzayat EA, 2005, UROLOGY, V66, P108, DOI 10.1016/j.urology.2005.06.006; Elzayat EA, 2006, WORLD J UROL, V24, P410, DOI 10.1007/s00345-006-0063-5; GILLING PJ, 1995, J ENDOUROL, V9, P151, DOI 10.1089/end.1995.9.151; Hettiarachchi JA, 2002, INT J UROL, V9, P233, DOI 10.1046/j.1442-2042.2002.00457.x; Jeong CW, 2012, INT BRAZ J UROL, V38, P362, DOI 10.1590/S1677-55382012000300009; Kim M, 2013, KOREAN J UROL, V54, P570, DOI 10.4111/kju.2013.54.9.570; KUO HC, 1993, EUR UROL, V24, P12; Kuo RL, 2003, UROLOGY, V62, P59, DOI 10.1016/S0090-4295(03)00124-9; Lane IF, 2000, VET CLIN N AM-SMALL, V30, P25, DOI 10.1016/S0195-5616(00)50002-3; Montorsi F, 2004, J UROLOGY, V172, P1926, DOI 10.1097/01.ju.0000140501.68841.a1; Okamura K, 2011, INT J UROL, V18, P304, DOI 10.1111/j.1442-2042.2010.02712.x; Peterson MD, 2005, J UROLOGY, V174, P998, DOI 10.1097/01.ju.0000170230.26743.e4; Placer J, 2009, UROLOGY, V73, P1042, DOI 10.1016/j.urology.2008.12.052; Rieken M, 2010, WORLD J UROL, V28, P53, DOI 10.1007/s00345-009-0504-z; Shimizu Nobutaka, 2006, Nihon Hinyokika Gakkai Zasshi, V97, P839; Suardi N, 2009, CURR OPIN UROL, V19, P38, DOI 10.1097/MOU.0b013e32831a7008; Tan A, 2007, BRIT J SURG, V94, P1201, DOI 10.1002/bjs.5916	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84938	10.1371/journal.pone.0084938	http://dx.doi.org/10.1371/journal.pone.0084938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465454	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500023
J	Shin, JY; Kim, YI; Cho, SJ; Lee, MK; Kook, MC; Lee, JH; Lee, SS; Ashktorab, H; Smoot, DT; Ryu, KW; Kim, YW; Choi, IJ				Shin, Ji-Young; Kim, Young-Il; Cho, Soo-Jeong; Lee, Mi Kyung; Kook, Myeong-Cherl; Lee, Jun Ho; Lee, Sang Soo; Ashktorab, Hassan; Smoot, Duane T.; Ryu, Keun Won; Kim, Young-Woo; Choi, Il Ju			MicroRNA 135a Suppresses Lymph Node Metastasis through Down-Regulation of ROCK1 in Early Gastric Cancer	PLOS ONE			English	Article							UPPER GASTROINTESTINAL-TRACT; SIGNALING PATHWAY; MESENCHYMAL TRANSITION; SUBMUCOSAL INVASION; CELL-PROLIFERATION; PROMOTES; FEASIBILITY; INHIBITION; EXPRESSION	MicroRNAs (miRNAs) play a critical role in gastric cancer progression and metastasis. This study investigated the role of miRNA-135a in early gastric cancer (EGC) including lymph node (LN) metastasis. We examined the correlation between miRNA-135a expression and clinical outcomes in 59 patients who underwent surgery for EGC. Using gastric cancer cell lines, we performed functional and target gene analyses. miRNA-135a expression was down-regulated in 33.9% of patients. These patients showed a significantly more advanced stage (TNM stage >= IB, 35.0% vs. 12.8%, p = 0.045) and higher rate of LN metastasis (30.0% vs. 5.1%, p = 0.014) than those with up-regulation of miRNA-135a expression. In a multivariate analysis, down-regulation of miRNA-135a was an independent risk factor for LN metastasis (adjusted odds ratio, 8.04; 95% confidence interval, 1.08-59.81; p = 0.042). Functional analyses using gastric cancer cell lines showed that miRNA-135a suppressed cell viability, epithelial-mesenchymal transition, cell invasion, and migration. ROCK1 was a target of miRNA-135a and its expression was inversely correlated to that of miRNA-135a. ROCK1 expression was significantly increased in EGC patients with LN metastasis than in those without LN metastasis. Our results confirm the tumor-suppressive role of miRNA-135a, and demonstrate its role in LN metastasis in EGC. miRNA-135a and its target gene ROCK1 may be novel therapeutic and prognostic targets for EGC.	[Shin, Ji-Young; Kim, Young-Il; Cho, Soo-Jeong; Lee, Mi Kyung; Kook, Myeong-Cherl; Lee, Jun Ho; Ryu, Keun Won; Kim, Young-Woo; Choi, Il Ju] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Shin, Ji-Young; Lee, Sang Soo] Paichai Univ, Dept Life Sci & Biotechnol, Taejon, South Korea; [Ashktorab, Hassan; Smoot, Duane T.] Howard Univ, Dept Med, Washington, DC 20059 USA	National Cancer Center - Korea (NCC); Pai Chai University; Howard University	Cho, SJ (corresponding author), Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea.	crystal522@daum.net	Ashktorab, hassan/AAJ-2908-2020	CHO, SOO-JEONG/0000-0001-7144-0589; Kim, Young-Woo/0000-0002-1559-9672	National Cancer Center, Korea [1110532-3]	National Cancer Center, Korea	This study was funded by grant 1110532-3 from the National Cancer Center, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; An JY, 2007, ANN SURG, V246, P749, DOI 10.1097/SLA.0b013e31811f3fb7; Arigami T, 2006, ANN SURG, V243, P341, DOI 10.1097/01.sla.0000201453.65534.f1; Borie F, 2000, ARCH SURG-CHICAGO, V135, P1218, DOI 10.1001/archsurg.135.10.1218; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Gao M, 2013, WORLD J GASTROENTERO, V19, P2019, DOI 10.3748/wjg.v19.i13.2019; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jia LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058637; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Park DJ, 2004, WORLD J GASTROENTERO, V10, P3549, DOI 10.3748/wjg.v10.i24.3549; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Ryu KW, 2012, J GASTRIC CANCER, V12, P1, DOI 10.5230/jgc.2012.12.1.1; Shimizu Y, 2012, ANN SURG ONCOL, V19, P469, DOI 10.1245/s10434-011-2122-4; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Song SM, 2013, NAT REV GASTRO HEPAT, V10, P109, DOI 10.1038/nrgastro.2012.210; Takeuchi H, 2013, ANN SURG ONCOL, V20, P522, DOI 10.1245/s10434-012-2602-1; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Wu H, 2012, CANCER BIOL THER, V13, P281, DOI 10.4161/cbt.18943; Wu Y J, 2013, ASIA-PAC J CLIN ONCO, DOI [10.1111/ajco.12052, DOI 10.1111/AJC0.12052]; Xu XT, 2012, HEPATO-GASTROENTEROL, V59, P2523, DOI 10.5754/hge12147; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yoon JH, 2013, J CELL BIOCHEM, V114, P1800, DOI 10.1002/jcb.24524; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714	42	36	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85205	10.1371/journal.pone.0085205	http://dx.doi.org/10.1371/journal.pone.0085205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465504	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500042
J	Yu, YY; Jiang, LM; Zhuang, ZQ; Liu, YW; Wang, XY; Liu, JY; Yang, MN; Chen, WH				Yu, Yanyan; Jiang, Luman; Zhuang, Ziqing; Liu, Yuewei; Wang, Xinyan; Liu, Juyuan; Yang, Mingna; Chen, Weihong			Fitting Characteristics of N95 Filtering-Facepiece Respirators Used Widely in China	PLOS ONE			English	Article							FACE ANTHROPOMETRIC SURVEY; HALF-MASK RESPIRATOR; TEST PANEL; FIT; PROTECTION; DIMENSIONS; WORKERS; SIZE	Background: Millions of people rely on N95 filtering facepiece respirators to reduce the risk of airborne particles and prevent them from respiratory infections. However, there are no respirator fit testing and training regulations in China. Meanwhile, no study has been conducted to investigate the fit of various respirators. The objective of this study was to investigate whether people obtained adequate fit when wearing N95 filtering facepiece respirators (FFRs) used widely in China. Methods: Fifty adult participants selected using the Chinese respirator fit test panel donned 10 common models of N95 FFRs. Fit factors (FF) and inward leakage were measured using the TSI PortaCount Plus. Each subject was tested with three replications for each model. A subject was considered to pass the fit test when at least two of the three FFs were greater than 100. Two models were conducted fit tests before and after training to assess the role of training. Results: The geometric mean FFs for each model and trained subjects ranged from <10 to 74.0. The fifth percentile FFs for only two individual respirator models were greater than 10 which is the expected level of performance for FFRs. The passing rates for these two models of FFRs were 44.7% and 20.0%. The passing rates were less than 10.0% for the other eight models. There were 27 (54%) participants who passed none of the 10 FFRs. The geometric mean FFs for both models when the subjects received training (49.7 and 74.0) were significantly larger than those when the same group of subjects did not receive any training (29.0 and 30.9) (P<0.05). Conclusions: FFRs used widely in China should be improved according to Chinese facial dimensions. Respirator users could benefit from respirator training and fit testing before using respirators.	[Yu, Yanyan; Jiang, Luman; Liu, Yuewei; Wang, Xinyan; Chen, Weihong] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yu, Yanyan; Jiang, Luman; Chen, Weihong] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Yu, Yanyan; Jiang, Luman; Chen, Weihong] Huazhong Univ Sci & Technol, Minist Environm Protect, Wuhan 430074, Peoples R China; [Yu, Yanyan; Jiang, Luman; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China; [Zhuang, Ziqing] NIOSH, Natl Personal Protect Technol Lab, Pittsburgh, PA USA; [Liu, Juyuan; Yang, Mingna] Guangzhou Occupat Safety & Hlth Safety Technol Co, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	wchen@mails.tjmu.edu.cn	Yu, Yan/GYV-4514-2022; Chen, Weihong/D-2177-2011; Liu, Yuewei/J-5147-2019	Chen, Weihong/0000-0001-8689-7311; Liu, Yuewei/0000-0001-5970-4262	Chinese National Basic Research Program of China [2011CB503804]; research project in Administration of Work Safety of Guangdong Province	Chinese National Basic Research Program of China; research project in Administration of Work Safety of Guangdong Province	This work was supported by research funds from Chinese National Basic Research Program of China (2011CB503804) and from research project in Administration of Work Safety of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charles EC, 1972, TR705 AER MED RES LA; Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206; Chen WH, 2009, ANN OCCUP HYG, V53, P297, DOI 10.1093/annhyg/men089; China National Institute of Standardization, 2006, GB26262006 CHIN NAT; China National Institute of Standardization, 2002, 186642002 GBT CHIN N; Coffey CC, 2004, J OCCUP ENVIRON HYG, V1, P262, DOI 10.1080/15459620490433799; Du LL, 2008, ANN OCCUP HYG, V52, P773, DOI 10.1093/annhyg/men056; Europen Committee for Standardization, 2001, EN149 EUR COMM STAND; HACK AL, 1978, AM IND HYG ASSOC J, V39, P970, DOI 10.1080/0002889778507897; Han DH, 2005, ANN OCCUP HYG, V49, P569, DOI 10.1093/annhyg/mei034; Han DH, 2000, ANN OCCUP HYG, V44, P227, DOI 10.1016/S0003-4878(99)00087-3; Health BoLSNIfOSa, 2003, RESP US PRIV SECT FI; KENNEDY KW, 1986, AAMRLTR85062 WRIGHT; Kiely PM, 2009, CLIN EXP OPTOM, V92, P490, DOI 10.1111/j.1444-0938.2009.00420.x; Martyny J, 2002, NEW ENGL J MED, V347, P824, DOI 10.1056/NEJMra012670; Ministry of Agriculture of China, 2009, CHIN ANN HLTH STAT R, P24; Occupational Safety and Healh Administration, 1995, AIDS ALERT, V10, P154; OESTENSTAD RK, 1990, AM IND HYG ASSOC J, V51, P285, DOI 10.1202/0002-8894(1990)051<0285:DOFLSO>2.0.CO;2; OESTENSTAD RK, 1992, AM IND HYG ASSOC J, V53, P639, DOI 10.1202/0002-8894(1992)053<0639:AAOCAD>2.0.CO;2; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Spies A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-17; Viscusi DJ, 2012, J OCCUP ENVIRON HYG, V9, P408, DOI 10.1080/15459624.2012.683757; Yang L, 2007, ANN OCCUP HYG, V51, P415, DOI 10.1093/annhyg/mem005; Yu Yan-yan, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P348; Zhuang Z., 2007, INT WORKSH DUST PATH, P35; Zhuang ZQ, 2008, J OCCUP ENVIRON HYG, V5, P617, DOI 10.1080/15459620802293810; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P641, DOI 10.1080/15459620500391668; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P567, DOI 10.1080/15459620500324727	28	22	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85299	10.1371/journal.pone.0085299	http://dx.doi.org/10.1371/journal.pone.0085299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465528	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500051
J	Zhang, YC; Lu, L; Jia, JP; Jia, LF; Geula, C; Pei, JJ; Xu, ZQ; Qin, W; Liu, RQ; Li, D; Pan, N				Zhang, Yichi; Lu, Lu; Jia, Jianping; Jia, Longfei; Geula, Changiz; Pei, Jinjing; Xu, Zhiqing; Qin, Wei; Liu, Ruiqin; Li, Dan; Pan, Na			A Lifespan Observation of a Novel Mouse Model: In Vivo Evidence Supports A beta Oligomer Hypothesis	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; TAU-HYPERPHOSPHORYLATION; SYNAPSE LOSS; NEURON LOSS; MUTANT PRESENILIN-1; NATURAL OLIGOMERS; MEMORY DEFICITS; BRAINS	Transgenic mouse models are powerful tools in exploring the mechanisms of AD. Most current transgenic models of AD mimic the memory impairment and the main pathologic features, among which the formation of beta-amyloid (A beta) plaques is considered a dominant pathologic event. Recently, A beta oligomers have been identified as more neurotoxic than A beta plaques. However, no ideal transgenic mouse model directly support A beta oligomers as a neurotoxic species due to the puzzling effects of amyloid plaques in the more widely-used models. Here, we constructed a single-mutant transgenic (Tg) model harboring the PS1(V97L) mutation and used Non-Tg littermates as a control group. Employing the Morris water maze, electrophysiology, immunohistochemistry, biochemistry, and electron microscopy, we investigated behavioral changes and pathology progression in our single-mutant transgenic model. We discovered the pathological alteration of intraneuronal accumulation of A beta oligomers without A beta plaques in the PS1(V97L)-Tg mouse model, which might be the result of PS1 gene mutation. Following A beta oligomers, we detected synaptic alteration, tau hyperphosphorylation and glial activation. This model supports an initial role for A beta oligomers in the onset of AD and suggests that A beta plaques may not be the only prerequisite. This model provides a useful tool for studying the role of A beta oligomers in AD pathogenesis.	[Zhang, Yichi; Lu, Lu; Jia, Jianping; Qin, Wei; Liu, Ruiqin; Li, Dan] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Jia, Jianping; Qin, Wei; Liu, Ruiqin; Li, Dan] Beijing Key Lab Geriatr Cognit Disorders, Beijing, Peoples R China; [Jia, Jianping; Qin, Wei; Liu, Ruiqin; Li, Dan] Minist Educ Peoples Republ China, Key Neurodegenerat Lab, Beijing, Peoples R China; [Jia, Longfei] Capital Med Univ, Beijing Tong Ren Hosp, Dept Neurol, Beijing, Peoples R China; [Pei, Jinjing] Karolinska Inst, Dept Neurobiol, Stockholm, Sweden; [Geula, Changiz] Northwestern Univ, Lab Cognit & Mol Morphometry, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Xu, Zhiqing; Pan, Na] Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China	Capital Medical University; Ministry of Education, China; Capital Medical University; Karolinska Institutet; Northwestern University; Capital Medical University	Jia, JP (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.	jiajp@vip.126.com	Xu, Zhi-Qing David/H-9757-2013	Xu, Zhi-Qing David/0000-0002-0387-7559	CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders [812111340]; National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period [2011ZX09307-001-02]; Science and Technology Plan of the Beijing Municipal Science & Technology Commission [SCW 2011-10]	CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders; National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period; Science and Technology Plan of the Beijing Municipal Science & Technology Commission	This work was supported by CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders (812111340), the National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period (2011ZX09307-001-02), and the major project of the Science and Technology Plan of the Beijing Municipal Science & Technology Commission (SCW 2011-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff I, 2006, J NEUROPATH EXP NEUR, V65, P740, DOI 10.1097/01.jnen.0000229986.17548.27; ALLSOP D, 1988, P NATL ACAD SCI USA, V85, P2790, DOI 10.1073/pnas.85.8.2790; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Ferretti MT, 2012, NEUROBIOL AGING, V33, P1329, DOI 10.1016/j.neurobiolaging.2011.01.007; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Jia JP, 2005, J ALZHEIMERS DIS, V7, P119; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leon WC, 2010, J ALZHEIMERS DIS, V20, P113, DOI 10.3233/JAD-2010-1349; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang Y, 2012, J NEUROCHEM, V121, P135, DOI 10.1111/j.1471-4159.2011.07489.x; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; Zheng K, 2005, NEUROPEPTIDES, V39, P259, DOI 10.1016/j.npep.2005.02.005	64	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85885	10.1371/journal.pone.0085885	http://dx.doi.org/10.1371/journal.pone.0085885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465766	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500136
J	Marinov, GK; Wang, YE; Chan, D; Wold, BJ				Marinov, Georgi K.; Wang, Yun E.; Chan, David; Wold, Barbara J.			Evidence for Site-Specific Occupancy of the Mitochondrial Genome by Nuclear Transcription Factors	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; ELECTRON-TRANSPORT CHAIN; NF-KAPPA-B; IN-VIVO; GENE-EXPRESSION; HEAVY-STRAND; GLUCOCORTICOID RECEPTOR; SIGNAL TRANSDUCER; THYROID-HORMONE; RNA-POLYMERASE	Mitochondria contain their own circular genome, with mitochondria-specific transcription and replication systems and corresponding regulatory proteins. All of these proteins are encoded in the nuclear genome and are post-translationally imported into mitochondria. In addition, several nuclear transcription factors have been reported to act in mitochondria, but there has been no comprehensive mapping of their occupancy patterns and it is not clear how many other factors may also be found in mitochondria. Here we address these questions by using ChIP-seq data from the ENCODE, mouseENCODE and modENCODE consortia for 151 human, 31 mouse and 35 C. elegans factors. We identified 8 human and 3 mouse transcription factors with strong localized enrichment over the mitochondrial genome that was usually associated with the corresponding recognition sequence motif. Notably, these sites of occupancy are often the sites with highest ChIP-seq signal intensity within both the nuclear and mitochondrial genomes and are thus best explained as true binding events to mitochondrial DNA, which exist in high copy number in each cell. We corroborated these findings by immunocytochemical staining evidence for mitochondrial localization. However, we were unable to find clear evidence for mitochondrial binding in ENCODE and other publicly available ChIP-seq data for most factors previously reported to localize there. As the first global analysis of nuclear transcription factors binding in mitochondria, this work opens the door to future studies that probe the functional significance of the phenomenon.	[Marinov, Georgi K.; Wang, Yun E.; Chan, David; Wold, Barbara J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chan, David] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Marinov, GK (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	georgi@caltech.edu			Beckman Institute Functional Genomics Center; Donald Bren Endowment; NIH [U54 HG004576, U54 HG006998, GM062967]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, U54HG004576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	Beckman Institute Functional Genomics Center; Donald Bren Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study has been supported by the Beckman Institute Functional Genomics Center, the Donald Bren Endowment, and NIH grants U54 HG004576, U54 HG006998, and GM062967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2000, FEBS LETT, V478, P4, DOI 10.1016/S0014-5793(00)01814-7; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Chueh FY, 2010, BIOCHEM BIOPH RES CO, V402, P778, DOI 10.1016/j.bbrc.2010.10.112; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; DEMONACOS C, 1993, J STEROID BIOCHEM, V46, P401, DOI 10.1016/0960-0760(93)90231-K; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; DUBUY HG, 1967, P NATL ACAD SCI USA, V57, P790; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Enriquez JA, 1999, BIOL CHEM, V380, P737, DOI 10.1515/BC.1999.094; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Heyne K, 2004, FEBS LETT, V578, P198, DOI 10.1016/j.febslet.2004.10.099; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson RF, 2011, CANCER RES, V71, P5588, DOI 10.1158/0008-5472.CAN-10-4252; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Koufali MM, 2003, MOL CELL ENDOCRINOL, V209, P51, DOI 10.1016/j.mce.2003.07.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Leigh-Brown S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-215; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Monje P, 2001, J CELL BIOCHEM, V82, P467, DOI 10.1002/jcb.1182; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nass S, 1965, BIOCHIM BIOPHYS ACTA, V95; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ogita K, 2003, J NEUROSCI RES, V73, P794, DOI 10.1002/jnr.10720; Ogita K, 2002, J NEUROSCI, V22, P2561, DOI 10.1523/JNEUROSCI.22-07-02561.2002; Psarra AMG, 2006, MOL CELL ENDOCRINOL, V246, P21, DOI 10.1016/j.mce.2005.11.025; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Szczepanek K, 2012, TRENDS CELL BIOL, V22, P429, DOI 10.1016/j.tcb.2012.05.001; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Szklarczyk R, 2010, PROTEOMICS, V10, P4012, DOI 10.1002/pmic.201000329; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074513; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yoshida Y, 2003, CANCER RES, V63, P3729	83	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84713	10.1371/journal.pone.0084713	http://dx.doi.org/10.1371/journal.pone.0084713			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465428	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330240500021
J	Aujoulat, F; Romano-Bertrand, S; Masnou, A; Marchandin, H; Jumas-Bilak, E				Aujoulat, Fabien; Romano-Bertrand, Sara; Masnou, Agnes; Marchandin, Helene; Jumas-Bilak, Estelle			Niches, Population Structure and Genome Reduction in Ochrobactrum intermedium: Clues to Technology-Driven Emergence of Pathogens	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPING SCHEME; SP NOV.; GENETIC DIVERSITY; BRUCELLA; BACTERIA; IDENTIFICATION; RESISTANCE; REVEALS; STRAINS	Ochrobactrum intermedium is considered as an emerging human environmental opportunistic pathogen with mild virulence. The distribution of isolates and sequences described in literature and databases showed frequent association with human beings and polluted environments. As population structures are related to bacterial lifestyles, we investigated by multi-locus approach the genetic structure of a population of 65 isolates representative of the known natural distribution of O. intermedium. The population was further surveyed for genome dynamics using pulsed-field gel electrophoresis and genomics. The population displayed a clonal epidemic structure with events of recombination that occurred mainly in clonal complexes. Concerning biogeography, clones were shared by human and environments and were both cosmopolitan and local. The main cosmopolitan clone was genetically and genomically stable, and grouped isolates that all harbored an atypical insertion in the rrs. Ubiquitism and stability of this major clone suggested a clonal succes in a particular niche. Events of genomic reduction were detected in the population and the deleted genomic content was described for one isolate. O. intermedium displayed allopatric characters associated to a tendancy of genome reduction suggesting a specialization process. Considering its relatedness with Brucella, this specialization might be a commitment toward pathogenic life-style that could be driven by technological selective pressure related medical and industrial technologies.	[Aujoulat, Fabien; Romano-Bertrand, Sara; Masnou, Agnes; Marchandin, Helene; Jumas-Bilak, Estelle] Univ Montpellier I, UMR ECOSYM 5119, Equipe Pathogenes & Environm, UFR Sci Pharmaceut & Biol, Montpellier, France; [Marchandin, Helene] Ctr Hosp Reg Univ Montpellier, Lab Bacteriol, Hop Arnaud de Villeneuve, Montpellier, France; [Jumas-Bilak, Estelle] CHU Montpellier, Lab Hyg Hosp, Montpellier, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Jumas-Bilak, E (corresponding author), Univ Montpellier I, UMR ECOSYM 5119, Equipe Pathogenes & Environm, UFR Sci Pharmaceut & Biol, Montpellier, France.	ebilak@univ-montp1.fr	Romano-Bertrand, Sara/N-3688-2016; MARCHANDIN, Hélène/AAM-8288-2021	MARCHANDIN, Hélène/0000-0003-2130-6335; Romano-Bertrand, Sara/0000-0002-6134-2210; Aujoulat, Fabien/0000-0001-6180-6903	French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	The funder is the French Ministry of Higher Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand M, 2007, INT J MED MICROBIOL, V297, P255, DOI 10.1016/j.ijmm.2007.02.001; Aujoulat F, 2012, GENES-BASEL, V3, P191, DOI 10.3390/genes3020191; Aujoulat F, 2011, J BACTERIOL, V193, P2608, DOI 10.1128/JB.00107-11; Babic I, 2000, MICROBIOL-UK, V146, P709, DOI 10.1099/00221287-146-3-709; Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893; Bevivino A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-228; Bidet P, 2007, J INFECT DIS, V196, P297, DOI 10.1086/518897; Boucher D, 2011, MICROB ECOL, V62, P868, DOI 10.1007/s00248-011-9887-7; Boukhatem ZF, 2012, FEMS MICROBIOL ECOL, V80, P534, DOI 10.1111/j.1574-6941.2012.01315.x; Bourg G, 2007, VET MICROBIOL, V125, P375, DOI 10.1016/j.vetmic.2007.06.002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eisenberg T, 2012, APPL ENVIRON MICROB, V78, P3753, DOI 10.1128/AEM.07509-11; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fischer D, 2012, J ZOO WILDLIFE MED, V43, P625, DOI 10.1638/2011-0005R2.1; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Graindorge A, 2012, J MED MICROBIOL, V61, P394, DOI 10.1099/jmm.0.036822-0; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Huber B, 2010, INT J SYST EVOL MICR, V60, P321, DOI 10.1099/ijs.0.011668-0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Imran A, 2010, INT J SYST EVOL MICR, V60, P1548, DOI 10.1099/ijs.0.013987-0; Iwashita S, 2004, APPL MICROBIOL BIOT, V65, P620, DOI 10.1007/s00253-004-1684-5; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Kaiser S, 2009, J BACTERIOL, V191, P2934, DOI 10.1128/JB.00892-08; Kavita B, 2012, 3 BIOTECH, V2, P79, DOI 10.1007/s13205-011-0038-0; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kulkarni G, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-7; Matyar F, 2008, SCI TOTAL ENVIRON, V407, P279, DOI 10.1016/j.scitotenv.2008.08.014; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Mira A, 2006, TRENDS MICROBIOL, V14, P200, DOI 10.1016/j.tim.2006.03.001; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nishino K, 2008, IUBMB LIFE, V60, P569, DOI 10.1002/iub.90; Pandey S, 2013, J MICROBIOL, V51, P11, DOI 10.1007/s12275-013-2330-7; Pandey S, 2010, CURR MICROBIOL, V61, P106, DOI 10.1007/s00284-010-9583-8; Perkins SD, 2010, FEMS MICROBIOL ECOL, V74, P643, DOI 10.1111/j.1574-6941.2010.00976.x; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Rezzonico F, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-204; Romano S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-267; Sallstrom B, 2005, CURR OPIN MICROBIOL, V8, P579, DOI 10.1016/j.mib.2005.08.002; Scholz HC, 2008, SYST APPL MICROBIOL, V31, P1, DOI 10.1016/j.syapm.2007.10.004; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; Teyssier C, 2005, J MED MICROBIOL, V54, P945, DOI 10.1099/jmm.0.46116-0; Teyssier C, 2005, ELECTROPHORESIS, V26, P2898, DOI 10.1002/elps.200410323; Teyssier C, 2003, PATHOL BIOL, V51, P5, DOI 10.1016/S0369-8114(02)00361-9; Teyssier C, 2003, J BACTERIOL, V185, P2901, DOI 10.1128/JB.185.9.2901-2909.2003; Teyssier C, 2007, INT J SYST EVOL MICR, V57, P1007, DOI 10.1099/ijs.0.64416-0; Thoma B, 2009, INT J MED MICROBIOL, V299, P209, DOI 10.1016/j.ijmm.2008.06.009; Tian YS, 2010, APPL ENVIRON MICROB, V76, P6001, DOI 10.1128/AEM.00770-10; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Wackerow-Kouzova ND, 2007, APPL BIOCHEM MICRO+, V43, P403, DOI 10.1134/S0003683807040084; Waranusantigul P, 2011, CHEMOSPHERE, V85, P584, DOI 10.1016/j.chemosphere.2011.06.086; Wattam AR, 2009, J BACTERIOL, V191, P3569, DOI 10.1128/JB.01767-08; Woo SG, 2011, INT J SYST EVOL MICR, V61, P2690, DOI 10.1099/ijs.0.025510-0; Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j	64	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83376	10.1371/journal.pone.0083376	http://dx.doi.org/10.1371/journal.pone.0083376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465379	gold, Green Published			2022-12-27	WOS:000330237000008
J	Comstock, SS; Hortos, K; Kovan, B; McCaskey, S; Pathak, DR; Fenton, JI				Comstock, Sarah S.; Hortos, Kari; Kovan, Bruce; McCaskey, Sarah; Pathak, Dorothy R.; Fenton, Jenifer I.			Adipokines and Obesity Are Associated with Colorectal Polyps in Adult Males: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; VISCERAL FAT ACCUMULATION; C-REACTIVE PROTEIN; LIFE-STYLE FACTORS; CANCER-RISK; ADIPONECTIN LEVELS; SERUM INTERLEUKIN-6; PLASMA ADIPONECTIN; SERRATED POLYPS; LEPTIN RECEPTOR	Background: Obesity increases the risk of colon cancer. It is also known that most colorectal cancers develop from adenomatous polyps. However, the effects of obesity and adipokines on colonic polyp formation are unknown. Methods: To determine if BMI, waist circumference or adipokines are associated with colon polyps in males, 126 asymptomatic men (48-65 yr) were recruited at time of colonoscopy, and anthropometric measures as well as blood were collected. Odds ratios were determined using polytomous logistic regression for polyp number (0 or >= 3) and polyp type (no polyp, hyperplastic polyp, tubular adenoma). Results: 41% of the men in our study were obese (BMI >= 30). The odds of an obese individual having >= 3 polyps was 6.5 (CI: 1.3-33.0) times greater than those of a lean (BMI <25) individual. Additionally, relative to lean individuals, obese individuals were 7.8 (CI: 2.0-30.8) times more likely to have a tubular adenoma than no polyp. As BMI category increased, participants were 2.9 (CI: 1.5-5.4) times more likely to have a tubular adenoma than no polyps. Serum leptin, IP-10 and TNF-alpha were significantly associated with tubular adenoma presence. Serum leptin and IP-10 were significantly associated with increased likelihood of >= 3 polyps, and TNF-alpha showed a trend (p = 0.09). Conclusions: Obese men are more likely to have at least three polyps and adenomas. This cross-sectional study provides evidence that colonoscopy should be recommended for obese, white males.	[Comstock, Sarah S.; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Hortos, Kari; Kovan, Bruce; McCaskey, Sarah; Fenton, Jenifer I.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Kovan, Bruce] Profess Corp, Tricty Gastroenterol, Clinton Township, MI USA; [Pathak, Dorothy R.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu			National Cancer Institute [1R03CA142000]; Clinical and Translational Sciences Institute at Michigan State University; NATIONAL CANCER INSTITUTE [R03CA142000] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Sciences Institute at Michigan State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from the National Cancer Institute 1R03CA142000 and Clinical and Translational Sciences Institute at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Birmingham JM, 2009, CARCINOGENESIS; Bobe G, 2010, CANCER EPIDEM BIOMAR, V19, P1441, DOI 10.1158/1055-9965.EPI-09-1082; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Chia VM, 2007, CANCER EPIDEM BIOMAR, V16, P2697, DOI 10.1158/1055-9965.EPI-07-0467; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Erarslan E, 2009, DIGEST DIS SCI, V54, P862, DOI 10.1007/s10620-008-0440-6; Fenton JI, 2008, MOL CARCINOGEN, V47, P9, DOI 10.1002/mc.20357; Fenton JI, 2006, CARCINOGENESIS, V27, P1507, DOI 10.1093/carcin/bgl018; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; Fenton JI, 2010, OPEN OBESITY J, V2, P23; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fu ZM, 2012, AM J EPIDEMIOL, V176, P766, DOI 10.1093/aje/kws157; Fukumoto J, 2008, CANCER SCI, V99, P781, DOI 10.1111/j.1349-7006.2008.00745.x; Groblewska M, 2008, CLIN CHEM LAB MED, V46, P1423, DOI 10.1515/CCLM.2008.278; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Harriss DJ, 2009, COLORECTAL DIS, V11, P547, DOI 10.1111/j.1463-1318.2009.01766.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Herder C, 2007, INT J OBESITY, V31, P403, DOI 10.1038/sj.ijo.0803432; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Jiang Z, 2010, MOL BIOL REP, V37, P3029, DOI 10.1007/s11033-009-9873-z; Kahi CJ, 2013, GASTROINTEST ENDOSC, V77, P335, DOI 10.1016/j.gie.2013.01.002; Kang M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-91; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kumor A, 2009, INT J COLORECTAL DIS, V24, P275, DOI 10.1007/s00384-008-0605-y; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lieberman DA, 2003, JAMA-J AM MED ASSOC, V290, P2959, DOI 10.1001/jama.290.22.2959; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Makkar R, 2012, CLEV CLIN J MED, V79, P865, DOI 10.3949/ccjm.79a.12034; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; Murashima M, 2012, J NUTR EDUC BEHAV, V44, P556, DOI 10.1016/j.jneb.2011.05.008; Nakajima TE, 2010, CANCER SCI, V101, P1286, DOI 10.1111/j.1349-7006.2010.01518.x; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Odze RD, 2010, ARCH PATHOL LAB MED, V134, P896, DOI 10.1043/1543-2165-134.6.896; Okabayashi K, 2012, AM J GASTROENTEROL, V107, P1175, DOI 10.1038/ajg.2012.180; Omata F, 2013, SCAND J GASTROENTERO, V48, P136, DOI 10.3109/00365521.2012.737364; Otake S, 2005, CLIN CANCER RES, V11, P3642, DOI 10.1158/1078-0432.CCR-04-1868; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Sandhofer A, 2003, OBES RES, V11, P760, DOI 10.1038/oby.2003.106; Sasaki Y, 2012, CLIN CANCER RES, V18, P392, DOI 10.1158/1078-0432.CCR-11-0896; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Tilg H, 2005, EXPERT OPIN THER TAR, V9, P245, DOI 10.1517/14728222.9.2.245; Toiyama Y, 2012, INT J ONCOL, V40, P560, DOI 10.3892/ijo.2011.1247; Wan MF, 2006, J SURG RES, V136, P53, DOI 10.1016/j.jss.2006.07.004; Wang W, 2013, CELL RES; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wernli KJ, 2010, GROWTH HORM IGF RES, V20, P305, DOI 10.1016/j.ghir.2010.04.001; WHO, 2013, WHO GLOB DAT BMI; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Yang XL, 2006, J LEUKOCYTE BIOL, V80, P1434, DOI 10.1189/jlb.0306212; Yuan Y, 2011, J STAT SOFTWARE, V45; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010; Zhang Y, 2003, J INVEST DERMATOL, V121, P713, DOI 10.1046/j.1523-1747.2003.12517.x	70	37	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85939	10.1371/journal.pone.0085939	http://dx.doi.org/10.1371/journal.pone.0085939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465801	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000078
J	Nakamura, T; Okada, T; Endo, M; Kadomatsu, T; Taniwaki, T; Sei, A; Odagiri, H; Masuda, T; Fujimoto, T; Nakamura, T; Oike, Y; Mizuta, H				Nakamura, Takayuki; Okada, Tatsuya; Endo, Motoyoshi; Kadomatsu, Tsuyoshi; Taniwaki, Takuya; Sei, Akira; Odagiri, Haruki; Masuda, Tetsuro; Fujimoto, Toru; Nakamura, Takafumi; Oike, Yuichi; Mizuta, Hiroshi			Angiopoietin-Like Protein 2 Induced by Mechanical Stress Accelerates Degeneration and Hypertrophy of the Ligamentum Flavum in Lumbar Spinal Canal Stenosis	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; TISSUE FIBROSIS; TGF-BETA; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; CALCINEURIN; INFLAMMATION; PATHOMECHANISM	Chronic inflammation and subsequent fibrosis induced by mechanical stress play an important role in ligamentum flavum (LF) hypertrophy and degeneration in patients with lumbar spinal canal stenosis (LSCS). Angiopoietin-like protein 2 (Angptl2) is a chronic inflammatory mediator induced under various pathological conditions and increases the expression of TGF-beta 1, which is a well-characterized mediator in LF hypertrophy. We investigated whether Angptl2 is induced by mechanical stress, and whether it contributes to LF hypertrophy and degeneration by activating the TGF-beta 1 signaling cascade. In this study, we investigated human LF tissue and LF fibroblasts isolated from patients who underwent lumbar surgery. We found that Angptl2 was abundantly expressed in fibroblasts of hypertrophied LF tissues at both the mRNA and protein levels. This expression was not only positively correlated with LF thickness and degeneration but also positively correlated with lumbar segmental motion. Our in vitro experiments with fibroblasts from hypertrophied LF tissue revealed that mechanical stretching stress increases the expression and secretion of Angptl2 via activation of calcineurin/NFAT pathways. In hypertrophied LF tissue, expression of TGF-beta 1 mRNA was also increased and TGF-beta 1/Smad signaling was activated. Angptl2 expression in LF tissue was positively correlated with the expression of TGF-beta 1 mRNA, suggesting cooperation between Angptl2 and TGF-beta 1 in the pathogenesis of LF hypertrophy. In vitro experiments revealed that Angptl2 increased levels of TGF-b1 and its receptors, and also activated TGF-beta 1/Smad signaling. Mechanical stretching stress increased TGF-beta 1 mRNA expression, which was partially attenuated by treatment with a calcineurin/NFAT inhibitor or Angptl2 siRNA, indicating that induction of TGF-beta 1 expression by mechanical stretching stress is partially mediated by Angptl2. We conclude that expression of Angptl2 induced by mechanical stress in LF fibroblasts promotes LF tissue degeneration by activation of TGF-beta 1/Smad signaling, which results in LF hypertrophy in patients with LSCS.	[Nakamura, Takayuki; Okada, Tatsuya; Taniwaki, Takuya; Sei, Akira; Odagiri, Haruki; Masuda, Tetsuro; Fujimoto, Toru; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan; [Nakamura, Takayuki; Endo, Motoyoshi; Kadomatsu, Tsuyoshi; Odagiri, Haruki; Masuda, Tetsuro; Oike, Yuichi] Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Chuo Ku, Kumamoto, Japan; [Nakamura, Takafumi] Nakamura Orthopaed Clin, Kita Ku, Kumamoto, Japan; [Oike, Yuichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST)	Okada, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan.	tatsuya-okada@fc.kuh.kumamoto-u.ac.jp	Endo, Motoyoshi/T-5840-2019		Grants-in-Aid for Scientific Research [25461192] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alam WCA, 2002, INDIAN J AEROSPACE M, V46, P48; Alameddine HS, 2012, NEUROBIOL DIS, V48, P508, DOI 10.1016/j.nbd.2012.07.023; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Aydemir ABC, 2007, ANN NY ACAD SCI, V1117, P138, DOI 10.1196/annals.1402.004; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; FUKUYAMA S, 1995, J SPINAL DISORD, V8, P126; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Iwano M, 2001, MOL THER, V3, P149, DOI 10.1006/mthe.2000.0251; Kong MH, 2009, SPINE, V34, P2537, DOI 10.1097/BRS.0b013e3181b353ea; Kosaka H, 2007, SPINE, V32, P2805, DOI 10.1097/BRS.0b013e31815b650f; Kubota Y, 2005, GENE EXPR PATTERNS, V5, P679, DOI 10.1016/j.modgep.2005.02.006; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lohr M, 2011, ACTA NEUROCHIR, V153, P134, DOI 10.1007/s00701-010-0839-7; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8; Ogata A, 2012, BIOCHEM BIOPH RES CO, V418, P494, DOI 10.1016/j.bbrc.2012.01.052; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Rana OR, 2009, J MOL CELL CARDIOL, V46, P568, DOI 10.1016/j.yjmcc.2008.12.006; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Shimoyama M, 2000, CIRCULATION, V102, P1996, DOI 10.1161/01.CIR.102.16.1996; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takahashi K, 2013, J CELL MOL MED, V17, P225, DOI 10.1111/jcmm.12027; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Wang JP, 2011, BIOCHEM BIOPH RES CO, V408, P269, DOI 10.1016/j.bbrc.2011.04.011; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	46	39	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85542	10.1371/journal.pone.0085542	http://dx.doi.org/10.1371/journal.pone.0085542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465594	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000042
J	Lee, BJ; Kim, JY				Lee, Bum Ju; Kim, Jong Yeol			A Comparison of the Predictive Power of Anthropometric Indices for Hypertension and Hypotension Risk	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE RISK; CORONARY HEART-DISEASE; TO-HEIGHT RATIO; WAIST-HIP RATIO; NECK CIRCUMFERENCE; DIABETES-MELLITUS; BLOOD-PRESSURE; SYSTOLIC HYPERTENSION; CARDIOMETABOLIC RISK	Background and Aims: It is commonly accepted that body fat distribution is associated with hypertension, but the strongest anthropometric indicator of the risk of hypertension is still controversial. Furthermore, no studies on the association of hypotension with anthropometric indices have been reported. The objectives of the present study were to determine the best predictors of hypertension and hypotension among various anthropometric indices and to assess the use of combined indices as a method of improving the predictive power in adult Korean women and men. Methods: For 12789 subjects 21-85 years of age, we assessed 41 anthropometric indices using statistical analyses and data mining techniques to determine their ability to discriminate between hypertension and normotension as well as between hypotension and normotension. We evaluated the predictive power of combined indices using two machine learning algorithms and two variable subset selection techniques. Results: The best indicator for predicting hypertension was rib circumference in both women (p=<0.0001; OR = 1.813; AUC = 0.669) and men (p=<0.0001; OR = 1.601; AUC = 0.627); for hypotension, the strongest predictor was chest circumference in women (p=<0.0001; OR = 0.541; AUC = 0.657) and neck circumference in men (p=<0.0001; OR = 0.522; AUC = 0.672). In experiments using combined indices, the areas under the receiver operating characteristic curves (AUC) for the prediction of hypertension risk in women and men were 0.721 and 0.652, respectively, according to the logistic regression with wrapper-based variable selection; for hypotension, the corresponding values were 0.675 in women and 0.737 in men, according to the naive Bayes with wrapper-based variable selection. Conclusions: The best indicators of the risk of hypertension and the risk of hypotension may differ. The use of combined indices seems to slightly improve the predictive power for both hypertension and hypotension.	[Lee, Bum Ju; Kim, Jong Yeol] Korea Inst Oriental Med, Div Med Res, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kim, JY (corresponding author), Korea Inst Oriental Med, Div Med Res, Taejon, South Korea.	ssmed@kiom.re.kr	Yeol, Kim Jong/AAP-5998-2020		National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [20062005173]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (No. 20062005173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alfie José, 2012, Rev. argent. cardiol., V80, P275; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Badaruddoza, 2009, ANTHROPOL ANZ, V67, P111, DOI 10.1127/0003-5548/2009/0014; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Ben-Noun L, 2003, OBES RES, V11, P226, DOI 10.1038/oby.2003.35; Ben-Noun LL, 2004, AM J HYPERTENS, V17, P409, DOI 10.1016/j.amjhyper.2004.02.005; BLANN AD, 1994, J HYPERTENS, V12, P925; Chen N, 2011, EXPERT SYST APPL, V38, P12939, DOI 10.1016/j.eswa.2011.04.090; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Feldstein CA, 2005, NUTR METAB CARDIOVAS, V15, P310, DOI 10.1016/j.numecd.2005.03.001; Fuchs FD, 2005, OBES RES, V13, P1515, DOI 10.1038/oby.2005.184; Grievink L, 2004, EUR J CLIN NUTR, V58, P1159, DOI 10.1038/sj.ejcn.1601944; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Guagnano MT, 2001, INT J OBESITY, V25, P1360, DOI 10.1038/sj.ijo.0801722; Gupta S, 2012, J COMMUN HEALTH, V37, P441, DOI 10.1007/s10900-011-9461-8; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; Iso H, 2001, AM J EPIDEMIOL, V153, P490, DOI 10.1093/aje/153.5.490; Jang E, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/604842; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jo I, 2001, J HYPERTENS, V19, P1523, DOI 10.1097/00004872-200109000-00002; Kennelly SP, 2009, AGEING RES REV, V8, P61, DOI 10.1016/j.arr.2008.11.001; Kim BG, 2005, J HUM HYPERTENS, V19, P877, DOI 10.1038/sj.jhh.1001904; Kim JA, 2007, J HUM HYPERTENS, V21, P107, DOI 10.1038/sj.jhh.1002119; KIM JS, 1994, AM J PREV MED, V10, P200, DOI 10.1016/S0749-3797(18)30591-9; Ko GTC, 1997, INT J CARDIOL, V61, P221, DOI 10.1016/S0167-5273(97)00156-3; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Laakso M, 2002, INT J OBESITY, V26, P873, DOI 10.1038/sj.ijo.0802002; Lee BJ, 2014, IEEE J BIOMED HEALTH, V18, P555, DOI 10.1109/JBHI.2013.2264509; Li M, 2010, DIABETES RES CLIN PR, V87, P401, DOI 10.1016/j.diabres.2009.12.004; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mansour AA, 2007, ARCH MED RES, V38, P253, DOI 10.1016/j.arcmed.2006.09.014; Mbanya JCN, 1998, INT J EPIDEMIOL, V27, P181, DOI 10.1093/ije/27.2.181; Nahar N, 2012, INDIAN J MED SPEC, V3, P6, DOI 10.7713/ijms.2012.0003; National Heart Lung and Blood Institute, WHAT IS HYP; Oda E, 2010, ACTA DIABETOL, V47, P309, DOI 10.1007/s00592-010-0203-7; Okosun IS, 1998, DIABETES CARE, V21, P1836, DOI 10.2337/diacare.21.11.1836; Olinto MTA, 2004, PUBLIC HEALTH NUTR, V7, P629, DOI 10.1079/PHN2003582; Oommen T, 2011, MATH GEOSCI, V43, P99, DOI 10.1007/s11004-010-9311-8; Panagiotakos DB, 2009, ATHEROSCLEROSIS, V206, P314, DOI 10.1016/j.atherosclerosis.2009.02.030; Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-0161; Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779; Barbosa AR, 2011, J NUTR HEALTH AGING, V15, P17, DOI 10.1007/s12603-011-0007-7; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sakurai M, 2006, HYPERTENS RES, V29, P75, DOI 10.1291/hypres.29.75; Sanchez-Viveros S, 2008, J NUTR HEALTH AGING, V12, P327, DOI 10.1007/BF02982664; Silva DAS, 2013, EUR J NUTR, V52, P237, DOI 10.1007/s00394-012-0314-8; SEIDELL JC, 1990, INT J EPIDEMIOL, V19, P303, DOI 10.1093/ije/19.2.303; SELBY JV, 1989, AM J EPIDEMIOL, V129, P43, DOI 10.1093/oxfordjournals.aje.a115123; Shinozaki K, 1996, DIABETES CARE, V19, P1, DOI 10.2337/diacare.19.1.1; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Tibana RA, 2012, EINSTEIN-SAO PAULO, V10, P329, DOI 10.1590/S1679-45082012000300013; Tseng CH, 2010, ATHEROSCLEROSIS, V210, P585, DOI 10.1016/j.atherosclerosis.2009.12.015; Uhernik AI, 2009, COLLEGIUM ANTROPOL, V33, P75; Verghese J, 2003, NEUROLOGY, V61, P1667, DOI 10.1212/01.WNL.0000098934.18300.BE; WANG ZQ, 1990, GENET EPIDEMIOL, V7, P447, DOI 10.1002/gepi.1370070606; Wasikowski M, 2010, IEEE T KNOWL DATA EN, V22, P1388, DOI 10.1109/TKDE.2009.187; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Wildman RP, 2005, AM J CLIN NUTR, V82, P1195, DOI 10.1093/ajcn/82.6.1195; World Health Organization, 1999, J HYPERTENS, V6, P66; YAO CH, 1991, AM J EPIDEMIOL, V134, P1278, DOI 10.1093/oxfordjournals.aje.a116031; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76	65	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84897	10.1371/journal.pone.0084897	http://dx.doi.org/10.1371/journal.pone.0084897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465449	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000010
J	Almeida, ICT; Soares, M; Bozza, FA; Shinotsuka, CR; Bujokas, R; Souza-Dantas, VC; Ely, EW; Salluh, JIF				Almeida, Isabel C. T.; Soares, Marcio; Bozza, Fernando A.; Shinotsuka, Cassia Righy; Bujokas, Renata; Souza-Dantas, Vicente Ces; Ely, E. Wesley; Salluh, Jorge I. F.			The Impact of Acute Brain Dysfunction in the Outcomes of Mechanically Ventilated Cancer Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; CONFUSION ASSESSMENT METHOD; DELIRIUM; ICU; RELIABILITY; ADMISSION; SEDATION; VALIDITY; TRIAL	Introduction: Delirium and coma are a frequent source of morbidity for ICU patients. Several factors are associated with the prognosis of mechanically ventilated (MV) cancer patients, but no studies evaluated delirium and coma (acute brain dysfunction). The present study evaluated the frequency and impact of acute brain dysfunction on mortality. Methods: The study was performed at National Cancer Institute, Rio de Janeiro, Brazil. We prospectively enrolled patients ventilated >48 h with a diagnosis of cancer. Acute brain dysfunction was assessed during the first 14 days of ICU using RASS/CAM-ICU. Patients were followed until hospital discharge. Univariate and multivariable analysis were performed to evaluate factors associated with hospital mortality. Results: 170 patients were included. 73% had solid tumors, age 65 [53-72 (median, IQR 25%-75%)] years. SAPS II score was 54[46-63] points and SOFA score was (7 [6-9]) points. Median duration of MV was 13 (6-21) days and ICU stay was 14 (7.5-22) days. ICU mortality was 54% and hospital mortality was 66%. Acute brain dysfunction was diagnosed in 161 patients (95%). Survivors had more delirium/coma-free days [4(1,5-6) vs 1(0-2), p<0.001]. In multivariable analysis the number of days of delirium/coma-free days were associated with better outcomes as they were independent predictors of lower hospital mortality [0.771 (0.681 to 0.873), p<0.001]. Conclusions: Acute brain dysfunction in MV cancer patients is frequent and independently associated with increased hospital mortality. Future studies should investigate means of preventing or mitigating acute brain dysfunction as they may have a significant impact on clinical outcomes.	[Almeida, Isabel C. T.; Soares, Marcio; Shinotsuka, Cassia Righy; Bujokas, Renata; Souza-Dantas, Vicente Ces; Salluh, Jorge I. F.] Inst Nacl Canc, Intens Care Unit, Rio De Janeiro, Brazil; [Almeida, Isabel C. T.; Soares, Marcio; Shinotsuka, Cassia Righy; Bujokas, Renata; Souza-Dantas, Vicente Ces; Salluh, Jorge I. F.] Inst Nacl Canc, Postgrad Program, Rio De Janeiro, Brazil; [Soares, Marcio; Bozza, Fernando A.; Shinotsuka, Cassia Righy; Salluh, Jorge I. F.] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Bozza, Fernando A.] Fundacao Oswaldo Cruz, Intens Care Lab, IPEC, Rio De Janeiro, Brazil; [Ely, E. Wesley] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ely, E. Wesley] Vet Affairs Tennessee Valley Geriatr Res Educ Cli, Nashville, TN USA	National Cancer Institute (Inca); National Cancer Institute (Inca); IDOR - Instituto D'Or de Ensino e Pesquisa; Fundacao Oswaldo Cruz; Vanderbilt University; Geriatric Research Education & Clinical Center	Salluh, JIF (corresponding author), Inst Nacl Canc, Intens Care Unit, Rio De Janeiro, Brazil.	jorgesalluh@gmail.com	Shinotsuka, Cássia Righy/H-9181-2013; Ely, E. Wesley/Z-2018-2019; Salluh, Jorge/AAF-2682-2021; Almeida, Igor C./AAF-9409-2019; dantas, vicente c souza/L-2648-2013; Soares, Marcio/B-3083-2013; Bozza, Fernando A/A-2618-2013	Shinotsuka, Cássia Righy/0000-0002-9206-9552; Ely, E. Wesley/0000-0003-3957-2172; Salluh, Jorge/0000-0002-8164-1453; Almeida, Igor C./0000-0002-2443-8213; Soares, Marcio/0000-0003-2503-6088; Bozza, Fernando A/0000-0003-4878-0256	CNPq; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	MS and JIFS received individual research grants from CNPq and FAPERJ, Brazilian governmental agencies for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Azoulay E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-5; Caraceni A, 2000, CANCER-AM CANCER SOC, V89, P1145, DOI 10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X; Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Gusmao-Flores D, 2011, CLINICS, V66, P1917, DOI 10.1590/S1807-59322011001100011; JJS MD, 2012, BEST PRACT RES CLIN, V26, P327, DOI [10.1016/j.bpa.2012.08.003., DOI 10.1016/J.BPA.2012.08.003]; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Lecuyer L, 2007, CRIT CARE MED, V35, P808, DOI 10.1097/01.CCM.0000256846.27192.7A; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MD GM, 2012, BEST PRACT RES CLIN, V26, P311, DOI [10.1016/j.bpa.2012.07.001., DOI 10.1016/J.BPA.2012.07.001]; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Neufeld KJ, 2011, PSYCHOSOMATICS, V52, P133, DOI 10.1016/j.psym.2010.12.018; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rosolem M, 2009, CRIT CARE, V13, pP56, DOI [10.1186/cc7858., DOI 10.1186/CC7858]; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Soares M, 2005, CRIT CARE MED, V33, P520, DOI 10.1097/01.ccm.0000155783.46747.04; Soares M, 2010, INTENS CARE MED, V36, P1188, DOI 10.1007/s00134-010-1807-7; Soares M, 2010, CRIT CARE CLIN, V26, P41, DOI 10.1016/j.ccc.2009.09.005; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Takeuchi M, 2012, ANN SURG ONCOL, V19, P3963, DOI 10.1245/s10434-012-2432-1; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487	32	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85332	10.1371/journal.pone.0085332	http://dx.doi.org/10.1371/journal.pone.0085332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465538	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100037
J	Marshall, ASJ; Barker, CIS; Pulickal, AS; Kibwana, E; Gautam, SC; Clutterbuck, EA; Thorson, SM; Shrestha, S; Adhikari, N; Pollard, AJ; Kelly, DF				Marshall, Andrew S. J.; Barker, Charlotte I. S.; Pulickal, Anoop S.; Kibwana, Elizabeth; Gautam, Samir C.; Clutterbuck, Elizabeth A.; Thorson, Stephen M.; Shrestha, Shrijana; Adhikari, Neelam; Pollard, Andrew J.; Kelly, Dominic F.			The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal	PLOS ONE			English	Article							CONJUGATE VACCINE; CAPSULAR POLYSACCHARIDE; ROUTINE IMMUNIZATION; ANTIBODY; CHILDREN; DISEASE; COLONIZATION; PROTECTION; INFANTS	Haemophilus influenzae type b (Hib) is now recognized as an important pathogen in Asia. To evaluate disease susceptibility, and as a marker of Hib transmission before routine immunization was introduced in Kathmandu, 71 participants aged 7 months-77 years were recruited and 15 cord blood samples were collected for analysis of anti-polyribosylribitol phosphate antibody levels by enzyme-linked immunosorbent assay. Only 20% of children under 5 years old had levels considered protective (>0.15 mu g/ml), rising to 83% of 15-54 year-olds. Prior to introduction of Hib vaccine in Kathmandu, the majority of young children were susceptible to disease.	[Marshall, Andrew S. J.; Barker, Charlotte I. S.; Pulickal, Anoop S.; Kibwana, Elizabeth; Clutterbuck, Elizabeth A.; Pollard, Andrew J.; Kelly, Dominic F.] Univ Oxford, Oxford Vaccine Grp, Oxford, England; [Marshall, Andrew S. J.; Barker, Charlotte I. S.; Pulickal, Anoop S.; Kibwana, Elizabeth; Clutterbuck, Elizabeth A.; Pollard, Andrew J.; Kelly, Dominic F.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Gautam, Samir C.; Thorson, Stephen M.; Shrestha, Shrijana; Adhikari, Neelam] Patan Hosp, Kathmandu, Nepal	University of Oxford; University of Oxford	Marshall, ASJ (corresponding author), Univ Oxford, Oxford Vaccine Grp, Oxford, England.	a.marshall@doctors.org.uk	Barker, Charlotte I S/D-5527-2014; Barker, Charlotte/AAO-4131-2021	Barker, Charlotte I S/0000-0002-6757-5867; Barker, Charlotte/0000-0002-6757-5867; Shrestha, Shrijana/0000-0001-9484-0227; Marshall, Andrew/0000-0003-0529-0425; Kelly, Dominic/0000-0002-6063-8896	Oxford Vaccine Group; NIHR Oxford Biomedical Research Centre (BRC); Rhodes Scholarship; NIHR BRC	Oxford Vaccine Group; NIHR Oxford Biomedical Research Centre (BRC); Rhodes Scholarship; NIHR BRC	This project was funded by the Oxford Vaccine Group (www.ovg.ox.ac.uk) with support from the NIHR Oxford Biomedical Research Centre (BRC) (http://oxfordbrc.nihr.ac.uk). A. S. P. was funded by a Rhodes Scholarship. D. F. K. receives salary support from the NIHR BRC. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Ballereau F, 1999, EUR J EPIDEMIOL, V15, P577, DOI 10.1023/A:1007668003578; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; Bennet JV, 2002, HAEMOPHILUS INFLUENZ; BOOY R, 1992, ARCH DIS CHILD, V67, P475, DOI 10.1136/adc.67.4.475; Fothergill LD, 1933, J IMMUNOL, V24, P273; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334; KAYHTY H, 1983, J INFECT DIS, V147, P1100; KAYHTY H, 1994, BIOLOGICALS, V22, P397, DOI 10.1006/biol.1994.1062; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Kelly DF, 2009, CLIN VACCINE IMMUNOL, V16, P246, DOI 10.1128/CVI.00023-08; Leino T, 2002, EPIDEMIOL INFECT, V129, P73, DOI 10.1017/S0950268802007173; Madore DV, 1996, CLIN DIAGN LAB IMMUN, V3, P84, DOI 10.1128/CDLI.3.1.84-88.1996; MAKELA PH, 1977, J INFECT DIS, V136, pS43; Metz JA, 2012, PEDIATR INFECT DIS J, V31, pE66, DOI 10.1097/INF.0b013e31824a9c37; MICHAELS RH, 1976, J CLIN MICROBIOL, V4, P413; Oh SY, 2008, J INFECT DIS, V197, P1275, DOI 10.1086/586716; Ojo LR, 2010, VACCINE, V28, P7117, DOI 10.1016/j.vaccine.2010.07.074; Olsen SJ, 2005, PEDIATR INFECT DIS J, V24, P739, DOI 10.1097/01.inf.0000172940.77549.94; Pulickal AS, 2009, CLIN VACCINE IMMUNOL, V16, P1413, DOI 10.1128/CVI.00245-09; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Williams EJ, 2011, J CLIN MICROBIOL, V49, P1323, DOI 10.1128/JCM.02200-10; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445	27	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85055	10.1371/journal.pone.0085055	http://dx.doi.org/10.1371/journal.pone.0085055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465475	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100021
J	McFadden, KL; Steinmetz, SE; Carroll, AM; Simon, ST; Wallace, A; Rojas, DC				McFadden, Kristina L.; Steinmetz, Sarah E.; Carroll, Adam M.; Simon, Steven T.; Wallace, Alissa; Rojas, Donald C.			Test-Retest Reliability of the 40 Hz EEG Auditory Steady-State Response	PLOS ONE			English	Article							SCHIZOTYPAL PERSONALITY-DISORDER; GAMMA-BAND ACTIVITY; 1ST-DEGREE RELATIVES; SELECTIVE ATTENTION; COGNITIVE-PROCESSES; BRAIN OSCILLATIONS; FREQUENCY-ANALYSIS; EVOKED-RESPONSES; BIPOLAR DISORDER; MODULATED TONES	Auditory evoked steady-state responses are increasingly being used as a marker of brain function and dysfunction in various neuropsychiatric disorders, but research investigating the test-retest reliability of this response is lacking. The purpose of this study was to assess the consistency of the auditory steady-state response (ASSR) across sessions. Furthermore, the current study aimed to investigate how the reliability of the ASSR is impacted by stimulus parameters and analysis method employed. The consistency of this response across two sessions spaced approximately 1 week apart was measured in nineteen healthy adults using electroencephalography (EEG). The ASSR was entrained by both 40 Hz amplitude-modulated white noise and click train stimuli. Correlations between sessions were assessed with two separate analytical techniques: a) channel-level analysis across the whole-head array and b) signal-space projection from auditory dipoles. Overall, the ASSR was significantly correlated between sessions 1 and 2 (p < 0.05, multiple comparison corrected), suggesting adequate test-retest reliability of this response. The current study also suggests that measures of inter-trial phase coherence may be more reliable between sessions than measures of evoked power. Results were similar between the two analysis methods, but reliability varied depending on the presented stimulus, with click train stimuli producing more consistent responses than white noise stimuli.	[McFadden, Kristina L.; Steinmetz, Sarah E.; Carroll, Adam M.; Wallace, Alissa; Rojas, Donald C.] Univ Colorado, Dept Psychiat, Aurora, CO 80045 USA; [McFadden, Kristina L.; Steinmetz, Sarah E.; Simon, Steven T.; Wallace, Alissa; Rojas, Donald C.] Univ Colorado, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rojas, DC (corresponding author), Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA.	Don.Rojas@ucdenver.edu	Legget, Kristina/AAU-8563-2020; Rojas, Don/AAX-6678-2020	Legget, Kristina/0000-0002-2948-506X; Rojas, Don/0000-0001-6560-9616; Simon, Steven/0000-0001-5385-3574	NIH [R01 MH08280, R01 MH081920]; NARSAD Independent Investigator Award; NIH/NIMH training grant [T32 MH015442]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081920, T32MH015442] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Independent Investigator Award(NARSAD); NIH/NIMH training grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by NIH grants R01 MH08280, R01 MH081920 and a NARSAD Independent Investigator Award to DCR, and NIH/NIMH training grant T32 MH015442 for KLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Brady Jr R. O., 2013, BIPOLAR DISORD; Brenner CA, 2003, AM J PSYCHIAT, V160, P2238, DOI 10.1176/appi.ajp.160.12.2238; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; CARDENAS VA, 1993, BIOL PSYCHIAT, V33, P335, DOI 10.1016/0006-3223(93)90322-5; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; COHEN LT, 1991, J ACOUST SOC AM, V90, P2467, DOI 10.1121/1.402050; DOBIE RA, 1993, ELECTROEN CLIN NEURO, V88, P516, DOI 10.1016/0168-5597(93)90040-V; First MB, 1991, STRUCTURED CLIN INTE; Frund I, 2007, CLIN NEUROPHYSIOL, V118, P221, DOI 10.1016/j.clinph.2006.09.013; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gaspar CM, 2011, NEUROIMAGE, V58, P620, DOI 10.1016/j.neuroimage.2011.06.052; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gowdy PD, 1999, VISION RES, V39, P4098, DOI 10.1016/S0042-6989(99)00115-7; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Heinrichs-Graham E, 2012, BIOL PSYCHOL, V91, P59, DOI 10.1016/j.biopsycho.2012.04.008; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Ihara A, 2003, NEUROSCI LETT, V339, P135, DOI 10.1016/S0304-3940(03)00005-3; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; ILLE N, 1997, BIOMED TECH S, V42, P80; Jacobson G P, 1999, J Am Acad Audiol, V10, P211; John MS, 2003, EAR HEARING, V24, P406, DOI 10.1097/01.AUD.0000090442.37624.BE; Keil A, 2003, BRAIN TOPOGR, V16, P101, DOI 10.1023/B:BRAT.0000006334.15919.2c; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Lee KH, 2001, CLIN NEUROPHYSIOL, V112, P1499, DOI 10.1016/S1388-2457(01)00584-3; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Maharajh K., 2007, INT CONG SERI, V1300, P707, DOI [10.1016/j.ics.2006.12.073, DOI 10.1016/J.ICS.2006.12.073]; McEvoy LK, 2000, CLIN NEUROPHYSIOL, V111, P457, DOI 10.1016/S1388-2457(99)00258-8; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Nikulin VV, 2004, CLIN NEUROPHYSIOL, V115, P1896, DOI 10.1016/j.clinph.2004.03.019; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; O'Donnell BF, 2004, NEUROREPORT, V15, P1369, DOI 10.1097/01.wnr.0000127348.64681.b2; Oda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039955; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PANTEV C, 1993, ELECTROEN CLIN NEURO, V88, P389, DOI 10.1016/0168-5597(93)90015-H; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Papp N, 1977, Biomed Sci Instrum, V13, P135; Pena M, 2012, J COGNITIVE NEUROSCI, V24, P1149, DOI 10.1162/jocn_a_00144; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PICTON TW, 1987, J OTOLARYNGOL, V16, P140; Pipa G, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.025.2009; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Pulvermuller F, 1996, ELECTROEN CLIN NEURO, V98, P76, DOI 10.1016/0013-4694(95)00191-3; Raikkonen K, 2003, NEUROREPORT, V14, P2121, DOI 10.1097/01.wnr.0000095493.09138.31; Rass O, 2012, SCHIZOPHR RES, V136, P143, DOI 10.1016/j.schres.2012.01.003; REES A, 1986, HEARING RES, V23, P123, DOI 10.1016/0378-5955(86)90009-2; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Robinson S. E., 1989, ADV BIOMAGNETISM, P599; Rojas DC, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-11; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Ross B, 2005, CEREB CORTEX, V15, P2029, DOI 10.1093/cercor/bhi078; Ross B, 2004, Neurol Clin Neurophysiol, V2004, P22; Ross B, 2002, HEARING RES, V165, P68, DOI 10.1016/S0378-5955(02)00285-X; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127; Scherg M, 1990, ADV AUDIOL, P40, DOI DOI 10.1016/J.BSPC.2015.01.004; SEGALOWITZ SJ, 1993, PSYCHOPHYSIOLOGY, V30, P451, DOI 10.1111/j.1469-8986.1993.tb02068.x; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Skosnik PD, 2007, NEUROSCI LETT, V420, P223, DOI 10.1016/j.neulet.2007.04.072; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tavabi K, 2011, NEUROREPORT, V22, P474, DOI 10.1097/WNR.0b013e3283476b84; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Teale P, 2008, NEUROIMAGE, V42, P1481, DOI 10.1016/j.neuroimage.2008.06.020; Tervaniemi M, 1999, CLIN NEUROPHYSIOL, V110, P1388, DOI 10.1016/S1388-2457(99)00108-X; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Vohs JL, 2010, INT J NEUROPSYCHOPH, V13, P487, DOI 10.1017/S1461145709990307; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002	89	44	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85748	10.1371/journal.pone.0085748	http://dx.doi.org/10.1371/journal.pone.0085748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465679	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100068
J	Sharbanee, JM; Hu, L; Stritzke, WGK; Wiers, RW; Rinck, M; MacLeod, C				Sharbanee, Jason M.; Hu, Litje; Stritzke, Werner G. K.; Wiers, Reinout W.; Rinck, Mike; MacLeod, Colin			The Effect of Approach/Avoidance Training on Alcohol Consumption Is Mediated by Change in Alcohol Action Tendency	PLOS ONE			English	Article							AUTOMATIC ACTION-TENDENCIES; BIAS MODIFICATION; ATTENTIONAL BIAS; FREQUENCY; VALIDITY; CHILD	Training people to respond to alcohol images by making avoidance joystick movements can affect subsequent alcohol consumption, and has shown initial efficacy as a treatment adjunct. However, the mechanisms that underlie the training's efficacy are unknown. The present study aimed to determine 1) whether the training's effect is mediated by a change in action tendency or a change in selective attention, and 2) whether the training's effect is moderated by individual differences in working memory capacity (WMC). Three groups of social drinkers (total N = 74) completed either approach-alcohol training, avoid-alcohol training or a sham-training on the Approach-Avoidance Task (AAT). Participants' WMC was assessed prior to training, while their alcohol-related action tendency and selective attention were assessed before and after the training on the recently developed Selective-Attention/Action Tendency Task (SA/ATT), before finally completing an alcohol taste-test. There was no significant main effect of approach/avoidance training on alcohol consumption during the taste-test. However, there was a significant indirect effect of training on alcohol consumption mediated by a change in action tendency, but no indirect effect mediated by a change in selective attention. There was inconsistent evidence of WMC moderating training efficacy, with moderation found only for the effect of approach-alcohol training on the AAT but not on the SA/ATT. Thus approach/avoidance training affects alcohol consumption specifically by changing the underlying action tendency. Multiple training sessions may be required in order to observe more substantive changes in drinking behaviour.	[Sharbanee, Jason M.; Stritzke, Werner G. K.; MacLeod, Colin] Univ Western Australia, Sch Psychol, Ctr Adv Res Emot, Crawley, Australia; [Hu, Litje; Rinck, Mike] Radboud Univ Nijmegen, Inst Behav Sci, Dept Clin Psychol, NL-6525 ED Nijmegen, Netherlands; [Wiers, Reinout W.] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Adapt Lab, Amsterdam, Netherlands	University of Western Australia; Radboud University Nijmegen; University of Amsterdam	Sharbanee, JM (corresponding author), Univ Western Australia, Sch Psychol, Ctr Adv Res Emot, Crawley, Australia.	jason.sharbanee@grs.uwa.edu.au	Wiers, Reinout/AAB-4008-2021; Sharbanee, Jason Mark/AFO-5659-2022; Sharbanee, Jason/L-5579-2013; Rinck, Mike/A-6944-2010	Wiers, Reinout/0000-0002-4312-9766; Sharbanee, Jason Mark/0000-0003-1822-9092; Sharbanee, Jason/0000-0003-1822-9092; MacLeod, Colin/0000-0003-2407-7339				Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 1969, MONOGRAPHS RUTGERS C; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Carey KB, 2001, J STUD ALCOHOL, V62, P79, DOI 10.15288/jsa.2001.62.79; Cohen J., 2003, APPL MULTIPLE REGRES; Eberl C, 2013, DEV COGN NEUROS-NETH, V4, P38, DOI 10.1016/j.dcn.2012.11.002; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Hayes A. F., 2013, STAT MEDIATION ANAL; HOMMEL B, 1994, PSYCHOL RES-PSYCH FO, V56, P261, DOI 10.1007/BF00419656; Jackman R. W., 1985, SOCIOL METHOD RES, V13, P510, DOI 10.1177/0049124185013004004; Kane MJ, 2008, VARIATION WORKING ME, P21; Kazdin AE, 2003, J CHILD PSYCHOL PSYC, V44, P1116, DOI 10.1111/1469-7610.00195; Kokotailo PK, 2004, ALCOHOL CLIN EXP RES, V28, P914, DOI 10.1097/01.ALC.0000128239.87611.F5; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Lewandowsky S, 2010, BEHAV RES METHODS, V42, P571, DOI 10.3758/BRM.42.2.571; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maric M, 2012, CLIN CHILD FAM PSYCH, V15, P177, DOI 10.1007/s10567-012-0114-y; McEvoy PM, 2004, ADDICTION, V99, P482, DOI 10.1111/j.1360-0443.2004.00714.x; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; R Core Team, 2012, R LANG ENV STAT COMP; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Salemink E, 2012, BEHAV RES THER, V50, P40, DOI 10.1016/j.brat.2011.10.006; Schoenmakers TM, 2010, DRUG ALCOHOL DEPEN, V109, P30, DOI 10.1016/j.drugalcdep.2009.11.022; Sharbanee JM, 2013, PSYCHOL ADDICT BEHAV, V27, P649, DOI 10.1037/a0029982; Sharbanee JM, 2013, ADDICTION, V108, P1758, DOI 10.1111/add.12256; Sharbanee JM, 2013, PSYCHOPHARMACOLOGY, DOI DOI 10.1007/S00213-013-3318-Z.ACCESSED; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Stritzke W.G., 2007, MOTIVATION HLTH BEHA, P31; Van der Meer T, 2010, AM SOCIOL REV, V75, P173, DOI 10.1177/0003122409359166; Watson P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00440; Wendt M, 2009, EXP PSYCHOL, V56, P206, DOI 10.1027/1618-3169.56.3.206; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Wiers RW, 2013, CLIN PSYCHOL SCI; Wiers RW, 2008, IDENTIFICATION TREAT, P187; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	48	29	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85855	10.1371/journal.pone.0085855	http://dx.doi.org/10.1371/journal.pone.0085855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465750	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100083
J	Emu, B; Moretto, WJ; Hoh, R; Krone, M; Martin, JN; Nixon, DF; Deeks, SG; McCune, JM				Emu, Brinda; Moretto, Walter J.; Hoh, Rebecca; Krone, Melissa; Martin, Jeffrey N.; Nixon, Douglas F.; Deeks, Steven G.; McCune, Joseph M.			Composition and Function of T Cell Subpopulations Are Slow to Change Despite Effective Antiretroviral Treatment of HIV Disease	PLOS ONE			English	Article							IMMUNE ACTIVATION; LYMPHOCYTE SUBSETS; INFECTED SUBJECTS; THERAPY; CD8; IMMUNODEFICIENCY; NAIVE; INTENSIFICATION; REPLICATION; RALTEGRAVIR	The ability to reconstitute a normal immune system with antiretroviral therapy in the setting of HIV infection remains uncertain. This study aimed to characterize quantitative and qualitative aspects of various T cell subpopulations that do not improve despite effective ART. CD4:CD8 ratio was evaluated in HIV-infected subjects with viral loads >10,000 copies/mu l ("non-controllers", n = 42), those with undetectable viral loads on ART ("ART-suppressed", n = 53), and HIV-uninfected subjects (n = 22). In addition, T cell phenotype and function were examined in 25 non-controllers, 18 ART-suppressed, and 7 HIV-uninfected subjects. CD4:CD8 ratio in non-controllers, ART-suppressed, and HIV-uninfected subjects was 0.25, 0.48, and 1.95 respectively (P<0.0001 for all comparisons). The increased ratio in ART-suppressed compared to non-controllers was driven by an increase of CD4+ T cells, with no change in the expanded CD8+ T cell population. Expansion of differentiated (CD28-CD27-CD45RA+/-CCR7-) T cell subpopulations persisted despite ART and minimal changes were noted in naive T cell frequencies over time. Increased number of CD8+CD28- T cells and increased CD8+ CMV-specific T cell responses were associated with a decreased CD4: CD8 ratio. Measures of T cell function demonstrated persistence of high frequencies of CD8+ T cells producing IFN-gamma. Lastly, though all CD8+ subpopulations demonstrated significantly lower Ki67 expression in ART-suppressed subjects, CD4+ T cell subpopulations did not consistently show this decrease, thus demonstrating different proliferative responses in the setting of T cell depletion. In summary, this study demonstrated that CD4:CD8 ratios remained significantly decreased and naive T cell numbers were slow to increase despite long-term viral suppression on ART. In addition, there is a evidence of differential regulation of the CD4+ and CD8+ T cell subpopulations, suggesting independent homeostatic regulation of the two compartments.	[Emu, Brinda] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Moretto, Walter J.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Hoh, Rebecca; Martin, Jeffrey N.; Deeks, Steven G.; McCune, Joseph M.] Univ Calif San Francisco, Posit Hlth Program, San Francisco, CA 94143 USA; [Krone, Melissa; Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nixon, Douglas F.; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Yale University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Emu, B (corresponding author), Yale Univ, Dept Med, New Haven, CT 06520 USA.	brinda.emu@yale.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Deeks, Steven/0000-0001-6371-747X	National Institute of Allergy and Infectious Diseases [AI052745, AI47062, AI43864, AI055273, AI44595, P30 AI027763, R24 AI067039]; amfAR [106710-40-RGRL]; California AIDS Research Center [CC99-SF, ID01-SF-049]; Center for AIDS Prevention Studies [P30 MH62246]; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research [DPI OD00329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, R01AI044595, R01AI052745, U01AI043864, R01AI047062, R01AI043864, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); amfAR; California AIDS Research Center; Center for AIDS Prevention Studies; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases (AI052745 to BE; AI47062 and AI43864 to JMM; and AI055273 and AI44595 to SGD; P30 AI027763 and R24 AI067039 to JNM), amfAR (106710-40-RGRL), the California AIDS Research Center (CC99-SF, ID01-SF-049), and the Center for AIDS Prevention Studies (P30 MH62246). JMM is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, funded through grant number DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BRINCHMANN JE, 1994, J INFECT DIS, V169, P730, DOI 10.1093/infdis/169.4.730; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Caggiari L, 2001, CYTOMETRY, V46, P233, DOI 10.1002/cyto.1132; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CHOREMIPAPADOPOULOU H, 1994, J ACQ IMMUN DEF SYND, V7, P245; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fagnoni FF, 2002, IMMUNOLOGY, V106, P27, DOI 10.1046/j.1365-2567.2002.01400.x; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Fleury S, 2000, P NATL ACAD SCI USA, V97, P5393, DOI 10.1073/pnas.97.10.5393; FRAZER IH, 1986, Q J MED, V61, P921; Haas A, 2010, EMBO MOL MED, V2, P231, DOI 10.1002/emmm.201000075; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Howard RR, 1996, CYTOMETRY, V26, P231, DOI 10.1002/(SICI)1097-0320(19960915)26:3<231::AID-CYTO9>3.3.CO;2-3; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; RIEDY MC, 1991, CYTOMETRY, V12, P133, DOI 10.1002/cyto.990120206; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SANSONI P, 1993, BLOOD, V82, P2767; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb	43	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85613	10.1371/journal.pone.0085613	http://dx.doi.org/10.1371/journal.pone.0085613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465619	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500082
J	Hou, M; Cui, JJ; Liu, JJ; Liu, F; Jiang, R; Liu, K; Wang, YS; Yin, L; Liu, WH; Yu, B				Hou, Meng; Cui, Jinjin; Liu, Jingjin; Liu, Fang; Jiang, Rui; Liu, Kai; Wang, Yongshun; Yin, Li; Liu, Wenhua; Yu, Bo			Angiopoietin-Like 4 Confers Resistance to Hypoxia/Serum Deprivation-Induced Apoptosis through PI3K/Akt and ERK1/2 Signaling Pathways in Mesenchymal Stem Cells	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ISCHEMIC-MYOCARDIUM; ADHESION; SURVIVAL; INTEGRINS; PROTEINS; MATRIX; HEART; CARDIOMYOCYTES; ANGIOGENESIS	Angiopoietin-like 4 (ANGPTL4) is a potential anti-apoptotic agent for various cells. We examined the protective effect of ANGPTL4 on hypoxia/serum deprivation (SD)-induced apoptosis of MSCs, as well as the possible mechanisms. MSCs were obtained from rat bone marrow and cultured in vitro. Apoptosis was induced by hypoxia/SD for up to 24 hr, and assessed by flow cytometry and TUNEL assay. Expression levels of Akt, ERK1/2, focal adhesion kinase (FAK), Src, Bcl-2, Bax, cytochrome C and cleaved caspase-3 were detected by Western blotting. Integrin beta 1 mRNA was detected by qRT-PCR. Mitochondrial membrane potential was assayed using a membrane-permeable dye. Hypoxia/SD-induced apoptosis was significantly attenuated by recombinant rat ANGPTL4 in a concentration dependent manner. Moreover, ANGPTL4 decreased the hypoxia/SD-induced caspase-3 cleavage and the cytochrome C release, but increased the Bcl-2/Bax ratio and the mitochondrial membrane potential. Decreased expression of integrin beta 1, the ANGPTL4 receptor was observed during hypoxia/SD conditions, however, such decrease was reversed by ANGPTL4. In addition, ANGPTL4 induced integrin beta 1-associated FAK and Src phosphorylation, which was blocked by anti-integrin beta 1 antibody. ANGPTL4 also reversed the hypoxia/SD-induced decrease of Akt and ERK 1/2 phosphorylation, and the effect of ANGPTL4 was abolished by inhibitors of either integrins, ERK1/2, or phosphatidylinositol 3-kinase (PI3K). Blocking integrin beta 1, Akt or ERK largely attenuated antiapoptotic effect of ANGPTL4. ANGPTL4 protects MSCs from hypoxia/SD-induced apoptosis by interacting with integrins to stimulate FAK complex, leading to downstream ERK1/2 and PI3K/Akt signaling pathways and mimicking the pathway in which MSCs contact with the extracellular matrix.	[Hou, Meng; Cui, Jinjin; Liu, Jingjin; Liu, Fang; Jiang, Rui; Liu, Kai; Wang, Yongshun; Yin, Li; Liu, Wenhua; Yu, Bo] Educ Minist Myocardial Ischemia Mech & Treatment, Key Labs, Harbin, Province Heilon, Peoples R China; [Hou, Meng; Cui, Jinjin; Liu, Jingjin; Liu, Fang; Jiang, Rui; Liu, Kai; Wang, Yongshun; Yin, Li; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Province Heilon, Peoples R China; [Liu, Wenhua] Harbin Med Univ, Affiliated Hosp 2, Intens Care Unit ICU Dept, Harbin, Province Heilon, Peoples R China	Harbin Medical University; Harbin Medical University	Yu, B (corresponding author), Educ Minist Myocardial Ischemia Mech & Treatment, Key Labs, Harbin, Province Heilon, Peoples R China.	yubodr@163.com			National Natural Science Foundation of China [30871064]; Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University), Ministry of Education [KF201315]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University), Ministry of Education	This study was supported by a grant from the National Natural Science Foundation of China (to BY, Grant No. 30871064). This work was also supported by grants from the Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University), Ministry of Education (to MH, Grant No: KF201315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter S, 2013, PROTEIN CELL, V4, P220, DOI 10.1007/s13238-013-2066-5; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Chen JH, 2008, STEM CELLS, V26, P135, DOI 10.1634/stemcells.2007-0098; Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Hui AY, 2009, J CELL BIOCHEM, V107, P1168, DOI 10.1002/jcb.22219; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; KATANASAKA Y, 2013, MOL CANCER, V25, P12; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ross RS, 2002, J CARD FAIL, V8, pS326, DOI 10.1054/jcaf.2002.129263; Salsmann A, 2005, J BIOL CHEM, V280, P33610, DOI 10.1074/jbc.M500146200; Shibata K, 2010, J CLIN PATHOL, V63, P1054, DOI 10.1136/jcp.2010.078600; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Song SW, 2009, STEM CELLS, V27, P1358, DOI 10.1002/stem.47; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stapleton CM, 2010, EXP CELL RES, V316, P507, DOI 10.1016/j.yexcr.2009.12.004; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Yu X, 2012, STEM CELLS, V30, P956, DOI 10.1002/stem.1064; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	42	34	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85808	10.1371/journal.pone.0085808	http://dx.doi.org/10.1371/journal.pone.0085808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465718	Green Published, gold			2022-12-27	WOS:000330244500116
J	Khan, SB; Rahman, MM; Akhtar, K; Asiri, AM; Rub, MA				Khan, Sher Bahadar; Rahman, Mohammed M.; Akhtar, Kalsoom; Asiri, Abdullah M.; Rub, Malik Abdul			Nitrophenol Chemi-Sensor and Active Solar Photocatalyst Based on Spinel Hetaerolite Nanoparticles	PLOS ONE			English	Article							PHOTO-CATALYST; HAUSMANNITE; FABRICATION; NANOHYBRID; NANORODS	In this contribution, a significant catalyst based on spinel ZnMn2O4 composite nanoparticles has been developed for electro-catalysis of nitrophenol and photo-catalysis of brilliant cresyl blue. ZnMn2O4 composite (hetaerolite) nanoparticles were prepared by easy low temperature hydrothermal procedure and structurally characterized by X-ray powder diffraction (XRD), field emission scanning electron microscopy (FESEM), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared (FTIR) and UV-visible spectroscopy which illustrate that the prepared material is optical active and composed of well crystalline body-centered tetragonal nanoparticles with average size of similar to 38 +/- 10 nm. Hetaerolite nanoparticles were applied for the advancement of a nitrophenol sensor which exhibited high sensitivity (1.500 mu Acm(-2) mM(-1)), stability, repeatability and lower limit of detection (20.0 mu M) in short response time (10 sec). Moreover, hetaerolite nanoparticles executed high solar photo-catalytic degradation when applied to brilliant cresyl blue under visible light.	[Khan, Sher Bahadar; Rahman, Mohammed M.; Asiri, Abdullah M.; Rub, Malik Abdul] King Abdulaziz Univ, CEAMR, Jeddah 21413, Saudi Arabia; [Khan, Sher Bahadar; Rahman, Mohammed M.; Asiri, Abdullah M.; Rub, Malik Abdul] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Akhtar, Kalsoom] Ewha Womans Univ, Div Nano Sci, Seoul, South Korea; [Akhtar, Kalsoom] Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea	King Abdulaziz University; King Abdulaziz University; Ewha Womans University; Ewha Womans University	Khan, SB (corresponding author), King Abdulaziz Univ, CEAMR, Jeddah 21413, Saudi Arabia.	sbkhan@kau.edu.sa	Khan, Sher Bahadar/H-5833-2012; Khan, Prof. Sher Bahadar/M-7968-2019; Asiri, Abdullah M./C-3458-2009; Akhtar, Kalsoom/Q-4743-2016; Rahman, Mohammed M./H-5823-2012; Rub, Malik Abdul/H-6027-2012	Khan, Sher Bahadar/0000-0001-9635-7175; Khan, Prof. Sher Bahadar/0000-0001-9635-7175; Asiri, Abdullah M./0000-0001-7905-3209; Rahman, Mohammed M./0000-0003-2773-1244; Rub, Malik Abdul/0000-0002-4798-5308	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-031-D1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (130-031-D1433). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors	Ansari SG, 2008, BIOSENS BIOELECTRON, V23, P1838, DOI 10.1016/j.bios.2008.02.022; Ansari SG, 2008, SENSOR ACTUAT B-CHEM, V132, P265, DOI 10.1016/j.snb.2008.01.036; Ansari SG, 2009, SENSOR ACTUAT B-CHEM, V137, P566, DOI 10.1016/j.snb.2009.01.018; Apte SK, 2006, MATER RES BULL, V41, P647, DOI 10.1016/j.materresbull.2005.08.028; Banik RM, 2008, SENSOR ACTUAT B-CHEM, V131, P295, DOI 10.1016/j.snb.2007.11.022; Du J, 2006, NANOTECHNOLOGY, V17, P4923, DOI 10.1088/0957-4484/17/19/024; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Faisal M, 2011, MATER LETT, V65, P1400, DOI 10.1016/j.matlet.2011.02.013; Jain RK, 2005, CURR SCI INDIA, V89, P101; Jamal A, 2013, MICRONANOSYST, V5, P22; Jamal A, 2012, APPL SURF SCI, V261, P52, DOI 10.1016/j.apsusc.2012.07.066; Jha A, 2012, MATER RES BULL, V47, P813, DOI 10.1016/j.materresbull.2011.11.057; Khan SB, 2012, INT J ELECTROCHEM SC, V7, P10965; Khan SB, 2012, NEW J CHEM, V36, P2368, DOI 10.1039/c2nj40549k; Khan SB, 2012, INT J ELECTROCHEM SC, V7, P4030; Khan SB, 2011, TALANTA, V85, P943, DOI 10.1016/j.talanta.2011.05.003; Khan SB, 2011, SCI TOTAL ENVIRON, V409, P2987, DOI 10.1016/j.scitotenv.2011.04.019; Khan SB, 2011, TALANTA, V84, P1005, DOI 10.1016/j.talanta.2011.02.036; Menaka, 2009, B MATER SCI, V32, P231, DOI 10.1007/s12034-009-0035-7; Mohapatra L, 2012, SEP PURIF TECHNOL, V91, P73, DOI 10.1016/j.seppur.2011.10.028; Parida KM, 2012, CHEM ENG J, V179, P131, DOI 10.1016/j.cej.2011.10.070; Rahman MM, 2012, ELECTROCHIM ACTA, V75, P164, DOI 10.1016/j.electacta.2012.04.093; Rahman MM, 2012, TALANTA, V95, P18, DOI 10.1016/j.talanta.2012.03.027; Rahman MM, 2011, BIOSENS BIOELECTRON, V28, P127, DOI 10.1016/j.bios.2011.07.024; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Rahman MM, 2011, J NANOPART RES, V13, P3789, DOI 10.1007/s11051-011-0301-7; Stanca SE, 2003, TALANTA, V61, P501, DOI 10.1016/S0039-9140(03)00310-2; Wang X, 2003, CHEM-EUR J, V9, P300, DOI 10.1002/chem.200390024; Yang J, 2000, CHEM MATER, V12, P3259, DOI 10.1021/cm0000144; Zhang P, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-323	31	37	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85290	10.1371/journal.pone.0085290	http://dx.doi.org/10.1371/journal.pone.0085290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465525	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500049
J	Matzke, NJ; Shih, PM; Kerfeld, CA				Matzke, Nicholas J.; Shih, Patrick M.; Kerfeld, Cheryl A.			Bayesian Analysis of Congruence of Core Genes in Prochlorococcus and Synechococcus and Implications on Horizontal Gene Transfer	PLOS ONE			English	Article							PHYLOGENETIC TREE SELECTION; GENOME EVOLUTION; PHOTOSYNTHESIS; CYANOBACTERIA; MODELS; CONFIDENCE; INFERENCE; ACCURACY; BACTERIA; SEQUENCE	It is often suggested that horizontal gene transfer is so ubiquitous in microbes that the concept of a phylogenetic tree representing the pattern of vertical inheritance is oversimplified or even positively misleading. "Universal proteins" have been used to infer the organismal phylogeny, but have been criticized as being only the "tree of one percent." Currently, few options exist for those wishing to rigorously assess how well a universal protein phylogeny, based on a relative handful of well-conserved genes, represents the phylogenetic histories of hundreds of genes. Here, we address this problem by proposing a visualization method and a statistical test within a Bayesian framework. We use the genomes of marine cyanobacteria, a group thought to exhibit substantial amounts of HGT, as a test case. We take 379 orthologous gene families from 28 cyanobacteria genomes and estimate the Bayesian posterior distributions of trees - a "treecloud" - for each, as well as for a concatenated dataset based on putative "universal proteins." We then calculate the average distance between trees within and between all treeclouds on various metrics and visualize this high-dimensional space with non-metric multidimensional scaling (NMMDS). We show that the tree space is strongly clustered and that the universal protein treecloud is statistically significantly closer to the center of this tree space than any individual gene treecloud. We apply several commonly-used tests for incongruence/HGT and show that they agree HGT is rare in this dataset, but make different choices about which genes were subject to HGT. Our results show that the question of the representativeness of the "tree of one percent" is a quantitative empirical question, and that the phylogenetic central tendency is a meaningful observation even if many individual genes disagree due to the various sources of incongruence.	[Matzke, Nicholas J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Shih, Patrick M.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Kerfeld, CA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	ckerfeld@lbl.gov	Matzke, Nicholas/L-4109-2015	Matzke, Nicholas/0000-0002-8698-7656	National Science Foundation (NSF) [DEB-0919451]; Wang Fellowship; Tien Fellowship; Google Summer of Code grant; U.C. Berkeley; Department of Integrative Biology; Center for Theoretical and Evolutionary Genetics; John Huelsenbeck; NSF [MCB-0851070]; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Wang Fellowship; Tien Fellowship; Google Summer of Code grant(Google Incorporated); U.C. Berkeley; Department of Integrative Biology; Center for Theoretical and Evolutionary Genetics; John Huelsenbeck; NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NJM was supported by National Science Foundation (NSF) Grant DEB-0919451, a Wang Fellowship, and a Tien Fellowship, and a Google Summer of Code grant, as well as U.C. Berkeley, the Department of Integrative Biology, the Center for Theoretical and Evolutionary Genetics, and John Huelsenbeck. PMS and CAK were funded by NSF Grant MCB-0851070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Ane C, 2007, MOL BIOL EVOL, V24, P412; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Doolittle WF, 2009, COLD SPRING HARBOR S; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gong ZQ, 2012, P NATL ACAD SCI USA, V109, pE234, DOI 10.1073/pnas.1119859109; Hillis DM, 2005, SYST BIOL, V54, P471, DOI 10.1080/10635150590946961; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Narechania A, 2012, GENOME BIOL EVOL, V4, P30, DOI 10.1093/gbe/evr121; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306; Zhaxybayeva O, 2011, CURR BIOL, V21, pR242, DOI 10.1016/j.cub.2011.01.045; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032	45	9	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85103	10.1371/journal.pone.0085103	http://dx.doi.org/10.1371/journal.pone.0085103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465485	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500036
J	Pires, L; Bosco, SDG; Baptista, MS; Kurachi, C				Pires, Layla; Gimenes Bosco, Sandra de Moraes; Baptista, Mauricio S.; Kurachi, Cristina			Photodynamic Therapy in Pythium insidiosum - An In Vitro Study of the Correlation of Sensitizer Localization and Cell Death	PLOS ONE			English	Article							PYTHIOSIS-INSIDIOSI; SUBCUTANEOUS PYTHIOSIS; BRAZIL; INFECTIONS; HORSES; DOGS	Pythiosis is an infectious disease caused by Pythium insidiosum, a fungus-like organism. Due to the lack of ergosterol on its cell membrane, antibiotic therapy is ineffective. The conventional treatment is surgery, but lesion recurrence is frequent, requiring several resections or limb amputation. Photodynamic therapy uses photo-activation of drugs and has the potential to be an attractive alternative option. The in vitro PDT response on the growing of Pythium insidiosum culture was investigated using three distinct photosensitizers: methylene blue, Photogem, and Photodithazine. The photosensitizer distribution in cell structures and the PDT response for incubation times of 30, 60, and 120 minutes were evaluated. Methylene blue did not penetrate in the pathogen's cell and consequently there was no PDT inactivation. Photogem showed heterogenous distribution in the hyphal structure with small concentration inside the cells. Porphyrin-PDT response was heterogenous, death and live cells were observed in the treated culture. After 48 hours, hyphae regrowth was observed. Photodithazine showed more homogenous distribution inside the cell and with the specific intracellular localization dependent on incubation time. Photodithazine first accumulates in intracellular vacuoles, and at incubation times of one hour, it is located at all cell membranes. Higher inhibition of the growing rates was achieved with Photodithazine -PDT, over 98%. Our results showed that the photosensitizers that cross more efficiently the Pythium insidiosum membranes are able to cause extensive damage to the organism under illumination and therefore, are the best options for clinical treatment.	[Pires, Layla; Kurachi, Cristina] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Paulo, Brazil; [Gimenes Bosco, Sandra de Moraes] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Sao Paulo, Brazil; [Baptista, Mauricio S.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Pires, L (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, Sao Paulo, Brazil.	laylabtu@gmail.com	de Moraes Gimenes Bosco, Sandra/AAP-1467-2021; Baptista, Mauricio S/A-5140-2008; Baptista, Mauricio S/AAO-5749-2021; Kurachi, Cristina/G-3731-2012; de M. G. Bosco, Sandra/B-2570-2013	de Moraes Gimenes Bosco, Sandra/0000-0002-6363-3740; Baptista, Mauricio S/0000-0001-7079-7666; Baptista, Mauricio S/0000-0001-7079-7666; Pires, Layla/0000-0003-4558-5199; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037	FAPESP (LP scholarhip); FAPESP (CEPID-Program); CNPq (INCT Program)	FAPESP (LP scholarhip); FAPESP (CEPID-Program); CNPq (INCT Program)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support by FAPESP (LP scholarhip, and CEPID-Program), and CNPq (INCT Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C. J., 1996; Bosco SDG, 2005, EMERG INFECT DIS, V11, P715; Calzavara-Pinton PG, 2005, J PHOTOCH PHOTOBIO B, V78, P1, DOI 10.1016/j.jphotobiol.2004.06.006; Choudhary S, 2009, LASER MED SCI, V24, P971, DOI 10.1007/s10103-009-0716-x; Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b; Dougherty TJ, 2008, PHOTOCHEM PHOTOBIOL, V38, P377; Dovigo LN, 2011, LASER SURG MED, V43, P927, DOI 10.1002/lsm.21110; Dykstra MJ, 1999, MED MYCOL, V37, P427, DOI 10.1046/j.1365-280X.1999.00248.x; Engelmann FM, 2007, J BIOENERG BIOMEMBR, V39, P175, DOI 10.1007/s10863-007-9075-0; Garcia RB, 2007, MYCOL RES, V111, P1352, DOI 10.1016/j.mycres.2007.08.005; Gonzales FP, 2012, PHOTOCHEM PHOTOBIOL, V86, P653; Maisch T, 2005, J GERMAN SOC DERMATO, V9, P360; Mendoza L, 2003, VACCINE, V21, P2797, DOI 10.1016/S0264-410X(03)00225-1; Mendoza L, 1996, J MYCOL MED, V6, P151; MENDOZA L, 1993, J CLIN MICROBIOL, V31, P2967, DOI 10.1128/JCM.31.11.2967-2973.1993; MENDOZA L, 1992, MYCOPATHOLOGIA, V119, P89, DOI 10.1007/BF00443939; MILLER RI, 1981, AUST VET J, V57, P377, DOI 10.1111/j.1751-0813.1981.tb00526.x; Ochsner M, 1997, J PHOTOCH PHOTOBIO B, V39, P1, DOI 10.1016/S1011-1344(96)07428-3; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Pupaibool J, 2006, EMERG INFECT DIS, V12, P517, DOI 10.3201/eid1203.051044; Santurio JM, 2003, VACCINE, V21, P2535, DOI 10.1016/S0264-410X(03)00035-5; Santurio JM, 1998, MYCOPATHOLOGIA, V141, P123, DOI 10.1023/A:1006995407665; Smolinska M, 2010, ACTA CHIMICA SLOVACA, V3, P41; Tabosa IM, 2004, VET PATHOL, V41, P412, DOI 10.1354/vp.41-4-412; TRISCOTT JA, 1993, J CUTAN PATHOL, V20, P267, DOI 10.1111/j.1600-0560.1993.tb00654.x; Wilson BC, 2008, PHYS MED BIOL, V53, pR61, DOI 10.1088/0031-9155/53/9/R01; Yangjunzhi Yinjiangzhong, 2012, MODIFIED P O ALGORIT, P1; Zeina B, 2001, BRIT J DERMATOL, V144, P274, DOI 10.1046/j.1365-2133.2001.04013.x; Zhu TC, 2008, MED PHYS, V35, P3127, DOI 10.1118/1.2937440	29	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85431	10.1371/journal.pone.0085431	http://dx.doi.org/10.1371/journal.pone.0085431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465559	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500064
J	Shao, SH; Li, ZL; Gao, W; Yu, GH; Liu, DX; Pan, F				Shao, Shuhong; Li, Zunling; Gao, Wei; Yu, Guohua; Liu, Dexiang; Pan, Fang			ADAM-12 as a Diagnostic Marker for the Proliferation, Migration and Invasion in Patients with Small Cell Lung Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; EXTRACELLULAR-MATRIX; HUMAN GLIOBLASTOMAS; TUMOR-PROGRESSION; FAMILY-MEMBERS; MESSENGER-RNA; EXPRESSION	Small cell lung cancer (SCLC) is highly aggressive and is characterized by malignant metastasis. Approximately 90% of patients die due to extensive metastasis. The extracellular matrix (ECM) is a natural barrier that can prevent cellular invasion and metastasis. Therefore, degradation of the ECM must take place in order for extensive metastasis to occur. A disintegrin and metalloprotease (ADAM) is a multi-domain protease that plays an important role in tumorigenesis, as well as tumor development, invasion and metastasis. However, there have been few reports on the expression and role of ADAMs in SCLC. In the current study, the expression and role of ADAMs in SCLC proliferation, invasion and metastasis was investigated. A total of 150 SCLC tissue samples were examined by immunohistochemistry for ADAMs expression. ADAM-12 was found to be abundantly expressed in 72.67% samples and other ADAMs were found to be expressed in 10% to 40% of samples. ADAM-12 levels in serum and urine, from 70 SCLC patients and 40 normal controls, were also measured using ELISA. ADAM-12 expression was significantly higher in SCLC patients than in healthy controls and in patients with extensive disease compared to those with more limited disease. Silencing the expression of ADAM-12 in H1688 cells through the use of specific siRNA significantly reduced cellular proliferation, invasion and metastasis. Supplementing the expression of ADAM-12-L or -S in H345 cells, significantly enhanced cellular proliferation, invasion and metastasis. Animal models with metastatic SCLC also exhibited increased expression of ADAM-12 along with enhanced invasion and metastasis. In brief, ADAM-12 is an independent prognostic factor and diagnostic marker, and is involved in the proliferation, invasion and metastasis of SCLC.	[Shao, Shuhong; Liu, Dexiang; Pan, Fang] Shandong Univ, Sch Med, Inst Med Psychol, Jinan 250100, Peoples R China; [Shao, Shuhong] Binzhou Med Univ, Dept Med Psychol, Yantai, Peoples R China; [Li, Zunling] Binzhou Med Univ, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Gao, Wei] Jinan Cent Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Yu, Guohua] Yuhuangding Hosp, Dept Pathol, Yantai, Shandong, Peoples R China	Shandong University; Binzhou Medical University; Binzhou Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Pan, F (corresponding author), Shandong Univ, Sch Med, Inst Med Psychol, Jinan 250100, Peoples R China.	panfang2003@hotmail.com			National Natural Science Foundation of China [81302017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81302017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Buttery RC, 2004, INT J BIOCHEM CELL B, V36, P1154, DOI 10.1016/S1357-2725(03)00261-9; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Chang MH, 2012, APMIS, V120, P28, DOI 10.1111/j.1600-0463.2011.02788.x; Costa FF, 2004, ONCOGENE, V23, P1481, DOI 10.1038/sj.onc.1207263; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Hu ZY, 2012, CARCINOGENESIS, V33, P1178, DOI 10.1093/carcin/bgs141; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Ishikawa N, 2004, CLIN CANCER RES, V10, P8363, DOI 10.1158/1078-0432.CCR-04-1436; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lei YH, 2012, ONCOL REP, V27, P151, DOI 10.3892/or.2011.1489; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Michael M, 1999, J CLIN ONCOL, V17, P1802, DOI 10.1200/JCO.1999.17.6.1802; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Schutz A, 2005, VIRCHOWS ARCH, V446, P421, DOI 10.1007/s00428-004-1193-z; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhang YL, 2013, J THORAC DIS, V5, P538, DOI 10.3978/j.issn.2072-1439.2013.07.04	35	47	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85936	10.1371/journal.pone.0085936	http://dx.doi.org/10.1371/journal.pone.0085936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465799	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500149
J	Xu, X; Cai, Y; Wei, Y; Donate, F; Juarez, J; Parry, G; Chen, LQ; Meehan, EJ; Ahn, RW; Ugolkov, A; Dubrovskyi, O; O'Halloran, TV; Huang, MD; Mazar, AP				Xu, Xiang; Cai, Yuan; Wei, Ying; Donate, Fernando; Juarez, Jose; Parry, Graham; Chen, Liqing; Meehan, Edward J.; Ahn, Richard W.; Ugolkov, Andrey; Dubrovskyi, Oleksii; O'Halloran, Thomas V.; Huang, Mingdong; Mazar, Andrew P.			Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (alpha M)	PLOS ONE			English	Article							UROKINASE-PLASMINOGEN-ACTIVATOR; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; CELL INVASION; BONE-MARROW; RECEPTOR; SYSTEM; EXPRESSION; MIGRATION; ASSOCIATION	The urokinase plasminogen activator receptor (uPAR) plays a role in tumor progression and has been proposed as a target for the treatment of cancer. We recently described the development of a novel humanized monoclonal antibody that targets uPAR and has anti-tumor activity in multiple xenograft animal tumor models. This antibody, ATN-658, does not inhibit ligand binding (i.e. uPA and vitronectin) to uPAR and its mechanism of action remains unclear. As a first step in understanding the anti-tumor activity of ATN-658, we set out to identify the epitope on uPAR to which ATN-658 binds. Guided by comparisons between primate and human uPAR, epitope mapping studies were performed using several orthogonal techniques. Systematic site directed and alanine scanning mutagenesis identified the region of aa 268-275 of uPAR as the epitope for ATN-658. No known function has previously been attributed to this epitope Structural insights into epitope recognition were obtained from structural studies of the Fab fragment of ATN-658 bound to uPAR. The structure shows that the ATN-658 binds to the DIII domain of uPAR, close to the C-terminus of the receptor, corroborating the epitope mapping results. Intriguingly, when bound to uPAR, the complementarity determining region (CDR) regions of ATN-658 closely mimic the binding regions of the integrin CD11b (alpha M), a previously identified uPAR ligand thought to be involved in leukocyte rolling, migration and complement fixation with no known role in tumor progression of solid tumors. These studies reveal a new functional epitope on uPAR involved in tumor progression and demonstrate a previously unrecognized strategy for the therapeutic targeting of uPAR.	[Xu, Xiang; Cai, Yuan; Huang, Mingdong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Cai, Yuan] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Wei, Ying] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Donate, Fernando] Agensys, St Santa Monica, CA USA; [Juarez, Jose] GNF, San Diego, CA USA; [Parry, Graham] Attenuon, San Diego, CA USA; [Chen, Liqing; Meehan, Edward J.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA; [Ugolkov, Andrey; Dubrovskyi, Oleksii; O'Halloran, Thomas V.; Mazar, Andrew P.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [O'Halloran, Thomas V.; Mazar, Andrew P.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [O'Halloran, Thomas V.; Mazar, Andrew P.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Ahn, Richard W.; O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Evanston, IL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Huntsville; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University	Huang, MD (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA.	mhuang1@bidmc.harvard.edu; a-mazar@northwestern.edu	Ugolkov, Andrey/T-3012-2019; O'Halloran, Thomas/ABE-6125-2021; Huang, Mingdong/J-4278-2017	O'Halloran, Thomas/0000-0001-8732-5059; Huang, Mingdong/0000-0003-0085-9141	NIH [HL086584]; NCI [CA125564, CA151461]; H Foundation and Lynn Sage Breast Cancer Foundation; services of the Tumor Biology Core (TBC) of Northwestern University; NATIONAL CANCER INSTITUTE [U01CA151461, R01CA125564, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); H Foundation and Lynn Sage Breast Cancer Foundation; services of the Tumor Biology Core (TBC) of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from NIH (HL086584) to M. H., NCI (CA125564), to Harold Chapman (Y.W.) and (CA151461) to (T.V.O. and A. P. M) and and the H Foundation and Lynn Sage Breast Cancer Foundation (A. P. M.). This work was supported by the services of the Tumor Biology Core (TBC) of Northwestern University which benefits from philanthropic support of the Robert H. Lurie Cancer Center and the Chemistry of Life Processes Institute. X-ray data for this study were measured at beamline x29 of the National Synchrotron Light Source and at APS SER-CAT beamline 22ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bass R, 2009, THROMB HAEMOSTASIS, V101, P954, DOI 10.1160/TH08-08-0558; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949; Bene MC, 2004, LEUKEMIA, V18, P394, DOI 10.1038/sj.leu.2403250; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantero D, 1997, BRIT J CANCER, V75, P388, DOI 10.1038/bjc.1997.63; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Chioda M, 2011, CANCER METAST REV, V30, P27, DOI 10.1007/s10555-011-9268-1; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Degryse B, 2011, CURR PHARM DESIGN, V17, P1872, DOI 10.2174/138161211796718161; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Ghosh S, 2006, J BIOL CHEM, V281, P13021, DOI 10.1074/jbc.M508526200; He C, 2001, J CANCER RES CLIN, V127, P180, DOI 10.1007/s004320000192; Hildenbrand R, 1999, J LEUKOCYTE BIOL, V66, P40, DOI 10.1002/jlb.66.1.40; Hildenbrand R, 2010, EXPERT OPIN INV DRUG, V19, P641, DOI 10.1517/13543781003767400; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2009, P NATL ACAD SCI USA, V106, P4349, DOI 10.1073/pnas.0810844106; Li YD, 2007, J MOL BIOL, V365, P1117, DOI 10.1016/j.jmb.2006.10.059; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; Rabbani SA, 2010, NEOPLASIA, V12, P778, DOI 10.1593/neo.10296; RIFKIN DB, 1990, CELL DIFFER DEV, V32, P313, DOI 10.1016/0922-3371(90)90045-X; SCHMITT M, 1992, BIOL CHEM H-S, V373, P611, DOI 10.1515/bchm3.1992.373.2.611; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Thomas C, 2009, BJU INT, V104, P29, DOI 10.1111/j.1464-410X.2008.08298.x; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Buren G, 2009, CANCER-AM CANCER SOC, V115, P3360, DOI 10.1002/cncr.24371; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; Xue W, 1997, CANCER RES, V57, P1682; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	58	25	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85349	10.1371/journal.pone.0085349	http://dx.doi.org/10.1371/journal.pone.0085349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465541	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500057
J	Bruxvoort, K; Goodman, C; Kachur, SP; Schellenberg, D				Bruxvoort, Katia; Goodman, Catherine; Kachur, S. Patrick; Schellenberg, David			How Patients Take Malaria Treatment: A Systematic Review of the Literature on Adherence to Antimalarial Drugs	PLOS ONE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; ARTESUNATE-MEFLOQUINE COMBINATION; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; SULFADOXINE-PYRIMETHAMINE; HOME TREATMENT; VIVAX MALARIA; COMMUNITY EFFECTIVENESS; PRIMAQUINE TREATMENT; CHILDHOOD FEVERS	Background: High levels of patient adherence to antimalarial treatment are important in ensuring drug effectiveness. To achieve this goal, it is important to understand levels of patient adherence, and the range of study designs and methodological challenges involved in measuring adherence and interpreting results. Since antimalarial adherence was reviewed in 2004, there has been a major expansion in the use of artemisinin-based combination therapies (ACTs) in the public sector, as well as initiatives to make them more widely accessible through community health workers and private retailers. These changes and the large number of recent adherence studies raise the need for an updated review on this topic. Objective: We conducted a systematic review of studies reporting quantitative results on patient adherence to antimalarials obtained for treatment. Results: The 55 studies identified reported extensive variation in patient adherence to antimalarials, with many studies reporting very high adherence (90-100%) and others finding adherence of less than 50%. We identified five overarching approaches to assessing adherence based on the definition of adherence and the methods used to measure it. Overall, there was no clear pattern in adherence results by approach. However, adherence tended to be higher among studies where informed consent was collected at the time of obtaining the drug, where patient consultations were directly observed by research staff, and where a diagnostic test was obtained. Conclusion: Variations in reported adherence may reflect factors related to patient characteristics and the nature of their consultation with the provider, as well as methodological variations such as interaction between the research team and patients before and during the treatment. Future studies can benefit from an awareness of the impact of study procedures on adherence outcomes, and the identification of improved measurement methods less dependent on self-report.	[Bruxvoort, Katia; Goodman, Catherine; Schellenberg, David] London Sch Hyg & Trop Med, London WC1, England; [Bruxvoort, Katia] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kachur, S. Patrick] US Ctr Dis Control & Prevent, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Centers for Disease Control & Prevention - USA	Bruxvoort, K (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	katia.bruxvoort@lshtm.ac.uk	Kachur, Patrick/ABE-7220-2021	Goodman, Catherine/0000-0002-2241-3485; Schellenberg, David/0000-0001-8222-0186; Bruxvoort, Katia/0000-0001-8277-2431	ACT Consortium through Bill & Melinda Gates Foundation [PHGB VG0410]	ACT Consortium through Bill & Melinda Gates Foundation	The work was funded by the ACT Consortium through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine (www.actconsortium.org, PHGB VG0410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaku Benjamin K, 2004, Afr Health Sci, V4, P171; Achan J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2763; Agyepong IA, 2002, SOC SCI MED, V55, P2215, DOI 10.1016/S0277-9536(01)00366-5; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-190; Amin AA, 2004, TROP MED INT HEALTH, V9, P967, DOI 10.1111/j.1365-3156.2004.01291.x; Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Beer N, 2009, TROP MED INT HEALTH, V14, P766, DOI 10.1111/j.1365-3156.2009.02289.x; Bell DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-204; Bloland PB, 2003, AM J TROP MED HYG, V68, P125, DOI 10.4269/ajtmh.2003.68.125; Blomstedt Y, 2012, GLOB HLTH ACTION, V5; Bruxvoort K, 2012, STUDY PROTOCOL CLUST; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Clark S, 2011, STUDY PROTOCOL INTRO; Cohen JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-83; Cohen JL, 2011, STUDY PROTOCOL DETER; Congpuong K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-43; Das J, 2011, IMPACT RECALL PERIOD; DEMING MS, 1989, B WORLD HEALTH ORGAN, V67, P695; Denis M B, 1998, Bull World Health Organ, V76 Suppl 1, P43; Depoortere E, 2004, ANN TROP MED PARASIT, V98, P635, DOI 10.1179/000349804225021271; Depoortere E, 2004, TROP MED INT HEALTH, V9, P62, DOI 10.1046/j.1365-3156.2003.01157.x; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dorsey G, 2003, J INFECT DIS, V188, P1231, DOI 10.1086/378523; Duarte EC, 2003, TROP MED INT HEALTH, V8, P518, DOI 10.1046/j.1365-3156.2003.01042.x; Dunyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017371; Faucher JF, 2009, J INFECT DIS, V200, P57, DOI 10.1086/599378; Fink G, 2011, PRESERVING ACTS PACT; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Fungladda W, 1998, Bull World Health Organ, V76 Suppl 1, P59; Gerstl S, 2010, T ROY SOC TROP MED H, V104, P328, DOI 10.1016/j.trstmh.2009.12.008; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Hodel EM, 2010, J INFECT DIS, V202, P1088, DOI 10.1086/655779; Hodel EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008184; Kabanywanyi AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-48; Kachur SP, 2004, AM J TROP MED HYG, V71, P715, DOI 10.4269/ajtmh.2004.71.715; Kalyango JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060481; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Keoluangkhot V, 2008, AM J TROP MED HYG, V78, P552, DOI 10.4269/ajtmh.2008.78.552; Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4; Kolaczinski JH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-40; Krause G, 2000, ANN TROP PAEDIATR, V20, P273, DOI 10.1080/02724936.2000.11748147; Lauwo J. A. K., 2006, Papua New Guinea Medical Journal, V49, P14; Lawford H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-281; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; NaBangchang K, 1997, BRIT J CLIN PHARMACO, V43, P639, DOI 10.1046/j.1365-2125.1997.00604.x; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Nsungwa-Sabiiti J, 2005, ANN TROP PAEDIATR, V25, P91, DOI 10.1179/146532805X45683; Okonkwo PO, 2001, T ROY SOC TROP MED H, V95, P320, DOI 10.1016/S0035-9203(01)90252-4; Onyango EO, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-143; Pereira EA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-355; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Qingjun L, 1998, Bull World Health Organ, V76 Suppl 1, P21; Rahman MM, 2008, T ROY SOC TROP MED H, V102, P861, DOI 10.1016/j.trstmh.2008.05.022; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Shwe T, 1998, Bull World Health Organ, V76 Suppl 1, P35; Simba DO, 2012, T ROY SOC TROP MED H, V106, P3, DOI 10.1016/j.trstmh.2011.09.006; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Souares A, 2008, T ROY SOC TROP MED H, V102, P751, DOI 10.1016/j.trstmh.2008.05.016; Souares A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-257; Takeuchi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-308; Thera MA, 2000, TROP MED INT HEALTH, V5, P876, DOI 10.1046/j.1365-3156.2000.00652.x; Twagirumukiza M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-206; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, GUID TREATM MAL, V2nd; Wiesner L, 2011, COMMUNICATION; Winch PJ, 2003, T ROY SOC TROP MED H, V97, P481, DOI 10.1016/S0035-9203(03)80001-9; Yeboah-Antwi K, 2001, B WORLD HEALTH ORGAN, V79, P394; Yepez M C, 2000, Rev Cubana Med Trop, V52, P81; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	78	73	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84555	10.1371/journal.pone.0084555	http://dx.doi.org/10.1371/journal.pone.0084555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465418	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000330240500018
J	Lin, CS; Ku, HL; Chao, HT; Tu, PC; Li, CT; Cheng, CM; Su, TP; Lee, YC; Hsieh, JC				Lin, Chia-Shu; Ku, Hsiao-Lun; Chao, Hsiang-Tai; Tu, Pei-Chi; Li, Cheng-Ta; Cheng, Chou-Ming; Su, Tung-Ping; Lee, Ying-Chiao; Hsieh, Jen-Chuen			Neural Network of Body Representation Differs between Transsexuals and Cissexuals	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; PRIMARY SOMATOSENSORY CORTEX; DEFAULT MODE; PREFRONTAL CORTEX; COGNITIVE CONTROL; BRAIN-FUNCTION; ORGANIZATION; DISORDER; EMOTION; SELF	Body image is the internal representation of an individual's own physical appearance. Individuals with gender identity disorder (GID), commonly referred to as transsexuals (TXs), are unable to form a satisfactory body image due to the dissonance between their biological sex and gender identity. We reasoned that changes in the resting-state functional connectivity (rsFC) network would neurologically reflect such experiential incongruence in TXs. Using graph theory-based network analysis, we investigated the regional changes of the degree centrality of the rsFC network. The degree centrality is an index of the functional importance of a node in a neural network. We hypothesized that three key regions of the body representation network, i.e., the primary somatosensory cortex, the superior parietal lobule and the insula, would show a higher degree centrality in TXs. Twenty-three pre-treatment TXs (11 male-to-female and 12 female-to-male TXs) as one psychosocial group and 23 age-matched healthy cissexual control subjects (CISs, 11 males and 12 females) were recruited. Resting-state functional magnetic resonance imaging was performed, and binarized rsFC networks were constructed. The TXs demonstrated a significantly higher degree centrality in the bilateral superior parietal lobule and the primary somatosensory cortex. In addition, the connectivity between the right insula and the bilateral primary somatosensory cortices was negatively correlated with the selfness rating of their desired genders. These data indicate that the key components of body representation manifest in TXs as critical function hubs in the rsFC network. The negative association may imply a coping mechanism that dissociates bodily emotion from body image. The changes in the functional connectome may serve as representational markers for the dysphoric bodily self of TXs.	[Lin, Chia-Shu] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Lin, Chia-Shu; Ku, Hsiao-Lun; Cheng, Chou-Ming; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res, Integrated Brain Res Unit, Taipei, Taiwan; [Ku, Hsiao-Lun; Tu, Pei-Chi; Li, Cheng-Ta; Su, Tung-Ping; Lee, Ying-Chiao] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Ku, Hsiao-Lun] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Chao, Hsiang-Tai] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Hsiang-Tai] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Obstet & Gynecol, Taipei 112, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping; Lee, Ying-Chiao] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Psychiat, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	yclee@vghtpe.gov.tw; jchsieh@ym.edu.tw	Li, Cheng-Ta/AAI-5759-2021; Lin, Chia-Shu/HGD-7267-2022; Ku, Hsiao-Lun/G-6053-2016; Lin, Chia-shu/AAA-5143-2019	Li, Cheng-Ta/0000-0002-0670-1153; Lin, Chia-Shu/0000-0002-6575-0887; Ku, Hsiao-Lun/0000-0002-5640-5256; 	National Science Council [99-2314-B-075-018]; Taipei Veterans General Hospital [V100E3-002, V101C-201, V101E3-002]; Brain Research Center of National Yang-Ming University [98A-C-B501_23]; Ministry of Education for National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center of National Yang-Ming University; Ministry of Education for National Yang-Ming University	This work was supported by the National Science Council (99-2314-B-075-018), the Taipei Veterans General Hospital (V100E3-002, V101C-201 and V101E3-002), the Brain Research Center of National Yang-Ming University (98A-C-B501_23) and the Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Alexopoulos GS, 2013, J AFFECT DISORDERS, V149, P398, DOI 10.1016/j.jad.2012.11.023; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arienzo D, 2013, NEUROPSYCHOPHARMACOL, V38, P1130, DOI 10.1038/npp.2013.18; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bond M, 1986, EMPIRICAL STUDIES EG, P127; Cisler JM, 2013, PSYCHOL MED, V43, P507, DOI 10.1017/S0033291712001390; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Daniels JK, 2011, J PSYCHIATR NEUROSCI, V36, P56, DOI 10.1503/jpn.100050; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Favaro A, 2012, BIOL PSYCHIAT, V72, P864, DOI 10.1016/j.biopsych.2012.04.025; Ferri F, 2012, J COGNITIVE NEUROSCI, V24, P1584, DOI 10.1162/jocn_a_00230; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Ham T, 2013, J NEUROSCI, V33, P7091, DOI 10.1523/JNEUROSCI.4692-12.2013; Harsay HA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00246; Hepp U, 2005, J PSYCHOSOM RES, V58, P259, DOI 10.1016/j.jpsychores.2004.08.010; KLEIN F, 1985, J HOMOSEXUAL, V11, P35, DOI 10.1300/J082v11n01_04; Ku HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070808; Lee YC, 2000, DEV DEFENSE STYLE QU; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; LINDGREN TW, 1975, ARCH SEX BEHAV, V4, P639, DOI 10.1007/BF01544272; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; Michel A, 2002, EUR PSYCHIAT, V17, P353, DOI 10.1016/S0924-9338(02)00703-4; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ramachandran VS, 2007, MED HYPOTHESES, V69, P1001, DOI 10.1016/j.mehy.2007.02.024; Romanski L.M., 2012, NEURAL BASEMULTISE; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Schurmann M, 2011, HUM BRAIN MAPP, V32, P612, DOI 10.1002/hbm.21049; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sehm B, 2012, J NEUROPHYSIOL, V108, P3253, DOI 10.1152/jn.00606.2012; Simmons WK, 2012, HUM BRAIN MAPP; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Straube T, 2011, NEUROIMAGE, V54, P2534, DOI 10.1016/j.neuroimage.2010.10.010; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanden Bulcke C, 2013, PAIN, V154, P1464, DOI 10.1016/j.pain.2013.05.009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yan CG, 2013, NEUROIMAGE; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	57	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85914	10.1371/journal.pone.0085914	http://dx.doi.org/10.1371/journal.pone.0085914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465785	Green Published, gold			2022-12-27	WOS:000330240500087
J	Boufassa, F; Lechenadec, J; Meyer, L; Costagliola, D; Hunt, PW; Pereyra, F; Deeks, S; Pancino, G; Taulera, O; Lichterfeld, M; Delobel, P; Saez-Cirion, A; Lambotte, O				Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence; Costagliola, Dominique; Hunt, Peter W.; Pereyra, Florencia; Deeks, Steve; Pancino, Gianfranco; Taulera, Olivier; Lichterfeld, Mathias; Delobel, Pierre; Saez-Cirion, Asier; Lambotte, Olivier		ANRS CO18 HIV Controllers Cohort; Cascade Collaboration Eurocoord; SCOPE Cohort; Int HIV Controllers Study	Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-LEVEL VIREMIA; CD4 CELL COUNTS; DISEASE PROGRESSION; VIRAL SUPPRESSION; ABSENCE; INFECTION; INDIVIDUALS; REPLICATION; COINFECTION	Objective: HIV "elite controllers'' (ECs) spontaneously control viral load, but some eventually require combination antiretroviral treatment (cART), due to a loss of viral control or a decline in CD4 T-cell counts. Here we studied the CD4 T-cell count dynamics after cART initiation among 34 ECs followed in U.S. and European cohorts, by comparison with chronically viremic patients (VIRs). Methods: ECs were defined as patients with at least >= 5 viral load (VL) measurements below 400 copies/mL during at least a 5-year period despite never receiving ART and were selected from the French ANRS CO18 cohort, the U.S. SCOPE cohort, the International HIV Controllers study and the European CASCADE collaboration. VIRs were selected from the ANRS COPANA cohort of recently-diagnosed (< 1 year) ART-naive HIV-1-infected adults. CD4 T-cell count dynamics after cART initiation in both groups were modelled with piecewise mixed linear models. Results: After cART initiation, CD4 T-cell counts showed a biphasic rise in VIRs with: an initial rapid increase during the first 3 months (+0.63 root CD4/month), followed by +0.19 root CD4/month. This first rapid phase was not observed in ECs, in whom the CD4Tc count increased steadily, at a rate similar to that of the second phase observed in VIRs. After cART initiation at a CD4 T-cell count of 300/mm(3), the estimated mean CD4 T-cell gain during the first 12 months was 139/mm(3) in VIRs and 80/mm(3) in ECs (p = 0.048). Conclusions: cART increases CD4 T-cell counts in elite controllers, albeit less markedly than in other patients.	[Boufassa, Faroudy; Meyer, Laurence] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Epidemiol HIV & STI Team, Le Kremlin Bicetre, France; [Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence] Univ Paris 11, Le Kremlin Bicetre, France; [Meyer, Laurence] Hop Bicetre, AP HP, Serv Sante Publ, Le Kremlin Bicetre, France; [Costagliola, Dominique] Univ Paris 06, Paris, France; [Costagliola, Dominique] INSERM, Paris, France; [Hunt, Peter W.; Deeks, Steve] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Hunt, Peter W.; Deeks, Steve] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Hunt, Peter W.; Deeks, Steve] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Pereyra, Florencia] Massachusetts Gen Hosp, Ragon Inst, MIT, Cambridge, MA USA; [Pereyra, Florencia] Harvard Univ, Cambridge, MA 02138 USA; [Taulera, Olivier] Hop St Louis, Paris, France; [Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Delobel, Pierre] Hop Purpan, Serv Malad Infect & Trop, Toulouse, France; [Delobel, Pierre] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Saez-Cirion, Asier] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Boufassa, F (corresponding author), CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Epidemiol HIV & STI Team, Le Kremlin Bicetre, France.	faroudy.boufassa@inserm.fr	Hunt, Peter W./P-2976-2017; Lambotte, Olivier/GRT-0160-2022; Costagliola, Dominique/H-5849-2011; Lichterfeld, Mathias/B-2042-2008; Delobel, Pierre/Q-6028-2019; Delobel, Pierre/K-3166-2014; Saez-Cirion, Asier/A-8640-2008	Hunt, Peter W./0000-0002-4571-4870; Costagliola, Dominique/0000-0003-0765-0869; Lichterfeld, Mathias/0000-0001-9865-8350; Delobel, Pierre/0000-0002-2874-3581; Delobel, Pierre/0000-0002-2874-3581; Saez-Cirion, Asier/0000-0003-2406-7536; Deeks, Steven/0000-0001-6371-747X; Hladek, Melissa/0000-0002-0625-2474	ANRS (Agence nationale de recherches sur le sida et les hepatites virales); European Union under EuroCoord [260694]; Bill and Melinda Gates Foundation; Harvard University Center for AIDS Research [P-30-AI060354]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [P30 AI027763]; AIDS Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P30AI027763] Funding Source: NIH RePORTER	ANRS (Agence nationale de recherches sur le sida et les hepatites virales)(ANRSFrench National Research Agency (ANR)); European Union under EuroCoord; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard University Center for AIDS Research; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The ANRS CO18 HIV Controllers Cohort was funded by ANRS (Agence nationale de recherches sur le sida et les hepatites virales). The CASCADE Collaboration has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement n<SUP>o</SUP> 260694. The Bill and Melinda Gates Foundation, AIDS Healthcare Foundation and Harvard University Center for AIDS Research (P-30-AI060354) for The International HIV Controllers Study and the SCOPE Cohort is supported by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases: P30 AI027763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Bosch RJ, 2006, JAIDS-J ACQ IMM DEF, V43, P433, DOI 10.1097/01.qai.0000243097.27029.b7; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2013, AIDS, V27, P2451, DOI 10.1097/01.aids.0000431945.72365.01; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sajadi MM, 2012, AIDS, V26, P1879, DOI 10.1097/QAD.0b013e328357f5d1; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Toulowni G, 2008, JAIDS-J ACQ IMM DEF, V49, P492, DOI 10.1097/QAI.0b013e318186ead2; Vingert B, 2012, J VIROL, V86, P10661, DOI 10.1128/JVI.00056-12; Wood E, 2000, AIDS, V14, P1955, DOI 10.1097/00002030-200009080-00011; Yang Y, 2012, AIDS, V26, P701, DOI 10.1097/QAD.0b013e3283519b22	33	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85516	10.1371/journal.pone.0085516	http://dx.doi.org/10.1371/journal.pone.0085516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465584	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000041
J	Ishtiaque, I; Shafique, K; Ul-Haq, Z; Shaikh, AR; Khan, NA; Memon, AR; Mirza, SS; Ishtiaque, A				Ishtiaque, Iqra; Shafique, Kashif; Ul-Haq, Zia; Shaikh, Abdul Rauf; Khan, Naveed Ali; Memon, Abdul Rauf; Mirza, Saira Saeed; Ishtiaque, Afra			Water-Pipe Smoking and Albuminuria: New Dog with Old Tricks	PLOS ONE			English	Article							RENAL-FUNCTION; UNIVERSITY-STUDENTS; CIGARETTE-SMOKING; TOXICANT EXPOSURE; NICOTINE EXPOSURE; TOBACCO SMOKING; DISEASE; VASOPRESSIN; PROGRESSION; INCREASES	Water-pipe (WP) smoking is on rise worldwide for the past few years, particularly among younger individuals. Growing evidence indicates that WP smoking is as harmful as cigarette smoking. To date, most of the research has focused on acute health effects of WP smoking, and evidence remains limited when it comes to chronic health effects in relation to long-term WP smoking. Therefore, the aim of this study was to examine the association between WP smoking and albuminuria in apparently healthy individuals. This analysis was conducted on data of a population-based cross-sectional study-the Urban Rural Chronic Diseases Study (URCDS). The study sample was recruited from three sites in Pakistan. Trained nurses carried out individual interviews and obtained the information on demographics, lifestyle factors, and past and current medical history. Measurements of complete blood count, lipid profile, fasting glucose level, and 24-hour albuminuria were also made by using blood and urine samples. Albumin excretion was classified into three categories using standard cut-offs: normal excretion, high-normal excretion and microalbuminuria. Multiple logistic regression models were used to examine the relationship between WP smoking and albuminuria. The final analysis included data from 1,626 health individuals, of which 829 (51.0%) were males and 797 (49.0%) females. Of 1,626 individuals, 267 (16.4%) were current WP smokers and 1,359 (83.6%) were non-WP smokers. WP smoking was significantly associated with high-normal albuminuria (OR = 2.33, 95% CI 1.68-3.22, p-value < 0.001) and microalbuminuria (OR = 1.75, 95% CI 1.18-2.58, p-value 0.005) after adjustment for age, sex, BMI, social class, hypertension, and diabetes mellitus. WP smoking was significantly associated with high-normal albuminuria and microalbuminuria when analysis was stratified on hypertension and diabetes mellitus categories. WP smoking has a strong association with albuminuria in apparently healthy individuals. More research is warranted to evaluate the temporality of this association between WP smoking and albuminuria.	[Ishtiaque, Iqra] Univ Med & Dent Coll, Faisalabad, Pakistan; [Shafique, Kashif] Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan; [Shafique, Kashif; Ul-Haq, Zia] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Ul-Haq, Zia] Khyber Med Univ, Inst Publ Hlth & Social Sci, Peshawar, Kpk, Pakistan; [Shaikh, Abdul Rauf] Dow Univ Hlth Sci, Dept Community Med, Karachi, Pakistan; [Khan, Naveed Ali] Dow Univ Hlth Sci, Dept Surg, Karachi, Pakistan; [Memon, Abdul Rauf] Dow Univ Hlth Sci, Dept Med, Karachi, Pakistan; [Mirza, Saira Saeed] Univ Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Ishtiaque, Afra] King Edward Med Univ, Lahore, Pakistan	Dow University of Health Sciences; University of Glasgow; Khyber Medical University; Dow University of Health Sciences; Dow University of Health Sciences; Dow University of Health Sciences; Erasmus University Rotterdam	Shafique, K (corresponding author), Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan.	k.shafique@duhs.edu.pk	Ul Haq, Zia/GZM-0053-2022	Shafique, Kashif/0000-0001-7151-5122; ul haq, zia/0000-0001-5124-2171				Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Al Ali R, 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2013-051206, DOI 10.1136/T0BACC0C0NTR0L-2013-051206]; ANDERSSON K, 1983, ACTA PHYSIOL SCAND, V118, P35, DOI 10.1111/j.1748-1716.1983.tb07237.x; Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212; Cooper RG, 2008, RENAL FAILURE, V30, P107, DOI 10.1080/08860220701742179; Daher N, 2010, ATMOS ENVIRON, V44, P8, DOI 10.1016/j.atmosenv.2009.10.004; Doggen K, 2013, J DIABETES COMPLICAT, V27, P370, DOI 10.1016/j.jdiacomp.2013.02.008; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Jacob P, 2011, CANCER EPIDEM BIOMAR, V20, P2345, DOI 10.1158/1055-9965.EPI-11-0545; Jawaid A, 2008, INT J TUBERC LUNG D, V12, P1077; Khabour OF, 2012, INHAL TOXICOL, V24, P667, DOI 10.3109/08958378.2012.710918; LIGHTMAN S, 1982, CLIN ENDOCRINOL, V16, P353, DOI 10.1111/j.1365-2265.1982.tb00727.x; Maziak W, 2004, ANN EPIDEMIOL, V14, P646, DOI 10.1016/j.annepidem.2003.11.003; Maziak W, 2004, PREV MED, V39, P330, DOI 10.1016/j.ypmed.2004.01.024; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Neergaard J, 2007, NICOTINE TOB RES, V9, P987, DOI 10.1080/14622200701591591; NEURINGER JR, 1993, AM J KIDNEY DIS, V22, P98, DOI 10.1016/S0272-6386(12)70174-9; Orth SR, 2002, CURR OPIN NEPHROL HY, V11, P483, DOI 10.1097/00041552-200209000-00002; Orth SR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018401.82863.FD; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Roskin J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-10; Shafagoj YA, 2002, INT J CLIN PHARM TH, V40, P249; Shafique K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039734; Shaikh R B, 2008, J Prev Med Hyg, V49, P101; Smith JR, 2011, AM J PUBLIC HEALTH, V101, P1876, DOI 10.2105/AJPH.2011.300196; Svensson MK, 2013, DIABETES VASC DIS RE, V10, P520, DOI 10.1177/1479164113500798; Tamaoki L, 2009, AM J NEPHROL, V30, P377, DOI 10.1159/000235622; Warnakulasuriya Saman, 2011, Evid Based Dent, V12, P44, DOI 10.1038/sj.ebd.6400790; WONG LTY, 1992, J PHARMACOL EXP THER, V261, P21	31	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85652	10.1371/journal.pone.0085652	http://dx.doi.org/10.1371/journal.pone.0085652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465635	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000330237000048
J	Mussen, TD; Cocherell, D; Poletto, JB; Reardon, JS; Hockett, Z; Ercan, A; Bandeh, H; Kavvas, ML; Cech, JJ; Fangue, NA				Mussen, Timothy D.; Cocherell, Dennis; Poletto, Jamilynn B.; Reardon, Jon S.; Hockett, Zachary; Ercan, Ali; Bandeh, Hossein; Kavvas, M. Levent; Cech, Joseph J., Jr.; Fangue, Nann A.			Unscreened Water-Diversion Pipes Pose an Entrainment Risk to the Threatened Green Sturgeon, Acipenser medirostris	PLOS ONE			English	Article							PACIFIC SALMONID SMOLTS; ACCELERATING FLOW; FISH PASSAGE; LATERAL-LINE; BEHAVIOR; RIVER; STIMULI; LIGHT; SIZE	Over 3,300 unscreened agricultural water diversion pipes line the levees and riverbanks of the Sacramento River (California) watershed, where the threatened Southern Distinct Population Segment of green sturgeon, Acipenser medirostris, spawn. The number of sturgeon drawn into (entrained) and killed by these pipes is greatly unknown. We examined avoidance behaviors and entrainment susceptibility of juvenile green sturgeon (35 +/- 0.6 cm mean fork length) to entrainment in a large (>500-kl) outdoor flume with a 0.46-m-diameter water-diversion pipe. Fish entrainment was generally high (range: 26-61%), likely due to a lack of avoidance behavior prior to entering inescapable inflow conditions. We estimated that up to 52% of green sturgeon could be entrained after passing within 1.5 m of an active water-diversion pipe three times. These data suggest that green sturgeon are vulnerable to unscreened water-diversion pipes, and that additional research is needed to determine the potential impacts of entrainment mortality on declining sturgeon populations. Data under various hydraulic conditions also suggest that entrainment-related mortality could be decreased by extracting water at lower diversion rates over longer periods of time, balancing agricultural needs with green sturgeon conservation.	[Mussen, Timothy D.; Cocherell, Dennis; Poletto, Jamilynn B.; Reardon, Jon S.; Cech, Joseph J., Jr.; Fangue, Nann A.] Univ Calif Davis, Wildlife Fish & Conservat Biol Dept, Davis, CA 95616 USA; [Hockett, Zachary; Ercan, Ali; Bandeh, Hossein; Kavvas, M. Levent] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Fangue, NA (corresponding author), Univ Calif Davis, Wildlife Fish & Conservat Biol Dept, Davis, CA 95616 USA.	nafangue@ucdavis.edu	Ercan, Ali/AAI-2418-2021	Ercan, Ali/0000-0003-1052-4302; Poletto, Jamilynn/0000-0002-5779-8709	California Department of Fish and Wildlife's Ecosystem Restoration Program [E0783004]; University of California Agricultural Experiment Station [2098-H]; U.S. Department of Interior's Anadromous Fish Screen Program; National Science Foundation (NSF)	California Department of Fish and Wildlife's Ecosystem Restoration Program; University of California Agricultural Experiment Station(University of California System); U.S. Department of Interior's Anadromous Fish Screen Program; National Science Foundation (NSF)(National Science Foundation (NSF))	The authors thank the California Department of Fish and Wildlife's Ecosystem Restoration Program (Agreement # E0783004 to NAF and JJC) and the University of California Agricultural Experiment Station (grant no. 2098-H to NAF) for providing funding. This research indirectly benefited from funding from the U.S. Department of Interior's Anadromous Fish Screen Program. JBP was supported through a National Science Foundation (NSF) Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Allen PJ, 2007, ENVIRON BIOL FISH, V79, P211, DOI 10.1007/s10641-006-9049-9; Allen PJ, 2009, T AM FISH SOC, V138, P240, DOI 10.1577/T08-061.1; [Anonymous], 2006, JWATCHER 1 0 INTRO U; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Beamesderfer RCP, 1997, ENVIRON BIOL FISH, V48, P407, DOI 10.1023/A:1007310916515; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P427, DOI 10.1023/A:1007382724251; Bowen M., 2004, INVENTORY BARRIERS F; Castro-Santos T, 2012, TELEMETRY TECHNIQUES: A USER GUIDE FOR FISHERIES RESEARCH, P427; Enders EC, 2009, CAN J FISH AQUAT SCI, V66, P2109, DOI 10.1139/F09-141; Gessner J, 1997, ENVIRON BIOL FISH, V79, P397; Gibbs MA, 2004, BRAIN BEHAV EVOLUT, V64, P70, DOI 10.1159/000079117; GLASS CW, 1995, FISH RES, V23, P165, DOI 10.1016/0165-7836(94)00331-P; Haro A, 1998, T AM FISH SOC, V127, P118, DOI 10.1577/1548-8659(1998)127<0118:EOWAOD>2.0.CO;2; Herren JR, 1997, FISH B, V2, P343; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Israel JA, 2010, MOL ECOL, V19, P1058, DOI 10.1111/j.1365-294X.2010.04533.x; IUCN, 2012, IUCN RED LIST THREAT; Kemp PS, 2005, J FISH BIOL, V67, P1381, DOI 10.1111/j.0022-1112.2005.00833.x; Kemp PS, 2005, T AM FISH SOC, V134, P390, DOI 10.1577/T04-039.1; Kemp PS, 2006, RIVER RES APPL, V22, P429, DOI 10.1002/rra.913; Kynard B, 2005, ENVIRON BIOL FISH, V72, P85, DOI 10.1007/s10641-004-6584-0; Meier D, 2013, COMMUNICATION; Moyle PB, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:UA]2.0.CO;2; Mussen TD, 2013, T AM FISH SOC, V142, P130, DOI 10.1080/00028487.2012.720633; Nobriga ML, 2004, AM FISH S S, V39, P281; Rasband W., 2006, IMAGEJ; Turnpenny A. W. H., 1998, UK GUIDE INTAKE FISH; Van Eenennaam JP, 2012, J APPL ICHTHYOL, V28, P505, DOI 10.1111/j.1439-0426.2012.02012.x; Van Eenennaam JP, 2001, T AM FISH SOC, V130, P159, DOI 10.1577/1548-8659(2001)130&lt;0159:ASALRO&gt;2.0.CO;2; Vogel D, 2011, INSIGHTS PROBLEMS PR; Vowles AS, 2012, ECOL ENG, V47, P247, DOI 10.1016/j.ecoleng.2012.06.021; Xin D, 2002, AM FISH S S, V28, P237	34	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86321	10.1371/journal.pone.0086321	http://dx.doi.org/10.1371/journal.pone.0086321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454967	Green Published, gold			2022-12-27	WOS:000330235100152
J	Chernyak, N; Sattel, H; Scheer, M; Baechle, C; Kruse, J; Henningsen, P; Icks, A				Chernyak, Nadja; Sattel, Heribert; Scheer, Marsel; Baechle, Christina; Kruse, Johannes; Henningsen, Peter; Icks, Andrea			Economic Evaluation of Brief Psychodynamic Interpersonal Therapy in Patients with Multisomatoform Disorder	PLOS ONE			English	Article							PRIMARY-CARE; HEALTH; SF-36	Background: A brief psychodynamic interpersonal therapy (PIT) in patients with multisomatoform disorder has been recently shown to improve health-related quality of life. Aims: To assess cost-effectiveness of PIT compared to enhanced medical care in patients with multisomatoform disorder. Method: An economic evaluation alongside a randomised controlled trial (International Standard Randomised Controlled Trial Number ISRCTN23215121) conducted in 6 German academic outpatient centres was performed. Incremental cost-effectiveness ratio (ICER) was calculated from the statutory health insurance perspective on the basis of quality adjusted life years (QALYs) gained at 12 months. Uncertainty surrounding the cost-effectiveness of PIT was presented by means of a cost-effectiveness acceptability curve. Results: Based on the complete-case analysis ICER was 41840 Euro per QALY. The results did not change greatly with the use of multiple imputation (ICER = 44222) and last observation carried forward (LOCF) approach to missing data (ICER = 46663). The probability of PIT being cost-effective exceeded 50% for thresholds of willingness to pay over 35 thousand Euros per QALY. Conclusions: Cost-effectiveness of PIT is highly uncertain for thresholds of willingness to pay under 35 thousand Euros per QALY.	[Chernyak, Nadja; Icks, Andrea] Univ Dusseldorf, Fac Med, Dept Publ Hlth, Dusseldorf, Germany; [Chernyak, Nadja; Scheer, Marsel; Baechle, Christina; Icks, Andrea] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Sattel, Heribert; Henningsen, Peter] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany; [Kruse, Johannes] Univ Dusseldorf, Dept Psychosomat Med, Dusseldorf, Germany; [Kruse, Johannes] Univ Giessen, Ctr Psychosomat Med, D-35390 Giessen, Germany	Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Technical University of Munich; Heinrich Heine University Dusseldorf; Justus Liebig University Giessen	Chernyak, N (corresponding author), Univ Dusseldorf, Fac Med, Dept Publ Hlth, Dusseldorf, Germany.	nadja.chernyak@uni-duesseldorf.de	Bächle, Christina/ABC-3136-2020		German Research Foundation (DFG) [He 3200/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The clinical trial was funded by the German Research Foundation (DFG; He 3200/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; BRAZIER J, 1995, PHARMACOECONOMICS, V7, P403, DOI 10.2165/00019053-199507050-00005; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gold MR, 1996, COST EFFECTIVENESS H; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Jackson JL, 2008, PSYCHOSOM MED, V70, P430, DOI 10.1097/PSY.0b013e31816aa0ee; Kroenke K, 1997, ARCH GEN PSYCHIAT, V54, P352; Mutebi A, 2011, QUAL LIFE RES, V20, P1477, DOI 10.1007/s11136-011-9881-z; Sattel H, 2012, BRIT J PSYCHIAT, V200, P60, DOI 10.1192/bjp.bp.111.093526; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463	13	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83894	10.1371/journal.pone.0083894	http://dx.doi.org/10.1371/journal.pone.0083894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465387	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100008
J	Yang, GH; Liu, RR; Peng, P; Long, LL; Zhang, XH; Yang, WJ; Tan, SH; Pan, HF; Long, XJ; He, TG; Anderson, L; Lai, YR				Yang, Gaohui; Liu, Rongrong; Peng, Peng; Long, Liling; Zhang, Xinhua; Yang, Weijia; Tan, Shaohong; Pan, Hongfei; Long, Xingjiang; He, Taigang; Anderson, Lisa; Lai, Yongrong			How Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major?	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CARDIAC IRON; VENTRICULAR-FUNCTION; GLOBAL EPIDEMIOLOGY; TREATED PATIENTS; TRANSFUSION; COMPLICATIONS; DEFEROXAMINE; SURVIVAL; DEFERIPRONE	Background: Myocardial siderosis is the most common cause of death in patients with beta thalassemia major(TM). This study aimed at investigating the occurrence, prevalence and severity of cardiac iron overload in a young Chinese population with beta TM. Methods and Results: We analyzed T2* cardiac magnetic resonance (CMR), left ventricular ejection fraction (LVEF) and serum ferritin (SF) in 201 beta TM patients. The median age was 9 years old. Patients received an average of 13 units of blood per year. The median SF level was 4536 ng/ml and 165 patients (82.1%) had SF>2500 ng/ml. Myocardial iron overload was detected in 68 patients (33.8%) and severe myocardial iron overload was detected in 26 patients (12.6%). Twenty-two patients <= 10 years old had myocardial iron overload, three of whom were only 6 years old. No myocardial iron overload was detected under the age of 6 years. Median LVEF was 64% (measured by CMR in 175 patients). Five of 6 patients with a LVEF<56% and 8 of 10 patients with cardiac disease had myocardial iron overload. Conclusions: The TM patients under follow-up at this regional centre in China patients are younger than other reported cohorts, more poorly-chelated, and have a high burden of iron overload. Myocardial siderosis occurred in patients younger than previously reported, and was strongly associated with impaired LVEF and cardiac disease. For such poorly-chelated TM patients, our data shows that the first assessment of cardiac T2* should be performed as early as 6 years old.	[Yang, Gaohui; Liu, Rongrong; Lai, Yongrong] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Peoples R China; [Peng, Peng; Long, Liling] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiol, Nanning, Peoples R China; [Zhang, Xinhua] 303rd Hosp Peoples Liberat Army, Dept Hematol, Nanning, Peoples R China; [Yang, Weijia] Women & Children Hosp Guilin, Dept Pediat, Guilin, Peoples R China; [Tan, Shaohong] Women & Children Hosp Yulin, Dept Pediat, Yulin, Peoples R China; [Pan, Hongfei] Youjiang Med Univ Nationality, Affiliated Hosp, Dept Pediat, Baise, Peoples R China; [Long, Xingjiang] Peoples Hosp Liuzhou, Dept Pediat, Liuzhou, Peoples R China; [He, Taigang; Anderson, Lisa] St Georges Univ London, Cardiovasc Sci Res Ctr, London, England; [He, Taigang] Royal Brompton Hosp, Biomed Res Unit, London SW3 6LY, England	Guangxi Medical University; Guangxi Medical University; Youjiang Medical University for Nationalities; St Georges University London; Royal Brompton Hospital	Lai, YR (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Peoples R China.	laiyongrong@hotmail.com		Long, Liling/0000-0003-3369-8532	National Natural Science Foundations of China [30860307, 81160175]; Guangxi Natural Science Foundations [2011GXNSFD018033]; Wellcome Trust; Higher Education Funding for England (HEFCE); British Heart Foundation (BHF) [FS/08/26225]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundations; Wellcome Trust(Wellcome TrustEuropean Commission); Higher Education Funding for England (HEFCE); British Heart Foundation (BHF)(British Heart Foundation)	This work was supported by research grants from National Natural Science Foundations of China (Grant No. 30860307; No. 81160175) and Guangxi Natural Science Foundations (Grant No. 2011GXNSFD018033). Dr. He receives support from Wellcome Trust, and Higher Education Funding for England (HEFCE) and British Heart Foundation (BHF) (FS/08/26225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; ALDOURI MA, 1990, ACTA HAEMATOL-BASEL, V84, P113; Alpendurada F, 2010, EUR HEART J, V31, P1648, DOI 10.1093/eurheartj/ehq106; Anderson LJ, 2002, LANCET, V360, P516, DOI 10.1016/S0140-6736(02)09740-4; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; [Anonymous], 2008, GUIDELINES CLIN MANA, P86; [Anonymous], 2008, GUIDELINES CLIN MANA, P61; BAROSI G, 1989, EUR J HAEMATOL, V42, P382; Bejaoui M, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.002; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brittenham GM, 2003, BLOOD, V101, P15, DOI 10.1182/blood-2002-06-1723; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Christianson A., 2006, GLOBAL REPORT BIRTH; Davis BA, 2004, BLOOD, V104, P263, DOI 10.1182/blood-2003-08-2841; ENGLE MA, 1964, CIRCULATION, V30, P698, DOI 10.1161/01.CIR.30.5.698; Fernandes JL, 2009, HAEMATOL-HEMATOL J, V94, P1776, DOI 10.3324/haematol.2009.013193; FITCHETT DH, 1980, CARDIOVASC RES, V14, P719, DOI 10.1093/cvr/14.12.719; He TG, 2013, J MAGN RESON IMAGING, V37, P479, DOI 10.1002/jmri.23780; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kremastinos DT, 2001, AM J MED, V111, P349, DOI 10.1016/S0002-9343(01)00879-8; Lai YR, 2013, TRANSFUSION MED, V23, P389, DOI 10.1111/tme.12077; Leung AWK, 2009, PEDIATR BLOOD CANCER, V53, P1054, DOI 10.1002/pbc.22170; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Positano V, 2009, NMR BIOMED, V22, P707, DOI 10.1002/nbm.1382; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Tanner MA, 2006, J CARDIOVASC MAGN R, V8, P543, DOI 10.1080/10976640600698155; Tanner MA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-12; Tziomalos K, 2010, WORLD J GASTROENTERO, V16, P1587, DOI 10.3748/wjg.v16.i13.1587; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; Westwood M, 2003, J MAGN RESON IMAGING, V18, P33, DOI 10.1002/jmri.10332; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Wood JC, 2008, HAEMATOLOGICA, V93, P917, DOI 10.3324/haematol.12513; Wood JC, 2008, BLOOD REV, V22, pS14, DOI 10.1016/S0268-960X(08)70004-3	41	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85379	10.1371/journal.pone.0085379	http://dx.doi.org/10.1371/journal.pone.0085379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465548	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330283100039
J	El Ridi, R; Tallima, H; Selim, S; Donnelly, S; Cotton, S; Santana, BG; Dalton, JP				El Ridi, Rashika; Tallima, Hatem; Selim, Sahar; Donnelly, Sheila; Cotton, Sophie; Santana, Bibiana Gonzales; Dalton, John P.			Cysteine Peptidases as Schistosomiasis Vaccines with Inbuilt Adjuvanticity	PLOS ONE			English	Article							HELPER TYPE-2 RESPONSE; IGE RESPONSES; CATHEPSIN-B; LIVER FLUKE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FASCIOLA-HEPATICA; TH2 RESPONSES; MANSONI; PROTEASE; MICE	Schistosomiasis is caused by several worm species of the genus Schistosoma and afflicts up to 600 million people in 74 tropical and sub-tropical countries in the developing world. Present disease control depends on treatment with the only available drug praziquantel. No vaccine exists despite the intense search for molecular candidates and adjuvant formulations over the last three decades. Cysteine peptidases such as papain and Der p 1 are well known environmental allergens that sensitize the immune system driving potent Th2-responses. Recently, we showed that the administration of active papain to mice induced significant protection (P<0.02, 50%) against an experimental challenge infection with Schistosoma mansoni. Since schistosomes express and secrete papain-like cysteine peptidases we reasoned that these could be employed as vaccines with inbuilt adjuvanticity to protect against these parasites. Here we demonstrate that subcutaneous injection of functionally active S. mansoni cathepsin B1 (SmCB1), or a cathepsin L from a related parasite Fasciola hepatica (FhCL1), elicits highly significant (P<0.0001) protection (up to 73%) against an experimental challenge worm infection. Protection and reduction in worm egg burden were further increased (up to 83%) when the cysteine peptidases were combined with other S. mansoni vaccine candidates, glyceraldehyde 3-phosphate dehydrogenase (SG3PDH) and peroxiredoxin (PRX-MAP), without the need to add chemical adjuvants. These studies demonstrate the capacity of helminth cysteine peptidases to behave simultaneously as immunogens and adjuvants, and offer an innovative approach towards developing schistosomiasis vaccines	[El Ridi, Rashika; Tallima, Hatem] Cairo Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Selim, Sahar] Menoufiya Univ, Natl Liver Inst, Shibin Al Kawm, Menoufiya, Egypt; [Donnelly, Sheila] Univ Technol Sydney, Inst I 3, Ultimo, Sydney, NSW 2007, Australia; [Cotton, Sophie; Santana, Bibiana Gonzales; Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Dalton, John P.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Menofia University; University of Technology Sydney; McGill University; Queens University Belfast	Dalton, JP (corresponding author), McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada.	john.dalton@mcgill.ca	Ridi, Rashika El/AAA-3840-2019; Dalton, John/K-4457-2014; Donnelly, Sheila/H-7733-2014; Ridi, Rashika El/ABG-2708-2020; Ibrahim, Essam Hassan/G-1960-2018; Tallima, Hatem/AAO-8061-2020	Ibrahim, Essam Hassan/0000-0003-0130-2257; Tallima, Hatem/0000-0003-3714-641X; El Ridi, Rashika/0000-0001-5094-6994; Donnelly, Sheila/0000-0003-2005-3698	Canada Institute of Health Research (CIHR) from the National Science and Engineering Research Council (NSERC) Canada; Science and Technology Development Fund (STDF), Egypt [2073]	Canada Institute of Health Research (CIHR) from the National Science and Engineering Research Council (NSERC) Canada; Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for this study was received from the Canada Institute of Health Research (CIHR) from the National Science and Engineering Research Council (NSERC) Canada to JPD for the molecular biology studies. Financial support was also received from the Science and Technology Development Fund (STDF), Egypt, grant No. 2073 to R. El Ridi for vaccine and immunological at studies.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bos DH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-488; Brady CP, 2000, EXP PARASITOL, V94, P75, DOI 10.1006/expr.1999.4478; Brady CP, 1999, BIOCHEM SOC T, V27, P740, DOI 10.1042/bst0270740; Brady CP, 1999, INFECT IMMUN, V67, P368, DOI 10.1128/IAI.67.1.368-374.1999; Caffrey CR, 1997, PARASITOL RES, V83, P37, DOI 10.1007/s004360050204; Caffrey CR, 2002, MOL BIOCHEM PARASIT, V121, P49, DOI 10.1016/S0166-6851(02)00022-1; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chapoval SP, 1999, J CLIN INVEST, V103, P1707, DOI 10.1172/JCI6175; CHAPPELL CL, 1988, AM J TROP MED HYG, V39, P463, DOI 10.4269/ajtmh.1988.39.463; CHAPPELL CL, 1990, AM J TROP MED HYG, V42, P335, DOI 10.4269/ajtmh.1990.42.335; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Cunningham PT, 2012, INT ARCH ALLERGY IMM, V158, P347, DOI 10.1159/000334280; Da'dara AA, 2002, PARASITE IMMUNOL, V24, P179, DOI 10.1046/j.1365-3024.2002.00453.x; Dalton JP, 1996, INFECT IMMUN, V64, P1328, DOI 10.1128/IAI.64.4.1328-1334.1996; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Fraga LAD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-56; Fraga LAD, 2010, J INFECT DIS, V201, P464, DOI 10.1086/649841; DEAN DA, 1984, AM J TROP MED HYG, V33, P97, DOI 10.4269/ajtmh.1984.33.97; DEAN DA, 1983, EXP PARASITOL, V55, P1, DOI 10.1016/0014-4894(83)90002-4; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Driguez P, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-4; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Dvorak J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000449; El Ridi R, 2003, J PARASITOL, V89, P1064, DOI 10.1645/GE-3122RN; El Ridi R, 2001, INFECT IMMUN, V69, P237, DOI 10.1128/IAI.69.1.237-244.2001; El Ridi R, 2013, J PARASITOL, V99, P194, DOI 10.1645/GE-3186.1; El Ridi R, 2010, MICROBES INFECT, V12, P700, DOI 10.1016/j.micinf.2010.04.012; ElRidi R, 1997, INT J PARASITOL, V27, P581, DOI 10.1016/S0020-7519(97)00006-4; Farias LP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000597; Figueiredo JP, 2012, PARASITE IMMUNOL, V34, P604, DOI 10.1111/pim.12001; Fitzsimmons CM, 2012, INFECT IMMUN, V80, P4264, DOI 10.1128/IAI.00641-12; GAAFAR T, 1993, PARASITOL RES, V79, P103, DOI 10.1007/BF00932254; Ganley-Leal LM, 2006, INFECT IMMUN, V74, P2169, DOI 10.1128/IAI.74.4.2169-2176.2006; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Jiz M, 2009, INFECT IMMUN, V77, P2051, DOI 10.1128/IAI.00012-09; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Siddiqui AA, 2011, HUM VACCINES, V7, P1192, DOI 10.4161/hv.7.11.17017; Skelly PJ, 2001, J PARASITOL, V87, P1218, DOI 10.1645/0022-3395(2001)087[1218:SMPSCB]2.0.CO;2; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stack CM, 2005, J IMMUNOL METHODS, V304, P151, DOI 10.1016/j.jim.2005.07.019; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Stirewalt M.A., 1974, Advances Parasit, V12, P115, DOI 10.1016/S0065-308X(08)60388-7; Tallima H, 2003, VACCINE, V21, P3290, DOI 10.1016/S0264-410X(03)00180-4; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Wynn TA, 1999, MICROBES INFECT, V1, P525, DOI 10.1016/S1286-4579(99)80092-6; Xu XD, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-54; ZERDA KS, 1988, EXP PARASITOL, V67, P238, DOI 10.1016/0014-4894(88)90071-9	58	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85401	10.1371/journal.pone.0085401	http://dx.doi.org/10.1371/journal.pone.0085401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465551	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500061
J	Rocha, CS; Gomes-Santos, AC; Moreira, TG; de Azevedo, M; Luerce, TD; Mariadassou, M; Delamare, APL; Langella, P; Maguin, E; Azevedo, V; de Faria, AMC; Miyoshi, A; van de Guchte, M				Rocha, Clarissa Santos; Gomes-Santos, Ana Cristina; Moreira, Thais Garcias; de Azevedo, Marcela; Luerce, Tessalia Diniz; Mariadassou, Mahendra; Longaray Delamare, Ana Paula; Langella, Philippe; Maguin, Emmanuelle; Azevedo, Vasco; Caetano de Faria, Ana Maria; Miyoshi, Anderson; van de Guchte, Maarten			Local and Systemic Immune Mechanisms Underlying the Anti-Colitis Effects of the Dairy Bacterium Lactobacillus delbrueckii	PLOS ONE			English	Article							T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; CROHNS-DISEASE; KAPPA-B; STRAINS; MICROFLORA; PROBIOTICS; INDUCTION; RESPONSES; PREVENTS	Several probiotic bacteria have been proposed for treatment or prevention of inflammatory bowel diseases (IBD), showing a protective effect in animal models of experimental colitis and for some of them also in human clinical trials. While most of these probiotic bacteria are isolated from the digestive tract, we recently reported that a Lactobacillus strain isolated from cheese, L. delbrueckii subsp. lactis CNRZ327 (Lb CNRZ327), also possesses anti-inflammatory effects in vitro and in vivo, demonstrating that common dairy bacteria may be useful in the treatment or prevention of IBD. Here, we studied the mechanisms underlying the protective effects of Lb CNRZ327 in vivo, in a mouse dextran sodium sulfate (DSS) colitis model. During colitis, Lb CNRZ327 modulated the production of TGF-beta, IL-6, and IL-12 in colonic tissue and of TGF-beta and IL-6 in the spleen, and caused an expansion of CD4+Foxp3+ regulatory T cells in the cecal lymph nodes. Moreover, a strong tendency to CD4+Foxp3+ expansion was also observed in the spleen. The results of this study for the first time show that orally administered dairy lactobacilli can not only modulate mucosal but also systemic immune responses and constitute an effective treatment of IBD.	[Rocha, Clarissa Santos; de Azevedo, Marcela; Luerce, Tessalia Diniz; Azevedo, Vasco; Miyoshi, Anderson] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Gomes-Santos, Ana Cristina; Moreira, Thais Garcias; Caetano de Faria, Ana Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Rocha, Clarissa Santos; Langella, Philippe; Maguin, Emmanuelle; van de Guchte, Maarten] INRA, Micalis UMR1319, Jouy En Josas, France; [Rocha, Clarissa Santos; Langella, Philippe; Maguin, Emmanuelle; van de Guchte, Maarten] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Mariadassou, Mahendra] INRA, UR1077, Jouy En Josas, France; [Longaray Delamare, Ana Paula] Univ Caxias do Sul, Inst Biotechnol, Caxias Do Sul, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Caxias do Sul	van de Guchte, M (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	maarten.vandeguchte@jouy.inra.fr	Langella, Philippe/N-8368-2017; Longaray Delamare, Ana Paula/AGZ-4312-2022; Azevedo, Vasco A.C/F-4315-2011; Delamare, Ana Paula Longaray/AHE-9445-2022; de Azevedo, Marcela Santiago Pacheco/AAO-2859-2020; Azevedo, Vasco/B-1556-2019	Langella, Philippe/0000-0001-5960-4341; Azevedo, Vasco A.C/0000-0002-4775-2280; Delamare, Ana Paula Longaray/0000-0001-9638-5483; de Azevedo, Marcela Santiago Pacheco/0000-0001-5694-4578; Azevedo, Vasco/0000-0002-4775-2280; Faria, Ana Maria/0000-0002-0604-8510	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brasil (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES); EC EST project "LABHEALTH" [MEST-2-CT-2004-514428]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brasil (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES); EC EST project "LABHEALTH"	This study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brasil (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES), and the EC EST project "LABHEALTH" (Marie Curie Contract MEST-2-CT-2004-514428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chung YW, 2008, CLIN EXP IMMUNOL, V151, P182, DOI 10.1111/j.1365-2249.2007.03549.x; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Moreno de Leblanc Alejandra, 2011, ISRN Gastroenterol, V2011, P892971, DOI 10.5402/2011/892971; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Diaz-Ropero MP, 2007, J APPL MICROBIOL, V102, P337, DOI 10.1111/j.1365-2672.2006.03102.x; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kim SW, 2010, INFLAMM BOWEL DIS, V16, P1514, DOI 10.1002/ibd.21262; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Malin M, 1996, ANN NUTR METAB, V40, P137, DOI 10.1159/000177907; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Maron R, 1999, INT IMMUNOL, V11, P1573, DOI 10.1093/intimm/11.9.1573; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; McCafferty DM, 2000, AM J PHYSIOL-GASTR L, V279, pG90, DOI 10.1152/ajpgi.2000.279.1.G90; Meijer BJ, 2011, J CLIN GASTROENTEROL, V45, pS139, DOI 10.1097/MCG.0b013e31822103f7; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nishitani Y, 2009, INT IMMUNOPHARMACOL, V9, P1444, DOI 10.1016/j.intimp.2009.08.018; O'Sullivan DJ, 2001, J AGR FOOD CHEM, V49, P1751, DOI 10.1021/jf0012244; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pallone F, 1998, GUT, V43, P735, DOI 10.1136/gut.43.6.735; Philippe D, 2011, INT J FOOD MICROBIOL, V149, P45, DOI 10.1016/j.ijfoodmicro.2010.12.020; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rocha CS, 2012, INFLAMM BOWEL DIS, V18, P657, DOI 10.1002/ibd.21834; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Solomon L., 2010, COMP CLIN PATHOL, V19, DOI [10.1007/s00580-010-0979-4, DOI 10.1007/S00580-010-0979-4]; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712	47	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85923	10.1371/journal.pone.0085923	http://dx.doi.org/10.1371/journal.pone.0085923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465791	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500146
J	Sarmiento-Ramirez, JM; Abella-Perez, E; Phillott, AD; Sim, J; van West, P; Martin, MP; Marco, A; Dieguez-Uribeondo, J				Sarmiento-Ramirez, Jullie M.; Abella-Perez, Elena; Phillott, Andrea D.; Sim, Jolene; van West, Pieter; Martin, Maria P.; Marco, Adolfo; Dieguez-Uribeondo, Javier			Global Distribution of Two Fungal Pathogens Threatening Endangered Sea Turtles	PLOS ONE			English	Article							SOLANI SPECIES COMPLEX; FUSARIUM-SOLANI; CARETTA-CARETTA; PHYLOGENETIC-RELATIONSHIPS; APHANOMYCES-ASTACI; RIBOSOMAL DNA; SP-NOV; INFECTIONS; SAPROLEGNIA; EVOLUTION	Nascent fungal infections are currently considered as one of the main threats for biodiversity and ecosystem health, and have driven several animal species into critical risk of extinction. Sea turtles are one of the most endangered groups of animals and only seven species have survived to date. Here, we described two pathogenic species, i.e., Fusarium falciforme and Fusarium keratoplasticum, that are globally distributed in major turtle nesting areas for six sea turtle species and that are implicated in low hatch success. These two fungi possess key biological features that are similar to emerging pathogens leading to host extinction, e. g., high virulence, and a broad host range style of life. Their optimal growth temperature overlap with the optimal incubation temperature for eggs, and they are able to kill up to 90% of the embryos. Environmental forcing, e. g., tidal inundation and clay/silt content of nests, were correlated to disease development. Thus, these Fusarium species constitute a major threat to sea turtle nests, especially to those experiencing environmental stressors. These findings have serious implications for the survival of endangered sea turtle populations and the success of conservation programs worldwide.	[Sarmiento-Ramirez, Jullie M.; Martin, Maria P.; Dieguez-Uribeondo, Javier] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain; [Abella-Perez, Elena; Marco, Adolfo] CSIC, Estn Biol Donana, Dept Biol Conservac, E-41080 Seville, Spain; [Phillott, Andrea D.] Asian Univ Women, Fac Sci, Chittagong, Bangladesh; [Phillott, Andrea D.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Sim, Jolene] Ascens Isl Govt, Conservat Off, George Town, Ascension Islan, Malaysia; [van West, Pieter] Univ Aberdeen, Coll Life Sci & Med, Aberdeen Oomycete Lab, Aberdeen AB9 1FX, Scotland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Asian University for Women; James Cook University; University of Aberdeen	Dieguez-Uribeondo, J (corresponding author), Real Jardin Bot CSIC, Dept Micol, Madrid, Spain.	dieguez@rjb.csic.es	Martín, María/HDL-9512-2022; Marco, Adolfo/B-7118-2009; Diéguez-Uribeondo, Javier/ABF-1130-2021; Martín, María/H-8069-2012; dieguez-uribeondo, javier/I-2178-2015	Marco, Adolfo/0000-0002-6523-9704; Diéguez-Uribeondo, Javier/0000-0002-4488-0658; Martín, María/0000-0002-1235-4418; dieguez-uribeondo, javier/0000-0002-4488-0658; van West, Pieter/0000-0002-0767-6017	Ministerio de Ciencia e Innovacion, Spain [CGL2009-10032, CGL2012-32934]; CSIC [JAEPre 0901804]; Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/J018333/1, BB/G012075/1] Funding Source: researchfish; BBSRC [BB/G012075/1, BB/J018333/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants of Ministerio de Ciencia e Innovacion, Spain (CGL2009-10032, CGL2012-32934). J.M.S.R was supported by PhD fellowship of the CSIC (JAEPre 0901804). The Natural Environment Research Council and the Biotechnology and Biological Sciences Research Council supported P. V. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Mesen Rafael Arturo, 1992, Brenesia, V38, P159; Adaskaveg JE, 1997, PHYTOPATHOLOGY, V87, P979, DOI 10.1094/PHYTO.1997.87.9.979; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; BLANCK CE, 1981, J EXP MAR BIOL ECOL, V49, P163, DOI 10.1016/0022-0981(81)90068-X; Booth C, 1977, FUSARIUM LAB GUIDE I; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Davidson OG, 2001, FIRE TURTLE HOUSE GR; Dieguez-Uribeondo J, 2003, PHYTOPATHOLOGY, V93, P923, DOI 10.1094/PHYTO.2003.93.8.923; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; ECKERT KL, 1990, BIOL CONSERV, V53, P37, DOI 10.1016/0006-3207(90)90061-S; Eckert KL, 1999, RES MANAGEMENT TECHN; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Guclu O, 2010, AFR J MICROBIOL RES, V4, P408; Hube B, 2009, CURR OPIN MICROBIOL, V12, P347, DOI 10.1016/j.mib.2009.06.009; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2004, IUCN RED LIST THREAT; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Kitancharoen N, 1996, FISH PATHOL, V31, P49, DOI 10.3147/jsfp.31.49; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kornerup A, 1978, MATHUEN HDB COLOR; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Miller J.D., 1985, Biology of Reptilia, V14, P269; Mo CL, 1990, 10 ANN WORKSH SEA TU, P249; MROSOVSKY N, 1994, J EXP ZOOL, V270, P16, DOI 10.1002/jez.1402700104; MROSOVSKY N, 1992, CAN J ZOOL, V70, P1920, DOI 10.1139/z92-261; Nelson EP, 1983, FUSARIUM SPECIES ILL; Nirenberg HI, 1998, MYCOLOGIA, V90, P434, DOI 10.2307/3761403; Nylander J.A.A., 2008, MRMODELTEST; O'Donnell K, 2000, MYCOLOGIA, V92, P919, DOI 10.2307/3761588; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez Elena Abella, 2011, Zoologia Caboverdiana, V2, P40; PETERS A, 1994, HERPETOLOGICA, V50, P369; Phillott A. D., 2004, Memoirs of the Queensland Museum, V49, P701; Phillott AD, 2001, AUST J ZOOL, V49, P713, DOI 10.1071/ZO00051; Phillott AD, 2001, J EXP ZOOL, V289, P317, DOI 10.1002/1097-010X(20010415/30)289:5<317::AID-JEZ5>3.0.CO;2-0; Phillott AD, 2003, FUNGAL COLONISATION; Phillott Andrea D., 2001, Chelonian Conservation and Biology, V4, P170; Ray H, 1998, PHYSIOL MOL PLANT P, V53, P81, DOI 10.1006/pmpp.1998.0165; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; SODERHALL K, 1978, MYCOPATHOLOGIA, V64, P9, DOI 10.1007/BF00443081; Solomon SE, 1980, 7 EUR C EL MICR FDN, P434; Spotila James R., 1997, P297; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Summerbell RC, 2002, J CLIN MICROBIOL, V40, P2866, DOI 10.1128/JCM.40.8.2866-2875.2002; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Vandersea MW, 2006, APPL ENVIRON MICROB, V72, P1551, DOI 10.1128/AEM.72.2.1551-1557.2006; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wharton P, 2007, MICHIGAN POTATO DIS; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WYNEKEN J, 1988, J HERPETOL, V22, P88, DOI 10.2307/1564360; Zhang N, 2006, J CLIN MICROBIOL, V44, P2186, DOI 10.1128/JCM.00120-06	67	55	59	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85853	10.1371/journal.pone.0085853	http://dx.doi.org/10.1371/journal.pone.0085853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465748	Green Published, Green Accepted, gold			2022-12-27	WOS:000330244500131
J	Sharma, VK; Casey, TA				Sharma, Vijay K.; Casey, Thomas A.			Determining the Relative Contribution and Hierarchy of hha and qseBC in the Regulation of Flagellar Motility of Escherichia coli O157:H7	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ENTEROCYTE EFFACEMENT; H-NS; VIRULENCE FACTORS; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; TERMINAL RECTUM; SENSOR KINASE; WEANED CALVES; III SECRETION	In recent studies, we demonstrated that a deletion of hha caused increased secretion of locus of enterocyte encoded adherence proteins and reduced motility of enterohemorrhagic Escherichia coli (EHEC) O157:H7. In addition to the importance of hha in positive regulation of motility, a two-component quorum sensing pathway encoded by the qseBC genes has been shown to activate bacterial motility in response to mammalian stress hormones epinephrine and norepinephrine as well as bacterially produced autoinducer-3. In this study, we compared regulatory contribution and hierarchy of hha, a member of the Hha/YmoA family of nucleoid-associated proteins, to that of qseBC in the expression of EHEC O157:H7 motility. Since norepinephrine affects motility of EHEC O157:H7 through a qseBC-encoded two-component quorum sensing signaling, we also determined whether the hha-mediated regulation of motility is affected by norepinephrine and whether this effect is qseBC dependent. We used single (Delta hha or Delta qseC) and double (Delta hha Delta qseC) deletion mutants to show that hha exerts a greater positive regulatory effect in comparison to qseBC on the expression of motility by EHEC O157:H7. We also show that Hha is hierarchically superior in transcriptional regulation of motility than QseBC because transcription of qseC was significantly reduced in the hha deletion mutant compared to that in the parental and the hha-complemented mutant strains. These results suggest that hha regulates motility of EHEC O157:H7 directly as well as indirectly by controlling the transcription of qseBC.	[Sharma, Vijay K.; Casey, Thomas A.] ARS, Food Safety & Enter Pathogens Res Unit, USDA, Natl Anim Dis Ctr, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Sharma, VK (corresponding author), ARS, Food Safety & Enter Pathogens Res Unit, USDA, Natl Anim Dis Ctr, Ames, IA 50011 USA.	vijay.sharma@ars.usda.gov			USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Clarke MB, 2005, MOL MICROBIOL, V58, P441, DOI 10.1111/j.1365-2958.2005.04819.x; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; Dean-Nystrom EA, 2008, APPL ENVIRON MICROB, V74, P6378, DOI 10.1128/AEM.00636-08; DeanNystrom EA, 1997, INFECT IMMUN, V65, P1842, DOI 10.1128/IAI.65.5.1842-1848.1997; Dobbin HS, 2006, INFECT IMMUN, V74, P2894, DOI 10.1128/IAI.74.5.2894-2905.2006; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Elliott SJ, 1999, INFECT IMMUN, V67, P4260, DOI 10.1128/IAI.67.8.4260-4263.1999; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; Friedberg D, 1999, MOL MICROBIOL, V34, P941, DOI 10.1046/j.1365-2958.1999.01655.x; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Honda N, 2009, MOL MICROBIOL, V74, P1393, DOI 10.1111/j.1365-2958.2009.06937.x; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Kendall MM, 2011, J BACTERIOL, V193, P6843, DOI 10.1128/JB.06141-11; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Madrid C, 2007, MOL MICROBIOL, V63, P7, DOI 10.1111/j.1365-2958.2006.05497.x; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; MCKEE ML, 1995, INFECT IMMUN, V63, P3739, DOI 10.1128/IAI.63.9.3739-3744.1995; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Mourino M, 1996, INFECT IMMUN, V64, P2881; Nart P, 2008, INFECT IMMUN, V76, P5366, DOI 10.1128/IAI.01223-07; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Pruss BM, 1997, J BACTERIOL, V179, P5602; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Rosser T, 2008, INFECT IMMUN, V76, P5598, DOI 10.1128/IAI.01180-08; Sharma VK, 2013, MICROB PATHOGENESIS, V57, P21, DOI 10.1016/j.micpath.2013.02.002; Sharma VK, 2012, INFECT IMMUN, V80, P1333, DOI 10.1128/IAI.05869-11; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Sharma VK, 2010, MICROBIOL-SGM, V156, P1303, DOI 10.1099/mic.0.034330-0; Sharma VK, 2005, FEMS MICROBIOL LETT, V243, P189, DOI 10.1016/j.femsle.2004.12.003; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 2002, INFECT IMMUN, V70, P3085, DOI 10.1128/IAI.70.6.3085-3093.2002; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Tree JJ, 2011, MOL MICROBIOL, V80, P1349, DOI 10.1111/j.1365-2958.2011.07650.x; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005	57	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85866	10.1371/journal.pone.0085866	http://dx.doi.org/10.1371/journal.pone.0085866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465756	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500134
J	Zhou, YJ; Zhu, JP; Zhou, T; Cheng, Q; Yu, LX; Wang, YX; Yang, S; Jiang, YF; Tong, W; Gao, F; Yu, H; Li, GX; Tong, GZ				Zhou, Yan-Jun; Zhu, Jian-Ping; Zhou, Tao; Cheng, Qun; Yu, Ling-Xue; Wang, Ya-Xin; Yang, Shen; Jiang, Yi-Feng; Tong, Wu; Gao, Fei; Yu, Hai; Li, Guo-Xin; Tong, Guang-Zhi			Identification of Differentially Expressed Proteins in Porcine Alveolar Macrophages Infected with Virulent/Attenuated Strains of Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							CELLULAR-PROTEINS; PROTEOMIC ALTERATION; CELLS; REPLICATION; INHIBITION; GLYCOLYSIS; ANNOTATION; BLAST2GO; REQUIRES; DISEASE	The highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) is still a serious threat to the swine industry. However, the pathogenic mechanism of HP-PRRSV remains unclear. We infected host porcine alveolar macrophages (PAMs) with the virulent HuN4 strain and the attenuated HuN4-F112 strain and then utilized fluorescent two-dimensional difference gel electrophoresis (2D-DIGE) to screen for intracellular proteins that were differentially expressed in host cells infected with the two strains. There were 153 proteins with significant different expression (P<0.01) observed, 42 of which were subjected to mass spectrometry, and 24 proteins were identified. PAM cells infected with the virulent strain showed upregulated expression of pyruvate kinase M2 (PKM2), heat shock protein beta-1 (HSPB1), and proteasome subunit alpha type 6 (PSMA6), which were downregulated in cells infected with the attenuated strain. The upregulation of PKM2 provides sufficient energy for viral replication, and the upregulation of HSPB1 inhibits host cell apoptosis and therefore facilitates mass replication of the virulent strain, while the upregulation of PSMA6 facilitates the evasion of immune surveillance by the virus. Studying on those molecules mentioned above may be able to help us to understand some unrevealed details of HP-PRRSV infection, and then help us to decrease its threat to the swine industry in the future.	[Zhou, Yan-Jun; Zhu, Jian-Ping; Cheng, Qun; Yu, Ling-Xue; Wang, Ya-Xin; Yang, Shen; Jiang, Yi-Feng; Tong, Wu; Gao, Fei; Yu, Hai; Li, Guo-Xin; Tong, Guang-Zhi] CAAS, Shanghai Vet Res Inst, Div Swine Infect Dis, Shanghai, Peoples R China; [Zhou, Tao] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Michigan State University	Tong, GZ (corresponding author), CAAS, Shanghai Vet Res Inst, Div Swine Infect Dis, Shanghai, Peoples R China.	gztong@shvri.ac.cn	jiang, yifeng/GWM-9104-2022; Zhou, Tao/B-5757-2017	Zhou, Tao/0000-0002-3648-9923	Natural Science Foundation of China [31100121]; National High Tech Plan (863 plan) [2011AA10A208]; National Basic Research Program of China [2014CB542702]; International Sci & Tech Cooperation Program [2010DFB33920]; Shanghai Sci & Tech Committee Program [11JC1415200]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Plan (863 plan); National Basic Research Program of China(National Basic Research Program of China); International Sci & Tech Cooperation Program; Shanghai Sci & Tech Committee Program	The study was supported by Natural Science Foundation of China (No. 31100121), National High Tech Plan (863 plan) (2011AA10A208), National Basic Research Program of China (No. 2014CB542702), International Sci & Tech Cooperation Program (2010DFB33920), Shanghai Sci & Tech Committee Program(11JC1415200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso P, 2004, PROTEOMICS, V4, P2037, DOI 10.1002/pmic.200300742; BARDELL D, 1974, INFECT IMMUN, V9, P824, DOI 10.1128/IAI.9.5.824-827.1974; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Ding Z, 2012, VET IMMUNOL IMMUNOP, V145, P206, DOI 10.1016/j.vetimm.2011.11.005; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Fukagawa Y, 2008, ELECTROPHORESIS, V29, P3192, DOI 10.1002/elps.200800086; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Jiang Yong, 2012, Protistology, V7, P34; Karpe YA, 2012, J VIROL, V86, P5948, DOI 10.1128/JVI.07039-11; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Lopez T, 2011, J VIROL, V85, P11964, DOI 10.1128/JVI.05286-11; McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502; Miller LC, 2008, DEV BIOLOGICALS, V132, P169, DOI 10.1159/000317157; Molitor TW, 1997, VET MICROBIOL, V55, P265, DOI 10.1016/S0378-1135(96)01327-2; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Pejsak Z, 1997, VET MICROBIOL, V55, P317, DOI 10.1016/S0378-1135(96)01326-0; Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84; Pol JMA, 1997, VET MICROBIOL, V55, P203, DOI 10.1016/S0378-1135(96)01329-6; Rodgers MA, 2009, J AM CHEM SOC, V131, P5030, DOI 10.1021/ja809949r; Rollin R, 2009, RHEUMATOL INT, V29, P969, DOI 10.1007/s00296-009-0891-x; Rossow KD, 1996, VET PATHOL, V33, P551, DOI 10.1177/030098589603300510; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; STECK TL, 1968, CANCER RES, V28, P1611; Sun JF, 2008, J PROTEOME RES, V7, P5263, DOI 10.1021/pr800546m; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Wang ZK, 2011, J VIROL, V85, P11457, DOI 10.1128/JVI.00879-11; WARBURG O, 1956, SCIENCE, V124, P269; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Xiao SQ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-107; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhang ZS, 2000, J BIOL CHEM, V275, P15157, DOI 10.1074/jbc.M910378199; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zhou YJ, 2011, CHINESE J ANIMAL INF, V19, P1	52	8	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85767	10.1371/journal.pone.0085767	http://dx.doi.org/10.1371/journal.pone.0085767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465692	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500107
J	Ansar, S; Chatzikonstantinou, E; Thiagarajah, R; Tritschler, L; Fatar, M; Hennerici, MG; Meairs, S				Ansar, Saema; Chatzikonstantinou, Eva; Thiagarajah, Rushani; Tritschler, Laurent; Fatar, Marc; Hennerici, Michael G.; Meairs, Stephen			Pro-Inflammatory Mediators and Apoptosis Correlate to rt-PA Response in a Novel Mouse Model of Thromboembolic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; TISSUE-PLASMINOGEN-ACTIVATOR; MATRIX METALLOPROTEINASES; BRAIN-INJURY; REPERFUSION; TRANSIENT; MATRIX-METALLOPROTEINASE-9; HISTOPATHOLOGY; THROMBOLYSIS; MECHANISMS	Background: A recent study suggests that patients with persistent occlusion of the middle cerebral artery (MCA) following treatment with recombinant tissue plasminogen activator (rt-PA) have better outcomes than patients with MCA occlusion not receiving rt-PA. We performed a study to elucidate possible mechanisms of this finding in a new model of thromboembolic stroke closely mimicking human pathophysiology. Methods: Thromboembolic stroke was induced by local injection of thrombin directly into the right MCA of C57 black/6J mice. Rt-PA was administered 20 and 40 min after clot formation. The efficiency of rt-PA to induce thrombolysis was measured by laser Doppler. After 24 h, all animals were euthanized and interleukin (IL)-6, tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase (MMP)-9, Caspase-3, hsp 32 and hsp 70 protein levels were investigated by immunofluorescence. Presence of hemorrhage was verified and infarct volume was measured using histology. Results: Thrombin injection resulted in clot formation giving rise to cortical brain infarction. Early rt-PA treatment starting at 20 min after the clot formation resulted in 100% recanalization. However, rt-PA-induced thrombolysis dissolved the clot in only 38% of the animals when administered 40 min after clot formation. Protein levels of IL-6, TNF-alpha, MMP-9, Caspase-3, hsp 32 and hsp 70 were increased after MCAO, whereas treatment with rt-PA attenuated the expressions of inflammatory markers in those animals where the thrombolysis was successful. In addition, the infarct size was significantly reduced with rt-PA treatment compared to non-treated MCAO, regardless of whether MCA thrombolysis was successful. Conclusions: The present study demonstrates a clear correlation of the protein expression of inflammatory mediators, apoptosis and stress genes with the recanalization data after rt-PA treatment. In this model rt-PA treatment decreases the infarct size regardless of whether vessel recanalization is successful.	[Ansar, Saema; Chatzikonstantinou, Eva; Thiagarajah, Rushani; Tritschler, Laurent; Fatar, Marc; Hennerici, Michael G.; Meairs, Stephen] Heidelberg Univ, Univ Med Mannheim, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Meairs, S (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Neurol, Heidelberg, Germany.	meairs@neuro.ma.uni-heidelberg.de	Tritschler, Laurent/G-9278-2018; Fatar, Marc/E-6892-2015	Tritschler, Laurent/0000-0002-7041-0764; 	European Union [201024, 202213]	European Union(European Commission)	This work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements no. 201024 and no. 202213 (European Stroke Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Dawson DA, 1997, BRAIN RES, V749, P200, DOI 10.1016/S0006-8993(96)01166-3; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kablau M, 2012, TREATMENT TPA PREDIC; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langhauser Friederike L, 2012, Exp Transl Stroke Med, V4, P18, DOI 10.1186/2040-7378-4-18; Langheinrich AC, 2007, ATHEROSCLEROSIS, V191, P73, DOI 10.1016/j.atherosclerosis.2006.05.021; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Muir KW, 2007, CURR OPIN NEUROL, V20, P334, DOI 10.1097/WCO.0b013e32813ba151; Nedelmann M, 2010, J CEREBR BLOOD F MET, V30, P1712, DOI 10.1038/jcbfm.2010.82; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Pfeuffer J, 2002, MAGNET RESON MED, V47, P903, DOI 10.1002/mrm.10154; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Sicard KM, 2006, STROKE, V37, P2593, DOI 10.1161/01.STR.0000239667.15532.c1; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Vogel J, 1999, STROKE, V30, P1134, DOI 10.1161/01.STR.30.5.1134; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006	31	10	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85849	10.1371/journal.pone.0085849	http://dx.doi.org/10.1371/journal.pone.0085849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465746	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500078
J	Benaglia, L; Cardellicchio, L; Filippi, F; Paffoni, A; Vercellini, P; Somigliana, E; Fedele, L				Benaglia, Laura; Cardellicchio, Lucia; Filippi, Francesca; Paffoni, Alessio; Vercellini, Paolo; Somigliana, Edgardo; Fedele, Luigi			The Rapid Growth of Fibroids during Early Pregnancy	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SMOOTH-MUSCLE-CELLS; UTERINE LEIOMYOMAS; LUTEINIZING-HORMONE; ULIPRISTAL ACETATE; IN-VITRO; MYOMAS; MANAGEMENT; PROLACTIN; WOMEN	Several studies aimed to disentangle whether pregnancy influences the growth of uterine fibroids but results were inconsistent. In this study, we speculated that fibroid enlargement during pregnancy may not be linear and we hypothesized that this phenomenon may mainly occur during initial pregnancy. To test this hypothesis, we set up a prospective cohort study of women with fibroids undergoing IVF. Cases were women achieving a viable pregnancy. Controls were the subsequent women with fibroids but failing to become pregnant. Twenty-five cases and 25 controls were recruited. The total number of fibroids in the two groups was 46 and 41, respectively. The mean +/- SD diameter of the fibroids was 17 +/- 10 and 20 +/- 11 mm, respectively (p = 0.18). A statistically significant enlargement emerged exclusively in pregnant women. The median (Interquartile Range) modification of the diameter of the lesions in cases and controls was +34% (+6%/+65%) and +2% (-6%/+12%), respectively (p<0.001). The median (Interquartile Range) modification of the volume of the lesions was +140% (+23%/+357%) and 0% (-18%/+37%), respectively (p<0.001). In pregnant women, we failed to document any significant correlation between the magnitude of the growth and ovarian responsiveness to hyper-stimulation, suggesting that steroids hormones are not the unique factors involved. In conclusion, fibroids undergo a rapid and remarkable growth during initial pregnancy. Reasons behind this phenomenon remain to be clarified. The early rise in steroids hormones during early pregnancy may not be sufficient to explain the process. Other pregnancy-related hormones and proteins may play also key roles.	[Benaglia, Laura; Cardellicchio, Lucia; Filippi, Francesca; Paffoni, Alessio; Vercellini, Paolo; Somigliana, Edgardo; Fedele, Luigi] Osped Maggiore Policlin, Fdn Ca Granda, Dept Obstet Gynecol, Milan, Italy; [Cardellicchio, Lucia; Filippi, Francesca; Vercellini, Paolo; Fedele, Luigi] Univ Milan, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Benaglia, L (corresponding author), Osped Maggiore Policlin, Fdn Ca Granda, Dept Obstet Gynecol, Milan, Italy.	laurabenaglia@hotmail.it	Somigliana, Edgardo/Z-3749-2019; Benaglia, Laura/ABC-7961-2020; Paffoni, Alessio/I-7404-2015; Vercellini, Paolo/K-5295-2016	Somigliana, Edgardo/0000-0002-0223-0032; Paffoni, Alessio/0000-0003-3112-3161; Vercellini, Paolo/0000-0003-4195-0996; fedele, luigi/0000-0001-6297-7165; Benaglia, Laura/0000-0002-7404-9830				AHARONI A, 1988, BRIT J OBSTET GYNAEC, V95, P510, DOI 10.1111/j.1471-0528.1988.tb12807.x; Baird DD, 2006, J SOC GYNECOL INVEST, V13, P130, DOI 10.1016/j.jsgi.2005.12.001; Benaglia L, 2011, FERTIL STERIL, V95, P2489, DOI 10.1016/j.fertnstert.2010.12.051; De Vivo A, 2011, ULTRASOUND OBST GYN, V37, P361, DOI 10.1002/uog.8826; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Fritz MA, 2011, CLIN GYNECOLOGIC END, P269; Hammoud AO, 2006, J MINIM INVAS GYN, V13, P386, DOI 10.1016/j.jmig.2006.04.003; Horiuchi A, 2000, MOL HUM REPROD, V6, P523, DOI 10.1093/molehr/6.6.523; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; KORNYEI JL, 1993, BIOL REPROD, V49, P1149, DOI 10.1095/biolreprod49.6.1149; La Marca A, 2005, HUM REPROD, V20, P1569, DOI 10.1093/humrep/deh819; LEVTOAFF AS, 1987, RADIOLOGY, V164, P375, DOI 10.1148/radiology.164.2.3299488; Neiger R, 2006, J REPROD MED, V51, P671; Nohara A, 1997, BIOCHEM BIOPH RES CO, V238, P473, DOI 10.1006/bbrc.1997.7322; Ozturk E, 2009, CLIN EXP OBSTET GYN, V36, P182; Parker WH, 2007, FERTIL STERIL, V88, P255, DOI 10.1016/j.fertnstert.2007.06.044; ROSATI P, 1992, J ULTRAS MED, V11, P511; SINGH M, 1995, BIOL REPROD, V53, P591, DOI 10.1095/biolreprod53.3.591; Somigliana E, 2011, HUM REPROD, V26, P834, DOI 10.1093/humrep/der015; STEWART EA, 1995, FERTIL STERIL, V64, P972, DOI 10.1016/S0015-0282(16)57912-6; Wallach EE, 2004, OBSTET GYNECOL, V104, P393, DOI 10.1097/01.AOG.0000136079.62513.39	22	28	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85933	10.1371/journal.pone.0085933	http://dx.doi.org/10.1371/journal.pone.0085933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465797	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500091
J	Hallmark, R; Patrie, JT; Liu, ZQ; Gaesser, GA; Barrett, EJ; Weltman, A				Hallmark, Rachel; Patrie, James T.; Liu, Zhenqi; Gaesser, Glenn A.; Barrett, Eugene J.; Weltman, Arthur			The Effect of Exercise Intensity on Endothelial Function in Physically Inactive Lean and Obese Adults	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; NITRIC-OXIDE FUNCTION; HEALTHY-YOUNG MEN; BRACHIAL-ARTERY; DEPENDENT VASODILATATION; REACTIVE HYPEREMIA; VASCULAR-RESPONSES; FAT ACCUMULATION; BODY-COMPOSITION; SHEAR-STRESS	Purpose: To examine the effects of exercise intensity on acute changes in endothelial function in lean and obese adults. Methods: Sixteen lean (BMI <25, age 23 +/- 3 yr) and 10 obese (BMI >30, age 26 +/- 6 yr) physically inactive adults were studied during 3 randomized admissions [control (C, no exercise), moderate-intensity exercise (M, @ lactate threshold (LT)) and high-intensity exercise (H, midway between LT and VO(2)peak) (30 min)]. Endothelial function was assessed by flow-mediated dilation (FMD) at baseline and 1, 2, and 4 h post-exercise. Results: RM ANCOVA revealed significant main effects for group, time, and group x condition interaction (p<0.05). A diurnal increase in FMD was observed in lean but not obese subjects. Lean subjects exhibited greater increases in FMD than obese subjects (p = 0.0005). In the obese group a trend was observed for increases in FMD at 2- and 4-hr after M (p = 0.08). For lean subjects, FMD was significantly elevated at all time points after H. The increase in FMD after H in lean subjects (3.2 +/- 0.5%) was greater than after both C (1.7 +/- 0.4%, p = 0.015) and M (1.4 +/- 0.4%, p = 0.002). FMD responses of lean and obese subjects significantly differed after C and H, but not after M. Conclusion: In lean young adults, high-intensity exercise acutely enhances endothelial function, while moderate-intensity exercise has no significant effect above that seen in the absence of exercise. The FMD response of obese adults is blunted compared to lean adults. Diurnal variation should be considered when examining the effects of acute exercise on FMD.	[Hallmark, Rachel; Gaesser, Glenn A.; Weltman, Arthur] Univ Virginia, Dept Human Serv, Charlottesville, VA 22903 USA; [Patrie, James T.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Liu, Zhenqi; Barrett, Eugene J.; Weltman, Arthur] Univ Virginia, Dept Med, Charlottesville, VA USA; [Barrett, Eugene J.; Weltman, Arthur] Univ Virginia, Gen Clin Res Ctr, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Weltman, A (corresponding author), Univ Virginia, Dept Human Serv, Charlottesville, VA 22903 USA.	alw2v@virginia.edu		Weltman, Arthur/0000-0002-0125-3769	NIH grant [RR00847]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by NIH grant to the GCRC RR00847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2003, MED SCI SPORT EXER, V35, P847, DOI 10.1249/01.MSS.0000064931.62916.8A; Arcaro G, 1999, INT J OBESITY, V23, P936, DOI 10.1038/sj.ijo.0801022; Bergholm R, 1999, ATHEROSCLEROSIS, V145, P341, DOI 10.1016/S0021-9150(99)00089-1; Birk GK, 2013, INT J SPORTS MED, V34, P409, DOI 10.1055/s-0032-1323829; Brook RD, 2001, AM J CARDIOL, V88, P1264, DOI 10.1016/S0002-9149(01)02088-4; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Currie KD, 2012, MED SCI SPORT EXER, V44, P2057, DOI 10.1249/MSS.0b013e318260ff92; Dawson EA, 2008, J APPL PHYSIOL, V105, P1562, DOI 10.1152/japplphysiol.90837.2008; Etsuda H, 1999, CLIN CARDIOL, V22, P417, DOI 10.1002/clc.4960220610; Gaenzer H, 2000, ATHEROSCLEROSIS, V149, P227; Green D, 2002, AM J PHYSIOL-HEART C, V283, pH1354, DOI 10.1152/ajpheart.00050.2002; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Green DJ, 2005, J PHYSIOL-LONDON, V562, P617, DOI 10.1113/jphysiol.2004.075929; Harris RA, 2006, VASC MED, V11, P1, DOI 10.1191/1358863x06vm641oa; Harris RA, 2008, OBESITY, V16, P578, DOI 10.1038/oby.2007.87; Harvey PJ, 2005, J HYPERTENS, V23, P285, DOI 10.1097/00004872-200502000-00010; Hashimoto M, 1998, INT J OBESITY, V22, P477, DOI 10.1038/sj.ijo.0800620; Herrington DM, 2001, J CARDIOVASC RISK, V8, P319, DOI 10.1097/00043798-200110000-00012; Hickner RC, 2006, INT J OBESITY, V30, P308, DOI 10.1038/sj.ijo.0803134; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Jones H, 2010, AM J PHYSIOL-REG I, V298, pR427, DOI 10.1152/ajpregu.00442.2009; Lippincott MF, 2008, AM J CARDIOL, V102, P348, DOI 10.1016/j.amjcard.2008.03.069; Mannion T C, 1998, Vasc Med, V3, P263, DOI 10.1177/1358836X9800300401; McCord JL, 2006, J APPL PHYSIOL, V101, P1693, DOI 10.1152/japplphysiol.00441.2006; MCCRORY MA, 1995, MED SCI SPORT EXER, V27, P1686; McGowan CL, 2006, AM J PHYSIOL-HEART C, V291, pH1797, DOI 10.1152/ajpheart.01113.2005; Neunteufl T, 2000, AM J CARDIOL, V86, P207, DOI 10.1016/S0002-9149(00)00857-2; Padilla J, 2006, EUR J APPL PHYSIOL, V98, P256, DOI 10.1007/s00421-006-0272-z; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; Rognmo O, 2008, J STRENGTH COND RES, V22, P535, DOI 10.1519/JSC.0b013e31816354b1; Silvestro A, 2002, ATHEROSCLEROSIS, V165, P277, DOI 10.1016/S0021-9150(02)00235-6; Siri W, 1969, TECHNIQUES MEASURING, P223; Thijssen DHJ, 2008, AM J PHYSIOL-HEART C, V295, pH1927, DOI 10.1152/ajpheart.00405.2008; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thijssen DHJ, 2009, MED SCI SPORT EXER, V41, P1072, DOI 10.1249/MSS.0b013e3181923957; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; van Harmelen V, 2008, DIABETES, V57, P378, DOI 10.2337/db07-0893; Vincent HK, 2004, MED SCI SPORT EXER, V36, P772, DOI 10.1249/01.MSS.0000126576.53038.E9; WELTMAN A, 1990, INT J SPORTS MED, V11, P26, DOI 10.1055/s-2007-1024757; Williams MRI, 2001, J CLIN ENDOCR METAB, V86, P5389, DOI 10.1210/jc.86.11.5389; Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929; Zhu WL, 2007, EUR J APPL PHYSIOL, V99, P585, DOI 10.1007/s00421-006-0378-3; Zhu WL, 2010, EUR J APPL PHYSIOL, V108, P727, DOI 10.1007/s00421-009-1283-3	44	28	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85450	10.1371/journal.pone.0085450	http://dx.doi.org/10.1371/journal.pone.0085450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465565	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500047
J	Lavelle, M; Healey, PGT; McCabe, R				Lavelle, Mary; Healey, Patrick G. T.; McCabe, Rosemarie			Participation during First Social Encounters in Schizophrenia	PLOS ONE			English	Article								Background: Patients with a diagnosis of schizophrenia are socially excluded. The aim of this study was to investigate how patients participate in first encounters with unfamiliar healthy participants, who are unaware of their diagnosis. Methods: Patterns of participation were investigated during interactions involving three-people. Three conversation roles were analysed: (i) speaker, (ii) primary recipient-focus of the speaker's attention and (iii) secondary recipient-unaddressed individual. Twenty patient interactions (1 patient, 2 healthy controls) and 20 control interactions (3 healthy participants) were recorded and motion captured in 3D. The participation of patients and their partners, in each conversation role, was compared with controls at the start, middle and end of the interaction. The relationship between patients' participation, their symptoms and the rapport others experienced with them was also explored. Results: At the start of the interaction patients spoke less (beta = -.639, p = .02) and spent more time as secondary recipient (beta = .349, p = .02). Patients' participation at the middle and end of the interaction did not differ from controls. Patients' partners experienced poorer rapport with patients who spent more time as a primary recipient at the start of the interaction (Rho(11) = -.755, p<.01). Patients' participation was not associated with symptoms. Conclusion: Despite their increased participation over time, patients' initial participation appears to be associated with others' experience of rapport with them. Thus, the opening moments of patients' first encounters appear to be interpersonally significant. Further investigation of patient and others' behaviour during these critical moments is warranted in order to understand, and possibly develop interventions to address, the difficulties schizophrenia patients experience here.	[Lavelle, Mary] Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London WC2R 2LS, England; [Healey, Patrick G. T.] Univ London, Sch Elect Engn & Comp Sci, Interact Media & Commun Res Grp, London, England; [McCabe, Rosemarie] Univ Exeter, Sch Med, Exeter, Devon, England	University of London; King's College London; University of London; University of Exeter	Lavelle, M (corresponding author), Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London WC2R 2LS, England.	mary.lavelle@kcl.ac.uk		Healey, Patrick/0000-0003-3079-3374; McCabe, Rose/0000-0003-2041-7383; Lavelle, Mary/0000-0002-3951-0011	Engineering and Physical Sciences Research Council Doctoral Training Programme [EP/P502683/1]	Engineering and Physical Sciences Research Council Doctoral Training Programme	This work was funded by the Engineering and Physical Sciences Research Council Doctoral Training Programme (EP/P502683/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2008, SCHIZOPHR RES, V99, P176, DOI 10.1016/j.schres.2007.07.004; Barbui C, 1996, EUR PSYCHIAT, V11, P306, DOI 10.1016/S0924-9338(96)89899-3; Battersby SA, 2010, P 32 ANN C COGN SCI; Berger K., 2011, VMV, P317; Burgess P.W., 1997, HAYLING BRIXTON TEST; Dimic S, 2010, PSYCHOPATHOLOGY, V43, P216, DOI 10.1159/000313519; Drolet AL, 2000, J EXP SOC PSYCHOL, V36, P26, DOI 10.1006/jesp.1999.1395; ERICKSON DH, 1989, AM J PSYCHIAT, V146, P1456; Goffman E., 1981, FORMS TALK; Jokinen K., 2010, P 2010 WORKSH EYE GA, P118, DOI [10.1145/2002333.2002352, DOI 10.1145/2002333.2002352]; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Lavelle M, 2013, SCHIZOPHRENIA BULL, V39, P1150, DOI 10.1093/schbul/sbs091; McCabe Rosemarie, 2012, P VID AN WORK INT TE, P97; Michael BF, 2002, STRUCTURED CLIN INTE; Penn DL, 2008, SCHIZOPHRENIA BULL, V34, P408, DOI 10.1093/schbul/sbn014; Purver M, 2003, SIGDIAL WORKSH, P23; RUMKE HC, 1941, ZENTRALBLATT GESAMTE, V102, P168; Wittenburg P., 2006, P 5 INT C LANG RES E, P1156; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e77506	10.1371/journal.pone.0077506	http://dx.doi.org/10.1371/journal.pone.0077506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465363	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330240500001
J	Serrano-Candelas, E; Farre, D; Aranguren-Ibanez, A; Martinez-Hoyer, S; Perez-Riba, M				Serrano-Candelas, Eva; Farre, Domenec; Aranguren-Ibanez, Alvaro; Martinez-Hoyer, Sergio; Perez-Riba, Merce			The Vertebrate RCAN Gene Family: Novel Insights into Evolution, Structure and Regulation	PLOS ONE			English	Article							CANDIDATE REGION 1; DSCR1L2 MESSENGER-RNA; CALCINEURIN INHIBITOR; GENOME DUPLICATIONS; NUCLEAR FACTOR; T-CELLS; EXPRESSION; IDENTIFICATION; SEQUENCES; PROTEINS	Recently there has been much interest in the Regulators of Calcineurin (RCAN) proteins which are important endogenous modulators of the calcineurin-NFATc signalling pathway. They have been shown to have a crucial role in cellular programmes such as the immune response, muscle fibre remodelling and memory, but also in pathological processes such as cardiac hypertrophy and neurodegenerative diseases. In vertebrates, the RCAN family form a functional subfamily of three members RCAN1, RCAN2 and RCAN3 whereas only one RCAN is present in the rest of Eukarya. In addition, RCAN genes have been shown to collocate with RUNX and CLIC genes in ACD clusters (ACD21, ACD6 and ACD1). How the RCAN genes and their clustering in ACDs evolved is still unknown. After analysing RCAN gene family evolution using bioinformatic tools, we propose that the three RCAN vertebrate genes within the ACD clusters, which evolved from single copy genes present in invertebrates and lower eukaryotes, are the result of two rounds of whole genome duplication, followed by a segmental duplication. This evolutionary scenario involves the loss or gain of some RCAN genes during evolution. In addition, we have analysed RCAN gene structure and identified the existence of several characteristic features that can be involved in RCAN evolution and gene expression regulation. These included: several transposable elements, CpG islands in the 59 region of the genes, the existence of antisense transcripts (NAT) associated with the three human genes, and considerable evidence for bidirectional promoters that regulate RCAN gene expression. Furthermore, we show that the CpG island associated with the RCAN3 gene promoter is unmethylated and transcriptionally active. All these results provide timely new insights into the molecular mechanisms underlying RCAN function and a more in depth knowledge of this gene family whose members are obvious candidates for the development of future therapies.	[Serrano-Candelas, Eva; Aranguren-Ibanez, Alvaro; Martinez-Hoyer, Sergio; Perez-Riba, Merce] Bellvitge Biomed Res Inst IDIBELL, Canc & Human Mol Genet Dept, Barcelona, Spain; [Farre, Domenec] IDIBAPS, Biol Aggress & Response Mechanisms Unit, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Perez-Riba, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Canc & Human Mol Genet Dept, Barcelona, Spain.	mpr@idibell.cat	Serrano Candelas, Eva/I-1892-2015; Perez-Riba, Merce/AAA-6880-2019; Farre, Domenec/K-8010-2014	Serrano Candelas, Eva/0000-0002-8929-5364; Farre, Domenec/0000-0001-8553-1983; Aranguren-Ibanez, Alvaro/0000-0001-8929-3521; Perez-Riba, Merce/0000-0003-1604-4617	Ministerio de Ciencia e Innovacion [SAF2009-08216]; Generalitat Catalunya [2009SGR1490]; Mutua Madrilena; Juan de la Cierva subprogramme (Ministerio de Economia y Competitividad); Generalitat de Catalunya;  [SAF009-08216]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Catalunya; Mutua Madrilena; Juan de la Cierva subprogramme (Ministerio de Economia y Competitividad); Generalitat de Catalunya(Generalitat de Catalunya); 	The research was supported by Ministerio de Ciencia e Innovacion grant SAF2009-08216 and Generalitat Catalunya grant 2009SGR1490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ESC was supported by SAF009-08216 and Mutua Madrilena, DF was supported by the Juan de la Cierva subprogramme (Ministerio de Economia y Competitividad), and AAI was a recipient of a FI fellowship from Generalitat de Catalunya.	Andreakis N, 2011, MOL BIOL EVOL, V28, P163, DOI 10.1093/molbev/msq179; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bassett JHD, 2012, ENDOCRINOLOGY, V153, P3537, DOI 10.1210/en.2011-1814; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Boratyn GM, 2013, NUCL ACIDS RES; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Canaider S, 2006, GENE, V372, P128, DOI 10.1016/j.gene.2005.12.029; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Cattell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022474; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Djuretic IM, 2009, ADV IMMUNOL, V104, P1, DOI 10.1016/S0065-2776(08)04001-7; Dores RM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00028; Dores RM, 2011, ENDOCRINOLOGY, V152, P4010, DOI 10.1210/en.2011-1694; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Estecha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033313; Facchin F, 2008, GENE, V407, P159, DOI 10.1016/j.gene.2007.10.006; Facchin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024508; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Glusman G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-43; Gurgen D, 2011, HYPERTENSION, V57, P648, DOI 10.1161/HYPERTENSIONAHA.110.166157; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Ho MR, 2012, GENOMICS, V100, P231, DOI 10.1016/j.ygeno.2012.06.011; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Johanson Z, 2006, BIOL LETTERS, V2, P443, DOI 10.1098/rsbl.2006.0470; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lee JY, 2009, BBA-GEN SUBJECTS, V1790, P1673, DOI 10.1016/j.bbagen.2009.08.005; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Martinez-Hoyer S, 2013, BBA-MOL CELL RES, V1833, P2311, DOI 10.1016/j.bbamcr.2013.05.021; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Nicholas KB, 1997, EMBNEW NEWS, V4; Ohno S., 1970, P1; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rennert J, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-4; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Shin SY, 2006, FEBS LETT, V580, P5965, DOI 10.1016/j.febslet.2006.09.064; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smith JJ, 2010, INTEGR COMP BIOL, V50, P130, DOI 10.1093/icb/icq023; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Strippoli P, 2002, MAMM GENOME, V13, P456, DOI 10.1007/s00335-001-2157-0; Strippoli P, 2000, GENE, V257, P223, DOI 10.1016/S0378-1119(00)00407-8; Strippoli P, 2000, GENOMICS, V64, P252, DOI 10.1006/geno.2000.6127; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vienne A, 2003, MOL BIOL EVOL, V20, P1290, DOI 10.1093/molbev/msg127; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang JY, 2009, BONE, V45, P1175, DOI 10.1016/j.bone.2009.08.012; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	85	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85539	10.1371/journal.pone.0085539	http://dx.doi.org/10.1371/journal.pone.0085539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465593	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500057
J	Andreeva, VA; Latarche, C; Hercberg, S; Briancon, S; Galan, P; Kesse-Guyot, E				Andreeva, Valentina A.; Latarche, Clotilde; Hercberg, Serge; Briancon, Serge; Galan, Pilar; Kesse-Guyot, Emmanuelle			B Vitamin and/or n-3 Fatty Acid Supplementation and Health-Related Quality of Life: Ancillary Findings from the SU.FOL.OM3 Randomized Trial	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL; MILD COGNITIVE IMPAIRMENT; HEART-FAILURE; MENTAL-HEALTH; DOUBLE-BLIND; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; OLDER PATIENTS; SF-36	Background: Despite growing attention to nutrition and quality of life in cardiovascular disease survivors, the impact of dietary factors according to disease type or to quality of life domain is poorly understood. We investigated the effects of B vitamin and/or n-3 fatty acid supplementation on health-related quality of life among survivors of stroke, myocardial infarction, or unstable angina. Methods: We performed ancillary analyses of the SU.FOL.OM3 trial (2003-2009; France). In total, 2,501 men (mean age = 61 y) and women (mean age = 63 y) were randomized in a 2x2 factorial design to: 1) 0.56 mg 5-methyltetrahydrofolate, 3 mg vitamin B6, 0.02 mg vitamin B12; 2) 600 mg eicosapentaenoic and docosahexaenoic acids in a 2: 1 ratio; 3) B vitamins and n-3 fatty acids combined; or 4) placebo. Health-related quality of life was evaluated at follow-up with the Medical Outcomes Study 36-Item Short Form Health Survey. Data from 2,029 individuals were used in this analysis. Results: After 3.1 +/- 0.4 y, no effects of supplementation with either B vitamins or n-3 fatty acids on quality of life (physical or mental health domains) were found. However, participants receiving B vitamins had slightly more activity limitations due to emotional problems compared with those not receiving B vitamins (mean difference = 3.8; 95% CI: 0.4, 7.1). A significant interaction of treatment by prior disease revealed an inverse association between n-3 fatty acids and vitality among myocardial infarction survivors (mean difference = 2.9; 95% CI: 0.5, 5.2). Conclusions: There were no beneficial effects of supplementation with relatively low doses of B vitamins or n-3 fatty acids on health-related quality of life in cardiovascular disease survivors. The adverse effects of B vitamins on activity limitations and of n-3 fatty acids on vitality among individuals with prior myocardial infarction merit confirmation.	[Andreeva, Valentina A.; Hercberg, Serge; Galan, Pilar; Kesse-Guyot, Emmanuelle] Univ Paris 13, Nutr Epidemiol Res Unit, Sorbonne Paris Cite, French Inst Hlth & Med Res,Natl Inst Agron Res,Na, Bobigny, France; [Latarche, Clotilde; Briancon, Serge] Univ Hosp Ctr, Dept Clin Epidemiol & Evaluat, Nancy, France; [Latarche, Clotilde; Briancon, Serge] Univ Paris 05, Univ Lorraine, Nancy, France; [Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Andreeva, VA (corresponding author), Univ Paris 13, Nutr Epidemiol Res Unit, Sorbonne Paris Cite, French Inst Hlth & Med Res,Natl Inst Agron Res,Na, Bobigny, France.	v.andreeva@uren.smbh.univ-paris13.fr	Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/F-2692-2017; Andreeva, Valentina/F-2680-2017; Pilar, Galan/F-2908-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Serge, Hercberg/F-3038-2017	Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Andreeva, Valentina/0000-0001-9480-5210; Pilar, Galan/0000-0003-1706-3107; HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350	French National Research Agency [ANR] [R02010JJ]; Ministry of Health; Sodexo; Candia; Unilever; Danone; Roche Laboratories; Merck Eprova AG; Pierre Fabre Laboratories; Catalent Pharma Solutions	French National Research Agency [ANR](French National Research Agency (ANR)); Ministry of Health; Sodexo; Candia; Unilever(Unilever); Danone(Danone Nutricia); Roche Laboratories; Merck Eprova AG; Pierre Fabre Laboratories; Catalent Pharma Solutions	This work was supported by the French National Research Agency [ANR grant R02010JJ], the Ministry of Health, Sodexo, Candia, Unilever, Danone, Roche Laboratories, Merck Eprova AG, Pierre Fabre Laboratories, and Catalent Pharma Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Anderson C, 1996, STROKE, V27, P1812, DOI 10.1161/01.STR.27.10.1812; Arostegui I, 2007, STAT MED, V26, P1318, DOI 10.1002/sim.2612; Brink E, 2005, QUAL LIFE RES, V14, P749, DOI 10.1007/s11136-004-0785-z; Centers for Disease Control and Prevention, 2020, DIS IMP ALL US; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Crowe FL, 2007, AM J CLIN NUTR, V86, P1278, DOI 10.1093/ajcn/86.5.1278; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; de Edelenyi FS, 2012, BRIT J NUTR, V107, P921, DOI 10.1017/S0007114511003692; Dempster M, 2000, HEART, V83, P641, DOI 10.1136/heart.83.6.641; Dolan P, 1999, PHARMACOECONOMICS, V15, P119, DOI 10.2165/00019053-199915020-00001; Drewnowski A, 2001, J GERONTOL A-BIOL, V56, P89, DOI 10.1093/gerona/56.suppl_2.89; Failde II, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-18; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Franzen-Dahlin A, 2012, J CLIN NURS, V21, P2386, DOI 10.1111/j.1365-2702.2011.04064.x; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Galan P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-35; Gariballa S, 2007, J AM GERIATR SOC, V55, P2030, DOI 10.1111/j.1532-5415.2007.01435.x; Gissi-Prevenzione Investigators, 1997, G ITAL CARDIOL, V27, P865; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Hickey A, 2005, PHARMACOECONOMICS, V23, P971, DOI 10.2165/00019053-200523100-00002; Hvas AM, 2003, J INTERN MED, V253, P146, DOI 10.1046/j.1365-2796.2003.01067.x; Kauhanen ML, 2000, ARCH PHYS MED REHAB, V81, P1541, DOI 10.1053/apmr.2000.9391; Kennedy ET, 2006, AM J CLIN NUTR, V83, p410S; Klingler M, 2012, BRIT J NUTR, V107, pS53, DOI 10.1017/S0007114512001468; Knapp M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6342; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Kuehneman T, 2002, J AM DIET ASSOC, V102, P1790, DOI 10.1016/S0002-8223(02)90384-6; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lane D, 2001, PSYCHOSOM MED, V63, P221, DOI 10.1097/00006842-200103000-00005; Laye S, 2010, PROSTAG LEUKOTR ESS, V82, P295, DOI 10.1016/j.plefa.2010.02.006; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Logan Alan C, 2003, Altern Med Rev, V8, P410; Moretti R, 2004, NEUROL INDIA, V52, P310; National Institute for Health and Care Excellence, 2013, NICE GUID RES REC; Norekval TM, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-58; Peduzzi P, 2002, EPIDEMIOL REV, V24, P26, DOI 10.1093/epirev/24.1.26; Poppitt SD, 2009, STROKE, V40, P3485, DOI 10.1161/STROKEAHA.109.555136; Ramirez EC, 2004, NUTRITION, V20, P890, DOI 10.1016/j.nut.2004.06.010; Rondanelli M, 2010, J AM COLL NUTR, V29, P55, DOI 10.1080/07315724.2010.10719817; Ruano C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-121; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Schiepers OJG, 2010, PROSTAG LEUKOTR ESS, V83, P31, DOI 10.1016/j.plefa.2010.02.030; Schweikert B, 2009, EUR HEART J, V30, P436, DOI 10.1093/eurheartj/ehn509; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Simpson E, 2003, CAN J CARDIOL, V19, P507; Sinn N, 2012, BRIT J NUTR, V107, P1682, DOI 10.1017/S0007114511004788; Sun Q, 2007, AM J CLIN NUTR, V86, P74, DOI 10.1093/ajcn/86.1.74; Swigris JJ, 2010, RESP MED, V104, P296, DOI 10.1016/j.rmed.2009.09.006; Thompson David R, 2003, Health Qual Life Outcomes, V1, P42, DOI 10.1186/1477-7525-1-42; van de Rest O, 2009, J AM GERIATR SOC, V57, P1481, DOI 10.1111/j.1532-5415.2009.02361.x; van der Meij BS, 2012, EUR J CLIN NUTR, V66, P399, DOI 10.1038/ejcn.2011.214; van Jaarsveld CHM, 2001, J AM GERIATR SOC, V49, P1052, DOI 10.1046/j.1532-5415.2001.49208.x; van Uffelen JGZ, 2007, QUAL LIFE RES, V16, P1137, DOI 10.1007/s11136-007-9219-z; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2011, NIH PUBL; Witte KKA, 2005, EUR HEART J, V26, P2238, DOI 10.1093/eurheartj/ehi442	59	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84844	10.1371/journal.pone.0084844	http://dx.doi.org/10.1371/journal.pone.0084844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465438	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000017
J	Meisner, MH; Rosenheim, JA				Meisner, Matthew H.; Rosenheim, Jay A.			Ecoinformatics Reveals Effects of Crop Rotational Histories on Cotton Yield	PLOS ONE			English	Article							PEST-MANAGEMENT; LYGUS-HESPERUS; INSECT; TILLAGE; PLANT	Crop rotation has been practiced for centuries in an effort to improve agricultural yield. However, the directions, magnitudes, and mechanisms of the yield effects of various crop rotations remain poorly understood in many systems. In order to better understand how crop rotation influences cotton yield, we used hierarchical Bayesian models to analyze a large ecoinformatics database consisting of records of commercial cotton crops grown in California's San Joaquin Valley. We identified several crops that, when grown in a field the year before a cotton crop, were associated with increased or decreased cotton yield. Furthermore, there was a negative association between the effect of the prior year's crop on June densities of the pest Lygus hesperus and the effect of the prior year's crop on cotton yield. This suggested that some crops may enhance L. hesperus densities in the surrounding agricultural landscape, because residual L. hesperus populations from the previous year cannot continuously inhabit a focal field and attack a subsequent cotton crop. In addition, we found that cotton yield declined approximately 2.4% for each additional year in which cotton was grown consecutively in a field prior to the focal cotton crop. Because L. hesperus is quite mobile, the effects of crop rotation on L. hesperus would likely not be revealed by small plot experimentation. These results provide an example of how ecoinformatics datasets, which capture the true spatial scale of commercial agriculture, can be used to enhance agricultural productivity.	[Meisner, Matthew H.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Meisner, Matthew H.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Rosenheim, Jay A.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Meisner, MH (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	mhmeisner@ucdavis.edu			California State Support Committee of Cotton Incorporated; University of California Statewide IPM Program; USDA-NRICGP [2006-01761]; California Department of Pesticide Regulation; National Science Foundation GRFP [DGE-1148897]	California State Support Committee of Cotton Incorporated; University of California Statewide IPM Program; USDA-NRICGP(United States Department of Agriculture (USDA)); California Department of Pesticide Regulation; National Science Foundation GRFP(National Science Foundation (NSF))	Funding Sources: 1. California State Support Committee of Cotton Incorporated. URL: http://www.ccgga.org/cotton_research/cssc.htm. 2. University of California Statewide IPM Program. URL: http://www.ipm.ucdavis.edu. 3. USDA-NRICGP (Grant 2006-01761). URL: http://www.csrees.usda.gov/funding/rfas/nri_rfa.html. 4. California Department of Pesticide Regulation. URL: http://www.cdpr.ca.gov. 5. National Science Foundation GRFP (Grant DGE-1148897). URL: http://www.nsfgrfp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson GO, 1985, P CORN SORGH RES C C, P161; Bordovsky JP, 2011, APPL ENG AGRIC, V27, P359; BORDOVSKY JP, 1994, AGRON J, V86, P1, DOI 10.2134/agronj1994.00021962008600010001x; Carriere Y, 2006, ENTOMOL EXP APPL, V118, P203, DOI 10.1111/j.1570-7458.2006.00384.x; Carriere Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039862; CONSTABLE GA, 1992, SOIL TILL RES, V23, P41, DOI 10.1016/0167-1987(92)90004-U; Cook RJ, 1984, ORGANIC FARMING CURR, P111; Crookston R. K., 1984, Crops and Soils Magazine, V36, P12; EDWARDS JH, 1988, AGRON J, V80, P76, DOI 10.2134/agronj1988.00021962008000010018x; Forbes AA, 2011, ENTOMOL EXP APPL, V139, P242, DOI 10.1111/j.1570-7458.2011.01125.x; Gelman A, 2009, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GOBBLE MM, 2013, RES TECHNOL MANAGE, V56, P64; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Godfrey LD, 2013, UC IPM PEST MANAGEME; Hoffman MD, 2013, J MACH LEAR IN PRESS; JOHNSON T. C., 1927, JOUR AMER SOC AGRON, V19, P518; KARLEN DL, 1994, ADV AGRON, V53, P1, DOI 10.1016/S0065-2113(08)60611-2; LIEBMAN M, 1993, ECOL APPL, V3, P92, DOI 10.2307/1941795; MITCHELL CC, 1991, AGRON J, V83, P24, DOI 10.2134/agronj1991.00021962008300010010x; Mitchell CC, 2008, AGRON J, V100, P1493, DOI 10.2134/agronj2007.0395; MUELLER AJ, 1974, J ECON ENTOMOL, V67, P77, DOI 10.1093/jee/67.1.77; O'Rourke ME, 2011, ECOL APPL, V21, P1782, DOI 10.1890/10-0241.1; Peairs FB, 2013, W CORN ROOTWORM; Rosenheim JA, 2006, ENVIRON ENTOMOL, V35, P1141, DOI 10.1603/0046-225X(2006)35[1141:ETIOLH]2.0.CO;2; Rosenheim JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080518; Rosenheim JA, 2011, J ECON ENTOMOL, V104, P331, DOI 10.1603/EC10380; Rosner D, 2013, ENVIRON RES, V120, P126, DOI 10.1016/j.envres.2012.08.011; Rothamsted Research Center, 2006, TECHNICAL REPORT; Russelle MP, 1987, SOIL CONS SOC AM, P41; Sevacherian B, 1975, ENVIRON ENTOMOL, V4, P163; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Stan Development Team, 2013, STAN MOD LANG US GUI; Stan Development Team, 2019, STAN C LIB PROBABILI; Streibich Karl-Heinz, 2013, Database and Network Journal, V43, P12; Wheeler TA, 2012, PLANT DIS, V96, P985, DOI 10.1094/PDIS-02-11-0111-RE; White K. D., 1970, AGR HIST, V44, P281; White K.D., 1970, ROMAN FARMING	38	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85710	10.1371/journal.pone.0085710	http://dx.doi.org/10.1371/journal.pone.0085710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465657	Green Published, gold			2022-12-27	WOS:000330237000053
J	Zhang, LJ; Li, ZQ; Li, XC; Zhang, J; Zheng, L; Jiang, CH; Li, J				Zhang, Lijuan; Li, Zhiqiang; Li, Xucheng; Zhang, Jie; Zheng, Liang; Jiang, Chenghua; Li, Jue			Study on the Trend and Disease Burden of Injury Deaths in Chinese Population, 2004-2010	PLOS ONE			English	Article							HEALTH SYSTEM REFORM; REGIONAL INEQUALITY; GLOBAL BURDEN; MORTALITY; RATES; URBAN; PROVINCE; SUICIDE; AREAS; AGE	Injuries are a growing public health concern in China, accounting for more than 30% of all Person Years of Life Lost (PYLL) due to premature mortality. This study analyzes the trend and disease burden of injury deaths in Chinese population from 2004 to 2010, using data from the National Disease Surveillance Points (DSPs) system, as injury deaths are classified based on the International Classification of Disease-10th Revision (ICD-10). We observed that injury death accounted for nearly 10% of all deaths in China throughout the period 2004-2010, and the injury mortality rates were higher in males than those in females, and higher in rural areas than in urban areas. Traffic crashes (33.79-38.47% of all injury deaths) and suicides (16.20-22.01%) were the two leading causes of injury deaths. Alarmingly, suicide surpassed traffic crashes as the leading cause of injury mortality in rural females, yet adults aged 65 and older suffered the greatest number of fatal falls (20,701 deaths, 2004-2010). The burden of injury among men (72.11%) was about three times more than that of women's (28.89%). This study provides indispensible evidence that China Authority needs to improve the surveillance and deterrence of three major types of injuries: Traffic-related injury deaths should be targeted for injury prevention activities in all population, people aged 65+ should be encouraged to take individual fall precautions, and prevention of suicidal behavior in rural females should be another key priority for the government of China.	[Zhang, Lijuan; Li, Zhiqiang; Li, Xucheng; Zhang, Jie; Zheng, Liang; Jiang, Chenghua; Li, Jue] Tongji Univ, Sch Med, Dept Prevent, Shanghai 200092, Peoples R China	Tongji University	Jiang, CH (corresponding author), Tongji Univ, Sch Med, Dept Prevent, Shanghai 200092, Peoples R China.	jiangchenghua@hotmail.com; jueli@tongji.edu.cn			Fundamental Research Funds for the Central Universities; Nature Science Foundation of China [81001252]; Ministry of Education of China [20100072120053]; International Science & Technology Cooperation Program of China [2011DFB30010]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); International Science & Technology Cooperation Program of China	This study was supported by grants from Fundamental Research Funds for the Central Universities (Study on the key technology of disaster warning and relief for rural remote areas); the Nature Science Foundation of China (No. 81001252); Ministry of Education of China (No. 20100072120053), International Science & Technology Cooperation Program of China(No. 2011DFB30010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke HK, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-14; Boland M, 2005, INJURY PREV, V11, P38, DOI 10.1136/ip.2004.005371; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Fan CC, 2008, EURASIAN GEOGR ECON, V49, P1, DOI 10.2747/1539-7216.49.1.1; Garrib A, 2011, TROP MED INT HEALTH, V16, P439, DOI 10.1111/j.1365-3156.2011.02730.x; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Herbert HK, 2011, INFECT DIS CLIN N AM, V25, P653, DOI 10.1016/j.idc.2011.06.004; Hu GQ, 2010, J RURAL HEALTH, V26, P73, DOI 10.1111/j.1748-0361.2009.00255.x; Jiang GH, 2011, INJURY, V42, P501, DOI 10.1016/j.injury.2009.10.050; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Li YH, 2013, BIOMED ENVIRON SCI, V26, P79, DOI 10.3967/0895-3988.2013.02.001; Liu Na, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P746; Liu Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-180; Ma JX, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-122; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Mitchell RJ, 2010, RURAL REMOTE HEALTH, V10; Mock CN, 1999, B WORLD HEALTH ORGAN, V77, P955; Peek-Asa C, 2004, AM J PUBLIC HEALTH, V94, P1689, DOI 10.2105/AJPH.94.10.1689; Peng XZ, 2011, SCIENCE, V333, P581, DOI 10.1126/science.1209396; Phillips MR, 2012, LANCET, V379, P2318, DOI 10.1016/S0140-6736(12)60913-1; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shan H, 2011, ASIA-PAC J PUBLIC HE, DOI [10.1177/1010539511428487, DOI 10.1177/1010539511428487.[]; Stone DH, 2006, INJURY PREV, V12, P327, DOI 10.1136/ip.2006.012344; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; Wang Li-jun, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P309; Wang P, 2010, TRAFFIC INJ PREV, V11, P425, DOI 10.1080/15389581003754593; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Zhang Jie, 2002, Arch Suicide Res, V6, P167, DOI 10.1080/13811110208951174; Zhang QH, 2012, ANN ECON FINANC, V13, P113; Zhang XJ, 2013, IRAN J PUBLIC HEALTH, V42, P7; Zhang YL, 2013, ZHONGGUO GONG GONG W, V29, P1425; Zhao ZT, 2003, HEALTH PROMOT INT, V18, P247, DOI 10.1093/heapro/dag020; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124	38	25	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85319	10.1371/journal.pone.0085319	http://dx.doi.org/10.1371/journal.pone.0085319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465534	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000030
J	Tian, L; Li, CW; Liu, YH; Chen, YC; Fu, MD				Tian, Li; Li, Chuanwei; Liu, Yinghui; Chen, Yucheng; Fu, Mingde			The Value and Distribution of High-Density Lipoprotein Subclass in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							CHOLESTEROL LEVELS; HEART-DISEASE; CARDIOVASCULAR RISK; HDL; PARTICIPANTS; PREVALENCE; PREDICTORS; MECHANISMS; PREVENTION; MIRACL	Background: High-density lipoprotein (HDL) enhances cholesterol efflux from the arterial wall and exhibits potent anti-inflammatory and anti-atherosclerosis (AS) properties. Whether raised HDL levels will clinically benefit patients with acute coronary syndrome (ACS) and the value at which these effects will be apparent, however, is debatable. This study examined the HDL subclass distribution profile in patients with ACS. Methods: Plasma HDL subclasses were measured in 158 patients with established ACS and quantified by two-dimensional gel electrophoresis and immunoblotting. ACS diagnosis was based on symptoms of cardiac ischemia, electrocardiogram (ECG) abnormalities, speciality cardiac enzyme change along with presence of coronary heart disease (CHD) on coronary angiography. Results: The small-sized pre beta 1-HDL, HDL3b, and HDL3a levels were significantly higher, and the large-sized HDL2a and HDL2b levels were significantly lower in patients with ACS than in those with stable angina pectoris (SAP) and in normal control subjects. Meanwhile, with an elevation in the low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), body mass index (BMI), and blood pressure (BP), and the reduction in the high density lipoprotein cholesterol (HDL-C) levels, the HDL2b contents significantly decreased and the preb1-HDL contents significantly increased in patients with ACS. The correlation analysis revealed that the apolipoprotein (apo) A-I levels were positively and significantly with all HDL subclasses contents; plasma total cholesterol (TC) and fasting plasma glucose (FPG) levels were inversely associated with HDL2a, and HDL2b. Moreover, the FPG levels were positively related to HDL3c, HDL3b, and HDL3a in ACS patients. Conclusion: The HDL subclass distribution profile remodeling was noted in the patients with ACS. Plasma lipoprotein and FPG levels, BP, and BMI play an important role in the HDL subclass metabolism disorder for patients with ACS. The HDL subclass distribution phenotype might be useful as a novel biomarker to assist in the risk stratification of patients with ACS.	[Tian, Li; Liu, Yinghui; Fu, Mingde] Sichuan Univ, West China Hosp, Lab Endocrinol & Metab, Chengdu 610064, Sichuan, Peoples R China; [Li, Chuanwei; Chen, Yucheng] Sichuan Univ, West China Hosp, Cardiovasc Dept, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Fu, MD (corresponding author), Sichuan Univ, West China Hosp, Lab Endocrinol & Metab, Chengdu 610064, Sichuan, Peoples R China.	apolipoprotein2009@126.com	Chen, Yi/HIR-2608-2022; Tian, Li/M-8251-2015; Chen, Yucheng/AAF-6181-2020; Chen, Yu/Y-3292-2019	Tian, Li/0000-0003-0807-2634; 	National Natural Science Foundation of China [31300648]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the grants from National Natural Science Foundation of China (Grant NO. 31300648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasadi K, 2011, OPEN CARDIOVASC MED, V5, P203, DOI 10.2174/1874192401105010203; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 1999, CIRCULATION, V99, P736, DOI 10.1161/01.CIR.99.6.736; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Chapman MJ, 2004, CURR MED RES OPIN, V20, P1253, DOI 10.1185/030079904125004402; Chenevard R, 2012, CARDIOVASC THER, V30, pe51, DOI 10.1111/j.1755-5922.2010.00221.x; CHEUNG MC, 1991, J LIPID RES, V32, P383; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hausenloy DJ, 2008, HEART, V94, P706, DOI 10.1136/hrt.2007.125401; HESLER CB, 1987, J BIOL CHEM, V262, P2275; Hovingh GK, 2005, CIRCULATION, V112, P879, DOI 10.1161/CIRCULATIONAHA.105.540427; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 2002, AM J CARDIOL, V90, P139, DOI 10.1016/S0002-9149(02)02436-0; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; WU X, 1999, CHIN J ARTERIOSCLER, V7, P253; Xu YH, 2003, CLIN CHIM ACTA, V332, P95, DOI 10.1016/S0009-8981(03)00138-4; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zambon A, 1998, ARTERIOSCL THROM VAS, V18, P1723, DOI 10.1161/01.ATV.18.11.1723	26	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85114	10.1371/journal.pone.0085114	http://dx.doi.org/10.1371/journal.pone.0085114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465490	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000012
J	Chong, Y; Shimoda, S; Yakushiji, H; Ito, Y; Aoki, T; Miyamoto, T; Kamimura, T; Shimono, N; Akashi, K				Chong, Yong; Shimoda, Shinji; Yakushiji, Hiroko; Ito, Yoshikiyo; Aoki, Takatoshi; Miyamoto, Toshihiro; Kamimura, Tomohiko; Shimono, Nobuyuki; Akashi, Koichi			Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis	PLOS ONE			English	Article							FEBRILE NEUTROPENIA; CANCER-PATIENTS; CIPROFLOXACIN PROPHYLAXIS; ANTIBIOTIC-PROPHYLAXIS; KLEBSIELLA-PNEUMONIAE; SPECTRUM; INFECTION; TRANSPLANTATION; CHEMOTHERAPY; NORFLOXACIN	Background: Fluoroquinolone prophylaxis in patients with neutropenia and hematological malignancies is said to be effective on febrile netropenia (FN)-related infection and mortality; however, the emergence of antibiotic resistance has become a concern. Ciprofloxacin and levofloxacin prophylaxis are most commonly recommended. A significant increase in the rate of quinolone-resistant Escherichia coli in fecal flora has been reported following ciprofloxacin prophylaxis. The acquisition of quinolone-resistant E. coli after levofloxacin use has not been evaluated. Methods: We prospectively examined the incidence of quinolone-resistant E. coli isolates recovered from stool cultures before and after levofloxacin prophylaxis in patients with neutropenia from August 2011 to May 2013. Some patients received chemotherapy multiple times. Results: In this trial, 68 patients were registered. Levofloxacin-resistant E. coli isolates were detected from 11 and 13 of all patients before and after the prophylaxis, respectively. However, this was not statistically significant (P = 0.65). Multiple prophylaxis for sequential chemotherapy did not induce additional quinolone resistance among E. coli isolates. Interestingly, quinolone-resistant E. coli, most of which were extended-spectrum beta-lactamase (ESBL) producers, were already detected in approximately 20% of all patients before the initiation of prophylaxis. FN-related bacteremia developed in 2 patients, accompanied by a good prognosis. Conclusions: Levofloxacin prophylaxis for neutropenia did not result in a significant acquisition of quinolone-resistant E. coli. However, we detected previous colonization of quinolone-resistant E. coli before prophylaxis, which possibly reflects the spread of ESBL. The epidemic spread of resistant E. coli as a local factor may influence strategies toward the use of quinolone prophylaxis.	[Chong, Yong; Shimoda, Shinji; Miyamoto, Toshihiro; Akashi, Koichi] Kyushu Univ Grad Sch Med Sci, Fukuoka, Japan; [Yakushiji, Hiroko] Hara Sanshin Hosp, Dept Clin Lab, Fukuoka, Japan; [Ito, Yoshikiyo; Aoki, Takatoshi; Kamimura, Tomohiko] Hara Sanshin Hosp, Dept Blood & Marrow Transplantat, Fukuoka, Japan; [Shimono, Nobuyuki] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 812, Japan	Kyushu University; Kyushu University	Chong, Y (corresponding author), Kyushu Univ Grad Sch Med Sci, Fukuoka, Japan.	ychong@gj9.so-net.ne.jp						Bow EJ, 2011, CURR OPIN INFECT DIS, V24, P545, DOI 10.1097/QCO.0b013e32834cf054; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; CARRATALA J, 1995, CLIN INFECT DIS, V20, P557, DOI 10.1093/clinids/20.3.557; Carratala J, 1996, ANTIMICROB AGENTS CH, V40, P503, DOI 10.1128/AAC.40.2.503; Chong Y, 2013, J MED MICROBIOL, V62, P1038, DOI 10.1099/jmm.0.059279-0; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Chong Y, 2011, INT J INFECT DIS, V15, pE277, DOI 10.1016/j.ijid.2010.12.010; COMETTA A, 1994, NEW ENGL J MED, V330, P1240, DOI 10.1056/NEJM199404283301717; Craig M, 2007, BONE MARROW TRANSPL, V39, P477, DOI 10.1038/sj.bmt.1705591; Cullen M, 2009, BRIT J CANCER, V101, pS11, DOI 10.1038/sj.bjc.6605270; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Gomez L, 2003, CANCER-AM CANCER SOC, V97, P419, DOI 10.1002/cncr.11044; Leibovici L, 2006, CANCER-AM CANCER SOC, V107, P1743, DOI 10.1002/cncr.22205; National Committee for Clinical Laboratory Standards, 2004, PERF STAND ANT SUS S; Ng EST, 2011, LEUKEMIA LYMPHOMA, V52, P131, DOI 10.3109/10428194.2010.518655; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Pascoe J, 2009, CURR OPIN HEMATOL, V16, P48, DOI 10.1097/MOH.0b013e32831ac543; Perea S, 1999, J ANTIMICROB CHEMOTH, V44, P117, DOI 10.1093/jac/44.1.117; Ramphal R, 2004, CLIN INFECT DIS, V39, pS25, DOI 10.1086/383048; Reuter S, 2005, CLIN INFECT DIS, V40, P1087, DOI 10.1086/428732; Saito T, 2008, EUR J CLIN MICROBIOL, V27, P209, DOI 10.1007/s10096-007-0428-8; Sohn BS, 2012, EUR J CLIN MICROBIOL, V31, P1653, DOI 10.1007/s10096-011-1489-2; Viscoli C, 2002, CURR OPIN INFECT DIS, V15, P377, DOI 10.1097/00001432-200208000-00004	25	17	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85210	10.1371/journal.pone.0085210	http://dx.doi.org/10.1371/journal.pone.0085210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465506	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100026
J	McDaniel, PA; Malone, RE				McDaniel, Patricia A.; Malone, Ruth E.			"People over Profits'': Retailers Who Voluntarily Ended Tobacco Sales	PLOS ONE			English	Article							OUTLET DENSITY; SCHOOL NEIGHBORHOODS; SMOKING; ASSOCIATION; YOUTH; DISPLAYS; PRODUCTS; DEMOGRAPHICS; PERCEPTIONS; PHARMACIES	Background: Tobacco retailers are key players in the ongoing tobacco epidemic. Tobacco outlet density is linked to a greater likelihood of youth and adult smoking and greater difficulty quitting. While public policy efforts to address the tobacco problem at the retail level have been limited, some retailers have voluntarily ended tobacco sales. A previous pilot study examined this phenomenon in California, a state with a strong tobacco program focused on denormalizing smoking and the tobacco industry. We sought to learn what motivated retailers in other states to end tobacco sales and how the public and media responded. Methods: We conducted interviews with owners, managers, or representatives of six grocery stores in New York and Ohio that had voluntarily ended tobacco sales since 2007. We also conducted unobtrusive observations at stores and analyzed media coverage of each retailer's decision. Results: Grocery store owners ended tobacco sales for two reasons, alone or in combination: health or ethics-related, including a desire to send a consistent health message to employees and customers, and business-related, including declining tobacco sales or poor fit with the store's image. The decision to end sales often appeared to resolve troubling contradictions between retailers' values and selling deadly products. New York retailers attributed declining sales to high state tobacco taxes. All reported largely positive customer reactions and most received media coverage. Forty-one percent of news items were letters to the editor or editorials; most (69%) supported the decision. Conclusion: Voluntary decisions by retailers to abandon tobacco sales may lay the groundwork for mandatory policies and further denormalize tobacco. Our study also suggests that high tobacco taxes may have both direct and indirect effects on tobacco use. Highlighting the contradictions between being a responsible business and selling deadly products may support voluntary decisions by retailers to end tobacco sales.	[McDaniel, Patricia A.; Malone, Ruth E.] Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	McDaniel, PA (corresponding author), Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA.	patricia.mcdaniel@ucsf.edu		McDaniel, Patricia A/0000-0002-2750-4124	National Cancer Institute [R01 CA143076]; NATIONAL CANCER INSTITUTE [R01CA143076] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the National Cancer Institute, grant # R01 CA143076 (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2013, J SCHOOL HEALTH, V83, P112, DOI 10.1111/josh.12006; [Anonymous], 2008, EDITORIAL ED BEST WA; [Anonymous], 2008, BUFFALO NEWS, pA6; [Anonymous], 2013, AM NONSM RIGHTS; Berrick AJ, 2013, TOB CONTROL, V22, P22, DOI 10.1136/tobaccocontrol-2012-050865; Burton S, 2012, ADDICTION, V107, P169, DOI 10.1111/j.1360-0443.2011.03584.x; California Department of Public Health, 2012, HLTH RET HLTH COMM I; Campaign for Tobacco-Free Kids, 2013, TOP COMB STAT LOC CI; Center for Public Health and Tobacco Policy, 2011, TOB RET LIC FEES; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chapman S, 2009, TOB CONTROL, V18, P496, DOI 10.1136/tc.2009.031724; Daynard RA, 2009, TOB CONTROL, V18, P2, DOI 10.1136/tc.2008.028308; Eshelman N, 2008, HARRISBURG PATRIOT N; Eule B, 2004, TOB CONTROL, V13, P429, DOI 10.1136/tc.2004.007872; Federation of Tax Administrators, 2013, CIG TAX INCR 2000 20; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Halonen JI, 2014, TOB CONTROL, V23, P146, DOI 10.1136/tobaccocontrol-2012-050726; Hartocollis A, 2013, NY TIMES, pA21; Henriksen L, 2004, AM J PUBLIC HEALTH, V94, P2081, DOI 10.2105/AJPH.94.12.2081; Henriksen L, 2002, J APPL SOC PSYCHOL, V32, P1771, DOI 10.1111/j.1559-1816.2002.tb00258.x; Henriksen L, 2008, PREV MED, V47, P210, DOI 10.1016/j.ypmed.2008.04.008; Hoek J, 2012, TOB CONTROL, V21, P497, DOI 10.1136/tc.2011.043687; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hyland A, 2003, AM J PUBLIC HEALTH, V93, P1075, DOI 10.2105/AJPH.93.7.1075; Institute of Medicine, 2007, ENDING TOBACCO PROBL; JACOBSON PD, 1993, J HEALTH POLIT POLIC, V18, P787; Khoo D, 2010, TOB CONTROL, V19, P355, DOI 10.1136/tc.2009.031153; Kroon LA, 2013, TOB CONTROL, V22, P369, DOI 10.1136/tobaccocontrol-2012-050602; Lipperman-Kreda S, 2012, J ADOLESCENT HEALTH, V50, P547, DOI 10.1016/j.jadohealth.2011.08.015; Loomis BR, 2013, PUBLIC HEALTH, V127, P333, DOI 10.1016/j.puhe.2013.01.013; Lovato CY, 2007, CAN J PUBLIC HEALTH, V98, P265, DOI 10.1007/BF03405400; Malone RE, 2013, TOB CONTROL, V22, P42, DOI 10.1136/tobaccocontrol-2012-050820; Marsh L, 2013, HEALTH PLACE, V23, P165, DOI 10.1016/j.healthplace.2013.07.003; McCormick R, 2009, CIGARETTE VENDORS HI; McDaniel PA, 2013, AM J PUBLIC IN PRESS; McDaniel PA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-848; Menashe CL, 1998, J HEALTH COMMUN, V3, P307, DOI 10.1080/108107398127139; New York State Liquor Authority Division of Alcoholic Beverage Control, 2013, HDB RET LIC; Novak SP, 2006, AM J PUBLIC HEALTH, V96, P670, DOI 10.2105/AJPH.2004.061622; O'Connell J, 2013, METROWEST DAILY NEWS; O'Connell ME, 2008, DECISION DESERVES PR, pA8; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Patwardhan Pallavi, 2013, BMC Res Notes, V6, P261, DOI 10.1186/1756-0500-6-261; Proctor RN, 2013, TOB CONTROL, V22, P27, DOI 10.1136/tobaccocontrol-2012-050811; QSR International, 2010, NVIVO QUAL DAT AN SO; Reid Robert J, 2013, J Ethn Subst Abuse, V12, P197, DOI 10.1080/15332640.2013.798750; Reitzel LR, 2011, AM J PUBLIC HEALTH, V101, P315, DOI 10.2105/AJPH.2010.191676; Rivers T, 2008, BATAVIA DAILY NEWS, p4A; Rodriguez D, 2013, TOB CONTROL, V22, P349, DOI 10.1136/tobaccocontrol-2011-050120; Schmitt CL, 2014, AM J HEALTH PROMOT, V28, P175, DOI 10.4278/ajhp.121023-QUAN-514; Schneider JE, 2005, PREV SCI, V6, P319, DOI 10.1007/s11121-005-0016-z; Seidenberg AB, 2013, TOB CONTROL, V22, P372, DOI 10.1136/tobaccocontrol-2012-050591; Slater SJ, 2007, ARCH PEDIAT ADOL MED, V161, P440, DOI 10.1001/archpedi.161.5.440; Summit County Fiscal Office, 2013, CIG LIC; The New York State Department of Taxation and Finance, 2012, CIG TOB PROD TAX; Wakefield M, 2008, ADDICTION, V103, P322, DOI 10.1111/j.1360-0443.2007.02062.x; Wicked Local Brookline, 2013, BUY SOM SMOK MIN AG; Wiles T, 2013, YOUTH GROUP DRAFTS P; Yu D, 2010, PUBLIC HEALTH, V124, P412, DOI 10.1016/j.puhe.2010.03.024	59	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85751	10.1371/journal.pone.0085751	http://dx.doi.org/10.1371/journal.pone.0085751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465682	Green Published, gold			2022-12-27	WOS:000330283100070
J	Pereira, NL; Redfield, MM; Scott, C; Tosakulwong, N; Olson, TM; Bailey, KR; Rodeheffer, RJ; Burnett, JC				Pereira, Naveen L.; Redfield, Margaret M.; Scott, Christopher; Tosakulwong, Nirubol; Olson, Timothy M.; Bailey, Kent R.; Rodeheffer, Richard J.; Burnett, John C., Jr.			A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction Study	PLOS ONE			English	Article							BLOOD-PRESSURE; HEART-FAILURE; GENERAL COMMUNITY; HYPERTENSION; POPULATION; ECHOCARDIOGRAPHY; HYPERTROPHY; ACTIVATION; SYSTEM; IMPACT	Objectives: To evaluate the impact of a functional genetic variant in the natriuretic peptide clearance receptor, NPR3, on circulating natriuretic peptides (NPs) and myocardial structure and function in the general community. Background: NPR3 plays an important role in the clearance of NPs and through direct signaling mechanisms modulates smooth muscle cell function and cardiac fibroblast proliferation. A NPR3 nonsynonymous single nucleotide polymorphism (SNP) rs2270915, resulting in a N521D substitution in the intracellular catalytic domain that interacts with Gi could affect receptor function. Whether this SNP is associated with alterations in NPs levels and altered cardiac structure and function is unknown. Methods: DNA samples of 1931 randomly selected residents of Olmsted County, Minnesota were genotyped. Plasma NT-proANP(1-98), ANP(1-28), proBNP(1-108), NT-proBNP(1-76), BNP1-32 and BNP3-32 levels were measured. All subjects underwent comprehensive echocardiography. Results: Genotype frequencies for rs2270915 were as follows: (A/A 60%, A/G 36%, G/G 4%). All analyses performed were for homozygotes G/G versus wild type A/A plus the heterozygotes A/G. Diastolic dysfunction was significantly more common (p = 0.007) in the homozygotes G/G (43%) than the A/A+A/G (28%) group. Multivariate regression adjusted for age, sex, body mass index and hypertension demonstrated rs2270915 to be independently associated with diastolic dysfunction (odds ratio 1.94, p = 0.03). There was no significant difference in NPs levels between the 2 groups suggesting that the clearance function of the receptor was not affected. Conclusions: A nonsynonymous NPR3 SNP is independently associated with diastolic dysfunction and this association does not appear to be related to alterations in circulating levels of natriuretic peptides.	[Pereira, Naveen L.; Redfield, Margaret M.; Olson, Timothy M.; Rodeheffer, Richard J.; Burnett, John C., Jr.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Pereira, Naveen L.; Redfield, Margaret M.; Olson, Timothy M.; Rodeheffer, Richard J.; Burnett, John C., Jr.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Scott, Christopher; Bailey, Kent R.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Tosakulwong, Nirubol] Mayo Clin, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pereira, NL (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	pereira.naveen@mayo.edu		Olson, Timothy/0000-0003-2716-9423	CTSA from the National Center for Advancing Translational Sciences [UL1 TR000135]; Pharmacogenomics Research Network [U19 GM61388];  [RO1 HL36634];  [PO1 HL76611]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036634, U10HL110262, P01HL076611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER	CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Pharmacogenomics Research Network; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by CTSA Grant Number UL1 TR000135 (NLP) from the National Center for Advancing Translational Sciences, U19 GM61388 (The Pharmacogenomics Research Network) and RO1 HL36634 (JCB) and PO1 HL76611 (JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Cannone V, 2011, J AM COLL CARDIOL, V58, P629, DOI 10.1016/j.jacc.2011.05.011; Cataliotti A, 2005, CIRCULATION, V112, P836, DOI 10.1161/CIRCULATIONAHA.105.538520; Charles CJ, 1996, AM J PHYSIOL-REG I, V271, pR373, DOI 10.1152/ajpregu.1996.271.2.R373; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; Cheung BMY, 1997, CLIN EXP PHARMACOL P, V24, P966, DOI 10.1111/j.1440-1681.1997.tb02729.x; Costello-Boerrigter LC, 2006, J AM COLL CARDIOL, V47, P345, DOI 10.1016/j.jacc.2005.09.025; Giuliani I, 2006, CLIN CHEM, V52, P1054, DOI 10.1373/clinchem.2005.061770; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Huntley BK, 2006, J CELL PHYSIOL, V209, P943, DOI 10.1002/jcp.20793; KOHNO M, 1992, AM J MED, V92, P29, DOI 10.1016/0002-9343(92)90011-Y; LEVY D, 1987, AM J CARDIOL, V59, P956, DOI 10.1016/0002-9149(87)91133-7; Liu Y, 2012, CLIN EXP HYPERTENS, V34, P504, DOI 10.3109/10641963.2012.681719; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; Mouawad R, 2004, MOL PHARMACOL, V65, P917, DOI 10.1124/mol.65.4.917; Munagala VK, 2004, CURR PROB CARDIOLOGY, V29, P707, DOI 10.1016/j.cpcardiol.2004.07.002; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pereira NL, 2013, CIRC-CARDIOVASC GENE, V6, P201, DOI 10.1161/CIRCGENETICS.112.964742; Pereira NL, 2010, J MOL CELL CARDIOL, V49, P864, DOI 10.1016/j.yjmcc.2010.07.020; Prins B A, 1996, Curr Opin Nephrol Hypertens, V5, P170, DOI 10.1097/00041552-199603000-00013; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; Sarzani R, 1999, J HYPERTENS, V17, P1301, DOI 10.1097/00004872-199917090-00010; Saulnier PJ, 2011, DIABETES CARE, V34, P1199, DOI 10.2337/dc10-2057; SHUB C, 1994, MAYO CLIN PROC, V69, P205, DOI 10.1016/S0025-6196(12)61058-1; Yamamoto K, 1997, AM J PHYSIOL-HEART C, V273, pH2406, DOI 10.1152/ajpheart.1997.273.5.H2406	33	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85708	10.1371/journal.pone.0085708	http://dx.doi.org/10.1371/journal.pone.0085708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465655	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100063
J	Sharma, M; Singh, SB; Sarkar, S				Sharma, Manish; Singh, Shashi Bala; Sarkar, Soma			Genome Wide Expression Analysis Suggests Perturbation of Vascular Homeostasis during High Altitude Pulmonary Edema	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; EXHALED NITRIC-OXIDE; GENE-EXPRESSION; STRESS FAILURE; BRONCHOALVEOLAR LAVAGE; MODERATE ALTITUDE; RECEPTOR; LUNG; RATS; HYPERTENSION	Background: High altitude pulmonary edema (HAPE) is a life-threatening form of non-cardiogenic edema which occurs in unacclimatized but otherwise normal individuals within two to four days after rapid ascent to altitude beyond 3000 m. The precise pathoetiology and inciting mechanisms regulating HAPE remain unclear. Methodology/Principle findings: We performed global gene expression profiling in individuals with established HAPE compared to acclimatized individuals. Our data suggests concurrent modulation of multiple pathways which regulate vascular homeostasis and consequently lung fluid dynamics. These pathways included those which regulate vasoconstriction through smooth muscle contraction, cellular actin cytoskeleton rearrangements and endothelial permeability/dysfunction. Some notable genes within these pathways included MYLK; rho family members ARGEF11, ARHGAP24; cell adhesion molecules such as CLDN6, CLDN23, PXN and VCAM1 besides other signaling intermediates. Further, several important regulators of systemic/pulmonary hypertension including ADRA1D, ECE1, and EDNRA were upregulated in HAPE. We also observed significant upregulation of genes involved in paracrine signaling through chemokines and lymphocyte activation pathways during HAPE represented by transcripts of TNF, JAK2, MAP2K2, MAP2K7, MAPK10, PLCB1, ARAF, SOS1, PAK3 and RELA amongst others. Perturbation of such pathways can potentially skew vascular homeostatic equilibrium towards altered vascular permeability. Additionally, differential regulation of hypoxia-sensing, hypoxia-response and OXPHOS pathway genes in individuals with HAPE were also observed. Conclusions/Significance: Our data reveals specific components of the complex molecular circuitry underlying HAPE. We show concurrent perturbation of multiple pathways regulating vascular homeostasis and suggest multi-genic nature of regulation of HAPE.	[Sharma, Manish; Singh, Shashi Bala; Sarkar, Soma] DRDO, Def Inst Physiol & Allied Sci DIPAS, Div Mol Biol, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Sarkar, S (corresponding author), DRDO, Def Inst Physiol & Allied Sci DIPAS, Div Mol Biol, Delhi, India.	soma_sarkar2000@yahoo.com	Singh, Shashi Bala/AAS-9889-2021		Defence Research and Development Organization, India [ST-PI-05/DIP-247]	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO))	Defence Research and Development Organization, India financially supported under the institutional project: Grant No. ST-PI-05/DIP-247 to Soma Sarkar. The funding agency had no role in study design, data collection, analysis, decision to publish or preparation of manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Bartsch P, 1997, RESPIRATION, V64, P435; Bartsch P, 1999, MED SCI SPORT EXER, V31, pS23; BONVALLET ST, 1994, AM J PHYSIOL, V266, pH1327, DOI 10.1152/ajpheart.1994.266.4.H1327; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Carpenter TC, 2000, AM J PHYSIOL-LUNG C, V279, pL547, DOI 10.1152/ajplung.2000.279.3.L547; Charu R, 2006, THORAX, V61, P1011, DOI 10.1136/thx.2006.066019; Chen SJ, 1997, J CARDIOVASC PHARM, V29, P713, DOI 10.1097/00005344-199706000-00003; Dehnert C, 2006, AM J RESP CRIT CARE, V174, P1132, DOI 10.1164/rccm.200606-780OC; Duplain H, 2000, AM J RESP CRIT CARE, V162, P221, DOI 10.1164/ajrccm.162.1.9908039; Durmowicz AG, 1997, J PEDIATR-US, V130, P838, DOI 10.1016/S0022-3476(97)80033-9; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Gabri AL, 2003, CHEST, V123, P49, DOI 10.1378/chest.123.1.49; Ganfornina MD, 2005, J PHYSIOL-LONDON, V566, P491, DOI 10.1113/jphysiol.2005.088815; GRISSOM C, 2006, RESP EMERGENCIES, P253; Grocott M, 2008, HIGH ALT MED BIOL, V9, P123, DOI 10.1089/ham.2008.1012; Grunig E, 2000, CIRCULATION, V102, P1145, DOI 10.1161/01.CIR.102.10.1145; Hackett P, 2002, JAMA-J AM MED ASSOC, V287, P2275, DOI 10.1001/jama.287.17.2275; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hopkins SR, 2010, EUR RESPIR J, V35, P470, DOI 10.1183/09031936.00178709; Hopkins SR, 2005, AM J RESP CRIT CARE, V171, P83, DOI 10.1164/rccm.200406-707OC; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji Y, 2007, P NATL ACAD SCI USA, V104, P8839, DOI 10.1073/pnas.0611416104; Katoh M, 2004, INT J MOL MED, V14, P333; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Kubo K, 1996, THORAX, V51, P739, DOI 10.1136/thx.51.7.739; LI H, 1994, AM J PHYSIOL, V266, pL553, DOI 10.1152/ajplung.1994.266.5.L553; Maggiorini M, 2001, CIRCULATION, V103, P2078; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ran Yu-Hua, 2011, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V27, P201; Ricci A, 1999, HYPERTENSION, V33, P708, DOI 10.1161/01.HYP.33.2.708; Sarkar S, 2012, IND J AEROSPACE MED, V56, P1; Sartori C, 1999, CIRCULATION, V99, P2665, DOI 10.1161/01.CIR.99.20.2665; Sartori C, 2010, PROG CARDIOVASC DIS, V52, P493, DOI 10.1016/j.pcad.2010.02.005; SCHMITZ JM, 1981, J PHARMACOL EXP THER, V219, P400; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; SCHOENE RB, 1988, J APPL PHYSIOL, V64, P2605, DOI 10.1152/jappl.1988.64.6.2605; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Shimoda LA, 2002, RESP PHYSIOL NEUROBI, V132, P93, DOI 10.1016/S1569-9048(02)00052-6; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Srivastava S, 2011, J RENIN-ANGIO-ALDO S, V13, P155; Stream JO, 2008, WILD ENVIRON MED, V19, P293, DOI 10.1580/07-WEME-REV-173.1; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; West JB, 2000, J APPL PHYSIOL, V89, P2483, DOI 10.1152/jappl.2000.89.6.2483; WEST JB, 1995, EUR RESPIR J, V8, P523; WEST JB, 1992, INT J SPORTS MED, V13, pS54, DOI 10.1055/s-2007-1024594; WHAYNE TF, 1968, J APPL PHYSIOL, V25, P729, DOI 10.1152/jappl.1968.25.6.729; WOODMAN OL, 1987, AM J PHYSIOL, V253, pH388, DOI 10.1152/ajpheart.1987.253.2.H388; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; ZHAO Y, 1993, AM J PHYSIOL, V265, pL87	55	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85902	10.1371/journal.pone.0085902	http://dx.doi.org/10.1371/journal.pone.0085902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465776	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100088
J	Cheah, KY; Howarth, GS; Bastian, SEP				Cheah, Ker Yeaw; Howarth, Gordon Stanley; Bastian, Susan Elaine Putnam			Grape Seed Extract Dose-Responsively Decreases Disease Severity in a Rat Model of Mucositis; Concomitantly Enhancing Chemotherapeutic Effectiveness in Colon Cancer Cells	PLOS ONE			English	Article							SMALL-INTESTINAL MUCOSITIS; PROANTHOCYANIDIN EXTRACT; LINE CACO-2; BREATH TEST; 5-FLUOROURACIL; APOPTOSIS; EXPRESSION; GROWTH; METHOTREXATE; INFLAMMATION	Objective: Mucositis is a serious disorder of the gastrointestinal tract that results from cancer chemotherapy. We investigated the effects of increasing grape seed extract doses on the severity of chemotherapy in a rat model and its coincident impact on chemotherapeutic effectiveness in colon cancer cells. Design: Female Dark Agouti rats were gavaged with grape seed extract (400-1000 mg/kg) or water (day 3-11) and were injected intraperitoneally with 5-Fluorouracil (150 mg/kg) or saline (control) on day 9 to induce mucositis. Daily metabolic data were collected and rats were sacrificed on day 12. Intestinal tissues were collected for histological and myeloperoxidase analyses. Caco-2 cell viability was examined in response to grape seed extract in combination with 5-Fluorouracil by 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide) assay. Results: Compared with 5-Fluorouracil controls, grape seed extract (400-1000 mg/kg) significantly decreased the histological damage score (P<0.05) in the jejunum. Grape seed extract (1000 mg/kg) increased jejunal crypt depth by 25% (P<0.05) in 5-Fluorouracil treated rats compared to 5-Fluorouracil controls, and attenuated the 5-Fluorouracil -induced reduction of mucosal thickness (25%, P<0.05). Grape seed extract (600 mg/kg) decreased myeloperoxidase activity by 55% (P<0.01) compared to 5-Fluorouracil controls. Grape seed extract was more effective at ameliorating 5-Fluorouracil induced intestinal injury, with effects most pronounced in the proximal jejunum. Grape seed extract (10-25 ug/mL) significantly enhanced the growth-inhibitory effects of 5-Fluorouracil by 26% (P<0.05) in Caco-2 cells and was more potent than 5-Fluorouracil at 50-100 mu g/mL. Conclusion: Grape seed extract may represent a new therapeutic option to decrease the symptoms of intestinal mucositis while concurrently impacting on the viability of colon cancer cells.	[Cheah, Ker Yeaw; Bastian, Susan Elaine Putnam] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA 5005, Australia; [Cheah, Ker Yeaw; Howarth, Gordon Stanley] Children Youth & Womens Hlth Serv, Ctr Paediat & Adolescent Gastroenterol, Adelaide, SA, Australia; [Howarth, Gordon Stanley] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide	Bastian, SEP (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Adelaide, SA 5005, Australia.	sue.bastian@adelaide.edu.au	Howarth, Gordon/AAM-8699-2020	Howarth, Gordon/0000-0001-6979-6084; Bastian, Susan/0000-0002-8790-2044	South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship; University of Adelaide	South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship; University of Adelaide	Professor Gordon Howarth is supported by a South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship. No financial agreements are in place. This research was supported by The University of Adelaide, being a member of the Wine Innovation Cluster, Waite Campus, Adelaide, South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2002, CARCINOGENESIS, V23, P1869, DOI 10.1093/carcin/23.11.1869; Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P1084, DOI 10.1021/jf803059z; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bindon KA, 2010, J AGR FOOD CHEM, V58, P2520, DOI 10.1021/jf9037453; Bowen JM, 2007, CANCER CHEMOTH PHARM, V59, P337, DOI 10.1007/s00280-006-0275-9; Cheah KY, 2013, DIGEST DIS SCI, V58, P970, DOI 10.1007/s10620-012-2464-1; Cheah KY, 2009, CANCER BIOL THER, V8, P382, DOI 10.4161/cbt.8.4.7453; Cho ML, 2009, IMMUNOL LETT, V124, P102, DOI 10.1016/j.imlet.2009.05.001; D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348; Dinicola S, 2010, BRIT J NUTR, V104, P824, DOI 10.1017/S0007114510001522; Duncan M, 2003, ALIMENT PHARM THER, V18, P853, DOI 10.1046/j.1365-2036.2003.01784.x; Engelbrecht AM, 2007, CANCER LETT, V258, P144, DOI 10.1016/j.canlet.2007.08.020; Fine A M, 2000, Altern Med Rev, V5, P144; Fishbein AB, 2009, ARCH PHARM RES, V32, P505, DOI 10.1007/s12272-009-1405-9; GLICK Z, 1970, J NUTR, V100, P509, DOI 10.1093/jn/100.5.509; Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613; Howarth GS, 1996, J NUTR, V126, P2519, DOI 10.1093/jn/126.10.2519; Hsu CP, 2009, ANTICANCER RES, V29, P283; Huynh-Delerme C, 2005, TOXICOL IN VITRO, V19, P439, DOI 10.1016/j.tiv.2004.08.003; Jordan A, 2003, EUR J NUTR, V42, P324, DOI 10.1007/s00394-003-0427-1; Keefe DM, 2008, EXPERT OPIN EMERG DR, V13, P511, DOI 10.1517/14728214.13.3.511 ; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Li WG, 2001, ACTA PHARMACOL SIN, V22, P1117; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mauger CA, 2007, DIGEST DIS SCI, V52, P612, DOI 10.1007/s10620-006-9464-y; Pelton NS, 2004, SCAND J GASTROENTERO, V39, P1015, DOI 10.1080/00365520410003416; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Stringer Andrea M, 2007, J Support Oncol, V5, P259; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; TOMAS FM, 1991, BIOCHEM J, V276, P547, DOI 10.1042/bj2760547; Tooley KL, 2006, CANCER BIOL THER, V5, P1275, DOI 10.4161/cbt.5.10.3303; Tsang C, 2005, BRIT J NUTR, V94, P170, DOI 10.1079/BJN20051480; Urpi-Sarda M, 2009, ANAL BIOANAL CHEM, V394, P1545, DOI 10.1007/s00216-009-2676-1; Watanabe H, 2013, MED MOL MORPHOL, V46, P97, DOI 10.1007/s00795-013-0012-5; Wren AF, 2002, J AGR FOOD CHEM, V50, P2180, DOI 10.1021/jf011066w; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6	44	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85184	10.1371/journal.pone.0085184	http://dx.doi.org/10.1371/journal.pone.0085184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465501	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500041
J	Chen, L; Ye, HL; Zhang, G; Yao, WM; Chen, XZ; Zhang, FC; Liang, G				Chen, Li; Ye, Hui-Lan; Zhang, Guo; Yao, Wen-Min; Chen, Xing-Zhou; Zhang, Fa-Can; Liang, Gang			Autophagy Inhibition Contributes to the Synergistic Interaction between EGCG and Doxorubicin to Kill the Hepatoma Hep3B Cells	PLOS ONE			English	Article							INDUCED DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; CANCER; KINASE; DEATH; RESISTANCE; RISK; SORAFENIB; GALLATE	(-)-Epigallocatechin-3-O-gallate(EGCG), the highest catechins from green tea, has promisingly been found to sensitize the efficacy of several chemotherapy agents like doxorubicin (DOX) in hepatocellular carcinoma (HCC) treatment. However, the detailed mechanisms by which EGCG augments the chemotherapeutic efficacy remain unclear. Herein, this study was designed to determine the synergistic impacts of EGCG and DOX on hepatoma cells and particularly to reveal whether the autophagic flux is involved in this combination strategy for the HCC. Electron microscopy and fluorescent microscopy confirmed that DOX significantly increased autophagic vesicles in hepatoma Hep3B cells. Western blot and trypan blue assay showed that the increasing autophagy flux by DOX impaired about 45% of DOX-induced cell death in these cells. Conversely, both qRT-PCR and western blotting showed that EGCG played dose-dependently inhibitory role in autophagy signaling, and that markedly promoted cellular growth inhibition. Amazingly, the combined treatment caused a synergistic effect with 40 to 60% increment on cell death and about 45% augmentation on apoptosis versus monotherapy pattern. The DOX-induced autophagy was abolished by this combination therapy. Rapamycin, an autophagic agonist, substantially impaired the anticancer effect of either DOX or combination with EGCG treatment. On the other hand, using small interference RNA targeting chloroquine autophagy-related gene Atg5 and beclin1 to inhibit autophagy signal, hepatoma cell death was dramatically enhanced. Furthermore, in the established subcutaneous Hep3B cells xenograft tumor model, about 25% reduction in tumor growth as well as 50% increment of apoptotic cells were found in combination therapy compared with DOX alone. In addition, immunohistochemistry analysis indicated that the suppressed tendency of autophagic hallmark microtubule-associated protein light chain 3 (LC3) expressions was consistent with thus combined usage in vitro. Taken together, the current study suggested that EGCG emerges as a chemotherapeutic augmenter and synergistically enhances DOX anticancer effects involving autophagy inhibition in HCC.	[Chen, Li] Guangxi Med Univ, Affiliated Hosp 1, New Drug Res & Dev Ctr, Nanning, Guangxi, Peoples R China; [Chen, Li; Ye, Hui-Lan; Zhang, Guo; Yao, Wen-Min; Chen, Xing-Zhou; Zhang, Fa-Can] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastroenterol, Nanning, Guangxi, Peoples R China; [Chen, Li; Liang, Gang] Guangxi Med Univ, Sch Pharm, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhang, G (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastroenterol, Nanning, Guangxi, Peoples R China.	zhangguogx@hotmail.com	Zhang, Guo/AAG-4155-2020; ZHANG, GUO/D-2556-2014		National Natural Science Foundation of China [81172260, 30960145, 81102495]; Guangxi Natural Science Foundation [2010GXNSFC013020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by grants from the National Natural Science Foundation of China (no. 81172260; 30960145 to GZ and no. 81102495 to LC) and Guangxi Natural Science Foundation (2010GXNSFC013020 to GZ). The URL of website is http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, PHYTOMEDICINE, V17, P902, DOI 10.1016/j.phymed.2010.03.008; Bhutia SK, 2013, ADV CANCER RES, V118, P61, DOI 10.1016/B978-0-12-407173-5.00003-0; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Choi JH, 2012, APMIS, V120, P597, DOI 10.1111/j.1600-0463.2012.02876.x; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Escalante AM, 2013, CANCER CHEMOTH PHARM, V71, P1567, DOI 10.1007/s00280-013-2156-3; Gluer AM, 2012, HPB, V14, P285, DOI 10.1111/j.1477-2574.2012.00446.x; Gong H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054198; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hashimoto K, 2008, ANTICANCER RES, V28, P1713; He W, 2013, ONCOGENE; Humbert M, 2013, BIOCHEM BIOPH RES CO, V431, P264, DOI 10.1016/j.bbrc.2012.12.120; Ca H, 2012, ANTICANCER RES, V32, P1379; Kang R, 2012, AM J CANCER RES, V2, P383; Kuo PL, 2003, J BIOMED SCI, V10, P219, DOI 10.1159/000068711; Kurahashi N, 2008, AM J EPIDEMIOL, V167, P71, DOI 10.1093/aje/kwm249; Lee AJX, 2012, J PATHOL, V226, P482, DOI 10.1002/path.2998; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Liang G, 2010, INT J ONCOL, V37, P111, DOI 10.3892/ijo_00000659; Lin SB, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-3; Liu FF, 2013, ONCOL LETT, V5, P1261, DOI 10.3892/ol.2013.1154; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Manov I, 2011, FEBS J, V278, P3494, DOI 10.1111/j.1742-4658.2011.08271.x; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Pan YZ, 2011, CLIN CANCER RES, V17, P3248, DOI 10.1158/1078-0432.CCR-10-0890; Schramm Laura, 2013, J Carcinog Mutagen, V4, P1000142; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Shimizu M, 2008, CANCER EPIDEM BIOMAR, V17, P3020, DOI 10.1158/1055-9965.EPI-08-0528; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Stelton CR, 2013, CLIN RHEUMATOL, V32, P895, DOI 10.1007/s10067-013-2226-2; Sul YH, 2013, BIOL PHARM BULL, V36, P158, DOI 10.1248/bpb.b12-00873; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Tu SH, 2011, MOL NUTR FOOD RES, V55, P455, DOI 10.1002/mnfr.201000254; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Xie BS, 2011, INT J MOL MED, V27, P599, DOI 10.3892/ijmm.2011.607; Xu N, 2012, BIOCHEM BIOPH RES CO, V423, P826, DOI 10.1016/j.bbrc.2012.06.048; Xu XM, 2012, J PHARMACOL EXP THER, V341, P183, DOI 10.1124/jpet.111.189589; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046749; Zheng J, 2011, EUR J PHARMACOL, V652, P82, DOI 10.1016/j.ejphar.2010.10.082; Zhu L, 2013, B CANC	49	82	85	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85771	10.1371/journal.pone.0085771	http://dx.doi.org/10.1371/journal.pone.0085771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465696	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500108
J	D'Adamo, S; Jinkerson, RE; Boyd, ES; Brown, SL; Baxter, BK; Peters, JW; Posewitz, MC				D'Adamo, Sarah; Jinkerson, Robert E.; Boyd, Eric S.; Brown, Susan L.; Baxter, Bonnie K.; Peters, John W.; Posewitz, Matthew C.			Evolutionary and Biotechnological Implications of Robust Hydrogenase Activity in Halophilic Strains of Tetraselmis	PLOS ONE			English	Article							ANAEROBIC ENERGY-METABOLISM; CHLAMYDOMONAS-REINHARDTII; GREEN-ALGA; MICROBIAL MATS; H-2 PRODUCTION; DUNALIELLA; EXPRESSION; DIVERSITY; PROTEIN; MICROORGANISMS	Although significant advances in H-2 photoproduction have recently been realized in fresh water algae (e.g. Chlamydomonas reinhardtii), relatively few studies have focused on H-2 production and hydrogenase adaptations in marine or halophilic algae. Salt water organisms likely offer several advantages for biotechnological H-2 production due to the global abundance of salt water, decreased H-2 and O-2 solubility in saline and hypersaline systems, and the ability of extracellular NaCl levels to influence metabolism. We screened unialgal isolates obtained from hypersaline ecosystems in the southwest United States and identified two distinct halophilic strains of the genus Tetraselmis (GSL1 and QNM1) that exhibit both robust fermentative and photo H-2-production activities. The influence of salinity (3.5%, 5.5% and 7.0% w/v NaCl) on H-2 production was examined during anoxic acclimation, with the greatest in vivo H-2-production rates observed at 7.0% NaCl. These Tetraselmis strains maintain robust hydrogenase activity even after 24 h of anoxic acclimation and show increased hydrogenase activity relative to C. reinhardtii after extended anoxia. Transcriptional analysis of Tetraselmis GSL1 enabled sequencing of the cDNA encoding the FeFe-hydrogenase structural enzyme (HYDA) and its maturation proteins (HYDE, HYDEF and HYDG). In contrast to freshwater Chlorophyceae, the halophilic Tetraselmis GSL1 strain likely encodes a single HYDA and two copies of HYDE, one of which is fused to HYDF. Phylogenetic analyses of HYDA and concatenated HYDA, HYDE, HYDF and HYDG in Tetraselmis GSL1 fill existing knowledge gaps in the evolution of algal hydrogenases and indicate that the algal hydrogenases sequenced to date are derived from a common ancestor. This is consistent with recent hypotheses that suggest fermentative metabolism in the majority of eukaryotes is derived from a common base set of enzymes that emerged early in eukaryotic evolution with subsequent losses in some organisms.	[D'Adamo, Sarah; Jinkerson, Robert E.; Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Boyd, Eric S.; Peters, John W.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Boyd, Eric S.; Peters, John W.] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA; [Brown, Susan L.] Univ Hawaii, Ctr Marine Microbial Ecol & Divers, Honolulu, HI 96822 USA; [Baxter, Bonnie K.] Westminster Coll, Dept Biol, Salt Lake City, UT USA; [Baxter, Bonnie K.] Westminster Coll, Great Salt Lake Inst, Salt Lake City, UT USA; [Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Colorado School of Mines; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Hawaii System; Montana State University System; Montana State University Bozeman	Posewitz, MC (corresponding author), Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA.	mposewit@mines.edu		Jinkerson, Robert/0000-0001-9399-1613; D'Adamo, Sarah/0000-0001-7654-941X; Peters, John/0000-0001-9117-9568	United States Air Force Office of Scientific Research [FA9550-11-1-0211, FA9550-11-1-0218]; Gordon and Betty Moore Foundation [2637]	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research is part of the United States Air Force Office of Scientific Research under Grant FA9550-11-1-0211 and FA9550-11-1-0218. For the transcriptome part this research was funded in part by the Gordon and Betty Moore Foundation through Grant #2637 to the National Center for Genome Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Narvaez-Zapata JA, 2011, BIOTECHNOL LETT, V33, P1021, DOI 10.1007/s10529-011-0523-x; Alkayal F, 2010, PLANT SCI, V179, P437, DOI 10.1016/j.plantsci.2010.07.001; Allakhverdiev SI, 2010, J PHOTOCH PHOTOBIO C, V11, P87; Ananyev G, 2008, APPL ENVIRON MICROB, V74, P6102, DOI 10.1128/AEM.01078-08; Antal TK, 2011, APPL MICROBIOL BIOT, V89, P3, DOI 10.1007/s00253-010-2879-6; Arakaki A, 2013, PHYTOCHEMISTRY, V85, P107, DOI 10.1016/j.phytochem.2012.09.006; Araujo GS, 2011, BIORESOURCE TECHNOL, V102, P5248, DOI 10.1016/j.biortech.2011.01.089; Arora M, 2013, EUR J PHYCOL, V48, P61, DOI 10.1080/09670262.2013.768357; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; Barz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013846; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Bhosale SH, 2009, MICROBIOL RES, V164, P131, DOI 10.1016/j.micres.2006.11.006; Bondioli P, 2012, BIORESOURCE TECHNOL, V114, P567, DOI 10.1016/j.biortech.2012.02.123; Boyd ES, 2010, ISME J, V4, P1485, DOI 10.1038/ismej.2010.76; Boyd ES, 2009, APPL ENVIRON MICROB, V75, P4620, DOI 10.1128/AEM.00582-09; Brazelton WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00268; Burow LC, 2012, ISME J, V6, P863, DOI 10.1038/ismej.2011.142; Cai GQ, 2011, BIOTECHNOL ADV, V29, P375, DOI 10.1016/j.biotechadv.2011.02.001; Carballo-Cardenas EC, 2003, BIOMOL ENG, V20, P139, DOI 10.1016/S1389-0344(03)00040-6; Carrieri D, 2010, APPL ENVIRON MICROB, V76, P6455, DOI 10.1128/AEM.00975-10; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Chen H, 2011, SCI TOTAL ENVIRON, V409, P1291, DOI 10.1016/j.scitotenv.2010.12.038; Chen H, 2009, J CELL PHYSIOL, V219, P251, DOI 10.1002/jcp.21715; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou CJ, 2008, METAB ENG, V10, P394, DOI 10.1016/j.ymben.2008.06.007; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Elliott LG, 2012, ALGAL RES, V1, P102, DOI 10.1016/j.algal.2012.05.002; Eroglu E, 2011, BIORESOURCE TECHNOL, V102, P8403, DOI 10.1016/j.biortech.2011.03.026; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Fan F, 2011, PROCESS BIOCHEM, V46, P1212, DOI 10.1016/j.procbio.2011.02.005; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Greenbaum E, 1999, BIOHYDROGEN, V31, P235; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hoehler TM, 2002, ANTON LEEUW INT J G, V81, P575, DOI 10.1023/A:1020517924466; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Jahnke LS, 2003, J PLANT PHYSIOL, V160, P1193, DOI 10.1078/0176-1617-01068; Jenney Jr FE, 2008, ANN NY ACAD SCI, V1125, P1; Jinkerson RE, 2013, BIOENGINEERED, V4, P37, DOI 10.4161/bioe.21880; Jinkerson RE, 2011, BIOFUELS-UK, V2, P125, DOI [10.4155/BFS.11.7, 10.4155/bfs.11.7]; Kosourov SN, 2009, BIOTECHNOL BIOENG, V102, P50, DOI 10.1002/bit.22050; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lim DKY, 2012, PLOS ONE, P7; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Melis A, 2004, PHOTOSYNTH RES, V80, P401, DOI 10.1023/B:PRES.0000030421.31730.cb; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Meuser JE, 2013, MICROB ECOL; Meuser JE, 2012, BIOCHEM BIOPH RES CO, V417, P704, DOI 10.1016/j.bbrc.2011.12.002; Meuser JE, 2011, PLANTA, V234, P829, DOI 10.1007/s00425-011-1431-y; Meuser JE, 2009, J BIOTECHNOL, V142, P21, DOI 10.1016/j.jbiotec.2009.01.015; Montoya H., 2009, NATURAL RESOURCES EN, V15, P127; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; NEWMAN SM, 1990, GENETICS, V126, P875; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Peters J.W., 2013, ALGAE BIOFUELS ENERG, P37; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Posewitz MC, 2009, CHLAMYDOMONAS SOURCE, P217, DOI [10.1016/B978-0-12-370873, DOI 10.1016/B978-0-12-370873]; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; REED RH, 1986, FEMS MICROBIOL LETT, V39, P51; ROESSLER PG, 1984, PLANT PHYSIOL, V75, P705, DOI 10.1104/pp.75.3.705; Schwarz C, 2010, ADV EXP MED BIOL, V675, P305, DOI 10.1007/978-1-4419-1528-3_18; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Skjanes K, 2008, INT J HYDROGEN ENERG, V33, P511, DOI 10.1016/j.ijhydene.2007.09.040; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Srirangan K, 2011, BIORESOURCE TECHNOL, V102, P8589, DOI 10.1016/j.biortech.2011.03.087; Stern D. B., 2009, CHLAMYDOMONAS SOURCE, V2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; Whitney LAS, 2011, NEW PHYTOL, V190, P488, DOI 10.1111/j.1469-8137.2010.03503.x; Work VH, 2013, ENVIRON PROG SUSTAIN, V32, P989, DOI 10.1002/ep.11849; Xu D, 2013, BIORESOURCE TECHNOL, V127, P386, DOI 10.1016/j.biortech.2012.09.068; Yao CH, 2012, BIORESOURCE TECHNOL, V118, P438, DOI 10.1016/j.biortech.2012.05.030; ZINN T, 1994, Z NATURFORSCH C, V49, P33	88	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85812	10.1371/journal.pone.0085812	http://dx.doi.org/10.1371/journal.pone.0085812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465722	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500118
J	Nombela, C; Rittman, T; Robbins, TW; Rowe, JB				Nombela, Cristina; Rittman, Timothy; Robbins, Trevor W.; Rowe, James B.			Multiple Modes of Impulsivity in Parkinson's Disease	PLOS ONE			English	Article							ADDENBROOKES COGNITIVE EXAMINATION; PLATELET SEROTONIN TRANSPORTER; OBSESSIVE-COMPULSIVE DISORDER; INFERIOR FRONTAL GYRUS; DEEP BRAIN-STIMULATION; STOP-SIGNAL TASK; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINERGIC MODULATION; BEHAVIORAL-INHIBITION	Cognitive problems are a major factor determining quality of life of patients with Parkinson's disease. These include deficits in inhibitory control, ranging from subclinical alterations in decision-making to severe impulse control disorders. Based on preclinical studies, we proposed that Parkinson's disease does not cause a unified disorder of inhibitory control, but rather a set of impulsivity factors with distinct psychological profiles, anatomy and pharmacology. We assessed a broad set of measures of the cognitive, behavioural and temperamental/trait aspects of impulsivity. Sixty adults, including 30 idiopathic Parkinson's disease patients (Hoehn and Yahr stage I-III) and 30 healthy controls, completed a neuropsychological battery, objective behavioural measures and self-report questionnaires. Univariate analyses of variance confirmed group differences in nine out of eleven metrics. We then used factor analysis (principal components method) to identify the structure of impulsivity in Parkinson's disease. Four principal factors were identified, consistent with four different mechanisms of impulsivity, explaining 60% of variance. The factors were related to (1) tests of response conflict, interference and self assessment of impulsive behaviours on the Barrett Impulsivity Scale, (2) tests of motor inhibitory control, and the self-report behavioural approach system, (3) time estimation and delay aversion, and (4) reflection in hypothetical scenarios including temporal discounting. The different test profiles of these four factors were consistent with human and comparative studies of the pharmacology and functional anatomy of impulsivity. Relationships between each factor and clinical and demographic features were examined by regression against factor loadings. Levodopa dose equivalent was associated only with factors (2) and (3). The results confirm that impulsivity is common in Parkinson's disease, even in the absence of impulse control disorders, and that it is not a unitary phenomenon. A better understanding of the structure of impulsivity in Parkinson's disease will support more evidence-based and effective strategies to treat impulsivity.	[Nombela, Cristina; Rittman, Timothy; Rowe, James B.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Robbins, Trevor W.; Rowe, James B.] Behav & Clin Neurosci Inst, Cambridge, England; [Rowe, James B.] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Nombela, C (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	cn331@cam.ac.uk	Tick, Beata/ABA-1728-2020; Otero, Cristina Nombela/AAA-1463-2019; Rittman, Timothy/K-7572-2019; Robbins, Trevor W/A-7551-2008; Rowe, James/C-3661-2013	Rittman, Timothy/0000-0003-1063-6937; Robbins, Trevor/0000-0003-0642-5977; Rowe, James/0000-0001-7216-8679; Nombela Otero, Cristina/0000-0002-9806-2351	Wellcome Trust [088324]; Medical Research Council [MC-A060-5PQ30, G1100464]; Parkinson's UK [RES/0211-7258]; NIHR Cambridge Biomedical Research Centre; MRC; Wellcome Trust; MRC [G1100464, MC_U105597119] Funding Source: UKRI; Medical Research Council [G0001354B, G0001354, MC_U105597119, G1000183B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (088324 to JBR); the Medical Research Council (MC-A060-5PQ30 and G1100464 Clinical training fellowship to TR); Parkinson's UK (RES/0211-7258 to CNO); and the NIHR Cambridge Biomedical Research Centre. The BCNI is co-funded by a grant from the MRC and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Altmann LJP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/238956; Antonelli F, 2011, J NEUROL SCI, V310, P202, DOI 10.1016/j.jns.2011.06.006; Antonini A, 2011, MOVEMENT DISORD, V26, P464, DOI 10.1002/mds.23501; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bari A, 2013, PSYCHOPHARMACOLOGY, V230, P89, DOI 10.1007/s00213-013-3141-6; Bari A, 2011, J NEUROSCI, V31, P9254, DOI 10.1523/JNEUROSCI.1543-11.2011; Bari A, 2009, PSYCHOPHARMACOLOGY, V205, P273, DOI 10.1007/s00213-009-1537-0; Barker RA, 2009, EXP NEUROL, V219, P382, DOI 10.1016/j.expneurol.2009.07.015; BARRATT E. S., 1959, PERCEPT MOTOR SKILLS, V9, P191; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Bouvard M, 2012, ENCEPHALE, V38, P418, DOI 10.1016/j.encep.2012.01.004; Brambilla F, 2010, PSYCHONEUROENDOCRINO, V35, P729, DOI 10.1016/j.psyneuen.2009.10.014; Brodsky MA, 2003, MOVEMENT DISORD, V18, P668, DOI 10.1002/mds.10429; Broos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036781; Buhusi CV, 2007, BEHAV PROCESS, V74, P159, DOI 10.1016/j.beproc.2006.10.004; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burrell JR, 2012, NEUROLOGY, V78, P1816, DOI 10.1212/WNL.0b013e318258f75c; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carver CSW, 1994, VIOLENCE MENTAL DISO, P61; Ceravolo R, 2009, PARKINSONISM RELAT D, V15, pS111, DOI 10.1016/S1353-8020(09)70847-8; Chamberlain SR, 2007, NEUROPSYCHOLOGIA, V45, P654, DOI 10.1016/j.neuropsychologia.2006.07.016; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Cherbuin N, 2008, SOC COGN AFFECT NEUR, V3, P262, DOI 10.1093/scan/nsn018; Cilia R, 2008, ARCH NEUROL-CHICAGO, V65, P1604, DOI 10.1001/archneur.65.12.1604; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Clark L, 2010, PHILOS T R SOC B, V365, P319, DOI 10.1098/rstb.2009.0147; Cools R, 2005, NEUROPSYCHOPHARMACOL, V30, P1362, DOI 10.1038/sj.npp.1300704; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Cumming Paul, 2012, Curr Top Behav Neurosci, V11, P117, DOI 10.1007/7854_2011_165; Czernecki V, 2002, NEUROPSYCHOLOGIA, V40, P2257, DOI 10.1016/S0028-3932(02)00108-2; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Del-Ben CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1724, DOI 10.1038/sj.npp.1300728; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Djamshidian A, 2011, NEUROPSYCHOLOGIA, V49, P2483, DOI 10.1016/j.neuropsychologia.2011.04.026; Djamshidian A, 2011, PARKINSONISM RELAT D, V17, P212, DOI 10.1016/j.parkreldis.2010.12.014; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Durana J, 1993, IMPULSIVE CLIENT THE; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; Evans AH, 2005, NEUROLOGY, V65, P1570, DOI 10.1212/01.wnl.0000184487.72289.f0; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fera F, 2007, BRAIN RES BULL, V74, P75, DOI 10.1016/j.brainresbull.2007.05.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goldstein DS, 2011, EUR J NEUROL, V18, P703, DOI 10.1111/j.1468-1331.2010.03246.x; Grant JE., 2008, IMPULSE CONTROL DISO; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; HALLIDAY GM, 1990, BRAIN RES, V510, P104, DOI 10.1016/0006-8993(90)90733-R; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Housden CR, 2010, NEUROPSYCHOPHARMACOL, V35, P2155, DOI 10.1038/npp.2010.84; Isaias IU, 2008, MOVEMENT DISORD, V23, P411, DOI 10.1002/mds.21872; Jones CRG, 2004, EXP BRAIN RES, V158, P366, DOI 10.1007/s00221-004-1912-3; Karalunas SL, 2011, J CLIN CHILD ADOLESC, V40, P837, DOI 10.1080/15374416.2011.614578; Kim J.-O., 1978, INTRO FACTOR ANAL WH; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Klein-Flugge MC, 2011, NEURON, V72, P654, DOI 10.1016/j.neuron.2011.08.024; Kobayakawa M, 2008, MOVEMENT DISORD, V23, P547, DOI 10.1002/mds.21865; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Krack P, 2010, TRENDS NEUROSCI, V33, P474, DOI 10.1016/j.tins.2010.07.002; Lee MS, 2011, ACTA NEUROL SCAND, V124, P196, DOI 10.1111/j.1600-0404.2010.01446.x; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Macoveanu J, 2012, EUR NEUROPSYCHOPHARM; Marazziti D, 2008, NEUROPSYCHOBIOLOGY, V57, P38, DOI 10.1159/000129665; Marazziti D, 2010, PHYSIOL BEHAV, V100, P364, DOI 10.1016/j.physbeh.2010.03.013; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Milenkova M, 2011, MOVEMENT DISORD, V26, P2004, DOI 10.1002/mds.23756; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mobini S, 2000, PSYCHOPHARMACOLOGY, V149, P313, DOI 10.1007/s002130000385; Nakahara H, 2010, NEURAL COMPUT, V22, P3062, DOI 10.1162/NECO_a_00049; NathanielJames DA, 1997, NEUROPSYCHOLOGIA, V35, P559, DOI 10.1016/S0028-3932(96)00104-2; O'Callaghan C, 2012, CORTEX; Obeso I, 2011, EXP BRAIN RES, V212, P371, DOI 10.1007/s00221-011-2736-6; Obeso VT, 2005, ACAD MED, V80, pS71, DOI 10.1097/00001888-200510001-00020; Olijslagers JE, 2006, CURR NEUROPHARMACOL, V4, P59, DOI 10.2174/157015906775203020; Overtoom CCE, 2009, BIOL PSYCHIAT, V65, P614, DOI 10.1016/j.biopsych.2008.10.048; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Penny WD, 2000, IEEE T REHABIL ENG, V8, P214, DOI 10.1109/86.847820; Perbal S, 2005, BRAIN COGNITION, V58, P35, DOI 10.1016/j.bandc.2005.02.003; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Potenza MN, 2007, NAT CLIN PRACT NEURO, V3, P664, DOI 10.1038/ncpneuro0680; Rae CL, 2012, NEUROIMAGE, V62, P1675, DOI 10.1016/j.neuroimage.2012.06.012; Rahman S, 2006, NEUROPSYCHOPHARMACOL, V31, P651, DOI 10.1038/sj.npp.1300886; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rakshi JS, 1999, BRAIN, V122, P1637, DOI 10.1093/brain/122.9.1637; Raust A, 2007, PSYCHOL MED, V37, P411, DOI 10.1017/S0033291706009111; Rittman T, 2013, J NEUROL NEUROSUR PS, V84, P544, DOI 10.1136/jnnp-2012-303618; Rivaud-Pechoux S, 2007, BRAIN, V130, P256, DOI 10.1093/brain/awl315; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Rotondo A, 2010, MOVEMENT DISORD, V25, P1994, DOI 10.1002/mds.23177; Rowe JB, 2010, NEUROBIOL AGING, V31, P1064, DOI 10.1016/j.neurobiolaging.2008.07.009; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; Schirmbeck F, 2011, PSYCHOL MED, V41, P2361, DOI 10.1017/S0033291711000419; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Spencer TJ, 2006, J CLIN PSYCHIAT, V67, P415, DOI 10.4088/JCP.v67n0312; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugden C, 2012, ANN SURG, V255, P222, DOI 10.1097/SLA.0b013e3182306c99; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Temel Y, 2009, EXP NEUROL, V216, P481, DOI 10.1016/j.expneurol.2009.01.007; Voon V, 2011, CURR OPIN NEUROL, V24, P324, DOI 10.1097/WCO.0b013e3283489687; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Voon V, 2010, PSYCHOPHARMACOLOGY, V207, P645, DOI 10.1007/s00213-009-1697-y; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Weintraub D, 2010, ANN NEUROL, V68, P963, DOI 10.1002/ana.22164; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Wolters EC, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-5010-5; Zapata MA, 2011, ADICCIONES, V23, P17, DOI 10.20882/adicciones.163	136	75	75	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85747	10.1371/journal.pone.0085747	http://dx.doi.org/10.1371/journal.pone.0085747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465678	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500103
J	Pontes, D; Azevedo, M; Innocentin, S; Blugeon, S; Lefevre, F; Azevedo, V; Miyoshi, A; Courtin, P; Chapot-Chartier, MP; Langella, P; Chatel, JM				Pontes, Daniela; Azevedo, Marcela; Innocentin, Silvia; Blugeon, Sebastien; Lefevre, Francois; Azevedo, Vasco; Miyoshi, Anderson; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Langella, Philippe; Chatel, Jean-Marc			Immune Response Elicited by DNA Vaccination Using Lactococcus lactis Is Modified by the Production of Surface Exposed Pathogenic Protein	PLOS ONE			English	Article							MAMMALIAN EPITHELIAL-CELLS; LISTERIA-MONOCYTOGENES; GENETIC IMMUNIZATION; BETA-LACTOGLOBULIN; INTESTINAL BARRIER; ESCHERICHIA-COLI; MUCOSAL DELIVERY; ALLERGEN; INTERNALIN; PLASMID	In this study, we compared immune responses elicited by DNA immunization using Lactococcus lactis or L. lactis expressing the Staphylococcus aureus invasin Fibronectin Binding Protein A (FnBPA) at its surface. Both strains carried pValac:BLG, a plasmid containing the cDNA of Beta-Lactoglobulin (BLG), and were designated LL-BLG and LL-FnBPA+ BLG respectively. A T(H)2 immune response characterized by the secretion of IL-4 and IL-5 in medium of BLG reactivated splenocytes was detected after either oral or intranasal administration of LL-FnBPA+ BLG. In contrast, intranasal administration of LL-BLG elicited a T(H)1 immune response. After BLG sensitization, mice previously intranasally administered with LL-BLG showed a significantly lower concentration of BLG-specific IgE than the mice non-administered. Altenatively administration of LL-FnBPA+ BLG didn't modify the BLG-specific IgE concentration obtained after sensitization, thus confirming the T(H)2 orientation of the immune response. To determine if the T(H)2-skewed immune response obtained with LL-FnBpA+ BLG was FnBPA-specific or not, mice received another L. lactis strain producing a mutated form of the Listeria monocytogenes invasin Internalin A intranasally, allowing thus the binding to murine E-cadherin, and containing pValac: BLG (LL-mInlA+ BLG). As with LL-FnBPA+ BLG, LL-mInlA+ BLG was not able to elicit a T(H)1 immune response. Furthermore, we observed that these difference were not due to the peptidoglycan composition of the cell wall as LL-FnBPA+ BLG, LL-mInlA+ BLG and LL-BLG strains shared a similar composition. DNA vaccination using LL-BLG elicited a pro-inflammatory T(H)1 immune response while using LL-FnBPA+ BLG or LL-mInlA+ BLG elicited an anti-inflammatory T(H)2 immune response.	[Pontes, Daniela] State Univ Paraiba, Dept Biol Sci, Joao Pessoa, Paraiba, Brazil; [Pontes, Daniela; Azevedo, Marcela; Innocentin, Silvia; Blugeon, Sebastien; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Langella, Philippe; Chatel, Jean-Marc] INRA, Micalis UMR1319, Domaine Vilvert, Jouy En Josas, France; [Pontes, Daniela; Azevedo, Marcela; Innocentin, Silvia; Blugeon, Sebastien; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Langella, Philippe; Chatel, Jean-Marc] AgroParisTech, Micalis UMR1319, Jouy En Josas, France; [Azevedo, Marcela; Azevedo, Vasco; Miyoshi, Anderson] Fed Univ Minas Gerais UFMG ICB, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Innocentin, Silvia] Babraham Inst, Lymphocyte Signaling & Dev Lab, Cambridge, England; [Lefevre, Francois] INRA, VIM, Domaine Vilvert, Jouy En Josas, France	Universidade Estadual da Paraiba; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chatel, JM (corresponding author), INRA, Micalis UMR1319, Domaine Vilvert, Jouy En Josas, France.	jean-marc.chatel@jouy.inra.fr	Chatel, Jean-marc/ABB-9837-2020; de Azevedo, Marcela Santiago Pacheco/AAO-2859-2020; Azevedo, Vasco/B-1556-2019; Langella, Philippe/N-8368-2017; Azevedo, Vasco A.C/F-4315-2011; PONTES, DANIELA SANTOS/O-2040-2015	de Azevedo, Marcela Santiago Pacheco/0000-0001-5694-4578; Azevedo, Vasco/0000-0002-4775-2280; Langella, Philippe/0000-0001-5960-4341; Azevedo, Vasco A.C/0000-0002-4775-2280; Chatel, Jean-Marc/0000-0003-4967-1414; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	LABHEALTH program [MEST-CT-2004-514428]; French-Brazilian CAPES COFECUB project [539/06]; Region Ile de France DIM ASTREA; European Community [215553-2]	LABHEALTH program; French-Brazilian CAPES COFECUB project; Region Ile de France DIM ASTREA(Region Ile-de-France); European Community(European Commission)	Silvia Innocentin was a recipient of a European Marie Curie Ph.D grant from the LABHEALTH program (MEST-CT-2004-514428). Daniela Pontes was a recipient of grants from the French-Brazilian CAPES COFECUB project no539/06 and from Region Ile de France DIM ASTREA. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no215553-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Wahid A, 2007, VACCINE, V25, P8372, DOI 10.1016/j.vaccine.2007.10.012; Adel-Patient K, 2003, CLIN EXP ALLERGY, V33, P376, DOI 10.1046/j.1365-2222.2003.01613.x; Adel-Patient K, 2001, INT ARCH ALLERGY IMM, V126, P59, DOI 10.1159/000049495; Adel-Patient K, 2000, J IMMUNOL METHODS, V235, P21, DOI 10.1016/S0022-1759(99)00210-0; Bermudez-Humaran LG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S4; Brun P, 2008, VACCINE, V26, P1934, DOI 10.1016/j.vaccine.2008.02.023; Chatel JM, 2008, GENE THER, V15, P1184, DOI 10.1038/gt.2008.59; Chatel JM, 2003, ALLERGY, V58, P641, DOI 10.1034/j.1398-9995.2003.00182.x; Cortes-Perez NG, 2007, VACCINE, V25, P6581, DOI 10.1016/j.vaccine.2007.06.062; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Critchley-Thorne RJ, 2006, MOL THER, V14, P183, DOI 10.1016/j.ymthe.2006.01.011; de Azevedo M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-299; Feltquate DM, 1997, J IMMUNOL, V158, P2278; Fredriksen L, 2012, APPL ENVIRON MICROB, V78, P5864, DOI 10.1128/AEM.01227-12; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Guimaraes VD, 2006, APPL ENVIRON MICROB, V72, P7091, DOI 10.1128/AEM.01325-06; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Harms Jerome S, 2009, J Immune Based Ther Vaccines, V7, P1, DOI 10.1186/1476-8518-7-1; Hartl A, 1999, INT ARCH ALLERGY IMM, V120, P17, DOI 10.1159/000024216; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lee SW, 1998, IMMUNOLOGY, V94, P285, DOI 10.1046/j.1365-2567.1998.00557.x; Li XM, 1999, J IMMUNOL, V162, P3045; Macho Fernandez E, GUT, V60, P1050; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Negroni L, 1998, J IMMUNOL METHODS, V220, P25, DOI 10.1016/S0022-1759(98)00150-1; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pontes D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044892; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; Schoen C, 2004, INT J MED MICROBIOL, V294, P319, DOI 10.1016/j.ijmm.2004.03.001; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Toda M, 2000, IMMUNOLOGY, V99, P179, DOI 10.1046/j.1365-2567.2000.00935.x; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049	38	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84509	10.1371/journal.pone.0084509	http://dx.doi.org/10.1371/journal.pone.0084509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465412	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500006
J	Song, B; Wang, YL; Zhao, XQ; Liu, LP; Wang, CX; Wang, AX; Du, WL; Wang, YJ				Song, Bo; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, Chunxue; Wang, Anxin; Du, Wanliang; Wang, Yongjun			Association between Statin Use and Short-Term Outcome Based on Severity of Ischemic Stroke: A Cohort Study	PLOS ONE			English	Article							SIMVASTATIN; ATTACK; ONSET; PHASE	Background: Statins reportedly improve clinical outcomes for ischemic stroke patients. However, it is unclear whether the contribution of statin treatment varies depending on the severity of stroke. We sought to investigate the relationship between statin use and the outcome of acute first-ever ischemic stroke patients stratified by stroke severity. Methods: A total of 7,455 acute first-ever ischemic stroke patients without statin treatment before onset were eligible from the China National Stroke Registry. A National Institutes of Health Stroke Scale (NIHSS) score of 0 to 4 was defined as minor stroke, and a NIHSS score of >4 was defined as non-minor stroke. We analyzed the association between statin use during hospitalization and mortality as well as functional outcome (measured by a modified Rankin Scale score of 0-5) at 3 months after onset using multivariable logistic regression models. Results: A total of 3,231 (43.3%) patients received statin treatment during hospitalization. Multivariable analysis showed that statin use during hospitalization decreased mortality of ischemic stroke patients (OR, 0.51; 95% CI, 0.38-0.67), but did not improve poor functional outcomes (OR, 0.95; 95CI%, 0.81-1.11) at 3 months. The interaction between statin use and stroke severity was significant both in dependence and death outcome (P = 0.04 for dependence outcome, P = 0.03 for death outcome). After stratification by stroke severity, statin use during hospitalization decreased the mortality of stroke (OR, 0.44; 95% CI, 0.31-0.62) and poor functional outcome (OR, 0.73; 95% CI, 0.57-0.92) at 3 months in the non-minor stroke group. Conclusions: Statin use during hospitalization may improve the clinical outcome of acute first-ever ischemic stroke depending on the severity of stroke. Non-minor stroke patients may obtain benefit from statin treatment with improvements in poor functional outcomes and mortality.	[Song, Bo; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, Chunxue; Wang, Anxin; Du, Wanliang; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022		Ministry of Science and Technology [2008ZX09312-008]; Ministry of Health of the People's Republic of China [2009CB521905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study was funded by the Ministry of Science and Technology (grant no. 2008ZX09312-008) and the Ministry of Health of the People's Republic of China (grant no. 2009CB521905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; [Anonymous], 1989, STROKE, V20, P1407; Aslanyan S, 2005, EUR J NEUROL, V12, P493, DOI 10.1111/j.1468-1331.2005.01049.x; Biffi A, 2011, STROKE, V42, P1314, DOI 10.1161/STROKEAHA.110.605923; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Fisher Marc, 2012, Curr Treat Options Cardiovasc Med, V14, P252, DOI 10.1007/s11936-012-0174-9; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; Fuentes B, 2009, CEREBROVASC DIS, V27, P126, DOI 10.1159/000200450; Hassan Y, 2011, FUND CLIN PHARMACOL, V25, P388, DOI 10.1111/j.1472-8206.2010.00846.x; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f; Martinez-Sanchez P, 2009, EUR J NEUROL, V16, P127, DOI 10.1111/j.1468-1331.2008.02370.x; Martinez-Sanchez P, 2013, NEUROLOGY, V80, P1800, DOI 10.1212/WNL.0b013e3182918d38; Montaner J, 2008, EUR J NEUROL, V15, P82, DOI 10.1111/j.1468-1331.2007.02015.x; Moonis M, 2005, STROKE, V36, P1298, DOI 10.1161/01.STR.0000165920.67784.58; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Ntaios G, 2010, CEREBROVASC DIS, V29, P484, DOI 10.1159/000297964; Reeves MJ, 2008, STROKE, V39, P1779, DOI 10.1161/STROKEAHA.107.501700; Squizzato A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007551, 10.1002/14651858.CD007551.pub2]; Szczepanska-Szerej A, 2011, CLIN NEUROPHARMACOL, V34, P191, DOI 10.1097/WNF.0b013e3182309418; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Yeh PS, 2010, AM J CARDIOL, V105, P1490, DOI 10.1016/j.amjcard.2009.07.065	27	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84389	10.1371/journal.pone.0084389	http://dx.doi.org/10.1371/journal.pone.0084389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465409	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500003
J	Stoeckel, S; Masson, JP				Stoeckel, Solenn; Masson, Jean-Pierre			The Exact Distributions of F-IS under Partial Asexuality in Small Finite Populations with Mutation	PLOS ONE			English	Article							GENETIC DIVERSITY; SEXUAL REPRODUCTION; CLONALITY; ORGANISMS; EVOLUTION; SELECTION; DIPLOIDS; COSTS; SIZE	Reproductive systems like partial asexuality participate to shape the evolution of genetic diversity within populations, which is often quantified by the inbreeding coefficient F-IS. Understanding how those mating systems impact the possible distributions of F-IS values in theoretical populations helps to unravel forces shaping the evolution of real populations. We proposed a population genetics model based on genotypic states in a finite population with mutation. For populations with less than 400 individuals, we assessed the impact of the rates of asexuality on the full exact distributions of F-IS, the probabilities of positive and negative F-IS, the probabilities of fixation and the probabilities to observe changes in the sign of F-IS over one generation. After an infinite number of generations, we distinguished three main patterns of effects of the rates of asexuality on genetic diversity that also varied according to the interactions of mutation and genetic drift. Even rare asexual events in mainly sexual populations impacted the balance between negative and positive F-IS and the occurrence of extreme values. It also drastically modified the probability to change the sign of F-IS value at one locus over one generation. When mutation prevailed over genetic drift, increasing rates of asexuality continuously increased the variance of F-IS that reached its highest value in fully asexual populations. In consequence, even ancient asexual populations showed the entire F-IS spectrum, including strong positive F-IS. The prevalence of heterozygous loci only occurred in full asexual populations when genetic drift dominated.	[Stoeckel, Solenn; Masson, Jean-Pierre] INRA, Inst Genet Environm & Plant Protect UMR1349, Le Rheu, France	INRAE	Stoeckel, S (corresponding author), INRA, Inst Genet Environm & Plant Protect UMR1349, Le Rheu, France.	Solenn.Stoeckel@rennes.inra.fr	Stoeckel, Solenn/K-8086-2017	Stoeckel, Solenn/0000-0001-6064-5941	French National Research Agency [CLONIX: ANR-11-BSV7-007]; Plant Health and Environment division of the French National Institute of Agricultural Research	French National Research Agency(French National Research Agency (ANR)); Plant Health and Environment division of the French National Institute of Agricultural Research	This study was funded by the French National Research Agency (project CLONIX: ANR-11-BSV7-007) and by the Plant Health and Environment division of the French National Institute of Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Allen DE, 2012, EVOLUTION, V66, P919, DOI 10.1111/j.1558-5646.2011.01488.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2012, PLOS ONE, V7; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Balloux F, 2003, GENETICS, V164, P1635; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Berg LM, 2000, J EVOLUTION BIOL, V13, P488; Birky CW, 2010, J HERED, V101, pS42, DOI 10.1093/jhered/esq014; Birky CW, 1996, GENETICS, V144, P427; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Ceplitis A, 2003, GENET RES, V82, P183, DOI 10.1017/S0016672303006487; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; Ramirez JD, 2012, MOL ECOL, V21, P4216, DOI 10.1111/j.1365-294X.2012.05699.x; de Meeus T, 2007, CELL MOL LIFE SCI, V64, P1355, DOI 10.1007/s00018-007-6515-2; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; de Meeus T, 2004, INFECT GENET EVOL, V4, P345, DOI 10.1016/j.meegid.2004.05.002; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Fehrer J, 2010, HEREDITY, V104, P421, DOI 10.1038/hdy.2010.12; FELSENSTEIN J, 1974, GENETICS, V78, P737; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Gale JS, 1990, THEORETICAL POPULATI; Goyeau H, 2007, FUNGAL GENET BIOL, V44, P474, DOI 10.1016/j.fgb.2007.02.006; GREEN RF, 1995, J THEOR BIOL, V174, P87, DOI 10.1006/jtbi.1995.0081; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Honnay O, 2010, EVOL ECOL, V24, P1393, DOI 10.1007/s10682-010-9408-z; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; Lewis W M Jr, 1987, Experientia Suppl, V55, P33; Marriage TN, 2012, J THEOR BIOL, V308, P25, DOI 10.1016/j.jtbi.2012.04.033; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; Meirmans S, 2012, Q REV BIOL, V87, P19, DOI 10.1086/663945; Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242; Navascues M, 2010, HEREDITY, V104, P482, DOI 10.1038/hdy.2009.159; Ness RW, 2012, GENETICS, V192, P1447, DOI 10.1534/genetics.112.145078; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Perron O, 1907, MATH ANN, V64, P248, DOI 10.1007/BF01449896; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Ross L, 2013, EVOLUTION, V67, P196, DOI 10.1111/j.1558-5646.2012.01784.x; ROUSSET F, 2001, HDB STAT GENETICS; Saxer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046759; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Shreve SM, 2011, MOL ECOL, V20, P4433, DOI 10.1111/j.1365-294X.2011.05298.x; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Stott I, 2010, METHODS ECOL EVOL, V1, P242, DOI 10.1111/j.2041-210X.2010.00032.x; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Vanoverbeke J, 2010, J EVOLUTION BIOL, V23, P997, DOI 10.1111/j.1420-9101.2010.01970.x; Villate L, 2010, MOL ECOL, V19, P856, DOI 10.1111/j.1365-294X.2009.04511.x; Whittaker JC, 2003, GENETICS, V164, P781; Wright S., 1969, THEORY GENE FREQUENC; Yonezawa K, 2004, GENETICS, V166, P1529, DOI 10.1534/genetics.166.3.1529	54	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85228	10.1371/journal.pone.0085228	http://dx.doi.org/10.1371/journal.pone.0085228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465510	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500045
J	Wigham, S; McConachie, H				Wigham, Sarah; McConachie, Helen			Systematic Review of the Properties of Tools Used to Measure Outcomes in Anxiety Intervention Studies for Children with Autism Spectrum Disorders	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; ETHNIC MEASUREMENT EQUIVALENCE; MULTIPLE INFORMANT AGREEMENT; COGNITIVE-BEHAVIORAL THERAPY; MASC FACTOR STRUCTURE; PSYCHOMETRIC PROPERTIES; EMOTIONAL DISORDERS; INTERVIEW SCHEDULE; MANIFEST ANXIETY; DSM-IV	Background: Evidence about relevant outcomes is required in the evaluation of clinical interventions for children with autism spectrum disorders (ASD). However, to date, the variety of outcome measurement tools being used, and lack of knowledge about the measurement properties of some, compromise conclusions regarding the most effective interventions. Objectives: This two-stage systematic review aimed to identify the tools used in studies evaluating interventions for anxiety for high-functioning children with ASD in middle childhood, and then to evaluate the tools for their appropriateness and measurement properties. Methods: Electronic databases including Medline, PsychInfo, Embase, and the Cochrane database and registers were searched for anxiety intervention studies for children with ASD in middle childhood. Articles examining the measurement properties of the tools used were then searched for using a methodological filter in PubMed, and the quality of the papers evaluated using the COSMIN checklist. Results: Ten intervention studies were identified in which six tools measuring anxiety and one of overall symptom change were used as primary outcomes. One further tool was included as it is recommended for standard use in UK children's mental health services. Sixty three articles on the properties of the tools were evaluated for the quality of evidence, and the quality of the measurement properties of each tool was summarised. Conclusions: Overall three questionnaires were found robust in their measurement properties, the Spence Children's Anxiety Scale, its revised version - the Revised Children's Anxiety and Depression Scale, and also the Screen for Child Anxiety Related Emotional Disorders. Crucially the articles on measurement properties provided almost no evidence on responsiveness to change, nor on the validity of use of the tools for evaluation of interventions for children with ASD.	[Wigham, Sarah; McConachie, Helen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	McConachie, H (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helen.mcconachie@ncl.ac.uk		Wigham, Sarah/0000-0002-7722-9108	Northumberland Tyne and Wear National Health Service Foundation Trust	Northumberland Tyne and Wear National Health Service Foundation Trust	The review was funded by Research Capacity Funding from the Northumberland Tyne and Wear National Health Service Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson ER, 2009, J ANXIETY DISORD, V23, P1098, DOI 10.1016/j.janxdis.2009.07.013; Arnold LE, 2003, J AM ACAD CHILD PSY, V42, P1443, DOI 10.1097/00004583-200312000-00011; Arnold LE, 2000, J AUTISM DEV DISORD, V30, P99, DOI 10.1023/A:1005451304303; Bailey KA, 2006, J PEDIATR PSYCHOL, V31, P512, DOI 10.1093/jpepsy/jsj044; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baldwin JS, 2007, J AM ACAD CHILD PSY, V46, P252, DOI 10.1097/01.chi.0000246065.93200.a1; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Blakeley-Smith A, 2012, RES AUTISM SPECT DIS, V6, P707, DOI 10.1016/j.rasd.2011.07.020; Bodden DHM, 2009, BEHAV RES THER, V47, P418, DOI 10.1016/j.brat.2009.01.015; Brown RC, 2013, CHILD PSYCHIAT HUM D, V44, P525, DOI 10.1007/s10578-012-0346-6; Brown-Jacobsen AM, 2011, ASSESSMENT, V18, P382, DOI 10.1177/1073191110375792; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Canavera KE, 2009, J CLIN CHILD ADOLESC, V38, P909, DOI 10.1080/15374410903258975; Chalfant AM, 2007, J AUTISM DEV DISORD, V37, P1842, DOI 10.1007/s10803-006-0318-4; Chorpita BF, 2005, BEHAV RES THER, V43, P309, DOI 10.1016/j.brat.2004.02.004; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Cole DA, 2000, PSYCHOL ASSESSMENT, V12, P174, DOI 10.1037//1040-3590.12.2.174; Comer JS, 2004, J AM ACAD CHILD PSY, V43, P878, DOI 10.1097/01.chi.0000125092.35109.c5; Dadds MR, 1998, J ABNORM CHILD PSYCH, V26, P311, DOI 10.1023/A:1022610702439; de Vet H.C.W., 2011, MEASUREMENT MED PRAC; Dierker LC, 2001, J AM ACAD CHILD PSY, V40, P929, DOI 10.1097/00004583-200108000-00015; Diggle T., 2003, COCHRANE DB SYST REV, V30, DOI [10.1002/14651858.cd003496, DOI 10.1002/14651858.CD003496]; Ebesutani C, 2012, PSYCHOL ASSESSMENT, V24, P833, DOI 10.1037/a0027283; Ebesutani C, 2011, J ABNORM CHILD PSYCH, V39, P173, DOI 10.1007/s10802-010-9460-8; Ebesutani C, 2010, J ABNORM CHILD PSYCH, V38, P249, DOI 10.1007/s10802-009-9363-8; Essau CA, 2011, J ANXIETY DISORD, V25, P19, DOI 10.1016/j.janxdis.2010.07.001; Gonzalez A, 2012, J CLIN CHILD ADOLESC, V41, P361, DOI 10.1080/15374416.2012.654462; Gotham K, 2013, AUTISM RES, V6, P33, DOI 10.1002/aur.1263; Grills AE, 2003, J AM ACAD CHILD PSY, V42, P30, DOI 10.1097/00004583-200301000-00008; Grills-Taquechel AE, 2008, DEPRESS ANXIETY, V25, P942, DOI 10.1002/da.20401; Grondhuis SN, 2012, RES AUTISM SPECT DIS, V6, P1345, DOI 10.1016/j.rasd.2012.04.006; Guy W., 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; . H, 1995, SOCIAL WORRIES QUEST; Hale WW, 2011, J CHILD PSYCHOL PSYC, V52, P80, DOI 10.1111/j.1469-7610.2010.02285.x; Hallett V, 2013, J CHILD PSYCHOL PSYC, V54, P1176, DOI 10.1111/jcpp.12068; Hedges DW, 2009, HUM PSYCHOPHARM CLIN, V24, P35, DOI 10.1002/hup.989; Higa-McMillan CK, 2008, J ABNORM CHILD PSYCH, V36, P1279, DOI 10.1007/s10802-008-9250-8; Honey E, 2012, RES AUTISM SPECT DIS, V6, P757, DOI 10.1016/j.rasd.2011.10.011; Keehn RHM, 2013, J AUTISM DEV DISORD, V43, P57, DOI 10.1007/s10803-012-1541-9; Kenny MC, 1997, J ANXIETY DISORD, V11, P463, DOI 10.1016/S0887-6185(97)00023-6; Langer DA, 2010, CHILD PSYCHIAT HUM D, V41, P549, DOI 10.1007/s10578-010-0187-0; Lewin AB, 2012, J CONSULT CLIN PSYCH, V80, P1103, DOI 10.1037/a0029991; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Lyneham HJ, 2007, J AM ACAD CHILD PSY, V46, P731, DOI 10.1097/chi.0b013e3180465a09; Lyneham HJ, 2005, J AM ACAD CHILD PSY, V44, P274, DOI 10.1097/00004583-200503000-00012; MacNeil BM, 2009, RES AUTISM SPECT DIS, V3, P1, DOI 10.1016/j.rasd.2008.06.001; Mano KEJ, 2012, J PEDIATR PSYCHOL, V37, P999, DOI 10.1093/jpepsy/jss069; March J. S., 1998, MULTIDIMENSIONAL ANX; March JS, 1999, J ANXIETY DISORD, V13, P349, DOI 10.1016/S0887-6185(99)00009-2; March JS, 1997, J AM ACAD CHILD PSY, V36, P554, DOI 10.1097/00004583-199704000-00019; Matson JL, 2007, RES DEV DISABIL, V28, P207, DOI 10.1016/j.ridd.2005.07.006; McConachie H, 2014, AUTISM, V18, P723, DOI 10.1177/1362361313488839; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Monga S, 2000, DEPRESS ANXIETY, V12, P85, DOI 10.1002/1520-6394(2000)12:2<85::AID-DA4>3.0.CO;2-2; Muris P, 1999, ANXIETY STRESS COPIN, V12, P411, DOI 10.1080/10615809908249319; Muris P, 2001, BRIT J CLIN PSYCHOL, V40, P323, DOI 10.1348/014466501163724; Muris P, 2004, J CHILD PSYCHOL PSYC, V45, P813, DOI 10.1111/j.1469-7610.2004.00274.x; Muris P, 2001, BRIT J CLIN PSYCHOL, V40, P35, DOI 10.1348/014466501163463; Nauta MH, 2004, BEHAV RES THER, V42, P813, DOI 10.1016/S0005-7967(03)00200-6; Nelson WM, 1995, J CLIN PSYCHOL, V51, P753, DOI 10.1002/1097-4679(199511)51:6<753::AID-JCLP2270510605>3.0.CO;2-N; Olatunji BO, 2009, PSYCHOL ASSESSMENT, V21, P412, DOI 10.1037/a0016206; Ooi YP, 2008, SINGAP MED J, V49, P215; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; PAGET KD, 1984, J LEARN DISABIL, V17, P137, DOI 10.1177/002221948401700302; PERRIN S, 1992, J ABNORM CHILD PSYCH, V20, P567, DOI 10.1007/BF00911241; Pina AA, 2009, J PERS ASSESS, V91, P58, DOI 10.1080/00223890802484183; Reaven JA, 2009, FOCUS AUTISM DEV DIS, V24, P27, DOI 10.1177/1088357608327666; Reaven J, 2012, J CHILD PSYCHOL PSYC, V53, P410, DOI 10.1111/j.1469-7610.2011.02486.x; Reichow B, 2009, J AUTISM DEV DISORD, V39, P23, DOI 10.1007/s10803-008-0596-0; Reuterskiold L, 2008, J PSYCHOPATHOL BEHAV, V30, P279, DOI 10.1007/s10862-008-9081-5; REYNOLDS CR, 1981, J CONSULT CLIN PSYCH, V49, P352, DOI 10.1037/0022-006X.49.3.352; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; Ross Carolyn J M, 2007, Clin Nurs Res, V16, P5, DOI 10.1177/1054773806295235; Russell E, 2005, AUST NZ J PSYCHIAT, V39, P633, DOI 10.1111/j.1440-1614.2005.01637.x; Rynn MA, 2006, J ANXIETY DISORD, V20, P139, DOI 10.1016/j.janxdis.2005.01.004; Seligman LD, 2004, J CLIN CHILD ADOLESC, V33, P557, DOI 10.1207/s15374424jccp3303_13; Silverman W, 1996, ANXIETY DISORDERS IN; Silverman WK, 2001, J AM ACAD CHILD PSY, V40, P937, DOI 10.1097/00004583-200108000-00016; Simon E, 2009, EUR CHILD ADOLES PSY, V18, P625, DOI 10.1007/s00787-009-0023-x; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Sofronoff K, 2005, J CHILD PSYCHOL PSYC, V46, P1152, DOI 10.1111/j.1469-7610.2005.00411.x; Spence SH, 2003, J ANXIETY DISORD, V17, P605, DOI 10.1016/S0887-6185(02)00236-0; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Storch EA, 2012, J CHILD ADOL PSYCHOP, V22, P292, DOI 10.1089/cap.2011.0114; Sung M, 2011, CHILD PSYCHIAT HUM D, V42, P634, DOI 10.1007/s10578-011-0238-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Thaler NS, 2010, CHILD PSYCHIAT HUM D, V41, P501, DOI 10.1007/s10578-010-0182-5; Trent LR, 2013, ASSESSMENT, V20, P175, DOI 10.1177/1073191112450907; van Steensel FJA, 2013, AUTISM, V17, P681, DOI 10.1177/1362361312455875; van Steensel FJA, 2011, CLIN CHILD FAM PSYCH, V14, P302, DOI 10.1007/s10567-011-0097-0; White KS, 2001, J CONSULT CLIN PSYCH, V69, P333, DOI 10.1037/0022-006X.69.2.333; White SW, 2012, J AUTISM DEV DISORD, V42, P1138, DOI 10.1007/s10803-011-1353-3; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Whiteside SP, 2008, J ANXIETY DISORD, V22, P1440, DOI 10.1016/j.janxdis.2008.02.006; Whiteside SPH, 2012, J ANXIETY DISORD, V26, P111, DOI 10.1016/j.janxdis.2011.10.002; WHO, 2001, WHO INT CLASS FUNCT; Williams K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004677.pub2; WISNIEWSKI JJ, 1987, PERCEPT MOTOR SKILL, V65, P67, DOI 10.2466/pms.1987.65.1.67; Wolery M, 2002, J AUTISM DEV DISORD, V32, P463, DOI 10.1023/A:1020598023809; Wood JJ, 2009, J AUTISM DEV DISORD, V39, P1608, DOI 10.1007/s10803-009-0791-7; Wood JJ, 2009, J CHILD PSYCHOL PSYC, V50, P224, DOI 10.1111/j.1469-7610.2008.01948.x; Wood JJ, 2002, J CLIN CHILD ADOLESC, V31, P335, DOI 10.1207/153744202760082595; World Health Organization, 1992, INT CLASS DIS ICD 10; Wren FJ, 2007, J AM ACAD CHILD PSY, V46, P332, DOI 10.1097/chi.0b013e31802f1267	108	62	63	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85268	10.1371/journal.pone.0085268	http://dx.doi.org/10.1371/journal.pone.0085268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465519	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500047
J	He, M; Wang, W; Zhang, XL; Huang, WY				He, Miao; Wang, Wei; Zhang, Xiulan; Huang, Wenyong			Ologen Implant versus Mitomycin C for Trabeculectomy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							COLLAGEN MATRIX IMPLANT; INTRAOCULAR-PRESSURE; GLAUCOMA; MODULATION; OCULUSGEN; EFFICACY	Objective: To evaluate the application of the Ologen implant compared to mitomycin C (MMC) on the outcome of trabeculectomy and to examine the balance of risks and benefits. Methods: A systematic literature search (Pubmed, Embase, the Cochrane Library, and the Chinese Biomedicine Database) was performed. Randomized controlled trials comparing the Ologen implant with MMC in trabeculectomy were selected. The efficacy measures were the weighted mean differences (WMDs) for the intraocular pressure reduction (IOPR), the reduction in glaucoma medications, and the relative risks (RRs) for success rates. The tolerability measures were RRs for adverse events. The pooled effects were calculated using the random-effects model. Results: Seven randomized controlled trials including 227 eyes were included in this meta-analysis. The WMDs of the IOPR comparing the Ologen group with the MMC group were -2.98 (95% Cl: -5.07 to -0.89) at one month, -1.41 (-3.72 to 0.91) at three months, -1.69 (-3.68 to 0.30) at six months, -1.94 (-3.88 to 0.01) at 12 months, and 0.65 (-2.17 to 0.47) at 24 months. There was no statistically significance except at one and 12 months after surgery. No significant difference in the reduction in glaucoma medications or complete and qualified success rates were found. The rates of adverse events also did not differ significantly between Ologen and MMC. Conclusions: The Ologen implant is comparable with MMC for trabeculectomy in IOP-lowering efficacy, reduction in the number of glaucoma medications, success rates, and tolerability. However, the results should be interpreted cautiously since relevant evidence is still limited, although it is accumulating. Further large-scale, well-designed randomized controlled trials are urgently needed.	[He, Miao; Wang, Wei; Zhang, Xiulan; Huang, Wenyong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Huang, WY (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	andyhwyz@aliyun.com		Huang, Wenyong/0000-0003-3167-0851				Boey PY, 2011, BRIT J OPHTHALMOL, V95, P340, DOI 10.1136/bjo.2009.177758; Cheng JW, 2011, J GLAUCOMA, V20, P322, DOI 10.1097/IJG.0b013e3181e3d2f7; Cheng JW, 2009, CAN J OPHTHALMOL, V44, P76, DOI 10.3129/i08-165; Cillino S, 2011, EYE, V25, P1598, DOI 10.1038/eye.2011.219; Codreanu A, 2011, CLIN EXP OPHTHALMOL, V39, P135, DOI 10.1111/j.1442-9071.2010.02436.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hollo G, 2012, DEV OPHTHALMOL, V50, P79, DOI 10.1159/000334790; Husain R, 2005, EYE, V19, P243, DOI 10.1038/sj.eye.6701477; La Rosa F A, 2000, Curr Opin Ophthalmol, V11, P90, DOI 10.1097/00055735-200004000-00004; Lin ZJ, 2012, J OCUL PHARMACOL TH, V28, P166, DOI 10.1089/jop.2011.0117; Lockwood A, 2013, CURR OPIN PHARMACOL, V13, P65, DOI 10.1016/j.coph.2012.10.008; Maheshwari D, 2012, GLAUCOMA 2 FREE PAPE, P363; Marey HM, 2013, J OCUL PHARMACOL TH, V29, P330, DOI 10.1089/jop.2012.0120; Mitra A, 2012, GLAUCOMA 2 FREE PAPE, P330; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Narayanaswamy A, 2012, CLIN EXPT OPHTHALMOL; Nilforushan N, 2011, IRAN J OPHTHALMOL, V23, P3; Nilforushan N, 2010, IRAN J OPHTHALMOL, V22, P55; Papaconstantinou D, 2010, ACTA OPHTHALMOL, V88, P80, DOI 10.1111/j.1755-3768.2009.01753.x; Rao K, 2009, EXPERT REV OPHTHALMO, V4, P491, DOI 10.1586/EOP.09.38; Razeghinejad MR, 2012, SURV OPHTHALMOL, V57, P1, DOI 10.1016/j.survophthal.2011.07.005; Rosentreter A, 2010, EYE, V24, P1450, DOI 10.1038/eye.2010.106; Rosentreter A, 2010, GRAEF ARCH CLIN EXP, V248, P1319, DOI 10.1007/s00417-010-1385-y; Seibold LK, 2012, SURV OPHTHALMOL, V57, P530, DOI 10.1016/j.survophthal.2012.01.008; Senthil S, 2013, INDIAN J OPHTHALMOL; Shaarawy T, 2005, EYE, V19, P298, DOI 10.1038/sj.eye.6701469; Stewart WC, 2008, OPHTHALMOLOGY, V115, P1117, DOI 10.1016/j.ophtha.2007.10.004; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004; Wang W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063591, 10.1155/2013/758750, 10.1371/journal.pone.0076538]; Zelefsky JR, 2008, EXPERT REV OPHTHALMO, V3, P613, DOI 10.1586/17469899.3.6.613	34	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85782	10.1371/journal.pone.0085782	http://dx.doi.org/10.1371/journal.pone.0085782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465704	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500072
J	Javle, M; Li, YN; Tan, DF; Dong, XQ; Chang, P; Kar, S; Li, DH				Javle, Milind; Li, Yanan; Tan, Dongfeng; Dong, Xiaoqun; Chang, Ping; Kar, Siddhartha; Li, Donghui			Biomarkers of TGF-beta Signaling Pathway and Prognosis of Pancreatic Cancer	PLOS ONE			English	Article							PREOPERATIVE PLASMA-LEVELS; REPAIR GENE POLYMORPHISMS; TUMOR MICROENVIRONMENT; ENHANCED EXPRESSION; DISEASE PROGRESSION; BREAST-CANCER; DPC4 GENE; CARCINOMA; TGF-BETA(1); SURVIVAL	Background: Transforming growth factor (TGF)-beta signaling pathway, may act both as a tumor suppressor and as a tumor promoter in pancreatic cancer, depending on tumor stage and cellular context. TGF-beta pathway has been under intensive investigation as a potential therapeutic target in the treatment of cancer. We hypothesized a correlation between TGF-beta R2/SMAD4 expression in the tumor, plasma TGF-beta 1 ligand level, genetic variation in TGF-B pathway and prognosis of pancreatic cancer. Method: We examined TGF-beta R2 and SMAD4 protein expression in biopsy or surgical samples from 91 patients with pancreatic ductal adenocarcinoma (PDAC) using immunohistochemistry. Plasma level of TGF-beta 1 was measured in 644 patients with PDAC using ELISA. Twenty-eight single nucleotide polymorphisms (SNP) of the TGF-beta 1, TGF-beta 2, TGF-beta 3, TGF-beta R1, TGF-beta R2, and SMAD4 genes were determined in 1636 patients with PDAC using the Sequenom method. Correlation between protein expression in the tumor, plasma TGF-beta 1 level, and genotypes with overall survival (OS) was evaluated with Cox proportional regression models. Results: The expression level of TGF-beta R2 and SMAD4 as an independent marker was not associated with OS. However, patients with both low nuclear staining of TGF-beta R2 and high nuclear staining of SMAD4 may have better survival (P = 0.06). The mean and median level of TGF-beta 1 was 15.44 (SD: 10.99) and 12.61 (interquartile range: 8.31 to 19.04) ng/ml respectively. Patients with advanced disease and in the upper quartile range of TGF-beta 1 level had significantly reduced survival than those with low levels (P = 0.02). A significant association of SMAD4 SNP rs113545983 with overall survival was observed (P<0.0001). Conclusion: Our data provides valuable baseline information regarding the TGF-beta pathway in pancreatic cancer, which can be utilized in targeted therapy clinical trials. High TGF-beta 1 plasma level, SMAD4 SNP or TGF-beta R2/SMAD4 tumor protein expression may suggest a dependence on this pathway in patients with advanced pancreatic cancer.	[Javle, Milind; Li, Yanan; Dong, Xiaoqun; Chang, Ping; Kar, Siddhartha; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Tan, Dongfeng] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Javle, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	mjavle@mdanderson.org; dli@mdanderson.org		Kar, Siddhartha P./0000-0002-2314-1426	Imclone Corporation/Eli Lilly; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA130821] Funding Source: NIH RePORTER	Imclone Corporation/Eli Lilly; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Imclone Corporation/Eli Lilly and by Donor Funds, a collection of funds from patients with pancreatic cancer or from their families. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bhayal AC, 2011, TUMOR BIOL, V32, P1049, DOI 10.1007/s13277-011-0208-z; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Crane CH, 2011, J CLIN ONCOL, V29, P3037, DOI 10.1200/JCO.2010.33.8038; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong XQ, 2009, J CLIN ONCOL, V27, P1592, DOI 10.1200/JCO.2008.20.1111; Fang F, 2010, MED ONCOL, V27, P1324, DOI 10.1007/s12032-009-9383-9; FRIESS H, 1993, CANCER RES, V53, P2704; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Fukuchi M, 2004, CLIN CANCER RES, V10, P2738, DOI 10.1158/1078-0432.CCR-1096-03; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hua Z, 2003, WORLD J GASTROENTERO, V9, P2764; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Ijichi H, 2001, BIOCHEM BIOPH RES CO, V289, P350, DOI 10.1006/bbrc.2001.5988; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Lin MB, 2011, CARCINOGENESIS, V32, P1050, DOI 10.1093/carcin/bgr067; Schutte M, 1996, CANCER RES, V56, P2527; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Shariat SF, 2001, CANCER-AM CANCER SOC, V92, P2985, DOI 10.1002/1097-0142(20011215)92:12<2985::AID-CNCR10175>3.0.CO;2-5; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang Y, 2013, DIGEST DIS SCI, V58, P1644, DOI 10.1007/s10620-012-2550-4; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559	31	85	88	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85942	10.1371/journal.pone.0085942	http://dx.doi.org/10.1371/journal.pone.0085942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465802	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500092
J	Ji, XL; Wang, Q; Li, XF; Qi, XL; Wang, YQ; Gao, HL; Gao, YL; Wang, XM				Ji, Xiaolin; Wang, Qi; Li, Xiaofei; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Gao, Yulong; Wang, Xiaomei			A 19-Nucleotide Insertion in the Leader Sequence of Avian Leukosis Virus Subgroup J Contributes to Its Replication in Vitro but Is Not Related to Its Pathogenicity in Vivo	PLOS ONE			English	Article							ROUS-SARCOMA VIRUS; DISEASE VIRUS; DESIGNATED-J; HOST-RANGE; CHICKENS; CHINA; VIRULENCE; ANTIBODIES; CLONE; RNA	Subgroup J avian leukosis virus (ALV-J) was first isolated from meat-type chickens that had developed myeloid leukosis and since 2008, ALV-J infections in chickens have become widespread in China. A comparison of the sequence of ALV-J epidemic isolates with HPRS-103, the ALV-J prototype virus, revealed several distinct features, one of which is a 19-nucleotide (nt) insertion in the leader sequence. To determine the role of the 19-nt insertion in ALV-J pathogenicity, a pair of viruses were constructed and rescued. The first virus was an ALV-J Chinese isolate (designated rSD1009) containing the 19-nt insertion in its leader sequence. The second virus was a clone, in which the leader sequence had a deleted 19-nt sequence (designated rSD1009 Delta 19). Compared with rSD1009 Delta 19, rSD1009 displayed a moderate growth advantage in vitro. However, no differences were demonstrated in either viral replication or oncogenicity between the two rescued viruses in chickens. These results indicated that the 19-nt insertion contributed to ALV-J replication in vitro but was not related to its pathogenicity in vivo.	[Ji, Xiaolin; Wang, Qi; Li, Xiaofei; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Gao, Yulong; Wang, Xiaomei] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Gao, YL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	ylg@hvri.ac.cn; xmw@hvri.ac.cn	Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [31072146, 31201923]; earmarked fund for the Modern Agro-industry Technology Research System [nycytx-42-G3-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agro-industry Technology Research System	This study was funded by the National Natural Science Foundation of China (31072146), the National Natural Science Foundation of China 31201923) and the earmarked fund for the Modern Agro-industry Technology Research System (no. nycytx-42-G3-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI J, 1995, J GEN VIROL, V76, P181, DOI 10.1099/0022-1317-76-1-181; Cheng Zi-qiang, 2005, Weishengwu Xuebao, V45, P584; Cheng ZQ, 2010, J VET MED SCI, V72, P1027, DOI 10.1292/jvms.09-0564; Chesters PM, 2006, J GEN VIROL, V87, P2685, DOI 10.1099/vir.0.81884-0; Deng XY, 2012, VIRUS RES, V167, P146, DOI 10.1016/j.virusres.2012.02.011; DONZE O, 1992, EMBO J, V11, P3747, DOI 10.1002/j.1460-2075.1992.tb05460.x; Dortmans JCFM, 2010, J VIROL, V84, P10113, DOI 10.1128/JVI.00097-10; Du Y., 1999, CHINA POULTRY SCI, V3, P1; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Gao Y, 2011, J CLIN MICROBIOL; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; HACKETT PB, 1982, J VIROL, V41, P527, DOI 10.1128/JVI.41.2.527-534.1982; Lai HZ, 2011, VET MICROBIOL, V151, P275, DOI 10.1016/j.vetmic.2011.03.037; Maas R, 2006, BIOLOGICALS, V34, P177, DOI 10.1016/j.biologicals.2005.09.002; Ogert RA, 1996, J VIROL, V70, P3834, DOI 10.1128/JVI.70.6.3834-3843.1996; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; PAYNE LN, 1993, VET REC, V132, P555, DOI 10.1136/vr.132.22.555; Qin AJ, 2001, AVIAN DIS, V45, P938, DOI 10.2307/1592872; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sacco MA, 2004, J VIROL, V78, P10525, DOI 10.1128/JVI.78.19.10525-10535.2004; Sun HL, 2010, ACTA VET HUNG, V58, P441, DOI 10.1556/AVet.58.2010.4.5; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; TSUKAMOTO K, 1985, AVIAN DIS, V29, P1118, DOI 10.2307/1590466; Venugopal K, 1999, RES VET SCI, V67, P113, DOI 10.1053/rvsc.1998.0283; Wang Q, 2012, J VIROL, V86, P12849, DOI 10.1128/JVI.01113-12; Wang Qi, 2011, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V33, P593; Yu F, 2013, VIROLOGY, V440, P204, DOI 10.1016/j.virol.2013.02.026	30	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84797	10.1371/journal.pone.0084797	http://dx.doi.org/10.1371/journal.pone.0084797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465434	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500024
J	Kaufusi, PH; Kelley, JF; Yanagihara, R; Nerurkar, VR				Kaufusi, Pakieli H.; Kelley, James F.; Yanagihara, Richard; Nerurkar, Vivek R.			Induction of Endoplasmic Reticulum-Derived Replication-Competent Membrane Structures by West Nile Virus Non-Structural Protein 4B	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CELL-ADHESION MOLECULES; AMINO-ACID SUBSTITUTION; DENGUE-VIRUS; NS4B PROTEIN; SUBCELLULAR-LOCALIZATION; GENETIC INTERACTION; SECRETORY PATHWAY; VIRAL REPLICATION; RNA REPLICATION	Replication of flaviviruses (family Flaviviridae) occurs in specialized virus-induced membrane structures (IMS). The cellular composition of these IMS varies for different flaviviruses implying different organelle origins for IMS biogenesis. The role of flavivirus non-structural (NS) proteins for the alteration of IMS remains controversial. In this report, we demonstrate that West Nile virus strain New York 99 (WNVNY99) remodels the endoplasmic reticulum (ER) membrane to generate specialized IMS. Within these structures, we observed an element of the cis-Golgi, viral double-stranded RNA, and viral-envelope, NS1, NS4A and NS4B proteins using confocal immunofluorescence microscopy. Biochemical analysis and microscopy revealed that NS4B lacking the 2K-signal peptide associates with the ER membrane where it initiates IMS formation in WNV-infected cells. Co-transfection studies indicated that NS4A and NS4B always remain co-localized in the IMS and are associated with the same membrane fractions, suggesting that these proteins function cooperatively in virus replication and may be an ideal target for antiviral drug discovery.	[Kaufusi, Pakieli H.; Kelley, James F.; Yanagihara, Richard; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Yanagihara, Richard] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96822 USA; [Kaufusi, Pakieli H.; Kelley, James F.; Yanagihara, Richard; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Nerurkar, VR (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	nerurkar@hawaii.edu	Nerurkar, Vivek R/F-5533-2011		Hawaii Community Foundation [43055]; Centers of Biomedical Research Excellence [P20GM103516]; National Institute of General Medical Sciences, National Institutes of Health (NIH); Institutional Funds; Research Centers in Minority Institutions Program [G12MD007601]; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	Hawaii Community Foundation; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional Funds; Research Centers in Minority Institutions Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was partially supported by grants from the Hawaii Community Foundation (43055), Centers of Biomedical Research Excellence (P20GM103516), National Institute of General Medical Sciences, National Institutes of Health (NIH), and Institutional Funds. Also Research Centers in Minority Institutions Program (G12MD007601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu CI, 2012, FEBS LETT; Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0; Blum R, 1999, J CELL SCI, V112, P537; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Chapagain ML, 2008, J NEUROVIROL, V14, P448, DOI 10.1080/13550280802235916; Cho NJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000331; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; CHU PWG, 1992, J VIROL METHODS, V37, P219, DOI 10.1016/0166-0934(92)90049-J; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0; Hanley KA, 2003, VIROLOGY, V312, P222, DOI 10.1016/S0042-6822(03)00197-1; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang Z, 2012, J BIOL CHEM, V287, P4492, DOI 10.1074/jbc.M111.315598; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006; Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000; Krause R, 2004, BIOESSAYS, V26, P1333, DOI 10.1002/bies.20141; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mackenzie JM, 2001, VIROLOGY, V279, P161, DOI 10.1006/viro.2000.0691; Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; NG ML, 1987, J GEN VIROL, V68, P577; NI HL, 1995, J GEN VIROL, V76, P409, DOI 10.1099/0022-1317-76-2-409; Paredes AM, 2008, J VIROL, V82, P10671, DOI 10.1128/JVI.00875-08; PETHEL M, 1992, J VIROL, V66, P7225, DOI 10.1128/JVI.66.12.7225-7231.1992; Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Sambrook J, 2001, MOL CLONING LAB MANU, V1, P110; SPEIGHT G, 1989, VIROLOGY, V170, P299, DOI 10.1016/0042-6822(89)90383-8; Tajima S, 2011, ARCH VIROL, V156, P63, DOI 10.1007/s00705-010-0816-8; Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENDLAND B, 1994, MOL ENDOCRINOL, V8, P1070, DOI 10.1210/me.8.8.1070; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12; Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003	60	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84040	10.1371/journal.pone.0084040	http://dx.doi.org/10.1371/journal.pone.0084040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465392	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500007
J	Rodrigues, JHD; Ueda-Nakamura, T; Correa, AG; Sangi, DP; Nakamura, CV				da Silva Rodrigues, Jean Henrique; Ueda-Nakamura, Tania; Correa, Arlene Goncalves; Sangi, Diego Pereira; Nakamura, Celso Vataru			A Quinoxaline Derivative as a Potent Chemotherapeutic Agent, Alone or in Combination with Benznidazole, against Trypanosoma cruzi	PLOS ONE			English	Article							IN-VITRO; SYNERGISTIC ACTIVITY; CELL-DEATH; AUTOPHAGY; DRUGS; EPIMASTIGOTE; PARTHENOLIDE; PATHOGENESIS; ECHINOMYCIN; TOXICITY	Background: Chagas' disease is a condition caused by the protozoan Trypanosoma cruzi that affects millions of people, mainly in Latin America where it is considered endemic. The chemotherapy for Chagas disease remains a problem; the standard treatment currently relies on a single drug, benznidazole, which unfortunately induces several side effects and it is not successful in the cure of most of the chronic patients. In order to improve the drug armamentarium against Chagas' disease, in the present study we describe the synthesis of the compound 3-chloro-7-methoxy-2-(methylsulfonyl) quinoxaline (quinoxaline 4) and its activity, alone or in combination with benznidazole, against Trypanosoma cruzi in vitro. Methodology/Principal Findings: Quinoxaline 4 was found to be strongly active against Trypanosoma cruzi Y strain and more effective against the proliferative forms. The cytotoxicity against LLCMK2 cells provided selective indices above one for all of the parasite forms. The drug induced very low hemolysis, but its anti-protozoan activity was partially inhibited when mouse blood was added in the experiment against trypomastigotes, an effect that was specifically related to blood cells. A synergistic effect between quinoxaline 4 and benznidazole was observed against epimastigotes and trypomastigotes, accompanied by an antagonistic interaction against LLCMK2 cells. Quinoxaline 4 induced several ultrastructural alterations, including formations of vesicular bodies, profiles of reticulum endoplasmic surrounding organelles and disorganization of Golgi complex. These alterations were also companied by cell volume reduction and maintenance of cell membrane integrity of treated-parasites. Conclusion/Significance: Our results demonstrated that quinoxaline 4, alone or in combination with benznidazole, has promising effects against all the main forms of T. cruzi. The compound at low concentrations induced several ultrastructural alterations and led the parasite to an autophagic-like cell death. Taken together these results may support the further development of a combination therapy as an alternative more effective in Chagas' disease treatment.	[da Silva Rodrigues, Jean Henrique] Univ Estadual Maringa, Programa Posgrad Ciencias Biol Biol Celular & Mol, Maringa, Parana, Brazil; [Ueda-Nakamura, Tania; Nakamura, Celso Vataru] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Lab Inovacao Tecnol Desenvolvimento Farmacos & Co, Maringa, Parana, Brazil; [Correa, Arlene Goncalves; Sangi, Diego Pereira] Univ Fed Sao Carlos, Dept Quim, Lab Sintese Prod Nat, Sao Paulo, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Federal de Sao Carlos	Nakamura, CV (corresponding author), Univ Estadual Maringa, Dept Ciencias Basicas Saude, Lab Inovacao Tecnol Desenvolvimento Farmacos & Co, Maringa, Parana, Brazil.	cvnakamura@uem.br	Sangi, Diego/D-4056-2016; Nogal-Ruiz, Juan Jose/H-1908-2017; Ueda-Nakamura, Tania/P-8250-2015; Rodrigues, Jean Henrique/G-6277-2017; Correa, Arlene/C-1926-2012; Nakamura, Celso Vataru/AAA-5620-2019; ESCARIO, JOSE ANTONIO/AAD-5497-2022; Gómez-Barrio, Alicia/K-1810-2014	Nogal-Ruiz, Juan Jose/0000-0002-8714-049X; Ueda-Nakamura, Tania/0000-0001-5057-3518; Rodrigues, Jean Henrique/0000-0003-2902-4578; Correa, Arlene/0000-0003-4247-2228; ESCARIO, JOSE ANTONIO/0000-0002-4742-2783; Gómez-Barrio, Alicia/0000-0002-0347-758X; Sangi, Diego/0000-0003-0388-5409	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP); Trust in Science Project - GlaxoSmithKline (GSK); Programa de Pos-Graduacao em Ciencias Biologicas; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Trust in Science Project - GlaxoSmithKline (GSK); Programa de Pos-Graduacao em Ciencias Biologicas; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP), Trust in Science Project - GlaxoSmithKline (GSK), Programa de Pos-Graduacao em Ciencias Biologicas and Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x; [Anonymous], 2012, C PART WHO FRAM CONV, P1; Barea C, 2012, MOLECULES, V17, P9451, DOI 10.3390/molecules17089451; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Becerra MC, 2012, EXP PARASITOL, V131, P57, DOI 10.1016/j.exppara.2012.02.028; Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; Silva CMBL, 2012, CHEM PHARM BULL, V60, P1372, DOI 10.1248/cpb.c12-00356; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Cencig S, 2012, INT J ANTIMICROB AG, V40, P527, DOI 10.1016/j.ijantimicag.2012.08.002; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chen LL, 2011, ANTIVIR RES, V91, P314, DOI 10.1016/j.antiviral.2011.07.008; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P549, DOI 10.1590/S0074-02762009000400002; Espinosa A, 2012, PARASITOL RES, V111, P2473, DOI 10.1007/s00436-012-3019-2; Estevez Y, 2011, EXP PARASITOL, V127, P745, DOI 10.1016/j.exppara.2011.01.009; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fernandes MC, 2012, PARASITOLOGY, V139, P26, DOI 10.1017/S0031182011001612; Font M, 1997, Drug Des Discov, V14, P305; Ishikawa H, 2012, BIOORG CHEM, V41-42, P1, DOI 10.1016/j.bioorg.2011.12.002; Izumi E, 2008, EXP PARASITOL, V118, P324, DOI 10.1016/j.exppara.2007.08.015; Izumi E, 2012, J MED CHEM, V55, P2994, DOI 10.1021/jm201451h; Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h; Jeon YW, 2013, ONCOL REP, V29, P819, DOI 10.3892/or.2012.2158; Kim YB, 2004, BIOORG MED CHEM LETT, V14, P541, DOI 10.1016/j.bmcl.2003.09.086; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krantz A, 1997, BLOOD CELL MOL DIS, V23, P58, DOI 10.1006/bcmd.1997.0119; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; LOPES JN, 1978, ANN TROP MED PARASIT, V72, P523, DOI 10.1080/00034983.1978.11719356; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; MALDONADO RA, 1993, ANTIMICROB AGENTS CH, V37, P1353, DOI 10.1128/AAC.37.6.1353; Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Park KS, 2012, CLIN RHEUMATOL, V31, P317, DOI 10.1007/s10067-011-1818-y; Pelizzaro-Rocha KJ, 2010, PHYTOMEDICINE, V18, P36, DOI 10.1016/j.phymed.2010.09.005; Perez-Mazliah DE, 2012, J ANTIMICROB CHEMOTH, V1, P1; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Reiners JJ, 2009, J PHARMACOL EXP THER, V328, P796, DOI 10.1124/jpet.108.144808; Sangi DP, 2010, J BRAZIL CHEM SOC, V21, P795, DOI 10.1590/S0103-50532010000500005; Schrijvers D, 2003, CLIN PHARMACOKINET, V42, P779, DOI 10.2165/00003088-200342090-00001; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Valdez RH, 2012, ANTIMICROB AGENTS CH, V56, P507, DOI 10.1128/AAC.05575-11; van der Vaart A, 2010, AUTOPHAGY, V6, P800, DOI 10.1091/mbc.E09-04-0345; Veiga-Santos P, 2010, PARASITOLOGY, V137, P1661, DOI 10.1017/S003118201000034X; Venkatesh C, 2005, ORG LETT, V7, P2169, DOI 10.1021/ol0505095; Larrea SCV, 2011, INT J PARASITOL, V41, P405, DOI 10.1016/j.ijpara.2010.11.008; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	56	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85706	10.1371/journal.pone.0085706	http://dx.doi.org/10.1371/journal.pone.0085706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465654	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000052
J	Guo, WW; Yan, LC; Yang, L; Liu, XY; E, QK; Gao, PY; Ye, XF; Liu, W; Zuo, J				Guo, Weiwei; Yan, Lichong; Yang, Ling; Liu, Xiaoyu; E, Qiukai; Gao, Peiye; Ye, Xiaofei; Liu, Wen; Zuo, Ji			Targeting GRP75 Improves HSP90 Inhibitor Efficacy by Enhancing p53-Mediated Apoptosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; MOLECULAR CHAPERONE; ELEVATED LEVELS; MORTALIN; EXPRESSION; BINDING; HSP70; ACTIVATION; MUTATIONS; PROTEINS	Heat shock protein 90 (HSP90) inhibitors are potential drugs for cancer therapy. The inhibition of HSP90 on cancer cell growth largely through degrading client proteins, like Akt and p53, therefore, triggering cancer cell apoptosis. Here, we show that the HSP90 inhibitor 17-AAG can induce the expression of GRP75, a member of heat shock protein 70 (HSP70) family, which, in turn, attenuates the anti-growth effect of HSP90 inhibition on cancer cells. Additionally, 17-AAG enhanced binding of GRP75 and p53, resulting in the retention of p53 in the cytoplasm. Blocking GRP75 with its inhibitor MKT-077 potentiated the anti-tumor effects of 17-AAG by disrupting the formation of GRP75-p53 complexes, thereby facilitating translocation of p53 into the nuclei and leading to the induction of apoptosis-related genes. Finally, dual inhibition of HSP90 and GRP75 was found to significantly inhibit tumor growth in a liver cancer xenograft model. In conclusion, the GRP75 inhibitor MKT-077 enhances 17-AAG-induced apoptosis in HCCs and increases p53-mediated inhibition of tumor growth in vivo. Dual targeting of GRP75 and HSP90 may be a useful strategy for the treatment of HCCs.	[Guo, Weiwei; Yan, Lichong; Yang, Ling; Liu, Xiaoyu; E, Qiukai; Gao, Peiye; Ye, Xiaofei; Liu, Wen; Zuo, Ji] Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai 200433, Peoples R China	Fudan University	Liu, W (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai 200433, Peoples R China.	liuwen@shmu.edu.cn; jzuo@shmu.edu.cn			National Natural Science Foundation of China [81000978]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81000978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Ayrault O, 2009, P NATL ACAD SCI USA, V106, P17037, DOI 10.1073/pnas.0902880106; Beliveau A, 2007, CELL CYCLE, V6, P1284, DOI 10.4161/cc.6.11.4298; Breinig M, 2009, HEPATOLOGY, V50, P102, DOI 10.1002/hep.22912; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Dimopoulos MA, 2011, CL LYMPH MYELOM LEUK, V11, P17, DOI 10.3816/CLML.2011.n.002; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2001, NEOPLASIA, V3, P110, DOI 10.1038/sj.neo.7900139; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Langer CJ, 2013, CANCER TREAT REV, V39, P252, DOI 10.1016/j.ctrv.2012.05.003; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; ORNATSKY OI, 1995, BIOCHEM J, V311, P119, DOI 10.1042/bj3110119; Pascale RM, 2005, HEPATOLOGY, V42, P1310, DOI 10.1002/hep.20962; Pimienta G, 2011, MOL PHARMACEUT, V8, P2252, DOI 10.1021/mp200346y; Pizzatti L, 2006, BBA-PROTEINS PROTEOM, V1764, P929, DOI 10.1016/j.bbapap.2006.02.004; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Propper DJ, 1999, ANN ONCOL, V10, P923, DOI 10.1023/A:1008336904585; Rozenberg P, 2013, INT J CANCER, V133, P514, DOI 10.1002/ijc.28029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCORSONE KA, 1992, CANCER RES, V52, P1635; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sharp SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044642; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Takano S, 1997, EXP CELL RES, V237, P38, DOI 10.1006/excr.1997.3754; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Xu J, 1999, ONCOL RES, V11, P429; Yang L, 2008, ACTA BIOCH BIOPH SIN, V40, P339, DOI 10.1111/j.1745-7270.2008.00409.x; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	48	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85766	10.1371/journal.pone.0085766	http://dx.doi.org/10.1371/journal.pone.0085766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465691	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000061
J	Muramatsu, M; Yoshida, R; Yokoyama, A; Miyamoto, H; Kajihara, M; Maruyama, J; Nao, N; Manzoor, R; Takada, A				Muramatsu, Mieko; Yoshida, Reiko; Yokoyama, Ayaka; Miyamoto, Hiroko; Kajihara, Masahiro; Maruyama, Junki; Nao, Naganori; Manzoor, Rashid; Takada, Ayato			Comparison of Antiviral Activity between IgA and IgG Specific to Influenza Virus Hemagglutinin: Increased Potential of IgA for Heterosubtypic Immunity	PLOS ONE			English	Article							2-DEOXY-2,3-DEHYDRO-N-TRIFLUOROACETYLNEURAMINIC ACID FANA; CLASS-SWITCH VARIANTS; CROSS-PROTECTION; INTRACELLULAR NEUTRALIZATION; MONOCLONAL-ANTIBODIES; MUCOSAL SURFACES; EPITHELIAL-CELLS; TISSUE-CULTURE; INFECTION; REPLICATION	Both IgA and IgG antibodies are known to play important roles in protection against influenza virus infection. While IgG is the major isotype induced systemically, IgA is predominant in mucosal tissues, including the upper respiratory tract. Although IgA antibodies are believed to have unique advantages in mucosal immunity, information on direct comparisons of the in vitro antiviral activities of IgA and IgG antibodies recognizing the same epitope is limited. In this study, we demonstrate differences in antiviral activities between these isotypes using monoclonal IgA and IgG antibodies obtained from hybridomas of the same origin. Polymeric IgA-producing hybridoma cells were successfully subcloned from those originally producing monoclonal antibody S139/1, a hemaggulutinin (HA)-specific IgG that was generated against an influenza A virus strain of the H3 subtype but had cross-neutralizing activities against the H1, H2, H13, and H16 subtypes. These monoclonal S139/1 IgA and IgG antibodies were assumed to recognize the same epitope and thus used to compare their antiviral activities. We found that both S139/1 IgA and IgG antibodies strongly bound to the homologous H3 virus in an enzyme-linked immunosorbent assay, and there were no significant differences in their hemagglutination-inhibiting and neutralizing activities against the H3 virus. In contrast, S139/1 IgA showed remarkably higher cross-binding to and antiviral activities against H1, H2, and H13 viruses than S139/1 IgG. It was also noted that S139/1 IgA, but not IgG, drastically suppressed the extracellular release of the viruses from infected cells. Electron microscopy revealed that S139/1 IgA deposited newly produced viral particles on the cell surface, most likely by tethering the particles. These results suggest that anti-HA IgA has greater potential to prevent influenza A virus infection than IgG antibodies, likely due to increased avidity conferred by its multivalency, and that this advantage may be particularly important for heterosubtypic immunity.	[Muramatsu, Mieko; Yoshida, Reiko; Yokoyama, Ayaka; Miyamoto, Hiroko; Kajihara, Masahiro; Maruyama, Junki; Nao, Naganori; Manzoor, Rashid; Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; University of Zambia	Takada, A (corresponding author), Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	YOSHIDA, Reiko/F-6883-2012; Maruyama, Junki/M-4735-2019; Manzoor, Rashid/ABB-8209-2020; Maruyama, Junki/H-7993-2013; Kajihara, Masahiro/AAF-5724-2020	Maruyama, Junki/0000-0003-0088-4793; Maruyama, Junki/0000-0003-0088-4793; 	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Global COE Program; Japan Science and Technology Agency Basic Research Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency Basic Research Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (http://www.crnid.riken.jp/jgrid/en/index.html), the Global COE Program (http://www.jsps.go.jp/english/e-globalcoe/index.html), Japan Science and Technology Agency Basic Research Programs, and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Ainai A, 2013, HUM VACCIN IMMUNOTHE, V9; ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; Corthesy B, 1999, CURR TOP MICROBIOL, V236, P93; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12; KIDA H, 1982, VIROLOGY, V122, P38, DOI 10.1016/0042-6822(82)90375-0; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; MANABE T, 1979, J BIOCHEM-TOKYO, V85, P649; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; MOORE JP, 1991, J VIROL, V65, P1133, DOI 10.1128/JVI.65.3.1133-1140.1991; Muramatsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071534; Murphy K, 2008, JANEWAYS IMMUNOBIOLO, Vxxi; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; OUTLAW MC, 1990, J GEN VIROL, V71, P69, DOI 10.1099/0022-1317-71-1-69; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; PALESE P, 1974, VIROLOGY, V59, P490, DOI 10.1016/0042-6822(74)90458-9; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; RENEGAR KB, 1991, J VIROL, V65, P2146, DOI 10.1128/JVI.65.4.2146-2148.1991; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; SPIRA G, 1984, J IMMUNOL METHODS, V74, P307, DOI 10.1016/0022-1759(84)90298-9; STEPLEWSKI Z, 1985, P NATL ACAD SCI USA, V82, P8653, DOI 10.1073/pnas.82.24.8653; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; TAMURA SI, 1992, J IMMUNOL, V149, P981; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weltzin R, 1999, CLIN MICROBIOL REV, V12, P383, DOI 10.1128/CMR.12.3.383; WILSON ID, 1969, J CLIN INVEST, V48, P2409, DOI 10.1172/JCI106207; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; Wright A, 2006, VIROLOGY, V356, P165, DOI 10.1016/j.virol.2006.08.006; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhou DH, 2011, J VIROL, V85, P11090, DOI 10.1128/JVI.00768-11	43	48	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85582	10.1371/journal.pone.0085582	http://dx.doi.org/10.1371/journal.pone.0085582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465606	Green Published, gold			2022-12-27	WOS:000330237000045
J	Samuel, ER; Beloki, L; Newton, K; Mackinnon, S; Lowdell, MW				Samuel, Edward R.; Beloki, Lorea; Newton, Katy; Mackinnon, Stephen; Lowdell, Mark W.			Isolation of Highly Suppressive CD25+FoxP3+T Regulatory Cells from G-CSF-Mobilized Donors with Retention of Cytotoxic Anti-Viral CTLs: Application for Multi-Functional Immunotherapy Post Stem Cell Transplantation	PLOS ONE			English	Article							CD8(+) T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; ALLOGENEIC BONE-MARROW; CYTOMEGALOVIRUS-INFECTION; ADOPTIVE TRANSFER; REACTIVE CD4(+); EX-VIVO; ANTIGEN; LYMPHOCYTES; EXPANSION	Previous studies have demonstrated the effective control of cytomegalovirus (CMV) infections post haematopoietic stem cell transplant through the adoptive transfer of donor derived CMV-specific T cells (CMV-T). Strategies for manufacturing CMV immunotherapies has involved a second leukapheresis or blood draw from the donor, which in the unrelated donor setting is not always possible. We have investigated the feasibility of using an aliquot of the original G-CSF-mobilized graft as a starting material for manufacture of CMV-T and examined the activation marker CD25 as a targeted approach for identification and isolation following CMVpp65 peptide stimulation. CD25+ cells isolated from G-CSF-mobilized apheresis revealed a significant increase in the proportion of FoxP3 expression when compared with conventional non-mobilized CD25+ cells and showed a superior suppressive capacity in a T cell proliferation assay, demonstrating the emergence of a population of Tregs not present in non-mobilized apheresis collections. The expansion of CD25+ CMV-T in short-term culture resulted in a mixed population of CD4+ and CD8+ T cells with CMV-specificity that secreted cytotoxic effector molecules and lysed CMVpp65 peptide-loaded phytohaemagglutinin-stimulated blasts. Furthermore CD25 expanded cells retained their suppressive capacity but did not maintain FoxP3 expression or secrete IL-10. In summary our data indicates that CD25 enrichment post CMV stimulation in G-CSF-mobilized PBMCs results in the simultaneous generation of both a functional population of anti-viral T cells and Tregs thus illustrating a potential single therapeutic strategy for the treatment of both GvHD and CMV reactivation following allogeneic haematopoietic stem cell transplantation. The use of G-CSF-mobilized cells as a starting material for cell therapy manufacture represents a feasible approach to alleviating the many problems incurred with successive donations and procurement of cells from unrelated donors. This approach may therefore simplify the clinical application of adoptive immunotherapy and broaden the approach for manufacturing multi-functional T cells.	[Samuel, Edward R.; Mackinnon, Stephen; Lowdell, Mark W.] UCL, Dept Haematol, London, England; [Beloki, Lorea] Navarrabiomed Miguel Servet Fdn, Oncohematol Res Grp, Pamplona, Spain; [Newton, Katy] Cell Med Ltd, London, England; [Newton, Katy] UCL, London, England; [Lowdell, Mark W.] Royal Free London NHS Fdn Trust, London, England	University of London; University College London; Navarrabiomed; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust	Samuel, ER (corresponding author), UCL, Dept Haematol, Royal Free Campus, London, England.	edward.samuel@ucl.ac.uk	Mackinnon, Stephen/C-5559-2008		UK Government Technology Strategy Board translational award	UK Government Technology Strategy Board translational award	The study was supported by a UK Government Technology Strategy Board translational award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi KKS, 2013, BONE MARROW TRANSPL, V48, P357, DOI 10.1038/bmt.2012.144; Adeegbe DO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00190; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Brincks EL, 2013, J IMMUNOL, V190, P3438, DOI 10.4049/jimmunol.1203140; Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Clancy LE, 2013, BIOL BLOOD MARROW TR, V19, P725, DOI 10.1016/j.bbmt.2013.01.021; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Feuchtinger T, 2004, EXP HEMATOL, V32, P282, DOI 10.1016/j.exphem.2003.12.009; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gallot G, 2001, J IMMUNOL, V167, P4196, DOI 10.4049/jimmunol.167.8.4196; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; KITABAYASHI A, 1995, BLOOD, V86, P2220, DOI 10.1182/blood.V86.6.2220.bloodjournal8662220; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Levine JE, 2002, J CLIN ONCOL, V20, P405, DOI 10.1200/JCO.20.2.405; Litjens NHR, 2012, J IMMUNOL, V188, P1083, DOI 10.4049/jimmunol.1101974; Lugthart G, 2012, J IMMUNOTHER, V35, P42, DOI 10.1097/CJI.0b013e31823569e2; Melenhorst JJ, 2008, CYTOTHERAPY, V10, P152, DOI 10.1080/14653240701853536; Micklethwaite K, 2007, BIOL BLOOD MARROW TR, V13, P707, DOI 10.1016/j.bbmt.2007.02.004; Moosmann A, 2010, BLOOD, V115, P2960, DOI 10.1182/blood-2009-08-236356; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; Pan LP, 1999, BLOOD, V93, P4071, DOI 10.1182/blood.V93.12.4071.412k41_4071_4078; Peggs KS, 2011, CLIN INFECT DIS, V52, P49, DOI 10.1093/cid/ciq042; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Powell DJ, 2005, J IMMUNOTHER, V28, P403, DOI 10.1097/01.cji.0000170363.22585.5a; REUSSER P, 1991, BLOOD, V78, P1373; RIDDELL SR, 1992, SCIENCE, V257, P238; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samuel ER, 2013, BRIT J HAEMATOL, V160, P87, DOI 10.1111/bjh.12082; Sloand EM, 2000, BLOOD, V95, P2269, DOI 10.1182/blood.V95.7.2269.007k37_2269_2274; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Tayebi H, 2001, EXP HEMATOL, V29, P458, DOI 10.1016/S0301-472X(01)00613-0; Toh HC, 2009, CLIN IMMUNOL, V132, P83, DOI 10.1016/j.clim.2009.03.509; Tovar-Salazar A, 2010, VIROLOGY, V398, P158, DOI 10.1016/j.virol.2009.11.038; Ukena SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051644; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Watanabe K, 2008, INT J HEMATOL, V88, P311, DOI 10.1007/s12185-008-0134-z; Wehler TC, 2008, J IMMUNOL METHODS, V339, P23, DOI 10.1016/j.jim.2008.07.017; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168	48	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85911	10.1371/journal.pone.0085911	http://dx.doi.org/10.1371/journal.pone.0085911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465783	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000074
J	Bonaldo, RM; Hay, ME				Bonaldo, Roberta M.; Hay, Mark E.			Seaweed-Coral Interactions: Variance in Seaweed Allelopathy, Coral Susceptibility, and Potential Effects on Coral Resilience	PLOS ONE			English	Article							MARINE PROTECTED AREAS; REGION-WIDE DECLINES; SCLERACTINIAN CORALS; DISEASE PREVALENCE; BENTHIC ALGAE; PHASE-SHIFTS; BAND DISEASE; REEF; COMPETITION; BIODIVERSITY	Tropical reefs are in global decline with seaweeds commonly replacing corals. Negative associations between macroalgae and corals are well documented, but the mechanisms involved, the dynamics of the interactions, and variance in effects of different macroalgal-coral pairings are poorly investigated. We assessed the frequency, magnitude, and dynamics of macroalgal-coral competition involving allelopathic and non-allelopathic macroalgae on three, spatially grouped pairs of no-take Marine Protected Areas (MPAs) and non-MPAs in Fiji. In non-MPAs, biomass of herbivorous fishes was 70-80% lower, macroalgal cover 4-9 fold higher, macroalgal-coral contacts 5-15 fold more frequent and 23-67 fold more extensive (measured as % of colony margin contacted by macroalgae), and coral cover 51-68% lower than in MPAs. Coral contacts with allelopathic macroalgae occurred less frequently than expected by chance across all sites, while contact with non-allelopathic macroalgae tended to occur more frequently than expected. Transplants of allelopathic macroalgae (Chlorodesmis fastigiata and Galaxaura filamentosa) against coral edges inflicted damage to Acropora aspera and Pocillopora damicornis more rapidly and extensively than to Porites cylindrica and Porites lobata, which appeared more resistant to these macroalgae. Montipora digitata experienced intermediate damage. Extent of damage from macroalgal contact was independent of coral colony size for each of the 10 macroalgal-coral pairings we established. When natural contacts with Galaxaura filamentosa were removed in the field, recovery was rapid for Porites lobata, but Pocillopora damicornis did not recover and damage continued to expand. As macroalgae increase on overfished tropical reefs, allelopathy could produce feedbacks that suppress coral resilience, prevent coral recovery, and promote the stability of algal beds in habitats previously available to corals.	[Bonaldo, Roberta M.; Hay, Mark E.] Georgia Tech, Sch Biol, Atlanta, GA 30332 USA; [Bonaldo, Roberta M.] Univ Sao Paulo, Dept Ecol, IB, Sao Paulo, Brazil	University System of Georgia; Georgia Institute of Technology; Universidade de Sao Paulo	Hay, ME (corresponding author), Georgia Tech, Sch Biol, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Science Foundation [OCE-0929119]; National Institutes of Health ICBG [U01-TW007401]; Teasley Endowment to Georgia Tech; FOGARTY INTERNATIONAL CENTER [U01TW007401, U19TW007401] Funding Source: NIH RePORTER; Directorate For Geosciences [0929119] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health ICBG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment to Georgia Tech; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by National Science Foundation grant OCE-0929119, National Institutes of Health ICBG grant U01-TW007401, and the Teasley Endowment to Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andras TD, 2012, J CHEM ECOL, V38, P1203, DOI 10.1007/s10886-012-0204-9; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bender D, 2012, J EXP MAR BIOL ECOL, V429, P15, DOI 10.1016/j.jembe.2012.06.014; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Coral Cay Conservation L, 2005, FISH RES ASS REP KOR; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Edwards KF, 2011, ECOLOGY, V92, P2085, DOI 10.1890/11-0395.1; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; FROESE R., 2012, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; HAY ME, 1986, AM NAT, V128, P617, DOI 10.1086/284593; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; LANG J, 1973, B MAR SCI, V23, P260; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Littler MM, 2006, HARMFUL ALGAE, V4, P1092; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mantyka CS, 2007, MARINE ECOLOGY PROGR, V352, P117; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McCook, 1998, REEF RES, V8, P5; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Morrow KM, 2013, MAR ECOL PROG SER, V488, P103, DOI 10.3354/meps10394; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; Team RDC, 2019, R LANG ENV STAT COMP; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Urban MC, 2011, J ANIM ECOL, V80, P505, DOI 10.1111/j.1365-2656.2011.01838.x	62	74	74	2	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85786	10.1371/journal.pone.0085786	http://dx.doi.org/10.1371/journal.pone.0085786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465707	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100073
J	Lindner, C; Dannlowski, U; Walhofer, K; Rodiger, M; Maisch, B; Bauer, J; Ohrmann, P; Lencer, R; Zwitserlood, P; Kersting, A; Heindel, W; Arolt, V; Kugel, H; Suslow, T				Lindner, Christian; Dannlowski, Udo; Walhoefer, Kirsten; Roediger, Maike; Maisch, Birgit; Bauer, Jochen; Ohrmann, Patricia; Lencer, Rebekka; Zwitserlood, Pienie; Kersting, Anette; Heindel, Walter; Arolt, Volker; Kugel, Harald; Suslow, Thomas			Social Alienation in Schizophrenia Patients: Association with Insula Responsiveness to Facial Expressions of Disgust	PLOS ONE			English	Article							DIFFERENTIAL NEURAL RESPONSE; BACKWARD-MASKING DEFICITS; EMOTION RECOGNITION; HUMAN AMYGDALA; FMRI; METAANALYSIS; ACTIVATION; FEARFUL; DISCRIMINATION; DEPRESSION	Introduction: Among the functional neuroimaging studies on emotional face processing in schizophrenia, few have used paradigms with facial expressions of disgust. In this study, we investigated whether schizophrenia patients show less insula activation to macro-expressions (overt, clearly visible expressions) and micro-expressions (covert, very brief expressions) of disgust than healthy controls. Furthermore, departing from the assumption that disgust faces signal social rejection, we examined whether perceptual sensitivity to disgust is related to social alienation in patients and controls. We hypothesized that high insula responsiveness to facial disgust predicts social alienation. Methods: We used functional magnetic resonance imaging to measure insula activation in 36 schizophrenia patients and 40 healthy controls. During scanning, subjects passively viewed covert and overt presentations of disgust and neutral faces. To measure social alienation, a social loneliness scale and an agreeableness scale were administered. Results: Schizophrenia patients exhibited reduced insula activation in response to covert facial expressions of disgust. With respect to macro-expressions of disgust, no between-group differences emerged. In patients, insula responsiveness to covert faces of disgust was positively correlated with social loneliness. Furthermore, patients' insula responsiveness to covert and overt faces of disgust was negatively correlated with agreeableness. In controls, insula responsiveness to covert expressions of disgust correlated negatively with agreeableness. Discussion: Schizophrenia patients show reduced insula responsiveness to micro-expressions but not macro-expressions of disgust compared to healthy controls. In patients, low agreeableness was associated with stronger insula response to micro- and macro-expressions of disgust. Patients with a strong tendency to feel uncomfortable with social interactions appear to be characterized by a high sensitivity for facial expression signaling social rejection. Given the associations of insula responsiveness to covert disgust expression with low agreeableness in healthy individuals, insula responsiveness to expressions of disgust might be in general a neural marker of the personality trait of agreeableness.	[Lindner, Christian; Dannlowski, Udo; Walhoefer, Kirsten; Roediger, Maike; Bauer, Jochen; Ohrmann, Patricia; Lencer, Rebekka; Arolt, Volker; Suslow, Thomas] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Dannlowski, Udo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Maisch, Birgit] Klin Schlossgarten, Dulmen, Germany; [Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Kersting, Anette; Suslow, Thomas] Univ Leipzig, Dept Psychosomat Med & Psychotherapy, D-04109 Leipzig, Germany; [Heindel, Walter; Kugel, Harald] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany	University of Munster; Philipps University Marburg; University of Munster; Leipzig University; University of Munster	Lindner, C (corresponding author), Univ Munster, Dept Psychiat, D-48149 Munster, Germany.	Christian.Lindner@ukmuenster.de	Bauer, Jochen/AAW-4539-2021; , Rebekka/A-4994-2009	Bauer, Jochen/0000-0001-9345-2126; , Rebekka/0000-0003-4032-7297; Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759; Suslow, Thomas/0000-0003-4560-0555	German Research Foundation DFG [SU 222/5-1, 5-2]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation DFG (www.dfg.de) to Thomas Suslow and Harald Kugel (SU 222/5-1 and 5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Gonzalez-Torres MA, 2007, SOC PSYCH PSYCH EPID, V42, P14, DOI 10.1007/s00127-006-0126-3; Beck A.T., 1987, BECK DEPRESSION INVE; Butler PD, 2003, SCHIZOPHR RES, V59, P199, DOI 10.1016/S0920-9964(01)00341-3; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Cadenhead KS, 1998, BIOL PSYCHIAT, V43, P132, DOI 10.1016/S0006-3223(97)00316-8; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dannlowski U, 2007, PSYCHIAT RES-NEUROIM, V154, P13, DOI 10.1016/j.pscychresns.2006.05.005; Dannlowski U, 2009, INT J NEUROPSYCHOPH, V12, P11, DOI 10.1017/S1461145708008973; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ekman P, 2003, ANN NY ACAD SCI, V1000, P205, DOI 10.1196/annals.1280.010; EKMAN P, 1969, PSYCHIATR, V32, P88, DOI 10.1080/00332747.1969.11023575; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gur RE, 2007, ARCH GEN PSYCHIAT, V64, P1356, DOI 10.1001/archpsyc.64.12.1356; Gurrera RJ, 2005, J NERV MENT DIS, V193, P714, DOI 10.1097/01.nmd.0000185938.30783.6b; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Johnston PJ, 2005, EUR J NEUROSCI, V22, P1221, DOI 10.1111/j.1460-9568.2005.04294.x; Killgore WDS, 2007, SOC NEUROSCI-UK, V2, P28, DOI 10.1080/17470910701214186; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kosaka H, 2002, SCHIZOPHR RES, V57, P87, DOI 10.1016/S0920-9964(01)00324-3; KRAUSE R, 1989, PSYCHIATRY, V52, P1; Lehrl S, 1995, ACTA NEUROL SCAND, V91, P333; Lundqvist D., 1998, KAROLINSKA DIRECTED; Lysaker Paul H, 2004, Health Qual Life Outcomes, V2, P15, DOI 10.1186/1477-7525-2-15; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Masten CL, 2011, J COGNITIVE NEUROSCI, V23, P1042, DOI 10.1162/jocn.2010.21520; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; MORRISON RL, 1988, SCHIZOPHRENIA BULL, V14, P67, DOI 10.1093/schbul/14.1.67; NEELEMAN J, 1994, SOC PSYCH PSYCH EPID, V29, P46; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Phillips ML, 1998, BRIT J PSYCHIAT, V172, P373, DOI 10.1192/bjp.172.5.373; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; Rozin P., 1993, HDB EMOTIONS, P575; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; Schneider F, 1998, SCHIZOPHR RES, V34, P133, DOI 10.1016/S0920-9964(98)00085-1; Schwab R., 1997, EINSAMKEIT GRUNDLAGE; Shepherd AM, 2012, BIOL PSYCHIAT, V72, P775, DOI 10.1016/j.biopsych.2012.04.020; Sherman GD, 2011, EMOT REV, V3, P245, DOI 10.1177/1754073911402396; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Suslow T, 2003, COMPR PSYCHIAT, V44, P303, DOI 10.1016/S0010-440X(03)00085-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	54	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85014	10.1371/journal.pone.0085014	http://dx.doi.org/10.1371/journal.pone.0085014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465469	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100020
J	Degache, F; Van Zaen, J; Oehen, L; Guex, K; Trabucchi, P; Millet, G				Degache, Francis; Van Zaen, Jerome; Oehen, Lukas; Guex, Kenny; Trabucchi, Pietro; Millet, Gegoire			Alterations in Postural Control during the World's Most Challenging Mountain Ultra-Marathon	PLOS ONE			English	Article							ANKLE PLANTARFLEXOR FATIGUE; SLEEP-DEPRIVATION; LOCAL FATIGUE; OPEN-LOOP; COGNITIVE PERFORMANCE; MUSCLE FATIGUE; FOOT MUSCLES; LOWER-LIMBS; BALANCE; STABILITY	We investigated postural control (PC) effects of a mountain ultra-marathon (MUM): a 330-km trail run with 24000 m of positive and negative change in elevation. PC was assessed prior to (PRE), during (MID) and after (POST) the MUM in experienced ultra-marathon runners (n = 18; finish time = 126 +/- 16 h) and in a control group (n = 8) with a similar level of sleep deprivation. Subjects were instructed to stand upright on a posturographic platform over a period of 51.2 seconds using a double-leg stance under two test conditions: eyes open (EO) and eyes closed (EC). Traditional measures of postural stability (center of pressure trajectory analysis) and stabilogram-diffusion analysis (SDA) parameters were analysed. For the SDA, a significantly greater short-term effective diffusion was found at POST compared with PRE in the medio-lateral (ML; Dxs) and antero-posterior (AP) directions (Dys) in runners (p<0.05) The critical time interval (Ctx) in the ML direction was significantly higher at MID (p<0.001) and POST (p<0.05) than at PRE in runners. At MID (p<0.001) and POST (p<0.05), there was a significant difference between the two groups. The critical displacement (Cdx) in the ML was significantly higher at MID and at POST (p<0.001) compared with PRE for runners. A significant difference in Cdx was observed between groups in EO at MID (p<0.05) and POST (p<0.005) in the ML direction and in EC at POST in the ML and AP directions (p<0.05). Our findings revealed significant effects of fatigue on PC in runners, including, a significant increase in Ctx (critical time in ML plan) in EO and EC conditions. Thus, runners take longer to stabilise their body at POST than at MID. It is likely that the mountainous characteristics of MUM (unstable ground, primarily uphill/downhill running, and altitude) increase this fatigue, leading to difficulty in maintaining balance.	[Degache, Francis] Univ Appl Sci Western Switzerland, Sch Hlth Sci, Hlth Res Unit, Lausanne, Switzerland; [Van Zaen, Jerome] Ecole Polytech Fed Lausanne, Appl Signal Proc Grp, Lausanne, Switzerland; [Oehen, Lukas; Millet, Gegoire] Univ Lausanne, Dept Physiol, Inst Sports Sci, Fac Biol & Med, Lausanne, Switzerland; [Guex, Kenny] Univ Appl Sci Western Switzerland, Dept Physiotherapy, Sch Hlth Sci, Lausanne, Switzerland; [Trabucchi, Pietro] Univ Verona, Fac Sports Sci, I-37100 Verona, Italy	University of Applied Sciences & Arts Western Switzerland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Applied Sciences & Arts Western Switzerland; University of Verona	Degache, F (corresponding author), Univ Appl Sci Western Switzerland, Sch Hlth Sci, Hlth Res Unit, Lausanne, Switzerland.	francis.degache@hesav.ch	Degache, Francis/Y-8618-2019	Degache, Francis/0000-0002-1620-9330; Millet, Gregoire/0000-0001-8081-4423				Avni N, 2006, PSYCHIAT CLIN NEUROS, V60, P340, DOI 10.1111/j.1440-1819.2006.01511.x; BIGLANDRITCHIE BR, 1986, J PHYSIOL-LONDON, V379, P451, DOI 10.1113/jphysiol.1986.sp016263; Bove M, 2007, NEUROSCI LETT, V418, P276, DOI 10.1016/j.neulet.2007.03.036; Boyas S, 2013, NEUROSCI LETT, V547, P48, DOI 10.1016/j.neulet.2013.05.003; Boyas S, 2013, GAIT POSTURE, V37, P547, DOI 10.1016/j.gaitpost.2012.09.014; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Burdet C, 2004, SCI SPORT, V19, P308, DOI 10.1016/j.scispo.2004.02.003; Caron O, 2003, NEUROSCI LETT, V340, P83, DOI 10.1016/S0304-3940(02)01455-6; Caron O, 2004, NEUROSCI LETT, V363, P18, DOI 10.1016/j.neulet.2004.03.038; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; COLLINS JJ, 1995, CHAOS, V5, P57, DOI 10.1063/1.166086; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; Delignieres D, 2003, J MOTOR BEHAV, V35, P86, DOI 10.1080/00222890309602124; Doppelmayr MM, 2005, PERCEPT MOTOR SKILL, V100, P473; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Fabbri M, 2006, NEUROPSYCHOLOGIA, V44, P2520, DOI 10.1016/j.neuropsychologia.2006.03.033; Fourchet F, 2012, EUR J APPL PHYSIOL, V112, P2645, DOI 10.1007/s00421-011-2220-9; Gimmon Y, 2011, J ELECTROMYOGR KINES, V21, P922, DOI 10.1016/j.jelekin.2011.08.005; Gribble PA, 2004, PERCEPT MOTOR SKILL, V99, P1035, DOI 10.2466/pms.99.3.1035-1045; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Headlee DL, 2008, J ELECTROMYOGR KINES, V18, P420, DOI 10.1016/j.jelekin.2006.11.004; Henriksson N.G., 1967, ACTA OTO-LARYNGOL, V224, P272; Hoffman MD, 2012, WILD ENVIRON MED, V23, P56, DOI 10.1016/j.wem.2011.11.001; INGLIN B, 1988, J GERONTOL, V43, pM105, DOI 10.1093/geronj/43.4.M105; JETTE AM, 1990, J GERONTOL, V45, pM203, DOI 10.1093/geronj/45.6.M203; Johnston RB, 1998, MED SCI SPORT EXER, V30, P1703, DOI 10.1097/00005768-199812000-00008; Kelly LA, 2011, CLIN BIOMECH BRISTOL; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Ledin T, 2004, GAIT POSTURE, V19, P184, DOI 10.1016/S0966-6362(03)00061-4; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Liebovitch LS, 1997, PHYS REV E, V56, P4557, DOI 10.1103/PhysRevE.56.4557; Liu Y, 2001, OCCUP MED-OXFORD, V51, P490, DOI 10.1093/occmed/51.8.490; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Mello RGT, 2010, IEEE ENG MED BIO, P2415, DOI 10.1109/IEMBS.2010.5626154; Mello RGT, 2009, IEEE ENG MED BIO, P1351, DOI 10.1109/IEMBS.2009.5334148; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nakano T, 2001, PSYCHIAT CLIN NEUROS, V55, P277, DOI 10.1046/j.1440-1819.2001.00858.x; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; NELSON DL, 1985, MED SCI SPORT EXER, V17, P445, DOI 10.1249/00005768-198508000-00007; O'Connor KM, 2004, CLIN BIOMECH, V19, P71, DOI 10.1016/j.clinbiomech.2003.09.001; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Pedersen J, 1998, NEUROSCIENCE, V84, P953, DOI 10.1016/S0306-4522(97)00403-X; Robach P, 2012, SCAND J MED SCI SPOR; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Sargent C, 2010, CHRONOBIOL INT, V27, P911, DOI 10.3109/07420528.2010.488901; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Schlesinger A, 1998, NEUROREPORT, V9, P49, DOI 10.1097/00001756-199801050-00010; Schutz UHW, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-78; Shumway-Cook A, 2007, MOTOR CONTROL THEY P; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tseng BY, 2010, STROKE RES TREAT, V2010, DOI 10.4061/2010/412964; Vitiello D, 2013, INT J CARDIOL, V165, P391, DOI 10.1016/j.ijcard.2012.08.053; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wojcik LA, 2011, HUM MOVEMENT SCI, V30, P574, DOI 10.1016/j.humov.2010.03.008; Wuehr M, 2013, J NEUROL, V260, P1314, DOI 10.1007/s00415-012-6797-7; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	68	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84554	10.1371/journal.pone.0084554	http://dx.doi.org/10.1371/journal.pone.0084554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465417	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500008
J	Liu, Y; Cao, L; Li, ZQ; Zhou, DZ; Liu, WQ; Shen, Q; Wu, YT; Zhang, D; Hu, X; Wang, T; Ye, JY; Weng, XL; Zhang, H; Zhang, D; Zhang, Z; Liu, FT; He, L; Shi, YY				Liu, Yun; Cao, Lan; Li, Zhiqiang; Zhou, Daizhan; Liu, Wanqing; Shen, Qin; Wu, Yanting; Zhang, Dan; Hu, Xun; Wang, Ting; Ye, Junyi; Weng, Xiaoling; Zhang, Hong; Zhang, Di; Zhang, Zhou; Liu, Fatao; He, Lin; Shi, Yongyong			A Genome-Wide Association Study Identifies a Locus on TERT for Mean Telomere Length in Han Chinese	PLOS ONE			English	Article							GENETIC-VARIATION; QUANTITATIVE PCR; COMMON VARIANTS; LUNG-CANCER; RISK; POPULATION; SUSCEPTIBILITY	Leukocyte telomere length (LTL) is a predictor of aging and a number of age-related diseases. We performed genome-wide association studies of mean LTL in 2632 individuals, with a two-stage replication in 3917 individuals from Chinese populations. To further validate our findings, we get the results of 696 samples from a cohort of European ancestry. We identified two loci associated with LTL that map in telomerase reverse transcriptase (TERT; rs2736100, P = 1.93x10(-5)) on chromosome 5p15.33 and near keratin 80 (KRT80; rs17653722, P = 6.96x10(-6)) on 12q13.13. In Chinese population each C allele of rs2736100 and T allele of rs17653722 was associated with a longer mean telomere length of 0.026 and 0.059 T/S, respectively, equivalent to about 3 and 7 years of average age-related telomere attrition. Our findings provide new insights into telomere regulatory mechanism and even pathogenesis of age-related diseases.	[Liu, Yun; Cao, Lan; Ye, Junyi; Weng, Xiaoling; Zhang, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Zhiqiang; Zhou, Daizhan; Zhang, Di; Zhang, Zhou; He, Lin; Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Liu, Wanqing] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA; [Shen, Qin; Wang, Ting; Liu, Fatao] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Grad Sch, Shanghai, Peoples R China; [Wu, Yanting; Zhang, Dan] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China; [Hu, Xun] Ruijin Hosp, Luwan Branch, Dept Stomatol, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Shanghai Jiao Tong University	He, L (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helin@bio-x.cn; shiyongyong@gmail.com	Li, Zhiqiang/AAI-4003-2021; wang, tingting/AAK-2640-2020; Shi, Yongyong/GSO-1627-2022	Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; Wu, Yanting/0000-0002-2293-1792	Natural Science Foundation of China [81130022, 81272302, 31000553, 81121001]; National 863 project [2012AA02A515]; 973 Program [2010CB529600]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1025]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201026]; Shanghai Rising-Star Program [12QA1401900]; "Shu Guang" project; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12SG17]; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 project(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Rising-Star Program; "Shu Guang" project(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University	This work was supported by the Natural Science Foundation of China (81130022, 81272302, 31000553, 81121001); the National 863 project (2012AA02A515); the 973 Program (2010CB529600); Program for Changjiang Scholars and Innovative Research Team in University (IRT1025); the Foundation for the Author of National Excellent Doctoral Dissertation of China (201026); Shanghai Rising-Star Program (12QA1401900); "Shu Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12SG17); and start-up fund (WL) from the Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Hosgood HD, 2009, LUNG CANCER, V66, P157, DOI 10.1016/j.lungcan.2009.02.005; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Ke JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062485; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059230; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Liu Y, 2008, DIABETOLOGIA, V51, P2134, DOI 10.1007/s00125-008-1141-6; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Shen M, 2011, LUNG CANCER, V73, P133, DOI 10.1016/j.lungcan.2010.11.009; Shen Q, 2012, J CLIN ENDOCR METAB, V97, P1371, DOI 10.1210/jc.2011-1562; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043	37	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85043	10.1371/journal.pone.0085043	http://dx.doi.org/10.1371/journal.pone.0085043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465473	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500030
J	Min, SY; Yan, F; Zhang, YL; Ye, XQ; Zhong, MQ; Cao, JS; Zou, HY; Chen, JH				Min, Shaoying; Yan, Fang; Zhang, Yueling; Ye, Xiangqun; Zhong, Mingqi; Cao, Jinsong; Zou, Haiying; Chen, Jiehui			Characterization of a Novel Hemolytic Activity of Human IgG Fractions Arising from Diversity in Protein and Oligosaccharide Components	PLOS ONE			English	Article							SHRIMP PENAEUS-VANNAMEI; IMMUNE-SYSTEM; ERYTHROCYTE-MEMBRANE; LITOPENAEUS-VANNAMEI; ALPHA-HEMOLYSIN; IDENTIFICATION; GLYCOSYLATION; HEMOCYANIN; BINDING; INVERTEBRATE	Human IgG is a well-established multifunctional antigen specific immunoglobulin molecule of the adaptive immune system. However, an antigen nonspecific immunological function of human IgG has never been reported. In this study, human IgG was isolated using ammonium sulfate fractional precipitation and diethylaminoethanol (DEAE) cellulose 52 ion exchange chromatography, from which h-IgG and hs-IgG fractions were purified on the basis of their differential binding to rabbit anti-shrimp hemocyanin antibody (h) and rabbit anti-shrimp hemocyanin's small subunit antibody (hs), respectively. We found that h-IgG had a higher hemolytic activity than hs-IgG against erythrocytes from humans, rabbits, mice and chickens, whereas the control IgG showed negligible activity. h-IgG could interact directly with erythrocyte membranes, and this interaction was suppressed by high molecular weight osmoprotectants, showing that it may follow a colloid-osmotic mechanism. In comparative proteomics and glycomics studies, h-IgG and hs-IgG yielded 20 and 5 significantly altered protein spots, respectively, on a 2-D gel. The mean carbohydrate content of h-IgG and hs-IgG was approximately 3.6- and 2-fold higher than that of IgG, respectively, and the alpha-D-mannose/alpha-D-glucose content was in the order of h-IgG. hs-IgG. IgG. In this study, a novel antigen nonspecific immune property of human IgG was investigated, and the diversity in the protein constituents and glycosylation levels may have functional signficance.	[Min, Shaoying; Yan, Fang; Zhang, Yueling; Zhong, Mingqi; Cao, Jinsong; Chen, Jiehui] Shantou Univ, Dept Biol, Shantou, Peoples R China; [Min, Shaoying; Yan, Fang; Zhang, Yueling; Zhong, Mingqi; Cao, Jinsong; Chen, Jiehui] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Peoples R China; [Yan, Fang] Mariculture Inst Shandong Prov, Qingdao, Peoples R China; [Ye, Xiangqun; Zou, Haiying] Shantou Univ, Coll Med, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University	Zhang, YL (corresponding author), Shantou Univ, Dept Biol, Shantou, Peoples R China.	zhangyl@stu.edu.cn			National Natural Science Foundation of China [31072237]; New Century Excellent Talents Program of Ministry of Education of China [NCET-11-0922]; Natural Science Foundation of Guangdong Province [10251503101000002]; Guangdong Province College Talent Introduction Project Special Funds; Key Innovation Project of Science and Technology of Guangdong Province College [2012CXZD0025]; Academic Innovation Team Construction Project of Shantou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Program of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Province College Talent Introduction Project Special Funds; Key Innovation Project of Science and Technology of Guangdong Province College; Academic Innovation Team Construction Project of Shantou University	This work was sponsored by National Natural Science Foundation of China (No. 31072237), New Century Excellent Talents Program of Ministry of Education of China (No. NCET-11-0922), Natural Science Foundation of Guangdong Province (No. 10251503101000002), Guangdong Province College Talent Introduction Project Special Funds (2011), The Key Innovation Project of Science and Technology of Guangdong Province College (No. 2012CXZD0025) and Academic Innovation Team Construction Project of Shantou University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda FJ, 2005, BBA-BIOMEMBRANES, V1713, P51, DOI 10.1016/j.bbamem.2005.05.003; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; Danchaivijitr P, 2011, AM J HEMATOL, V86, P331, DOI 10.1002/ajh.21950; Dishaw LJ, 2011, P NATL ACAD SCI USA, V108, P16747, DOI 10.1073/pnas.1109687108; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; FigueroaSoto CG, 1997, COMP BIOCHEM PHYS B, V117, P203, DOI 10.1016/S0305-0491(96)00321-5; FLEISCHMAN JB, 1963, BIOCHEM J, V88, P220, DOI 10.1042/bj0880220; Gala FA, 2002, J BIOL CHEM, V277, P29005, DOI 10.1074/jbc.M203258200; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Gu S, 2008, PROTEOMICS, V8, P3061, DOI 10.1002/pmic.200700715; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; Hoek RM, 1996, EUR J IMMUNOL, V26, P939, DOI 10.1002/eji.1830260433; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hou SZ, 2011, CHEM-BIOL INTERACT, V192, P184, DOI 10.1016/j.cbi.2011.03.007; Hughes AL, 1997, BIOESSAYS, V19, P777, DOI 10.1002/bies.950190907; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kang B, 2000, PROG BIOCHEM BIOPHYS, V27, P210; Kasahara M, 2004, TRENDS IMMUNOL, V25, P105, DOI 10.1016/j.it.2003.11.005; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; LASER H, 1951, SCIENCE, V113, P609, DOI 10.1126/science.113.2943.609; LEDDY JP, 1993, J CLIN INVEST, V91, P1672, DOI 10.1172/JCI116376; LIN DC, 1979, BIOCHEM BIOPH RES CO, V91, P761, DOI 10.1016/0006-291X(79)91945-4; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P1214, DOI 10.1073/pnas.74.3.1214; Promdonkoy B, 2003, BIOCHEM J, V374, P255, DOI 10.1042/BJ20030437; Qiao J, 2011, FISH SHELLFISH IMMUN, V31, P736, DOI 10.1016/j.fsi.2011.07.005; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schluter SF, 1999, DEV COMP IMMUNOL, V23, P107; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; STEFANINI M, 1961, AM J MED SCI, V242, P303, DOI 10.1097/00000441-196109000-00005; Thomas P, 2009, SCIENCE, V325, P393, DOI 10.1126/science.325_393a; TITANI K, 1965, SCIENCE, V149, P1090, DOI 10.1126/science.149.3688.1090; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhang YL, 2006, J PROTEOME RES, V5, P815, DOI 10.1021/pr0503984; Zhang YL, 2004, J EXP MAR BIOL ECOL, V301, P39, DOI 10.1016/j.jembe.2003.09.011; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017	48	3	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85711	10.1371/journal.pone.0085711	http://dx.doi.org/10.1371/journal.pone.0085711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465658	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500094
J	Pong, T; Scherrer-Crosbie, M; Atochin, DN; Bloch, KD; Huang, PL				Pong, Terrence; Scherrer-Crosbie, Marielle; Atochin, Dmitriy N.; Bloch, Kenneth D.; Huang, Paul L.			Phosphomimetic Modulation of eNOS Improves Myocardial Reperfusion and Mimics Cardiac Postconditioning in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PERCUTANEOUS CORONARY INTERVENTION; BLOOD-FLOW; CONTRAST ECHOCARDIOGRAPHY; PARADIGM SHIFT; IN-VIVO; INJURY; INFARCTION; ISCHEMIA; HEART	Objective: Myocardial infarction resulting from ischemia-reperfusion injury can be reduced by cardiac postconditioning, in which blood flow is restored intermittently prior to full reperfusion. Although key molecular mechanisms and prosurvival pathways involved in postconditioning have been identified, a direct role for eNOS-derived NO in improving regional myocardial perfusion has not been shown. The objective of this study is to measure, with high temporal and spatial resolution, regional myocardial perfusion during ischemia-reperfusion and postconditioning, in order to determine the contribution of regional blood flow effects of NO to infarct size and protection. Methods and Results: We used myocardial contrast echocardiography to measure regional myocardial blood flow in mice over time. Reperfusion after myocardial ischemia-reperfusion injury is improved by postconditioning, as well as by phosphomimetic eNOS modulation. Knock-in mice expressing a phosphomimetic S1176D form of eNOS showed improved myocardial reperfusion and significantly reduced infarct size. eNOS knock-out mice failed to show cardioprotection from postconditioning. The size of the no-reflow zone following ischemia-reperfusion is substantially reduced by postconditioning and by the phosphomimetic eNOS mutation. Conclusions and Significance: Using myocardial contrast echocardiography, we show that temporal dynamics of regional myocardial perfusion restoration contribute to reduced infarct size after postconditioning. eNOS has direct effects on myocardial blood flow following ischemia-reperfusion, with reduction in the size of the no-reflow zone. These results have important implications for ongoing clinical trials on cardioprotection, because the degree of protective benefit may be significantly influenced by the regional hemodynamic effects of eNOS-derived NO.	[Pong, Terrence; Scherrer-Crosbie, Marielle; Atochin, Dmitriy N.; Bloch, Kenneth D.; Huang, Paul L.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Pong, Terrence; Huang, Paul L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Pong, Terrence; Huang, Paul L.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Scherrer-Crosbie, Marielle] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiac Ultrasound Lab, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Huang, PL (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA.	phuang1@partners.org	Atochin, Dmitriy/Q-3150-2016; Atochin, Dmitriy/AAH-8843-2020	Huang, Paul/0000-0002-5436-8658; Atochin, Dmitriy/0000-0002-2405-2070	American Heart Association; NIH [R01 NS33335, HL57818]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033335] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by an American Heart Association predoctoral fellowship to T. Pong and by NIH R01 NS33335 and HL57818 to P. Huang. THe funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Costa ADT, 2008, CARDIOVASC RES, V77, P344, DOI 10.1093/cvr/cvm050; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Huang PL, 2005, CIRC RES, V96, P1129, DOI 10.1161/01.RES.0000170705.56583.45; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Kashiwagi S, 2013, BIOCHEM BIOPH RES CO, V431, P284, DOI 10.1016/j.bbrc.2012.12.110; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; KAUL S, 1989, J AM COLL CARDIOL, V13, P468, DOI 10.1016/0735-1097(89)90528-7; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; Kitakaze M, 1998, HEART VESSELS, V13, P211, DOI 10.1007/BF03257244; Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274; Laskey WK, 2008, CATHETER CARDIO INTE, V72, P212, DOI 10.1002/ccd.21583; Lefer DJ, 2011, J CARDIOVASC PHARM T, V16, P332, DOI 10.1177/1074248411414155; LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; Mewton N, 2010, DIS MODEL MECH, V3, P39, DOI 10.1242/dmm.004309; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Raher MJ, 2007, CIRCULATION, V116, P1250, DOI 10.1161/CIRCULATIONAHA.107.707737; Reffelmann T, 2006, BASIC RES CARDIOL, V101, P359, DOI 10.1007/s00395-006-0615-2; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Scherrer-Crosbie M, 2000, J AM SOC ECHOCARDIOG, V13, P353, DOI 10.1016/S0894-7317(00)70004-6; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Thibault H, 2008, CIRCULATION, V117, P1037, DOI 10.1161/CIRCULATIONAHA.107.729780; Wei K, 1998, CIRCULATION, V97, P473; Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	38	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85946	10.1371/journal.pone.0085946	http://dx.doi.org/10.1371/journal.pone.0085946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465805	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500152
J	Steidl, S; Wang, HL; Wise, RA				Steidl, Stephan; Wang, Huiling; Wise, Roy A.			Lesions of Cholinergic Pedunculopontine Tegmental Nucleus Neurons Fail to Affect Cocaine or Heroin Self-Administration or Conditioned Place Preference in Rats	PLOS ONE			English	Article							ACETYLCHOLINE-RELEASE; GLUTAMATE RECEPTORS; DOPAMINE EFFLUX; BRAIN; AREA; STIMULATION; REWARD; INVOLVEMENT; ACTIVATION; ACCUMBENS	Cholinergic input to the ventral tegmental area (VTA) is known to contribute to reward. Although it is known that the pedunculopontine tegmental nucleus (PPTg) provides an important source of excitatory input to the dopamine system, the specific role of PPTg cholinergic input to the VTA in cocaine reward has not been previously determined. We used a diphtheria toxin conjugated to urotensin-II (Dtx::UII), the endogenous ligand for urotensin-II receptors expressed by PPTg cholinergic but not glutamatergic or GABAergic cells, to lesion cholinergic PPTg neurons. Dtx::UII toxin infusion resulted in the loss of 95.78 (+/- 0.65)% of PPTg cholinergic cells but did not significantly alter either cocaine or heroin self-administration or the development of cocaine or heroin conditioned place preferences. Thus, cholinergic cells originating in PPTg do not appear to be critical for the rewarding effects of cocaine or of heroin.	[Steidl, Stephan; Wang, Huiling; Wise, Roy A.] NIDA, Intramural Res Program, NIH, US Dept HHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Steidl, S (corresponding author), Loyola Univ, Dept Psychol, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	ssteidl@luc.edu			National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile AS, 2002, P NATL ACAD SCI USA, V99, P11452, DOI 10.1073/pnas.162371899; BECHARA A, 1992, BEHAV NEUROSCI, V106, P798, DOI 10.1037/0735-7044.106.5.798; Clark SD, 2007, J NEUROCHEM, V102, P112, DOI 10.1111/j.1471-4159.2007.04529.x; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; Forster GL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0001.2002; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Ikemoto S, 2002, J NEUROSCI, V22, P9895; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Olmstead MC, 1998, J NEUROSCI, V18, P5035; Omelchenko N, 2006, J COMP NEUROL, V494, P863, DOI 10.1002/cne.20852; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rada PV, 2000, PHARMACOL BIOCHEM BE, V65, P375, DOI 10.1016/S0091-3057(99)00218-X; Rezayof A, 2007, EUR J PHARMACOL, V562, P92, DOI 10.1016/j.ejphar.2007.01.081; Schmidt HD, 2009, EUR J NEUROSCI, V30, P1358, DOI 10.1111/j.1460-9568.2009.06904.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Steidl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027538; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Westerink BHC, 1996, J NEUROSCI, V16, P2605; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Yeomans J, 1997, PHARMACOL BIOCHEM BE, V57, P915, DOI 10.1016/S0091-3057(96)00467-4; YEOMANS JS, 1993, BEHAV NEUROSCI, V107, P1077, DOI 10.1037/0735-7044.107.6.1077; YEOMANS JS, 1985, BRAIN RES, V329, P19, DOI 10.1016/0006-8993(85)90508-6; You ZB, 2008, J NEUROSCI, V28, P9021, DOI 10.1523/JNEUROSCI.0694-08.2008	28	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84412	10.1371/journal.pone.0084412	http://dx.doi.org/10.1371/journal.pone.0084412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465410	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500004
J	Hagiwara, K; Obayashi, T; Sakayori, N; Yamanishi, E; Hayashi, R; Osumi, N; Nakazawa, T; Nishida, K				Hagiwara, Kunie; Obayashi, Takeshi; Sakayori, Nobuyuki; Yamanishi, Emiko; Hayashi, Ryuhei; Osumi, Noriko; Nakazawa, Toru; Nishida, Kohji			Molecular and Cellular Features of Murine Craniofacial and Trunk Neural Crest Cells as Stem Cell-Like Cells	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; GENE; MIGRATION; DEFICIENT; MESODERM; LINEAGE; ORIGIN; SOX10; BETA	The outstanding differentiation capacities and easier access from adult tissues, cells derived from neural crest cells (NCCs) have fascinated scientists in developmental biology and regenerative medicine. Differentiation potentials of NCCs are known to depend on their originating regions. Here, we report differential molecular features between craniofacial (cNCCs) and trunk (tNCCs) NCCs by analyzing transcription profiles and sphere forming assays of NCCs from P0-Cre/floxed-EGFP mouse embryos. We identified up-regulation of genes linked to carcinogenesis in cNCCs that were not previously reported to be related to NCCs, which was considered to be, an interesting feature in regard with carcinogenic potentials of NCCs such as melanoma and neuroblastoma. Wnt signal related genes were statistically up-regulated in cNCCs, also suggesting potential involvement of cNCCs in carcinogenesis. We also noticed intense expression of mesenchymal and neuronal markers in cNCCs and tNCCs, respectively. Consistent results were obtained from in vitro sphere-forming and differentiation assays. These results were in accordance with previous notion about differential potentials of cNCCs and tNCCs. We thus propose that sorting NCCs from P0-Cre/floxed-EGFP mice might be useful for the basic and translational research of NCCs. Furthermore, these newly-identified genes up-regulated in cNCC would provide helpful information on NC-originating tumors, developmental disorders in NCC derivatives, and potential applications of NCCs in regenerative medicine.	[Hagiwara, Kunie; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, Sendai, Miyagi 980, Japan; [Obayashi, Takeshi] Tohoku Univ, Grad Sch Informat Sci, Div Appl Informat Human & Life Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Sakayori, Nobuyuki; Yamanishi, Emiko; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Aoba Ku, Sendai, Miyagi 980, Japan; [Hagiwara, Kunie; Hayashi, Ryuhei; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University	Osumi, N (corresponding author), Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Aoba Ku, Seiryo Cho, Sendai, Miyagi 980, Japan.	osumi@med.tohoku.ac.jp	Osumi, Noriko/T-2823-2019; Obayashi, Takeshi/E-9663-2011; Hayashi, Ryuhei/AAW-4737-2020	Osumi, Noriko/0000-0003-0548-6452; Obayashi, Takeshi/0000-0002-3106-722X; Nishida, Kohji/0000-0001-9069-3610; Sakayori, Nobuyuki/0000-0003-1611-4187; Hayashi, Ryuhei/0000-0002-4699-8617	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; KAKENHI from MEXT; Grants-in-Aid for Scientific Research [12J08042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a project for the realization of regenerative medicine from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan given to K.N. and by KAKENHI from MEXT to N.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Brault V, 2001, DEVELOPMENT, V128, P1253; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; Chandrasekharan S, 2002, MOL CELL BIOL, V22, P5235, DOI 10.1128/MCB.22.14.5235-5247.2002; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Conway SJ, 1997, DEVELOPMENT, V124, P505; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kikuchi M, 2011, GENES CELLS, V16, P273, DOI 10.1111/j.1365-2443.2011.01485.x; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Le Douarin N, 1999, NEURAL CREST, V36; LEE J, 1994, GENE, V138, P247, DOI 10.1016/0378-1119(94)90817-6; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; O'Neill ID, 2011, STEM CELLS, V29, P1909, DOI 10.1002/stem.751; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Platt JB, 1894, ECTODERMIC ORIGIN CA; Ros MA, 1997, DEVELOPMENT, V124, P1821; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Soriano P, 1997, DEVELOPMENT, V124, P2691; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stone L S, 1929, Wilhelm Roux Arch Entwickl Mech Org, V118, P40, DOI 10.1007/BF02108871; Stone LS, 1926, J EXP ZOOL, V44, P95, DOI 10.1002/jez.1400440104; Suzuki J, 2013, NEUROSCI RES, V75, P112, DOI 10.1016/j.neures.2012.11.005; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Team R, 2010, R LANG ENV STAT COMP; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; TISSIERSETA JP, 1995, MECH DEVELOP, V51, P3, DOI 10.1016/0925-4773(94)00343-L; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Trentin A, 2004, P NATL ACAD SCI USA, V101, P4495, DOI 10.1073/pnas.0400629101; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Wu JL, 2003, TRENDS NEUROSCI, V26, P40, DOI 10.1016/S0166-2236(02)00011-5; Xu LS, 2012, MOL CELL BIOCHEM, V364, P235, DOI 10.1007/s11010-011-1222-6; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	58	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84072	10.1371/journal.pone.0084072	http://dx.doi.org/10.1371/journal.pone.0084072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465393	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500008
J	Styer, AM; Roesch, SL; Argyropoulos, G				Styer, Amanda M.; Roesch, Stephen L.; Argyropoulos, George			Modulation of Fibroblast Growth Factor 19 Expression by Bile Acids, Meal Replacement and Energy Drinks, Milk, and Coffee	PLOS ONE			English	Article							DECAFFEINATED COFFEE; METABOLIC-RATE; WEIGHT-LOSS; RISK; FIBROBLAST-GROWTH-FACTOR-19; FGF19; ACTIVATION; INDUCTION; CAFFEINE	Background: The enterohepatic pathway involving the fibroblast growth factor 19 (FGF19) and bile acids (BA) has been linked with the etiology and remission of type 2 diabetes (T2D) following Roux-en-Y gastric bypass (RYGB) surgery. Specifically, diabetic patients had lower FGF19 circulating levels but postoperative FGF19 and BA levels were higher in diabetic patients that experience remission of T2D, as compared to non-diabetic patients and diabetic patients that do not experience remission. It has been proposed that this may be due to the direct flow of digestate-free bile acids into the ileum benefiting mostly T2D patients without severe diabetes. Methods/Results: We used a human colorectal cell line (LS174T) that endogenously expresses FGF19, real time PCR, and Elisas for precise quantitation of FGF19 mRNA and secreted protein levels. We report here that BA and fractions of BA stimulated FGF19 in vitro but this effect was partially blocked when BA were pre-incubated with a lipoprotein mix which emulates digested food. In addition, we show that FGF19 mRNA was stimulated by meal replacement drinks (Ensure, Glucerna, SlimFast), non-fat milk, and coffee which has been linked with reduced risk for developing diabetes. Pure caffeine and the 5-hour Energy drink, on the other hand, decreased FGF19 mRNA. Conclusions: In summary, FGF19 expression in vitro is modifiable by popular drinks suggesting that such approaches could potentially be used for modulating FGF19 expression in humans.	[Styer, Amanda M.; Roesch, Stephen L.; Argyropoulos, George] Geisinger Hlth Syst, Weis Ctr Res, Danville, PA 17821 USA; [Argyropoulos, George] Geisinger Hlth Syst, Inst Obes, Danville, PA USA	Geisinger Health System; Geisinger Health System	Argyropoulos, G (corresponding author), Geisinger Hlth Syst, Weis Ctr Res, Danville, PA 17821 USA.	gargyropoulos1@geisinger.edu						Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603; Cheng BA, 2011, J AGR FOOD CHEM, V59, P13147, DOI 10.1021/jf201702h; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Foster GD, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.3; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Ge HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033603; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Gerhard GS, 2013, INT J OBES; Gerhard GS, 2013, DIABETES CA IN PRESS; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Keogh JB, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/918571; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Miyata M, 2012, J STEROID BIOCHEM, V132, P41, DOI 10.1016/j.jsbmb.2012.04.008; Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93; Wistuba W, 2007, WORLD J GASTROENTERO, V13, P4230, DOI 10.3748/wjg.v13.i31.4230; Wu X, J BIOL CHEM, V285, P5165; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang JH, 2013, AM J PHYSIOL-GASTR L, V304, pG940, DOI 10.1152/ajpgi.00398.2012; Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251	32	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85558	10.1371/journal.pone.0085558	http://dx.doi.org/10.1371/journal.pone.0085558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465600	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500058
J	van Welzen, PC; Strijk, JS; van Konijnenburg-van Cittert, JHA; Nucete, M; Merckx, VSFT				van Welzen, Peter C.; Strijk, Joeri S.; van Konijnenburg-van Cittert, Johanna H. A.; Nucete, Monica; Merckx, Vincent S. F. T.			Dated Phylogenies of the Sister Genera Macaranga and Mallotus (Euphorbiaceae): Congruence in Historical Biogeographic Patterns?	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; SPECIES EUPHORBIACEAE; CENOZOIC TECTONICS; DNA-SEQUENCE; DISTANCE; AFRICA; REGION; EAST; S.S.	Molecular phylogenies and estimates of divergence times within the sister genera Macaranga and Mallotus were estimated using Bayesian relaxed clock analyses of two generic data sets, one per genus. Both data sets were based on different molecular markers and largely different samples. Per genus three calibration points were utilised. The basal calibration point (crown node of all taxa used) was taken from literature and used for both taxa. The other three calibrations were based on fossils of which two were used per genus. We compared patterns of dispersal and diversification in Macaranga and Mallotus using ancestral area reconstruction in RASP (S-DIVA option) and contrasted our results with biogeographical and geological records to assess accuracy of inferred age estimates. A check of the fossil calibration point showed that the Japanese fossil, used for dating the divergence of Mallotus, probably had to be attached to a lower node, the stem node of all pioneer species, but even then the divergence time was still younger than the estimated age of the fossil. The African (only used in the Macaranga data set) and New Zealand fossils (used for both genera) seemed reliably placed. Our results are in line with existing geological data and the presence of stepping stones that provided dispersal pathways from Borneo to New Guinea-Australia, from Borneo to mainland Asia and additionally at least once to Africa and Madagascar via land and back to India via Indian Ocean island chains. The two genera show congruence in dispersal patterns, which corroborate divergence time estimates, although the overall mode and tempo of dispersal and diversification differ significantly as shown by distribution patterns of extant species.	[van Welzen, Peter C.; van Konijnenburg-van Cittert, Johanna H. A.; Nucete, Monica; Merckx, Vincent S. F. T.] Nat Biodivers Ctr, Sect Herbarium, Leiden, Netherlands; [van Welzen, Peter C.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Strijk, Joeri S.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	van Welzen, PC (corresponding author), Nat Biodivers Ctr, Sect Herbarium, Leiden, Netherlands.	peter.vanwelzen@naturalis.nl	Merckx, Vincent/C-6025-2011; Strijk, Joeri S./F-8220-2019; van Welzen, Peter/GYR-0640-2022	Merckx, Vincent/0000-0002-3959-8623; Strijk, Joeri S./0000-0003-1109-7015; 				[Anonymous], 2014, TRACER V1 6; Banfer G, 2006, MOL ECOL, V15, P4409, DOI 10.1111/j.1365-294X.2006.03064.x; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Blattner FR, 2001, MOL PHYLOGENET EVOL, V19, P331, DOI 10.1006/mpev.2001.0941; Conti E, 2002, EVOLUTION, V56, P1931; De Boer A. J., 1995, Tijdschrift voor Entomologie, V138, P169; Drummond A.J., 2012, BEAST V 1 7 5; Drummond AJ, 2013, MOL BIOL EVOL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Govaerts R, 2000, WORLD CHECKLIST BIBL; Gradstein F.M., 2004, A; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Kubitzki K., 1996, FLORISTIC CHARACTERI, P65; Kulju KKM, 2007, BLUMEA, V52, P115, DOI 10.3767/000651907X612364; Kulju KKM, 2007, AM J BOT, V94, P1726, DOI 10.3732/ajb.94.10.1726; Lee DE, 2010, REV PALAEOBOT PALYNO, V163, P127, DOI 10.1016/j.revpalbo.2010.10.002; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Massini JLG, 2010, PALAEONTOL ELECTRON, V13; Metais G, 2009, J ASIAN EARTH SCI, V34, P154, DOI 10.1016/j.jseaes.2008.04.006; Michaux B, 2010, BIOL J LINN SOC, V101, P193, DOI 10.1111/j.1095-8312.2010.01473.x; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morley Robert J., 1998, P211; Nucete M, 2012, PALAEOGEOGR PALAEOCL, V353, P104, DOI 10.1016/j.palaeo.2012.07.016; Ogg J. G., 2008, CONCISE GEOLOGICAL T; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; Raes N, 2009, BLUMEA, V54, P6, DOI 10.3767/000651909X475888; Rambaut A., 2009, FIGTREE TREE FIGURE; Rambaut A., 2002, PHYLOGEN PHYLOGENETI, V1.1; Rogl F., 1999, EVOLUTION NEOGENE TE, V1, P8, DOI [10.1017/CBO9780511542329.002, DOI 10.1017/CBO9780511542329.002]; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; SCHMIDTKE EA, 1990, TECTONICS, V9, P123, DOI 10.1029/TC009i001p00123; Sierra SEC, 2007, BLUMEA, V52, P361, DOI 10.3767/000651907X609106; Sierra SEC, 2010, TAXON, V59, P101, DOI 10.1002/tax.591011; Slik JWF, 2003, ECOL INDIC, V2, P311; Slik JWF, 2001, SYST BOT, V26, P786; Strijk JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042932; TANAI T, 1990, Bulletin of the National Science Museum Series C (Geology and Paleontology), V16, P91; TANAI T, 1989, Bulletin of the National Science Museum Series C (Geology and Paleontology), V15, P121; Van Balgooy M. M. J., 1996, P191; van Ufford AQ, 2005, AAPG BULL, V89, P119, DOI 10.1306/08300403073; van Welzen PC, 2009, BLUMEA, V54, P25, DOI 10.3767/000651909X474078; Wakita K, 2005, J ASIAN EARTH SCI, V24, P679, DOI 10.1016/j.jseaes.2004.04.004; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Welzen P. C. van, 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P199; Whitmore TC, 2008, GENUS MACARANGA PROD; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Yu Y, 2011, SYSTEM BIOL IN PRESS; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou LL, 2012, J BIOGEOGR, V39, P322, DOI 10.1111/j.1365-2699.2011.02598.x	58	17	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85713	10.1371/journal.pone.0085713	http://dx.doi.org/10.1371/journal.pone.0085713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465660	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000054
J	Kindt, M; Soeter, M				Kindt, Merel; Soeter, Marieke			Fear Inhibition in High Trait Anxiety	PLOS ONE			English	Article							POTENTIATED STARTLE PARADIGM; CONDITIONED INHIBITION; EXTINCTION; MEMORY; TRACE; AWARENESS; RECONSOLIDATION; ACQUISITION; EXPRESSION; RETRIEVAL	Trait anxiety is recognized as an individual risk factor for the development of anxiety disorders but the neurobiological mechanisms remain unknown. Here we test whether trait anxiety is associated with impaired fear inhibition utilizing the AX+/BX-conditional discrimination procedure that allows for the independent evaluation of startle fear potentiation and inhibition of fear [1]. Sixty undergraduate students participated in the study - High Trait Anxious: n = 28 and Low Trait Anxious: n = 32. We replicated earlier findings that a transfer of conditioned inhibition for startle responses requires contingency awareness. However, contrary to the fear inhibition hypothesis, our data suggest that high trait anxious individuals show a normal fear inhibition of conditioned startle responding. Only at the cognitive level the high trait anxious individuals showed evidence for impaired inhibitory learning of the threat cue. Together with other findings where impaired fear inhibition was only observed in those PTSD patients who were either high on hyperarousal symptoms [2] or with current anxiety symptoms [3], we question whether impaired fear inhibition is a biomarker for the development of anxiety disorders.	[Kindt, Merel; Soeter, Marieke] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Kindt, Merel] Univ Amsterdam, Res Prior Program Brain & Cognit, Cognit Sci Ctr Amsterdam, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	m.kindt@uva.nl			Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	MK and MS are funded by a Vici grant (MK) from the Netherlands Organization for Scientific Research. The funders had no role in study design, decision to publish, or preparation of the manuscript.	BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Buchel C, 1999, J NEUROSCI, V19, P10869; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Craske MG, 2008, BEHAV RES THER, V46, P954, DOI 10.1016/j.brat.2008.04.011; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Davis M., 2000, CONT ISSUES MODELING; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Fendt M, 2005, BEHAV NEUROSCI, V119, P834, DOI 10.1037/0735-7044.119.3.834; Gazendam FJ, 2013, BIOL PSYCHOL, V92, P342, DOI 10.1016/j.biopsycho.2012.11.006; Grillon C, 2001, PSYCHOPHYSIOLOGY, V38, P807, DOI 10.1111/1469-8986.3850807; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Hamm AO, 1996, PSYCHOPHYSIOLOGY, V33, P698, DOI 10.1111/j.1469-8986.1996.tb02366.x; Jovanovic T, 2005, BIOL PSYCHIAT, V57, P1559, DOI 10.1016/j.biopsych.2005.02.025; Jovanovic T, 2006, BEHAV NEUROSCI, V120, P995, DOI 10.1037/0735-7044.120.5.995; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Liberman LC, 2006, BEHAV RES THER, V44, P1491, DOI 10.1016/j.brat.2005.11.004; Lissek S, 2009, BEHAV RES THER, V47, P111, DOI 10.1016/j.brat.2008.10.017; Myers KM, 2004, LEARN MEMORY, V11, P464, DOI 10.1101/lm.74704; Ormel J, 2004, SOC PSYCH PSYCH EPID, V39, P906, DOI 10.1007/s00127-004-0873-y; Pavlov I.P., 1927, CONDITIONED REFLEXES; RESCORLA RA, 1969, PSYCHOL BULL, V72, P77, DOI 10.1037/h0027760; Sevenster D, 2013, SCIENCE, V339, P830, DOI 10.1126/science.1231357; Sevenster D, 2012, PSYCHOPHYSIOLOGY, V49, P1426, DOI 10.1111/j.1469-8986.2012.01450.x; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2012, NEUROPSYCHOPHARMACOL, V37, P1204, DOI 10.1038/npp.2011.307; Soeter M, 2011, NEUROBIOL LEARN MEM, V96, P263, DOI 10.1016/j.nlm.2011.05.003; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x	34	34	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e86462	10.1371/journal.pone.0086462	http://dx.doi.org/10.1371/journal.pone.0086462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	24454969	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000026
J	Di, DD; Cui, BY; Wang, H; Zhao, HY; Piao, DR; Tian, LL; Tian, GZ; Kang, JL; Mao, X; Zhang, XJ; Du, PF; Zhu, L; Zhao, Z; Mao, LL; Yao, WQ; Guan, PY; Fan, WX; Jiang, H				Di, Dongdong; Cui, Buyun; Wang, Heng; Zhao, Hongyan; Piao, Dongri; Tian, Lili; Tian, Guozhong; Kang, Jingli; Mao, Xiang; Zhang, Xiaojun; Du, Pengfei; Zhu, Lin; Zhao, Zhuo; Mao, Lingling; Yao, Wenqing; Guan, Pingyuan; Fan, Weixing; Jiang, Hai			Genetic Polymorphism Characteristics of Brucella canis Isolated in China	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; SINGLE-NUCLEOTIDE POLYMORPHISMS; OUTER-MEMBRANE PROTEINS; TANDEM-REPEAT ANALYSIS; RAPID IDENTIFICATION; NUMBER; MELITENSIS; LADDER; SUIS; DISCRIMINATION	In China, brucellosis is an endemic disease typically caused by Brucella melitensis infection (biovars 1 and 3). Brucella canis infection in dogs has not traditionally recognized as a major problem. In recent years however, brucellosis resulting from Brucella canis infection has also been reported, suggesting that infections from this species may be increasing. Data concerning the epidemiology of brucellosis resulting from Brucella canis infection is limited. Therefore, the purpose of this study was to assess the diversity among Chinese Brucella canis strains for epidemiological purposes. First, we employed a 16-marker VNTR assay (Brucella MLVA-16) to assess the diversity and epidemiological relationship of 29 Brucella canis isolates from diverse locations throughout China with 38 isolates from other countries. MLVA-16 analysis separated the 67 Brucella canis isolates into 57 genotypes that grouped into five clusters with genetic similarity coefficients ranging from 67.73 to 100%. Moreover, this analysis revealed a new genotype (2-3-9-11-3-1-5-1:118), which was present in two isolates recovered from Guangxi in 1986 and 1987. Second, multiplex PCR and sequencing analysis were used to determine whether the 29 Chinese Brucella canis isolates had the characteristic BMEI1435 gene deletion. Only two isolates had this deletion. Third, amplification of the omp25 gene revealed that 26 isolates from China had a T545C mutation. Collectively, this study reveals that considerable diversity exists among Brucella canis isolates in China and provides resources for studying the genetic variation and microevolution of Brucella.	[Di, Dongdong; Tian, Lili; Kang, Jingli; Du, Pengfei; Zhu, Lin; Fan, Weixing] MOA, China Anim Hlth & Epidemiol Ctr, Lab Zoonoses, Qingdao, Peoples R China; [Cui, Buyun; Zhao, Hongyan; Piao, Dongri; Tian, Guozhong; Jiang, Hai] Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Heng] Hangzhou Ctr Dis Control & Prevent, Lab Endem & Parasit Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Mao, Xiang] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaojun] Jining Dist Agr & Anim Husb Bur, Jining Dist Anim Dis Control Ctr, Wulanchabu, Peoples R China; [Zhao, Zhuo; Mao, Lingling; Yao, Wenqing] Liaoning Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Guan, Pingyuan] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China	China Animal Health & Epidemiology Center; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Nanjing Agricultural University; Inner Mongolia Agricultural University	Yao, WQ (corresponding author), Liaoning Ctr Dis Control & Prevent, Shenyang, Peoples R China.	yaowenqing@lncdc.com; gpynm@sina.com; fwxsjl@126.com; jianghai@icdc.cn	zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [81271900]; Science and Technology Basic Work Program [2012FY111000]; MOST (Ministry of Science and Technology of the People's Republic of China) [2012ZX10004-209]; NIH	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Basic Work Program; MOST (Ministry of Science and Technology of the People's Republic of China)(Ministry of Science and Technology, China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Natural Science Foundation of China (81271900), the Science and Technology Basic Work Program (2012FY111000), MOST (Ministry of Science and Technology of the People's Republic of China) (2012ZX10004-209), and the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alton GG, 1975, MONOGR SER WHO, P1; Bricker BJ, 2002, VET MICROBIOL, V90, P435, DOI 10.1016/S0378-1135(02)00228-6; Cloeckaert A, 1996, FEMS MICROBIOL LETT, V145, P1, DOI 10.1016/0378-1097(96)00373-4; CLOECKAERT A, 1995, MICROBIOL-UK, V141, P2111, DOI 10.1099/13500872-141-9-2111; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; Gandara B, 2001, J CLIN MICROBIOL, V39, P235, DOI 10.1128/JCM.39.1.235-240.2001; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; Garcia-Yoldi D, 2007, J CLIN MICROBIOL, V45, P4070, DOI 10.1128/JCM.01096-07; Gopaul KK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-86; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Holst BS, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-18; Huber B, 2009, INT J MED MICROBIOL, V299, P563, DOI 10.1016/j.ijmm.2009.05.002; Jiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076332; Jiang H, 2012, VET MICROBIOL, V154, P419, DOI 10.1016/j.vetmic.2011.07.014; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kang SI, 2011, J VET MED SCI, V73, P779, DOI 10.1292/jvms.10-0334; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Koylass MS, 2010, VET MICROBIOL, V142, P450, DOI 10.1016/j.vetmic.2009.10.013; Kulakov YK, 2012, MOL GENET MICROBIOL+, V27, P167, DOI 10.3103/S0891416812040052; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; Lopez-Goni I, 2011, VET MICROBIOL, V154, P152, DOI 10.1016/j.vetmic.2011.06.035; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Moreno E, 2002, VET MICROBIOL, V90, P209, DOI 10.1016/S0378-1135(02)00210-9; Nomura A, 2010, EMERG INFECT DIS, V16, P1183, DOI 10.3201/eid1607.090209; OUAHRANI S, 1993, J GEN MICROBIOL, V139, P3265, DOI 10.1099/00221287-139-12-3265; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; Sayan M, 2011, JPN J INFECT DIS, V64, P516; Scott JC, 2007, APPL ENVIRON MICROB, V73, P7331, DOI 10.1128/AEM.00976-07; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Vizcaino N, 2000, MICROBES INFECT, V2, P1089, DOI 10.1016/S1286-4579(00)01263-6; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Whatmore AM, 2005, J CLIN MICROBIOL, V43, P761, DOI 10.1128/JCM.43.2.761-769.2005	38	20	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84862	10.1371/journal.pone.0084862	http://dx.doi.org/10.1371/journal.pone.0084862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465442	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000007
J	Kirchner, M; Schubert, P; Liebherr, M; Haas, CT				Kirchner, Marietta; Schubert, Patric; Liebherr, Magnus; Haas, Christian T.			Detrended Fluctuation Analysis and Adaptive Fractal Analysis of Stride Time Data in Parkinson's Disease: Stitching Together Short Gait Trials	PLOS ONE			English	Article							WALKING SPEED; OLDER-ADULTS; VARIABILITY; DYNAMICS; SERIES; QUANTIFICATION; RELIABILITY; COMPLEXITY; PARAMETERS; STABILITY	Variability indicates motor control disturbances and is suitable to identify gait pathologies. It can be quantified by linear parameters (amplitude estimators) and more sophisticated nonlinear methods (structural information). Detrended Fluctuation Analysis (DFA) is one method to measure structural information, e. g., from stride time series. Recently, an improved method, Adaptive Fractal Analysis (AFA), has been proposed. This method has not been applied to gait data before. Fractal scaling methods (FS) require long stride-to-stride data to obtain valid results. However, in clinical studies, it is not usual to measure a large number of strides (e. g., <100 strides). Amongst others, clinical gait analysis is limited due to short walkways, thus, FS seem to be inapplicable. The purpose of the present study was to evaluate FS under clinical conditions. Stride time data of five self-paced walking trials (25 strides each) of subjects with PD and a healthy control group (CG) was measured. To generate longer time series, stride time sequences were stitched together. The coefficient of variation (CV), fractal scaling exponents alpha (DFA) and H (AFA) were calculated. Two surrogate tests were performed: A) the whole time series was randomly shuffled; B) the single trials were randomly shuffled separately and afterwards stitched together. CV did not discriminate between PD and CG. However, significant differences between PD and CG were found concerning alpha and H. Surrogate version B yielded a higher mean squared error and empirical quantiles than version A. Hence, we conclude that the stitching procedure creates an artificial structure resulting in an overestimation of true alpha. The method of stitching together sections of gait seems to be appropriate in order to distinguish between PD and CG with FS. It provides an approach to integrate FS as standard in clinical gait analysis and to overcome limitations such as short walkways.	[Kirchner, Marietta; Schubert, Patric; Liebherr, Magnus; Haas, Christian T.] Univ Appl Sci, Hsch Fresenius, Fac Hlth & Social Sci, Idstein, Germany		Kirchner, M (corresponding author), Univ Appl Sci, Hsch Fresenius, Fac Hlth & Social Sci, Idstein, Germany.	marietta.kirchner@gmail.com			LOEWE focus PreBionics; Hilde-Ulrichs Foundation	LOEWE focus PreBionics; Hilde-Ulrichs Foundation	This research was supported by the LOEWE focus PreBionics and Hilde-Ulrichs Foundation for Parkinson's research. Please consult the website: http://praeventive-biomechanik.eu/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch R, 2007, PHYSICA A, V383, P455, DOI 10.1016/j.physa.2007.04.120; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Beauchet O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-37; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bloem BR, 2004, CLIN DISORDERS BALAN, V2, P173; Brach JS, 2008, ARCH PHYS MED REHAB, V89, P2293, DOI 10.1016/j.apmr.2008.06.010; Cavanaugh JT, 2010, J GERONTOL A-BIOL, V65, P197, DOI 10.1093/gerona/glp144; Chang MD, 2010, HUM MOVEMENT SCI, V29, P977, DOI 10.1016/j.humov.2010.04.009; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Delignieres D, 2011, COMPUT BIOL, V7; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Diniz A, 2011, HUM MOVEMENT SCI, V30, P889, DOI 10.1016/j.humov.2010.07.006; Dutta S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00274; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Frenkel-Toledo Silvi, 2005, J Neuroeng Rehabil, V2, P23, DOI 10.1186/1743-0003-2-23; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hausdorff J. M., 2005, J NEUROENG REHABIL, V2, P2; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; Kuznetsov N, 2013, ANN BIOMED ENG, V41, P1646, DOI 10.1007/s10439-012-0646-9; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Ota L., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P521, DOI 10.1109/ICCME.2012.6275643; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Priest AW, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-29; Riley MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00371; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schubert P, 2013, DEUT Z SPORTMED, V64, P132, DOI 10.5960/dzsm.2012.064; Simon SR, 2004, J BIOMECH, V37, P1869, DOI 10.1016/j.jbiomech.2004.02.047; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Winter DA, 1993, J MOTOR BEHAV, V15; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	57	41	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85787	10.1371/journal.pone.0085787	http://dx.doi.org/10.1371/journal.pone.0085787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465708	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000024
J	Ngarina, M; Tarimo, EAM; Naburi, H; Kilewo, C; Mwanyika-Sando, M; Chalamilla, G; Biberfeld, G; Ekstrom, AM				Ngarina, Matilda; Tarimo, Edith A. M.; Naburi, Helga; Kilewo, Charles; Mwanyika-Sando, Mary; Chalamilla, Guerino; Biberfeld, Gunnel; Ekstrom, Anna Mia			Women's Preferences Regarding Infant or Maternal Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission of HIV during Breastfeeding and Their Views on Option B plus in Dar es Salaam, Tanzania	PLOS ONE			English	Article							THERAPY; PREGNANCY; BOTSWANA; STIGMA	Background: The WHO 2010 guidelines for prevention of mother-to-child transmission (PMTCT) of HIV recommended prophylactic antiretroviral treatment (ART) either for infants (Option A) or mothers (Option B) during breastfeeding for pregnant women with a CD4 count of >350 cell/mu L in low-income countries. In 2012, WHO proposed that all HIV-infected pregnant women should receive triple ART for life (B+) irrespective of CD4 count. Tanzania has recently switched from Option A to B+, with a few centers practicing B. However, more information on the real-life feasibility of these options is needed. This qualitative study explored women's preferences for Option A vs B and their views on Option B+ in Dar es Salaam, Tanzania. Methods: We conducted four focus group discussions with a total of 27 pregnant women with unknown HIV status, attending reproductive and child health clinics, and 31 in-depth interviews among HIV-infected pregnant and post-delivery women, 17 of whom were also asked about B+. Results: Most participants were in favor of Option B compared to A. The main reasons for choosing Option B were: HIV-associated stigma, fear of drug side-effects on infants and difficult logistics for postnatal drug adherence. Some of the women asked about B+ favored it as they agreed that they would eventually need ART for their own survival. Some were against B+ anticipating loss of motivation after protecting the child, fearing drug side-effects and not feeling ready to embark on lifelong medication. Some were undecided. Conclusion: Option B was preferred. Since Tanzania has recently adopted Option B+, women with CD4 counts of >350 cell/mu L should be counseled about the possibility to "opt-out" from ART after cessation of breastfeeding. Drug safety and benefits, economic concerns and available resources for laboratory monitoring and evaluation should be addressed during B+ implementation to enhance long-term feasibility and effectiveness.	[Ngarina, Matilda] Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania; [Ngarina, Matilda; Biberfeld, Gunnel] Swedish Inst Communicable Dis Control, Solna, Sweden; [Ngarina, Matilda; Biberfeld, Gunnel] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Tarimo, Edith A. M.] Muhimbili Univ Hlth & Allied Sci, Dept Nursing Management, Dar Es Salaam, Tanzania; [Naburi, Helga] Muhimbili Univ Hlth & Allied Sci, Dept Pediat, Dar Es Salaam, Tanzania; [Naburi, Helga; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Naburi, Helga; Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Kilewo, Charles] Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania; [Mwanyika-Sando, Mary; Chalamilla, Guerino] Management & Dev Hlth, Dar Es Salaam, Tanzania	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Muhimbili University of Health & Allied Sciences	Ngarina, M (corresponding author), Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania.	mmosi_2@yahoo.com		Naburi, Helga/0000-0003-1659-5224	Swedish International Development Cooperation Agency (Sida)	Swedish International Development Cooperation Agency (Sida)	This study was funded by the Swedish International Development Cooperation Agency (Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarson AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053993; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; [Anonymous], 2012, COUNTRY PROGR REPORT; [Anonymous], 2005, QUALITATIVE INTERVIE; Bloor M, 2001, FOCUS GROUPS SOCIAL, DOI DOI 10.4135/9781849209175; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Creek TL, 2010, JAIDS-J ACQ IMM DEF, V53, P14, DOI 10.1097/QAI.0b013e3181bdf676; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gamell A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13775; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kuhn L, 2012, ADV EXP MED BIOL, V743, P273, DOI 10.1007/978-1-4614-2251-8_20; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Kvale S, 1996, INTERVIEWS INTRO QUA; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mepham SO, 2011, BJOG-INT J OBSTET GY, V118, P202, DOI 10.1111/j.1471-0528.2010.02733.x; Myers G, 2001, DEV FOCUS GROUP RES; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Patton M. Q., 1990, QUALITATIVE EVALUATI; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Tenthani LN, 2013, 7 INT AIDS SOC C HIV; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas KT, 2011, PLOS MED, V8; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; UNAIDS, REG FACT SHEET 2012; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; United republic of Tanzania, TANZ EL MTCT HIV PLA; *WHO, UN ACC SCAL PRIOR HI; WHO, 2010, WHO 2010 REVISED REC; WHO HIV/AIDS Programme, 2010, ANT DRUGS TREAT PREG; WHO/UNAIDS/UNICEF, 2011, GLOBAL HIV AIDS RESP; World Health Organization, 2012, PROGR UPD US ANT DRU	41	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85310	10.1371/journal.pone.0085310	http://dx.doi.org/10.1371/journal.pone.0085310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465532	Green Submitted, gold, Green Published			2022-12-27	WOS:000330283100036
J	Sharma, A; Vandenberg, B; Hollingsworth, B				Sharma, Anurag; Vandenberg, Brian; Hollingsworth, Bruce			Minimum Pricing of Alcohol versus Volumetric Taxation: Which Policy Will Reduce Heavy Consumption without Adversely Affecting Light and Moderate Consumers?	PLOS ONE			English	Article							DEMAND; TAX; US; METAANALYSIS; ENGLAND; PRICES; IMPACT; INCOME; SALES	Background: We estimate the effect on light, moderate and heavy consumers of alcohol from implementing a minimum unit price for alcohol (MUP) compared with a uniform volumetric tax. Methods: We analyse scanner data from a panel survey of demographically representative households (n = 885) collected over a one-year period (24 Jan 2010-22 Jan 2011) in the state of Victoria, Australia, which includes detailed records of each household's off-trade alcohol purchasing. Findings: The heaviest consumers (3% of the sample) currently purchase 20% of the total litres of alcohol (LALs), are more likely to purchase cask wine and full strength beer, and pay significantly less on average per standard drink compared to the lightest consumers (A$1.31 [95% CI 1.20-1.41] compared to $2.21 [95% CI 2.10-2.31]). Applying a MUP of A$1 per standard drink has a greater effect on reducing the mean annual volume of alcohol purchased by the heaviest consumers of wine (15.78 LALs [95% CI 14.86-16.69]) and beer (1.85 LALs [95% CI 1.64-2.05]) compared to a uniform volumetric tax (9.56 LALs [95% CI 9.10-10.01] and 0.49 LALs [95% CI 0.46-0.41], respectively). A MUP results in smaller increases in the annual cost for the heaviest consumers of wine ($393.60 [95% CI 374.19-413.00]) and beer ($108.26 [95% CI 94.76-121.75]), compared to a uniform volumetric tax ($552.46 [95% CI 530.55-574.36] and $163.92 [95% CI 152.79-175.03], respectively). Both a MUP and uniform volumetric tax have little effect on changing the annual cost of wine and beer for light and moderate consumers, and likewise little effect upon their purchasing. Conclusions: While both a MUP and a uniform volumetric tax have potential to reduce heavy consumption of wine and beer without adversely affecting light and moderate consumers, a MUP offers the potential to achieve greater reductions in heavy consumption at a lower overall annual cost to consumers.	[Sharma, Anurag] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Vandenberg, Brian] Canc Council Victoria, Melbourne, Vic, Australia; [Hollingsworth, Bruce] Univ Lancaster, Div Hlth Res, Lancaster LA1 4YW, England	Monash University; Cancer Council Victoria; Lancaster University	Sharma, A (corresponding author), Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia.	anurag.sharma@monash.edu	Hollingsworth, Bruce/ABH-7283-2020; SHARMA, ANURAG/GQA-9578-2022; Sharma, Anurag/B-4769-2008	SHARMA, ANURAG/0000-0002-5769-8185; Vandenberg, Brian/0000-0003-3325-6152; Sharma, Anurag/0000-0001-7570-852X; Hollingsworth, Bruce/0000-0002-4314-6523	Australian Research Council [DP120102252]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery Project Grant number DP120102252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian MK, 2012, AGR APPL EC ASS ANN; AIHW, 2011, 2010 NAT DRUG STRAT; Alviola PA, 2010, AGRIBUSINESS, V26, P369, DOI 10.1002/agr.20227; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Australia's Future Tax System (AFTS), 2010, REP TREAS; Australian Bureau of Statistics (ABS), 2013, 2011 CENS QUICK STAT; Australian Bureau of Statistics (ABS), 2007, TAX HOUS INC 2003 04; Australian National Preventive Health Agency (ANPHA), 2012, EXPL PUBL I IN PRESS; Australian Tax Office (ATO), 2010, EXC ESS WORK PAG; Ayyagari P, 2013, HEALTH ECON, V22, P89, DOI 10.1002/hec.1817; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; BBC News, 2013, BBC NEWS; Bergman U.M., 2010, ARE EXCISE TAX UNPUB; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Boffa J, 2009, REDUCING HARM ALCOHO; Brennan A., 2008, INDEPENDENT REV EFFE; Byrnes J, 2012, APPL HEALTH ECON HEA, V10, P37, DOI 10.2165/11594850-000000000-00000; Byrnes JM, 2010, MED J AUSTRALIA, V192, P439, DOI 10.5694/j.1326-5377.2010.tb03581.x; Caetano R, 2012, ADDICTION, V107, P60, DOI 10.1111/j.1360-0443.2011.03567.x; Carragher N, 2011, WHAT ARE OPTIONS PRI; Centre for Economics and Business Research (CEBR), 2010, MIN ALC PRIC TARG ME; Chikritzhs T, 2005, ADDICTION, V100, P1625, DOI 10.1111/j.1360-0443.2005.01234.x; Cnossen S, 2009, MELB I C AUSTR FUT T; Cobiac L, 2009, ADDICTION, V104, P1646, DOI 10.1111/j.1360-0443.2009.02708.x; Collins D., 2008, AVOIDABLE COSTS ALCO; Craven BM, 2013, ECON AFFA, V33, P174, DOI 10.1111/ecaf.12015; Crawford MJ, 2012, ALCOHOL ALCOHOLISM, V47, P738, DOI 10.1093/alcalc/ags091; Einav L., 2008, 69 USDA EC RES SERV; Euromonitor International, 2012, ALC DRINKS AUSTR; Farrell S, 2003, J HEALTH ECON, V22, P117, DOI 10.1016/S0167-6296(02)00099-1; Finkelstein EA, 2012, J HLTH EC, V32, P219; Fogarty J, 2006, BRIT FOOD J, V108, P316, DOI 10.1108/00070700610657155; Fogarty JJ, 2012, FORUM HLTH EC POLICY, V15; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78; Gruenewald PJ, 2006, ALCOHOL CLIN EXP RES, V30, P96, DOI 10.1111/j.1530-0277.2006.00011.x; Harding M, 2010, HETEROGENEOUS GEOGRA; Hill L, 2011, ADDRESSING HARMFUL U; HM Treasury, 2010, REV ALC TAX; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Kerr WC, 2007, ALCOHOL CLIN EXP RES, V31, P1714, DOI 10.1111/j.1530-0277.2007.00467.x; Leppanen K., 2001, CONSUMPTION ALCOHOL; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marsden Jacob Associates (MJA), 2012, BING COLL DAM BEN CO; Meier PS, 2010, ADDICTION, V105, P383, DOI 10.1111/j.1360-0443.2009.02721.x; Meng Y, 2013, ESTIMATION OWN CROSS; Ng SW, 2012, J ACAD NUTR DIET, V112, P1828, DOI 10.1016/j.jand.2012.07.009; OECD, 2012, TRENDS ADM ISS; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rabinovich L, 2012, FURTHER STUDY AFFORD; Ramstedt M, 2010, ADDICTION, V105, P649, DOI 10.1111/j.1360-0443.2009.02839.x; Robinson M, 2013, ALCOHOL ALCOHOLISM, V48, P231, DOI 10.1093/alcalc/ags098; Ruhm CJ, 2012, J HEALTH ECON, V31, P851, DOI 10.1016/j.jhealeco.2012.08.002; Sornpaisarn B, 2012, ADDICTION, V107, P1372, DOI 10.1111/j.1360-0443.2011.03681.x; Stockwell T., 2013, IS ALCOHOL TOO CHEAP; Stockwell T, 2012, AM J PUBLIC HLTH, V102, P10; Stockwell T, 2012, ADDICTION, V107, P912, DOI 10.1111/j.1360-0443.2011.03763.x; Thamarangsi T, 2006, ALCOHOL TAXATION W P; Thomas G., 2012, ALCOHOL PRICE POLICY; UK Home Office, 2013, NEXT STEPS FOLL CONS; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Warren N, 2005, EJOURNAL TAX RES, V3, P114; Woodhouse J, 2013, SNHA5021 HOUS COMM L; World Health Organization, 2000, INT GUID MON ALC CON; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	66	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e80936	10.1371/journal.pone.0080936	http://dx.doi.org/10.1371/journal.pone.0080936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465368	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100002
J	Zajac, D; Spolnik, G; Roszkowski, P; Danikiewicz, W; Czarnocki, Z; Pokorski, M				Zajac, Dominika; Spolnik, Grzegorz; Roszkowski, Piotr; Danikiewicz, Witold; Czarnocki, Zbigniew; Pokorski, Mieczyslaw			Metabolism of N-Acylated-Dopamine	PLOS ONE			English	Article							OLEOYL-DOPAMINE; AGONIST ACTIVITY; CAROTID-BODY; RAT; CAPSAICIN; BRAIN; OLEOYLDOPAMINE; TRPV1; ACTIVATION; INHIBITORS	N-oleoyl-dopamine (OLDA) is a novel lipid derivative of dopamine. Its biological action includes the interaction with dopamine and the transient receptor potential vanilloid (TRPV1) receptors. It seems to be synthesized in a dopamine-like manner, but there has been no information on its degradation. The aim of the study was, therefore, to determine whether OLDA metabolism proceeds the way dopamine proper does. We addressed the issue by examining the occurrence of O-methylation of exogenously supplemented OLDA via catechol-O-methyltransferase (COMT) under in vitro, ex vivo, and in vivo conditions using rat brain tissue. The results show that OLDA was methylated by COMT in all conditions studied, yielding the O-methylated derivative. The methylation was reversed by tolcapone, a potent COMT inhibitor, in a dose-dependent manner. We conclude that OLDA enters the metabolic pathway of dopamine. Methylation of OLDA may enhance its bioactive properties, such as the ability to interact with TRPV1 receptors.	[Zajac, Dominika; Pokorski, Mieczyslaw] Polish Acad Sci, Med Res Ctr, Dept Resp Res, Warsaw, Poland; [Spolnik, Grzegorz; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem, Mass Spectrometry Grp 1, Warsaw, Poland; [Roszkowski, Piotr; Czarnocki, Zbigniew] Warsaw Univ, Lab Nat Prod Chem, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; University of Warsaw	Pokorski, M (corresponding author), Polish Acad Sci, Med Res Ctr, Dept Resp Res, Warsaw, Poland.	m_pokorski@hotmail.com	Danikiewicz, Witold/H-2257-2016; Pokorski, Mieczyslaw/K-6395-2018; Zając, Dominika/ADT-7442-2022	Danikiewicz, Witold/0000-0003-0484-2689; Pokorski, Mieczyslaw/0000-0002-8710-9775; Zajac, Dominika/0000-0002-0910-5912; Spolnik, Grzegorz/0000-0002-7779-7690	Polish Academy of Sciences Medical Research Center in Warsaw	Polish Academy of Sciences Medical Research Center in Warsaw	This research was funded by the statutory budget of the Polish Academy of Sciences Medical Research Center in Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov MG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P681, DOI 10.1134/S0006297909060133; Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Bezuglov V, 2001, BIOORG MED CHEM LETT, V11, P447, DOI 10.1016/S0960-894X(00)00689-2; Brannan T, 1997, J NEURAL TRANSM, V104, P77, DOI 10.1007/BF01271296; Chu CJ, 2003, J BIOL CHEM, V278, P13633, DOI 10.1074/jbc.M211231200; Czarnocki Z, 1998, ORG PREP PROCED INT, V30, P699, DOI 10.1080/00304949809355327; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hu SSJ, 2009, PROSTAG LEUKOTR ESS, V81, P291, DOI 10.1016/j.plefa.2009.05.026; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Institute for Laboratory Animal Research (ILAR), 1996, GUIDE CARE USE LAB A; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; KLOPMAN G, 1995, J COMPUT AID MOL DES, V9, P283, DOI 10.1007/BF00124458; Konieczny J, 2009, INT J IMMUNOPATH PH, V22, P21, DOI 10.1177/039463200902200104; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Pokorski M, 2003, DRUG DEVELOP RES, V60, P217, DOI 10.1002/ddr.10298; Pokorski M, 1998, MED HYPOTHESES, V50, P131, DOI 10.1016/S0306-9877(98)90198-0; Pokorski M, 2006, ADV EXP MED BIOL, V580, P173, DOI 10.1007/0-387-31311-7_26; Przegalinski E, 2006, INT J IMMUNOPATH PH, V19, P897, DOI 10.1177/039463200601900419; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szolcsanyi J, 2004, NEUROSCI LETT, V361, P155, DOI 10.1016/j.neulet.2003.12.025; WALPOLE CSJ, 1993, J MED CHEM, V36, P2362, DOI 10.1021/jm00068a014; Zajac D, 2006, J PHYSIOL PHARMACOL, V57, P403; Zajac D, 2007, INT C ADV PNEUM 10 1; Zhong BH, 2008, AM J PHYSIOL-HEART C, V295, pH728, DOI 10.1152/ajpheart.00022.2008	27	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85259	10.1371/journal.pone.0085259	http://dx.doi.org/10.1371/journal.pone.0085259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465516	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100031
J	Burghardt, KM; Avinashi, V; Kosar, C; Xu, W; Wales, PW; Avitzur, Y; Muise, A				Burghardt, Karolina Maria; Avinashi, Vishal; Kosar, Christina; Xu, Wei; Wales, Paul W.; Avitzur, Yaron; Muise, Aleixo			A CARD9 Polymorphism Is Associated with Decreased Likelihood of Persistent Conjugated Hyperbilirubinemia in Intestinal Failure	PLOS ONE			English	Article							COLITIS SUSCEPTIBILITY LOCI; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INNATE IMMUNITY; CROHNS-DISEASE; PARENTERAL-NUTRITION; PROTEIN CARD9; GENE; ACTIVATION; RECEPTORS	Recently, genetic associations have been described in intestinal transplants. Namely, Crohn's disease susceptibility gene NOD2 polymorphisms have been reported to be more prevalent in patients with graft failure following intestinal transplantation (IT). Therefore, we sought to determine if polymorphisms in the NOD2 signaling cascade, including NOD2, CARD9, RAC1 and ATG16L1 are associated with intestinal failure (IF) or its complications. We carried out a cross-sectional study of 59 children with IF and 500 healthy Caucasian controls. Using the Taqman platform we determined the prevalence of NOD2 as well as ATG16L1, RAC1 and CARD9 SNPs. NOD2 pathway polymorphisms were evaluated in relation to outcomes of episodes of sepsis, ICU admissions, hyperbilirubinemia and need for IT. We found that the minor allele of a CARD9 SNP was associated with protection from developing IF when compared to healthy controls and was also associated with decreased odds of sustained conjugated hyperbilirubinemia. Therefore, IF patients with CARD9 polymorphism are less likely to develop progressive liver disease and suggests that host innate immunity may play a role in IF associated liver disease.	[Burghardt, Karolina Maria; Kosar, Christina; Wales, Paul W.; Avitzur, Yaron] Transplant Ctr, Grp Improvement Intestinal Funct & Treatment GIFT, Toronto, ON, Canada; [Burghardt, Karolina Maria; Avitzur, Yaron; Muise, Aleixo] Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Muise, Aleixo] Univ Toronto, Hosp Sick Children, Cell Biol Program, SickKids IBD Ctr, Toronto, ON M5G 1X8, Canada; [Avinashi, Vishal] BC Children Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada; [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); BC Childrens Hospital; University of Toronto	Avitzur, Y (corresponding author), Transplant Ctr, Grp Improvement Intestinal Funct & Treatment GIFT, Toronto, ON, Canada.	Yaron.avitzur@sickkids.ca; Aleixo.muise@sickkids.ca		Avitzur, Yaron/0000-0002-8072-5727; Avinashi, Vishal/0000-0003-4507-3425; Belza, Christina/0000-0001-6917-295X	Ontario Ministry of Research and Innovation; Canadian Institute of Health Research [MOP119457]; Sick Kids Transplant Centre Astellas Research Competition Grant	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Sick Kids Transplant Centre Astellas Research Competition Grant	AMM is supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation and funded by a Canadian Institute of Health Research - Operating Grant (MOP119457). Partial funding was provided by a Sick Kids Transplant Centre Astellas Research Competition Grant to AMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Fishbein I, 2008, CIRCULATION, V117, P2096, DOI 10.1161/CIRCULATIONAHA.107.746412; Fishbein T, 2008, GUT, V57, DOI 10.1136/gut.2007.133322; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Janse M, 2009, ROLE GENETIC CROHNS; Janse M, 2011, HEPATOLOGY, V53, P1977, DOI 10.1002/hep.24307; Jensen SR, 2011, INFLAMM BOWEL DIS, V17, P2392, DOI 10.1002/ibd.21656; Lang R, 2011, IMMUNOBIOLOGY, V216, P1184, DOI 10.1016/j.imbio.2011.06.005; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Miyake Y, 2012, HEPATOL RES; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Moran CJ, 2012, INFLAMM BOWEL DIS, DOI 10.1002/ibd.22974; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Muise AM, 2007, CURR BIOL, V17, P1212, DOI 10.1016/j.cub.2007.06.013; Muise AM, 2012, GASTROENTEROLOGY, V143, P285, DOI 10.1053/j.gastro.2012.06.025; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Nasr A, 2007, J PEDIATR SURG, V42, P359, DOI 10.1016/j.jpedsurg.2006.10.008; Ningappa M, 2011, AM J GASTROENTEROL, V106, P157, DOI 10.1038/ajg.2010.322; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quiros-Tejeira RE, 2004, J PEDIATR-US, V145, P157, DOI 10.1016/j.jpeds.2004.02.030; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sokol H, 2013, GASTROENTEROLOGY; Travassos LH, 2010, AUTOPHAGY, V6, P409, DOI 10.4161/auto.6.3.11305; Willis TC, 2010, JPEN-PARENTER ENTER, V34, P32, DOI 10.1177/0148607109332772; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85915	10.1371/journal.pone.0085915	http://dx.doi.org/10.1371/journal.pone.0085915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465786	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500143
J	Lacy, P; McKay, RT; Finkel, M; Karnovsky, A; Woehler, S; Lewis, MJ; Chang, D; Stringer, KA				Lacy, Paige; McKay, Ryan T.; Finkel, Michael; Karnovsky, Alla; Woehler, Scott; Lewis, Michael J.; Chang, David; Stringer, Kathleen A.			Signal Intensities Derived from Different NMR Probes and Parameters Contribute to Variations in Quantification of Metabolites	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ACUTE LUNG INJURY; ANALYTICAL REPRODUCIBILITY; QUANTITATIVE-ANALYSIS; METABOLOMICS DATA; SOLVENT SIGNAL; URINE SAMPLES; METABONOMICS; SUPPRESSION; CREATININE	We discovered that serious issues could arise that may complicate interpretation of metabolomic data when identical samples are analyzed at more than one NMR facility, or using slightly different NMR parameters on the same instrument. This is important because cross-center validation metabolomics studies are essential for the reliable application of metabolomics to clinical biomarker discovery. To test the reproducibility of quantified metabolite data at multiple sites, technical replicates of urine samples were assayed by 1D-H-1-NMR at the University of Alberta and the University of Michigan. Urine samples were obtained from healthy controls under a standard operating procedure for collection and processing. Subsequent analysis using standard statistical techniques revealed that quantitative data across sites can be achieved, but also that previously unrecognized NMR parameter differences can dramatically and widely perturb results. We present here a confirmed validation of NMR analysis at two sites, and report the range and magnitude that common NMR parameters involved in solvent suppression can have on quantitated metabolomics data. Specifically, saturation power levels greatly influenced peak height intensities in a frequency-dependent manner for a number of metabolites, which markedly impacted the quantification of metabolites. We also investigated other NMR parameters to determine their effects on further quantitative accuracy and precision. Collectively, these findings highlight the importance of and need for consistent use of NMR parameter settings within and across centers in order to generate reliable, reproducible quantified NMR metabolomics data.	[Lacy, Paige] Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB, Canada; Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Finkel, Michael; Stringer, Kathleen A.] Univ Michigan, Coll Pharm, Dept Clin Social & Adm Sci, Ann Arbor, MI 48109 USA; [Karnovsky, Alla; Stringer, Kathleen A.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Woehler, Scott] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Woehler, Scott] Univ Michigan, Coll Pharm, Biochem Nucl Magnet Resonance Core, Ann Arbor, MI 48109 USA; [Lewis, Michael J.; Chang, David] Chenomx Inc, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stringer, KA (corresponding author), Univ Michigan, Coll Pharm, Dept Clin Social & Adm Sci, 428 Church St, Ann Arbor, MI 48109 USA.	stringek@umich.edu	Lacy, Paige/A-6021-2010	Lacy, Paige/0000-0001-8885-6011; Stringer, Kathleen/0000-0003-0238-7774; McKay, Ryan/0000-0002-0255-159X	Department of Computational Medicine and Bioinformatics, Department of Medicine, University of Michigan;; University of Michigan Claude D. Pepper Older Americans Independence Center (NIA) [AGA024824]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000433-06]; Canada Foundation for Innovation [19119]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	Department of Computational Medicine and Bioinformatics, Department of Medicine, University of Michigan;; University of Michigan Claude D. Pepper Older Americans Independence Center (NIA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Department of Computational Medicine and Bioinformatics, Department of Medicine, University of Michigan; the University of Michigan Claude D. Pepper Older Americans Independence Center (NIA Grant AGA024824); and the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000433-06. The University of Toronto's NMR 3 mm probe and spectrometer were provided by Canada Foundation for Innovation grant #19119. The content of the manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, JAMA J AM MED ASS, V284, P3043; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Curran-Everett D, 2004, AM J PHYSIOL-ENDOC M, V287, pE189, DOI 10.1152/ajpendo.00213.2004; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; FOXALL PJD, 1993, J PHARMACEUT BIOMED, V11, P21, DOI 10.1016/0731-7085(93)80145-Q; Garde AH, 2004, ANN OCCUP HYG, V48, P171, DOI 10.1093/annhyg/meh019; Gregory RM, 2009, CONCEPT MAGN RESON A, V34A, P305, DOI 10.1002/cmr.a.20147; Griffin JL, 2003, CURR OPIN CHEM BIOL, V7, P648, DOI 10.1016/j.cbpa.2003.08.008; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GUERON M, 1991, PROG NUCL MAG RES SP, V23, P135, DOI 10.1016/0079-6565(91)80007-O; Heather LC, 2013, J MOL CELL CARDIOL, V55, P2, DOI 10.1016/j.yjmcc.2012.12.001; HOULT DI, 1976, J MAGN RESON, V21, P337, DOI 10.1016/0022-2364(76)90081-0; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; JAHNKE W, 1994, J BIOMOL NMR, V4, P735, DOI 10.1007/BF00404281; Keifer PA, 1999, CONCEPT MAGNETIC RES, V11, P165, DOI 10.1002/(SICI)1099-0534(1999)11:3<165::AID-CMR4>3.0.CO;2-D; Keun HC, 2002, CHEM RES TOXICOL, V15, P1380, DOI 10.1021/tx0255774; Kohl SM, 2012, METABOLOMICS, V8, pS146, DOI 10.1007/s11306-011-0350-z; Koulman A, 2009, ANAL BIOANAL CHEM, V394, P663, DOI 10.1007/s00216-009-2690-3; KUPCE E, 1993, J MAGN RESON SER A, V105, P234, DOI 10.1006/jmra.1993.1277; Lacy P, 2011, AM J PHYSIOL-LUNG C, V300, pL1, DOI 10.1152/ajplung.00375.2010; Ludbrook J, 2008, CLIN EXP PHARMACOL P, V35, P1271, DOI 10.1111/j.1440-1681.2008.05003.x; McClay JL, 2010, J PROTEOME RES, V9, P3083, DOI 10.1021/pr1000048; McKay RT, 2009, 50 EXP NUCL MAGN RES; McKay RT, 2011, CONCEPT MAGN RESON A, V38A, P197, DOI 10.1002/cmr.a.20223; McKay RT, 2009, ANNU REP NMR SPECTRO, V66, P33, DOI 10.1016/S0066-4103(08)00402-X; Mercier P, 2011, J BIOMOL NMR, V49, P307, DOI 10.1007/s10858-011-9480-x; Mo HP, 2008, J MAGN RESON, V190, P1, DOI 10.1016/j.jmr.2007.09.016; Mo HP, 2010, MAGN RESON CHEM, V48, P235, DOI 10.1002/mrc.2563; Nagrath D, 2011, BBA-BIOENERGETICS, V1807, P650, DOI 10.1016/j.bbabio.2011.03.006; Nevedomskaya E, 2012, METABOLOMICS, V8, P1227, DOI 10.1007/s11306-012-0411-y; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Orita Y, 1966, Jpn Circ J, V30, P225; Park Y, 2009, AM J PHYSIOL-REG I, V297, pR202, DOI 10.1152/ajpregu.90757.2008; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; PRADELLA M, 1988, CRC CR REV CL LAB SC, V26, P195, DOI 10.3109/10408368809105890; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Reynolds WF, 2002, J NAT PROD, V65, P221, DOI 10.1021/np010444o; Serkova NJ, 2012, BIOANALYSIS, V4, P321, DOI [10.4155/bio.11.320, 10.4155/BIO.11.320]; Shishmarev D, 2011, J MAGN RESON, V213, P76, DOI 10.1016/j.jmr.2011.08.040; Slupsky CM, 2010, CLIN CANCER RES, V16, P5835, DOI 10.1158/1078-0432.CCR-10-1434; Slupsky CM, 2009, J PROTEOME RES, V8, P3029, DOI 10.1021/pr900103y; Sololenko S, 2013, METABOLOMICS, DOI [10.1007/s11306-013-0503-3, DOI 10.1007/S11306-013-0503-3]; Spector DA, 2007, AM J PHYSIOL-RENAL, V292, pF467, DOI 10.1152/ajprenal.00181.2006; Stringer KA, 2011, AM J PHYSIOL-LUNG C, V300, pL4, DOI 10.1152/ajplung.00231.2010; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; White BC, 2010, AM J PRIMATOL, V72, P1082, DOI 10.1002/ajp.20867; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wu PSC, 2005, J MAGN RESON, V176, P115, DOI 10.1016/j.jmr.2005.05.018; Xia JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-507; Yang BX, 2005, AM J PHYSIOL-RENAL, V288, pF881, DOI 10.1152/ajprenal.00367.2004	54	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85732	10.1371/journal.pone.0085732	http://dx.doi.org/10.1371/journal.pone.0085732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465670	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500100
J	Bagatini, IL; Eiler, A; Bertilsson, S; Klaveness, D; Tessarolli, LP; Vieira, AAH				Bagatini, Inessa Lacativa; Eiler, Alexander; Bertilsson, Stefan; Klaveness, Dag; Tessarolli, Leticia Piton; Henriques Vieira, Armando Augusto			Host-Specificity and Dynamics in Bacterial Communities Associated with Bloom-Forming Freshwater Phytoplankton	PLOS ONE			English	Article							MICROCYSTIS-AERUGINOSA; HETEROTROPHIC BACTERIA; CYLINDROSPERMOPSIS-RACIBORSKII; CYANOBACTERIAL BLOOMS; BACTERIOPLANKTON; DIVERSITY; FLAVOBACTERIA; POPULATIONS; HYDROLYSIS; PHOSPHORUS	Many freshwater phytoplankton species have the potential to form transient nuisance blooms that affect water quality and other aquatic biota. Heterotrophic bacteria can influence such blooms via nutrient regeneration but also via antagonism and other biotic interactions. We studied the composition of bacterial communities associated with three bloom-forming freshwater phytoplankton species, the diatom Aulacoseira granulata and the cyanobacteria Microcystis aeruginosa and Cylindrospermopsis raciborskii. Experimental cultures incubated with and without lake bacteria were sampled in three different growth phases and bacterial community composition was assessed by 454-Pyrosequencing of 16S rRNA gene amplicons. Betaproteobacteria were dominant in all cultures inoculated with lake bacteria, but decreased during the experiment. In contrast, Alphaproteobacteria, which made up the second most abundant class of bacteria, increased overall during the course of the experiment. Other bacterial classes responded in contrasting ways to the experimental incubations causing significantly different bacterial communities to develop in response to host phytoplankton species, growth phase and between attached and free-living fractions. Differences in bacterial community composition between cyanobacteria and diatom cultures were greater than between the two cyanobacteria. Despite the significance, major differences between phytoplankton cultures were in the proportion of the OTUs rather than in the absence or presence of specific taxa. Different phytoplankton species favoring different bacterial communities may have important consequences for the fate of organic matter in systems where these bloom forming species occur. The dynamics and development of transient blooms may also be affected as bacterial communities seem to influence phytoplankton species growth in contrasting ways.	[Bagatini, Inessa Lacativa; Tessarolli, Leticia Piton; Henriques Vieira, Armando Augusto] Univ Fed Sao Carlos, Dept Bot, Lab Ficol, BR-13560 Sao Carlos, SP, Brazil; [Eiler, Alexander; Bertilsson, Stefan] Uppsala Univ, Dept Ecol & Genet Limnol & Sci Life Labs, Uppsala, Sweden; [Klaveness, Dag] Univ Oslo, Dept Biosci, Oslo, Norway	Universidade Federal de Sao Carlos; Uppsala University; University of Oslo	Bagatini, IL (corresponding author), Univ Fed Sao Carlos, Dept Bot, Lab Ficol, BR-13560 Sao Carlos, SP, Brazil.	inessalacativa@gmail.com	Bagatini, I.L./H-9960-2017; Fapesp, Biota/F-8655-2017; Eiler, Alexander/V-9220-2017	Bagatini, I.L./0000-0002-5549-2255; Fapesp, Biota/0000-0002-9887-8449; Eiler, Alexander/0000-0001-9916-9567	Brazilian agencies CAPES [BEX: 1111-12-4]; FAPESP [2011/50054-4]; Swedish Research Council; Department of Biology of University of Oslo; K&A Wallenberg foundation; Science for Life Laboratories	Brazilian agencies CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Department of Biology of University of Oslo; K&A Wallenberg foundation(Knut & Alice Wallenberg Foundation); Science for Life Laboratories	The study was partially funded by the Brazilian agencies CAPES (grant #BEX: 1111-12-4 and a scholarship grant to ILB), by FAPESP (process 2011/50054-4), the Swedish Research Council (grant to SB), and by the Department of Biology of University of Oslo. The 454 pyrosequencing was enabled by an instrument grant from the K&A Wallenberg foundation and Science for Life Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Beier S, 2011, LIMNOL OCEANOGR, V56, P1179, DOI 10.4319/lo.2011.56.4.1179; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Bertilsson S., 2003, AQUATIC ECOSYSTEMS I, P3, DOI DOI 10.1016/B978-012256371-3/50002-0; Besemer K, 2009, ISME J, V3, P1318, DOI 10.1038/ismej.2009.73; Bruckner CG, 2011, ENVIRON MICROBIOL, V13, P1052, DOI 10.1111/j.1462-2920.2010.02411.x; Casamatta DA, 2000, MICROB ECOL, V40, P64, DOI 10.1007/s002480000035; Colombo V, 2006, THESIS U FEDERAL SAO; CYNAR FJ, 1985, MICROBIAL ECOL, V11, P281, DOI 10.1007/BF02016812; Dabney A, 2013, QVALUE Q VALUE ESTIM; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Dellamano-Oliveira MJ, 2008, FUND APPL LIMNOL, V171, P27, DOI 10.1127/1863-9135/2008/0171-0027; Doucette Gregory J., 1995, Natural Toxins, V3, P65, DOI 10.1002/nt.2620030202; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eigemann F, 2013, FEMS MICROBIOL ECOL, V83, P650, DOI 10.1111/1574-6941.12022; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2007, APPL ENVIRON MICROB, V73, P3511, DOI 10.1128/AEM.02534-06; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Figueredo CC, 2007, J PHYCOL, V43, P256, DOI 10.1111/j.1529-8817.2007.00333.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Vieira AAH, 2008, LIMNOL OCEANOGR, V53, P1887, DOI 10.4319/lo.2008.53.5.1887; Vieira AAH, 2013, AQUAT MICROB ECOL, V69, P169, DOI 10.3354/ame01629; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; Jiang LJ, 2007, HYDROBIOLOGIA, V581, P161, DOI 10.1007/s10750-006-0518-0; Karsten U, 2002, J PHYCOL, V35, P967; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; KLAVENESS D, 1982, Nordic Journal of Botany, V2, P183, DOI 10.1111/j.1756-1051.1982.tb01179.x; KOGURE K, 1981, J EXP MAR BIOL ECOL, V56, P197, DOI 10.1016/0022-0981(81)90189-1; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; LEGENDRE P, 1998, NUMERICAL ECOLOGY DE, P20; Li HB, 2011, WATER RES, V45, P1702, DOI 10.1016/j.watres.2010.11.011; Li N, 2011, CHIN J OCEANOL LIMN, V29, P505, DOI 10.1007/s00343-011-0056-0; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; MARCHANT HJ, 1983, J MICROSC-OXFORD, V131, P127, DOI 10.1111/j.1365-2818.1983.tb04239.x; Marinho MM, 2007, AQUAT ECOL, V41, P525, DOI 10.1007/s10452-007-9118-y; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2007, AQUAT MICROB ECOL, V50, P51, DOI 10.3354/ame01143; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mummey D, 2006, MICROB ECOL, V51, P404, DOI 10.1007/s00248-006-9020-5; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nusch E.A., 1980, ARCH HYDROBIOLOGIE B, V14, P14; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 1996, MICROSC RES TECHNIQ, V33, P47; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2012, R LANG ENV STAT COMP; Rashidan KK, 2001, MICROBIAL ECOL, V41, P97; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rooney-Varga JN, 2005, MICROB ECOL, V49, P163, DOI 10.1007/s00248-003-1057-0; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schafer H, 2002, FEMS MICROBIOL ECOL, V42, P25, DOI 10.1111/j.1574-6941.2002.tb00992.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sher D, 2011, ISME J, V5, P1125, DOI 10.1038/ISMEJ.2011.1; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Shi LM, 2011, ANN LIMNOL-INT J LIM, V47, P355, DOI 10.1051/limn/2011047; Shi LM, 2010, J FRESHWATER ECOL, V25, P193; Shi LM, 2009, J ENVIRON SCI, V21, P1581, DOI 10.1016/S1001-0742(08)62459-6; Sinha R, 2012, WATER RES, V46, P1408, DOI 10.1016/j.watres.2011.12.019; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Worm J, 1998, AQUAT MICROB ECOL, V14, P19, DOI 10.3354/ame014019; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0	72	72	74	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85950	10.1371/journal.pone.0085950	http://dx.doi.org/10.1371/journal.pone.0085950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465807	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500093
J	Blasiak, LC; Schmidt, AW; Andriamiarinoro, H; Mulaw, T; Rasolomampianina, R; Applequist, WL; Birkinshaw, C; Rejo-Fienena, F; Lowry, PP; Schmidt, TM; Hill, RT				Blasiak, Leah C.; Schmidt, Alex W.; Andriamiarinoro, Honore; Mulaw, Temesgen; Rasolomampianina, Rado; Applequist, Wendy L.; Birkinshaw, Chris; Rejo-Fienena, Felicitee; Lowry, Porter P., II; Schmidt, Thomas M.; Hill, Russell T.			Bacterial Communities in Malagasy Soils with Differing Levels of Disturbance Affecting Botanical Diversity	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PH; FERTILIZATION; BIOGEOGRAPHY; MANAGEMENT; PREDICTOR; IMPACT; FOREST; CARBON; SHIFTS	Madagascar is well-known for the exceptional biodiversity of its macro-flora and fauna, but the biodiversity of Malagasy microbial communities remains relatively unexplored. Understanding patterns of bacterial diversity in soil and their correlations with above-ground botanical diversity could influence conservation planning as well as sampling strategies to maximize access to bacterially derived natural products. We present the first detailed description of Malagasy soil bacterial communities from a targeted 16S rRNA gene survey of greater than 290,000 sequences generated using 454 pyrosequencing. Two sampling plots in each of three forest conservation areas were established to represent different levels of disturbance resulting from human impact through agriculture and selective exploitation of trees, as well as from natural impacts of cyclones. In parallel, we performed an in-depth characterization of the total vascular plant morphospecies richness within each plot. The plots representing different levels of disturbance within each forest did not differ significantly in bacterial diversity or richness. Changes in bacterial community composition were largest between forests rather than between different levels of impact within a forest. The largest difference in bacterial community composition with disturbance was observed at the Vohibe forest conservation area, and this difference was correlated with changes in both vascular plant richness and soil pH. These results provide the first survey of Malagasy soil bacterial diversity and establish a baseline of botanical diversity within important conservation areas.	[Blasiak, Leah C.; Mulaw, Temesgen; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Schmidt, Alex W.; Schmidt, Thomas M.] Univ Maryland, Ctr Microbial Sci, Baltimore, MD 21201 USA; [Andriamiarinoro, Honore; Applequist, Wendy L.; Birkinshaw, Chris; Lowry, Porter P., II] Missouri Bot Garden, St Louis, MO USA; [Rasolomampianina, Rado; Rejo-Fienena, Felicitee] Ctr Natl Rech Environm, Lab Microbiol Environm, Antananarivo, Madagascar; [Lowry, Porter P., II] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR 7205, F-75231 Paris, France	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore; Missouri Botanical Gardens; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Hill, Russell/AAF-4190-2019	Hill, Russell/0000-0002-9832-1851; Schmidt, Thomas/0000-0002-8209-6055	National Science Foundation (NSF) Directorate for Biological Sciences Integrative Organismal Systems [IOS-0919728]; Fogarty International Center; National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Institute of Mental Health; National Institute on Drug Abuse; National Heart Lung and Blood Institute; National Center for Complementary and Alternative Medicine; Office of Dietary Supplements; National Institute of General Medical Sciences; Office of Biological and Environmental Research of the U.S. Department of Energy [U01 TW00313]; International Cooperative Biodiversity Groups; National Research Initiative of the Cooperative State Research, Education and Extension Service, USDA [2008-35621-04732]; Biological Sciences Directorate of the NSF; FOGARTY INTERNATIONAL CENTER [U01TW000313] Funding Source: NIH RePORTER	National Science Foundation (NSF) Directorate for Biological Sciences Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Biological and Environmental Research of the U.S. Department of Energy(United States Department of Energy (DOE)); International Cooperative Biodiversity Groups; National Research Initiative of the Cooperative State Research, Education and Extension Service, USDA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biological Sciences Directorate of the NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the National Science Foundation (NSF) Directorate for Biological Sciences Integrative Organismal Systems (IOS-0919728), Fogarty International Center, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute on Drug Abuse, National Heart Lung and Blood Institute, National Center for Complementary and Alternative Medicine, Office of Dietary Supplements, National Institute of General Medical Sciences, Biological Sciences Directorate of the NSF, and the Office of Biological and Environmental Research of the U.S. Department of Energy under Cooperative Agreement U01 TW00313 with the International Cooperative Biodiversity Groups. This project was also supported by the National Research Initiative of the Cooperative State Research, Education and Extension Service, USDA, Grant #2008-35621-04732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Suleiman AKA, 2013, SYST APPL MICROBIOL, V36, P137, DOI 10.1016/j.syapm.2012.10.007; Andrew DR, 2012, APPL ENVIRON MICROB, V78, P7527, DOI 10.1128/AEM.01459-12; Aubert G., 1978, METHODE ANAL SOLS; Berthrong ST, 2013, MICROB ECOL, V66, P158, DOI 10.1007/s00248-013-0225-0; Bremner JM, 1982, METHODS SOIL ANAL 2, P610; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Callmander MW, 2011, PLANT ECOL EVOL, V144, P121, DOI 10.5091/plecevo.2011.513; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornet A., 1974, NOTICE EXPLICATIVE, V55, P1; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; Du Puy DJ, 1996, REFINED CLASSIFICATI, P205; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Keddy P, 2005, ANN BOT-LONDON, V96, P177, DOI 10.1093/aob/mci166; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levine UY, 2011, ISME J, V5, P1683, DOI 10.1038/ismej.2011.40; Liliensiek AK, 2012, MICROB ECOL, V63, P509, DOI 10.1007/s00248-011-9985-6; Lupwayi NZ, 1998, SOIL BIOL BIOCHEM, V30, P1733, DOI 10.1016/S0038-0717(98)00025-X; Mitchell RJ, 2010, PLANT SOIL, V333, P417, DOI 10.1007/s11104-010-0357-7; Moat P, 2007, ATLAS VEGETATION MAD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Nemergut DR, 2010, SOIL BIOL BIOCHEM, V42, P2153, DOI 10.1016/j.soilbio.2010.08.011; Oksanen J., 2013, VEGAN COMMUNITY ECOL, V2; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Phillipson P.B., 2006, TAXONOMY ECOLOGY AFR, P613; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Reddy BVB, 2012, APPL ENVIRON MICROB, V78, P3744, DOI 10.1128/AEM.00102-12; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Team RC., 2012, LANG ENV STAT COMP; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Zabinski CA, 1997, ENVIRON MANAGE, V21, P233, DOI 10.1007/s002679900022	55	6	6	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85097	10.1371/journal.pone.0085097	http://dx.doi.org/10.1371/journal.pone.0085097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465484	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500032
J	Ma, RCW; Lee, HM; Lam, VKL; Tam, CHT; Ho, JSK; Zhao, HL; Guan, J; Kong, APS; Lau, E; Zhang, GZ; Luk, A; Wang, Y; Tsui, SKW; Chan, TF; Hu, C; Jia, WP; Park, KS; Lee, HK; Furuta, H; Nanjo, K; Tai, ES; Ng, DPK; Tang, NLS; Woo, J; Leung, PC; Xue, H; Wong, J; Leung, PS; Lau, TCK; Tong, PCY; Xu, G; Ng, MCY; So, WY; Chan, JCN				Ma, Ronald Ching Wan; Lee, Heung Man; Lam, Vincent Kwok Lim; Tam, Claudia Ha Ting; Ho, Janice Siu Ka; Zhao, Hai-Lu; Guan, Jing; Kong, Alice Pik Shan; Lau, Eric; Zhang, Guozhi; Luk, Andrea; Wang, Ying; Tsui, Stephen Kwok Wing; Chan, Ting Fung; Hu, Cheng; Jia, Wei Ping; Park, Kyong Soo; Lee, Hong Kyu; Furuta, Hiroto; Nanjo, Kishio; Tai, E. Shyong; Ng, Daniel Peng-Keat; Tang, Nelson Leung Sang; Woo, Jean; Leung, Ping Chung; Xue, Hong; Wong, Jeffrey; Leung, Po Sing; Lau, Terrence C. K.; Tong, Peter Chun Yip; Xu, Gang; Ng, Maggie Chor Yin; So, Wing Yee; Chan, Juliana Chung Ngor			Familial Young-Onset Diabetes, Pre-Diabetes and Cardiovascular Disease Are Associated with Genetic Variants of DACH1 in Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HONG-KONG CHINESE; METABOLIC SYNDROME; SUSCEPTIBILITY LOCUS; CONSERVED ROLE; TYPE-2; GROWTH; RISK; BETA; PATHOPHYSIOLOGY	In Asia, young-onset type 2 diabetes (YOD) is characterized by obesity and increased risk for cardiovascular disease (CVD). In a genome-wide association study (GWAS) of 99 Chinese obese subjects with familial YOD diagnosed before 40-year-old and 101 controls, the T allele of rs1408888 in intron 1 of DACH1(Dachshund homolog 1) was associated with an odds ratio (OR) of 2.49(95% confidence intervals: 1.57-3.96, P = 8.4610(-5)). Amongst these subjects, we found reduced expression of DACH1 in peripheral blood mononuclear cells (PBMC) from 63 cases compared to 65 controls (P = 0.02). In a random cohort of 1468 cases and 1485 controls, amongst top 19 SNPs from GWAS, rs1408888 was associated with type 2 diabetes with a global P value of 0.0176 and confirmation in a multiethnic Asian case-control cohort (7370/7802) with an OR of 1.07(1.02-1.12, P-meta = 0.012). In 599 Chinese non-diabetic subjects, rs1408888 was linearly associated with systolic blood pressure and insulin resistance. In a case-control cohort (n = 953/953), rs1408888 was associated with an OR of 1.54(1.07-2.22, P = 0.019) for CVD in type 2 diabetes. In an autopsy series of 173 non-diabetic cases, TT genotype of rs1408888 was associated with an OR of 3.31(1.19-9.19, P = 0.0214) and 3.27(1.25-11.07, P = 0.0184) for coronary heart disease (CHD) and coronary arteriosclerosis. Bioinformatics analysis revealed that rs1408888 lies within regulatory elements of DACH1 implicated in islet development and insulin secretion. The T allele of rs1408888 of DACH1 was associated with YOD, prediabetes and CVD in Chinese.	[Ma, Ronald Ching Wan; Lee, Heung Man; Lam, Vincent Kwok Lim; Tam, Claudia Ha Ting; Ho, Janice Siu Ka; Zhao, Hai-Lu; Guan, Jing; Kong, Alice Pik Shan; Lau, Eric; Zhang, Guozhi; Luk, Andrea; Wang, Ying; Woo, Jean; Tong, Peter Chun Yip; Xu, Gang; Ng, Maggie Chor Yin; So, Wing Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Ma, Ronald Ching Wan; Tong, Peter Chun Yip; Xu, Gang; So, Wing Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Ma, Ronald Ching Wan; Lee, Heung Man; Lam, Vincent Kwok Lim; Kong, Alice Pik Shan; Tang, Nelson Leung Sang; Xu, Gang; So, Wing Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Tsui, Stephen Kwok Wing; Leung, Po Sing; Lau, Terrence C. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Chan, Ting Fung] Chinese Univ Hong Kong, Sch Life Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Hu, Cheng; Jia, Wei Ping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Clin Ctr Metab, Shanghai Key Lab Diabet Mellitus,Shanghai Clin Ct, Shanghai 200030, Peoples R China; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama, Japan; [Tai, E. Shyong; Ng, Daniel Peng-Keat] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Leung, Ping Chung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Xue, Hong; Wong, Jeffrey] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Seoul National University (SNU); Seoul National University (SNU); Wakayama Medical University; National University of Singapore; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong University of Science & Technology	Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	jchan@cuhk.edu.hk	Park, Kyong Soo/C-2265-2008; Leung, Po Sing/P-5758-2014; Woo, Jean/K-2625-2014; Hu, Cheng/C-3346-2008; Lau, Terrence/ABB-7900-2021; Chan, TingFung/A-6161-2013; Chan, Juliana/B-7918-2016; Kong, Alice/P-3703-2015; Tang, Nelson L/P-5018-2017; Luk, Andrea/B-5766-2016; Ma, Ronald/C-2788-2009; Jia, Weiping/B-7483-2012; Lau, Eric S.H./AGZ-2920-2022; Tsui, Stephen Kwok-Wing/E-4385-2015	Park, Kyong Soo/0000-0003-3597-342X; Leung, Po Sing/0000-0001-8074-3178; Woo, Jean/0000-0001-7593-3081; Hu, Cheng/0000-0003-4314-2386; Lau, Terrence/0000-0002-7505-7306; Chan, TingFung/0000-0002-0489-3884; Chan, Juliana/0000-0003-1325-1194; Kong, Alice/0000-0001-8927-6764; Tang, Nelson L/0000-0002-3607-5819; Ma, Ronald/0000-0002-1227-803X; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Lau, Eric S.H./0000-0003-1581-5643; Wong, J. Tze-Fei/0000-0001-8539-8537; Xue, Hong/0000-0002-8133-9828; Tai, E Shyong/0000-0003-2929-8966	Research Grant Council (RGC) Central Allocation Scheme [CUHK 1/04C]; RGC earmarked grant [CUHK4462/06M]; US National Institutes of Health [U01-DK085545-05]; Hong Kong Foundation for Research and Development in Diabetes; Liao Wun Yuk Diabetes Research Memorial Fund established under the CUHK; National Natural Scientific Foundation of China [30630061]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Ministry of Health, Welfare and Family Affair, Republic of Korea [00-PJ3-PG6-GN07-001]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17019047]; Biomedical Research Council of Singapore [BMRC 05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore [NMRC/1174/2008]; NationalMedical Research Council [NMRC 0796/2003, IRG07nov013, NMRC/STaR/0003/2008]; Biomedical Research Council (BMRC) [09/1/35/19/616]; National Medical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085545] Funding Source: NIH RePORTER	Research Grant Council (RGC) Central Allocation Scheme; RGC earmarked grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Foundation for Research and Development in Diabetes; Liao Wun Yuk Diabetes Research Memorial Fund established under the CUHK; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Diabetes Mellitus; Ministry of Health, Welfare and Family Affair, Republic of Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); NationalMedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by the Research Grant Council (RGC) Central Allocation Scheme (CUHK 1/04C), RGC earmarked grant (CUHK4462/06M), US National Institutes of Health (U01-DK085545-05) as well as the Hong Kong Foundation for Research and Development in Diabetes and Liao Wun Yuk Diabetes Research Memorial Fund established under the CUHK. The research in Shanghai Chinese was supported by grants from National Natural Scientific Foundation of China (30630061) and Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200). The study in Korea was funded by a grant from the Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affair, Republic of Korea (00-PJ3-PG6-GN07-001 to K. S. P.). The work in Japan was supported by Grant-in-Aid for Scientific Research on Priority Areas 'Applied Genomics' no. 17019047 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The Singapore Prospective Study Program was funded through grants from the Biomedical Research Council of Singapore (BMRC 05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC/1174/2008). The Singapore Malay Eye Study was funded by the NationalMedical Research Council (NMRC 0796/2003, IRG07nov013, and NMRC/STaR/0003/2008) and Biomedical Research Council (BMRC, 09/1/35/19/616). EST also receives additional support from the National Medical Research Council through a clinician scientist award. The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-40; Chan JCN, 2011, CURR CARDIOVASC RISK, V5, P230, DOI 10.1007/s12170-011-0172-6; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Davis RJ, 2001, MOL CELL BIOL, V21, P1484, DOI 10.1128/MCB.21.5.1484-1490.2001; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dreja T, 2010, DIABETOLOGIA, V53, P309, DOI 10.1007/s00125-009-1576-4; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Guan J, 2009, NEPHROL DIAL TRANSPL, V24, P1889, DOI 10.1093/ndt/gfn734; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Kalousova A, 2010, DEV BIOL, V348, P143, DOI 10.1016/j.ydbio.2010.09.007; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Liu KH, 2006, DIABETES CARE, V29, P379, DOI 10.2337/diacare.29.02.06.dc05-1578; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Ng MCY, 2001, DIABETES CARE, V24, P663, DOI 10.2337/diacare.24.4.663; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Okamoto N, 2012, P NATL ACAD SCI USA, V109, P2406, DOI 10.1073/pnas.1116050109; Ozaki R, 2007, ARCH DIS CHILD, V92, P224, DOI 10.1136/adc.2006.100453; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Popov VM, 2010, TRENDS ENDOCRIN MET, V21, P41, DOI 10.1016/j.tem.2009.08.002; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ramos-Mondragon R, 2008, VASC HEALTH RISK MAN, V4, P1289; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shu XO, 2010, PLOS GENET, V6; Suen PM, 2008, INT J BIOCHEM CELL B, V40, P789, DOI 10.1016/j.biocel.2007.10.020; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Wang Y, 2013, BMC PUBLIC IN PRESS; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Yang SNY, 2010, J DIABETES, V2, P233, DOI 10.1111/j.1753-0407.2010.00089.x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao HL, 2004, DIABETES, V53, P2984, DOI 10.2337/diabetes.53.11.2984; Zhou J, 2010, P NATL ACAD SCI USA, V107, P6864, DOI 10.1073/pnas.1002746107	47	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84770	10.1371/journal.pone.0084770	http://dx.doi.org/10.1371/journal.pone.0084770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465431	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500022
J	Moura, CS; Lollo, PCB; Morato, PN; Nisishima, LH; Carneiro, EM; Amaya-Farfan, J				Moura, Carolina Soares; Barboza Lollo, Pablo Christiano; Morato, Priscila Neder; Nisishima, Luciana Hisayama; Carneiro, Everardo Magalhaes; Amaya-Farfan, Jaime			Whey Protein Hydrolysate Enhances HSP90 but Does Not Alter HSP60 and HSP25 in Skeletal Muscle of Rats	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHAPERONE; HSP70	Whey protein hydrolysate (WPH) intake has shown to increase HSP70 expression. The aim of the present study was to investigate whether WPH intake would also influences HSP90, HSP60 and HSP25 expression, as well as associated parameters. Forty-eight male Wistar rats were divided into sedentary (unstressed) and exercised (stressed) groups, and were fed with three different sources of protein: whey protein (WP), whey protein hydrolysate (WPH) and casein (CAS) as a control, based on the AIN93G diet for 3 weeks. WPH intake increased HSP90 expression in both sedentary and exercised animals compared to WP or CAS, however no alteration was found from exercise or diet to HSP60 or HSP25. Co-chaperone Aha1 and p-HSF1 were also increased in the exercised animals fed with WPH in comparison with WP or CAS, consistent with enhanced HSP90 expression. VEGF and p-AKT were increased in the WPH exercised group. No alteration was found in BCKDH, PI3-Kinase (p85), GFAT, OGT or PGC for diet or exercise. The antioxidant system GPx, catalase and SOD showed different responses to diet and exercise. The data indicate that WPH intake enhanced factors related to cell survival, such as HSP90 and VEGF, but does not alter HSP60 or HSP25 in rat skeletal muscle.	[Moura, Carolina Soares; Barboza Lollo, Pablo Christiano; Morato, Priscila Neder; Nisishima, Luciana Hisayama; Amaya-Farfan, Jaime] Univ Campinas UNICAMP, Fac Food Engn, Dept Food & Nutr, Sao Paulo, Brazil; [Carneiro, Everardo Magalhaes] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Moura, CS (corresponding author), Univ Campinas UNICAMP, Fac Food Engn, Dept Food & Nutr, Sao Paulo, Brazil.	linanutricao@yahoo.com.br	Morato, Priscila Neder/AAN-6178-2021; Carneiro, Everardo/D-4758-2012		Foundation for Research of the State of Sao Paulo, Brazil (FAPESP) [2011/13035-1]	Foundation for Research of the State of Sao Paulo, Brazil (FAPESP)	The authors are grateful to the Foundation for Research of the State of Sao Paulo, Brazil (FAPESP no 2011/13035-1) for financial support and to Hilmar Ingredients (Hilmar, California, USA) for providing the whey protein products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo A, 2005, PHYSIOL BEHAV, V84, P1, DOI 10.1016/j.physbeh.2004.07.034; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Lollo PCB, 2011, J HUM KINET, V30, P49, DOI 10.2478/v10078-011-0072-3; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de Moura CS, 2013, FOOD CHEM, V136, P1350, DOI 10.1016/j.foodchem.2012.09.070; Folkesson ALM, 2013, ACTA PHYSL, P1; FRIDOVICH I, 1978, PHOTOCHEM PHOTOBIOL, V28, P733, DOI 10.1111/j.1751-1097.1978.tb07009.x; Gad AS, 2011, NUTRITION, V27, P582, DOI 10.1016/j.nut.2010.04.002; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Hamiel CR, 2009, AM J PHYSIOL-CELL PH, V297, pC1509, DOI 10.1152/ajpcell.00240.2009; HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281; Jiang YQ, 2013, BRAIN RES, V1519, P105, DOI 10.1016/j.brainres.2013.04.059; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Khassaf M, 2001, J APPL PHYSIOL, V90, P1031, DOI 10.1152/jappl.2001.90.3.1031; Kinnunen S, 2009, RES VET SCI, V87, P462, DOI 10.1016/j.rvsc.2009.04.009; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Latchman DS, 2004, CURR NEUROVASC RES, V1, P21, DOI 10.2174/1567202043480206; Lee MW, 2005, J THERM BIOL, V30, P43, DOI 10.1016/j.jtherbio.2004.06.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Morato PN, 2013, FOOD CHEM, V139, P853, DOI 10.1016/j.foodchem.2012.12.062; Nery-Diez ACC, 2010, J MED FOOD, V13, P992, DOI 10.1089/jmf.2009.0149; OhIshi S, 1997, AM J RESP CRIT CARE, V156, P1579, DOI 10.1164/ajrccm.156.5.96-11035; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pinho RA, 2006, CELL BIOL INT, V30, P848, DOI 10.1016/j.cellbi.2006.03.011; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Terblanche SE, 1999, CELL BIOL INT, V23, P749, DOI 10.1006/cbir.1999.0442; Pimenta FMV, 2006, INT DAIRY J, V16, P984, DOI 10.1016/j.idairyj.2005.12.006; Waring WS, 2006, DIABETES, V55, P3127, DOI 10.2337/db06-0283; WHITE JA, 1986, J AUTOM CHEM, V8, P170, DOI 10.1155/S1463924686000330; Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403, DOI 10.1152/jappl.2001.90.6.2403; Zhang QX, 2012, BIOTECHNOL LETT, V34, P2001, DOI 10.1007/s10529-012-1017-1	39	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e83437	10.1371/journal.pone.0083437	http://dx.doi.org/10.1371/journal.pone.0083437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465380	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500005
J	Feng, H; Hu, GQ; Wang, HL; Liang, M; Liang, HR; Guo, H; Zhao, PS; Yang, YJ; Zheng, XX; Zhang, ZF; Zhao, YK; Gao, YW; Yang, ST; Xia, XZ				Feng, Hao; Hu, Gui-qiu; Wang, Hua-lei; Liang, Meng; Liang, Hongru; Guo, He; Zhao, Pingsen; Yang, Yu-jiao; Zheng, Xue-xing; Zhang, Zhi-fang; Zhao, Yong-kun; Gao, Yu-wei; Yang, Song-tao; Xia, Xian-zhu			Canine Parvovirus VP2 Protein Expressed in Silkworm Pupae Self-Assembles into Virus-Like Particles with High Immunogenicity	PLOS ONE			English	Article							CYTOTOXIC T-CELLS; NEUTRALIZING ANTIBODIES; FOREIGN EPITOPES; DENDRITIC CELLS; SURFACE-ANTIGEN; CLADE-A; VACCINE; RESPONSES; INFECTION; MICE	The VP2 structural protein of parvovirus can produce virus-like particles (VLPs) by a self-assembly process in vitro, making VLPs attractive vaccine candidates. In this study, the VP2 protein of canine parvovirus (CPV) was expressed using a baculovirus expression system and assembled into parvovirus-like particles in insect cells and pupae. Electron micrographs of VLPs showed that they were very similar in size and morphology when compared to the wild-type parvovirus. The immunogenicity of the VLPs was investigated in mice and dogs. Mice immunized intramuscularly with purified VLPs, in the absence of an adjuvant, elicited CD4(+) and CD8(+) T cell responses and were able to elicit a neutralizing antibody response against CPV, while the oral administration of raw homogenates containing VLPs to the dogs resulted in a systemic immune response and long-lasting immunity. These results demonstrate that the CPV-VLPs stimulate both cellular and humoral immune responses, and so CPV-VLPs may be a promising candidate vaccine for the prevention of CPV-associated disease.	[Feng, Hao; Wang, Hua-lei; Liang, Hongru; Zheng, Xue-xing; Zhao, Yong-kun; Gao, Yu-wei; Yang, Song-tao; Xia, Xian-zhu] Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin Province, Peoples R China; [Hu, Gui-qiu; Liang, Meng; Guo, He; Yang, Yu-jiao] Jilin Univ, Div Agr, Coll Anim Sci & Vet Med, Changchun 130023, Jilin Province, Peoples R China; [Hu, Gui-qiu] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin Province, Peoples R China; [Zhao, Pingsen] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Zhao, Pingsen] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Zhi-fang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Academy of Military Medical Sciences - China; Jilin University; Jilin Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Yang, ST (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin Province, Peoples R China.	yst610223@hotmail.com; xiaxianzhu@gmail.com	Wang, Hualei/S-7920-2018; Zhao, Pingsen/GON-6370-2022	Wang, Hualei/0000-0001-8008-3878; Feng, Hao/0000-0001-6873-1174	Special Fund for Agri-scientific Research in the Public Interest [201303042]	Special Fund for Agri-scientific Research in the Public Interest	This work was supported by the Special Fund for Agri-scientific Research in the Public Interest (No. 201303042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonis AFG, 2006, VACCINE, V24, P5481, DOI 10.1016/j.vaccine.2006.03.089; Appel JJG, 1979, VET REC, V105, P156; Buonaguro L, 2007, VACCINE, V25, P5968, DOI 10.1016/j.vaccine.2007.05.052; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Buonaguro L, 2005, J VIROL, V79, P7059, DOI 10.1128/JVI.79.11.7059-7067.2005; Buonaguro L, 2002, ANTIVIR RES, V54, P189, DOI 10.1016/S0166-3542(02)00004-9; Buonaguro L, 2009, J VIROL, V83, P304, DOI 10.1128/JVI.01606-08; BUONAVOGLIA C, 1983, ZBL VET MED B, V30, P526; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; Chalmers WSK, 1999, VET MICROBIOL, V69, P41, DOI 10.1016/S0378-1135(99)00085-1; CHANG SF, 1992, J VIROL, V66, P6858, DOI 10.1128/JVI.66.12.6858-6867.1992; Feng H, 2011, VET MICROBIOL, V154, P49, DOI 10.1016/j.vetmic.2011.06.022; Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.0818-9641.2004.01271.x; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Madalinski K, 2001, VACCINE, V20, P92, DOI 10.1016/S0264-410X(01)00312-7; Maranga Luis, 2002, Adv Biochem Eng Biotechnol, V74, P183; MCCANCE DJ, 1977, INFECT IMMUN, V18, P196, DOI 10.1128/IAI.18.1.196-202.1977; Murata K, 2003, P NATL ACAD SCI USA, V100, P6753, DOI 10.1073/pnas.1131929100; Muzyczka N., 2001, FIELDS VIROLOGY, P2327; NATHANSON N, 1995, AM J EPIDEMIOL, V142, P109, DOI 10.1093/oxfordjournals.aje.a117611; Paliard X, 2000, AIDS RES HUM RETROV, V16, P273, DOI 10.1089/088922200309368; POLLOCK RVH, 1982, CORNELL VET, V72, P103; ROY P, 1992, VACCINE, V10, P28, DOI 10.1016/0264-410X(92)90415-G; ROY P, 1994, VACCINE, V12, P805, DOI 10.1016/0264-410X(94)90289-5; Schirmbeck R, 1996, INTERVIROLOGY, V39, P111, DOI 10.1159/000150482; Sedlik C, 1997, P NATL ACAD SCI USA, V94, P7503, DOI 10.1073/pnas.94.14.7503; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Truyen U, 2006, VET MICROBIOL, V117, P9, DOI 10.1016/j.vetmic.2006.04.003; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Woo WP, 2006, J VIROL, V80, P3975, DOI 10.1128/JVI.80.8.3975-3984.2006; Wu XF, 2004, J BIOTECHNOL, V111, P253, DOI 10.1016/j.jbiotec.2004.04.016; Yule TD, 1997, VACCINE, V15, P720, DOI 10.1016/S0264-410X(96)00232-0	33	25	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e79575	10.1371/journal.pone.0079575	http://dx.doi.org/10.1371/journal.pone.0079575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465364	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000001
J	Fogelson, B; Mogilner, A				Fogelson, Ben; Mogilner, Alex			Computational Estimates of Membrane Flow and Tension Gradient in Motile Cells	PLOS ONE			English	Article							LEADING-EDGE; TETHER FORMATION; PLASMA-MEMBRANE; LIPID FLOW; ACTIN; SHAPE; ENDOCYTOSIS; MODULATION; EXOCYTOSIS; DIFFUSION	All parts of motile cells, including the plasma membrane, have to translocate in the direction of locomotion. Both directed intracellular membrane transport coupled with polarized endo- and exocytosis and fluid flow in the plane of the plasma membrane can contribute to this overall plasma membrane translocation. It remains unclear how strong a force is required to generate this flow. We numerically solve Stokes equations for the viscous membrane flow across a flat plasma membrane surface in the presence of transmembrane proteins attached to the cytoskeleton and find the membrane tension gradient associated with this flow. This gradient is sensitive to the size and density of the transmembrane proteins attached to the cytoskeleton and can become significant enough to slow down cell movement. We estimate the influence of intracellular membrane transport and actin growth and contraction on the tension gradient, and discuss possible 'tank tread' flow at ventral and dorsal surfaces.	[Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Mogilner, A (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	mogilner@math.ucdavis.edu		Fogelson, Ben/0000-0002-3606-3340	National Institute of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the National Institute of Health and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Velasco C, 1999, MOL BIOL CELL, V10, P4419, DOI 10.1091/mbc.10.12.4419; Anderson KI, 1996, J CELL BIOL, V134, P1209, DOI 10.1083/jcb.134.5.1209; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bray D., 2000, CELL MOVEMENTS MOL M; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Carman PC, 1937, T I CHEM ENG-LOND, V15, P150; Chizmadzhev YA, 1999, BIOPHYS J, V76, P2951, DOI 10.1016/S0006-3495(99)77450-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cooper GM, 2000, CELL MOL APPROACH; Cortez R, 2001, SIAM J SCI COMPUT, V23, P1204, DOI 10.1137/S106482750038146X; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; DAI JW, 1995, CELL, V83, P693; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; EVANS EA, 1979, CRC CR REV BIOM ENG, V3, P181; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jiang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055408; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; KUCIK DF, 1989, NATURE, V340, P315, DOI 10.1038/340315a0; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schweitzer Y, 2013, SOFT MATTER, V9, P5186, DOI 10.1039/c3sm50723h; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sohn JS, 2010, J COMPUT PHYS, V229, P119, DOI 10.1016/j.jcp.2009.09.017; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Tajparast M, 2009, BBA-BIOMEMBRANES, V1788, P1009, DOI 10.1016/j.bbamem.2009.01.019; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; WAUGH RE, 1982, BIOPHYS J, V38, P29, DOI 10.1016/S0006-3495(82)84527-X; Weisswange I, 2005, J CELL SCI, V118, P4375, DOI 10.1242/jcs.02551; Wessels D, 2000, J CELL SCI, V113, P21	51	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84524	10.1371/journal.pone.0084524	http://dx.doi.org/10.1371/journal.pone.0084524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465414	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000014
J	Lovett, PB; Kahn, JA; Greene, SE; Bloch, MA; Brandt, DR; Minckler, MR				Lovett, Paris B.; Kahn, J. Akiva; Greene, Stuart E.; Bloch, Matthew A.; Brandt, Daniel R.; Minckler, Michael R.			Early Quick Acuity Score Provides More Complete Data on Emergency Department Walkouts	PLOS ONE			English	Article							LEAVE; PATIENT; PHYSICIAN; CARE	Introduction: Many prior studies have compared the acuity of Emergency Department (ED) patients who have Left Without Being Seen (LWBS) against non-LWBS patients. A weakness in these studies is that patients may walk out prior to the assignment of a triage score, biasing comparisons. We report an operational change whereby acuity was assessed immediately upon patient arrival. We hypothesized more patients would receive acuity scores with EQAS. We also sought to compare LWBS and non-LWBS patient characteristics with reduced bias. Methods: Setting: urban, academic medical center. Retrospective cohort study, electronic chart review, collecting data on all ED patients presenting between 4/1/2010 and 10/31/2011 ("Traditional Acuity Score'' period, TAS) and from 11/1/2011 to 3/31/2012 ("Early Quick Acuity Score'' period, EQAS). We recorded disposition (LWBS versus non-LWBS), acuity and demographics. For each subject during the EQAS period, we calculated how many prior ED visits and how many prior walkouts the subject had had during the TAS period. Results: Acuity was recorded in 92,275 of 94,526 patients (97.6%) for TAS period, and 25,577 of 25,760 patients (99.3%) for EQAS period, a difference of 1.7% (1.5%, 1.8%). LWBS patients had acuity scores recorded in 5,180 of 7,040 cases (73.6%) during TAS period, compared with 897 of 1,010 cases (88.8%) during the EQAS period, a difference of 15.2% (14.8%, 15.7%). LWBS were more likely than non-LWBS to be male, were younger and had lower acuity scores. LWBS averaged 5.3 prior ED visits compared with 2.8 by non-LWBS, a difference of 2.5 (1.5, 3.5). LWBS averaged 1.3 prior ED walkouts compared with 0.2 among non-LWBS, a difference of 1.1 (0.8, 1.3). Conclusions: EQAS resulted in a higher proportion of patients receiving acuity scores, particularly among LWBS. This offers more complete data when comparing LWBS and non-LWBS patient characteristics. The comparison reinforced findings from prior studies.	[Lovett, Paris B.] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Kahn, J. Akiva] Providence Little Co Mary Hosp, Dept Emergency Med, Torrance, CA USA; [Greene, Stuart E.] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Bloch, Matthew A.] Thomas Jefferson Univ, Coordinating Ctr Clin Res, Philadelphia, PA 19107 USA; [Brandt, Daniel R.; Minckler, Michael R.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University	Lovett, PB (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.	parislovett@gmail.com			Department of Emergency Medicine at Thomas Jefferson University	Department of Emergency Medicine at Thomas Jefferson University	This research was internally funded by the Department of Emergency Medicine at Thomas Jefferson University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baibergenova Akerke, 2006, Healthc Policy, V1, P35; BAKER DW, 1991, JAMA-J AM MED ASSOC, V266, P1085, DOI 10.1001/jama.266.8.1085; BINDMAN AB, 1991, JAMA-J AM MED ASSOC, V266, P1091, DOI 10.1001/jama.266.8.1091; Crilly J, 2013, EUR J EMERG MED, V20, P248, DOI 10.1097/MEJ.0b013e328356fa0e; Ding R, 2006, ANN EMERG MED, V48, P686, DOI 10.1016/j.annemergmed.2006.05.022; Gilboy N, 2011, EMERGENCY SEVERITY I, P7; Gilligan P, 2009, EMERG MED J, V26, P780, DOI 10.1136/emj.2008.063388; Goldman RD, 2005, CAN MED ASSOC J, V172, P39, DOI 10.1503/cmaj.1031817; Goodacre S, 2005, EMERG MED J, V22, P93, DOI 10.1136/emj.2003.007690; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Hobbs D, 2000, AM J EMERG MED, V18, P767, DOI 10.1053/ajem.2000.18075; Hsia RY, 2011, ANN EMERG MED, V58, P24, DOI 10.1016/j.annemergmed.2011.01.009; Kyriacou DN, 1999, ANN EMERG MED, V34, P326, DOI 10.1016/S0196-0644(99)70126-5; Mohsin Mohammed, 2005, Emerg Med Australas, V17, P434, DOI 10.1111/j.1742-6723.2005.00774.x; Mohsin M, 2007, EMERG MED J, V24, P175, DOI 10.1136/emj.2006.038679; Monzon Jose, 2005, CJEM, V7, P107; Pham JC, 2009, ACAD EMERG MED, V16, P949, DOI 10.1111/j.1553-2712.2009.00515.x; Rowe BH, 2006, ACAD EMERG MED, V13, P848, DOI 10.1197/j.aem.2006.01.028; STOCK LM, 1994, ANN EMERG MED, V23, P294, DOI 10.1016/S0196-0644(94)70043-5; Tropea J, 2012, ACAD EMERG MED, V19, P439, DOI 10.1111/j.1553-2712.2012.01327.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vieth TL, 2006, AM J EMERG MED, V24, P787, DOI 10.1016/j.ajem.2006.03.026; Wartman S A, 1984, J Community Health, V9, P261, DOI 10.1007/BF01338726; Ng Y, 2012, J PAEDIATR CHILD H, V48, P10, DOI 10.1111/j.1440-1754.2011.02187.x	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85776	10.1371/journal.pone.0085776	http://dx.doi.org/10.1371/journal.pone.0085776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465699	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000064
J	Poespoprodjo, JR; Fobia, W; Kenangalem, E; Lampah, DA; Sugiarto, P; Tjitra, E; Anstey, NM; Price, RN				Poespoprodjo, Jeanne Rini; Fobia, Wendy; Kenangalem, Enny; Lampah, Daniel A.; Sugiarto, Paulus; Tjitra, Emiliana; Anstey, Nicholas M.; Price, Ric N.			Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATION PHARMACOKINETICS; DEVELOPMENTAL TOXICITY; CHLOROQUINE; ARTESUNATE; PAPUA; AMODIAQUINE; INDONESIA; EFFICACY; WOMEN	Background: Artemisinin combination therapy (ACT) is recommended for the treatment of multidrug resistant malaria in the second and third trimesters of pregnancy, but the experience with ACTs is limited. We review the exposure of pregnant women to the combination dihydroartemisinin-piperaquine over a 6 year period. Methods: From April 2004-June 2009, a prospective hospital-based surveillance screened all pregnant women for malaria and documented maternal and neonatal outcomes. Results: Data were available on 6519 pregnant women admitted to hospital; 332 (5.1%) women presented in the first trimester, 324 (5.0%) in the second, 5843 (89.6%) in the third, and in 20 women the trimester was undocumented. Peripheral parasitaemia was confirmed in 1682 women, of whom 106 (6.3%) had severe malaria. Of the 1217 women admitted with malaria in the second and third trimesters without an impending adverse outcome, those treated with DHP were more likely to be discharged with an ongoing pregnancy compared to those treated with a non-ACT regimen (Odds Ratio OR = 2.48 [1.26-4.86]); p = 0.006. However in the first trimester 63% (5/8) of women treated with oral DHP miscarried compared to 2.6% (1/38) of those receiving oral quinine; p<0.001. Of the 847 women admitted for delivery those reporting a history of malaria during their pregnancy who had been treated with quinine-based regimens rather than DHP had a higher risk of malaria at delivery (adjusted OR = 1.56 (95% CI 0.97-2.5), p = 0.068) and perinatal mortality (adjusted OR = 3.17 [95% CI: 1.17-8.60]; p = 0.023). Conclusions: In the second and third trimesters of pregnancy, a three day course of DHP simplified antimalarial treatment and had significant benefits over quinine-based regimens in reducing recurrent malaria and poor fetal outcome. These data provide reassuring evidence for the rational design of prospective randomized clinical trials and pharmacokinetic studies.	[Poespoprodjo, Jeanne Rini; Kenangalem, Enny; Lampah, Daniel A.] Dist Hlth Author, Timika, Papua, Indonesia; [Poespoprodjo, Jeanne Rini; Fobia, Wendy; Kenangalem, Enny; Lampah, Daniel A.] Natl Inst Hlth Res, Menzies Sch Hlth Res, Timika, Papua, Indonesia; [Poespoprodjo, Jeanne Rini; Fobia, Wendy; Kenangalem, Enny; Lampah, Daniel A.] Dev Res Program, Timika, Papua, Indonesia; [Sugiarto, Paulus] Mitra Masyarakat Hosp, Timika, Papua, Indonesia; [Tjitra, Emiliana] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Anstey, Nicholas M.; Price, Ric N.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	National Institute of Health Research & Development (NIHRD); Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Oxford	Price, RN (corresponding author), Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia.	rprice@menzies.edu.au	Poespoprodjo, Jeanne/AAF-1698-2020	Poespoprodjo, Jeanne/0000-0003-1573-734X; Price, Richard/0000-0003-2000-2874	Wellcome Trust-NHRMC (Wellcome Trust) [ICRG GR071614MA- NHMRC ICRG ID 283321]; NHMRC; Wellcome Trust [091625]; AusAID Australian Leadership Award; AusAID	Wellcome Trust-NHRMC (Wellcome Trust); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); AusAID Australian Leadership Award; AusAID(Australian Aid (AusAID))	The study was funded by the Wellcome Trust-NHRMC (Wellcome Trust ICRG GR071614MA- NHMRC ICRG ID 283321). NMA is supported by an NHMRC Practitioner Fellowship, RNP by a Wellcome Trust Senior Research Fellowship in Clinical Science (091625) and JRP by an AusAID Australian Leadership Award. The Timika Translational Research Facility is supported by AusAID. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam I, 2012, AM J TROP MED HYG, V87, P35, DOI 10.4269/ajtmh.2012.11-0410; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Batty KT, 2010, REPROD TOXICOL, V29, P206, DOI 10.1016/j.reprotox.2009.10.013; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027; Clark RL, 2008, BIRTH DEFECTS RES B, V83, P418, DOI 10.1002/bdrb.20163; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; Hasugian AR, 2009, ANTIMICROB AGENTS CH, V53, P1094, DOI 10.1128/AAC.01511-08; Hidayat M, 2001, RAPID SURVEY MATERNA; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; McGready R, 2002, T ROY SOC TROP MED H, V96, P180, DOI 10.1016/S0035-9203(02)90297-X; Mimika DHO, 2005, MIM DISTR HLTH OFF A; Nosten F, 2006, CURR DRUG SAF, V1, P1, DOI 10.2174/157488606775252584; Nosten F, 2007, LANCET INFECT DIS, V7, P118, DOI 10.1016/S1473-3099(07)70023-3; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; Rijken MJ, 2008, AM J TROP MED HYG, V78, P543, DOI 10.4269/ajtmh.2008.78.543; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Tarning J, 2012, ANTIMICROB AGENTS CH, V56, P1997, DOI 10.1128/AAC.05756-11; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 1996, CAT HLTH IND SEL IMP, p[20, 51]; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization. Regional Office for Africa, 2004, STRATEGIC FRAMEWORK	29	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84976	10.1371/journal.pone.0084976	http://dx.doi.org/10.1371/journal.pone.0084976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465458	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000019
J	Zhou, Z; Yu, FL; Buchanan, A; Fu, YY; Campos, M; Wu, KK; Chambless, LE; Folsom, AR; Boerwinkle, E; Dong, JF				Zhou, Zhou; Yu, Fuli; Buchanan, Ashley; Fu, Yuanyuan; Campos, Marco; Wu, Kenneth K.; Chambless, Lloyd E.; Folsom, Aaron R.; Boerwinkle, Eric; Dong, Jing-fei			Possible Race and Gender Divergence in Association of Genetic Variations with Plasma von Willebrand Factor: A Study of ARIC and 1000 Genome Cohorts	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CORONARY-HEART-DISEASE; ABO BLOOD-GROUP; FACTOR-VIII; ATHEROSCLEROSIS RISK; HEMOSTATIC FACTORS; DIAGNOSIS; LOCUS	The synthesis, secretion and clearance of von Willebrand factor (VWF) are regulated by genetic variations in coding and promoter regions of the VWF gene. We have previously identified 19 single nucleotide polymorphisms (SNPs), primarily in introns that are associated with VWF antigen levels in subjects of European descent. In this study, we conducted race by gender analyses to compare the association of VWF SNPs with VWF antigen among 10,434 healthy Americans of European (EA) or African (AA) descent from the Atherosclerosis Risk in Communities (ARIC) study. Among 75 SNPs analyzed, 13 and 10 SNPs were associated with VWF antigen levels in EA male and EA female subjects, respectively. However, only one SNP (RS1063857) was significantly associated with VWF antigen in AA females and none was in AA males. Haplotype analysis of the ARIC samples and studying racial diversities in the VWF gene from the 1000 genomes database suggest a greater degree of variations in the VWF gene in AA subjects as compared to EA subjects. Together, these data suggest potential race and gender divergence in regulating VWF expression by genetic variations.	[Zhou, Zhou; Fu, Yuanyuan] CAMS, Fuwai Hosp, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Zhou, Zhou; Fu, Yuanyuan] PUMC, Fuwai Hosp, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Yu, Fuli] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Human & Mol Genet, Houston, TX 77030 USA; [Yu, Fuli] Tianjin Med Univ, Gen Hosp, Inst Neurol, Tianjin, Peoples R China; [Buchanan, Ashley; Chambless, Lloyd E.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Campos, Marco] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; [Wu, Kenneth K.] Natl Hlth Res Inst, Taipei, Taiwan; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Boerwinkle, Eric] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Dong, Jing-fei] Puget Sound Blood Ctr, Puget Sound Blood Res Inst, Seattle, WA 98104 USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Baylor College of Medicine; Tianjin Medical University; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; National Health Research Institutes - Taiwan; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Puget Sound Blood Center; University of Washington; University of Washington Seattle	Dong, JF (corresponding author), Puget Sound Blood Ctr, Puget Sound Blood Res Inst, Seattle, WA 98104 USA.	jfdong@psbc.org			ARIC [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Heart, Lung, and Blood Institute [HL71895, HL085769]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055016, N01HC055018, N01HC055020, N01HC055022, N01HC055015, N01HC055019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071895, R01HL085769] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	ARIC; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the ARIC contracts (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022) and the grants HL71895 and HL085769 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellissimo DB, 2012, BLOOD, V119, P2135, DOI 10.1182/blood-2011-10-384610; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Campos M, 2012, BLOOD, V119, P1929, DOI 10.1182/blood-2011-10-383661; Campos M, 2011, BLOOD, V117, P5224, DOI 10.1182/blood-2010-08-300152; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; FOLSOM A R, 1992, Ethnicity and Disease, V2, P35; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Franchini M, 2006, ANN HEMATOL, V85, P415, DOI 10.1007/s00277-006-0085-5; Franchini M, 2008, SEMIN THROMB HEMOST, V34, P663, DOI 10.1055/s-0028-1104545; GILL JC, 1987, BLOOD, V69, P1691; Goodeve AC, 2010, BLOOD REV, V24, P123, DOI 10.1016/j.blre.2010.03.003; GREEN D, 1994, ARTERIOSCLER THROMB, V14, P686, DOI 10.1161/01.ATV.14.5.686; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Keightley AM, 1999, BLOOD, V93, P4277, DOI 10.1182/blood.V93.12.4277.412k03_4277_4283; Lacquemant C, 2000, KIDNEY INT, V57, P1437, DOI 10.1046/j.1523-1755.2000.00988.x; Miller CH, 2001, AM J HEMATOL, V67, P125, DOI 10.1002/ajh.1090; Morange PE, 2004, CIRCULATION, V109, P1343, DOI 10.1161/01.CIR.0000120705.55512.EC; Pareti FI, 2000, CIRCULATION, V102, P1290, DOI 10.1161/01.CIR.102.11.1290; SHIMA M, 1995, VOX SANG, V68, P236, DOI 10.1111/j.1423-0410.1995.tb02579.x; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2000, ARTERIOSCL THROM VAS, V20, P2024, DOI 10.1161/01.ATV.20.8.2024; TAKAHASHI Y, 1987, BLOOD, V70, P1679; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; Vischer UM, 1998, BLOOD, V91, P118, DOI 10.1182/blood.V91.1.118.118_118_127; Wang QY, 2013, J THROMB HAEMOST, V11, P261, DOI 10.1111/jth.12093; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	26	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84810	10.1371/journal.pone.0084810	http://dx.doi.org/10.1371/journal.pone.0084810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465435	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000016
J	Du, S; Guan, ZZ; Hao, LH; Song, Y; Wang, L; Gong, LL; Liu, L; Qi, XY; Hou, ZY; Shao, SJ				Du, Sha; Guan, Zhuzhu; Hao, Lihong; Song, Yang; Wang, Lan; Gong, Linlin; Liu, Lu; Qi, Xiaoyu; Hou, Zhaoyuan; Shao, Shujuan			Fructose-Bisphosphate Aldolase A Is a Potential Metastasis-Associated Marker of Lung Squamous Cell Carcinoma and Promotes Lung Cell Tumorigenesis and Migration	PLOS ONE			English	Article							GLYCOLYTIC-ENZYMES; HEMOLYTIC-ANEMIA; IDENTIFICATION; PROTEINS; TUBULIN; CANCER; MUSCLE; GENE	Fructose-bisphosphate aldolase A (ALDOA) is a key enzyme in glycolysis and is responsible for catalyzing the reversible conversion of fructose-1,6-bisphosphate to glyceraldehydes-3-phosphate and dihydroxyacetone phosphate. ALDOA contributes to various cellular functions such as muscle maintenance, regulation of cell shape and mobility, striated muscle contraction, actin filament organization and ATP biosynthetic process. Here, we reported that ALDOA is a highly expressed in lung squamous cell carcinoma (LSCC) and its expression level is correlated with LSCC metastasis, grades, differentiation status and poor prognosis. Depletion of ALDOA expression in the lung squamous carcinoma NCI-H520 cells reduces the capabilities of cell motility and tumorigenesis. These data suggest that ALDOA could be a potential marker for LSCC metastasis and a therapeutic target for drug development.	[Du, Sha; Guan, Zhuzhu; Hao, Lihong; Song, Yang; Wang, Lan; Gong, Linlin; Liu, Lu; Qi, Xiaoyu; Shao, Shujuan] Dalian Med Univ, Dept Histol & Embryol, Liaoning, Peoples R China; [Du, Sha; Hou, Zhaoyuan] Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Liaoning, Peoples R China; [Guan, Zhuzhu; Shao, Shujuan] Dalian Med Univ, Liaoning Key Lab Prote, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University	Hou, ZY (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Liaoning, Peoples R China.	houzy@sjtu.edu.cn; shaoshujuan2006@126.com			National Basic Research Program of China (973 Program) [2012CB967003]; Natural Science Foundation of China [20935004, 81071784, 81172028]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Basic Research Program of China (973 Program, No. 2012CB967003 to S. Shao), Natural Science Foundation of China (NO. 20935004, 81071784 to S. Shao, and 81172028 to Z. Hou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD H, 1968, EUR J BIOCHEM, V6, P163, DOI 10.1111/j.1432-1033.1968.tb00434.x; CARR D, 1993, BIOCHEM BIOPH RES CO, V195, P289, DOI 10.1006/bbrc.1993.2043; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; CLARKE FM, 1975, BIOCHIM BIOPHYS ACTA, V381, P37, DOI 10.1016/0304-4165(75)90187-7; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Kajita E, 2001, MECH DEVELOP, V102, P283, DOI 10.1016/S0925-4773(01)00324-0; KISHI H, 1987, P NATL ACAD SCI USA, V84, P8623, DOI 10.1073/pnas.84.23.8623; KNULL HR, 1992, CURR TOP CELL REGUL, V33, P15; Kusakabe T, 1997, ARCH BIOCHEM BIOPHYS, V344, P184, DOI 10.1006/abbi.1997.0204; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; May Caroline, 2012, Methods Mol Biol, V893, P75, DOI 10.1007/978-1-61779-885-6_6; MIWA S, 1981, AM J HEMATOL, V11, P425, DOI 10.1002/ajh.2830110412; PFLEIDERER G, 1975, BEITR PATHOL, V156, P266; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; St-Jean M, 2007, J BIOL CHEM, V282, P14309, DOI 10.1074/jbc.M611505200; Tochio T, 2010, J DERMATOL SCI, V58, P123, DOI 10.1016/j.jdermsci.2010.02.012; WALSH JL, 1989, BIOCHIM BIOPHYS ACTA, V999, P64, DOI 10.1016/0167-4838(89)90031-9; WALSH JL, 1988, BIOCHIM BIOPHYS ACTA, V952, P83, DOI 10.1016/0167-4838(88)90104-5; Yao DC, 2004, BLOOD, V103, P2401, DOI 10.1182/blood-2003-09-3160	21	86	95	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85804	10.1371/journal.pone.0085804	http://dx.doi.org/10.1371/journal.pone.0085804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465716	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000026
J	Xiang, Y; Ma, L; Wu, WD; Liu, W; Li, YG; Zhu, X; Wang, Q; Ma, JF; Cao, MQ; Wang, Q; Yao, XM; Yang, L; Wubuli, A; Merle, C; Milligan, P; Mao, Y; Gu, JY; Xin, XM				Xiang, Yang; Ma, Long; Wu, Weidong; Liu, Wei; Li, Yongguang; Zhu, Xia; Wang, Qian; Ma, Jinfeng; Cao, Mingqin; Wang, Qian; Yao, Xuemei; Yang, Lei; Wubuli, Atikaimu; Merle, Corinne; Milligan, Paul; Mao, Ying; Gu, Jiayi; Xin, Xiumei			The Incidence of Liver Injury in Uyghur Patients Treated for TB in Xinjiang Uyghur Autonomous Region, China, and Its Association with Hepatic Enzyme Polymorphisms NAT2, CYP2E1, GSTM1 and GSTT1	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; GLUTATHIONE-S-TRANSFERASE; CYTOCHROME-P450 2E1 GENOTYPE; GENETIC POLYMORPHISMS; ANTITUBERCULOSIS DRUGS; METABOLIZING-ENZYMES; NULL MUTATIONS; RISK-FACTORS; SUSCEPTIBILITY; M1	Background and Objective: Of three first-line anti-tuberculosis (anti-TB) drugs, isoniazid is most commonly associated with hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, NAT2, CYP2E1, GSTM1and GSTT1, that code for drug-metabolizing enzymes. This study evaluated whether the polymorphisms in these enzymes were associated with an increased risk of anti-TB drug-induced hepatitis in patients and could potentially be used to identify patients at risk of liver injury. Methods and Design: In a cross-sectional study, 2244 tuberculosis patients were assessed two months after the start of treatment. Anti-TB drug-induced liver injury (ATLI) was defined as an ALT, AST or bilirubin value more than twice the upper limit of normal. NAT2, CYP2E1, GSTM1 and GSTT1 genotypes were determined using the PCR/ligase detection reaction assays. Results: 2244 patients were evaluated, there were 89 cases of ATLI, a prevalence of 4% 9 patients (0.4%) had ALT levels more than 5 times the upper limit of normal. The prevalence of ATLI was greater among men than women, and there was a weak association with NAT2*5 genotypes, with ATLI more common among patients with the NAT2*5*CT genotype. The sensitivity of the CT genotype for identifying patients with ATLI was 42% and the positive predictive value 5.9%. CT ATLI was more common among slow acetylators (prevalence ratio 2.0 (95% CI 0.95,4.20)) compared to rapid acetylators. There was no evidence that ATLI was associated with CYP2E1 RsaIc1/c1genotype, CYP2E1 RsaIc1/c2 or c2/c2 genotypes, or GSTM1/GSTT1 null genotypes. Conclusions: In Xinjiang Uyghur TB patients, liver injury was associated with the genetic variant NAT2*5, however the genetic markers studied are unlikely to be useful for screening patients due to the low sensitivity and low positive predictive values for identifying persons at risk of liver injury.	[Xiang, Yang; Ma, Jinfeng; Cao, Mingqin; Wang, Qian; Yao, Xuemei; Yang, Lei; Wubuli, Atikaimu; Mao, Ying; Gu, Jiayi] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Ma, Long] Red Cross Xinjiang Uygur Autonomous Reg, Urumqi, Xinjiang, Peoples R China; [Wu, Weidong] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Ctr TB Control & Prevent, Urumqi, Xinjiang, Peoples R China; [Liu, Wei] Xinjiang Ili Kazak Autonomous Prefecture Ctr Dis, Ili, Xinjiang, Peoples R China; [Li, Yongguang] Xinjiang Aksu Dist Ctr Dis Control & Prevent, Aksu, Xinjiang, Peoples R China; [Zhu, Xia] Lib Xinjiang Med Univ, Urumqi, Xinjiang, Peoples R China; [Wang, Qian] Xinjiang Med Univ, Grad Sch, Urumqi, Xinjiang, Peoples R China; [Merle, Corinne; Milligan, Paul] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Xin, Xiumei] Xinjiang Med Univ, Care Div, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; University of London; London School of Hygiene & Tropical Medicine; Xinjiang Medical University	Ma, L (corresponding author), Red Cross Xinjiang Uygur Autonomous Reg, Urumqi, Xinjiang, Peoples R China.	893664450@qq.com	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395; Merle, Corinne/0000-0003-4229-365X	National Natural Science Foundation of China [30960328]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by National Natural Science Foundation of China (NO. 30960328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; An Hui-ru, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P36; BENICHOU C, 1990, J HEPATOL, V11, P272; Bose PD, 2011, J GASTROEN HEPATOL, V26, P312, DOI 10.1111/j.1440-1746.2010.06355.x; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Chatterjee S, 2010, J CLIN PHARM THER, V35, P465, DOI 10.1111/j.1365-2710.2009.01101.x; [陈怡 Chen Yi], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P748; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; Das Roy P, 2008, PHARMACOGENOMICS, V9, P311, DOI 10.2217/14622416.9.3.311; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; De Rosa HJ, 2007, BIOPHARM DRUG DISPOS, V28, P291, DOI 10.1002/bdd.557; Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167; Dossing M, 1996, TUBERCLE LUNG DIS, V77, P335, DOI 10.1016/S0962-8479(96)90098-2; [郭梅 GUO Mei], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P99; Guo Mingruo, 2009, P1; HEIN DW, 1995, CANCER RES, V55, P3531; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Huang DS, 2011, ZHONGHUA SHENG WU YI, V17, P444; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2007, EXPERT OPIN DRUG MET, V3, P1, DOI 10.1517/17425255.3.1.1; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kim SH, 2010, TUBERCULOSIS, V90, P39, DOI 10.1016/j.tube.2009.12.001; Kim SH, 2009, PHARMACOGENOMICS, V10, P1767, DOI 10.2217/PGS.09.100; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Leiro V, 2008, LIVER INT, V28, P835, DOI 10.1111/j.1478-3231.2008.01700.x; Lv XZ, 2012, ANN HEPATOL, V11, P700, DOI 10.1016/S1665-2681(19)31446-2; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Roy B, 2006, J GASTROEN HEPATOL, V21, P784, DOI 10.1111/j.1440-1746.2006.04197.x; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; RungeMorris M, 1996, DRUG METAB DISPOS, V24, P734; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shakya R, 2004, ANN PHARMACOTHER, V38, P1074, DOI 10.1345/aph.1D525; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Sotsuka T, 2011, IN VIVO, V25, P803; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; SUNAHARA S, 1961, SCIENCE, V134, P1530, DOI 10.1126/science.134.3489.1530; Tang SW, 2012, J CLIN PHARM THER, V37, P588, DOI 10.1111/j.1365-2710.2012.01334.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Wang JH, 2004, ACAD J PLA POSTGRAD, V25, P239; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Wang Tao, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P585; Wu Yu-Mei, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P467, DOI 10.3760/cma.j.issn.1007-3418.2010.06.017; Xie HG, 1997, PHARMACOGENETICS, V7, P503, DOI 10.1097/00008571-199712000-00009; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; YAMAMOTO T, 1986, HEPATOLOGY, V6, P295, DOI 10.1002/hep.1840060223; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x; Zhu Dong-lin, 2011, Zhongguo Kangshengsu Zazhi, V36, P864	61	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85905	10.1371/journal.pone.0085905	http://dx.doi.org/10.1371/journal.pone.0085905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465778	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000032
J	Vazquez-Cintron, EJ; Vakulenko, M; Band, PA; Stanker, LH; Johnson, EA; Ichtchenko, K				Vazquez-Cintron, Edwin J.; Vakulenko, Maksim; Band, Philip A.; Stanker, Larry H.; Johnson, Eric A.; Ichtchenko, Konstantin			Atoxic Derivative of Botulinum Neurotoxin A as a Prototype Molecular Vehicle for Targeted Delivery to the Neuronal Cytoplasm	PLOS ONE			English	Article							LIGHT-CHAIN; PROTEIN; TOXIN; TRANSLOCATION; CELLS; MEMBRANES; SEQUENCE; ANTIBODY; SNAP-25; BINDING	We have previously described genetic constructs and expression systems that enable facile production of recombinant derivatives of botulinum neurotoxins (BoNTs) that retain the structural and trafficking properties of wt BoNTs. In this report we describe the properties of one such derivative, BoNT/A ad, which was rendered atoxic by introducing two amino acid mutations to the light chain (LC) of wt BoNT/A, and which is being developed as a molecular vehicle for delivering drugs to the neuronal cytoplasm. The neuronal binding, internalization, and intracellular trafficking of BoNT/A ad in primary hippocampal cultures was evaluated using three complimentary techniques: flow cytometry, immunohistochemistry, and Western blotting. Neuronal binding of BoNT ad was significantly increased when neurons were incubated in depolarizing medium. Flow cytometry demonstrated that BoNT/A ad internalized into neurons but not glia. After 24 hours, the majority of the neuron-bound BoNT/A ad became internalized, as determined by its resistance to pronase E-induced proteolytic degradation of proteins associated with the plasma membrane of intact cells. Significant amounts of the atoxic LC accumulated in a Triton X-100-extractable fraction of the neurons, and persisted as such for at least 11 days with no evidence of degradation. Immunocytochemical analysis demonstrated that the LC of BoNT/A ad was translocated to the neuronal cytoplasm after uptake and was specifically targeted to SNARE proteins. The atoxic LC consistently co-localized with synaptic markers SNAP-25 and VAMP-2, but was rarely co-localized with markers for early or late endosomes. These data demonstrate that BoNT/A ad mimics the trafficking properties of wt BoNT/A, confirming that our platform for designing and expressing BoNT derivatives provides an accessible system for elucidating the molecular details of BoNT trafficking, and can potentially be used to address multiple medical and biodefense needs.	[Vazquez-Cintron, Edwin J.; Vakulenko, Maksim; Band, Philip A.; Ichtchenko, Konstantin] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Band, Philip A.] New York Univ Hosp Joint Dis, Dept Orthopaed Surg, New York, NY USA; [Stanker, Larry H.] ARS, USDA, Albany, CA USA; [Johnson, Eric A.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	New York University; New York University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Ichtchenko, K (corresponding author), New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	ichtck01@med.nyu.edu		Ichtchenko, Konstantin/0000-0002-2198-1325; Vazquez-Cintron, Edwin/0000-0002-4397-3713; BAND, PHILIP/0000-0002-5363-853X	National Institute Of Allergy And Infectious Diseases [R01-AI093504]; USDA CRIS [5325-42000-043-00D]; National Cancer Institute [5P30CA016087-32]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093504] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the National Institute Of Allergy And Infectious Diseases R01-AI093504 to KI and EAJ and by USDA CRIS Project 5325-42000-043-00D to LHS. The NYU SoM Flow Cytometry Core is supported in part by grant 5P30CA016087-32 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Band PA, 2010, PROTEIN EXPRES PURIF, V71, P62, DOI 10.1016/j.pep.2009.12.013; Barash JR, 2013, J INFECT DIS; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dover N, 2013, J INFECT DIS; Dressler D, 2012, CURR OPIN MICROBIOL, V15, P325, DOI 10.1016/j.mib.2012.05.012; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; FRANCIS JW, 1995, J BIOL CHEM, V270, P15434, DOI 10.1074/jbc.270.25.15434; Fujinaga Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/974943; Gibert M, 2007, FEBS LETT, V581, P1287, DOI 10.1016/j.febslet.2007.02.041; Goodnough MC, 2002, FEBS LETT, V513, P163, DOI 10.1016/S0014-5793(02)02268-8; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Ho MF, 2011, PROTEIN ENG DES SEL, V24, P247, DOI 10.1093/protein/gzq093; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson EA, 2005, J CLIN MICROBIOL, V43, P2602, DOI 10.1128/JCM.43.6.2602-2607.2005; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kuo CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020352; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Pellett S, 2011, BIOCHEM BIOPH RES CO, V405, P673, DOI 10.1016/j.bbrc.2011.01.093; Sanders JD, 1998, J NEUROSCI RES, V53, P670, DOI 10.1002/(SICI)1097-4547(19980915)53:6<670::AID-JNR5>3.3.CO;2-H; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Scotcher MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004924; Simpson LL, 2004, J PHARMACOL EXP THER, V308, P857, DOI 10.1124/jpet.103.058149; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Singh BR, 2010, BIOCHIMIE, V92, P1252, DOI 10.1016/j.biochi.2010.03.005; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Vicario-Abejon Carlos, 2004, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0302s26; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zhang Peng, 2009, BMC Pharmacology, V9, P12, DOI 10.1186/1471-2210-9-12	42	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85517	10.1371/journal.pone.0085517	http://dx.doi.org/10.1371/journal.pone.0085517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465585	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100045
J	Balfour, L; Spaans, JN; Fergusson, D; Huff, H; Mills, EJ; la Porte, CJ; Walmsley, S; Singhal, N; Rosenes, R; Tremblay, N; Gill, MJ; Loemba, H; Conway, B; Rachlis, A; Ralph, E; Loutfy, M; Mallick, R; Moorhouse, R; Cameron, DW				Balfour, Louise; Spaans, Johanna N.; Fergusson, Dean; Huff, Harold; Mills, Edward J.; la Porte, Charles J.; Walmsley, Sharon; Singhal, Neera; Rosenes, Ron; Tremblay, Nancy; Gill, M. John; Loemba, Hugues; Conway, Brian; Rachlis, Anita; Ralph, Edward; Loutfy, Mona; Mallick, Ranjeeta; Moorhouse, Rika; Cameron, D. William		MAINTAIN Study Grp	Micronutrient Deficiency and Treatment Adherence in a Randomized Controlled Trial of Micronutrient Supplementation in ART-Naive Persons with HIV	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; ANTIRETROVIRAL THERAPY; MEDICATION; NUTRITION; READINESS; AFRICA; SYSTEM; ISSUES; WOMEN; SCALE	Introduction: The MAINTAIN study is an on-going RCT comparing high-dose micronutrient and anti-oxidant supplementation versus recommended daily allowance (RDA) vitamins in slowing HIV immune deficiency progression in ART-naive people with HIV infection. Objective: We planned analysis of the first 127 participants to determine the baseline prevalence of serum micronutrient deficiencies and correlates, as well as tolerance and adherence to study interventions. Methods: Participants receive eight capsules twice daily of 1) high-dose or 2) RDA supplements for two years and are followed-up quarterly for measures of immune deficiency progression, safety and tolerability. Regression analysis was used to identify correlates of micronutrient levels at baseline. Adherence was measured by residual pill count, self-report using the General Treatment Scale (GTS) and short-term recall HIV Adherence Treatment Scale (HATS). Results: Prior micronutrient supplementation (within 30 days) was 27% at screening and 10% of study population, and was not correlated with baseline micronutrient levels. Low levels were frequent for carotene (24%<1 nmol/L), vitamin D (24%<40 nmol/L) and serum folate (20%<15 nmol/L). The proportion with B-12 deficiency (<133 pmol/L) was 2.4%. Lower baseline levels of B-12 correlated lower baseline CD4 count (r = 0.21, p = 0.02) with a 21 pmol/L reduction in B-12 per 100 cells/mu L CD4. Vitamin D levels were higher in men (p<0.001). After a median follow-up of 1.63 years, there were 19 (15%) early withdrawals from the study treatment. Mean treatment adherence using pill count was 88%. Subjective adherence by the GTS was 81% and was moderately but significantly correlated with pill count (r = 0.29, p<0.001). Adherence based on short-term recall (HATS) was >80% in 75% of participants. Conclusion: Micronutrient levels in asymptomatic HIV+ persons are in keeping with population norms, but micronutrient deficiencies are frequent. Adherence levels are high, and will permit a valid evaluation of treatment effects.	[Balfour, Louise; Spaans, Johanna N.; Walmsley, Sharon; Singhal, Neera; Rosenes, Ron; Tremblay, Nancy; Gill, M. John; Loemba, Hugues; Conway, Brian; Rachlis, Anita; Ralph, Edward; Loutfy, Mona; Cameron, D. William] CIHR Canadian HIV Trials Network CTN, Vancouver, BC, Canada; [Balfour, Louise; la Porte, Charles J.; Tremblay, Nancy; Cameron, D. William] Univ Ottawa, Dept Med, Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada; [Spaans, Johanna N.; Fergusson, Dean; la Porte, Charles J.; Singhal, Neera; Moorhouse, Rika; Cameron, D. William] Univ Ottawa, OHRI, Clin Epidemiol Program, Ottawa, ON, Canada; [Huff, Harold] Canadian Coll Naturopath Med, Toronto, ON, Canada; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Walmsley, Sharon; Rachlis, Anita; Loutfy, Mona] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Gill, M. John] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Loemba, Hugues] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Conway, Brian] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Ralph, Edward] Univ Western Ontario, Dept Med, Div Infect Dis, London, ON, Canada; [Mallick, Ranjeeta] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Calgary; University of Ottawa; University of British Columbia; Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute	Cameron, DW (corresponding author), CIHR Canadian HIV Trials Network CTN, Vancouver, BC, Canada.	bcameron@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Fergusson, Dean/0000-0002-3389-2485; Walmsley, Sharon/0000-0002-3959-5692	Ontario HIV Treatment Network (OHTN); OHTN [ROGB G117]; Career Scientist Awards from the OHTN	Ontario HIV Treatment Network (OHTN); OHTN; Career Scientist Awards from the OHTN	Board Directed Funds from the Ontario HIV Treatment Network (OHTN) were received for development of the study protocol with community representation. Coordinating centre operating costs are funded through an OHTN operating grant (ROGB G117). The study sites receive infrastructure support from the CIHR Canadian HIV Trials Network (CTN). The study medications were supplied by K-PAX (R) USA Inc. DWC and SW were supported in part by Career Scientist Awards from the OHTN. Study medications and pharmaceutical stability reports on the formulation are provided by the proprietor, K-PAX (R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OHTN: http://www.ohtn.on.ca/CIHR Canadian HIV Trials Network: http://www.hivnet.ubc.ca/home/	Allard JP, 1998, AIDS, V12, P1653, DOI 10.1097/00002030-199813000-00013; Altice FL, 1998, ANN INTERN MED, V129, P503, DOI 10.7326/0003-4819-129-6-199809150-00015; Austin J, 2006, EUR J CLIN NUTR, V60, P1266, DOI 10.1038/sj.ejcn.1602447; Balfour L, 2006, AIDS CARE, V18, P830, DOI 10.1080/09540120500466820; Balfour L, 2007, ASSESSMENT, V14, P408, DOI 10.1177/1073191107304295; BAUM M, 1994, NUTRITION, V10, P16; Baylin A, 2005, EUR J CLIN NUTR, V59, P960, DOI 10.1038/sj.ejcn.1602201; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Boyle BA, 2008, HIV CLIN TRIALS, V9, P164, DOI 10.1310/hct0903-164; Canadian Health Measures Survey, 2013, CANADIAN HLTH MEASUR; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; DiMatteo M R, 1992, Oncology (Williston Park), V6, P50; Dunbar-Jacob J, 2000, Annu Rev Nurs Res, V18, P48; Farley J, 2003, JAIDS-J ACQ IMM DEF, V33, P211, DOI 10.1097/00126334-200306010-00016; Friedmen LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Irlam JH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003650.pub3; Jiamton S, 2003, AIDS, V17, P2461, DOI 10.1097/00002030-200311210-00008; Marston B, 2004, NEW ENGL J MED, V351, P78, DOI 10.1056/NEJMe048134; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Semba RD, 2007, JAIDS-J ACQ IMM DEF, V45, P298; Sheehan NL, 2012, MOLECULES, V17, P688, DOI 10.3390/molecules17010688; Shevitz AH, 2001, CLIN INFECT DIS, V32, P1769, DOI 10.1086/320761; Singhal N, 2010, CONTEMP CLIN TRIALS, V31, P604, DOI 10.1016/j.cct.2010.08.003; Szakacs TA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-97; Tang AM, 2005, AIDS, V19, P847, DOI 10.1097/01.aids.0000171398.77500.a9; Van Servellen G, 2002, AIDS PATIENT CARE ST, V16, P269, DOI 10.1089/10872910260066705; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977	29	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85607	10.1371/journal.pone.0085607	http://dx.doi.org/10.1371/journal.pone.0085607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465617	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500081
J	Karlsson, E; Macellaro, A; Bystrom, M; Forsman, M; Frangoulidis, D; Janse, I; Larsson, P; Lindgren, P; Ohrman, C; van Rotterdam, B; Sjodin, A; Myrtennas, K				Karlsson, Edvin; Macellaro, Anna; Bystrom, Mona; Forsman, Mats; Frangoulidis, Dimitrios; Janse, Ingmar; Larsson, Par; Lindgren, Petter; Ohrman, Caroline; van Rotterdam, Bart; Sjodin, Andreas; Myrtennas, Kerstin			Eight New Genomes and Synthetic Controls Increase the Accessibility of Rapid Melt-MAMA SNP Typing of Coxiella burnetii	PLOS ONE			English	Article							Q-FEVER OUTBREAK; BULK-TANK MILK; REAL-TIME PCR; FRANCISELLA-TULARENSIS; MOLECULAR CHARACTERIZATION; SEQUENCE; PHYLOGEOGRAPHY; DIVERSITY; TRANSMISSION; NETHERLANDS	The case rate of Q fever in Europe has increased dramatically in recent years, mainly because of an epidemic in the Netherlands in 2009. Consequently, there is a need for more extensive genetic characterization of the disease agent Coxiella burnetii in order to better understand the epidemiology and spread of this disease. Genome reference data are essential for this purpose, but only thirteen genome sequences are currently available. Current methods for typing C. burnetii are criticized for having problems in comparing results across laboratories, require the use of genomic control DNA, and/or rely on markers in highly variable regions. We developed in this work a method for single nucleotide polymorphism (SNP) typing of C. burnetii isolates and tissue samples based on new assays targeting ten phylogenetically stable synonymous canonical SNPs (canSNPs). These canSNPs represent previously known phylogenetic branches and were here identified from sequence comparisons of twenty-one C. burnetii genomes, eight of which were sequenced in this work. Importantly, synthetic control templates were developed, to make the method useful to laboratories lacking genomic control DNA. An analysis of twenty-one C. burnetii genomes confirmed that the species exhibits high sequence identity. Most of its SNPs (7,493/7,559 shared by >1 genome) follow a clonal inheritance pattern and are therefore stable phylogenetic typing markers. The assays were validated using twenty-six genetically diverse C. burnetii isolates and three tissue samples from small ruminants infected during the epidemic in the Netherlands. Each sample was assigned to a clade. Synthetic controls (vector and PCR amplified) gave identical results compared to the corresponding genomic controls and are viable alternatives to genomic DNA. The results from the described method indicate that it could be useful for cheap and rapid disease source tracking at non-specialized laboratories, which requires accurate genotyping, assay accessibility and inter-laboratory comparisons.	[Karlsson, Edvin; Macellaro, Anna; Bystrom, Mona; Forsman, Mats; Larsson, Par; Lindgren, Petter; Ohrman, Caroline; Sjodin, Andreas; Myrtennas, Kerstin] Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden; [Frangoulidis, Dimitrios] Bundeswehr Inst Microbiol, Munich, Germany; [Janse, Ingmar; van Rotterdam, Bart] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Saab Group; Bundeswehr Institute of Microbiology (IMB); Netherlands National Institute for Public Health & the Environment	Myrtennas, K (corresponding author), Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden.	kerstin.myrtennas@foi.se	Forsman, Mats/A-1426-2016; Sjödin, Andreas/A-7245-2008	Forsman, Mats/0000-0002-4466-5325; Sjödin, Andreas/0000-0001-5350-4219; Ohrman, Caroline/0000-0001-8489-757X; Karlsson, Edvin/0000-0002-1260-769X; van Rotterdam, Bart/0000-0003-2837-9465	Coxiella Genome Sequencing Consortium (CGSC); Swedish Ministry of Defence; German Bundeswehr as a part of the European Biodefense Laboratory Network (EBLN)	Coxiella Genome Sequencing Consortium (CGSC); Swedish Ministry of Defence; German Bundeswehr as a part of the European Biodefense Laboratory Network (EBLN)	This work was performed under the auspices of the Coxiella Genome Sequencing Consortium (CGSC) (http://coxiella.net) and was funded by the Swedish Ministry of Defence and the German Bundeswehr as a part of the European Biodefense Laboratory Network (EBLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Agger JF, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-5; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Chanturia G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-139; Charrel RN, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-21; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; de Bruin A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-165; ECDC, 2010, EUR CTR DIS PREV CON; Garcia-Perez AL, 2009, J DAIRY SCI, V92, P1581, DOI 10.3168/jds.2008-1672; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; HEINZEN R, 1990, ANN NY ACAD SCI, V590, P504, DOI 10.1111/j.1749-6632.1990.tb42260.x; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Howe GB, 2009, MOL CELL PROBE, V23, P127, DOI 10.1016/j.mcp.2009.01.004; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Kelvin, 2010, BMC Res Notes, V3, P191, DOI 10.1186/1756-0500-3-191; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Miceli MH, 2010, VECTOR-BORNE ZOONOT, V10, P539, DOI 10.1089/vbz.2009.0101; Murphy K, 2004, BIOINFORMATICS, V20, P588, DOI 10.1093/bioinformatics/btg466; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; Pearson T, 2013, SYST BIOL, V62, P752, DOI 10.1093/sysbio/syt038; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2009, TIJDSCHR DIERGENEESK, V134, P300; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Rouli L, 2012, J BACTERIOL, V194, P6939, DOI 10.1128/JB.01856-12; Rustscheff S, 2000, SCAND J INFECT DIS, V32, P605, DOI 10.1080/003655400459496; Schimmer B, 2009, EUROSURVEILLANCE, V14, P14; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sidi-Boumedine K, 2009, CLIN MICROBIOL INFEC, V15, P194, DOI 10.1111/j.1469-0691.2008.02271.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sukrija Z, 2006, ANN NY ACAD SCI, V1078, P124, DOI 10.1196/annals.1374.128; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11; Valergakis GE, 2012, VET REC, V171, DOI 10.1136/vr.100908; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VOGLER AJ, 2009, J BACTERIOL; Vogler AJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001319	54	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85417	10.1371/journal.pone.0085417	http://dx.doi.org/10.1371/journal.pone.0085417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465554	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500062
J	Lee, Y; Kim, S; Kim, JY; Arooj, M; Kim, S; Hwang, S; Kim, BW; Park, KH; Lee, KW				Lee, Yuno; Kim, Songmi; Kim, Jun Young; Arooj, Mahreen; Kim, Siu; Hwang, Swan; Kim, Byeong-Woo; Park, Ki Hun; Lee, Keun Woo			Binding Mode Analyses and Pharmacophore Model Development for Stilbene Derivatives as a Novel and Competitive Class of alpha-Glucosidase Inhibitors	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; MECHANICAL CALCULATIONS; SULFONAMIDE CHALCONE; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEINS; IMPLEMENTATION; SIMULATIONS; AMBER	Stilbene urea derivatives as a novel and competitive class of non-glycosidic a-glucosidase inhibitors are effective for the treatment of type II diabetes and obesity. The main purposes of our molecular modeling study are to explore the most suitable binding poses of stilbene derivatives with analyzing the binding affinity differences and finally to develop a pharmacophore model which would represents critical features responsible for a-glucosidase inhibitory activity. Three-dimensional structure of S. cerevisiae a-glucosidase was built by homology modeling method and the structure was used for the molecular docking study to find out the initial binding mode of compound 12, which is the most highly active one. The initial structure was subjected to molecular dynamics (MD) simulations for protein structure adjustment at compound 12-bound state. Based on the adjusted conformation, the more reasonable binding modes of the stilbene urea derivatives were obtained from molecular docking and MD simulations. The binding mode of the derivatives was validated by correlation analysis between experimental K-i value and interaction energy. Our results revealed that the binding modes of the potent inhibitors were engaged with important hydrogen bond, hydrophobic, and p-interactions. With the validated compound 12-bound structure obtained from combining approach of docking and MD simulation, a proper four featured pharmacophore model was generated. It was also validated by comparison of fit values with the K-i values. Thus, these results will be helpful for understanding the relationship between binding mode and bioactivity and for designing better inhibitors from stilbene derivatives.	[Lee, Yuno; Kim, Songmi; Kim, Jun Young; Arooj, Mahreen; Kim, Siu; Hwang, Swan; Kim, Byeong-Woo; Park, Ki Hun; Lee, Keun Woo] GNU, RINS, PMBBRC, Div Appl Life Sci,BK21 Program,SSAC, Jinju, South Korea		Lee, KW (corresponding author), GNU, RINS, PMBBRC, Div Appl Life Sci,BK21 Program,SSAC, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020; Park, Ki Hun/A-1724-2012	Arooj, Mahreen/0000-0003-1975-5289	National Research Foundation of Korea (NRF); Korean Government (NRF); Basic Science Research Program [2012R1A1A4A01013657]; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the NRF [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (NRF)(Korean Government); Basic Science Research Program; Pioneer Research Center Program; Management of Climate Change Program through the NRF(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This work was supported by National Research Foundation of Korea (NRF) Grant funded by the Korean Government (NRF-2012-Fostering Core Leaders of the Future Basic Science Program). This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the NRF funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, DISCOVERY STUDIO; Asano N, 1998, J MED CHEM, V41, P2565, DOI 10.1021/jm970836l; Aschenbrenner D, 2008, DRUG THERAPY NURSING; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bharatham K, 2008, J MOL GRAPH MODEL, V26, P1202, DOI 10.1016/j.jmgm.2007.11.002; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cheng A.Y.Y., 2004, DRUG DISCOV TODAY TH, V1, P201; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Melo EB, 2006, TETRAHEDRON, V62, P10277, DOI 10.1016/j.tet.2006.08.055; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ferreira SB, 2010, J MED CHEM, V53, P2364, DOI 10.1021/jm901265h; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Houston TA, 2003, MINI-REV MED CHEM, V3, P669, DOI 10.2174/1389557033487827; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim JY, 2010, CHEMBIOCHEM, V11, P2125, DOI 10.1002/cbic.201000376; Kordik CP, 1999, J MED CHEM, V42, P181, DOI 10.1021/jm980521l; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang PH, 2006, CHEMBIOCHEM, V7, P165, DOI 10.1002/cbic.200500321; Matsui I, 2000, J BIOL CHEM, V275, P4871, DOI 10.1074/jbc.275.7.4871; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Muraki M, 2000, BIOCHEMISTRY-US, V39, P292, DOI 10.1021/bi991402q; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Park H, 2008, BIOORGAN MED CHEM, V16, P284, DOI 10.1016/j.bmc.2007.09.036; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rapp C, 2011, J CHEM INFORM MODELI; Scott LJ, 2000, DRUGS, V59, P521, DOI 10.2165/00003495-200059030-00012; Seo WD, 2005, BIOORG MED CHEM LETT, V15, P5514, DOI 10.1016/j.bmcl.2005.08.087; Tomich CH, 2005, J COMPUT AID MOL DES, V19, P83, DOI 10.1007/s10822-005-1486-6; Umezawa Y, 1998, BIOORGAN MED CHEM, V6, P2507, DOI 10.1016/S0968-0896(98)80024-2; Van der Spoel D, 2006, GROMACS USER MANUAL, V4, P9747; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104	38	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85827	10.1371/journal.pone.0085827	http://dx.doi.org/10.1371/journal.pone.0085827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465730	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500122
J	Wu, YC; Coulson, S				Wu, Ying Choon; Coulson, Seana			A Psychometric Measure of Working Memory Capacity for Configured Body Movement	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ICONIC GESTURES; COMMUNICATION; RELIABILITY; INFORMATION; STABILITY; PATTERNS; SPEECH; EYE	Working memory (WM) models have traditionally assumed at least two domain-specific storage systems for verbal and visuo-spatial information. We review data that suggest the existence of an additional slave system devoted to the temporary storage of body movements, and present a novel instrument for its assessment: the movement span task. The movement span task assesses individuals' ability to remember and reproduce meaningless configurations of the body. During the encoding phase of a trial, participants watch short videos of meaningless movements presented in sets varying in size from one to five items. Immediately after encoding, they are prompted to reenact as many items as possible. The movement span task was administered to 90 participants along with standard tests of verbal WM, visuo-spatial WM, and a gesture classification test in which participants judged whether a speaker's gestures were congruent or incongruent with his accompanying speech. Performance on the gesture classification task was not related to standard measures of verbal or visuo-spatial working memory capacity, but was predicted by scores on the movement span task. Results suggest the movement span task can serve as an assessment of individual differences in WM capacity for body-centric information.	[Wu, Ying Choon; Coulson, Seana] Univ Calif San Diego, Ctr Res Language, La Jolla, CA 92093 USA; [Wu, Ying Choon] Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Coulson, Seana] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wu, YC (corresponding author), Univ Calif San Diego, Ctr Res Language, La Jolla, CA 92093 USA.	yingchoon@gmail.com		Coulson, Seana/0000-0003-1246-9394	National Science Foundation [BCS-0843946, SMA 1041755]	National Science Foundation(National Science Foundation (NSF))	This study was funded by generous grants from the National Science Foundation (BCS-0843946) to S.C. and (SMA 1041755) to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW., 2005, SPAT COGN COMPUT, V5, P307, DOI [10.1207/s15427633scc0504_2, DOI 10.1207/S15427633SCC0504_2]; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bangerter A, 2004, PSYCHOL SCI, V15, P415, DOI 10.1111/j.0956-7976.2004.00694.x; BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; Cassell J., 1999, PRAGMAT COGN, V7, P1, DOI [DOI 10.1075/PC.7.1.03CAS, 10.1075/pc.7.1.03cas]; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cook SW, 2009, COGNITION, V113, P98, DOI 10.1016/j.cognition.2009.06.006; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; ENGLE RW, 1992, J EXP PSYCHOL LEARN, V18, P972, DOI 10.1037/0278-7393.18.5.972; Friedman NP, 2005, BEHAV RES METHODS, V37, P581, DOI 10.3758/BF03192728; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Goldin-Meadow S., 2005, HEARING GESTURE OUR; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; Hegarty M, 2005, SPAT COGN COMPUT, V5, P333, DOI DOI 10.1207/S15427633SCC0504_3; Holle H, 2007, J COGNITIVE NEUROSCI, V19, P1175, DOI 10.1162/jocn.2007.19.7.1175; Klein K, 1999, BEHAV RES METH INS C, V31, P429, DOI 10.3758/BF03200722; Lawrence BM, 2004, PSYCHON B REV, V11, P488, DOI 10.3758/BF03196600; Lawrence BM, 2001, MEMORY, V9, P433, DOI 10.1080/09658210143000047; Mecklinger A, 2002, CEREB CORTEX, V12, P1115, DOI 10.1093/cercor/12.11.1115; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Ozyurek A, 2007, J COGNITIVE NEUROSCI, V19, P605, DOI 10.1162/jocn.2007.19.4.605; Pearson DG, 2003, Q J EXP PSYCHOL-A, V56, P1089, DOI 10.1080/02724980343000044; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Rumiati RI, 1998, J EXP PSYCHOL HUMAN, V24, P631, DOI 10.1037/0096-1523.24.2.631; Rumiati RI, 2002, EXP BRAIN RES, V142, P425, DOI 10.1007/s00221-001-0956-x; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; Smyrnis N, 2005, J NEUROPHYSIOL, V93, P3703, DOI 10.1152/jn.00972.2004; Smyrnis N, 2013, EXPT BRAIN RES; SMYTH MM, 1988, Q J EXP PSYCHOL-A, V40, P497, DOI 10.1080/02724988843000041; SMYTH MM, 1990, Q J EXP PSYCHOL-A, V42, P291, DOI 10.1080/14640749008401223; SMYTH MM, 1989, Q J EXP PSYCHOL-A, V41, P235, DOI 10.1080/14640748908402363; Theeuwes J, 2005, PSYCHOL SCI, V16, P196, DOI 10.1111/j.0956-7976.2005.00803.x; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Waters GS, 1996, Q J EXP PSYCHOL-A, V49, P51, DOI 10.1080/027249896392801; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wilson M, 2001, PSYCHON B REV, V8, P44, DOI 10.3758/BF03196138; Woodin ME, 1996, Q J EXP PSYCHOL-A, V49, P357, DOI 10.1080/027249896392685; Wu YC, 2007, BRAIN LANG, V101, P234, DOI 10.1016/j.bandl.2006.12.003; Wu YC, 2011, BRAIN LANG, V119, P184, DOI 10.1016/j.bandl.2011.07.002	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84834	10.1371/journal.pone.0084834	http://dx.doi.org/10.1371/journal.pone.0084834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465437	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500017
J	Abdulle, A; Al-Junaibi, A; Nagelkerke, N				Abdulle, Abdishakur; Al-Junaibi, Abdulla; Nagelkerke, Nicolaas			High Blood Pressure and Its Association with Body Weight among Children and Adolescents in the United Arab Emirates	PLOS ONE			English	Article							4 AUTOMATIC DEVICES; INTERNATIONAL PROTOCOL; SCIENTIFIC STATEMENT; WAIST CIRCUMFERENCE; CHILDHOOD OBESITY; EUROPEAN-SOCIETY; SELF-MEASUREMENT; HYPERTENSION; PREVENTION; PREVALENCE	Objectives: To estimate the prevalence of high blood pressure (BP) and its relationship with obesity among children and adolescents. Methodology/Principal Findings: In this cross-sectional population (Emirati) representative study, we invited a random sample of 1600 students (grades 1-12) attending 23 out of all 246 schools in the Emirate of Abu Dhabi, United Arab Emirates. But analysis was restricted to Emirati nationals aged 6-17 years. We measured BP, height, weight, waist circumferences (WC), and calculated body mass index (BMI) by standard methods. BP levels >= 90th percentile but <95th percentile and >= 95th for age, sex, and height (CDC percentiles) were classified as pre-hypertension (pre-HTN) and hypertension (HTN), respectively. Associations between BP, age, BMI, WC, and sex, were investigated by (multiple) linear regression methods. A total of 999 (47% girls) students provided complete results. The prevalence of pre-HTN was 10.5% and 11.4% and the prevalence of HTN was 15.4% and 17.8% among boys and girls, respectively. The prevalence of systolic/diastolic HTN was 14.4%/2.5% and 14.8/7.4% among boys and girls, respectively. BMI CDC percentile was positively correlated with WC percentile (r = 0.734, p<0.01), and both systolic (r = 0.34, p<0.001) and diastolic (r = 0.21, p<0.001) standardized BP. WC percentile was less strongly correlated with standardized SBP (r = 0.255, p<0.01) and DBP (r = 0.175, p<0.01) than BMI. Conclusions/Significance: The prevalence of elevated BP, notably systolic was significantly high among the Emirati children and adolescents in Abu Dhabi. High BP was strongly related to body weight, and appears more strongly associated with BMI than WC. Further studies are required to investigate the impact of childhood obesity on HTN.	[Abdulle, Abdishakur] UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Abu Dhabi, U Arab Emirates; [Al-Junaibi, Abdulla] Zayed Mil Hosp, Dept Pediat, Abu Dhabi, U Arab Emirates; [Nagelkerke, Nicolaas] UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Abu Dhabi, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Abdulle, A (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Abu Dhabi, U Arab Emirates.	shakur.a@uaeu.ac.ae			Medical Services Corps, UAE Armed Forces	Medical Services Corps, UAE Armed Forces	This research was supported by a grant from Medical Services Corps, UAE Armed Forces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Junaibi A, 2013, INT J OBESITY, V37, P68, DOI 10.1038/ijo.2012.131; Altunkan S, 2008, BLOOD PRESS MONIT, V13, P117, DOI 10.1097/MBP.0b013e3282f3fb50; Belghazi J, 2007, VASC HEALTH RISK MAN, V3, P389; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Chiolero A, 2007, PEDIATRICS, V119, P544, DOI 10.1542/peds.2006-2136; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Croix B, 2006, PEDIATR NEPHROL, V21, P527, DOI 10.1007/s00467-006-0013-x; Daniels SR, 1999, J PEDIATR-US, V134, P665, DOI 10.1016/S0022-3476(99)70277-5; Duncan MJ, 2013, ANN HUM BIOL, V40, P163, DOI 10.3109/03014460.2012.752861; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Feber J, 2010, CLIN SCI, V119, P151, DOI 10.1042/CS20090544; Flynn J, 2013, PEDIATR NEPHROL, V28, P1059, DOI 10.1007/s00467-012-2344-0; Gauer R, 2012, J FAM PRACTICE, V61, P425; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Jayawardana R, 2013, DIABETES RES CLIN PR, V99, P292, DOI 10.1016/j.diabres.2012.12.013; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; LaRosa Christopher, 2010, J Med Liban, V58, P132; Li JS, 2013, CIRCULATION, V127, P260, DOI 10.1161/CIR.0b013e3182756d8e; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Brien E, 2001, BMJ-BRIT MED J, V322, P1167, DOI 10.1136/bmj.322.7295.1167; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Raj M, 2013, INDIAN J PEDIATR, V80, pS71, DOI 10.1007/s12098-012-0851-4; Redwine KM, 2012, J PEDIATR-US, V160, P98, DOI 10.1016/j.jpeds.2011.07.010; Reilly JJ, 2012, ADV NUTR, V3, p636S, DOI 10.3945/an.112.002014; Saadi H, 2007, DIABETES RES CLIN PR, V78, P369, DOI 10.1016/j.diabres.2007.04.008; Topouchian J, 2011, VASC HEALTH RISK MAN, V7, P709, DOI 10.2147/VHRM.S27193; Zhang YX, 2013, INT J CARDIOL, V168, P1516, DOI 10.1016/j.ijcard.2012.12.097	32	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85129	10.1371/journal.pone.0085129	http://dx.doi.org/10.1371/journal.pone.0085129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465493	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500034
J	Zhang, W; Chen, S; Li, N; Zhang, JZ; Chen, W				Zhang, Wei; Chen, Song; Li, Na; Zhang, Jia Zheng; Chen, Wei			Correlated Diffusion of Colloidal Particles near a Liquid-Liquid Interface	PLOS ONE			English	Article							TIME SELF-DIFFUSION; HYDRODYNAMIC INTERACTION; QUASI-2-DIMENSIONAL SUSPENSIONS; SPHERICAL-PARTICLE; PLANAR BOUNDARY; WATER-INTERFACE; BROWNIAN-MOTION; SPHERES; MICRORHEOLOGY; MEMBRANE	Optical microscopy and multi-particle tracking are used to investigate the cross-correlated diffusion of quasi two-dimensional colloidal particles near an oil-water interface. The behaviors of the correlated diffusion along longitudinal and transverse direction are asymmetric. It is shown that the characteristic length for longitudinal and transverse correlated diffusion are particle diameter d and the distance z from particle center to the interface, respectively, for large particle separation r. The longitudinal and transverse correlated diffusion coefficient D-parallel to(r) and D-perpendicular to(r) are independent of the colloidal area fraction n when n<0.3, which indicates that the hydrodynamic interactions(HIs) among the particles are dominated by HIs through the surrounding fluid for small n. For high area fraction n>0.4, the power law exponent for the spatial decay of D-perpendicular to(r) begins to decrease, which suggests the HIs are more contributed from the 2D particle monolayer self for large n.	[Zhang, Wei; Chen, Song; Li, Na; Zhang, Jia Zheng; Chen, Wei] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; [Zhang, Wei] Northwestern Polytech Univ, Dept Appl Phys, Xian 710072, Peoples R China; [Zhang, Wei] Jinan Univ, Dept Phys, Guangzhou, Guangdong, Peoples R China; [Chen, Wei] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing, Peoples R China	Fudan University; Northwestern Polytechnical University; Jinan University; Chinese Academy of Sciences	Zhang, W (corresponding author), Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China.	wzhangph@gmail.com; phchenwei@fudan.edu.cn	Chen, Song/AAB-1137-2021	Chen, Song/0000-0003-0813-2545	National Science Fund for Talent Trainning in Basic Science [J1103204]	National Science Fund for Talent Trainning in Basic Science	National Science Fund for Talent Trainning in Basic Science (Grant No. J1103204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041403; Binks BP, 2006, COLLOIDAL PARTICLES; Blawzdziewicz J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3475217; Chen W, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/28003; Cichocki B, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2724815; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; Cui BX, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.258301; Diamant H, 2005, J PHYS-CONDENS MAT, V17, pS4047, DOI 10.1088/0953-8984/17/49/003; Diamant H, 2005, J PHYS-CONDENS MAT, V17, pS2787, DOI 10.1088/0953-8984/17/31/003; Dufresne ER, 2000, PHYS REV LETT, V85, P3317, DOI 10.1103/PhysRevLett.85.3317; LEE SH, 1979, J FLUID MECH, V93, P705, DOI 10.1017/S0022112079001981; Levine AJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061606; Lin BH, 2000, PHYS REV E, V62, P3909, DOI 10.1103/PhysRevE.62.3909; Mbamala EC, 2002, J PHYS-CONDENS MAT, V14, P4881, DOI 10.1088/0953-8984/14/19/313; Oppenheimer N, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041912; Oppenheimer N, 2009, BIOPHYS J, V96, P3041, DOI 10.1016/j.bpj.2009.01.020; Ortega F, 2010, CURR OPIN COLLOID IN, V15, P237, DOI 10.1016/j.cocis.2010.03.001; Peng Y, 2009, J FLUID MECH, V618, P243, DOI 10.1017/S0022112008004114; PERKINS GS, 1992, PHYSICA A, V189, P447, DOI 10.1016/0378-4371(92)90056-V; PERKINS GS, 1991, PHYSICA A, V171, P575, DOI 10.1016/0378-4371(91)90302-S; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Pushkar P L, 2011, SOFT MATTER, V7, P6844; SAFFMAN PG, 1976, J FLUID MECH, V73, P593, DOI 10.1017/S0022112076001511; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Shlomovitz R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137802; Sickert M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.126104; Wang GM, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044009; Wang GM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.248303; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Wu CY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3243334; Wu J, 2006, APPL PHYS LETT, V89; Zhang W, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.168304	33	9	9	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85173	10.1371/journal.pone.0085173	http://dx.doi.org/10.1371/journal.pone.0085173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465498	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500036
J	Zhao, J; Ni, T; Li, Y; Xiong, W; Ran, W; Shen, BA; Shen, QR; Zhang, RF				Zhao, Jun; Ni, Tian; Li, Yong; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu			Responses of Bacterial Communities in Arable Soils in a Rice-Wheat Cropping System to Different Fertilizer Regimes and Sampling Times	PLOS ONE			English	Article							MICROBIAL BIOMASS CALIBRATION; FUMIGATION-EXTRACTION METHOD; 16S RIBOSOMAL-RNA; MANAGEMENT INFLUENCES; FUNGAL COMMUNITIES; DIVERSITY; PH; BIODIVERSITY; GRADIENT; NITROGEN	Soil physicochemical properties, soil microbial biomass and bacterial community structures in a rice-wheat cropping system subjected to different fertilizer regimes were investigated in two seasons (June and October). All fertilizer regimes increased the soil microbial biomass carbon and nitrogen. Both fertilizer regime and time had a significant effect on soil physicochemical properties and bacterial community structure. The combined application of inorganic fertilizer and manure organic-inorganic fertilizer significantly enhanced the bacterial diversity in both seasons. The bacterial communities across all samples were dominated by Proteobacteria, Acidobacteria and Chloroflexi at the phylum level. Permutational multivariate analysis confirmed that both fertilizer treatment and season were significant factors in the variation of the composition of the bacterial community. Hierarchical cluster analysis based on Bray-Curtis distances further revealed that bacterial communities were separated primarily by season. The effect of fertilizer treatment is significant (P = 0.005) and accounts for 7.43% of the total variation in bacterial community. Soil nutrients (e. g., available K, total N, total P and organic matter) rather than pH showed significant correlation with the majority of abundant taxa. In conclusion, both fertilizer treatment and seasonal changes affect soil properties, microbial biomass and bacterial community structure. The application of NPK plus manure organic-inorganic fertilizer may be a sound fertilizer practice for sustainable food production.	[Zhao, Jun; Ni, Tian; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu] Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Zhao, Jun; Ni, Tian; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu] Nanjing Agr Univ, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China; [Zhao, Jun; Ni, Tian; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu] Nanjing Agr Univ, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Li, Yong] Jintan Agr & Forestry Bur, Soil & Fertilizer Tech Guidance Stn Jintan City, Jintan, Jiangsu, Peoples R China; [Shen, Qirong; Zhang, Ruifu] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Zhang, RF (corresponding author), Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China.	rfzhang@njau.edu.cn	Zhang, Ruifu/HDN-0340-2022; Zhao, Jun/U-8586-2018; Zhang, Kevin/F-5215-2010; Shen, Qirong/AAB-6531-2020; Zhang, Ruifu/HDN-0417-2022	Zhao, Jun/0000-0002-6691-2999; 	Agricultural Ministry of China [201103004]; Chinese Ministry of Science and Technology [2011BAD11B03]; 111 Project [B12009]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This research was financially supported by the Agricultural Ministry of China (201103004) and the Chinese Ministry of Science and Technology (2011BAD11B03), RZ and QS were also supported by the 111 Project (B12009) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035; Brady N.C., 1996, NATURE PROPERTIES SO; Bremer C, 2009, FEMS MICROBIOL ECOL, V70, P377, DOI 10.1111/j.1574-6941.2009.00732.x; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chaer G, 2009, MICROB ECOL, V58, P414, DOI 10.1007/s00248-009-9508-x; Chao A, 1984, SCAND J STAT, P265; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; DIAZRAVINA M, 1995, BIOL FERT SOILS, V19, P220, DOI 10.1007/BF00336163; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Gu YF, 2009, EUR J SOIL BIOL, V45, P239, DOI 10.1016/j.ejsobi.2009.02.005; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Islam MR, 2011, BIOL FERT SOILS, V47, P599, DOI 10.1007/s00374-010-0524-2; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kennedy N, 2006, CAN J MICROBIOL, V52, P689, DOI 10.1139/W06-015; Kennedy NM, 2005, FEMS MICROBIOL ECOL, V53, P329, DOI 10.1016/j.femsec.2005.01.013; Kikuchi H, 2007, SOIL SCI PLANT NUTR, V53, P448, DOI 10.1111/j.1747-0765.2007.00177.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Lv MR, 2011, BIOL FERT SOILS, V47, P777, DOI 10.1007/s00374-011-0584-y; Masto RE, 2006, SOIL BIOL BIOCHEM, V38, P1577, DOI 10.1016/j.soilbio.2005.11.012; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Orr CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052891; Plaza C, 2004, SOIL BIOL BIOCHEM, V36, P1577, DOI 10.1016/j.soilbio.2004.07.017; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schutter ME, 2001, BIOL FERT SOILS, V34, P397, DOI 10.1007/s00374-001-0423-7; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Shi ChunYu, 2004, Plant Nutrition and Fertilizer Science, V10, P584; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh BK, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c1; Sparling G. P., 1997, P97; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; Yu WT, 2013, MICROBIAL BIOMASS CO; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	70	115	144	12	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85301	10.1371/journal.pone.0085301	http://dx.doi.org/10.1371/journal.pone.0085301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465530	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500040
J	Lacroix, L; Post, SF; Valent, A; Melkane, AE; Vielh, P; Egile, C; Castell, C; Larois, C; Micallef, S; Saulnier, P; Goulaouic, H; Lefebvre, AM; Temam, S				Lacroix, Ludovic; Post, Sophie F.; Valent, Alexander; Melkane, Antoine E.; Vielh, Philippe; Egile, Coumaran; Castell, Christelle; Larois, Christelle; Micallef, Sandrine; Saulnier, Patrick; Goulaouic, Helene; Lefebvre, Anne-Marie; Temam, Stephane			MET Genetic Abnormalities Unreliable for Patient Selection for Therapeutic Intervention in Oropharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; C-MET; HUMAN-PAPILLOMAVIRUS; COPY NUMBER; HEAD; EXPRESSION; SURVIVAL; CANCER; OVEREXPRESSION	Background: Identification of MET genetic alteration, mutation, or amplification in oropharyngeal squamous cell carcinoma (OPSCC) could lead to development of MET selective kinase inhibitors. The aim of this study was to assess the frequency and prognostic value of MET gene mutation, amplification, and protein expression in primary OPSCC. Methods: A retrospective chart review was conducted of patients treated for single primary OPSCC between January 2007 and December 2009. Pre-treatment OPSCC tissue samples were analyzed for MET mutations, gene amplification, and overexpression using Sanger sequencing, FISH analysis, and immunohistochemistry respectively. Univariate and multivariate analyses were used to analyze correlations between molecular abnormalities and patient survival. Results: 143 patients were included in this study. Six cases (4%) were identified that had a genetic variation, but previously described mutations such as p. Tyr1235Asp (Y1235D) or p.Tyr1230Cys (Y1230C) were not detected. There were 15 high polysomy cases, and only 3 cases met the criteria for true MET amplification, with >= 10% amplified cells per case. Immunohistochemistry evaluation showed 43% of cases were c-MET negative and in 57% c-MET was observed at the tumor cell level. Multivariate analysis showed no significant association between MET mutation, amplification, or expression and survival. Conclusions: Our study shows a low frequency of MET mutations and amplification in this cohort of OPSCC. There was no significant correlation between MET mutations, amplification, or expression and patient survival. These results suggest that patient selection based on these MET genetic abnormalities may not be a reliable strategy for therapeutic intervention in OPSCC.	[Lacroix, Ludovic; Valent, Alexander; Vielh, Philippe] Inst Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France; [Lacroix, Ludovic; Valent, Alexander; Vielh, Philippe; Saulnier, Patrick] Inst Gustave Roussy, Translat Res Lab, Villejuif, France; [Lacroix, Ludovic; Valent, Alexander; Vielh, Philippe; Saulnier, Patrick] Inst Gustave Roussy, Biobank, Villejuif, France; [Post, Sophie F.; Melkane, Antoine E.; Temam, Stephane] Inst Gustave Roussy, Dept Head & Neck Surg Oncol, Villejuif, France; [Post, Sophie F.] Univ Groningen, Univ Med Ctr Groningen, Dept Plast Surg, NL-9713 AV Groningen, Netherlands; [Egile, Coumaran; Castell, Christelle; Goulaouic, Helene] Sanofi, Dept Oncol, Vitry Sur Seine, France; [Larois, Christelle; Lefebvre, Anne-Marie] Sanofi, Dept Biol Sci Core Platform BioSCP, Vitry Sur Seine, France; [Micallef, Sandrine] Sanofi, Dept Sci Core Platform Clin & Sci Operat SCP CSO, Vitry Sur Seine, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Groningen; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Temam, S (corresponding author), Inst Gustave Roussy, Dept Head & Neck Surg Oncol, Villejuif, France.	stephane.temam@igr.fr		Lefebvre, Anne-Marie/0000-0001-5644-0441	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Funding was received from Sanofi-Aventis for laboratory work done at the Gustave Roussy Cancer Institute (labor, assay development, reagents). Sanofi performed the immunohistochemistry, and provided xenograft tumor tissue with different levels of MET amplification for the characterization of the MET FISH probe. Sanofi also provided assistance for statistical analysis and was involved in data analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aebersold DM, 2003, ONCOGENE, V22, P8519, DOI 10.1038/sj.onc.1206968; Aebersold DM, 2001, INT J CANCER, V96, P41, DOI 10.1002/1097-0215(20010220)96:1<41::AID-IJC5>3.0.CO;2-F; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Chen YS, 2004, J ORAL PATHOL MED, V33, P209, DOI 10.1111/j.0904-2512.2004.00118.x; Cortesina G, 2000, INT J CANCER, V89, P286, DOI 10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.3.CO;2-L; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; De Herdt MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P2516, DOI 10.2741/2863; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Druzgal CH, 2005, HEAD NECK-J SCI SPEC, V27, P771, DOI 10.1002/hed.20246; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Galeazzi E, 1997, EUR ARCH OTO-RHINO-L, V254, pS138, DOI 10.1007/BF02439745; Garcia S, 2007, BRIT J CANCER, V96, P329, DOI 10.1038/sj.bjc.6603569; Ghadjar P, 2009, CLIN EXP METASTAS, V26, P809, DOI 10.1007/s10585-009-9280-9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim CH, 2006, ACTA OTO-LARYNGOL, V126, P88, DOI 10.1080/00016480510037014; Kim CH, 2007, ORAL ONCOL, V43, P1021, DOI 10.1016/j.oraloncology.2006.11.016; Kim CH, 2010, HEAD NECK-J SCI SPEC, V32, P1655, DOI 10.1002/hed.21383; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lim YC, 2012, ORAL ONCOL; Lo Muzio L, 2006, TUMOR BIOL, V27, P115, DOI 10.1159/000092716; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mehanna H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1439; Melkane AE, 2013, HEAD NECK; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Morello S, 2001, J CELL PHYSIOL, V189, P285, DOI 10.1002/jcp.10010; Nakajima M, 1999, CANCER, V85, P1894; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Park S, 2012, HISTOL HISTOPATHOL, V27, P197, DOI 10.14670/HH-27.197; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Peters S, 2012, NAT REV CLIN ONCOL; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Uchida D, 2001, INT J CANCER, V93, P489, DOI 10.1002/ijc.1368; van Monsjou HS, 2012, INT J CANCER, V130, P1806, DOI 10.1002/ijc.26195; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84319	10.1371/journal.pone.0084319	http://dx.doi.org/10.1371/journal.pone.0084319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465403	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000011
J	Sigruener, A; Kleber, ME; Heimerl, S; Liebisch, G; Schmitz, G; Maerz, W				Sigruener, Alexander; Kleber, Marcus E.; Heimerl, Susanne; Liebisch, Gerhard; Schmitz, Gerd; Maerz, Winfried			Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study	PLOS ONE			English	Article							FREE FATTY-ACIDS; LIPIDOMICS REVEALS; GENETIC-VARIATION; CERAMIDE; PLASMA; APOPTOSIS; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION; DISEASE; ROLES	Vascular and metabolic diseases cause half of total mortality in Europe. New prognostic markers would provide a valuable tool to improve outcome. First evidence supports the usefulness of plasma lipid species as easily accessible markers for certain diseases. Here we analyzed association of plasma lipid species with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Plasma lipid species were quantified by electrospray ionization tandem mass spectrometry and Cox proportional hazards regression was applied to assess their association with total and cardiovascular mortality. Overall no differences were detected between total and cardiovascular mortality. Highly polyunsaturated phosphatidylcholine species together with lysophosphatidylcholine species and long chain saturated sphingomyelin and ceramide species seem to be associated with a protective effect. The predominantly circulating phosphatidylcholine-based as well as phosphatidylethanolamine-based ether species and phosphatidylethanolamine species were positively associated with total and cardiovascular mortality. Saturated and monounsaturated phosphatidylcholine species, especially phosphatidylcholine 32:0 (most probably dipalmitoyl-phosphatidylcholine) and palmitate containing sphingomyelin and ceramide species showed together with 24:1 containing sphingomyelin and ceramide species strongest positive association with mortality. A quotient of the sums of the six most protective species and the six species with the strongest positive mortality association indicated an almost 3-fold increased risk of mortality, which was higher than the hazard ratio for known risk factors in our cohort. Plasma lipid species levels and especially ratios of certain species may be valuable prognostic marker for cardiovascular and total mortality.	[Sigruener, Alexander; Heimerl, Susanne; Liebisch, Gerhard; Schmitz, Gerd] Regensburg Univ Med Ctr, Inst Lab Med & Transfus Med, Regensburg, Germany; [Kleber, Marcus E.; Maerz, Winfried] Heidelberg Univ, Med Clin 5, Mannheim Med Fac, Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Inst Clin Med, Graz, Austria; [Maerz, Winfried] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany	University of Regensburg; Ruprecht Karls University Heidelberg; Medical University of Graz; Medical University of Graz; SYNLAB Group	Sigruener, A (corresponding author), Regensburg Univ Med Ctr, Inst Lab Med & Transfus Med, Regensburg, Germany.	alexander.sigruener@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Kleber, Marcus/0000-0003-0663-7275	European Community [202272]; IP-Project LipidomicNet; BMBF ("SysMBo'') [0315494C]	European Community(European Commission); IP-Project LipidomicNet; BMBF ("SysMBo'')(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet and BMBF ("SysMBo'', sponsorship number 0315494C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Horres CR, 2012, NEUROCHEM RES, V37, P1137, DOI 10.1007/s11064-011-0692-y; Hu CX, 2011, MOL BIOSYST, V7, P3271, DOI 10.1039/c1mb05342f; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Kleber ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-157; Kopf T., 2012, GENETICS MEETS METAB, P191; Leskinen T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012609; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2005, BBA-MOL CELL BIOL L, V1734, P86, DOI 10.1016/j.bbalip.2005.01.002; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2013, J LIPID RES; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Orensic M, 2013, DIABETOLOGIA; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pilz S, 2007, EUR HEART J, V28, P2763, DOI 10.1093/eurheartj/ehm343; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; Scarborough P, 2010, CORONARY HEART DIS S; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sorensen CM, 2010, CLIN BIOCHEM, V43, P948, DOI 10.1016/j.clinbiochem.2010.04.075; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Stojakovic T, 2010, ATHEROSCLEROSIS, V208, P564, DOI 10.1016/j.atherosclerosis.2009.07.026; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019477; Sysi-Aho M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015744; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	45	98	98	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85724	10.1371/journal.pone.0085724	http://dx.doi.org/10.1371/journal.pone.0085724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465667	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000055
J	van Assen, MALM; van Aert, RCM; Nuijten, MB; Wicherts, JM				van Assen, Marcel A. L. M.; van Aert, Robbie C. M.; Nuijten, Michele B.; Wicherts, Jelte M.			Why Publishing Everything Is More Effective than Selective Publishing of Statistically Significant Results	PLOS ONE			English	Article							PUBLICATION BIAS; PSYCHOLOGICAL SCIENCE; PSYCHOTHERAPEUTIC INTERVENTIONS; METAANALYSIS; REPLICABILITY; EFFICACY; MODELS; EXCESS	Background: De Winter and Happee [1] examined whether science based on selective publishing of significant results may be effective in accurate estimation of population effects, and whether this is even more effective than a science in which all results are published (i.e., a science without publication bias). Based on their simulation study they concluded that "selective publishing yields a more accurate meta-analytic estimation of the true effect than publishing everything, (and that) publishing nonreplicable results while placing null results in the file drawer can be beneficial for the scientific collective" (p.4). Methods and Findings: Using their scenario with a small to medium population effect size, we show that publishing everything is more effective for the scientific collective than selective publishing of significant results. Additionally, we examined a scenario with a null effect, which provides a more dramatic illustration of the superiority of publishing everything over selective publishing. Conclusion: Publishing everything is more effective than only reporting significant outcomes.	[van Assen, Marcel A. L. M.; van Aert, Robbie C. M.; Nuijten, Michele B.; Wicherts, Jelte M.] Tilburg Univ, Dept Methodol & Stat, Tilburg Sch Behav Sci, NL-5000 LE Tilburg, Netherlands	Tilburg University	van Assen, MALM (corresponding author), Tilburg Univ, Dept Methodol & Stat, Tilburg Sch Behav Sci, NL-5000 LE Tilburg, Netherlands.	m.a.l.m.vanassen@uvt.nl	Wicherts, Jelte M./A-2664-2008; Nuijten, Michèle B./N-2483-2014	Wicherts, Jelte M./0000-0003-2415-2933; Nuijten, Michèle B./0000-0002-1468-8585; van Assen, Marcel/0000-0002-7517-6081	Netherlands Organisation for Research [016.125.385]	Netherlands Organisation for Research	VIDI Grant no. 016.125.385 from the Netherlands Organisation for Research awarded to Jelte Wicherts. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Borenstein M, 2009, INTRO META ANAL; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; de Winter J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066463; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733; Francis G, 2012, PSYCHON B REV, V19, P151, DOI 10.3758/s13423-012-0227-9; GERBER AS, 2001, POLIT ANAL, V0009; Giner-Sorolla R, 2012, PERSPECT PSYCHOL SCI, V7, P562, DOI 10.1177/1745691612457576; Hopewell S, 2009, COCHRANE DATABASE SY; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kraemer HC, 1998, PSYCHOL METHODS, V3, P23, DOI 10.1037/1082-989X.3.1.23; Nelson LD, 2012, PSYCHOL INQ, V23, P291, DOI 10.1080/1047840X.2012.705245; Niemeyer H, 2013, J CONSULT CLIN PSYCH, V81, P58, DOI 10.1037/a0031152; Niemeyer H, 2012, SCHIZOPHR RES, V138, P103, DOI 10.1016/j.schres.2012.03.023; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Nosek BA, 2012, PSYCHOL INQ, V23, P217, DOI 10.1080/1047840X.2012.692215; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rothstein HR, 2012, PSYCHOL METHODS, V17, P129, DOI 10.1037/a0027128; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; van Assen MALM, 2013, META ANALYSIS USING; Van Noorden R, 2013, NATURE, V495, P426, DOI 10.1038/495426a; Viechtbauer W, 2007, BRIT J MATH STAT PSY, V60, P29, DOI 10.1348/000711005X64042; Viechtbauer Wolfgang, 2010, METAFOR PACKAGE META	35	67	67	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84896	10.1371/journal.pone.0084896	http://dx.doi.org/10.1371/journal.pone.0084896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465448	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000018
J	Zhao, RX; Tang, DQ; Yi, SN; Li, WJ; Wu, CL; Lu, YR; Hou, XG; Song, J; Lin, P; Chen, L; Sun, L				Zhao, Ruxing; Tang, Dongqi; Yi, Shounan; Li, Wenjuan; Wu, Chuanlong; Lu, Yiran; Hou, Xinguo; Song, Jun; Lin, Peng; Chen, Li; Sun, Lei			Elevated Peripheral Frequencies of Th22 Cells: A Novel Potent Participant in Obesity and Type 2 Diabetes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE INFLAMMATION; INDUCED INSULIN-RESISTANCE; TNF-ALPHA; T-CELLS; INTERLEUKIN 22; KAPPA-B; FAT; POPULATION; ACCUMULATION	Objective: Chronic low-grade inflammation has long been recognized as the central link between obesity and type 2 diabetes (T2D). The novel subset of T helper (Th) cells, Th22, plays an emerging role in chronic inflammation. We investigated the potential association between Th22 and the pathogenesis of obesity and T2D. Methods: Ninety T2D inpatients (T2D group), 30 healthy participants with BMI ranged from 19 to 23.9 kg/m2 (CTL group) and 30 metabolically healthy obese controls with BMI >= 30 kg/m2 (MHO group) were employed in our study. Peripheral frequencies of Th22 and Th1 and Th17 cells were determined by flow cytometry based on their specific cytokine patterns. Cytokine levels in fresh plasma were quantified by ELISA. Results: Compared to that in CTL group (1.18 +/- 0.06%, n = 28), peripheral frequency of Th22 cells was significantly increased in MHO group (1.88 +/- 0.10%, n = 30) and in T2D group (2.247 +/- 0.10%, n = 89). There was a consistent notable increase in plasma interleukin (IL)-22 of T2D patients [47.56 (30.55-76.89) pg/mL] as compared with that of MHO group [36.65 (29.52-55.70) pg/ml; *P<0.0001] and CTLs [36.33 (31.93-40.62) pg/mL; *P<0.0001]. Furthermore, other than Th1/Th17, previously frequently described participants in obesity and T2D, there was a strong correlation between Th22 frequency and the homeostasis model of assessment for insulin resistance index (r = 0.6771, *P<0.0001) and HOMA for beta-cell function (r = 20.7264, *P<0.0001). Conclusions: There were increased Th22 frequencies and IL-22 levels in obesity and T2D. Elevated Th22 and IL-22 also aided in the differentiation of MHO from T2D patients. The notable correlation implied that Th22 might play a more determinant role in both insulin resistance and b-cell impairment.	[Zhao, Ruxing; Li, Wenjuan; Wu, Chuanlong; Lu, Yiran; Hou, Xinguo; Song, Jun; Lin, Peng; Chen, Li; Sun, Lei] Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan 250100, Peoples R China; [Zhao, Ruxing; Chen, Li; Sun, Lei] Shandong Univ, Inst Endocrinol & Metab, Jinan 250100, Peoples R China; [Zhao, Ruxing; Tang, Dongqi] Shandong Univ, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Peoples R China; [Yi, Shounan] Univ Sydney, Westmead Hosp, Ctr Transplant & Renal Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia	Shandong University; Shandong University; Shandong University; University of Sydney; Westmead Institute for Medical Research	Chen, L (corresponding author), Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan 250100, Peoples R China.	sduchenli@gmail.com; sunlei1@medmail.com.cn	Stefanadis, Christodoulos/ABH-2232-2020; Lu, YiRan/GQO-9465-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; hou, xinguo/0000-0003-2045-1290	National Natural Science Foundation of China [81000326, 81100617]; China Postdoctoral Science Foundation [2012M521354]; Jinan Overseas Students Pioneer plan [20100205, 20110407]; Special Fund of Clinical Research of Chinese Medical Association [12030420342]; Shandong International Scientific Corporation Plan [2012GGE27126]; Shandong Natural Science Foundation [ZR2012HM014]; Shandong Provincial Health & Medical Development Project [2011HD005]; National Key Technology R D Program [2009BAI80B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jinan Overseas Students Pioneer plan; Special Fund of Clinical Research of Chinese Medical Association; Shandong International Scientific Corporation Plan; Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Provincial Health & Medical Development Project; National Key Technology R D Program(National Key Technology R&D Program)	This study was financially supported by the National Natural Science Foundation of China (Grant No. 81000326; 81100617), China Postdoctoral Science Foundation (Grant No. 2012M521354), Jinan Overseas Students Pioneer plan (Grant No. 20100205; 20110407), The Special Fund of Clinical Research of Chinese Medical Association(Grant No. 12030420342), Shandong International Scientific Corporation Plan(Grant No. 2012GGE27126), Shandong Natural Science Foundation (Grant No. ZR2012HM014), Shandong Provincial Health & Medical Development Project (Grant No. 2011HD005), National Key Technology R & D Program Grant No. 2009BAI80B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulet LP, 2008, CLIN INVEST MED, V31, pE386, DOI 10.25011/cim.v31i6.4926; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Festa A, 2001, INT J OBESITY, V25, P1407, DOI 10.1038/sj.ijo.0801792; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fink C, 2012, INFLAMM BOWEL DIS, V18, P1550, DOI 10.1002/ibd.22893; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Habib Samy L, 2013, ISRN Oncol, V2013, P583786, DOI 10.1155/2013/583786; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hannan MT, 2013, ARTHRIT CARE RES, V65, P4, DOI 10.1002/acr.21904; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411; Katsuki A, 1998, J CLIN ENDOCR METAB, V83, P859, DOI 10.1210/jc.83.3.859; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Peng D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068446; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Shao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051339; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tian T, 2013, EXPERT OPIN THER TAR, V17, P113, DOI 10.1517/14728222.2013.736497; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y; Zinman B, 1999, J CLIN ENDOCR METAB, V84, P272, DOI 10.1210/jc.84.1.272	41	50	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85770	10.1371/journal.pone.0085770	http://dx.doi.org/10.1371/journal.pone.0085770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465695	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000063
J	Eggeling, R; Gohr, A; Keilwagen, J; Mohr, M; Posch, S; Smith, AD; Grosse, I				Eggeling, Ralf; Gohr, Andre; Keilwagen, Jens; Mohr, Michaela; Posch, Stefan; Smith, Andrew D.; Grosse, Ivo			On the Value of Intra-Motif Dependencies of Human Insulator Protein CTCF	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION FACTORS; HUMAN GENOME; REGULATORY ELEMENTS; DNA INTERACTIONS; SEQUENCE MOTIFS; SIMPLE-MODELS; ZINC FINGERS; EM ALGORITHM; SPECIFICITY	The binding affinity of DNA-binding proteins such as transcription factors is mainly determined by the base composition of the corresponding binding site on the DNA strand. Most proteins do not bind only a single sequence, but rather a set of sequences, which may be modeled by a sequence motif. Algorithms for de novo motif discovery differ in their promoter models, learning approaches, and other aspects, but typically use the statistically simple position weight matrix model for the motif, which assumes statistical independence among all nucleotides. However, there is no clear justification for that assumption, leading to an ongoing debate about the importance of modeling dependencies between nucleotides within binding sites. In the past, modeling statistical dependencies within binding sites has been hampered by the problem of limited data. With the rise of high-throughput technologies such as ChIP-seq, this situation has now changed, making it possible to make use of statistical dependencies effectively. In this work, we investigate the presence of statistical dependencies in binding sites of the human enhancer-blocking insulator protein CTCF by using the recently developed model class of inhomogeneous parsimonious Markov models, which is capable of modeling complex dependencies while avoiding overfitting. These findings lead to a more detailed characterization of the CTCF binding motif, which is only poorly represented by independent nucleotide frequencies at several positions, predominantly at the 3 ' end.	[Eggeling, Ralf; Gohr, Andre; Posch, Stefan; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany; [Keilwagen, Jens] Fed Res Ctr Cultivated Plants, JKI, Inst Biosafety Plant Biotechnol, Quedlinburg, Germany; [Keilwagen, Jens; Mohr, Michaela; Grosse, Ivo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Seeland Ot Gatersleben, Germany; [Smith, Andrew D.] Univ So Calif, Los Angeles, CA USA; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Julius Kuhn-Institut; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Southern California	Eggeling, R (corresponding author), Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany.	eggeling@informatik.uni-halle.de	Eggeling, Ralf/P-3403-2019; Smith, Andrew D./G-4104-2013	Eggeling, Ralf/0000-0002-3583-1029; Smith, Andrew D./0000-0002-3337-1970; Keilwagen, Jens/0000-0002-6792-7076	Reisestipendium des allg. Stiftungsfonds der MLU Halle-Wittenberg; DFG [GR3526_1-1]; BMBF [0312706A/D]	Reisestipendium des allg. Stiftungsfonds der MLU Halle-Wittenberg; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by "Reisestipendium des allg. Stiftungsfonds der MLU Halle-Wittenberg (website http://www.uni-halle.de), DFG (grant no. GR3526_1-1, website http://www.dfg.de) and BMBF (grant no. 0312706A/D, website http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bourguignon PY, 2004, P JOBIM; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eggeling R, 2013, SPRINGER LECT NOTES, P321; Grau J, 2012, J MACH LEARN RES, V13, P1967; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kim NK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-262; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; O'Flanagan RA, 2005, BIOINFORMATICS, V21, P2254, DOI 10.1093/bioinformatics/bti361; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Schneider T, 1990, NUCLEIC ACIDS RES, V18; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siddharthan R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000156; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2971, DOI 10.1093/nar/10.9.2971; The ENCODE Project Consortium, 2007, NATURE, V447, P7146; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wang H, 2012, GENOME RES, V9; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; ZHANG MQ, 1993, COMPUT APPL BIOSCI, V9, P499; Zhao XY, 2005, J COMPUT BIOL, V12, P894, DOI 10.1089/cmb.2005.12.894; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	52	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85629	10.1371/journal.pone.0085629	http://dx.doi.org/10.1371/journal.pone.0085629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465627	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100054
J	Bragin, A; Almajano, J; Kheiri, F; Engel, J				Bragin, Anatol; Almajano, Joel; Kheiri, Farshad; Engel, Jerome, Jr.			Functional Connectivity in the Brain Estimated by Analysis of Gamma Events	PLOS ONE			English	Article							FEEDFORWARD INHIBITION; VISUAL-CORTEX; OSCILLATIONS; SYNCHRONIZATION; INTEGRATION; MECHANISMS; NETWORKS; STATE; RAT; ORGANIZATION	It is known that gamma activity is generated by local networks. In this paper we introduced a new approach for estimation of functional connectivity between neuronal networks by measuring temporal relations between peaks of gamma event amplitudes. We have shown in freely moving rats that gamma events recorded between electrodes 1.5 mm apart in the majority of cases, are generated by different neuronal modules interfering with each other. The map of functional connectivity between brain areas during the resting state, created based on gamma event temporal relationships is in agreement with anatomical connections and with maps described by fMRI methods during the resting state. The transition from the resting state to exploratory activity is accompanied by decreased functional connectivity between most brain areas. Our data suggest that functional connectivity between interhemispheric areas depends on GABAergic transmission, while intrahemispheric functional connectivity is kainate receptor dependent. This approach presents opportunities for merging electrographic and fMRI data on brain functional connectivity in normal and pathological conditions.	[Bragin, Anatol; Almajano, Joel; Kheiri, Farshad; Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Bragin, Anatol; Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bragin, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	abragin@ucla.edu; engel@ucla.edu		Bragin, Anatol/0000-0003-1207-8481	National Institute of Neurological Disorders and Stroke [NS065877, NS33310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033310, R01NS065877, R37NS033310] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke: NS065877 (A. B) and NS33310 (J.E. Jr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BUZSAKI G, 1989, J NEUROSCI METH, V28, P209, DOI 10.1016/0165-0270(89)90038-1; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; DAVEY NJ, 1986, J NEUROSCI METH, V17, P153, DOI 10.1016/0165-0270(86)90068-3; De Groof G, 2013, BEHAV BRAIN RES, V239, P43, DOI 10.1016/j.bbr.2012.10.044; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; HUBEL DH, 1967, J NEUROPHYSIOL, V30, P1561, DOI 10.1152/jn.1967.30.6.1561; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kheiri F, 2013, J NEUROSCI METH, V214, P184, DOI 10.1016/j.jneumeth.2013.01.007; Kim DJ, 2012, HUMAN BRAIN MAPPING; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Legendre P., 2012, NUMERICAL ECOLOGY; MANLY BFJ, 2007, RANDOMISATION BOOTST; MANTEL N, 1967, CANCER RES, V27, P209; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	39	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85900	10.1371/journal.pone.0085900	http://dx.doi.org/10.1371/journal.pone.0085900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465774	Green Published, gold			2022-12-27	WOS:000330244500138
J	Lu, L; Fu, DL; Li, HQ; Liu, AJ; Li, JH; Zheng, GQ				Lu, Lin; Fu, Deng-lei; Li, Hui-qin; Liu, Ai-ju; Li, Ji-huang; Zheng, Guo-qing			Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies	PLOS ONE			English	Article							POPULATION; INSULIN; SMOKING; ASSOCIATION; AGE; HYPERINSULINEMIA; HYPERTENSION; DISORDERS; DEMENTIA; CANCERS	Background: Whether diabetes increases the risk of Parkinson's disease (PD) is still inconclusive. The objective of this updated meta-analysis is to synthesize evidence from case-control studies that evaluated the association between diabetes and the risk of PD. Methods: Seven databases were searched to identify case-control studies that evaluated the association between diabetes and PD. The methodological quality of included studies was assessed using Newcastle-Ottawa scale. All data were analyzed using Review Manager 5.1 software. Subgroup analyses were also adopted, according to stratification on gender, geographic location, source of the control group, smoking, anti-diabetes drug prescription and duration of DM. Results: Fourteen studies fulfilled inclusion criteria for meta-analysis, yielding a total of 21395 PD patients and 84579 control subjects. Individuals with diabetes were found to have a negative association with future PD (OR 0.75; 95% CI 0.58-0.98) in spite of significant heterogeneity. In subgroup analyses, the negative correlation was still found in studies from North America, non-PD control groups from general population, never smoking individuals, and DM ascertainment based on questionnaire or self-report. Stratification of gender and DM duration showed no significant association. No association was also found in European and Asian individuals, hospital-based controls, ever smoking subjects, DM assessment by medical record or physician diagnosis, and insulin prescription for DM. Conclusion: Evidence from case-control studies suggested that diabetic individuals may have a decreased incidence of PD despite significant heterogeneity. More researches are warranted to clarify an understanding of the association between diabetes and risk of PD.	[Lu, Lin; Fu, Deng-lei; Li, Hui-qin; Liu, Ai-ju; Li, Ji-huang; Zheng, Guo-qing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou, Peoples R China	Wenzhou Medical University	Zheng, GQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou, Peoples R China.	gq_zheng@sohu.com	Zheng, Guo-qing/A-4412-2019	Zheng, Guo-qing/0000-0001-5286-5696	Xinmiao Planning Project of Science and Technology Department of Zhejiang Province [2008R40G2090034]; Administration of Traditional Chinese Medicine of Zhejiang Province [2010ZQ010]; Wenzhou Municipal Science and Technology Bureau in Zhejiang province [H20070044, Y20080145]	Xinmiao Planning Project of Science and Technology Department of Zhejiang Province; Administration of Traditional Chinese Medicine of Zhejiang Province; Wenzhou Municipal Science and Technology Bureau in Zhejiang province	This work is supported by the Xinmiao Planning Project of Science and Technology Department of Zhejiang Province (2008R40G2090034), Administration of Traditional Chinese Medicine of Zhejiang Province (2010ZQ010), and Project of Wenzhou Municipal Science and Technology Bureau in Zhejiang province (H20070044, Y20080145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029; Becker C, 2008, DIABETES CARE, V31, P1808, DOI 10.2337/dc08-0479; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Cardoso S, 2009, J ALZHEIMERS DIS, V18, P483, DOI 10.3233/JAD-2009-1155; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Cereda E, 2012, Neurology, V78, P1507, DOI 10.1212/WNL.0b013e3182553cc9; Cereda E, 2013, MOVEMENT DISORD, V28, P257, DOI 10.1002/mds.25211; Cereda E, 2011, DIABETES CARE, V34, P2614, DOI 10.2337/dc11-1584; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Choi Y, 2012, BRIT J NUTR, V108, P1934, DOI 10.1017/S0007114512003984; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Dillin A, 2007, SCIENCE, V317, P461, DOI 10.1126/science.1146585; Driver JA, 2008, DIABETES CARE, V31, P2003, DOI 10.2337/dc08-0688; Facchini FS, 2000, FREE RADICAL BIO MED, V29, P1302, DOI 10.1016/S0891-5849(00)00438-X; Fagard RH, 2009, PRIM CARE DIABETES, V3, P205, DOI 10.1016/j.pcd.2009.09.003; Herishanu YO, 2001, CAN J NEUROL SCI, V28, P144, DOI 10.1017/S0317167100052835; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HO SC, 1989, NEUROLOGY, V39, P1314, DOI 10.1212/WNL.39.10.1314; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jiang X, 2013, EUR J NUTR; KESSLER II, 1972, AM J EPIDEMIOL, V96, P242, DOI 10.1093/oxfordjournals.aje.a121455; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Leibson CL, 2006, MOVEMENT DISORD, V21, P446, DOI 10.1002/mds.20685; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; McIntyre RS, 2013, BEHAV BRAIN RES, V237, P164, DOI 10.1016/j.bbr.2012.09.021; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Miyake Y, 2010, J NEUROL SCI, V293, P82, DOI 10.1016/j.jns.2010.03.002; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MORANO A, 1994, ACTA NEUROL SCAND, V89, P164; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Palacios N, 2013, MOVEMENT DISORD, V28, P258, DOI 10.1002/mds.25208; Peila R, 2004, NEUROLOGY, V63, P228, DOI 10.1212/01.WNL.0000129989.28404.9B; Powers KM, 2006, PARKINSONISM RELAT D, V12, P185, DOI 10.1016/j.parkreldis.2005.09.004; Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123; Rugbjerg K, 2009, NEUROLOGY, V73, P1462, DOI 10.1212/WNL.0b013e3181c06635; Rugbjerg K, 2012, INT J CANCER, V131, P1904, DOI 10.1002/ijc.27443; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Savica R, 2012, MOVEMENT DISORD, V27, P974, DOI 10.1002/mds.25016; Schernhammer E, 2011, DIABETES CARE, V34, P1102, DOI 10.2337/dc10-1333; Scheuing N, 2013, PARKINSONISM RELAT D, V19, P687, DOI 10.1016/j.parkreldis.2013.03.011; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; Shapiro S, 1997, J CLIN EPIDEMIOL, V50, P223, DOI 10.1016/S0895-4356(96)00360-5; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Skeie GO, 2013, PARKINSONISM RELAT D, V19, P53, DOI 10.1016/j.parkreldis.2012.07.003; Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780; Soop M, 2002, AM J PHYSIOL-ENDOC M, V282, pE1276, DOI 10.1152/ajpendo.00535.2001; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Tonstad S, 2009, DIABETES RES CLIN PR, V85, P4, DOI 10.1016/j.diabres.2009.04.013; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Wells G, 2000, NEWCASTLE OTTAWA SCA; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	60	78	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85781	10.1371/journal.pone.0085781	http://dx.doi.org/10.1371/journal.pone.0085781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465703	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500112
J	Peedikayil, MC; AlSohaibani, FI; Alkhenizan, AH				Peedikayil, Musthafa Chalikandy; AlSohaibani, Fahad Ibrahim; Alkhenizan, Abdullah Hamad			Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CONTAINING TRIPLE THERAPY; QUADRUPLE THERAPY; CONSENSUS REPORT; CLINICAL-TRIAL; INFECTION; RESISTANCE; CLARITHROMYCIN; AMOXICILLIN; METRONIDAZOLE; MANAGEMENT	Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with varying success. We examined the efficacy and safety of first-line levofloxacin-based treatment in comparison to standard first-line therapy for H pylori eradication. Materials and Methods: We searched literature databases from Medline, EMBASE, and the Cochrane Register of Randomized Controlled Trials through March 2013 for randomized controlled trials comparing first-line levofloxacin and standard therapy. We included randomized controlled trials conducted only on naive H pylori infected patients in adults. A systematic review was conducted. Meta-analysis was performed with Review Manager 5.2. Treatment effect was determined by relative risk with a random or fixed model by the Mantel-Haenszel method. Results: Seven trials were identified with 888 patients receiving 7 days of first-line levofloxacin and 894 treated with standard therapy (Amoxicillin, Clarithromycin and proton pump inhibitor) for 7 days. The overall crude eradication rate in the Levofloxacin group was 79.05% versus 81.4% in the standard group (risk ratio 0.97; 95% CI; 0.93, 1.02). The overall dropout was 46 (5.2%) in the levofloxacin group and 52 (5.8%) for standard therapy. The dizziness was more common among group who took Levofloxacin based treatment and taste disturbance was more common among group who took standard therapy. Meta-analysis of overall adverse events were similar between the two groups with a relative risk of 1.06 (95% CI 0.72, 1.57). Conclusion: Helicobacter pylori eradication with 7 days of Levofloxacin-based first line therapy was safe and equal compared to 7 days of standard first-line therapy.	[Peedikayil, Musthafa Chalikandy; AlSohaibani, Fahad Ibrahim] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia; [Alkhenizan, Abdullah Hamad] King Faisal Specialist Hosp & Res Ctr, Dept Family Med & Polyclin, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Peedikayil, MC (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Med, POB 3354, Riyadh 11211, Saudi Arabia.	musthafacpdr@gmail.com	Alkhenizan, Abdullah/ABE-7878-2020					Abadi ATB, 2012, INTERN EMERG MED, V7, P447, DOI 10.1007/s11739-011-0563-1; Antos D, 2006, HELICOBACTER, V11, P39, DOI 10.1111/j.0083-8703.2006.00375.x; Assem M, 2010, EUR J INTERN MED, V21, P310, DOI 10.1016/j.ejim.2010.05.011; Basu PP, 2011, AM J GASTROENTEROL, V106, P1970, DOI 10.1038/ajg.2011.306; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Cammarota G, 2000, ALIMENT PHARM THER, V14, P1339, DOI 10.1046/j.1365-2036.2000.00846.x; Carothers JJ, 2007, CLIN INFECT DIS, V44, pE5, DOI 10.1086/510074; Castro-Fernandez M, 2009, REV ESP ENFERM DIG, V101, P395, DOI 10.4321/s1130-01082009000600004; Chang WL, 2009, J GASTROEN HEPATOL, V24, P1230, DOI 10.1111/j.1440-1746.2009.05829.x; Chen LW, 2010, INT J CLIN PRACT, V64, P1530, DOI 10.1111/j.1742-1241.2010.02482.x; Cheng Hong, 2010, Zhonghua Yi Xue Za Zhi, V90, P79; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Choi KH, 2011, J KOREAN MED SCI, V26, P785, DOI 10.3346/jkms.2011.26.6.785; Correa P, 1997, J Physiol Pharmacol, V48 Suppl 4, P19; Cuadrado-Lavin A, 2012, J ANTIMICROB CHEMOTH, V67, P2254, DOI 10.1093/jac/dks209; Di Caro S, 2002, EUR J GASTROEN HEPAT, V14, P1309, DOI 10.1097/00042737-200212000-00004; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Gisbert JP, 2010, DIGEST LIVER DIS, V42, P287, DOI 10.1016/j.dld.2009.06.007; Gisbert JP, 2007, HELICOBACTER, V12, P50, DOI 10.1111/j.1523-5378.2007.00576.x; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Goh KL, 2011, HELICOBACTER, V16, P241, DOI 10.1111/j.1523-5378.2011.00841.x; Hung IFN, 2009, HELICOBACTER, V14, P505, DOI 10.1111/j.1523-5378.2009.00722.x; Iacopini F, 2005, DIGEST LIVER DIS, V37, P571, DOI 10.1016/j.dld.2005.03.007; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Karczewska E, 2011, PHARMACOL REP, V63, P799, DOI 10.1016/S1734-1140(11)70592-8; Li YQ, 2010, WIEN KLIN WOCHENSCHR, V122, P413, DOI 10.1007/s00508-010-1404-3; Liao JX, 2013, HELICOBACTER, V18, P373, DOI 10.1111/hel.12052; Liou JM, 2010, GUT, V59, P572, DOI 10.1136/gut.2009.198309; Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Molina-Infante J, 2010, ALIMENT PHARM THER, V31, P1077, DOI 10.1111/j.1365-2036.2010.04274.x; Molina-Infante J, 2011, GUT, V60, P1605, DOI 10.1136/gut.2010.233015; Nista EC, 2006, AM J GASTROENTEROL, V101, P1985, DOI 10.1111/j.1572-0241.2006.00716.x; O'Connor A, 2013, IRISH J MED SCI, V182, P693, DOI 10.1007/s11845-013-0957-3; Perna F, 2007, DIGEST LIVER DIS, V39, P1001, DOI 10.1016/j.dld.2007.06.016; Rispo A, 2007, HELICOBACTER, V12, P364, DOI 10.1111/j.1523-5378.2007.00517.x; Saad RJ, 2006, AM J GASTROENTEROL, V101, P488, DOI 10.1111/j.1572-0241.2006.00637.x; Schrauwen RWM, 2009, NETH J MED, V67, P96; Zhang Zhi-feng, 2008, Zhonghua Yi Xue Za Zhi, V88, P2722; Zullo A, 2007, DIGEST LIVER DIS, V39, P806, DOI 10.1016/j.dld.2007.05.021; Zullo A, 2007, ALIMENT PHARM THER, V25, P1429, DOI 10.1111/j.1365-2036.2007.03331.x	41	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85620	10.1371/journal.pone.0085620	http://dx.doi.org/10.1371/journal.pone.0085620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465624	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500085
J	Heigh, RI; Yab, TC; Taylor, WR; Hussain, FTN; Smyrk, TC; Mahoney, DW; Domanico, MJ; Berger, BM; Lidgard, GP; Ahlquist, DA				Heigh, Russell I.; Yab, Tracy C.; Taylor, William R.; Hussain, Fareeda T. N.; Smyrk, Thomas C.; Mahoney, Douglas W.; Domanico, Michael J.; Berger, Barry M.; Lidgard, Graham P.; Ahlquist, David A.			Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)	PLOS ONE			English	Article							HIGH DETECTION RATES; SCREEN-DETECTION; AVERAGE-RISK; CANCER; COLONOSCOPY; POPULATION; NEOPLASIA; ADENOMAS; PREVALENCE; CARCINOMA	Objectives: Precursors to 1/3 of colorectal cancer (CRC), serrated polyps have been under-detected by screening due to their inconspicuous, non-hemorrhagic, and proximal nature. A new multi-target stool DNA test (multi-target sDNA) shows high sensitivity for both CRC and advanced adenomas. Screen detection of serrated polyps by this approach requires further validation. We sought to assess and compare noninvasive detection of sessile serrated polyps (SSP) >= 1 cm by sDNA and an occult blood fecal immunochemical test (FIT). Methods: In a blinded prospective study, a single stool sample used for both tests was collected from 456 asymptomatic adults prior to screening or surveillance colonoscopy (criterion standard). All 29 patients with SSP >= 1 cm were included as cases and all 232 with no neoplastic findings as controls. Buffered stool samples were processed and frozen on receipt; Exact Sciences performed sDNA in batches using optimized analytical methods. The sDNA multi-marker panel targets methylated BMP3 (mBMP3) and NDRG4, mutant KRAS, beta-actin, and hemoglobin. FIT (Polymedco OC-FIT Check) was performed in separate lab <= 2 days post defecation and evaluated at cutoffs of 50 (FIT-50) and 100 ng/ml (FIT-100). Results: Median ages: cases 61 (range 57-77), controls 62 (52-70), p = NS. Women comprised 59% and 51%, p = NS, respectively. SSP median size was 1.2 cm (1-3 cm), 93% were proximal, and 64% had synchronous diminutive polyps. Among multi-target sDNA markers, mBMP3 proved highly discriminant for detection of SSP >= 1 cm (AUC = 0.87, p<0.00001); other DNA markers provided no incremental sensitivity. Hemoglobin alone showed no discrimination (AUC = 0.50, p = NS). At matched specificities, detection of SSP >= 1 cm by stool mBMP3 was significantly greater than by FIT-50 (66% vs 10%, p = 0.0003) or FIT-100 (63% vs 0%, p<0.0001). Conclusions: In a screening and surveillance setting, SSP >= 1 cm can be detected noninvasively by stool assay of exfoliated DNA markers, especially mBMP3. FIT appears to have no value in SSP detection.	[Heigh, Russell I.] Mayo Clin, Div Gastroenterol, Scottsdale, AZ 85259 USA; [Yab, Tracy C.; Taylor, William R.; Ahlquist, David A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Hussain, Fareeda T. N.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA; [Smyrk, Thomas C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Mahoney, Douglas W.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Domanico, Michael J.; Berger, Barry M.; Lidgard, Graham P.] Exact Sci Corp, Madison, WI USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Heigh, RI (corresponding author), Mayo Clin, Div Gastroenterol, Scottsdale, AZ 85259 USA.	heigh.russell@mayo.edu			Charles Oswald Foundation; Helen Vandendriesche; Exact Sciences Corporation; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	Charles Oswald Foundation; Helen Vandendriesche; Exact Sciences Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by grants from the Charles Oswald Foundation, Helen Vandendriesche, and Exact Sciences Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist D ZH, 2010, AACR M PHIL PA; Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Ahlquist DA, 2012, CLIN GASTROENTEROL H, V10, P272, DOI 10.1016/j.cgh.2011.10.008; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Berger BM, 2012, PATHOLOGY, V44, P80, DOI 10.1097/PAT.0b013e3283502fdf; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gupta AK, 2005, CLIN GASTROENTEROL H, V3, P150, DOI 10.1016/S1542-3565(04)00664-0; Hussain FT, 2010, DDW; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jass JR, 2001, J PATHOL, V193, P283, DOI 10.1002/1096-9896(200103)193:3<283::AID-PATH799>3.0.CO;2-9; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Kahi CJ, 2011, CLIN GASTROENTEROL H, V9, P42, DOI 10.1016/j.cgh.2010.09.013; Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Lazarus R, 2005, AM J CLIN PATHOL, V123, P349, DOI 10.1309/VBAGV3BR96N2EQTR; Lidgard GP DM, 2012, AACR FRONTIERS CANC; Lidgard GP DM, 2012, GASTROENTEROLOGY, V142, pS1; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Oka S, 2004, GASTROINTEST ENDOSC, V59, P213, DOI 10.1016/S0016-5107(03)02693-2; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Sheridan TB, 2006, AM J CLIN PATHOL, V126, P564, DOI 10.1309/C7JE88VL8420V5VT; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	37	52	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85659	10.1371/journal.pone.0085659	http://dx.doi.org/10.1371/journal.pone.0085659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465639	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500066
J	Hoekman, P; Ide, G; Kassoumou, AS; Hayatou, MM				Hoekman, Patrick; Ide, Garba; Kassoumou, Akambi Sanoussi; Hayatou, Mahamadou Malam			Hip Arthrodesis with the Anterolateral Plate: An Innovating Technique for an Orphaned Procedure	PLOS ONE			English	Article							FOLLOW-UP; FUSION; TUBERCULOSIS; OSTEOTOMY; ARTHROPLASTY; REPLACEMENT; JOINT	Background: In developing countries hip osteoarthritis constitutes a major public health issue as it is highly prevalent in all age ranges of population, including the young. It often remains untreated because of the low accessibility of total hip prostheses. Hip arthrodesis still represents a major treatment option, but, for several reasons which are discussed in this paper, is nowadays infrequently performed. By means of reporting the results of a new simple technique, using a self-devised plate, the relevancy of hip arthrodesis in this particular environment is emphasized. Methods and Findings: Our series included 35 patients with painful hip osteoarthritis who underwent a hip fusion with the anterolateral arthrodesis plate. Two of them had a concurrent femoral osteotomy for correction of a vicious position of the limb and another patient had a femoral diaphysis osteotomy and placement of a Wagner elongating device in order to proceed with a limb lengthening by callotasis. The follow-up period averaged 16,9 months ( 9 to 34). All hips, except two, achieved solid fusion between 6 and 15 months after surgery. One failure of fusion was in the oldest patient, who presented a loosening of plate and screws due to an advanced degree of osteoporosis; the other was in a young patient who admitted having walked on his leg too soon. Patient satisfaction was high. We concluded that this technique is reliable and effective. Conclusions: The results of this study should convince the hesitant surgeon and patient to consider hip arthrodesis an acceptable treatment option for disabling hip arthritis, compared to no treatment at all.	[Hoekman, Patrick; Ide, Garba; Kassoumou, Akambi Sanoussi; Hayatou, Mahamadou Malam] Natl Hosp Niamey, Dept Orthopaed Surg, Niamey, Niger		Hoekman, P (corresponding author), Natl Hosp Niamey, Dept Orthopaed Surg, Niamey, Niger.	patrick_hoekman@yahoo.fr						ABBOTT LC, 1954, J BONE JOINT SURG AM, V36-A, P1129, DOI 10.2106/00004623-195436060-00002; APLEY AG, 1955, J BONE JOINT SURG BR, V37, P185, DOI 10.1302/0301-620X.37B2.185; AXER A, 1961, J BONE JOINT SURG AM, V43, P492, DOI 10.2106/00004623-196143040-00004; Banskota AK, 2009, INDIAN J ORTHOP, V43, P383, DOI 10.4103/0019-5413.55977; BARMADA R, 1976, J BONE JOINT SURG AM, V58, P541, DOI 10.2106/00004623-197658040-00018; Beaule Paul E, 2002, J Am Acad Orthop Surg, V10, P249; Benaroch TE, 1996, J PEDIATR ORTHOPED, V16, P30, DOI 10.1097/01241398-199601000-00007; BREWSTER RC, 1975, J BONE JOINT SURG AM, VA 57, P27, DOI 10.2106/00004623-197557010-00005; BRITTAIN HA, 1948, J BONE JOINT SURG BR, V30, P642, DOI 10.1302/0301-620X.30B4.642; CALLAGHAN JJ, 1985, J BONE JOINT SURG AM, V67A, P1328, DOI 10.2106/00004623-198567090-00004; CHAN KP, 1968, J BONE JOINT SURG AM, VA 50, P1341, DOI 10.2106/00004623-196850070-00004; CHOLMELEY JA, 1956, J BONE JOINT SURG BR, V38, P342, DOI 10.1302/0301-620X.38B1.342; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P2267, DOI 10.2106/JBJS.G.01267; Clohisy JC, 2010, CLIN ORTHOP RELAT R, V468, P3207, DOI 10.1007/s11999-010-1468-4; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; DOBSON J, 1948, J BONE JOINT SURG BR, V30, P95, DOI 10.1302/0301-620X.30B1.95; Dormans JP, 2002, J BONE JOINT SURG AM, V84A, P1086, DOI 10.2106/00004623-200206000-00039; Dudkiewicz I, 2003, ISR MED ASSOC J, V5, P709; Emms NW, 2010, J BONE JOINT SURG BR, V92B, P856, DOI 10.1302/0301-620X.92B6.23666; Fernandez-Fairen M, 2011, CLIN ORTHOP RELAT R, V469, P1971, DOI 10.1007/s11999-010-1704-y; FOLEY WB, 1949, J BONE JOINT SURG BR, V31, P222, DOI 10.1302/0301-620X.31B2.222; HAHN D, 1963, J BONE JOINT SURG BR, V45, P477, DOI 10.1302/0301-620X.45B3.477; HARDINGE K, 1986, CLIN ORTHOP RELAT R, P173; Karol LA, 2000, J BONE JOINT SURG AM, V82A, P561, DOI 10.2106/00004623-200004000-00011; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; LIPSCOMB PR, 1961, J BONE JOINT SURG AM, V43, P923, DOI 10.2106/00004623-196143070-00001; Lubega N, 2009, J BONE JOINT SURG BR, V91B, P341, DOI 10.1302/0301-620X.91B3.21706; Matta JM, 1997, CLIN ORTHOP RELAT R, P129; MURRELL GAC, 1994, CLIN ORTHOP RELAT R, P147; NIEBAUER JJ, 1946, J BONE JOINT SURG, V28, P103; Panagiotopoulos K P, 2001, Instr Course Lect, V50, P297; Peterson ED, 2009, CLIN ORTHOP RELAT R, V467, P2880, DOI 10.1007/s11999-009-1027-z; PRICE CT, 1980, J BONE JOINT SURG AM, V62, P1118, DOI 10.2106/00004623-198062070-00008; Roberts C S, 1990, J Arthroplasty, V5, P89, DOI 10.1016/S0883-5403(06)80015-X; Schafroth MU, 2010, INT ORTHOP, V34, P805, DOI 10.1007/s00264-009-0860-8; SCHNEIDER R, 1974, RECONS SURG, V14, P1; Schuh A, 2005, ORTHOPADE, V34, P218, DOI 10.1007/s00132-004-0723-3; Sidhu AS, 2009, J BONE JOINT SURG BR, V91B, P1301, DOI 10.1302/0301-620X.91B10.22541; SOFUE M, 1989, INT ORTHOP, V13, P129; SPONSELLER PD, 1984, J BONE JOINT SURG AM, V66A, P853, DOI 10.2106/00004623-198466060-00005; STINCHFIELD FE, 1950, J BONE JOINT SURG AM, V32-A, P48, DOI 10.2106/00004623-195032010-00004; Stover MD, 2004, CLIN ORTHOP RELAT R, P126; THOMPSON FR, 1956, J BONE JOINT SURG AM, V38, P13, DOI 10.2106/00004623-195638010-00002; Wager M, 1996, ORTHOPADE, V25, P129; WATSONJONES R, 1956, J BONE JOINT SURG BR, V38, P353, DOI 10.1302/0301-620X.38B1.353; Watts HG, 1996, J BONE JOINT SURG AM, V78A, P288, DOI 10.2106/00004623-199602000-00019; Wong K, 2008, J BONE JOINT SURG BR, V90B, P510, DOI 10.1302/0301-620X.90B4.20120; Wong T. C., 2004, SMJ Singapore Medical Journal, V45, P85	48	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85868	10.1371/journal.pone.0085868	http://dx.doi.org/10.1371/journal.pone.0085868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465757	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500083
J	Nangia-Makker, P; Yu, YJ; Vasudevan, A; Farhana, L; Rajendra, SG; Levi, E; Majumdar, APN				Nangia-Makker, Pratima; Yu, Yingjie; Vasudevan, Anita; Farhana, Lulu; Rajendra, Sindhu G.; Levi, Edi; Majumdar, Adhip P. N.			Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ABERRANT CRYPT FOCI; CELL-CYCLE ARREST; STEM-CELLS; BREAST-CANCER; MESENCHYMAL TRANSITION; MATRIX METALLOPROTEASES; OCIMUM-GRATISSIMUM; IN-VIVO; GROWTH	Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties. However, most of the studies to evaluate therapeutic efficacy of metformin have been on primary cancer. No information is available whether metformin could be effectively used for recurrent cancer, specifically colorectal cancer (CRC) that affects up to 50% of patients treated by conventional chemotherapies. Although the reasons for recurrence are not fully understood, it is thought to be due to re-emergence of chemotherapy-resistant cancer stem/stem-like cells (CSCs/CSLCs). Therefore, development of non-toxic treatment strategies targeting CSCs would be of significant therapeutic benefit. In the current investigation, we have examined the effectiveness of metformin, in combination with 5-fluorouracil and oxaliplatin (FuOx), the mainstay of colon cancer therapeutics, on survival of chemo-resistant colon cancer cells that are highly enriched in CSCs/CSLCs. Our data show that metformin acts synergistically with FuOx to (a) induce cell death in chemo resistant (CR) HT-29 and HCT-116 colon cancer cells, (b) inhibit colonospheres formation and (c) enhance colonospheres disintegration. In vitro cell culture studies have further demonstrated that the combinatorial treatment inhibits migration of CR colon cancer cells. These changes were associated with increased miRNA 145 and reduction in miRNA 21. Wnt/beta-catenin signaling pathway was also down-regulated indicating its pivotal role in regulating the growth of CR colon cancer cells. Data from SCID mice xenograft model of CR HCT-116 and CR HT-29 cells show that the combination of metformin and FuOX is highly effective in inhibiting the growth of colon tumors as evidenced by similar to 50% inhibition in growth following 5 weeks of combination treatment, when compared with the vehicle treated controls. Our current data suggest that metformin together with conventional chemotherapy could be an effective treatment regimen for recurring colorectal cancer (CRC).	[Nangia-Makker, Pratima; Yu, Yingjie; Vasudevan, Anita; Farhana, Lulu; Rajendra, Sindhu G.; Levi, Edi; Majumdar, Adhip P. N.] Wayne State Univ, Vet Affairs Med Ctr, Detroit, MI 48202 USA; [Nangia-Makker, Pratima; Majumdar, Adhip P. N.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Nangia-Makker, Pratima; Yu, Yingjie; Vasudevan, Anita; Farhana, Lulu; Majumdar, Adhip P. N.] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Majumdar, APN (corresponding author), Wayne State Univ, Vet Affairs Med Ctr, Detroit, MI 48202 USA.	a.majumdar@wayne.edu		Nangia-Makker, Pratima/0000-0002-1917-169X; Levi, Edi/0000-0003-1809-2866	NIH [AG014343]; Department of Veteran Affairs [I101BX001927]; NATIONAL INSTITUTE ON AGING [R01AG014343] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the NIH (AG014343) and the Department of Veteran Affairs (I101BX001927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feng YH, 2012, INT J MOL MED, V29, P920, DOI 10.3892/ijmm.2012.910; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kanwar SS, 2011, PHARM RES-DORDR, V28, P827, DOI 10.1007/s11095-010-0336-y; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Martinez JA, 1999, CELL MOL BIOL, V45, P137; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nangia-Makker P, 2007, INT J CANCER, V121, P884, DOI 10.1002/ijc.22733; Nangia-Makker P, 2013, CANCER BIOL THER, V14, P417, DOI 10.4161/cbt.23762; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nautiyal Jyoti, 2011, J Mol Signal, V6, P7, DOI 10.1186/1750-2187-6-7; Oh PS, 2011, AM J PHYSIOL-GASTR L, V301, pG347, DOI 10.1152/ajpgi.00403.2010; Padhye S, 2009, PHARM RES-DORDR, V26, P1874, DOI 10.1007/s11095-009-9900-8; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Roy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068543; Roy Sanchita, 2012, J Mol Signal, V7, P11, DOI 10.1186/1750-2187-7-11; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schulenburg A, 2010, CRIT REV ONCOL HEMAT, V76, P79, DOI 10.1016/j.critrevonc.2010.01.001; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yu YJ, 2013, TRANSL ONCOL, V6, P180, DOI 10.1593/tlo.12397; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	66	87	95	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84369	10.1371/journal.pone.0084369	http://dx.doi.org/10.1371/journal.pone.0084369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465408	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500017
J	Loescher, H; Ayres, E; Duffy, P; Luo, HY; Brunke, M				Loescher, Henry; Ayres, Edward; Duffy, Paul; Luo, Hongyan; Brunke, Max			Spatial Variation in Soil Properties among North American Ecosystems and Guidelines for Sampling Designs	PLOS ONE			English	Article							WATER CONTENT; SPATIOTEMPORAL VARIABILITY; MOISTURE VARIABILITY; SURFACE MOISTURE; FOREST SOIL; TEMPERATURE; FIELD; CATCHMENT; RESOURCES; PATTERNS	Soils are highly variable at many spatial scales, which makes designing studies to accurately estimate the mean value of soil properties across space challenging. The spatial correlation structure is critical to develop robust sampling strategies (e. g., sample size and sample spacing). Current guidelines for designing studies recommend conducting preliminary investigation(s) to characterize this structure, but are rarely followed and sampling designs are often defined by logistics rather than quantitative considerations. The spatial variability of soils was assessed across similar to 1 ha at 60 sites. Sites were chosen to represent key US ecosystems as part of a scaling strategy deployed by the National Ecological Observatory Network. We measured soil temperature (T-s) and water content (SWC) because these properties mediate biological/biogeochemical processes below-and above-ground, and quantified spatial variability using semivariograms to estimate spatial correlation. We developed quantitative guidelines to inform sample size and sample spacing for future soil studies, e. g., 20 samples were sufficient to measure T-s to within 10% of the mean with 90% confidence at every temperate and subtropical site during the growing season, whereas an order of magnitude more samples were needed to meet this accuracy at some high-latitude sites. SWC was significantly more variable than T-s at most sites, resulting in at least 10x more SWC samples needed to meet the same accuracy requirement. Previous studies investigated the relationship between the mean and variability (i.e., sill) of SWC across space at individual sites across time and have often (but not always) observed the variance or standard deviation peaking at intermediate values of SWC and decreasing at low and high SWC. Finally, we quantified how far apart samples must be spaced to be statistically independent. Semivariance structures from 10 of the 12-dominant soil orders across the US were estimated, advancing our continental-scale understanding of soil behavior.	[Loescher, Henry; Ayres, Edward; Luo, Hongyan; Brunke, Max] NEON, Sci Team, Boulder, CO 80301 USA; [Loescher, Henry; Ayres, Edward; Luo, Hongyan] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA; [Ayres, Edward] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Duffy, Paul] Neptune & Co Inc, Lakewood, CO USA	University of Colorado System; University of Colorado Boulder; Colorado State University	Loescher, H (corresponding author), NEON, Sci Team, Boulder, CO 80301 USA.	hloescher@neoninc.org	Ayres, Edward/A-4172-2008	Ayres, Edward/0000-0001-5190-258X	National Science Foundation (NSF); Direct For Biological Sciences [1029808] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Ecological Observatory Network (NEON) is a project sponsored by the National Science Foundation (NSF) and managed under cooperative agreement by NEON, Inc. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.' be formally acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil F, 2002, J HYDROL, V260, P30, DOI 10.1016/S0022-1694(01)00600-X; Ayres E, 2011, SOIL TEMPERATURE MOI; Beckett PHT, 1971, SOILS FERTILIZERS, V34, P1; Bond-Lamberty B, 2006, CAN J FOREST RES, V36, P2794, DOI 10.1139/X06-160; Boone RD, 1999, LT EC RES NETWK SER, V2, P3; Brocca L, 2007, J HYDROL, V333, P356, DOI 10.1016/j.jhydrol.2006.09.004; Brocca L, 2012, J HYDROL, V422, P63, DOI 10.1016/j.jhydrol.2011.12.039; Brocca L, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008016; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; Castrignano A, 2000, GEODERMA, V97, P39, DOI 10.1016/S0016-7061(00)00025-2; Chaplot V, 2003, HYDROL PROCESS, V17, P2567, DOI 10.1002/hyp.1273; Choi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028247; CHUNG CK, 1995, COMMUN SOIL SCI PLAN, V26, P741, DOI 10.1080/00103629509369332; Coffey G. N., 1912, USDA BUR SOILS B, V85; DI HJ, 1989, SOIL SCI SOC AM J, V53, P1163, DOI 10.2136/sssaj1989.03615995005300040028x; Dobermann A, 1997, SOIL SCI SOC AM J, V61, P1483, DOI 10.2136/sssaj1997.03615995006100050028x; Dokuchaev V.V., 1883, ISRAEL PROG SCI T; ELKINS NZ, 1986, OECOLOGIA, V68, P521, DOI 10.1007/BF00378766; Ettema CH, 1998, ECOLOGY, V79, P2721, DOI 10.1890/0012-9658(1998)079[2721:SDOBNA]2.0.CO;2; Famiglietti JS, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005804; Famiglietti JS, 1998, J HYDROL, V210, P259, DOI 10.1016/S0022-1694(98)00187-5; Famiglietti JS, 1999, WATER RESOUR RES, V35, P1839, DOI 10.1029/1999WR900047; Fitzjohn C, 1998, CATENA, V32, P55, DOI 10.1016/S0341-8162(97)00045-3; Gallardo A, 2003, ECOSYSTEMS, V6, P564, DOI 10.1007/s10021-003-0198-9; GIESE K, 1975, ADV MOL RELAX INT PR, V7, P45, DOI 10.1016/0001-8716(75)80013-7; Global Carbon Observing System GCOS, 2007, GLOB CLIM OBS SYST E; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Gorres JH, 1998, SOIL BIOL BIOCHEM, V30, P219, DOI 10.1016/S0038-0717(97)00107-7; GRIGAL DF, 1991, SOIL SCI, V151, P282, DOI 10.1097/00010694-199104000-00003; Hargrove WW, 2004, ENVIRON MANAGE, V34, pS39, DOI 10.1007/s00267-003-1084-0; Hargrove WW, 1999, COMPUT SCI ENG, V1, P18, DOI 10.1109/5992.774837; Herbst M, 2009, VADOSE ZONE J, V8, P762, DOI 10.2136/vzj2008.0068; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; HORST TW, 1995, J ATMOS OCEAN TECH, V12, P447, DOI 10.1175/1520-0426(1995)012<0447:>2.0.CO;2; Huang XD, 2011, SCI TOTAL ENVIRON, V409, P4572, DOI 10.1016/j.scitotenv.2011.07.044; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jenny H., 1941, FACTORS SOIL FORMATI; KAIMAL JC, 1990, BOUND-LAY METEOROL, V50, P31, DOI 10.1007/BF00120517; KASPAR TC, 1992, SOIL SCI, V154, P290, DOI 10.1097/00010694-199210000-00005; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Klironomos JN, 1999, APPL SOIL ECOL, V12, P227, DOI 10.1016/S0929-1393(99)00014-1; Kosugi Y, 2007, AGR FOREST METEOROL, V147, P35, DOI 10.1016/j.agrformet.2007.06.005; Larson KM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036013; Lee H, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000906; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEMON EDGAR R., 1960, AGRON JOUR, V52, P697; Li B, 2013, HYDROL EARTH SYST SC, V17, P1177, DOI 10.5194/hess-17-1177-2013; LOAGUE K, 1992, J HYDROL, V139, P233, DOI 10.1016/0022-1694(92)90204-9; Loescher HW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006932; Loescher HW, 2002, J TROP ECOL, V18, P397, DOI 10.1017/S0266467402002274; MCBRATNEY AB, 1983, SOIL SCI, V135, P177, DOI 10.1097/00010694-198303000-00007; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Mittelbach H, 2012, HYDROL EARTH SYST SC, V16, P2169, DOI 10.5194/hess-16-2169-2012; MOHANTY BP, 1995, SOIL SCI SOC AM J, V59, P752, DOI 10.2136/sssaj1995.03615995005900030017x; MONTEITH JL, 1960, Q J ROY METEOR SOC, V86, P205, DOI 10.1002/qj.49708636810; Nyberg L, 1996, HYDROL PROCESS, V10, P89, DOI 10.1002/(SICI)1099-1085(199601)10:1&lt;89::AID-HYP303&gt;3.0.CO;2-W; Panosso AR, 2009, SOIL TILL RES, V105, P275, DOI 10.1016/j.still.2009.09.008; Petersen R. G., 1996, Methods of soil analysis. Part 3 - chemical methods., P1; PIERSON FB, 1991, J RANGE MANAGE, V44, P491, DOI 10.2307/4002751; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; ROBERTSON GP, 1988, ECOLOGY, V69, P1517, DOI 10.2307/1941649; Robertson GP, 1997, ECOL APPL, V7, P158, DOI 10.1890/1051-0761(1997)007[0158:SRMAAP]2.0.CO;2; Ryu D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025831; Schaefer GL, 2007, J ATMOS OCEAN TECH, V24, P2073, DOI 10.1175/2007JTECHA930.1; SCHARRINGA M, 1976, AGR METEOROL, V16, P263, DOI 10.1016/0002-1571(76)90046-7; Schimel D.S., 2011, NEON 2011 SCI STRATE; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SCHMID HP, 1994, BOUND-LAY METEOROL, V67, P293, DOI 10.1007/BF00713146; Schmid HP, 1997, AGR FOREST METEOROL, V87, P179, DOI 10.1016/S0168-1923(97)00011-7; Shaw DC, 2004, ECOSYSTEMS, V7, P427, DOI 10.1007/s10021-004-0135-6; SITAULA BK, 1993, SOIL BIOL BIOCHEM, V25, P1415, DOI 10.1016/0038-0717(93)90056-H; Sokal RR, 1995, BIOMETRY; Teuling AJ, 2006, HYDROL EARTH SYST SC, V10, P755, DOI 10.5194/hess-10-755-2006; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Wang CM, 2008, J HYDROL, V352, P309, DOI 10.1016/j.jhydrol.2008.01.011; WEBSTER R, 1992, J SOIL SCI, V43, P177, DOI 10.1111/j.1365-2389.1992.tb00128.x; Western AW, 1998, J HYDROL, V205, P20, DOI 10.1016/S0022-1694(97)00142-X; Western AW, 2004, J HYDROL, V286, P113, DOI 10.1016/j.jhydrol.2003.09.014; Zreda M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035655; [No title captured]; [No title captured]	83	43	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83216	10.1371/journal.pone.0083216	http://dx.doi.org/10.1371/journal.pone.0083216			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465377	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000006
J	Selvaraj, S; Borkar, DS; Prasad, V				Selvaraj, Senthil; Borkar, Durga S.; Prasad, Vinay			Media Coverage of Medical Journals: Do the Best Articles Make the News?	PLOS ONE			English	Article							PRESS RELEASES; TRIALS; CANCER	Background: News coverage of medical research is followed closely by many Americans and affects the practice of medicine and influence of scientific research. Prior work has examined the quality of media coverage, but no investigation has characterized the choice of stories covered in a controlled manner. We examined whether the media systematically covers stories of weaker study design. Methods: We compared study characteristics of 75 clinically-oriented journal articles that received coverage in the top five newspapers by circulation against 75 clinically-oriented journal articles that appeared in the top five medical journals by impact factor over a similar timespan. Subgroup analysis was performed to determine whether differences between investigations from both sources varied by study type (randomized controlled trial [RCT] or observational study). Results: Investigations receiving coverage from newspapers were less likely to be RCTs (17% vs. 35%, p < 0.016) and more likely to be observational studies (75% vs. 47%, p < 0.001). No difference was observed in number of people studied (median: 1034 vs. 1901, p = 0.14) or length of follow-up (median: 1.80 vs. 1.00 years, p = 0.22). In subgroup analysis, observational studies from the media used smaller sample sizes (median: 1984 vs. 21136, p = 0.029) and were more likely to be cross-sectional (71% vs. 31%, p < 0.001), while no differences were observed for RCTs. Conclusions: Newspapers were more likely to cover observational studies and less likely to cover RCTs than high impact journals. Additionally, when the media does cover observational studies, they select articles of inferior quality. Newspapers preferentially cover medical research with weaker methodology.	[Selvaraj, Senthil] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Borkar, Durga S.] Beth Israel Deaconess Brockton, Dept Med, Brockton, MA USA; [Prasad, Vinay] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prasad, V (corresponding author), NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA.	vinayak.prasad@nih.gov		Prasad, Vinayak/0000-0002-6110-8221; Selvaraj, Senthil/0000-0001-8418-7623				Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; [Anonymous], 2012, US NEWSPAPER    0930; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408; Concato John, 2004, NeuroRx, V1, P341, DOI 10.1007/BF03206619; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Heartwire, 2012, HEARTW; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103; Morin M, LOS ANGELES TIMES; National Institutes of Health OoER Glossary & Acronym List, CLIN RES; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Prasad V, 2013, J CLIN EPIDEMIOL; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Schwitzer G, 2012, MUCH BOTCHED NEWS CO; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Stryker JE, 2002, PREV MED, V35, P519, DOI 10.1006/pmed.2002.1102; USPSTF, 2011, US PREV SERV TASK FO; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wolff T, 2009, APPENDIX USPSTF HIER; Woloshin S, 2009, JNCI-J NATL CANCER I, V101, P1596, DOI 10.1093/jnci/djp409; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	30	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85355	10.1371/journal.pone.0085355	http://dx.doi.org/10.1371/journal.pone.0085355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465543	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000031
J	Yamaguchi, K; Yamaguchi, R; Takahashi, N; Ikenoue, T; Fujii, T; Shinozaki, M; Tsurita, G; Hata, K; Niida, A; Imoto, S; Miyano, S; Nakamura, Y; Furukawa, Y				Yamaguchi, Kiyoshi; Yamaguchi, Rui; Takahashi, Norihiko; Ikenoue, Tsuneo; Fujii, Tomoaki; Shinozaki, Masaru; Tsurita, Giichiro; Hata, Keisuke; Niida, Atsushi; Imoto, Seiya; Miyano, Satoru; Nakamura, Yusuke; Furukawa, Yoichi			Overexpression of Cohesion Establishment Factor DSCC1 through E2F in Colorectal Cancer	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; APOPTOSIS RESISTANCE; GENETIC-ANALYSIS; TRANSCRIPTION; EXPRESSION; FAMILY; SURVIVAL; SUGGESTS; DISTINCT; TARGET	Ctf18-replication factor C complex including Dscc1 (DNA replication and sister chromatid cohesion 1) is implicated in sister chromatid cohesion, DNA replication, and genome stability in S. cerevisiae and C. elegans. We previously performed gene expression profiling in primary colorectal cancer cells in order to identify novel molecular targets for the treatment of colorectal cancer. A feature of the cancer-associated transcriptional signature revealed from this effort is the elevated expression of the proto-oncogene DSCC1. Here, we have interrogated the molecular basis for deviant expression of human DSCC1 in colorectal cancer and its ability to promote survival of cancer cells. Quantitative PCR and immunohistochemical analyses corroborated that the expression level of DSCC1 is elevated in 60-70% of colorectal tumors compared to their matched noncancerous colonic mucosa. An in silico evaluation of the presumptive DSCC1 promoter region for consensus DNA transcriptional regulatory elements revealed a potential role for the E2F family of DNA-binding proteins in controlling DSCC1 expression. RNAi-mediated reduction of E2F1 reduced expression of DSCC1 in colorectal cancer cells. Gain- and loss-of-function experiments demonstrated that DSCC1 is involved in the viability of cancer cells in response to genotoxic stimuli. We reveal that E2F-dependent expression of DSCC1 confers anti-apoptotic properties in colorectal cancer cells, and that its suppression may be a useful option for the treatment of colorectal cancer.	[Yamaguchi, Kiyoshi; Takahashi, Norihiko; Ikenoue, Tsuneo; Fujii, Tomoaki; Furukawa, Yoichi] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan; [Yamaguchi, Rui; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Shinozaki, Masaru; Tsurita, Giichiro; Hata, Keisuke] Univ Tokyo, Inst Med Sci, Dept Surg, Res Hosp, Tokyo, Japan; [Niida, Atsushi; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab DNA Informat Anal, Ctr Human Genome, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Yamaguchi, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan.	kiyamagu@ims.u-tokyo.ac.jp		Hata, Keisuke/0000-0003-4064-8701; Miyano, Satoru/0000-0002-1753-6616	MEXT/JSPS, Japan [23790126]; Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases'', MEXT/Japan Society for the Promotion of Science, Japan	MEXT/JSPS, Japan; Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases'', MEXT/Japan Society for the Promotion of Science, Japan	This work was supported in part by Grant-in-Aid for Young Scientists (#23790126), MEXT/JSPS, Japan to K. Yamaguchi, and Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases'', MEXT/Japan Society for the Promotion of Science, Japan to Y. Furukawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee D, 2000, CANCER RES, V60, P2365; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; DeGregori J, 2006, CURR MOL MED, V6, P739; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Gellon L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001298; Hirano G, 2010, MOL CANCER RES, V8, P864, DOI 10.1158/1541-7786.MCR-09-0458; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Shimokawa T, 2003, CANCER RES, V63, P6116; Suzuki T, 1999, INT J CANCER, V81, P535, DOI 10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wong JV, 2011, CELL CYCLE, V10; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yamaguchi K, 2010, BRIT J CANCER, V102, P325, DOI 10.1038/sj.bjc.6605500; Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	32	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85750	10.1371/journal.pone.0085750	http://dx.doi.org/10.1371/journal.pone.0085750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465681	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000059
J	Kinker, KG; Gibson, AM; Bass, SA; Day, BP; Deng, JY; Medvedovic, M; Figueroa, JAL; Hershey, GKK; Chen, WG				Kinker, Kayla G.; Gibson, Aaron M.; Bass, Stacey A.; Day, Brandy P.; Deng, Jingyuan; Medvedovic, Mario; Figueroa, Julio A. Landero; Hershey, Gurjit K. Khurana; Chen, Weiguo			Overexpression of Dimethylarginine Dimethylaminohydrolase 1 Attenuates Airway Inflammation in a Mouse Model of Asthma	PLOS ONE			English	Article							MASS-SPECTROMETRY METHOD; NITRIC-OXIDE SYNTHESIS; ASYMMETRIC DIMETHYLARGININE; METHYLARGININE METABOLISM; GENE-EXPRESSION; DNA METHYLATION; IDENTIFICATION; LUNG; INHIBITORS; SYNTHASE	Levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, are increased in lung, sputum, exhaled breath condensate and plasma samples from asthma patients. ADMA is metabolized primarily by dimethylarginine dimethylaminohydrolase 1 (DDAH1) and DDAH2. We determined the effect of DDAH1 overexpression on development of allergic inflammation in a mouse model of asthma. The expression of DDAH1 and DDAH2 in mouse lungs was determined by RT-quantitative PCR (qPCR). ADMA levels in bronchoalveolar lavage fluid (BALF) and serum samples were determined by mass spectrometry. Wild type and DDAH1-transgenic mice were intratracheally challenged with PBS or house dust mite (HDM). Airway inflammation was assessed by bronchoalveolar lavage (BAL) total and differential cell counts. The levels of IgE and IgG1 in BALF and serum samples were determined by ELISA. Gene expression in lungs was determined by RNA-Seq and RT-qPCR. Our data showed that the expression of DDAH1 and DDAH2 was decreased in the lungs of mice following HDM exposure, which correlated with increased ADMA levels in BALF and serum. Transgenic overexpression of DDAH1 resulted in decreased BAL total cell and eosinophil numbers following HDM exposure. Total IgE levels in BALF and serum were decreased in HDM-exposed DDAH1-transgenic mice compared to HDM-exposed wild type mice. RNA-Seq results showed downregulation of genes in the inducible nitric oxide synthase (iNOS) signaling pathway in PBS-treated DDAH1-transgenic mice versus PBS-treated wild type mice and downregulation of genes in IL-13/FOXA2 signaling pathway in HDM-treated DDAH1-transgenic mice versus HDM-treated wild type mice. Our findings suggest that decreased expression of DDAH1 and DDAH2 in the lungs may contribute to allergic asthma and overexpression of DDAH1 attenuates allergen-induced airway inflammation through modulation of Th2 responses.	[Kinker, Kayla G.; Gibson, Aaron M.; Bass, Stacey A.; Day, Brandy P.; Hershey, Gurjit K. Khurana; Chen, Weiguo] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Deng, Jingyuan; Medvedovic, Mario] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Figueroa, Julio A. Landero] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Chen, WG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.	Weiguo.Chen@cchmc.org		Landero, Julio/0000-0001-8641-0497	National Institutes of Health [NIAID R01-AI058157, NIAMS R01-AR054490, NHLBI P01-HL076383, NIAID R56-AI084414]; NIH, Center for Environmental Genetics [NIEHS P30-ES006096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058157, R56AI084414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Center for Environmental Genetics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants NIAID R01-AI058157 (GKKH), NIAMS R01-AR054490 (GKKH), NHLBI P01-HL076383 (GKKH), NIAID R56-AI084414 (GKKH) and Center for Environmental Genetics NIEHS P30-ES006096 (WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BOGLE RG, 1992, BRIT J PHARMACOL, V105, P768, DOI 10.1111/j.1476-5381.1992.tb09053.x; Brandt EB, 2013, J ALLERGY CLIN IMMUN, DOI [10.1016/j.jaci.2013.06.048, DOI 10.1016/J.JACI.2013.06.048.[]; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Carraro S, 2013, CHEST; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Chen WG, 2004, J ALLERGY CLIN IMMUN, V114, P553, DOI 10.1016/j.jaci.2004.04.044; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; Di Gangi IM, 2012, ANAL CHIM ACTA, V754, P67, DOI 10.1016/j.aca.2012.09.032; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Kelada SNP, 2011, AM J RESP CELL MOL, V45, P817, DOI 10.1165/rcmb.2010-0315OC; Kimoto M, 1998, EUR J BIOCHEM, V258, P863, DOI 10.1046/j.1432-1327.1998.2580863.x; Klein E, 2010, AM J PHYSL LUNG CELL; Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC; Kwon NH, 2008, J CLIN IMMUNOL, V28, P139, DOI 10.1007/s10875-007-9148-1; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Lee GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060632; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Malerba Giovanni, 2005, Journal of Applied Genetics, V46, P93; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; SCHMIDT K, 1993, MOL PHARMACOL, V44, P615; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Sivaprasad U, 2010, J IMMUNOL, V185, P6802, DOI 10.4049/jimmunol.1002118; Smith CL, 2005, PLOS MED, V2, P1031, DOI 10.1371/journal.pmed.0020264; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tomikawa J, 2006, J BIOL CHEM, V281, P12163, DOI 10.1074/jbc.M513782200; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VALLANCE P, 1992, LANCET, V339, P572; Warrier MR, 2008, J ASTHMA, V45, P257, DOI 10.1080/02770900801966180; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Wells SM, 2009, AM J RESP CELL MOL, V40, P179, DOI 10.1165/rcmb.2008-0148OC; Ye SJ, 2008, BIOINFORMATION, V2, P335, DOI 10.6026/97320630002335; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zimmermann N, 2006, EUR J PHARMACOL, V533, P253, DOI 10.1016/j.ejphar.2005.12.047	46	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85148	10.1371/journal.pone.0085148	http://dx.doi.org/10.1371/journal.pone.0085148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24465497	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200041
J	Lee, CH; Lee, JH; Kim, HM				Lee, Chang Ho; Lee, Jun Ho; Kim, Hyoung-Mi			Flexible Integration of Laser Myringotomy and Ventilation Tube for Bilateral Otitis Media with Effusion: Analysis of Laser Tympanostomy versus Ventilation Tube	PLOS ONE			English	Article							TYMPANIC MEMBRANE FENESTRATION; ASSISTED TYMPANOSTOMY; RANDOMIZED-TRIAL; MIDDLE-EAR; ANESTHESIA; CHILDREN; INSERTION; EXPOSURE; SURGERY	Background: The aim of this study was to evaluate the efficacy of laser myringotomy (LM) compared to ventilation tube (VT), and to assess the clinical success criteria of LM-assisted VT insertion as the flexible alternatives avoiding GA for the treatment of bilateral consistent otitis media with effusion (OME). Methods and Findings: LM under topical anesthesia was followed by VT insertion in cooperative children using Acuspot (R) 712 CO2 laser micromanipulator attached microscope. Sixty children failed VT and bilateral laser tympanostomy was done (group LL), and 130 children tolerated VT on one side but LM on the other side (group LV). The efficacy of LM was compared to VT regarding recurrent effusion and reoperation as the outcome measure; firstly, by ear-to-ear matched pair analysis in LV, and secondly between LL vs. LV. Long-term outcome was compared to control group who received both VT under GA (group GAVT) regarding the outcome of additional VT and GA. Results: The effectiveness of LM per ear was equivocal as 46.9% and 40.8% in LV and LL respectively; but the effectiveness per children was further lower in LL as 28.3%, which was a limitation of LM for bilateral OME. LL required reoperation in 71.7% mostly requiring impending GA in 51.7% within 4.7 months, thus was a controversial treatment. But LV required GA in 20.8% during the 27.2 months long-term follow-up, which was second set of VT and adenoidectomy that were also comparably required in GAVT control with multiple GA. Conclusion: Standard GAVT was more recommended for bilateral OME than bilateral LM (LL) in our practice. But LM was selectively effective for some children, that combined approach with LM plus VT provided comparable period to outgrow OME as effectively as GAVT, when LM was supplemented with one VT side with recovered hearing.	[Lee, Chang Ho; Kim, Hyoung-Mi] CHA Univ, CHA Bundang Med Ctr, Dept Otolaryngol, Songnam, South Korea; [Lee, Jun Ho] CHA Univ, CHA Bundang Med Ctr, Dept Pediat, Songnam, South Korea	Pochon Cha University; Pochon Cha University	Kim, HM (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Otolaryngol, Songnam, South Korea.	hyoungkim1024@gmail.com						BLACK N, 1984, LANCET, V1, P835; Brodsky L, 1999, LARYNGOSCOPE, V109, P2009, DOI 10.1097/00005537-199912000-00022; Browning GG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001801.pub3; Cook SP, 2001, LARYNGOSCOPE, V111, P251, DOI 10.1097/00005537-200102000-00012; Cotter CS, 2004, LARYNGOSCOPE, V114, P486, DOI 10.1097/00005537-200403000-00018; Coyte PC, 2001, JAMA-J AM MED ASSOC, V286, P2128, DOI 10.1001/jama.286.17.2128; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; Haupert MS, 2004, ARCH OTOLARYNGOL, V130, P1025, DOI 10.1001/archotol.130.9.1025; Hoffman RA, 2001, LARYNGOSCOPE, V111, P1636, DOI 10.1097/00005537-200109000-00027; Jang CH, 2000, KOREAN J OTOLARYNGOL, V43, P1045; Koopman JP, 2004, LARYNGOSCOPE, V114, P844, DOI 10.1097/00005537-200405000-00010; Lee Chang Ho, 2004, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V47, P714; Lee CH, 2011, INT J PEDIATR OTORHI, V75, P635, DOI 10.1016/j.ijporl.2011.01.040; Mitka M, 1999, JAMA-J AM MED ASSOC, V282, P1803, DOI 10.1001/jama.282.19.1803; Prokopakis EP, 2002, INT J PEDIATR OTORHI, V62, P207, DOI 10.1016/S0165-5876(01)00613-9; Ro KY, 2006, KOREAN J OTOLARYNGOL, V49, P18; Rosenfeld RM, 2005, INT J PEDIATR OTORHI, V69, P1027, DOI 10.1016/j.ijporl.2005.05.007; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Rosenfeld RM, 2003, EVIDENCE BASED OTITI, P180; Rovers MM, 2005, ARCH DIS CHILD, V90, P480, DOI 10.1136/adc.2004.059444; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Rovers MM, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e42; Sedlmaier B, 2002, LARYNGOSCOPE, V112, P661, DOI 10.1097/00005537-200204000-00013; Siegel GJ, 2002, OTOLARYNG HEAD NECK, V127, P60, DOI 10.1067/mhn.2002.126475; Silverstein H, 2001, LARYNGOSCOPE, V111, P905, DOI 10.1097/00005537-200105000-00028; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; Timmerman AA, 2008, EUR ARCH OTO-RHINO-L, V265, P1047, DOI 10.1007/s00405-008-0591-2	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84966	10.1371/journal.pone.0084966	http://dx.doi.org/10.1371/journal.pone.0084966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465456	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000011
J	Barros, AGD; Bridi, JC; de Souza, BR; de Castro, C; Torres, KCD; Malard, L; Jorio, A; de Miranda, DM; Ashrafi, K; Romano-Silva, MA				de Almeida Barros, Alexandre Guimaraes; Bridi, Jessika Cristina; de Souza, Bruno Rezende; de Castro Junior, Celio; de Lima Torres, Karen Cecilia; Malard, Leandro; Jorio, Ado; de Miranda, Debora Marques; Ashrafi, Kaveh; Romano-Silva, Marco Aurelio			Dopamine Signaling Regulates Fat Content through beta-Oxidation in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; FEEDING-BEHAVIOR; DEFICIENT MICE; D2 RECEPTORS; FOOD-INTAKE; SEROTONIN; OBESITY; DISTINCT; STORAGE; SYSTEM	The regulation of energy balance involves an intricate interplay between neural mechanisms that respond to internal and external cues of energy demand and food availability. Compelling data have implicated the neurotransmitter dopamine as an important part of body weight regulation. However, the precise mechanisms through which dopamine regulates energy homeostasis remain poorly understood. Here, we investigate mechanisms through which dopamine modulates energy storage. We showed that dopamine signaling regulates fat reservoirs in Caenorhabditis elegans. We found that the fat reducing effects of dopamine were dependent on dopaminergic receptors and a set of fat oxidation enzymes. Our findings reveal an ancient role for dopaminergic regulation of fat and suggest that dopamine signaling elicits this outcome through cascades that ultimately mobilize peripheral fat depots.	[de Almeida Barros, Alexandre Guimaraes; Bridi, Jessika Cristina; de Castro Junior, Celio; de Lima Torres, Karen Cecilia; de Miranda, Debora Marques; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, Fac Med, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil; [de Souza, Bruno Rezende] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Malard, Leandro; Jorio, Ado] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Fis, Belo Horizonte, MG, Brazil; [Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of California System; University of California San Francisco	Romano-Silva, MA (corresponding author), Univ Fed Minas Gerais, Fac Med, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil.	romanosilva@gmail.com	Romano-Silva, Marco Aurelio/A-1790-2008; Jorio, Ado/AFK-5647-2022; Souza, Bruno R/A-9854-2010; Castro, Célio J/K-2303-2014; Romano-Silva, Marco Aurelio/T-8321-2019; Miranda, Debora/AAQ-1952-2020; Souza, Bruno Rezende/Z-6035-2019; Jorio, Ado/F-2141-2010	Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Jorio, Ado/0000-0002-5978-2735; Souza, Bruno R/0000-0002-7064-7956; Miranda, Debora/0000-0002-7081-8401; Souza, Bruno Rezende/0000-0002-7064-7956; Jorio, Ado/0000-0002-5978-2735	FAPEMIG; CNPq; INCT de Medicina Molecular; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT de Medicina Molecular; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by FAPEMIG (http://www.fapemig.br/), CNPq (http://www.cnpq.br/), INCT de Medicina Molecular (http://www.medicina.ufmg.br/inct/) and CAPES (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi Kaveh, 2007, WormBook, P1; AVERY L, 1993, GENETICS, V133, P897; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Cumming P, 2011, SYNAPSE, V65, P892, DOI 10.1002/syn.20916; Barros AGD, 2012, METHOD CELL BIOL, V107, P383, DOI 10.1016/B978-0-12-394620-1.00013-8; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; DiLeone RJ, 2009, INT J OBESITY, V33, pS25, DOI 10.1038/ijo.2009.68; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gallant P, 2003, EUR J BIOCHEM, V270, P664, DOI 10.1046/j.1432-1033.2003.03417.x; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kimura KD, 2010, J NEUROSCI, V30, P16365, DOI 10.1523/JNEUROSCI.6023-09.2010; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potma E. O., 2008, HDB BIOMEDICAL NONLI, P164; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	61	11	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85874	10.1371/journal.pone.0085874	http://dx.doi.org/10.1371/journal.pone.0085874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465759	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100085
J	Liu, H; Yanamandala, M; Lee, TC; Kim, JK				Liu, Han; Yanamandala, Mounica; Lee, Tiffany C.; Kim, Jin Kyung			Mitochondrial p38 beta and Manganese Superoxide Dismutase Interaction Mediated by Estrogen in Cardiomyocytes	PLOS ONE			English	Article							ANTIOXIDANT ENZYME EXPRESSION; ACTIVATED PROTEIN-KINASES; P38 MAP-KINASES; REPERFUSION INJURY; CARDIAC MYOCYTES; RECEPTOR-BETA; NITRIC-OXIDE; IN-VITRO; LOCALIZATION; APOPTOSIS	Aims: While etiology behind the observed acceleration of ischemic heart disease in postmenopausal women is poorly understood, collective scientific data suggest cardioprotective effects of the endogenous female sex hormone, estrogen. We have previously shown that 17 beta-estradiol (E2) protects cardiomyocytes exposed to hypoxia-reoxygenation (H/R) by inhibiting p38 alpha - p53 signaling in apoptosis and activating pro-survival p38 beta mitogen activated protein kinase (p38 beta MAPK), leading to suppression of reactive oxygen species (ROS) post H/R. However, little is known about the mechanism behind the antioxidant actions of E2-dependent p38 beta. The aim of this study is to determine whether the cytoprotection by estrogen involves regulation of manganese superoxide dismutase (MnSOD), a major mitochondrial ROS scavenging enzyme, via cardiac p38 beta. Methods and Results: We identified mitochondrial p38 beta by immunocytochemistry and by immunoblotting in mitochondria isolated from neonatal cardiomyocytes of Sprague-Dawley rats. E2 facilitated the mitochondrial localization of the active form of the kinase, phosphorylated p38 beta (p-p38 beta). E2 also reduced the H/R-induced mitochondrial membrane potential decline, augmented the MnSOD activity and suppressed anion superoxide generation, while the dismutase protein expression remained unaltered. Co-immunoprecipitation studies showed physical association between MnSOD and p38 beta. p38 beta phosphorylated MnSOD in an E2-dependent manner in in-vitro kinase assays. Conclusion: This work demonstrates for the first time a mitochondrial pool of active p38 beta and E2-mediated phosphorylation of MnSOD by the kinase. The results shed light on the mechanism behind the cytoprotective actions of E2 in cardiomyocytes under oxidative stress.	[Liu, Han; Kim, Jin Kyung] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Liu, Han; Yanamandala, Mounica; Lee, Tiffany C.; Kim, Jin Kyung] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kim, JK (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	jkim13@uci.edu			National Heart, Lung, Blood Institute at the National Institutes of Health [K08HL89066, R01HL111180]; University of California, Irvine School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089066, R01HL111180] Funding Source: NIH RePORTER	National Heart, Lung, Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California, Irvine School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, Blood Institute at the National Institutes of Health (K08HL89066 and R01HL111180 to J.K.K.) and the Faculty Research Grant 2012-2013 from the University of California, Irvine School of Medicine to J.K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikainen TM, 1998, AM J RESP CELL MOL, V19, P942, DOI 10.1165/ajrcmb.19.6.3248; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Borras C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chakraborty S, 2012, BIOPHYS CHEM, V170, P42, DOI 10.1016/j.bpc.2012.09.002; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Gottipati S, 2008, MOL VIS, V14, P898; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Li QX, 2008, J BIOL CHEM, V283, P11014, DOI 10.1074/jbc.M709682200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Mackay J, 2004, ATLAS HEART DIS STRO; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Murph E, 2007, CARDIOVASC RES, V75, P478, DOI 10.1016/j.cardiores.2007.03.025; Murphy E, 2007, HEART FAIL REV, V12, P293, DOI 10.1007/s10741-007-9035-0; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Pelzer T, 2000, BIOCHEM BIOPH RES CO, V268, P192, DOI 10.1006/bbrc.2000.2073; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101	42	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85272	10.1371/journal.pone.0085272	http://dx.doi.org/10.1371/journal.pone.0085272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465521	Green Published, gold			2022-12-27	WOS:000330283100033
J	Stoler-Barak, L; Moussion, C; Shezen, E; Hatzav, M; Sixt, M; Alon, R				Stoler-Barak, Liat; Moussion, Christine; Shezen, Elias; Hatzav, Miki; Sixt, Michael; Alon, Ronen			Blood Vessels Pattern Heparan Sulfate Gradients between Their Apical and Basolateral Aspects	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; LYMPHOCYTE TRAFFICKING; LEUKOCYTE ADHESION; CELL-MIGRATION; CHEMOKINES; INFLAMMATION; VENULES; MICE; VISUALIZATION; HEMODYNAMICS	A hallmark of immune cell trafficking is directional guidance via gradients of soluble or surface bound chemokines. Vascular endothelial cells produce, transport and deposit either their own chemokines or chemokines produced by the underlying stroma. Endothelial heparan sulfate (HS) was suggested to be a critical scaffold for these chemokine pools, but it is unclear how steep chemokine gradients are sustained between the lumenal and ablumenal aspects of blood vessels. Addressing this question by semi-quantitative immunostaining of HS moieties around blood vessels with a pan anti-HS IgM mAb, we found a striking HS enrichment in the basal lamina of resting and inflamed post capillary skin venules, as well as in high endothelial venules (HEVs) of lymph nodes. Staining of skin vessels with a glycocalyx probe further suggested that their lumenal glycocalyx contains much lower HS density than their basolateral extracellular matrix (ECM). This polarized HS pattern was observed also in isolated resting and inflamed microvascular dermal cells. Notably, progressive skin inflammation resulted in massive ECM deposition and in further HS enrichment around skin post capillary venules and their associated pericytes. Inflammation-dependent HS enrichment was not compromised in mice deficient in the main HS degrading enzyme, heparanase. Our results suggest that the blood vasculature patterns steep gradients of HS scaffolds between their lumenal and basolateral endothelial aspects, and that inflammatory processes can further enrich the HS content nearby inflamed vessels. We propose that chemokine gradients between the lumenal and ablumenal sides of vessels could be favored by these sharp HS scaffold gradients.	[Stoler-Barak, Liat; Shezen, Elias; Hatzav, Miki; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Moussion, Christine; Sixt, Michael] IST Austria, Klosterneuburg, Austria	Weizmann Institute of Science; Institute of Science & Technology - Austria	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369; Sixt, Michael/0000-0002-6620-9179	Israel Science Foundation; U.S. Israel Binational Science Foundation (BSF), FAMRI; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; European Research Council (ERC); FP7 ITN "Stroma''	Israel Science Foundation(Israel Science Foundation); U.S. Israel Binational Science Foundation (BSF), FAMRI; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; European Research Council (ERC)(European Research Council (ERC)); FP7 ITN "Stroma''	R. Alon is an incumbent of the Linda Jacobs Chair in Immune and Stem Cell Research, and his research is supported by the Israel Science Foundation, the U.S. Israel Binational Science Foundation (BSF), FAMRI, the Flight Attendant Medical Research Institute Foundation, and the Minerva Foundation, Germany. Michael Sixt's research is supported by the European Research Council (ERC Starting grant) and by the FP7 ITN "Stroma''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Attreed M, 2012, NAT METHODS, V9, P477, DOI [10.1038/nmeth.1945, 10.1038/NMETH.1945]; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bao X, 2010, IMMUNITY; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chen GP, 2004, BIOCHEMISTRY-US, V43, P4971, DOI 10.1021/bi0356552; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Damiano ER, 2004, J FLUID MECH, V512, P1, DOI 10.1017/S0022112004008766; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lipowsky HH, 2011, AM J PHYSIOL-HEART C, V301, pH2235, DOI 10.1152/ajpheart.00803.2011; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ostrovsky L, 1998, BLOOD, V91, P3028, DOI 10.1182/blood.V91.8.3028.3028_3028_3036; Overstreet MG, 2013, NAT IMMUNOL; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Patterson AM, 2005, ARTHRITIS RHEUM-US, V52, P2331, DOI 10.1002/art.21222; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schmidt EP, 2012, NAT MED; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Severin IC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00293; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Tsuboi K, 2013, J IMMUNOL, V191, P448, DOI 10.4049/jimmunol.1203061; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	53	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85699	10.1371/journal.pone.0085699	http://dx.doi.org/10.1371/journal.pone.0085699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465652	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100061
J	Cloutier, J; Freeman, JB; Ambady, N				Cloutier, Jasmin; Freeman, Jonathan B.; Ambady, Nalini			Investigating the Early Stages of Person Perception: The Asymmetry of Social Categorization by Sex vs. Age	PLOS ONE			English	Article							FACIAL AFFECT; TIME-COURSE; FACES; DISCRIMINATION; STEREOTYPES; PARALLEL; IMPRESSIONS; ACTIVATION; PREJUDICE; COGNITION	Early perceptual operations are central components of the dynamics of social categorization. The wealth of information provided by facial cues presents challenges to our understanding of these early stages of person perception. The current study aimed to uncover the dynamics of processing multiply categorizable faces, notably as a function of their gender and age. Using a modified four-choice version of a mouse-tracking paradigm (which assesses the relative dominance of two categorical dimensions), the relative influence that sex and age have on each other during categorization of infant, younger adult, and older adult faces was investigated. Results of these experiments demonstrate that when sex and age dimensions are simultaneously categorized, only for infant faces does age influence sex categorization. In contrast, the sex of both young and older adults was shown to influence age categorization. The functional implications of these findings are discussed in light of previous person perception research.	[Cloutier, Jasmin] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Freeman, Jonathan B.] Dartmouth Coll, Hanover, NH 03755 USA; [Ambady, Nalini] Stanford Univ, Palo Alto, CA 94304 USA	University of Chicago; Dartmouth College; Stanford University	Cloutier, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	jcloutier@uchicago.edu						Adams R. B., 2011, HDB SOCIAL NEUROSCIE, P394; Allport G. W., 1954, NATURE PREJUDICE; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; BERRY DS, 1986, PSYCHOL BULL, V100, P3, DOI 10.1037/0033-2909.100.1.3; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; BORNSTEIN R, 1986, INT J AGING HUM DEV, V23, P127, DOI 10.2190/QN8T-8PB7-YXYK-30WR; Brewer M., 1988, ADV SOCIAL COGNITION, P1; BRUCE V, 1986, PERCEPTION, V15, P387, DOI 10.1068/p150387; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Cloutier J, 2008, SOC NEUROSCI-UK, V3, P69, DOI 10.1080/17470910701563483; Cloutier J, 2007, EUR J SOC PSYCHOL, V37, P1298, DOI 10.1002/ejsp.433; Corneille O, 2007, J PERS SOC PSYCHOL, V93, P335, DOI 10.1037/0022-3514.93.3.335; CORNELL EH, 1974, J EXP CHILD PSYCHOL, V18, P98, DOI 10.1016/0022-0965(74)90092-7; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; FAGOT BI, 1993, DEV REV, V13, P205, DOI 10.1006/drev.1993.1009; Farmer TA, 2007, J MEM LANG, V57, P570, DOI 10.1016/j.jml.2007.04.003; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Freeman JB, SOCIAL COGN IN PRESS; Freeman JB, 2008, J EXP PSYCHOL GEN, V137, P673, DOI 10.1037/a0013875; Freeman JB, 2011, PSYCHON B REV, V18, P705, DOI 10.3758/s13423-011-0097-6; Freeman JB, 2011, PSYCHOL REV, V118, P247, DOI 10.1037/a0022327; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Freeman JB, 2010, J EXP SOC PSYCHOL, V46, P179, DOI 10.1016/j.jesp.2009.10.002; Freeman JB, 2009, PSYCHOL SCI, V20, P1183, DOI 10.1111/j.1467-9280.2009.02422.x; FRIEDMAN H, 1992, PERS SOC PSYCHOL B, V18, P430, DOI 10.1177/0146167292184006; Hess U, 2009, J VISION, V9, DOI 10.1167/9.12.19; Hugenberg K, 2005, EMOTION, V5, P267, DOI 10.1037/1528-3542.5.3.267; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Johnson KL, 2012, J PERS SOC PSYCHOL, V102, P116, DOI 10.1037/a0025335; Kang SK, 2009, J EXP SOC PSYCHOL, V45, P1281, DOI 10.1016/j.jesp.2009.07.002; KITE ME, 1991, PSYCHOL AGING, V6, P19, DOI 10.1037/0882-7974.6.1.19; Kunda Z, 1996, PSYCHOL REV, V103, P284, DOI 10.1037/0033-295X.103.2.284; Ma DS, 2011, J EXPT SOCIAL PSYCHO, V47; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Martin D, 2007, EUR J SOC PSYCHOL, V37, P806, DOI 10.1002/ejsp.445; MCARTHUR LZ, 1983, PSYCHOL REV, V90, P215, DOI 10.1037/0033-295X.90.3.215; MESSICK DM, 1989, ANNU REV PSYCHOL, V40, P45, DOI 10.1146/annurev.ps.40.020189.000401; Montepare JM, 1998, ADV EXP SOC PSYCHOL, V30, P93, DOI 10.1016/S0065-2601(08)60383-4; Quinn KA, 2005, J PERS SOC PSYCHOL, V88, P467, DOI 10.1037/0022-3514.88.3.467; Quinn KA, 2011, BRIT J PSYCHOL, V102, P849, DOI 10.1111/j.2044-8295.2011.02030.x; Rossion B, 2002, VIS COGN, V9, P1003, DOI 10.1080/13506280143000485; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Song JH, 2008, VISION RES, V48, P853, DOI 10.1016/j.visres.2007.12.015; Song JH, 2006, J VISION, V6, P982, DOI 10.1167/6.9.11; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Wiese H, 2008, PSYCHOPHYSIOLOGY, V45, P957, DOI 10.1111/j.1469-8986.2008.00707.x; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wojnowicz MT, 2009, PSYCHOL SCI, V20, P1428, DOI 10.1111/j.1467-9280.2009.02448.x; Yu Z, SOCIAL COGN IN PRESS; ZEBROWITZ LA, 1993, J PERS SOC PSYCHOL, V64, P453, DOI 10.1037/0022-3514.64.3.453; Zebrowitz LA, 2006, SOC COGNITION, V24, P657, DOI 10.1521/soco.2006.24.5.657	55	29	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84677	10.1371/journal.pone.0084677	http://dx.doi.org/10.1371/journal.pone.0084677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465423	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500010
J	Yang, CY; Liu, ZH; Liu, K; Yang, P				Yang, Chunyan; Liu, Zhonghui; Liu, Kai; Yang, Ping			Mechanisms of Ghrelin Anti-Heart Failure: Inhibition of Ang II-Induced Cardiomyocyte Apoptosis by Down-Regulating AT1R Expression	PLOS ONE			English	Article							MYOCYTE APOPTOSIS; TYPE-2 RECEPTOR; ANGIOTENSIN; RATS; PROLIFERATION; HYPERTROPHY; DYSFUNCTION; DISEASE; SYSTEM; INJURY	Background: Ghrelin is a novel growth hormone-releasing peptide administered to treat chronic heart failure (CHF). However, the underlying mechanism of its protective effects against heart failure (HF) remains unclear. Methods and Results: A total of 68 patients with CHF and 20 healthy individuals were included. The serum levels of Angiotensin II (Ang II) and ghrelin were measured using ELISA. The results showed that Ang II and ghrelin were both significantly increased in CHF patients and that the ghrelin levels were significantly positively correlated with Ang II. The left anterior descending coronary artery was ligated to establish a rat model of CHF, and cultured cardiomyocytes from neonatal rats were stimulated with Ang II to explore the role of ghrelin in CHF. The results showed that ghrelin inhibited cardiomyocyte apoptosis both in vivo and in vitro. Furthermore, caspase-3 expression was examined, and the results revealed that Ang II induces cardiomyocyte apoptosis through the caspase-3 pathway, whereas ghrelin inhibits this action. Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression. Conclusions: These data suggest that the serum levels of ghrelin are significantly positively correlated with Ang II in CHF patients and that ghrelin can inhibit Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R, thereby playing a role in preventing HF.	[Yang, Chunyan; Liu, Zhonghui; Yang, Ping] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China; [Liu, Zhonghui] Jilin Univ, Norman Bethune Coll Med, Dept Immunol, Changchun 130023, Peoples R China; [Liu, Kai] Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Yang, P (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China.	pyang@jlu.edu.cn			Natural Science Foundation of China [81270315]; Project of Science and Technology of Jilin Province [201115094]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Jilin Province	This study was supported by grants provided by the Natural Science Foundation of China (Grant No. 81270315) and the Project of Science and Technology of Jilin Province (Grant No 201115094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Chang L, 2004, J CARDIOVASC PHARM, V43, P165, DOI 10.1097/00005344-200402000-00001; Dell'Italia LJ, 2011, CIRC RES, V109, P437, DOI 10.1161/CIRCRESAHA.110.238550; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; Hurst PR, 2006, HUM REPROD, V21, P1974, DOI 10.1093/humrep/del109; Kang PM, 2000, CIRC RES, V86, P1107; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Kuranaga E, 2012, GENES CELLS, V17, P83, DOI 10.1111/j.1365-2443.2011.01579.x; Ledderose C, 2011, RECENT PATENTS ENDOC, V5, P1, DOI 10.2174/187221411794351897; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; LOPEZ JJ, 1994, AM J PHYSIOL, V267, pH844, DOI 10.1152/ajpheart.1994.267.2.H844; Mel'nikova NP, 2006, INT J CARDIOL, V112, P219, DOI 10.1016/j.ijcard.2005.09.003; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; Pettersson I, 2002, J ENDOCRINOL, V175, P201, DOI 10.1677/joe.0.1750201; Qi YF, 2012, EXP PHYSIOL, V97, P89, DOI 10.1113/expphysiol.2011.060673; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schroder D, 2006, J MOL MED, V84, P975, DOI 10.1007/s00109-006-0090-0; Soeki T, 2008, AM J PHYSIOL-HEART C, V294, pH426, DOI 10.1152/ajpheart.00643.2007; Tsutsui H, 2007, CIRC J, V71, P449, DOI 10.1253/circj.71.449; Ukkola O, 2012, J HUM HYPERTENS, V26, P452, DOI 10.1038/jhh.2011.51; Unger T, 2004, J RENIN-ANGIO-ALDO S, V5, pS7, DOI 10.3317/jraas.2004.024; van de Wal RMA, 2006, INT J CARDIOL, V106, P367, DOI 10.1016/j.ijcard.2005.02.016; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5; Xu JP, 2010, J PEPT SCI, V16, P392, DOI 10.1002/psc.1253; Yang CY, 2012, J CARDIOVASC PHARM, V59, P465, DOI 10.1097/FJC.0b013e31824a7b60	30	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85785	10.1371/journal.pone.0085785	http://dx.doi.org/10.1371/journal.pone.0085785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465706	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500113
J	Broeckx, S; Zimmerman, M; Crocetti, S; Suls, M; Marien, T; Ferguson, SJ; Chiers, K; Duchateau, L; Franco-Obregon, A; Wuertz, K; Spaas, JH				Broeckx, Sarah; Zimmerman, Marieke; Crocetti, Sara; Suls, Marc; Marien, Tom; Ferguson, Stephen J.; Chiers, Koen; Duchateau, Luc; Franco-Obregon, Alfredo; Wuertz, Karin; Spaas, Jan H.			Regenerative Therapies for Equine Degenerative Joint Disease: A Preliminary Study	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PLATELET-RICH PLASMA; STROMAL CELLS; BONE-MARROW; TENDON; DIFFERENTIATION; MULTIPOTENT; HORSE; P63	Degenerative joint disease (DJD) is a major cause of reduced athletic function and retirement in equine performers. For this reason, regenerative therapies for DJD have gained increasing interest. Platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) were isolated from a 6-year-old donor horse. MSCs were either used in their native state or after chondrogenic induction. In an initial study, 20 horses with naturally occurring DJD in the fetlock joint were divided in 4 groups and injected with the following: 1) PRP; 2) MSCs; 3) MSCs and PRP; or 4) chondrogenic induced MSCs and PRP. The horses were then evaluated by means of a clinical scoring system after 6 weeks (T-1), 12 weeks (T-2), 6 months (T-3) and 12 months (T-4) post injection. In a second study, 30 horses with the same medical background were randomly assigned to one of the two combination therapies and evaluated at T-1. The protein expression profile of native MSCs was found to be negative for major histocompatibility (MHC) II and p63, low in MHC I and positive for Ki67, collagen type II (Col II) and Vimentin. Chondrogenic induction resulted in increased mRNA expression of aggrecan, Col II and cartilage oligomeric matrix protein (COMP) as well as in increased protein expression of p63 and glycosaminoglycan, but in decreased protein expression of Ki67. The combined use of PRP and MSCs significantly improved the functionality and sustainability of damaged joints from 6 weeks until 12 months after treatment, compared to PRP treatment alone. The highest short-term clinical evolution scores were obtained with chondrogenic induced MSCs and PRP. This study reports successful in vitro chondrogenic induction of equine MSCs. In vivo application of (induced) MSCs together with PRP in horses suffering from DJD in the fetlock joint resulted in a significant clinical improvement until 12 months after treatment.	[Broeckx, Sarah; Spaas, Jan H.] Global Stem Cell Technol, Meldert Lummen, Belgium; [Zimmerman, Marieke; Suls, Marc] Equine Vet Practice Dr Suls, Weert, Netherlands; [Crocetti, Sara; Ferguson, Stephen J.; Franco-Obregon, Alfredo; Wuertz, Karin] ETH, Dept Biomech, Zurich, Switzerland; [Marien, Tom] Equitom Equine Hosp, Meldert Lummen, Belgium; [Ferguson, Stephen J.; Franco-Obregon, Alfredo; Wuertz, Karin] Univ Zurich, Competence Ctr Appl Biotechnol & Mol Med CABMM, Zurich, Switzerland; [Chiers, Koen] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium; [Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Ghent University; Ghent University; National University of Singapore	Wuertz, K (corresponding author), ETH, Dept Biomech, Zurich, Switzerland.	kwuertz@ethz.ch; janspaas@gst.be	Wuertz-Kozak, Karin/G-3144-2012; Franco-Obregon, Alfredo/F-3056-2019; Ferguson, Stephen J./A-4118-2012	Wuertz-Kozak, Karin/0000-0002-3281-4629; Ferguson, Stephen J./0000-0003-0650-5889; Franco-Obregon, Alfredo/0000-0002-2514-1083	agency for innovation by science and technology Flanders (IWT Vlaanderen) [130543]	agency for innovation by science and technology Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was supported by a grant (number 130543) to SB and JHS from the agency for innovation by science and technology Flanders (IWT Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerts C., 2013, J TISSUE SCI ENG, V4, P1, DOI DOI 10.4172/2157-7552.1000125; Berg LC, 2009, VET COMP ORTHOPAED, V22, P363, DOI 10.3415/VCOT-08-10-0107; Broeckx S., 2012, J TISSUE SCI ENG, P1, DOI [10.4172/2157-7552.S11-001, DOI 10.4172/2157-7552.S11-001]; Broeckx S, 2013, J STEM CELL RES THER, V3, P1; Carrade DD, 2011, CYTOTHERAPY, V13, P1180, DOI 10.3109/14653249.2011.602338; Carrade DD, 2011, CYTOTHERAPY, V13, P419, DOI 10.3109/14653249.2010.536213; Chen L, 2012, J ORTHOP RES, V30, P991, DOI 10.1002/jor.22033; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang BJ, 2007, PEDIATR TRANSPLANT, V11, P814, DOI 10.1111/j.1399-3046.2007.00780.x; Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142, DOI 10.1055/s-0038-1632990; Frisbie DD, 2009, J ORTHOP RES, V27, P1675, DOI 10.1002/jor.20933; Frisbie DD, 2005, VET CLIN N AM-EQUINE, V21, P713, DOI 10.1016/j.cveq.2005.07.001; Goodrich LR, 2006, VET J, V171, P51, DOI 10.1016/j.tvjl.2004.07.008; Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Jonitz A, 2012, INT J MOL MED, V30, P666, DOI 10.3892/ijmm.2012.1042; Koch TG, 2007, EXPERT OPIN BIOL TH, V7, P1621, DOI 10.1517/14712598.7.11.1621; Lim MN, 2012, MOL VIS, V18, P1289; Lu YJ, 2013, GENE, V519, P251, DOI 10.1016/j.gene.2013.02.021; Malone ED, 2002, VET CLIN N AM-EQUINE, V18, P411, DOI 10.1016/S0749-0739(02)00024-X; Martinello T, 2010, TISSUE ENG PART C-ME, V16, P771, DOI [10.1089/ten.tec.2009.0512, 10.1089/ten.TEC.2009.0512]; Martinello T, 2013, J ORTHOP RES, V31, P306, DOI 10.1002/jor.22205; McIlwraith CW, 2011, ARTHROSCOPY, V27, P1552, DOI 10.1016/j.arthro.2011.06.002; MCILWRAITH CW, 1982, J AM VET MED ASSOC, V180, P239; Mishra A, 2009, TISSUE ENG PART C-ME, V15, P431, DOI 10.1089/ten.tec.2008.0534; Mokbel AN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-259; NIZOLEK DJH, 1981, CORNELL VET, V71, P355; Perry KJ, 2013, DEV BIOL, V374, P281, DOI 10.1016/j.ydbio.2012.12.005; Reinshagen H, 2011, ACTA OPHTHALMOL, V89, P741, DOI 10.1111/j.1755-3768.2009.01812.x; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Russell RP, 2013, SPORTS MED ARTHROSC, V21, P186, DOI 10.1097/JSA.0000000000000007; Smith RKW, 2005, BRIT J SPORT MED, V39, P582, DOI 10.1136/bjsm.2005.015834; Spaas JH, 2012, VLAAMS DIERGEN TIJDS, V81, P11; Spaas JH, 2013, VET J, V195, P107, DOI 10.1016/j.tvjl.2012.05.006; Spaas JH, 2012, SPORTS MED, V42, P871, DOI 10.2165/11635390-000000000-00000; Weber CF, 2012, ANASTH INTENSIV NOTF, V47, P425; Weber CF, 2012, ANASTH INTENSIV NOTF, V47, P418, DOI 10.1055/s-0032-1316484; Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382; Zubrod CJ, 2005, VET CLIN N AM-EQUINE, V21, P691, DOI 10.1016/j.cveq.2005.07.004	44	73	74	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85917	10.1371/journal.pone.0085917	http://dx.doi.org/10.1371/journal.pone.0085917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465787	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000330240500088
J	Capurro, A; Baroni, F; Kuebler, LS; Karpati, Z; Dekker, T; Lei, H; Hansson, BS; Pearce, TC; Olsson, SB				Capurro, Alberto; Baroni, Fabiano; Kuebler, Linda S.; Karpati, Zsolt; Dekker, Teun; Lei, Hong; Hansson, Bill S.; Pearce, Timothy C.; Olsson, Shannon B.			Temporal Features of Spike Trains in the Moth Antennal Lobe Revealed by a Comparative Time-Frequency Analysis	PLOS ONE			English	Article							APERIODIC STOCHASTIC RESONANCE; FALSE DISCOVERY RATE; NEURAL CODES; PHEROMONE; DYNAMICS; PATTERNS; INSECTS; DISTANT; SYSTEMS; ODORS	The discrimination of complex sensory stimuli in a noisy environment is an immense computational task. Sensory systems often encode stimulus features in a spatiotemporal fashion through the complex firing patterns of individual neurons. To identify these temporal features, we have developed an analysis that allows the comparison of statistically significant features of spike trains localized over multiple scales of time-frequency resolution. Our approach provides an original way to utilize the discrete wavelet transform to process instantaneous rate functions derived from spike trains, and select relevant wavelet coefficients through statistical analysis. Our method uncovered localized features within olfactory projection neuron (PN) responses in the moth antennal lobe coding for the presence of an odor mixture and the concentration of single component odorants, but not for compound identities. We found that odor mixtures evoked earlier responses in biphasic response type PNs compared to single components, which led to differences in the instantaneous firing rate functions with their signal power spread across multiple frequency bands (ranging from 0 to 45.71 Hz) during a time window immediately preceding behavioral response latencies observed in insects. Odor concentrations were coded in excited response type PNs both in low frequency band differences (2.86 to 5.71 Hz) during the stimulus and in the odor trace after stimulus offset in low (0 to 2.86 Hz) and high (22.86 to 45.71 Hz) frequency bands. These high frequency differences in both types of PNs could have particular relevance for recruiting cellular activity in higher brain centers such as mushroom body Kenyon cells. In contrast, neurons in the specialized pheromone-responsive area of the moth antennal lobe exhibited few stimulus-dependent differences in temporal response features. These results provide interesting insights on early insect olfactory processing and introduce a novel comparative approach for spike train analysis applicable to a variety of neuronal data sets.	[Capurro, Alberto; Pearce, Timothy C.] Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England; [Baroni, Fabiano] Monash Univ, Sch Psychol & Psychiat, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Baroni, Fabiano] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Baroni, Fabiano] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia; [Kuebler, Linda S.; Hansson, Bill S.; Olsson, Shannon B.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Karpati, Zsolt] Hungarian Acad Sci, Inst Plant Protect, Dept Zool, Agr Res Ctr, Budapest, Hungary; [Dekker, Teun] Swedish Univ Agr Sci, Div Chem Ecol, Alnarp, Sweden; [Lei, Hong] Univ Arizona, Sch Mind Brain & Behav, Dept Neurosci, Tucson, AZ USA	University of Leicester; Monash University; University of Melbourne; University of Melbourne; Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Swedish University of Agricultural Sciences; University of Arizona	Olsson, SB (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	solsson@ice.mpg.de	Baroni, Fabiano/R-8180-2019; Dekker, Teun/R-9396-2018; Hansson, Bill S/G-2774-2013; Karpati, Zsolt/AAX-9991-2021; Lei, Hong/ABH-1356-2020	Baroni, Fabiano/0000-0001-6047-8100; Dekker, Teun/0000-0001-5395-6602; Hansson, Bill S/0000-0002-4811-1223; Karpati, Zsolt/0000-0002-5767-460X; Capurro, Alberto/0000-0001-6773-6512; Olsson, Shannon/0000-0003-4126-7353	Hungarian Scientific Research Fund [PD 1041310]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Max Planck Society; Future and Emerging Technologies EU Framework Programme 6 Specific Targeted Research Project iChem (Biosynthetic Infochemical Communication) [FP6-IST: 032275];  [DMS-1200004]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Max Planck Society(Max Planck Society); Future and Emerging Technologies EU Framework Programme 6 Specific Targeted Research Project iChem (Biosynthetic Infochemical Communication); 	The authors acknowledge the following sources of funding: Hungarian Scientific Research Fund PD 1041310 and Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences for support of ZK; HL is supported by DMS-1200004; SO and BSH are supported by the Max Planck Society; AC, TCP, SO, and BSH also supported by the Future and Emerging Technologies EU Framework Programme 6 Specific Targeted Research Project iChem (Biosynthetic Infochemical Communication; FP6-IST: 032275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2013, NEUROIMAGE, V66, P672, DOI 10.1016/j.neuroimage.2012.10.062; Belmabrouk H, 2011, P NATL ACAD SCI USA, V108, P19790, DOI 10.1073/pnas.1112367108; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cao S, 2003, SPIKE TRAIN CHARACTE; Capurro A, 1998, PHYSICA A, V257, P149, DOI 10.1016/S0378-4371(98)00137-X; Capurro A, 1998, PHYS REV E, V58, P4820, DOI 10.1103/PhysRevE.58.4820; Capurro A, 1999, PHYSICA A, V265, P235, DOI 10.1016/S0378-4371(98)00471-3; Capurro Alberto, 2012, Front Neuroeng, V5, P6, DOI 10.3389/fneng.2012.00006; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Chong KY, 2012, PLOS ONE, V7, P107, DOI 10.1371/journal.pone.0029602; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Daubechies I, 1992, CMBS NSF REGIONAL C; Debdas S., 2011, INT J SCI ENG RES, V2, P1; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Ito I, 2009, NEURON, V64, P692, DOI 10.1016/j.neuron.2009.10.004; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; KAISSLING KE, 1989, ARCH INSECT BIOCHEM, V10, P273, DOI 10.1002/arch.940100403; Karpati Z, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-286; Klampfl S, 2010, NEURAL COMPUT, V22, P2979, DOI 10.1162/NECO_a_00050; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kuebler LS, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00007; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laubach M, 2004, J NEUROSCI METH, V134, P159, DOI 10.1016/j.jneumeth.2003.11.007; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Mallat S., 2009, WAVELET TOUR SIGNAL; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meisel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030371; MURLIS J, 1981, PHYSIOL ENTOMOL, V6, P71, DOI 10.1111/j.1365-3032.1981.tb00262.x; Namiki S, 2011, BIOSYSTEMS, V103, P348, DOI 10.1016/j.biosystems.2010.11.007; Nawrot MP, 2012, APIDOLOGIE, V43, P269, DOI 10.1007/s13592-012-0131-3; Olsson SB, 2011, J NEUROSCI METH, V195, P1, DOI 10.1016/j.jneumeth.2010.09.020; Olsson SB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-285; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Quiroga RQ, 2000, PHYSICA D, V145, P278, DOI 10.1016/S0167-2789(00)00116-0; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Wang ZS, 2007, COMPUT BIOL MED, V37, P463, DOI 10.1016/j.compbiomed.2006.08.011; Wiskott L, 2003, ZOOLOGY, V106, P373, DOI 10.1078/0944-2006-00132; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040	54	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84037	10.1371/journal.pone.0084037	http://dx.doi.org/10.1371/journal.pone.0084037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465391	Green Published, Green Accepted, gold			2022-12-27	WOS:000330240500006
J	Dames, DN; Blackman, E; Butler, R; Taioli, E; Eckstein, S; Devarajan, K; Griffith-Bowe, A; Gomez, P; Ragin, C				Dames, Dionne N.; Blackman, Elizabeth; Butler, Raleigh; Taioli, Emanuela; Eckstein, Stacy; Devarajan, Karthik; Griffith-Bowe, Andrea; Gomez, Perry; Ragin, Camille		African Caribbean Canc Consortium	High-Risk Cervical Human Papillomavirus Infections among Human Immunodeficiency Virus-Positive Women in the Bahamas	PLOS ONE			English	Article							HIV; HPV; PREVALENCE; ABNORMALITIES; PERSISTENCE; GENOTYPES; CYTOLOGY; IMPACT	Background: High-risk (HR) HPV genotypes other than 16 and 18 have been detected in a significant proportion of immunocompromised females. We aim to evaluate the frequency of HR HPV genotypes in a population of HIV-positive Caribbean women. Methods: One hundred sixty-seven consecutive, non-pregnant, HIV-positive females >= 18 years were recruited in this study. Each participant received a vaginal examination, PAP smear, and completed a questionnaire. DNA was extracted for HPV testing in 86 patients. Results: Mean age was 39.1 years for women positive for HR HPV and 43.1 years for women negative for HR HPV (P value = 0.040). 78% (130/167) of the women had HR HPV infections; the prevalence of abnormal cervical cytology was 38% among women who were HR HPV-positive compared to women who were HR HPV-negative (22%). Fifty-one percent of the 86 women with available genotype carried infections with HPV 16 and/or HPV 18; genotypes of unknown risk were also frequently observed. Women who had a CD4+ count of <= 200 had 7 times increased odds of carrying HR HPV infection in comparison to women with CD4+>200. Conclusions: HR HPV infections in HIV infected females may consist of more than just HPV 16 and 18, but also HPV 52 and 58. Further studies are needed to determine whether HPV 52 and 58 play a significant role in the development of cervical cytological abnormalities in HIV+ women.	[Dames, Dionne N.; Gomez, Perry] Princess Margaret Hosp, Dept Med, Nassau, Bahamas; [Blackman, Elizabeth; Ragin, Camille] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19122 USA; [Butler, Raleigh; Griffith-Bowe, Andrea] Princess Margaret Hosp, Dept Obstet & Gynecol, Nassau, Bahamas; [Taioli, Emanuela] North Shore Long Isl Jewish Hofstra Sch Med, Dept Populat Hlth, Manhasset, NY USA; [Eckstein, Stacy] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Eckstein, Stacy] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hofstra University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fox Chase Cancer Center	Ragin, C (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19122 USA.	camille.ragin@fccc.edu		Blackman, Eric/0000-0002-9405-8435	National Cancer Institute, National Institutes of Health [R13CA130596A, P20CA132385-01, CA006927]; Commonwealth of Pennsylvania; University of Pittsburgh Graduate School of Public Health, Dean's Office; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA006927, P20CA132385] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth of Pennsylvania; University of Pittsburgh Graduate School of Public Health, Dean's Office; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Cancer Institute, National Institutes of Health [R13CA130596A, P20CA132385-01, and CA006927] and by an appropriation from the Commonwealth of Pennsylvania. This work was also supported in part by funds from the University of Pittsburgh Graduate School of Public Health, Dean's Office and the University of Pittsburgh Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Banura C, 2008, J INFECT DIS, V197, P555, DOI 10.1086/526792; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Dames Dionne N, 2009, Infect Agent Cancer, V4 Suppl 1, pS8, DOI 10.1186/1750-9378-4-S1-S8; De Vuyst H, 2013, INT J CANCER, V133, P1441, DOI 10.1002/ijc.28131; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Luque AE, 2006, J INFECT DIS, V194, P428, DOI 10.1086/505876; Maranga Innocent O, 2013, Open Virol J, V7, P19, DOI 10.2174/1874357901307010019; Massad LS, 2001, J ACQ IMMUN DEF SYND, V27, P432, DOI 10.1097/00126334-200108150-00003; MASSAD LS, 2013, J LOW GENIT IN PRESS; Minkoff H, 1998, AM J OBSTET GYNECOL, V178, P982, DOI 10.1016/S0002-9378(98)70535-6; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Patel SJ, 2013, INT J STD AIDS, V24, P221, DOI 10.1177/0956462412472446; Pista A, 2011, CLIN MICROBIOL INFEC, V17, P941, DOI 10.1111/j.1469-0691.2010.03387.x; Ragin CCR, 2007, BIOMARKERS, V12, P510, DOI 10.1080/13547500701340384; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1	22	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85429	10.1371/journal.pone.0085429	http://dx.doi.org/10.1371/journal.pone.0085429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465558	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330288000014
J	Luan, HM; Meng, N; Fu, J; Chen, XM; Xu, X; Feng, Q; Jiang, H; Dai, J; Yuan, XE; Lu, YP; Roberts, AA; Luo, X; Chen, MS; Xu, ST; Li, J; Hamilton, CJ; Fang, CX; Wang, J				Luan, Hemi; Meng, Nan; Fu, Jin; Chen, Xiaomin; Xu, Xun; Feng, Qiang; Jiang, Hui; Dai, Jun; Yuan, Xune; Lu, Yanping; Roberts, Alexandra A.; Luo, Xiao; Chen, Maoshan; Xu, Shengtao; Li, Jun; Hamilton, Chris J.; Fang, Chengxiang; Wang, Jun			Genome-Wide Transcriptome and Antioxidant Analyses on Gamma-Irradiated Phases of Deinococcus radiodurans R1	PLOS ONE			English	Article							IONIZING-RADIATION; OXIDATIVE STRESS; DNA-DAMAGE; RESISTANCE; SURVIVAL; IDENTIFICATION; BIOSYNTHESIS; BACILLITHIOL; CAROTENOIDS; MECHANISMS	Adaptation of D. radiodurans cells to extreme irradiation environments requires dynamic interactions between gene expression and metabolic regulatory networks, but studies typically address only a single layer of regulation during the recovery period after irradiation. Dynamic transcriptome analysis of D. radiodurans cells using strand-specific RNA sequencing (ssRNA-seq), combined with LC-MS based metabolite analysis, allowed an estimate of the immediate expression pattern of genes and antioxidants in response to irradiation. Transcriptome dynamics were examined in cells by ssRNA-seq covering its predicted genes. Of the 144 non-coding RNAs that were annotated, 49 of these were transfer RNAs and 95 were putative novel antisense RNAs. Genes differentially expressed during irradiation and recovery included those involved in DNA repair, degradation of damaged proteins and tricarboxylic acid (TCA) cycle metabolism. The knockout mutant crtB (phytoene synthase gene) was unable to produce carotenoids, and exhibited a decreased survival rate after irradiation, suggesting a role for these pigments in radiation resistance. Network components identified in this study, including repair and metabolic genes and antioxidants, provided new insights into the complex mechanism of radiation resistance in D. radiodurans.	[Luan, Hemi; Meng, Nan; Fu, Jin; Chen, Xiaomin; Xu, Xun; Feng, Qiang; Jiang, Hui; Yuan, Xune; Lu, Yanping; Luo, Xiao; Chen, Maoshan; Xu, Shengtao; Li, Jun; Wang, Jun] BGI Shenzhen, Dept Sci & Technol, Shenzhen, Peoples R China; [Dai, Jun; Fang, Chengxiang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Dai, Jun] Hubei Univ Technol, Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Key Lab Fermentat Engn, Wuhan, Peoples R China; [Roberts, Alexandra A.; Hamilton, Chris J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Luan, Hemi] Hong Kong Baptist Univ, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Beijing Genomics Institute (BGI); Wuhan University; Hubei University of Technology; University of East Anglia; Hong Kong Baptist University; University of Copenhagen; King Abdulaziz University	Fang, CX (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	cxfang@whu.edu.cn; wangj@genomics.cn	Luan, Hemi/M-5406-2016; Wang, Jun/A-7261-2013; Luo, Xiao/CAG-5937-2022; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Luan, Hemi/0000-0002-3807-2363; Xu, Xun/0000-0002-5338-5173; Roberts, Alexandra/0000-0002-0705-1615; Dai, Jun/0000-0001-6143-4732; CHEN, MAOSHAN/0000-0002-3827-4969; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Open Research Program of Shenzhen Key Laboratory of Environmental Genomics of Microbes and Applications; Shenzhen Key Laboratory of Trans-omics Biotechnologies; National Natural Science Foundation of China [31300003]	Open Research Program of Shenzhen Key Laboratory of Environmental Genomics of Microbes and Applications; Shenzhen Key Laboratory of Trans-omics Biotechnologies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Open Research Program of Shenzhen Key Laboratory of Environmental Genomics of Microbes and Applications, Shenzhen Key Laboratory of Trans-omics Biotechnologies and National Natural Science Foundation of China (No. 31300003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Earl AM, 2002, J BACTERIOL, V184, P1003, DOI 10.1128/jb.184.4.1003-1009.2002; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Graf A, 2012, INT J BIOCH CELL BIO; HAGEN U, 1994, RADIAT ENVIRON BIOPH, V33, P45, DOI 10.1007/BF01255273; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin RX, 2009, J PROTEOME RES, V8, P390, DOI 10.1021/pr800699w; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Obiero J, 2010, J BACTERIOL, V192, P494, DOI 10.1128/JB.01046-09; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; POCKER Y, 1991, ADV EXP MED BIOL, V284, P315; Rivera S, 2011, ANAL BIOANAL CHEM, V400, P1339, DOI 10.1007/s00216-011-4825-6; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Schmid AK, 2005, J PROTEOME RES, V4, P709, DOI 10.1021/pr049815n; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shuryak I, 2009, J THEOR BIOL, V261, P305, DOI 10.1016/j.jtbi.2009.08.003; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SMITH MD, 1988, J BACTERIOL, V170, P2126, DOI 10.1128/jb.170.5.2126-2135.1988; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Tian B, 2009, LETT APPL MICROBIOL, V49, P689, DOI 10.1111/j.1472-765X.2009.02727.x; TREMPY JE, 1989, J BACTERIOL, V171, P3348, DOI 10.1128/jb.171.6.3348-3353.1989; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; VILLEGAS CN, 1972, PLANT PHYSIOL, V50, P694, DOI 10.1104/pp.50.6.694; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]; Zhang HY, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2073-c1; Zhang L, 2007, ARCH MICROBIOL, V188, P411, DOI 10.1007/s00203-007-0262-5; Zhou ZF, 2011, MOL BIOSYST, V7, P1613, DOI 10.1039/c0mb00336k	43	33	36	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85649	10.1371/journal.pone.0085649	http://dx.doi.org/10.1371/journal.pone.0085649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465634	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000330288000020
J	Notari, L; Riera, DC; Sun, R; Bohl, JA; McLean, LP; Madden, KB; van Rooijen, N; Vanuytsel, T; Urban, JF; Zhao, AP; Shea-Donohue, T				Notari, Luigi; Riera, Diana C.; Sun, Rex; Bohl, Jennifer A.; McLean, Leon P.; Madden, Kathleen B.; van Rooijen, Nico; Vanuytsel, Tim; Urban, Joseph F., Jr.; Zhao, Aiping; Shea-Donohue, Terez			Role of Macrophages in the Altered Epithelial Function during a Type 2 Immune Response Induced by Enteric Nematode Infection	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; HELIGMOSOMOIDES-POLYGYRUS INFECTION; INDUCIBLE FACTOR-I; BRUSH-BORDER; GLUCOSE-METABOLISM; SUGAR ABSORPTION; TASTE RECEPTORS; GLUT2; EXPRESSION; LEPTIN	Parasitic enteric nematodes induce a type 2 immune response characterized by increased production of Th2 cytokines, IL-4 and IL-13, and recruitment of alternatively activated macrophages ( M2) to the site of infection. Nematode infection is associated with changes in epithelial permeability and inhibition of sodium-linked glucose absorption, but the role of M2 in these effects is unknown. Clodronate-containing liposomes were administered prior to and during nematode infection to deplete macrophages and prevent the development of M2 in response to infection with Nippostrongylus brasiliensis. The inhibition of epithelial glucose absorption that is associated with nematode infection involved a macrophage-dependent reduction in SGLT1 activity, with no change in receptor expression, and a macrophage-independent down-regulation of GLUT2 expression. The reduced transport of glucose into the enterocyte is compensated partially by an up-regulation of the constitutive GLUT1 transporter consistent with stress-induced activation of HIF-1 alpha. Thus, nematode infection results in a "lean" epithelial phenotype that features decreased SGLT1 activity, decreased expression of GLUT2 and an emergent dependence on GLUT1 for glucose uptake into the enterocyte. Macrophages do not play a role in enteric nematode infection-induced changes in epithelial barrier function. There is a greater contribution, however, of paracellular absorption of glucose to supply the energy demands of host resistance. These data provide further evidence of the ability of macrophages to alter glucose metabolism of neighboring cells.	[Notari, Luigi; Sun, Rex; Bohl, Jennifer A.; McLean, Leon P.; Zhao, Aiping; Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Notari, Luigi; Sun, Rex; Bohl, Jennifer A.; McLean, Leon P.; Zhao, Aiping; Shea-Donohue, Terez] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Riera, Diana C.] Walter Reed Army Med Ctr, Dept Pediat, Washington, DC 20307 USA; [Riera, Diana C.; Madden, Kathleen B.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands; [Vanuytsel, Tim] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Vrije Universiteit Amsterdam; KU Leuven; University Hospital Leuven; United States Department of Agriculture (USDA)	Shea-Donohue, T (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	tdonohue@mbrc.maryland.edu	Van Rooijen, Nico/Z-1578-2019; Vanuytsel, Tim/O-9972-2016	Urban, Joseph/0000-0002-1590-8869; Vanuytsel, Tim/0000-0001-8728-0903	National Institutes of Health [R01-AI/DK49316, DK083418, T32 DK-067872]; U.S. Department of Agriculture CRIS Project [1235-52000-053]; Flanders research foundation (FWO, Fonds Wetenschappelijk Onderzoek); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083418, T32DK067872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture CRIS Project; Flanders research foundation (FWO, Fonds Wetenschappelijk Onderzoek); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-AI/DK49316 (to T.S.-D.), DK083418 (to A.Z.), T32 DK-067872 (to L. P. M., J.A.B., and R. S.), by U.S. Department of Agriculture CRIS Project 1235-52000-053 (to J.F.U.) and by a grant from the Flanders research foundation (FWO, Fonds Wetenschappelijk Onderzoek) (to T. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Omar A, 2011, DIABETES, V60, P2598, DOI 10.2337/db10-1740; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Au A, 2002, BIOCHEM J, V367, P247, DOI 10.1042/BJ20020393; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Blum AM, 2012, J IMMUNOL, V189, P2512, DOI 10.4049/jimmunol.1102892; Boudry G, 2007, AM J PHYSIOL-REG I, V292, pR862, DOI 10.1152/ajpregu.00655.2006; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; Dehne N, 2010, EXP CELL RES, V316, P1179, DOI 10.1016/j.yexcr.2010.02.019; Dyer J, 1997, GUT, V41, P56, DOI 10.1136/gut.41.1.56; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Greijer AE, 2008, VIRCHOWS ARCH, V452, P535, DOI 10.1007/s00428-008-0578-9; Halaihel N, 2000, J VIROL, V74, P9464, DOI 10.1128/JVI.74.20.9464-9470.2000; Hang L, 2010, J IMMUNOL, V185, P3184, DOI 10.4049/jimmunol.1000941; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Inigo C, 2007, ACTA PHYSIOL, V190, P303, DOI 10.1111/j.1748-1716.2007.01707.x; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kihira Y, 2011, INT J BIOCHEM CELL B, V43, P1602, DOI 10.1016/j.biocel.2011.07.009; Kinne RKH, 2011, HANDB EXP PHARMACOL, V203, P105, DOI 10.1007/978-3-642-17214-4_5; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Krimi RB, 2009, DIABETES, V58, P2032, DOI 10.2337/db08-1786; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Madden KB, 2002, J IMMUNOL, V172, P5616; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; Morimoto M, 2003, PCR PRIMER; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park SK, 2007, INT J ONCOL, V30, P341; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Sekikawa S, 2003, INT J PARASITOL, V33, P1419, DOI 10.1016/S0020-7519(03)00183-8; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Shepherd EJ, 2004, J PHYSIOL-LONDON, V560, P281, DOI 10.1113/jphysiol.2004.072447; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Sutton TL, 2008, INFECT IMMUN, V76, P4772, DOI 10.1128/IAI.00744-07; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong T, 2007, GASTROENTEROLOGY, V133, P1979, DOI 10.1053/j.gastro.2007.09.006; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13; Yoshikawa T, 2011, HISTOCHEM CELL BIOL, V135, P183, DOI 10.1007/s00418-011-0779-1; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2006, GASTROENTEROLOGY, V131, P568, DOI 10.1053/j.gastro.2006.05.013; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	66	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84763	10.1371/journal.pone.0084763	http://dx.doi.org/10.1371/journal.pone.0084763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465430	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000006
J	Bradley, CJ; Madigan, DJ; Block, BA; Popp, BN				Bradley, Christina J.; Madigan, Daniel J.; Block, Barbara A.; Popp, Brian N.			Amino Acid Isotope Incorporation and Enrichment Factors in Pacific Bluefin Tuna, Thunnus orientalis	PLOS ONE			English	Article							STABLE-ISOTOPES; TROPHIC POSITION; NORTH-ATLANTIC; NITROGEN; TISSUES; DELTA-N-15; FRACTIONATION; TURNOVER; RATIOS; CARBON	Compound specific isotopic analysis (CSIA) of amino acids has received increasing attention in ecological studies in recent years due to its ability to evaluate trophic positions and elucidate baseline nutrient sources. However, the incorporation rates of individual amino acids into protein and specific trophic discrimination factors (TDFs) are largely unknown, limiting the application of CSIA to trophic studies. We determined nitrogen turnover rates of individual amino acids from a long-term (up to 1054 days) laboratory experiment using captive Pacific bluefin tuna, Thunnus orientalis (PBFT), a large endothermic pelagic fish fed a controlled diet. Small PBFT (white muscle delta N-15 similar to 11.5 parts per thousand) were collected in San Diego, CA and transported to the Tuna Research and Conservation Center (TRCC) where they were fed a controlled diet with high delta N-15 values relative to PBFT white muscle (diet delta N-15 similar to 13.9 parts per thousand). Half-lives of trophic and source amino acids ranged from 28.6 to 305.4 days and 67.5 to 136.2 days, respectively. The TDF for the weighted mean values of amino acids was 3.0 parts per thousand, ranging from 2.2 to 15.8 parts per thousand for individual combinations of 6 trophic and 5 source amino acids. Changes in the delta N-15 values of amino acids across trophic levels are the underlying drivers of the trophic N-15 enrichment. Nearly all amino acid delta N-15 values in this experiment changed exponentially and could be described by a single compartment model. Significant differences in the rate of N-15 incorporation were found for source and trophic amino acids both within and between these groups. Varying half-lives of individual amino acids can be applied to migratory organisms as isotopic clocks, determining the length of time an individual has spent in a new environment. These results greatly enhance the ability to interpret compound specific isotope analyses in trophic studies.	[Bradley, Christina J.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Madigan, Daniel J.] Tuna Res & Conservat Ctr, Pacific Grove, CA USA; [Madigan, Daniel J.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Block, Barbara A.] Monterey Bay Aquarium, Monterey, CA USA; [Popp, Brian N.] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA	University of Hawaii System; Stanford University; Monterey Bay Aquarium Research Institute; University of Hawaii System	Bradley, CJ (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	cjbradle@hawaii.edu		Popp, Brian/0000-0001-7021-5478	National Science Foundation [OCE1041329]; Direct For Biological Sciences [1305791] Funding Source: National Science Foundation; Directorate For Geosciences [1041329] Funding Source: National Science Foundation; Division Of Ocean Sciences [1040810] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under Grant No. OCE1041329 to Brian N. Popp and Jeffrey C. Drazen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliff W.H., 1991, Inter-American Tropical Tuna Commission Bulletin, V20, P1; Bosley KL, 2002, MAR ECOL PROG SER, V236, P233, DOI 10.3354/meps236233; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Carleton SA, 2010, FUNCTIONAL ECOLOGY, P9999; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Chikaraishi Y., 2010, FURTHER EVALUATION T, P37; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Choy CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050133; Cowie GL, 1992, LIMNOLOGY OCEANOGRAP, V37; Dale JJ, 2011, MARINE ECOLOGY PROGR, V433; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; Emmett RL, 2005, CAL COOP OCEAN FISH, V46, P122; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Guelinckx J, 2008, OECOLOGIA, V157, P41, DOI 10.1007/s00442-008-1045-7; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; Herzka SZ, 2005, ESTUAR COAST SHELF S, V64, P58, DOI 10.1016/j.ecss.2005.02.006; Herzka SZ, 2001, J EXP MAR BIOL ECOL, V265, P49, DOI 10.1016/S0022-0981(01)00324-0; Hesslein RH, 1993, CANADIAN J FISHERIES, V50; Hobson KA, 1992, CONDOR, V94; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Madigan DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049220; Martinez-Montano E, 2010, AQUACULTURE, V299, P134, DOI 10.1016/j.aquaculture.2009.12.003; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McCarthy MD, 2013, GEOCHIM COSMOCHIM AC, V103, P104, DOI 10.1016/j.gca.2012.10.037; McClelland JW, 2003, DEEP-SEA RES PT I, V50, P849, DOI 10.1016/S0967-0637(03)00073-6; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCullagh J, 2008, RAPID COMMUN MASS SP, V22, P1817, DOI 10.1002/rcm.3554; Metges CC, 1996, J MASS SPECTROM, V31, P367, DOI 10.1002/(SICI)1096-9888(199604)31:4<367::AID-JMS310>3.0.CO;2-V; Mill AC, 2007, FUNCT ECOL, V21, P1137, DOI 10.1111/j.1365-2435.2007.01330.x; Miller TW, 2010, MAR ECOL PROG SER, V420, P15, DOI 10.3354/meps08876; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Popp B.N., 2007, INSIGHT TROPHIC ECOL; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; Rosas A, 2008, AQUACULT NUTR, V14, DOI 10.1111/j.1365-2095.2007.00553.x; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Styring AK, 2010, GEOCHIM COSMOCHIM AC, V74, P241, DOI 10.1016/j.gca.2009.09.022; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; UEDA K, 1989, ANAL CHEM, V61, P265, DOI 10.1021/ac00178a015; Vollaire Y, 2007, COMP BIOCHEM PHYS A, V148, P504, DOI 10.1016/j.cbpa.2007.06.419; Wolf N, 2009, FUNCTIONAL ECOLOGY, V23	50	51	51	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85818	10.1371/journal.pone.0085818	http://dx.doi.org/10.1371/journal.pone.0085818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465724	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100078
J	Kijanka, G; Prokopowicz, M; Schellekens, H; Brinks, V				Kijanka, Grzegorz; Prokopowicz, Malgorzata; Schellekens, Huub; Brinks, Vera			Influence of Aggregation and Route of Injection on the Biodistribution of Mouse Serum Albumin	PLOS ONE			English	Article							HUMAN INTERFERON-BETA; MULTIPLE-SCLEROSIS; GROWTH-HORMONE; IMMUNOGENICITY; BIOAVAILABILITY; ANTIBODIES; PROTEINS	Protein aggregates are a major risk factor for immunogenicity. Until now most studies on aggregate-driven immunogenicity have focused on linking physicochemical features of the aggregates to the formation of anti-drug antibodies. Lacking is however, basic knowledge on the effect of aggregation on the biodistribution and clearance of therapeutic proteins in vivo. The aim of current study was to get insight into the effect of aggregation on biodistribution in mice using different routes of administration. Fluorescently labeled stressed and unstressed mouse serum albumin was injected via different routes in mice and detected via in vivo fluorescence imaging up to 48 hrs post-injection. We found that biodistribution of stressed MSA significantly differed from its unstressed counterpart. Subcutaneous and intramuscular administration resulted in accumulation of protein at the site of injection, from which clearance of stressed MSA was considerably slower than clearance of unstressed MSA. Upon intravenous and intraperitoneal injection of stressed MSA, fluorescent "hotspots" were observed in the spleens, livers and lungs. Further and more detailed examination of biodistribution after intraperitoneal injection showed higher fluorescence in most of tested organs suggesting more efficient diffusion and/or lymphatic uptake from peritoneum of unstressed MSA than the stressed formulation.	[Kijanka, Grzegorz; Prokopowicz, Malgorzata; Schellekens, Huub; Brinks, Vera] Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Innovat Management, Utrecht, Netherlands	Utrecht University; Utrecht University	Brinks, V (corresponding author), Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands.	V.Brinks@uu.nl	Prokopowicz, Małgorzata/G-6565-2014	Prokopowicz, Małgorzata/0000-0002-0160-9884	Utrecht University	Utrecht University	This study was funded by Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration. FaD. Adalimumab, 2002, PHARM REV AD PROD AP; Bertolotto A, 2000, IMMUNOPHARMACOLOGY, V48, P95, DOI 10.1016/S0162-3109(00)00182-X; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Brunskill NJ, 2004, CELLULAR PROTEINS TH, P79; Drummond DC, 1999, PHARMACOL REV, V51, P691; Filipe V, 2010, AGGREGATION THERAPEU, P403; Filipe V, 2012, PHARM RES-DORDR, V29, P2202, DOI 10.1007/s11095-012-0749-x; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Kijanka G, 2013, PHARM RES-DORDR, V30, P1553, DOI 10.1007/s11095-013-0992-9; Laursen T, 1996, CLIN ENDOCRINOL, V45, P333, DOI 10.1046/j.1365-2265.1996.00814.x; MOORE WV, 1980, J CLIN ENDOCR METAB, V51, P691, DOI 10.1210/jcem-51-4-691; OCKNER RK, 1983, AM J PHYSIOL, V245, pG13, DOI 10.1152/ajpgi.1983.245.1.G13; Oliveira S, 2012, MOL IMAGING, V11, P33, DOI 10.2310/7290.2011.00025; Peng A, 2012, AAPS J, V14, P35, DOI 10.1208/s12248-011-9309-2; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P157, DOI 10.1016/S0169-409X(01)00153-3; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ross C, 2000, ANN NEUROL, V48, P706, DOI 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.3.CO;2-M; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schellekens H, 2004, J NEUROL, V251, P4, DOI 10.1007/s00415-004-1202-9; Singh SK, 2011, J PHARM SCI, V100, P4; Srinivas NR, 1997, PHARM RES-DORDR, V14, P911, DOI 10.1023/A:1012156001831; van Beers MMC, 2010, J INTERF CYTOK RES, V30, P767, DOI 10.1089/jir.2010.0086	22	21	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85281	10.1371/journal.pone.0085281	http://dx.doi.org/10.1371/journal.pone.0085281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465523	Green Published, gold			2022-12-27	WOS:000330283100034
J	Chen, C; Liu, Q; Hao, Q; Xu, B; Ma, C; Zhang, HJ; Shen, QJ; Lu, JP				Chen, Chao; Liu, Qi; Hao, Qiang; Xu, Bing; Ma, Chao; Zhang, Huojun; Shen, Qianjin; Lu, Jianping			Study of 320-Slice Dynamic Volume CT Perfusion in Different Pathologic Types of Kidney Tumor: Preliminary Results	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; MINIMAL FAT DIFFERENTIATION; HELICAL CT; ANGIOMYOLIPOMA; SUBTYPES; HETEROGENEITY; NEOPLASMS; DIAGNOSIS; PHASE	Objective: To investigate microcirculatory differences between pathologic types of kidney tumor using 320-slice dynamic volume CT perfusion. Methods: Perfusion imaging with 320-slice dynamic volume CT was prospectively performed in 85 patients with pathologically proven clear cell renal cell carcinoma (RCC) (n = 66), papillary RCC (n = 7), chromophobe RCC (n = 5), angiomyolipoma (AML) with minimal fat (n = 7), or RCC (n = 78). Equivalent blood volume (Equiv BV), permeability surface-area product (PS; clearance/unit volume = permeability), and blood flow (BF) of tumor and normal renal cortex were measured and analyzed. Effective radiation dose was calculated. Results: There was a significant difference in all three parameters between tumor and normal renal cortex (P<0.001). Equiv BV was significantly different between RCC and AML with minimal fat (P = 0.038) and between clear cell RCC and AML with minimal fat (P<0.001). Mean Equiv BV and BF were significantly higher in clear cell RCC than in papillary RCC (P<0.001 for both) and mean Equiv BV was higher in clear cell RCC than in chromophobe RCC (P<0.001). The effective radiation dose of the CT perfusion protocol was 18.5 mSv. Conclusion: Perfusion imaging using 320-slice dynamic volume CT can be used to evaluate hemodynamic features of the whole kidney and kidney tumors, which may be useful in the differential diagnosis of these four pathologic types of kidney tumor.	[Chen, Chao; Liu, Qi; Hao, Qiang; Xu, Bing; Ma, Chao; Zhang, Huojun; Shen, Qianjin; Lu, Jianping] Second Mil Med Univ, Changhai Hosp Shang Hai, Dept Radiol, Shanghai, Peoples R China	Naval Medical University	Lu, JP (corresponding author), Second Mil Med Univ, Changhai Hosp Shang Hai, Dept Radiol, Shanghai, Peoples R China.	cjr.lujianping@vip.163.com		Ma, Chao/0000-0002-2473-387X	Changhai Hospital of Shanghai [CH125520800, CH125520303]; Youth Scientific Research Funds of Changhai Hospital	Changhai Hospital of Shanghai; Youth Scientific Research Funds of Changhai Hospital	This work was supported by the "1255 Academic Discipline Project of Changhai Hospital of Shanghai (CH125520800, CH125520303) and Youth Scientific Research Funds of Changhai Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Said J, 2010, SAUDI J KIDNEY DIS T, V21, P123; BOSNIAK MA, 1988, AM J ROENTGENOL, V151, P497, DOI 10.2214/ajr.151.3.497; Chen Y, 2010, ABDOM IMAGING, V35, P622, DOI 10.1007/s00261-009-9565-0; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Eberhard A, 2000, CANCER RES, V60, P1388; Goh V, 2012, INVEST RADIOL, V47, P2, DOI 10.1097/RLI.0b013e318229ff3e; Helck A, 2010, INVEST RADIOL, V45, P387, DOI 10.1097/RLI.0b013e3181e332d0; Helenon O, 2012, Diagn Interv Imaging, V93, P232, DOI 10.1016/j.diii.2012.01.016; Helenon O, 1997, RADIOGRAPHICS, V17, P129, DOI 10.1148/radiographics.17.1.9017804; Herts BR, 2002, AM J ROENTGENOL, V178, P367, DOI 10.2214/ajr.178.2.1780367; Jiang T, 2012, INVEST RADIOL, V47, P11, DOI 10.1097/RLI.0b013e3182199bb5; Jin HW, 2006, AM J ROENTGENOL, V186, P1423, DOI 10.2214/AJR.04.1408; Jinzaki M, 2000, J COMPUT ASSIST TOMO, V24, P835, DOI 10.1097/00004728-200011000-00002; Jinzaki M, 1997, RADIOLOGY, V205, P497, DOI 10.1148/radiology.205.2.9356635; Jung SC, 2012, ACTA RADIOL, V53, P112, DOI 10.1258/ar.2011.110221; Kambadakone AR, 2011, EUR RADIOL, V21, P1293, DOI 10.1007/s00330-010-2048-4; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Kim JK, 2004, RADIOLOGY, V230, P677, DOI 10.1148/radiol.2303030003; Kim JK, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781499; Lam JS, 2005, J UROLOGY, V173, P1853, DOI 10.1097/01.ju.0000165693.68449.c3; MCCLENNAN BL, 1994, RADIOL CLIN N AM, V32, P55; MILES KA, 1994, INVEST RADIOL, V29, P911, DOI 10.1097/00004424-199410000-00008; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; Miles KA, 2003, BRIT J RADIOL, V76, pS36, DOI 10.1259/bjr/18486642; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Ng CS, 2010, AM J ROENTGENOL, V194, P166, DOI 10.2214/AJR.09.3105; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Paul JF, 2001, RADIOLOGY, V221, P261, DOI 10.1148/radiol.2211001558; PRESS GA, 1984, AM J ROENTGENOL, V143, P1005, DOI 10.2214/ajr.143.5.1005; Reiner CS, 2012, INVEST RADIOL, V47, P33, DOI 10.1097/RLI.0b013e31822598c3; Ruppert-Kohlmayr AJ, 2004, AM J ROENTGENOL, V183, P1387, DOI 10.2214/ajr.183.5.1831387; SANT GR, 1984, UROLOGY, V24, P293, DOI 10.1016/0090-4295(84)90365-0; Sasiwimonphan K, 2012, RADIOLOGY, V263, P160, DOI 10.1148/radiol.12111205; Schrader AJ, 2008, BJU INT, V101, P1343, DOI 10.1111/j.1464-410X.2008.07462.x; Shamalov NA, 2012, ZH NEVROL PSIKHIATR, V112, P3; Sheir KZ, 2005, J UROLOGY, V174, P451, DOI 10.1097/01.ju.0000165341.08396.a9; Squillaci E, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-138; Sun MRM, 2009, RADIOLOGY, V250, P793, DOI 10.1148/radiol.2503080995; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Yan G, 2011, CHINESE GERMAN J CLI, V10, P35; Yilmaz O, 2009, J PEDIATR SURG, V44, P1977, DOI 10.1016/j.jpedsurg.2009.01.072; Young JR, 2013, RADIOLOGY, V267, P444, DOI 10.1148/radiol.13112617; Zhang J, 2007, RADIOLOGY, V244, P494, DOI 10.1148/radiol.2442060927; Zhang YY, 2013, CLIN RADIOL, V68, P365, DOI 10.1016/j.crad.2012.08.028; Zhao XJ, 2013, CHINESE MED J-PEKING, V126, P991, DOI 10.3760/cma.j.issn.0366-6999.20120672	45	32	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85522	10.1371/journal.pone.0085522	http://dx.doi.org/10.1371/journal.pone.0085522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465588	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500070
J	Gou, HF; Huang, J; Shi, HS; Chen, XC; Wang, YS				Gou, Hong-Feng; Huang, Juan; Shi, Hua-Shan; Chen, Xin-chuan; Wang, Yong-Sheng			Chemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice	PLOS ONE			English	Article							T-CELLS COOPERATE; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; GENE-TRANSFER; IL-7; EXPRESSION; EXPANSION; MELANOMA; CD8(+); HOMEOSTASIS	Combination of immunotherapy and chemotherapy has shown promise for cancer. Interleukin-7 (IL-7) can potentially enhance immune responses against tumor, while oxaliplatin (OXP), a platinum-based drug, can promote a favorable immune microenvironment and stimulate anticancer immune responses. We evaluated the anti-tumor activity of IL-7 combining OXP against a murine colon carcinoma in vitro and in vivo and studied the tumor immune microenvironment to investigate whether the combined treatment affects on the local immune cell populations. Utilizing lung and abdomen metastasis models by inoculation of CT26 mice colon cancer cells, we evaluated the anti-tumor efficacy of combining IL-7 and OXP in mice models. Tumor immune microenvironment was evaluated by flow cytometric analysis and immunohistochemical staining. Our study showed that the in vivo administration of IL-7 combined with OXP markedly inhibited the growth of tumors in lung and abdomen metastasis models of colon cancer. IL-7 alone had no effect on tumor growth in mice and IL-7 did not alter cell sensitivity to OXP in culture. The antitumor effect of combining IL-7 and OXP correlated with a marked increase in the number of tumor-infiltrating activated CD8+ T cells and a marked decrease in the number of regulatory T (Treg) cells in spleen. Our data suggest that OXP plus IL-7 treatment inhibits tumor cell growth by immunoregulation rather than direct cytotoxicity. Our findings justify further evaluation of combining IL-7 and chemotherapy as a novel experimental cancer therapy.	[Gou, Hong-Feng; Huang, Juan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Abdominal Canc,Canc Ctr,State Key Lab Biothe, Chengdu 610064, Peoples R China; [Shi, Hua-Shan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Head & Neck Canc,Canc Ctr,State Key Lab Biot, Chengdu 610064, Peoples R China; [Chen, Xin-chuan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Hematol, Chengdu 610064, Peoples R China; [Wang, Yong-Sheng] Sichuan Univ, West China Med Sch, West China Hosp, Dept Thorac Canc,Canc Ctr,State Key Lab Biotherap, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wang, YS (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, Dept Thorac Canc,Canc Ctr,State Key Lab Biotherap, Chengdu 610064, Peoples R China.	wangys75@gmail.com		Shi, Hua-shan/0000-0002-9958-9892				Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; AOKI T, 1992, P NATL ACAD SCI USA, V89, P3850, DOI 10.1073/pnas.89.9.3850; Aspinall R, 2004, ANN NY ACAD SCI, V1019, P116, DOI 10.1196/annals.1297.021; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Cho Y, 2003, CANCER RES, V63, P1555; DUBINETT SM, 1993, J IMMUNOL, V151, P6670; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gonzalez-Aparicio M, 2011, GUT, V60, P341, DOI 10.1136/gut.2010.211722; Hernandez-Alcoceba R, 2012, ONCOIMMUNOLOGY, V1, P97, DOI 10.4161/onci.1.1.17930; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; JICHA DL, 1991, J EXP MED, V174, P1511, DOI 10.1084/jem.174.6.1511; Kilinc MO, 2009, J IMMUNOL, V183, P7656, DOI 10.4049/jimmunol.0902625; KOS FJ, 1993, J IMMUNOL, V150, P387; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lai LJ, 2011, CANCER RES, V71, P61, DOI 10.1158/0008-5472.CAN-10-3198; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li B, 2007, CLIN IMMUNOL, V123, P155, DOI 10.1016/j.clim.2007.01.002; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; MEHROTRA PT, 1995, J IMMUNOL, V154, P5093; MILLER AR, 1993, BLOOD, V82, P3686; Molino A, 1997, INT J CANCER, V74, P433, DOI 10.1002/(SICI)1097-0215(19970822)74:4<433::AID-IJC12>3.0.CO;2-A; Moller P, 1998, BRIT J CANCER, V77, P1907, DOI 10.1038/bjc.1998.317; MURPHY WJ, 1993, J CLIN INVEST, V92, P1918, DOI 10.1172/JCI116785; Overwijk WW, 2009, CLIN IMMUNOL, V132, P153, DOI 10.1016/j.clim.2009.03.512; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Ridolfi R, 2002, J CLIN ONCOL, V20, P1600, DOI 10.1200/JCO.20.6.1600; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Sharma S, 2003, HUM GENE THER, V14, P1511, DOI 10.1089/104303403322495025; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sin JI, 2000, CLIN DIAGN LAB IMMUN, V7, P751, DOI 10.1128/CDLI.7.5.751-758.2000; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356	45	37	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85789	10.1371/journal.pone.0085789	http://dx.doi.org/10.1371/journal.pone.0085789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465710	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500114
J	Kraus, MW; Callaghan, B				Kraus, Michael W.; Callaghan, Bennett			Noblesse Oblige? Social Status and Economic Inequality Maintenance among Politicians	PLOS ONE			English	Article							AFFIRMATIVE-ACTION; STEREOTYPE THREAT; GROUP POSITION; GENDER; RACE; SYSTEM; PREJUDICE; EDUCATION; STUDENTS; LIBERALS	Economic inequality is at historically high levels in the United States and is among the most pressing issues facing society. And yet, predicting the behavior of politicians with respect to their support of economic inequality remains a significant challenge. Given that high status individuals tend to conceive of the current structure of society as fair and just, we expected that high status members of the U.S. House of Representatives would be more likely to support economic inequality in their legislative behavior than would their low status counterparts. Results supported this prediction particularly among Democratic members of Congress: Whereas Republicans tended to support legislation increasing economic inequality regardless of their social status, the social status of Democrats - measured in terms of average wealth, race, or gender - was a significant predictor of support for economic inequality. Policy implications of the observed relationship between social status and support for economic inequality are considered.	[Kraus, Michael W.; Callaghan, Bennett] Univ Illinois, Dept Psychol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Kraus, MW (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL USA.	mwkraus@illinois.edu						Anderson C, 2012, PSYCHOL SCI, V23, P764, DOI 10.1177/0956797611434537; Anderson S, 2012, C REPORT CARD 99; BLUMER H, 1958, PAC SOCIOL REV, V1, P3; Bobo LD, 1999, J SOC ISSUES, V55, P445, DOI 10.1111/0022-4537.00127; Boyce CJ, 2010, PSYCHOL SCI, V21, P471, DOI 10.1177/0956797610362671; Boykin AW, 1997, J BLACK STUD, V27, P409, DOI 10.1177/002193479702700308; Brandt MJ, 2013, J PERS SOC PSYCHOL, V104, P765, DOI 10.1037/a0031751; Campbell D.T., 1965, NEBRASKA S MOTIVATIO, V13, P283; Carnegie Andrew., 1899, N AM REV, V148, P653; Croizet JC, 1998, PERS SOC PSYCHOL B, V24, P588, DOI 10.1177/0146167298246003; Crosby FJ, 2003, AM PSYCHOL, V58, P93, DOI 10.1037/0003-066X.58.2.93; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; Degler C., 1991, SEARCH HUMAN NATURE; DOMHOFF GW, 1998, WHO RULES AM POWER P; EBERHARDT JL, 1994, BASIC APPL SOC PSYCH, V15, P201, DOI 10.1207/s15324834basp1501&2_9; Fiske S. T., 2010, HDB SOCIAL PSYCHOL V, V2, P941, DOI [10.1002/9780470561119.socpsy002026, DOI 10.1002/9780470561119.SOCPSY002026]; GOULD SJ, 1981, MISMEASURE MAN; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gramsci Antonio, 2011, PRISON NOTEBOOKS, V1; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Kane EW, 2001, GENDER SOC, V15, P710, DOI 10.1177/089124301015005005; Kraus MW, 2013, J PERS SOC PSYCHOL, V105, P247, DOI 10.1037/a0032895; Kraus MW, 2012, SOC PERSONAL PSYCHOL, V6, P642, DOI 10.1111/j.1751-9004.2012.00453.x; Kraus MW, 2013, PSYCHOL INQ, V24, P81, DOI 10.1080/1047840X.2013.778803; Kraus MW, 2012, PSYCHOL REV, V119, P546, DOI 10.1037/a0028756; Kraus MW, 2009, J PERS SOC PSYCHOL, V97, P992, DOI 10.1037/a0016357; MESSICK DM, 1979, J EXP SOC PSYCHOL, V15, P418, DOI 10.1016/0022-1031(79)90047-7; Moody J., 2013, NETW SCI, V1, P119, DOI DOI 10.1017/NWS.2012.3; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; Norton MI, 2011, PERSPECT PSYCHOL SCI, V6, P9, DOI 10.1177/1745691610393524; O'Brien LT, 2005, PERS SOC PSYCHOL B, V31, P1718, DOI 10.1177/0146167205278261; Parker CP, 1997, J APPL PSYCHOL, V82, P376, DOI 10.1037/0021-9010.82.3.376; Phillips, 2002, WEALTH DEMOCRACY POL; Ridgeway CL, 1993, GENDER STATUS SOCIAL; Sidanius J., 2001, SOCIAL DOMINANCE INT; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stephens NM, 2012, PSYCHOL REV, V119, P723, DOI 10.1037/a0029028; STRAKA G, 1962, ENGL HIST REV, V77, P638; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC	40	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85293	10.1371/journal.pone.0085293	http://dx.doi.org/10.1371/journal.pone.0085293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465526	Green Published, gold			2022-12-27	WOS:000330244500050
J	Rektorova, I; Biundo, R; Marecek, R; Weis, L; Aarsland, D; Antonini, A				Rektorova, Irena; Biundo, Roberta; Marecek, Radek; Weis, Luca; Aarsland, Dag; Antonini, Angelo			Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; ITALIAN POPULATION-SAMPLE; SOURCE-BASED MORPHOMETRY; DEFAULT MODE NETWORK; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; NORMATIVE VALUES; CEREBRAL ATROPHY; LEWY BODIES; DEMENTIA	Background: Cortical changes associated with cognitive decline in Parkinson's disease (PD) are not fully explored and require investigations with established diagnostic classification criteria. Objective: We used MRI source-based morphometry to evaluate specific differences in grey matter volume patterns across 4 groups of subjects: healthy controls (HC), PD with normal cognition (PD-NC), PD with mild cognitive impairment (MCI-PD) and PD with dementia (PDD). Methods: We examined 151 consecutive subjects: 25 HC, 75 PD-NC, 29 MCI-PD, and 22 PDD at an Italian and Czech movement disorder centre. Operational diagnostic criteria were applied to classify MCI-PD and PDD. All structural MRI images were processed together in the Czech centre. The spatial independent component analysis was used to assess group differences of local grey matter volume. Results: We identified two independent patterns of grey matter volume deviations: a) Reductions in the hippocampus and temporal lobes; b) Decreases in fronto-parietal regions and increases in the midbrain/cerebellum. Both patterns differentiated PDD from all other groups and correlated with visuospatial deficits and letter verbal fluency, respectively. Only the second pattern additionally differentiated PD-NC from HC. Conclusion: Grey matter changes in PDD involve areas associated with Alzheimer-like pathology while fronto-parietal abnormalities are possibly an early marker of PD cognitive decline. These findings are consistent with a non-linear cognitive progression in PD.	[Rektorova, Irena; Marecek, Radek] Masaryk Univ, Cent European Inst Technol, Brain & Mind Res Program, Brno, Czech Republic; [Rektorova, Irena; Marecek, Radek] Masaryk Univ, Sch Med, Dept Neurol 1, Brno, Czech Republic; [Rektorova, Irena; Marecek, Radek] St Annes Univ Hosp, Brno, Czech Republic; [Biundo, Roberta; Weis, Luca; Antonini, Angelo] Fdn Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Ctr Parkinsons Dis & Movement Disorder, Venice, Italy; [Aarsland, Dag] Karolinska Inst, Dept Neurol & Clin Neurosci, Stockholm, Sweden; [Aarsland, Dag] Karolinska Univ Hosp, Stockholm, Sweden; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Dis, Stavanger, Norway	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); IRCCS Ospedale San Camillo; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stavanger University Hospital	Rektorova, I (corresponding author), Masaryk Univ, Cent European Inst Technol, Brain & Mind Res Program, Brno, Czech Republic.	irena.rektorova@fnusa.cz	Weis, Luca/J-2805-2018; Marecek, Radek/AAM-4984-2020; Antonini, Angelo/H-9726-2019; Rektorova, Irena/H-4665-2014	Weis, Luca/0000-0002-2286-0795; Antonini, Angelo/0000-0003-1040-2807; Marecek, Radek/0000-0001-8399-3455; Biundo, Roberta/0000-0001-5846-755X; Aarsland, Dag/0000-0001-6314-216X; Rektorova, Irena/0000-0002-5455-4573	project 'Central European Institute of Technology' European Regional Development Fund [CZ.1.05/1.1.00/02.0068];  [N RF-2009-1530177]	project 'Central European Institute of Technology' European Regional Development Fund; 	The study was supported by the project 'Central European Institute of Technology' (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund and by the Italian Research Grant N RF-2009-1530177. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Apostolova L, 2012, NEUROBIOL AGING, V33, P2113, DOI 10.1016/j.neurobiolaging.2011.06.014; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Aron AR, 2012, MOVEMENT DISORD, V27, P339, DOI 10.1002/mds.24936; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Biundo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064222; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Caffarra P., 2002, NUOVA RIV NEUROL, V12, P111; Cerasa A, 2011, MOVEMENT DISORD, V26, P807, DOI 10.1002/mds.23660; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dalaker TO, 2010, MOVEMENT DISORD, V25, P629, DOI 10.1002/mds.22867; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Friston KJ, 2004, NEUROIMAGE, V23, P21, DOI 10.1016/j.neuroimage.2004.04.021; Garrard P, 2002, J NEUROL NEUROSUR PS, V73, P191, DOI 10.1136/jnnp.73.2.191; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Huang C, 2008, NEUROLOGY, V70, P1470, DOI 10.1212/01.wnl.0000304050.05332.9c; Hummelova-Fanfrdlova Z, 2009, CESK PSYCHOL, V53, P376; Ibarretxe-Bilbao N, 2009, MOVEMENT DISORD, V24, pS748, DOI 10.1002/mds.22670; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jech R, 2013, BRAIN, V136, DOI 10.1093/brain/awt015; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Kasparek T, 2010, HUM BRAIN MAPP, V31, P300, DOI 10.1002/hbm.20865; Kaszas B, 2012, PARKINSONISM RELAT D, V18, P553, DOI 10.1016/j.parkreldis.2012.02.010; Krajcovicova L, 2012, J NEURAL TRANSM, V119, P443, DOI 10.1007/s00702-011-0723-5; Leh SE, 2010, NEUROPSYCHOPHARMACOL, V35, P70, DOI 10.1038/npp.2009.88; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McColgan P, 2012, MOVEMENT DISORD, V27, P1172, DOI 10.1002/mds.25084; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Pereira JB, 2009, MOVEMENT DISORD, V24, P1193, DOI 10.1002/mds.22560; Poletti M, 2011, PARKINSONISM RELAT D, V17, P579, DOI 10.1016/j.parkreldis.2011.03.013; Rektorova I, 2012, NEURODEGENER DIS, V10, P232, DOI 10.1159/000334765; Reyes MA, 2009, EUR J NEUROL, V16, P142, DOI 10.1111/j.1468-1331.2008.02384.x; Rittman T, 2013, J NEUROL NEUROSUR PS, V84, P544, DOI 10.1136/jnnp-2012-303618; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; SPINNLER H, 1987, ITAL J NEUROL SCI S8, V6, P1; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Tam CWC, 2005, NEUROLOGY, V64, P861, DOI 10.1212/01.WNL.0000153070.82309.D4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; WARD CD, 1990, ADV NEUROL, V53, P245; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	56	58	59	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85595	10.1371/journal.pone.0085595	http://dx.doi.org/10.1371/journal.pone.0085595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465612	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500080
J	San Martin, A; Ceballo, S; Baeza-Lehnert, F; Lerchundi, R; Valdebenito, R; Contreras-Baeza, Y; Alegria, K; Barros, LF				San Martin, Alejandro; Ceballo, Sebastian; Baeza-Lehnert, Felipe; Lerchundi, Rodrigo; Valdebenito, Rocio; Contreras-Baeza, Yasna; Alegria, Karin; Felipe Barros, L.			Imaging Mitochondrial Flux in Single Cells with a FRET Sensor for Pyruvate	PLOS ONE			English	Article							IN-VIVO; GLYCOLYSIS; TRANSPORT; CARRIER; STIMULATION; ASTROCYTES; CALCIUM; LACTATE; CITRATE; MUSCLE	Mitochondrial flux is currently accessible at low resolution. Here we introduce a genetically-encoded FRET sensor for pyruvate, and methods for quantitative measurement of pyruvate transport, pyruvate production and mitochondrial pyruvate consumption in intact individual cells at high temporal resolution. In HEK293 cells, neurons and astrocytes, mitochondrial pyruvate uptake was saturated at physiological levels, showing that the metabolic rate is determined by intrinsic properties of the organelle and not by substrate availability. The potential of the sensor was further demonstrated in neurons, where mitochondrial flux was found to rise by 300% within seconds of a calcium transient triggered by a short theta burst, while glucose levels remained unaltered. In contrast, astrocytic mitochondria were insensitive to a similar calcium transient elicited by extracellular ATP. We expect the improved resolution provided by the pyruvate sensor will be of practical interest for basic and applied researchers interested in mitochondrial function.	[San Martin, Alejandro; Ceballo, Sebastian; Baeza-Lehnert, Felipe; Lerchundi, Rodrigo; Valdebenito, Rocio; Contreras-Baeza, Yasna; Alegria, Karin; Felipe Barros, L.] Ctr Estudios Cient, Valdivia, Chile; [San Martin, Alejandro; Lerchundi, Rodrigo; Contreras-Baeza, Yasna] Univ Austral Chile, Valdivia, Chile	Universidad Austral de Chile	Barros, LF (corresponding author), Ctr Estudios Cient, Valdivia, Chile.	fbarros@cecs.cl	Ceballo, Sebastian/B-2372-2016; Ceballo, Sebastian/M-2902-2019	Ceballo, Sebastian/0000-0001-7710-421X; San Martin, Alejandro/0000-0002-5608-5117	CONICYT-Chile; Deutsche Forschungsgemeinschaft [DFG-12, DE 231/25-1]; Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	This work was partly funded by a joint grant from CONICYT-Chile and the Deutsche Forschungsgemeinschaft to L. Felipe Barros and Joachim W. Deitmer (DFG-12, DE 231/25-1). The Centro de Estudios Cientificos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bittner CX, 2010, FRONT NEUROENERGETIC, V2, P1, DOI [10.3389/fnene.2010.00026, DOI 10.3389/FNENE.2010.00026]; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brennan AM, 2006, J CEREBR BLOOD F MET, V26, P1389, DOI 10.1038/sj.jcbfm.9600292; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brix B, 2012, J NEUROSCI, V32, P9727, DOI 10.1523/JNEUROSCI.0879-12.2012; Cerdan S, 2006, NEUROCHEM INT, V48, P523, DOI 10.1016/j.neuint.2005.12.036; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gellerich FN, 2013, IUBMB LIFE, V65, P180, DOI 10.1002/iub.1131; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; KAUPPINEN RA, 1982, BIOCHIM BIOPHYS ACTA, V681, P286, DOI 10.1016/0005-2728(82)90033-0; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; PANDE SV, 1978, J BIOL CHEM, V253, P1565; PARADIES G, 1983, CANCER RES, V43, P5068; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; QUAIL MA, 1995, MOL MICROBIOL, V15, P519, DOI 10.1111/j.1365-2958.1995.tb02265.x; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Xu P, 2008, J BIOSCI BIOENG, V105, P169, DOI 10.1263/jbb.105.169; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	36	107	112	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85780	10.1371/journal.pone.0085780	http://dx.doi.org/10.1371/journal.pone.0085780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465702	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500111
J	Song, YJC; Korgaonkar, MS; Armstrong, LV; Eagles, S; Williams, LM; Grieve, SM				Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Armstrong, Lucy V.; Eagles, Sarah; Williams, Leanne M.; Grieve, Stuart M.			Tractography of the Brainstem in Major Depressive Disorder Using Diffusion Tensor Imaging	PLOS ONE			English	Article							VAGUS NERVE-STIMULATION; PREDICT OPTIMIZED TREATMENT; CONNECTIVITY; AMYGDALA; NUCLEUS; STRESS; ACTIVATION; MECHANISMS; PROTOCOL; NEURONS	Background: The brainstem is the main region that innervates neurotransmitter release to the Hypothalamic-Pituitary Adrenal (HPA) axis and fronto-limbic circuits, two key brain circuits found to be dysfunctional in Major Depressive Disorder (MDD). However, the brainstem's role in MDD has only been evaluated in limited reports. Using Diffusion Tensor Imaging (DTI), we investigated whether major brainstem white matter tracts that relate to these two circuits differ in MDD patients compared to healthy controls. Methods: MDD patients (n = 95) and age-and gender-matched controls (n = 34) were assessed using probabilistic tractography of DTI to delineate three distinct brainstem tracts: the nigrostriatal tract (connecting brainstem to striatum), solitary tract (connecting brainstem to amygdala) and corticospinal tract (connecting brainstem to precentral cortex). Fractional anisotropy (FA) was used to measure the white matter integrity of these tracts, and measures were compared between MDD and control participants. Results: MDD participants were characterized by a significant and specific decrease in white matter integrity of the right solitary tract (p<0.009 using independent t-test), which is a "bottom up'' afferent pathway that connects the brainstem to the amygdala. This decrease was not related to symptom severity. Conclusions: The results provide new evidence to suggest that structural connectivity between the brainstem and the amygdala is altered in MDD. These results are interesting in light of predominant theories regarding amygdala-mediated emotional reactivity observed in functional imaging studies of MDD. The characterization of altered white matter integrity in the solitary tract in MDD supports the possibility of dysfunctional brainstem-amygdala connectivity impacting vulnerable circuits in MDD.	[Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Armstrong, Lucy V.; Eagles, Sarah; Williams, Leanne M.; Grieve, Stuart M.] Univ Sydney, Sydney Med Sch, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Armstrong, Lucy V.; Eagles, Sarah; Williams, Leanne M.; Grieve, Stuart M.] Westmead Millennium Inst, Sydney, NSW, Australia; [Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Williams, Leanne M.] Univ Sydney, Westmead Hosp, Sydney Med Sch, Discipline Psychiat, Sydney, NSW 2006, Australia; [Williams, Leanne M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Stanford University	Grieve, SM (corresponding author), Univ Sydney, Sydney Med Sch, Brain Dynam Ctr, Sydney, NSW 2006, Australia.	sgrieve@med.usyd.edu.au	Williams, Leanne/GLU-4975-2022; Williams, Leanne M/B-4095-2012; Korgaonkar, Mayuresh/K-7447-2014; Grieve, Stuart/A-5093-2012	Williams, Leanne/0000-0001-9987-7360; Korgaonkar, Mayuresh/0000-0002-1339-2221; Grieve, Stuart/0000-0002-2712-157X	Brain Resource Company Operations Pty Ltd.	Brain Resource Company Operations Pty Ltd.	This study was sponsored by the Brain Resource Company Operations Pty Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Aihara M, 2007, PSYCHIAT RES-NEUROIM, V155, P245, DOI 10.1016/j.pscychresns.2006.11.002; Arnold JF, 2012, PSYCHIAT RES-NEUROIM, V204, P40, DOI 10.1016/j.pscychresns.2012.07.010; Barnes A, 2003, EUR J NUCL MED MOL I, V30, P301, DOI 10.1007/s00259-002-1026-8; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berry SM, 2013, MED DEVICES-EVID RES, V6, P17, DOI 10.2147/MDER.S41017; Blier P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0536; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Commons KG, 2003, NEUROPSYCHOPHARMACOL, V28, P206, DOI 10.1038/sj.npp.1300045; Curtis AL, 2002, J NEUROENDOCRINOL, V14, P667, DOI 10.1046/j.1365-2826.2002.00821.x; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; GRAY TS, 1993, ANN NY ACAD SCI, V697, P53, DOI 10.1111/j.1749-6632.1993.tb49922.x; Grieve SM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-224; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Korgaonkar MS, 2012, NEUROREPORT, V23, P566, DOI 10.1097/WNR.0b013e3283546264; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Krahl SE, 1998, EPILEPSIA, V39, P709, DOI 10.1111/j.1528-1157.1998.tb01155.x; Lee HY, 2011, J AFFECT DISORDERS, V133, P128, DOI 10.1016/j.jad.2011.04.006; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nemeroff CB, 2006, NEUROPSYCHOPHARMACOL, V31, P1345, DOI 10.1038/sj.npp.1301082; Schutter DJLG, 2012, MED HYPOTHESES, V79, P779, DOI 10.1016/j.mehy.2012.08.027; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHAH SA, 1992, ACTA PSYCHIAT SCAND, V85, P474, DOI 10.1111/j.1600-0447.1992.tb03214.x; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Sperling W, 2010, PHARMACOPSYCHIATRY, V43, P7, DOI 10.1055/s-0029-1237374; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Wang JJ, 2001, ANN NY ACAD SCI, V940, P237; Watson S., 2006, PSYCHIATRY, V5, P166, DOI [DOI 10.1383/PSYT.2006.5.5.166, 10.1383/psyt.2006.5.5.166]; Williams LM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-4; Zobel A, 2005, PSYCHIAT RES-NEUROIM, V139, P165, DOI 10.1016/j.pscychresns.2005.02.010	36	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84825	10.1371/journal.pone.0084825	http://dx.doi.org/10.1371/journal.pone.0084825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465436	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500016
J	Vera, J; Pezzoli, M; Pereira, U; Bacigalupo, J; Sanhueza, M				Vera, Jorge; Pezzoli, Maurizio; Pereira, Ulises; Bacigalupo, Juan; Sanhueza, Magdalena			Electrical Resonance in the theta Frequency Range in Olfactory Amygdala Neurons	PLOS ONE			English	Article							CORTEX LAYER-II; MEDIAL ENTORHINAL CORTEX; STELLATE CELLS; SUBTHRESHOLD OSCILLATIONS; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; IN-VITRO; IONIC MECHANISMS; ELECTROPHYSIOLOGICAL PROPERTIES; INTRINSIC OSCILLATIONS	The cortical amygdala receives direct olfactory inputs and is thought to participate in processing and learning of biologically relevant olfactory cues. As for other brain structures implicated in learning, the principal neurons of the anterior cortical nucleus (ACo) exhibit intrinsic subthreshold membrane potential oscillations in the theta-frequency range. Here we show that nearly 50% of ACo layer II neurons also display electrical resonance, consisting of selective responsiveness to stimuli of a preferential frequency (2-6 Hz). Their impedance profile resembles an electrical band-pass filter with a peak at the preferred frequency, in contrast to the low-pass filter properties of other neurons. Most ACo resonant neurons displayed frequency preference along the whole subthreshold voltage range. We used pharmacological tools to identify the voltage-dependent conductances implicated in resonance. A hyperpolarization-activated cationic current depending on HCN channels underlies resonance at resting and hyperpolarized potentials; notably, this current also participates in resonance at depolarized subthreshold voltages. KV7/KCNQ K+ channels also contribute to resonant behavior at depolarized potentials, but not in all resonant cells. Moreover, resonance was strongly attenuated after blockade of voltage-dependent persistent Na+ channels, suggesting an amplifying role. Remarkably, resonant neurons presented a higher firing probability for stimuli of the preferred frequency. To fully understand the mechanisms underlying resonance in these neurons, we developed a comprehensive conductance-based model including the aforementioned and leak conductances, as well as Hodgkin and Huxley-type channels. The model reproduces the resonant impedance profile and our pharmacological results, allowing a quantitative evaluation of the contribution of each conductance to resonance. It also replicates selective spiking at the resonant frequency and allows a prediction of the temperature-dependent shift in resonance frequency. Our results provide a complete characterization of the resonant behavior of olfactory amygdala neurons and shed light on a putative mechanism for network activity coordination in the intact brain.	[Vera, Jorge; Pezzoli, Maurizio; Pereira, Ulises; Bacigalupo, Juan; Sanhueza, Magdalena] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile	Universidad de Chile	Sanhueza, M (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	masanhue@uchile.cl	Vera, Jorge/HDO-5376-2022	Pezzoli, Maurizio/0000-0002-5763-3031	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN [ICM-P05-001-F]; Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1080630, 1100682]; Consejo Nacional de Ciencia y Tecnologia (CONICYT)	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN; Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Ciencia y Tecnologia (CONICYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Supported by Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN ICM-P05-001-F (JB, MS), Fondo Nacional de Ciencia y Tecnologia (FONDECYT) 1080630 (MS), 1100682 (JB), Doctoral Fellowship and Thesis grant by the Consejo Nacional de Ciencia y Tecnologia (CONICYT) (JV, MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Boehlen A, 2013, J NEUROPHYSIOL, V109, P445, DOI 10.1152/jn.00743.2011; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; Burton BG, 2008, J NEUROPHYSIOL, V100, P3144, DOI 10.1152/jn.90424.2008; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Carnevale NT, 2006, NEURON BOOK; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Ehrlich DE, 2012, J PHYSIOL-LONDON, V590, P4819, DOI 10.1113/jphysiol.2012.237453; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; Gire DH, 2013, NAT NEUROSCI, V16, P991, DOI 10.1038/nn.3432; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Kajiwara R, 2007, EUR J NEUROSCI, V25, P3648, DOI 10.1111/j.1460-9568.2007.05610.x; Kalimullina L B, 2004, Neurosci Behav Physiol, V34, P551, DOI 10.1023/B:NEAB.0000028283.55130.69; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOCH C, 1984, BIOL CYBERN, V50, P15, DOI 10.1007/BF00317936; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Magee JC, 1998, J NEUROSCI, V18, P7613; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pare D, 2000, J NEUROSCI, V20, P2701; Paxinos G, 1999, CHEMOARCHITECTONIC A; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; PUIL E, 1987, J NEUROPHYSIOL, V58, P66, DOI 10.1152/jn.1987.58.1.66; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sanhueza M, 2005, EUR J NEUROSCI, V22, P1618, DOI 10.1111/j.1460-9568.2005.04341.x; Sevelinges Y, 2004, LEARN MEMORY, V11, P761, DOI 10.1101/lm.83604; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; SPAIN WJ, 1987, J NEUROPHYSIOL, V57, P1555, DOI 10.1152/jn.1987.57.5.1555; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang WT, 2006, NEUROSCIENCE, V140, P45, DOI 10.1016/j.neuroscience.2006.01.033; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577	70	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85826	10.1371/journal.pone.0085826	http://dx.doi.org/10.1371/journal.pone.0085826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465729	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500121
J	Collemare, J; Griffiths, S; Iida, Y; Jashni, MK; Battaglia, E; Cox, RJ; de Wit, PJGM				Collemare, Jerome; Griffiths, Scott; Iida, Yuichiro; Jashni, Mansoor Karimi; Battaglia, Evy; Cox, Russell J.; de Wit, Pierre J. G. M.			Secondary Metabolism and Biotrophic Lifestyle in the Tomato Pathogen Cladosporium fulvum	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; SYNTHASE-ENCODING GENES; POLYKETIDE SYNTHASE; ELSINOCHROME PHYTOTOXIN; PHYLOGENOMIC ANALYSIS; MAGNAPORTHE-GRISEA; PKS-NRPS; BIOSYNTHESIS; FERRICHROME; VIRULENCE	Cladosporium fulvum is a biotrophic fungal pathogen that causes leaf mould of tomato. Analysis of its genome suggested a high potential for production of secondary metabolites (SM), which might be harmful to plants and animals. Here, we have analysed in detail the predicted SM gene clusters of C. fulvum employing phylogenetic and comparative genomic approaches. Expression of the SM core genes was measured by RT-qrtPCR and produced SMs were determined by LC-MS and NMR analyses. The genome of C. fulvum contains six gene clusters that are conserved in other fungal species, which have undergone rearrangements and gene losses associated with the presence of transposable elements. Although being a biotroph, C. fulvum has the potential to produce elsinochrome and cercosporin toxins. However, the corresponding core genes are not expressed during infection of tomato. Only two core genes, PKS6 and NPS9, show high expression in planta, but both are significantly down regulated during colonization of the mesophyll tissue. In vitro SM profiling detected only one major compound that was identified as cladofulvin. PKS6 is likely involved in the production of this pigment because it is the only core gene significantly expressed under these conditions. Cladofulvin does not cause necrosis on Solanaceae plants and does not show any antimicrobial activity. In contrast to other biotrophic fungi that have a reduced SM production capacity, our studies on C. fulvum suggest that down-regulation of SM biosynthetic pathways might represent another mechanism associated with a biotrophic lifestyle.	[Collemare, Jerome; Griffiths, Scott; Iida, Yuichiro; Jashni, Mansoor Karimi; Battaglia, Evy; de Wit, Pierre J. G. M.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Collemare, Jerome; de Wit, Pierre J. G. M.] Ctr Biosyst Genom, Wageningen, Netherlands; [Iida, Yuichiro] Natl Inst Vegetable & Tea Sci, Tsu, Mie, Japan; [Jashni, Mansoor Karimi] Tarbiat Modares Univ, Dept Plant Pathol, Tehran, Iran; [Cox, Russell J.] Univ Bristol, Sch Chem, Bristol, Avon, England	Wageningen University & Research; Centre for BioSystems Genomics; National Agriculture & Food Research Organization - Japan; Tarbiat Modares University; University of Bristol	Collemare, J (corresponding author), Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands.	jerome.collemare@wur.nl	de Wit, Pierre J. G.M./CAI-9966-2022; Cox, Russell John/F-9190-2015; Jashni, Mansoor/AAI-8218-2021; de Wit, Pierre/A-1998-2013; Jashni, Mansoor/AHB-5808-2022	Cox, Russell John/0000-0002-1844-0157; de Wit, Pierre/0000-0002-4208-288X; Collemare, Jerome/0000-0001-8152-6642; Karimi-Jashni, Mansoor/0000-0001-8464-6500	Wageningen University	Wageningen University(European Commission)	Funding from Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Baker SE, 2012, MICROBIOL-SGM, V158, P147, DOI 10.1099/mic.0.053462-0; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; Bradshaw RE, 2013, NEW PHYTOL, V198, P525, DOI 10.1111/nph.12161; Brown DW, 2012, FUNGAL BIOL-UK, V116, P318, DOI 10.1016/j.funbio.2011.12.005; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chettri P, 2013, FUNGAL GENET BIOL, V51, P12, DOI 10.1016/j.fgb.2012.11.006; Chiang YM, 2011, FUNGAL GENET BIOL, V48, P430, DOI 10.1016/j.fgb.2010.12.001; Chiang YM, 2010, APPL ENVIRON MICROB, V76, P2067, DOI 10.1128/AEM.02187-09; Choquer M, 2005, MOL PLANT MICROBE IN, V18, P468, DOI 10.1094/MPMI-18-0468; Chung KR, 2008, MICROBIOL-SGM, V154, P3556, DOI 10.1099/mic.0.2008/019414-0; Collemare J, 2012, EFFECTORS PLANT MICR, P377; Collemare J, 2008, MYCOL RES, V112, P207, DOI 10.1016/j.mycres.2007.08.003; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Dalmais B, 2011, MOL PLANT PATHOL, V12, P564, DOI [10.1111/j.1364-3703.2010.00692.x, 10.1111/J.1364-3703.2010.00692.X]; DAVIES DG, 1974, J CHEM SOC PERK T 1, P2403, DOI 10.1039/p19740002403; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Henrikson JC, 2009, ORG BIOMOL CHEM, V7, P435, DOI 10.1039/b819208a; Hof C, 2007, MOL PLANT PATHOL, V8, P163, DOI 10.1111/j.1364-3703.2007.00380.x; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Liao HL, 2008, MOL PLANT MICROBE IN, V21, P469, DOI 10.1094/MPMI-21-4-0469; Lim FY, 2012, APPL ENVIRON MICROB, V78, P6395, DOI 10.1128/AEM.01926-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Munawar A, 2013, CHEMBIOCHEM, V14, P388, DOI 10.1002/cbic.201200587; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Sambrook J., 2001, MOL CLONING LAB MANU; Schwecke T, 2006, CHEMBIOCHEM, V7, P612, DOI 10.1002/cbic.200500301; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; Tokuoka M, 2008, FUNGAL GENET BIOL, V45, P1608, DOI 10.1016/j.fgb.2008.09.006; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Westerink N, 2004, MOL MICROBIOL, V54, P533, DOI 10.1111/j.1365-2958.2004.04288.x; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556; Yuan WM, 2001, J BACTERIOL, V183, P4040, DOI 10.1128/JB.183.13.4040-4051.2001	55	45	53	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85877	10.1371/journal.pone.0085877	http://dx.doi.org/10.1371/journal.pone.0085877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465762	Green Submitted, gold, Green Published			2022-12-27	WOS:000330237000070
J	Noonan, MJ; Markham, A; Newman, C; Trigoni, N; Buesching, CD; Ellwood, SA; Macdonald, DW				Noonan, Michael J.; Markham, Andrew; Newman, Chris; Trigoni, Niki; Buesching, Christina D.; Ellwood, Stephen A.; Macdonald, David W.			Climate and the Individual: Inter-Annual Variation in the Autumnal Activity of the European Badger (Meles meles)	PLOS ONE			English	Article							FOOD AVAILABILITY; BODY-MASS; SPATIAL-ORGANIZATION; REPRODUCTIVE SUCCESS; POPULATION-DYNAMICS; LIFE-HISTORIES; ACCELERATION; BEHAVIOR; DENSITY; PATTERNS	We establish intra-individual and inter-annual variability in European badger (Meles meles) autumnal nightly activity in relation to fine-scale climatic variables, using tri-axial accelerometry. This contributes further to understanding of causality in the established interaction between weather conditions and population dynamics in this species. Modelling found that measures of daylight, rain/humidity, and soil temperature were the most supported predictors of ACTIVITY, in both years studied. In 2010, the drier year, the most supported model included the SOLAR*RH interaction, RAIN, and30cmTEMP (w=0.557), while in 2012, a wetter year, the most supported model included the SOLAR*RH interaction, and the RAIN*10cmTEMP (w=0.999). ACTIVITY also differed significantly between individuals. In the 2012 autumn study period, badgers with the longest per noctem activity subsequently exhibited higher Body Condition Indices (BCI) when recaptured. In contrast, under drier 2010 conditions, badgers in good BCI engaged in less per noctem activity, while badgers with poor BCI were the most active. When compared on the same calendar dates, to control for night length, duration of mean badger nightly activity was longer (9.5 hrs 63.3 SE) in 2010 than in 2012 (8.3 hrs 61.9 SE). In the wetter year, increasing nightly activity was associated with net-positive energetic gains (from BCI), likely due to better foraging conditions. In a drier year, with greater potential for net-negative energy returns, individual nutritional state proved crucial in modifying activity regimes; thus we emphasise how a 'one size fits all' approach should not be applied to ecological responses.	[Noonan, Michael J.; Newman, Chris; Buesching, Christina D.; Ellwood, Stephen A.; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Tubney, Oxon, England; [Markham, Andrew; Trigoni, Niki] Univ Oxford, Dept Comp Sci, Tubney, Oxon, England	University of Oxford; University of Oxford	Macdonald, DW (corresponding author), Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Tubney House, Tubney, Oxon, England.	david.macdonald@zoo.ox.ac.uk	Noonan, Michael J/H-9613-2019	Markham, Andrew/0000-0001-5716-3941; Trigoni, Niki/0000-0001-6236-9645	Peoples Trust for Endangered Species; Rhodes Trust; NSERC; EPSRC C-DIP postdoctoral fellowship [3D EP/I026959/1]; EPSRC [EP/E013678/1, EP/I026959/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E013678/1, EP/I026959/1] Funding Source: researchfish	Peoples Trust for Endangered Species; Rhodes Trust; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); EPSRC C-DIP postdoctoral fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Peoples Trust for Endangered Species generously supported much of this core study. MJN is supported by the Rhodes Trust and an NSERC postgraduate scholarship. ACM is supported by an EPSRC C-DIP postdoctoral fellowship (EPSRC Undertracker: Underground Animal Tracking and Mapping in 3D EP/I026959/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 1987, SYM ZOOL SOC; Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; Barth JAC, 1999, CHEM GEOL, V159, P107, DOI 10.1016/S0009-2541(99)00036-4; Blank James L., 1992, P186; BOYCE MS, 1979, AM NAT, V114, P569, DOI 10.1086/283503; BOYLE K, 1990, Irish Naturalists' Journal, V23, P199; Buesching CD, 2003, BEHAVIOUR, V140, P965, DOI 10.1163/156853903322589597; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Byrne AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050807; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; CASWELL H, 1982, ECOLOGY, V63, P1218, DOI 10.2307/1938846; Catalan J, 2002, J PALEOLIMNOL, V28, P125; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; DASILVA J, 1993, OECOLOGIA, V95, P558, DOI 10.1007/BF00317441; Do Linh San E, 2007, CAN J ZOOL, V85, P973, DOI 10.1139/Z07-085; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; Dyo V., 2010, P 8 ACM C EMBEDDED N, P127, DOI DOI 10.1145/1869983.1869997; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ellwood Stephen A., 2006, P105; Ferguson SH, 2004, J ZOOL, V262, P125, DOI 10.1017/S0952836903004552; Fero O, 2008, ECOL APPL, V18, P1563, DOI 10.1890/07-1012.1; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; FOWLER PA, 1988, J ZOOL, V214, P635, DOI 10.1111/j.1469-7998.1988.tb03763.x; GAEDKE U, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P163; Giroud Sylvain, 2012, P481; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Goransson G, 1983, ACTA ZOOL FENN, V174, P179; Goszczynski J, 2000, J ZOOL, V250, P495, DOI 10.1111/j.1469-7998.2000.tb00792.x; Greco S, 1996, GLOBAL CHANGE BIOL, V2, P183, DOI 10.1111/j.1365-2486.1996.tb00071.x; HARLOW HJ, 1981, PHYSIOL ZOOL, V54, P267, DOI 10.1086/physzool.54.3.30159941; Hays GC, 2007, J ANIM ECOL, V76, P183, DOI 10.1111/j.1365-2656.2006.01181.x; HOFER H, 1988, MAMMAL REV, V18, P25, DOI 10.1111/j.1365-2907.1988.tb00068.x; Holmstrup M, 1996, COMP BIOCHEM PHYS A, V115, P91, DOI 10.1016/0300-9629(96)00010-2; Huxman TE, 2003, OECOLOGIA, V134, P537, DOI 10.1007/s00442-002-1131-1; Ishii HT, 2004, FOREST SCI, V50, P342; Johnson DDP, 2002, J BIOGEOGR, V29, P411, DOI 10.1046/j.1365-2699.2002.00680.x; Johnson DDP, 2001, BMC ECOL, V2, P1, DOI DOI 10.1186/1472-6785-1-2; Kaneko Yayoi, 2010, International Journal of Ecology, V2010, P1; Kilshaw K, 2009, J MAMMAL, V90, P1188, DOI 10.1644/08-MAMM-A-200.1; KIMMEL E, 1991, J AGR ENG RES, V49, P227, DOI 10.1016/0021-8634(91)80041-C; King D, 2005, J APPL ECOL, V42, P779, DOI 10.1111/j.1365-2664.2005.01089.x; Kowalczyk R, 2004, ACTA THERIOL, V49, P75, DOI 10.1007/BF03192510; Kowalczyk R, 2003, J BIOGEOGR, V30, P463, DOI 10.1046/j.1365-2699.2003.00804.x; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; KRUUK H, 1985, J APPL ECOL, V22, P705, DOI 10.2307/2403223; Kruuk H., 1989, SOCIAL BADGER; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Lenart EA, 2002, CAN J ZOOL, V80, P664, DOI 10.1139/Z02-034; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Macdonald D.W., 1983, P393; Macdonald DW, 2010, GLOBAL CHANGE BIOL, V16, P2913, DOI 10.1111/j.1365-2486.2010.02208.x; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; MACDONALD DW, 1976, Z TIERPSYCHOL, V42, P170; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Macdonald DW, 2002, ECOLOGY, V83, P2056, DOI 10.2307/3071787; Markham A, 2012, IEEE SENS J, V12, P1809, DOI 10.1109/JSEN.2011.2178064; MAY RM, 1986, PROC R SOC SER B-BIO, V228, P241, DOI 10.1098/rspb.1986.0054; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; McLaren GW, 2005, VET ANAESTH ANALG, V32, P48, DOI 10.1111/j.1467-2995.2004.00182.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Muldowney J, 2003, PEDOBIOLOGIA, V47, P913, DOI 10.1016/S0031-4056(04)70289-9; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Newman C, 2013, TERRESTRIAL BIODIVER; Newman C, 2011, MAMM STUDY, V36, P169, DOI 10.3106/041.036.0401; Nouvellet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068116; Nuutinen V, 2009, SOIL BIOL BIOCHEM, V41, P1580, DOI 10.1016/j.soilbio.2009.04.019; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; OWEN M, 1992, ORNIS SCAND, V23, P451, DOI 10.2307/3676676; Palphramand KL, 2007, BEHAV ECOL SOCIOBIOL, V61, P401, DOI 10.1007/s00265-006-0268-z; Post DM, 2006, FUNCT ECOL, V20, P717, DOI 10.1111/j.1365-2435.2006.01142.x; Post Eric, 1999, Ecological Bulletins, V47, P117; Revilla E, 2002, J ANIM ECOL, V71, P497, DOI 10.1046/j.1365-2656.2002.00617.x; Roff Derek, 2002, pi; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; SANDELL M, 1990, Q REV BIOL, V65, P23, DOI 10.1086/416583; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Stewart PD, 2001, J ZOOL, V255, P191, DOI 10.1017/S0952836901001261; Thornton PD, 2005, VET ANAESTH ANALG, V32, P40, DOI 10.1111/j.1467-2995.2004.00163.x; THORNTON PS, 1988, MAMMAL REV, V18, P11, DOI 10.1111/j.1365-2907.1988.tb00066.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tinkler E, 2009, J ZOOL, V278, P313, DOI 10.1111/j.1469-7998.2009.00578.x; Tuljapurkar S, 2010, J ANIM ECOL, V79, P1, DOI 10.1111/j.1365-2656.2009.01619.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; WEBB DR, 1984, J THERM BIOL, V9, P189, DOI 10.1016/0306-4565(84)90020-2; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; WOODROFFE R, 1995, J ZOOL, V236, P183, DOI 10.1111/j.1469-7998.1995.tb04486.x; WOODROFFE R, 1995, J ANIM ECOL, V64, P12, DOI 10.2307/5823; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yoda K, 1999, J EXP BIOL, V202, P3121	95	41	41	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83156	10.1371/journal.pone.0083156	http://dx.doi.org/10.1371/journal.pone.0083156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465376	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000005
J	Roy, AH; Rhea, LK; Mayer, AL; Shuster, WD; Beaulieu, JJ; Hopton, ME; Morrison, MA; St Amand, A				Roy, Allison H.; Rhea, Lee K.; Mayer, Audrey L.; Shuster, William D.; Beaulieu, Jake J.; Hopton, Matthew E.; Morrison, Matthew A.; St Amand, Ann			How Much Is Enough? Minimal Responses of Water Quality and Stream Biota to Partial Retrofit Stormwater Management in a Suburban Neighborhood	PLOS ONE			English	Article							IMPACT DEVELOPMENT PRACTICES; ENVIRONMENTAL IMPACTS; COMMUNITY STRUCTURE; RESTORATION; SYSTEMS; SCALE; BIORETENTION; ECOLOGY; RUNOFF; BACI	Decentralized stormwater management approaches (e. g., biofiltration swales, pervious pavement, green roofs, rain gardens) that capture, detain, infiltrate, and filter runoff are now commonly used to minimize the impacts of stormwater runoff from impervious surfaces on aquatic ecosystems. However, there is little research on the effectiveness of retrofit, parcel-scale stormwater management practices for improving downstream aquatic ecosystem health. A reverse auction was used to encourage homeowners to mitigate stormwater on their property within the suburban, 1.8 km(2) Shepherd Creek catchment in Cincinnati, Ohio (USA). In 2007-2008, 165 rain barrels and 81 rain gardens were installed on 30% of the properties in four experimental (treatment) subcatchments, and two additional subcatchments were maintained as controls. At the base of the subcatchments, we sampled monthly baseflow water quality, and seasonal (5x/year) physical habitat, periphyton assemblages, and macroinvertebrate assemblages in the streams for the three years before and after treatment implementation. Given the minor reductions in directly connected impervious area from the rain barrel installations (11.6% to 10.4% in the most impaired subcatchment) and high total impervious levels (13.1% to 19.9% in experimental subcatchments), we expected minor or no responses of water quality and biota to stormwater management. There were trends of increased conductivity, iron, and sulfate for control sites, but no such contemporaneous trends for experimental sites. The minor effects of treatment on streamflow volume and water quality did not translate into changes in biotic health, and the few periphyton and macroinvertebrate responses could be explained by factors not associated with the treatment (e.g., vegetation clearing, drought conditions). Improvement of overall stream health is unlikely without additional treatment of major impervious surfaces (including roads, apartment buildings, and parking lots). Further research is needed to define the minimum effect threshold and restoration trajectories for retrofitting catchments to improve the health of stream ecosystems.	[Roy, Allison H.] Univ Massachusetts, US Geol Survey, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Rhea, Lee K.; Shuster, William D.; Beaulieu, Jake J.; Hopton, Matthew E.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Mayer, Audrey L.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Mayer, Audrey L.] Michigan Technol Univ, Dept Social Sci, Houghton, MI 49931 USA; [Morrison, Matthew A.] SABIC, Mt Vernon, IN USA; [St Amand, Ann] PhycoTech Inc, St Joseph, MI USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Environmental Protection Agency; Michigan Technological University; Michigan Technological University	Roy, AH (corresponding author), Univ Massachusetts, US Geol Survey, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA.	aroy@eco.umass.edu	Hopton, Matthew E/E-4464-2018; Mayer, AL/AAO-3225-2020; Hopton, Matt/AAX-9079-2020	Hopton, Matthew E/0000-0001-7962-6820; Mayer, AL/0000-0003-3278-1182; Hopton, Matt/0000-0001-7962-6820; Shuster, William/0000-0001-7688-0110	U.S. Environmental Protection Agency (USEPA) through the Office of Research and Development (ORD); Pegasus Technical Services, Inc. under EPA [EP-C-05-056]; USEPA's ORD under the Scientific, Technical, Research, Engineering and Modeling Support (STREAMS) [EP-C-05-061]; USEPA's ORD through simplified acquisitions [3C-R312-TTSA, EP10C000111, EP05C00134]; Rhithron Associates, Inc. [EP07C000170, EP10C000110]	U.S. Environmental Protection Agency (USEPA) through the Office of Research and Development (ORD); Pegasus Technical Services, Inc. under EPA; USEPA's ORD under the Scientific, Technical, Research, Engineering and Modeling Support (STREAMS); USEPA's ORD through simplified acquisitions; Rhithron Associates, Inc.	The project was largely funded by the U.S. Environmental Protection Agency (USEPA) through the Office of Research and Development (ORD). Field sampling was conducted by USEPA employees and volunteers and supported in part by Pegasus Technical Services, Inc. under EPA Contract # EP-C-05-056. The auction, installation, and maintenance of rain gardens and rain barrels was funded by the USEPA's ORD under the Scientific, Technical, Research, Engineering and Modeling Support (STREAMS) contract EP-C-05-061, Task Order 8 to TetraTech, Inc. Biotic identification was funded by the USEPA's ORD through simplified acquisitions to PhycoTech, Inc. in 2003-2004 (3C-R312-TTSA) and 2007-2010 (EP10C000111), to EnviroScience, Inc. in 2005-06 (EP05C00134), and Rhithron Associates, Inc. in 2007-2010 (EP07C000170 and EP10C000110). As such, the funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahiablame LM, 2012, WATER AIR SOIL POLL, V223, P4253, DOI 10.1007/s11270-012-1189-2; Alig RJ, 2004, LANDSCAPE URBAN PLAN, V69, P219, DOI 10.1016/j.landurbplan.2003.07.004; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; American Society for Testing and Materials (ASTM), 1997, STAND TEST METH DET; Ando AW, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR011070; ARAR E. J, 1997, 4460 US EPA; Arnscheidt J, 2007, SCI TOTAL ENVIRON, V382, P1, DOI 10.1016/j.scitotenv.2007.03.036; Barbour MT, 1999, RAPID BIOASSESSMENT, V2nd; Beaulieu JJ, 2013, FRESHWATER BIOL, DOI [10.111/fwb12097, DOI 10.111/FWB12097]; Bedan ES, 2009, J AM WATER RESOUR AS, V45, P998, DOI 10.1111/j.1752-1688.2009.00342.x; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Bernhardt ES, 2007, FRESHWATER BIOL, V52, P738, DOI 10.1111/j.1365-2427.2006.01718.x; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; Bradley DC, 2001, J ANIM ECOL, V70, P987, DOI 10.1046/j.0021-8790.2001.00551.x; Burns MJ, 2012, LANDSCAPE URBAN PLAN, V105, P230, DOI 10.1016/j.landurbplan.2011.12.012; Clarke A, 2010, CAN J FISH AQUAT SCI, V67, P1649, DOI 10.1139/F10-087; Davis AP, 2009, J ENVIRON ENG, V135, P109, DOI 10.1061/(ASCE)0733-9372(2009)135:3(109); DENICOLA DM, 1992, J N AM BENTHOL SOC, V11, P391; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; FAITH DP, 1991, AUST J MAR FRESH RES, V42, P589; Fletcher TD, 2011, WATER SCI TECHNOL, V64, P494, DOI 10.2166/wst.2011.184; Gilroy KL, 2009, J HYDROL, V367, P228, DOI 10.1016/j.jhydrol.2009.01.008; Green R. H., 1979, Sampling design and statistical methods for environmental biologists.; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hamilton SK, 2012, FRESHWATER BIOL, V57, P43, DOI 10.1111/j.1365-2427.2011.02685.x; Hatt BE, 2009, J HYDROL, V365, P310, DOI 10.1016/j.jhydrol.2008.12.001; Hill BH, 2000, J N AM BENTHOL SOC, V19, P50, DOI 10.2307/1468281; Hunt WF, 2012, J ENVIRON ENG, V138, P698, DOI 10.1061/(ASCE)EE.1943-7870.0000504; Jackson JK, 2006, FRESHWATER BIOL, V51, P591, DOI 10.1111/j.1365-2427.2006.01503.x; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; Konrad CP, 2005, AM FISH S S, V47, P157; Lee JG, 2012, ENVIRON MODELL SOFTW, V37, P6, DOI 10.1016/j.envsoft.2012.04.011; Lepori F, 2005, ECOL APPL, V15, P2060, DOI 10.1890/04-1372; Li H, 2009, J HYDROL ENG, V14, P407, DOI 10.1061/(ASCE)1084-0699(2009)14:4(407); Line DE, 2012, J ENVIRON ENG-ASCE, V138, P680, DOI 10.1061/(ASCE)EE.1943-7870.0000515; Louhi P, 2011, ECOL APPL, V21, P1950, DOI 10.1890/10-0591.1; Mayer AL, 2012, ENVIRON PRAC, V14, P57, DOI 10.1017/S1466046611000494; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; *OH ENV PROT AG, 2002, FIELD EV MAN OH PRIM; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Perez-Pedini C, 2005, J WATER RES PLAN MAN, V131, P441, DOI 10.1061/(ASCE)0733-9496(2005)131:6(441); PhycoTech, 2011, TECHN APPR ALG ID; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Rice E.W., 2005, STANDARD METHODS EXA; Rosen BH, 1995, BIOL ASSESSMENT CRIT, P209; Roy AH, 2003, J N AM BENTHOL SOC, V22, P292, DOI 10.2307/1467999; Roy AH, 2008, ENVIRON MANAGE, V42, P344, DOI 10.1007/s00267-008-9119-1; Roy AH, 2009, J AM WATER RESOUR AS, V45, P198, DOI 10.1111/j.1752-1688.2008.00271.x; Shuster W, 2013, J HYDROL, V485, P177, DOI 10.1016/j.jhydrol.2012.10.043; Sieker F, 1998, WATER SCI TECHNOL, V38, P65, DOI 10.1016/S0273-1223(98)00734-3; Smith RF, 2009, J N AM BENTHOL SOC, V28, P1022, DOI 10.1899/08-176.1; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Thurston HW, 2010, ENVIRON SCI POLICY, V13, P405, DOI 10.1016/j.envsci.2010.03.008; Thurston HW, 2003, J WATER RES PL-ASCE, V129, P409, DOI 10.1061/(ASCE)0733-9496(2003)129:5(409); Thurston HW, 2008, EPA600R08129; Trowsdale SA, 2011, J HYDROL, V397, P167, DOI 10.1016/j.jhydrol.2010.11.023; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; United Nations, 2011, WORLD URB PROSP 2010; United States Environmental Protection Agency, 1991, 883R91100 US EPA OFF; Urbonas B., 1993, STORMWATER BEST MANA; Walsh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045814; Walsh CJ, 2000, HYDROBIOLOGIA, V431, P107, DOI 10.1023/A:1004029715627; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Williams DD, 1996, J N AM BENTHOL SOC, V15, P634, DOI 10.2307/1467813	70	78	79	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85011	10.1371/journal.pone.0085011	http://dx.doi.org/10.1371/journal.pone.0085011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465468	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000020
J	Maher, C; Olds, T; Mire, E; Katzmarzyk, PT				Maher, Carol; Olds, Tim; Mire, Emily; Katzmarzyk, Peter T.			Reconsidering the Sedentary Behaviour Paradigm	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; UNITED-STATES; LEISURE-TIME; MORTALITY; OBESITY; ADULTS; SPENT; RISK	Aims: Recent literature has posed sedentary behaviour as an independent entity to physical inactivity. This study investigated whether associations between sedentary behaviour and cardio-metabolic biomarkers remain when analyses are adjusted for total physical activity. Methods: Cross-sectional analyses were undertaken on 4,618 adults from the 2003/04 and 2005/06 U. S. National Health and Nutrition Examination Survey. Minutes of sedentary behaviour and moderate-to-vigorous physical activity (MVPA), and total physical activity (total daily accelerometer counts minus counts accrued during sedentary minutes) were determined from accelerometry. Associations between sedentary behaviour and cardio-metabolic biomarkers were examined using linear regression. Results: Results showed that sedentary behaviour was detrimentally associated with 8/11 cardio-metabolic biomarkers when adjusted for MVPA. However, when adjusted for total physical activity, the associations effectively disappeared, except for C-reactive protein, which showed a very small, favourable association (beta = -0.06) and triglycerides, which showed a very small, detrimental association (beta = 0.04). Standardised betas suggested that total physical activity was consistently, favourably associated with cardio-metabolic biomarkers (9/11 biomarkers, standardized beta = 0.08-0.30) while sedentary behaviour was detrimentally associated with just 1 biomarker (standardized beta = 0.12). Conclusion: There is virtually no association between sedentary behaviour and cardio-metabolic biomarkers once analyses are adjusted for total physical activity. This suggests that sedentary behaviour may not have health effects independent of physical activity.	[Maher, Carol; Olds, Tim] Univ S Australia, Sch Hlth Sci, Hlth & Use Time Grp, Adelaide, SA 5001, Australia; [Mire, Emily; Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Div Populat Sci, Baton Rouge, LA 70808 USA	University of South Australia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Maher, C (corresponding author), Univ S Australia, Sch Hlth Sci, Hlth & Use Time Grp, Adelaide, SA 5001, Australia.	carol.maher@unisa.edu.au	Katzmarzyk, Peter T/N-1974-2017; Olds, Tim/A-1223-2008; Maher, Carol/C-8169-2009	Katzmarzyk, Peter T/0000-0002-9280-6022; Olds, Tim/0000-0001-6894-5519; Maher, Carol/0000-0002-8676-0224				Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; [Anonymous], 1989, APPL LINEAR REGRESSI; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention/National Center for Health Statistics, 2009, DOC COD FREQ PHYS AC; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colley Rachel C, 2011, Health Rep, V22, P7; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, P167, DOI DOI 10.1007/0-387-22440-8_8; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2010, FOODS FOOD COMP RED, P30; Wannamethee SG, 2001, SPORTS MED, V31, P101, DOI 10.2165/00007256-200131020-00003; Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Wissmann M., 2007, ROLE CATEGORICAL VAR	24	75	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86403	10.1371/journal.pone.0086403	http://dx.doi.org/10.1371/journal.pone.0086403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454968	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000330235100153
J	Carter, RR; DiFeo, A; Bogie, K; Zhang, GQ; Sun, JY				Carter, Rebecca R.; DiFeo, Analisa; Bogie, Kath; Zhang, Guo-Qiang; Sun, Jiayang			Crowdsourcing Awareness: Exploration of the Ovarian Cancer Knowledge Gap through Amazon Mechanical Turk	PLOS ONE			English	Article							BREAST; WOMEN; MAMMOGRAPHY; STATISTICS; ACCURACY; SYMPTOMS	Background: Ovarian cancer is the most lethal gynecologic disease in the United States, with more women dying from this cancer than all gynecological cancers combined. Ovarian cancer has been termed the "silent killer" because some patients do not show clear symptoms at an early stage. Currently, there is a lack of approved and effective early diagnostic tools for ovarian cancer. There is also an apparent severe knowledge gap of ovarian cancer in general and of its indicative symptoms among both public and many health professionals. These factors have significantly contributed to the late stage diagnosis of most ovarian cancer patients (63% are diagnosed at Stage III or above), where the 5-year survival rate is less than 30%. The paucity of knowledge concerning ovarian cancer in the United States is unknown. Methods: The present investigation examined current public awareness and knowledge about ovarian cancer. The study implemented design strategies to develop an unbiased survey with quality control measures, including the modern application of multiple statistical analyses. The survey assessed a reasonable proxy of the US population by crowdsourcing participants through the online task marketplace Amazon Mechanical Turk, at a highly condensed rate of cost and time compared to traditional recruitment methods. Conclusion: Knowledge of ovarian cancer was compared to that of breast cancer using repeated measures, bias control and other quality control measures in the survey design. Analyses included multinomial logistic regression and categorical data analysis procedures such as correspondence analysis, among other statistics. We confirmed the relatively poor public knowledge of ovarian cancer among the US population. The simple, yet novel design should set an example for designing surveys to obtain quality data via Amazon Mechanical Turk with the associated analyses.	[Carter, Rebecca R.; Sun, Jiayang] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [DiFeo, Analisa; Zhang, Guo-Qiang] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Bogie, Kath] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Bogie, Kath] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sun, JY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	jsun@case.edu		Sun, Jiayang/0000-0002-0870-7014; DiFeo, Analisa/0000-0001-8319-6763; Bogie, Kath/0000-0003-1020-9695	Choose Ohio First Scholarship program in Biomedical Informatics through the EECS Department in Computer Science & Engineering at Case Western Reserve University; Division of Medical Informatics at Case Western School of Medicine; NIH/NCATS [UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Choose Ohio First Scholarship program in Biomedical Informatics through the EECS Department in Computer Science & Engineering at Case Western Reserve University; Division of Medical Informatics at Case Western School of Medicine; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Choose Ohio First Scholarship program in Biomedical Informatics through the EECS Department in Computer Science & Engineering at Case Western Reserve University and the Division of Medical Informatics at Case Western School of Medicine for RRC. GQZ acknowledges support from NIH/NCATS award UL1TR000439. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abel EK, 1998, SELECTIVE COMPLIANCE, P310; Baldwin LM, 2012, ANN INTERN MED, V156, P182, DOI 10.7326/0003-4819-156-3-201202070-00006; Bergh J, 2001, ACTA ONCOL, V40, P253, DOI 10.1080/02841860151116349; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Catalano R, 2003, EUR J EPIDEMIOL, V18, P545, DOI 10.1023/A:1024620617272; d'Agincourt-Canning Lori, 2005, J Genet Couns, V14, P55, DOI 10.1007/s10897-005-1500-0; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Gardner RM, 2012, BODY IMAGE, V9, P532, DOI 10.1016/j.bodyim.2012.06.006; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Goodman JK, 2012, J BEHAV DECIS MAK; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Green PE, 1978, RES MARKETING DECISI; Greenlaw C, 2009, EVALUATION REV, V33, P464, DOI 10.1177/0193841X09340214; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Howden LM, 2010, AGE SEX COMPOSITION; Jacobsen GD, 2011, J HEALTH ECON, V30, P55, DOI 10.1016/j.jhealeco.2010.11.005; Kenen R, 2004, PSYCHO-ONCOL, V13, P335, DOI 10.1002/pon.745; Kenen R, 2003, SOCIOL HEALTH ILL, V25, P838, DOI 10.1046/j.1467-9566.2003.00372.x; Kobel M, 2010, AM J SURG PATHOL, V34, P984, DOI 10.1097/PAS.0b013e3181e1a3bb; Lerner BH, 2002, NAT REV CANCER, V2, P225, DOI 10.1038/nrc744; Low EL, 2013, J FAM PLAN REPROD H, V39, P163, DOI 10.1136/jfprhc-2012-100473; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McAllister M, 2002, J HEALTH PSYCHOL, V7, P491, DOI 10.1177/1359105302007005628; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; R Development Core Team, 2008, R LANG ENV STAT COMP; RADLOW R, 1975, J AM STAT ASSOC, V70, P811, DOI 10.2307/2285440; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Schonlau M, 2002, MR1480RC RAND; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon AE, 2012, J FAM PLAN REPROD H, V38, P167, DOI 10.1136/jfprhc-2011-100118; Slomski A, 2012, JAMA-J AM MED ASSOC, V307, P2474, DOI 10.1001/jama.2012.5646; Sulik G. A., 2007, QUAL SOCIOL, V30, P297, DOI DOI 10.1007/S11133-007-9057-X; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VENABLES WN, 1997, MODERN APPL STAT S P; Wu S, 2003, J HEALTH ECON, V22, P675, DOI 10.1016/S0167-6296(03)00042-0	41	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85508	10.1371/journal.pone.0085508	http://dx.doi.org/10.1371/journal.pone.0085508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465580	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100043
J	Bean, GJ; Jaeger, PA; Bahr, S; Ideker, T				Bean, Gordon J.; Jaeger, Philipp A.; Bahr, Sondra; Ideker, Trey			Development of Ultra-High-Density Screening Tools for Microbial "Omics"	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; SCALE; MAP	High-throughput genetic screens in model microbial organisms are a primary means of interrogating biological systems. In numerous cases, such screens have identified the genes that underlie a particular phenotype or a set of gene-gene, gene-environment or protein-protein interactions, which are then used to construct highly informative network maps for biological research. However, the potential test space of genes, proteins, or interactions is typically much larger than current screening systems can address. To push the limits of screening technology, we developed an ultra-high-density, 6144-colony arraying system and analysis toolbox. Using budding yeast as a benchmark, we find that these tools boost genetic screening throughput 4-fold and yield significant cost and time reductions at quality levels equal to or better than current methods. Thus, the new ultra-high-density screening tools enable researchers to significantly increase the size and scope of their genetic screens.	[Bean, Gordon J.] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Jaeger, Philipp A.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jaeger, Philipp A.; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bahr, Sondra] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	tideker@ucsd.edu		Jaeger, Philipp A./0000-0002-3624-0802; Ideker, Trey/0000-0002-1708-8454	National Institutes of Health [GM084279, GM085764]; Genomics Ontario Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM084279, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genomics Ontario Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM084279 and GM085764 to TI and a grant to develop a "High density replicator System" by Genomics Ontario Inc. to SB. This research was conducted while PAJ was an Ellison Medical Foundation/AFAR Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Bean GJ, 2013, COLONY ANAL TOOLKIT, P1; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wagih O, 2013, NUCLEIC ACIDS RES, V41, pW591, DOI 10.1093/nar/gkt400	15	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85177	10.1371/journal.pone.0085177	http://dx.doi.org/10.1371/journal.pone.0085177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465499	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500040
J	Miskimins, WK; Ahn, HJ; Kim, JY; Ryu, S; Jung, YS; Choi, JY				Miskimins, W. Keith; Ahn, Hyun Joo; Kim, Ji Yeon; Ryu, Sun; Jung, Yuh-Seog; Choi, Joon Young			Synergistic Anti-Cancer Effect of Phenformin and Oxamate	PLOS ONE			English	Article							BREAST-CANCER CELLS; TUMOR-CELLS; IN-VITRO; LACTIC-ACIDOSIS; NECK-CANCER; METFORMIN; INHIBITION; LACTATE; GROWTH; GLYCOLYSIS	Phenformin (phenethylbiguanide; an anti-diabetic agent) plus oxamate [lactate dehydrogenase (LDH) inhibitor] was tested as a potential anti-cancer therapeutic combination. In in vitro studies, phenformin was more potent than metformin, another biguanide, recently recognized to have anti-cancer effects, in promoting cancer cell death in the range of 25 times to 15 million times in various cancer cell lines. The anti-cancer effect of phenformin was related to complex I inhibition in the mitochondria and subsequent overproduction of reactive oxygen species (ROS). Addition of oxamate inhibited LDH activity and lactate production by cells, which is a major side effect of biguanides, and induced more rapid cancer cell death by decreasing ATP production and accelerating ROS production. Phenformin plus oxamate was more effective than phenformin combined with LDH knockdown. In a syngeneic mouse model, phenformin with oxamate increased tumor apoptosis, reduced tumor size and F-18-fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography compared to control. We conclude that phenformin is more cytotoxic towards cancer cells than metformin. Furthermore, phenformin and oxamate have synergistic anti-cancer effects through simultaneous inhibition of complex I in the mitochondria and LDH in the cytosol, respectively.	[Miskimins, W. Keith] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA; [Miskimins, W. Keith] Univ S Dakota, Sanford Sch Med, Dept Obstet & Gynecol, Sioux Falls, SD USA; [Miskimins, W. Keith] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Sioux Falls, SD USA; [Ahn, Hyun Joo; Kim, Ji Yeon; Ryu, Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Jung, Yuh-Seog] Natl Canc Ctr, Res Inst & Hosp, Ctr Thyroid Canc, Head & Neck Oncol Clin,Ctr Specif Organs Canc, Goyang Si, Gyeonggi Do, South Korea; [Choi, Joon Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea	Sanford Health; University of South Dakota; University of South Dakota; Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center	Ahn, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	hyunjooahn@skku.edu	Choi, Joon Young/D-6140-2017	Ahn, Hyun Joo/0000-0003-1576-5308	Susan G. Komen for the Cure [KG100497]; National Cancer Institute of the National Institutes of Health [1R01CA180033]; National Institute of General Medical Sciences of the National Institutes of Health [015P20GM10358]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0013087]; Samsung Medical Center [SMR1120911]; NATIONAL CANCER INSTITUTE [R01CA180033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103548] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Medical Center(Samsung); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by Susan G. Komen for the Cure award number KG100497 (WKM), by the National Cancer Institute of the National Institutes of Health award number 1R01CA180033 (WKM), by National Institute of General Medical Sciences of the National Institutes of Health award number 015P20GM10358 (WKM), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology award number 2011-0013087, and by Samsung Medical Center grant award number SMR1120911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; [Anonymous], 2013, Cancer Discov, V3, pOF14, DOI 10.1158/2159-8290.CD-RW2013-023; Appleyard MVCL, 2012, BRIT J CANCER, V106, P1117, DOI 10.1038/bjc.2012.56; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Chan DK, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-19; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Coppock JD, 2013, NEOPLASIA, V15, P620, DOI 10.1593/neo.13432; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; ELWOOD JC, 1968, CANCER RES, V28, P2056; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Goetze K, 2011, INT J ONCOL, V39, P453, DOI 10.3892/ijo.2011.1055; GOLDBERG EB, 1965, J BIOL CHEM, V240, P2786; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Hadad S, 2011, BREAST CANCER RES TR, V128, P783, DOI 10.1007/s10549-011-1612-1; Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; KANNO H, 1988, ACTA HAEMATOL JAPON, V51, P715; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2011, CLIN CANCER RES, V17, P4892, DOI 10.1158/1078-0432.CCR-10-2918; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lea MA, 2011, ANTICANCER RES, V31, P421; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; MARTINREQUERO A, 1986, J BIOL CHEM, V261, P13973; McLarty K, 2009, J NUCL MED, V50, P1848, DOI 10.2967/jnumed.109.067231; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PAPACONSTANTINOU J, 1961, J BIOL CHEM, V236, P285; Quennet V, 2006, RADIOTHER ONCOL, V81, P130, DOI 10.1016/j.radonc.2006.08.012; REYNOLDS V H, 1963, Surg Forum, V14, P128; Rosand J, 1997, ANN INTERN MED, V127, P170, DOI 10.7326/0003-4819-127-2-199707150-00034; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2; SCHAFER G, 1983, DIABETES METAB, V9, P148; Soini Y, 2001, J PATHOL, V195, P156, DOI 10.1002/path.946; Spanos WC, 2009, ARCH OTOLARYNGOL, V135, P1137, DOI 10.1001/archoto.2009.159; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wieking BG, 2012, CANCER GENE THER, V19, P667, DOI 10.1038/cgt.2012.55; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Yaromina A, 2012, STRAHLENTHER ONKOL, V188, P431, DOI 10.1007/s00066-011-0054-3; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	53	87	89	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85576	10.1371/journal.pone.0085576	http://dx.doi.org/10.1371/journal.pone.0085576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465604	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500077
J	Preston, C; Ehrsson, HH				Preston, Catherine; Ehrsson, H. Henrik			Illusory Changes in Body Size Modulate Body Satisfaction in a Way That Is Related to Non-Clinical Eating Disorder Psychopathology	PLOS ONE			English	Article							ANOREXIA-NERVOSA; MULTISENSORY ILLUSIONS; GENDER-DIFFERENCES; EXTERNAL OBJECTS; RUBBER HAND; MASS INDEX; IMAGE; DISSATISFACTION; WEIGHT; MEDIA	Historically, body size overestimation has been linked to abnormal levels of body dissatisfaction found in eating disorders. However, recently this relationship has been called into question. Indeed, despite a link between how we perceive and how we feel about our body seeming intuitive, until now lack of an experimental method to manipulate body size has meant that a causal link, even in healthy participants, has remained elusive. Recent developments in body perception research demonstrate that the perceptual experience of the body can be readily manipulated using multisensory illusions. The current study exploits such illusions to modulate perceived body size in an attempt to influence body satisfaction. Participants were presented with stereoscopic video images of slimmer and wider mannequin bodies viewed through head-mounted displays from first person perspective. Illusory ownership was induced by synchronously stroking the seen mannequin body with the unseen real body. Pre and post-illusion affective and perceptual measures captured changes in perceived body size and body satisfaction. Illusory ownership of a slimmer body resulted in participants perceiving their actual body as slimmer and giving higher ratings of body satisfaction demonstrating a direct link between perceptual and affective body representations. Change in body satisfaction following illusory ownership of a wider body, however, was related to degree of (non-clinical) eating disorder psychopathology, which can be linked to fluctuating body representations found in clinical samples. The results suggest that body perception is linked to body satisfaction and may be of importance for eating disorder symptomology.	[Preston, Catherine; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	Karolinska Institutet	Preston, C (corresponding author), Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden.	catherine.preston@ki.se			European Research Council; Swedish Foundation for Strategic Research; James S. McDonnell Foundation; Swedish Research Council; Soderberska Stiftelsen; Wednner-Gren Foundations; Marie Curie Actions	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); James S. McDonnell Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberska Stiftelsen; Wednner-Gren Foundations; Marie Curie Actions(European Commission)	This study was funded by the European Research Council; the Swedish Foundation for Strategic Research; the James S. McDonnell Foundation; the Swedish Research Council; and Soderberska Stiftelsen. CP was funded by Wednner-Gren Foundations; and Marie Curie Actions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliata D, 2004, J SOC CLIN PSYCHOL, V23, P7, DOI 10.1521/jscp.23.1.7.26988; Algars M, 2009, J AGING HEALTH, V21, P1112, DOI 10.1177/0898264309348023; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Calzo JP, 2012, J ADOLESCENT HEALTH, V51, P517, DOI 10.1016/j.jadohealth.2012.02.021; Cash Thomas F, 2002, Eat Disord, V10, P103, DOI 10.1080/10640260290081678; Castro-Fornieles J, 2008, J PSYCHIATR RES, V43, P331, DOI 10.1016/j.jpsychires.2008.03.013; Cornelissen PL, 2013, BODY IMAGE, V10, P103, DOI 10.1016/j.bodyim.2012.09.003; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Dodgson NA, 2004, PROC SPIE, V5291, P36, DOI 10.1117/12.529999; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Espeset EMS, 2012, CLIN PSYCHOL PSYCHOT, V19, P518, DOI 10.1002/cpp.760; Espeset Ester M S, 2011, Eat Disord, V19, P175, DOI 10.1080/10640266.2011.551635; Fairburn CG, 2000, ARCH GEN PSYCHIAT, V57, P659, DOI 10.1001/archpsyc.57.7.659; Ferrer-Garcia M, 2012, BODY IMAGE, V9, P1, DOI 10.1016/j.bodyim.2011.10.001; Friederich HC, 2007, NEUROIMAGE, V37, P674, DOI 10.1016/j.neuroimage.2007.05.039; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; Haggard P, 2009, PERCEPTION, V38, P1796, DOI 10.1068/p6399; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Keel PK, 2005, AM J PSYCHIAT, V162, P2263, DOI 10.1176/appi.ajp.162.12.2263; Keizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064602; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Mascolo M, 2012, INT J EAT DISORDER, V45, P977, DOI 10.1002/eat.22035; Mond JM, 2008, BEHAV RES THER, V46, P612, DOI 10.1016/j.brat.2008.02.003; Morry MM, 2001, CAN J BEHAV SCI, V33, P269, DOI 10.1037/h0087148; Myers TA, 2009, J ABNORM PSYCHOL, V118, P683, DOI 10.1037/a0016763; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Pingitore R, 1997, OBES RES, V5, P402, DOI 10.1002/j.1550-8528.1997.tb00662.x; Preston C, 2012, PERCEPTION, V41, P247, DOI 10.1068/p7103; Preston C, 2011, RHEUMATOLOGY, V50, P2314, DOI 10.1093/rheumatology/ker104; Ramachandran VS, 2005, CLIN MED, V5, P368, DOI 10.7861/clinmedicine.5-4-368; RIDGEWAY RT, 2005, PSYCHOL MEN MASCULIN, V6, P209, DOI DOI 10.1037/1524-9220.6.3.209; Riva G, 2012, MED HYPOTHESES, V78, P254, DOI 10.1016/j.mehy.2011.10.039; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Schmalzl L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00121; Schmalzl L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00034; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Smeets E, 2011, INT J EAT DISORDER, V44, P50, DOI 10.1002/eat.20776; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Soh NL, 2006, EUR EAT DISORD REV, V14, P54, DOI 10.1002/erv.678; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Stunkard AJ, 1983, GENETICS NEUROLOGICA, P115; THOMPSON JK, 1991, INT J EAT DISORDER, V10, P615, DOI 10.1002/1098-108X(199109)10:5<615::AID-EAT2260100514>3.0.CO;2-K; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Wagner A, 2006, INT J EAT DISORDER, V39, P276, DOI 10.1002/eat.20251	61	78	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85773	10.1371/journal.pone.0085773	http://dx.doi.org/10.1371/journal.pone.0085773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465698	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500109
J	Westmoreland, SV; Converse, AP; Hrecka, K; Hurley, M; Knight, H; Piatak, M; Lifson, J; Mansfield, KG; Skowronski, J; Desrosiers, RC				Westmoreland, Susan V.; Converse, A. Peter; Hrecka, Kasia; Hurley, Mollie; Knight, Heather; Piatak, Michael; Lifson, Jeffrey; Mansfield, Keith G.; Skowronski, Jacek; Desrosiers, Ronald C.			SIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; COLONY-STIMULATING FACTOR; SAMHD1 RESTRICTS; RHESUS-MONKEYS; HIV-1 INFECTION; PRIMATE LENTIVIRUSES; DISEASE PROGRESSION; VACCINE PROTECTION; IMMUNE-RESPONSES	Analysis of rhesus macaques infected with a vpx deletion mutant virus of simian immunodeficiency virus mac239 (SIV Delta vpx) demonstrates that Vpx is essential for efficient monocyte/macrophage infection in vivo but is not necessary for development of AIDS. To compare myeloid-lineage cell infection in monkeys infected with SIV Delta vpx compared to SIVmac239, we analyzed lymphoid and gastrointestinal tissues from SIV Delta vpx-infected rhesus (n = 5), SIVmac239-infected rhesus with SIV encephalitis (7 SIV239E), those without encephalitis (4 SIV239noE), and other SIV mutant viruses with low viral loads (4 SIV Delta nef, 2 SIV Delta 3). SIV+ macrophages and the percentage of total SIV+ cells that were macrophages in spleen and lymph nodes were significantly lower in rhesus infected with SIV Delta vpx (2.2%) compared to those infected with SIV239E (22.7%), SIV239noE (8.2%), and SIV mutant viruses (10.1%). In colon, SIV Delta vpx monkeys had fewer SIV+ cells, no SIV+ macrophages, and lower percentage of SIV+ cells that were macrophages than the other 3 groups. Only 2 SIV Delta vpx monkeys exhibited detectable virus in the colon. We demonstrate that Vpx is essential for efficient macrophage infection in vivo and that simian AIDS and death can occur in the absence of detectable macrophage infection.	[Westmoreland, Susan V.; Converse, A. Peter; Hurley, Mollie; Knight, Heather; Mansfield, Keith G.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA; [Piatak, Michael; Lifson, Jeffrey] NCI, AIDS & Canc Virus Program, SAIC Frederick, Frederick, MD 21701 USA; [Hrecka, Kasia; Skowronski, Jacek] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Desrosiers, Ronald C.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Microbiol, Southborough, MA 01772 USA	Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Case Western Reserve University; Harvard University	Westmoreland, SV (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA.	susan_westmoreland@hms.harvard.edu			NIH [P51 1OD011103, 5 R01 AI25328-22, R01 AI077459, T32 OD011064]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100673, R01AI025328, R01AI077459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103, T32OD011064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH grants P51 1OD011103, 5 R01 AI25328-22, R01 AI077459, T32 OD011064, National Cancer Institute, National Institutes of Health under contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2013, CURR HIV-AIDS REP, V10, P3, DOI 10.1007/s11904-012-0149-1; Alexander L, 2003, J VIROL, V77, P6823, DOI 10.1128/JVI.77.12.6823-6835.2003; Annamalai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014429; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; BAGASRA O, 1992, P NATL ACAD SCI USA, V89, P6285, DOI 10.1073/pnas.89.14.6285; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BERGAMINI A, 1994, BLOOD, V84, P3405; Bloch N, 2013, AIDS RES HUMAN RETRO; Borda JT, 2004, AM J PATHOL, V165, P2111, DOI 10.1016/S0002-9440(10)63261-0; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Breed MW, 2013, J VIROL, V87, P1528, DOI 10.1128/JVI.01928-12; Campbell BJ, 1997, J VIROL, V71, P5593, DOI 10.1128/JVI.71.7.5593-5602.1997; Cline AN, 2005, J MED PRIMATOL, V34, P303; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; DESROSIERS RC, 1991, AM J PATHOL, V139, P29; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Igarashi T, 2003, J VIROL, V77, P13042, DOI 10.1128/JVI.77.24.13042-13052.2003; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchoff V, 2002, ARCH VIROL, V147, P321, DOI 10.1007/s705-002-8322-9; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; Newstein MC, 2001, J INFECT DIS, V184, P1262, DOI 10.1086/324079; O'Neil SP, 2004, AM J PATHOL, V164, P1157, DOI 10.1016/S0002-9440(10)63204-X; O'Neil SP, 2000, J INFECT DIS, V182, P1051, DOI 10.1086/315823; Puigdomenech I, 2013, J VIROL, V87, P2846, DOI 10.1128/JVI.02514-12; RINGLER DJ, 1988, ANN NEUROL, V23, pS101, DOI 10.1002/ana.410230726; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sharp PM, 1996, NATURE, V383, P586, DOI 10.1038/383586a0; SIMON MA, 1992, AIDS RES HUM RETROV, V8, P327, DOI 10.1089/aid.1992.8.327; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Tristem M, 1998, VIROLOGY, V240, P232, DOI 10.1006/viro.1997.8929; VALLANCE SJ, 1990, BIOCHEM J, V265, P359, DOI 10.1042/bj2650359; WILEY CA, 1994, ADV NEUROIMMUNOL, V4, P319, DOI 10.1016/S0960-5428(06)80272-X; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Yearley JH, 2009, LAB INVEST, V89, P657, DOI 10.1038/labinvest.2009.29	51	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84463	10.1371/journal.pone.0084463	http://dx.doi.org/10.1371/journal.pone.0084463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465411	Green Submitted, gold, Green Published			2022-12-27	WOS:000330244500005
J	Mocco, J; Afzal, A; Ansari, S; Wolfe, A; Caldwell, K; Connolly, ES; Scott, EW				Mocco, J.; Afzal, Aqeela; Ansari, Saeed; Wolfe, Annemarie; Caldwell, Kenneth; Connolly, E. S.; Scott, Edward W.			SDF1-A Facilitates Lin-/Sca1+Cell Homing following Murine Experimental Cerebral Ischemia	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; PERIPHERAL-BLOOD; CHEMOKINE SDF-1; CD34(+) CELLS; IN-VIVO; CXCR4; RECEPTOR	Background: Hematopoietic stem cells mobilize to the peripheral circulation in response to stroke. However, the mechanism by which the brain initiates this mobilization is uncharacterized. Methods: Animals underwent a murine intraluminal filament model of focal cerebral ischemia and the SDF1-A pathway was evaluated in a blinded manner via serum and brain SDF1-A level assessment, Lin-/Sca1+ cell mobilization quantification, and exogenous cell migration confirmation; all with or without SDF1-A blockade. Results: Bone marrow demonstrated a significant increase in Lin-/Sca1+ cell counts at 24 hrs (272+/-60%; P<0.05 vs sham). Mobilization of Lin-/Sca1+ cells to blood was significantly elevated at 24 hrs (607+/-159%; P<0.05). Serum SDF1-A levels were significant at 24 hrs (Sham (103614), 4 hrs (94+/-20%, p = NS) and 24 hrs (130617; p<0.05)). Brain SDF1-A levels were significantly elevated at both 4 hrs and 24 hrs (11367 pg/ml and 112610 pg/ml, respectively; p<0.05 versus sham 76611 pg/ml). Following administration of an SDF1-A antibody, Lin-/Sca1+ cells failed to mobilize to peripheral blood following stroke, despite continued up regulation in bone marrow (stroke bone marrow cell count: 536665, blood cell count 127624; p<0.05 versus placebo). Exogenously administered Lin-/Sca1+ cells resulted in a significant reduction in infarct volume: 42+/-5% (stroke alone), versus 21+/-15% (Stroke+Lin-/Sca1+cells), and administration of an SDF1-A antibody concomitant to exogenous administration of the Lin-/Sca1+ cells prevented this reduction. Following stroke, exogenously administered Lin-/Sca1+ FISH positive cells were significantly reduced when administered concomitant to an SDF1-A antibody as compared to without SDF1-A antibody (1064 vs 0.7+/-1, p<0.05). Conclusions: SDF1-A appears to play a critical role in modulating Lin-/Sca1+ cell migration to ischemic brain.	[Mocco, J.; Afzal, Aqeela] Vanderbilt Univ, Dept Neurol Surg, Nashville, TN 37235 USA; [Ansari, Saeed; Wolfe, Annemarie; Caldwell, Kenneth] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Connolly, E. S.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Scott, Edward W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Vanderbilt University; State University System of Florida; University of Florida; Columbia University; State University System of Florida; University of Florida	Mocco, J (corresponding author), Vanderbilt Univ, Dept Neurol Surg, 221 Kirkland Hall, Nashville, TN 37235 USA.	j.mocco@vanderbilt.edu		Afzal, Aqeela/0000-0001-6406-2233; Caldwell, Kenneth/0000-0003-0654-8758	James and Esther King Foundation [2KN06]	James and Esther King Foundation	This study was funded by the James and Esther King Foundation; 2KN06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bonavia R, 2003, TOXICOL LETT, V139, P181, DOI 10.1016/S0378-4274(02)00432-0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caveliers V, 2007, Q J NUCL MED MOL IM, V51, P61; Chu K, 2008, STROKE, V39, P1441, DOI 10.1161/STROKEAHA.107.499236; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Dai SJ, 2010, J MOL CELL CARDIOL, V49, P587, DOI 10.1016/j.yjmcc.2010.07.010; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; DELALUZ SM, 2004, BLOOD, V103, P2452, DOI [DOI 10.1182/BL00D-2003-08-2857, 10.1182/blood-2003-08-2857]; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Haast RAM, 2012, J CEREBR BLOOD F MET, V32, P2100, DOI 10.1038/jcbfm.2012.141; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hochsmann B, 2009, NEUROLOGY, V72, P1277, DOI 10.1212/01.wnl.0000345669.99690.e9; Huang CY, 2011, SURGERY, V150, P197, DOI 10.1016/j.surg.2011.05.010; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kucia M, 2004, J MOL HISTOL, V35, P233; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Liang X, 2010, INT J RADIAT BIOL, V86, P230, DOI 10.3109/09553000903422555; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Pituch-Noworolska A, 2003, FOLIA HISTOCHEM CYTO, V41, P13; Reddy K, 2008, INT J CANCER, V123, P831, DOI 10.1002/ijc.23582; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; Steiner B, 2012, NEUROSCI LETT, V513, P25, DOI 10.1016/j.neulet.2012.01.078; Tang YL, 2005, REGUL PEPTIDES, V125, P1, DOI 10.1016/j.regpep.2004.10.014; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85615	10.1371/journal.pone.0085615	http://dx.doi.org/10.1371/journal.pone.0085615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465621	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500060
J	Dunmire, SK; Odumade, OA; Porter, JL; Reyes-Genere, J; Schmeling, DO; Bilgic, H; Fan, DH; Baechler, EC; Balfour, HH; Hogquist, KA				Dunmire, Samantha K.; Odumade, Oludare A.; Porter, Jean L.; Reyes-Genere, Juan; Schmeling, David O.; Bilgic, Hatice; Fan, Danhua; Baechler, Emily C.; Balfour, Henry H., Jr.; Hogquist, Kristin A.			Primary EBV Infection Induces an Expression Profile Distinct from Other Viruses but Similar to Hemophagocytic Syndromes	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD; MACROPHAGE ACTIVATION; POSSIBLE ETIOLOGY; INTERFERON; GAMMA; PREVALENCE; RESPONSES; REACTIVATION	Epstein-Barr Virus (EBV) causes infectious mononucleosis and establishes lifelong infection associated with cancer and autoimmune disease. To better understand immunity to EBV, we performed a prospective study of natural infection in healthy humans. Transcriptome analysis defined a striking and reproducible expression profile during acute infection but no lasting gene changes were apparent during latent infection. Comparing the EBV response profile to multiple other acute viral infections, including influenza A (influenza), respiratory syncytial virus (RSV), human rhinovirus (HRV), attenuated yellow fever virus (YFV), and Dengue fever virus (DENV), revealed similarity only to DENV. The signature shared by EBV and DENV was also present in patients with hemophagocytic syndromes, suggesting these two viruses cause uncontrolled inflammatory responses. Interestingly, while EBV induced a strong type I interferon response, a subset of interferon induced genes, including MX1, HERC5, and OAS1, were not upregulated, suggesting a mechanism by which viral antagonism of immunity results in a profound inflammatory response. These data provide an important first description of the response to a natural herpesvirus infection in humans.	[Dunmire, Samantha K.; Odumade, Oludare A.; Porter, Jean L.; Reyes-Genere, Juan; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Schmeling, David O.; Balfour, Henry H., Jr.; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Bilgic, Hatice; Baechler, Emily C.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Fan, Danhua] Univ Minnesota, Sch Med, Biostat & Bioinformat Core, Minneapolis, MN 55455 USA; [Schmeling, David O.; Balfour, Henry H., Jr.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Hogquist, Kristin/0000-0001-9963-5687; Reyes Genere, Juan/0000-0001-9818-110X	National Institutes of Health [T32 AI007313, F31 AI084524, T32 GM008244, PO1 AI35296]; International Center for Antiviral Research and Epidemiology; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, F31AI084524, P01AI035296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Center for Antiviral Research and Epidemiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (T32 AI007313 to SKD, F31 AI084524 and T32 GM008244 to OAO, and PO1 AI35296 to KAH) and by the International Center for Antiviral Research and Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Balfour Jr HH, 2012, J INFECT DIS; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chen CJ, 2005, J RHEUMATOL, V32, P44; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Diercks A, 2012, CURR TOP MICROBIOL I; Englebienne P, 2003, MED HYPOTHESES, V60, P175, DOI 10.1016/S0306-9877(02)00353-5; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fraser AR, 2006, J LEUKOCYTE BIOL, V80, P862, DOI 10.1189/jlb.0605297; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harley JB, 2010, ARTHRITIS RHEUM-US, V62, P1571, DOI 10.1002/art.27421; Hermesh T, 2010, VIRUSES-BASEL, V2, P2541, DOI 10.3390/v2112541; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; HOAGLAND RJ, 1955, AM J MED SCI, V229, P262; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; James JA, 2012, CURR OPIN RHEUMATOL, V24, P383, DOI 10.1097/BOR.0b013e3283535801; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Lin Z, 2010, J VIROL, V84, P13053, DOI 10.1128/JVI.01521-10; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Quan TE, 2010, ARTHRITIS RHEUM-US, V62, P1693, DOI 10.1002/art.27408; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SAVOIE A, 1994, BLOOD, V83, P2715; Selman M, 2003, AM J RESP CRIT CARE, V167, P945, DOI 10.1164/rccm.2301004; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sumegi J, 2011, BLOOD, V117, pE151, DOI 10.1182/blood-2010-08-300046; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Tselis A, 2012, CURR OPIN RHEUMATOL, V24, P424, DOI 10.1097/BOR.0b013e3283542cf8; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Yager EJ, 2009, VIRAL IMMUNOL, V22, P67, DOI 10.1089/vim.2008.0086; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	51	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85422	10.1371/journal.pone.0085422	http://dx.doi.org/10.1371/journal.pone.0085422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465555	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000033
J	Ravussin, Y; Xiao, CY; Gavrilova, O; Reitman, ML				Ravussin, Yann; Xiao, Cuiying; Gavrilova, Oksana; Reitman, Marc L.			Effect of Intermittent Cold Exposure on Brown Fat Activation, Obesity, and Energy Homeostasis in Mice	PLOS ONE			English	Article							UNCOUPLING PROTEIN GENE; WHITE ADIPOSE-TISSUE; PLASMA LEPTIN; DIET; ANTAGONIST; EXPRESSION; AGONIST; THERMOGENESIS; EXPENDITURE; ADIPOCYTES	Homeotherms have specific mechanisms to maintain a constant core body temperature despite changes in thermal environment, food supply, and metabolic demand. Brown adipose tissue, the principal thermogenic organ, quickly and efficiently increases heat production by dissipating the mitochondrial proton motive force. It has been suggested that activation of brown fat, via either environmental (i.e. cold exposure) or pharmacologic means, could be used to increase metabolic rate and thus reduce body weight. Here we assess the effects of intermittent cold exposure (4 degrees C for one to eight hours three times a week) on C57BL/6J mice fed a high fat diet. Cold exposure increased metabolic rate approximately twofold during the challenge and activated brown fat. In response, food intake increased to compensate fully for the increased energy expenditure; thus, the mice showed no reduction in body weight or adiposity. Despite the unchanged adiposity, the cold-treated mice showed transient improvements in glucose homeostasis. Administration of the cannabinoid receptor-1 inverse agonist AM251 caused weight loss and improvements in glucose homeostasis, but showed no further improvements when combined with cold exposure. These data suggest that intermittent cold exposure causes transient, meaningful improvements in glucose homeostasis, but without synergy when combined with AM251. Since energy expenditure is significantly increased during cold exposure, a drug that dissociates food intake from metabolic demand during cold exposure may achieve weight loss and further metabolic improvements.	[Ravussin, Yann; Xiao, Cuiying; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Reitman, Marc/B-4448-2013; Ravussin, Yann/ABE-8061-2021; Ravussin, Yann/AAE-1440-2020	Reitman, Marc/0000-0002-0426-9475; Ravussin, Yann/0000-0002-6699-3944; 	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH [ZIA DK075062, ZIA DK075064, ZIA DK070002]; Swiss National Fund for Scientific Research (SNF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075062, ZICDK070002, ZIADK075064] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; Swiss National Fund for Scientific Research (SNF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program (ZIA DK075062, ZIA DK075064, ZIA DK070002) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. YR was supported by a grant from the Swiss National Fund for Scientific Research (SNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; BARNETT SA, 1965, BIOL REV, V40, P5, DOI 10.1111/j.1469-185X.1965.tb00794.x; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; CONTI PS, 1986, AM J CLIN ONCOL-CANC, V9, P537, DOI 10.1097/00000421-198612000-00014; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gavrilova O, 2000, DIABETES, V49, P1910, DOI 10.2337/diabetes.49.11.1910; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Haman F, FRONT BIOSCI SCHOL E, V2, P1155; Hamer M, 2010, CURR OPIN LIPIDOL, V21, P1, DOI 10.1097/MOL.0b013e328331dd21; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; HOLLOSZY JO, 1986, J APPL PHYSIOL, V61, P1656, DOI 10.1152/jappl.1986.61.5.1656; Judge MK, 2009, J ENDOCRINOL, V203, P281, DOI 10.1677/JOE-09-0210; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lusk G., 1928, SCI NUTR; MAYER J, 1954, AM J PHYSIOL, V177, P544, DOI 10.1152/ajplegacy.1954.177.3.544; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; Mercer JG, 1997, FEBS LETT, V402, P185, DOI 10.1016/S0014-5793(96)01525-6; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Ravussin Y, 2013, INT J OBES LOND, V37, P473; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Robidoux J, 2004, ANNU REV PHARMACOL, V44, P297, DOI 10.1146/annurev.pharmtox.44.101802.121659; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Shefer VI, 1997, EXP GERONTOL, V32, P325, DOI 10.1016/S0531-5565(96)00131-3; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; TALAN MI, 1985, J GERONTOL, V40, P8, DOI 10.1093/geronj/40.1.8; TRAYHURN P, 1995, BIOCHEM J, V311, P729, DOI 10.1042/bj3110729; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; YOSHIDA T, 1994, EUR J ENDOCRINOL, V131, P97, DOI 10.1530/eje.0.1310097; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	45	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85876	10.1371/journal.pone.0085876	http://dx.doi.org/10.1371/journal.pone.0085876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465761	gold, Green Submitted, Green Published			2022-12-27	WOS:000330237000069
J	Trapecar, M; Goropevsek, A; Gorenjak, M; Gradisnik, L; Rupnik, MS				Trapecar, Martin; Goropevsek, Ales; Gorenjak, Mario; Gradisnik, Lidija; Rupnik, Marjan Slak			A Co-Culture Model of the Developing Small Intestine Offers New Insight in the Early Immunomodulation of Enterocytes and Macrophages by Lactobacillus spp. through STAT1 and NF-kB p65 Translocation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; IMMUNE CELLS; GUT; MODULATION; PATHWAYS; RECEPTOR; STRAINS; ELICIT	The early establishment of a complete microbiome has been shown to play an integral part in the development and maintenance of an intact intestine and its immune system, although much remains unknown about the specific mechanisms of immune modulation in newborns. In our study we show in a co-culture model of the undeveloped small intestine that members of Lactobacillus spp. influence STAT1 and NF-kB p65 nuclear translocation in both intestinal epithelial cells as well as underlying macrophages. Moreover, by using imaging flow cytometry we were able to monitor each individual cell and create a framework of the percentage of cells in which translocation occurred in challenged versus control cell populations. We also observed a significant difference in baseline translocation in intestinal cells when cultured alone versus those in a co-culture model, underpinning the importance of 3D models over monolayer set-ups in epithelial in vitro research. In conclusion, our work offers new insights into the potential routes by which the commensal microbiome primes the early immune system to fight pathogens, and shows how strain-specific these mechanisms really are.	[Trapecar, Martin; Gradisnik, Lidija; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Goropevsek, Ales] Univ Clin Ctr Maribor, Dept Lab Diagnost, Maribor, Slovenia; [Gorenjak, Mario] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor; University of Maribor	Trapecar, M (corresponding author), Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia.	martin.trapecar@gmail.com	Slak Rupnik, Marjan/E-6246-2015; Rupnik, Marjan Slak/R-4738-2019; Trapecar, Martin/AAL-5800-2020	Slak Rupnik, Marjan/0000-0002-3744-4882; Rupnik, Marjan Slak/0000-0002-3744-4882; Trapecar, Martin/0000-0002-0860-8948; Goropevsek, Ales/0000-0002-2188-578X; Gorenjak, Mario/0000-0003-4208-9683				Boirivant M, 2008, MUCOSAL IMMUNOL, V1, pS47, DOI 10.1038/mi.2008.52; Botic T, 2007, INT J FOOD MICROBIOL, V115, P227, DOI 10.1016/j.ijfoodmicro.2006.10.044; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Clavel Thomas, 2007, Curr Issues Intest Microbiol, V8, P25; Cross ML, 2001, INT IMMUNOPHARMACOL, V1, P891, DOI 10.1016/S1567-5769(01)00025-X; Curtis MM, 2011, MUCOSAL IMMUNOL, V4, P133, DOI 10.1038/mi.2010.89; de Kivit S, 2011, IMMUNOBIOLOGY, V216, P518, DOI 10.1016/j.imbio.2010.08.005; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Haller D, 2004, IMMUNOLOGY, V112, P310, DOI 10.1111/j.1365-2567.2004.01874.x; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Maragkoudakis PA, 2010, INT J FOOD MICROBIOL, V141, pS91, DOI 10.1016/j.ijfoodmicro.2009.12.024; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; MohanKumar K, 2012, AM J PHYSIOL-GASTR L, V303, pG93, DOI 10.1152/ajpgi.00016.2012; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Parlesak A, 2004, SCAND J IMMUNOL, V60, P477, DOI 10.1111/j.0300-9475.2004.01495.x; Patel RM, 2010, GUT MICROBES, V1, P186, DOI 10.4161/gmic.1.3.12484; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Sanz Y, 2009, INT REV IMMUNOL, V28, P397, DOI 10.3109/08830180903215613; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Trapecar M, 2011, APMIS, V119, P877, DOI 10.1111/j.1600-0463.2011.02797.x; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41	30	34	35	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e86297	10.1371/journal.pone.0086297	http://dx.doi.org/10.1371/journal.pone.0086297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454965	gold, Green Submitted, Green Published			2022-12-27	WOS:000330236000025
J	Jayaraman, A; Jamil, K				Jayaraman, Archana; Jamil, Kaiser			Drug Targets for Cell Cycle Dysregulators in Leukemogenesis: In Silico Docking Studies	PLOS ONE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; DEPENDENT KINASES CDK2; EXPRESSION; CHILDHOOD; PROTEIN; ACTIVATION; INHIBITORS; D3; DIFFERENTIATION; PROGRESSION	Alterations in cell cycle regulating proteins are a key characteristic in neoplastic proliferation of lymphoblast cells in patients with Acute Lymphoblastic Leukemia (ALL). The aim of our study was to investigate whether the routinely administered ALL chemotherapeutic agents would be able to bind and inhibit the key deregulated cell cycle proteins such as - Cyclins E1, D1, D3, A1 and Cyclin Dependent Kinases (CDK) 2 and 6. We used Schrodinger Glide docking protocol to dock the chemotherapeutic drugs such as Doxorubicin and Daunorubicin and others which are not very common including Clofarabine, Nelarabine and Flavopiridol, to the crystal structures of these proteins. We observed that the drugs were able to bind and interact with cyclins E1 and A1 and CDKs 2 and 6 while their docking to cyclins D1 and D3 were not successful. This binding proved favorable to interact with the G1/S cell cycle phase proteins that were examined in this study and may lead to the interruption of the growth of leukemic cells. Our observations therefore suggest that these drugs could be explored for use as inhibitors for these cell cycle proteins. Further, we have also highlighted residues which could be important in the designing of pharmacophores against these cell cycle proteins. This is the first report in understanding the mechanism of action of the drugs targeting these cell cycle proteins in leukemia through the visualization of drug-target binding and molecular docking using computational methods.	[Jayaraman, Archana; Jamil, Kaiser] Jawaharlal Nehru Inst Adv Studies, Sch Life Sci, Ctr Biotechnol & Bioinformat, Secunderabad, Andhra Pradesh, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Jamil, K (corresponding author), Jawaharlal Nehru Inst Adv Studies, Sch Life Sci, Ctr Biotechnol & Bioinformat, Secunderabad, Andhra Pradesh, India.	kj.bmmrc@gmail.com						Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Ahmed M, 2012, OPEN ACCESS SCI REPO, V1, P458; Ahmed M., 2011, BIOL MED PARIS, V3, P60; Ahmed M, 2012, INT J PHARM SCI HLTH, V2, P76; Ardekani Ali M., 2011, Avicenna Journal of Medical Biotechnology, V3, P177; Aref S, 2006, HEMATOLOGY, V11, P31, DOI 10.1080/10245330500322321; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Bonet J, 2006, PROTEINS, V63, P65, DOI 10.1002/prot.20791; BOSTROM B, 1993, AM J PEDIAT HEMATOL, V15, P80; Bueso-Ramos C, 2005, J CLIN ONCOL, V23, P3932, DOI 10.1200/JCO.2005.02.998; Byth KF, 2009, MOL CANCER THER, V8, P1856, DOI 10.1158/1535-7163.MCT-08-0836; Chilosi M, 1998, AM J PATHOL, V152, P209; Cho YS, 2010, J MED CHEM, V53, P7938, DOI 10.1021/jm100571n; Clare PM, 2001, J BIOL CHEM, V276, P48292, DOI 10.1074/jbc.M102034200; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Einsiedel HG, 2002, BLOOD, V99, P4629, DOI 10.1182/blood.V99.12.4629; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Goto H, 2012, ANTI-CANCER DRUG, V23, P417, DOI 10.1097/CAD.0b013e32834fb731; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Holm C, 2006, LEUKEMIA RES, V30, P254, DOI 10.1016/j.leukres.2005.07.010; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Jamil Kaiser, 2012, Avicenna Journal of Medical Biotechnology, V4, P121; Jamil Kaiser, 2011, BIOL MED, V3, P70; Jayaraman A, 2011, BIOL MED, V3; Jayaraman A., 2012, BIOL MED, V4, P37; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Joyce Michael J, 2013, J Pediatr Hematol Oncol, V35, P32, DOI 10.1097/MPH.0b013e318279afdd; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Kim SH, 2009, ARCH PHARM RES, V32, P915, DOI 10.1007/s12272-009-1614-2; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kotra S, 2008, J MOL GRAPH MODEL, V27, P244, DOI 10.1016/j.jmgm.2008.04.010; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuo TC, 2011, MOL CELL BIOL, V31, P2566, DOI 10.1128/MCB.01349-10; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Markaki EA, 2006, PEDIATR BLOOD CANCER, V47, P14, DOI 10.1002/pbc.20730; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Miller ME, 2005, YEAST, V22, P1021, DOI 10.1002/yea.1292; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Rivera G K, 1992, Semin Oncol, V19, P51; Sasaki E, 2007, PATHOL INT, V57, P53, DOI 10.1111/j.1440-1827.2006.02058.x; Schmitz NMR, 2005, LEUKEMIA, V19, P1783, DOI 10.1038/sj.leu.2403900; Scuderi R, 1996, BLOOD, V87, P3360, DOI 10.1182/blood.V87.8.3360.bloodjournal8783360; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shorey LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034975; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Stockwell SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028568; Volm M, 1997, INT J CANCER, V74, P508, DOI 10.1002/(SICI)1097-0215(19971021)74:5<508::AID-IJC5>3.0.CO;2-7; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; Zunino SJ, 2006, CANCER LETT, V240, P123, DOI 10.1016/j.canlet.2005.09.001	56	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86310	10.1371/journal.pone.0086310	http://dx.doi.org/10.1371/journal.pone.0086310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454966	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100151
J	Calhoun, KC; Padilla-Banks, E; Jefferson, WN; Liu, LW; Gerrish, KE; Young, SL; Wood, CE; Hunt, PA; VandeVoort, CA; Williams, CJ				Calhoun, Kathryn C.; Padilla-Banks, Elizabeth; Jefferson, Wendy N.; Liu, Liwen; Gerrish, Kevin E.; Young, Steven L.; Wood, Charles E.; Hunt, Patricia A.; VandeVoort, Catherine A.; Williams, Carmen J.			Bisphenol A Exposure Alters Developmental Gene Expression in the Fetal Rhesus Macaque Uterus	PLOS ONE			English	Article							FOOT-GENITAL SYNDROME; WIDESPREAD EXPOSURE; MACACA-FASCICULARIS; REPRODUCTIVE-TRACT; MAMMARY-GLAND; MONKEY; MOUSE; MUTATION; ADULT; WNT4	Bisphenol A (BPA) exposure results in numerous developmental and functional abnormalities in reproductive organs in rodent models, but limited data are available regarding BPA effects in the primate uterus. To determine if maternal oral BPA exposure affects fetal uterine development in a non-human primate model, pregnant rhesus macaques carrying female fetuses were exposed orally to 400 mu g/kg BPA or vehicle control daily from gestation day (GD) 50-100 or GD100-165. Fetal uteri were collected at the completion of treatment (GD100 or GD165); tissue histology, cell proliferation, and expression of estrogen receptor alpha (ER alpha) and progesterone receptor (PR) were compared to that of controls. Gene expression analysis was conducted using rhesus macaque microarrays. There were no significant differences in histology or in the percentage of cells expressing the proliferation marker Ki-67, ER alpha, or PR in BPA-exposed uteri compared to controls at GD100 or GD165. Minimal differences in gene expression were observed between BPA-exposed and control GD100 uteri. However, at GD165, BPA-exposed uteri had significant differences in gene expression compared to controls. Several of the altered genes, including HOXA13, WNT4, and WNT5A, are critical for reproductive organ development and/or adult function. We conclude that second or third trimester BPA exposure does not significantly affect fetal uterus development based on morphological, proliferation, and steroid hormone receptor assessments. However, differences in expression of key developmental genes after third trimester exposure suggest that BPA could alter transcriptional signals influencing uterine function later in life.	[Calhoun, Kathryn C.; Padilla-Banks, Elizabeth; Jefferson, Wendy N.; Williams, Carmen J.] NIEHS, Reprod Med Grp, Lab Reprod & Dev Toxicol, Res Triangle Pk, NC 27709 USA; [Calhoun, Kathryn C.; Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC USA; [Liu, Liwen; Gerrish, Kevin E.] NIEHS, Microarray Grp, Res Triangle Pk, NC 27709 USA; [Wood, Charles E.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Hunt, Patricia A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [VandeVoort, Catherine A.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [VandeVoort, Catherine A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); United States Environmental Protection Agency; Washington State University; University of California System; University of California Davis; University of California System; University of California Davis	Williams, CJ (corresponding author), NIEHS, Reprod Med Grp, Lab Reprod & Dev Toxicol, POB 12233, Res Triangle Pk, NC 27709 USA.	williamsc5@niehs.nih.gov	Williams, Carmen J/E-2170-2013; Young, Steven L/G-2304-2014	Williams, Carmen J/0000-0001-6440-7086; Young, Steven L/0000-0002-5205-4495	National Institutes of Health, National Institutes of Environmental Health Sciences [ES102405, ES016770, ES013527]; National Center for Research Resources, Office of the Director to the California National Primate Research Center [RR000169/OD011107]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102405, R01ES016770, R01ES013527, ZICES102445] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources, Office of the Director to the California National Primate Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institutes of Environmental Health Sciences [ES102405 to C.J.W.], National Institutes of Health, National Institutes of Environmental Health Sciences (http://www.niehs.nih.gov/) [ES016770 to C. A. V. and P. A. H. and ES013527 to P. A. H.], and the National Center for Research Resources (http://www.nih.gov/about/almanac/organization/NCRR.htm), Office of the Director to the California National Primate Research Center [RR000169/OD011107]. This manuscript was approved for publication by the National Health and Environmental Effects Research Laboratory of the Environmental Protection Agency but does not necessarily represent the opinions or policy of the agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1982, TOXICOL LETT, V11, P43, DOI 10.1016/0378-4274(82)90103-5; ATKINSON LE, 1975, BIOL REPROD, V12, P335, DOI 10.1095/biolreprod12.3.335; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; BERNASCONE I, 2013, TRENDS CELL BIOL; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Brisken C, 2000, GENE DEV, V14, P650; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; Doerge DR, 2011, TOXICOL APPL PHARM, V255, P261, DOI 10.1016/j.taap.2011.07.009; DONNENFELD AE, 1992, AM J MED GENET, V44, P482, DOI 10.1002/ajmg.1320440419; Elsworth JD, 2013, NEUROTOXICOLOGY, V35, P113, DOI 10.1016/j.neuro.2013.01.001; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Illig R, 2013, DEV DYNAM, V242, P53, DOI 10.1002/dvdy.23893; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V317, P106, DOI 10.1016/j.mce.2009.11.013; Jefferson WN, 2011, ENVIRON HEALTH PERSP, V119, P1575, DOI 10.1289/ehp.1104018; Kwon HE, 2004, ANN NY ACAD SCI, V1034, P1, DOI 10.1196/annals.1335.001; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Smith CC, 2007, FASEB J, V21, P239, DOI 10.1096/fj.06-6635com; STILLMAN RJ, 1982, AM J OBSTET GYNECOL, V142, P905, DOI 10.1016/S0002-9378(16)32540-6; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Taylor HS, 1997, BIOL REPROD, V57, P1338, DOI 10.1095/biolreprod57.6.1338; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Valdes-Dapena M.A, 1973, THE UTERUS, P40; Van Esch E, 2008, TOXICOL PATHOL, V36, p67S, DOI 10.1177/0192623308326149; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Weinbauer GF, 2008, TOXICOL PATHOL, V36, p7S, DOI 10.1177/0192623308327412; Yin Y, 2005, J BIOCHEM, V137, P677, DOI 10.1093/jb/mvi087; Young T, 2009, CURR TOP DEV BIOL, V88, P235, DOI 10.1016/S0070-2153(09)88008-3	43	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85894	10.1371/journal.pone.0085894	http://dx.doi.org/10.1371/journal.pone.0085894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465770	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000031
J	Krings, GM; Carpantier, JF; Delvenne, JC				Krings, Gautier M.; Carpantier, Jean-Francois; Delvenne, Jean-Charles			Trade Integration and Trade Imbalances in the European Union: A Network Perspective	PLOS ONE			English	Article							EVOLUTION; MARKET	We study the ever more integrated and ever more unbalanced trade relationships between European countries. To better capture the complexity of economic networks, we propose two global measures that assess the trade integration and the trade imbalances of the European countries. These measures are the network (or indirect) counterparts to traditional (or direct) measures such as the trade-to-GDP (Gross Domestic Product) and trade deficit-to-GDP ratios. Our indirect tools account for the European inter-country trade structure and follow (i) a decomposition of the global trade flow into elementary flows that highlight the long-range dependencies between exporting and importing economies and (ii) the commute-time distance for trade integration, which measures the impact of a perturbation in the economy of a country on another country, possibly through intermediate partners by domino effect. Our application addresses the impact of the launch of the Euro. We find that the indirect imbalance measures better identify the countries ultimately bearing deficits and surpluses, by neutralizing the impact of trade transit countries, such as the Netherlands. Among others, we find that ultimate surpluses of Germany are quite concentrated in only three partners. We also show that for some countries, the direct and indirect measures of trade integration diverge, thereby revealing that these countries (e. g. Greece and Portugal) trade to a smaller extent with countries considered as central in the European Union network.	[Krings, Gautier M.; Delvenne, Jean-Charles] Catholic Univ Louvain, Inst Informat & Commun Technol Elect & Appl Math, B-1348 Louvain, Belgium; [Krings, Gautier M.] Real Impact Analyt Belgium, Brussels, Belgium; [Carpantier, Jean-Francois] Univ Luxembourg, Ctr Res Econ & Management, Luxembourg, Luxembourg; [Delvenne, Jean-Charles] Catholic Univ Louvain, Ctr Operat Res & Econometr, B-1348 Louvain, Belgium	Universite Catholique Louvain; University of Luxembourg; Universite Catholique Louvain	Delvenne, JC (corresponding author), Catholic Univ Louvain, Inst Informat & Commun Technol Elect & Appl Math, B-1348 Louvain, Belgium.	jean-charles.delvenne@uclouvain.be			Belgian Programme of Interuniversity Attraction Poles; Belgian Federal Science Policy Office; Action de Recherche Concerte (ARC) of the French Community of Belgium	Belgian Programme of Interuniversity Attraction Poles; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Action de Recherche Concerte (ARC) of the French Community of Belgium	G.K. and J.-C.D. are supported by the Belgian Programme of Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy Office and an Action de Recherche Concerte (ARC) of the French Community of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RE, 2006, WORKING PAPER SERIES; Bhattacharya K, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02002; Boley D, 2011, LINEAR ALGEBRA APPL, V435, P224, DOI 10.1016/j.laa.2011.01.030; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Duenas M, 2013, LEM PAPERS SERIES; Engel C, 2004, ECON POLICY, P347; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Fracasso A, 2009, J POLICY MODEL, V31, P601, DOI 10.1016/j.jpolmod.2009.05.016; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Grinstead C, 2006, INTRO PROBABILITY; HALL KM, 1970, MANAGE SCI, V17, P219, DOI 10.1287/mnsc.17.3.219; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198701; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; HIRSCHMAN AO, 1964, AM ECON REV, V54, P761; Koren Y, 2005, COMPUT MATH APPL, V49, P1867, DOI 10.1016/j.camwa.2004.08.015; Reyes J, 2008, ADV COMPLEX SYST, V11, P685, DOI 10.1142/S0219525908001945; Rnyi A, 1961, 4 BERK S MATH STAT P, P547; Rose AK, 2000, ECON POLICY, P7; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Soramaki K, 2007, PHYSICA A, V379, P317, DOI 10.1016/j.physa.2006.11.093	23	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83448	10.1371/journal.pone.0083448	http://dx.doi.org/10.1371/journal.pone.0083448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465381	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100004
J	Noorlander, CW; Tijsseling, D; Hessel, EVS; de Vries, WB; Derks, JB; Visser, GHA; de Graan, PNE				Noorlander, Cornelle W.; Tijsseling, Deodata; Hessel, Ellen V. S.; de Vries, Willem B.; Derks, Jan B.; Visser, Gerard H. A.; de Graan, Pierre N. E.			Antenatal Glucocorticoid Treatment Affects Hippocampal Development in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; NMDA RECEPTOR ACTIVATION; FETAL LUNG MATURATION; RAT DENTATE GYRUS; ADULT NEUROGENESIS; FOLLOW-UP; DEXAMETHASONE TREATMENT; CELL-PROLIFERATION; ADRENAL-STEROIDS	Synthetic glucocorticoids are administered to pregnant women at risk for preterm delivery, to enhance fetal lung maturation. The benefit of this treatment is well established, however caution is necessary because of possible unwanted side effects on development of different organ systems, including the brain. Actions of glucocorticoids are mediated by corticosteroid receptors, which are highly expressed in the hippocampus, a brain structure involved in cognitive functions. Therefore, we analyzed the effects of a single antenatal dexamethasone treatment on the development of the mouse hippocampus. A clinically relevant dose of dexamethasone (0.4 mg/kg) was administered to pregnant mice at embryonic day 15.5 and the hippocampus was analyzed from embryonic day 16 until adulthood. We investigated the effects of dexamethasone treatment on anatomical changes, apoptosis and proliferation in the hippocampus, hippocampal volume and on total body weight. Our results show that dexamethasone treatment reduced body weight and hippocampal volume transiently during development, but these effects were no longer detected at adulthood. Dexamethasone treatment increased the number of apoptotic cells in the hippocampus until birth, but postnatally no effects of dexamethasone treatment on apoptosis were found. During the phase with increased apoptosis, dexamethasone treatment reduced the number of proliferating cells in the subgranular zone of the dentate gyrus. The number of proliferative cells was increased at postnatal day 5 and 10, but was decreased again at the adult stage. This latter long-term and negative effect of antenatal dexamethasone treatment on the number of proliferative cells in the hippocampus may have important implications for hippocampal network function.	[Noorlander, Cornelle W.; Hessel, Ellen V. S.; de Graan, Pierre N. E.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Noorlander, Cornelle W.; Tijsseling, Deodata; Derks, Jan B.; Visser, Gerard H. A.] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands; [de Vries, Willem B.] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Tijsseling, D (corresponding author), Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands.	d.tijsseling-2@umcutrecht.nl	hessel, ellen/ABB-4007-2021	Hessel, Ellen/0000-0003-3960-7523; Hessel, Volker/0000-0002-9494-1519	Hersenstichting Nederland [8F00(2).32]	Hersenstichting Nederland	Funding source: Hersenstichting Nederland, Grant number: 8F00(2).32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea A, 1996, P NATL ACAD SCI USA, V93, P714, DOI 10.1073/pnas.93.2.714; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Derks JB, 1997, J PHYSIOL-LONDON, V499, P217, DOI 10.1113/jphysiol.1997.sp021922; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fisher BJ, 2002, INT J RADIAT ONCOL, V52, P996, DOI 10.1016/S0360-3016(01)02720-1; Fletcher AJW, 2002, J PHYSIOL-LONDON, V545, P649, DOI 10.1113/jphysiol.2001.015693; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOULD E, 1991, J COMP NEUROL, V313, P479, DOI 10.1002/cne.903130308; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1996, DEV NEUROSCI-BASEL, V18, P22, DOI 10.1159/000111392; Gould E, 1997, J NEUROSCI, V17, P2492; Guinn DA, 2001, JAMA-J AM MED ASSOC, V286, P1581, DOI 10.1001/jama.286.13.1581; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; Kanagawa T, 2006, AM J OBSTET GYNECOL, V194, P231, DOI 10.1016/j.ajog.2005.06.015; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Meijer OC, 1998, CRIT REV NEUROBIOL, V12, P1; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; MOSIER HD, 1987, PEDIATR RES, V22, P92; MUNCK A, 1971, PERSPECT BIOL MED, V14, P265; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Newnham J P, 2001, Semin Neonatol, V6, P285, DOI 10.1053/siny.2001.0064; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Noorlander CW, 2006, J COMP NEUROL, V499, P924, DOI 10.1002/cne.21162; Noorlandler CW, 2008, DEV NEUROBIOL, V68, P237, DOI 10.1002/dneu.20583; O'Shea TM, 2007, PEDIATRICS, V120, P594, DOI 10.1542/peds.2007-0486; Quinlivan JA, 2002, J PERINAT MED, V30, P209, DOI 10.1515/JPM.2002.029; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rodriiguez-Pinilla E, 2006, MED CLIN-BARCELONA, V127, P361, DOI 10.1157/13092436; Sandau US, 2007, NEUROSCIENCE, V144, P482, DOI 10.1016/j.neuroscience.2006.10.003; SAPOLSKY RM, 1985, BRAIN RES, V359, P300, DOI 10.1016/0006-8993(85)91440-4; SAPOLSKY RM, 1986, NEUROENDOCRINOLOGY, V43, P440, DOI 10.1159/000124561; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; SCHMAND B, 1990, PEDIATRICS, V86, P58; Sinha A, 2000, BRIT J OBSTET GYNAEC, V107, P578, DOI 10.1111/j.1471-0528.2000.tb13291.x; SMOLDERSDEHAAS H, 1990, PEDIATRICS, V86, P65; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tauber SC, 2006, BRAIN PATHOL, V16, P209, DOI 10.1111/j.1750-3639.2006.00021.x; Tijsseling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033369; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; Weiler HA, 1997, BIOL NEONATE, V71, P53, DOI 10.1159/000244397; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; ZARROW MX, 1970, NATURE, V226, P1058, DOI 10.1038/2261058a0; Zuloaga DG, 2012, J NEUROSCI RES, V90, P1403, DOI 10.1002/jnr.23026	65	46	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85671	10.1371/journal.pone.0085671	http://dx.doi.org/10.1371/journal.pone.0085671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465645	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100058
J	Rotheram-Borus, MJ; Richter, LM; van Heerden, A; van Rooyen, H; Tomlinson, M; Harwood, JM; Comulada, WS; Stein, A				Rotheram-Borus, Mary Jane; Richter, Linda M.; van Heerden, Alastair; van Rooyen, Heidi; Tomlinson, Mark; Harwood, Jessica M.; Comulada, W. Scott; Stein, Alan			A Cluster Randomized Controlled Trial Evaluating the Efficacy of Peer Mentors to Support South African Women Living with HIV and Their Infants	PLOS ONE			English	Article							CHILD-DEVELOPMENT; DEPRESSION; SERVICES; MOTHERS; PMTCT; TRANSMISSION; SURVIVAL; OUTCOMES; RISK	Objective: We evaluate the effect of clinic-based support by HIV-positive Peer Mentors, in addition to standard clinic care, on maternal and infant well-being among Women Living with HIV (WLH) from pregnancy through the infant's first year of life. Methods: In a cluster randomized controlled trial in KwaZulu-Natal, South Africa, eight clinics were randomized for pregnant WLH to receive either: a Standard Care condition (SC; 4 clinics; n = 656 WLH); or an Enhanced Intervention (EI; 4 clinics; n = 544 WLH). WLH in the EI were invited to attend four antenatal and four postnatal meetings led by HIV-positive Peer Mentors, in addition to SC. WLH were recruited during pregnancy, and at least two post-birth assessment interviews were completed by 57% of WLH at 1.5, 6 or 12 months. EI's effect was ascertained on 19 measures of maternal and infant wellbeing using random effects regressions to control for clinic clustering. A binomial test for correlated outcomes evaluated EI's overall efficacy. Findings: WLH attended an average of 4.1 sessions (SD = 2.0); 13% did not attend any sessions. Significant overall benefits were found in EI compared to SC using the binomial test. Secondarily, over time, WLH in the EI reported significantly fewer depressive symptoms and fewer underweight infants than WLH in the SC condition. EI WLH were significantly more likely to use one feeding method for six months and exclusively breastfeed their infants for at least 6 months. Conclusions: WLH benefit by support from HIV-positive Peer Mentors, even though EI participation was partial, with incomplete follow-up rates from 6-12 months.	[Rotheram-Borus, Mary Jane; Harwood, Jessica M.; Comulada, W. Scott] Univ Calif Los Angeles, Global Ctr Children & Families, Los Angeles, CA 90095 USA; [Richter, Linda M.; van Heerden, Alastair; van Rooyen, Heidi] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, Gauteng, South Africa; [Richter, Linda M.] Human Sci Res Council, Durban, South Africa; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, Matieland, South Africa; [Stein, Alan] Univ Oxford, Dept Psychiat, Oxford, England	University of California System; University of California Los Angeles; University of Witwatersrand; Human Sciences Research Council-South Africa; Stellenbosch University; University of Oxford	Rotheram-Borus, MJ (corresponding author), Univ Calif Los Angeles, Global Ctr Children & Families, Los Angeles, CA 90095 USA.	CCHPublications@mednet.ucla.edu	Van Heerden, Alastair/AAY-6262-2020	Van Heerden, Alastair/0000-0003-2530-6885; Stein, Alan/0000-0001-8207-2822	NIMH [R01MH077553]; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH [P30MH058107]; UCLA AIDS Institute; UCLA Center for AIDS Research (CFAR) NIH [P30AI028697]; National Center for Advancing Translational Sciences through UCLA CSTI [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, R01MH077553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022919] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH; UCLA AIDS Institute; UCLA Center for AIDS Research (CFAR) NIH; National Center for Advancing Translational Sciences through UCLA CSTI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by the NIMH grant R01MH077553. In addition, this work was supported by the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant P30MH058107; the UCLA AIDS Institute and the UCLA Center for AIDS Research (CFAR) NIH grant P30AI028697; and the National Center for Advancing Translational Sciences through UCLA CSTI grant UL1TR000124. The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; [Anonymous], 2001, MOB RES VERS 4 0 0 S; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; Childinfo, MON SIT CHILDR WOM W; Cogill B, 2003, ANTHROPOMETRIC INDIC; Doherty T, 2011, B WORLD HEALTH ORGAN, V89, P62, DOI 10.2471/BLT.10.079798; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Kharsany ABM, 2004, 15 INT AIDS C BANGK; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; le Roux IM, 2011, VULNERABLE CHILD YOU, V6, P91, DOI 10.1080/17450128.2011.564224; Leshabari SC, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-22; Mothers2Mothers South Africa website, 2011 ANN REP; National Department of Health, 2008, POLICY IMPLEMENTATIO, P1; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rotheram-Borus MJ, 2011, PREV SCI, V12, P372, DOI 10.1007/s11121-011-0238-1; Rotheram-Borus MJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-2; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Smedslund G, 2004, J PSYCHOSOM RES, V57, P123, DOI 10.1016/S0022-3999(03)00575-0; Spensley A, 2009, AM J PUBLIC HEALTH, V99, P631, DOI 10.2105/AJPH.2007.114421; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Teasdale CA, 2008, S AFR J HIV MED, P60; Tomlinson M, 2006, CHILD CARE HLTH DEV, V32, P81, DOI 10.1111/j.1365-2214.2006.00598.x; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, 2009, 4 UNAIDS; UNICEF website, 2012, INF COUNTR PROGR; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; World Health Organization, 2008, MAT MENT HLTH CHILD; World Health Organization, 2007, TASK SHIFT TACKL HLT; World Health Organization website, PERC MEAN DAYS MONTH	34	52	52	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84867	10.1371/journal.pone.0084867	http://dx.doi.org/10.1371/journal.pone.0084867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465444	Green Published, gold			2022-12-27	WOS:000330283100015
J	Goddard, CA; Mysore, SP; Bryant, AS; Huguenard, JR; Knudsen, EI				Goddard, C. Alex; Mysore, Shreesh P.; Bryant, Astra S.; Huguenard, John R.; Knudsen, Eric I.			Spatially Reciprocal Inhibition of Inhibition within a Stimulus Selection Network in the Avian Midbrain	PLOS ONE			English	Article							OWL OPTIC TECTUM; FLEXIBLE CATEGORIZATION; GAMMA OSCILLATIONS; ENTORHINAL CORTEX; RANGE INHIBITION; VISUAL-CORTEX; CONNECTIONS; NUCLEUS; NEURONS; CIRCUIT	Reciprocal inhibition between inhibitory projection neurons has been proposed as the most efficient circuit motif to achieve the flexible selection of one stimulus among competing alternatives. However, whether such a motif exists in networks that mediate selection is unclear. Here, we study the connectivity within the nucleus isthmi pars magnocellularis (Imc), a GABAergic nucleus that mediates competitive selection in the midbrain stimulus selection network. Using laser photostimulation of caged glutamate, we find that feedback inhibitory connectivity is global within the Imc. Unlike typical lateral inhibition in other circuits, intra-Imc inhibition remains functionally powerful over long distances. Anatomically, we observed long-range axonal projections and retrograde somatic labeling from focal injections of bi-directional tracers in the Imc, consistent with spatial reciprocity of intra-Imc inhibition. Together, the data indicate that spatially reciprocal inhibition of inhibition occurs throughout the Imc. Thus, the midbrain selection circuit possesses the most efficient circuit motif possible for fast, reliable, and flexible selection.	[Goddard, C. Alex; Mysore, Shreesh P.; Bryant, Astra S.; Knudsen, Eric I.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Huguenard, John R.] Stanford Med Sch, Dept Neurol, Stanford, CA USA	Stanford University; Stanford University	Goddard, CA (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	alex.goddard@gmail.com	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bryant, Astra/0000-0002-0887-2044; Mysore, Shreesh/0000-0002-7781-8252	Stanford Dean's Postdoctoral fellowship; NEI [F32 EY018787, EY019179-31]; NINDS [NS34774]; Stanford Neuroscience Microscopy Service; NIH [NS069375]; NATIONAL EYE INSTITUTE [R01EY019179, F32EY018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034774, P30NS069375, R01NS034774, R01NS006477] Funding Source: NIH RePORTER	Stanford Dean's Postdoctoral fellowship; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford Neuroscience Microscopy Service; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Stanford Dean's Postdoctoral fellowship (CAG, SPM), NEI F32 EY018787 (CAG), NINDS NS34774 (JRH), NEI EY019179-31 (EIK), and the Stanford Neuroscience Microscopy Service, supported by NIH NS069375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi A, 2011, J NEUROSCI, V31, P6088, DOI 10.1523/JNEUROSCI.0023-11.2011; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Deleuze C, 2006, J NEUROSCI, V26, P8633, DOI 10.1523/JNEUROSCI.2333-06.2006; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Goddard CA, 2012, NEURON, V73, P567, DOI 10.1016/j.neuron.2011.11.028; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; Matsui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048730; MCDONALD CT, 1993, J NEUROSCI, V13, P768; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Mysore SP, 2013, NAT NEUROSCI, V16, P473, DOI 10.1038/nn.3352; Mysore SP, 2012, NEURON, V73, P193, DOI 10.1016/j.neuron.2011.10.037; Mysore SP, 2011, J NEUROSCI, V31, P7745, DOI 10.1523/JNEUROSCI.5425-10.2011; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; PETERS A, 1990, J COMP NEUROL, V302, P124, DOI 10.1002/cne.903020110; Pinto A, 2006, J COMP NEUROL, V495, P722, DOI 10.1002/cne.20905; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; SIK A, 1994, SCIENCE, V265, P1722, DOI 10.1126/science.8085161; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Tombol T, 1998, CELL TISSUE RES, V291, P255, DOI 10.1007/s004410050995; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035	33	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85865	10.1371/journal.pone.0085865	http://dx.doi.org/10.1371/journal.pone.0085865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465755	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500133
J	Hammitt, LL; Ojal, J; Bashraheil, M; Morpeth, SC; Karani, A; Habib, A; Borys, D; Goldblatt, D; Scott, JAG				Hammitt, Laura L.; Ojal, John; Bashraheil, Mahfudh; Morpeth, Susan C.; Karani, Angela; Habib, Ahsan; Borys, Dorota; Goldblatt, David; Scott, J. Anthony G.			Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1-4 Years: A Randomized Controlled Trial	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; STREPTOCOCCUS-PNEUMONIAE; PHID-CV; INFANTS; DISEASE; TODDLERS; BACTEREMIA	Background: The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown. Methods: 600 Kenyan children aged 12-59 months were vaccinated at days 0, 60 and 180 in a double-blind randomized controlled trial according to the following vaccine sequence: Group A: PHiD-CV, PHiD-CV, diphtheria/tetanus/acellular pertussis vaccine (DTaP); Group B: PHiD-CV, DTaP, PHiD-CV; Group C: hepatitis A vaccine (HAV), DTaP, HAV. Nasopharyngeal carriage of Streptococcus pneumoniae was measured at five timepoints. In 375 subjects, serotype-specific responses were measured by 22F-inhibition ELISA and opsonophagocytic killing assays (OPA) one month after vaccination. Results: Following one dose of PHiD-CV, >90% of recipients developed IgG >= 0.35 mu g/mL to serotypes 1, 4, 5, 7F, 9V and 18C and OPA >= 8 to serotypes 4, 7F, 9V, 18C, 23F. After a second dose >90% of recipients had IgG >= 0.35 mu g/mL to all vaccine serotypes and OPA >= 8 to all vaccine serotypes except 1 and 6B. At day 180, carriage of vaccine-type pneumococci was 21% in recipients of two doses of PHiD-CV (Group A) compared to 31% in controls (p = 0.04). Fever after dose 1 was reported by 41% of PHiD-CV recipients compared to 26% of HAV recipients (p<0.001). Other local and systemic adverse experiences were similar between groups. Conclusions: Vaccination of children aged 12-59 months with two doses of PHiD-CV two to six months apart was immunogenic, reduced vaccine-type pneumococcal carriage and was well-tolerated. Administration of PHiD-CV would be expected to provide effective protection against vaccine-type disease.	[Hammitt, Laura L.; Ojal, John; Bashraheil, Mahfudh; Morpeth, Susan C.; Karani, Angela; Scott, J. Anthony G.] Ctr Geog Med Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Hammitt, Laura L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Morpeth, Susan C.; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Habib, Ahsan; Borys, Dorota] GlaxoSmithKline Vaccines, Wavre, Belgium; [Goldblatt, David] UCL, Inst Child Hlth, London, England; [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; GlaxoSmithKline; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Hammitt, LL (corresponding author), Ctr Geog Med Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	lhammitt@jhsph.edu	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242; Ojal, John/0000-0002-3010-1158	GlaxoSmithKline Biologicals; GAVI through the PneumoADIP; Wellcome Trust of Great Britain [081835]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	GlaxoSmithKline Biologicals(GlaxoSmithKline); GAVI through the PneumoADIP; Wellcome Trust of Great Britain(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This was an investigator-initiated trial funded by GlaxoSmithKline Biologicals. The funders had no role in study design, data collection and analysis or decision to publish. D. B. and A. H. are employed by the funder and contributed to the manuscript. L. L. H. and S. C. M. are funded by GAVI through the PneumoADIP. J.A.G.S. is funded by a fellowship from the Wellcome Trust of Great Britain (No. 081835).	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bermal N, 2009, PEDIATR INFECT DIS J, V28, pS89, DOI 10.1097/INF.0b013e318199f901; Binks MJ, 2012, 8 INT S PNEUM PNEUM; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dicko A, 2012, 8 INT S PNEUM PNEUM; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hammitt LL, 2012, 8 INT S PNEUM PNEUM; Henckaerts I, 2007, VACCINE, V25, P2518, DOI 10.1016/j.vaccine.2006.09.029; Knuf M, 2009, PEDIATR INFECT DIS J, V28, pS97, DOI 10.1097/INF.0b013e318199f61b; Lagos RM, 2011, HUM VACCINES, V7, P511, DOI 10.4161/hv.7.5.14634; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Maaroufi Y, 2007, J CLIN MICROBIOL, V45, P2305, DOI 10.1128/JCM.00102-07; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; O'Brien KL, 2007, J INFECT DIS, V196, P104, DOI 10.1086/518438; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Palmu AA, 2012, LANCET, V12, P61854; Plikaytis BD, 2000, J CLIN MICROBIOL, V38, P2043; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Prymula R, 2012, 8 INT S PNEUM PNEUM; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Sandstedt SA, 2008, J MICROBIOL METH, V75, P369, DOI 10.1016/j.mimet.2008.06.023; Schuerman L, 2011, CLIN VACCINE IMMUNOL, V18, P2161, DOI 10.1128/CVI.05313-11; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Silfverdal SA, 2012, 8 INT S PNEUM PNEUM; Smilie WG, 1940, AM J HYG, V32, P79, DOI 10.1093/oxfordjournals.aje.a118651; van den Bergh MR, 2012, 8 INT S PNEUM PNEUM; Vesikari T, 2011, PEDIATR INFECT DIS J, V30, pE130, DOI 10.1097/INF.0b013e31821d1790; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; World Health Organization, 2022, MOV FORW GOAL BOOST	34	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85459	10.1371/journal.pone.0085459	http://dx.doi.org/10.1371/journal.pone.0085459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465570	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330244500067
J	Koletsi, D; Fleming, PS; Seehra, J; Bagos, PG; Pandis, N				Koletsi, Despina; Fleming, Padhraig S.; Seehra, Jadbinder; Bagos, Pantelis G.; Pandis, Nikolaos			Are Sample Sizes Clear and Justified in RCTs Published in Dental Journals?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; MEDICAL-RESEARCH; STATISTICS; POWER; QUALITY	Sample size calculations are advocated by the CONSORT group to justify sample sizes in randomized controlled trials (RCTs). The aim of this study was primarily to evaluate the reporting of sample size calculations, to establish the accuracy of these calculations in dental RCTs and to explore potential predictors associated with adequate reporting. Electronic searching was undertaken in eight leading specific and general dental journals. Replication of sample size calculations was undertaken where possible. Assumed variances or odds for control and intervention groups were also compared against those observed. The relationship between parameters including journal type, number of authors, trial design, involvement of methodologist, single-/multi-center study and region and year of publication, and the accuracy of sample size reporting was assessed using univariable and multivariable logistic regression. Of 413 RCTs identified, sufficient information to allow replication of sample size calculations was provided in only 121 studies (29.3%). Recalculations demonstrated an overall median overestimation of sample size of 15.2% after provisions for losses to follow-up. There was evidence that journal, methodologist involvement (OR = 1.97, CI: 1.10, 3.53), multi-center settings (OR = 1.86, CI: 1.01, 3.43) and time since publication (OR = 1.24, CI: 1.12, 1.38) were significant predictors of adequate description of sample size assumptions. Among journals JCP had the highest odds of adequately reporting sufficient data to permit sample size recalculation, followed by AJODO and JDR, with 61% (OR = 0.39, CI: 0.19, 0.80) and 66% (OR = 0.34, CI: 0.15, 0.75) lower odds, respectively. Both assumed variances and odds were found to underestimate the observed values. Presentation of sample size calculations in the dental literature is suboptimal; incorrect assumptions may have a bearing on the power of RCTs.	[Koletsi, Despina] Univ Athens, Sch Med, Dept Orthodont, GR-11527 Athens, Greece; [Fleming, Padhraig S.] Queen Mary Univ London, Inst Dent, Barts & London Sch Med & Dent, London, England; [Seehra, Jadbinder] Kings Coll Hosp NHS Fdn Trust, Dept Orthodont, London, England; [Bagos, Pantelis G.] Univ Thessaly, Dept Comp Sci & Biomed Informat, Lamia, Greece; [Pandis, Nikolaos] Univ Bern, Fac Med, Sch Dent, Dept Orthodont & Dentofacial Orthoped, CH-3012 Bern, Switzerland	Athens Medical School; National & Kapodistrian University of Athens; University of London; Queen Mary University London; King's College Hospital NHS Foundation Trust; University of Bern; University of Geneva	Pandis, N (corresponding author), Univ Bern, Fac Med, Sch Dent, Dept Orthodont & Dentofacial Orthoped, CH-3012 Bern, Switzerland.	npandis@yahoo.com	Bagos, Pantelis/U-7140-2019; Koletsi, Despina/AAX-9366-2020	Bagos, Pantelis/0000-0003-4935-2325; Koletsi, Despina/0000-0001-6280-9372; Seehra, Jadbinder/0000-0002-3243-1580				ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Ayeni O, 2012, PLAST RECONSTR SURG, V130, p78E, DOI 10.1097/PRS.0b013e318254b1d1; Bacchetti P, 2002, BRIT MED J, V324, P1271, DOI 10.1136/bmj.324.7348.1271; Benson P, 2011, J ORTHOD, V38, P75, DOI 10.1179/14653121141290; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; Friede T, 2006, BIOMETRICAL J, V48, P537, DOI 10.1002/bimj.200510238; Gunsolley JC, 1992, J PERIODONTOL, V69, P521; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; HUJOEL PP, 1992, J CLIN PERIODONTOL, V19, P779, DOI 10.1111/j.1600-051X.1992.tb02170.x; Jokstad A, 2002, INT J PROSTHODONT, V15, P230; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; Koletsi D, 2013, EUR J ORTHO IN PRESS; Lesaffre E, 2007, J CLIN PERIODONTOL, V34, P756, DOI 10.1111/j.1600-051X.2007.01118.x; Machin D, 1997, SAMPLE SIZE TABLES C; Pandis Nikolaos, 2011, J Evid Based Dent Pract, V11, P75, DOI 10.1016/j.jebdp.2010.11.026; Pandis N, 2010, J DENT, V38, P713, DOI 10.1016/j.jdent.2010.05.014; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Prihoda T J, 1992, J Prosthodont, V1, P51, DOI 10.1111/j.1532-849X.1992.tb00428.x; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Vickers AJ, 2003, J CLIN EPIDEMIOL, V56, P717, DOI 10.1016/S0895-4356(03)00141-0; Williams JL, 1997, AM J PHYSIOL-HEART C, V273, pH487, DOI 10.1152/ajpheart.1997.273.1.H487; WITTES J, 1990, STAT MED, V9, P65, DOI 10.1002/sim.4780090113; Wooding W. M, 1994, PLANNING PHARM CLIN	27	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85949	10.1371/journal.pone.0085949	http://dx.doi.org/10.1371/journal.pone.0085949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465806	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500153
J	Kotlo, K; Xing, YN; Lather, S; Grillon, JM; Johnson, K; Skidgel, RA; Solaro, RJ; Danziger, RS				Kotlo, Kumar; Xing, Yongna; Lather, Sonia; Grillon, Jean Michel; Johnson, Keven; Skidgel, Randal A.; Solaro, R. John; Danziger, Robert S.			PR65A Phosphorylation Regulates PP2A Complex Signaling	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; HEART-FAILURE; CARDIAC MYOCYTES; TUMOR-ANTIGENS; A-SUBUNIT; DEPHOSPHORYLATION; HOLOENZYME; STIMULATION; MECHANISM; INSIGHTS	Serine-threonine Protein phosphatase 2 A (PP2A), a member of the PPP family of phosphatases, regulates a variety of essential cellular processes, including cell-cycling, DNA replication, transcription, translation, and secondary signaling pathways. In the heart, increased PP2A activity/signaling has been linked to cardiac remodeling, contractile dysfunction and, in failure, arrythmogenicity. The core PP2A complex is a hetero-trimeric holoenzyme consisting of a 36 kDa catalytic subunit (PP2Ac); a regulatory scaffold subunit of 65 kDa (PR65A or PP2Aa); and one of at least 18 associated variable regulatory proteins (B subunits) classified into 3 families. In the present study, three in vivo sites of phosphorylation in cardiac PR65A are identified (S303, T268, S314). Using HEK cells transfected with recombinant forms of PR65A with phosphomimetic (P-PR65A) and non-phosphorylated (N-PR65A) amino acid substitutions at these sites, these phosphorylations were shown to inhibit the interaction of PR65A with PP2Ac and PP2A holoenzyme signaling. Forty-seven phospho-proteins were increased in abundance in HEK cells transfected with P-PR65A versus N-PR65A by phospho-protein profiling using 2D-DIGE analysis on phospho-enriched whole cell protein extracts. Among these proteins were elongation factor 1 alpha (EF1A), elongation factor 2, heat shock protein 60 (HSP60), NADPH-dehydrogenase 1 alpha sub complex, annexin A, and PR65A. Compared to controls, failing hearts from the Dahl rat had less phosphorylated PR65A protein abundance and increased PP2A activity. Thus, PR65A phosphorylation is an in vivo mechanism for regulation of the PP2A signaling complex and increased PP2A activity in heart failure.	[Kotlo, Kumar; Grillon, Jean Michel; Solaro, R. John; Danziger, Robert S.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Kotlo, Kumar; Grillon, Jean Michel; Solaro, R. John; Danziger, Robert S.] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL USA; [Solaro, R. John; Danziger, Robert S.] Univ Illinois, Dept Physiol, Chicago, IL USA; [Lather, Sonia; Danziger, Robert S.] Jesse Brown Vet Adm, Chicago, IL USA; [Xing, Yongna] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Johnson, Keven; Skidgel, Randal A.; Danziger, Robert S.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Danziger, RS (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	rdanzig@uic.edu			R21 Veterans Administration Merit Award; NIH [R21HL096031, KO1 DK071641, T32 HL 07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, R21HL096031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER	R21 Veterans Administration Merit Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by R21 Veterans Administration Merit Award (RSD) and NIH grants R21HL096031 (RSD), KO1 DK071641 (KK), and T32 HL 07692 (KRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; ALTSCHULD RA, 1995, CIRCULATION, V92, P1612, DOI 10.1161/01.CIR.92.6.1612; Basu S, 2011, CURR PROTEIN PEPT SC, V12, P3, DOI 10.2174/138920311795659443; Briston SJ, 2011, J PHYSIOL-LONDON, V589, P1367, DOI 10.1113/jphysiol.2010.203984; Buscemi N, 2002, CIRC RES, V91, P509, DOI 10.1161/01.RES.0000035246.27856.53; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Dorovkov MV, 2011, BIOCHEMISTRY-US, V50, P2187, DOI 10.1021/bi101963h; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kohr MJ, 2009, NITRIC OXIDE-BIOL CH, V20, P217, DOI 10.1016/j.niox.2009.01.003; Kotlo K, 2012, J PROTEOMICS, V77, P1, DOI 10.1016/j.jprot.2012.05.041; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; MOVSESIAN MA, 1990, J CLIN INVEST, V85, P1698, DOI 10.1172/JCI114623; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Niizeki T, 2008, AM J CARDIOL, V102, P606, DOI 10.1016/j.amjcard.2008.04.030; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Qin C, 2012, BR J PHARM; Ritchie RH, 2003, EUR J PHARMACOL, V461, P171, DOI 10.1016/S0014-2999(03)01314-1; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Vittone L, 2008, FRONT BIOSCI-LANDMRK, V13, P5988, DOI 10.2741/3131; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	34	8	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85000	10.1371/journal.pone.0085000	http://dx.doi.org/10.1371/journal.pone.0085000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465463	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500025
J	Lin, YT; Kuo, CH; Hwang, IS				Lin, Yen-Ting; Kuo, Chia-Hua; Hwang, Ing-Shiou			Fatigue Effect on Low-Frequency Force Fluctuations and Muscular Oscillations during Rhythmic Isometric Contraction	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; MANUAL TRACKING; MUSCLE FATIGUE; CORTICOMUSCULAR COHERENCE; OUTPUT VARIABILITY; DISCHARGE PATTERNS; LIMB ACCELERATION; MOTOR DRIVE; INTERMITTENCY; TASK	Continuous force output containing numerous intermittent force pulses is not completely smooth. By characterizing force fluctuation properties and force pulse metrics, this study investigated adaptive changes in trajectory control, both force-generating capacity and force fluctuations, as fatigue progresses. Sixteen healthy subjects (20-24 years old) completed rhythmic isometric gripping with the non-dominant hand to volitional failure. Before and immediately following the fatigue intervention, we measured the gripping force to couple a 0.5 Hz sinusoidal target in the range of 50-100% maximal voluntary contraction. Dynamic force output was off-line decomposed into 1) an ideal force trajectory spectrally identical to the target rate; and 2) a force pulse trace pertaining to force fluctuations and error-correction attempts. The amplitude of ideal force trajectory regarding to force-generating capacity was more suppressed than that of the force pulse trace with increasing fatigue, which also shifted the force pulse trace to lower frequency bands. Multi-scale entropy analysis revealed that the complexity of the force pulse trace at high time scales increased with fatigue, contrary to the decrease in complexity of the force pulse trace at low time scales. Statistical properties of individual force pulses in the spatial and temporal domains varied with muscular fatigue, concurrent with marked suppression of gamma muscular oscillations (4060 Hz) in the post-fatigue test. In conclusion, this study first reveals that muscular fatigue impairs the amplitude modulation of force pattern generation more than it affects the amplitude responsiveness of fine-tuning a force trajectory. Besides, motor fatigue results disadvantageously in enhancement of motor noises, simplification of short-term force-tuning strategy, and slow responsiveness to force errors, pertaining to dimensional changes in force fluctuations, scaling properties of force pulse, and muscular oscillation.	[Lin, Yen-Ting] Asia Univ, Phys Educ Off, Taichung, Taiwan; [Lin, Yen-Ting; Kuo, Chia-Hua] Univ Taipei, Dept Sports Sci, Taipei, Taiwan; [Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan; [Hwang, Ing-Shiou] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan 70101, Taiwan	Asia University Taiwan; University of Taipei; National Cheng Kung University; National Cheng Kung University	Hwang, IS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan.	ishwang@mail.ncku.edu.tw		Kuo, Chia-Hua/0000-0002-1731-4984				Allen TJ, 2010, J PHYSIOL-LONDON, V588, P1369, DOI 10.1113/jphysiol.2010.187732; Andersen B, 2012, J APPL PHYSIOL, V112, P832, DOI 10.1152/japplphysiol.00917.2009; Andrykiewicz A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-101; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Bedrov YA, 2007, BIOSYSTEMS, V89, P50, DOI 10.1016/j.biosystems.2006.04.011; Boonstra TW, 2012, J NEUROPHYSIOL, V107, P796, DOI 10.1152/jn.00066.2011; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074273; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; DESMEDT JE, 1978, J PHYSIOL-LONDON, V285, P185, DOI 10.1113/jphysiol.1978.sp012566; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Feldman A G, 1998, Motor Control, V2, P189; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Househam E, 2004, MUSCLE NERVE, V29, P401, DOI 10.1002/mus.10564; Huang CT, 2007, EUR J APPL PHYSIOL, V100, P675, DOI 10.1007/s00421-007-0460-5; Huang CT, 2006, EUR J APPL PHYSIOL, V97, P362, DOI 10.1007/s00421-006-0166-0; IYER MB, 1994, NEUROSCI LETT, V170, P94, DOI 10.1016/0304-3940(94)90247-X; Jones LA, 1995, ADV EXP MED BIOL, V384, P305; Jordan K, 2004, EXP BRAIN RES, V156, P451, DOI 10.1007/s00221-003-1806-9; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Li K, 2013, NEUROSCI LETT, V545, P1, DOI 10.1016/j.neulet.2013.04.011; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Missenard O, 2009, MUSCLE NERVE, V40, P1019, DOI 10.1002/mus.21331; Mottram CJ, 2005, J NEUROPHYSIOL, V93, P1381, DOI 10.1152/jn.00837.2004; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Park WH, 2007, EXP BRAIN RES, V182, P169, DOI 10.1007/s00221-007-0978-0; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; Selen LPJ, 2006, J NEUROPHYSIOL, V96, P2750, DOI 10.1152/jn.00552.2006; Singh T, 2010, NEUROSCI LETT, V485, P204, DOI 10.1016/j.neulet.2010.09.012; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Slifkin AB, 2000, J MOTOR BEHAV, V32, P141, DOI 10.1080/00222890009601366; Sosnoff JJ, 2005, J MOTOR BEHAV, V37, P325, DOI 10.3200/JMBR.37.4.325-336; Sosnoff JJ, 2005, BEHAV BRAIN RES, V158, P301, DOI 10.1016/j.bbr.2004.09.009; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2000, EUR J APPL PHYSIOL, V83, P106, DOI 10.1007/s004210000269; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vila-Cha C, 2012, MED SCI SPORT EXER, V44, P616, DOI 10.1249/MSS.0b013e318235d81d; Westad C, 2003, J PHYSIOL-LONDON, V552, P645, DOI 10.1113/jphysiol.2003.044990; Z'Graggen WJ, 2005, CLIN NEUROPHYSIOL, V116, P1628, DOI 10.1016/j.clinph.2005.03.012	56	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85578	10.1371/journal.pone.0085578	http://dx.doi.org/10.1371/journal.pone.0085578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465605	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500078
J	Dai, Q; Zhan, XJ; Lu, B; Fu, JZ; Wang, Q; Qi, DW				Dai, Qiang; Zhan, Xiangjiang; Lu, Bin; Fu, Jinzhong; Wang, Qian; Qi, Dunwu			Spatial Genetic Structure Patterns of Phenotype-Limited and Boundary-Limited Expanding Populations: A Simulation Study	PLOS ONE			English	Article							RANGE EXPANSION; CLIMATE-CHANGE; DIVERSITY; DIFFERENTIATION; DISTRIBUTIONS; AMERICAN; FRONT	Range expansions may create a unique spatial genetic pattern characterized by alternate genetically homogeneous domains and allele frequency clines. Previous attempts to model range expansions have mainly focused on the loss of genetic diversity during expansions. Using individual-based models, we examined spatial genetic patterns under two expansion scenarios, boundary-limited range expansions (BLRE) and phenotype-limited range expansions (PhLRE). Our simulation revealed that the genetic diversity within populations lost quickly during the range expansion, while the genetic difference accumulated between populations. Consequently, accompanying the expansions, the overall diversity featured a slow decrease. Specifically, during BLREs, high speed of boundary motion facilitated the maintenance of total genetic diversity and sharpened genetic clines. Very slight constraints on boundary motion of BLREs drastically narrowed the homogeneous domains and increased the allele frequency fluctuations from those levels exhibited by PhLREs. Even stronger constraints, however, surprisingly brought the width of homogeneous domains and the allele frequency fluctuations back to the normal levels of PhLREs. Furthermore, high migration rates maintained a higher total genetic diversity than low ones did during PhLREs. Whereas, the total genetic diversities during BLREs showed a contrary pattern: higher when migration was low than those when migration was high. Besides, the increase of migration rates helped maintain a greater number of homogeneous domains during PhLREs, but their effects on the number of homogeneous domains during BLREs were not monotonous. Previous studies have showed that the homogenous domains can merge to form a few broad domains as the expansion went on, leading to fewer homogeneous domains. Our simulations, meanwhile, revealed that the range expansions could also rebuild homogeneous domains from the clines during the range expansion. It is possible that that the number of homogeneous domains was determined by the interaction of merging and newly emerging homogeneous domains.	[Dai, Qiang; Lu, Bin; Fu, Jinzhong; Wang, Qian] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhan, Xiangjiang] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Dai, Qiang; Qi, Dunwu] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife, Chengdu, Sichuan, Peoples R China; [Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Cardiff University; University of Guelph	Dai, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	daiqiang@cib.ac.cn	Dai, Qiang/L-6867-2019	Dai, Qiang/0000-0002-7850-997X	National Natural Science Foundation of China; National Sciences and Engineering Research Council; Leading Foundation of the Chinese Academy of Sciences [XDA05050404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leading Foundation of the Chinese Academy of Sciences	This project is supported by a National Natural Science Foundation of China grant and a National Sciences and Engineering Research Council Discovery grant to JF and Leading Foundation of the Chinese Academy of Sciences (XDA05050404) to QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Armbruster P, 1998, EVOLUTION, V52, P1697, DOI 10.1111/j.1558-5646.1998.tb02249.x; Behrman KD, 2011, J EVOLUTION BIOL, V24, P665, DOI 10.1111/j.1420-9101.2010.02195.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; D'Andrea L, 2009, J BIOGEOGR, V36, P1573, DOI 10.1111/j.1365-2699.2008.02060.x; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; EPPERSON BK, 1995, GENETICS, V140, P1431; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Ficetola GF, 2007, BIOL INVASIONS, V9, P767, DOI 10.1007/s10530-006-9080-y; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Habel JC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-215; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Hallatschek O, 2010, EVOLUTION, V64, P193, DOI 10.1111/j.1558-5646.2009.00809.x; Hallatschek O, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108103; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Holt RD, 2003, EVOL ECOL RES, V5, P159; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kluver J, 2011, COMPLEXITY, V16, P10, DOI 10.1002/cplx.20317; Korolev KS, 2010, REV MOD PHYS, V82, P1691, DOI 10.1103/RevModPhys.82.1691; Korolev KS, 2011, AM NAT, V178, P538, DOI 10.1086/661897; Kuhr JT, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113013; Legendre P., 2012, NUMERICAL ECOLOGY; Lihova J, 2010, AM J BOT, V97, P1058, DOI 10.3732/ajb.0900361; Maclean IMD, 2008, GLOBAL CHANGE BIOL, V14, P2489, DOI 10.1111/j.1365-2486.2008.01666.x; McInerny GJ, 2009, P ROY SOC B-BIOL SCI, V276, P1527, DOI 10.1098/rspb.2008.1567; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nullmeier J, 2013, EVOLUTION, V67, P1307, DOI 10.1111/evo.12037; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Provan J, 2012, P ROY SOC B-BIOL SCI, V279, P39, DOI 10.1098/rspb.2011.0536; R Core Team, 2012, R LANG ENV STAT COMP; Roques L, 2012, P NATL ACAD SCI USA, V109, P8828, DOI 10.1073/pnas.1201695109; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schmitt T, 2002, HEREDITY, V89, P20, DOI 10.1038/sj.hdy.6800087; SOKAL RR, 1983, GENETICS, V105, P219; SOKAL RR, 1989, GENETICS, V121, P845; TAKAHATA N, 1985, GENETICS, V110, P325; Vandewoestijne S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013810; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x	41	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85778	10.1371/journal.pone.0085778	http://dx.doi.org/10.1371/journal.pone.0085778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465700	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500071
J	Handtke, S; Schroeter, R; Jurgen, B; Methling, K; Schluter, R; Albrecht, D; van Hijum, SAFT; Bongaerts, J; Maurer, KH; Lalk, M; Schweder, T; Hecker, M; Voigt, B				Handtke, Stefan; Schroeter, Rebecca; Juergen, Britta; Methling, Karen; Schlueter, Rabea; Albrecht, Dirk; van Hijum, Sacha A. F. T.; Bongaerts, Johannes; Maurer, Karl-Heinz; Lalk, Michael; Schweder, Thomas; Hecker, Michael; Voigt, Birgit			Bacillus pumilus Reveals a Remarkably High Resistance to Hydrogen Peroxide Provoked Oxidative Stress	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MOLECULAR-WEIGHT THIOL; TRANSCRIPTIONAL CONTROL; ESCHERICHIA-COLI; GLOBAL REGULATOR; SUBTILIS-FUR; KATX GENE; PROTEIN; DNA; BACILLITHIOL	Bacillus pumilus is characterized by a higher oxidative stress resistance than other comparable industrially relevant Bacilli such as B. subtilis or B. licheniformis. In this study the response of B. pumilus to oxidative stress was investigated during a treatment with high concentrations of hydrogen peroxide at the proteome, transcriptome and metabolome level. Genes/proteins belonging to regulons, which are known to have important functions in the oxidative stress response of other organisms, were found to be upregulated, such as the Fur, Spx, SOS or CtsR regulon. Strikingly, parts of the fundamental PerR regulon responding to peroxide stress in B. subtilis are not encoded in the B. pumilus genome. Thus, B. pumilus misses the catalase KatA, the DNA-protection protein MrgA or the alkyl hydroperoxide reductase AhpCF. Data of this study suggests that the catalase KatX2 takes over the function of the missing KatA in the oxidative stress response of B. pumilus. The genome-wide expression analysis revealed an induction of bacillithiol (Cys-GlcN-malate, BSH) relevant genes. An analysis of the intracellular metabolites detected high intracellular levels of this protective metabolite, which indicates the importance of bacillithiol in the peroxide stress resistance of B. pumilus.	[Handtke, Stefan; Schlueter, Rabea; Albrecht, Dirk; Hecker, Michael; Voigt, Birgit] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Schroeter, Rebecca; Juergen, Britta; Schweder, Thomas] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Greifswald, Germany; [Methling, Karen; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany; [van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, CMBI, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.] NIZO Food Res BV, Div Proc & Safety, Ede, Netherlands; [Bongaerts, Johannes] Aachen Univ Appl Sci, Dept Chem & Biotechnol, Julich, Germany; [Maurer, Karl-Heinz] AB Enzymes GmbH, Darmstadt, Germany; [Schweder, Thomas; Hecker, Michael; Voigt, Birgit] Inst Marine Biotechnol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Radboud University Nijmegen; NIZO Food Research	Voigt, B (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany.	birgit.voigt@uni-greifswald.de	van Hijum, Sacha/F-6445-2014; Lalk, Michael/C-1618-2010	Lalk, Michael/0000-0002-9230-0267; Voigt, Birgit/0000-0003-4534-6315; van Hijum, Sacha/0000-0003-0741-2991; Schweder, Thomas/0000-0002-7213-3596	Competence Network "Mipro - Microbes for production: A genomics-based approach to engineer novel industrial production strains" [0315594B]; German Federal Ministry of Education and Research (BMBF); project "Ausbau und Profilierung von COAST Fun-Gene" of the Bildungsministerium of Mecklenburg-Vorpommern [UG11043, ESF/IV-BM-B35-0003/12]; Henkel KGaA	Competence Network "Mipro - Microbes for production: A genomics-based approach to engineer novel industrial production strains"; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); project "Ausbau und Profilierung von COAST Fun-Gene" of the Bildungsministerium of Mecklenburg-Vorpommern; Henkel KGaA	This work was financially supported by funds of the Competence Network "Mipro - Microbes for production: A genomics-based approach to engineer novel industrial production strains" (0315594B) by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de) and the project "Ausbau und Profilierung von COAST Fun-Gene" (UG11043, ESF/IV-BM-B35-0003/12) of the Bildungsministerium of Mecklenburg-Vorpommern (www.regierung-mv.de). The transcriptome analysis was financially supported by the Henkel KGaA (www.henkel.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Bagyan I, 1998, J BACTERIOL, V180, P2057, DOI 10.1128/JB.180.8.2057-2062.1998; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Borodovsky M., 2003, CURRENT PROTOCOLS BI; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; FERNANDO MR, 1992, EUR J BIOCHEM, V209, P917, DOI 10.1111/j.1432-1033.1992.tb17363.x; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gaballa A, 2007, MOL MICROBIOL, V66, P164, DOI 10.1111/j.1365-2958.2007.05905.x; Gaballa A, 2013, MICROBIOL-SGM, V159, P2025, DOI 10.1099/mic.0.070482-0; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Guo FB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-9; Hecker M, 2001, ADV MICROB PHYSIOL, V44, P35, DOI 10.1016/S0065-2911(01)44011-2; Hecker M, 2009, RES MICROBIOL, V160, P245, DOI 10.1016/j.resmic.2009.03.008; Hoi LT, 2006, PROTEOMICS, V6, P3582, DOI 10.1002/pmic.200500842; Homuth G, 1997, J BACTERIOL, V179, P1153, DOI 10.1128/jb.179.4.1153-1164.1997; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ito M, 1999, J BACTERIOL, V181, P2394, DOI 10.1128/JB.181.8.2394-2402.1999; Kajiyama Y, 2007, J BACTERIOL, V189, P7511, DOI 10.1128/JB.00968-07; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; KEMPF B, 1995, J BIOL CHEM, V270, P16701, DOI 10.1074/jbc.270.28.16701; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Krishnamurthy M, 2010, NUCLEIC ACIDS RES, V38, P455, DOI 10.1093/nar/gkp909; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leichert LIO, 2003, J BACTERIOL, V185, P1967, DOI 10.1128/JB.185.6.1967-1975.2003; LOVE PE, 1985, P NATL ACAD SCI USA, V82, P6201, DOI 10.1073/pnas.82.18.6201; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Miller MC, 1996, J BIOL CHEM, V271, P33502, DOI 10.1074/jbc.271.52.33502; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Petersohn A, 1999, MOL GEN GENET, V262, P173, DOI 10.1007/s004380051072; Pothera DC, 2013, INT J MED MICROBIOL, V303, P114, DOI 10.1016/j.ijmm.2013.01.003; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Schroeter R, 2011, PROTEOMICS, V11, P2851, DOI 10.1002/pmic.201000461; Schweder T, 2004, ADV BIOCHEM ENG BIOT, V89, P47; Sharma SV, 2011, ANGEW CHEM INT EDIT, V50, P7101, DOI 10.1002/anie.201100196; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tu WY, 2012, J BACTERIOL, V194, P925, DOI 10.1128/JB.06005-11; Upton H, 2012, FEBS LETT, V586, P1004, DOI 10.1016/j.febslet.2012.02.028; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Voigt B, 2004, PROTEOMICS, V4, P1465, DOI 10.1002/pmic.200300684; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	69	36	37	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85625	10.1371/journal.pone.0085625	http://dx.doi.org/10.1371/journal.pone.0085625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465625	Green Published, gold			2022-12-27	WOS:000330240500061
J	Kiparsky, M; Joyce, B; Purkey, D; Young, C				Kiparsky, Michael; Joyce, Brian; Purkey, David; Young, Charles			Potential Impacts of Climate Warming on Water Supply Reliability in the Tuolumne and Merced River Basins, California	PLOS ONE			English	Article							SIERRA-NEVADA; HYDROLOGY; MODEL; RESOURCES; DRIVEN	We present an integrated hydrology/water operations simulation model of the Tuolumne and Merced River Basins, California, using the Water Evaluation and Planning (WEAP) platform. The model represents hydrology as well as water operations, which together influence water supplied for agricultural, urban, and environmental uses. The model is developed for impacts assessment using scenarios for climate change and other drivers of water system behavior. In this paper, we describe the model structure, its representation of historical streamflow, agricultural and urban water demands, and water operations. We describe projected impacts of climate change on hydrology and water supply to the major irrigation districts in the area, using uniform 2 degrees C, 4 degrees C, and 6 degrees C increases applied to climate inputs from the calibration period. Consistent with other studies, we find that the timing of hydrology shifts earlier in the water year in response to temperature warming (5-21 days). The integrated agricultural model responds with increased water demands 2 degrees C (1.4-2.0%), 4 degrees C (2.8-3.9%), and 6 degrees C (4.2-5.8%). In this sensitivity analysis, the combination of altered hydrology and increased demands results in decreased reliability of surface water supplied for agricultural purposes, with modeled quantity-based reliability metrics decreasing from a range of 0.84-0.90 under historical conditions to 0.75-0.79 under 6 degrees C warming scenario.	[Kiparsky, Michael] Univ Calif Berkeley, Wheeler Inst Water Law & Policy, Berkeley, CA 94720 USA; [Joyce, Brian; Purkey, David; Young, Charles] Stockholm Environm Inst, Davis, CA USA	University of California System; University of California Berkeley	Kiparsky, M (corresponding author), Univ Calif Berkeley, Wheeler Inst Water Law & Policy, Berkeley, CA 94720 USA.	kiparsky@berkeley.edu			NSF Graduate Research Fellowship; NSF Doctoral Dissertation Research Improvement Grant; CALFED Bay-Delta Program Fellowship; California Energy Commission PIER program	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF Doctoral Dissertation Research Improvement Grant; CALFED Bay-Delta Program Fellowship; California Energy Commission PIER program	This study received funding from an NSF Graduate Research Fellowship, an NSF Doctoral Dissertation Research Improvement Grant, a CALFED Bay-Delta Program Fellowship, and the California Energy Commission PIER program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami NK, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004745; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; BEVEN K, 1993, ADV WATER RESOUR, V16, P41, DOI 10.1016/0309-1708(93)90028-E; Beven K, 2001, HYDROL EARTH SYST SC, V5, P1, DOI 10.5194/hess-5-1-2001; California Department of Water Resources, 2006, CAL LAND WAT US DAT; Cayan D, 2009, CLIMATE CHANGE SCENA; CH2M Hill, 2001, MERC WAT SUPPL PLAN; Cooley H, 2008, MORE LESS AGR WATER; Dettinger M.D., 2005, SAN FRANCISCO ESTUAR, V3; Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f; Dracup J.A., 2005, CEC5002005053 PIER E; Draper AJ, 2004, J WATER RES PLAN MAN, V130, P480, DOI 10.1061/(ASCE)0733-9496(2004)130:6(480); DWR, 2004, BULLETIN, V118; DWR, 2003, BULLETIN, V118; DWR, 1975, BULLETIN, V113-3; ESRI, 2007, ARCGIS 9 2; ESRI, 2007, ARCHYDRO TOOLK; Evolving Logic, 2010, COMP AID REAS SOFTW; Flint LE, 2007, 1703B USGS; Getches DH, 2003, WATER AND CLIMATE IN THE WESTERN UNITED STATES, P183; GLEICK PH, 1987, CLIMATIC CHANGE, V10, P137, DOI 10.1007/BF00140252; Groves DG, 2005, QUANTIFIED SCENARIOS; HASHIMOTO T, 1982, WATER RESOUR RES, V18, P14, DOI 10.1029/WR018i001p00014; Joyce B, 2006, CLIMATE CHANGE IMPAC; Kiparsky M, 2005, WORLDS WATER 2004 20; Kiparsky M, 2003, CEC5002004073ED2; Kiparsky M, 2011, P AWRA 2011 SPRING S; Kiparsky M, 2012, ANNU REV ENV RESOUR, V37, P163, DOI 10.1146/annurev-environ-050311-093931; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Knowles N, 2000, HYDROCLIMATE SAN FRA; Koczot KM, 2005, 20045202 US GEOL SUR; Loucks DP, 2005, WATER RESOURCES SYST, P255; Lundquist J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006995; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; MBK Engineers, 2001, MERC WAT SUPPL PLAN; Multi-Resolution Land Characteristics Consortium, 2001, NAT LAND COV DAT; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; National Atlas of the United States, 2006, MAJ DAMS US; Natural Resources Conservation Service, 2006, US GEN SOIL MAP STAT; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Purkey DR, 2008, CLIMATIC CHANGE, V87, pS109, DOI 10.1007/s10584-007-9375-8; San Joaquin River Group Authority, 2001, ADD WAT SAN JOAQ RIV; Sanstad AH, 2009, LONG RUN SO IN PRESS; Schwarzenegger A., 2005, EXECUTIVE ORDER S 3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; State Water Resources Control Board, 1999, FIN ENV IMP REP IMPL, V1; State Water Resources Control Board, 1999, FIN ENV IMP REP IMPL, V2; State Water Resources Control Board, 2009, 20X2020 WAT CONS PLA; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Stockholm Environment Institute, 2011, WAT EV PLANN VERS 3; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; United States Bureau of Reclamation, 2003, STAT WAT DISTR CAL V; United States Bureau of Reclamation, 2006, FED WAT DISTR MIDP R; United States Department of Agriculture, 2006, SOIL SURV GEOGR SSUR; United States Geological Survey, 2007, NAT EL DAT; United States Geological Survey, 2013, NAT WAT INF SYST; URS, 2008, DELT MEND CAN REC IN; USBR, 2005, CALSIM 2 SA IN PRESS; USGS, 2007, NAT WAT INF SYST; Vicuna S, 2007, CLIMATIC CHANGE, V82, P327, DOI 10.1007/s 10584-006-9207-2; Vicuna S., 2010, CLIMATIC CHANGE; Wilby RL, 2009, INT J CLIMATOL, V29, P1193, DOI 10.1002/joc.1839; Yates D, 2005, WATER INT, V30, P487, DOI 10.1080/02508060508691893; Yates D, 2009, J WATER RES PLAN MAN, V135, P303, DOI 10.1061/(ASCE)0733-9496(2009)135:5(303); Young CA, 2009, J AM WATER RESOUR AS, V45, P1409, DOI 10.1111/j.1752-1688.2009.00375.x	68	15	15	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84946	10.1371/journal.pone.0084946	http://dx.doi.org/10.1371/journal.pone.0084946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465455	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500025
J	Oikonomou, G; Bicalho, ML; Meira, E; Rossi, RE; Foditsch, C; Machado, VS; Teixeira, AGV; Santisteban, C; Schukken, YH; Bicalho, RC				Oikonomou, Georgios; Bicalho, Marcela Lucas; Meira, Enoch; Rossi, Rodolfo Elke; Foditsch, Carla; Machado, Vinicius Silva; Teixeira, Andre Gustavo Vieira; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho			Microbiota of Cow's Milk; Distinguishing Healthy, Sub-Clinically and Clinically Diseased Quarters	PLOS ONE			English	Article							SOMATIC-CELL COUNTS; COAGULASE-NEGATIVE STAPHYLOCOCCI; RIBOSOMAL-RNA SEQUENCES; MASTITIS PATHOGENS; DAIRY-COWS; IDENTIFICATION; BACTERIA; LIFE; HERD; LACTATION	The objective of this study was to use pyrosequencing of the 16S rRNA genes to describe the microbial diversity of bovine milk samples derived from clinically unaffected quarters across a range of somatic cell counts (SCC) values or from clinical mastitis, culture negative quarters. The obtained microbiota profiles were used to distinguish healthy, subclinically and clinically affected quarters. Two dairy farms were used for the collection of milk samples. A total of 177 samples were used. Fifty samples derived from healthy, culture negative quarters with a SCC of less than 20,000 cells/ml (group 1); 34 samples derived from healthy, culture negative quarters, with a SCC ranging from 21,000 to 50,000 cells/ml (group 2); 26 samples derived from healthy, culture negative quarters with a SCC greater than 50,000 cells/ml (group 3); 34 samples derived from healthy, culture positive quarters, with a SCC greater than 400,000 (group 4, subclinical); and 33 samples derived from clinical mastitis, culture negative quarters (group 5, clinical). Bacterial DNA was isolated from these samples and the 16S rRNA genes were individually amplified and pyrosequenced. All samples analyzed revealed great microbial diversity. Four bacterial genera were present in every sample obtained from healthy quarters (Faecalibacterium spp., unclassified Lachnospiraceae, Propionibacterium spp. and Aeribacillus spp.). Discriminant analysis models showed that samples derived from healthy quarters were easily discriminated based on their microbiota profiles from samples derived from clinical mastitis, culture negative quarters; that was also the case for samples obtained from different farms. Staphylococcus spp. and Streptococcus spp. were among the most prevalent genera in all groups while a general multivariable linear model revealed that Sphingobacterium and Streptococcus prevalences were associated with increased 10 log SCC. Conversely, Nocardiodes and Paenibacillus were negatively correlated, and a higher percentage of the genera was associated with a lower 10 log SCC.	[Oikonomou, Georgios; Bicalho, Marcela Lucas; Meira, Enoch; Rossi, Rodolfo Elke; Foditsch, Carla; Machado, Vinicius Silva; Teixeira, Andre Gustavo Vieira; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Schukken, Ynte/ABD-3352-2021; Schukken, Ynte H/C-3405-2008	Schukken, Ynte/0000-0002-8250-4194; Schukken, Ynte H/0000-0002-8250-4194; Rossi, Rodolfo/0000-0002-4776-1232				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; Boyer PJ, 1997, VET REC, V141, P55; Bradley AJ, 2007, VET REC, V160, P253, DOI 10.1136/vr.160.8.253; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chen H, 2012, INT J SYST EVOL MICR, V62, P2835, DOI 10.1099/ijs.0.039636-0; Debois D, 2013, J AM SOC MASS SPECTR; Eberl G, 2009, MUCOSAL IMMUNOL, V2, P478, DOI 10.1038/mi.2009.114; Elad D, 2004, EMERG INFECT DIS, V10, P505, DOI 10.3201/eid1003.020592; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Green MJ, 2004, J DAIRY SCI, V87, P1256, DOI 10.3168/jds.S0022-0302(04)73276-2; Grohn YT, 2005, PREV VET MED, V71, P105, DOI 10.1016/j.prevetmed.2005.06.002; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hertl JA, 2010, J DAIRY SCI, V93, P1551, DOI 10.3168/jds.2009-2599; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jara S, 2011, ANAEROBE, V17, P474, DOI 10.1016/j.anaerobe.2011.07.008; Jost T, 2013, BR J NUTR, P1; Koskinen MT, 2010, J DAIRY SCI, V93, P5707, DOI 10.3168/jds.2010-3167; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Li MJ, 2012, VET MICROBIOL, V155, P72, DOI 10.1016/j.vetmic.2011.08.007; Luthje P, 2006, J ANTIMICROB CHEMOTH, V57, P966, DOI 10.1093/jac/dk1061; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Norman HD, 2000, J DAIRY SCI, V83, P2782, DOI 10.3168/jds.S0022-0302(00)75175-7; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Peeler EJ, 2003, PREV VET MED, V59, P169, DOI 10.1016/S0167-5877(03)00076-X; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Ranieri ML, 2012, APPL ENVIRON MICROB, V78, P5855, DOI 10.1128/AEM.01361-12; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROBERSON JR, 1994, J DAIRY SCI, V77, P3354, DOI 10.3168/jds.S0022-0302(94)77277-5; Rozen S, 2000, Methods Mol Biol, V132, P365; Schepers AJ, 1997, J DAIRY SCI, V80, P1833, DOI 10.3168/jds.S0022-0302(97)76118-6; Schukken YH, 2003, VET RES, V34, P579, DOI 10.1051/vetres:2003028; Shome BR, 2011, J APPL MICROBIOL, V111, P1349, DOI 10.1111/j.1365-2672.2011.05169.x; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Suriyasathaporn W, 2000, J DAIRY SCI, V83, P1248, DOI 10.3168/jds.S0022-0302(00)74991-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Zadoks RN, 2005, VET MICROBIOL, V109, P257, DOI 10.1016/j.vetmic.2005.05.008; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	42	131	134	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85904	10.1371/journal.pone.0085904	http://dx.doi.org/10.1371/journal.pone.0085904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465777	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500086
J	Di Caro, V; Phillips, B; Engman, C; Harnaha, J; Trucco, M; Giannoukakis, N				Di Caro, Valentina; Phillips, Brett; Engman, Carl; Harnaha, Jo; Trucco, Massimo; Giannoukakis, Nick			Involvement of Suppressive B-Lymphocytes in the Mechanism of Tolerogenic Dendritic Cell Reversal of Type 1 Diabetes in NOD Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIGEN-PRESENTING CELLS; ISLET BETA-CELLS; RETINOIC ACID; B10 CELLS; IN-VIVO; HOMEOSTATIC PROLIFERATION; DELAYED-HYPERSENSITIVITY; ANTIBODY PREVENTS; IMMUNE-RESPONSES	The objective of the study was to identify immune cell populations, in addition to Foxp3+ T-regulatory cells, that participate in the mechanisms of action of tolerogenic dendritic cells shown to prevent and reverse type 1 diabetes in the Non-Obese Diabetic (NOD) mouse strain. Co-culture experiments using tolerogenic dendritic cells and B-cells from NOD as well as transgenic interleukin-10 promoter-reporter mice along with transfer of tolerogenic dendritic cells and CD19+ B-cells into NOD and transgenic mice, showed that these dendritic cells increased the frequency and numbers of interleukin-10-expressing B-cells in vitro and in vivo. The expansion of these cells was a consequence of both the proliferation of preexisting interleukin-10-expressing B-lymphocytes and the conversion of CD19+ B-lymphcytes into interleukin-10-expressing cells. The tolerogenic dendritic cells did not affect the suppressive activity of these B-cells. Furthermore, we discovered that the suppressive murine B-lymphocytes expressed receptors for retinoic acid which is produced by the tolerogenic dendritic cells. These data assist in identifying the nature of the B-cell population increased in response to the tolerogenic dendritic cells in a clinical trial and also validate very recent findings demonstrating a mechanistic link between human tolerogenic dendritic cells and immunosuppressive regulatory B-cells.	[Di Caro, Valentina; Engman, Carl; Harnaha, Jo; Trucco, Massimo; Giannoukakis, Nick] Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15261 USA; [Di Caro, Valentina] RiMed Fdn, Palermo, Italy; [Phillips, Brett] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Giannoukakis, Nick] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Giannoukakis, N (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15261 USA.	ngiann1@pitt.edu		Phillips, Brett/0000-0001-6062-4892	RiMed Foundation; NIH NIDDK [DK063499]; JDRF [17-2007-1066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063499, R33DK063499] Funding Source: NIH RePORTER	RiMed Foundation; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the RiMed Foundation (to Massimo Trucco and Valentina Di Caro), and in part by NIH NIDDK DK063499 (to Massimo Trucco) and JDRF 17-2007-1066 (to Nick Giannoukakis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2006, IMMUNOL REV, V211, P280, DOI 10.1111/j.0105-2896.2006.00398.x; Anolik JH, 2009, IMMUNOL RES, V45, P144, DOI 10.1007/s12026-009-8096-7; Basten A, 2010, CURR OPIN IMMUNOL, V22, P566, DOI 10.1016/j.coi.2010.08.001; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Bresson D, 2007, AUTOIMMUN REV, V6, P315, DOI 10.1016/j.autrev.2006.09.013; Brezar V, 2011, ENDOCR REV, V32, P623, DOI 10.1210/er.2011-0010; Cabatingan MS, 2002, J IMMUNOL, V169, P6795, DOI 10.4049/jimmunol.169.12.6795; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Carvello M, 2012, DIABETES, V61, P155, DOI 10.2337/db11-0684; Chaparro RJ, 2010, EXPERT REV CLIN IMMU, V6, P939, DOI [10.1586/eci.10.68, 10.1586/ECI.10.68]; Chentoufi AA, 2004, DIABETES, V53, P354, DOI 10.2337/diabetes.53.2.354; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Di Caro V, 2013, CLIN EXP IMMUNOL, V174, P302, DOI 10.1111/cei.12177; Di Caro V, 2013, CLIN EXPT IMMUNOLOGY; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Dong P, 2010, NUTRITION, V26, P740, DOI 10.1016/j.nut.2009.08.011; DORNER T, 2013, CURR OPIN RHEUMATOL; El-Amine M, 2000, J IMMUNOL, V165, P5631, DOI 10.4049/jimmunol.165.10.5631; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Falcone M, 1998, J IMMUNOL, V161, P1163; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Fiorina Paolo, 2009, F1000 Biol Rep, V1, P39, DOI 10.3410/B1-39; Fousteri G, 2007, ADV EXP MED BIOL, V601, P313; Giannoukakis N, 2000, MOL THER, V1, P430, DOI 10.1006/mthe.2000.0060; Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472; Greeley SAW, 2002, NAT MED, V8, P399, DOI 10.1038/nm0402-399; Grupillo M, 2012, CELL IMMUNOL, V273, P115, DOI 10.1016/j.cellimm.2011.12.010; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2011, J IMMUNOL, V187, P1998, DOI 10.4049/jimmunol.1100539; Hilkens CMU, 2010, INT REV IMMUNOL, V29, P156, DOI 10.3109/08830180903281193; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Hussain S, 2007, J IMMUNOL, V179, P7225, DOI 10.4049/jimmunol.179.11.7225; Inoue Y, 2007, J IMMUNOL, V179, P764, DOI 10.4049/jimmunol.179.2.764; ITOH K, 1995, J IMMUNOL, V154, P4341; Iwata M, 2011, VITAM HORM, V86, P127, DOI 10.1016/B978-0-12-386960-9.00006-X; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Kehry MR, 1996, J IMMUNOL, V156, P2345; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kretschmer Karsten, 2008, V94, P8, DOI 10.1159/000154846; Lee KM, 2014, CELL TRANSPLANT, V23, P51, DOI 10.3727/096368912X658962; LeGuern C, 2011, CRIT REV IMMUNOL, V31, P189, DOI 10.1615/CritRevImmunol.v31.i3.20; LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977; Li YP, 2006, BIO-MED MATER ENG, V16, pS163; Lipsky PE, 1997, ANN NY ACAD SCI, V815, P372, DOI 10.1111/j.1749-6632.1997.tb52088.x; Luce S, 2013, DIABETES OBES METAB, V15, P89, DOI 10.1111/dom.12159; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Machen J, 2004, J IMMUNOL, V173, P4331, DOI 10.4049/jimmunol.173.7.4331; Manjarrez-Orduno N, 2009, J INVEST DERMATOL, V129, P278, DOI 10.1038/jid.2008.240; Marino E, 2008, DIABETES, V57, P395, DOI 10.2337/db07-0589; Marino E, 2012, AUTOIMMUNITY, V45, P377, DOI 10.3109/08916934.2012.665527; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Michels AW, 2011, CURR OPIN ENDOCRINOL, V18, P235, DOI 10.1097/MED.0b013e32834803ae; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; Moreb JS, 2011, CHEM BIOL INTERACT; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; NETA R, 1974, J IMMUNOL, V113, P1716; Noorchashm H, 1999, J IMMUNOL, V163, P743; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; Nouri-Shirazi M, 2006, EXPERT OPIN BIOL TH, V6, P325, DOI 10.1517/14712598.6.4.325; O'Gorman MR, 2001, CURR PROTOC CYTOM; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PARKER D, 1975, INT ARCH ALLER A IMM, V49, P276, DOI 10.1159/000231407; Parsons RF, 2012, SEMIN IMMUNOL, V24, P109, DOI 10.1016/j.smim.2011.08.016; Parsons RF, 2011, J IMMUNOL, V186, P614, DOI 10.4049/jimmunol.1002873; Pescovitz MD, 2011, J ALLERGY CLIN IMMUN, V128, P1295, DOI 10.1016/j.jaci.2011.08.008; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Roll P, 2008, ARTHRITIS RHEUM-US, V58, P1566, DOI 10.1002/art.23473; Ryan GA, 2010, J IMMUNOL, V185, P2800, DOI 10.4049/jimmunol.1000856; Serreze DV, 1998, J IMMUNOL, V161, P3912; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Steinbrink K, 2009, HUM IMMUNOL, V70, P289, DOI 10.1016/j.humimm.2009.02.003; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tchao NK, 2012, AM J TRANSPLANT, V12, P1079, DOI 10.1111/j.1600-6143.2012.04008.x; Tian J, 2006, J IMMUNOL, V176, P2654, DOI 10.4049/jimmunol.176.4.2654; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vavassori S, 2009, EUR J IMMUNOL, V39, P2224, DOI 10.1002/eji.200839163; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	102	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83575	10.1371/journal.pone.0083575	http://dx.doi.org/10.1371/journal.pone.0083575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465383	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330237000009
J	Eckel, SP; Linn, WS; Berhane, K; Rappaport, EB; Salam, MT; Zhang, Y; Gilliland, FD				Eckel, Sandrah P.; Linn, William S.; Berhane, Kiros; Rappaport, Edward B.; Salam, Muhammad T.; Zhang, Yue; Gilliland, Frank D.			Estimation of Parameters in the Two-Compartment Model for Exhaled Nitric Oxide	PLOS ONE			English	Article							EXTENDED NO ANALYSIS; ALVEOLAR; ASTHMA; SYNTHASE; DIFFUSION; POLLUTION; AIRWAYS	The fractional concentration of exhaled nitric oxide (FeNO) is a biomarker of airway inflammation that is being increasingly considered in clinical, occupational, and epidemiological applications ranging from asthma management to the detection of air pollution health effects. FeNO depends strongly on exhalation flow rate. This dependency has allowed for the development of mathematical models whose parameters quantify airway and alveolar compartment contributions to FeNO. Numerous methods have been proposed to estimate these parameters using FeNO measured at multiple flow rates. These methods-which allow for non-invasive assessment of localized airway inflammation-have the potential to provide important insights on inflammatory mechanisms. However, different estimation methods produce different results and a serious barrier to progress in this field is the lack of a single recommended method. With the goal of resolving this methodological problem, we have developed a unifying framework in which to present a comprehensive set of existing and novel statistical methods for estimating parameters in the simple two-compartment model. We compared statistical properties of the estimators in simulation studies and investigated model fit and parameter estimate sensitivity across methods using data from 1507 schoolchildren from the Southern California Children's Health Study, one of the largest multiple flow FeNO studies to date. We recommend a novel nonlinear least squares model with natural log transformation on both sides that produced estimators with good properties, satisfied model assumptions, and fit the Children's Health Study data well.	[Eckel, Sandrah P.; Linn, William S.; Berhane, Kiros; Rappaport, Edward B.; Salam, Muhammad T.; Gilliland, Frank D.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Zhang, Yue] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	University of Southern California; Utah System of Higher Education; University of Utah	Eckel, SP (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	eckel@usc.edu		Salam, Muhammad/0000-0002-3565-8916	National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center [5P30ES007048]; National Institute of Environmental Health Sciences; Children's Environmental Health Center [5P01ES009581, R826708-01, RD831861-01]; National Institute of Environmental Health Sciences and the Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627]; James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768, R01HL076647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, K22ES022987, P01ES011627, R01ES023262, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Children's Environmental Health Center; National Institute of Environmental Health Sciences and the Environmental Protection Agency(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01 and RD831861-01) funded by the National Institute of Environmental Health Sciences and the Environmental Protection Agency; the National Institute of Environmental Health Sciences (grant 5P01ES011627); the James H. Zumberge Research and Innovation Fund, and the Hastings Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Bastain TM, 2010, EUR RESP J; Bates D., 1988, NONLINEAR REGRESSION; Bates D.M., 1992, STAT MODELS S; Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410; Breton CV, 2011, AM J RESP CRIT CARE, V184, P191, DOI 10.1164/rccm.201012-2029OC; Condorelli P, 2007, J APPL PHYSIOL, V102, P417, DOI 10.1152/japplphysiol.00533.2006; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; Davidian M., 1995, NONLINEAR MODELS REP; DENNIS JE, 1981, ACM T MATH SOFTWARE, V7, P369, DOI 10.1145/355958.355966; Eckel SP, 2013, OCCUP ENVIRON MED, V70, P519, DOI 10.1136/oemed-2013-101458; Eckel SP, 2011, ENV HLTH PERSPECT; Eco Medics AG, 2006, ANAL CLD 88 SERIES O; FIELLER EC, 1957, BIOMETRIKA, V44, P470, DOI 10.2307/2332878; Garcia-Rio F, 2011, J ASTHMA, V48, P329, DOI 10.3109/02770903.2011.565847; GAY DM, 1981, SIAM J SCI STAT COMP, V2, P186, DOI 10.1137/0902016; Gelb AF, 2010, THORAX, V65, P619, DOI 10.1136/thx.2009.132696; George SC, 2004, J APPL PHYSIOL, V96, P831, DOI 10.1152/japplphysiol.00950.2003; George SC, 2008, J APPL PHYSIOL, V104, P909, DOI 10.1152/japplphysiol.00111.2008; Hogman M, 2000, RESP MED, V94, P985, DOI 10.1053/rmed.2000.0872; Hogman M, 1997, ACTA PHYSIOL SCAND, V159, P345, DOI 10.1046/j.1365-201X.1997.00101.x; Hogman M, 2002, RESP MED, V96, P24, DOI 10.1053/rmed.2001.1204; Hogman M, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/2/024001; Hogman M, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/4/047103; Hogman M, 2009, CLIN PHYSIOL FUNCT I, V29, P18, DOI 10.1111/j.1475-097X.2008.00831.x; Keen C, 2011, RESP MED, V105, P1476, DOI 10.1016/j.rmed.2011.04.004; Kerckx Y, 2008, J APPL PHYSIOL, V104, P918, DOI 10.1152/japplphysiol.01032.2007; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lehouck A, 2010, RESP MED, V104, P1020, DOI 10.1016/j.rmed.2010.01.001; Linn WS, 2009, J EXPO SCI ENV EPID, V19, P674, DOI 10.1038/jes.2008.64; Linn WS, 2009, PEDIATR PULM, V44, P1033, DOI 10.1002/ppul.21101; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Linn WS, 2013, PEDIAT PULMONOL; Mahut B, 2010, ALLERGY, V65, P636, DOI 10.1111/j.1398-9995.2009.02221.x; Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92; Pietropaoli AP, 1999, J APPL PHYSIOL, V87, P1532, DOI 10.1152/jappl.1999.87.4.1532; Puckett JL, 2010, PEDIATR PULM, V45, P174, DOI 10.1002/ppul.21172; R Core Team, 2021, R LANGUAGE ENV STAT; Rodway G W, 2009, Chron Respir Dis, V6, P19, DOI 10.1177/1479972308095936; Rosa MJ, 2011, PEDIATR PULM, V46, P83, DOI 10.1002/ppul.21328; Rottier BL, 2005, J APPL PHYSIOL, V99, P378, DOI 10.1152/japplphysiol.00163.2005; Roy K, 2007, EUR RESPIR J, V29, P651, DOI 10.1183/09031936.00149706; Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x; Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shorter JH, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037108; Silkoff PE, 2000, AM J RESP CRIT CARE, V161, P1218, DOI 10.1164/ajrccm.161.4.9903111; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; Suresh V, 2008, J APPL PHYSIOL, V104, P1743, DOI 10.1152/japplphysiol.01355.2007; Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653, DOI 10.1152/jappl.1998.85.2.653; Verbanck S, 2012, EUR RESPIR J, V39, P1258, DOI 10.1183/09031936.00105611	52	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85471	10.1371/journal.pone.0085471	http://dx.doi.org/10.1371/journal.pone.0085471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465571	Green Submitted, gold, Green Published			2022-12-27	WOS:000330237000037
J	Azcarate, IG; Marin-Garcia, P; Kamali, AN; Perez-Benavente, S; Puyet, A; Diez, A; Bautista, JM				Azcarate, Isabel G.; Marin-Garcia, Patricia; Kamali, Ali N.; Perez-Benavente, Susana; Puyet, Antonio; Diez, Amalia; Bautista, Jose M.			Differential Immune Response Associated to Malaria Outcome Is Detectable in Peripheral Blood following Plasmodium yoelii Infection in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; B-CELLS; IN-VITRO; PROTECTIVE IMMUNITY; KNOWLESI MEROZOITES; ACQUIRED-IMMUNITY; DENDRITIC CELLS; B-1 CELLS; FALCIPARUM; PARASITE	Malaria infection in humans elicits a wide range of immune responses that can be detected in peripheral blood, but we lack detailed long-term follow-up data on the primary and subsequent infections that lead to naturally acquired immunity. Studies on antimalarial immune responses in mice have been based on models yielding homogenous infection profiles. Here, we present a mouse model in which a heterogeneous course of Plasmodium yoelii lethal malaria infection is produced in a non-congenic ICR strain to allow comparison among different immunological and clinical outcomes. Three different disease courses were observed ranging from a fatal outcome, either early or late, to a self-resolved infection that conferred long-term immunity against re-infection. Qualitative and quantitative changes produced in leukocyte subpopulations and cytokine profiles detected in peripheral blood during the first week of infection revealed that monocytes, dendritic cells and immature B cells were the main cell subsets present in highly-parasitized mice dying in the first week after infection. Besides, CD4(+)CD25(high) T cells expanded at an earlier time point in early deceased mice than in surviving mice and expressed higher levels of intracellular Foxp3 protein. In contrast, survivors showed a limited increase of cytokines release and stable circulating innate cells. From the second week of infection, mice that would die or survive showed similar immune profiles, although CD4(+)CD25(high) T cells number increased earlier in mice with the worst prognosis. In surviving mice the expansion of activated circulating T cell and switched-class B cells with a long-term protective humoral response from the second infection week is remarkable. Our results demonstrate that the follow-up studies of immunological blood parameters during a malaria infection can offer information about the course of the pathological process and the immune response.	[Azcarate, Isabel G.; Marin-Garcia, Patricia; Kamali, Ali N.; Perez-Benavente, Susana; Puyet, Antonio; Diez, Amalia; Bautista, Jose M.] Univ Complutense Madrid, Fac Vet, Dept Biochem & Mol Biol 4, Madrid, Spain; [Azcarate, Isabel G.; Puyet, Antonio; Diez, Amalia; Bautista, Jose M.] Univ Hosp 12 Octubre, Res Inst Hosp 12 Octubre, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre	Bautista, JM (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Biochem & Mol Biol 4, Ciudad Univ, Madrid, Spain.	jmbau@ucm.es	Bautista, José M./B-7899-2013; Marin-Garcia, Patricia/I-5497-2014; Diez, Amalia/I-4852-2014; Gonzalez Azcarate, Isabel/I-4856-2014; Diez, Amalia/AAG-4274-2021; Kamali, Ali/AAO-2926-2021; Puyet, Antonio/I-4720-2014	Bautista, José M./0000-0001-8926-881X; Marin-Garcia, Patricia/0000-0002-2168-6668; Diez, Amalia/0000-0002-2619-9252; Gonzalez Azcarate, Isabel/0000-0003-4545-1254; Diez, Amalia/0000-0002-2619-9252; Puyet, Antonio/0000-0002-2026-7955; Kamali, Ali Naghi/0000-0002-6225-9726	Spanish Ministry of Innovation and Science [BIO2010-17039, BIO2007-67885]; Programme of Consolidated Research Teams from the UCM-Comunidad de Madrid [920267]	Spanish Ministry of Innovation and Science(Spanish Government); Programme of Consolidated Research Teams from the UCM-Comunidad de Madrid	This work was supported by the Spanish Ministry of Innovation and Science (grant BIO2010-17039) and by the Programme of Consolidated Research Teams from the UCM-Comunidad de Madrid (Research Team 920267). I. G. A. holds a fellowship awarded by the Spanish Ministry of Innovation and Science (grant BIO2007-67885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; Ardavin C, 1999, J IMMUNOL, V162, P2538; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Chandele A, 2011, IMMUNOLOGY, V132, P273, DOI 10.1111/j.1365-2567.2010.03363.x; Chen G, 2009, PARASITOLOGY, V136, P1107, DOI 10.1017/S0031182009990370; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; EPSTEIN N, 1981, J IMMUNOL, V127, P212; FERRANTE A, 1990, IMMUNOL LETT, V25, P179, DOI 10.1016/0165-2478(90)90112-4; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; FREEMAN RR, 1981, EXP PARASITOL, V52, P18, DOI 10.1016/0014-4894(81)90056-4; Good MF, 2011, NAT MED, V17, P49, DOI 10.1038/nm0111-49; GREY HM, 1971, J EXP MED, V133, P289, DOI 10.1084/jem.133.2.289; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; JAYAWARDENA AN, 1978, IMMUNOLOGY, V34, P157; Kamali AN, 2012, IMMUNOBIOLOGY, V217, P823, DOI 10.1016/j.imbio.2012.05.002; Kanda Y, 2010, CELL IMMUNOL, V263, P49, DOI 10.1016/j.cellimm.2010.02.015; Kawabe S, 2004, CLIN EXP IMMUNOL, V135, P200, DOI 10.1111/j.1365-2249.2003.02361.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; LANGHORNE J, 1991, J IMMUNOL, V146, P2771; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; LISSE IM, 1994, T ROY SOC TROP MED H, V88, P709, DOI 10.1016/0035-9203(94)90242-9; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; LUNEL F, 1989, INFECT IMMUN, V57, P2043, DOI 10.1128/IAI.57.7.2043-2049.1989; Luyendyk J, 2002, INFECT IMMUN, V70, P2941, DOI 10.1128/IAI.70.6.2941-2949.2002; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; MILLER LH, 1975, J IMMUNOL, V114, P1237; Moneriz C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-103; Nduati EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015007; Perlmann P, 2002, CHEM IMMUNOL, V80, P229; Petritus PM, 2008, J IMMUNOL, V180, P444, DOI 10.4049/jimmunol.180.1.444; Sagaert X, 2007, LEUKEMIA, V21, P1378, DOI 10.1038/sj.leu.2404737; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sanni Latifu A, 2002, Methods Mol Med, V72, P57, DOI 10.1385/1-59259-271-6:57; Scholzen A, 2010, TRENDS PARASITOL, V26, P16, DOI 10.1016/j.pt.2009.10.004; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singh B, 2000, MICROBES INFECT, V2, P473, DOI 10.1016/S1286-4579(00)00321-X; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Stevenson MM, 2011, INT J BIOL SCI, V7, P1311, DOI 10.7150/ijbs.7.1311; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; Tachikawa S, 2008, CLIN EXP IMMUNOL, V153, P448, DOI 10.1111/j.1365-2249.2008.03709.x; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; Taylor-Robinson AW, 1998, SCAND J IMMUNOL, V48, P527; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; VINETZ JM, 1990, J IMMUNOL, V144, P1069; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Wang QH, 2009, EXP PARASITOL, V121, P268, DOI 10.1016/j.exppara.2008.11.013; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Weaver JL, 2002, TOXICOL MECH METHOD, V12, P95, DOI 10.1080/10517230290075341; WEINBAUM FI, 1976, J IMMUNOL, V117, P1999; WHITE WI, 1991, INFECT IMMUN, V59, P3547, DOI 10.1128/IAI.59.10.3547-3554.1991; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; Worku S, 1997, CLIN EXP IMMUNOL, V108, P34, DOI 10.1046/j.1365-2249.1997.d01-981.x; Wu Y, 2007, EXP PARASITOL, V115, P301, DOI 10.1016/j.exppara.2006.09.015; Wykes MN, 2007, PLOS PATHOG, V3, P904, DOI 10.1371/journal.ppat.0030096	86	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85664	10.1371/journal.pone.0085664	http://dx.doi.org/10.1371/journal.pone.0085664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465641	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000021
J	Ferenczi, MA; Bershitsky, SY; Koubassova, NA; Kopylova, GV; Fernandez, M; Narayanan, T; Tsaturyan, AK				Ferenczi, Michael A.; Bershitsky, Sergey Y.; Koubassova, Natalia A.; Kopylova, Galina V.; Fernandez, Manuel; Narayanan, Theyencheri; Tsaturyan, Andrey K.			Why Muscle is an Efficient Shock Absorber	PLOS ONE			English	Article							X-RAY-DIFFRACTION; FROG SKELETAL-MUSCLE; FORCE GENERATION; MYOSIN HEADS; ISOMETRIC CONTRACTION; SINGLE FIBERS; INSECT FLIGHT; MECHANISM; RABBIT; ACTIN	Skeletal muscles power body movement by converting free energy of ATP hydrolysis into mechanical work. During the landing phase of running or jumping some activated skeletal muscles are subjected to stretch. Upon stretch they absorb body energy quickly and effectively thus protecting joints and bones from impact damage. This is achieved because during lengthening, skeletal muscle bears higher force and has higher instantaneous stiffness than during isometric contraction, and yet consumes very little ATP. We wish to understand how the actomyosin molecules change their structure and interaction to implement these physiologically useful mechanical and thermodynamical properties. We monitored changes in the low angle x-ray diffraction pattern of rabbit skeletal muscle fibers during ramp stretch compared to those during isometric contraction at physiological temperature using synchrotron radiation. The intensities of the off-meridional layer lines and fine interference structure of the meridional M3 myosin x-ray reflection were resolved. Mechanical and structural data show that upon stretch the fraction of actin-bound myosin heads is higher than during isometric contraction. On the other hand, the intensities of the actin layer lines are lower than during isometric contraction. Taken together, these results suggest that during stretch, a significant fraction of actin-bound heads is bound non-stereo-specifically, i.e. they are disordered azimuthally although stiff axially. As the strong or stereo-specific myosin binding to actin is necessary for actin activation of the myosin ATPase, this finding explains the low metabolic cost of energy absorption by muscle during the landing phase of locomotion.	[Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Ferenczi, Michael A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Bershitsky, Sergey Y.; Kopylova, Galina V.] Russian Acad Sci, Ural Branch, Inst Immunol & Physiol, Ekaterinburg, Russia; [Koubassova, Natalia A.; Tsaturyan, Andrey K.] Moscow MV Lomonosov State Univ, Inst Mech, Moscow, Russia; [Fernandez, Manuel; Narayanan, Theyencheri] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Lomonosov Moscow State University; European Synchrotron Radiation Facility (ESRF)	Ferenczi, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	m.ferenczi@ntu.edu.sg	Tsaturyan, Andrey/GXF-8722-2022; Tsaturyan, Andrey K/B-1037-2014; Kopylova, Galina/ABF-2117-2020; Bershitsky, Sergey/AAE-6814-2019; Ferenczi, Michael/F-9510-2015; Koubassova, Natalia/AAI-6490-2021; Bershitsky, Sergey/S-4829-2016	Tsaturyan, Andrey K/0000-0002-0447-7725; Kopylova, Galina/0000-0003-2976-2108; Ferenczi, Michael/0000-0002-0349-331X; Koubassova, Natalia/0000-0002-0238-4920; Bershitsky, Sergey/0000-0001-5342-1739; Narayanan, Theyencheri/0000-0003-1957-1041	Russian Foundation for Basic Research (RFBR) [11-04-00908, 11-04-00750]; Presidium of the Russian Academy of Sciences; Medical Research Council (UK) [G0501704]; EBSA Travel Fellowship; Royal Society Travel award; MRC [G0501704] Funding Source: UKRI; Medical Research Council [G0501704] Funding Source: researchfish	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EBSA Travel Fellowship; Royal Society Travel award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Russian Foundation for Basic Research (RFBR) grants 11-04-00908 to A. K. T. and 11-04-00750 to S.Y.B., by the Presidium of the Russian Academy of Sciences to S. Y. B., by the Medical Research Council (UK) G0501704 to M. A. F, by an EBSA Travel Fellowship to G. V. K., and by a Royal Society Travel award to N.A.K. and A. K. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershitsky SY, 2009, FRONT BIOSCI-LANDMRK, V14, P3188, DOI 10.2741/3444; Bershitsky SY, 2002, J PHYSIOL-LONDON, V540, P971, DOI 10.1113/jphysiol.2001.013483; BERSHITSKY SY, 1995, BIOPHYS J, V69, P1011, DOI 10.1016/S0006-3495(95)79976-3; Bickham DC, 2011, BIOPHYS J, V101, P2445, DOI 10.1016/j.bpj.2011.10.007; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Curtin N A, 1975, J Mechanochem Cell Motil, V3, P147; Ferenczi MA, 2005, STRUCTURE, V13, P131, DOI 10.1016/j.str.2004.11.007; Fusi L, 2010, J PHYSIOL-LONDON, V588, P495, DOI 10.1113/jphysiol.2009.178137; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Herzog W, 2013, J APPL PHYSIOL; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; Koubassova NA, 2008, BIOPHYS J, V95, P2880, DOI 10.1529/biophysj.107.120832; Kubasova N A, 2009, Mol Biol (Mosk), V43, P689; Linari M, 2000, J PHYSIOL-LONDON, V526, P589, DOI 10.1111/j.1469-7793.2000.00589.x; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; Linari M, 2003, J PHYSIOL-LONDON, V548, P461, DOI 10.1113/jphysiol.2002.032185; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOVELL SJ, 1981, NATURE, V293, P664, DOI 10.1038/293664a0; MALINCHIK SB, 1992, J MUSCLE RES CELL M, V13, P406, DOI 10.1007/BF01738036; PIAZZESI G, 1992, J PHYSIOL-LONDON, V445, P659, DOI 10.1113/jphysiol.1992.sp018945; Piazzesi G, 2003, J PHYSIOL-LONDON, V549, P93, DOI 10.1113/jphysiol.2002.038703; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Tsaturyan AK, 2011, BIOPHYS J, V101, P404, DOI 10.1016/j.bpj.2011.06.008	29	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85739	10.1371/journal.pone.0085739	http://dx.doi.org/10.1371/journal.pone.0085739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465673	Green Published, gold			2022-12-27	WOS:000330288000022
J	Mizui, T; Sekino, Y; Yamazaki, H; Ishizuka, Y; Takahashi, H; Kojima, N; Kojima, M; Shirao, T				Mizui, Toshiyuki; Sekino, Yuko; Yamazaki, Hiroyuki; Ishizuka, Yuta; Takahashi, Hideto; Kojima, Nobuhiko; Kojima, Masami; Shirao, Tomoaki			Myosin II ATPase Activity Mediates the Long-Term Potentiation-Induced Exodus of Stable F-Actin Bound by Drebrin A from Dendritic Spines	PLOS ONE			English	Article							REGULATED BRAIN PROTEINS; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; IN-VIVO; PLASTICITY; MORPHOGENESIS; CYTOSKELETON; FILAMENTS; RAT; PHOSPHORYLATION	The neuronal actin-binding protein drebrin A forms a stable structure with F-actin in dendritic spines. NMDA receptor activation causes an exodus of F-actin bound by drebrin A (DA-actin) from dendritic spines, suggesting a pivotal role for DA-actin exodus in synaptic plasticity. We quantitatively assessed the extent of DA-actin localization to spines using the spine-dendrite ratio of drebrin A in cultured hippocampal neurons, and found that (1) chemical long-term potentiation (LTP) stimulation induces rapid DA-actin exodus and subsequent DA-actin re-entry in dendritic spines, (2) Ca2+ influx through NMDA receptors regulates the exodus and the basal accumulation of DA-actin, and (3) the DA-actin exodus is blocked by myosin II ATPase inhibitor, but is not blocked by myosin light chain kinase (MLCK) or Rho-associated kinase (ROCK) inhibitors. These results indicate that myosin II mediates the interaction between NMDA receptor activation and DA-actin exodus in LTP induction. Furthermore, myosin II seems to be activated by a rapid actin-linked mechanism rather than slow MLC phosphorylation. Thus the myosin-II mediated DA-actin exodus might be an initial event in LTP induction, triggering actin polymerization and spine enlargement.	[Mizui, Toshiyuki; Sekino, Yuko; Yamazaki, Hiroyuki; Ishizuka, Yuta; Takahashi, Hideto; Kojima, Nobuhiko; Shirao, Tomoaki] Gunma Univ, Grad Sch Med, Dept Neurobiol & Behav, Maebashi, Gunma 371, Japan; [Sekino, Yuko; Kojima, Masami] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Mizui, Toshiyuki; Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Biointerface Res Grp, Ikeda, Osaka, Japan	Gunma University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Sekino, Y (corresponding author), Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo, Japan.	yukos@nihs.go.jp; tshirao@gunma-u.ac.jp	Mizui, Toshiyuki/M-3502-2018; Ishizuka, Yuta/ACN-8245-2022; Takahashi, Hideto/T-2650-2018; Ishizuka, Yuta/AAB-9170-2019; Shirao, Tomoaki/I-9257-2016	Mizui, Toshiyuki/0000-0001-9142-5626; Ishizuka, Yuta/0000-0002-2036-902X; Takahashi, Hideto/0000-0002-6473-5060; Shirao, Tomoaki/0000-0003-4323-028X	Ministry of Education, Culture, Sports, Science and Technology of Japan [16300117, 19200029, 20021002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (16300117, 19200029) and on Priority Areas - Elucidation of neural network function in the brain - from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20021002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; ASADA H, 1994, J NEUROSCI RES, V38, P149, DOI 10.1002/jnr.490380205; Cheng XT, 2000, NEUROSCI RES, V36, P167, DOI 10.1016/S0168-0102(99)00123-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Hanamura K, 2010, NEUROSCIENCE, V169, P1489, DOI 10.1016/j.neuroscience.2010.06.043; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Iki J, 2005, EUR J NEUROSCI, V22, P2985, DOI 10.1111/j.1460-9568.2005.04510.x; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Konishi M, 1998, JPN J PHYSIOL, V48, P421, DOI 10.2170/jjphysiol.48.421; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mikati MA, 2013, J BIOL CHEM, V288, P19926, DOI 10.1074/jbc.M113.472647; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; SHIRAO T, 1986, DEV BRAIN RES, V29, P233, DOI 10.1016/0165-3806(86)90099-4; SHIRAO T, 1989, P JPN ACAD B-PHYS, V65, P169, DOI 10.2183/pjab.65.169; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takahashi H, 2009, J CELL SCI, V122, P1211, DOI 10.1242/jcs.043729; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Xie H, 1984, CELL STRUCT FUNCT, V8, P315; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	39	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85367	10.1371/journal.pone.0085367	http://dx.doi.org/10.1371/journal.pone.0085367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465547	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100038
J	Pettinato, L; Calistri, E; Di Patti, F; Livi, R; Luccioli, S				Pettinato, Lucia; Calistri, Elisa; Di Patti, Francesca; Livi, Roberto; Luccioli, Stefano			Genome-Wide Analysis of Promoters: Clustering by Alignment and Analysis of Regular Patterns	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION-FACTOR; NONLINEAR MODEL; NEURAL-NETWORK; DNA; SEQUENCE; IDENTIFICATION; EVOLUTION; INSIGHTS; DATABASE	In this paper we perform a genome-wide analysis of H. sapiens promoters. To this aim, we developed and combined two mathematical methods that allow us to (i) classify promoters into groups characterized by specific global structural features, and (ii) recover, in full generality, any regular sequence in the different classes of promoters. One of the main findings of this analysis is that H. sapiens promoters can be classified into three main groups. Two of them are distinguished by the prevalence of weak or strong nucleotides and are characterized by short compositionally biased sequences, while the most frequent regular sequences in the third group are strongly correlated with transposons. Taking advantage of the generality of these mathematical procedures, we have compared the promoter database of H. sapiens with those of other species. We have found that the above-mentioned features characterize also the evolutionary content appearing in mammalian promoters, at variance with ancestral species in the phylogenetic tree, that exhibit a definitely lower level of differentiation among promoters.	[Pettinato, Lucia; Di Patti, Francesca; Livi, Roberto] Univ Firenze, Dipartimento Fis & Astron, Sesto Fiorentino, Italy; [Pettinato, Lucia; Livi, Roberto] Ist Nazl Fis Nucl, Sesto Fiorentino, Italy; [Calistri, Elisa; Di Patti, Francesca; Livi, Roberto] Ctr Interdipartimentale Studio Dinam Complesse, Sesto Fiorentino, Italy; [Calistri, Elisa] Univ Firenze, Dipartimento Biol, Sesto Fiorentino, Italy; [Livi, Roberto; Luccioli, Stefano] CNR, Ist Sistemi Complessi, Sesto Fiorentino, Italy; [Luccioli, Stefano] Tel Aviv Univ, Joint Italian Israeli Lab Integrat Network Neuros, Ramat Aviv, Israel	University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Tel Aviv University	Livi, R (corresponding author), Univ Firenze, Dipartimento Fis & Astron, Sesto Fiorentino, Italy.	livi@fi.infn.it	Di Patti, Francesca/G-7072-2011	Di Patti, Francesca/0000-0003-1288-0079	Ente Cassa di Risparmio di Firenze; program PRIN of the Italian Ministery of University and Research	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); program PRIN of the Italian Ministery of University and Research(Ministry of Education, Universities and Research (MIUR))	This work has been partially supported by Ente Cassa di Risparmio di Firenze and by the program PRIN2009 of the Italian Ministery of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Akiyama Yutaka, TFSEARCH SEARCHING T; Avino A, 2003, J AM CHEM SOC, V125, P16127, DOI 10.1021/ja035039t; Bais AS, 2007, J BIOSCIENCES, V32, P841, DOI 10.1007/s12038-007-0084-2; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Blanco E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-138; Bolshoy A, 2000, GENOME RES, V10, P1185, DOI 10.1101/gr.10.8.1185; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Calistri E., 2008, THESIS; Calistri E, 2011, MOL PHYLOGENET EVOL, V60, P228, DOI 10.1016/j.ympev.2011.04.015; Campa A, 1998, PHYS REV E, V58, P3585, DOI 10.1103/PhysRevE.58.3585; Carey MF, 2012, COLD SPRING HARBOR P, V2012; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; DAUXOIS T, 1993, PHYS REV E, V47, P684, DOI 10.1103/PhysRevE.47.684; DAUXOIS T, 1993, PHYS REV E, V47, pR44, DOI 10.1103/PhysRevE.47.R44; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grandi FC, 2013, MOL BIOL EVOL, V30, P503, DOI 10.1093/molbev/mss251; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hemberg M, 2012, NUCLEIC ACIDS RES, V40, P7858, DOI 10.1093/nar/gks477; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Jaumot J, 2010, BIOCHIMIE, V92, P1016, DOI 10.1016/j.biochi.2010.04.024; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koch KA, 1999, J BIOL CHEM, V274, P23752, DOI 10.1074/jbc.274.34.23752; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Matsunami M, 2010, J MOL EVOL, V71, P427, DOI 10.1007/s00239-010-9396-1; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sela I, 2011, BIOPHYS J, V101, P160, DOI 10.1016/j.bpj.2011.04.037; Shelenkov A, 2009, COMPUT BIOL CHEM, V33, P196, DOI 10.1016/j.compbiolchem.2009.03.001; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sun J., 1990, MATRIX PERTURBATION; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Taher L, 2011, GENOME RES, V21, P1139, DOI 10.1101/gr.119016.110; Tchernaenko V, 2008, BIOCHEMISTRY-US, V47, P1871, DOI 10.1021/bi701289g; Testori A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-400; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Venkataram S, 2010, GENOME BIOL EVOL, V2, P851, DOI 10.1093/gbe/evq066; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; YANG ZY, 1994, J BIOL CHEM, V269, P10079	73	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85260	10.1371/journal.pone.0085260	http://dx.doi.org/10.1371/journal.pone.0085260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465517	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100032
J	De Vleminck, A; Pardon, K; Beernaert, K; Deschepper, R; Houttekier, D; Van Audenhove, C; Deliens, L; Vander Stichele, R				De Vleminck, Aline; Pardon, Koen; Beernaert, Kim; Deschepper, Reginald; Houttekier, Dirk; Van Audenhove, Chantal; Deliens, Luc; Vander Stichele, Robert			Barriers to Advance Care Planning in Cancer, Heart Failure and Dementia Patients: A Focus Group Study on General Practitioners' Views and Experiences	PLOS ONE			English	Article							PALLIATIVE CARE; COMMUNICATION-SKILLS; OLDER-PEOPLE; BAD-NEWS; DIRECTIVES; PROFESSIONALS; PERSPECTIVES; DISCUSSIONS; PERCEPTIONS; NATIONWIDE	Background: The long-term and often lifelong relationship of general practitioners (GPs) with their patients is considered to make them the ideal initiators of advance care planning (ACP). However, in general the incidence of ACP discussions is low and ACP seems to occur more often for cancer patients than for those with dementia or heart failure. Objective: To identify the barriers, from GPs' perspective, to initiating ACP and to gain insight into any differences in barriers between the trajectories of patients with cancer, heart failure and dementia. Method: Five focus groups were held with GPs (n = 36) in Flanders, Belgium. The focus group discussions were transcribed verbatim and analyzed using the method of constant comparative analysis. Results: Three types of barriers were distinguished: barriers relating to the GP, to the patient and family and to the health care system. In cancer patients, a GP's lack of knowledge about treatment options and the lack of structural collaboration between the GP and specialist were expressed as barriers. Barriers that occured more often with heart failure and dementia were the lack of GP familiarity with the terminal phase, the lack of key moments to initiate ACP, the patient's lack of awareness of their diagnosis and prognosis and the fact that patients did not often initiate such discussions themselves. The future lack of decision-making capacity of dementia patients was reported by the GPs as a specific barrier for the initiation of ACP. Conclusion: The results of our study contribute to a better understanding of the factors hindering GPs in initiating ACP. Multiple barriers need to be overcome, of which many can be addressed through the development of practical guidelines and educational interventions.	[De Vleminck, Aline; Pardon, Koen; Beernaert, Kim; Deschepper, Reginald; Houttekier, Dirk; Deliens, Luc; Vander Stichele, Robert] Univ Ghent, End Of Life Care Res Grp, Brussels, Belgium; [De Vleminck, Aline; Pardon, Koen; Beernaert, Kim; Deschepper, Reginald; Houttekier, Dirk; Deliens, Luc; Vander Stichele, Robert] Vrije Univ Brussel, Brussels, Belgium; [Van Audenhove, Chantal] Catholic Univ Louvain, LUCAS Ctr Care Res & Consultancy, B-3000 Louvain, Belgium; [Deliens, Luc] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Deliens, Luc] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Vander Stichele, Robert] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium	Ghent University; Vrije Universiteit Brussel; Universite Catholique Louvain; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ghent University	De Vleminck, A (corresponding author), Univ Ghent, End Of Life Care Res Grp, Brussels, Belgium.	adevlemi@vub.ac.be	Stichele, Robert Vander/K-7203-2015; Deschepper, Reginald/B-8103-2013; Houttekier, Dirk/F-4073-2011	Stichele, Robert Vander/0000-0001-9118-9651; Deschepper, Reginald/0000-0002-4222-3945; Houttekier, Dirk/0000-0003-0837-9898; Van Audenhove, Chantal/0000-0002-5504-5439; Deliens, Luc/0000-0002-8158-2422	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT) [100036]	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT)	This study is part of the 'Flanders Study to Improve End-of-Life Care and Evaluation Tools (FLIECE-project)', a collaboration between the Vrije Universiteit Brussel, Ghent University, the Katholieke Universiteit Leuven, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. This study is supported by a grant from the Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT nr. 100036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PV, 1999, AM FAM PHYSICIAN, V59, P605; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Baile WF, 2011, J PEDIAT HEMATOL ONC, V33, pS115, DOI 10.1097/MPH.0b013e318237d4d5; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Barnes S, 2006, HEALTH SOC CARE COMM, V14, P482, DOI 10.1111/j.1365-2524.2006.00636.x; Boddy J, 2013, AUST J PRIM HEALTH, V19, P38, DOI 10.1071/PY11070; Boyd K, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X544032; Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018; Brown Margaret, 2002, Aust Fam Physician, V31, P60; Buntinx F, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-60; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; Department of Health, 2009, LIVING WELL DEMENTIA; Evans N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057965; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Hanratty B, 2002, BRIT MED J, V325, P581, DOI 10.1136/bmj.325.7364.581; Harding R, 2008, J PAIN SYMPTOM MANAG, V36, P149, DOI 10.1016/j.jpainsymman.2007.09.012; Hewitt-Taylor J, 2001, Nurs Stand, V15, P39; Hickey DP, 2005, FAM MED, V37, P536; Hirschman KB, 2008, ALZ DIS ASSOC DIS, V22, P293, DOI 10.1097/WAD.0b013e318169d669; Johnson CE, 2012, ASIA PAC J CLIN ONCO; Kass-Bartelems BL, 2003, ADV CARE PLANNING PR; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Meeussen K, 2012, INT PSYCHOGERIATR, V24, P1581, DOI 10.1017/S1041610212000865; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Meeussen K, 2009, BRIT J GEN PRACT, V59, P665, DOI 10.3399/bjgp09X454124; Michiels E, 2007, PALLIATIVE MED, V21, P409, DOI 10.1177/0269216307078503; Minto F, 2011, INT J PALLIAT NURS, V17, P278, DOI 10.12968/ijpn.2011.17.6.278; Mitchell GK, 2012, HEALTH SOC CARE COMM, V20, P607, DOI 10.1111/j.1365-2524.2012.01075.x; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Morgan DL, 1998, POLYAMINE PROTOCOLS, P1; Munday D, 2007, J ROY SOC MED, V100, P211, DOI 10.1258/jrsm.100.5.211; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Nagraj S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X549009; NHS End of Life Care Program, 2010, GOLD STAND FRAM; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Rijksinstituut voor ziekte-en invaliditeitsverzekering (RIZIV), 2005, REG HUIS AANT PROF H; Robinson L, 2012, TLS-TIMES LIT SUPPL, P21; Royal College of Physicians, 2009, ADV CAR PLANN NAT GU, P1; Seymour, 2008, ADV CARE PLANNING GU; Seymour J, 2012, ADV CARE PLANNING EN, P16; Snyder S, 2012, AM J HOSP PALLIAT CA; Teno JM, 1998, J GEN INTERN MED, V13, P439, DOI 10.1046/j.1525-1497.1998.00132.x; Thompson TDB, 2003, PALLIATIVE MED, V17, P403, DOI 10.1191/0269216303pm784oa; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1111/j.1525-1497.2001.00215.x; World Health Organization, 2004, BETTER PALLIATIVE CA	46	112	112	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84905	10.1371/journal.pone.0084905	http://dx.doi.org/10.1371/journal.pone.0084905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465450	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500020
J	Dermauw, V; Alonso, ML; Duchateau, L; Du Laing, G; Tolosa, T; Dierenfeld, E; Clauss, M; Janssens, GPJ				Dermauw, Veronique; Lopez Alonso, Marta; Duchateau, Luc; Du Laing, Gijs; Tolosa, Tadele; Dierenfeld, Ellen; Clauss, Marcus; Janssens, Geert Paul Jules			Trace Element Distribution in Selected Edible Tissues of Zebu (Bos indicus) Cattle Slaughtered at Jimma, SW Ethiopia	PLOS ONE			English	Article							DISTRICTS SURROUNDING KARATINA; MINERAL STATUS; COPPER STATUS; SHEEP LIVER; MUSCLE; GRASS; ZINC; MEAT; KIDNEY; BLOOD	The amount of trace elements present in edible bovine tissues is of importance for both animal health and human nutrition. This study presents data on trace element concentrations in semitendinosus and cardiac muscles, livers and kidneys of 60 zebu (Bos indicus) bulls, sampled at Jimma, Ethiopia. From 28 of these bulls, blood samples were also obtained. Deficient levels of copper were found in plasma, livers, kidneys and semitendinosus muscles. Suboptimal selenium concentrations were found in plasma and semitendinosus muscles. Semitendinosus muscles contained high iron concentrations. Trace elements were mainly stored in the liver, except for iron and selenium. Cardiac muscles generally contained higher concentrations of trace elements than semitendinous muscles except for zinc. A strong association was found between liver and kidney concentrations of copper, iron, cobalt and molybdenum. Liver storage was well correlated with storage in semitendinosus muscle for selenium and with cardiac muscle for cobalt and selenium. Plasma concentrations of copper, selenium, cobalt were well related with their respective liver concentrations and for cobalt and selenium, also with cardiac muscle concentrations. The data suggest multiple trace element deficiencies in zebu cattle in South-West Ethiopia, with lowered tissue concentrations as a consequence. Based on the comparison of our data with other literature, trace element concentrations in selected edible tissues of Bos indicus seem quite similar to those in Bos taurus. However, tissue threshold values for deficiency in Bos taurus cattle need to be refined and their applicability for Bos indicus cattle needs to be evaluated.	[Dermauw, Veronique; Janssens, Geert Paul Jules] Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium; [Lopez Alonso, Marta] Univ Santiago de Compostela, Dept Patol Anim, Lugo, Spain; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium; [Du Laing, Gijs] Univ Ghent, Fac Biosci Engn, Lab Analyt Chem & Appl Ecochem, B-9000 Ghent, Belgium; [Tolosa, Tadele] Jimma Univ, Coll Agr & Vet Med, Sch Vet Med, Jimma, Ethiopia; [Tolosa, Tadele] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, M Team & Mastitis Qual Res Unit, Merelbeke, Belgium; [Dierenfeld, Ellen] Univ Missouri Columbia, Div Anim Sci, Columbia, MO USA; [Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland	Ghent University; Universidade de Santiago de Compostela; Ghent University; Ghent University; Jimma University; Ghent University; University of Missouri System; University of Missouri Columbia; University of Zurich	Dermauw, V (corresponding author), Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium.	veronique.dermauw@ugent.be	López-Alonso, Marta/K-9437-2013; Dermauw, Veronique/AFO-8354-2022; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/A-4710-2008; Janssens, Geert/C-2264-2008; Tolosa, Tadele/N-9237-2014; Clauss, Marcus/M-8702-2019	López-Alonso, Marta/0000-0001-6426-4273; Dermauw, Veronique/0000-0001-8745-5304; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Tolosa, Tadele/0000-0002-4492-688X; Clauss, Marcus/0000-0003-3841-6207; Du Laing, Gijs/0000-0001-6661-1312	Agency for the Promotion of Innovation through Science in Flanders (IWT-Vlaanderen) [093348]	Agency for the Promotion of Innovation through Science in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was performed within the doctoral research project of Veronique Dermauw, funded by the Agency for the Promotion of Innovation through Science in Flanders (IWT-Vlaanderen), grant no. 093348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso ML, 2000, SCI TOTAL ENVIRON, V246, P237, DOI 10.1016/S0048-9697(99)00461-1; Alonso ML, 2000, FOOD ADDIT CONTAM A, V17, P447, DOI 10.1080/02652030050034028; Alonso ML, 2004, BIOMETALS, V17, P389, DOI 10.1023/B:BIOM.0000029434.89679.a2; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; BENEMARIYA H, 1993, SCI TOTAL ENVIRON, V128, P83, DOI 10.1016/0048-9697(93)90181-5; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Blanco-Penedo I, 2006, ENVIRON INT, V32, P901, DOI 10.1016/j.envint.2006.05.012; Blanco-Penedo I, 2010, FOOD ADDIT CONTAM A, V27, P36, DOI 10.1080/02652030903161598; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Cabrera MC, 2010, MEAT SCI, V84, P518, DOI 10.1016/j.meatsci.2009.10.007; Caramelli D., 2006, HUM EVOL, V21, P107; CLAYPOOL DW, 1975, J ANIM SCI, V41, P911, DOI 10.2527/jas1975.413911x; de Freitas AK, 2014, MEAT SCI, V96, P353, DOI 10.1016/j.meatsci.2013.07.021; Dermauw V, 2013, LIVEST SCI, V155, P255, DOI 10.1016/j.livsci.2013.05.027; Dermauw V, 2013, TROP ANIM HEALTH PRO, V45, P1139, DOI 10.1007/s11250-012-0337-4; Duckett SK, 2009, J ANIM SCI, V87, P2961, DOI 10.2527/jas.2009-1850; FROSLIE A, 1983, NORD VET MED, V35, P213; FROSLIE A, 1983, NORD VET MED, V35, P209; Garcia-Vaquero M, 2011, FOOD CHEM TOXICOL, V49, P1443, DOI 10.1016/j.fct.2011.03.041; Giuffrida-Mendoza M, 2007, MEAT SCI, V75, P487, DOI 10.1016/j.meatsci.2006.08.011; Herdt TH, 2011, VET CLIN N AM-FOOD A, V27, P255, DOI 10.1016/j.cvfa.2011.02.004; HUBAUX A, 1970, ANAL CHEM, V42, P849, DOI 10.1021/ac60290a013; Huerta-Leidenz N, 2003, ARCH LATINOAM NUTR, V53, P96; KHALILI M, 1993, TROP ANIM HEALTH PRO, V25, P193, DOI 10.1007/BF02250867; Kincaid R.L., 1999, J ANIM SCI, V77, P1, DOI [10.2527/jas2000.77E-Suppl1x, DOI 10.2527/JAS2000.77E-SUPPL1X]; KORSRUD GO, 1985, CAN J COMP MED, V49, P159; Leheska JM, 2008, J ANIM SCI, V86, P3575, DOI 10.2527/jas.2007-0565; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Mullis LA, 2003, J ANIM SCI, V81, P318; Nriagu J, 2009, ECOTOX ENVIRON SAFE, V72, P564, DOI 10.1016/j.ecoenv.2008.05.001; Pavlata L, 2001, ACTA VET BRNO, V70, P277, DOI 10.2754/avb200170030277; Puls R., 1994, Mineral levels in animal health: diagnostic data.; Sedki A, 2003, SCI TOTAL ENVIRON, V317, P201, DOI 10.1016/S0048-9697(03)00050-0; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; TARTOUR G, 1975, Tropical Animal Health and Production, V7, P87; Waegeneers N, 2009, FOOD ADDIT CONTAM A, V26, P326, DOI 10.1080/02652030802429096; WARD JD, 1995, J ANIM SCI, V73, P571; WHO, 1996, TRAC EL HUM NUTR HLT; Windisch W., 2008, P187	39	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85300	10.1371/journal.pone.0085300	http://dx.doi.org/10.1371/journal.pone.0085300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465529	Green Accepted, gold, Green Published			2022-12-27	WOS:000330244500052
J	Feng, L; Nian, SY; Zhang, JH				Feng, Lei; Nian, Shi-yan; Zhang, Jihong			The GG Genotype of Telomerase Reverse Transcriptase at Genetic Locus rs2736100 Is Associated with Human Atherosclerosis Risk in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; FUTURE; TERT	A single nucleotide polymorphism (SNP) in the second intron of human TERT (hTERT), rs2736100, acts as a critical factor in hTERT synthesis and activation. The rs2736100 SNP was found to be associated with susceptibility to many cancers. Recently, inhibition of telomerase and marked telomere shortening were determined to be closely associated with the increasing severity of atherosclerosis. The association between the SNP of rs2736100 and the presence of atherosclerosis was evaluated in 84 atherosclerosis patients and 257 healthy controls using multivariate logistic regression analyses. The proportion of the GG genotype in atherosclerosis patients (17.9%) was significantly higher than in the control group (9.7%). Eight variables, including age, gender, cholesterol, high density lipoprotein, homocysteine, total bilirubin, indirect bilirubin, and rs2736100 GG genotype, were associated with atherosclerosis with odds ratios of 1.88, 2.11, 1.66, 0.23, 1.27, 1.29, 1.53, and 1.74, respectively, using multivariate logistic regression analyses. Homozygous GG was demonstrated to be associated with the presence of atherosclerosis in our population.	[Feng, Lei] Peoples Hosp Yuxi City, Dept Lab, Yuxi, Yunnan Province, Peoples R China; [Nian, Shi-yan] Peoples Hosp Yuxi City, Intens Care Unit, Yuxi, Yunnan Province, Peoples R China; [Zhang, Jihong] Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan Province, Peoples R China	Kunming University of Science & Technology	Zhang, JH (corresponding author), Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan Province, Peoples R China.	zhjihong2000@126.com			National Natural Science Foundation of China [81260501]; Natural Science Foundation of Yunnan Province Education Department [KKSA201126061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province Education Department(Natural Science Foundation of Yunnan Province)	This work was supported by the National Natural Science Foundation of China (No. 81260501), the Natural Science Foundation of Yunnan Province Education Department (KKSA201126061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babizhayev MA, 2011, AM J THER, V18, pE209, DOI 10.1097/MJT.0b013e3181cf8ebb; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Kanter JE, 2013, CIRC RES, V113, P352, DOI 10.1161/CIRCRESAHA.113.301998; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Leem SH, 2002, ONCOGENE, V21, P769, DOI 10.1038/sj.onc.1205122; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Melin BS, 2012, GENET EPIDEMIOL, V36, P368, DOI 10.1002/gepi.21630; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Narducci ML, 2007, J AM COLL CARDIOL, V50, P2369, DOI 10.1016/j.jacc.2007.08.048; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Park ES, 2013, ATHEROSCLEROSIS, V228, P53, DOI 10.1016/j.atherosclerosis.2013.02.002; Pletcher MJ, 2013, CIRCULATION IN PRESS; Raynaud CM, 2008, CRIT REV ONCOL HEMAT, V66, P99, DOI 10.1016/j.critrevonc.2007.11.006; Reddy KS, 1998, CIRCULATION, V97, P596; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017	27	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85719	10.1371/journal.pone.0085719	http://dx.doi.org/10.1371/journal.pone.0085719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465664	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500096
J	Mehmood, R; Varga, G; Mohanty, SQ; Laing, SW; Lu, YF; Johnson, CL; Kharitonenkov, A; Pin, CL				Mehmood, Rashid; Varga, Gabor; Mohanty, Sonali Q.; Laing, Scott W.; Lu, Yuefeng; Johnson, Charis L.; Kharitonenkov, Alexei; Pin, Christopher L.			Epigenetic Reprogramming in Mist1(-/-) Mice Predicts the Molecular Response to Cerulein-Induced Pancreatitis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MIST1; HISTONE H3; ACTIVE GENES; METHYLATION; EXPRESSION; EXOCRINE; ACTIVATION; MECHANISMS; REGIONS; STRESS	Gene expression is affected by modifications to histone core proteins within chromatin. Changes in these modifications, or epigenetic reprogramming, can dictate cell fate and promote susceptibility to disease. The goal of this study was to determine the extent of epigenetic reprogramming in response to chronic stress that occurs following ablation of MIST1 (Mist1(-/-)), which is repressed in pancreatic disease. Chromatin immunoprecipitation for trimethylation of lysine residue 4 on histone 3 (H3K4Me3) in purified acinar cells from wild type and Mist1(-/-) mice was followed by Next Generation sequencing (ChIP-seq) or ChIP-qPCR. H3K4Me3-enriched genes were assessed for expression by qRT-PCR in pancreatic tissue before and after induction of cerulein-induced pancreatitis. While most of H3K4Me3-enrichment is restricted to transcriptional start sites, >25% of enrichment sites are found within, downstream or between annotated genes. Less than 10% of these sites were altered in Mist1(-/-) acini, with most changes in H3K4Me3 enrichment not reflecting altered gene expression. Ingenuity Pathway Analysis of genes differentially-enriched for H3K4Me3 revealed an association with pancreatitis and pancreatic ductal adenocarcinoma in Mist1(-/-) tissue. Most of these genes were not differentially expressed but several were readily induced by acute experimental pancreatitis, with significantly increased expression in Mist1(-/-) tissue relative to wild type mice. We suggest that the chronic cell stress observed in the absence of MIST1 results in epigenetic reprogramming of genes involved in promoting pancreatitis to a poised state, thereby increasing the sensitivity to events that promote disease.	[Mehmood, Rashid; Laing, Scott W.; Johnson, Charis L.; Pin, Christopher L.] Childrens Hlth Res Inst, London, ON, Canada; [Mehmood, Rashid; Laing, Scott W.; Johnson, Charis L.; Pin, Christopher L.] Childrens Hlth Res Inst, Dept Paediat, London, ON, Canada; [Laing, Scott W.; Pin, Christopher L.] Childrens Hlth Res Inst, Dept Physiol & Pharmacol, London, ON, Canada; [Pin, Christopher L.] Univ Western Ontario, London, ON, Canada; [Varga, Gabor; Mohanty, Sonali Q.; Kharitonenkov, Alexei] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Lu, Yuefeng] Sanofi US, Biostat & Programming, Framingham, MA USA	Western University (University of Western Ontario); Eli Lilly	Pin, CL (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	cpin@uwo.ca		Pin, Christopher/0000-0002-1245-1058	Canadian Institutes of Health Research [MOE 58083]; Children's Health Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Health Foundation	This work was supported by operating grant MOE 58083 from the Canadian Institutes of Health Research (www.cihr.ca), as well as local support from the Children's Health Research Institute (www.chri.org) and Lawson Health Research Institute (www.lawsonresearch.com). RM was supported by a postdoctoral fellowship from the Children's Health Foundation (childhealth.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028863; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Direnzo D, 2012, GASTROENTEROLOGY; Dupont C, 2009, SEMIN REPROD MED, V27, P351, DOI 10.1055/s-0029-1237423; Dusetti NJ, 2000, BIOCHEM BIOPH RES CO, V277, P660, DOI 10.1006/bbrc.2000.3734; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Goicoechea SM, 2013, ONCOGENE; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; IOVANNA JL, 1991, AM J PHYSIOL, V261, pG485, DOI 10.1152/ajpgi.1991.261.3.G485; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jia D, 2008, GASTROENTEROLOGY, V135, P1687, DOI 10.1053/j.gastro.2008.07.026; Johnson CL, 2012, J PATHOL, V228, P351, DOI 10.1002/path.4015; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalik AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1123, DOI 10.1152/ajpgi.00512.2006; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lardon J, 2004, HEPATOLOGY, V39, P1499, DOI 10.1002/hep.20213; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Pogribny I. P., 2010, Experimental Oncology, V32, P132; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Rukstalis JM, 2003, J CELL SCI, V116, P3315, DOI 10.1242/jcs.00631; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Suter MA, 2012, EPIGENOMICS-UK, V4, P115, DOI [10.2217/epi.12.7, 10.2217/EPI.12.7]; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Xu H, 2012, METHODS MOL BIOL, V802, P293, DOI 10.1007/978-1-61779-400-1_19; Yaragatti M, 2008, GENOME RES, V18, P930, DOI 10.1101/gr.073460.107; Zhang ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038112	50	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84182	10.1371/journal.pone.0084182	http://dx.doi.org/10.1371/journal.pone.0084182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465395	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500001
J	Miklavc, P; Ehinger, K; Thompson, KE; Hobi, N; Shimshek, DR; Frick, M				Miklavc, Pika; Ehinger, Konstantin; Thompson, Kristin E.; Hobi, Nina; Shimshek, Derya R.; Frick, Manfred			Surfactant Secretion in LRRK2 Knock-Out Rats: Changes in Lamellar Body Morphology and Rate of Exocytosis	PLOS ONE			English	Article							REPEAT KINASE 2; II CELLS; LYSOSOMAL COMPARTMENT; CONTENT RELEASE; VESICLE; PATHWAYS; FUSION; CA2+; PARKINSONISM; LOCALIZATION	Leucine-rich repeat kinase 2 (LRRK2) is known to play a role in the pathogenesis of various diseases including Parkinson disease, morbus Crohn, leprosy and cancer. LRRK2 is suggested to be involved in a number of cell biological processes such as vesicular trafficking, transcription, autophagy and lysosomal pathways. Recent histological studies of lungs of LRRK2 knock-out (LRRK2 -/-) mice revealed significantly enlarged lamellar bodies (LBs) in alveolar type II (ATII) epithelial cells. LBs are large, lysosome-related storage organelles for pulmonary surfactant, which is released into the alveolar lumen upon LB exocytosis. In this study we used high-resolution, subcellular live-cell imaging assays to investigate whether similar morphological changes can be observed in primary ATII cells from LRRK2 -/- rats and whether such changes result in altered LB exocytosis. Similarly to the report in mice, ATII cells from LRRK2 -/-rats contained significantly enlarged LBs resulting in a >50% increase in LB volume. Stimulation of ATII cells with ATP elicited LB exocytosis in a significantly increased proportion of cells from LRRK2 -/- animals. LRRK2 -/- cells also displayed increased intracellular Ca2+ release upon ATP treatment and significant triggering of LB exocytosis. These findings are in line with the strong Ca2+-dependence of LB fusion activity and suggest that LRRK2 -/- affects exocytic response in ATII cells via modulating intracellular Ca2+ signaling. Post-fusion regulation of surfactant secretion was unaltered. Actin coating of fused vesicles and subsequent vesicle compression to promote surfactant expulsion were comparable in cells from LRRK2 -/- and wt animals. Surprisingly, surfactant (phospholipid) release from LRRK2 -/- cells was reduced following stimulation of LB exocytosis possibly due to impaired LB maturation and surfactant loading of LBs. In summary our results suggest that LRRK2 -/- affects LB size, modulates intracellular Ca2+ signaling and promotes LB exocytosis upon stimulation of ATII cells with ATP.	[Miklavc, Pika; Ehinger, Konstantin; Thompson, Kristin E.; Hobi, Nina; Frick, Manfred] Univ Ulm, Inst Gen Physiol, D-89069 Ulm, Germany; [Hobi, Nina] Med Univ Innsbruck, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Shimshek, Derya R.] Novartis Inst BioMed Res, Dept Autoimmun Transplantat Inflammat Neurosci, Basel, Switzerland	Ulm University; Medical University of Innsbruck; Novartis	Frick, M (corresponding author), Univ Ulm, Inst Gen Physiol, D-89069 Ulm, Germany.	manfred.frick@uni-ulm.de	Frick, Manfred/E-1374-2012	Frick, Manfred/0000-0002-4763-1104; Ehinger, Konstantin/0000-0002-3018-343X; Shimshek, Derya/0000-0001-8602-7850	BiU grant [D.5006]; DFG [D-1402/3-1]; Ministry of Science, Research and the Arts Baden-Wurttemberg	BiU grant; DFG(German Research Foundation (DFG)); Ministry of Science, Research and the Arts Baden-Wurttemberg	This work was funded by BiU grant D.5006 and DFG grant D-1402/3-1 (www.dfg.de). P. M. is supported by a Margarete von Wrangell fellowship from the Ministry of Science, Research and the Arts Baden-Wurttemberg (www.margarete-von-wrangell.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Berwick DC, 2011, TRENDS CELL BIOL, V21, P257, DOI 10.1016/j.tcb.2011.01.001; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dietl P, 2001, NEWS PHYSIOL SCI, V16, P239; Dietl P, 2012, CELL CALCIUM, V52, P296, DOI 10.1016/j.ceca.2012.04.010; Dihanich S, 2011, J NEUROSCI, V31, P9787, DOI 10.1523/JNEUROSCI.1976-11.2011; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Drolet RE, 2011, J NEUROGENET, V25, P140, DOI 10.3109/01677063.2011.627072; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Garcia-Verdugo I, 2008, AM J PHYSIOL-LUNG C, V295, pL708, DOI 10.1152/ajplung.00536.2007; Gomez-Suaga P, 2012, AUTOPHAGY, V8, P692, DOI 10.4161/auto.19305; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Haller T, 2001, J CELL BIOL, V155, P279, DOI 10.1083/jcb.200102106; Haller T, 1996, CELL CALCIUM, V19, P157, DOI 10.1016/S0143-4160(96)90084-6; Hassin-Baer S, 2009, J NEUROL, V256, P483, DOI 10.1007/s00415-009-0117-x; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Hills BA, 1999, J APPL PHYSIOL, V87, P1567, DOI 10.1152/jappl.1999.87.5.1567; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kett LR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009407; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mair N, 2004, AM J PHYSIOL-LUNG C, V287, pL1284, DOI 10.1152/ajplung.00177.2004; Mair N, 1999, AM J PHYSIOL-LUNG C, V276, pL376, DOI 10.1152/ajplung.1999.276.2.L376; Miklavc P, 2012, JCELL SCI; Miklavc P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00171; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Ravasio A, 2011, AM J PHYSIOL-CELL PH, V300, pC1456, DOI 10.1152/ajpcell.00427.2010; Sanna G, 2012, BIOCHEM SOC T, V40, P1117, DOI 10.1042/BST20120117; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Singer W, 2003, BIOPHYS J, V84, P1344, DOI 10.1016/S0006-3495(03)74950-9; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wang ZD, 1996, J LIPID RES, V37, P790; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Yang YX, 2009, NEUROREPORT, V20, P150, DOI 10.1097/WNR.0b013e32831c50df; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	58	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84926	10.1371/journal.pone.0084926	http://dx.doi.org/10.1371/journal.pone.0084926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465451	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500021
J	Pioz, M; Guis, H; Pleydell, D; Gay, E; Calavas, D; Durand, B; Ducrot, C; Lancelot, R				Pioz, Maryline; Guis, Helene; Pleydell, David; Gay, Emilie; Calavas, Didier; Durand, Benoit; Ducrot, Christian; Lancelot, Renaud			Did Vaccination Slow the Spread of Bluetongue in France?	PLOS ONE			English	Article							VIRUS SEROTYPE 8; CULICOIDES-OBSOLETUS GROUP; SPATIAL AUTOCORRELATION; CONTROL STRATEGY; ABIOTIC FACTORS; FLIGHT ACTIVITY; RACCOON RABIES; GREAT-BRITAIN; CERATOPOGONIDAE; DISTRIBUTIONS	Vaccination is one of the most efficient ways to control the spread of infectious diseases. Simulations are now widely used to assess how vaccination can limit disease spread as well as mitigate morbidity or mortality in susceptible populations. However, field studies investigating how much vaccines decrease the velocity of epizootic wave-fronts during outbreaks are rare. This study aimed at investigating the effect of vaccination on the propagation of bluetongue, a vector-borne disease of ruminants. We used data from the 2008 bluetongue virus serotype 1 (BTV-1) epizootic of southwest France. As the virus was newly introduced in this area, natural immunity of livestock was absent. This allowed determination of the role of vaccination in changing the velocity of bluetongue spread while accounting for environmental factors that possibly influenced it. The average estimated velocity across the country despite restriction on animal movements was 5.4 km/day, which is very similar to the velocity of spread of the bluetongue virus serotype 8 epizootic in France also estimated in a context of restrictions on animal movements. Vaccination significantly reduced the propagation velocity of BTV-1. In comparison to municipalities with no vaccine coverage, the velocity of BTV-1 spread decreased by 1.7 km/day in municipalities with immunized animals. For the first time, the effect of vaccination has been quantified using data from a real epizootic whilst accounting for environmental factors known to modify the velocity of bluetongue spread. Our findings emphasize the importance of vaccination in limiting disease spread across natural landscape. Finally, environmental factors, specifically those related to vector abundance and activity, were found to be good predictors of the velocity of BTV-1 spread, indicating that these variables need to be adequately accounted for when evaluating the role of vaccination on bluetongue spread.	[Pioz, Maryline; Guis, Helene; Lancelot, Renaud] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Pioz, Maryline; Guis, Helene; Lancelot, Renaud] Inst Natl Rech Agron INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Pleydell, David] Inst Natl Rech Agron INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Petit Bourg, Guadeloupe, France; [Pleydell, David] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Petit Bourg, Guadeloupe, France; [Gay, Emilie; Calavas, Didier] Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol, Lyon, France; [Durand, Benoit] Agence Natl Securite Sanit Alimentat Environm & T, Lab Sante Anim, Maisons Alfort, France; [Ducrot, Christian] Inst Natl Rech Agron INRA, Unite Rech Epidemiol Anim 346, St Genes Champanelle, France	CIRAD; INRAE; INRAE; CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE	Pioz, M (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France.	maryline.pioz@hotmail.fr	Lancelot, Renaud/HGE-1086-2022; Pioz, Maryline/AAI-3325-2020; Durand, Benoit/GSE-2511-2022	Lancelot, Renaud/0000-0002-5826-5242; Durand, Benoit/0000-0003-0669-1394; Pioz, Maryline/0000-0003-0331-4403; Guis, Helene/0000-0002-0355-0898	EU [FP7-261504 EDENext]; Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture; EU [FP7-261504 EDENext]; Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture	EU(European Commission); Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture; EU(European Commission); Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture	This study was funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext122 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. HG and RL are partially funded by the Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian JZ, 2007, AM J TROP MED HYG, V76, P365, DOI 10.4269/ajtmh.2007.76.365; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; [Anonymous], 2012, R PACKAGE VERSION 2; [Anonymous], 2012, R PACKAGE VERSION 1; Ball F.G., 1985, P255; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Caporale V, 2010, REV SCI TECH OIE, V29, P573, DOI 10.20506/rst.29.3.2001; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; de Diego ACP, 2012, SCI WORLD J, DOI 10.1100/2012/147158; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; Dohoo I, 2009, METHODS EPIDEMIOLOGI, V2nd, P365; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Gerbier G, 2004, Vet Ital, V40, P611; Gethmann J, 2009, VACCINE, V27, P4118, DOI 10.1016/j.vaccine.2009.04.072; Giovannini A, 2004, RISK ANAL, V24, P1737, DOI 10.1111/j.0272-4332.2004.00563.x; Gubbins S, 2012, PREV VET MED, V105, P297, DOI 10.1016/j.prevetmed.2012.02.016; Haining R, 1990, SPATIAL DATA ANAL SO; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lorusso A, 2013, INFECT GENET EVOL, V19, P81, DOI 10.1016/j.meegid.2013.06.028; Lucey BT, 2002, VECTOR-BORNE ZOONOT, V2, P77, DOI 10.1089/153036602321131878; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; McKillup S, 2006, STAT EXPLAINED INTRO; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Meroc E, 2008, VET MICROBIOL, V131, P133, DOI 10.1016/j.vetmic.2008.03.012; Moore DA, 1999, PREV VET MED, V40, P19, DOI 10.1016/S0167-5877(99)00005-7; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Patta C, 2004, Vet Ital, V40, P601; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; ProMED-mail, 2013, BLUET EUR 05 FRANC C; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; R Development Core Team, 2010, R FDN STAT COMP R ST; R package version 1.6-35, 2001, R PACKAGE VERSION 1; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sanchez-Cordon PJ, 2013, VET MICROBIOL, V166, P184, DOI 10.1016/j.vetmic.2013.05.032; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; Sumner T, 2013, EPIDEMIOL INFECT, V141, P102, DOI 10.1017/S0950268812000532; Szmaragd C, 2010, EPIDEMICS-NETH, V2, P139, DOI 10.1016/j.epidem.2010.05.002; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; Vidal JP, 2010, INT J CLIMATOL, V30, P1627, DOI 10.1002/joc.2003; Wackerlin R, 2010, VACCINE, V28, P4348, DOI 10.1016/j.vaccine.2010.04.055; Willgert KJE, 2011, GEOSPATIAL HEALTH, V5, P227, DOI 10.4081/gh.2011.175; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	58	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85444	10.1371/journal.pone.0085444	http://dx.doi.org/10.1371/journal.pone.0085444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465562	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500066
J	Hui, SP; Sengupta, D; Lee, SGP; Sen, T; Kundu, S; Mathavan, S; Ghosh, S				Hui, Subhra Prakash; Sengupta, Dhriti; Lee, Serene Gek Ping; Sen, Triparna; Kundu, Sudip; Mathavan, Sinnakaruppan; Ghosh, Sukla			Genome Wide Expression Profiling during Spinal Cord Regeneration Identifies Comprehensive Cellular Responses in Zebrafish	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CYCLIN D1 EXPRESSION; DORSAL-ROOT GANGLIA; GENE-EXPRESSION; WALLERIAN DEGENERATION; AXONAL REGENERATION; FIN REGENERATION; HOX GENES; TGF-BETA; DIFFERENTIAL EXPRESSION	Background: Among the vertebrates, teleost and urodele amphibians are capable of regenerating their central nervous system. We have used zebrafish as a model to study spinal cord injury and regeneration. Relatively little is known about the molecular mechanisms underlying spinal cord regeneration and information based on high density oligonucleotide microarray was not available. We have used a high density microarray to profile the temporal transcriptome dynamics during the entire phenomenon. Results: A total of 3842 genes expressed differentially with significant fold changes during spinal cord regeneration. Cluster analysis revealed event specific dynamic expression of genes related to inflammation, cell death, cell migration, cell proliferation, neurogenesis, neural patterning and axonal regrowth. Spatio-temporal analysis of stat3 expression suggested its possible function in controlling inflammation and cell proliferation. Genes involved in neurogenesis and their dorsoventral patterning (sox2 and dbx2) are differentially expressed. Injury induced cell proliferation is controlled by many cell cycle regulators and some are commonly expressed in regenerating fin, heart and retina. Expression pattern of certain pathway genes are identified for the first time during regeneration of spinal cord. Several genes involved in PNS regeneration in mammals like stat3, socs3, atf3, mmp9 and sox11 are upregulated in zebrafish SCI thus creating PNS like environment after injury. Conclusion: Our study provides a comprehensive genetic blue print of diverse cellular response(s) during regeneration of zebrafish spinal cord. The data highlights the importance of different event specific gene expression that could be better understood and manipulated further to induce successful regeneration in mammals.	[Hui, Subhra Prakash; Sengupta, Dhriti; Kundu, Sudip; Ghosh, Sukla] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India; [Lee, Serene Gek Ping; Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore, Singapore; [Sen, Triparna] Chittaranjan Natl Canc Res Inst, Kolkata, India	University of Calcutta; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ghosh, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India.	suklagh2010@gmail.com		Sengupta, Dhriti/0000-0001-6315-7804	Department of Science and Technology, Department of Biotechnology [BT/PR13953/AAQ/03/523/2010]; Ministry of Science and Technology, Govt. of India [INT/CP-STIO/2006-2007/39/2006, BT/BI/04/001/93]; Department of Biophysics, Molecular Biology and Bioinformatics at the University of Calcutta; Genome Institute of Singapore	Department of Science and Technology, Department of Biotechnology(Department of Science & Technology (India)); Ministry of Science and Technology, Govt. of India; Department of Biophysics, Molecular Biology and Bioinformatics at the University of Calcutta; Genome Institute of Singapore	This work was supported by Department of Science and Technology, Department of Biotechnology (BT/PR13953/AAQ/03/523/2010), Ministry of Science and Technology (INT/CP-STIO/2006-2007/39/2006), Govt. of India to SG and DIC (Establishment ... BT/BI/04/001/93), and the Department of Biophysics, Molecular Biology and Bioinformatics at the University of Calcutta. Generous funding was extended by the Genome Institute of Singapore for zebrafish array work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bernhardt RR, 1999, EXP NEUROL, V157, P223, DOI 10.1006/exnr.1999.7059; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Cameron DA, 2005, MOL VIS, V11, P775; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Caubit X, 1997, DEV DYNAM, V210, P1, DOI 10.1002/(SICI)1097-0177(199709)210:1<1::AID-AJA1>3.0.CO;2-L; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Cheung KK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-76; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Devine CA, 2008, DEV BIOL, V313, P371, DOI 10.1016/j.ydbio.2007.10.040; DING AH, 1988, J IMMUNOL, V141, P2407; Dutta A, 2009, J ONCOL, V2009, DOI 10.1155/2009/627840; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghosh S, 2008, DEV GROWTH DIFFER, V50, P289, DOI [10.1111/j.1440-169x.2008.01000.x, 10.1111/j.1440-169X.2008.01000.x]; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guner B, 2007, GENE EXPR PATTERNS, V7, P596, DOI 10.1016/j.modgep.2007.01.002; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; Harrison MRM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-24; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ho DM, 2008, DEV BIOL, V315, P203, DOI 10.1016/j.ydbio.2007.12.031; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hu P, 2003, EXP NEUROL, V184, P590, DOI 10.1016/S0014-4886(03)00307-8; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Hunt D, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-9; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kedinger V, 2005, GENE EXPR PATTERNS, V5, P545, DOI 10.1016/j.modgep.2004.10.011; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Koshida S, 1998, DEVELOPMENT, V125, P1957; Kronenberg G, 2010, J CLIN INVEST, V120, P1383, DOI 10.1172/JCI40764; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Ling CC, 2006, BIOCHEM BIOPH RES CO, V349, P906, DOI 10.1016/j.bbrc.2006.08.111; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; LU X, 1993, J NEUROCYTOL, V22, P334, DOI 10.1007/BF01195557; Lufkin T, 1996, CURR OPIN GENET DEV, V6, P575, DOI 10.1016/S0959-437X(96)80086-4; Luk HW, 2003, J NEUROSCI RES, V73, P644, DOI 10.1002/jnr.10701; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Monaghan JR, 2007, J NEUROCHEM, V101, P27, DOI 10.1111/j.1471-4159.2006.04344.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; MUNEOKA K, 1982, NATURE, V298, P369, DOI 10.1038/298369a0; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; Nona SN, 2000, J NEUROCYTOL, V29, P285, DOI 10.1023/A:1026575805331; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Poh A, 2002, INT J DEV BIOL, V46, P597; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Prince VE, 1998, DEVELOPMENT, V125, P407; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Roos M, 1999, MECH DEVELOP, V87, P103, DOI 10.1016/S0925-4773(99)00153-7; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saul KE, 2010, COMP BIOCHEM PHYS A, V155, P172, DOI 10.1016/j.cbpa.2009.10.042; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Sheppard AM, 1995, DEV BIOL, V172, P504, DOI 10.1006/dbio.1995.8034; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Stadler JA, 2005, DEV DYNAM, V233, P883, DOI 10.1002/dvdy.20427; Stocum DL, 1996, INT J DEV BIOL, V40, P773; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tysseling VM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-16; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	126	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84212	10.1371/journal.pone.0084212	http://dx.doi.org/10.1371/journal.pone.0084212			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465396	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500010
J	Irvine, AG; Wallis, AK; Sanghera, N; Rowe, ML; Ruddock, LW; Howard, MJ; Williamson, RA; Blindauer, CA; Freedman, RB				Irvine, Alistair G.; Wallis, A. Katrine; Sanghera, Narinder; Rowe, Michelle L.; Ruddock, Lloyd W.; Howard, Mark J.; Williamson, Richard A.; Blindauer, Claudia A.; Freedman, Robert B.			Protein Disulfide-Isomerase Interacts with a Substrate Protein at All Stages along Its Folding Pathway	PLOS ONE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ENDOPLASMIC-RETICULUM; RIBONUCLEASE-A; BOND FORMATION; BINDING-SITE; STRUCTURAL-CHARACTERIZATION; IN-VITRO; INTERMEDIATE; CATALYSIS; DOMAINS	In contrast to molecular chaperones that couple protein folding to ATP hydrolysis, protein disulfide-isomerase (PDI) catalyzes protein folding coupled to formation of disulfide bonds (oxidative folding). However, we do not know how PDI distinguishes folded, partly-folded and unfolded protein substrates. As a model intermediate in an oxidative folding pathway, we prepared a two-disulfide mutant of basic pancreatic trypsin inhibitor (BPTI) and showed by NMR that it is partly-folded and highly dynamic. NMR studies show that it binds to PDI at the same site that binds peptide ligands, with rapid binding and dissociation kinetics; surface plasmon resonance shows its interaction with PDI has a K-d of ca. 10(-5) M. For comparison, we characterized the interactions of PDI with native BPTI and fully-unfolded BPTI. Interestingly, PDI does bind native BPTI, but binding is quantitatively weaker than with partly-folded and unfolded BPTI. Hence PDI recognizes and binds substrates via permanently or transiently unfolded regions. This is the first study of PDI's interaction with a partly-folded protein, and the first to analyze this folding catalyst's changing interactions with substrates along an oxidative folding pathway. We have identified key features that make PDI an effective catalyst of oxidative protein folding - differential affinity, rapid ligand exchange and conformational flexibility.	[Irvine, Alistair G.; Wallis, A. Katrine; Sanghera, Narinder; Freedman, Robert B.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Irvine, Alistair G.; Blindauer, Claudia A.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Rowe, Michelle L.; Howard, Mark J.; Williamson, Richard A.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Ruddock, Lloyd W.] Univ Oulu, Dept Biochem, Oulu, Finland	University of Warwick; University of Warwick; University of Kent; Finland National Institute for Health & Welfare; University of Oulu	Freedman, RB (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.b.freedman@warwick.ac.uk	Blindauer, Claudia/G-3237-2011	Blindauer, Claudia/0000-0001-8396-9332; Ruddock, Lloyd/0000-0002-6247-686X; Howard, Mark/0000-0002-0762-2887; Wallis, Katrine/0000-0002-2162-6454	MOAC Doctoral Training Programme; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D017807]; Wellcome Trust [093125/Z/10Z, 047795/Z/96]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/D017807/1, BB/D018072/1] Funding Source: researchfish; BBSRC [BB/D017807/1, BB/D018072/1] Funding Source: UKRI	MOAC Doctoral Training Programme; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AGI was supported by a studentship from the MOAC Doctoral Training Programme, funded by the Engineering and Physical Sciences Research Council. The research was also supported by grants from the Biotechnology and Biological Sciences Research Council (BB/D017807) and the Wellcome Trust (093125/Z/10Z and 047795/Z/96), and by the Royal Society (Olga Kennard Fellowship to CAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Biamonti C, 1996, THESIS RUTGERS U; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; CREIGHTON TE, 1974, J MOL BIOL, V87, P603, DOI 10.1016/0022-2836(74)90106-5; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CREIGHTON TE, 1975, J MOL BIOL, V95, P167, DOI 10.1016/0022-2836(75)90389-7; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; GOLDENBERG DP, 1992, TRENDS BIOCHEM SCI, V17, P257, DOI 10.1016/0968-0004(92)90405-X; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jimenez-Roldan JE, 2013, DYNAMICS FLEXI UNPUB; Karala AR, 2007, ANTIOXID REDOX SIGN, V9, P527, DOI 10.1089/ars.2006.1473; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Laity JH, 1997, BIOCHEMISTRY-US, V36, P12683, DOI 10.1021/bi970878b; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Narayan M, 2000, ACCOUNTS CHEM RES, V33, P805, DOI 10.1021/ar000063m; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Shin HC, 2000, J MOL BIOL, V300, P995, DOI 10.1006/jmbi.2000.3928; TALLURI S, 1994, BIOCHEMISTRY-US, V33, P10437, DOI 10.1021/bi00200a027; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; van den Berg B, 1999, J MOL BIOL, V290, P781, DOI 10.1006/jmbi.1999.2915; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; VANMIERLO CPM, 1994, J MOL BIOL, V235, P1044, DOI 10.1006/jmbi.1994.1056; VANMIERLO CPM, 1993, J MOL BIOL, V229, P1125, DOI 10.1006/jmbi.1993.1108; VENETIANER P, 1963, BIOCHIM BIOPHYS ACTA, V67, P166; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WAGNER G, 1984, EUR J BIOCHEM, V145, P431, DOI 10.1111/j.1432-1033.1984.tb08572.x; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091	45	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e82511	10.1371/journal.pone.0082511	http://dx.doi.org/10.1371/journal.pone.0082511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465374	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500004
J	Gypens, N; Borges, AV; Speeckaert, G; Lancelot, C				Gypens, Nathalie; Borges, Alberto V.; Speeckaert, Gaelle; Lancelot, Christiane			The Dimethylsulfide Cycle in the Eutrophied Southern North Sea: A Model Study Integrating Phytoplankton and Bacterial Processes	PLOS ONE			English	Article							BELGIAN COASTAL WATERS; MARINE SURFACE WATERS; DMSP-LYASE ACTIVITY; MICROBIAL FOOD-WEB; EMILIANIA-HUXLEYI; DIMETHYLSULFONIOPROPIONATE DMSP; PHAEOCYSTIS BLOOMS; SULFIDE PRODUCTION; SULFUR-COMPOUNDS; DISSOLVED DMSP	We developed a module describing the dimethylsulfoniopropionate (DMSP) and dimethylsulfide (DMS) dynamics, including biological transformations by phytoplankton and bacteria, and physico-chemical processes (including DMS air-sea exchange). This module was integrated in the MIRO ecological model and applied in a 0D frame in the Southern North Sea (SNS). The DMS(P) module is built on parameterizations derived from available knowledge on DMS(P) sources, transformations and sinks, and provides an explicit representation of bacterial activity in contrast to most of existing models that only include phytoplankton process (and abiotic transformations). The model is tested in a highly productive coastal ecosystem (the Belgian coastal zone, BCZ) dominated by diatoms and the Haptophyceae Phaeocystis, respectively low and high DMSP producers. On an annual basis, the particulate DMSP (DMSPp) production simulated in 1989 is mainly related to Phaeocystis colonies (78%) rather than diatoms (13%) and nanoflagellates (9%). Accordingly, sensitivity analysis shows that the model responds more to changes in the sulfur: carbon (S: C) quota and lyase yield of Phaeocystis. DMS originates equally from phytoplankton and bacterial DMSP-lyase activity and only 3% of the DMS is emitted to the atmosphere. Model analysis demonstrates the sensitivity of DMS emission towards the atmosphere to the description and parameterization of biological processes emphasizing the need of adequately representing in models both phytoplankton and bacterial processes affecting DMS(P) dynamics. This is particularly important in eutrophied coastal environments such as the SNS dominated by high non-diatom blooms and where empirical models developed from data-sets biased towards open ocean conditions do not satisfactorily predict the timing and amplitude of the DMS seasonal cycle. In order to predict future feedbacks of DMS emissions on climate, it is needed to account for hotspots of DMS emissions from coastal environments that, if eutrophied, are dominated not only by diatoms.	[Gypens, Nathalie; Speeckaert, Gaelle; Lancelot, Christiane] Univ Libre Bruxelles, Brussels, Belgium; [Borges, Alberto V.] Univ Liege, Unite Oceanog Chim, Liege, Belgium	Universite Libre de Bruxelles; University of Liege	Gypens, N (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	ngypens@ulb.ac.be	Borges, Alberto Vieira/C-4989-2008	Borges, Alberto Vieira/0000-0002-5434-2247; Gypens, Nathalie/0000-0002-8154-5613	Fonds de la Recherche Fondamentale Collective DMS-SNS [1882638]; Fonds de la Recherche Scientifique	Fonds de la Recherche Fondamentale Collective DMS-SNS(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	The present work is a contribution to the Fonds de la Recherche Fondamentale Collective DMS-SNS project (1882638) funded by the Fonds de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2001, J MARINE SYST, V30, P1, DOI 10.1016/S0924-7963(01)00028-8; Archer SD, 2004, CAN J FISH AQUAT SCI, V61, P765, DOI 10.1139/F04-028; Archer SD, 2002, DEEP-SEA RES PT II, V49, P3067, DOI 10.1016/S0967-0645(02)00072-3; Archer SD, 2001, AQUAT MICROB ECOL, V24, P225, DOI 10.3354/ame024225; Archer SD, 2010, LIMNOL OCEANOGR, V55, P1579, DOI 10.4319/lo.2010.55.4.1579; Aumont O, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/1999JC000111; Belviso S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002193; BELVISO S, 1990, LIMNOL OCEANOGR, V35, P1810, DOI 10.4319/lo.1990.35.8.1810; Bopp L, 2008, DEEP-SEA RES PT II, V55, P901, DOI 10.1016/j.dsr2.2007.12.002; BRIMBLECOMBE P, 1986, MAR CHEM, V19, P343, DOI 10.1016/0304-4203(86)90055-1; Brugger A, 1998, MAR CHEM, V59, P321, DOI 10.1016/S0304-4203(97)00090-X; Cadee GC, 2002, J SEA RES, V48, P97, DOI 10.1016/S1385-1101(02)00161-2; Cameron-Smith P, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047069; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; del Valle DA, 2007, MAR CHEM, V103, P197, DOI 10.1016/j.marchem.2006.07.005; DICKSON DMJ, 1987, NEW PHYTOL, V106, P645, DOI 10.1111/j.1469-8137.1987.tb00165.x; Evans C, 2006, LIMNOL OCEANOGR, V51, P2468, DOI 10.4319/lo.2006.51.5.2468; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fredrickson KA, 2009, J PLANKTON RES, V31, P135, DOI 10.1093/plankt/fbn112; GABRIC A, 1993, J GEOPHYS RES-OCEANS, V98, P22805, DOI 10.1029/93JC01773; Gabric A., 2001, CHEMOSPHERE GLOBAL C, V3, P377, DOI [10.1016/S1465-9972(01)00018-6, DOI 10.1016/S1465-9972(01)00018-6]; Gasparini S, 2000, J SEA RES, V43, P345, DOI 10.1016/S1385-1101(00)00016-2; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Gypens N, 2009, GLOBAL CHANGE BIOL, V15, P1040, DOI 10.1111/j.1365-2486.2008.01773.x; Gypens N, 2007, J SEA RES, V57, P19, DOI 10.1016/j.seares.2006.07.004; Halloran PR, 2010, BIOGEOSCIENCES, V7, P1645, DOI 10.5194/bg-7-1645-2010; Harada H, 2009, AQUAT BOT, V90, P37, DOI 10.1016/j.aquabot.2008.05.004; Hatton AD, 2012, BIOGEOCHEMISTRY, V110, P131, DOI 10.1007/s10533-012-9702-7; Ho DT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026817; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Jodwalis CM, 2000, J GEOPHYS RES-ATMOS, V105, P14387, DOI 10.1029/2000JD900023; Karsten U, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P143; KARSTEN U, 1992, POLAR BIOL, V12, P603; Keller MD, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P131; KELLER MD, 1989, ACS SYM SER, V393, P167; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kieber DJ, 1996, J GEOPHYS RES-OCEANS, V101, P3715, DOI 10.1029/95JC03624; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 2000, GEOCHIM COSMOCHIM AC, V64, P2797, DOI 10.1016/S0016-7037(00)00399-9; Kiene RP, 2006, LIMNOL OCEANOGR-METH, V4, P80, DOI 10.4319/lom.2006.4.80; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; KIENE RP, 1990, NATURE, V345, P702, DOI 10.1038/345702a0; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; Kiene RP, 2000, LIMNOL OCEANOGR, V45, P849, DOI 10.4319/lo.2000.45.4.0849; Kirst GO, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P121; Kwint RLJ, 1996, MAR ECOL PROG SER, V134, P217, DOI 10.3354/meps134217; Lana A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003850; Lana A, 2012, BIOGEOCHEMISTRY, V110, P173, DOI 10.1007/s10533-011-9677-9; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; LANCELOT C, 1995, SCI TOTAL ENVIRON, V165, P83, DOI 10.1016/0048-9697(95)04545-C; LANCELOT C, 1987, MAR ECOL PROG SER, V37, P239, DOI 10.3354/meps037239; Laroche D, 1999, MAR ECOL PROG SER, V180, P37, DOI 10.3354/meps180037; Le Clainche Y, 2004, CAN J FISH AQUAT SCI, V61, P788, DOI 10.1139/F04-027; Le Clainche Y, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003721; LECK C, 1990, J GEOPHYS RES-OCEANS, V95, P3353, DOI 10.1029/JC095iC03p03353; Lefevre M, 2002, DEEP-SEA RES PT I, V49, P2221, DOI 10.1016/S0967-0637(02)00121-8; Levasseur M, 2011, NAT GEOSCI, V4, P351, DOI 10.1038/ngeo1175; LISS PS, 1994, J MARINE SYST, V5, P41, DOI 10.1016/0924-7963(94)90015-9; LISS PS, 1993, PHILOS T ROY SOC A, V343, P531, DOI 10.1098/rsta.1993.0064; Malin G, 1998, LIMNOL OCEANOGR, V43, P1389, DOI 10.4319/lo.1998.43.6.1389; MATRAI PA, 1994, MAR BIOL, V119, P61, DOI 10.1007/BF00350107; Miles CJ, 2012, BIOGEOCHEMISTRY, V110, P201, DOI 10.1007/s10533-011-9697-5; NGUYEN BC, 1988, MAR CHEM, V24, P133, DOI 10.1016/0304-4203(88)90044-8; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; Niki T, 2000, MAR BIOL, V136, P759, DOI 10.1007/s002279900235; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Polimene L, 2012, BIOGEOCHEMISTRY, V110, P243, DOI 10.1007/s10533-011-9674-z; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Rousseau V, 2002, MAR ECOL PROG SER, V236, P61, DOI 10.3354/meps236061; Ruiz-Gonzalez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045545; SALTZMAN ES, 1993, J GEOPHYS RES-OCEANS, V98, P16481, DOI 10.1029/93JC01858; Simo R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001829; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Simo R, 1999, GLOBAL BIOGEOCHEM CY, V13, P1173, DOI 10.1029/1999GB900081; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Six KD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002674; Six KD, 2013, NAT CLIM CHANGE, V3, P975, DOI [10.1038/NCLIMATE1981, 10.1038/nclimate1981]; Slezak D, 2007, AQUAT SCI, V69, P377, DOI 10.1007/s00027-007-0896-z; Spielmeyer A, 2012, J EXP MAR BIOL ECOL, V413, P121, DOI 10.1016/j.jembe.2011.12.004; Spielmeyer A, 2011, CHEMBIOCHEM, V12, P2276, DOI 10.1002/cbic.201100416; Stefels J, 1996, MAR ECOL PROG SER, V131, P307, DOI 10.3354/meps131307; STEFELS J, 1995, MAR ECOL PROG SER, V123, P235, DOI 10.3354/meps123235; STEFELS J, 1993, MAR ECOL PROG SER, V97, P11, DOI 10.3354/meps097011; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Steiner N, 2008, DEEP-SEA RES PT I, V55, P847, DOI 10.1016/j.dsr.2008.02.010; Steinke M, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P317; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Steinke M, 2002, AQUAT MICROB ECOL, V26, P259, DOI 10.3354/ame026259; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Taylor BF, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P265; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Toole DA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000426; TURNER SM, 1988, LIMNOL OCEANOGR, V33, P364, DOI 10.4319/lo.1988.33.3.0364; Turner SM, 1996, MAR CHEM, V54, P245, DOI 10.1016/0304-4203(96)00028-X; VAIRAVAMURTHY A, 1985, LIMNOL OCEANOGR, V30, P59, DOI 10.4319/lo.1985.30.1.0059; Vallina SM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000415; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; van Duyl FC, 1998, J SEA RES, V40, P221, DOI 10.1016/S1385-1101(98)00024-0; vandenBerg AJ, 1996, MAR ECOL PROG SER, V145, P233, DOI 10.3354/meps145233; Vezina AF, 2004, CAN J FISH AQUAT SCI, V61, P845, DOI 10.1139/F04-025; Vila-Costa M, 2008, LIMNOL OCEANOGR, V53, P198, DOI 10.4319/lo.2008.53.1.0198; Vila-Costa M, 2006, ENVIRON MICROBIOL, V8, P2189, DOI 10.1111/j.1462-2920.2006.01102.x; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Watanabe YW, 2007, MAR CHEM, V103, P347, DOI 10.1016/j.marchem.2006.10.004; Wolfe GV, 1996, LIMNOL OCEANOGR, V41, P1151, DOI 10.4319/lo.1996.41.6.1151; Wolfe GV, 1999, AQUAT MICROB ECOL, V18, P197, DOI 10.3354/ame018197; Yang M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006526; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zubkov M, 2004, MAR ECOL PROG SER, V271, P77, DOI 10.3354/meps271077; Zubkov MV, 2001, ENVIRON MICROBIOL, V3, P304, DOI 10.1046/j.1462-2920.2001.00196.x; Zubkov MV, 2002, DEEP-SEA RES PT II, V49, P3017, DOI 10.1016/S0967-0645(02)00069-3	117	12	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85862	10.1371/journal.pone.0085862	http://dx.doi.org/10.1371/journal.pone.0085862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465753	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000068
J	Jappelli, R; Perrin, MH; Lewis, KA; Vaughan, JM; Tzitzilonis, C; Rivier, JE; Vale, WW; Riek, R				Jappelli, Roberto; Perrin, Marilyn H.; Lewis, Kathy A.; Vaughan, Joan M.; Tzitzilonis, Christos; Rivier, Jean E.; Vale, Wylie W.; Riek, Roland			Expression and Functional Characterization of Membrane-Integrated Mammalian Corticotropin Releasing Factor Receptors 1 and 2 in Escherichia coli	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; PERIPHERAL CANNABINOID RECEPTOR; 1ST EXTRACELLULAR DOMAIN; RAT NEUROTENSIN RECEPTOR; N-TERMINAL DOMAIN; SIGNAL-PEPTIDE; NMR STRUCTURE; STRUCTURAL BASIS; HIGH-AFFINITY; SOLUBLE FORM	Corticotropin-Releasing Factor Receptors (CRFRs) are class B1 G-protein-coupled receptors, which bind peptides of the corticotropin releasing factor family and are key mediators in the stress response. In order to dissect the receptors' binding specificity and enable structural studies, full-length human CRFR1 alpha and mouse CRFR2 beta as well as fragments lacking the N-terminal extracellular domain, were overproduced in E. coli. The characteristics of different CRFR2 beta -PhoA gene fusion products expressed in bacteria were found to be in agreement with the predicted ones in the hepta-helical membrane topology model. Recombinant histidine-tagged CRFR1 alpha and CRFR2 beta expression levels and bacterial subcellular localization were evaluated by cell fractionation and Western blot analysis. Protein expression parameters were assessed, including the influence of E. coli bacterial hosts, culture media and the impact of either PelB or DsbA signal peptide. In general, the large majority of receptor proteins became inserted in the bacterial membrane. Across all experimental conditions significantly more CRFR2 beta product was obtained in comparison to CRFR1 alpha. Following a detergent screen analysis, bacterial membranes containing CRFR1 alpha and CRFR2 beta were best solubilized with the zwitterionic detergent FC-14. Binding of different peptide ligands to CRFR1 alpha and CRFR2 beta membrane fractions were similar, in part, to the complex pharmacology observed in eukaryotic cells. We suggest that our E. coli expression system producing functional CRFRs will be useful for large-scale expression of these receptors for structural studies.	[Jappelli, Roberto] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Perrin, Marilyn H.; Lewis, Kathy A.; Vaughan, Joan M.] Salk Inst Biol Studies, Lab Neuronal Struct & Funct, La Jolla, CA 92037 USA; [Tzitzilonis, Christos; Riek, Roland] ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland; [Rivier, Jean E.; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute	Riek, R (corresponding author), ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch			National Institute of Diabetes and Digestive and Kidney Diseases [DK026741-33]; Clayton Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clayton Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by award DK026741-33 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Clayton Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BERTIN B, 1992, J BIOL CHEM, V267, P8200; Bouvier M, 2013, NAT STRUCT MOL BIOL, V20, P539, DOI 10.1038/nsmb.2584; BOYD D, 1993, J BACTERIOL, V175, P553, DOI 10.1128/JB.175.2.553-556.1993; CHAPOT MP, 1990, EUR J BIOCHEM, V187, P137, DOI 10.1111/j.1432-1033.1990.tb15287.x; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Couvineau A, 2004, REGUL PEPTIDES, V123, P181, DOI 10.1016/j.regpep.2004.06.025; Furukawa H, 2000, J BIOCHEM-TOKYO, V127, P151, DOI 10.1093/oxfordjournals.jbchem.a022577; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grammatopoulos DK, 2012, BRIT J PHARMACOL, V166, P85, DOI 10.1111/j.1476-5381.2011.01631.x; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1994, RECEPTOR CHANNEL, V2, P295; Hampe W, 2000, J BIOTECHNOL, V77, P219, DOI 10.1016/S0168-1656(99)00216-3; Harmar AJ, 2001, GENOME BIOL, V2; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hulme Edward C., 1998, Biochemical Society Transactions, V26, pS361; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006; Klammt C, 2011, PROTEIN SCI, V20, P1030, DOI 10.1002/pro.636; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LACATENA RM, 1994, P NATL ACAD SCI USA, V91, P10521, DOI 10.1073/pnas.91.22.10521; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P2048, DOI 10.1210/me.11.13.2048; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; MARULLO S, 1988, P NATL ACAD SCI USA, V85, P7551, DOI 10.1073/pnas.85.20.7551; McCusker EC, 2007, BIOTECHNOL PROGR, V23, P540, DOI 10.1021/bp060349b; Michalke K, 2010, ANAL BIOCHEM, V401, P74, DOI 10.1016/j.ab.2010.02.017; Michalke K, 2009, ANAL BIOCHEM, V386, P147, DOI 10.1016/j.ab.2008.12.016; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schmidt P, 2009, BIOTECHNOL PROGR, V25, P1732, DOI 10.1002/btpr.266; Schulein R, 2012, EUR J CELL BIOL, V91, P294, DOI 10.1016/j.ejcb.2011.02.006; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Zhou Y, 2012, AMINO ACIDS, V43, P1147, DOI 10.1007/s00726-011-1170-1; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1	67	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84013	10.1371/journal.pone.0084013	http://dx.doi.org/10.1371/journal.pone.0084013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465390	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000010
J	Kulma, K; Low, M; Bensch, S; Qvarnstrom, A				Kulma, Katarzyna; Low, Matthew; Bensch, Staffan; Qvarnstrom, Anna			Malaria-Infected Female Collared Flycatchers (Ficedula albicollis) Do Not Pay the Cost of Late Breeding	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; HISTORY TRADE-OFF; REPRODUCTIVE EFFORT; TERMINAL INVESTMENT; FOOD ABUNDANCE; BLUE TITS; WILD; PLASMODIUM; COEXISTENCE; PREVALENCE	Life-history theory predicts that the trade-off between parasite defense and other costly traits such as reproduction may be most evident when resources are scarce. The strength of selection that parasites inflict on their host may therefore vary across environmental conditions. Collared flycatchers (Ficedula albicollis) breeding on the Swedish island Oland experience a seasonal decline in their preferred food resource, which opens the possibility to test the strength of life-history trade-offs across environmental conditions. We used nested-PCR and quantitative-PCR protocols to investigate the association of Haemosporidia infection with reproductive performance of collared flycatcher females in relation to a seasonal change in the external environment. We show that despite no difference in mean onset of breeding, infected females produced relatively more of their fledglings late in the season. This pattern was also upheld when considering only the most common malaria lineage (hPHSIB1), however there was no apparent link between the reproductive output and the intensity of infection. Infected females produced heavier-than-average fledglings with higher-than-expected recruitment success late in the season. This reversal of the typical seasonal trend in reproductive output compensated them for lower fledging and recruitment rates compared to uninfected birds earlier in the season. Thus, despite different seasonal patterns of reproductive performance the overall number of recruits was the same for infected versus uninfected birds. A possible explanation for our results is that infected females breed in a different microhabitat where food availability is higher late in the season but also is the risk of infection. Thus, our results suggest that another trade-off than the one we aimed to test is more important for explaining variation in reproductive performance in this natural population: female flycatchers appear to face a trade-off between the risk of infection and reproductive success late in the season.	[Kulma, Katarzyna; Qvarnstrom, Anna] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Low, Matthew] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Lund University	Kulma, K (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	katarzyna.kulma@ebc.uu.se		Qvarnstrom, Anna/0000-0002-1178-4053; Low, Matthew/0000-0002-7345-6063	Swedish Research Council; Swedish Research Council for Environment, Agricultural and Spatial Planning; European Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural and Spatial Planning(Swedish Research Council Formas); European Research Foundation(European Science Foundation (ESF))	Our work is funded by the Swedish Research Council (VR to AQ) and the Swedish Research Council for Environment, Agricultural and Spatial Planning (Formas to ML) and the European Research Foundation (AQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; Atkinson C.T., 2009, PARASITIC DIS WILD B; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; DOBSON A, 1994, TRENDS ECOL EVOL, V9, P393, DOI 10.1016/0169-5347(94)90062-0; Ebert Dieter, 1996, Trends in Ecology and Evolution, V11, P79, DOI 10.1016/0169-5347(96)81047-0; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Ilmonen P, 1999, OIKOS, V86, P79, DOI 10.2307/3546571; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Knowles SCL, 2011, MOL ECOL, V20, P1062, DOI 10.1111/j.1365-294X.2010.04909.x; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kulma K, 2013, MOL ECOL, V22, P4591, DOI 10.1111/mec.12409; Loye J.E., 1991, BIRD PARASITE INTERA; Lundberg A, 1992, PIED FLYCATCHER; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2012, MALARIA PARASITES, P135, DOI DOI 10.5772/33730; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Messina FJ, 1999, PHYSIOL ENTOMOL, V24, P358, DOI 10.1046/j.1365-3032.1999.00151.x; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Mullarney K, 2000, BIRDS EUROPE; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; PART T, 1992, AM NAT, V140, P868, DOI 10.1086/285445; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Qvarnstrom A, 2005, BIOL LETTERS, V1, P68, DOI 10.1098/rsbl.2004.0265; Qvarnstrom A, 2010, PHILOS T R SOC B, V365, P1841, DOI 10.1098/rstb.2009.0306; Qvarnstrom A, 2009, ECOLOGY, V90, P1948, DOI 10.1890/08-0494.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Rice AM, 2013, HORM BEHAV, V63, P813, DOI 10.1016/j.yhbeh.2013.03.019; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; Stearns S.C., 1992, pi; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Thomas DW, 2007, FUNCT ECOL, V21, P947, DOI 10.1111/j.1365-2435.2007.01301.x; Valkinas G., 2005, AVIAN MALARIA PARASI; Veen T, 2010, OECOLOGIA, V162, P873, DOI 10.1007/s00442-009-1544-1; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x	49	10	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85822	10.1371/journal.pone.0085822	http://dx.doi.org/10.1371/journal.pone.0085822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465726	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000027
J	Lee, JJ; Yeh, CY; Jung, CJ; Chen, CW; Du, MK; Yu, HM; Yang, CJ; Lin, HY; Sun, A; Ko, JY; Cheng, SJ; Chang, YL; Chia, JS				Lee, Jang-Jaer; Yeh, Chiou-Yueh; Jung, Chiau-Jing; Chen, Ching-Wen; Du, Mao-Kuang; Yu, Hui-Ming; Yang, Chia-Ju; Lin, Hui-yi; Sun, Andy; Ko, Jenq-Yuh; Cheng, Shih Jung; Chang, Yen-Liang; Chia, Jean-San			Skewed Distribution of IL-7 Receptor-alpha-Expressing Effector Memory CD8(+) T Cells with Distinct Functional Characteristics in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE CELLS; CANCER; INTERLEUKIN-7; IMMUNOTHERAPY; GENERATION; HEAD; IDENTIFICATION; PROLIFERATION; LYMPHOCYTES	CD8(+) T cells play important roles in anti-tumor immunity but distribution profile or functional characteristics of effector memory subsets during tumor progression are unclear. We found that, in oral squamous carcinoma patients, circulating CD8(+) T cell pools skewed toward effector memory subsets with the distribution frequency of CCR7(-) CD45RA(-) CD8(+) T cells and CCR7(-) CD45RA(+) CD8(+) T cells negatively correlated with each other. A significantly higher frequency of CD127(lo) CCR7(-) CD45RA(-) CD8(+) T cells or CCR7(-) CD45RA(+) CD8(+) T cells among total CD8(+) T cells was found in peripheral blood or tumor infiltrating lymphocytes, but not in regional lymph nodes. The CD127(hi) CCR7(-) CD45RA(-) CD8(+) T cells or CCR7(-) CD45RA(+) CD8(+) T cells maintained significantly higher IFN-gamma, IL-2 productivity and ex vivo proliferative capacity, while the CD127(lo) CCR7(-) CD45RA(-) CD8(+) T cells or CCR7(-) CD45RA(+) CD8(+) T cells exhibited higher granzyme B productivity and susceptibility to activation induced cell death. A higher ratio of CCR7(-) CD45RA(+) CD8(+) T cells to CCR7(-) CD45RA(-) CD8(+) T cells was associated with advanced cancer staging and poor differentiation of tumor cells. Therefore, the CD127(lo) CCR7(-) CD45RA(-) CD8(+) T cells and CCR7(-) CD45RA(+) CD8(+) T cells are functionally similar CD8(+) T cell subsets which exhibit late differentiated effector phenotypes and the shift of peripheral CD8(+) effector memory balance toward CCR7(-) CD45RA(+) CD8(+) T cells is associated with OSCC progression.	[Lee, Jang-Jaer; Sun, Andy; Cheng, Shih Jung] Natl Taiwan Univ Hosp, Dept Oral Maxillofacial Surg, Taipei, Taiwan; [Yeh, Chiou-Yueh; Jung, Chiau-Jing; Chen, Ching-Wen; Du, Mao-Kuang; Yang, Chia-Ju; Chia, Jean-San] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Yu, Hui-Ming] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Hui-yi; Chia, Jean-San] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Ko, Jenq-Yuh] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chang, Yen-Liang] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Chang, Yen-Liang] Cathay Gen Hosp, Dept Otolaryngol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Cathay General Hospital	Chia, JS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	chiajs@ntu.edu.tw	Chen, Ching-wen/ABH-8484-2020	Sun, Andy/0000-0002-4912-5424; LEE, JANG-JAER/0000-0003-0964-0840; CHIA, JEAN-SAN/0000-0002-5431-0712; Cheng, Shih-Jung/0000-0003-4674-4892	National Taiwan University Hospital [NTUH.97-S-833, NTUH.99-S1334, NTUH.100-S1603, NTUH.101-S1834]; National Science Council [NSC100-2314-B-002-096, NSC101-2314-B-002-101-MY2, NSC101-2321-B-002-074, NSC 101-2321-B-002-016]	National Taiwan University Hospital(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by National Taiwan University Hospital (NTUH.97-S-833, NTUH.99-S1334, NTUH.100-S1603, and NTUH.101-S1834); National Science Council (NSC100-2314-B-002-096, NSC101-2314-B-002-101-MY2, NSC101-2321-B-002-074 and NSC 101-2321-B-002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1990, J EXP MED, V172, P577, DOI 10.1084/jem.172.2.577; Czystowska M, 2013, CLIN CANC RES, V19, P889; Duray A, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/701657; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Govekar RB, 2009, PROTEOM CLIN APPL, V3, P1451, DOI 10.1002/prca.200900023; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hoffmann TK, 2000, J IMMUNOL, V165, P5938, DOI 10.4049/jimmunol.165.10.5938; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Kim HR, 2006, BLOOD, V107, P2855, DOI 10.1182/blood-2005-09-3560; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Laimer K, 2011, ORAL ONCOL, V47, P352, DOI 10.1016/j.oraloncology.2011.03.007; Lee JJ, 2011, HEAD NECK-J SCI SPEC, V33, P1301, DOI 10.1002/hed.21607; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pretscher D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-292; Ralhan R, 2011, PROTEOMICS, V11, P2363, DOI 10.1002/pmic.201000186; Reichert TE, 2002, CLIN CANCER RES, V8, P3137; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; SMYTH MJ, 1991, CELL IMMUNOL, V138, P390, DOI 10.1016/0008-8749(91)90163-6; Sun HY, 2007, J ANTIMICROB CHEMOTH, V60, P599, DOI 10.1093/jac/dkm243; Takata H, 2012, BLOOD, V119, P1390, DOI 10.1182/blood-2011-03-343251; Thompson JA, 2003, CLIN CANCER RES, V9, P3562; Timar J, 2005, J CLIN ONCOL, V23, P3421, DOI 10.1200/JCO.2005.06.005; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Waller ECP, 2007, BLOOD, V110, P4360, DOI 10.1182/blood-2007-07-104604; WANG A, 2012, SCI TRANSL MED, V4, P149, DOI DOI 10.1126/SCITRANSLMED.3004306; WHITESIDE TL, 1993, CANCER RES, V53, P5654	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85521	10.1371/journal.pone.0085521	http://dx.doi.org/10.1371/journal.pone.0085521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465587	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000016
J	Musinguzi, G; Bwayo, D; Kiwanuka, N; Coutinho, S; Mukose, A; Kabanda, J; Sekabembe, L; Nuwaha, F				Musinguzi, Geofrey; Bwayo, Denis; Kiwanuka, Noah; Coutinho, Sheila; Mukose, Aggrey; Kabanda, Joseph; Sekabembe, Lilian; Nuwaha, Fred			Sexual Behavior among Persons Living with HIV in Uganda: Implications for Policy and Practice	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; URBAN UGANDA; PREVENTION; HIV/AIDS; PREVALENCE; WOMEN; MEN	Introduction: HIV epidemics are sustained and propagated by new cases of infection which result from transmission from infected persons to uninfected susceptible individuals. People living with HIV (PLHIV) play a critical role in prevention if they adopt safer sexual behaviors. This study estimated the prevalence of and factors associated with safer sexual behaviors among PLHIV seeking care from civil society organizations (CSOs). Methods: In a cross sectional study PLHIV were interviewed about their sexual practices, use of alcohol, HIV status of their regular sexual partners, desire for more children and about their socio-demographic characteristics. We calculated the proportion of PLHIV who abstained and consistently used condoms in the previous twelve months. Independent associations between safer sex and other variables were estimated using adjusted prevalence ratios (aPR) and their 95% confidence intervals (CI). \Results: Of the 939 PLHIV, 54% (508) were either abstaining or using condoms consistently and 291 (31%) desired more children. The prevalence of consistent condom use among the sexually active was 41.3% (300/ 731). Consistent condom use was higher among PLHIV who: didn't use alcohol (aPR 1.30, CI 1.03-1.63); were educated about re-infection with a new strain of HIV (aPR 1.84, CI 1.08-3.12) and had regular sexual partner who was HIV negative (aPR 1.29, CI 1.05-1.57). Prevalence of abstinence was 22.2% (208/ 939). Abstinence increased with age from 9.4% among PLHIV<25 years to 40.5% among those >50 years. Abstinence was extremely low (2.5%) among PLHIV who were married. Conclusions: Effective interventions that reduce alcohol consumption among PLHIV are needed to avert HIV transmission, prevent acquisition of new HIV strains and STIs. In addition, strategies are needed to address needs of PLHIV who desire more children.	[Musinguzi, Geofrey; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Bwayo, Denis; Coutinho, Sheila; Kabanda, Joseph; Sekabembe, Lilian] Civil Soc Fund, Kampala, Uganda; [Kiwanuka, Noah; Mukose, Aggrey] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	Makerere University; Makerere University	Musinguzi, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.				United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The study was funded by the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, CULT HEALTH SEX, V13, P529, DOI 10.1080/13691058.2011.558593; Amirkhanian YA, 2005, AIDS, V19, P1897, DOI 10.1097/01.aids.0000189867.74806.fb; [Anonymous], 2009, STUD FAMILY PLANN, V40, P161; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Berry S., 2006, WHY IS UGANDA INTERE; Biraro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055060; Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Kish L, 1965, SURVEY SAMPLING; Manjunatha R, 2011, AUSTRALAS MED J, V4, P150, DOI 10.4066/AMJ.2011.577; Matovu SN, 2012, OCCUP THER INT, V19, P176, DOI 10.1002/oti.1330; MoH, 2011, STAT ANT THER SERV U; Moore AR, 2007, SOC SCI MED, V64, P1057, DOI 10.1016/j.socscimed.2006.10.004; MPFED, 2012, KEY FACTS UG POP; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Ncube N M, 2012, Ghana Med J, V46, P27; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Saniel OP, 2010, INT MARIT HEALTH, V61, P215; Sarna A, 2008, INT J STD AIDS, V19, P85, DOI 10.1258/ijsa.2007.007097; Sarna A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-9; Schackman BR, 2008, AIDS PATIENT CARE ST, V22, P123, DOI 10.1089/apc.2007.0037; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Signorelli D, 1998, Clin Podiatr Med Surg, V15, P179; Tumukunde D, 2010, East Afr Med J, V87, P91; UAC, 2011, UG AIDS IND SURV 201; UAC, 2010, NAT HIV PREV STRAT 2; Wandera B, 2011, JAIDS-J ACQ IMM DEF, V57, P62, DOI 10.1097/QAI.0b013e318211b3f2; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85646	10.1371/journal.pone.0085646	http://dx.doi.org/10.1371/journal.pone.0085646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24465631	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000019
J	Kwon, YW; Chung, YJ; Kim, J; Lee, HJ; Park, J; Roh, TY; Cho, HJ; Yoon, CH; Koo, BK; Kim, HS				Kwon, Yoo-Wook; Chung, Yeon-Ju; Kim, Joonoh; Lee, Ho-Jae; Park, Jihwan; Roh, Tae-Young; Cho, Hyun-Jai; Yoon, Chang-Hwan; Koo, Bon-Kwon; Kim, Hyo-Soo			Comparative Study of Efficacy of Dopaminergic Neuron Differentiation between Embryonic Stem Cell and Protein-Based Induced Pluripotent Stem Cell	PLOS ONE			English	Article							PARKINSONS-DISEASE; IN-VITRO; ANIMAL-MODEL; RAT MODEL; TRANSPLANTATION; MIDBRAIN; MICE; INDUCTION; TRANSCRIPTION; EXPRESSION	In patients with Parkinson's disease (PD), stem cells can serve as therapeutic agents to restore or regenerate injured nervous system. Here, we differentiated two types of stem cells; mouse embryonic stem cells (mESCs) and protein-based iPS cells (P-iPSCs) generated by non-viral methods, into midbrain dopaminergic (mDA) neurons, and then compared the efficiency of DA neuron differentiation from these two cell types. In the undifferentiated stage, P-iPSCs expressed pluripotency markers as ES cells did, indicating that protein-based reprogramming was stable and authentic. While both stem cell types were differentiated to the terminally-matured mDA neurons, P-iPSCs showed higher DA neuron-specific markers' expression than ES cells. To investigate the mechanism of the superior induction capacity of DA neurons observed in P-iPSCs compared to ES cells, we analyzed histone modifications by genome-wide ChIP sequencing analysis and their corresponding microarray results between two cell types. We found that Wnt signaling was up-regulated, while SFRP1, a counter-acting molecule of Wnt, was more suppressed in P-iPSCs than in mESCs. In PD rat model, transplantation of neural precursor cells derived from both cell types showed improved function. The present study demonstrates that P-iPSCs could be a suitable cell source to provide patient-specific therapy for PD without ethical problems or rejection issues.	[Kwon, Yoo-Wook; Chung, Yeon-Ju; Kim, Joonoh; Lee, Ho-Jae; Cho, Hyun-Jai; Kim, Hyo-Soo] Seoul Natl Univ, Natl Res Lab Stem Cell Niche, Seoul, South Korea; [Kwon, Yoo-Wook; Chung, Yeon-Ju; Kim, Joonoh; Lee, Ho-Jae; Cho, Hyun-Jai; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul 110744, South Korea; [Park, Jihwan; Roh, Tae-Young] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea; [Yoon, Chang-Hwan] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Seoul, South Korea; [Cho, Hyun-Jai; Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, HS (corresponding author), Seoul Natl Univ, Natl Res Lab Stem Cell Niche, Seoul, South Korea.	hyosoo@snu.ac.kr		Yoon, Chang-Hwan/0000-0001-6305-4442; Roh, Tae-Young/0000-0001-5833-0844	Innovative Research Institute for Cell Therapy [A062260]; Bio & Medical Technology Development Program of the National Research Foundation; Korean government (MEST) [2010-0020258]; Korean Health Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100476]	Innovative Research Institute for Cell Therapy; Bio & Medical Technology Development Program of the National Research Foundation(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean Health Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Innovative Research Institute for Cell Therapy (A062260) and the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government (MEST) (2010-0020258) and a grant of the Korean Health Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; Dani C, 1997, J CELL SCI, V110, P1279; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kamei Y, 2010, OBESITY, V18, P314, DOI 10.1038/oby.2009.246; Kele J, 2012, STEM CELLS, V30, P865, DOI 10.1002/stem.1049; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim BG, 2000, BRAIN RES, V855, P162, DOI 10.1016/S0006-8993(99)02374-4; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kimura H, 2005, NEUROL RES, V27, P812, DOI 10.1179/016164105X63629; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lindvall Olle, 2004, NeuroRx, V1, P382; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Schwartz CM, 2012, J NEUROSCI RES, V90, P1367, DOI 10.1002/jnr.23064; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yoon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188078; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	45	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85736	10.1371/journal.pone.0085736	http://dx.doi.org/10.1371/journal.pone.0085736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465672	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100066
J	Thresher, R; Althaus, F; Adkins, J; Gowlett-Holmes, K; Alderslade, P; Dowdney, J; Cho, W; Gagnon, A; Staples, D; McEnnulty, F; Williams, A				Thresher, Ronald; Althaus, Franziska; Adkins, Jess; Gowlett-Holmes, Karen; Alderslade, Phil; Dowdney, Jo; Cho, Walter; Gagnon, Alex; Staples, David; McEnnulty, Felicity; Williams, Alan			Strong Depth-Related Zonation of Megabenthos on a Rocky Continental Margin (similar to 700-4000 m) off Southern Tasmania, Australia	PLOS ONE			English	Article							DEEP-SEA; MEGAFAUNAL BIOMASS; SPECIES-DIVERSITY; NEW-ENGLAND; SEAMOUNTS; OCEAN; ATLANTIC; COMMUNITIES; TEMPERATURE; CHEMISTRY	Assemblages of megabenthos are structured in seven depth-related zones between similar to 700 and 4000 m on the rocky and topographically complex continental margin south of Tasmania, southeastern Australia. These patterns emerge from analysis of imagery and specimen collections taken from a suite of surveys using photographic and in situ sampling by epibenthic sleds, towed video cameras, an autonomous underwater vehicle and a remotely operated vehicle (ROV). Seamount peaks in shallow zones had relatively low biomass and low diversity assemblages, which may be in part natural and in part due to effects of bottom trawl fishing. Species richness was highest at intermediate depths (1000-1300 m) as a result of an extensive coral reef community based on the bioherm-forming scleractinian Solenosmilia variabilis. However, megabenthos abundance peaked in a deeper, low diversity assemblage at 2000-2500 m. The S. variabilis reef and the deep biomass zone were separated by an extensive dead, sub-fossil S. variabilis reef and a relatively low biomass stratum on volcanic rock roughly coincident with the oxygen minimum layer. Below 2400 m, megabenthos was increasingly sparse, though punctuated by occasional small pockets of relatively high diversity and biomass. Nonetheless, megabenthic organisms were observed in the vast majority of photographs on all seabed habitats and to the maximum depths observed - a sandy plain below 3950 m. Taxonomic studies in progress suggest that the observed depth zonation is based in part on changing species mixes with depth, but also an underlying commonality to much of the seamount and rocky substrate biota across all depths. Although the mechanisms supporting the extraordinarily high biomass in 2000-2500 m depths remains obscure, plausible explanations include equatorwards lateral transport of polar production and/or a response to depth-stratified oxygen availability.	[Thresher, Ronald; Althaus, Franziska; Gowlett-Holmes, Karen; Alderslade, Phil; Dowdney, Jo; McEnnulty, Felicity; Williams, Alan] CSIRO Wealth Oceans Flagship, Hobart, Tas, Australia; [Adkins, Jess; Gagnon, Alex] CALTECH, Pasadena, CA 91125 USA; [Cho, Walter] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Staples, David] Museum Victoria, Melbourne, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; Woods Hole Oceanographic Institution; Museum Victoria	Thresher, R (corresponding author), CSIRO Wealth Oceans Flagship, Hobart, Tas, Australia.	Ron.Thresher@csiro.au	Althaus, Franziska/E-4660-2017; Williams, Alan/C-6999-2012; Althaus, Franziska/B-6873-2015; McEnnulty, Felicity R/K-6741-2018; Adkins, Jess/GYI-8778-2022	Althaus, Franziska/0000-0002-5336-4612; Williams, Alan/0000-0002-2867-7713; McEnnulty, Felicity R/0000-0002-3819-044X; Gagnon, Alexander/0000-0003-0717-2916	National Science Foundation; Australian Department of Environment, Water, Heritage, and the Arts; Australian Commonwealth Environmental Research Fund; CSIRO Wealth from Oceans and Climate Adaptation Flagships; Directorate For Geosciences [1204211] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Australian Department of Environment, Water, Heritage, and the Arts(Australian Government); Australian Commonwealth Environmental Research Fund; CSIRO Wealth from Oceans and Climate Adaptation Flagships; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Components of this work were supported by the National Science Foundation, the Australian Department of Environment, Water, Heritage, and the Arts, the Australian Commonwealth Environmental Research Fund, a grant of ship time by the Australian National Research Facility, and the CSIRO Wealth from Oceans and Climate Adaptation Flagships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson TJ, 2011, DEEP-SEA RES PT II, V58, P979, DOI 10.1016/j.dsr2.2010.10.053; Biscoito M, 1998, CAH BIOL MAR, V39, P223; Buckeridge JS, 1999, NEW ZEAL J MAR FRESH, V33, P521, DOI 10.1080/00288330.1999.9516897; Cairns SD, 2007, P BIOL SOC WASH, V120, P243, DOI 10.2988/0006-324X(2007)120[243:SOWAOG]2.0.CO;2; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Cho W, 2008, THESIS MIT; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Druffel ERM, 2000, GEOPHYS RES LETT, V27, P1495, DOI 10.1029/1999GL002398; Fallon SJ, CORAL REEFS IN PRESS; Freiwald A., 2005, COLD WATER CORALS EC; German CR, 2008, DEEP-SEA RES PT I, V55, P203, DOI 10.1016/j.dsr.2007.11.004; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; HAEDRICH RL, 1977, NATURE, V269, P141, DOI 10.1038/269141a0; Herring R, 2002, BIOL DEEP OCEAN; Honjo S, 2000, DEEP-SEA RES PT II, V47, P3521, DOI 10.1016/S0967-0645(00)00077-1; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; KAUFMANN RS, 1989, DEEP-SEA RES, V36, P1863, DOI 10.1016/0198-0149(89)90116-7; Koslow J.A., 2007, SILENT DEEP; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; McClain CR, 2005, OIKOS, V109, P555, DOI 10.1111/j.0030-1299.2005.13529.x; McClain CR, 2001, MAR BIOL, V139, P681; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; O'Hara TD, 2008, DIVERS DISTRIB, P1; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; Roberts J. M., 2009, COLD WATER CORALS; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Sautya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016162; Shortis MR, 2008, MAR TECHNOL SOC J, V42, P28, DOI 10.4031/002533208787157624; Thiagarajan N, 2013, PALEOCEANOGRAPHY, V28, P227, DOI 10.1002/palo.20023; Thresher RE, 2011, SCI REP-UK, V1, DOI 10.1038/srep00119; Thresher RE, 2011, MAR ECOL PROG SER, V442, P87, DOI 10.3354/meps09400; Thresher RE, 2010, GEOCHIM COSMOCHIM AC, V74, P4655, DOI 10.1016/j.gca.2010.05.024; Waller RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016153; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	48	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85872	10.1371/journal.pone.0085872	http://dx.doi.org/10.1371/journal.pone.0085872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465758	gold, Green Published			2022-12-27	WOS:000330283100084
J	Xu, MJ; Wen, XF; Wang, HM; Zhang, WJ; Dai, XQ; Song, J; Wang, YD; Fu, XL; Liu, YF; Sun, XM; Yu, GR				Xu, Mingjie; Wen, Xuefa; Wang, Huimin; Zhang, Wenjiang; Dai, Xiaoqin; Song, Jie; Wang, Yidong; Fu, Xiaoli; Liu, Yunfen; Sun, Xiaomin; Yu, Guirui			Effects of Climatic Factors and Ecosystem Responses on the Inter-Annual Variability of Evapotranspiration in a Coniferous Plantation in Subtropical China	PLOS ONE			English	Article							ASIAN SUMMER MONSOON; TROPICAL RAIN-FOREST; SAP-FLOW; CANOPY CONDUCTANCE; ENERGY-EXCHANGE; CARBON-DIOXIDE; WATER-VAPOR; SEASONAL-VARIATION; SOIL RESPIRATION; DECIDUOUS FOREST	Because evapotranspiration (ET) is the second largest component of the water cycle and a critical process in terrestrial ecosystems, understanding the inter-annual variability of ET is important in the context of global climate change. Eight years of continuous eddy covariance measurements (2003-2010) in a subtropical coniferous plantation were used to investigate the impacts of climatic factors and ecosystem responses on the inter-annual variability of ET. The mean and standard deviation of annual ET for 2003-2010 were 786.9 and 103.4 mm (with a coefficient of variation of 13.1%), respectively. The inter-annual variability of ET was largely created in three periods: March, May-June, and October, which are the transition periods between seasons. A set of look-up table approaches were used to separate the sources of inter-annual variability of ET. The annual ETs were calculated by assuming that (a) both the climate and ecosystem responses among years are variable (Vcli-eco), (b) the climate is variable but the ecosystem responses are constant (V-cli), and (c) the climate is constant but ecosystem responses are variable (V-eco). The ETs that were calculated under the above assumptions suggested that the inter-annual variability of ET was dominated by ecosystem responses and that there was a negative interaction between the effects of climate and ecosystem responses. These results suggested that for long-term predictions of water and energy balance in global climate change projections, the ecosystem responses must be taken into account to better constrain the uncertainties associated with estimation.	[Xu, Mingjie; Wen, Xuefa; Wang, Huimin; Dai, Xiaoqin; Fu, Xiaoli; Liu, Yunfen; Sun, Xiaomin; Yu, Guirui] Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Xu, Mingjie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Wenjiang] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu 610064, Peoples R China; [Song, Jie] No Illinois Univ, Dept Geog, De Kalb, IL USA; [Wang, Yidong] Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan University; Northern Illinois University; Tianjin Normal University	Wang, HM (corresponding author), Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	wanghm@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; Wang, Yidong/I-4027-2014; wang, huimin/HDM-8421-2022	于, 贵瑞/0000-0002-1859-8966; Wang, Yidong/0000-0002-5399-2803; Xu, Mingjie/0000-0002-5923-2901	National Key Basic Research Special Foundation Project [2010CB833501]; Major Program of National Natural Science Foundation of China [31290221]; National Natural Science Foundation of China [31070559, 31210103920]; National Key Basic Research Program of China [2012CB416903]	National Key Basic Research Special Foundation Project(National Basic Research Program of China); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Key Basic Research Special Foundation Project (2010CB833501), Major Program of National Natural Science Foundation of China (31290221), National Natural Science Foundation of China (31070559, 31210103920) and the National Key Basic Research Program of China (2012CB416903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiral SW, 2006, AGR FOREST METEOROL, V140, P308, DOI 10.1016/j.agrformet.2006.03.017; Alfieri JG, 2007, J HYDROMETEOROL, V8, P207, DOI 10.1175/JHM569.1; Bader MKF, 2010, PLANTA, V232, P1115, DOI 10.1007/s00425-010-1240-8; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Bernier PY, 2006, AGR FOREST METEOROL, V140, P64, DOI 10.1016/j.agrformet.2006.03.019; Betts AK, 1999, J CLIMATE, V12, P1601, DOI 10.1175/1520-0442(1999)012<1601:COEIAB>2.0.CO;2; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bracho R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000469; Bucci SJ, 2008, AGR FOREST METEOROL, V148, P839, DOI 10.1016/j.agrformet.2007.11.013; BUTLER DR, 1976, AGR METEOROL, V16, P277, DOI 10.1016/0002-1571(76)90047-9; Cernusak LA, 2013, FUNCT PLANT BIOL, V40, P531, DOI 10.1071/FP12309; Chang XX, 2006, AGR FOREST METEOROL, V138, P132, DOI 10.1016/j.agrformet.2006.04.003; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; FAO, 2006, FAO FORESTRY PAPER; FAVER KL, 1989, AGR FOREST METEOROL, V48, P175, DOI 10.1016/0168-1923(89)90015-4; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Ge ZM, 2011, ECOL MODEL, V222, P1626, DOI 10.1016/j.ecolmodel.2011.02.022; Gholz HL, 2002, AGR FOREST METEOROL, V112, P87, DOI 10.1016/S0168-1923(02)00059-X; Granier A, 2007, AGR FOREST METEOROL, V143, P123, DOI 10.1016/j.agrformet.2006.12.004; Granier A, 2000, AGR FOREST METEOROL, V100, P291, DOI [10.1016/S0168-1923(99)00151-3, 10.1016/0168-1923(95)02252-X]; Ham JM, 1998, AGR FOREST METEOROL, V89, P1, DOI 10.1016/S0168-1923(97)00062-2; Hollinger DY, 2004, GLOBAL CHANGE BIOL, V10, P1689, DOI 10.1111/j.1365-2486.2004.00847.x; Holtum JAM, 2010, FUNCT PLANT BIOL, V37, P694, DOI 10.1071/FP10001; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Iida S, 2006, J HYDROL, V326, P166, DOI 10.1016/j.jhydrol.2005.11.002; Jassal RS, 2009, AGR FOREST METEOROL, V149, P1168, DOI 10.1016/j.agrformet.2009.02.004; [戴丽君 Dai Lijun], 2012, [生态环境学报, Ecology and Environmental Sciences], V21, P1266; Kelliher FM, 1997, AGR FOREST METEOROL, V85, P135, DOI 10.1016/S0168-1923(96)02424-0; Kim W, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048521; Kochendorfer J, 2011, AGR FOREST METEOROL, V151, P544, DOI 10.1016/j.agrformet.2010.12.012; Komatsu H, 2012, J HYDROL, V420, P380, DOI 10.1016/j.jhydrol.2011.12.030; Kosugi Y, 2007, J HYDROL, V337, P269, DOI 10.1016/j.jhydrol.2007.01.039; Kumagai T, 2004, ADV WATER RESOUR, V27, P1135, DOI 10.1016/j.advwatres.2004.10.002; Kume T, 2008, AGR FOREST METEOROL, V148, P1181, DOI 10.1016/j.agrformet.2008.02.010; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Li J, 2006, ACTA ECOLOGICA SINIC, V26, P2449; Li ZH, 2010, HYDROL PROCESS, V24, P2405, DOI 10.1002/hyp.7643; Liu SG, 1998, ECOL MODEL, V114, P19, DOI 10.1016/S0304-3800(98)00103-3; Lundquist JD, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010050; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2110, DOI 10.1111/j.1365-2486.2007.01432.x; Marcolla B, 2011, AGR FOREST METEOROL, V151, P1233, DOI 10.1016/j.agrformet.2011.04.015; Maximov T, 2008, AGR FOREST METEOROL, V148, P2013, DOI 10.1016/j.agrformet.2008.10.004; McCaughey JH, 2006, AGR FOREST METEOROL, V140, P79, DOI 10.1016/j.agrformet.2006.08.010; McPhaden MJ, 2004, B AM METEOROL SOC, V85, P677, DOI 10.1175/BAMS-85-5-677; Miao HX, 2009, AGR FOREST METEOROL, V149, P1810, DOI 10.1016/j.agrformet.2009.06.011; Monteith J., 1965, EVAPORATION ENV, P4; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Ohta T, 2008, AGR FOREST METEOROL, V148, P1941, DOI 10.1016/j.agrformet.2008.04.012; Oishi AC, 2010, ECOSYSTEMS, V13, P421, DOI 10.1007/s10021-010-9328-3; Parka H, 2008, AGR FOREST METEOROL, V148, P1990, DOI 10.1016/j.agrformet.2008.06.018; Parry M. L., 2007, CLIMATE CHANGE 2007; Pejam MR, 2006, HYDROL PROCESS, V20, P3709, DOI 10.1002/hyp.6384; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Powell TL, 2005, CAN J FOREST RES, V35, P1568, DOI 10.1139/X05-075; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2007, GLOBAL CHANGE BIOL, V13, P788, DOI 10.1111/j.1365-2486.2007.01330.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Ryu Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009263; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; SAUGIER B, 1991, AGR FOREST METEOROL, V54, P263, DOI 10.1016/0168-1923(91)90009-F; Scott RL, 2004, AGR FOREST METEOROL, V122, P65, DOI 10.1016/j.agrformet.2003.09.001; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; Si JH, 2007, J INTEGR PLANT BIOL, V49, P425, DOI 10.1111/j.1744-7909.2007.00388.x; Stoy PC, 2006, GLOBAL CHANGE BIOL, V12, P2115, DOI 10.1111/j.1365-2486.2006.01244.x; Sumner DM, 2005, ESTUARIES, V28, P844, DOI 10.1007/BF02696014; Tanaka N, 2008, AGR FOREST METEOROL, V148, P807, DOI 10.1016/j.agrformet.2008.01.011; Taylor G, 2008, GLOBAL CHANGE BIOL, V14, P264, DOI 10.1111/j.1365-2486.2007.01473.x; Tian FX, 2011, J ARID ENVIRON, V75, P648, DOI 10.1016/j.jaridenv.2011.02.001; Tognetti R, 2009, AGR FOREST METEOROL, V149, P1229, DOI 10.1016/j.agrformet.2009.02.008; Tu Jie, 2008, Scientia Silvae Sinicae, V44, P46; Urban O, 2012, PLANT PHYSIOL BIOCH, V58, P135, DOI 10.1016/j.plaphy.2012.06.023; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Wang YD, 2011, CAN J FOREST RES, V41, P1897, DOI [10.1139/X11-105, 10.1139/x11-105]; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; [魏焕奇 Wei Huanqi], 2012, [自然资源学报, Journal of Natural Resources], V27, P778; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wilson KB, 2000, AGR FOREST METEOROL, V100, P1, DOI 10.1016/S0168-1923(99)00088-X; Wilson KB, 2001, AGR FOREST METEOROL, V106, P153, DOI 10.1016/S0168-1923(00)00199-4; Wu J, 2012, BIOGEOSCIENCES, V9, P13, DOI 10.5194/bg-9-13-2012; Xue BL, 2012, HYDROL PROCESS, V26, P2360, DOI 10.1002/hyp.9195; Yoshida M, 2010, J HYDROL, V395, P180, DOI 10.1016/j.jhydrol.2010.10.023; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Zha TS, 2010, AGR FOREST METEOROL, V150, P1476, DOI 10.1016/j.agrformet.2010.08.003; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang LM, 2006, SCI CHINA SER D, V49, P47, DOI 10.1007/s11430-006-8047-2; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011; Zhu Z, 2005, SCI CHINA D, V48	96	25	31	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85593	10.1371/journal.pone.0085593	http://dx.doi.org/10.1371/journal.pone.0085593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465610	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100049
J	Chen, J; Liu, WB; Jia, WD; Xu, GL; Ma, JL; Ren, Y; Chen, H; Sun, SN; Huang, M; Li, JS				Chen, Jing; Liu, Wen-Bin; Jia, Wei-Dong; Xu, Ge-Liang; Ma, Jin-Liang; Ren, Yun; Chen, Hao; Sun, Si-Nan; Huang, Mei; Li, Jian-Sheng			Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							IN-VIVO SELECTION; MOLECULAR-MECHANISMS; CELL-MIGRATION; CANCER; EXPRESSION; PROMOTES; PROLIFERATION; ANGIOGENESIS; METASTASIS; APOPTOSIS	Background: Nodal, a TGF-b-related embryonic morphogen, is involved in multiple biologic processes. However, the expression of Nodal in hepatocellular carcinoma (HCC) and its correlation with tumor angiogenesis, epithelial-mesenchymal transition, and prognosis is unclear. Methods: We used real-time PCR and Western blotting to investigate Nodal expression in 6 HCC cell lines and 1 normal liver cell line, 16 pairs of tumor and corresponding paracarcinomatous tissues from HCC patients. Immunohistochemistry was performed to examine Nodal expression in HCC and corresponding paracarcinomatous tissues from 96 patients. CD34 and Vimentin were only examined in HCC tissues of patients mentioned above. Nodal gene was silenced by shRNA in MHCC97H and HCCLM3 cell lines, and cell migration and invasion were detected. Statistical analyses were applied to evaluate the prognostic value and associations of Nodal expression with clinical parameters. Results: Nodal expression was detected in HCC cell lines with high metastatic potential alone. Nodal expression is up-regulated in HCC tissues compared with paracarcinomatous and normal liver tissues. Nodal protein was expressed in 70 of the 96 (72.9%) HCC tumors, and was associated with vascular invasion (P = 0.000), status of metastasis (P = 0.004), AFP (P = 0.049), ICGR15 (indocyanine green retention rate at 15 min) (P = 0.010) and tumor size (P = 0.000). High Nodal expression was positively correlated with high MVD (microvessal density) (P = 0.006), but not with Vimentin expression (P = 0.053). Significantly fewer migrated and invaded cells were seen in shRNA group compared with blank group and negative control group (P<0.05). High Nodal expression was found to be an independent factor for predicting overall survival of HCC. Conclusions: Our study demonstrated that Nodal expression is associated with aggressive characteristics of HCC. Its aberrant expression may be a predictive factor of unfavorable prognosis for HCC after surgery.	[Chen, Jing; Liu, Wen-Bin; Jia, Wei-Dong; Xu, Ge-Liang; Ma, Jin-Liang; Ren, Yun; Chen, Hao; Sun, Si-Nan] Anhui Med Univ, Anhui Prov Hosp, Dept Hepat Surg, Hefei, Peoples R China; [Huang, Mei] Anhui Med Univ, Anhui Prov Hosp, Anhui Prov Key Lab Hepatopancreatobiliary Surg, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Li, JS (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Dept Hepat Surg, Hefei, Peoples R China.	lijiansheng1953@gmail.com			National Natural Science Foundation of China [81272398]; Science and Technological Fund of Anhui Province [12010402112]; Anhui Provincial Natural Science Foundation of Institution of Higher Education [KJ2011A171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province; Anhui Provincial Natural Science Foundation of Institution of Higher Education	This work was supported by the National Natural Science Foundation of China (No. 81272398, http://www.nsfc.gov.cn), the Science and Technological Fund of Anhui Province (No. 12010402112, http://www.ahkjt.gov.cn), and Anhui Provincial Natural Science Foundation of Institution of Higher Education (No. KJ2011A171, http://www.ahedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MHS, 2008, MODERN PATHOL, V21, P1183, DOI 10.1038/modpathol.2008.90; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kimura H, 1998, LIVER, V18, P14; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Postovit LM, 2008, PIGM CELL MELANOMA R, V21, P348, DOI 10.1111/j.1755-148X.2008.00463.x; Quail DF, 2013, INT J BIOCHEM CELL B, V45, P885, DOI 10.1016/j.biocel.2012.12.021; Quail DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048237; Quail DF, 2012, CANCER RES, V72, P3851, DOI 10.1158/0008-5472.CAN-11-3951; Quail DF, 2013, ONCOGENE; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Strizzi L, 2012, CANCER RES, V72, P1915, DOI 10.1158/0008-5472.CAN-11-3419; Strizzi Luigi, 2008, Breast Dis, V29, P91; Sun C, 2013, INT J BIOCHEM CELL B, V45, P1099, DOI 10.1016/j.biocel.2013.02.017; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Yu LM, 2010, MODERN PATHOL, V23, P1209, DOI 10.1038/modpathol.2010.101; Zhong Yu, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P83	35	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85840	10.1371/journal.pone.0085840	http://dx.doi.org/10.1371/journal.pone.0085840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465741	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500129
J	Damaj, G; Joris, M; Chandesris, O; Hanssens, K; Soucie, E; Canioni, D; Kolb, B; Durieu, I; Gyan, E; Livideanu, C; Cheze, S; Diouf, M; Garidi, R; Georgin-Lavialle, S; Asnafi, V; Lhermitte, L; Lavigne, C; Launay, D; Arock, M; Lortholary, O; Dubreuil, P; Hermine, O				Damaj, Gandhi; Joris, Magalie; Chandesris, Olivia; Hanssens, Katia; Soucie, Erinn; Canioni, Danielle; Kolb, Brigitte; Durieu, Isabelle; Gyan, Emanuel; Livideanu, Cristina; Cheze, Stephane; Diouf, Momar; Garidi, Reda; Georgin-Lavialle, Sophie; Asnafi, Vahid; Lhermitte, Ludovic; Lavigne, Christian; Launay, David; Arock, Michel; Lortholary, Olivier; Dubreuil, Patrice; Hermine, Olivier			ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases	PLOS ONE			English	Article							POLYCYTHEMIA-VERA; LINEAGE DISEASES; KITD816V; CRITERIA	Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) is a rare and heterogeneous subtype of SM and few studies on this specific entity have been reported. Sixty two patients with Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) were presented. Myeloid AHNMD was the most frequent (82%) cases. This subset of patients were older, had more cutaneous lesions, splenomegaly, liver enlargement, ascites; lower bone mineral density and hemoglobin levels and higher tryptase level than lymphoid AHNMD. Defects in KIT, TET2, ASXL1 and CBL were positive in 87%, 27%, 14%, and 11% of cases respectively. The overall survival of patients with SM-AHNMD was 85.2 months. Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p = 0.044,). In univariate analysis, the presence of C-findings, the AHNMD subtypes (SM-MDS/CMML/AML versus SM-MPN/hypereosinophilia) (p = 0.044), Neutropenia (p = 0.015), high monocyte level (p = 0.015) and the presence of ASXL1 mutation had detrimental effects on OS (p = 0.007). In multivariate analysis and penalized Cox model, only the presence of ASXL1 mutation remained an independent prognostic factor that negatively affected OS (p = 0.035). SM-AHNMD is heterogeneous with variable prognosis according to the type of the AHNMD. ASXL1 is mutated in a subset of myeloid AHNMD and adversely impact on OS.	[Damaj, Gandhi; Joris, Magalie] Hop Sud, Ctr Hosp Univ, Serv Hematol, Amiens, France; [Damaj, Gandhi; Chandesris, Olivia; Hermine, Olivier] Univ Paris 06, Ctr Reference Mastocytoses, Paris, France; [Damaj, Gandhi; Chandesris, Olivia; Canioni, Danielle; Asnafi, Vahid; Lhermitte, Ludovic; Lortholary, Olivier; Hermine, Olivier] AP HP Necker Enfants Malad, Paris, France; [Damaj, Gandhi; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, CNRS UMR 8147, Paris, France; [Damaj, Gandhi; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Inst Imagine, Paris, France; [Chandesris, Olivia; Hermine, Olivier] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Serv Hematol Adulte, Paris, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] CRCM, INSERM, U1068, Marseille, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] Aix Marseille Univ, Marseille, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] CNRS, UMR7258, Marseille, France; [Canioni, Danielle] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Serv Anatomopathol, Paris, France; [Kolb, Brigitte] Ctr Hosp Univ, Serv Hematol, Reims, France; [Durieu, Isabelle] Grp Hosp Sud Hosp Civils, Serv Med Interne, Lyon, France; [Gyan, Emanuel] CHU Tours, CIC INSERMU202, Serv Hematol & Therapie Cellulaire, Tours, France; [Livideanu, Cristina] Ctr Hosp Univ, Dept Dermatol, Toulouse, France; [Cheze, Stephane] CHU Caen, Serv Hematol, F-14000 Caen, France; [Diouf, Momar] Ctr Hosp Univ, Dept Biostat & Rech Clin, Amiens, France; [Garidi, Reda] Ctr Hosp, Serv Hematol, St Quentin en Yvelines, France; [Georgin-Lavialle, Sophie] Univ Paris 06, Hop Tenon, AP HP, Serv Med Interne, Paris, France; [Asnafi, Vahid; Lhermitte, Ludovic] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Lab Hematol Biol, Paris, France; [Asnafi, Vahid; Lhermitte, Ludovic] Univ Paris 05, Sorbonne Paris Cite, Fac Med, UMR CNRS 8147, Paris, France; [Lavigne, Christian] CHU Angers, Serv Hematol, Angers, France; [Launay, David] CHRU Lille, Serv Med Interne, F-59037 Lille, France; [Arock, Michel] Ecole Normale Super, CNRS UMR 8113, Lab Biol & Pharmacol Appl, Cachan, France; [Arock, Michel] Grp Hosp Pitie Salpetriere, Lab Cent Hematol, F-75634 Paris, France; [Lortholary, Olivier] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Serv Med Interne & Malad Infect, Paris, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; CHU Lyon; CHU Tours; CHU de Toulouse; CHU de Caen NORMANDIE; Universite de Caen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Damaj, G (corresponding author), Hop Sud, Ctr Hosp Univ, Serv Hematol, Amiens, France.	damaj.gandhi@chu-amiens.fr	Dubreuil, Patrice/V-4816-2019; Launay, David/A-5270-2018; Launay, David/H-1674-2016; Soucie, Erinn L/R-1731-2016; Hermine, Olivier/Q-7072-2018; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; Launay, David/0000-0003-1840-1817; Launay, David/0000-0003-1840-1817; Soucie, Erinn L/0000-0001-6347-3954; dubreuil, patrice/0000-0003-1155-1150; GYAN, Emmanuel/0000-0002-7651-9189; Bulai Livideanu, Cristina/0000-0002-5275-6868; CHANDESRIS, Marie-Olivia/0000-0002-9795-1085; Hermine, Olivier/0000-0003-2574-3874				Ambler G, 2012, STAT MED, V31, P1150, DOI 10.1002/sim.4371; Delhommeau F, 2007, BLOOD, V109, P71, DOI 10.1182/blood-2006-03-007146; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Gelsi-Boyer V, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-12; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Hermine O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002266; Horny AC, 2008, WHO CLASSIFICATION T, P53; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP, 2004, J CLIN PATHOL, V57, P604, DOI 10.1136/jcp.2003.014860; Lanternier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001906; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Pardanani A, 2009, BLOOD, V114, P3769, DOI 10.1182/blood-2009-05-220145; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sotlar K, 2010, J PATHOL, V220, P586, DOI 10.1002/path.2677; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; TRAVIS WD, 1988, MEDICINE, V67, P345, DOI 10.1097/00005792-198811000-00001; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8	23	56	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85362	10.1371/journal.pone.0085362	http://dx.doi.org/10.1371/journal.pone.0085362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465546	Green Published, Green Submitted			2022-12-27	WOS:000330244500060
J	Ge, L; Wang, JC; Li, JL; Liang, L; An, N; Shi, XT; Liu, YC; Tian, JH				Ge, Long; Wang, Jian-cheng; Li, Jin-long; Liang, Li; An, Ni; Shi, Xin-tong; Liu, Yin-chun; Tian, Jin-hui			The Assessment of the Quality of Reporting of Systematic Reviews/Meta-Analyses in Diagnostic Tests Published by Authors in China	PLOS ONE			English	Article								Background: The quality of reporting in systematic reviews (SRs)/meta-analyses (MAs) of diagnostic tests published by authors in China has not been evaluated. The aims of present study are to evaluate the quality of reporting in diagnostic SRs/MAs using the PRISMA statement and determine the changes in the quality of reporting over time. Methods: According to the inclusion and exclusion criteria, we searched five databases including Chinese Biomedical Literature Database, PubMed, EMBASE, the Cochrane Library, and Web of knowledge, to identify SRs/MAs on diagnostic tests. The searches were conducted on July 14, 2012 and the cut off for inclusion of the SRs/MAs was December 31st 2011. The PRISMA statement was used to assess the quality of reporting. Analysis was performed using Excel 2003, RevMan 5. Results: A total of 312 studies were included. Fifteen diseases systems were covered. According to the PRISMA checklist, there had been serious reporting flaws in following items: structured summary (item 2, 22.4%), objectives (item 4, 18.9%), protocol and registration (item 5, 2.6%), risk of bias across studies (item 15, 26.3%), funding (item 27, 28.8%). The subgroup analysis showed that there had been some statistically significant improvement in total compliance for 9 PRISMA items after the PRISMA was released, 6 items were statistically improved regarding funded articles, 3 items were statistically improved for CSCD articles, and there was a statistically significant increase in the proportion of reviews reporting on 22 items for SCI articles (P<0.050). Conclusion: The numbers of diagnostic SRs/MAs is increasing annually. The quality of reporting has measurably been improved over the previous years. Unfortunately, there are still many deficiencies in the reporting including protocol and registration, search, risk of bias across studies, and funding. Future Chinese reviewers should address issues on these aspects.	[Ge, Long; Wang, Jian-cheng; Li, Jin-long; Liang, Li; An, Ni; Shi, Xin-tong; Liu, Yin-chun; Tian, Jin-hui] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China; [Ge, Long; Li, Jin-long; Liang, Li; An, Ni; Shi, Xin-tong; Liu, Yin-chun] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Tian, JH (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China.	tianjh@lzu.edu.cn	Ge, Long/G-8876-2017	Ge, Long/0000-0002-3555-1107				An N, 2013, CHIN J EVID BASES PE, V8, P87; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dong JW, 2008, INT STAT CLASSIFICAT; Liberati A., 2009, J CLIN EPIDEMIOL, V62, pE1, DOI [DOI 10.1016/J.JCLINEPI.2009.06.006, 10.1016/j.jclinepi.2009.06.006]; Liu J, 2001, CHIN J LUNG CANC, V4, P241; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Swartz MK, 2011, J PEDIATR HEALTH CAR, V25, P1, DOI 10.1016/j.pedhc.2010.09.006; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-163; Wu L, 2013, J HUBEI U MED, V3, P201	14	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85908	10.1371/journal.pone.0085908	http://dx.doi.org/10.1371/journal.pone.0085908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465781	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500141
J	Kuchenbuch, A; Paraskevopoulos, E; Herholz, SC; Pantev, C				Kuchenbuch, Anja; Paraskevopoulos, Evangelos; Herholz, Sibylle C.; Pantev, Christo			Audio-Tactile Integration and the Influence of Musical Training	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; PREFRONTAL CORTEX; MUSICIANS BRAIN; RESPONSES; DISCRIMINATION; DURATION; FREQUENCY; NETWORKS; PIANISTS; AUDITION	Perception of our environment is a multisensory experience; information from different sensory systems like the auditory, visual and tactile is constantly integrated. Complex tasks that require high temporal and spatial precision of multisensory integration put strong demands on the underlying networks but it is largely unknown how task experience shapes multisensory processing. Long-term musical training is an excellent model for brain plasticity because it shapes the human brain at functional and structural levels, affecting a network of brain areas. In the present study we used magnetoencephalography (MEG) to investigate how audio-tactile perception is integrated in the human brain and if musicians show enhancement of the corresponding activation compared to non-musicians. Using a paradigm that allowed the investigation of combined and separate auditory and tactile processing, we found a multisensory incongruency response, generated in frontal, cingulate and cerebellar regions, an auditory mismatch response generated mainly in the auditory cortex and a tactile mismatch response generated in frontal and cerebellar regions. The influence of musical training was seen in the audio-tactile as well as in the auditory condition, indicating enhanced higher-order processing in musicians, while the sources of the tactile MMN were not influenced by long-term musical training. Consistent with the predictive coding model, more basic, bottom-up sensory processing was relatively stable and less affected by expertise, whereas areas for top-down models of multisensory expectancies were modulated by training.	[Kuchenbuch, Anja; Paraskevopoulos, Evangelos; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Herholz, Sibylle C.] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Herholz, Sibylle C.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Munster; McGill University; Universite de Montreal; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Pantev, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-3/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-3/1]. (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka K, 2005, CLIN NEUROPHYSIOL, V116, P1930, DOI 10.1016/j.clinph.2005.04.021; Akatsuka K, 2007, EXP BRAIN RES, V181, P607, DOI 10.1007/s00221-007-0958-4; Akatsuka K, 2007, CLIN NEUROPHYSIOL, V118, P403, DOI 10.1016/j.clinph.2006.09.030; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Butler JS, 2012, J NEUROSCI, V32, P15338, DOI 10.1523/JNEUROSCI.1796-12.2012; Butler JS, 2011, J NEUROSCI, V31, P3400, DOI 10.1523/JNEUROSCI.3296-10.2011; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; James CE, 2008, NEUROIMAGE, V42, P1597, DOI 10.1016/j.neuroimage.2008.06.025; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Kekoni J, 1997, BIOL PSYCHOL, V46, P125, DOI 10.1016/S0301-0511(97)05249-6; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Liu HG, 2013, J NEUROSCI, V33, P6782, DOI 10.1523/JNEUROSCI.4882-12.2013; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1989, NEUROSCI LETT, V107, P347, DOI 10.1016/0304-3940(89)90844-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Paraskevopoulos E, 2012, J NEUROSCI, V32, P18196, DOI 10.1523/JNEUROSCI.1947-12.2012; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pieszek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053634; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reed CL, 2004, HUM BRAIN MAPP, V21, P236, DOI 10.1002/hbm.10162; Restuccia D, 2007, BRAIN, V130, P276, DOI 10.1093/brain/awl236; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Shinozaki N, 1998, COGNITIVE BRAIN RES, V7, P165, DOI 10.1016/S0926-6410(98)00020-2; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spackman LA, 2007, EXP BRAIN RES, V177, P21, DOI 10.1007/s00221-006-0650-0; Stewart L, 2004, PERCEPT PSYCHOPHYS, V66, P183, DOI 10.3758/BF03194871; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Vuust P, 2009, CORTEX, V45, P80, DOI 10.1016/j.cortex.2008.05.014; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	58	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85743	10.1371/journal.pone.0085743	http://dx.doi.org/10.1371/journal.pone.0085743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465675	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500102
J	Lo, YH; Chuang, CN; Wang, TF				Lo, Yu-Hui; Chuang, Chi-Ning; Wang, Ting-Fang			Pch2 Prevents Mec1/Tel1-Mediated Hop1 Phosphorylation Occurring Independently of Red1 in Budding Yeast Meiosis	PLOS ONE			English	Article							MEIOTIC CHECKPOINT CONTROL; SISTER-CHROMATID COHESION; AXIAL-ELEMENT PROTEIN; STRAND BREAK REPAIR; SYNAPTONEMAL COMPLEX; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; DNA-DAMAGE; INTERHOMOLOG RECOMBINATION; PHOSPHATASE COMPLEX	A prominent feature of meiosis in most sexually reproducing organisms is interhomolog recombination whereby a significant fraction of the programmed meiotic double-strand breaks are repaired using intact homologous non-sister chromatids rather than sister chromatids. Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1. Mec1 and Tel1 also phosphorylate gamma H2A and the synaptonemal complex protein Zip1 independently of Red1 to facilitate premeiotic DNA replication and to destabilize homology-independent centromere pairing, respectively. It has been unclear why Hop1 phosphorylation is Red1-dependent. Here, we report that the pachytene checkpoint protein 2 (Pch2) specifically prevents Red1-independent Hop1 phosphorylation. Our findings reveal a new function for Pch2 in linking two axial element proteins Red1 and Hop1 thus coordinating their effects in meiotic recombination and the checkpoint network.	[Lo, Yu-Hui; Wang, Ting-Fang] Natl Def Med Ctr, Inst Life Sci, Taipei, Taiwan; [Lo, Yu-Hui; Chuang, Chi-Ning; Wang, Ting-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Wang, TF (corresponding author), Natl Def Med Ctr, Inst Life Sci, Taipei, Taiwan.	tfwang@gate.sinica.edu.tw	Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505	National Science Council; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants to TFW from the National Science Council and Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Carballo JA, 2007, CHROMOSOME RES, V15, P539, DOI 10.1007/s10577-007-1145-y; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cheng YH, 2013, MOL CELL BIOL, V33, P3365, DOI 10.1128/MCB.00438-13; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Farmer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039724; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lin FM, 2010, EMBO J, V29, P586, DOI 10.1038/emboj.2009.362; Lui DY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003197; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Shima H, 2005, GENETICS, V170, P71, DOI 10.1534/genetics.104.037580; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Terentyev Y, 2010, NUCLEIC ACIDS RES, V38, P4349, DOI 10.1093/nar/gkq137; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069	43	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85687	10.1371/journal.pone.0085687	http://dx.doi.org/10.1371/journal.pone.0085687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465650	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500091
J	Simpson, MJ; Haridas, P; McElwain, DLS				Simpson, Matthew J.; Haridas, Parvathi; McElwain, D. L. Sean			Do Pioneer Cells Exist?	PLOS ONE			English	Article							TIME-LAPSE; IN-VITRO; MIGRATION ASSAY; NERVOUS-SYSTEM; INVASION; MODEL; PROLIFERATION; BEHAVIOR; CANCER; MECHANISMS	Most mathematical models of collective cell spreading make the standard assumption that the cell diffusivity and cell proliferation rate are constants that do not vary across the cell population. Here we present a combined experimental and mathematical modeling study which aims to investigate how differences in the cell diffusivity and cell proliferation rate amongst a population of cells can impact the collective behavior of the population. We present data from a three-dimensional transwell migration assay that suggests that the cell diffusivity of some groups of cells within the population can be as much as three times higher than the cell diffusivity of other groups of cells within the population. Using this information, we explore the consequences of explicitly representing this variability in a mathematical model of a scratch assay where we treat the total population of cells as two, possibly distinct, subpopulations. Our results show that when we make the standard assumption that all cells within the population behave identically we observe the formation of moving fronts of cells where both subpopulations are well-mixed and indistinguishable. In contrast, when we consider the same system where the two subpopulations are distinct, we observe a very different outcome where the spreading population becomes spatially organized with the more motile subpopulation dominating at the leading edge while the less motile subpopulation is practically absent from the leading edge. These modeling predictions are consistent with previous experimental observations and suggest that standard mathematical approaches, where we treat the cell diffusivity and cell proliferation rate as constants, might not be appropriate.	[Simpson, Matthew J.; Haridas, Parvathi; McElwain, D. L. Sean] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Simpson, Matthew J.; Haridas, Parvathi] Queensland Univ Technol, Inst Hlth & Biomed Innovat IHBI, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Simpson, Matthew/0000-0001-6254-313X; McElwain, Sean/0000-0002-7046-0251	Australian Research Council [DP120100551]	Australian Research Council(Australian Research Council)	We acknowledge the Australian Research Council Discovery Project Grant DP120100551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2004, DEVELOPMENT, V131, P5127, DOI 10.1242/dev.01398; Aigouy B, 2008, J NEUROSCI, V28, P11635, DOI 10.1523/JNEUROSCI.1361-08.2008; [Anonymous], 2011, PRINCIPLES DEV; Baker RE, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041905; Binder BJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031912; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Cai AQ, 2007, J THEOR BIOL, V245, P576, DOI 10.1016/j.jtbi.2006.10.024; Carey SP, 2013, CLIN EXP METASTAS, V30, P615, DOI 10.1007/s10585-013-9565-x; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Chapra S. C., 1998, NUMERICAL METHODS EN; Chowdhury D, 2005, PHYS LIFE REV, V2, P318, DOI 10.1016/j.plrev.2005.09.001; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Fisher R A, 1937, ANN EUGEN, V7, P353, DOI DOI 10.1111/J.1469-1809.1937.TB02153.X; Gatenby RA, 1996, CANCER RES, V56, P5745; GREENSPAN HP, 1972, STUD APPL MATH, V52, P317; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hickey WF, 2000, BRAIN, V123, P1073, DOI 10.1093/brain/123.6.1073; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hughes B. D., 1995, RANDOM WALKS RANDOM, VI; Johnston ST, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051922; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Kashyap AS, 2011, ENDOCRINOLOGY, V152, P1388, DOI 10.1210/en.2010-0897; Khain E, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011904; Kolmogoroff A., 1937, MOSCOW U B MATH, V1, P1; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Kulesa PM, 2010, DEV BIOL, V344, P566, DOI 10.1016/j.ydbio.2010.05.005; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Maini PK, 2004, APPL MATH LETT, V17, P575, DOI 10.1016/S0893-9659(04)90128-0; Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Research Services Branch National Institute of Health, 2012, IMAGEJ US GUID; Sato A, 2013, J NEUROSCI, V33, P556, DOI 10.1523/JNEUROSCI.4568-12.2013; Scott J, 2012, NAT REV CANCER, V12, P445, DOI 10.1038/nrc3287; Sengers BG, 2009, ANN BIOMED ENG, V37, P1165, DOI 10.1007/s10439-009-9676-3; Sengers BG, 2007, J R SOC INTERFACE, V4, P1107, DOI 10.1098/rsif.2007.0233; SHERRATT JA, 1990, P ROY SOC B-BIOL SCI, V241, P29, DOI 10.1098/rspb.1990.0061; SHERRATT JA, 1991, J MATH BIOL, V29, P389, DOI 10.1007/BF00160468; Simpson MJ, 2007, ADV WATER RESOUR, V30, P2026, DOI 10.1016/j.advwatres.2007.04.005; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Simpson MJ, 2013, B MATH BIOL, V75, P871, DOI 10.1007/s11538-013-9839-0; Simpson MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0007; Simpson MJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051922; Simpson MJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041901; Simpson MJ, 2010, PHYSICA A, V389, P3779, DOI 10.1016/j.physa.2010.05.020; Simpson MJ, 2009, PHYSICA A, V388, P399, DOI 10.1016/j.physa.2008.10.038; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; van Horssen R, 2011, J CELL PHYSIOL, V226, P288, DOI 10.1002/jcp.22330; Wanner SJ, 2013, DEVELOPMENT, V140, P906, DOI 10.1242/dev.087148; Weinberg RA, 2006, BIOL CANC; Wynn ML, 2012, J R SOC INTERFACE, V9, P1576, DOI 10.1098/rsif.2011.0726; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85488	10.1371/journal.pone.0085488	http://dx.doi.org/10.1371/journal.pone.0085488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465576	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500069
J	Yasaka, R; Nguyen, HD; Ho, SYW; Duchene, S; Korkmaz, S; Katis, N; Takahashi, H; Gibbs, AJ; Ohshima, K				Yasaka, Ryosuke; Nguyen, Huy D.; Ho, Simon Y. W.; Duchene, Sebastian; Korkmaz, Savas; Katis, Nikolaos; Takahashi, Hideki; Gibbs, Adrian J.; Ohshima, Kazusato			The Temporal Evolution and Global Spread of Cauliflower mosaic virus, a Plant Pararetrovirus	PLOS ONE			English	Article							MOLECULAR EVOLUTION; GENETIC-STRUCTURE; STREAK-VIRUS; RECOMBINATION; POPULATIONS; SEQUENCES; PROGRAM; TIME; DIVERSIFICATION; PHYLOGENETICS	Cauliflower mosaic virus (CaMV) is a plant pararetrovirus with a double-stranded DNA genome. It is the type member of the genus Caulimovirus in the family Caulimoviridae. CaMV is transmitted by sap inoculation and in nature by aphids in a semi-persistent manner. To investigate the patterns and timescale of CaMV migration and evolution, we sequenced and analyzed the genomes of 67 isolates of CaMV collected mostly in Greece, Iran, Turkey, and Japan together with nine published sequences. We identified the open-reading frames (ORFs) in the genomes and inferred their phylogeny. After removing recombinant sequences, we estimated the substitution rates, divergence times, and phylogeographic patterns of the virus populations. We found that recombination has been a common feature of CaMV evolution, and that ORFs I-V have a different evolutionary history from ORF VI. The ORFs have evolved at rates between 1.71 and 5.81x10(-4) substitutions/site/year, similar to those of viruses with RNA or ssDNA genomes. We found four geographically confined lineages. CaMV probably spread from a single population to other parts of the world around 400-500 years ago, and is now widely distributed among Eurasian countries. Our results revealed evidence of frequent gene flow between populations in Turkey and those of its neighboring countries, with similar patterns observed for Japan and the USA. Our study represents the first report on the spatial and temporal spread of a plant pararetrovirus.	[Yasaka, Ryosuke; Nguyen, Huy D.; Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan; [Nguyen, Huy D.; Ohshima, Kazusato] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Ho, Simon Y. W.; Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Korkmaz, Savas] Univ Canakkale Onsekiz Mart, Fac Agr, Dept Plant Protect, Canakkale, Turkey; [Katis, Nikolaos] Aristotle Univ Thessaloniki, Fac Agr, Plant Pathol Lab, GR-54006 Thessaloniki, Greece; [Takahashi, Hideki] Tohoku Univ, Fac Agr, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Gibbs, Adrian J.] Australian Natl Univ, Emeritus Fac, Canberra, ACT, Australia	Saga University; Kagoshima University; University of Sydney; Canakkale Onsekiz Mart University; Aristotle University of Thessaloniki; Tohoku University; Australian National University	Ohshima, K (corresponding author), Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan.	ohshimak@cc.saga-u.ac.jp	Ho, Simon YW/A-8417-2008	Ho, Simon YW/0000-0002-0361-2307; Yasaka, Ryosuke/0000-0002-2240-1767; Duchene, Sebastian/0000-0002-2863-0907	Saga University; Japan Society for the Promotion of Science (JSPS) KAKENHI [18405022, 24405026]; JSPS [21.09320]	Saga University; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part funded by Saga University, and supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 18405022 and 24405026. This work was in part supported by JSPS Postdoctoral Fellowships for Foreign Researchers Grant Number 21.09320 to KO and S. Farzadfar (Saga University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; BUCK P. A., 1956, ECON BOT, V10, P250, DOI 10.1007/BF02899000; CHENAULT KD, 1994, J MOL EVOL, V39, P496, DOI 10.1007/BF00173419; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Crisp P., 1995, EVOLUTION CROP PLANT, P86; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farzadfar S, 2013, VIRUS GENES, V47, P347, DOI 10.1007/s11262-013-0948-5; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Gayral P, 2010, J VIROL, V84, P7346, DOI 10.1128/JVI.00401-10; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; GRAY AR, 1982, ECON BOT, V36, P397, DOI 10.1007/BF02862698; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas M, 2002, MOL PLANT PATHOL, V3, P419, DOI 10.1046/j.1364-3703.2002.00136.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Harkins GW, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-104; Harlan J.R., 1998, ORIGINS AGR CROP DOM, P1; Hemingway JS, 1995, EVOLUTION CROP PLANT, P82; Hodgkin T, 1995, EVOLUTION CROP PLANT, P76; Hohn T, 2013, CURR OPIN VIROL, V3, P1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katz SH, 2003, ENCY FOOD CULTURE, P284; King AMQ, 2012, 9 INT COMM TAX VIR, P432; Kobayashi K, 2004, MOL PLANT MICROBE IN, V17, P475, DOI 10.1094/MPMI.2004.17.5.475; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P62; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P68; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Monjane AL, 2011, J VIROL, V85, P9623, DOI 10.1128/JVI.00640-11; Monsion B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000174; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055336; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Ohshima K, 2010, J GEN VIROL, V91, P788, DOI 10.1099/vir.0.016055-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Podevin Nancy, 2012, GM Crops Food, V3, P296, DOI 10.4161/gmcr.21406; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; Rodelo-Urrego M, 2013, MOL ECOL, V22, P2325, DOI 10.1111/mec.12232; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Sacristan S, 2008, MOL PLANT PATHOZ; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sawyer S, 1999, GENECONV COMPUTER PA; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shepherd RJ, 1981, CMI AAB DESCRIPTIONS; SHOCKEY MW, 1980, VIROLOGY, V105, P575, DOI 10.1016/0042-6822(80)90057-4; SMITH JM, 1992, J MOL EVOL, V34, P126; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomimura K, 2004, VIROLOGY, V330, P408, DOI 10.1016/j.virol.2004.09.040; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Traore O, 2005, MOL ECOL, V14, P2097, DOI 10.1111/j.1365-294X.2005.02578.x; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Zhang CL, 2011, VIRUS RES, V158, P188, DOI 10.1016/j.virusres.2011.03.031	74	37	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85641	10.1371/journal.pone.0085641	http://dx.doi.org/10.1371/journal.pone.0085641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465629	Green Published, gold			2022-12-27	WOS:000330244500086
J	Zhou, L; Liu, L; Liu, XY; Chen, PY; Liu, L; Zhang, YQ; Wu, YZ; Pettigrew, JC; Cheng, DX; Yi, D				Zhou, Liang; Liu, Ling; Liu, Xiaoyu; Chen, Pinyi; Liu, Ling; Zhang, Yanqi; Wu, Yazhou; Pettigrew, Julia Christine; Cheng, Dixiang; Yi, Dong			Systematic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Chinese Herbal Decoction for the Treatment of Gout	PLOS ONE			English	Article							HYPERURICEMIA; PREVALENCE; DISEASE	Background: In East Asia, numerous reports describe the utilization of traditional Chinese herbal decoctions to treat gout. However, the reported clinical effects vary. Objectives: In this study, we reviewed and analyzed a large number of randomized controlled clinical trials to systematically assess the clinical efficacy and adverse reactions of Chinese herbal decoctions for treating gout. Methods: We performed a comprehensive search of databases, such as PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, Chinese biomedical literature database, et al. In addition, we manually searched the relevant meeting information in the library of the Third Military Medical University. Results: Finally, 17 randomized controlled trials with a sample size of 1,402 cases met the criteria and were included in the study. The results of the meta-analysis showed that when gout had progressed to the stage of acute arthritis, there was no significant difference in clinical efficacy between Chinese herbal decoctions and traditional Western medicine, as indicated based on the following parameters: serum uric acid (standardized mean difference (SMD): 0.35, 95% confidence interval (CI): 0.03 to 0.67), C reactive protein (SMD: 0.25, 95% CI: -0.18 to 0.69), erythrocyte sedimentation rate (SMD: 0.21, 95% CI: -0.02 to 0.45) and overall clinical response (relative risk (RR): 1.05, 95% CI: 1.01 to 1.10). However, the Chinese herbal decoction was significantly better than traditional Western medicine in controlling adverse drug reactions (RR: 0.06, 95% CI: 0.03 to 0.13). Conclusions: Through a systematic review of the clinical efficacy and safety of Chinese herbal decoctions and traditional Western medicine for the treatment of gout, we found that Chinese herbal decoction and traditional Western medicine led to similar clinical efficacy, but the Chinese herbal decoctions were superior to Western medicine in terms of controlling adverse drug reactions.	[Zhou, Liang; Liu, Ling; Liu, Xiaoyu; Chen, Pinyi; Liu, Ling; Zhang, Yanqi; Wu, Yazhou; Yi, Dong] Third Mil Med Univ, Dept Hlth Stat, Coll Prevent Med, Chongqing, Peoples R China; [Liu, Ling] Chongqing Univ Arts & Sci, PE Dept Phys Educ, Chongqing, Peoples R China; [Pettigrew, Julia Christine] Univ Washington, Sch Arts & Sci, Dept Biol Sci, Seattle, WA 98195 USA; [Pettigrew, Julia Christine] Univ Washington, Dept Asian Language & Literature, Seattle, WA 98195 USA; [Cheng, Dixiang] Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China	Army Medical University; Chongqing University of Arts & Sciences; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Chongqing University of Posts & Telecommunications	Yi, D (corresponding author), Third Mil Med Univ, Dept Hlth Stat, Coll Prevent Med, Chongqing, Peoples R China.	yd_house@hotmail.com			Natural Science Foundation of China [81172773, 30872184, 30901242]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by three Natural Science Foundation of China (No. 81172773, No. 30872184 and No. 30901242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Arroyo MP, 2004, BRIT J DERMATOL, V150, P581, DOI 10.1111/j.1365-2133.2004.05838.x; Banares R, 2002, HEPATOLOGY, V35, P609, DOI 10.1053/jhep.2002.31354; BARKER DJP, 1998, EPIDEMIOLOGY MED PRA; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Deveci OS, 2010, INT J CLIN PRACT, V64, P900, DOI 10.1111/j.1742-1241.2009.02263.x; Ding Y, 2011, J CHANGCHUN COLL TRA, V27, P436; Ding Y, 2006, CHINESE J PRIMARY ME, V13, P1085; Fan L, 2009, CHINA PHARMACIST, V9, P1360; Gianluca T, 2013, ANN RHEUM DIS, V72, P694; Han Y, 2011, INFORM TRADITIONAL C, V24, P102; Huang L, 2003, CLIN J ANHUI TRADITI, V15, P114; Huang YK, 2011, ACTA ACAD CPAPF, V20, P135; Huang Z, 2002, CHINESE MED, P461; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Ji B, 2010, LIAONING J TRADITION, V37, P147; Li G, 1992, TRADITIONAL CHINESE, P46; Li T, 2010, TRADITIONAL CHINESE; [李廷谦 LI Tingqian], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P180; Li Y, 2004, HUNAN J TRADITIONAL, V20, P42; Lianqun Q, 2007, CHINA MED HERALD, V4, P87; Liming L, 2007, EPIDEMIOLOGY, P71; Liu M., 2011, LIAONING J TRADI CHI, V38, P675; Lu Y, 2008, CHINA PRACTICAL MED, V3, P102; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Ozdogu H, 2007, RHEUMATOL INT, V27, P763, DOI 10.1007/s00296-006-0285-2; Qin B, 2011, CHINA J EXPT TRADITI, V17, P279; Roddy E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3199; Shin T, 1996, DIAGNOSIS THERAPY, V84, P905; Tang C, 2008, HEILONGJIANG J TRADI, V6, P12; The Chinese medical association, 2005, CLIN DIAGN TREATM GU, P321; The Ministry of Health of the People's Republic of China, 1995, CHIN HERB MED NEW ME, P179; Wallace KL, 2004, J RHEUMATOL, V31, P1582; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wang B, 2012, AM J CHINESE MED, V40, P25, DOI 10.1142/S0192415X12500036; Wang H, 2008, J EMERGENCY TRADITIO, V4, P187; Wang X. X., 2010, ZHEJIANG J TRADITION, V45, P430; Yang J, 2010, YUNNAN J TRADITIONAL, V31, P53; Ye Rengao, 2001, INTERNAL MED, P877; [余俊文 Yu Junwen], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P455; Yu Z, 2005, GOUT; Zhang, 2006, J PRACTICAL DIAGNOSI, V20, P505; Zhang XZ, 2011, J EMERGENCY TRADITIO, V20, P964; Zhang Y, 2000, CHINESE J TRADITIONA, V7, P50; Zhong B, 2007, J TRADITIONAL CHINES, V39, P645; 赵岭梅, 2007, [中医杂志, Journal of Traditional Chinese Medicine], V48, P533; 杨崇青, 2006, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V21, P474; 郑文洁, 2002, [中华医学杂志, National Medical Journal of China], V82, P716	50	22	26	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85008	10.1371/journal.pone.0085008	http://dx.doi.org/10.1371/journal.pone.0085008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465466	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500027
J	Biswas, N; Friese, RS; Gayen, JR; Bandyopadhyay, G; Mahata, SK; O'Connor, DT				Biswas, Nilima; Friese, Ryan S.; Gayen, Jiaur R.; Bandyopadhyay, Gautam; Mahata, Sushil K.; O'Connor, Daniel T.			Discovery of a Novel Target for the Dysglycemic Chromogranin A Fragment Pancreastatin: Interaction with the Chaperone GRP78 to Influence Metabolism	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; RAT-LIVER MEMBRANES; PROSTATE-CANCER CELLS; REGULATOR GRP78/BIP; INHIBITS INSULIN; ER STRESS; ESSENTIAL-HYPERTENSION; DIABETES-MELLITUS; HEPATIC STEATOSIS	Rationale: The chromogranin A-derived peptide pancreastatin (PST) is a dysglycemic, counter-regulatory peptide for insulin action, especially in liver. Although previous evidence for a PST binding protein has been reported, such a receptor has not been identified or sequenced. Methods and Results: We used ligand affinity to purify the PST target, with biotinylated human PST (hCHGA(273-301)-amide) as "bait" and mouse liver homogenate as "prey", and identified GRP78 (a.k.a. "78 kDa Glucose Regulated Protein", HSPA5, BIP) as a major interacting partner of PST. GRP78 belongs to the family of heat shock proteins (chaperones), involved in several cellular processes including protein folding and glucose metabolism. We analyzed expression of GRP78 in the absence of PST in a mouse knockout model lacking its precursor CHGA: hepatic transcriptome data revealed global overexpression of not only GRP78 but also other heat shock transcripts (of the "adaptive UPR") in CHGA(2/2) mice compared to wild-type (+/+). By contrast, we found a global decline in expression of hepatic pro-apoptotic transcripts in CHGA(-/-) mice. GRP78's ATPase enzymatic activity was dose-dependently inhibited by PST (IC50 similar to 5.2 mu M). PST also inhibited the up-regulation of GRP78 expression during UPR activation (by tunicamycin) in hepatocytes. PST inhibited insulin-stimulated glucose uptake in adipocytes, and increased hepatic expression of G6Pase (the final step in gluconeogenesis/glycogenolysis). In hepatocytes not only PST but also other GRP78-ATPase inhibitors (VER-155008 or ADP) increased G6Pase expression. GRP78 over-expression inhibited G6Pase expression in hepatocytes, with partial restoration by GRP78-ATPase inhibitors PST, VER-155008, or ADP. Conclusions: Our results indicate that an unexpected major hepatic target of PST is the adaptive UPR chaperone GRP78. PST not only binds to GRP78 (in pH-dependent fashion), but also inhibits GRP78's ATPase enzymatic activity, and impairs its biosynthetic response to UPR activation. PST decreases insulin-stimulated cellular glucose uptake, and PST as well as other chaperone ATPase activity inhibitors augment expression of G6Pase; GRP78 over-expression antagonizes this PST action. Analysis of the novel PST/GRP78 interaction may provide a new avenue of investigation into cellular glycemic control as well as dysglycemia.	[Biswas, Nilima; Friese, Ryan S.; Gayen, Jiaur R.; Bandyopadhyay, Gautam; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Mahata, Sushil K.; O'Connor, Daniel T.] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	O'Connor, DT (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	doconnor@ucsd.edu	Mahata, Sushil/AAF-8781-2021		National Institutes of Health; Department of Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Friese RS, 2010, PHYSIOL GENOMICS, V40, P195, DOI 10.1152/physiolgenomics.00164.2009; FUNAKOSHI A, 1990, REGUL PEPTIDES, V30, P159, DOI 10.1016/0167-0115(90)90056-3; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; Gonzalez-Yanes C, 2001, CELL SIGNAL, V13, P43, DOI 10.1016/S0898-6568(00)00127-3; Gonzalez-Yanes C, 1999, BBA-MOL CELL RES, V1451, P153, DOI 10.1016/S0167-4889(99)00084-1; HAKANSON R, 1995, GASTROENTEROLOGY, V108, P1445, DOI 10.1016/0016-5085(95)90693-2; Inageda K, 2010, FEBS LETT, V584, P3649, DOI 10.1016/j.febslet.2010.07.040; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; KITAYAMA N, 1994, LIFE SCI, V54, P1571; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Novosyadlyy R, 2008, CELL DEATH DIFFER, V15, P1304, DOI 10.1038/cdd.2008.52; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OSTENSON CG, 1989, PANCREAS, V4, P441; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SANCHEZ V, 1990, BIOSCIENCE REP, V10, P87, DOI 10.1007/BF01116856; Sanchez-Margalet V, 2000, ADV EXP MED BIOL, V482, P247; Sanchez-Margalet V, 2000, EUR J PHARMACOL, V397, P229, DOI 10.1016/S0014-2999(00)00253-3; Sanchez-Margalet V, 1998, DIABETES CARE, V21, P1951, DOI 10.2337/diacare.21.11.1951; Sanchez-Margalet V, 1998, AM J PHYSIOL-ENDOC M, V275, pE1055, DOI 10.1152/ajpendo.1998.275.6.E1055; Sanchez-Margalet V, 2010, REGUL PEPTIDES, V165, P71, DOI 10.1016/j.regpep.2010.10.004; SanchezMargalet V, 1996, J MOL ENDOCRINOL, V16, P1, DOI 10.1677/jme.0.0160001; SANCHEZMARGALET V, 1992, HORM METAB RES, V24, P455, DOI 10.1055/s-2007-1003361; SANCHEZMARGALET V, 1995, NEUROPEPTIDES, V29, P97, DOI 10.1016/0143-4179(95)90090-X; SANCHEZMARGALET V, 1995, J HYPERTENS, V13, P251; SANCHEZMARGALET V, 1994, J CELL BIOCHEM, V55, P173, DOI 10.1002/jcb.240550204; SANCHEZMARGALET V, 1994, BIOCHEM J, V303, P51, DOI 10.1042/bj3030051; SANCHEZMARGALET V, 1994, MOL PHARMACOL, V46, P24; Santos-Alvarez J, 1999, J CELL BIOCHEM, V73, P469, DOI 10.1002/(SICI)1097-4644(19990615)73:4<469::AID-JCB5>3.0.CO;2-U; Santos-Alvarez J, 2000, ARCH BIOCHEM BIOPHYS, V378, P151, DOI 10.1006/abbi.2000.1789; SCHMIDT WE, 1988, P NATL ACAD SCI USA, V85, P8231, DOI 10.1073/pnas.85.21.8231; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Streeper RS, 2000, J BIOL CHEM, V275, P12108, DOI 10.1074/jbc.275.16.12108; TAMAMURA H, 1990, EUR J BIOCHEM, V191, P33, DOI 10.1111/j.1432-1033.1990.tb19090.x; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yamagishi N, 2012, BIOCHEM BIOPH RES CO, V417, P364, DOI 10.1016/j.bbrc.2011.11.118; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	62	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84132	10.1371/journal.pone.0084132	http://dx.doi.org/10.1371/journal.pone.0084132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465394	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500009
J	Choi, SH; Lee, HJ; Jin, YB; Jang, J; Kang, GY; Lee, M; Kim, CH; Kim, J; Yoon, SS; Lee, YS; Lee, YJ				Choi, Seo-hyun; Lee, Hae-June; Jin, Yeung Bae; Jang, Junho; Kang, Ga-Young; Lee, Minyoung; Kim, Chun-Ho; Kim, Joon; Yoon, Sam S.; Lee, Yun-Sil; Lee, Yoon-Jin			MMP9 Processing of HSPB1 Regulates Tumor Progression	PLOS ONE			English	Article							SHOCK-PROTEIN EXPRESSION; MATRIX METALLOPROTEINASES; CANCER-THERAPY; LUNG-CANCER; CELL-DEATH; HSP27; ANGIOGENESIS; INHIBITION; CARCINOMA; SERUM	Matrix metalloproteinases regulate pathophysiological events by processing matrix proteins and secreted proteins. Previously, we demonstrated that soluble heat shock protein B1 (HSPB1) is released primarily from endothelial cells (ECs) and regulates angiogenesis via direct interaction with vascular endothelial growth factor (VEGF). Here we report that MMP9 can cleave HSPB1 and release anti-angiogenic fragments, which play a key role in tumorprogression. We mapped the cleavage sites and explored their physiological relevance during these processing events. HSPB1 cleavage by MMP9 inhibited VEGF-induced ECs activation and the C-terminal HSPB1 fragment exhibited more interaction with VEGF than did full-length HSPB1. HSPB1 cleavage occurs during B16F10 lung progression in wild-type mice. Also, intact HSPB1 was more detected on tumor endothelium of MMP9 null mice than wild type mice. Finally, we confirmed that secretion of C-terminal HSPB1 fragment was significantly inhibited lung and liver tumor progression of B16F10 melanoma cells and lung tumor progression of CT26 colon carcinoma cells, compared to full-length HSPB1. These data suggest that in vivo MMP9-mediated processing of HSPB1 acts to regulate VEGF-induced ECs activation for tumor progression, releasing anti-angiogenic HSPB1 fragments. Moreover, these findings potentially explain an anti-target effect for the failure of MMP inhibitors in clinical trials, suggesting that MMP inhibitors may have pro-tumorigenic effects by reducing HSPB1 fragmentation.	[Choi, Seo-hyun; Lee, Hae-June; Jin, Yeung Bae; Jang, Junho; Lee, Minyoung; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Radiat Effects, Seoul, South Korea; [Choi, Seo-hyun; Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Kang, Ga-Young; Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Kang, Ga-Young; Lee, Yun-Sil] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Kim, Chun-Ho] Korea Inst Radiol & Med Sci, Lab Tissue Engn, Seoul, South Korea; [Yoon, Sam S.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Yoon, Sam S.] Harvard Univ, Sch Med, Boston, MA USA	Korea Institute of Radiological & Medical Sciences; Korea University; Ewha Womans University; Ewha Womans University; Korea Institute of Radiological & Medical Sciences; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, YS (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul, South Korea.	yslee0425@ewha.ac.kr; yjlee8@kcch.re.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Nuclear Research and Development Program [NRF-2012M2A2A7012483, NRF-2011-0031697, NRF-2013M2A2A7043580]; KIRAMS research project [50520-2013]; Nuclear Research and Development Program; Basic Science Research Program [R1A4A002]; Mid-career Researcher Program of the National Research Foundation of Korea (NRF) [2011-0013364]; Korean Ministry of Education, Science, and Technology (MEST); Ewha Womans University	Nuclear Research and Development Program; KIRAMS research project; Nuclear Research and Development Program; Basic Science Research Program; Mid-career Researcher Program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ewha Womans University	This work was supported by the Nuclear Research and Development Program (Grant No. NRF-2012M2A2A7012483, NRF-2011-0031697 and NRF-2013M2A2A7043580) and a KIRAMS research project (Grant No. 50520-2013) funded by the Nuclear Research and Development Program. This work also supported by the Basic Science Research Program (Grant No. R1A4A002), Mid-career Researcher Program (Grant No. 2011-0013364) of the National Research Foundation of Korea (NRF), funded by the Korean Ministry of Education, Science, and Technology (MEST) and the Ewha Global Top5 Grant 2011 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Berrieman HK, 2006, ONCOL REP, V15, P283; Cho NH, 2003, EUR UROL, V44, P560, DOI 10.1016/S0302-2838(03)00362-2; Cornford PA, 2000, CANCER RES, V60, P7099; De AK, 2004, J IMMUNOASS IMMUNOCH, V25, P159, DOI 10.1081/IAS-120030525; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Didelot C, 2006, HANDB EXP PHARM, V172, P171; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Feldman AL, 2000, CLIN CANCER RES, V6, P4628; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Geisler JP, 2004, EUR J GYNAECOL ONCOL, V25, P165; Genersch E, 2000, J CELL SCI, V113, P4319; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Guo H, 2010, J CLIN ONCOL, V28, P1928, DOI 10.1200/JCO.2009.24.4954; Guo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-100; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; Hwang SJ, 2008, PROTEIN J, V27, P319, DOI 10.1007/s10930-008-9140-5; Jimenez RE, 2000, ANN SURG, V231, P644, DOI 10.1097/00000658-200005000-00004; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Lee YJ, 2005, ONCOGENE, V24, P3715, DOI 10.1038/sj.onc.1208440; Lee YJ, 2005, J BIOL CHEM, V280, P18108, DOI 10.1074/jbc.M501131200; Lee YJ, 2012, ANGIOGENESIS; Lee YJ, 2012, ANGIOGENESIS, V15, P229, DOI 10.1007/s10456-012-9255-3; Lee YJ, 2010, CANCER RES, V70, P948, DOI 10.1158/0008-5472.CAN-09-3094; Liao WC, 2009, PANCREAS, V38, P422, DOI 10.1097/MPA.0b013e318198281d; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Marquez E, 2012, CLIN CHIM ACTA; Martin-Ventura JL, 2006, ARTERIOSCL THROM VAS, V26, P1337, DOI 10.1161/01.ATV.0000220108.97208.67; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Missotten GS, 2003, INVEST OPHTH VIS SCI, V44, P3059, DOI 10.1167/iovs.02-1038; Okazaki I, 2012, ANTICANCER AGENTS ME; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Overall Christopher M, 2004, Biochem J, V383, pe5; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Ren H, 2006, WORLD J GASTROENTERO, V12, P2789, DOI 10.3748/wjg.v12.i17.2789; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065	48	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85509	10.1371/journal.pone.0085509	http://dx.doi.org/10.1371/journal.pone.0085509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465581	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500054
J	Hargreaves, MK; Liu, JG; Buchowski, MS; Patel, KA; Larson, CO; Schlundt, DG; Kenerson, DM; Hill, KE; Burk, RF; Blot, WJ				Hargreaves, Margaret K.; Liu, Jianguo; Buchowski, Maciej S.; Patel, Kushal A.; Larson, Celia O.; Schlundt, David G.; Kenerson, Donna M.; Hill, Kristina E.; Burk, Raymond F.; Blot, William J.			Plasma Selenium Biomarkers in Low Income Black and White Americans from the Southeastern United States	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; FOOD FREQUENCY QUESTIONNAIRE; NUTRITION EXAMINATION SURVEY; SOUTHERN COMMUNITY COHORT; BODY-MASS INDEX; SERUM SELENIUM; SELENOPROTEIN-P; GLUTATHIONE-PEROXIDASE; CANCER INCIDENCE; PROSTATE-CANCER	Biomarkers of selenium are necessary for assessing selenium status in humans, since soil variation hinders estimation of selenium intake from foods. In this study, we measured the concentration of plasma selenium, selenoprotein P (SEPP1), and glutathione peroxidase (GPX3) activity and their interindividual differences in 383 low-income blacks and whites selected from a stratified random sample of adults aged 40-79 years, who were participating in a long-term cohort study in the southeastern United States (US). We assessed the utility of these biomarkers to determine differences in selenium status and their association with demographic, socio-economic, dietary, and other indicators. Dietary selenium intake was assessed using a validated food frequency questionnaire designed for the cohort, matched with region-specific food selenium content, and compared with the US Recommended Dietary Allowances (RDA) set at 55 mu g/day. We found that SEPP1, a sensitive biomarker of selenium nutritional status, was significantly lower among blacks than whites (mean 4.4 +/- 1.1 vs. 4.7 +/- 1.0 mg/L, p = 0.006), with blacks less than half as likely to have highest vs. lowest quartile SEPP1 concentration (Odds Ratio (OR) 0.4, 95% Confidence Interval (CI) 0.2-0.8). The trend in a similar direction was observed for plasma selenium among blacks and whites, (mean 115 +/- 15.1 vs. 118 +/- 17.7 mu g/L, p = 0.08), while GPX3 activity did not differ between blacks and whites (136 +/- 33.3 vs. 132 +/- 33.5 U/L, p = 0.320). Levels of the three biomarkers were not correlated with estimated dietary selenium intake, except for SEPP1 among 10% of participants with the lowest selenium intake (<= 57 mu g/day). The findings suggest that SEPP1 may be an effective biomarker of selenium status and disease risk in adults and that low selenium status may disproportionately affect black and white cohort participants.	[Hargreaves, Margaret K.; Liu, Jianguo; Kenerson, Donna M.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Buchowski, Maciej S.; Hill, Kristina E.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Patel, Kushal A.] Tennessee State Univ, Dept Publ Hlth Hlth Adm & Hlth Sci, Nashville, TN 37203 USA; [Larson, Celia O.] Metro Publ Hlth Dept, Dept Populat Hlth, Nashville, TN USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Blot, William J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Meharry Medical College; Vanderbilt University; Tennessee State University; Vanderbilt University; Vanderbilt University	Hargreaves, MK (corresponding author), Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.	mhargreaves@mmc.edu	Kenerson, Donna/GPX-3456-2022	Buchowski, Maciej/0000-0002-0566-1743	National Institutes of Health from the National Cancer Institute [R01CA092447, U01CA114641, U54CA153708]; NATIONAL CANCER INSTITUTE [R01CA092447, U01CA114641, U54CA153708] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported in part by National Institutes of Health grants R01CA092447, U01CA114641, and U54CA153708 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Taie OH, 2003, NUTR CANCER, V46, P125, DOI 10.1207/S15327914NC4602_04; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Burk RF, 2006, BBA-GEN SUBJECTS, V1760, P1789, DOI 10.1016/j.bbagen.2006.08.010; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Burk RF, 2006, CANCER EPIDEM BIOMAR, V15, P804, DOI 10.1158/1055-9965.EPI-05-0950; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Cohen SS, 2012, ANN NUTR METAB, V60, P90, DOI 10.1159/000336180; Cohen SS, 2011, ANN EPIDEMIOL, V21, P86, DOI 10.1016/j.annepidem.2010.10.011; Combs GF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-75; Combs GF, 2005, J NUTR, V135, P343, DOI 10.1093/jn/135.2.343; Daniels LA, 2004, MED J AUSTRALIA, V180, P373, DOI 10.5694/j.1326-5377.2004.tb05986.x; DEAGEN JT, 1993, ANAL BIOCHEM, V208, P176, DOI 10.1006/abio.1993.1025; Devesa SS, 1999, NIH PUBLICATION; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Epplein M, 2011, CANCER PREV RES, V4, P871, DOI 10.1158/1940-6207.CAPR-10-0398; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; Hargreaves MK, 2005, MULTICULTURAL MED HL, P485; Hill KE, 1996, J NUTR, V126, P138, DOI 10.1093/jn/126.1.138; Holben DH, 1999, J AM DIET ASSOC, V99, P836, DOI 10.1016/S0002-8223(99)00198-4; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Institute of Medicine (US) Panel on Micronutrients, 2000, DIET REF INT VIT C V, P284, DOI [10.17226/9810, DOI 10.17226/9810]; JASKIEWICZ K, 1988, CANCER, V62, P2635, DOI 10.1002/1097-0142(19881215)62:12<2635::AID-CNCR2820621232>3.0.CO;2-5; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kafai MR, 2003, J TRACE ELEM MED BIO, V17, P13, DOI 10.1016/S0946-672X(03)80040-8; Klapcinska B, 2005, BIOL TRACE ELEM RES, V108, P1, DOI 10.1385/BTER:108:1-3:001; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Lee B. L., 2005, J ANIM SCI S, V62, P2414; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lyons GH, 2004, MED J AUSTRALIA, V180, P383, DOI 10.5694/j.1326-5377.2004.tb05990.x; MACPHERSON AK, 1988, ANALYST, V113, P281, DOI 10.1039/an9881300281; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; MCCOY KEM, 1969, J NUTR, V98, P383, DOI 10.1093/jn/98.4.383; Neve J, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P317; Niskar AS, 2003, BIOL TRACE ELEM RES, V91, P1, DOI 10.1385/BTER:91:1:1; Nomura AMY, 2000, CANCER EPIDEM BIOMAR, V9, P883; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Saito Y, 2001, J HEALTH SCI, V47, P346, DOI 10.1248/jhs.47.346; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Vogt TM, 2007, AM J EPIDEMIOL, V166, P280, DOI 10.1093/aje/kwm075; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Wasowicz W, 2003, TOXICOL LETT, V137, P95, DOI 10.1016/S0378-4274(02)00383-1; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829; XIA YM, 1989, J NUTR, V119, P1318, DOI 10.1093/jn/119.9.1318; Zhang XL, 2008, DIS MARKERS, V24, P351, DOI 10.1155/2008/509138	58	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84972	10.1371/journal.pone.0084972	http://dx.doi.org/10.1371/journal.pone.0084972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465457	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500026
J	Hindra; Moody, MJ; Jones, SE; Elliot, MA				Hindra; Moody, Matthew J.; Jones, Stephanie E.; Elliot, Marie A.			Complex Intra-Operonic Dynamics Mediated by a Small RNA in Streptomyces coelicolor	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTIBIOTIC PRODUCTION; GENOME SEQUENCE; GENES; DIFFERENTIATION; BIOSYNTHESIS; A3(2); TRANSCRIPTOME; AVERMITILIS; REGULATORS	Streptomyces are predominantly soil-dwelling bacteria that are best known for their multicellular life cycle and their prodigious metabolic capabilities. They are also renowned for their regulatory capacity and flexibility, with each species encoding >60 sigma factors, a multitude of transcription factors, and an increasing number of small regulatory RNAs. Here, we describe our characterization of a conserved small RNA (sRNA), scr4677. In the model species Streptomyces coelicolor, this sRNA is located in the intergenic region separating SCO4677 (an anti-sigma factor-encoding gene) and SCO4676 (a putative regulatory protein-encoding gene), close to the SCO4676 translation start site in an antisense orientation. There appears to be considerable genetic interplay between these different gene products, with wild type expression of scr4677 requiring function of the anti-sigma factor SCO4677, and scr4677 in turn influencing the abundance of SCO4676-associated transcripts. The scr4677-mediated effects were independent of RNase III (a double stranded RNA-specific nuclease), with RNase III having an unexpectedly positive influence on the level of SCO4676-associated transcripts. We have shown that both SCO4676 and SCO4677 affect the production of the blue-pigmented antibiotic actinorhodin under specific growth conditions, and that this activity appears to be independent of scr4677.	[Elliot, Marie A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Elliot, MA (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	melliot@mcmaster.ca	Hindra, Hindra/I-9753-2019	Hindra, Hindra/0000-0002-8411-8123; jones, stephanie/0000-0001-9290-6835	Natural Sciences and Engineering Research Council of Canada [312495]; Canada Research Chairs (CRC) program; Province of Ontario; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs (CRC) program(Canada Research Chairs); Province of Ontario; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant No. 312495), the Canada Research Chairs (CRC) program, and graduate student awards from the Province of Ontario (to H and MJM) and NSERC (to SEJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti DJ, 1998, J BACTERIOL, V180, P3100, DOI 10.1128/JB.180.12.3100-3106.1998; ADAMIDIS T, 1992, J BACTERIOL, V174, P4622, DOI 10.1128/JB.174.14.4622-4628.1992; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Castro-Melchor M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-578; CHATER KF, 1993, ANNU REV MICROBIOL, V47, P685, DOI 10.1146/annurev.micro.47.1.685; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; DAVIS NK, 1990, MOL MICROBIOL, V4, P1679, DOI 10.1111/j.1365-2958.1990.tb00545.x; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Duong A, 2012, MOL MICROBIOL, V83, P992, DOI 10.1111/j.1365-2958.2012.07983.x; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Gatewood ML, 2012, J BACTERIOL, V194, P2228, DOI 10.1128/JB.06541-11; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Haiser HJ, 2009, J BACTERIOL, V191, P6501, DOI 10.1128/JB.00767-09; Hindra, 2010, J BACTERIOL, V192, P4973, DOI 10.1128/JB.00681-10; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Kang SG, 1998, FEMS MICROBIOL LETT, V168, P221, DOI 10.1111/j.1574-6968.1998.tb13277.x; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kelemen GH, 1998, J BACTERIOL, V180, P2515, DOI 10.1128/JB.180.9.2515-2521.1998; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim ES, 2008, J BACTERIOL, V190, P7559, DOI 10.1128/JB.00470-08; Kirby R, 2011, FEMS MICROBIOL LETT, V319, P1, DOI 10.1111/j.1574-6968.2011.02242.x; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Moody MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-558; Nicholson AW, 2011, NUCLEIC ACIDS MOL BI, V26, P269, DOI 10.1007/978-3-642-21078-5_11; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Resch A, 2008, RNA, V14, P454, DOI 10.1261/rna.603108; SAMBROOK J, 2000, MOL CLONING LAB MANU; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sello JK, 2008, J BACTERIOL, V190, P4079, DOI 10.1128/JB.01889-07; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; STUTTARD C, 1982, J GEN MICROBIOL, V128, P115; Swiercz JP, 2012, BACTERIAL SPORES: CURRENT RESEARCH AND APPLICATIONS, P39; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Ulrych A, 2013, MOL BIOSYST, V9, P1453, DOI 10.1039/c3mb25542e; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85856	10.1371/journal.pone.0085856	http://dx.doi.org/10.1371/journal.pone.0085856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465751	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500080
J	Hochmeister, S; Pekar, T; Lindner, M; Kitic, M; Haindl, M; Storch, M; Fazekas, F; Linington, C				Hochmeister, Sonja; Pekar, Thomas; Lindner, Maren; Kitic, Maja; Haindl, Michaela; Storch, Maria; Fazekas, Franz; Linington, Christopher			Maternal Neurofascin-Specific Autoantibodies Bind to Structures of the Fetal Nervous System during Pregnancy, but Have No Long Term Effect on Development in the Rat	PLOS ONE			English	Article							AXON INITIAL SEGMENT; CELL-ADHESION MOLECULE; MULTIPLE-SCLEROSIS; LUPUS-ERYTHEMATOSUS; MYASTHENIA-GRAVIS; RANVIER; NODES; DISRUPTION; DOMAINS; DEMYELINATION	Neurofascin was recently reported as a target for axopathic autoantibodies in patients with multiple sclerosis (MS), a response that will exacerbate axonal pathology and disease severity in an animal model of multiple sclerosis. As transplacental transfer of maternal autoantibodies can permanently damage the developing nervous system we investigated whether intrauterine exposure to this neurofascin-specific response had any detrimental effect on white matter tract development. To address this question we intravenously injected pregnant rats with either a pathogenic anti-neurofascin monoclonal antibody or an appropriate isotype control on days 15 and 18 of pregnancy, respectively, to mimic the physiological concentration of maternal antibodies in the circulation of the fetus towards the end of pregnancy. Pups were monitored daily with respect to litter size, birth weight, growth and motor development. Histological studies were performed on E20 embryos and pups sacrificed on days 2, 10, 21, 32 and 45 days post partum. Results: Immunohistochemistry for light and confocal microscopy confirmed passively transferred anti-neurofascin antibody had crossed the placenta to bind to distinct structures in the developing cortex and cerebellum. However, this did not result in any significant differences in litter size, birth weight, or general physical development between litters from control mothers or those treated with the neurofascin-specific antibody. Histological analysis also failed to identify any neuronal or white matter tract abnormalities induced by the neurofascin-specific antibody. Conclusions: We show that transplacental transfer of circulating anti-neurofascin antibodies can occur and targets specific structures in the CNS of the developing fetus. However, this did not result in any pre- or post-natal abnormalities in the offspring of the treated mothers. These results assure that even if anti-neurofascin responses are detected in pregnant women with multiple sclerosis these are unlikely to have a negative effect on their children.	[Hochmeister, Sonja; Pekar, Thomas; Haindl, Michaela; Storch, Maria; Fazekas, Franz] Med Univ Graz, Dept Neurol, Graz, Austria; [Kitic, Maja] Med Univ Vienna, Brain Res Inst, Dept Neuroimmunol, Vienna, Austria; [Lindner, Maren; Linington, Christopher] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Medical University of Graz; Medical University of Vienna; University of Glasgow	Hochmeister, S (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	sonja.hochmeister@medunigraz.at	Linington, Chris/M-4883-2019	Pekar, Thomas/0000-0002-2331-0488; Linington, Christopher/0000-0002-0937-9526				Basak S, 2007, DEV BIOL, V311, P408, DOI 10.1016/j.ydbio.2007.08.045; Buttermore ED, 2012, J NEUROSCI, V32, P4724, DOI 10.1523/JNEUROSCI.5602-11.2012; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Elliott C, 2012, BRAIN, V135, P1819, DOI 10.1093/brain/aws105; GIACOIA G P, 1991, Obstetrical and Gynecological Survey, V46, P723; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Hughes RAC, 2012, NEUROLOGY, V79, P2224, DOI 10.1212/WNL.0b013e3182768b55; King G, 1997, J PATHOL, V183, P237, DOI 10.1002/(SICI)1096-9896(199710)183:2<237::AID-PATH893>3.0.CO;2-0; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Kriebel M, 2012, INT J BIOCHEM CELL B, V44, P694, DOI 10.1016/j.biocel.2012.01.012; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; LAHITA RG, 1988, PSYCHONEUROENDOCRINO, V13, P385, DOI 10.1016/0306-4530(88)90045-5; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Mathey EK, 2013, J NEUROL SCI, V333, P37, DOI 10.1016/j.jns.2012.10.020; McAllister D L, 1997, J Int Neuropsychol Soc, V3, P370; Meinl E, 2011, J NEUROL SCI, V306, P180, DOI 10.1016/j.jns.2010.08.009; Neri F, 2004, LUPUS, V13, P805, DOI 10.1191/0961203304lu2018oa; Ng JKM, 2012, NEUROLOGY, V79, P2241, DOI 10.1212/WNL.0b013e31827689ad; Oskoui M, 2008, NEUROLOGY, V71, P2010, DOI 10.1212/01.wnl.0000336929.38733.7a; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Pomicter AD, 2010, BRAIN, V133, P389, DOI 10.1093/brain/awp341; Pruss H, 2011, BRAIN, V134, DOI 10.1093/brain/awq372; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Ross G, 2003, ARCH PEDIAT ADOL MED, V157, P397, DOI 10.1001/archpedi.157.4.397; Saint-Faust M, 2010, AM J PERINAT, V27, P107, DOI 10.1055/s-0029-1224873; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Thaxton C, 2011, NEURON, V69, P244, DOI 10.1016/j.neuron.2010.12.016; Tincani A, 2006, LUPUS, V15, P801, DOI 10.1177/0961203306071005; VASS K, 1986, ACTA NEUROPATHOL, V70, P149, DOI 10.1007/BF00691433; Wang L, 2012, J EXP MED, V209, P1083, DOI 10.1084/jem.20111986; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	37	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85393	10.1371/journal.pone.0085393	http://dx.doi.org/10.1371/journal.pone.0085393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465550	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000330240500045
J	van Gennip, RGP; van de Water, SGP; van Rijn, PA				van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.			Bluetongue Virus Nonstructural Protein NS3/NS3a Is Not Essential for Virus Replication	PLOS ONE			English	Article							CELL-LINES; EPITHELIAL-CELLS; INFECTED-CELLS; RELEASE; TRAFFICKING; PARTICLES; SYSTEMS; NS3	Orbiviruses form the largest genus of the family Reoviridae consisting of at least 23 different virus species. One of these is the bluetongue virus (BTV) and causes severe hemorrhagic disease in ruminants, and is transmitted by bites of Culicoides midges. BTV is a non-enveloped virus which is released from infected cells by cell lysis and/or a unique budding process induced by nonstructural protein NS3/NS3a encoded by genome segment 10 (Seg-10). Presence of both NS3 and NS3a is highly conserved in Culicoides borne orbiviruses which is suggesting an essential role in virus replication. We used reverse genetics to generate BTV mutants to study the function of NS3/NS3a in virus replication. Initially, BTV with small insertions in Seg-10 showed no CPE but after several passages these BTV mutants reverted to CPE phenotype comparable to wtBTV, and NS3/NS3a expression returned by repair of the ORF. These results show that there is a strong selection for functional NS3/NS3a. To abolish NS3 and/or NS3a expression, Seg-10 with one or two mutated start codons (mutAUG1, mutAUG2 and mutAUG1+ 2) were used to generate BTV mutants. Surprisingly, all three BTV mutants were generated and the respective AUG(Met)-> GCC(Ala) mutations were maintained. The lack of expression of NS3, NS3a, or both proteins was confirmed by westernblot analysis and immunostaining of infected cells with NS3/NS3a Mabs. Growth of mutAUG1 and mutAUG1+ 2 virus in BSR cells was retarded in both insect and mammalian cells, and particularly virus release from insect cells was strongly reduced. Our findings now enable research on the role of RNA sequences of Seg-10 independent of known gene products, and on the function of NS3/NS3a proteins in both types of cells as well as in the host and insect vector.	[van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands	Wageningen University & Research	van Gennip, RGP (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands.	rene.vangennip@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research was funded by the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Celma CCP, 2011, J VIROL, V85, P4783, DOI 10.1128/JVI.02352-10; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; CLAYSON ET, 1989, J VIROL, V63, P2278, DOI 10.1128/JVI.63.5.2278-2288.1989; FRENCH TJ, 1990, J VIROL, V64, P1530, DOI 10.1128/JVI.64.4.1530-1536.1990; Griffin SDC, 2009, P NATL ACAD SCI USA, V106, P12567, DOI 10.1073/pnas.0906760106; Han ZY, 2004, J BIOL CHEM, V279, P43092, DOI 10.1074/jbc.M403663200; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOMAN EJ, 1988, VET MICROBIOL, V16, P15, DOI 10.1016/0378-1135(88)90123-X; HYATT AD, 1989, VIROLOGY, V173, P21, DOI 10.1016/0042-6822(89)90218-3; HYATT AD, 1991, J GEN VIROL, V72, P2263, DOI 10.1099/0022-1317-72-9-2263; JENNINGS M, 1979, ARCH VIROL, V59, P121, DOI 10.1007/BF01317901; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Meiring TL, 2009, ARCH VIROL, V154, P263, DOI 10.1007/s00705-008-0302-8; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Noad R, 2009, BIOL ANIM INFECT, P53, DOI 10.1016/B978-012369368-6.50008-3; OIE, 2006, MANUAL DIAGNOSTIC TE; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; TUCKER SP, 1993, J VIROL, V67, P4274, DOI 10.1128/JVI.67.7.4274-4282.1993; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044619; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; Watanabe S, 2009, J VIROL, V83, P5947, DOI 10.1128/JVI.00450-09; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wirblich C, 2006, J VIROL, V80, P460, DOI 10.1128/JVI.80.1.460-473.2006; WU XY, 1992, J VIROL, V66, P7104, DOI 10.1128/JVI.66.12.7104-7112.1992	31	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85788	10.1371/journal.pone.0085788	http://dx.doi.org/10.1371/journal.pone.0085788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465709	Green Published, gold			2022-12-27	WOS:000330240500074
J	Maroteaux, M; Valjent, E; Longueville, S; Topilko, P; Girault, JA; Herve, D				Maroteaux, Matthieu; Valjent, Emmanuel; Longueville, Sophie; Topilko, Piotr; Girault, Jean-Antoine; Herve, Denis			Role of the Plasticity-Associated Transcription Factor Zif268 in the Early Phase of Instrumental Learning	PLOS ONE			English	Article							EARLY GENE ZIF268; NUCLEUS-ACCUMBENS; BASAL GANGLIA; SUBSTANTIA-NIGRA; PARS RETICULATA; DORSAL STRIATUM; DOPAMINE D-1; C-FOS; EXPRESSION; COCAINE	Gene transcription is essential for learning, but the precise role of transcription factors that control expression of many other genes in specific learning paradigms is yet poorly understood. Zif268 (Krox24/Egr-1) is a transcription factor and an immediate-early gene associated with memory consolidation and reconsolidation, and induced in the striatum after addictive drugs exposure. In contrast, very little is known about its physiological role at early stages of operant learning. We investigated the role of Zif268 in operant conditioning for food. Zif268 expression was increased in all regions of the dorsal striatum and nucleus accumbens in mice subjected to the first session of operant conditioning. In contrast, Zif268 increase in the dorsomedial caudate-putamen and nucleus accumbens core was not detected in yoked mice passively receiving the food reward. This indicates that Zif268 induction in these structures is linked to experiencing or learning contingency, but not to reward delivery. When the task was learned (5 sessions), Zif268 induction disappeared in the nucleus accumbens and decreased in the medial caudate-putamen, whereas it remained high in the lateral caudate-putamen, previously implicated in habit formation. In transgenic mice expressing green fluorescent protein (GFP) in the striatonigral neurons, Zif268 induction occured after the first training session in both GFP-positive and negative neurons indicating an enhanced Zif268 expression in both striatonigral and striatopallidal neurons. Mutant mice lacking Zif268 expression obtained less rewards, but displayed a normal discrimination between reinforced and non-reinforced targets, and an unaltered approach to food delivery box. In addition, their motivation to obtain food rewards, evaluated in a progressive ratio schedule, was blunted. In conclusion, Zif268 participates in the processes underlying performance and motivation to execute food-conditioned instrumental task.	[Maroteaux, Matthieu; Longueville, Sophie; Girault, Jean-Antoine; Herve, Denis] INSERM, UMR S 839, Paris, France; [Maroteaux, Matthieu; Longueville, Sophie; Girault, Jean-Antoine; Herve, Denis] Univ Paris 06, Paris, France; [Maroteaux, Matthieu; Longueville, Sophie; Girault, Jean-Antoine; Herve, Denis] Inst Fer Moulin, Paris, France; [Valjent, Emmanuel] INSERM, UMR S 661, Montpellier, France; [Valjent, Emmanuel] CNRS, UMR 5203, Montpellier, France; [Valjent, Emmanuel] Univ Montpellier I & II, Montpellier, France; [Topilko, Piotr] Ecole Normale Super, CNRS, UMR 8197, IBENS,Dev Biol Sect,Inserm,UMR S 1024, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Herve, D (corresponding author), INSERM, UMR S 839, Paris, France.	denis.herve@inserm.fr	HERVE, Denis/E-2929-2017; Girault, Jean-Antoine/F-7518-2013	HERVE, Denis/0000-0003-1376-1522; Girault, Jean-Antoine/0000-0002-7900-1705; Valjent, Emmanuel/0000-0002-1034-606X	Inserm; UPMC; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-BLAN08-1_346422]; ERC	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	This work was supported by Inserm, UPMC, and grants from the Fondation pour la Recherche Medicale, the Agence Nationale de la Recherche (ANR-BLAN08-1_346422,) and ERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Besnard A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072006; BHAT RV, 1992, J PHARMACOL EXP THER, V263, P343; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Flagel SB, 2011, NEUROSCIENCE, V196, P80, DOI 10.1016/j.neuroscience.2011.09.004; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gore BB, 2013, J NEUROSCI, V33, P8640, DOI 10.1523/JNEUROSCI.5532-12.2013; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kravitz AV, 2012, NAT NEUROSCI; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; MORATALLA R, 1992, J NEUROSCI, V12, P2609; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Segovia KN, 2012, EUR J NEUROSCI, V35, P1354, DOI 10.1111/j.1460-9568.2012.08036.x; Shiflett MW, 2011, PROG NEUROBIOL, V95, P1, DOI 10.1016/j.pneurobio.2011.05.007; Shiflett MW, 2011, BEHAV BRAIN RES, V218, P240, DOI 10.1016/j.bbr.2010.12.010; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thomas KL, 2003, EUR J NEUROSCI, V17, P1964, DOI 10.1046/j.1460-9568.2003.02617.x; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	62	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e81868	10.1371/journal.pone.0081868	http://dx.doi.org/10.1371/journal.pone.0081868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465372	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000001
J	Amso, D; Haas, S; Markant, J				Amso, Dima; Haas, Sara; Markant, Julie			An Eye Tracking Investigation of Developmental Change in Bottom-up Attention Orienting to Faces in Cluttered Natural Scenes	PLOS ONE			English	Article							VISUAL-ATTENTION; STIMULI; SALIENCY; INFANTS; SEARCH; MODEL	This study examined the contribution of visual salience to bottom-up attention orienting to faces in cluttered natural scenes across development. We eye tracked participants 4 months to 24 years of age as they freely viewed 16 natural scenes, all of which had faces in them. In half, the face was also the winner-take-all salient area in the display as determined by the MATLAB SaliencyToolbox. In the other half, a random location was the winner-take-all salient area in the display and the face was visually non-salient. We found that proportion of attended faces, in the first second of scene viewing, improved after the first year. Visually salient faces attracted bottom-up attention orienting more than non-salient faces reliably and robustly only after infancy. Preliminary data indicate that this shift to use of visual salience to guide bottom-up attention orienting after infancy may be a function of stabilization of visual skills. Moreover, sociodemographic factors including number of siblings in the home and family income were agents of developmental change in orienting to faces in cluttered natural scenes in infancy.	[Amso, Dima; Haas, Sara; Markant, Julie] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Brown University	Amso, D (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	Dima_Amso@Brown.edu		Markant, Julie/0000-0001-9963-1766	James S. McDonnell Foundation; NIGMS [1P20GM103645-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103645] Funding Source: NIH RePORTER	James S. McDonnell Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the James S. McDonnell Foundation, http://www.jsmf.org and the NIGMS, 1P20GM103645-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus N, 2012, CHILD DEV, V83, P1122, DOI 10.1111/j.1467-8624.2012.01766.x; Amso D, J AUTISM DEV DISORD; Amso D, 2006, DEV PSYCHOL, V42, P1236, DOI 10.1037/0012-1649.42.6.1236; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Clearfield MW, 2013, INFANT CHILD DEV, V22, P53, DOI 10.1002/icd.1770; Dawson G, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-11; DeNicola CA, 2013, INT J BEHAV DEV, V37, P143, DOI 10.1177/0165025412474751; Di Giorgio E, 2012, J EXP CHILD PSYCHOL, V113, P66, DOI 10.1016/j.jecp.2012.04.012; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Frank MC, 2014, J EXP CHILD PSYCHOL, V118, P13, DOI 10.1016/j.jecp.2013.08.012; Frank MC, 2009, COGNITION, V110, P160, DOI 10.1016/j.cognition.2008.11.010; Freeth M, 2011, NEUROPSYCHOLOGIA, V49, P156, DOI 10.1016/j.neuropsychologia.2010.11.012; Gliga T, 2009, INFANCY, V14, P550, DOI 10.1080/15250000903144199; Gluckman M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00527; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Knoblauch K, 1998, VISION RES, V38, P1753, DOI 10.1016/S0042-6989(97)00383-0; KOCH C, 1985, HUM NEUROBIOL, V4, P219; MORRONE MC, 1993, VISION RES, V33, P2535, DOI 10.1016/0042-6989(93)90133-H; Niebur E, 1996, CONTROL SELECTIVE VI; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Nothdurft HC, 2000, VISION RES, V40, P2421, DOI 10.1016/S0042-6989(00)00112-7; Otsuka Y, 2013, J EXP CHILD PSYCHOL, V115, P598, DOI 10.1016/j.jecp.2013.01.006; Pallett PM, 2013, VISUAL NEUROSCI, P1, DOI DOI 10.1017/S0952523813000217; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Schlesinger M, 2007, DEVELOPMENTAL SCI, V15, P739; Schlesinger M, 2012, DEVELOPMENTAL SCI, V15, P739, DOI 10.1111/j.1467-7687.2012.01177.x; SIRETEANU R, 1992, BEHAV BRAIN RES, V49, P133, DOI 10.1016/S0166-4328(05)80203-7; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	33	71	72	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85701	10.1371/journal.pone.0085701	http://dx.doi.org/10.1371/journal.pone.0085701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465653	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100062
J	Hamrefors, V; Hedblad, B; Hindy, G; Smith, JG; Almgren, P; Engstrom, G; Sjogren, M; Gransbo, K; Orho-Melander, M; Melander, O				Hamrefors, Viktor; Hedblad, Bo; Hindy, George; Smith, J. Gustav; Almgren, Peter; Engstrom, Gunnar; Sjogren, Marketa; Gransbo, Klas; Orho-Melander, Marju; Melander, Olle			Smoking Modifies the Associated Increased Risk of Future Cardiovascular Disease by Genetic Variation on Chromosome 9p21	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; LOCUS; POPULATION; COHORT; STROKE	Aims: Genetic predisposition for cardiovascular disease (CVD) is likely to be modified by environmental exposures. We tested if the associated risk of CVD and CVD-mortality by the single nucleotide polymorphism rs4977574 on chromosome 9p21 is modified by life-style factors. Methods and results: A total of 24944 middle-aged subjects (62% females) from the population-based Malmo-Diet-and-Cancer-Cohort were genotyped. Smoking, education and physical activity-levels were recorded. Subjects were followed for 15 years for incidence of coronary artery disease (CAD; N = 2309), ischemic stroke (N = 1253) and CVD-mortality (N = 1156). Multiplicative interactions between rs4977574 and life-style factors on endpoints were tested in Cox-regression-models. We observed an interaction between rs4977574 and smoking on incident CAD (P = 0.035) and CVD-mortality (P = 0.012). The hazard ratios (HR) per risk allele of rs4977574 were highest in never smokers (N = 9642) for CAD (HR = 1.26; 95% CI 1.13-1.40; P < 0.001) and for CVD-mortality (HR = 1.40; 95% CI 1.20-1.63; P < 0.001), whereas the risk increase by rs4977574 was attenuated in current smokers (N = 7000) for both CAD (HR = 1.05; 95% CI 0.95-1.16; P = 0.326) and CVD-mortality (HR = 1.08; 95% CI 0.94-1.23; P = 0.270). A meta-analysis supported the finding that the associated increased risk of CAD by the risk-allele was attenuated in smokers. Neither education nor physical activity-levels modified the associated risk of CAD, ischemic stroke and CVD mortality conferred by rs4977574. Conclusion: Smoking may modify the associated risk of CAD and CVD-mortality conferred by genetic variation on chromosome 9p21. Whether the observed attenuation of the genetic risk reflects a pathophysiological mechanism or is a result of smoking being such a strong risk-factor that it may eliminate the associated genetic effect, requires further investigation.	[Hamrefors, Viktor; Hedblad, Bo; Hindy, George; Smith, J. Gustav; Almgren, Peter; Engstrom, Gunnar; Sjogren, Marketa; Gransbo, Klas; Orho-Melander, Marju; Melander, Olle] Lund Univ, Fac Med, Dept Clin Sci, Malmo, Sweden; [Hamrefors, Viktor] Skane Univ Hosp, Clin Physiol & Nucl Med Unit, Malmo, Sweden; [Smith, J. Gustav] Lund Univ, Fac Med, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Gransbo, Klas; Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Skane University Hospital	Hamrefors, V (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Malmo, Sweden.	Viktor.Hamrefors@med.lu.se		Hindy, George/0000-0002-7257-9299; Engstrom, Gunnar/0000-0002-8618-9152; Melander, Olle/0000-0002-2581-484X	European Research Council [StG-282255]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; LUA/ALF from the Sahlgrenska Academy at Goteborg University; MalmoUniversity Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Novo Nordic Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden [NNF13OC0005339, NNF14OC0009819, NNF14OC0011049] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; LUA/ALF from the Sahlgrenska Academy at Goteborg University; MalmoUniversity Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the European Research Council (StG-282255), the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, LUA/ALF from the Sahlgrenska Academy at Goteborg University, MalmoUniversity Hospital, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, Novo Nordic Foundation, the Region Skane, Hulda and Conrad Mossfelt Foundation and King Gustaf V and Queen Victoria Foundation, the Lennart Hanssons Memorial Fund and the Marianne and Marcus Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Anderson CD, 2010, STROKE, V41, P1123, DOI 10.1161/STROKEAHA.110.580589; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Folsom AR, 2012, ATHEROSCLEROSIS, V224, P435, DOI 10.1016/j.atherosclerosis.2012.08.007; Germano G, 2012, EUR HEART J, V33, P137; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hiura Y, 2008, CIRC J, V72, P1213, DOI 10.1253/circj.72.1213; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khan FA, 2004, STROKE, V35, P2054, DOI 10.1161/01.STR.0000135761.18954.0b; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Li C, 2009, EUR J CLIN NUTR, V63, P1448, DOI 10.1038/ejcn.2009.69; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Ordovas JM, 2008, CURR OPIN LIPIDOL, V19, P158, DOI 10.1097/MOL.0b013e3282f6a809; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; The Swedish National Board of Health and Welfare, 2000, EV QUAL DIAGN AC MYO; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85893	10.1371/journal.pone.0085893	http://dx.doi.org/10.1371/journal.pone.0085893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465769	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100087
J	Nijhuis, LE; Olivier, BJ; Dhawan, S; Hilbers, FW; Boon, L; Wolkers, MC; Samsom, JN; de Jonge, WJ				Nijhuis, Laurens E.; Olivier, Brenda J.; Dhawan, Shobit; Hilbers, Francisca W.; Boon, Louis; Wolkers, Monika C.; Samsom, Janneke N.; de Jonge, Wouter J.			Adrenergic beta 2 Receptor Activation Stimulates Anti-Inflammatory Properties of Dendritic Cells In Vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; VAGUS NERVE; T-CELLS; IMMUNE-RESPONSE; INFLAMMATION; SYSTEM; MODULATION	Vagal nerve efferent activation has been shown to ameliorate the course of many inflammatory disease states. This neuro-modulatory effect has been suggested to rest on acetylcholine receptor (AChR) activation on tissue macrophages or dendritic cells (DCs). In more recent studies, vagal anti-inflammatory activity was shown involve adrenergic, splenic, pathways. Here we provide evidence that the adrenergic, rather than cholinergic, receptor activation on bone marrow derived DCs results in enhanced endocytosis uptake, enhanced IL-10 production but a decreased IL-6, IL-12p70 and IL-23 production. In antigen specific T cell stimulation assays, adrenergic beta 2 receptor activation on bone marrow DCs led to an enhanced potential to induce Foxp3 positive suppressive Treg cells. These effects were independent of IL10-R activation, TGF beta release, or retinoic acid (RA) secretion. Hence, adrenergic receptor b2 activation modulates DC function resulting in skewing towards anti-inflammatory T cell phenotypes.	[Nijhuis, Laurens E.; Olivier, Brenda J.; Dhawan, Shobit; Hilbers, Francisca W.; de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Gastrointestinal & Liver Res, NL-1105 AZ Amsterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Samsom, Janneke N.] Erasmus MC, Lab Pediat Gastroenterol, Rotterdam, Netherlands; [Wolkers, Monika C.] Sanquin Res Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Bioceros B.V.; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam	de Jonge, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Gastrointestinal & Liver Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.j.dejonge@amc.nl	Boon, Laurence/HCI-3629-2022	Wolkers, Monika/0000-0003-3242-1363; Boon, Louis/0000-0002-0937-9171	Dutch Organization for Scientific Research (NWO-VIDI)	Dutch Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	SD, FWH and WdeJ were funded by a grant from the Dutch Organization for Scientific Research (NWO-VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrenergic modulation of dendritic cells function: relevance for the immune homeostasis, 2005, CURR NEUROVASC RES, V2, P169; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cailotto C, 2011, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Dhawan S, 2012, LIFE SCI, V91, P1038, DOI 10.1016/j.lfs.2012.04.042; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Fujii T, 2012, LIFE SCI, V91, P981, DOI 10.1016/j.lfs.2012.04.031; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim BJ, 2010, BRAIN BEHAV IMMUN, V24, P1126, DOI 10.1016/j.bbi.2010.05.003; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; LIVNAT S, 1985, J NEUROIMMUNOL, V10, P5, DOI 10.1016/0165-5728(85)90031-1; Maestroni GJM, 2006, ANN NY ACAD SCI, V1069, P195, DOI 10.1196/annals.1351.017; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Manni M, 2011, CYTOKINE, V55, P380, DOI 10.1016/j.cyto.2011.05.013; Nijhuis LEJ, 2010, BIOCHEM PHARMACOL, V80, P2002, DOI 10.1016/j.bcp.2010.06.034; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Salamone G, 2011, J NEUROIMMUNOL, V236, P47, DOI 10.1016/j.jneuroim.2011.05.007; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system, 2000, PHARM REV, V52, P595; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Yanagawa Y, 2010, J IMMUNOL, V185, P5762, DOI 10.4049/jimmunol.1001899	34	55	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85086	10.1371/journal.pone.0085086	http://dx.doi.org/10.1371/journal.pone.0085086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465481	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100022
J	Ortega-Gonzalez, M; de Medina, FS; Molina-Santiago, C; Lopez-Posadas, R; Pacheco, D; Krell, T; Martinez-Augustin, O; Abdelali, D				Ortega-Gonzalez, Mercedes; Sanchez de Medina, Fermin; Molina-Santiago, Carlos; Lopez-Posadas, Rocio; Pacheco, Daniel; Krell, Tino; Martinez-Augustin, Olga; Abdelali, Daddaoua			Fructooligosacharides Reduce Pseudomonas aeruginosa PAO1 Pathogenicity through Distinct Mechanisms	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BIOFILM FORMATION; EPITHELIAL-CELLS; SECRETION SYSTEM; II SECRETION; ANTIMICROBIAL ACTIVITY; PROTEIN SECRETION; GENE-EXPRESSION; LUNG INFECTION; IV PILI	Pseudomonas aeruginosa is ubiquitously present in the environment and acts as an opportunistic pathogen on humans, animals and plants. We report here the effects of the prebiotic polysaccharide inulin and its hydrolysed form FOS on this bacterium. FOS was found to inhibit bacterial growth of strain PAO1, while inulin did not affect growth rate or yield in a significant manner. Inulin stimulated biofilm formation, whereas a dramatic reduction of the biofilm formation was observed in the presence of FOS. Similar opposing effects were observed for bacterial motility, where FOS inhibited the swarming and twitching behaviour whereas inulin caused its stimulation. In co-cultures with eukaryotic cells ( macrophages) FOS and, to a lesser extent, inulin reduced the secretion of the inflammatory cytokines IL-6, IL-10 and TNF-alpha. Western blot experiments indicated that the effects mediated by FOS in macrophages are associated with a decreased activation of the NF-kappa B pathway. Since FOS and inulin stimulate pathway activation in the absence of bacteria, the FOS mediated effect is likely to be of indirect nature, such as via a reduction of bacterial virulence. Further, this modulatory effect is observed also with the highly virulent ptxS mutated strain. Co-culture experiments of P. aeruginosa with IEC18 eukaryotic cells showed that FOS reduces the concentration of the major virulence factor, exotoxin A, suggesting that this is a possible mechanism for the reduction of pathogenicity. The potential of these compounds as components of antibacterial and anti-inflammatory cocktails is discussed.	[Ortega-Gonzalez, Mercedes; Martinez-Augustin, Olga] Univ Granada, Sch Pharm, Ctr Networked Biomed Res Hepat & Digest Dis, Dept Biochem & Mol Biol 2, Granada, Spain; [Molina-Santiago, Carlos; Pacheco, Daniel; Krell, Tino; Abdelali, Daddaoua] CSIC, Environm Protect Dept, Granada, Spain; [Sanchez de Medina, Fermin; Lopez-Posadas, Rocio] Univ Granada, Sch Pharm, Ctr Networked Biomed Res Hepat & Digest Dis, Dept Pharmacol, Granada, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada	Abdelali, D (corresponding author), CSIC, Environm Protect Dept, C Prof Albareda 1, Granada, Spain.	abdelali.daddaoua@eez.csic.es	de Medina, Fermin Sanchez/B-3782-2013; Molina, Carlos/AAS-5053-2020; Krell, Tino/G-7296-2015; Sánchez, Daniel Pacheco/AAC-1354-2021; Lorente, M Dolores/N-1313-2014; Augustin, Olga Martínez/K-6720-2014; Daddaoua, Abdelali/D-6930-2014	de Medina, Fermin Sanchez/0000-0002-4516-5824; Molina, Carlos/0000-0002-1131-8917; Krell, Tino/0000-0002-9040-3166; Sánchez, Daniel Pacheco/0000-0002-2293-7721; Augustin, Olga Martínez/0000-0001-8291-3468; Daddaoua, Abdelali/0000-0002-7348-6393	FEDER funds; Fondo Social Europeo through grants from the Spanish Ministry of Economy and Competitiveness [SAF2011-22922, SAF2011-22812]; Andalusian regional government Junta de Andalucia [CVI-7335]; Centre of Networked Biomedical Research on Hepatic and Digestive Diseases (CIBERehd); Carlos III Health Institute; Ramon Areces Foundation, Spain	FEDER funds(European Commission); Fondo Social Europeo through grants from the Spanish Ministry of Economy and Competitiveness; Andalusian regional government Junta de Andalucia(Junta de Andalucia); Centre of Networked Biomedical Research on Hepatic and Digestive Diseases (CIBERehd); Carlos III Health Institute(Instituto de Salud Carlos III); Ramon Areces Foundation, Spain	The authors acknowledge financial support from FEDER funds and Fondo Social Europeo through grants from the Spanish Ministry of Economy and Competitiveness (grants SAF2011-22922, SAF2011-22812) the Andalusian regional government Junta de Andalucia (grant CVI-7335) and the Centre of Networked Biomedical Research on Hepatic and Digestive Diseases (CIBERehd) which is funded by the Carlos III Health Institute and the Ramon Areces Foundation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Amer LS, 2010, BIOCHEM BIOPH RES CO, V396, P246, DOI 10.1016/j.bbrc.2010.04.073; Babu US, 2012, VET IMMUNOL IMMUNOP, V149, P92, DOI 10.1016/j.vetimm.2012.05.003; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bosscher D, 2006, NUTR RES REV, V19, P216, DOI 10.1017/S0954422407249686; Bosscher D, 2003, NUTRITION, V19, P641, DOI 10.1016/S0899-9007(03)00063-7; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Buddington KK, 2002, J NUTR, V132, P472, DOI 10.1093/jn/132.3.472; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Ciofu O, 2012, FEMS IMMUNOL MED MIC, V65, P215, DOI 10.1111/j.1574-695X.2012.00983.x; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Colmer JA, 1998, MOL GEN GENET, V258, P250, DOI 10.1007/s004380050729; Daddaoua A, 2006, J NUTR, V136, P672, DOI 10.1093/jn/136.3.672; Daddaoua A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039390; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Durand E., 2009, Infectious Disorders - Drug Targets, V9, P518; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Garrido D, 2012, ADV NUTR, V3, p415S, DOI 10.3945/an.111.001586; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Giltner CL, 2006, MOL MICROBIOL, V59, P1083, DOI 10.1111/j.1365-2958.2005.05002.x; GREEN SK, 1974, APPL MICROBIOL, V28, P987, DOI 10.1128/AEM.28.6.987-991.1974; HALPRIN KM, 1966, J INVEST DERMATOL, V47, P222, DOI 10.1038/jid.1966.133; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hay ID, 2009, APPL ENVIRON MICROB, V75, P1110, DOI 10.1128/AEM.02416-08; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Hoiby Niels, 2005, Ugeskr Laeger, V167, P2429; Hosono A, 2003, BIOSCI BIOTECH BIOCH, V67, P758, DOI 10.1271/bbb.67.758; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Knol J, 2005, ACTA PAEDIATR, V94, P31, DOI 10.1080/08035320510043529; Kondepudi KK, 2012, ANAEROBE, V18, P489, DOI 10.1016/j.anaerobe.2012.08.005; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Martinez-Ferez A RS, 2005, INT DAIRY J, V16, P8; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Munoz M, 2012, ANAEROBE, V18, P321, DOI 10.1016/j.anaerobe.2012.01.007; Nenaah G, 2013, WORLD J MICROB BIOT, V29, P1255, DOI 10.1007/s11274-013-1288-2; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Olivas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044326; Paolillo R, 2011, INT J IMMUNOPATH PH, V24, P961, DOI 10.1177/039463201102400414; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; PERITI P, 1992, CLIN PHARMACOKINET, V23, P106, DOI 10.2165/00003088-199223020-00004; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schultz MJ, 2000, FEMS IMMUNOL MED MIC, V29, P227, DOI 10.1016/S0928-8244(00)00209-1; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; SMITH AJ, 1985, J IMMUNOL METHODS, V84, P125, DOI 10.1016/0022-1759(85)90421-1; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Velez E, 2013, BRIT J NUTR, V109, P1971, DOI 10.1017/S0007114512004230; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Yasuda A, 2012, BIOCHEM BIOPH RES CO, V422, P546, DOI 10.1016/j.bbrc.2012.05.007; Yu FSX, 2006, INVEST OPHTH VIS SCI, V47, P1255, DOI 10.1167/iovs.05-0956	74	14	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85772	10.1371/journal.pone.0085772	http://dx.doi.org/10.1371/journal.pone.0085772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465697	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100072
J	Ricotta, C; Celesti-Grapow, L; Kuhn, I; Rapson, G; Pysek, P; La Sorte, FA; Thompson, K				Ricotta, Carlo; Celesti-Grapow, Laura; Kuehn, Ingolf; Rapson, Gillian; Pysek, Petr; La Sorte, Frank A.; Thompson, Ken			Geographical Constraints Are Stronger than Invasion Patterns for European Urban Floras	PLOS ONE			English	Article							ALIEN PLANTS; PROPAGULE PRESSURE; BIOTIC HOMOGENIZATION; BIOLOGICAL INVASIONS; SPECIES RICHNESS; TEMPORAL TRENDS; RESIDENCE TIME; TRAITS; COMMUNITIES; INVASIVENESS	Understanding the mechanisms that affect invasion success of alien species is an important prerequisite for the effective management of present and future aliens. To gain insight into this matter we asked the following questions: Are the geographical patterns of species distributions in urban floras different for native compared with alien plant species? Does the introduction of alien species contribute to the homogenization of urban floras? We used a Mantel test on Jaccard dissimilarity matrices of 30 urban floras across the British Isles, Italy and central Europe to compare the spatial distribution of native species with four classes of alien species: archaeophytes, all neophytes, non-invasive neophytes, and invasive neophytes. Archaeophytes and neophytes are species that were introduced into Europe before and after 1500 AD, respectively. To analyze the homogenizing effect of alien species on the native urban floras, we tested for differences in the average dissimilarity of individual cities from their group centroid in ordination space. Our results show that the compositional patterns of native and alien species seem to respond to the same environmental drivers, such that all four classes of alien species were significantly related to native species across urban floras. In this framework, alien species may have an impact on biogeographic patterns of urban floras in ways that reflect their history of introduction and expansion: archaeophytes and invasive neophytes tended to homogenize, while non-invasive neophytes tended to differentiate urban floras.	[Ricotta, Carlo; Celesti-Grapow, Laura] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy; [Kuehn, Ingolf] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Kuehn, Ingolf] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Rapson, Gillian] Massey Univ, Ecol Grp, Inst Agr & Environm, Palmerston North, New Zealand; [Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [La Sorte, Frank A.] Cornell Lab Ornithol, Ithaca, NY USA; [Thompson, Ken] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Sapienza University Rome; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Massey University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Cornell University; University of Sheffield	Ricotta, C (corresponding author), Univ Roma La Sapienza, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	carlo.ricotta@uniroma1.it	Kühn, Ingolf/B-9756-2009; Pysek, Petr/B-1957-2012; CELESTI, Laura/ABA-2552-2021	Kühn, Ingolf/0000-0003-1691-8249; CELESTI, Laura/0000-0002-9533-6919; RICOTTA, Carlo/0000-0003-0818-3959	University of Rome 'La Sapienza'; Academy of Sciences of the Czech Republic [RVO 67985939]; Praemium Academiae award from the Academy of Sciences of the Czech Republic	University of Rome 'La Sapienza'; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Praemium Academiae award from the Academy of Sciences of the Czech Republic	Funding provided by the University of Rome 'La Sapienza'. PP was supported by long-term research development project no. RVO 67985939 (Academy of Sciences of the Czech Republic), institutional resources of Ministry of Education, Youth and Sports of the Czech Republic, and acknowledges the support by Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], 2004, PERMDISP FORTRAN COM; [Anonymous], 1998, STANDARDLISTE FARN B; [Anonymous], 1983, MANS IMPACT VEGETATI, DOI DOI 10.1007/978-94-009-7269-8_19; [Anonymous], 2008, EXKUSIONSFLORA OSTER; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Botham MS, 2009, DIVERS DISTRIB, V15, P338, DOI 10.1111/j.1472-4642.2008.00539.x; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; Celesti-Grapow L, 2009, PLANT BIOSYST, V143, P386, DOI 10.1080/11263500902722824; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gasso N., 2012, NeoBiota, P25; Gasso N, 2009, DIVERS DISTRIB, V15, P50, DOI 10.1111/j.1472-4642.2008.00501.x; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hill MO, 2003, PLANTATT ATTRIBUTES; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2011, TRENDS ECOL EVOL, V26, P318, DOI 10.1016/j.tree.2011.03.018; Kent M, 1999, J BIOGEOGR, V26, P1281, DOI 10.1046/j.1365-2699.1999.00350.x; Knapp S, 2012, ECOL LETT, V15, P696, DOI 10.1111/j.1461-0248.2012.01787.x; Krivanek M, 2006, CONSERV BIOL, V20, P1487, DOI 10.1111/j.1523-1739.2006.00477.x; Kubesova M, 2010, PRESLIA, V82, P81; Kuehn Ingolf, 2007, V193, P181; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; Kuhn I, 2004, EVOL ECOL RES, V6, P749; Kuhn I., 2003, FEDDES REPERT, V114, P559, DOI DOI 10.1002/FEDR.200311015; La Sorte FA, 2008, GLOBAL ECOL BIOGEOGR, V17, P363, DOI 10.1111/j.1466-8238.2007.00369.x; La Sorte FA, 2006, DIVERS DISTRIB, V12, P679, DOI 10.1111/j.1472-4642.2006.00276.x; La Sorte FA, 2009, ECOLOGY, V90, P2589, DOI 10.1890/08-1528.1; Lambdon PW, 2008, PRESLIA, V80, P101; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Maskell LC, 2006, J ECOL, V94, P1052, DOI 10.1111/j.1365-2745.2006.01172.x; McKinney ML, 2007, GLOBAL ECOL BIOGEOGR, V16, P394, DOI 10.1111/j.1466-8238.2007.00296.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2005, DIVERS DISTRIB, V11, P367, DOI 10.1111/j.1366-9516.2005.00181.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moravcova L, 2010, PRESLIA, V82, P365; Owen S. J, 1997, ECOLOGICAL WEEDS CON; Preston C, 2002, NEW ATLAS BRIT IRISH; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; Pysek P, 2005, ECOLOGY, V86, P772, DOI 10.1890/04-0012; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 1998, J BIOGEOGR, V25, P155, DOI 10.1046/j.1365-2699.1998.251177.x; Pysek Petr, 2007, V193, P97; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Pysek P, 2011, ECOL MONOGR, V81, P277, DOI 10.1890/10-0630.1; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Qian H, 2008, BASIC APPL ECOL, V9, P617, DOI 10.1016/j.baae.2007.11.004; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ricotta C, 2012, GLOBAL ECOL BIOGEOGR, V21, P751, DOI 10.1111/j.1466-8238.2011.00715.x; Ricotta C, 2009, J ECOL, V97, P1243, DOI 10.1111/j.1365-2745.2009.01548.x; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stace C., 1997, NEW FLORA BRIT ISLES; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Webb D., 1985, WATSONIA, V15, P231; Williamson M., 1996, BIOL INVASIONS; Williamson M, 2009, DIVERS DISTRIB, V15, P158, DOI 10.1111/j.1472-4642.2008.00528.x; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Winter M, 2010, GLOBAL ECOL BIOGEOGR, V19, P332, DOI 10.1111/j.1466-8238.2010.00520.x; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	82	18	19	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85661	10.1371/journal.pone.0085661	http://dx.doi.org/10.1371/journal.pone.0085661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465640	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100056
J	Cao, Z; Song, J; Wang, J; Guo, XF; Yu, SJ; Dong, WG				Cao, Zhuo; Song, Jia; Wang, Jun; Guo, Xufeng; Yu, Shijie; Dong, Weiguo			Association between Polymorphisms in XRCC1 Gene and Treatment Outcomes of Patients with Advanced Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							OXALIPLATIN-BASED CHEMOTHERAPY; DNA-REPAIR; LUNG-CANCER; SURVIVAL; PROGNOSIS; CISPLATIN; GSTP1; LYMPHOCYTES; PREDICTS; PATHWAY	Background: Many reports have shown inconsistent results on the relationship between single nucleotide polymorphisms (SNPs) of X-ray repair cross complementing protein (XRCC1) gene and platinum-based chemotherapeutic efficacy. This meta-analysis aimed to summarize published data about the association between two SNPs of XRCC1 (Arg194Trp and Arg399Gln) and treatment outcomes of patients with advanced gastric cancer. Methodology/Principal Findings: We retrieved the relevant articles from MEDLINE, Web of Knowledge, and the China National Knowledge Infrastructure (CNKI) databases. Studies were selected according to specific inclusion and exclusion criteria. Study quality was assessed according to the guidelines outlined by Hayden, et al. and PRISMA guidelines. We estimated the odds ratio (OR) for response rate versus no response after platinum-based chemotherapy. Progression-free survival (PFS) and overall survival (OS) were evaluated by pooled Cox proportional hazard ratios (HRs) and 95% confidence intervals (CIs). We found that none of the XRCC1 Arg194Trp and Arg399Gln polymorphisms was significantly associated with tumor response. Stratified analysis by ethnicity or sensitivity analysis also showed that XRCC1 SNPs were not related with chemotherapy response. Patients with minor variant A allele were likely to have poorer 2-year survival rate than those with G/G genotype. However, in the group of 5-year follow up, there was no significant association between the A allele and OS yet. Conclusions/Significance: There is no evidence to support the use of XRCC1 Arg194Trp and Arg399Gln polymorphisms as prognostic predictors of TR and PFS in gastric patients treated with platinum-based chemotherapy. The relationship between minor variant A allele and OS requires further verification.	[Cao, Zhuo; Song, Jia; Wang, Jun; Guo, Xufeng; Yu, Shijie; Dong, Weiguo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Dong, WG (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China.	whdwg@whu.edu.cn			Fundamental Research Funds for the Central Universities [2012302020209]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is financially Supported by "the Fundamental Research Funds for the Central Universities (No. 2012302020209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 2000, CANCER LETT, V159, P63, DOI 10.1016/S0304-3835(00)00532-2; Bernig T, 2006, EXPERT REV MOL DIAGN, V6, P319, DOI 10.1586/14737159.6.3.319; Bosken CH, 2002, JNCI-J NATL CANCER I, V94, P1091; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cao C, 2010, CHIN J CLIN RATIONAL, V3, P4; Cui ZG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-71; Goekkurt E, 2009, J CLIN ONCOL, V27, P2863, DOI 10.1200/JCO.2008.19.1718; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Huang ZH, 2009, CANCER CHEMOTH PHARM, V64, P1001, DOI 10.1007/s00280-009-0956-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji M, 2013, ONKOLOGIE, V36, P335, DOI 10.1159/000351260; Keam B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-148; [梁军 Liang Jun], 2010, [中华肿瘤杂志, Chinese Journal of Oncology], V32, P515; Liu BR, 2007, EUR J HUM GENET, V15, P1049, DOI 10.1038/sj.ejhg.5201884; Liu YF, 2013, STAT INTERFACE, V6, P1; Lv HY, 2012, PATHOL ONCOL RES, V18, P1009, DOI 10.1007/s12253-012-9536-6; Marsh S, 2004, BRIT J CANCER, V90, P8, DOI 10.1038/sj.bjc.6601487; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nagasubramanian R, 2003, ANNU REV MED, V54, P437, DOI 10.1146/annurev.med.54.101601.152352; Ott K, 2011, ANN SURG ONCOL, V18, P2688, DOI 10.1245/s10434-011-1601-y; Park SR, 2011, BRIT J CANCER, V104, P1126, DOI 10.1038/bjc.2011.24; Qiu D, 2009, J RADIOIMMANOL, V22, P630; Ruzzo A, 2006, J CLIN ONCOL, V24, P1883, DOI 10.1200/JCO.2005.04.8322; Savas S, 2004, CANCER EPIDEM BIOMAR, V13, P801; Shim HJ, 2010, CANCER SCI, V101, P1247, DOI 10.1111/j.1349-7006.2010.01514.x; Tahara T, 2011, ANTICANCER RES, V31, P705; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang LE, 2011, J CLIN ONCOL, V29, P4121, DOI 10.1200/JCO.2010.34.3616; Wei J, 2007, CHIN J PUBLIC HLTH, V23, P839; Won DY, 2010, J KOREAN SURG SOC, V78, P350, DOI 10.4174/jkss.2010.78.6.350; Wu JJ, 2012, CLIN CANCER RES, V18, P3972, DOI 10.1158/1078-0432.CCR-11-1531; Ye FH, 2013, CANCER CHEMOTH PHARM, V71, P733, DOI 10.1007/s00280-012-2067-8; Zhu GY, 2009, BIOCHEMISTRY-US, V48, P4916, DOI 10.1021/bi900389b; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011; Zou HZ, 2012, ASIAN PAC J CANCER P, V13, P6187, DOI 10.7314/APJCP.2012.13.12.6187	39	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85357	10.1371/journal.pone.0085357	http://dx.doi.org/10.1371/journal.pone.0085357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465544	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500059
J	Farnan, L; Ivanova, A; Peddada, SD				Farnan, Laura; Ivanova, Anastasia; Peddada, Shyamal D.			Linear Mixed Effects Models under Inequality Constraints with Applications	PLOS ONE			English	Article							ORDER-RESTRICTED INFERENCE; ZERO DOSE CONTROL; CELL-CYCLE; GENE-EXPRESSION; LONGITUDINAL DATA; FISSION YEAST; HEARING-LOSS; BRAIN; RATES; TIME	Constraints arise naturally in many scientific experiments/studies such as in, epidemiology, biology, toxicology, etc. and often researchers ignore such information when analyzing their data and use standard methods such as the analysis of variance (ANOVA). Such methods may not only result in a loss of power and efficiency in costs of experimentation but also may result poor interpretation of the data. In this paper we discuss constrained statistical inference in the context of linear mixed effects models that arise naturally in many applications, such as in repeated measurements designs, familial studies and others. We introduce a novel methodology that is broadly applicable for a variety of constraints on the parameters. Since in many applications sample sizes are small and/or the data are not necessarily normally distributed and furthermore error variances need not be homoscedastic (i.e. heterogeneity in the data) we use an empirical best linear unbiased predictor (EBLUP) type residual based bootstrap methodology for deriving critical values of the proposed test. Our simulation studies suggest that the proposed procedure maintains the desired nominal Type I error while competing well with other tests in terms of power. We illustrate the proposed methodology by re-analyzing a clinical trial data on blood mercury level. The methodology introduced in this paper can be easily extended to other settings such as nonlinear and generalized regression models.	[Farnan, Laura] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ivanova, Anastasia] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Peddada, Shyamal D.] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Peddada, SD (corresponding author), NIEHS, Biostat Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	peddada@niehs.nih.gov		Peddada, Shyamal/0000-0002-5014-6513	NIEHS, National Institutes of Health [Z01 ES102345-04]; National Institutes of Health [RO1 CA120082-01A1]; NATIONAL CANCER INSTITUTE [R01CA120082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102345, ZIAES101744] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research of SDP was supported by the Intramural Research Program of the NIEHS, National Institutes of Health (Z01 ES102345-04). LF and AI work was supported in part by National Institutes of Health grant RO1 CA120082-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Cao Y, 2011, J PEDIATR-US, V158, P480, DOI 10.1016/j.jpeds.2010.08.036; Davidov O, 2011, BIOSTATISTICS, V12, P327, DOI 10.1093/biostatistics/kxq051; Davis KA, 2012, CAN J STAT, V40, P243, DOI 10.1002/cjs.11126; DINSE GE, 1985, BIOMETRICS, V41, P751, DOI 10.2307/2531296; Fernandez MA, 2012, NUCLEIC ACIDS RES, V40, P2823, DOI 10.1093/nar/gkr1077; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HWANG JTG, 1994, ANN STAT, V22, P67, DOI 10.1214/aos/1176325358; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Khuri A. I., 1998, STAT TESTS MIXED LIN; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lelandais G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000409; MUKERJEE H, 1988, BIOMETRIKA, V75, P616, DOI 10.1093/biomet/75.3.616; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Peddada S, 2005, BIOINFORMATICS, V21, P3933, DOI 10.1093/bioinformatics/bti637; Peddada SD, 2003, BIOINFORMATICS, V19, P834, DOI 10.1093/bioinformatics/btg093; Peddada SD, 2001, BIOMETRICS, V57, P1219, DOI 10.1111/j.0006-341X.2001.01219.x; Peddada SD, 2007, J AM STAT ASSOC, V102, P1212, DOI 10.1198/016214506000001356; Rao C. R., 1988, ESTIMATION VARIANCE; RAO CR, 1972, J AM STAT ASSOC, V67, P112, DOI 10.2307/2284708; Rogan WJ, 1998, PAEDIATR PERINAT EP, V12, P313; Rosen S, 2012, STAT MED, V31, P1761, DOI 10.1002/sim.5335; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Searle S. R., 1992, VARIANCE COMPONENTS; Silvapulle MJ, 1997, STAT PROBABIL LETT, V36, P23, DOI 10.1016/S0167-7152(97)00044-8; Silvapulle MJ, 2005, CONSTRAINED STAT INF; SINGH B, 1990, STAT PROBABIL LETT, V9, P195, DOI 10.1016/0167-7152(92)90016-X; WILLIAMS DA, 1977, BIOMETRIKA, V64, P9, DOI 10.2307/2335763; WILLIAMS DA, 1971, BIOMETRICS, V27, P103, DOI 10.2307/2528930; WILLIAMS DA, 1972, BIOMETRICS, V28, P519, DOI 10.2307/2556164	30	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84778	10.1371/journal.pone.0084778	http://dx.doi.org/10.1371/journal.pone.0084778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465432	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500015
J	Kim, DH; Kim, HR; Choi, EJ; Kim, DY; Kim, KK; Kim, BS; Park, JW; Lee, BJ				Kim, Dong Hee; Kim, Han Rae; Choi, Eun Jung; Kim, Dong Yeol; Kim, Kwang Kon; Kim, Byung Sam; Park, Jeong Woo; Lee, Byung Ju			Neural Epidermal Growth Factor-Like Like Protein 2 (NELL2) Promotes Aggregation of Embryonic Carcinoma P19 Cells by Inducing N-Cadherin Expression	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN; EGF-LIKE REPEATS; NEURONAL DIFFERENTIATION; RETINOIC-ACID; RAT-BRAIN; RXR HETERODIMERS; STEM-CELLS; GENE; ADHESION; TRANSCRIPTION	NELL2 was first identified as a mammalian homolog of chick NEL (Neural EGF-like) protein. It is almost exclusively expressed in neurons of the rat brain and has been suggested to play a role in neural differentiation. However, there is still no clear evidence for the detailed function of NELL2 in the differentiation of neurons. In this study, we identified NELL2 function during neural differentiation of mouse embryonic carcinoma P19 cells. Endogenous expression of NELL2 in the P19 cells increased in parallel with the neuronal differentiation induced by retinoic acid (RA). We found that the mouse NELL2 promoter contains RA response elements (RAREs) and that treatment with RA increased NELL2 promoter activity. Transfection of P19 cells with NELL2 expression vectors induced a dramatic increase in cell aggregation, resulting in the facilitation of neural differentiation. Moreover, NELL2 significantly increased N-cadherin expression in the P19 cell. These data suggest that NELL2 plays an important role in the regulation of neuronal differentiation via control of N-cadherin expression and cell aggregation.	[Kim, Dong Hee; Kim, Han Rae; Choi, Eun Jung; Kim, Dong Yeol; Kim, Kwang Kon; Kim, Byung Sam; Park, Jeong Woo; Lee, Byung Ju] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea	University of Ulsan	Lee, BJ (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr		Kim, Han Rae/0000-0002-9108-2421	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2009-0073730]; Original Technology Research Program for Brain Science through the NRF; Ministry of Science, ICT & Future Planning [NRF-2011-0019235]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Original Technology Research Program for Brain Science through the NRF(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF: www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (NRF-2009-0073730), and was also supported by the Original Technology Research Program for Brain Science through the NRF funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0019235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Choi EJ, 2010, J BIOL CHEM, V285, P25074, DOI 10.1074/jbc.M110.100545; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Guo XX, 2001, ELECTROPHORESIS, V22, P3067, DOI 10.1002/1522-2683(200108)22:14<3067::AID-ELPS3067>3.0.CO;2-V; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Hung SP, 2005, J CELL BIOCHEM, V96, P1061, DOI 10.1002/jcb.20626; IMRIK P, 1991, ACTA PHYSIOL HUNG, V78, P345; Jeong JK, 2008, MOL CELLS, V26, P186; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; KUHN R, 1991, MOL CELL BIOL, V11, P4642, DOI 10.1128/MCB.11.9.4642; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Maden M, 2001, INT REV CYTOL, V209, P1; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Nelson BR, 2002, MECH DEVELOP, V119, pS11, DOI 10.1016/S0925-4773(03)00084-4; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Ryu BJ, 2011, MOL CELLS, V32, P203, DOI 10.1007/s10059-011-0086-7; SMITH SC, 1987, J CELL PHYSIOL, V131, P74, DOI 10.1002/jcp.1041310112; STAINES WA, 1994, NEUROSCIENCE, V58, P735, DOI 10.1016/0306-4522(94)90451-0; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; XIAO JH, 1995, J BIOL CHEM, V270, P3001, DOI 10.1074/jbc.270.7.3001; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85898	10.1371/journal.pone.0085898	http://dx.doi.org/10.1371/journal.pone.0085898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465772	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500137
J	Knudsen, L; Atochina-Vasserman, EN; Guo, CJ; Scott, PA; Haenni, B; Beers, MF; Ochs, M; Gow, AJ				Knudsen, Lars; Atochina-Vasserman, Elena N.; Guo, Chang-Jiang; Scott, Pamela A.; Haenni, Beat; Beers, Michael F.; Ochs, Matthias; Gow, Andrew J.			NOS2 Is Critical to the Development of Emphysema in Sftpd Deficient Mice but Does Not Affect Surfactant Homeostasis	PLOS ONE			English	Article							NITRIC-OXIDE METABOLISM; II CELL CHANGES; NF-KAPPA-B; PROTEIN-D; IN-VIVO; STEREOLOGICAL ESTIMATION; PULMONARY ABNORMALITIES; ALVEOLAR MACROPHAGES; S-NITROSYLATION; LUNG-FUNCTION	Rationale: Surfactant protein D (SP-D) has important immuno-modulatory properties. The absence of SP-D results in an inducible NO synthase (iNOS, coded by NOS2 gene) related chronic inflammation, development of emphysema-like pathophysiology and alterations of surfactant homeostasis. Objective: In order to test the hypothesis that SP-D deficiency related abnormalities in pulmonary structure and function are a consequence of iNOS induced inflammation, we generated SP-D and iNOS double knockout mice (DiNOS). Methods: Structural data obtained by design-based stereology to quantify the emphysema-like phenotype and disturbances of the intracellular surfactant were correlated to invasive pulmonary function tests and inflammatory markers including activation markers of alveolar macrophages and compared to SP-D (Sftpd(-/-)) and iNOS single knockout mice (NOS2(-/-)) as well as wild type (WT) littermates. Measurements and Results: DiNOS mice had reduced inflammatory cells in BAL and BAL-derived alveolar macrophages showed an increased expression of markers of an alternative activation as well as reduced inflammation. As evidenced by increased alveolar numbers and surface area, emphysematous changes were attenuated in DiNOS while disturbances of the surfactant system remained virtually unchanged. Sftpd(-/-) demonstrated alterations of intrinsic mechanical properties of lung parenchyma as shown by reduced stiffness and resistance at its static limits, which could be corrected by additional ablation of NOS2 gene in DiNOS. Conclusion: iNOS related inflammation in the absence of SP-D is involved in the emphysematous remodeling leading to a loss of alveoli and associated alterations of elastic properties of lung parenchyma while disturbances of surfactant homeostasis are mediated by different mechanisms.	[Knudsen, Lars; Haenni, Beat; Ochs, Matthias] Univ Bern, Inst Anat, Bern, Switzerland; [Knudsen, Lars; Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Knudsen, Lars; Ochs, Matthias] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Atochina-Vasserman, Elena N.; Beers, Michael F.] Univ Penn, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Guo, Chang-Jiang; Scott, Pamela A.; Gow, Andrew J.] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Ochs, Matthias] REBIRTH Cluster Excellence, Hannover, Germany	University of Bern; Hannover Medical School; University of Pennsylvania; Rutgers State University New Brunswick	Gow, AJ (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA.	Gow@rci.rutgers.edu	Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013; Knudsen, Lars/G-3146-2013; Atochina-Vasserman, Elena/AAN-2286-2020	Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Knudsen, Lars/0000-0002-7926-3879; Guo, Changjiang/0000-0002-7447-3762; Atochina-Vasserman, Elena N/0000-0001-7950-7004	Schweizerischer Nationalfonds [SNF 3100-116417]; NIH ES [P30-013508]; NIH [HL086621]; NIEHS [NIEHS P30E5S005022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, P30ES005022] Funding Source: NIH RePORTER	Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF)); NIH ES; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this work has been provided by Schweizerischer Nationalfonds (Grant Number SNF 3100-116417, to MO), NIH ES P30-013508 (to MFB), and NIH HL086621 (to AJG). Additional support has been provided by the NIEHS sponsored Center for Environmental Exposures and Disease (CEED-Grant Number NIEHS P30E5S005022) at EOHSI (to CJG and AJG). This work has not been reviewed by and does not represent the opinions of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atochina EN, 2004, J INFECT DIS, V189, P1528, DOI 10.1086/383130; Atochina EN, 2004, AM J RESP CELL MOL, V30, P271, DOI 10.1165/rcmb.2003-0091OC; Atochina-Vasserman EN, 2009, B EXP BIOL MED+, V147, P415, DOI 10.1007/s10517-009-0525-z; Atochina-Vasserman EN, 2007, J IMMUNOL, V179, P8090, DOI 10.4049/jimmunol.179.12.8090; Bates JHT, 2005, RESP PHYSIOL NEUROBI, V148, P153, DOI 10.1016/j.resp.2005.04.021; Betsuyaku T, 2004, EUR RESPIR J, V24, P964, DOI 10.1183/09031936.04.00064004; Botas C, 1998, P NATL ACAD SCI USA, V95, P11869, DOI 10.1073/pnas.95.20.11869; Collins RA, 2003, PEDIATR RES, V53, P463, DOI 10.1203/01.PDR.0000049464.46191.BF; Fehrenbach A, 1999, J ANAT, V194, P127, DOI 10.1046/j.1469-7580.1999.19410127.x; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Groves AM, 2012, AM J RESP CELL MOL, V47, P776, DOI 10.1165/rcmb.2011-0433OC; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Ichinose M, 2000, AM J RESP CRIT CARE, V162, P701, DOI 10.1164/ajrccm.162.2.9908132; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Jung A, 2005, ANAT REC PART A, V286A, P885, DOI 10.1002/ar.a.20225; Kingma PS, 2006, J BIOL CHEM, V281, P24496, DOI 10.1074/jbc.M600651200; Knudsen L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-70; Knudsen L, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-79; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Kobayashi A, 1998, CHEST, V113, P1632, DOI 10.1378/chest.113.6.1632; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Maestrelli P, 2003, EUR RESPIR J, V21, P971, DOI 10.1183/09031936.03.00098203; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Muhlfeld Christian, 2013, Methods Mol Biol, V931, P367, DOI 10.1007/978-1-62703-056-4_18; Ochs M, 2004, AM J PHYSIOL-LUNG C, V287, pL1333, DOI 10.1152/ajplung.00137.2004; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Weibel ER, 2009, SWISS MED WKLY, V139, P375, DOI smw-12270; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514; Zhang LQ, 2002, J BIOL CHEM, V277, P22453, DOI 10.1074/jbc.M201632200; Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200	43	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85722	10.1371/journal.pone.0085722	http://dx.doi.org/10.1371/journal.pone.0085722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465666	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500098
J	Manshadi, SD; Ishiguro, L; Sohn, KJ; Medline, A; Renlund, R; Croxford, R; Kim, YI				Manshadi, Shaidah Deghan; Ishiguro, Lisa; Sohn, Kyoung-Jin; Medline, Alan; Renlund, Richard; Croxford, Ruth; Kim, Young-In			Folic Acid Supplementation Promotes Mammary Tumor Progression in a Rat Model	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; BREAST-CANCER RISK; DIETARY-FOLATE; COLORECTAL-CANCER; COLON-CANCER; DIHYDROFOLATE-REDUCTASE; PLASMA FOLATE; B-VITAMINS; CELL-DEATH; WOMEN	Folic acid supplementation may prevent the development of cancer in normal tissues but may promote the progression of established (pre) neoplastic lesions. However, whether or not folic acid supplementation can promote the progression of established (pre) neoplastic mammary lesions is unknown. This is a critically important issue because breast cancer patients and survivors in North America are likely exposed to high levels of folic acid owing to folic acid fortification and widespread supplemental use after cancer diagnosis. We investigated whether folic acid supplementation can promote the progression of established mammary tumors. Female Sprague-Dawley rats were placed on a control diet and mammary tumors were initiated with 7,12-dimethylbenza[a]anthracene at puberty. When the sentinel tumor reached a predefined size, rats were randomized to receive a diet containing the control, 2.5x, 4x, or 5x supplemental levels of folic acid for up to 12 weeks. The sentinel mammary tumor growth was monitored weekly. At necropsy, the sentinel and all other mammary tumors were analyzed histologically. The effect of folic acid supplementation on the expression of proteins involved in proliferation, apoptosis, and mammary tumorigenesis was determined in representative sentinel adenocarcinomas. Although no clear dose-response relationship was observed, folic acid supplementation significantly promoted the progression of the sentinel mammary tumors and was associated with significantly higher sentinel mammary tumor weight and volume compared with the control diet. Furthermore, folic acid supplementation was associated with significantly higher weight and volume of all mammary tumors. The most significant and consistent mammary tumor-promoting effect was observed with the 2.5x supplemental level of folic acid. Folic acid supplementation was also associated with an increased expression of BAX, PARP, and HER2. Our data suggest that folic acid supplementation may promote the progression of established mammary tumors. The potential tumor-promoting effect of folic acid supplementation in breast cancer patients and survivors needs further clarification.	[Manshadi, Shaidah Deghan; Ishiguro, Lisa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Manshadi, Shaidah Deghan; Ishiguro, Lisa; Sohn, Kyoung-Jin; Kim, Young-In] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Sohn, Kyoung-Jin] Univ Toronto, Dept Med, Toronto, ON, Canada; [Medline, Alan; Renlund, Richard] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kim, Young-In] Univ Toronto, St Michaels Hosp, Dept Med, Div Gastroenterol, Toronto, ON M5B 1W8, Canada; [Kim, Young-In] Univ Toronto, St Michaels Hosp, Dept Nutr Sci, Div Gastroenterol, Toronto, ON, Canada; [Medline, Alan] Humber River Reg Hosp, Dept Pathol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Kim, YI (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Div Gastroenterol, Toronto, ON M5B 1W8, Canada.	youngin.kim@utoronto.ca			Canadian Institutes of Health Research [14126]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant # 14126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu B, 2001, NUTRITION, V17, P652, DOI 10.1016/S0899-9007(01)00594-9; Alamian A, 2006, NUTR CANCER, V54, P157, DOI 10.1207/s15327914nc5402_1; BAGGOTT JE, 1992, JNCI-J NATL CANCER I, V84, P1740, DOI 10.1093/jnci/84.22.1740; Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bright-Gbebry M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-30; Carrier J, 2003, CANCER EPIDEM BIOMAR, V12, P1262; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; CRAVO ML, 1992, CANCER RES, V52, P5002; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ericson U, 2010, J NUTR, V140, P1661, DOI 10.3945/jn.110.124313; Figueiredo JC, 2011, INT J CANCER, V129, P192, DOI 10.1002/ijc.25872; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Giovannucci E, 2010, J CLIN ONCOL, V28, P4081, DOI 10.1200/JCO.2009.27.3219; Holmes RS, 2010, CANCER EPIDEM BIOMAR, V19, P2023, DOI 10.1158/1055-9965.EPI-09-1097; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Institute of Medicine, 1998, FOL DIET REF INT THI, P196; Jaszewski R, 1999, AM J PHYSIOL-CELL PH, V277, pC1142, DOI 10.1152/ajpcell.1999.277.6.C1142; Khosraviani K, 2002, GUT, V51, P195, DOI 10.1136/gut.51.2.195; Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732; Kim YI, 2008, CANCER EPIDEM BIOMAR, V17, P2220, DOI 10.1158/1055-9965.EPI-07-2557; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Kotsopoulos J, 2005, CARCINOGENESIS, V26, P1603, DOI 10.1093/carcin/bgi117; Kotsopoulos J, 2003, CARCINOGENESIS, V24, P937, DOI 10.1093/carcin/bgg036; Kotsopoulos J, 2012, CANCER CAUSE CONTROL, V23, P1405, DOI 10.1007/s10552-012-0022-y; Kwan ML, 2011, BREAST CANCER RES TR, V130, P195, DOI 10.1007/s10549-011-1557-4; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Lewis SJ, 2006, JNCI-J NATL CANCER I, V98, P1607, DOI 10.1093/jnci/djj440; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Lindzon GM, 2009, CARCINOGENESIS, V30, P1536, DOI 10.1093/carcin/bgp152; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Ly A, 2012, ANTIOXID REDOX SIGN, V17, P302, DOI 10.1089/ars.2012.4554; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Miller JW, 2013, LANCET, V381, P974, DOI 10.1016/S0140-6736(13)60110-5; *NAT RES COUNC, 1995, NUTR REQ LAB AN, P11; Neuhouser ML, 2011, CANCER EPIDEM BIOMAR, V20, P1912, DOI 10.1158/1055-9965.EPI-10-1352; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; NORTON L, 1988, CANCER RES, V48, P7067; Pfeiffer CM, 2007, AM J CLIN NUTR, V86, P718, DOI 10.1093/ajcn/86.3.718; Russo IH, 1996, ENVIRON HEALTH PERSP, V104, P938, DOI 10.2307/3433143; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Shane B., 2010, FOLATE HLTH DIS, V2nd, P1; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Song J, 2000, CANCER RES, V60, P5434; Song J, 2000, CANCER RES, V60, P3191; Sowers R, 2003, MOL CANCER THER, V2, P535; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Terada K, 2009, CARCINOGENESIS, V30, P466, DOI 10.1093/carcin/bgp021; Thompson HJ, 2000, J MAMMARY GLAND BIOL, V5, P409, DOI 10.1023/A:1009582012493; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P2226, DOI 10.1158/1055-9965.EPI-07-2952; Velicer CM, 2008, J CLIN ONCOL, V26, P665, DOI 10.1200/JCO.2007.13.5905; Vollset SE, 2013, LANCET; Wien TN, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000653; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wright AJA, 2007, BRIT J NUTR, V98, P667, DOI 10.1017/S0007114507777140; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083	67	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84635	10.1371/journal.pone.0084635	http://dx.doi.org/10.1371/journal.pone.0084635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465421	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500009
J	Moretti, D; Thomas, L; Marques, T; Harwood, J; Dilley, A; Neales, B; Shaffer, J; McCarthy, E; New, L; Jarvis, S; Morrissey, R				Moretti, David; Thomas, Len; Marques, Tiago; Harwood, John; Dilley, Ashley; Neales, Bert; Shaffer, Jessica; McCarthy, Elena; New, Leslie; Jarvis, Susan; Morrissey, Ronald			A Risk Function for Behavioral Disruption of Blainville's Beaked Whales (Mesoplodon densirostris) from Mid-Frequency Active Sonar	PLOS ONE			English	Article								There is increasing concern about the potential effects of noise pollution on marine life in the world's oceans. For marine mammals, anthropogenic sounds may cause behavioral disruption, and this can be quantified using a risk function that relates sound exposure to a measured behavioral response. Beaked whales are a taxon of deep diving whales that may be particularly susceptible to naval sonar as the species has been associated with sonar-related mass stranding events. Here we derive the first empirical risk function for Blainville's beaked whales (Mesoplodon densirostris) by combining in situ data from passive acoustic monitoring of animal vocalizations and navy sonar operations with precise ship tracks and sound field modeling. The hydrophone array at the Atlantic Undersea Test and Evaluation Center, Bahamas, was used to locate vocalizing groups of Blainville's beaked whales and identify sonar transmissions before, during, and after Mid-Frequency Active (MFA) sonar operations. Sonar transmission times and source levels were combined with ship tracks using a sound propagation model to estimate the received level (RL) at each hydrophone. A generalized additive model was fitted to data to model the presence or absence of the start of foraging dives in 30-minute periods as a function of the corresponding sonar RL at the hydrophone closest to the center of each group. This model was then used to construct a risk function that can be used to estimate the probability of a behavioral change (cessation of foraging) the individual members of a Blainville's beaked whale population might experience as a function of sonar RL. The function predicts a 0.5 probability of disturbance at a RL of 150dBrms re mu Pa (CI: 144 to 155) This is 15dB lower than the level used historically by the US Navy in their risk assessments but 10 dB higher than the current 140 dB step-function.	[Moretti, David; Dilley, Ashley; Neales, Bert; Shaffer, Jessica; McCarthy, Elena; Jarvis, Susan; Morrissey, Ronald] Naval Undersea Warfare Ctr, Newport, RI 02841 USA; [Thomas, Len; Marques, Tiago; Harwood, John] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [New, Leslie] US Marine Mammal Commiss, Bethesda, MD USA	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; University of St Andrews	Moretti, D (corresponding author), Naval Undersea Warfare Ctr, Newport, RI 02841 USA.	david.moretti@navy.mil	New, Leslie/C-8796-2018; Marques, Tiago A/A-5530-2010; Marques, Tiago A./M-3253-2019	Marques, Tiago A/0000-0002-2581-1972; Marques, Tiago A./0000-0002-2581-1972; Thomas, Len/0000-0002-7436-067X	U.S. Navy's Office of Naval Research (ONR); Living Marine Resources Program (LMR) [N0002512WX06703, N0001412WX20964]	U.S. Navy's Office of Naval Research (ONR); Living Marine Resources Program (LMR)	Funding was provided by the U.S. Navy's Office of Naval Research (ONR, http://www.onr.navy.mil/) and the Living Marine Resources Program (LMR, http://www.lmr.navy.mil/), award number: N0002512WX06703 and N0001412WX20964 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird R. W., 2004, AB133F03SE0986 NAT M; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Balcomb Kenneth C. III, 2001, Bahamas Journal of Science, V8, P2; Bowling SR, 2009, J IND ENG MANAG-JIEM, V2, P114, DOI 10.3926/jiem.2009.v2n1.p114-127; Bureau of Ocean Energy Management (Dec. 2011) Department of Navy (DON) National Oceanic and Atmospheric Administration (NOAA), 2011, MAR MAMM SOUND WORKS; CONNELL D.W., 2009, INTRO ECOTOXICOLOGY; D'Amico A, 2009, ACQUATIC MAMMALS, V35, P435; England G., 2001, JOINT INTERIM REPORT; Fetherston T, 2011, CURRENTS MAGAZINE; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; Finneran J, 2004, EDO DYNAMIC SYSTEMS; Finneran J. J., 2012, CRITERIA THRESHOLDS; Fromm D, 2004, ACOUSTIC MODELING RE; Jarvis SM, MTS J IN PRESS; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Marine Mammal Commission, 2007, MAR MAMM NOIS SOUND; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moretti D, 2010, APPL ACOUST, V71, P1036, DOI 10.1016/j.apacoust.2010.04.011; NAVOCEANO, 1998, OC ATM MAST LIB SUMM; Nowacek DP, 2004, P ROY SOC B-BIOL SCI, V271, P227, DOI 10.1098/rspb.2003.2570; R Core Team, 2012, R LANG ENV STAT COMP; Richardson W.J., 1998, MARINE MAMMALS NOISE, V1st ed.; Shaffer JW, 2013, J ACOUST SOC AM, V133, P1770, DOI 10.1121/1.4776177; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; U. S. EPA, 1998, GUID EC RISK ASS; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Weinberg H, 1996, J ACOUST SOC AM, V100, P1421, DOI 10.1121/1.415989; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277	32	47	47	0	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85064	10.1371/journal.pone.0085064	http://dx.doi.org/10.1371/journal.pone.0085064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465477	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500033
J	van Oeffelen, L; Peeters, E; Minh, PNL; Charlier, D				van Oeffelen, Liesbeth; Peeters, Eveline; Phu Nguyen Le Minh; Charlier, Daniel			The 'Densitometric Image Analysis Software' and Its Application to Determine Stepwise Equilibrium Constants from Electrophoretic Mobility Shift Assays	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; NUCLEIC ACID INTERACTIONS; SS-LRPB; COOPERATIVITY; SPECIFICITY; SULFOLOBUS	Current software applications for densitometric analysis, such as ImageJ, QuantityOne (BioRad) and the Intelligent or Advanced Quantifier (Bio Image) do not allow to take the non-linearity of autoradiographic films into account during calibration. As a consequence, quantification of autoradiographs is often regarded as problematic, and phosphorimaging is the preferred alternative. However, the non-linear behaviour of autoradiographs can be described mathematically, so it can be accounted for. Therefore, the 'Densitometric Image Analysis Software' has been developed, which allows to quantify electrophoretic bands in autoradiographs, as well as in gels and phosphorimages, while providing optimized band selection support to the user. Moreover, the program can determine protein-DNA binding constants from Electrophoretic Mobility Shift Assays (EMSAs). For this purpose, the software calculates a chosen stepwise equilibrium constant for each migration lane within the EMSA, and estimates the errors due to non-uniformity of the background noise, smear caused by complex dissociation or denaturation of double-stranded DNA, and technical errors such as pipetting inaccuracies. Thereby, the program helps the user to optimize experimental parameters and to choose the best lanes for estimating an average equilibrium constant. This process can reduce the inaccuracy of equilibrium constants from the usual factor of 2 to about 20%, which is particularly useful when determining position weight matrices and cooperative binding constants to predict genomic binding sites. The MATLAB source code, platform-dependent software and installation instructions are available via the website http://micr.vub.ac.be.	[van Oeffelen, Liesbeth; Peeters, Eveline; Phu Nguyen Le Minh; Charlier, Daniel] Vrije Univ Brussel, Microbiol Res Grp, Brussels, Belgium; [van Oeffelen, Liesbeth] IMEC, Louvain, Belgium	Vrije Universiteit Brussel; IMEC	van Oeffelen, L (corresponding author), Vrije Univ Brussel, Microbiol Res Grp, Brussels, Belgium.	Liesbeth.van.Oeffelen@vub.ac.be			Research Foundation - Flanders (FWO)	Research Foundation - Flanders (FWO)(FWO)	L. van Oeffelen has a Ph. D. fellowship of the Research Foundation - Flanders (FWO). E. Peeters and P. Nguyen Le Minh are postdoctoral fellows of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerenza L, 1997, BBA-PROTEIN STRUCT M, V1339, P155, DOI 10.1016/S0167-4838(96)00228-2; CANN JR, 1989, J BIOL CHEM, V264, P17032; Fried MG, 1998, ELECTROPHORESIS, V19, P1247, DOI 10.1002/elps.1150190804; Garces J, 2008, J BIOL PHYS, V34, P213, DOI 10.1007/s10867-008-9116-x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; Peeters E, 2007, NUCLEIC ACIDS RES, V35, P623, DOI 10.1093/nar/gkl1095; Peeters E, 2013, GENE, V524, P330, DOI 10.1016/j.gene.2013.03.118; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Song NN, 2013, NUCLEIC ACIDS RES, V41, P2932, DOI 10.1093/nar/gkt021; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Tkhun WM, 2006, INSTRUM EXP TECH+, V49, P703, DOI 10.1134/S0020441206050174; van Oeffelen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn140	13	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85146	10.1371/journal.pone.0085146	http://dx.doi.org/10.1371/journal.pone.0085146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465496	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500039
J	Kimura, T; Ohashi, M; Crailsheim, K; Schmickl, T; Okada, R; Radspieler, G; Ikeno, H				Kimura, Toshifumi; Ohashi, Mizue; Crailsheim, Karl; Schmickl, Thomas; Okada, Ryuichi; Radspieler, Gerald; Ikeno, Hidetoshi			Development of a New Method to Track Multiple Honey Bees with Complex Behaviors on a Flat Laboratory Arena	PLOS ONE			English	Article							SYSTEM	A computer program that tracks animal behavior, thereby revealing various features and mechanisms of social animals, is a powerful tool in ethological research. Because honeybee colonies are populated by thousands of bees, individuals co-exist in high physical densities and are difficult to track unless specifically tagged, which can affect behavior. In addition, honeybees react to light and recordings must be made under special red-light conditions, which the eyes of bees perceive as darkness. The resulting video images are scarcely distinguishable. We have developed a new algorithm, K-Track, for tracking numerous bees in a flat laboratory arena. Our program implements three main processes: (A) The object (bee's) region is detected by simple threshold processing on gray scale images, (B) Individuals are identified by size, shape and spatiotemporal positional changes, and (C) Centers of mass of identified individuals are connected through all movie frames to yield individual behavioral trajectories. The tracking performance of our software was evaluated on movies of mobile multi-artificial agents and of 16 bees walking around a circular arena. K-Track accurately traced the trajectories of both artificial agents and bees. In the latter case, K-track outperformed Ctrax, well-known software for tracking multiple animals. To investigate interaction events in detail, we manually identified five interaction categories; 'crossing', 'touching', 'passing', 'overlapping' and 'waiting', and examined the extent to which the models accurately identified these categories from bee's interactions. All 7 identified failures occurred near a wall at the outer edge of the arena. Finally, K-Track and Ctrax successfully tracked 77 and 60 of 84 recorded interactive events, respectively. K-Track identified multiple bees on a flat surface and tracked their speed changes and encounters with other bees, with good performance.	[Kimura, Toshifumi; Ohashi, Mizue; Ikeno, Hidetoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan; [Crailsheim, Karl; Schmickl, Thomas; Radspieler, Gerald] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Okada, Ryuichi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan	University of Hyogo; University of Graz; Tokushima Bunri University	Kimura, T (corresponding author), Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan.	kimura@shse.u-hyogo.ac.jp	; Ikeno, Hidetoshi/O-3034-2018	Schmickl, Thomas/0000-0001-8598-7462; Ikeno, Hidetoshi/0000-0002-5134-5485	KAKENHI [23650157, 24657019]; FWF [P19478-B16, P23943-N13]; EU [601074]; Austrian Science Fund (FWF) [P 23943] Funding Source: researchfish	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FWF(Austrian Science Fund (FWF)); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Kimura was supported by the Grant-in-Aid for Scientific Research (KAKENHI) (No. 23650157). Ohashi, Ikeno, Okada and Kimura were partly supported by the Grant-in-Aid for Scientific Research (KAKENHI) (No. 24657019). Schmickl was supported by the FWF-funded (Austrian Science Foundation) research grant Temperature-induced aggregation of young honey bees, no. P19478-B16, the FWF-funded project REBODIMENT (no. P23943-N13) and EU grant "ASSISI_bf", no. 601074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani R, 2013, INTERFACE, DOI [10.1098/rsif.2012.05475, DOI 10.1098/RSIF.2012.05475]; BALCH T, 2001, P 5 INT C AUT AG, V2001, P521; Barry MJ, 2012, CHEMOSPHERE, V86, P938, DOI 10.1016/j.chemosphere.2011.11.011; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Benice TS, 2008, J NEUROSCI METH, V168, P422, DOI 10.1016/j.jneumeth.2007.11.002; Bodi M, 2012, MATH COMP MODEL DYN, V18, P87, DOI 10.1080/13873954.2011.601420; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Camazine S, 1998, APIDOLOGIE; DALTORIO KA, 2012, P 2012 IEEE INT C RO, P2261; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Farina WM, 1991, ANIMAL BEHAV; Feldman A., 2003, P 2 INT WORKSH MATH P 2 INT WORKSH MATH, P53; Franklin EL, 2012, ANIM BEHAV, V84, P361, DOI 10.1016/j.anbehav.2012.05.002; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Fry SN, 2002, J COMP PHYSIOL A, V187, P1009, DOI 10.1007/s00359-001-0272-8; Hamann H, 2012, NEURAL COMPUT APPL, V21, P207, DOI 10.1007/s00521-010-0368-6; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Johnson BR, 2003, P ROY SOC B-BIOL SCI, V270, P147, DOI 10.1098/rspb.2002.2207; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Khan Z, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P254; Kimura T, 2005, IEEE PACIF, P149; KIMURA T, 2012, 2012 5 INT C EM TREN, P36; Kimura T, 2011, APIDOLOGIE, V42, P607, DOI 10.1007/s13592-011-0060-6; Korst P, 1982, NATURE TROPHALLAXIS; Mekdara NT, 2012, J EXP ZOOL PART A, V317A, P382, DOI 10.1002/jez.1731; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Morioka R, 2011, 6 AS PAC C CHEM EC, V120; Moritz RFA, 1990, ANIMAL BEHAV; Okada R, 2012, J EXP BIOL, V215, P1633, DOI 10.1242/jeb.068650; Patt JM, 2009, ENTOMOL EXP APPL, V132, P13, DOI 10.1111/j.1570-7458.2009.00865.x; Perera A. A., 2006, 2006 IEEE COMPUTER S, V1, P666; Ramdya P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048381; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Schmickl T, 2008, AUTON ROBOT, V25, P171, DOI 10.1007/s10514-007-9073-4; Schmickl T, 2011, BIO-INSPIRED COMPUTING AND NETWORKING, P95; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; White KE, 2010, FRONT NEUROSCI, V4, P1; Willis MA, 2008, J EXP BIOL, V211, P2317, DOI 10.1242/jeb.016006	45	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84656	10.1371/journal.pone.0084656	http://dx.doi.org/10.1371/journal.pone.0084656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465422	Green Published, gold			2022-12-27	WOS:000330240500020
J	Long, SKR; Fulkerson, E; Breese, R; Hernandez, G; Davis, C; Melton, MA; Chandran, RR; Butler, N; Jiang, L; Estes, P				Long, Sarah K. R.; Fulkerson, Eric; Breese, Rebecca; Hernandez, Giovanna; Davis, Cara; Melton, Mark A.; Chandran, Rachana R.; Butler, Napoleon; Jiang, Lan; Estes, Patricia			A Comparison of Midline and Tracheal Gene Regulation during Drosophila Development	PLOS ONE			English	Article							BHLH-PAS PROTEIN; GROWTH CONE GUIDANCE; LOOP-HELIX PROTEINS; CNS MIDLINE; TRANSCRIPTIONAL ENHANCERS; BRANCHING MORPHOGENESIS; COMMISSURAL AXONS; DNA RECOGNITION; NERVOUS-SYSTEM; TUBE FORMATION	Within the Drosophila embryo, two related bHLH-PAS proteins, Single-minded and Trachealess, control development of the central nervous system midline and the trachea, respectively. These two proteins are bHLH-PAS transcription factors and independently form heterodimers with another bHLH-PAS protein, Tango. During early embryogenesis, expression of Single-minded is restricted to the midline and Trachealess to the trachea and salivary glands, whereas Tango is ubiquitously expressed. Both Single-minded/Tango and Trachealess/Tango heterodimers bind to the same DNA sequence, called the CNS midline element (CME) within cis-regulatory sequences of downstream target genes. While Single-minded/Tango and Trachealess/Tango activate some of the same genes in their respective tissues during embryogenesis, they also activate a number of different genes restricted to only certain tissues. The goal of this research is to understand how these two related heterodimers bind different enhancers to activate different genes, thereby regulating the development of functionally diverse tissues. Existing data indicates that Single-minded and Trachealess may bind to different co-factors restricted to various tissues, causing them to interact with the CME only within certain sequence contexts. This would lead to the activation of different target genes in different cell types. To understand how the context surrounding the CME is recognized by different bHLH-PAS heterodimers and their co-factors, we identified and analyzed novel enhancers that drive midline and/or tracheal expression and compared them to previously characterized enhancers. In addition, we tested expression of synthetic reporter genes containing the CME flanked by different sequences. Taken together, these experiments identify elements overrepresented within midline and tracheal enhancers and suggest that sequences immediately surrounding a CME help dictate whether a gene is expressed in the midline or trachea.	[Long, Sarah K. R.; Fulkerson, Eric; Breese, Rebecca; Hernandez, Giovanna; Davis, Cara; Butler, Napoleon; Estes, Patricia] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Melton, Mark A.] St Augustines Univ, Dept Biol & Phys Sci, Raleigh, NC USA; [Chandran, Rachana R.; Jiang, Lan] Oakland Univ, Dept Biol Sci, Rochester, MI USA	University of North Carolina; North Carolina State University; Oakland University	Estes, P (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	pat_estes@ncsu.edu		Jiang23, Lan/0000-0002-1845-5500	National Science Foundation [0416812, 0750620]	National Science Foundation(National Science Foundation (NSF))	This work was funded by grants 0416812 and 0750620 from the National Science Foundation Grants website: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Apitz H, 2005, DEV GENES EVOL, V215, P460, DOI 10.1007/s00427-005-0005-z; Apitz H, 2004, DEV GENES EVOL, V214, P453, DOI 10.1007/s00427-004-0423-3; Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bailey TL, 1994, FITTING MIXTURE MODE; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Battye R, 1999, DEVELOPMENT, V126, P2475; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; Certel K, 1996, MOL CELL BIOL, V16, P1813; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chung S, 2011, DEV BIOL, V360, P160, DOI 10.1016/j.ydbio.2011.09.014; Claessens F, 2004, ESSAYS BIOCHEM, V40, P59, DOI 10.1042/bse0400059; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cotnoir-White D, 2011, MOL CELL ENDOCRINOL, V334, P76, DOI 10.1016/j.mce.2010.10.021; Crews S, 1988, CELL, V15, P143; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; DECELIS JF, 1995, DEVELOPMENT, V121, P3405; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Draganescu A, 1998, J MOL BIOL, V276, P529, DOI 10.1006/jmbi.1997.1567; Englund C, 2002, DEVELOPMENT, V129, P4941; Estes P, 2008, GENETICS, V178, P787, DOI 10.1534/genetics.107.080440; Fulkerson E, 2011, J EXP ZOOL PART B, V316B, P61, DOI 10.1002/jez.b.21382; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hong JW, 2013, DEV BIOL, V380, P335, DOI 10.1016/j.ydbio.2013.05.015; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; Jiang L, 2003, MOL CELL BIOL, V23, P5625, DOI 10.1128/MCB.23.16.5625-5637.2003; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Jiang L, 2007, J BIOL CHEM, V282, P28659, DOI 10.1074/jbc.M703803200; Jiang L, 2006, MOL CELL BIOL, V26, P6547, DOI 10.1128/MCB.00284-06; Jiang L, 2010, MECH DEVELOP, V127, P265, DOI 10.1016/j.mod.2010.03.003; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kulkarni MM, 2005, MOL CELL BIOL, V25, P3411, DOI 10.1128/MCB.25.9.3411-3420.2005; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li JH, 2003, MECH DEVELOP, V120, P1455, DOI 10.1016/j.mod.2003.09.004; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Ma Y, 2000, J NEUROSCI, V20, P4596, DOI 10.1523/JNEUROSCI.20-12-04596.2000; Manning Gerards, 1993, P609; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Maruyama R, 2012, DEV DYNAM, V241, P119, DOI 10.1002/dvdy.22775; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McGovern VL, 2002, DEV BIOL, V247, P482; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; NAMBU JR, 1993, COMP BIOCHEM PHYS A, V104, P399, DOI 10.1016/0300-9629(93)90439-B; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pearson JC, 2012, DEV BIOL, V366, P420, DOI 10.1016/j.ydbio.2012.04.001; Pereanu W, 2007, DEV BIOL, V302, P169, DOI 10.1016/j.ydbio.2006.09.022; Renault AD, 2009, DEV BIOL, V328, P355, DOI 10.1016/j.ydbio.2009.01.042; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SEEGER MA, 1992, MOL BIOL CELL, V3, pA190; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; Sotillos S, 2010, DEV BIOL, V340, P571, DOI 10.1016/j.ydbio.2010.02.015; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Veitia RA, 2008, BIOESSAYS, V30, P1052, DOI 10.1002/bies.20849; Wang ZX, 2013, CELL RES, V23, P213, DOI 10.1038/cr.2012.170; Ward MP, 1998, DEVELOPMENT, V125, P1599; Watson JD, 2011, DEVELOPMENT, V138, P1285, DOI 10.1242/dev.056895; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; WHARTON KA, 1994, DEVELOPMENT, V120, P3563; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Wolf B, 1998, DEVELOPMENT, V125, P3853; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zelzer E, 2000, MECH DEVELOP, V91, P163, DOI 10.1016/S0925-4773(99)00295-6; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026197	106	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85518	10.1371/journal.pone.0085518	http://dx.doi.org/10.1371/journal.pone.0085518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465586	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500055
J	Zhang, YL; Song, FL; Gao, ZY; Ding, W; Qiao, LX; Yang, SF; Chen, X; Jin, RH; Chen, DX				Zhang, Yulin; Song, Fengli; Gao, Ziyun; Ding, Wei; Qiao, Luxin; Yang, Sufang; Chen, Xi; Jin, Ronghua; Chen, Dexi			Long-Term Exposure of Mice to Nucleoside Analogues Disrupts Mitochondrial DNA Maintenance in Cortical Neurons	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; LACTIC-ACIDOSIS; TOXICITY; DYSFUNCTION; BRAIN; HYPERLACTATEMIA; HIV/AIDS; CAPTURE; GENOME	Nucleoside analogue reverse transcriptase inhibitor (NRTI), an integral component of highly active antiretroviral therapy (HAART), was widely used to inhibit HIV replication. Long-term exposure to NRTIs can result in mitochondrial toxicity which manifests as lipoatrophy, lactic acidosis, cardiomyopathy and myopathy, as well as polyneuropathy. But the cerebral neurotoxicity of NRTIs is still not well known partly due to the restriction of blood-brain barrier (BBB) and the complex microenvironment of the central nervous system (CNS). In this study, the Balb/c mice were administered 50 mg/kg stavudine (D4T), 100 mg/kg zidovudine (AZT), 50 mg/kg lamivudine (3TC) or 50 mg/kg didanosine (DDI) per day by intraperitoneal injection, five days per week for one or four months, and primary cortical neurons were cultured and exposed to 25 mu M D4T, 50 mu M AZT, 25 mu M 3TC or 25 mu M DDI for seven days. Then, single neuron was captured from mouse cerebral cortical tissues by laser capture microdissection. Mitochondrial DNA (mtDNA) levels of the primary cultured cortical neurons, and captured neurons or glial cells, and the tissues of brains and livers and muscles were analyzed by relative quantitative real-time PCR. The data showed that mtDNA did not lose in both NRTIs exposed cultured neurons and one month NRTIs treated mouse brains. In four months NRTIs treated mice, brain mtDNA levels remained unchanged even if the mtDNA levels of liver (except for 3TC) and muscle significantly decreased. However, mtDNA deletion was significantly higher in the captured neurons from mtDNA unchanged brains. These results suggest that long-term exposure to NRTIs can result in mtDNA deletion in mouse cortical neurons.	[Zhang, Yulin; Song, Fengli; Ding, Wei; Qiao, Luxin; Yang, Sufang; Jin, Ronghua; Chen, Dexi] Capital Med Univ, Beijing You An Hosp, Dept Infect Dis, Beijing, Peoples R China; [Gao, Ziyun] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China; [Chen, Xi] Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China	Capital Medical University; Nanchang University; Nanjing Medical University	Chen, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China.	jsxycx@sina.com; jin_eagle@sina.com; dexi0963@yahoo.com			National Natural Science Foundation of China [81371399, 81272266, 30910103915]; Twelfth Key Science and Technology Five Year Plan of China [2012ZX10001-002, 2012ZX10001-003, 2012ZX10001-004]; Beijing Natural Science Foundation [7092045, 7101005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Key Science and Technology Five Year Plan of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by The National Natural Science Foundation of China (81371399, 81272266, 30910103915) and The Twelfth Key Science and Technology Five Year Plan of China (2012ZX10001-002, 2012ZX10001-003, 2012ZX10001-004). and Beijing Natural Science Foundation (7092045, 7101005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogly SB, 2011, AIDS RES HUM RETROV, V27, P777, DOI [10.1089/aid.2010.0204, 10.1089/AID.2010.0204]; Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X; Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x; Davison FD, 1996, J NEUROL, V243, P648, DOI 10.1007/BF00878661; Dragovic G, 2012, BIOMED PHARMACOTHER, V66, P308, DOI 10.1016/j.biopha.2011.09.016; Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;107::AID-DVG3&gt;3.0.CO;2-D; Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010; Ewings EL, 2000, J ACQ IMMUN DEF SYND, V24, P100; FELDMAN D, 1994, ACTA NEUROPATHOL, V87, P71; FLINT OP, 1994, TOXICOL IN VITRO, V8, P677, DOI 10.1016/0887-2333(94)90042-6; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Gallagher RI, 2012, METHODS MOL BIOL, V823, P157, DOI 10.1007/978-1-60327-216-2_11; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Kandanearatchi A, 2003, BRAIN PATHOL, V13, P104, DOI 10.1111/j.1750-3639.2003.tb00011.x; Koczor C, 2010, METHODS, V51, P399, DOI 10.1016/j.ymeth.2009.12.013; Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1; Kohler JJ, 2011, METHODS MOL BIOL, V755, P267, DOI 10.1007/978-1-61779-163-5_22; Lanoy E, 2011, NEUROLOGY, V76, P644, DOI 10.1212/WNL.0b013e31820c3089; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Moyle G, 2000, DRUG SAFETY, V23, P467, DOI 10.2165/00002018-200023060-00001; Nolan D, 2004, ANTIVIR THER, V9, P849; Obiako O R, 2011, West Afr J Med, V30, P354; Papp E, 2008, J ANTIMICROB CHEMOTH, V61, P1048, DOI 10.1093/jac/dkn067; Pavili L, 2010, FERTIL STERIL, V94, P2151, DOI 10.1016/j.fertnstert.2009.12.080; Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1; Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Tozzi V, 2001, J ACQ IMMUN DEF SYND, V28, P19, DOI 10.1097/00042560-200109010-00004; Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009; Wester CW, 2012, AIDS RES HUM RETROV, V28, P759, DOI [10.1089/aid.2011.0303, 10.1089/AID.2011.0303]; Zhang YL, 2012, BRAIN RES, V1458, P1, DOI 10.1016/j.brainres.2012.04.001	32	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85637	10.1371/journal.pone.0085637	http://dx.doi.org/10.1371/journal.pone.0085637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465628	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500063
J	Bilican, B; Livesey, MR; Haghi, G; Qiu, J; Burr, K; Siller, R; Hardingham, GE; Wyllie, DJA; Chandran, S				Bilican, Bilada; Livesey, Matthew R.; Haghi, Ghazal; Qiu, Jing; Burr, Karen; Siller, Rick; Hardingham, Giles E.; Wyllie, David J. A.; Chandran, Siddharthan			Physiological Normoxia and Absence of EGF Is Required for the Long-Term Propagation of Anterior Neural Precursors from Human Pluripotent Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; OXYGEN-TENSION; CEREBRAL-CORTEX; SELF-RENEWAL; SPECIFICATION; SURVIVAL; NEURONS; CALCIUM; GROWTH	Widespread use of human pluripotent stem cells (hPSCs) to study neuronal physiology and function is hindered by the ongoing need for specialist expertise in converting hPSCs to neural precursor cells (NPCs). Here, we describe a new methodology to generate cryo-preservable hPSC-derived NPCs that retain an anterior identity and are propagatable long-term prior to terminal differentiation, thus abrogating regular de novo neuralization. Key to achieving passagable NPCs without loss of identity is the combination of both absence of EGF and propagation in physiological levels (3%) of O-2. NPCs generated in this way display a stable long-term anterior forebrain identity and importantly retain developmental competence to patterning signals. Moreover, compared to NPCs maintained at ambient O-2(21%), they exhibit enhanced uniformity and speed of functional maturation, yielding both deep and upper layer cortical excitatory neurons. These neurons display multiple attributes including the capability to form functional synapses and undergo activity-dependent gene regulation. The platform described achieves long-term maintenance of anterior neural precursors that can give rise to forebrain neurones in abundance, enabling standardised functional studies of neural stem cell maintenance, lineage choice and neuronal functional maturation for neurodevelopmental research and disease-modelling.	[Bilican, Bilada; Livesey, Matthew R.; Haghi, Ghazal; Burr, Karen; Chandran, Siddharthan] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Bilican, Bilada; Burr, Karen; Siller, Rick; Chandran, Siddharthan] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Bilican, Bilada; Livesey, Matthew R.; Haghi, Ghazal; Burr, Karen; Siller, Rick; Chandran, Siddharthan] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Livesey, Matthew R.; Haghi, Ghazal; Qiu, Jing; Hardingham, Giles E.; Wyllie, David J. A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Wyllie, DJA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	dwyllie1@staffmail.ed.ac.uk; siddharthan.chandran@ed.ac.uk	Wyllie, David J A/AAK-4678-2021; Qiu, Jing/GQH-8027-2022	Wyllie, David J A/0000-0002-4957-6049; Hardingham, Giles/0000-0002-7629-5314; Siller, Richard/0000-0001-6691-9261; Livesey, Matthew/0000-0002-3441-7977	Wellcome Trust [092742/Z/10/Z]; MRC; Euan MacDonald Centre; MRC [G0902044] Funding Source: UKRI; Medical Research Council [G0902044] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Euan MacDonald Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by a grant from The Wellcome Trust (www.wellcome.ac.uk) funding the salary of M. R. L. and G. H. (D.J.A.W., G.E.H., S.C.; No: 092742/Z/10/Z), an MRC (www.mrc.ac.uk) Senior Non-Clinical Research Fellowship (G. E. H.) and funds from the Euan MacDonald Centre (www.euanmacdonaldcentre.com) (S.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bahrey HLP, 2003, J NEUROPHYSIOL, V89, P1761, DOI 10.1152/jn.00972.2002; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; DRAGO J, 1991, J NEUROSCI METH, V37, P251, DOI 10.1016/0165-0270(91)90031-T; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Fu LJ, 2003, J COMP NEUROL, V462, P265, DOI 10.1002/cne.10727; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; KAPLAN FS, 1986, BRAIN RES, V384, P199, DOI 10.1016/0006-8993(86)91240-0; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; MINTA A, 1989, J BIOL CHEM, V264, P8171; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380; Stacpoole SRL, 2011, CELL DEATH DIFFER, V18, P1016, DOI 10.1038/cdd.2010.171; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tiede LM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.128; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	63	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85932	10.1371/journal.pone.0085932	http://dx.doi.org/10.1371/journal.pone.0085932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465796	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000077
J	Indolfi, G; Mangone, G; Bartolini, E; Nebbia, G; Calvo, PL; Moriondo, M; Tovo, PA; de Martino, M; Azzari, C; Resti, M				Indolfi, Giuseppe; Mangone, Giusi; Bartolini, Elisa; Nebbia, Gabriella; Calvo, Pier Luigi; Moriondo, Maria; Tovo, Pier-Angelo; de Martino, Maurizio; Azzari, Chiara; Resti, Massimo			Comparative Analysis of rs12979860 SNP of the IFNL3 Gene in Children with Hepatitis C and Ethnic Matched Controls Using 1000 Genomes Project Data	PLOS ONE			English	Article							SPONTANEOUS CLEARANCE; VIRUS-INFECTION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; NATURAL-HISTORY; VIRAL CLEARANCE; INTERLEUKIN-28B; RIBAVIRIN; RESPONSES; IMMUNITY	The rs12979860 single nucleotide polymorphism located on chromosome 19q13.13 near the interferon L3 gene (formerly and commonly known as interleukin 28B gene) has been associated in adults with both spontaneous and treatment induced clearance of hepatitis C virus. Although the exact mechanism of these associations remains unclear, it suggests that variation in genes involved in the immune response against the virus favours viral clearance. Limited and preliminary data are available on this issue in children. The aim of the present study was to evaluate, in a representative cohort of children with perinatal infection, the potential association between rs12979860 single nucleotide polymorphism and the outcome of hepatitis C virus infection. Alleles and genotypes frequencies were evaluated in 30 children who spontaneously cleared the virus and in 147 children with persistent infection and were compared with a population sample of ethnically matched controls with unknown hepatitis C status obtained using the 1000 Genomes Project data. The C allele and the C/C genotype showed greater frequencies in the clearance group (76.7% and 56.7%, respectively) when compared with both children with viral persistence (C allele 56.5%, p = 0.004; C/C genotype 32.7%, p = 0.02) and with the ethnically matched individuals (C allele 59.7%, p = 0.02; C/C genotype 34.7%, p = 0.03). Children with the C/C genotype were 2 times more likely to clear hepatitis C virus relative to children with the C/T and T/T genotypes combined (odds ratio: 2.7; 90% confidence intervals: 1.3-5.8). The present study provides the evidence that the rs12979860 single nucleotide polymorphism influences the natural history of hepatitis C virus in children.	[Indolfi, Giuseppe; Bartolini, Elisa; Resti, Massimo] Meyer Childrens Univ Hosp Florence, Paediat & Liver Unit, Florence, Italy; [Mangone, Giusi; Moriondo, Maria; Azzari, Chiara] Meyer Childrens Univ Hosp Florence, Immunol Unit & Lab, Florence, Italy; [Nebbia, Gabriella] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Pediat 2, Milan, Italy; [Calvo, Pier Luigi; Tovo, Pier-Angelo] Univ Turin, Dept Pediat, Infect Dis Unit, Italy Regina Margherita Childrens Hosp, I-10124 Turin, Italy; [de Martino, Maurizio; Azzari, Chiara] Univ Florence, Dept Hlth Sci, Florence, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Turin; University of Florence	Indolfi, G (corresponding author), Meyer Childrens Univ Hosp Florence, Paediat & Liver Unit, Florence, Italy.	g.indolfi@meyer.it	Mangone, Giusi/K-5330-2016; Resti, Massimo/AAB-8756-2019; Moriondo, Maria/AAB-7883-2019; Indolfi, Giuseppe/AAK-5548-2020; Azzari, Chiara/AAB-8584-2019	Mangone, Giusi/0000-0002-9322-1069; Resti, Massimo/0000-0001-6350-1361; Moriondo, Maria/0000-0001-9653-8371; Indolfi, Giuseppe/0000-0003-3830-9823; Azzari, Chiara/0000-0001-7236-1655; Tovo, Pier Angelo/0000-0002-0192-3240; Nebbia, Gabriella/0000-0003-1810-7722; Calvo, Pier Luigi/0000-0001-9264-3465				Afdhal NH, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-832922; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bortolotti F, 2008, GASTROENTEROLOGY, V134, P1900, DOI 10.1053/j.gastro.2008.02.082; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Indolfi G, 2006, J MED VIROL, V78, P911, DOI 10.1002/jmv.20640; Indolfi G, 2013, J PEDIATR-US, V163, P1549, DOI 10.1016/j.jpeds.2013.06.077; Indolfi G, 2011, HEPATOLOGY, V54, P1490, DOI 10.1002/hep.24482; Indolfi G, 2009, J MED VIROL, V81, P836, DOI 10.1002/jmv.21437; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pembrey L, 2005, CLIN INFECT DIS, V41, P45, DOI 10.1086/430601; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Resti M, 2003, J MED VIROL, V70, P373, DOI 10.1002/jmv.10405; Ruiz-Extremera A, 2011, HEPATOLOGY, V53, P1830, DOI 10.1002/hep.24298; Stathias V, 2012, ANN HUM GENET, V76, P472, DOI 10.1111/j.1469-1809.2012.00730.x; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban T, 2012, HEPATOLOGY, V56, P361, DOI 10.1002/hep.25794; Yan KK, 2008, WORLD J GASTROENTERO, V14, P3416, DOI 10.3748/wjg.14.3416	22	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85899	10.1371/journal.pone.0085899	http://dx.doi.org/10.1371/journal.pone.0085899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465773	Green Submitted, gold, Green Published			2022-12-27	WOS:000330237000072
J	Zhang, H; Long, ZY; Ge, RY; Xu, LL; Jin, Z; Yao, L; Liu, YJ				Zhang, Hang; Long, Zhiying; Ge, Ruiyang; Xu, Lele; Jin, Zhen; Yao, Li; Liu, Yijun			Motor Imagery Learning Modulates Functional Connectivity of Multiple Brain Systems in Resting State	PLOS ONE			English	Article							NETWORKS; MRI; PLASTICITY; PRECUNEUS	Background: Learning motor skills involves subsequent modulation of resting-state functional connectivity in the sensory-motor system. This idea was mostly derived from the investigations on motor execution learning which mainly recruits the processing of sensory-motor information. Behavioral evidences demonstrated that motor skills in our daily lives could be learned through imagery procedures. However, it remains unclear whether the modulation of resting-state functional connectivity also exists in the sensory-motor system after motor imagery learning. Methodology/Principal Findings: We performed a fMRI investigation on motor imagery learning from resting state. Based on previous studies, we identified eight sensory and cognitive resting-state networks (RSNs) corresponding to the brain systems and further explored the functional connectivity of these RSNs through the assessments, connectivity and network strengths before and after the two-week consecutive learning. Two intriguing results were revealed: (1) The sensory RSNs, specifically sensory-motor and lateral visual networks exhibited greater connectivity strengths in precuneus and fusiform gyrus after learning; (2) Decreased network strength induced by learning was proved in the default mode network, a cognitive RSN. Conclusions/Significance: These results indicated that resting-state functional connectivity could be modulated by motor imagery learning in multiple brain systems, and such modulation displayed in the sensory-motor, visual and default brain systems may be associated with the establishment of motor schema and the regulation of introspective thought. These findings further revealed the neural substrates underlying motor skill learning and potentially provided new insights into the therapeutic benefits of motor imagery learning.	[Zhang, Hang; Ge, Ruiyang; Xu, Lele; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Zhang, Hang; Liu, Yijun] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Hang] Chinese Acad Sci, C Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Long, Zhiying; Yao, Li] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Jin, Zhen] PLA, Hosp 306, Lab Magnet Resonance Imaging, Beijing, Peoples R China	Beijing Normal University; Peking University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Beijing Normal University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yao, L (corresponding author), Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China.	yaoli@bnu.edu.cn; yjliufl@gmail.com	Xu, Le/HDN-9623-2022		National Key Basic Research Program of China (973 Program) [2012CB720704]; Key Program of National Natural Science Foundation of China [60931003, 61131003]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Key Basic Research Program of China (973 Program) (2012CB720704); The Key Program of National Natural Science Foundation of China (60931003 and 61131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Pasquale F, 2013, NEUROIMAGE, V69, P51, DOI 10.1016/j.neuroimage.2012.11.051; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; KARNI A, 1995, NATURE, V377, P155; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Miall RC, 2006, CURR BIOL, V16, pR998, DOI 10.1016/j.cub.2006.10.041; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006; Olsson CJ, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.005.2008; Ostby Y, 2012, P NATL ACAD SCI USA, V109, P16800, DOI 10.1073/pnas.1210627109; Pearson K, 2000, CURR OPIN NEUROBIOL, V10, P649, DOI 10.1016/S0959-4388(00)00130-6; Rabin E, 2004, EXP BRAIN RES, V155, P362, DOI 10.1007/s00221-003-1736-6; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sommerville JA, 2006, PSYCHON B REV, V13, P179, DOI 10.3758/BF03193831; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Taylor VA, 2013, SOC COGN AFFECT NEUR, V8, P4, DOI 10.1093/scan/nsr087; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036052; Zhang H, 2011, BRAIN RES, V1407, P38, DOI 10.1016/j.brainres.2011.06.038	48	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85489	10.1371/journal.pone.0085489	http://dx.doi.org/10.1371/journal.pone.0085489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465577	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000039
J	Kher, SS; Struckhoff, AP; Alberts, AS; Worthylake, RA				Kher, Swapnil S.; Struckhoff, Amanda P.; Alberts, Arthur S.; Worthylake, Rebecca A.			A Novel Role for p115RhoGEF in Regulation of Epithelial Plasticity	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; CELL-CELL ADHESION; RHO FAMILY GTPASES; E-CADHERIN; MESENCHYMAL TRANSITION; ADHERENS JUNCTIONS; MORPHOGENESIS; MIGRATION; PROTEIN; ROCK	Epithelial plasticity plays a critical role during physiological processes, such as wound healing and tissue regeneration, and dysregulation of epithelial plasticity can lead to pathological conditions, such as cancer. Cell-cell junctions are a critical feature of epithelial cells and loss of junctions is associated with acquisition of mesenchymal features, such as enhanced protrusion and migration. Although Rho has been implicated in regulation of junctions in epithelial cells, the role of Rho signaling in the regulation of epithelial plasticity has not been understood. We show that members of the RGS RhoGEFs family play a critical role in regulation of epithelial cell-cell junctions in breast epithelial cells. We identify a novel role for p115RhoGEF in regulation of epithelial plasticity. Loss of p115RhoGEF leads to decreased junctional E-cadherin and enhanced protrusiveness and migration. Conversely, overexpression of p115RhoGEF enhanced junctional E-cadherin and inhibited cell protrusion and migration. siRNA screen of 23 Rho effectors showed that members of the Diaphanous-Related Formin (DRF) family are required for p115RhoGEF-mediated changes in epithelial plasticity. Thus, our data indicates a novel role for p115RhoGEF in regulation of epithelial plasticity, which is dependent on Rho-DRF signaling module.	[Kher, Swapnil S.] LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA; [Struckhoff, Amanda P.] LSU Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Alberts, Arthur S.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI USA; [Worthylake, Rebecca A.] LSU Hlth Sci Ctr, Dept Oral Biol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Van Andel Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Worthylake, RA (corresponding author), LSU Hlth Sci Ctr, Dept Oral Biol, New Orleans, LA USA.	blakeworthy@gmail.com			Louisiana Cancer Research Consortium; NIH from the National Center for Research Resources [P20RR020160, P20RR021970]; NIH from the National Institute of Dental and Craniofacial Research [R03DE19166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020160, P20RR021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium; NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from the National Institute of Dental and Craniofacial Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank all of the members of the LSU Cell Migration Group for ongoing input and critique of this research. The authors also acknowledge funding from the Louisiana Cancer Research Consortium, and the following NIH grants: Grant Numbers P20RR020160 and P20RR021970 from the National Center for Research Resources, Grant Number R03DE19166 from the National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kher SS, 2012, NAT CELL BIOL, V14, P784, DOI 10.1038/ncb2553; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mulinari S, 2008, MOL BIOL CELL, V19, P1883, DOI 10.1091/mbc.E07-12-1230; Mulinari Shai, 2010, Small GTPases, V1, P28; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Rana MK, 2012, J BIOL CHEM, V287, P21836, DOI 10.1074/jbc.M112.346114; Ratheesh A, 2012, NAT CELL BIOL; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Struckhoff AP, 2013, J CELL SCI, V126, P4514, DOI 10.1242/jcs.132381; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Terry SJ, 2011, NAT CELL BIOL; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586	41	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85409	10.1371/journal.pone.0085409	http://dx.doi.org/10.1371/journal.pone.0085409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465552	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000013
J	Quach, TN; Tran, LSP; Valliyodan, B; Nguyen, HTM; Kumar, R; Neelakandan, AK; Guttikonda, SK; Sharp, RE; Nguyen, HT				Quach, Truyen N.; Lam-Son Phan Tran; Valliyodan, Babu; Nguyen, Hanh T. M.; Kumar, Rajesh; Neelakandan, Anjanasree K.; Guttikonda, Satish Kumar; Sharp, Robert E.; Nguyen, Henry T.			Functional Analysis of Water Stress-Responsive Soybean GmNAC003 and GmNAC004 Transcription Factors in Lateral Root Development in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID; DROUGHT RESISTANCE; SYSTEM ARCHITECTURE; EXPRESSION ANALYSIS; GENE NETWORKS; GLYCINE-MAX; GROWTH; AUXIN; THALIANA; ETHYLENE	In Arabidopsis, NAC (NAM, ATAF and CUC) transcription factors have been found to promote lateral root number through the auxin signaling pathway. In the present study, the role of water stress-inducible soybean GmNAC003 and GmNAC004 genes in the enhancement of lateral root development under water deficit conditions was investigated. Both genes were highly expressed in roots, leaves and flowers of soybean and were strongly induced by water stress and moderately induced by a treatment with abscisic acid (ABA). They showed a slight response to treatment with 2,4-dichlorophenoxyacetic acid (2,4-D). The transgenic Arabidopsis plants overexpressing GmNAC004 showed an increase in lateral root number and length under non-stress conditions and maintained higher lateral root number and length under mild water stress conditions compared to the wild-type (WT), while the transgenic plants overexpressing GmNAC003 did not show any response. However, LR development of GmNAC004 transgenic Arabidopsis plants was not enhanced in the water-stressed compared to the well-watered treatment. In the treatment with ABA, LR density of the GmNAC004 transgenic Arabidopsis was less suppressed than that of the WT, suggesting that GmNAC004 counteracts ABA-induced inhibition of lateral root development. In the treatment with 2,4-D, lateral root density was enhanced in both GmNAC004 transgenic Arabidopsis and WT plants but the promotion was higher in the transgenic plants. Conversely, in the treatment with naphthylphthalamic acid (NPA), lateral root density was inhibited and there was no difference in the phenotype of the GmNAC004 transgenic Arabidopsis and WT plants, indicating that auxin is required for the action of GmNAC004. Transcript analysis for a number of known auxin and ABA related genes showed that GmNAC004's role may suppress ABA signaling but promote auxin signaling to increase lateral root development in the Arabidopsis heterologous system.	[Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Natl Ctr Soybean Biotechnol, Columbia, MO 65211 USA; Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Nguyen, HT (corresponding author), Univ Missouri, Div Plant Sci, Natl Ctr Soybean Biotechnol, Columbia, MO 65211 USA.	nguyenhenry@missouri.edu	Tran, Lam-Son P/A-1346-2009	Tran, Lam-Son P/0000-0001-9883-9768; Valliyodan, Babu/0000-0001-9457-9508	Missouri Soybean Merchandising Council	Missouri Soybean Merchandising Council	This work was funded by a grant from the Missouri Soybean Merchandising Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMARAS R R, 1975, Soil Science Society of America Proceedings, V39, P771; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bolle Cordelia, 2009, V479, P35, DOI 10.1007/978-1-59745-289-2_3; BOYER JS, 1965, P NATL ACAD SCI USA, V54, P1044, DOI 10.1073/pnas.54.4.1044; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Brocard-Gifford I, 2004, PLANT CELL, V16, P406, DOI 10.1105/tpc.018077; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Deak KI, 2005, PLANT J, V43, P17, DOI 10.1111/j.1365-313X.2005.02425.x; DREW MC, 1979, PLANTA, V147, P83, DOI 10.1007/BF00384595; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Guo DL, 2009, PLANT GROWTH REGUL, V58, P173, DOI 10.1007/s10725-009-9365-0; Gutierrez-Gonzalez JJ, 2010, PLANT CELL PHYSIOL, V51, P936, DOI 10.1093/pcp/pcq065; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; He Y, 2008, THESIS U MISSOURI; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; HOOGENBOOM G, 1987, AGRON J, V79, P607, DOI 10.2134/agronj1987.00021962007900040004x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; HUCK MG, 1983, PLANT PHYSIOL, V73, P422, DOI 10.1104/pp.73.2.422; Ivanchenko MG, 2008, PLANT J, V55, P335, DOI 10.1111/j.1365-313X.2008.03528.x; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P550, DOI 10.4161/psb.11088; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P255, DOI 10.4161/psb.5.3.10550; Liao H, 2001, PLANT SOIL, V232, P69, DOI 10.1023/A:1010381919003; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Mochida K, 2010, BIOINFORMATICS, V26, P290, DOI 10.1093/bioinformatics/btp645; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Nakashima K, 2011, BIOCH BIOPHYS ACTA; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Narang RA, 2000, PLANT PHYSIOL, V124, P1786, DOI 10.1104/pp.124.4.1786; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S., 2012, TRENDS PLANT SCI; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; READ DJ, 1972, J APPL ECOL, V9, P487, DOI 10.2307/2402447; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sharp RE, 2002, PLANT CELL ENVIRON, V25, P211, DOI 10.1046/j.1365-3040.2002.00798.x; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shkolnik-Inbar D, 2010, PLANT CELL, V22, P3560, DOI 10.1105/tpc.110.074641; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Turner NC, 2001, ADV AGRON, V71, P193, DOI 10.1016/S0065-2113(01)71015-2; van der Weele CM, 2000, J EXP BOT, V51, P1555, DOI 10.1093/jexbot/51.350.1555; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141	72	32	42	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84886	10.1371/journal.pone.0084886	http://dx.doi.org/10.1371/journal.pone.0084886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465446	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000008
J	Hall, DP; MacCormick, IJC; Phythian-Adams, AT; Rzechorzek, NM; Hope-Jones, D; Cosens, S; Jackson, S; Bates, MGD; Collier, DJ; Hume, DA; Freeman, T; Thompson, AAR; Baillie, JK				Hall, David P.; MacCormick, Ian J. C.; Phythian-Adams, Alex T.; Rzechorzek, Nina M.; Hope-Jones, David; Cosens, Sorrel; Jackson, Stewart; Bates, Matthew G. D.; Collier, David J.; Hume, David A.; Freeman, Thomas; Thompson, A. A. Roger; Baillie, John Kenneth			Network Analysis Reveals Distinct Clinical Syndromes Underlying Acute Mountain Sickness	PLOS ONE			English	Article							VISUAL ANALOG SCALE; PLACEBO-CONTROLLED TRIAL; HIGH-ALTITUDE HEADACHE; NERVE SHEATH DIAMETER; INTRACRANIAL-PRESSURE; EXPRESSION DATA; PAIN SEVERITY; DOUBLE-BLIND; VISUALIZATION; VARIABILITY	Acute mountain sickness (AMS) is a common problem among visitors at high altitude, and may progress to life-threatening pulmonary and cerebral oedema in a minority of cases. International consensus defines AMS as a constellation of subjective, non-specific symptoms. Specifically, headache, sleep disturbance, fatigue and dizziness are given equal diagnostic weighting. Different pathophysiological mechanisms are now thought to underlie headache and sleep disturbance during acute exposure to high altitude. Hence, these symptoms may not belong together as a single syndrome. Using a novel visual analogue scale (VAS), we sought to undertake a systematic exploration of the symptomatology of AMS using an unbiased, data-driven approach originally designed for analysis of gene expression. Symptom scores were collected from 292 subjects during 1110 subject-days at altitudes between 3650 m and 5200 m on Apex expeditions to Bolivia and Kilimanjaro. Three distinct patterns of symptoms were consistently identified. Although fatigue is a ubiquitous finding, sleep disturbance and headache are each commonly reported without the other. The commonest pattern of symptoms was sleep disturbance and fatigue, with little or no headache. In subjects reporting severe headache, 40% did not report sleep disturbance. Sleep disturbance correlates poorly with other symptoms of AMS (Mean Spearman correlation 0.25). These results challenge the accepted paradigm that AMS is a single disease process and describe at least two distinct syndromes following acute ascent to high altitude. This approach to analysing symptom patterns has potential utility in other clinical syndromes.	[Hall, David P.] Royal Air Force Ctr Aviat Med, Raf Henlow, Beds, England; [Hall, David P.; MacCormick, Ian J. C.; Phythian-Adams, Alex T.; Rzechorzek, Nina M.; Hope-Jones, David; Cosens, Sorrel; Jackson, Stewart; Bates, Matthew G. D.; Thompson, A. A. Roger; Baillie, John Kenneth] Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Rzechorzek, Nina M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Bates, Matthew G. D.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Collier, David J.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Hume, David A.; Freeman, Thomas; Baillie, John Kenneth] Roslin Inst, Div Genet & Genom, Edinburgh, Midlothian, Scotland; [Thompson, A. A. Roger] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Newcastle University - UK; University of London; Queen Mary University London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Sheffield	Baillie, JK (corresponding author), Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	j.k.baillie@ed.ac.uk	Baillie, John Kenneth/F-3124-2011; MacCormick, Ian JC/AFW-1885-2022; Phythian-Adams, Alexander/O-5051-2014; Baillie, Kenneth/AEK-6650-2022; MacCormick, Ian/GPW-8622-2022; Thompson, Roger/G-7397-2018	Baillie, John Kenneth/0000-0001-5258-793X; MacCormick, Ian JC/0000-0002-8171-0332; Phythian-Adams, Alexander/0000-0003-0426-6562; Baillie, Kenneth/0000-0001-5258-793X; MacCormick, Ian/0000-0002-8171-0332; Thompson, Roger/0000-0002-0717-4551; Hume, David/0000-0002-2615-1478; Rzechorzek, Nina/0000-0003-3209-5019; Freeman, Thomas/0000-0001-5235-8483	Wellcome Trust Clinical Fellowship through the Edinburgh Clinical Academic Track [090385/Z/09/Z]; BBSRC [BBS/E/D/20251969] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; National Institute for Health Research [ACF-2006-04-005, CL-2012-04-001] Funding Source: researchfish	Wellcome Trust Clinical Fellowship through the Edinburgh Clinical Academic Track; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	JKB is supported by a Wellcome Trust Clinical Fellowship (090385/Z/09/Z) through the Edinburgh Clinical Academic Track. No external funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Baillie JK, 2009, QJM-INT J MED, V102, P341, DOI 10.1093/qjmed/hcp026; Bartsch P, 2004, HIGH ALT MED BIOL, V5, P110, DOI 10.1089/1527029041352108; Bates MGD, 2011, HIGH ALT MED BIOL, V12, P207, DOI 10.1089/ham.2011.0007; Burgess KR, 2004, RESPIROLOGY, V9, P485, DOI 10.1111/j.1440-1843.2004.00625.x; DeLoach LJ, 1998, ANESTH ANALG, V86, P102, DOI 10.1097/00000539-199801000-00020; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fagenholz PJ, 2009, J APPL PHYSIOL, V106, P1207, DOI 10.1152/japplphysiol.01188.2007; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Harris NS, 2003, J EMERG MED, V24, P383, DOI 10.1016/S0736-4679(03)00034-9; Hext F, 2011, HIGH ALT MED BIOL, V12, P329, DOI 10.1089/ham.2010.1055; Hume DA, 2010, GENOMICS, V95, P328, DOI 10.1016/j.ygeno.2010.03.002; Jackson SJ, 2010, HIGH ALT MED BIOL, V11, P217, DOI 10.1089/ham.2010.1003; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Kayser B, 2010, HIGH ALT MED BIOL, V11, P69, DOI 10.1089/ham.2009.1046; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Morocz IA, 2001, EXP NEUROL, V168, P96, DOI 10.1006/exnr.2000.7596; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; RDCT, 2011, R LANG ENV STAT COMP; Roach RC, 2001, J EXP BIOL, V204, P3161; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roach R, 2007, HIGH ALT MED BIOL, V8, P171, DOI 10.1089/ham.2007.8301; Summers KM, 2010, EUR J HUM GENET, V18, P1209, DOI 10.1038/ejhg.2010.91; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Thompson AAR, 2006, HEART, V92, P539, DOI 10.1136/hrt.2005.065375; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Van Roo JD, 2011, WILD ENVIRON MED, V22, P7, DOI 10.1016/j.wem.2010.10.002; Wagner DR, 2007, HIGH ALT MED BIOL, V8, P27, DOI 10.1089/ham.2006.0814; West JB, 2011, HIGH ALT MED BIOL, V12, P23, DOI 10.1089/ham.2010.1068; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6	37	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e81229	10.1371/journal.pone.0081229	http://dx.doi.org/10.1371/journal.pone.0081229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465370	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330283100003
J	Wang, CS; Tai, K; Ku, G; Galinsky, AD				Wang, Cynthia S.; Tai, Kenneth; Ku, Gillian; Galinsky, Adam D.			Perspective-Taking Increases Willingness to Engage in Intergroup Contact	PLOS ONE			English	Article							HETEROSEXUALS ATTITUDES; STEREOTYPE SUPPRESSION; GAY MEN; PREJUDICE; SELF; PERCEPTION; EMPATHY; ANXIETY; CONSEQUENCES; INDIVIDUALS	The current research explored whether perspective-taking increases willingness to engage in contact with stereotyped outgroup members. Across three studies, we find that perspective-taking increases willingness to engage in contact with negatively-stereotyped targets. In Study 1, perspective-takers sat closer to, whereas stereotype suppressors sat further from, a hooligan compared to control participants. In Study 2, individual differences in perspective-taking tendencies predicted individuals' willingness to engage in contact with a hooligan, having effects above and beyond those of empathic concern. Finally, Study 3 demonstrated that perspective-taking's effects on intergroup contact extend to the target's group (i.e., another homeless man), but not to other outgroups (i.e., a man of African descent). Consistent with other perspective-taking research, our findings show that perspective-taking facilitates the creation of social bonds by increasing contact with stereotyped outgroup members.	[Wang, Cynthia S.] Oklahoma State Univ, Stillwater, OK 74078 USA; [Tai, Kenneth] Singapore Management Univ, Singapore 178902, Singapore; [Ku, Gillian] London Business Sch, London NW1 4SA, England; [Galinsky, Adam D.] Columbia Univ, New York, NY USA	Oklahoma State University System; Oklahoma State University - Stillwater; Singapore Management University; University of London; London Business School; Columbia University	Wang, CS (corresponding author), Oklahoma State Univ, Stillwater, OK 74078 USA.	cynthia.wang@okstate.edu	Wang, Cynthia S/B-3081-2018; Ku, Gillian/C-3155-2014; TAI, Kenneth Tze Suen/H-6827-2013	Wang, Cynthia S/0000-0003-3880-8753; Tai, Kenneth/0000-0002-7817-3599				Allport G. W., 1954, NATURE PREJUDICE; Aronson E., 1997, JIGSAW CLASSROOM BUI; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P495, DOI 10.1037/0022-3514.73.3.495; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Blair IV, 2003, GROUP PROCESS INTERG, V6, P151, DOI 10.1177/1368430203006002002; Blatt B, 2010, ACAD MED, V85, P1445, DOI 10.1097/ACM.0b013e3181eae5ec; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Davis M. H., 1980, CATALOG SELECTED DOC, V10, P85; Davis MH, 1996, J PERS SOC PSYCHOL, V70, P713, DOI 10.1037/0022-3514.70.4.713; Deutsch M., 1951, INTERRACIAL HOUSING; Dixon J, 2005, AM PSYCHOL, V60, P697, DOI 10.1037/0003-066X.60.7.697; Dovidio JF, 2002, PREJUDICE INTERGROUP, P153; Esses VM, 2002, PERS SOC PSYCHOL B, V28, P1202, DOI 10.1177/01461672022812006; Fiske ST, 2002, CURR DIR PSYCHOL SCI, V11, P123, DOI 10.1111/1467-8721.00183; Galinsky AD, 2005, GROUP PROCESS INTERG, V8, P109, DOI 10.1177/1368430205051060; Galinsky AD, 2004, PERS SOC PSYCHOL B, V30, P594, DOI 10.1177/0146167203262802; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Galinsky AD, 2003, SOCIAL JUDGMENTS IMP, P343; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P404, DOI 10.1037/0022-3514.95.2.404; Galinsky AD, 2008, PSYCHOL SCI, V19, P378, DOI 10.1111/j.1467-9280.2008.02096.x; Gerard Harold B., 1988, ELIMINATING RACISM P, P225; Goette L, 2011, SCIENCE, V334, P1356, DOI 10.1126/science.1215617; HEREK GM, 1987, PERS SOC PSYCHOL B, V13, P34, DOI 10.1177/0146167287131003; HEREK GM, 1993, J SEX RES, V30, P239, DOI 10.1080/00224499309551707; Herek GM, 1996, PERS SOC PSYCHOL B, V22, P412, DOI 10.1177/0146167296224007; ISLAM MR, 1993, PERS SOC PSYCHOL B, V19, P700, DOI 10.1177/0146167293196005; Ku G, 2010, J EXP SOC PSYCHOL, V46, P792, DOI 10.1016/j.jesp.2010.04.001; MACRAE CN, 1994, J PERS SOC PSYCHOL, V67, P808, DOI 10.1037/0022-3514.67.5.808; Mallett RK, 2008, J PERS SOC PSYCHOL, V94, P265, DOI 10.1037/0022-3514.94.2.94.2.265; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; McLaren LM, 2003, SOC FORCES, V81, P909, DOI 10.1353/sof.2003.0038; Monteith MJ, 1998, J EXP SOC PSYCHOL, V34, P355, DOI 10.1006/jesp.1998.1355; Paolini S, 2004, PERS SOC PSYCHOL B, V30, P770, DOI 10.1177/0146167203262848; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Richeson JA, 2004, J EXP SOC PSYCHOL, V40, P417, DOI 10.1016/j.jesp.2003.09.002; Sanitioso RB, 2004, PERS SOC PSYCHOL B, V30, P412, DOI 10.1177/0146167203261882; Shelton JN, 2005, J PERS SOC PSYCHOL, V88, P91, DOI 10.1037/0022-3514.88.1.91; Shih M, 2009, GROUP PROCESS INTERG, V12, P565, DOI 10.1177/1368430209337463; Staub E, 1996, AM PSYCHOL, V51, P117, DOI 10.1037/0003-066X.51.2.117; Staub E, 1994, REASON HOPE PSYCHOL; Todd AR, 2012, J EXP SOC PSYCHOL, V48, P738, DOI 10.1016/j.jesp.2011.12.011; Todd AR, 2011, J PERS SOC PSYCHOL, V100, P1027, DOI 10.1037/a0022308; Vescio TK, 2003, EUR J SOC PSYCHOL, V33, P455, DOI 10.1002/ejsp.163; Vorauer JD, 2009, PSYCHOL SCI, V20, P838, DOI 10.1111/j.1467-9280.2009.02369.x; Vorauer JD, 2009, J PERS SOC PSYCHOL, V96, P811, DOI 10.1037/a0013411; Vorauer JD, 2009, PSYCHOL SCI, V20, P191, DOI 10.1111/j.1467-9280.2009.02265.x; Wang CS, 2013, SOCIAL PSYCHOL PERSO; Wolsko C, 2000, J PERS SOC PSYCHOL, V78, P635, DOI 10.1037//0022-3514.78.4.635; Wyer NA, 2000, PERS SOC PSYCHOL B, V26, P13, DOI 10.1177/0146167200261002	51	39	44	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85681	10.1371/journal.pone.0085681	http://dx.doi.org/10.1371/journal.pone.0085681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465648	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100060
J	Gutierrez-Aguirre, MA; Cervantes-Martinez, A; Elias-Gutierrez, M				Angelica Gutierrez-Aguirre, Martha; Cervantes-Martinez, Adrian; Elias-Gutierrez, Manuel			An Example of How Barcodes Can Clarify Cryptic Species: The Case of the Calanoid Copepod Mastigodiaptomus albuquerquensis (Herrick)	PLOS ONE			English	Article							DNA; ZOOPLANKTON; TAXONOMY; DIAPTOMIDAE; DIVERSITY; MEXICO	Background: The freshwater calanoid Mastigodiaptomus is a genus with high richness in the Americas and is composed of nine species, seven recorded in Mexico and four that are apparently endemic to small areas. Mastigodiaptomus albuquerquensis is a common, widely distributed species ranging from the southern USA to Central America. This species can be easily identified by a notable butterfly-like sclerotization on the basis of the right fifth leg of males. Nevertheless, morphological differences observed among populations throughout this species distributional range have led to the description of several related species or subspecies, such as M. albuquerquensis patzcuarensis from Lake Patzcuaro in the Central Plateau of Mexico. Methods: Genetic results based on barcodes, morphology based on scanning electron and light microscopy images, and morphometric analyses were used to describe cryptic species within the M. albuquerquensis complex. Results: The morphological analyses coincided partially with the genetic markers, suggesting the existence of at least two sibling species: M. albuquerquensis s. str. and M. patzcuarensis. A third species was genetically separated but was morphologically indistinguishable from the M. patzcuarensis group. Conclusions: Hidden diversity has been a major problem in establishing real patterns of species distribution and genetic acquisition from megadiverse hotspots such as Mexico, where the Nearctic and the Neotropical regions of the Americas meet. Barcodes can help taxonomists to reveal and formally name these new species. Here, we describe two of three potential species highlighted by the use of barcodes: M. albuquerquensis s. str. in the northern semi-desert and M. patzcuarensis on the Central Plateau at more than 2000 m above sea level.	[Angelica Gutierrez-Aguirre, Martha; Cervantes-Martinez, Adrian] Univ Quintana Roo, Cozumel Quintana, Roo, Mexico; [Elias-Gutierrez, Manuel] Colegio Frontera Sur, Chetumal Quintana, Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Elias-Gutierrez, M (corresponding author), Colegio Frontera Sur, Chetumal Quintana, Roo, Mexico.	melias@ecosur.mx	Gutiérrez-Aguirre, Martha/CAG-4952-2022; Elias-Gutierrez, Manuel/A-8952-2013	Elias-Gutierrez, Manuel/0000-0003-2562-4584	National Council of Science and Technology (CONACYT) through the Mexican Barcode of Life (MEXBOL) [194045, 194025]; Comision Nacional Para el Conocimiento y Uso de la Biodiversidad [CONABIO HE009]; National Science Foundation [NSF DEB-0516032]; Genome Canada; Ontario Genomics Institute	National Council of Science and Technology (CONACYT) through the Mexican Barcode of Life (MEXBOL); Comision Nacional Para el Conocimiento y Uso de la Biodiversidad; National Science Foundation(National Science Foundation (NSF)); Genome Canada(Genome Canada); Ontario Genomics Institute	The authors received grants from the National Council of Science and Technology (CONACYT) through the Mexican Barcode of Life (MEXBOL)(Grants 194045, 194025), Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO HE009), National Science Foundation (NSF DEB-0516032), and Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life (iBOL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; ALLAN JD, 1984, EVOLUTION, V38, P280, DOI 10.1111/j.1558-5646.1984.tb00287.x; BAYS JS, 1983, CAN J FISH AQUAT SCI, V40, P1813, DOI 10.1139/f83-210; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Bowman T.E., 1986, SYLLOGEUS, V58, P237; Carrera-Parra Luis F., 2011, Zootaxa, V2880, P51; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Defaye D, 2000, J CRUSTACEAN BIOL, V20, P245, DOI 10.1651/0278-0372(2000)020[0245:GSASPI]2.0.CO;2; DosSantosSilva EN, 1996, HYDROBIOLOGIA, V328, P207, DOI 10.1007/BF00017631; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gutierrez-Aguirre MA, 2013, J NAT HIST, V47, P479, DOI 10.1080/00222933.2012.742587; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Herrick CL, 1895, SYNOPSIS ENTOMOSTRAC, P67; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kiefer F, 1938, ZOOL ANZ, V115, P274; Marsh C.D., 1907, T WIS ACAD SCI ARTS, V15, P381; Miracle MR, 2013, J NAT HIST, V47, P863, DOI 10.1080/00222933.2012.744432; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; Pearse AS, 1904, AM NAT, V38, P889, DOI 10.1086/278467; Plath K, 2001, ECOLOGY, V82, P1260, DOI 10.1890/0012-9658(2001)082[1260:MLOZSC]2.0.CO;2; Prosser S, 2013, MOL ECOLOGY IN PRESS; Quiroz-Vazquez P, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2236.1.4; Silva-Briano M, 1998, SCI NATURAE, V1, P37; Suarez-Morales E, 2000, J NAT HIST, V34, P693, DOI 10.1080/002229300299363; Suarez-Morales E, 1998, SOUTHWEST NAT, V43, P256; Sukhikh N, 2013, J NAT HIST, V47, P753, DOI 10.1080/00222933.2012.716865; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Williamson Craig E., 2001, P915, DOI 10.1016/B978-012690647-9/50023-5; Winder M, 2003, FRESHWATER BIOL, V48, P795, DOI 10.1046/j.1365-2427.2003.01054.x; [No title captured]	32	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85019	10.1371/journal.pone.0085019	http://dx.doi.org/10.1371/journal.pone.0085019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465470	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500029
J	Caradec, T; Pupin, M; Vanvlassenbroeck, A; Devignes, MD; Smail-Tabbone, M; Jacques, P; Leclere, V				Caradec, Thibault; Pupin, Maude; Vanvlassenbroeck, Aurelien; Devignes, Marie-Dominique; Smail-Tabbone, Malika; Jacques, Philippe; Leclere, Valerie			Prediction of Monomer Isomery in Florine: A Workflow Dedicated to Nonribosomal Peptide Discovery	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; IN-SILICO PREDICTION; SWARMING MOTILITY; CONDENSATION; SEQUENCE; IDENTIFICATION; CYCLIZATION; SYNTHETASE; DOMAINS; TOMATO	Nonribosomal peptides represent a large variety of natural active compounds produced by microorganisms. Due to their specific biosynthesis pathway through large assembly lines called NonRibosomal Peptide Synthetases (NRPSs), they often display complex structures with cycles and branches. Moreover they often contain non proteogenic or modified monomers, such as the D-monomers produced by epimerization. We investigate here some sequence specificities of the condensation (C) and epimerization (E) domains of NRPS that can be used to predict the possible isomeric state (D or L) of each monomer in a putative peptide. We show that C-and E-domains can be divided into 2 sub-regions called Up-Seq and Down-Seq. The Up-Seq region corresponds to an InterPro domain (IPR001242) and is shared by C-and E-domains. The Down-Seq region is specific to the enzymatic activity of the domain. Amino-acid signatures (represented as sequence logos) previously described for complete C-and E-domains have been restricted to the Down-Seq region and amplified thanks to additional sequences. Moreover a new Down-Seq signature has been found for Ct-domains found in fungi and responsible for terminal cyclization of the peptides. The identification of these signatures has been included in a workflow named Florine, aimed to predict nonribosomal peptides from NRPS sequence analyses. In some cases, the prediction of isomery is guided by genus-specific rules. Florine was used on a Pseudomonas genome to allow the determination of the type of pyoverdin produced, the update of syringafactin structure and the identification of novel putative products.	[Caradec, Thibault; Vanvlassenbroeck, Aurelien; Jacques, Philippe; Leclere, Valerie] Univ Lille1 Sci & Technol, Lab ProBioGEM, Villeneuve Dascq, France; [Pupin, Maude] Univ Lille 1, CNRS, UMR 8022, LIFL, F-59655 Villeneuve Dascq, France; [Pupin, Maude] INRIA Lille Nord Europe, Villeneuve Dascq, France; [Devignes, Marie-Dominique; Smail-Tabbone, Malika] CNRS, LORIA, UMR 7503, Vandoeuvre Les Nancy, France; [Devignes, Marie-Dominique; Smail-Tabbone, Malika] Univ Lorraine, LORIA, UMR 7503, Vandoeuvre Les Nancy, France; [Devignes, Marie-Dominique; Smail-Tabbone, Malika] INRIA, Villers Les Nancy, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine; Inria	Leclere, V (corresponding author), Univ Lille1 Sci & Technol, Lab ProBioGEM, Villeneuve Dascq, France.	valerie.leclere@univ-lille1.fr	Leclère, Valérie/Y-6312-2018; Devignes, Marie-Dominique/AAI-4554-2020; Pupin, Maude/I-7437-2015	Leclère, Valérie/0000-0003-2463-5361; Devignes, Marie-Dominique/0000-0002-0399-8713; Pupin, Maude/0000-0003-3197-0715; Caradec, Thibault/0000-0002-4461-654X	University of Lille; INRIA; Region Lorraine; European Funds of INTERREG IVa Phytobio project	University of Lille; INRIA; Region Lorraine(Region Grand-Est); European Funds of INTERREG IVa Phytobio project	The funders are: University of Lille, INRIA, Region Lorraine, and European Funds of INTERREG IVa Phytobio project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2011, APPL MICROBIOL BIOT, V92, P571, DOI 10.1007/s00253-011-3453-6; Abdo A, 2012, J COMPUT AID MOL DES, V26, P1187, DOI 10.1007/s10822-012-9608-4; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Balibar CJ, 2005, CHEM BIOL, V12, P1189, DOI 10.1016/j.chembiol.2005.08.010; Bechet M, 2012, APPL MICROBIOL BIOT, V95, P593, DOI 10.1007/s00253-012-4181-2; Berti AD, 2007, J BACTERIOL, V189, P6312, DOI 10.1128/JB.00725-07; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Caboche S, 2009, BMC STRUCT BIOL, V18, P9; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Caboche S, 2010, J BACTERIOL, V192, P5143, DOI 10.1128/JB.00315-10; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; di Salvo ML, 2013, ARCH BIOCHEM BIOPHYS, V529, P55, DOI 10.1016/j.abb.2012.11.011; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Hou J, 2011, CHEM BIOL, V18, P655, DOI 10.1016/j.chembiol.2011.02.012; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Jenke-Kodama H, 2009, NAT PROD REP, V26, P874, DOI 10.1039/b810283j; Johnston C, 2012, MEDCHEMCOMM, V3, P932, DOI 10.1039/c2md20120h; Jones AM, 2007, J BACTERIOL, V189, P6773, DOI 10.1128/JB.00827-07; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Li J, 2008, CHEM BIOL, V15, P118, DOI 10.1016/j.chembiol.2007.12.014; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez JS, 2003, P NATL ACAD SCI USA, V100, P3754, DOI 10.1073/pnas.0637444100; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Pauwelyn E, 2013, MOL PLANT MICROBE IN, V26, P585, DOI 10.1094/MPMI-11-12-0258-R; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Roongsawang N, 2011, INT J MOL SCI, V12, P141, DOI 10.3390/ijms12010141; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Tang GL, 2007, J BIOL CHEM, V282, P20273, DOI 10.1074/jbc.M702814200; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	50	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85667	10.1371/journal.pone.0085667	http://dx.doi.org/10.1371/journal.pone.0085667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465643	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500089
J	Das, S; Bhattacharyya, NP				Das, Srijit; Bhattacharyya, Nitai Pada			Transcription Regulation of HYPK by Heat Shock Factor 1	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; HUNTINGTIN INTERACTING PROTEIN; N-TERMINAL HUNTINGTIN; GENOME-WIDE ANALYSIS; MOLECULAR CHAPERONES; GENE-EXPRESSION; FACTOR-I; HSF1; INDUCTION; STRESS	HYPK (Huntingtin Yeast Partner K) was originally identified by yeast two-hybrid assay as an interactor of Huntingtin, the protein mutated in Huntington's disease. HYPK was characterized earlier as an intrinsically unstructured protein having chaperone-like activity in vitro and in vivo. HYPK has the ability of reducing rate of aggregate formation and subsequent toxicity caused by mutant Huntingtin. Further investigation revealed that HYPK is involved in diverse cellular processes and required for normal functioning of cells. In this study we observed that hyperthermia increases HYPK expression in human and mouse cells in culture. Expression of exogenous Heat Shock Factor 1 (HSF1), upon heat treatment could induce HYPK expression, whereas HSF1 knockdown reduced endogenous as well as heat-induced HYPK expression. Putative HSF1-binding site present in the promoter of human HYPK gene was identified and validated by reporter assay. Chromatin immunoprecipitation revealed in vivo interaction of HSF1 and RNA polymerase II with HYPK promoter sequence. Additionally, acetylation of histone H4, a known epigenetic marker of inducible HSF1 binding, was observed in response to heat shock in HYPK gene promoter. Overexpression of HYPK inhibited cells from lethal heat-induced death whereas knockdown of HYPK made the cells susceptible to lethal heat shock-induced death. Apart from elevated temperature, HYPK was also upregulated by hypoxia and proteasome inhibition, two other forms of cellular stress. We concluded that chaperone-like protein HYPK is induced by cellular stress and under transcriptional regulation of HSF1.	[Das, Srijit; Bhattacharyya, Nitai Pada] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Bhattacharyya, NP (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	nitai_sinp@yahoo.com	Das, Srijit/E-8457-2017	Das, Srijit/0000-0001-8302-7257	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Work was funded by Department of Atomic Energy, Government of India, as an Institutional Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BENJAMIN IJ, 1990, P NATL ACAD SCI USA, V87, P6263, DOI 10.1073/pnas.87.16.6263; Bush KT, 1997, J BIOL CHEM, V272, P9086; Choudhury KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051415; Datta M, 2011, J BIOL CHEM, V286, P33759, DOI 10.1074/jbc.M111.265173; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fortin A, 2000, INT J RADIAT ONCOL, V46, P1259, DOI 10.1016/S0360-3016(99)00410-1; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gonsalves SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015934; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; HALLADAY JT, 1995, MOL CELL BIOL, V15, P4890; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lee J, 2013, J BIOL CHEM, V288, P1582, DOI 10.1074/jbc.M112.401554; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Raychaudhuri S, 2008, PROTEINS, V71, P1686, DOI 10.1002/prot.21856; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031304; Saidi Y, 2011, NEW PHYTOL, V190, P556, DOI 10.1111/j.1469-8137.2010.03571.x; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; WANG Y, 1994, NUCLEIC ACIDS RES, V22, P3113, DOI 10.1093/nar/22.15.3113; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xia WL, 1999, CELL STRESS CHAPERON, V4, P8, DOI 10.1054/csac.1998.0113; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	60	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85552	10.1371/journal.pone.0085552	http://dx.doi.org/10.1371/journal.pone.0085552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465598	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500074
J	Divashuk, MG; Alexandrov, OS; Razumova, OV; Kirov, IV; Karlov, GI				Divashuk, Mikhail G.; Alexandrov, Oleg S.; Razumova, Olga V.; Kirov, Ilya V.; Karlov, Gennady I.			Molecular Cytogenetic Characterization of the Dioecious Cannabis sativa with an XY Chromosome Sex Determination System	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; HUMULUS-JAPONICUS SIEBOLD; SILENE-LATIFOLIA; REPETITIVE DNA; EVOLUTIONARY STRATA; Y-CHROMOSOME; LUPULUS L.; PLANT; IDENTIFICATION; MARKERS	Hemp (Cannabis sativa L.) was karyotyped using by DAPI/C-banding staining to provide chromosome measurements, and by fluorescence in situ hybridization with probes for 45 rDNA (pTa71), 5S rDNA (pCT4.2), a subtelomeric repeat (CS-1) and the Arabidopsis telomere probes. The karyotype has 18 autosomes plus a sex chromosome pair (XX in female and XY in male plants). The autosomes are difficult to distinguish morphologically, but three pairs could be distinguished using the probes. The Y chromosome is larger than the autosomes, and carries a fully heterochromatic DAPI positive arm and CS-1 repeats only on the less intensely DAPI-stained, euchromatic arm. The X is the largest chromosome of all, and carries CS-1 subtelomeric repeats on both arms. The meiotic configuration of the sex bivalent locates a pseudoautosomal region of the Y chromosome at the end of the euchromatic CS-1-carrying arm. Our molecular cytogenetic study of the C. sativa sex chromosomes is a starting point for helping to make C. sativa a promising model to study sex chromosome evolution.	[Divashuk, Mikhail G.; Alexandrov, Oleg S.; Razumova, Olga V.; Kirov, Ilya V.; Karlov, Gennady I.] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy	Karlov, GI (corresponding author), Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia.	karlovg@gmail.com	Razumova, Olga/N-1037-2016; Alexandrov, Oleg/L-8344-2016; Karlov, Gennady/F-7403-2013; Divashuk, Mikhail/T-7621-2019; Киров, Илья/G-2570-2019	Alexandrov, Oleg/0000-0002-7146-4094; Karlov, Gennady/0000-0002-9016-103X; Divashuk, Mikhail/0000-0001-6221-3659; Киров, Илья/0000-0003-3885-3837; Razumova, Olga/0000-0001-5157-0087	Russian Ministry of Science and Education [8588]; Russian Foundation of Basic Research [13-04-01804, 13-04-02116]	Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Ministry of Science and Education (No. 8588) and Russian Foundation of Basic Research No. 13-04-01804 and No. 13-04-02116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov OS, 2011, RUSS J GENET+, V47, P1016, DOI 10.1134/S1022795411080023; Alexandrov OS, 2012, COMP CYTOGENET, V6, P239, DOI 10.3897/CompCytogen.v6i3.3261; Armstrong SJ, 2008, CYTOGENET GENOME RES, V120, P241, DOI 10.1159/000121073; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Chattopadhyay D, 1991, FEDDES REPERT, V102, P29; Chibalina MV, 2011, CURR BIOL, V21, P1475, DOI 10.1016/j.cub.2011.07.045; Cunado N, 2007, CHROMOSOME RES, V15, P825, DOI 10.1007/s10577-007-1166-6; Danilova TV, 2006, EUPHYTICA, V151, P15, DOI 10.1007/s10681-005-9020-4; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241, DOI 10.1105/tpc.5.10.1241; Divashuk MG, 2011, CYTOGENET GENOME RES, V134, P213, DOI 10.1159/000328831; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Filatov DA, 2001, MOL BIOL EVOL, V18, P1442, DOI 10.1093/oxfordjournals.molbev.a003930; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Grabowska-Joachimiak A, 2012, CYTOGENET GENOME RES, V137, P70, DOI 10.1159/000339383; Grabowska-Joachimiak A, 2011, CYTOGENET GENOME RES, V132, P203, DOI 10.1159/000321584; Grabowska-Joachimiak A, 2006, ACTA SOC BOT POL, V75, P207, DOI 10.5586/asbp.2006.024; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Jamilena M, 2008, CYTOGENET GENOME RES, V120, P255, DOI 10.1159/000121075; Janousek B, 2010, BIOL J LINN SOC, V100, P737, DOI 10.1111/j.1095-8312.2010.01470.x; Karlov GI, 2003, EUPHYTICA, V132, P185, DOI 10.1023/A:1024646818324; Kato A, 2004, P NATL ACAD SCI USA, V101, P13554, DOI 10.1073/pnas.0403659101; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045519; Kim SY, 2008, GENES GENOM, V30, P157; Kubesova M, 2010, PRESLIA, V82, P81; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lengerova M, 2004, THEOR APPL GENET, V108, P1193, DOI 10.1007/s00122-003-1568-6; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Mandolino G, 1999, THEOR APPL GENET, V98, P86, DOI 10.1007/s001220051043; Mariotti B, 2006, GENOME, V49, P114, DOI 10.1139/G05-089; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Matsunaga S, 2001, PLANT BIOLOGY, V3, P481, DOI 10.1055/s-2001-17735; Ming R, 2007, AM J BOT, V94, P141, DOI 10.3732/ajb.94.2.141; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Murakami A, 2006, HEREDITY, V97, P66, DOI 10.1038/sj.hdy.6800839; Murakami A, 2000, BREEDING SCI, V50, P155, DOI 10.1270/jsbbs.50.155; Muyle A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001308; Navajas-Perez R, 2009, GENETICA, V135, P87, DOI 10.1007/s10709-008-9261-y; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Peil A, 2003, THEOR APPL GENET, V107, P102, DOI 10.1007/s00122-003-1212-5; Pillay M, 2006, PLANT SYST EVOL, V258, P97, DOI 10.1007/s00606-005-0396-3; Polley A, 1997, GENOME, V40, P357, DOI 10.1139/g97-048; Sakamoto K, 2000, PLANT MOL BIOL, V44, P723, DOI 10.1023/A:1026574405717; Sakamoto K, 2005, GENOME, V48, P931, DOI 10.1139/g05-056; Sakamoto Koichi, 1998, Cytologia (Tokyo), V63, P459, DOI 10.1508/cytologia.63.459; Shephard HL, 2000, NEW PHYTOL, V148, P397, DOI 10.1046/j.1469-8137.2000.00771.x; Sousa A, 2013, CYTOGENET GENOME RES, V139, P107, DOI 10.1159/000345370; Spigler RB, 2010, J HERED, V101, pS107, DOI 10.1093/jhered/esq001; Torjek O, 2002, EUPHYTICA, V127, P209, DOI 10.1023/A:1020204729122; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Yang MQ, 2013, TAXON, V62, P473, DOI 10.12705/623.9; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004; Zonneveld BJM, 2005, ANN BOT-LONDON, V96, P229, DOI 10.1093/aob/mci170	62	57	61	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85118	10.1371/journal.pone.0085118	http://dx.doi.org/10.1371/journal.pone.0085118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465491	gold, Green Submitted, Green Published			2022-12-27	WOS:000330244500038
J	Kohlhase, S; Bogdanova, NV; Schurmann, P; Bermisheva, M; Khusnutdinova, E; Antonenkova, N; Park-Simon, TW; Hillemanns, P; Meyer, A; Christiansen, H; Schindler, D; Dork, T				Kohlhase, Sandra; Bogdanova, Natalia V.; Schuermann, Peter; Bermisheva, Marina; Khusnutdinova, Elza; Antonenkova, Natalia; Park-Simon, Tjoung-Won; Hillemanns, Peter; Meyer, Andreas; Christiansen, Hans; Schindler, Detlev; Doerk, Thilo			Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ATM GENE; SUSCEPTIBILITY; RISK; ENDONUCLEASE; ERCC4; ERCC1-XPF; FREQUENCY; VARIANTS; LOCI	The ERCC4 protein forms a structure-specific endonuclease involved in the DNA damage response. Different cancer syndromes such as a subtype of Xeroderma pigmentosum, XPF, and recently a subtype of Fanconi Anemia, FA-Q, have been attributed to biallelic ERCC4 gene mutations. To investigate whether monoallelic ERCC4 gene defects play some role in the inherited component of breast cancer susceptibility, we sequenced the whole ERCC4 coding region and flanking untranslated portions in a series of 101 Byelorussian and German breast cancer patients selected for familial disease (set 1, n = 63) or for the presence of the rs1800067 risk haplotype (set 2, n = 38). This study confirmed six known and one novel exonic variants, including four missense substitutions but no truncating mutation. Missense substitution p.R415Q (rs1800067), a previously postulated breast cancer susceptibility allele, was subsequently screened for in a total of 3,698 breast cancer cases and 2,868 controls from Germany, Belarus or Russia. The Gln415 allele appeared protective against breast cancer in the German series, with the strongest effect for ductal histology (OR 0.67; 95%CI 0.49; 0.92; p = 0.003), but this association was not confirmed in the other two series, with the combined analysis yielding an overall Mantel-Haenszel OR of 0.94 (95% CI 0.81; 1.08). There was no significant effect of p.R415Q on breast cancer survival in the German patient series. The other three detected ERCC4 missense mutations included two known rare variants as well as a novel substitution, p.E17V, that we identified on a p.R415Q haplotype background. The p.E17V mutation is predicted to be probably damaging but was present in just one heterozygous patient. We conclude that the contribution of ERCC4/FANCQ coding mutations to hereditary breast cancer in Central and Eastern Europe is likely to be small.	[Kohlhase, Sandra; Bogdanova, Natalia V.; Schuermann, Peter; Bermisheva, Marina; Park-Simon, Tjoung-Won; Hillemanns, Peter; Doerk, Thilo] Hannover Med Sch, Clin Obstet, Hannover, Germany; [Kohlhase, Sandra; Bogdanova, Natalia V.; Schuermann, Peter; Bermisheva, Marina; Park-Simon, Tjoung-Won; Hillemanns, Peter; Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, Hannover, Germany; [Bogdanova, Natalia V.; Meyer, Andreas; Christiansen, Hans] Hannover Med Sch, Clin Radiat Oncol, Hannover, Germany; [Bermisheva, Marina; Khusnutdinova, Elza] Inst Biochem & Genet, Ufa, Russia; [Antonenkova, Natalia] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Bioctr, Wurzburg, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; University of Wurzburg	Dork, T (corresponding author), Hannover Med Sch, Clin Obstet, Hannover, Germany.	doerk.thilo@mh-hannover.de	Khusnutdinova, Elza Kamilevna/A-4810-2013; Dörk, Thilo/J-8620-2012; Bogdanova, Natalia V./Y-2205-2019	Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Dörk, Thilo/0000-0002-9458-0282; 				Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Backe J, 1999, GYNECOL ONCOL, V72, P402, DOI 10.1006/gyno.1998.5270; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Bogdanova NV, 2010, CLIN GENET, V78, P364, DOI 10.1111/j.1399-0004.2010.01473.x; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Bogdanova N, 2007, J CLIN ONCOL, V25, pE26, DOI 10.1200/JCO.2007.11.4223; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Bogdanova N, 2009, BREAST CANCER RES TR, V118, P207, DOI 10.1007/s10549-008-0189-9; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Ding DP, 2011, BREAST CANCER RES TR, V129, P203, DOI 10.1007/s10549-011-1447-9; Dork T, 2001, CANCER RES, V61, P7608; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Fadda E, 2013, BIOPHYS J, V104, P2503, DOI 10.1016/j.bpj.2013.04.023; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Ghoussaini M, 2013, AM J PATHOL, V183, P1038, DOI 10.1016/j.ajpath.2013.07.003; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Jorgensen TJ, 2009, CANCER EPIDEM BIOMAR, V18, P346, DOI 10.1158/1055-9965.EPI-08-0659; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Landwehr R, 2011, BREAST CANCER RES TR, V130, P1021, DOI 10.1007/s10549-011-1681-1; McDaniel LD, 2008, ADV EXP MED BIOL, V637, P65; McNeil EM, 2012, NUCLEIC ACIDS RES, V40, P9990, DOI 10.1093/nar/gks818; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Osorio A, 2013, HUM MUTAT, V34, P1615, DOI 10.1002/humu.22438; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Prokofyeva D, 2013, BREAST CANCER RES TR, V137, P533, DOI 10.1007/s10549-012-2357-1; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7	34	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85334	10.1371/journal.pone.0085334	http://dx.doi.org/10.1371/journal.pone.0085334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465539	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500056
J	Okusaga, O; Muravitskaja, O; Fuchs, D; Ashraf, A; Hinman, S; Giegling, I; Hartmann, AM; Konte, B; Friedl, M; Schiffman, J; Hong, E; Reeves, G; Groer, M; Dantzer, R; Rujescu, D; Postolache, TT				Okusaga, Olaoluwa; Muravitskaja, Olesja; Fuchs, Dietmar; Ashraf, Ayesha; Hinman, Sarah; Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Friedl, Marion; Schiffman, Jason; Hong, Elliot; Reeves, Gloria; Groer, Maureen; Dantzer, Robert; Rujescu, Dan; Postolache, Teodor T.			Elevated Levels of Plasma Phenylalanine in Schizophrenia: A Guanosine Triphosphate Cyclohydrolase-1 Metabolic Pathway Abnormality?	PLOS ONE			English	Article							NEUTRAL AMINO-ACIDS; SERUM PHENYLALANINE; HEALTHY-SUBJECTS; TYROSINE; TETRAHYDROBIOPTERIN; PHENYLKETONURIA; BIOPTERIN; PATHOPHYSIOLOGY; PEROXYNITRITE; ACTIVATION	Background: Phenylalanine and tyrosine are precursor amino acids required for the synthesis of dopamine, the main neurotransmitter implicated in the neurobiology of schizophrenia. Inflammation, increasingly implicated in schizophrenia, can impair the function of the enzyme Phenylalanine hydroxylase (PAH; which catalyzes the conversion of phenylalanine to tyrosine) and thus lead to elevated phenylalanine levels and reduced tyrosine levels. This study aimed to compare phenylalanine, tyrosine, and their ratio (a proxy for PAH function) in a relatively large sample of schizophrenia patients and healthy controls. Methods: We measured non-fasting plasma phenylalanine and tyrosine in 950 schizophrenia patients and 1000 healthy controls. We carried out multivariate analyses to compare log transformed phenylalanine, tyrosine, and phenylalanine: tyrosine ratio between patients and controls. Results: Compared to controls, schizophrenia patients had higher phenylalanine (p < 0.0001) and phenylalanine: tyrosine ratio (p < 0.0001) but tyrosine did not differ between the two groups (p = 0.596). Conclusions: Elevated phenylalanine and phenylalanine: tyrosine ratio in the blood of schizophrenia patients have to be replicated in longitudinal studies. The results may relate to an abnormal PAH function in schizophrenia that could become a target for novel preventative and interventional approaches.	[Okusaga, Olaoluwa; Muravitskaja, Olesja; Ashraf, Ayesha; Hinman, Sarah; Postolache, Teodor T.] Univ Maryland, Sch Med, Mood & Anxiety Program, Baltimore, MD 21201 USA; [Okusaga, Olaoluwa] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Fuchs, Dietmar] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Friedl, Marion; Rujescu, Dan] Univ Munich, Sect Mol & Clin Neurobiol, Munich, Germany; [Schiffman, Jason] Univ Maryland, Dept Psychol, Baltimore, MD 21201 USA; [Hong, Elliot] Univ Maryland, Sch Med, Dept Psychiat, MPRC, Baltimore, MD 21201 USA; [Reeves, Gloria] Univ Maryland, Sch Med, Div Child & Adolescent Psychiat, Baltimore, MD 21201 USA; [Reeves, Gloria; Postolache, Teodor T.] Univ Maryland, Child & Adolescent Mental Hlth Innovat Ctr, Baltimore, MD 21201 USA; [Groer, Maureen] Univ S Florida, Tampa, FL USA; [Dantzer, Robert] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany; [Postolache, Teodor T.] Mental Illness Res Educ & Clin Ctr, VISN Capitol Hlth Care Network 5, Baltimore, MD USA; [Postolache, Teodor T.] VISN 19 MIRECC, Denver, CO USA	University System of Maryland; University of Maryland Baltimore; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Medical University of Innsbruck; University of Munich; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of South Florida; University of Texas System; UTMD Anderson Cancer Center; Martin Luther University Halle Wittenberg	Postolache, TT (corresponding author), Univ Maryland, Sch Med, Mood & Anxiety Program, Baltimore, MD 21201 USA.	tpostolache@psych.umaryland.edu	Hartmann, Annette/AAS-6331-2021; Konte, Bettina/AAT-1142-2021; Fuchs, Dietmar/AAL-8011-2021; Rujescu, Dan/GRS-3875-2022; Giegling, Ina/ABA-3677-2021	Konte, Bettina/0000-0001-5287-308X; Fuchs, Dietmar/0000-0003-1627-9563; Okusaga, Olaoluwa O/0000-0002-4263-9086; Postolache, Teodor/0000-0001-6056-4244; Dantzer, Robert/0000-0001-9399-6107	American Foundation for Suicide Prevention; VISN 5 Capitol Health Care Network Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, MD, USA; VISN 19 MIRECC, Denver, Colorado, USA; University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston (Okusaga)	American Foundation for Suicide Prevention; VISN 5 Capitol Health Care Network Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, MD, USA; VISN 19 MIRECC, Denver, Colorado, USA; University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston (Okusaga)	Financial support was provided by a Standard Research Grant (PI Postolache, coPI Rujescu) and a Distinguished Investigator Award (PI Postolache) from the American Foundation for Suicide Prevention, VISN 5 Capitol Health Care Network Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, MD, USA and VISN 19 MIRECC, Denver, Colorado, USA (Postolache), University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA (Postolache), and Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston (Okusaga). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bilder DA, 2013, MOL GENET METAB, V108, P155, DOI 10.1016/j.ymgme.2012.12.006; BJERKENSTEDT L, 1985, BRIT J PSYCHIAT, V147, P276, DOI 10.1192/bjp.147.3.276; Blau N., 2001, METABOLIC MOL BASIS, P1725; Couce ML, 2012, JIMD REP, V2, P91, DOI 10.1007/8904_2011_53; First MB, 2002, STRUCTURED CLIN INTE; Fuchs JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053005; Hoekstra R, 2001, PSYCHIAT RES, V103, P115, DOI 10.1016/S0165-1781(01)00282-7; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kay S, 1987, SCHIZOPHR B, V1, P261, DOI DOI 10.1093/SCHBUL/13.2.261; Laursen JB, 2001, CIRCULATION, V103, P1282; LEEMING RJ, 1976, ARCH DIS CHILD, V51, P771, DOI 10.1136/adc.51.10.771; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; MAHER TJ, 1984, AM J CLIN NUTR, V39, P722, DOI 10.1093/ajcn/39.5.722; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Neurauter G, 2008, CANCER LETT, V272, P141, DOI 10.1016/j.canlet.2008.07.002; Okusaga O, 2013, WORLD J BIOL PSYCHIA, V14, P509, DOI 10.3109/15622975.2012.747699; PERRY TL, 1973, NEW ENGL J MED, V289, P395, DOI 10.1056/NEJM197308232890803; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; POISNER AM, 1960, J NERV MENT DIS, V131, P74, DOI 10.1097/00005053-196007000-00009; POTKIN SG, 1983, ARCH GEN PSYCHIAT, V40, P749; RAO ML, 1990, PSYCHIAT RES, V34, P243, DOI 10.1016/0165-1781(90)90003-N; Richardson MA, 2005, NEUROPSYCHOBIOLOGY, V52, P190, DOI 10.1159/000089002; Richardson MA, 2007, NEUROCHEM RES, V32, P107, DOI 10.1007/s11064-006-9233-5; SMERALDI E, 1987, HUM GENET, V76, P138, DOI 10.1007/BF00284910; Teraishi T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.48; van Spronsen FJ, 2009, J INHERIT METAB DIS, V32, P46, DOI 10.1007/s10545-008-0946-2; WEI J, 1995, SCHIZOPHR RES, V14, P257, DOI 10.1016/0920-9964(94)00080-R; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WURTMAN RJ, 1968, NEW ENGL J MED, V279, P171, DOI 10.1056/NEJM196807252790401; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004; Zoller H, 2012, J INTERF CYTOK RES, V32, P216, DOI 10.1089/jir.2011.0093	36	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85945	10.1371/journal.pone.0085945	http://dx.doi.org/10.1371/journal.pone.0085945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465804	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500151
J	Pardini, B; Verderio, P; Pizzamiglio, S; Nici, C; Maiorana, MV; Naccarati, A; Vodickova, L; Vymetalkova, V; Veneroni, S; Daidone, MG; Ravagnani, F; Bianchi, T; Bujanda, L; Carracedo, A; Castells, A; Ruiz-Ponte, C; Morreau, H; Howarth, K; Jones, A; Castellvi-Bel, S; Li, L; Tomlinson, I; Van Wezel, T; Vodicka, P; Radice, P; Peterlongo, P				Pardini, Barbara; Verderio, Paolo; Pizzamiglio, Sara; Nici, Carmela; Maiorana, Maria Valeria; Naccarati, Alessio; Vodickova, Ludmila; Vymetalkova, Veronika; Veneroni, Silvia; Daidone, Maria Grazia; Ravagnani, Fernando; Bianchi, Tiziana; Bujanda, Luis; Carracedo, Angel; Castells, Antoni; Ruiz-Ponte, Clara; Morreau, Hans; Howarth, Kimberley; Jones, Angela; Castellvi-Bel, Sergi; Li, Li; Tomlinson, Ian; Van Wezel, Tom; Vodicka, Pavel; Radice, Paolo; Peterlongo, Paolo		EPICOLON Consortium	Association between CASP8-652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENE; METAANALYSIS; PROGNOSIS; PROMOTER	The common 2652 6N del variant in the CASP8 promoter (rs3834129) has been described as a putative low-penetrance risk factor for different cancer types. In particular, some studies suggested that the deleted allele (del) was inversely associated with CRC risk while other analyses failed to confirm this. Hence, to better understand the role of this variant in the risk of developing CRC, we performed a multi-centric case-control study. In the study, the variant 2652 6N del was genotyped in a total of 6,733 CRC cases and 7,576 controls recruited by six different centers located in Spain, Italy, USA, England, Czech Republic and the Netherlands collaborating to the international consortium COGENT (COlorectal cancer GENeTics). Our analysis indicated that rs3834129 was not associated with CRC risk in the full data set. However, the del allele was under-represented in one set of cases with a family history of CRC (per allele model OR = 0.79, 95% CI = 0.69-0.90) suggesting this allele might be a protective factor versus familial CRC. Since this multi-centric case-control study was performed on a very large sample size, it provided robust clarification of the effect of rs3834129 on the risk of developing CRC in Caucasians.	[Pardini, Barbara] Human Genet Fdn, Genom Variat Human Populat & Complex Dis Unit, Turin, Italy; [Verderio, Paolo; Pizzamiglio, Sara] Ist Nazl Tumori, Fdn Ist Ric & Cura Carattere Sci, Unit Med Stat Biometry & Bioinformat, I-20133 Milan, Italy; [Nici, Carmela; Maiorana, Maria Valeria; Peterlongo, Paolo] Fdn Ist Italian Fdn Canc Res Oncol Mol, Milan, Italy; [Naccarati, Alessio] Human Genet Fdn, Mol & Genet Epidemiol Unit, Turin, Italy; [Naccarati, Alessio; Vodickova, Ludmila; Vymetalkova, Veronika; Vodicka, Pavel] Acad Sci Czech Republic, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic; [Vodickova, Ludmila; Vymetalkova, Veronika; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Veneroni, Silvia; Daidone, Maria Grazia] Fdn Ist Ric Cura & Carattere Sci Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Ravagnani, Fernando] Fdn Ist Ric Cura & Carattere Sci Ist Nazl Tumori, Immunohematol & Transfus Med Serv, Milan, Italy; [Bianchi, Tiziana] Assoc Italiana Volontari Sangue Comunale Milano, Milan, Italy; [Bujanda, Luis] Univ Basque Country, Networked Biomed Res Ctr Hepat & Digest Dis, Hosp Donostia, Dept Gastroenterol, San Sebastian, Spain; [Carracedo, Angel; Ruiz-Ponte, Clara] Univ Santiago de Compostela, Hosp Clin, Genom Med Grp, Ctr Invest Biomed Red Enfermedades Raras,Galician, Santiago De Compostela, Galicia, Spain; [Castells, Antoni; Castellvi-Bel, Sergi] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol,Hosp Clin, Barcelona, Catalonia, Spain; [Morreau, Hans; Van Wezel, Tom] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Howarth, Kimberley; Jones, Angela; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [Howarth, Kimberley; Jones, Angela; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Natl Inst Hlth Res Comprehens Biomed Res Ctr, Oxford, England; [Li, Li] Case Western Reserve Univ, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA; [Li, Li] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Radice, Paolo] Fdn Ist Ric & Cura Carattere Sci Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Case Western Reserve University; Case Western Reserve University	Pardini, B (corresponding author), Human Genet Fdn, Genom Variat Human Populat & Complex Dis Unit, Turin, Italy.	barbara.pardini@hugef-torino.org	Carracedo, Angel/D-4257-2012; Castells, Antoni/ABC-1002-2021; van Wezel, Tom/Z-3092-2019; Bujanda, Luis/AAB-2485-2021; Rodrigo, Luis/A-6278-2010; Radice, Paolo/O-3119-2013; Enriquez-Navascues, Jose M/AAG-8632-2020; BALAGUER, FRANCESC/G-2389-2016; Felis, Carmen Pinol/C-6397-2011; van Wezel, Tom/AAL-5626-2021; Ruiz-Ponte, Clara/I-3849-2015; Vymetalkova, Veronika/H-3167-2014; RIESTRA, SABINO/N-2897-2019; Daidone, Maria Grazia/E-9232-2017; Veneroni, Silvia/F-3651-2017; Pardini, Barbara/ABI-2295-2020; Pizzamiglio, Sara/C-1061-2017; Vodicka, Pavel/H-3370-2014; Verderio, Paolo/B-5034-2017; CUBIELLA, JOAQUIN/G-7692-2017; Moreira, Leticia/AAN-9863-2021; Pardini, Barbara/K-9451-2016; van Wezel, Tom/A-9599-2008; Peterlongo, Paolo/Q-4717-2018; Vodickova, Ludmila/H-3083-2014; Carballo, Fernando/M-4668-2016	Carracedo, Angel/0000-0003-1085-8986; Castells, Antoni/0000-0001-8431-2033; van Wezel, Tom/0000-0001-5773-7730; Bujanda, Luis/0000-0002-4353-9968; Rodrigo, Luis/0000-0003-1717-9345; Radice, Paolo/0000-0001-6298-4111; Enriquez-Navascues, Jose M/0000-0002-6486-1489; Felis, Carmen Pinol/0000-0003-0626-1298; Ruiz-Ponte, Clara/0000-0002-2200-0162; Vymetalkova, Veronika/0000-0001-6870-6788; Daidone, Maria Grazia/0000-0002-4786-1321; Veneroni, Silvia/0000-0001-9223-4151; Pardini, Barbara/0000-0001-9571-4257; Pizzamiglio, Sara/0000-0002-7759-0550; Verderio, Paolo/0000-0002-9231-1281; CUBIELLA, JOAQUIN/0000-0002-9994-4831; Moreira, Leticia/0000-0002-4518-8591; Pardini, Barbara/0000-0001-9571-4257; van Wezel, Tom/0000-0001-5773-7730; Peterlongo, Paolo/0000-0001-6951-6855; Bessa Caserras, Xavier/0000-0003-4680-1228; Carballo, Fernando/0000-0003-1152-1517; Castellvi-Bel, Sergi/0000-0003-1217-5097; Naccarati, Alessio/0000-0001-5774-0905; Alenda, Cristina/0000-0002-0560-1759; Sanchez Hernandez, Eloy/0000-0003-2493-8303; Pinol, Virginia/0000-0003-3669-6989; Vodicka, Pavel/0000-0003-2376-1243; ESTEVE, MARIA/0000-0001-7716-0027; Poca Sans, Maria/0000-0002-0235-1395	COST Action [BM1206]; Fondo de Investigacion Sanitaria [CP 03-0070]; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria/FEDER [08/0024, 08/1276, PS09/02368, 11/00219, 11/00681]; Instituto de Salud Carlos III (Accion Transversal de Cancer), Xunta de Galicia [07PXIB9101209PR]; Ministerio de Ciencia e Innovacion [SAF2010-19273]; Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona); FundacioOlga Torres; FP7 CHIBCHA Consortium; National Institutes of Health [R01CA136726]; Wellcome Trust [090532/Z/09/Z]; Grant agency of the Czech Republic (GACR) [GACR: GA P304/10/1286, P304/12/1585]; Ministry of Education, Youth and Sport, Czech Republic [Prvouk-P27/LF1/1]; Dutch Cancer Society [KWF-UL-2010-4656]; NATIONAL CANCER INSTITUTE [R01CA136726] Funding Source: NIH RePORTER	COST Action(European Cooperation in Science and Technology (COST)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria/FEDER(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Accion Transversal de Cancer), Xunta de Galicia; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona); FundacioOlga Torres; FP7 CHIBCHA Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sport, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	For all cohorts: This work was supported by COST Action BM1206. Spanish cohort: The authors are sincerely grateful to all patients participating in this study who were recruited in 25 (EPICOLON 1) and 14 (EPICOLON 2) Spanish hospitals as part of the EPICOLON project. The authors are also indebted to the Genomics Unit of the Institut d'Investigacions Biome` diques August Pi i Sunyer for technical help. The work was carried out (in part) at the Esther Koplowitz Centre, Barcelona. SCB is supported by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070 to SCB). Networked Biomedical Research Centre for Hepatic and Digestive Diseases and Centro de Investigacion Biomedica en Red de Enfermedades Raras are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigacion Sanitaria/FEDER (08/0024, 08/1276, PS09/02368, 11/00219, 11/00681), Instituto de Salud Carlos III (Accion Transversal de Cancer), Xunta de Galicia (07PXIB9101209PR), Ministerio de Ciencia e Innovacion (SAF2010-19273), Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona), FundacioOlga Torres (SCB and CRP), FP7 CHIBCHA Consortium (SCB and A. Carracedo). Italian cohort: The authors thank all individuals who agreed to participate in the study. The authors also thank the personnel of Tissue Bank of Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto dei Tumori for sample collection and all pathologists for their contribution and collaboration. American cohort: Kentucky Colon Cancer Genetic Epidemiology Study is supported by National Institutes of Health grant R01CA136726 to LL. English cohort: Core funding to the Wellcome Trust Centre for Human Genetics was provided by the Wellcome Trust (090532/Z/09/Z). Czech cohort: Grant agency of the Czech Republic (GACR) [CZ: GACR: GA P304/10/1286 and P304/12/1585] and by Prvouk-P27/LF1/1 from Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic as a recipient). Dutch cohort: Dutch Cancer Society, grant KWF-UL-2010-4656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; Fernandez-Rozadilla C, 2013, CARCINOGENESIS, V34, P314, DOI 10.1093/carcin/bgs357; Haiman CA, 2008, NAT GENET, V40, P259, DOI 10.1038/ng0308-259; HOSMER DW, 1989, BIOMETRICS, V45, P1265, DOI 10.2307/2531779; Houlston RS, 2012, MUTAGENESIS, V27, P143, DOI 10.1093/mutage/ger059; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Li L, 2008, CLIN CANCER RES, V14, P633, DOI 10.1158/1078-0432.CCR-07-1211; Liu B, 2010, MOL CARCINOGEN, V49, P75, DOI 10.1002/mc.20579; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Naccarati A, 2012, CARCINOGENESIS, V33, P1346, DOI 10.1093/carcin/bgs172; Pittman AM, 2008, BRIT J CANCER, V98, P1434, DOI 10.1038/sj.bjc.6604314; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Theodoropoulos GE, 2011, INT J COLORECTAL DIS, V26, P1113, DOI 10.1007/s00384-011-1217-5; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Wu ZW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0565-0; Xiao MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067577; Yin M, 2010, CARCINOGENESIS, V31, P850, DOI 10.1093/carcin/bgq047; Zhang F, 2012, MUTAGENESIS, V27, P559, DOI 10.1093/mutage/ges019	19	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85538	10.1371/journal.pone.0085538	http://dx.doi.org/10.1371/journal.pone.0085538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465592	Green Published, gold			2022-12-27	WOS:000330244500073
J	Pasanen, T; Koskela, S; Mero, S; Tarkka, E; Tissari, P; Vaara, M; Kirveskari, J				Pasanen, Tanja; Koskela, Suvi; Mero, Sointu; Tarkka, Eveliina; Tissari, Paivi; Vaara, Martti; Kirveskari, Juha			Rapid Molecular Characterization of Acinetobacter baumannii Clones with rep-PCR and Evaluation of Carbapenemase Genes by New Multiplex PCR in Hospital District of Helsinki and Uusimaa	PLOS ONE			English	Article							EPIDEMIOLOGY; THREAT	Multidrug-resistant Acinetobacter baumannii (MDRAB) is an increasing problem worldwide. Prevalence of carbapenem resistance in Acinetobacter spp. due to acquired carbapenemase genes is not known in Finland. The purpose of this study was to examine prevalence and clonal spread of multiresistant A. baumannii group species, and their carbapenemase genes. A total of 55 Acinetobacter isolates were evaluated with repetitive PCR (DiversiLab) to analyse clonality of isolates, in conjunction with antimicrobial susceptibility profile for ampicillin/sulbactam, colistin, imipenem, meropenem, rifampicin and tigecycline. In addition, a new real-time PCR assay, detecting most clinically important carbapenemase genes just in two multiplex reactions, was developed. The assay detects genes for KPC, VIM, IMP, GES-1/-10, OXA-48, NDM, GIM-1, SPM-1, IMI/NMC-A, SME, CMY-10, SFC-1, SIM-1, OXA-23-like, OXA-24/40-like, OXA-58 and ISAbaI-OXA-51-like junction, and allows confident detection of isolates harbouring acquired carbapenemase genes. There was a time-dependent, clonal spread of multiresistant A. baumannii strongly correlating with carbapenamase gene profile, at least in this geographically restricted study material. The new carbapenemase screening assay was able to detect all the genes correctly suggesting it might be suitable for epidemiologic screening purposes in clinical laboratories.	[Pasanen, Tanja; Koskela, Suvi; Mero, Sointu; Tarkka, Eveliina; Tissari, Paivi; Vaara, Martti; Kirveskari, Juha] Helsinki Univ Hosp, Div Clin Microbiol, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Pasanen, T (corresponding author), Helsinki Univ Hosp, Div Clin Microbiol, Helsinki, Finland.	tanja.holma@hus.fi						Antikainen J, 2009, EUR J CLIN MICROBIOL, V28, P899, DOI 10.1007/s10096-009-0720-x; Carretto E, 2008, DIAGN MICR INFEC DIS, V60, P1, DOI [10.1016/j.diagmicrobio.2007.07.002, 10.1016/S0732-8893(07)00539-1]; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Fontana C, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-79; Grisold AJ, 2010, J INFECTION, V60, P44, DOI 10.1016/j.jinf.2009.10.045; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2012, J CLIN MICROBIOL, V15; Kaase M, 2012, J CLIN MICROBIOL, V50, P3115, DOI 10.1128/JCM.00991-12; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Kohlenberg A, 2009, J MED MICROBIOL, V58, P1499, DOI 10.1099/jmm.0.012302-0; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V31; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4896, DOI 10.1128/AAC.00481-11; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Yan ZQ, 2010, INT J ANTIMICROB AG, V35, P269, DOI 10.1016/j.ijantimicag.2009.10.016	25	35	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85854	10.1371/journal.pone.0085854	http://dx.doi.org/10.1371/journal.pone.0085854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465749	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500132
J	Wang, XD; Huang, XF; Yan, QR; Bao, CD				Wang, Xiao-dong; Huang, Xin-fang; Yan, Qing-ran; Bao, Chun-de			Aberrant Activation of the WNT/beta-Catenin Signaling Pathway in Lupus Nephritis	PLOS ONE			English	Article							ERYTHEMATOSUS; CLASSIFICATION; CANCER	Objective: The canonical WNT pathway has been implicated as playing important roles in the pathogenesis of a variety of kidney diseases. Recently, WNT pathway activity was reported to be elevated in the renal tissue of a lupus mouse model. This study aimed to evaluate the potential role of the WNT pathway in the pathogenesis of human lupus nephritis. Methods: The expression of beta-catenin was evaluated in renal biopsy specimens from lupus nephritis patients and control kidney tissues by immunohistochemistry and western blotting. Real-time polymerase chain reaction (RT-PCR) was used to detect RNA expression of beta-catenin, Dkk-1 and Axin2. Plasma concentrations of Dkk-1 were measured by ELISA. Results: Immunohistochemistry and western blotting revealed increased expression of beta-catenin in the kidneys of patients with lupus nephritis compared with control kidney tissues (p<0.05), accompanied by an increase in mRNA expression of beta-catenin (p<0.01) and axin2 (p<0.05). beta-catenin was significantly greater in LN patients without renal interstitial fibrosis compared with those with renal interstitial fibrosis (p<0.01) at the mRNA expression level; the increase in beta-catenin mRNA positively correlated with the creatinine clearance rate (Ccr) and negatively correlated with chronicity indices of renal tissue injury. Greater plasma Dkk-1 concentrations were found in LN patients compared with controls (p<0.05). Plasma Dkk-1 concentrations also correlated negatively with anti-dsDNA antibody levels and positively with serum C3 levels. Conclusions: The canonical WNT/beta-catenin signaling pathway was activated in lupus nephritis patients, accompanied by an increase in plasma levels of Dkk-1. Altered WNT/beta-catenin signaling was related to the pathogenesis of lupus nephritis and might play a role in renal fibrosis.	[Wang, Xiao-dong; Huang, Xin-fang; Yan, Qing-ran; Bao, Chun-de] Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Sch Med, Dept Rheumatol,Ren Ji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, XF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Sch Med, Dept Rheumatol,Ren Ji Hosp, Shanghai 200030, Peoples R China.	hxf343@126.com; baochunde_1678@126.com	Yan, Qingran/AAH-4402-2020		Ministry of Health [201202004]; National Natural Science Foundation of China [30801026]; Shanghai Jiao Tong University School of Medicine [BXJ201020]	Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported in part by the Special Fund for Public Benefit Research from Ministry of Health (201202004), the National Natural Science Foundation of China (No. 30801026), the Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Benali SL, 2013, VET J; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tveita A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2532; Tveita AA, 2011, ARTHRITIS RHEUM-US, V63, P513, DOI 10.1002/art.30116; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007	15	37	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84852	10.1371/journal.pone.0084852	http://dx.doi.org/10.1371/journal.pone.0084852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465439	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500018
J	Zhuang, ZH; Zhao, YL; Wu, QL; Li, M; Liu, HC; Sun, LM; Gao, W; Wang, DY				Zhuang, Ziheng; Zhao, Yunli; Wu, Qiuli; Li, Min; Liu, Haicui; Sun, Lingmei; Gao, Wei; Wang, Dayong			Adverse Effects from Clenbuterol and Ractopamine on Nematode Caenorhabditis elegans and the Underlying Mechanism	PLOS ONE			English	Article							ENVIRONMENTAL RELEVANT CONCENTRATIONS; MICROCYSTIN-LR EXPOSURE; SKELETAL-MUSCLE; LOCOMOTION BEHAVIORS; OXIDATIVE DAMAGE; INDUCED TOXICITY; C.-ELEGANS; LIFE-SPAN; NANOPARTICLES; LONGEVITY	In the present study, we used Caenorhabditis elegans assay system to investigate in vivo toxicity from clentuberol and ractopamine and the possible underlying mechanism. Both acute and prolonged exposures to clentuberol or ractopamine decreased brood size and locomotion behavior, and induced intestinal autofluorescence and reactive oxygen species (ROS) production. Although acute exposure to the examined concentrations of clentuberol or ractopamine did not induce lethality, prolonged exposure to 10 mu g/L of clentuberol and ractopamine reduced lifespan. At relatively high concentrations, ractopamine exhibited more severe toxicity than clentuberol on nematodes. Overexpression of sod-2 gene encoding a Mn-SOD to prevent induction of oxidative stress effectively inhibited toxicity from clentuberol or ractopamine. Besides oxidative stress, we found that clentuberol might reduce lifespan through influencing insulin/IGF signaling pathway; however, ractopamine might reduce lifespan through affecting both insulin/IGF signaling pathway and TOR signaling pathway. Ractopamine more severely decreased expression levels of daf-16, sgk-1, skn-1, and aak-2 genes than clentuberol, and increased expression levels of daf-2 and age-1 genes at the examined concentration. Therefore, the C. elegans assay system may be useful for assessing the possible toxicity from weight loss agents, and clentuberol and ractopamine may induce toxicity through different molecular mechanisms.	[Zhuang, Ziheng; Li, Min] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou, Peoples R China; [Zhao, Yunli; Wu, Qiuli; Li, Min; Sun, Lingmei; Wang, Dayong] Southeast Univ, Minist Educ, Sch Med, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Gao, Wei] Jiangsu Prov Prod Qual Supervis & Inspect Inst, Nanjing, Jiangsu, Peoples R China; [Liu, Haicui] Xiuli Biol Technol Co Ltd, Changzhou, Peoples R China	Changzhou University; Southeast University - China	Gao, W (corresponding author), Jiangsu Prov Prod Qual Supervis & Inspect Inst, Nanjing, Jiangsu, Peoples R China.	jszjgaowei@126.com; dayongw@seu.edu.cn			Changzhou University [ZMF11020011]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120092120064]; National Natural Science Foundation of China [81172698, 81202233]	Changzhou University; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by scientific Starting Fund from Changzhou University (ZMF11020011), Specialized Research Fund for the Doctoral Program of Higher Education of China (20120092120064), and National Natural Science Foundation of China (81172698, 81202233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Avila D, 2012, HUM EXP TOXICOL, V31, P236, DOI 10.1177/0960327110392084; Badino P, 2008, FOOD CHEM TOXICOL, V46, P2239, DOI 10.1016/j.fct.2008.02.025; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Bilkoo Pareena, 2007, Conn Med, V71, P89; Boyd WA, 2009, PLOS ONE, V4, pe7204; BRENNER S, 1974, GENETICS, V77, P71; Chai J, 2013, SPECTROCHIM ACTA A, V105, P200, DOI 10.1016/j.saa.2012.12.017; Chan TYK, 1999, J TOXICOL-CLIN TOXIC, V37, P517, DOI 10.1081/CLT-100102525; DONKIN SG, 1993, ARCH ENVIRON CON TOX, V25, P145, DOI 10.1007/BF00212125; Douillard A, 2012, CLIN EXP PHARMACOL P, V39, P364, DOI 10.1111/j.1440-1681.2012.05677.x; Douillard A, 2011, CAN J PHYSIOL PHARM, V89, P117, DOI [10.1139/Y10-114, 10.1139/y10-114]; Downie D, 2008, MOL REPROD DEV, V75, P785, DOI 10.1002/mrd.20795; Gojmerac T, 2002, VET HUM TOXICOL, V44, P269; He KW, 2009, NEUROSCI BULL, V25, P335, DOI 10.1007/s12264-009-6123-2; Hoffman RJ, 2001, J TOXICOL-CLIN TOXIC, V39, P339, DOI 10.1081/CLT-100105152; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Ju JJ, 2013, ENVIRON SCI POLLUT R, V20, P1823, DOI 10.1007/s11356-012-1151-2; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044688; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071180; Li YH, 2009, J ENVIRON SCI, V21, P971, DOI 10.1016/S1001-0742(08)62370-0; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Lust EB, 2011, J EMERG MED, V40, P198, DOI 10.1016/j.jemermed.2009.09.026; Mazzanti G, 2007, FOOD CHEM TOXICOL, V45, P1694, DOI 10.1016/j.fct.2007.03.002; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; Patiyal SN, 2005, JPN J PHYSIOL, V55, P165, DOI 10.2170/jjphysiol.R2118; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Rui Q, 2009, FRONT MED-PRC, V3, P76; Sangha JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043990; Shashikumar S, 2011, INDIAN J BIOCHEM BIO, V48, P191; Shen LL, 2010, NEUROSCI BULL, V26, P91, DOI 10.1007/s12264-010-0162-6; Shen LL, 2010, MECH AGEING DEV, V131, P732, DOI 10.1016/j.mad.2010.10.005; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang Da-Yong, 2007, Environmental Bioindicators, V2, P89, DOI 10.1080/15555270701457695; Wang DY, 2013, METHODS MOL BIOL, V1048, P65, DOI 10.1007/978-1-62703-556-9_6; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P1221, DOI 10.1016/j.ecoenv.2010.05.002; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Wu QL, 2013, NANOSCALE, V5, P9934, DOI 10.1039/c3nr02084c; Wu QL, 2013, CHEMOSPHERE, V90, P1123, DOI 10.1016/j.chemosphere.2012.09.019; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Xing X, 2009, B ENVIRON CONTAM TOX, V83, P530, DOI 10.1007/s00128-009-9816-3; Xing XJ, 2009, ENVIRON TOXICOL PHAR, V28, P104, DOI 10.1016/j.etap.2009.03.006; Yaeger MJ, 2012, VET PATHOL, V49, P569, DOI 10.1177/0300985811424752; Ye BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014052; Yen M, 2012, J MED TOXICOL, V8, P145, DOI 10.1007/s13181-012-0213-7; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029; Zhang YF, 2010, ARCH ENVIRON CON TOX, V59, P129, DOI 10.1007/s00244-009-9456-y; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093; Zhao YL, 2014, NANOMED-NANOTECHNOL, V10, P89, DOI 10.1016/j.nano.2013.07.004; Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	67	33	35	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85482	10.1371/journal.pone.0085482	http://dx.doi.org/10.1371/journal.pone.0085482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465573	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500068
J	Devine, S; Markewitz, D; Hendrix, P; Coleman, D				Devine, Scott; Markewitz, Daniel; Hendrix, Paul; Coleman, David			Soil Aggregates and Associated Organic Matter under Conventional Tillage, No-Tillage, and Forest Succession after Three Decades	PLOS ONE			English	Article							MICROBIAL BIOMASS; CARBON; STABILIZATION; GRASSLAND; MECHANISMS; FRACTIONS; DYNAMICS; SEQUESTRATION; AGROECOSYSTEM; DECOMPOSITION	Impacts of land use on soil organic C (SOC) are of interest relative to SOC sequestration and soil sustainability. The role of aggregate stability in SOC storage under contrasting land uses has been of particular interest relative to conventional tillage (CT) and no-till (NT) agriculture. This study compares soil structure and SOC fractions at the 30-yr-old Horseshoe Bend Agroecosystem Experiment (HSB). This research is unique in comparing NT and CT with adjacent land concurrently undergoing forest succession (FS) and in sampling to depths (15-28 cm) previously not studied at HSB. A soil moving experiment (SME) was also undertaken to monitor 1-yr changes in SOC and aggregation. After 30 years, enhanced aggregate stability under NT compared to CT was limited to a depth of 5 cm, while enhanced aggregate stability under FS compared to CT occurred to a depth of 28 cm and FS exceeded NT from 5-28 cm. Increases in SOC concentrations generally followed the increases in stability, except that no differences in SOC concentration were observed from 15-28 cm despite greater aggregate stability. Land use differences in SOC were explained equally by differences in particulate organic carbon (POC) and in silt-clay associated fine C. Enhanced structural stability of the SME soil was observed under FS and was linked to an increase of 1 Mg SOC ha(-1) in 0-5 cm, of which 90% could be attributed to a POC increase. The crushing of macroaggregates in the SME soil also induced a 10% reduction in SOC over 1 yr that occurred under all three land uses from 5-15 cm. The majority of this loss was in the fine C fraction. NT and FS ecosystems had greater aggregation and carbon storage at the soil surface but only FS increased aggregation below the surface, although in the absence of increased carbon storage.	[Devine, Scott; Markewitz, Daniel] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Hendrix, Paul; Coleman, David] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Markewitz, D (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	dmarke@uga.edu	Devine, Scott/AAR-1265-2020	Devine, Scott/0000-0002-2306-8281; Markewitz, Daniel/0000-0002-2697-9865; Coleman, David/0000-0003-0390-1501				Arce Flores S, 2006, THESIS U GEORGIA ATH; BAKELAAR RG, 1978, ECOLOGY, V59, P660, DOI 10.2307/1938767; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; BARRETT GW, 1968, ECOLOGY, V49, P1019, DOI 10.2307/1934487; Barros E, 2001, GEODERMA, V100, P193, DOI 10.1016/S0016-7061(00)00086-0; BEARE MH, 1993, GEODERMA, V56, P87, DOI 10.1016/0016-7061(93)90102-Q; Beare MH, 1997, APPL SOIL ECOL, V5, P211, DOI 10.1016/S0929-1393(96)00142-4; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P777, DOI 10.2136/sssaj1994.03615995005800030020x; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P787, DOI 10.2136/sssaj1994.03615995005800030021x; Bossuyt H, 2002, SOIL SCI SOC AM J, V66, P1965, DOI 10.2136/sssaj2002.1965; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Causarano HJ, 2008, SOIL SCI SOC AM J, V72, P221, DOI 10.2136/sssaj2006.0274; Chan KY, 2001, SOIL USE MANAGE, V17, P217, DOI 10.1079/SUM200180; Coleman D, 2006, EUR J SOIL BIOL, V42, pS79, DOI 10.1016/j.ejsobi.2006.07.019; Coleman DC, 2009, AGROECOSYSTEM MANAGE; Devine S, 2011, FOREST SCI, V57, P36; ELLIOTT ET, 1991, AGR ECOSYST ENVIRON, V34, P443, DOI 10.1016/0167-8809(91)90127-J; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Feeney DS, 2006, MICROB ECOL, V52, P151, DOI 10.1007/s00248-006-9062-8; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Gale WJ, 2000, SOIL SCI SOC AM J, V64, P190, DOI 10.2136/sssaj2000.641190x; Gale WJ, 2000, SOIL SCI SOC AM J, V64, P201, DOI 10.2136/sssaj2000.641201x; Hendrix P. F., 1997, SOIL ORGANIC MATTER, P235; HORN R, 1994, SOIL TILL RES, V30, P187, DOI 10.1016/0167-1987(94)90005-1; HORN R, 1989, SOIL TILL RES, V13, P253, DOI 10.1016/0167-1987(89)90002-0; HU S, 1995, SOIL BIOL BIOCHEM, V27, P1127, DOI 10.1016/0038-0717(95)00041-C; INGHAM ER, 1991, SOIL BIOL BIOCHEM, V23, P465, DOI 10.1016/0038-0717(91)90011-8; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P189, DOI 10.1016/0038-0717(76)90003-1; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Kemper W.D., 1965, SIZE DISTRIBUTION 1, P499; Lachnicht SL, 2004, APPL SOIL ECOL, V27, P135, DOI 10.1016/j.apsoil.2004.05.001; Mack MC, 2003, ECOL APPL, V13, P154, DOI 10.1890/1051-0761(2003)013[0154:EGACOS]2.0.CO;2; Mikutta R, 2006, BIOGEOCHEMISTRY, V77, P25, DOI 10.1007/s10533-005-0712-6; NADELHOFFER KJ, 1992, ECOLOGY, V73, P1139, DOI 10.2307/1940664; NEILL C, 1992, ECOLOGY, V73, P1918, DOI 10.2307/1940044; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Odum E. P., 1973, Proceedings. Annual Tall Timbers Fire Ecology Conference, P399; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Skjemstad JO, 2006, AUST J SOIL RES, V44, P255, DOI 10.1071/SR05124; Smucker AJM, 2007, VADOSE ZONE J, V6, P282, DOI 10.2136/vzj2007.0031; TIESSEN H, 1983, SOIL SCI SOC AM J, V47, P509, DOI 10.2136/sssaj1983.03615995004700030023x; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yoder LE., 1936, J AM SOC AGRON, V28, P337, DOI DOI 10.2134/AGRONJ1936.00021962002800050001X	53	87	98	5	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84988	10.1371/journal.pone.0084988	http://dx.doi.org/10.1371/journal.pone.0084988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465460	gold, Green Published, Green Submitted			2022-12-27	WOS:000330240500027
J	Pilch, W; Szygula, Z; Tyka, AK; Palka, T; Tyka, A; Cison, T; Pilch, P; Teleglow, A				Pilch, Wanda; Szygula, Zbigniew; Tyka, Anna K.; Palka, Tomasz; Tyka, Aleksander; Cison, Tomasz; Pilch, Pawel; Teleglow, Aneta			Disturbances in Pro-Oxidant-Antioxidant Balance after Passive Body Overheating and after Exercise in Elevated Ambient Temperatures in Athletes and Untrained Men	PLOS ONE			English	Article							OXIDATIVE STRESS; HEAT-STRESS; CIRCULATORY MARKERS; INDUCED DEHYDRATION; ANAEROBIC EXERCISE; REACTIVE OXYGEN; FREE-RADICALS; MECHANISMS; FATIGUE	The aim of the study was to investigate pro-oxidant-antioxidant balance in two series of examinations with two types of stressors (exogenous heat and the combined exogenous and endogenous heat) in trained and untrained men. The exogenous stressor was provided by Finnish sauna session, whereas the combined stressor was represented by the exercise in elevated ambient temperature. The men from the two groups performed the physical exercise on a cycle ergometer with the load of 53 +/- 2% maximal oxygen uptake at the temperature of 33 +/- 1 degrees C and relative humidity of 70% until their rectal temperature rose by 1.2 degrees C. After a month from completion of the exercise test the subjects participated in a sauna bathing session with the temperature of 96 +/- 2 degrees C, and relative humidity of 16 +/- 5%. 15-minutes heating and 2-minute cool-down in a shower with the temperature of 20 degrees C was repeated until rectal temperature rose by 1.2 degrees C compared to the initial value. During both series of tests rectal temperature was measured at 5-minute intervals. Before both series of tests and after them body mass was measured and blood samples were taken for biochemical tests. Serum total protein, serum concentration of lipid peroxidation products and serum antioxidants were determined. The athletes were characterized by higher level of antioxidant status and lower concentration of lipid peroxidation products. Physical exercise at elevated ambient temperature caused lower changes in oxidative stress indices compared to sauna bathing. Sauna induced a shift in prooxidant-antioxidant balance towards oxidation, which was observed less intensively in the athletes compared to the untrained men. This leads to the conclusion that physical exercise increases tolerance to elevated ambient temperature and oxidative stress.	[Pilch, Wanda; Palka, Tomasz; Tyka, Aleksander; Cison, Tomasz] Univ Sch Phys Educ, Dept Physiol & Biochem, Krakow, Poland; [Szygula, Zbigniew] Univ Sch Phys Educ, Dept Sports Med, Krakow, Poland; [Tyka, Anna K.] Univ Sch Phys Educ, Dept Recreat & Biol Regenerat, Krakow, Poland; [Pilch, Pawel] Rydygier Mem Hosp, Krakow, Poland; [Teleglow, Aneta] Univ Sch Phys Educ, Dept Clin Rehabil, Krakow, Poland; [Tyka, Anna K.; Cison, Tomasz] State Higher Vocat Sch, Inst Phys Educ, Nowysacz, Poland		Tyka, AK (corresponding author), Univ Sch Phys Educ, Dept Recreat & Biol Regenerat, Krakow, Poland.	anna.tyka@awf.krakow.pl	TELEGŁÓW, ANETA/CAJ-1849-2022	TELEGŁÓW, ANETA/0000-0001-5420-4779; Pilch, Wanda/0000-0001-6689-0155; Palka, Tomasz/0000-0001-5225-9397; Szygula, Zbigniew/0000-0002-6685-6579; Tyka, Anna/0000-0002-2743-2618; Tyka, Aleksander/0000-0001-8681-5531	University School of Physical Education in Cracow, Poland [AWF/1/7/2011]	University School of Physical Education in Cracow, Poland	The source of funding for this work was The University School of Physical Education in Cracow, Poland, University Grant No. AWF/1/7/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio HM, 2000, MED SCI SPORT EXER, V32, P1576; Bloomer RJ, 2005, J STRENGTH COND RES, V19, P276; Bloomer RJ, 2004, CAN J APPL PHYSIOL, V29, P245, DOI 10.1139/h04-017; Child RB, 1999, J SPORT MED PHYS FIT, V39, P282; CLEMENS MR, 1987, CHEM PHYS LIPIDS, V45, P251, DOI 10.1016/0009-3084(87)90068-5; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Fehrenbach E, 2001, EXERC IMMUNOL REV, V7, P66; Garrett AT, 2009, EUR J APPL PHYSIOL, V107, P659, DOI 10.1007/s00421-009-1182-7; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Gore A, 2010, J IMMUNOTOXICOL, V7, P239, DOI 10.3109/1547691X.2010.492254; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; HALLIWELL B, 1994, NUTR REV, V52, P253; HARRISON MH, 1985, PHYSIOL REV, V65, P149, DOI 10.1152/physrev.1985.65.1.149; Hillman AR, 2011, APPL PHYSIOL NUTR ME, V36, P698, DOI [10.1139/H11-080, 10.1139/h11-080]; Hubner-Wozniak E, 2000, MED SPORTIVA, V4, P257; Jethon Zbigniew, 2005, Postepy Biologii Komorki, V32, P697; Ji L, 2000, FREE RADICALS EXERCI, P35; Ji LL, 2006, ANN NY ACAD SCI, V1067, P425, DOI 10.1196/annals.1354.061; Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x; Knez WL, 2007, MED SCI SPORT EXER, V39, P283, DOI 10.1249/01.mss.0000246999.09718.0c; KRAEMER RR, 1986, EUR J APPL PHYSIOL O, V55, P579, DOI 10.1007/BF00423200; KUBICA R, 1979, Acta Physiologica Polonica, V30, P5; Kubica R, 1996, J PHYSIOL PHARMACOL, V47, P515; Kukkonen-Harjula K, 2006, INT J CIRCUMPOL HEAL, V65, P195, DOI 10.3402/ijch.v65i3.18102; Laitano O, 2012, EUR J APPL PHYSIOL, V112, P1937, DOI 10.1007/s00421-011-2170-2; Laitano O, 2010, EUR J APPL PHYSIOL, V110, P953, DOI 10.1007/s00421-010-1577-5; Leewenburgh C, 1997, AM J PHYSIOL, V272, P363; MATSUO M, 2000, FREE RADICALS EXERCI, P1; McAnulty SR, 2005, INT J SPORTS MED, V26, P188, DOI 10.1055/s-2004-820990; McBride JM, 1999, J STRENGTH COND RES, V13, P175; Nielsen B., 1981, SCAND J MED SCI SPOR, V3, P2; Paik IY, 2009, BIOCHEM BIOPH RES CO, V383, P103, DOI 10.1016/j.bbrc.2009.03.135; PIWONKA RW, 1965, J APPL PHYSIOL, V20, P379, DOI 10.1152/jappl.1965.20.3.379; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Robergs R, 2000, FUNDAMENTAL PRINCIPL, P134; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Vandenboom R, 2004, CAN J APPL PHYSIOL, V29, P330, DOI 10.1139/h04-022; Vincent HK, 2000, EUR J APPL PHYSIOL, V81, P67, DOI 10.1007/PL00013799; Vincent HK, 1999, EUR J APPL PHYSIOL O, V79, P268, DOI 10.1007/s004210050505; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wozniak-Grygiel E, 2007, MED SPORT, V11, P17; Wright HE, 2010, EUR J APPL PHYSIOL, V108, P987, DOI 10.1007/s00421-009-1294-0; Zembron-Lacny A, 1999, BIOL SPORT, V16, P51; Zembron-Lacny A, 2002, MED SPORT, V6, P29; Zinchuk V., 2012, MED SPORTIVA J ROMAN, V8, P1883	47	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85320	10.1371/journal.pone.0085320	http://dx.doi.org/10.1371/journal.pone.0085320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465535	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500042
J	Yamashita, T; Suplido, SA; Ladines-Llave, C; Tanaka, Y; Senba, N; Matsuo, H				Yamashita, Tadashi; Ann Suplido, Sherri; Ladines-Llave, Cecilia; Tanaka, Yuko; Senba, Naomi; Matsuo, Hiroya			A Cross-Sectional Analytic Study of Postpartum Health Care Service Utilization in the Philippines	PLOS ONE			English	Article							POSTNATAL CARE; INCENTIVES; SURVIVAL; COVERAGE	Background: The maternal mortality ratio in the Philippines remains high; thus, it will be difficult to achieve the Millennium Development Goals 5 by 2015. Approximately two-thirds of all maternal deaths occur during the postpartum period. Therefore, we conducted the present study to examine the current state of postpartum health care service utilization in the Philippines, and identify challenges to accessing postpartum care. Methods: A questionnaire and knowledge test were distributed to postpartum women in the Philippines. The questionnaire collected demographical characteristics and information about their utilization of health care services during pregnancy and the postpartum period. The knowledge test consisted of 11 questions regarding 6 topics related to possible physical and mental symptoms after delivery. Sixty-four questionnaires and knowledge tests were analyzed. Results: The mean time of first postpartum health care visit was 5.1+/-5.2 days after delivery. Postpartum utilization of health care services was significantly correlated with delivery location (p<0.01). Women who delivered at home had a lower rate of postpartum health care service utilization than women who delivered at medical facilities. The majority of participants scored low on the knowledge test. Conclusion: We found inadequate postpartum health care service utilization, especially for women who delivered at home. Our results also suggest that postpartum women lack knowledge about postpartum health concerns. In the Philippines, Barangay health workers may play a role in educating postpartum women regarding health care service utilization to improve their knowledge of possible concerns and their overall utilization of health care services.	[Yamashita, Tadashi] Kobe City Coll Nursing, Kobe, Hyogo, Japan; [Yamashita, Tadashi; Matsuo, Hiroya] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo 657, Japan; [Ann Suplido, Sherri; Ladines-Llave, Cecilia] Philippine Gen Hosp, Dept Obstet & Gynecol, Manila, Philippines; [Ladines-Llave, Cecilia] Univ Philippines, Coll Med, Manila, Philippines; [Tanaka, Yuko] Seisen Univ, Dept Nursing, Hikone, Japan; [Senba, Naomi] Kobe Univ, Grad Sch Hlth Sci, Dept Matern Nursing, Kobe, Hyogo 657, Japan	Kobe University; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Kobe University	Yamashita, T (corresponding author), Kobe City Coll Nursing, Kobe, Hyogo, Japan.	tadashi_y_kobe@yahoo.co.jp		YAMASHITA, TADASHI/0000-0001-5254-0082	Japanese Ministry of Education [24792581]; Grants-in-Aid for Scientific Research [23593299] Funding Source: KAKEN	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research no. 24792581 from the Japanese Ministry of Education(website; http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; [Anonymous], 1999, Birth, V26, P255; Asia Pacific Observatory on Health Systems and Policies, 2011, PHIL HLTH SYST REV; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chakraborty N, 2002, HEALTH SOC CARE COMM, V10, P492, DOI 10.1046/j.1365-2524.2002.00389.x; Ekirapa-Kiracho E, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S11; Elo I T, 1992, Health Transit Rev, V2, P49; Health Philippines Department of Health, 2004, BAS EM OBST CAR TRAI; Kozhimannil KB, 2009, HEALTH POLICY, V92, P55, DOI 10.1016/j.healthpol.2009.02.009; Langlois EV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-55; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; National Statistical Coodination Board, 2009, NSCB REL 2009 PHIL S; National Statistics Office Manila Philippines, 2008, PHIL 2008 NAT DEM HL; Onah HE, 2006, SOC SCI MED, V63, P1870, DOI 10.1016/j.socscimed.2006.04.019; Philippine Obstetrical and Gynecological Society, 2010, CAP ENH PROJ MIDW MA; Philippines National Statistics Office, 2010, POP ANN GROWTH RAT P; Philippines National Statistics Office, 2012, 2010 CENS POP HOUS R; Ray Alison M, 2004, J Obstet Gynaecol, V24, P5, DOI 10.1080/01443610310001620206; Republic of the Philippines Department of Health National Epidemiology Center Manila, 2009, 2009 PHIL HLTH STAT; Republic of the Philippines National Statistics Office, 2010, 2003 NAT DEM HLTH SU; Republic of the Philippines National Statistics Office, 2004, INF MORT PHIL HIGH O; Ronsmans C, 2009, B WORLD HEALTH ORGAN, V87, P416, DOI 10.2471/BLT.08.051581; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Shanna E, 2004, FACTORS AFFECTING MA; Spector JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-43; Titaley CR, 2009, J EPIDEMIOL COMMUN H, V63, P827, DOI 10.1136/jech.2008.081604; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-61; United Nations, 2012, MILLENNIUM DEV GOALS; World Health Organization Department of Making Pregnancy Safer, 2010, WHO TECHN CONS POSTP; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Zupan J, 2005, NEW ENGL J MED, V352, P2047, DOI 10.1056/NEJMp058032	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85627	10.1371/journal.pone.0085627	http://dx.doi.org/10.1371/journal.pone.0085627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465626	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500062
J	Zilverstand, A; Sorger, B; Zimmermann, J; Kaas, A; Goebel, R				Zilverstand, Anna; Sorger, Bettina; Zimmermann, Jan; Kaas, Amanda; Goebel, Rainer			Windowed Correlation: A Suitable Tool for Providing Dynamic fMRI-Based Functional Connectivity Neurofeedback on Task Difficulty	PLOS ONE			English	Article							REAL-TIME FMRI; MOOD-REGULATING CIRCUIT; RESTING-STATE; PHYSIOLOGICAL NOISE; BRAIN ACTIVATION; MOTOR CORTEX; NETWORK; MODULATION; DEMAND; FUTURE	The goal of neurofeedback training is to provide participants with relevant information on their ongoing brain processes in order to enable them to change these processes in a meaningful way. Under the assumption of an intrinsic brain-behavior link, neurofeedback can be a tool to guide a participant towards a desired behavioral state, such as a healthier state in the case of patients. Current research in clinical neuroscience regarding the most robust indicators of pathological brain processes in psychiatric and neurological disorders indicates that fMRI-based functional connectivity measures may be among the most important biomarkers of disease. The present study therefore investigated the general potential of providing fMRI neurofeedback based on functional correlations, computed from short-window time course data at the level of single task periods. The ability to detect subtle changes in task performance with block-wise functional connectivity measures was evaluated based on imaging data from healthy participants performing a simple motor task, which was systematically varied along two task dimensions representing two different aspects of task difficulty. The results demonstrate that fMRI-based functional connectivity measures may provide a better indicator for an increase in overall ( motor) task difficulty than activation level-based measures. Windowed functional correlations thus seem to provide relevant and unique information regarding ongoing brain processes, which is not captured equally well by standard activation level-based neurofeedback measures. Functional connectivity markers, therefore, may indeed provide a valuable tool to enhance and monitor learning within an fMRI neurofeedback setup.	[Zilverstand, Anna; Sorger, Bettina; Zimmermann, Jan; Kaas, Amanda; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Goebel, Rainer] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands	Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Zilverstand, A (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	anna.zilverstand@maastrichtuniversity.nl	Zilverstand, Anna/AFR-0554-2022	Zilverstand, Anna/0000-0002-4889-9700; Goebel, Rainer/0000-0003-1780-2467; Sorger, Bettina/0000-0003-1393-3144; Zimmermann, Jan/0000-0003-3345-6074; Kaas, Amanda/0000-0002-2847-8167	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06011]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of the BrainGain Smart Mix Programme of The Netherlands Ministry of Economic Affairs and The Netherlands Ministry of Education, Culture and Science (grant number: SSM06011). http://www.government.nl/ministries/ocw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2012, NEUROIMAGE, V62, P1267, DOI 10.1016/j.neuroimage.2012.01.026; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Engstrom M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00140; Esposito F, 2003, NEUROIMAGE, V20, P2209, DOI 10.1016/j.neuroimage.2003.08.012; Fall S, 2008, BIOL CYBERN, V98, P101, DOI 10.1007/s00422-007-0198-5; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fu CHY, 2006, NEUROIMAGE, V30, P266, DOI 10.1016/j.neuroimage.2005.09.035; Goebel R., 2010, IMAGING MED, V2, P407; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010; Koush Y, 2012, NEUROIMAGE, V59, P478, DOI 10.1016/j.neuroimage.2011.07.076; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Posse S, 2001, HUM BRAIN MAPP, V12, P25, DOI 10.1002/1097-0193(200101)12:1<25::AID-HBM30>3.0.CO;2-H; Posse S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00479; Poston KL, 2012, NEUROIMAGE, V62, P2261, DOI 10.1016/j.neuroimage.2011.12.021; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Rogers BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003708; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Ruiz Sergio, 2013, Front Psychiatry, V4, P17, DOI 10.3389/fpsyt.2013.00017; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Talairach G, 1988, COPLANAR STEREOTAXIC; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; Weiskopf N., 2011, NEUROIMAGE; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Yoo K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00049; Zaitsev M, 2006, NEUROIMAGE, V31, P1038, DOI 10.1016/j.neuroimage.2006.01.039	62	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85929	10.1371/journal.pone.0085929	http://dx.doi.org/10.1371/journal.pone.0085929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465794	Green Published, gold			2022-12-27	WOS:000330240500090
J	Damodaram, KJP; Kempraj, V; Aurade, RM; Venkataramanappa, RK; Nandagopal, B; Verghese, A; Bruce, T				Damodaram, Kamala Jayanthi Pagadala; Kempraj, Vivek; Aurade, Ravindra Mahadappa; Venkataramanappa, Ravindra Kothapalli; Nandagopal, Bakthavatsalam; Verghese, Abraham; Bruce, Toby			Oviposition Site-Selection by Bactrocera dorsalis Is Mediated through an Innate Recognition Template Tuned to gamma-Octalactone	PLOS ONE			English	Article							PHEROMONE; EVOLUTION; DIPTERA	Innate recognition templates (IRTs) in insects are developed through many years of evolution. Here we investigated olfactory cues mediating oviposition behavior in the oriental fruit fly, Bactrocera dorsalis, and their role in triggering an IRT for oviposition site recognition. Behavioral assays with electrophysiologically active compounds from a preferred host, mango, revealed that one of the volatiles tested, c-octalactone, had a powerful effect in eliciting oviposition by gravid B. dorsalis females. Electrophysiological responses were obtained and flies clearly differentiated between treated and untreated substrates over a wide range of concentrations of c-octalactone. It triggered an innate response in flies, overriding inputs from other modalities required for oviposition site evaluation. A complex blend of mango volatiles not containing c-octalactone elicited low levels of oviposition, whereas c-octalactone alone elicited more oviposition response. Naive flies with different rearing histories showed similar responses to c-octalactone. Taken together, these results indicate that oviposition site selection in B. dorsalis is mediated through an IRT tuned to c-octalactone. Our study provides empirical data on a cue underpinning innate behavior and may also find use in control operations against this invasive horticultural pest.	[Damodaram, Kamala Jayanthi Pagadala; Kempraj, Vivek; Aurade, Ravindra Mahadappa; Nandagopal, Bakthavatsalam] Indian Inst Hort Res, Div Entomol & Nematol, Natl Fellow Lab, Bangalore, Karnataka, India; [Venkataramanappa, Ravindra Kothapalli; Verghese, Abraham] Natl Bur Agr Important Insects, Dept Ecol, Bangalore, Karnataka, India; [Bruce, Toby] Rothamsted Res, Biol Chem & Crop Protect, Harpenden, Herts, England	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agricultural Insect Resources; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Damodaram, KJP (corresponding author), Indian Inst Hort Res, Div Entomol & Nematol, Natl Fellow Lab, Bangalore, Karnataka, India.	jaiinsect@gmail.com	parepally, saravan kumar/AAH-7186-2019; Bruce, Toby JA/H-3131-2011	Bruce, Toby JA/0000-0002-9912-0605; Kempraj, Vivek/0000-0002-6151-8618	Indian Council for Agricultural Research's [ICAR]; BBSRC [BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish	Indian Council for Agricultural Research's [ICAR]; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Indian Council for Agricultural Research's [ICAR] National Fellow Project awarded to PDKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVITAL E, 1994, ANIM BEHAV, V48, P1195, DOI 10.1006/anbe.1994.1351; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bernays EA, 1996, ENTOMOL EXP APPL, V80, P125, DOI 10.1007/BF00194741; COURTNEY SP, 1983, OECOLOGIA, V59, P317, DOI 10.1007/BF00378856; del Campo ML, 2001, NATURE, V411, P186, DOI 10.1038/35075559; DETHIER VG, 1982, J GEN PHYSIOL, V79, P549, DOI 10.1085/jgp.79.4.549; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; Jaenike J, 1989, INSECT CHEM ECOLOGY, P245; Jayanthi PDK, 2012, J CHEM ECOL, V38, P361, DOI 10.1007/s10886-012-0093-y; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P31; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Martelli C, 2013, J NEUROSCI, V33, P6285, DOI 10.1523/JNEUROSCI.0426-12.2013; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Pandit SS, 2009, J SCI FOOD AGR, V89, P2071, DOI 10.1002/jsfa.3692; Paukku S, 2008, J INSECT BEHAV, V21, P505, DOI 10.1007/s10905-008-9146-z; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; ROTHSCHILD M, 1977, NATURE, V266, P352, DOI 10.1038/266352a0; Schwartz NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037910; Shelly TE, 2000, ANN ENTOMOL SOC AM, V93, P559, DOI 10.1603/0013-8746(2000)093[0559:FOFOFF]2.0.CO;2; Sherman Paul W., 1997, P69; Simone BG, 1998, THESIS DURHAM U; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; TIERNEY AJ, 1986, ANIM LEARN BEHAV, V14, P339, DOI 10.3758/BF03200077; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Yuan M., 2008, J ANHUI AGR SCI, V22, P9619	33	27	26	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85764	10.1371/journal.pone.0085764	http://dx.doi.org/10.1371/journal.pone.0085764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465690	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000023
J	Korir, A; Mauti, N; Moats, P; Gurka, MJ; Mutuma, G; Metheny, C; Mwamba, PM; Oyiro, PO; Fisher, M; Ayers, LW; Rochford, R; Mwanda, WO; Remick, SC				Korir, Anne; Mauti, Nathan; Moats, Pamela; Gurka, Matthew J.; Mutuma, Geoffrey; Metheny, Christine; Mwamba, Peter M.; Oyiro, Peter O.; Fisher, Melanie; Ayers, Leona W.; Rochford, Rosemary; Mwanda, Walter O.; Remick, Scot C.			Developing Clinical Strength-of-Evidence Approach to Define HIV-Associated Malignancies for Cancer Registration in Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PERSONS; RISK; IMMUNODEFICIENCY; CHALLENGE; MORTALITY; UGANDA; PEOPLE	Background: Sub-Saharan Africa cancer registries are beset by an increasing cancer burden further exacerbated by the AIDS epidemic where there are limited capabilities for cancer-AIDS match co-registration. We undertook a pilot study based on a "strength-of-evidence" approach using clinical data that is abstracted at the time of cancer registration for purposes of linking cancer diagnosis to AIDS diagnosis. Methods/Findings: The standard Nairobi Cancer Registry form was modified for registrars to abstract the following clinical data from medical records regarding HIV infection/AIDS in a hierarchal approach at time of cancer registration from highest-to-lowest strength-of-evidence: 1) documentation of positive HIV serology; 2) antiretroviral drug prescription; 3) CD4+ lymphocyte count; and 4) WHO HIV clinical stage or immune suppression syndrome (ISS), which is Kenyan terminology for AIDS. Between August 1 and October 31, 2011 a total of 1,200 cancer cases were registered. Of these, 171 cases (14.3%) met clinical strength-of-evidence criteria for association with HIV infection/AIDS; 69% (118 cases were tumor types with known HIV association - Kaposi's sarcoma, cervical cancer, non-Hodgkin's and Hodgkin's lymphoma, and conjunctiva carcinoma) and 31% (53) were consistent with non-AIDS defining cancers. Verifiable positive HIV serology was identified in 47 (27%) cases for an absolute seroprevalence rate of 4% among the cancer registered cases with an upper boundary of 14% among those meeting at least one of strength-of-evidence criteria. Conclusions/Significance: This pilot demonstration of a hierarchal, clinical strength-of-evidence approach for cancer-AIDS registration in Kenya establishes feasibility, is readily adaptable, pragmatic, and does not require additional resources for critically under staffed cancer registries. Cancer is an emerging public health challenge, and African nations need to develop well designed population-based studies in order to better define the impact and spectrum of malignant disease in the backdrop of HIV infection.	[Korir, Anne; Mauti, Nathan; Mutuma, Geoffrey] Nairobi Canc Registry, Kenya Med Res Inst, Nairobi, Kenya; [Moats, Pamela; Metheny, Christine] West Virginia Univ Hosp, Hlth Informat Management Canc Registry, Morgantown, WV USA; [Gurka, Matthew J.] W Virginia Univ, Dept Biostat, Sch Publ Hlth, Morgantown, WV 26506 USA; [Mwamba, Peter M.; Oyiro, Peter O.; Mwanda, Walter O.] Univ Nairobi, Coll Hlth Sci, UNITID, Nairobi, Kenya; [Mwamba, Peter M.; Oyiro, Peter O.; Mwanda, Walter O.] Kenyatta Natl Hosp, Nairobi, Kenya; [Fisher, Melanie; Remick, Scot C.] W Virginia Univ, Dept Med, Sch Med, Global Hlth Program MF, Morgantown, WV 26506 USA; [Fisher, Melanie; Remick, Scot C.] W Virginia Univ, Mary Babb Randolph Canc Ctr SCR, Sch Med, Morgantown, WV 26506 USA; [Ayers, Leona W.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Rochford, Rosemary] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	Kenya Medical Research Institute; West Virginia University; West Virginia University; University of Nairobi; Kenyatta National Hospital; West Virginia University; West Virginia University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Korir, A (corresponding author), Nairobi Canc Registry, Kenya Med Res Inst, Nairobi, Kenya.	annkroir@yahoo.com; sremick@hsc.wvu.edu			US Department of Health and Human Services National Institutes of Health [D43 CA153707, U54 GM104942]; NATIONAL CANCER INSTITUTE [D43CA153707, R01CA102667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	US Department of Health and Human Services National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by US Department of Health and Human Services National Institutes of Health grant nos.: D43 CA153707 and U54 GM104942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach CJ, 2011, AIDS, V25, P691, DOI 10.1097/QAD.0b013e3283437f77; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Ferlay J, 2003, IARC CANCERBASE, V5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; International Association of Cancer Registries (IACR), 2013, CANREG 5; International Association of Cancer Registries (IACR), 2001, CANREG 4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Lingwood RJ, 2008, NAT REV CANCER, V8, P398, DOI 10.1038/nrc2372; Mathers CD, PROJECTIONS GLOBAL M, DOI DOI 10.1371/J0URNAL.PMED.0030442.ACCESSED; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Nagaiah G, 2010, CURR OPIN ONCOL, V22, P437, DOI 10.1097/CCO.0b013e32833cfcf9; NASCOP NASCOP, 2005, GUID ANT DRUG THER K; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2003, IARC SCI PUBLICATION, V153; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Remick SC, 2009, AM SOC CLIN ONCOL ED, P670; Sansom C, 2002, LANCET ONCOL, V3, P456, DOI 10.1016/S1470-2045(02)00826-4; Sasco AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008621; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Silverberg MJ, 2007, AIDS, V21, P1957, DOI 10.1097/QAD.0b013e3282ed6338; Stewart BW, 2003, WORLD CANC REPORT 20; Tyerman Z, 2012, AIDS REV, V14, P3; UNAIDS The Joint United Nations Programme on HIV/AIDS, 2009, AIDS EP UPD REG E SO; UNAIDS The Joint United Nations Programme on HIV/ AIDS, 2009, AIDS EP UPD; UNAIDS The Joint United Nations Programme on HIV/AIDS, 2009, COUNTR REP KEN; WHO, 2010, ANT THER HIV INF AD; Wikepedia, LARG CIT AFR; World Health Organization, 2009, GLOB SUMM HIV AIDS E; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2007, FUT HLTH PROJ DEATHS; World Health Organization, 2011, CANCER; Yu JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010477; Zucchetto A, 2010, CLIN INFECT DIS, V51, P1099, DOI 10.1086/656629	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85881	10.1371/journal.pone.0085881	http://dx.doi.org/10.1371/journal.pone.0085881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465764	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000030
J	McKay, PF; Cope, AV; Mann, JFS; Joseph, S; Esteban, M; Tatoud, R; Carter, D; Reed, SG; Weber, J; Shattock, RJ				McKay, Paul F.; Cope, Alethea V.; Mann, Jamie F. S.; Joseph, Sarah; Esteban, Mariano; Tatoud, Roger; Carter, Darrick; Reed, Steven G.; Weber, Jonathan; Shattock, Robin J.			Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN DENDRITIC CELLS; IMMUNE-RESPONSES; CLADE-C; NEUTRALIZING ANTIBODIES; LYMPHOCYTE RESPONSES; GENETIC-VARIATION; RHESUS-MONKEYS; GAG; IMMUNOGENICITY	Using a unique vaccine antigen matched and single HIV Clade C approach we have assessed the immunogenicity of a DNA-poxvirus-protein strategy in mice and rabbits, administering MVA and protein immunizations either sequentially or simultaneously and in the presence of a novel TLR4 adjuvant, GLA-AF. Mice were vaccinated with combinations of HIV env/gag-pol-nef plasmid DNA followed by MVA-C (HIV env/gag-pol-nef) with HIV CN54gp140 protein (+/2GLA-AF adjuvant) and either co-administered in different muscles of the same animal with MVA-C or given sequentially at 3-week intervals. The DNA prime established a population of B cells that were able to mount a statistically significant anamnestic response to the boost vaccines. The greatest antigen-specific antibody response was observed in animals that received all vaccine components. Moreover, a high proportion of the total mucosal IgG (20 - 50%) present in the vaginal vault of these vaccinated animals was vaccine antigen-specific. The potent elicitation of antigen-specific immune responses to this vaccine modality was also confirmed in rabbits. Importantly, co-administration of MVA-C with the GLA-AF adjuvanted HIV CN54gp140 protein significantly augmented the antigen-specific T cell responses to the Gag antigen, a transgene product expressed by the MVA-C vector in a separate quadriceps muscle. We have demonstrated that co-administration of MVA and GLA-AF adjuvanted HIV CN54gp140 protein was equally effective in the generation of humoral responses as a sequential vaccination modality thus shortening and simplifying the immunization schedule. In addition, a significant further benefit of the condensed vaccination regime was that T cell responses to proteins expressed by the MVA-C were potently enhanced, an effect that was likely due to enhanced immunostimulation in the presence of systemic GLA-AF.	[McKay, Paul F.; Cope, Alethea V.; Mann, Jamie F. S.; Tatoud, Roger; Weber, Jonathan; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, London, England; [Joseph, Sarah] MRC, Clin Trials Unit, London, England; [Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Carter, Darrick; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA	Imperial College London; Medical Research Council Clinical Trials Unit; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	McKay, PF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Norfolk Pl, London, England.	p.mckay@imperial.ac.uk	Esteban, Mariano/ABG-5375-2020; Carter, Darrick/N-3304-2016	Esteban, Mariano/0000-0003-0846-2827; TATOUD, Roger/0000-0002-3999-8264; McKay, Paul/0000-0001-5195-6254; Tatoud, Roger/0000-0002-2394-6435; Mann, Jamie/0000-0001-7037-1286; Carter, Darrick/0000-0001-5901-3402	Wellcome Trust; Dormeur Investment Service Ltd; Sir Joseph Hotung Trust Fellowship; Medical Research Council [MC_U122861400, G1001784] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish; MRC [MC_U122861400, G1001784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Dormeur Investment Service Ltd; Sir Joseph Hotung Trust Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by a grant to the UK HIV Vaccine Consortium (UK HVC) by the Wellcome Trust. The authors gratefully acknowledge Dormeur Investment Service Ltd for providing funds to purchase equipment used in these studies. PMK was supported by a Sir Joseph Hotung Trust Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Amara RR, 2002, J VIROL, V76, P6138, DOI 10.1128/JVI.76.12.6138-6146.2002; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Barouch DH, 2003, J VIROL, V77, P8729, DOI 10.1128/JVI.77.16.8729-8735.2003; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Brave A, 2007, VACCINE, V25, P6882, DOI 10.1016/j.vaccine.2007.07.012; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; DA'Dara AA, 2003, PARASITE IMMUNOL, V25, P429, DOI 10.1111/j.1365-3024.2003.00651.x; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035485; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Ferraro B, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.0.14574; Fox CB, 2012, CLIN VACCINE IMMUNOL, V19, P1633, DOI 10.1128/CVI.00235-12; Gomes R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001610; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; Hallengard D, 2012, VIRAL IMMUNOL, V25, P423, DOI 10.1089/vim.2012.0046; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hurwitz Julia L, 2007, J Pediatr Pharmacol Ther, V12, P68, DOI 10.5863/1551-6776-12.2.68; Jalah R, 2012, HUM VACCIN IMMUNOTHE, V8; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Khawaja G, 2012, VIROLOGY, V425, P61, DOI 10.1016/j.virol.2012.01.001; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618; Lu S, 2008, EXPERT REV VACCINES, V7, P175, DOI 10.1586/14760584.7.2.175; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Mann JFS, 2012, J CONTROL RELEASE, V158, P240, DOI 10.1016/j.jconrel.2011.11.009; Mann JFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067412; Mansky LM, 1998, J GEN VIROL, V79, P1337, DOI 10.1099/0022-1317-79-6-1337; McKay PF, 2004, EUR J IMMUNOL, V34, P1011, DOI 10.1002/eji.200324840; Montefiori DC, 2001, J VIROL, V75, P5879, DOI 10.1128/JVI.75.13.5879-5890.2001; Otero M, 2004, VACCINE, V22, P1782, DOI 10.1016/j.vaccine.2004.01.037; Park Su-Hyung, 2010, Immune Netw, V10, P198, DOI 10.4110/in.2010.10.6.198; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Santra S, 2002, J VIROL, V76, P6376, DOI 10.1128/JVI.76.12.6376-6381.2002; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Thorner AR, 2006, J VIROL, V80, P12009, DOI 10.1128/JVI.01749-06; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Xiao L, 2012, VACCINE, V30, P2570, DOI 10.1016/j.vaccine.2012.01.074; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109	55	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84707	10.1371/journal.pone.0084707	http://dx.doi.org/10.1371/journal.pone.0084707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465426	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000005
J	Bassett, IV; Govindasamy, D; Erlwanger, AS; Hyle, EP; Kranzer, K; van Schaik, N; Noubary, F; Paltiel, AD; Wood, R; Walensky, RP; Losina, E; Bekker, LG; Freedberg, KA				Bassett, Ingrid V.; Govindasamy, Darshini; Erlwanger, Alison S.; Hyle, Emily P.; Kranzer, Katharina; van Schaik, Nienke; Noubary, Farzad; Paltiel, A. David; Wood, Robin; Walensky, Rochelle P.; Losina, Elena; Bekker, Linda-Gail; Freedberg, Kenneth A.			Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; RESOURCE-POOR SETTINGS; CARE; METAANALYSIS; PROPHYLAXIS; PREVENTION; MORTALITY; COUNTRIES; EFFICACY; ROUTINE	Background: Mobile HIV screening may facilitate early HIV diagnosis. Our objective was to examine the cost-effectiveness of adding a mobile screening unit to current medical facility-based HIV testing in Cape Town, South Africa. Methods and Findings: We used the Cost Effectiveness of Preventing AIDS Complications International (CEPAC-I) computer simulation model to evaluate two HIV screening strategies in Cape Town: 1) medical facility-based testing (the current standard of care) and 2) addition of a mobile HIV-testing unit intervention in the same community. Baseline input parameters were derived from a Cape Town-based mobile unit that tested 18,870 individuals over 2 years: prevalence of previously undiagnosed HIV (6.6%), mean CD4 count at diagnosis (males 423/mL, females 516/mL), CD4 count-dependent linkage to care rates (males 31%-58%, females 49%-58%), mobile unit intervention cost (includes acquisition, operation and HIV test costs, $29.30 per negative result and $31.30 per positive result). We conducted extensive sensitivity analyses to evaluate input uncertainty. Model outcomes included site of HIV diagnosis, life expectancy, medical costs, and the incremental cost-effectiveness ratio (ICER) of the intervention compared to medical facility-based testing. We considered the intervention to be "very cost-effective" when the ICER was less than South Africa's annual per capita Gross Domestic Product (GDP) ($8,200 in 2012). We projected that, with medical facility-based testing, the discounted (undiscounted) HIV-infected population life expectancy was 132.2 (197.7) months; this increased to 140.7 (211.7) months with the addition of the mobile unit. The ICER for the mobile unit was $2,400/year of life saved (YLS). Results were most sensitive to the previously undiagnosed HIV prevalence, linkage to care rates, and frequency of HIV testing at medical facilities. Conclusion: The addition of mobile HIV screening to current testing programs can improve survival and be very cost-effective in South Africa and other resource-limited settings, and should be a priority.	[Bassett, Ingrid V.; Hyle, Emily P.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.; Erlwanger, Alison S.; Hyle, Emily P.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bassett, Ingrid V.; Erlwanger, Alison S.; Hyle, Emily P.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Bassett, Ingrid V.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Govindasamy, Darshini; van Schaik, Nienke; Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Wood, Robin] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Tufts Medical Center; Tufts University; Yale University; University of Cape Town; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	ibassett@partners.org	Kranzer, Katharina/O-8845-2014; Bekker, Linda-Gail/AAZ-8929-2020; Bassett, Ingrid V./ABI-7674-2020	Kranzer, Katharina/0000-0001-5691-7270; Bassett, Ingrid V./0000-0001-6920-6080; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Paltiel, A. David/0000-0002-4861-3290	National Institute of Allergy and Infectious Disease [R01 AI058736, T32 AI007433]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; President's Emergency Plan for AIDS Relief (PEPFAR); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program; Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, T32AI007433, U01AI069519, R01AI058736, P30AI060354, UM1AI069519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294, R01MH090326, R01MH073445] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program(United States Agency for International Development (USAID)); Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by: the National Institute of Allergy and Infectious Disease: R01 AI058736, T32 AI007433; the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Mental Health: R01 MH090326, R01 MH073445; the President's Emergency Plan for AIDS Relief (PEPFAR); and the Claflin Distinguished Scholar Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The mobile testing unit was partially funded by PEPFAR through the Anova Health Institute and the United States Agency for International Development program and received further funding through the Agence Francaise de Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, AIDS CARE, V25, P85, DOI 10.1080/09540121.2012.686597; [Anonymous], 2012, NATL TREASURY REPUBL; [Anonymous], 2012, REPUBLIC S AFRICA GL; [Anonymous], 2012, W CAPE BUDGET OVERVI; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; CLEARY S, 2004, COST EFFECTIVENESS A; Cleary S, 2005, S AFRICAN HLTH REV; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammond R, 2008, INT J STD AIDS, V19, P291, DOI 10.1258/ijsa.2007.007248; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; IMF, 2012, INT MON FUND WORLD E; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Matsoso MP, 2012, LETT REACCELERATING; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Medecins Sans Frontieres, 2004, MED SANS FRONTIERS K; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; *SANAC, 2010, S AFR ANT TREATM GUI; SANAC, 2010, S AFR NAT DEP HLTH C; SANAC National Strategic Plan on HIV, STIS TB 2012 2016; Seyler C, 2003, ANTIVIR THER, V8, P385; Shisana O, 2009, S AFRICAN NATL HIV P; Statistics South Africa, 2011, MID POP EST 2011; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; The Clinton Foundation HIV/AIDS Initiative, 2012, ANT PRIC LIST; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; UNAIDS HIV and AIDS Estimates, 2009, UNAIDS HIV AIDS ESTI; van Rooyen H, 2012, AIDS BEHAV, V11; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Venkatesh KK, 2010, FUTURE VIROL, V5, P405, DOI 10.2217/FVL.10.38; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; World Health Organization, 2012, CHOOSING INT AR COST; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	58	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85197	10.1371/journal.pone.0085197	http://dx.doi.org/10.1371/journal.pone.0085197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465503	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100025
J	Caldovic, L; Haskins, N; Mumo, A; Majumdar, H; Pinter, M; Tuchman, M; Krufka, A				Caldovic, Ljubica; Haskins, Nantaporn; Mumo, Amy; Majumdar, Himani; Pinter, Mary; Tuchman, Mendel; Krufka, Alison			Expression Pattern and Biochemical Properties of Zebrafish N-Acetylglutamate Synthase	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; ORNITHINE-UREA CYCLE; ACETYL-L-GLUTAMATE; STINGRAY HIMANTURA-SIGNIFER; BREATHING WALKING CATFISH; TROUT ONCORHYNCHUS-MYKISS; EARLY-LIFE STAGES; FREE AMINO-ACIDS; FRESH-WATER; NITROGEN-METABOLISM	The urea cycle converts ammonia, a waste product of protein catabolism, into urea. Because fish dispose ammonia directly into water, the role of the urea cycle in fish remains unknown. Six enzymes, N-acetylglutamate synthase (NAGS), carbamylphosphate synthetase III, ornithine transcarbamylase, argininosuccinate synthase, argininosuccinate lyase and arginase 1, and two membrane transporters, ornithine transporter and aralar, comprise the urea cycle. The genes for all six enzymes and both transporters are present in the zebrafish genome. NAGS (EC 2.3.1.1) catalyzes the formation of N-acetylglutamate from glutamate and acetyl coenzyme A and in zebrafish is partially inhibited by L-arginine. NAGS and other urea cycle genes are highly expressed during the first four days of zebrafish development. Sequence alignment of NAGS proteins from six fish species revealed three regions of sequence conservation: the mitochondrial targeting signal (MTS) at the N-terminus, followed by the variable and conserved segments. Removal of the MTS yields mature zebrafish NAGS (zfNAGS-M) while removal of the variable segment from zfNAGS-M results in conserved NAGS (zfNAGS-C). Both zfNAGS-M and zfNAGS-C are tetramers in the absence of L-arginine; addition of L-arginine decreased partition coefficients of both proteins. The zfNAGS-C unfolds over a broader temperature range and has higher specific activity than zfNAGS-M. In the presence of L-arginine the apparent V-max of zfNAGS-M and zfNAGS-C decreased, their K-m(app) for acetyl coenzyme A increased while the K-m(app) for glutamate remained unchanged. The expression pattern of NAGS and other urea cycle genes in developing zebrafish suggests that they may have a role in citrulline and/or arginine biosynthesis during the first day of development and in ammonia detoxification thereafter. Biophysical and biochemical properties of zebrafish NAGS suggest that the variable segment may stabilize a tetrameric state of zfNAGS-M and that under physiological conditions zebrafish NAGS catalyzes formation of N-acetylglutamate at the maximal rate.	[Caldovic, Ljubica; Haskins, Nantaporn; Majumdar, Himani; Tuchman, Mendel] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Caldovic, Ljubica] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Haskins, Nantaporn] Univ Maryland, Mol & Cellular Biol Program, College Pk, MD 20742 USA; [Mumo, Amy] Amer Soc Radiat Oncol, Fairfax, VA USA; [Pinter, Mary; Krufka, Alison] Rowan Univ, Dept Biol Sci, Glassboro, NJ USA	Children's National Health System; George Washington University; University System of Maryland; University of Maryland College Park; Rowan University	Caldovic, L (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	lcaldovic@cnmcresearch.org		Krufka, Alison/0000-0002-8921-6291	Public Health Service from the National Institutes of Health [R01DK064913]; Rowan University non-salary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; Rowan University non-salary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant R01DK064913 from the National Institutes of Health and by the Rowan University non-salary financial support grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; ANDERSON PM, 1980, SCIENCE, V208, P291, DOI 10.1126/science.6245445; ANDERSON PM, 1981, J BIOL CHEM, V256, P2228; ANDERSON PM, 1995, NITROGEN METABOLISM, P33; Atkinson B. G., 1995, NITROGEN METABOLISM, P133; BARBOSA P, 1991, J BIOL CHEM, V266, P22319; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; Brusilow S W, 1996, Adv Pediatr, V43, P127; Bucking C, 2013, J EXP ZOOL PART A, V319, P391, DOI 10.1002/jez.1802; Caldovic L, 2006, MOL GENET METAB, V87, P226, DOI 10.1016/j.ymgme.2005.10.003; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2003, HUM GENET, V112, P364, DOI 10.1007/s00439-003-0909-5; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2007, HUM MUTAT, V28, P754, DOI 10.1002/humu.20518; Caldovic L, 2010, MOL GENET METAB, V100, pS13, DOI 10.1016/j.ymgme.2010.02.018; CARLISKY NJ, 1972, COMP BIOCHEM PHYSIOL, V41, P857, DOI 10.1016/0305-0491(72)90099-5; CASEY CA, 1983, J BIOL CHEM, V258, P8723; Chadwick TD, 1999, J EXP BIOL, V202, P2653; Chakraborty AR, 1999, BIOCHEMISTRY-US, V38, P2435, DOI 10.1021/bi982150g; Chew SF, 2006, J EXP BIOL, V209, P484, DOI 10.1242/jeb.02002; Chew SF, 2003, J EXP BIOL, V206, P3615, DOI 10.1242/jeb.00619; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; CHIOU SH, 1991, BIOCHEM J, V273, P295, DOI 10.1042/bj2730295; CHIOU SH, 1994, BIOTECHNOL APPL BIOC, V19, P99; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DABROWSKI KR, 1986, COMP BIOCHEM PHYS A, V85, P639, DOI 10.1016/0300-9629(86)90272-0; de Cima S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034734; DKHAR J, 1991, BIOCHEM INT, V25, P1061; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Essex-Fraser PA, 2005, J BIOL CHEM, V280, P20268, DOI 10.1074/jbc.M412338200; FINN RN, 1995, COMP BIOCHEM PHYS A, V111, P647, DOI 10.1016/0300-9629(95)00048-C; FREEDLAND RA, 1985, FED PROC, V44, P2453; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; GOLDSTEIN L, 1971, COMP BIOCHEM PHYSIOL, V39, P415, DOI 10.1016/0305-0491(71)90186-6; GOLDSTEIN L, 1971, AM J PHYSIOL, V220, P742, DOI 10.1152/ajplegacy.1971.220.3.742; GOLDSTEIN L, 1995, NITROGEN METABOLISM, P91; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Haskins Nantaporn, 2008, BMC Biochemistry, V9, P24, DOI 10.1186/1471-2091-9-24; Hernandez C, 1999, AQUAT TOXICOL, V45, P195, DOI 10.1016/S0166-445X(98)00094-0; Horyn O, 2005, BIOCHEM J, V388, P419, DOI 10.1042/BJ20041260; Ip YK, 2003, J EXP BIOL, V206, P3625, DOI 10.1242/jeb.00612; Julsrud EA, 1998, ARCH BIOCHEM BIOPHYS, V350, P55, DOI 10.1006/abbi.1997.0511; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kharbuli ZY, 2006, COMP BIOCHEM PHYS B, V143, P44, DOI 10.1016/j.cbpb.2005.09.014; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korte JJ, 1997, J BIOL CHEM, V272, P6270, DOI 10.1074/jbc.272.10.6270; LeMoine CMR, 2013, AM J PHYSIOL-REG I, V304, pR991, DOI 10.1152/ajpregu.00411.2012; Lindley TE, 1999, J BIOL CHEM, V274, P29858, DOI 10.1074/jbc.274.42.29858; Loong AM, 2005, J EXP ZOOL PART A, V303A, P354, DOI 10.1002/jez.a.147; MARVIL DK, 1977, J BIOL CHEM, V252, P3295; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Monzani PS, 2008, FISH PHYSIOL BIOCHEM, V34, P139, DOI 10.1007/s10695-007-9154-5; Morizono H, 2004, MOL GENET METAB, V81, pS4, DOI 10.1016/j.ymgme.2003.10.017; Nakada T, 2007, AM J PHYSIOL-REG I, V293, pR1743, DOI 10.1152/ajpregu.00248.2007; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Piatigorsky J, 1996, BBA-PROTEIN STRUCT M, V1295, P158, DOI 10.1016/0167-4838(96)00030-1; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; Rauch GJ, 2003, SUBMISSION CURATION; Rombough P, 2002, J EXP BIOL, V205, P1787; Rombough P.J., 1988, P59; RONNESTAD I, 1992, MAR ECOL PROG SER, V88, P195, DOI 10.3354/meps088195; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; RONNESTAD I, 1992, MAR BIOL, V114, P517, DOI 10.1007/BF00357249; Saha N, 2002, COMP BIOCHEM PHYS A, V132, P353, DOI 10.1016/S1095-6433(02)00044-2; Saha N, 2001, COMP BIOCHEM PHYS A, V128, P137, DOI 10.1016/S1095-6433(00)00282-8; Saha N, 1997, COMP BIOCHEM PHYS B, V116, P57, DOI 10.1016/S0305-0491(96)00193-9; Saheki T, 2002, METAB BRAIN DIS, V17, P335, DOI 10.1023/A:1021961919148; Sancho-Vaello E, 2008, FEBS LETT, V582, P1081, DOI 10.1016/j.febslet.2008.02.060; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Shi DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028825; SHIGESADA K, 1978, EUR J BIOCHEM, V85, P385, DOI 10.1111/j.1432-1033.1978.tb12250.x; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; SIESS EA, 1976, FEBS LETT, V69, P265, DOI 10.1016/0014-5793(76)80701-6; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SMITH S, 1947, J EXP BIOL, V23, P357; STEWART PM, 1980, J BIOL CHEM, V255, P5270; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tam WL, 2003, J EXP BIOL, V206, P2931, DOI 10.1242/jeb.00510; Terjesen BF, 2000, COMP BIOCHEM PHYS B, V126, P521, DOI 10.1016/S0305-0491(00)00221-2; Thisse B, 2004, ZFIN DIRECT DATA SUB; Waterlow JC, 1999, NUTR RES REV, V12, P25, DOI 10.1079/095442299108728857; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wilkie MP, 1996, COMP BIOCHEM PHYS B, V113, P665, DOI 10.1016/0305-0491(95)02092-6; WISTOW G, 1990, P NATL ACAD SCI USA, V87, P6277, DOI 10.1073/pnas.87.16.6277; WRIGHT PA, 1995, J EXP BIOL, V198, P127; Xu Y, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-4	87	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85597	10.1371/journal.pone.0085597	http://dx.doi.org/10.1371/journal.pone.0085597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465614	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100051
J	Schalcher, TR; Borges, RS; Coleman, MD; Batista, J; Salgado, CG; Vieira, JLF; Romao, PRT; Oliveira, FR; Monteiro, MC				Schalcher, Taysa Ribeiro; Borges, Rosivaldo S.; Coleman, Michael D.; Batista Junior, Joao; Salgado, Claudio G.; Vieira, Jose Luiz F.; Romao, Pedro R. T.; Oliveira, Fabio R.; Monteiro, Marta Chagas			Clinical Oxidative Stress during Leprosy Multidrug Therapy: Impact of Dapsone Oxidation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT CAPACITY; N-HYDROXYLATION; METABOLISM; TOXICITY; METHEMOGLOBINEMIA; CYTOCHROME-P450; GLUTATHIONE; GROWTH	This study aims to assess the oxidative stress in leprosy patients under multidrug therapy (MDT; dapsone, clofazimine and rifampicin), evaluating the nitric oxide (NO) concentration, catalase (CAT) and superoxide dismutase (SOD) activities, glutathione (GSH) levels, total antioxidant capacity, lipid peroxidation, and methemoglobin formation. For this, we analyzed 23 leprosy patients and 20 healthy individuals from the Amazon region, Brazil, aged between 20 and 45 years. Blood sampling enabled the evaluation of leprosy patients prior to starting multidrug therapy (called MDT 0) and until the third month of multidrug therapy (MDT 3). With regard to dapsone (DDS) plasma levels, we showed that there was no statistical difference in drug plasma levels between multibacillary (0.518 +/- 0.029 mu g/mL) and paucibacillary (0.662 +/- 0.123 mu g/mL) patients. The methemoglobin levels and numbers of Heinz bodies were significantly enhanced after the third MDT supervised dose, but this treatment did not significantly change the lipid peroxidation and NO levels in these leprosy patients. In addition, CAT activity was significantly reduced in MDT-treated leprosy patients, while GSH content was increased in these patients. However, SOD and Trolox equivalent antioxidant capacity levels were similar in patients with and without treatment. These data suggest that MDT can reduce the activity of some antioxidant enzyme and influence ROS accumulation, which may induce hematological changes, such as methemoglobinemia in patients with leprosy. We also explored some redox mechanisms associated with DDS and its main oxidative metabolite DDS-NHOH and we explored the possible binding of DDS to the active site of CYP2C19 with the aid of molecular modeling software.	[Schalcher, Taysa Ribeiro; Borges, Rosivaldo S.; Vieira, Jose Luiz F.; Oliveira, Fabio R.; Monteiro, Marta Chagas] Univ Fed Para UFPA, Fac Farm, Lab Microbiol & Imunol Clin UFPA, Belem, Para, Brazil; [Schalcher, Taysa Ribeiro; Borges, Rosivaldo S.; Vieira, Jose Luiz F.; Oliveira, Fabio R.; Monteiro, Marta Chagas] Univ Fed Para UFPA, Fac Farm, Programa Posgrad Ciencias Farmaceut, Belem, Para, Brazil; [Coleman, Michael D.] Aston Univ, Dept Pharmaceut Sci, Mechanisms Drug Tox Grp, Birmingham B4 7ET, W Midlands, England; [Batista Junior, Joao] SEP SUL EQ 704 904 CONJ A, Ctr Univ Dist Fed UDF, Brasilia, DF, Brazil; [Salgado, Claudio G.] Univ Fed Para UFPA, Inst Ciencias Biol, Programa Posgrad Neurociencias & Biol Celular, Belem, Para, Brazil; [Romao, Pedro R. T.] Univ Fed Ciencias Saude Porto Alegre, Programa Posgrad Ciencias Saude, Porto Alegre, RS, Brazil	Universidade Federal do Para; Universidade Federal do Para; Aston University; Centro Universitario do Distrito Federal; Universidade Federal do Para; Universidade Federal de Ciencias da Saude de Porto Alegre	Monteiro, MC (corresponding author), Univ Fed Para UFPA, Fac Farm, Lab Microbiol & Imunol Clin UFPA, Rua Augusto Correa, Belem, Para, Brazil.	martachagas2@yahoo.com.br	Borges, Rosivaldo/U-3039-2019; vieira, jose luiz/F-9032-2012; Borges, Rosivaldo RSB/K-4807-2016; Romao, Pedro R/N-4826-2015; Salgado, Claudio G/C-5206-2014; Monteiro, Marta C./F-6575-2010; Salgado, Claudio G/K-8931-2012; Coleman, Michael Damian/AAD-5503-2019; Júnior, João Batista/ABB-2303-2020	Borges, Rosivaldo/0000-0003-4072-7573; Romao, Pedro R/0000-0002-1039-2509; Salgado, Claudio G/0000-0003-3961-7764; Monteiro, Marta C./0000-0002-3328-5650; Salgado, Claudio G/0000-0003-3961-7764; Júnior, João Batista/0000-0002-8972-8131; Coleman, MIchael D/0000-0002-5510-6852	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos do Governo Federal, FAPESPA; Federal University of Para/PA; CNPq scholarship	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos do Governo Federal, FAPESPA; Federal University of Para/PA; CNPq scholarship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos do Governo Federal, FAPESPA and Federal University of Para/PA. PRTR and MCM were recipients of fellowships from CNPq, while CGS has a CNPq scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P317; Banerjee P, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nen090; Barnes J, 1951, LEPROSY REV, V12, P54; Imbiriba ENB, 2009, REV SAUDE PUBL, V43, P656, DOI 10.1590/S0034-89102009005000046; Beutler E., 1975, RED CELL METABOLISM, P8; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bohm HJ, 2008, VIRTUAL SCREENING BI; Borges RS, 2013, J COMPUT THEOR NANOS, V10, P2029, DOI 10.1166/jctn.2013.3165; Carrazza MZN, 2000, REV SAUDE PUBL, V34, P396, DOI 10.1590/S0034-89102000000400013; Coleman MD, 2004, ENVIRON TOXICOL PHAR, V17, P55, DOI 10.1016/j.etap.2004.01.005; Coleman MD, 1996, DRUG SAFETY, V14, P394, DOI 10.2165/00002018-199614060-00005; COLEMAN MD, 1993, BRIT J DERMATOL, V129, P507, DOI 10.1111/j.1365-2133.1993.tb00476.x; Dalpino D., 1998, Hansenologia Internationalis, V23, P14; de Moraes NV, 2008, REV BRAS CIENC FARM, V44, P97, DOI 10.1590/S1516-93322008000100011; ELLARD GA, 1966, BRIT J PHARM CHEMOTH, V26, P212, DOI 10.1111/j.1476-5381.1966.tb01823.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Vieira JLF, 2010, BRAZ J INFECT DIS, V14, P319, DOI 10.1590/S1413-86702010000300022; FLEMING CM, 1992, MOL PHARMACOL, V41, P975; Ganesan S, 2010, J APPL TOXICOL, V30, P271, DOI 10.1002/jat.1493; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Gill HJ, 1995, BRIT J CLIN PHARMACO, V40, P531, DOI 10.1111/j.1365-2125.1995.tb05797.x; de Sousa MWG, 2012, AN BRAS DERMATOL, V87, P389, DOI 10.1590/S0365-05962012000300006; Grace Mary, 2011, Indian Dermatol Online J, V2, P88, DOI 10.4103/2229-5178.85999; Granger DL, 1999, METHOD ENZYMOL, V301, P49; Hummel MA, 2004, BIOCHEM PHARMACOL, V67, P1831, DOI 10.1016/j.bcp.2004.01.017; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; Khanolkar-Young S, 1998, CLIN EXP IMMUNOL, V113, P438; Kwadijk S, 2002, BIOMED CHROMATOGR, V16, P203, DOI 10.1002/bmc.132; Mahmud R, 1997, TOXICOLOGY, V117, P1, DOI 10.1016/S0300-483X(96)03548-2; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mendes APS, 2011, J COMPUT THEOR NANOS, V8, P1428, DOI 10.1166/jctn.2011.1832; MITRA AK, 1995, CLIN PHARMACOL THER, V58, P556, DOI 10.1016/0009-9236(95)90176-0; Osadolor HB, 2008, CONTINENTAL J BIOMED, V2, P1; Patten AR, 2013, J NUTR BIOCHEM, V24, P760, DOI 10.1016/j.jnutbio.2012.04.003; Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16; Prasad CVB, 2007, LEPROSY REV, V78, P391; Price D, 1994, GOLDFRANKS TOXICOLOG, P1169; Queiroz R H, 1997, Pharm Acta Helv, V72, P209, DOI 10.1016/S0031-6865(97)00016-2; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; REIMER DL, 1994, GENOMICS, V21, P325, DOI 10.1006/geno.1994.1273; Reynald RL, 2012, J BIOL CHEM, V287, P44581, DOI 10.1074/jbc.M112.424895; RIMIOLLI LF, 2001, HANSENOL INT, V26, P93; Romao PRT, 2006, BRAZ J MED BIOL RES, V39, P355, DOI 10.1590/S0100-879X2006000300006; Sanches LAT, 2007, REV SOC BRAS MED TRO, V40, P541, DOI 10.1590/S0037-86822007000500010; Schalcher TR, 2013, REV SOC BRAS MED TRO, V46, P645, DOI 10.1590/0037-8682-1506-2013; Schon T, 2001, BRIT J DERMATOL, V145, P809, DOI 10.1046/j.1365-2133.2001.04491.x; SMITH RS, 1959, BMJ-BRIT MED J, V1, P625, DOI 10.1136/bmj.1.5122.625; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Szabo A., 2012, MODERN QUANTUM CHEM; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Tingle MD, 1997, J PHARMACOL EXP THER, V283, P817; Trindade MAB, 2008, HANSEN INT, V33, P31; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; Veggi LM, 2008, LIFE SCI, V83, P155, DOI 10.1016/j.lfs.2008.05.016; WHITE JC, 1959, BRIT MED BULL, V15, P33, DOI 10.1093/oxfordjournals.bmb.a069711; World Health Organization, 2012, WEEKLY EPIDEMIOLOGIC, V34, P87; WRIGHT JD, 1995, BRIT J CLIN PHARMACO, V39, P441, DOI 10.1111/j.1365-2125.1995.tb04474.x; Zoete V, 2009, J CELL MOL MED, V13, P238, DOI 10.1111/j.1582-4934.2008.00665.x; ZUIDEMA J, 1986, CLIN PHARMACOKINET, V11, P299, DOI 10.2165/00003088-198611040-00003	59	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85712	10.1371/journal.pone.0085712	http://dx.doi.org/10.1371/journal.pone.0085712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465659	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330283100064
J	Schnittker, J; Bacak, V				Schnittker, Jason; Bacak, Valerio			The Increasing Predictive Validity of Self-Rated Health	PLOS ONE			English	Article							UNITED-STATES; MEDICAL-CARE; MORTALITY; TRENDS; INFORMATION; INTERNET; QUALITY; ILLNESS; CANCER; LIFE	Using the 1980 to 2002 General Social Survey, a repeated cross-sectional study that has been linked to the National Death Index through 2008, this study examines the changing relationship between self-rated health and mortality. Research has established that self-rated health has exceptional predictive validity with respect to mortality, but this validity may be deteriorating in light of the rapid medicalization of seemingly superficial conditions and increasingly high expectations for good health. Yet the current study shows the validity of self-rated health is increasing over time. Individuals are apparently better at assessing their health in 2002 than they were in 1980 and, for this reason, the relationship between self-rated health and mortality is considerably stronger across all levels of self-rated health. Several potential mechanisms for this increase are explored. More schooling and more cognitive ability increase the predictive validity of self-rated health, but neither of these influences explains the growing association between self-rated health and mortality. The association is also invariant to changing causes of death, including a decline in accidental deaths, which are, by definition, unanticipated by the individual. Using data from the final two waves of data, we find suggestive evidence that exposure to more health information is the driving force, but we also show that the source of information is very important. For example, the relationship between self-rated health and mortality is smaller among those who use the internet to find health information than among those who do not.	[Schnittker, Jason; Bacak, Valerio] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	University of Pennsylvania	Schnittker, J (corresponding author), Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA.	jschnitt@ssc.upenn.edu		Bacak, Valerio/0000-0001-7074-7677				[Anonymous], HLTH US 2006; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Bernstam EV, 2008, CANCER-AM CANCER SOC, V112, P1206, DOI 10.1002/cncr.23308; Bopp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030795; Cassels Alan., 2012, SEEKING SICKNESS MED; Clarke AE, 2003, AM SOCIOL REV, V68, P161, DOI 10.2307/1519765; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Conrad P, 2007, MED SOC; COX DR, 1972, J R STAT SOC B, V34, P187; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dowd JB, 2007, INT J EPIDEMIOL, V36, P1214, DOI 10.1093/ije/dym214; Elliot C, 2004, BETTER WELL AM MED M; Flynn, 2007, WHAT IS INTELLIGENCE; Ford J, 2008, AGE AGEING, V37, P194, DOI 10.1093/ageing/afm171; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Howard DH, 2009, HEALTH AFFAIR, V28, P1838, DOI 10.1377/hlthaff.28.6.1838; Huisman M, 2007, INT J EPIDEMIOL, V36, P1207, DOI 10.1093/ije/dym095; Idler E, 2004, J HEALTH SOC BEHAV, V45, P336, DOI 10.1177/002214650404500307; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Malhotra N., 2007, METHODOLOGICAL REPOR, V11; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Mechanic David, 2006, TRUTH HLTH CARE WHY; Muennig Peter, 2011, BMC Res Notes, V4, P385, DOI 10.1186/1756-0500-4-385; Pew Research Centre, 2011, SOC LIF HLTH INF 201; Salomon JA, 2009, AM J EPIDEMIOL, V170, P343, DOI 10.1093/aje/kwp144; Schnittker J, 2009, SOC FORCES, V87, P2155; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Seale C., 2002, MEDIA HLTH, DOI 10.4135/9781446216286; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Smith JP, 2004, POPUL DEV REV, V30, P108; Smith T. W., 2011, GEN SOC SURVEY 1972; Thorndike RL, 1942, J APPL PSYCHOL, V26, P128, DOI 10.1037/h0060053; Tiefer L., 2006, SEXUALITIES, V9, P273, DOI [10.1177/1363460706065049, DOI 10.1177/1363460706065049]; Vaisey S, 2006, SOC FORCES, V85, P835, DOI 10.1353/sof.2007.0028; Viswanath K, 2005, NAT REV CANCER, V5, P828, DOI 10.1038/nrc1718; Wakefield, 2007, LOSS SADNESS PSYCHIA; Welch HG, 2011, OVERIDAGNOSED MAKING; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; Williams W. M., 1998, RISING CURVE LONG TE, P125; Zack MM, 2004, PUBLIC HEALTH REP, V119, P493, DOI 10.1016/j.phr.2004.07.007; Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x	47	284	287	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84933	10.1371/journal.pone.0084933	http://dx.doi.org/10.1371/journal.pone.0084933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465452	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100017
J	van Dommelen, P; de Kroon, MLA; Cameron, N; Schonbeck, Y; van Buuren, S				van Dommelen, Paula; de Kroon, Marlou L. A.; Cameron, Noel; Schonbeck, Yvonne; van Buuren, Stef			The Impact of Height during Childhood on the National Prevalence Rates of Overweight	PLOS ONE			English	Article							CHILDREN; OBESITY; GROWTH; ADIPOSITY; PATTERNS; RISK; BMI; AGE; STANDARDS; ADULTS	Background: It is known that height and body mass index (BMI) are correlated in childhood. However, its impact on the (trend of) national prevalence rates of overweight and obesity has never been investigated. The aim of our study is to investigate the relation between height and national prevalence rates of overweight and obesity in childhood between 1980, 1997, and 2009, and to calculate which fixed value of p (2.0,2.1,., 3.0) in kg/m(p) during childhood is most accurate in predicting adult overweight. Methods and findings: Cross-sectional growth data of children from three Dutch nationwide surveys in 1980, 1997, and 2009, and longitudinal data from the Terneuzen Birth Cohort and the Harpenden Growth Study were used. Relative risks (RR) and 95% confidence intervals (CI) were calculated. Our study showed that tall (. 1 standard deviation (SD)) girls aged 5.0-13.9 y were more often overweight (RR = 3.5,95% CI: 2.8-4.4) and obese (RR = 3.9,95% CI: 2.1-7.4) than short girls (, 21 SD). Similar results were found in boys aged 5.0-14.9 y (RR = 4.4,95% CI: 3.4-5.7 and RR = 5.3,95% CI: 2.6-11.0). No large differences were found in the other age groups and in comparison with children with an average stature. Tall boys aged 2.0-4.9 y had a significantly higher positive trend in overweight between 1980 and 1997 compared to short boys (RR = 4.0,95% CI: 1.38-11.9). For other age groups and in girls, no significant trends were found. The optimal Area Under the Curve (AUC) to predict adult overweight was found for p = 2.0. Conclusions and significance: Tall girls aged 5.0-13.9y and tall boys 5.0-14.9 have much higher prevalence rates of overweight and obesity than their shorter peers. We suggest taking into account the impact of height when evaluating trends and variations of BMI distributions in childhood, and to use BMI to predict adult overweight.	[van Dommelen, Paula; van Buuren, Stef] TNO, Dept Life Style, Leiden, Netherlands; [de Kroon, Marlou L. A.] Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Cameron, Noel] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Schonbeck, Yvonne] TNO, Dept Child Hlth, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Loughborough University; Netherlands Organization Applied Science Research; Utrecht University	van Dommelen, P (corresponding author), TNO, Dept Life Style, Leiden, Netherlands.	Paula.vanDommelen@tno.nl	de Kroon, Marlou MLA/M-4040-2014	van Buuren, Stef/0000-0003-1098-2119; Schonbeck, Yvonne/0000-0002-4998-5117; de Kroon, Marlou/0000-0003-1730-4994				Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; Ambrosini GL, 2013, P NUTR SOC, P1; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Buchan IE, 2007, INT J OBESITY, V31, P23, DOI 10.1038/sj.ijo.0803435; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1986, ANN HUM BIOL, V13, P433, DOI 10.1080/03014468600008621; Corvalan C, 2012, SKELETAL MATURATION; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Freedman DS, 2004, OBES RES, V12, P846, DOI 10.1038/oby.2004.102; Freedman DS, 2004, INT J OBESITY, V28, P10, DOI 10.1038/sj.ijo.0802544; Freedman DS, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e23; Frontini MG, 2001, J CLIN EPIDEMIOL, V54, P817, DOI 10.1016/S0895-4356(01)00343-2; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Johnson W, 2012, INT J OBESITY, V36, P535, DOI 10.1038/ijo.2011.238; MARUBINI E, 1972, HUM BIOL, V44, P511; McArdle WD, 2010, EXERCISE PHYSL NUTR, V7th; Metcalf BS, 2011, INT J OBESITY, V35, P541, DOI 10.1038/ijo.2010.258; Mulligan J, 1999, BRIT MED J, V319, P1103, DOI 10.1136/bmj.319.7217.1103; ROEDE MJ, 1985, TIJDSCHR SOC GEZON S, V63, P1, DOI DOI 10.1007/978-1-4471-1721-6_10; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Stovitz SD, 2008, OBESITY, V16, P2336, DOI 10.1038/oby.2008.359; Stovitz SD, 2010, AM J PREV MED, V38, P74, DOI 10.1016/j.amepre.2009.09.033; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Telford RD, 2008, OBESITY, V16, P2173, DOI 10.1038/oby.2008.332; van Buuren S, 2009, STAT MED, V28, P1569, DOI 10.1002/sim.3567; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85769	10.1371/journal.pone.0085769	http://dx.doi.org/10.1371/journal.pone.0085769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465694	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100071
J	Carbonero, F; Oakley, BB; Purdy, KJ				Carbonero, Franck; Oakley, Brian B.; Purdy, Kevin J.			Metabolic Flexibility as a Major Predictor of Spatial Distribution in Microbial Communities	PLOS ONE			English	Article							ESTUARINE GRADIENT; ECOLOGICAL SPECIALIZATION; GENOTYPIC DISTRIBUTION; BACTERIAL COMMUNITIES; MODEL MICROORGANISM; SULFATE REDUCTION; ORGANIC-MATTER; RIBOSOMAL-RNA; UK ESTUARY; DIVERSITY	A better understand the ecology of microbes and their role in the global ecosystem could be achieved if traditional ecological theories can be applied to microbes. In ecology organisms are defined as specialists or generalists according to the breadth of their niche. Spatial distribution is often used as a proxy measure of niche breadth; generalists have broad niches and a wide spatial distribution and specialists a narrow niche and spatial distribution. Previous studies suggest that microbial distribution patterns are contrary to this idea; a microbial generalist genus (Desulfobulbus) has a limited spatial distribution while a specialist genus (Methanosaeta) has a cosmopolitan distribution. Therefore, we hypothesise that this counter-intuitive distribution within generalist and specialist microbial genera is a common microbial characteristic. Using molecular fingerprinting the distribution of four microbial genera, two generalists, Desulfobulbus and the methanogenic archaea Methanosarcina, and two specialists, Methanosaeta and the sulfate-reducing bacteria Desulfobacter were analysed in sediment samples from along a UK estuary. Detected genotypes of both generalist genera showed a distinct spatial distribution, significantly correlated with geographic distance between sites. Genotypes of both specialist genera showed no significant differential spatial distribution. These data support the hypothesis that the spatial distribution of specialist and generalist microbes does not match that seen with specialist and generalist large organisms. It may be that generalist microbes, while having a wider potential niche, are constrained, possibly by intrageneric competition, to exploit only a small part of that potential niche while specialists, with far fewer constraints to their niche, are more capable of filling their potential niche more effectively, perhaps by avoiding intrageneric competition. We suggest that these counter-intuitive distribution patterns may be a common feature of microbes in general and represent a distinct microbial principle in ecology, which is a real challenge if we are to develop a truly inclusive ecology.	[Carbonero, Franck; Oakley, Brian B.; Purdy, Kevin J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Carbonero, Franck] Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA; [Oakley, Brian B.] ARS, USDA, Richard B Russell Res Ctr, Athens, GA USA	University of Warwick; University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA)	Purdy, KJ (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	k.purdy@warwick.ac.uk	Carbonero, Franck/L-2292-2019; Oakley, Brian Oakley B/AAG-4015-2019; Carbonero, Franck/AAF-9523-2019; Purdy, Kevin/A-1900-2009	Carbonero, Franck/0000-0003-3389-3725; Purdy, Kevin/0000-0002-2997-9342; Oakley, Brian/0000-0003-2098-6439	EU Commission [MEXT-CT-2005-024112]; NERC [NE/J024503/1] Funding Source: UKRI; Natural Environment Research Council [NE/J024503/1] Funding Source: researchfish	EU Commission(European CommissionEuropean Commission Joint Research Centre); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was performed as part of an EU Commission funded Marie Curie Excellence Grant for Teams, MicroComXT (MEXT-CT-2005-024112) to KJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Begon M., 1996, ECOLOGY; Boone DR, 2001, BERGEYS MANUAL SYSTE, P269; Brenner D. J., 2005, BERGEYS MANUAL SYSTE, Vtwo, P961; Carbonero F, 2012, MICROB ECOL, V63, P856, DOI 10.1007/s00248-011-9993-6; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fitzsimons MF, 2001, ENVIRON EXP BOT, V46, P225, DOI 10.1016/S0098-8472(01)00102-2; Flynn AM, 2008, J COASTAL RES, P76, DOI 10.2112/SI55-010.1; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P179, DOI 10.1046/j.1466-822x.2001.00225.x; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hawkins RJ, 2007, FEMS MICROBIOL ECOL, V62, P187, DOI 10.1111/j.1574-6941.2007.00376.x; JORGENSEN BB, 1977, MAR BIOL, V41, P7, DOI 10.1007/BF00390576; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kuever J, 2005, BERGEYS MANUAL SYSTE, V2, P988; LAANBROEK HJ, 1982, ARCH MICROBIOL, V133, P178, DOI 10.1007/BF00414998; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; MANTEL N, 1980, AM J EPIDEMIOL, V112, P129, DOI 10.1093/oxfordjournals.aje.a112962; Nedwell DB, 2004, AQUAT MICROB ECOL, V37, P209, DOI 10.3354/ame037209; Oakley BB, 2012, ISME J, V6, P905, DOI 10.1038/ismej.2011.165; Oakley BB, 2011, FEMS MICROBIOL ECOL, V77, P17, DOI 10.1111/j.1574-6941.2011.01079.x; Oakley BB, 2010, ISME J, V4, P488, DOI 10.1038/ismej.2009.146; Patel GB, 2001, BERGEYS MANUAL SYSTE, P289; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Purdy KJ, 2005, METHOD ENZYMOL, V397, P271, DOI 10.1016/S0076-6879(05)97016-X; Purdy KJ, 1996, APPL ENVIRON MICROB, V62, P3905, DOI 10.1128/AEM.62.10.3905-3907.1996; Purdy KJ, 2003, FEMS MICROBIOL ECOL, V44, P361, DOI 10.1016/S0168-6496(03)00078-3; Purdy KJ, 2002, FEMS MICROBIOL ECOL, V39, P17, DOI 10.1111/j.1574-6941.2002.tb00902.x; Purdy KJ, 2011, ADV ECOLOG RES, V43, P88; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Silva S, 2004, ACTIVITY DIVERSITY S; SPOONER GM, 1947, J MAR BIOL ASSOC UK, V27, P1, DOI 10.1017/S0025315400014107; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x	46	34	34	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85105	10.1371/journal.pone.0085105	http://dx.doi.org/10.1371/journal.pone.0085105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465487	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500037
J	Hagmann, H; Bossung, V; Belaidi, AA; Fridman, A; Karumanchi, SA; Thadhani, R; Schermer, B; Mallmann, P; Schwarz, G; Benzing, T; Brinkkoetter, PT				Hagmann, Henning; Bossung, Verena; Belaidi, Abdel Ali; Fridman, Alexander; Karumanchi, S. Ananth; Thadhani, Ravi; Schermer, Bernhard; Mallmann, Peter; Schwarz, Guenter; Benzing, Thomas; Brinkkoetter, Paul T.			Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; TYROSINE KINASE 1; ANGIOGENIC FACTORS; SOLUBLE ENDOGLIN; EARLY-PREGNANCY; WOMEN; RISK; PREECLAMPSIA; PERMSELECTIVITY; MACROMOLECULES	Rationale: Preeclampsia is a devastating medical complication of pregnancy which leads to maternal and fetal morbidity and mortality. While the etiology of preeclampsia is unclear, human and animal studies suggest that excessive circulating levels of soluble fms-like tyrosine-kinase-1 (sFlt-1), an alternatively spliced variant of VEGF-receptor1, contribute to the signs and symptoms of preeclampsia. Since sFlt-1 binds to heparin and heparan sulfate proteoglycans, we hypothesized that the anticoagulant heparin, which is often used in pregnancy, may interfere with the levels, distribution and elimination of sFlt-1 in vivo. Objective: We systematically determined serum and urine levels of angiogenic factors in preeclamptic women before and after administration of low molecular weight heparin and further characterized the interaction with heparin in biochemical studies. Methods and Results: Serum and urine samples were used to measure sFlt-1 levels before and after heparin administration. Serum levels of sFlt-1 increased by 25% after heparin administration in pregnant women. The magnitude of the increase in circulating sFlt-1 correlated with initial sFlt-1 serum levels. Urinary sFlt-1 levels were also elevated following heparin administration and levels of elimination were dependent on the underlying integrity of the glomerular filtration barrier. Biochemical binding studies employing cation exchange chromatography revealed that heparin bound sFlt-1 had decreased affinity to negatively charged surfaces when compared to sFlt-1 alone. Conclusion: Low molecular weight heparin administration increased circulating sFlt1 levels and enhanced renal elimination. We provide evidence that both effects may be due to heparin binding to sFlt1 and masking the positive charges on sFlt1 protein.	[Hagmann, Henning; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.] Univ Cologne, Div Nephrol, Dept Internal Med, D-50931 Cologne, Germany; [Hagmann, Henning; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Bossung, Verena; Fridman, Alexander; Mallmann, Peter] Univ Cologne, Dept Obstet & Gynecol, D-50931 Cologne, Germany; [Belaidi, Abdel Ali; Schwarz, Guenter] Univ Cologne, Dept Biochem, D-50931 Cologne, Germany; [Karumanchi, S. Ananth] Howard Hughes Med Inst, Boston, MA 02115 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Karumanchi, S. Ananth] Harvard Univ, Sch Med, Boston, MA USA; [Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol,Dept Med, Boston, MA USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hagmann, H (corresponding author), Univ Cologne, Div Nephrol, Dept Internal Med, D-50931 Cologne, Germany.	henning.hagmann@uk-koeln.de	Karumanchi, Subbian Ananth/AAI-1694-2021; Schwarz, Guenter/ABE-9643-2021; Belaidi, Abdel Ali/T-7593-2017; Bossung, Verena/GOV-6766-2022; Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019	Schwarz, Guenter/0000-0002-2118-9338; Belaidi, Abdel Ali/0000-0003-0792-8728; Bossung, Verena/0000-0001-5561-1827; Schermer, Bernhard/0000-0002-5194-9000; 	Forschungspool "Klinische Studien", Faculty of Medicine, University of Cologne; DFG [SFB 635, BR2955]	Forschungspool "Klinische Studien", Faculty of Medicine, University of Cologne; DFG(German Research Foundation (DFG))	This work was supported by Forschungspool "Klinische Studien", Faculty of Medicine, University of Cologne and by the DFG (SFB 635 to T. B. and BR2955 to P. T. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583; BRENNER BM, 1977, KIDNEY INT, V12, P229, DOI 10.1038/ki.1977.107; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V192, P734, DOI 10.1016/j.ajog.2004.12.052; CHANG RLS, 1975, BIOPHYS J, V15, P887, DOI 10.1016/S0006-3495(75)85863-2; Conserva V, 2012, J MATERN-FETAL NEO M, V25, P1467, DOI 10.3109/14767058.2011.643326; DEEN WM, 1979, KIDNEY INT, V16, P353, DOI 10.1038/ki.1979.138; Diab AE, 2008, INT J GYNECOL OBSTET, V102, P146, DOI 10.1016/j.ijgo.2008.02.016; Dodd JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006780.pub2; Drewlo S, 2011, J THROMB HAEMOST, V9, P2486, DOI 10.1111/j.1538-7836.2011.04526.x; Espinoza J, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.002; Hagmann H, 2012, CLIN CHEM, V58, P837, DOI 10.1373/clinchem.2011.169094; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kupferminc M, 2011, BLOOD COAGUL FIBRIN, V22, P123, DOI 10.1097/MBC.0b013e328343315c; Kupferminc MJ, 2011, J MATERN-FETAL NEO M, V24, P1042, DOI 10.3109/14767058.2010.545911; Kupferminc MJ, 2001, HYPERTENS PREGNANCY, V20, P35, DOI 10.1081/PRG-100104170; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Martinelli I, 2012, BLOOD, V119, P3269, DOI 10.1182/blood-2011-11-391383; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mello G, 2005, HYPERTENSION, V45, P86, DOI 10.1161/01.HYP.0000149950.05182.a3; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts J, 1998, LANCET, P19; Rosenberg VA, 2011, CIRCULATION, V124, P2543, DOI 10.1161/CIRCULATIONAHA.111.046821; Salahuddin S, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.010; Schiettecatte J, 2010, CLIN BIOCHEM, V43, P768, DOI 10.1016/j.clinbiochem.2010.02.010; Searle J, 2011, ARTERIOSCL THROM VAS, V31, P2972, DOI 10.1161/ATVBAHA.111.237784; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Stepan H, 2007, HYPERTENSION, V49, P818, DOI 10.1161/01.HYP.0000258404.21552.a3; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Sunderji S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.025; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016	41	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85258	10.1371/journal.pone.0085258	http://dx.doi.org/10.1371/journal.pone.0085258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465515	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500046
J	Jia, ZY; Lilly, MB; Koziol, JA; Chen, X; Xia, XQ; Wang, YP; Skarecky, D; Sutton, M; Sawyers, A; Ruckle, H; Carpenter, PM; Wang-Rodriguez, J; Jiang, J; Deng, MS; Pan, C; Zhu, JG; McLaren, CE; Gurley, MJ; Lee, C; McClelland, M; Ahlering, T; Kattan, MW; Mercola, D				Jia, Zhenyu; Lilly, Michael B.; Koziol, James A.; Chen, Xin; Xia, Xiao-Qin; Wang, Yipeng; Skarecky, Douglas; Sutton, Manuel; Sawyers, Anne; Ruckle, Herbert; Carpenter, Philip M.; Wang-Rodriguez, Jessica; Jiang, Jun; Deng, Mingsen; Pan, Cong; Zhu, Jian-guo; McLaren, Christine E.; Gurley, Michael J.; Lee, Chung; McClelland, Michael; Ahlering, Thomas; Kattan, Michael W.; Mercola, Dan			Generation of "Virtual" Control Groups for Single Arm Prostate Cancer Adjuvant Trials	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; RADICAL PROSTATECTOMY; POSTOPERATIVE NOMOGRAMS; SMOOTHING SCATTERPLOTS; PREOPERATIVE NOMOGRAM; 10-YEAR PROBABILITY; DISEASE RECURRENCE; CLINICAL-TRIAL; FOLLOW-UP; HIGH-RISK	It is difficult to construct a control group for trials of adjuvant therapy (Rx) of prostate cancer after radical prostatectomy (RP) due to ethical issues and patient acceptance. We utilized 8 curve-fitting models to estimate the time to 60%, 65%, ... 95% chance of progression free survival (PFS) based on the data derived from Kattan post-RP nomogram. The 8 models were systematically applied to a training set of 153 post-RP cases without adjuvant Rx to develop 8 subsets of cases (reference case sets) whose observed PFS times were most accurately predicted by each model. To prepare a virtual control group for a single-arm adjuvant Rx trial, we first select the optimal model for the trial cases based on the minimum weighted Euclidean distance between the trial case set and the reference case set in terms of clinical features, and then compare the virtual PFS times calculated by the optimum model with the observed PFSs of the trial cases by the logrank test. The method was validated using an independent dataset of 155 post-RP patients without adjuvant Rx. We then applied the method to patients on a Phase II trial of adjuvant chemo-hormonal Rx post RP, which indicated that the adjuvant Rx is highly effective in prolonging PFS after RP in patients at high risk for prostate cancer recurrence. The method can accurately generate control groups for single-arm, post-RP adjuvant Rx trials for prostate cancer, facilitating development of new therapeutic strategies.	[Jia, Zhenyu; Lee, Chung] Univ Akron, Dept Stat, Akron, OH 44325 USA; [Lilly, Michael B.] Med Univ S Carolina, Div Hematol Oncol, Charleston, SC 29425 USA; [Koziol, James A.] Ashford Univ, Coll Hlth Human Serv & Sci, San Diego, CA 92128 USA; [Chen, Xin; Sutton, Manuel; Sawyers, Anne; Carpenter, Philip M.; Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Xia, Xiao-Qin] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Wang, Yipeng] AltheaDx Inc, San Diego, CA USA; [Skarecky, Douglas; Ahlering, Thomas] Univ Calif Irvine, Dept Urol, Irvine, CA USA; [Ruckle, Herbert] Loma Linda Univ, Dept Urol, Loma Linda, CA 92350 USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Jia, Zhenyu; Jiang, Jun; Deng, Mingsen; Pan, Cong; Zhu, Jian-guo] Guizhou Normal Coll, Guizhou Prov Key Lab Computat Nanomat Sci, Guiyang, Peoples R China; [Zhu, Jian-guo] Guizhou Prov Peoples Hosp, Dept Urol, Guiyang, Guizhou, Peoples R China; [McLaren, Christine E.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Gurley, Michael J.; Lee, Chung] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [McClelland, Michael] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Kattan, Michael W.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Jia, Zhenyu] Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH USA	University System of Ohio; University of Akron; Medical University of South Carolina; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; University of California System; University of California Irvine; Loma Linda University; University of California System; University of California San Diego; Guizhou Education University; University of California System; University of California Irvine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Irvine; Cleveland Clinic Foundation; Northeast Ohio Medical University (NEOMED)	Jia, ZY (corresponding author), Univ Akron, Dept Stat, Akron, OH 44325 USA.	zjia@uakron.edu	mercola, dan/L-4182-2013; Chen, Xin/ABA-3794-2020; Deng, Mingsen/AAH-4808-2021; Kattan, Michael/AAF-9735-2021	mercola, dan/0000-0002-0281-9840; Deng, Mingsen/0000-0002-3331-3850; Kattan, Michael/0000-0002-3840-4161; Ahlering, Thomas/0000-0002-6492-4910; xia, xiao qin/0000-0002-8034-1096; McClelland, Michael/0000-0003-1788-9347	United States National Institutes of Health [NCI UO1CA11480, NCI UO1CA152738]; University of California Irvine Faculty Career Development Award; University of California Chao Family Comprehensive Cancer Center Seed Grant; National Cancer Institute [P30CA062203]; CDMRP [W81XWH-08-1-0720]; NATIONAL CANCER INSTITUTE [P30CA062203, U01CA152738] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Irvine Faculty Career Development Award; University of California Chao Family Comprehensive Cancer Center Seed Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CDMRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by United States National Institutes of Health grants NCI UO1CA11480 and NCI UO1CA152738 to D. Mercola and the University of California Irvine Faculty Career Development Award and Chao Family Comprehensive Cancer Center Seed Grant to Z. Jia. M. McClelland was supported in part by Award Number P30CA062203 from the National Cancer Institute and W81XWH-08-1-0720 from the CDMRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2007, J CLIN ONCOL, V25, P675, DOI 10.1200/JCO.2006.07.0649; Cantor AB, 1996, CONTROL CLIN TRIALS, V17, P111, DOI 10.1016/S0197-2456(96)80002-X; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045178; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Creelman CD, 1998, CONTEMP PSYCHOL, V43, P840, DOI 10.1037/001877; Ebrahimi K, 2008, J UROLOGY, V179, P558, DOI 10.1016/S0022-5347(08)61643-2; Gulley JL, 2010, CANCER IMMUNOL IMMUN, V59, P663, DOI 10.1007/s00262-009-0782-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heller G, 2007, MED DECIS MAKING, V27, P380, DOI 10.1177/0272989X07303826; Jia Z, 2012, ANTICANCER AGENTS ME; Jia ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041371; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kattan Michael W, 2002, Semin Urol Oncol, V20, P79; Kattan MW, 2009, CANCER-AM CANCER SOC, V115, P1005, DOI 10.1002/cncr.24083; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Kibel AS, 2007, J UROLOGY, V177, P1777, DOI 10.1016/j.juro.2007.01.028; Kumar S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006019.pub2; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Messing EM, 2006, LANCET ONCOL, V7, P472, DOI 10.1016/S1470-2045(06)70700-8; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Petrylak DP, 1999, SEMIN ONCOL, V26, P28; RUBINSTEIN LV, 1981, J CHRON DIS, V34, P469, DOI 10.1016/0021-9681(81)90007-2; SCHOENBERG IJ, 1946, Q APPL MATH, V4, P112, DOI 10.1090/qam/16705; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Swanson GP, 2011, UROLOGY, V78, P105, DOI 10.1016/j.urology.2011.01.061; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Wilcoxon F., 1946, J ECON ENTOMOL, V39, P269, DOI DOI 10.2307/3001968	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85010	10.1371/journal.pone.0085010	http://dx.doi.org/10.1371/journal.pone.0085010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465467	gold, Green Published			2022-12-27	WOS:000330244500028
J	Novick, D; Barak, S; Ilan, N; Vlodavsky, I				Novick, Daniela; Barak, Sara; Ilan, Neta; Vlodavsky, Israel			Heparanase Interacts with Resistin and Augments Its Activity	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; MAMMALIAN HEPARANASE; INSULIN-RESISTANCE; CELLULAR UPTAKE; SERUM RESISTIN; RECEPTOR; ANGIOGENESIS; PROTEIN; INFLAMMATION; EXPRESSION	In an attempt to isolate a heparanase receptor, postulated to mediate non-enzymatic functions of the heparanase protein, we utilized human urine collected from healthy volunteers. Affinity chromatography of this rich protein source on immobilized heparanase revealed resistin as a heparanase binding protein. Co-immunoprecipitation and ELISA further confirmed the interaction between heparanase and resistin. Importantly, we found that heparanase potentiates the bioactivity of resistin in its standard bioassay in which monocytic human leukemia cell line, THP1, differentiates into adherent macrophage-like foam cells. It is thus conceivable that this newly identified complex of heparanase and resistin exerts a stimulatory effect also in various inflammatory conditions known to be affected by the two proteins.	[Novick, Daniela; Barak, Sara] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Novick, D (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	daniela.novick@weizmann.ac.il; vlodavsk@mail.huji.ac.il			National Institutes of Health (NIH) [CA106456]; Israel Science Foundation (ISF) [593/10]; Israel Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation (ISF)(Israel Science Foundation); Israel Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Israel Vlodavsky is supported by National Institutes of Health (NIH) grant CA106456; the Israel Science Foundation (ISF grant 593/10); and the Israel Ministry of Health. Israel Vlodavsky is a Research Professor of the Israel Cancer Research Fund (ICRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dalamaga M, 2013, CLIN BIOCHEM, V46, P584, DOI 10.1016/j.clinbiochem.2013.01.001; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Efstathiou SP, 2007, CLIN CHIM ACTA, V378, P78, DOI 10.1016/j.cca.2006.10.023; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Fargnoli JL, 2010, EUR J ENDOCRINOL, V162, P281, DOI 10.1530/EJE-09-0555; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Hermano E, 2012, CELL MOL LIFE SCI, V69, P2501, DOI 10.1007/s00018-012-0930-8; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kusminski CM, 2007, J CLIN ENDOCR METAB, V92, P270, DOI 10.1210/jc.2006-1151; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Novick D, 2012, METHODS MOL BIOL, V820, P195, DOI 10.1007/978-1-61779-439-1_12; Osterholm C, 2013, ATHEROSCLEROSIS, V226, P67, DOI 10.1016/j.atherosclerosis.2012.09.030; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rae C, 2007, FEBS LETT, V581, P4877, DOI 10.1016/j.febslet.2007.09.014; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Vazzana N, 2012, CURR MED CHEM, V19, P5837, DOI 10.2174/092986712804143349; Vlodavsky I, 2012, CANC MICROENVIRON; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weikert C, 2008, J CLIN ENDOCR METAB, V93, P2647, DOI 10.1210/jc.2007-2735; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	57	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85944	10.1371/journal.pone.0085944	http://dx.doi.org/10.1371/journal.pone.0085944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465803	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500150
J	Yu, JG; Feng, YF; Xiang, Y; Huang, JH; Savini, G; Parisi, V; Yang, WJ; Fu, XA				Yu, Ji-guo; Feng, Yi-fan; Xiang, Yi; Huang, Jin-hai; Savini, Giacomo; Parisi, Vincenzo; Yang, Wan-ju; Fu, Xun-an			Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-Analysis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; IMPAIRMENT; GLAUCOMA; ABILITY; BIAS	Background: Parkinson disease (PD) is a neurodegenerative process that leads to a selective loss of dopaminergic neurons, mainly in the basal ganglia of the brain. Numerous studies have analyzed the ability of optical coherence tomography (OCT) to detect retinal nerve fiber layer (RNFL) thickness abnormalities and changes in PD, but the results have not always been consistent. Therefore, we carried out a meta-analysis to evaluate the RNFL thickness measured with OCT in PD. Methods and Findings: Case-control studies were selected through an electronic search of the Cochrane Controlled Trials Register, PUBMED and EMBASE. For the continuous outcomes, we calculated the weighted mean difference (WMD) and 95% confidence interval (CI). The statistical analysis was performed by RevMan 5.0 software. Thirteen case-control studies were included in the present meta-analysis, containing a total of 644 eyes in PD patients and 604 eyes in healthy controls. The results of our study showed that there was a significant reduction in average RNFL thickness in patients with PD compared to healthy controls (WMD = -5.76, 95% CI: -8.99 to -2.53, P = 0.0005). Additionally, differences of RNFL thickness in superior quadrant (WMD = -4.44, 95% CI: -6.93 to -1.94, P = 0.0005), inferior quadrant (WMD = -7.56, 95% CI: -11.33 to -3.78, P<0.0001), nasal quadrant (WMD = -3.12, 95% CI: -5.63 to -0.61, P = 0.01) and temporal quadrant (WMD = -4.63, 95% CI: -7.20 to -2.06, P = 0.0004) were all significant between the two groups. Conclusion: In view of these results and the noninvasive nature of OCT technology, we surmise that OCT could be a useful tool for evaluating the progression of the Parkinson disease.	[Yu, Ji-guo; Xiang, Yi; Yang, Wan-ju; Fu, Xun-an] Cent Hosp Wuhan, Dept Ophthalmol, Wuhan, Hebei, Peoples R China; [Feng, Yi-fan] Fudan Univ, Zhongshan Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Huang, Jin-hai] Wenzhou Med Univ, Affiliated Eye Hosp, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo; Parisi, Vincenzo] GB Bietti Eye Fdn IRCCS, Rome, Italy	Fudan University; Wenzhou Medical University; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Fu, XA (corresponding author), Cent Hosp Wuhan, Dept Ophthalmol, Wuhan, Hebei, Peoples R China.	fxayanke@163.com	Huang, Jinhai/ABH-4519-2020; Savini, Giacomo/J-9196-2018; Parisi, Vincenzo/J-6137-2018	Savini, Giacomo/0000-0003-0075-3582; Yang, Wanju/0000-0002-3071-2805				Aaker GD, 2010, CLIN OPHTHALMOL, V4, P1427, DOI 10.2147/OPTH.S15136; Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891; Altintas O, 2008, DOC OPHTHALMOL, V116, P137, DOI 10.1007/s10633-007-9091-8; Archibald NK, 2011, PARKINSONISM RELAT D, V17, P431, DOI 10.1016/j.parkreldis.2011.03.004; Bayer AU, 2002, AM J OPHTHALMOL, V133, P135, DOI 10.1016/S0002-9394(01)01196-5; Biousse V, 2004, NEUROLOGY, V62, P177, DOI 10.1212/01.WNL.0000103444.45882.D8; BODISWOLLNER I, 1990, TRENDS NEUROSCI, V13, P296, DOI 10.1016/0166-2236(90)90113-O; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng YF, 2013, RETINAL NERVE FIBER; FREDERICK JM, 1982, J COMP NEUROL, V210, P65, DOI 10.1002/cne.902100108; Gaenslen A, 2010, INT REV NEUROBIOL, V90, P81, DOI 10.1016/S0074-7742(10)90006-8; Garcia-Martin E, 2011, MULT SCLER J, V17, P830, DOI 10.1177/1352458510397414; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hood DC, 2011, OPTOMETRY VISION SCI, V88, P113, DOI 10.1097/OPX.0b013e3181fc3625; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; Jackson GR, 2003, NEUROL CLIN, V21, P709, DOI 10.1016/S0733-8619(02)00107-X; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P62, DOI 10.1097/WNO.0b013e3182701745; La Morgia C, 2013, EUR J NEUROL, V20, P198, DOI 10.1111/j.1468-1331.2012.03701.x; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; Martinez A, 2008, BRIT J OPHTHALMOL, V92, P1069, DOI 10.1136/bjo.2008.137471; Moreno-Ramos T, 2013, J ALZHEIMERS DIS, V34, P659, DOI 10.3233/JAD-121975; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Parisi V, 2007, EUR J NEUROL, V14, P627, DOI 10.1111/j.1468-1331.2007.01795.x; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Rohani M, 2012, NEUROL SCI; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Satue M, 2013, EYE, V27, P507, DOI 10.1038/eye.2013.4; Sen A, 2013, EUR J OPHTHALMOL; Spund B, 2013, J NEURAL TRANSM, V120, P745, DOI 10.1007/s00702-012-0909-5; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Thenganatt MA, 2012, EXPERT REV NEUROTHER, V12, P687, DOI [10.1586/ern.12.49, 10.1586/ERN.12.49]; Tsironi EE, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-54; Wells G.A., NEWCASTLE OTTAWA SCA; Yavas GF, 2007, EUR J OPHTHALMOL, V17, P812, DOI 10.1177/112067210701700520	41	119	125	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85718	10.1371/journal.pone.0085718	http://dx.doi.org/10.1371/journal.pone.0085718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465663	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500095
J	Zeng, WP; McFarland, MM				Zeng, Wei-ping; McFarland, Margaret M.			Rapid and Unambiguous Detection of DNase I Hypersensitive Site in Rare Population of Cells	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELLS; CHROMATIN; PCR	DNase I hypersensitive (DHS) sites are important for understanding cis regulation of gene expression. However, existing methods for detecting DHS sites in small numbers of cells can lead to ambiguous results. Here we describe a simple new method, in which DNA fragments with ends generated by DNase I digestion are isolated and used as templates for two PCR reactions. In the first PCR, primers are derived from sequences up-and down-stream of the DHS site. If the DHS site exists in the cells, the first PCR will not produce PCR products due to the cuts of the templates by DNase I between the primer sequences. In the second PCR, one primer is derived from sequence outside the DHS site and the other from the adaptor. This will produce a smear of PCR products of different sizes due to cuts by DNase I at different positions at the DHS site. With this design, we detected a DHS site at the CD4 gene in two CD4 T cell populations using as few as 2x10(4) cells. We further validated this method by detecting a DHS site of the IL-4 gene that is specifically present in type 2 but not type 1 T helper cells. Overall, this method overcomes the interference by genomic DNA not cut by DNase I at the DHS site, thereby offering unambiguous detection of DHS sites in the cells.	[Zeng, Wei-ping; McFarland, Margaret M.] Marshall Univ, Dept Biochem & Microbiol, Huntington, WV 25755 USA; [Zeng, Wei-ping] Marshall Univ, Dept Paediat, Joan C Edwards Sch Med, Huntington, WV USA; [Zeng, Wei-ping] Marshall Univ, Coll Sci, Dept Biol, Ctr Cell Dev & Differentiat, Huntington, WV USA	Marshall University; Marshall University; Marshall University	Zeng, WP (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Huntington, WV 25755 USA.	zengw@marshall.edu		zeng, wei-ping/0000-0002-8268-3583	WV Experimental Program to Stimulate Competitive Research National Science Foundation; West Virginia Research Challenge grant	WV Experimental Program to Stimulate Competitive Research National Science Foundation; West Virginia Research Challenge grant	This work is in part supported by WV Experimental Program to Stimulate Competitive Research National Science Foundation Research Infrastructure Improvement T1 grant and a West Virginia Research Challenge grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cockerill P N, 2000, Methods Mol Biol, V130, P29; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Follows GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm108; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Itoh M, 1999, J IMMUNOL, V162, P5317; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ohnesorg T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-412; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Young N, 2005, J IMMUNOL, V175, P8287, DOI 10.4049/jimmunol.175.12.8287; Zeng WP, 2011, MOL IMMUNOL, V48, P1932, DOI 10.1016/j.molimm.2011.05.023; Zeng WP, 2009, J IMMUNOL, V183, P3583, DOI 10.4049/jimmunol.0900146	19	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85740	10.1371/journal.pone.0085740	http://dx.doi.org/10.1371/journal.pone.0085740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465674	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500101
J	Kong, B; Guo, GL				Kong, Bo; Guo, Grace L.			Soluble Expression of Disulfide Bond Containing Proteins FGF15 and FGF19 in the Cytoplasm of Escherichia coli	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CHAIN FV ANTIBODIES; TRANSGENIC MICE; FIBROBLAST-GROWTH-FACTOR-19; STRATEGIES; SUBFAMILY; RECEPTOR; FGF-19; GENES	Fibroblast growth factor 19 (FGF19) is the human ortholog of mouse FGF15, and both proteins function as an endocrine signal to regulate various liver functions. FGF15/FGF19 protein contains two disulfide bonds. It is unfavorable to form disulfide bonds in Escherichia coli (E. coli) cytoplasm because of the bacterial cytoplasmic reducing environment. Modification of the cytoplasmic reducing environment and/or co-expression of protein chaperones are common strategies to express disulfide bond containing proteins in E. coli. In the current study, we report a method to produce soluble FGF15/FGF19 protein in cytoplasm of E. coli. Several commercial available strains with the disruption of thiol-redox pathways, and/or co-expression of redoxase or refolding chaperones were used to develop this novel method for expression of FGF15/FGF19 in E. coli. Mutation of the thiol-disulfide bond reducing pathway in E. coli or N-terminal fusion of thioredox (TRX) alone is not enough to support disulfide bond formation in FGF15/19 proteins. However, TRX fusion protein improved FGF19 solubility in strains of thiol-redox system mutants. In addition, DsbC co-expressed in thiol-redox system mutants alone improved and further enhanced FGF19 solubility with combination of TRX fusion tag. The soluble FGF19 proteins were easily purified through Ni-NTA affinity chromatography and anion exchange chromatography, and the purified protein maintained its biological activities, confirmed by suppressing hepatic Cyp7a1 gene transcription in mice and by activating ERK1/2 signaling pathway in HepG2 cells. In contrast, soluble FGF15 protein in cytoplasm remained very low using these strategies. In summary, we have successfully developed a method to express functional FGF19 protein in prokaryotic cells, and this strategy may be adapted for the expression of other disulfide-containing proteins.	[Kong, Bo; Guo, Grace L.] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Guo, GL (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA.	guo@eohsi.rutgers.edu	Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817	National Institutes of Health [DK081343, DK090036]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343, R56DK090036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health fund [DK081343 & DK090036 (GLG)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BRADLEY MK, 1990, METHODS ENZYMOL, V182, P112; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Jurado P, 2006, J MOL BIOL, V357, P49, DOI 10.1016/j.jmb.2005.12.058; Katzen F, 2002, METHOD ENZYMOL, V348, P54, DOI 10.1016/S0076-6879(02)48626-0; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740; Kong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020307; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; Palmer I., 2004, CURRENT PROTOCOLS PR, DOI DOI 10.1002/0471140864.PS0603S38.UNIT6.3; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Subedi GP, 2012, PROTEIN EXPRES PURIF, V82, P197, DOI 10.1016/j.pep.2011.12.010; Swietnicki W, 2006, CURR OPIN BIOTECH, V17, P367, DOI 10.1016/j.copbio.2006.05.011; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Wingfield P T, 2001, Curr Protoc Protein Sci, VChapter 6, DOI 10.1002/0471140864.ps0605s00; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Zhang Z, 2002, PROTEIN EXPRES PURIF, V26, P218, DOI 10.1016/S1046-5928(02)00502-8	30	36	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85890	10.1371/journal.pone.0085890	http://dx.doi.org/10.1371/journal.pone.0085890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465767	Green Submitted, gold, Green Published			2022-12-27	WOS:000330240500084
J	Liang, YJ; Yan, ZR; Sun, BL; Cai, CZ; Jiang, H; Song, AQ; Qiu, CX				Liang, Yajun; Yan, Zhongrui; Sun, Binglun; Cai, Chuanzhu; Jiang, Hui; Song, Aiqin; Qiu, Chengxuan			Cardiovascular Risk Factor Profiles for Peripheral Artery Disease and Carotid Atherosclerosis among Chinese Older People: A Population-Based Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ANKLE-BRACHIAL INDEX; NUTRITION EXAMINATION SURVEY; VASCULAR-DISEASE; NATIONAL-HEALTH; PREVALENCE; ASSOCIATION; LIPOPROTEIN; CORONARY; STROKE	Objectives: Epidemiological data concerning atherosclerotic disease among older people in rural China are sparse. We seek to determine prevalence and cardiovascular risk factor profiles for peripheral artery disease (PAD) and carotid atherosclerosis (CAS) among Chinese older people living in a rural community. Methods: This cross-sectional study included 1499 participants (age >= 60 years, 59.0% women) of the Confucius Hometown Aging Project in Shandong, China. From June 2010-July 2011, data were collected through interviews, clinical examinations, and laboratory tests. PAD was defined as an ankle-brachial index <= 0.9. Carotid intima-media thickness (cIMT) and carotid artery stenosis were assessed by ultrasonography. We defined moderate stenosis as carotid stenosis >= 50%, and severe stenosis as carotid stenosis >= 70%. cIMT >= 1.81 mm was considered as an increased cIMT (a measure of CAS). Data were analyzed with multiple logistic models. Results: The prevalence was 5.7% for PAD, 8.9% for moderate stenosis, 1.8% for severe stenosis, and 11.2% for increased cIMT. After controlling for multiple potential confounders, diabetes, an increased low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio, and hypertension were significantly or marginally associated with PAD. Ever smoking, hypertension, and an increased LDL-C/HDL-C ratio were significantly associated with an increased likelihood of increased cIMT. An increasing number of those cardiovascular risk factors were significantly associated with an increasing odds ratio of PAD and increased cIMT, respectively (p for linear trend < 0.001). Conclusion: Among Chinese older people living in a rural community, PAD, carotid artery stenosis, and an increased cIMT are relatively uncommon. Cardiovascular risk factor profiles for PAD and CAS are slightly different, with hypertension and an increased LDL-C/HDL-C ratio being associated with an increased likelihood of both PAD and increased cIMT.	[Liang, Yajun; Song, Aiqin] Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China; [Liang, Yajun; Qiu, Chengxuan] Stockholm Univ, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, S-10691 Stockholm, Sweden; [Yan, Zhongrui] Jining First Peoples Hosp, Dept Neurol, Jining, Shandong, Peoples R China	Jining Medical University; Karolinska Institutet; Stockholm University	Liang, YJ (corresponding author), Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China.	yajun.liang@ki.se; chengxuan.qiu@ki.se		Qiu, Chengxuan/0000-0003-1922-4912	Department of Science and Technology [2008GG00221]; Department of Health [2009-067]; Natural Science Foundation of Shandong Province, China [ZR2010HL031]; Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet; Swedish Research Council and Karolinska Institutet, Stockholm, Sweden	Department of Science and Technology(Department of Science & Technology (India)); Department of Health; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet; Swedish Research Council and Karolinska Institutet, Stockholm, Sweden	The Confucius Hometown Aging Project was supported in part by grants from the Department of Science and Technology (2008GG00221), Department of Health (2009-067), and Natural Science Foundation (ZR2010HL031) of Shandong Province, China and by the Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet. Dr Qiu was supported by the Swedish Research Council and Karolinska Institutet, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Chien KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003435; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; de Weerd M, 2009, STROKE, V40, P1105, DOI 10.1161/STROKEAHA.108.532218; Elias-Smale SE, 2012, EUR J PREV CARDIOL, V19, P698, DOI 10.1177/1741826711414623; Enomoto M, 2011, J LIPIDS, V2011, DOI 10.1155/2011/549137; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Grenon S Marlene, 2009, N Engl J Med, V361, pe40, DOI 10.1056/NEJMvcm0807012; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gurdasani D, 2012, ARTERIOSCL THROM VAS, V32, P3058, DOI 10.1161/ATVBAHA.112.255521; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; Johansen Odd E, 2003, Am J Cardiovasc Drugs, V3, P283, DOI 10.2165/00129784-200303040-00007; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lim S, 2012, INT J CARDIOL, V155, P126, DOI 10.1016/j.ijcard.2011.05.054; Mathur R, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572454; McDermott MM, 2005, AM J EPIDEMIOL, V162, P33, DOI 10.1093/aje/kwi167; Momiyama Y, 2012, ATHEROSCLEROSIS, V222, P241, DOI 10.1016/j.atherosclerosis.2012.02.008; Nasr N, 2011, STROKE, V42, P3616, DOI 10.1161/STROKEAHA.111.624684; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Paramsothy P, 2012, AM J CARDIOL, V109, P658, DOI 10.1016/j.amjcard.2011.10.021; Prabhakaran S, 2006, STROKE, V37, P2696, DOI 10.1161/01.STR.0000244780.82190.a4; Sangiorgi G, 2013, J VASC SURG, V57, P338, DOI 10.1016/j.jvs.2012.07.052; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Song AQ, 2014, EUR J PREV CARDIOL, V21, P1267, DOI 10.1177/2047487313487621; Starke RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071954; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Welmer AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065815; Wendell CR, 2012, STROKE, V43, P3319, DOI 10.1161/STROKEAHA.112.672527; World Health Organization (WHO), STEPWISE APPR SURV S; Ylitalo KR, 2011, DIABETES CARE, V34, P1642, DOI 10.2337/dc10-2150; Zhan YQ, 2012, J EPIDEMIOL, V22, P454, DOI 10.2188/jea.JE20110140	38	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85927	10.1371/journal.pone.0085927	http://dx.doi.org/10.1371/journal.pone.0085927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465793	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000076
J	Meng, L; Kramer, MA; Middleton, SJ; Whittington, MA; Eden, UT				Meng, Liang; Kramer, Mark A.; Middleton, Steven J.; Whittington, Miles A.; Eden, Uri T.			A Unified Approach to Linking Experimental, Statistical and Computational Analysis of Spike Train Data	PLOS ONE			English	Article							SINGLE-NEURON MODELS; SPECTRUM; CONSTRUCTION; EXCITABILITY; CONDUCTANCE; CURRENTS	A fundamental issue in neuroscience is how to identify the multiple biophysical mechanisms through which neurons generate observed patterns of spiking activity. In previous work, we proposed a method for linking observed patterns of spiking activity to specific biophysical mechanisms based on a state space modeling framework and a sequential Monte Carlo, or particle filter, estimation algorithm. We have shown, in simulation, that this approach is able to identify a space of simple biophysical models that were consistent with observed spiking data (and included the model that generated the data), but have yet to demonstrate the application of the method to identify realistic currents from real spike train data. Here, we apply the particle filter to spiking data recorded from rat layer V cortical neurons, and correctly identify the dynamics of an slow, intrinsic current. The underlying intrinsic current is successfully identified in four distinct neurons, even though the cells exhibit two distinct classes of spiking activity: regular spiking and bursting. This approach - linking statistical, computational, and experimental neuroscience - provides an effective technique to constrain detailed biophysical models to specific mechanisms consistent with observed spike train data.	[Meng, Liang; Kramer, Mark A.; Eden, Uri T.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Middleton, Steven J.; Whittington, Miles A.] York Univ, Hull York Med Sch, York, N Yorkshire, England	Boston University; University of Hull; University of York - UK	Eden, UT (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.	tzvi@bu.edu	Kramer, Mark/A-1291-2014	Whittington, Miles Adrian/0000-0002-0247-1362; Kramer, Mark/0000-0002-9979-7202; Middleton, Steven/0000-0001-8875-8956	National Science Foundation [IIS-06439952]; National Institute of Neurological Disorders and Stroke [R01 NS073118, R01 NS072023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073118, R01NS072023] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Science Foundation (IIS-06439952) and from the National Institute of Neurological Disorders and Stroke (R01 NS073118) to UTE, and from the National Institute of Neurological Disorders and Stroke (R01 NS072023) to UTE and MAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Catmull E, 1974, COMPUT AIDED GEOM D, V74, P317; Daley D. J., 2007, INTRO THEORY POINT P, V2; Doucet A, 2001, SEQUENTIAL MONTE CAR, V1; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Ergun A, 2007, IEEE T BIO-MED ENG, V54, P419, DOI 10.1109/TBME.2006.888821; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huys QJM, 2006, J NEUROPHYSIOL, V96, P872, DOI 10.1152/jn.00079.2006; Huys QJM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000379; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Lansky P, 2008, BIOL CYBERN, V99, P253, DOI 10.1007/s00422-008-0237-x; Liu J., 1999, COMBINED PARAMETER S; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; Meng L, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065006; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mullowney P, 2008, J COMPUT NEUROSCI, V24, P179, DOI 10.1007/s10827-007-0047-5; NADIM F, 1995, J COMPUT NEUROSCI, V2, P215, DOI 10.1007/BF00961435; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pawitan Y, 2001, ALL LIKELIHOOD STAT; PERCIVAL DB, 1993, SPECTRAL ANAL PHYS A, P583; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Schiff SJ, 2008, J NEURAL ENG, V5, P1, DOI 10.1088/1741-2560/5/1/001; Shepherd G.M., 2003, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Thomson DJ, 2007, IEEE SIGNAL PROC MAG, V24, P20, DOI 10.1109/MSP.2007.4286561; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; WONNACOTT TH, 1990, INTRO STAT	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85269	10.1371/journal.pone.0085269	http://dx.doi.org/10.1371/journal.pone.0085269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465520	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000029
J	Liu, L; Hao, ZZ; Liu, YY; Wei, XX; Cun, YZ; Wang, XQ				Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan; Wei, Xiao-Xin; Cun, Yu-Zhi; Wang, Xiao-Quan			Phylogeography of Pinus armandii and Its Relatives: Heterogeneous Contributions of Geography and Climate Changes to the Genetic Differentiation and Diversification of Chinese White Pines	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; POPULATION-GROWTH; MITOCHONDRIAL; PINACEAE; CHLOROPLAST; PHYLOGENY; HISTORY; DIVERGENCE; SOFTWARE; IMPRINTS	Geographic barriers and Quaternary climate changes are two major forces driving the evolution, speciation, and genetic structuring of extant organisms. In this study, we used Pinus armandii and eleven other Asian white pines (subsection Strobus, subgenus Pinus) to explore the influences of geographic factors and Pleistocene climatic oscillations on species in South China, a region known to be centers of plant endemism and biodiversity hotspots. Range-wide patterns of genetic variation were investigated using chloroplast and mitochondrial DNA markers, with extensive sampling throughout the entire range of P. armandii. Both cpDNA and mtDNA revealed that P. armandii exhibits high levels of genetic diversity and significant population differentiation. Three geographically distinct subdivisions corresponding to the Qinling-Daba Mountains (QDM), Himalaya-Hengduan Mountains (HHM) and Yungui Plateau (YGP) were revealed in mainland China by cpDNA. Their break zone was located in the southeastern margin of the Qinghai-Tibetan Plateau (QTP). A series of massive mountains, induced by the QTP uplift, imposed significant geographic barriers to genetic exchange. The disjunct distribution patterns of ancestral haplotypes suggest that a large continuous population of the white pines may have existed from southwest to subtropical China. Repeated range shifts in response to the Pleistocene glaciations led to the isolation and diversification of the subtropical species. The two Taiwanese white pines share a common ancestor with the species in mainland China and obtain their chloroplasts via long-distance pollen dispersal from North Asian pines. Distinct genetic patterns were detected in populations from the Qinling-Daba Mountains, Yungui Plateau, Himalaya-Hengduan Mountains, and subtropical China, indicating significant contributions of geographic factors to the genetic differentiation in white pines. Our study depicts a clear picture of the evolutionary history of Chinese white pines and highlights the heterogeneous contributions of geography and Pleistocene climatic fluctuations to the extremely high plant species diversity and endemism in South China.	[Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan; Wei, Xiao-Xin; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cun, Yu-Zhi] Dali Univ, Dali, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dali University	Wei, XX (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	weixx@ibcas.ac.cn			National Natural Science Foundation of China [31270422, 30730010, 31160047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant nos. 31270422, 30730010, 31160047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2007, MOL ECOL, V16, P3393, DOI 10.1111/j.1365-294X.2007.03391.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Businsky Roman, 2004, Willdenowia, V34, P209, DOI 10.3372/wi.34.34120; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; [陈之端 Chen Zhiduan], 2012, [植物学报, Chinese Bulletin of Botany], V47, P551; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; CRITCHFIELD WB, 1984, P 8 N AM FOR BIOL WO, P70; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duminil J, 2002, MOL ECOL NOTES, V2, P428, DOI 10.1046/j.1471-8286.2002.00263.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farjon A, 2001, WORLD CHECKLIST BIBL; Fu L.G., 1999, FLORA CHINA, V4; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma C. G., 1992, S SEL OPT SEED SOURC; Ma XF, 2006, MOL BIOL EVOL, V23, P807, DOI 10.1093/molbev/msj100; Mayr E, 1942, SYSTEMATICS ORIGIN S; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nylander JAA., 2004, BIOINFORMATICS; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian S, 2008, ANN BOT-LONDON, V102, P69, DOI 10.1093/aob/mcn068; Tian S, 2010, PLANT SYST EVOL, V284, P219, DOI 10.1007/s00606-009-0246-9; Tsutsui K, 2009, J PLANT RES, V122, P509, DOI 10.1007/s10265-009-0246-4; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang H., 2004, USDA SERV P RMRS P, V32, P73; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang XQ, 2000, MOL BIOL EVOL, V17, P773, DOI 10.1093/oxfordjournals.molbev.a026356; Wei XX, 2011, TREE GENET GENOMES, V7, P1025, DOI 10.1007/s11295-011-0392-4; WILLYARD A, 2006, MOL BIOL EVOL, V23, P1; Wu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055315; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang DC, 2009, NORD J BOT, V27, P405, DOI 10.1111/j.1756-1051.2008.00235.x	66	53	60	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85920	10.1371/journal.pone.0085920	http://dx.doi.org/10.1371/journal.pone.0085920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24533149	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500144
J	Li, SS; Fan, H; An, XP; Fan, HH; Jiang, HH; Chen, YB; Tong, YG				Li, Shasha; Fan, Hang; An, Xiaoping; Fan, Huahao; Jiang, Huanhuan; Chen, Yubao; Tong, Yigang			Scrutinizing Virus Genome Termini by High-Throughput Sequencing	PLOS ONE			English	Article							BACILLUS-SUBTILIS; DNA-REPLICATION; HOST-TAKEOVER; PHAGE; COMPONENT; REVEAL; GENE	Analysis of genomic terminal sequences has been a major step in studies on viral DNA replication and packaging mechanisms. However, traditional methods to study genome termini are challenging due to the time-consuming protocols and their inefficiency where critical details are lost easily. Recent advances in next generation sequencing (NGS) have enabled it to be a powerful tool to study genome termini. In this study, using NGS we sequenced one iridovirus genome and twenty phage genomes and confirmed for the first time that the high frequency sequences (HFSs) found in the NGS reads are indeed the terminal sequences of viral genomes. Further, we established a criterion to distinguish the type of termini and the viral packaging mode. We also obtained additional terminal details such as terminal repeats, multi-termini, asymmetric termini. With this approach, we were able to simultaneously detect details of the genome termini as well as obtain the complete sequence of bacteriophage genomes. Theoretically, this application can be further extended to analyze larger and more complicated genomes of plant and animal viruses. This study proposed a novel and efficient method for research on viral replication, packaging, terminase activity, transcription regulation, and metabolism of the host cell.	[Li, Shasha; Fan, Hang; An, Xiaoping; Fan, Huahao; Jiang, Huanhuan; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Chen, Yubao] Beijing Comp Ctr, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Chen, YB (corresponding author), Beijing Comp Ctr, Beijing, Peoples R China.	allexchen@126.com; tong.yigang@gmail.com	Fan, Huahao/AAR-8062-2021; Fan, Hang/AAA-8489-2022	Fan, Huahao/0000-0001-5007-2158; Fan, Hang/0000-0002-7927-1684; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [30872223]; National Hi-Tech Research and Development (863) Program of China [2012AA022-003]; China Mega-Project on Infectious Disease Prevention [2013ZX10004-605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); China Mega-Project on Infectious Disease Prevention	This research was supported by grants from the National Natural Science Foundation of China (NO. 30872223), the National Hi-Tech Research and Development (863) Program of China (No. 2012AA022-003), and the China Mega-Project on Infectious Disease Prevention (No. 2013ZX10004-605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BHATTACHARYYA SP, 1994, GENE, V146, P67, DOI 10.1016/0378-1119(94)90834-6; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; Born Y, 2011, APPL ENVIRON MICROB, V77, P5945, DOI 10.1128/AEM.03022-10; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ESCARMIS C, 1981, P NATL ACAD SCI-BIOL, V78, P1446, DOI 10.1073/pnas.78.3.1446; Fan HH, 2012, J VIROL, V86, P13861, DOI 10.1128/JVI.02684-12; Fouts DE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-165; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; GOORHA R, 1982, P NATL ACAD SCI-BIOL, V79, P248, DOI 10.1073/pnas.79.2.248; GORDON A., 2011, FASTX TOOLKIT COMPUT; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kutter E., 2005, BACTERIOPHAGES BIOL; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lobocka M, 2012, ADV VIRUS RES, V83, P143, DOI 10.1016/B978-0-12-394438-2.00005-0; MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989; OHMORI H, 1988, J MOL BIOL, V202, P1, DOI 10.1016/0022-2836(88)90512-8; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Pennisi E, 2010, SCIENCE, V327, P1190, DOI 10.1126/science.327.5970.1190; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Sambrook J., 2001, MOL CLONING LAB MANU; Sampath A, 2004, J BACTERIOL, V186, P1785, DOI 10.1128/JB.186.6.1785-1792.2004; Sheng W, 2010, J MED COLL PLA, V25, P331; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stewart CR, 2009, VIROLOGY, V392, P271, DOI 10.1016/j.virol.2009.06.046; Stewart CR, 2009, J MOL BIOL, V388, P48, DOI 10.1016/j.jmb.2009.03.009; Stewart CR, 1998, VIROLOGY, V246, P329, DOI 10.1006/viro.1998.9197; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; WEI P, 1993, J BACTERIOL, V175, P7887, DOI 10.1128/JB.175.24.7887-7900.1993; ZABALLOS A, 1986, GENE, V43, P103, DOI 10.1016/0378-1119(86)90013-2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2011, J GENETICS GENOMICS	39	179	185	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85806	10.1371/journal.pone.0085806	http://dx.doi.org/10.1371/journal.pone.0085806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465717	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500075
J	Kim, JA; Choi, HJ; Kwon, YK; Ryu, DH; Kwon, TH; Hwang, GS				Kim, Ju-Ae; Choi, Hyo-Jung; Kwon, Yong-Kook; Ryu, Do Hyun; Kwon, Tae-Hwan; Hwang, Geum-Sook			H-1 NMR-Based Metabolite Profiling of Plasma in a Rat Model of Chronic Kidney Disease	PLOS ONE			English	Article							EXPERIMENTAL CHRONIC UREMIA; AMINO-ACID-METABOLISM; SKELETAL-MUSCLE; GLUTAMINE FORMATION; SERUM METABOLITES; PROXIMAL TUBULE; PROTEIN; ALANINE; CITRATE; COTRANSPORTER	Chronic kidney disease (CKD) is characterized by the gradual loss of the kidney function to excrete wastes and fluids from the blood. H-1 NMR-based metabolomics was exploited to investigate the altered metabolic pattern in rats with CKD induced by surgical reduction of the renal mass (i.e., 5/6 nephrectomy (5/6 Nx)), particularly for identifying specific metabolic biomarkers associated with early of CKD. Plasma metabolite profiling was performed in CKD rats (at 4- or 8-weeks after 5/6 Nx) compared to sham-operated rats. Principle components analysis (PCA), partial least squares-discriminant analysis (PLS-DA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) score plots showed a significant separation between the groups. The resulting metabolic profiles demonstrated significantly increased plasma levels of organic anions, including citrate, beta-hydroxybutyrate, lactate, acetate, acetoacetate, and formate in CKD. Moreover, levels of alanine, glutamine, and glutamate were significantly higher. These changes were likely to be associated with complicated metabolic acidosis in CKD for counteracting systemic metabolic acidosis or increased protein catabolism from muscle. In contrast, levels of VLDL/LDL (CH2)(n) and N-acetylglycoproteins were decreased. Taken together, the observed changes of plasma metabolite profiles in CKD rats provide insights into the disturbed metabolism in early phase of CKD, in particular for the altered metabolism of acid-base and/or amino acids.	[Kim, Ju-Ae; Kwon, Yong-Kook; Hwang, Geum-Sook] Korea Basic Sci Inst, Integrated Metabol Res Grp, Seoul Ctr, Seoul, South Korea; [Kim, Ju-Ae; Ryu, Do Hyun] Sungkyunkwan Univ, Dept Chem, Suwon, South Korea; [Choi, Hyo-Jung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea; [Kwon, Yong-Kook; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Basic Science Institute (KBSI); Sungkyunkwan University (SKKU); Kyungpook National University; Chungnam National University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea.	thkwon@knu.ac.kr; gshwang@kbsi.re.kr	Ryu, Do Hyun/ADI-9819-2022; Kwon, Tae-Hwan/ABA-1981-2020		National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning, Korea [2010-0019393, 2010-0019394, 2013R1A1A2007266, 2013M3A9B6046418]; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea [A111345]; Korea Basic Science Institute [T33409]; Creative Allied Project (CAP); Kyungpook National University Research Fund	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Korea; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea; Korea Basic Science Institute; Creative Allied Project (CAP); Kyungpook National University Research Fund	This study was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea (2010-0019393, 2010-0019394, 2013R1A1A2007266, and 2013M3A9B6046418); the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Korea (A111345), Korea Basic Science Institute (T33409), the Creative Allied Project (CAP), and Kyungpook National University Research Fund, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A RJ, 2000, KIDNEY, P455; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; ALPERN RJ, 1990, PHYSIOL REV, V70, P79, DOI 10.1152/physrev.1990.70.1.79; ALPERN RJ, 1995, KIDNEY INT, V47, P1205, DOI 10.1038/ki.1995.171; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BOUBY N, 1993, KIDNEY INT, V44, P676, DOI 10.1038/ki.1993.300; BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; CHARLES J.C., 2005, HOSP PHYS, V1, P37; Choi HJ, 2012, J PROTEOME RES, V11, P3816, DOI 10.1021/pr300309d; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi JY, 2011, NEPHROL DIAL TRANSPL, V26, P1304, DOI 10.1093/ndt/gfq554; CONDON JR, 1971, CLIN CHIM ACTA, V32, P333, DOI 10.1016/0009-8981(71)90433-5; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; FARBER MO, 1976, CLIN SCI MOL MED, V50, P165, DOI 10.1042/cs0500165; GARBER AJ, 1976, J BIOL CHEM, V251, P826; GARBER AJ, 1978, J CLIN INVEST, V62, P633, DOI 10.1172/JCI109170; GARBER AJ, 1978, J CLIN INVEST, V62, P623, DOI 10.1172/JCI109169; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Hong YS, 2010, ARCH PHARM RES, V33, P1091, DOI 10.1007/s12272-010-0716-1; Hwang GS, 2010, AM J PHYSIOL-RENAL, V298, pF461, DOI 10.1152/ajprenal.00389.2009; Jang ZH, 2012, MOL BIOSYST, V8, P2001, DOI 10.1039/c2mb25073j; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590, DOI 10.1152/ajprenal.1985.249.4.F590; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kim CD, 2010, TRANSPLANTATION, V90, P748, DOI 10.1097/TP.0b013e3181edd69a; Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kwon TH, 2002, AM J PHYSIOL-RENAL, V282, pF341, DOI 10.1152/ajprenal.00104.2001; Kwon TH, 1998, AM J PHYSIOL-RENAL, V275, pF724, DOI 10.1152/ajprenal.1998.275.5.F724; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF257, DOI 10.1152/ajprenal.1999.277.2.F257; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; MADDOX DA, 1986, J CLIN INVEST, V77, P1639, DOI 10.1172/JCI112481; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Roderick PJ, 2007, COCHRANE DB SYST REV, V1; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; Weiner ID, 2011, CORE CONCEPTS DISORD, P203; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014	46	89	100	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85445	10.1371/journal.pone.0085445	http://dx.doi.org/10.1371/journal.pone.0085445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24647444	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500046
J	Knowles, SE; Toms, G; Sanders, C; Bee, P; Lovell, K; Rennick-Egglestone, S; Coyle, D; Kennedy, CM; Littlewood, E; Kessler, D; Gilbody, S; Bower, P				Knowles, Sarah E.; Toms, Gill; Sanders, Caroline; Bee, Penny; Lovell, Karina; Rennick-Egglestone, Stefan; Coyle, David; Kennedy, Catriona M.; Littlewood, Elizabeth; Kessler, David; Gilbody, Simon; Bower, Peter			Qualitative Meta-Synthesis of User Experience of Computerised Therapy for Depression and Anxiety	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; STEPPED CARE; SELF-HELP; ACCEPTABILITY; ETHNOGRAPHY; MANAGEMENT; BARRIERS; SYSTEM; AGENTS	Objective: Computerised therapies play an integral role in efforts to improve access to psychological treatment for patients with depression and anxiety. However, despite recognised problems with uptake, there has been a lack of investigation into the barriers and facilitators of engagement. We aimed to systematically review and synthesise findings from qualitative studies of computerised therapies, in order to identify factors impacting on engagement. Method: Systematic review and meta-synthesis of qualitative studies of user experiences of computer delivered therapy for depression and/or anxiety. Results: 8 studies were included in the review. All except one were of desktop based cognitive behavioural treatments. Black and minority ethnic and older participants were underrepresented, and only one study addressed users with a comorbid physical health problem. Through synthesis, we identified two key overarching concepts, regarding the need for treatments to be sensitive to the individual, and the dialectal nature of user experience, with different degrees of support and anonymity experienced as both positive and negative. We propose that these factors can be conceptually understood as the 'non-specific' or 'common' factors of computerised therapy, analogous to but distinct from the common factors of traditional face-to-face therapies. Conclusion: Experience of computerised therapy could be improved through personalisation and sensitisation of content to individual users, recognising the need for users to experience a sense of 'self' in the treatment which is currently absent. Exploiting the common factors of computerised therapy, through enhancing perceived connection and collaboration, could offer a way of reconciling tensions due to the dialectal nature of user experience. Future research should explore whether the findings are generalisable to other patient groups, to other delivery formats (such as mobile technology) and other treatment modalities beyond cognitive behaviour therapy. The proposed model could aid the development of enhancements to current packages to improve uptake and support engagement.	[Knowles, Sarah E.; Toms, Gill; Sanders, Caroline; Bower, Peter] Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England; [Bee, Penny; Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Rennick-Egglestone, Stefan] Univ Nottingham, Mixed Real Lab, Sch Comp Sci, Nottingham NG7 2RD, England; [Coyle, David] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Kennedy, Catriona M.] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Littlewood, Elizabeth; Gilbody, Simon] Univ York, Mental Hlth & Addict Res Grp, York YO10 5DD, N Yorkshire, England; [Kessler, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Manchester; University of Manchester; University of Nottingham; University of Bristol; University of Birmingham; University of York - UK; University of Bristol	Knowles, SE (corresponding author), Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England.	sarah.knowles@manchester.ac.uk	Coyle, David/P-3920-2019; Sanders, Caroline/G-8021-2014; Kessler, david/ABB-6489-2021; Bower, Peter/A-1508-2011; Bee, Penny E/O-8822-2014; Lonsdale, Chris/T-8710-2017; Gilbody, Simon/AAY-3720-2021; Sanders, Taren/N-9511-2018; Lovell, Karina S E/E-6410-2012	Coyle, David/0000-0002-5103-0379; Sanders, Caroline/0000-0002-0539-928X; Bower, Peter/0000-0001-9558-3349; Bee, Penny E/0000-0002-5600-0400; Lonsdale, Chris/0000-0002-2523-5565; Gilbody, Simon/0000-0002-8236-6983; Sanders, Taren/0000-0002-4504-6008; Lovell, Karina S E/0000-0001-8821-895X; Knowles, Sarah/0000-0002-0863-5866; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Kennedy, Catriona/0000-0003-3510-9113; Cliff, Dylan/0000-0001-6863-3996	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council [G0401181] Funding Source: researchfish; National Institute for Health Research [SPCR-040, 06/43/05, 06/43/504] Funding Source: researchfish	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded as part of the UK National Institute of Health Research (NIHR) School for Primary Care Research. The research team were independent from the funding agency. The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advocat J, 2010, SOC SCI MED, V70, P485, DOI 10.1016/j.socscimed.2009.10.051; [Anonymous], 1994, QUAL HEALTH RES, DOI [10.1177/104973239400400102, DOI 10.1177/104973239400400102]; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Bate P., 2007, J APPL BEHAV SCI, V43, P41, DOI [10.1177/0021886306297014, DOI 10.1177/0021886306297014]; Bickmore T, 2010, HARVARD REV PSYCHIAT, V18, P119, DOI 10.3109/10673221003707538; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Bradley KL., 2012, INT J MENT HEALTH PR, V14, P23, DOI [10.1080/14623730.2012.665337, DOI 10.1080/14623730.2012.665337]; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Cavanagh Kate, 2009, Cognitive Behaviour Therapy, V38, P235, DOI 10.1080/16506070802561256; Chambers DA, 2013, GEN HOSP PSYCHIAT, V35, P329, DOI 10.1016/j.genhosppsych.2013.03.006; Coyle D, 2007, INTERACT COMPUT, V19, P545, DOI 10.1016/j.intcom.2007.02.001; Coyle D, 2008, ONTORACT 2008: FIRST INTERNATIONAL WORKSHOP ON ONTOLOGIES IN INTERACTIVE SYSTEMS, PROCEEDINGS, P18, DOI 10.1109/ONTORACT.2008.12; Dehn DM, 2000, INT J HUM-COMPUT ST, V52, P1, DOI 10.1006/ijhc.1999.0325; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Doherty G., 2012, P 2012 ACM ANN C HUM, P1421, DOI DOI 10.1145/2207676.2208602; Farzanfar R, 2007, COMPUT HUM BEHAV, V23, P1167, DOI 10.1016/j.chb.2004.11.015; Gerhards SAH, 2011, J AFFECT DISORDERS, V129, P117, DOI 10.1016/j.jad.2010.09.012; Green KE, 2009, PROF PSYCHOL-RES PR, V40, P96, DOI 10.1037/a0012847; Helgadottir FD, 2009, BEHAV CHANGE, V26, P245, DOI 10.1375/bech.26.4.245; Hind D, 2010, PSYCHOL HEALTH, V25, P699, DOI 10.1080/08870440902842739; Iloabachie C, 2011, GEN HOSP PSYCHIAT, V33, P543, DOI 10.1016/j.genhosppsych.2011.08.004; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Klein B, 2008, J APPL PSYCHOL, V4; Knowles SE, 2012, 2012 C PRIM CAR MENT; Lambert MJ, 2005, J CLIN PSYCHOL, V61, P855, DOI 10.1002/jclp.20130; Layard R, 2006, DEPRESSION REPORT; Malpass A, 2009, SOC SCI MED, V68, P154, DOI 10.1016/j.socscimed.2008.09.068; Marks I, 2009, ANNU REV CLIN PSYCHO, V5, P121, DOI 10.1146/annurev.clinpsy.032408.153538; Mitchell J., 2005, PRIMARY CARE MENTAL, V3, P27; Mitchell N, 2007, COUNS PSYCHOTHER RES, V7, P144, DOI 10.1080/14733140701565987; NHS Confederation Mental Health Network, 2013, E MENT HLTH WHATS AL; NICE, 2009, DEPR AD UPD NICE CLI; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Peck DF, 2010, CLIN PSYCHOL PSYCHOT, V17, P147, DOI 10.1002/cpp.669; Pilgrim D, 2009, HEALTH-LONDON, V13, P235, DOI 10.1177/1363459308099686; Prevost S., 2000, EMBODIED CONVERSATIO, DOI DOI 10.7551/MITPRESS/2697.001.0001; Reeves B, 1996, CSLI PUBLICATIONS ST; Richards DA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-3; Rosser BA, 2009, J TELEMED TELECARE, V15, P327, DOI 10.1258/jtt.2009.090116; Ryan RM, 2011, COUNS PSYCHOL, V39, P193, DOI 10.1177/0011000009359313; Sanders C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-220; Schneider J, 2012, COMPUTERISED CBT COM; Simon GE, 2009, LANCET, V374, P594, DOI 10.1016/S0140-6736(09)61415-X; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; STRUPP H, 1978, HDB PSYCHOTHERAPY BE; The King's Fund, 2011, PAT CTR CAR KINGS FU; Timmermans S, 2003, SOCIOL HEALTH ILL, V25, P97, DOI 10.1111/1467-9566.00342; Titov N, 2010, COMPUTER DELIVERED C; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224; Watkins DC, 2011, J TELEMED TELECARE, V17, P378, DOI 10.1258/jtt.2011.110105	51	143	148	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84323	10.1371/journal.pone.0084323	http://dx.doi.org/10.1371/journal.pone.0084323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24643129	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000012
J	Machado, L; Magnusson, M; Paul, NA; de Nys, R; Tomkins, N				Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky; Tomkins, Nigel			Effects of Marine and Freshwater Macroalgae on In Vitro Total Gas and Methane Production	PLOS ONE			English	Article							RED ALGA ASPARAGOPSIS; VOLATILE FATTY-ACIDS; RUMINAL FERMENTATION; ASCOPHYLLUM-NODOSUM; REGRESSION TREES; MITIGATION; EMISSIONS; FORAGE; METHANOGENESIS; DIGESTION	This study aimed to evaluate the effects of twenty species of tropical macroalgae on in vitro fermentation parameters, total gas production (TGP) and methane (CH4) production when incubated in rumen fluid from cattle fed a low quality roughage diet. Primary biochemical parameters of macroalgae were characterized and included proximate, elemental, and fatty acid (FAME) analysis. Macroalgae and the control, decorticated cottonseed meal (DCS), were incubated in vitro for 72 h, where gas production was continuously monitored. Post-fermentation parameters, including CH4 production, pH, ammonia, apparent organic matter degradability (OMd), and volatile fatty acid (VFA) concentrations were measured. All species of macroalgae had lower TGP and CH4 production than DCS. Dictyota and Asparagopsis had the strongest effects, inhibiting TGP by 53.2% and 61.8%, and CH4 production by 92.2% and 98.9% after 72 h, respectively. Both species also resulted in the lowest total VFA concentration, and the highest molar concentration of propionate among all species analysed, indicating that anaerobic fermentation was affected. Overall, there were no strong relationships between TGP or CH4 production and the >70 biochemical parameters analysed. However, zinc concentrations >0.10 g.kg(-1) may potentially interact with other biochemical components to influence TGP and CH4 production. The lack of relationship between the primary biochemistry of species and gas parameters suggests that significant decreases in TGP and CH4 production are associated with secondary metabolites produced by effective macroalgae. The most effective species, Asparagopsis, offers the most promising alternative for mitigation of enteric CH4 emissions.	[Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Tomkins, Nigel] James Cook Univ, CSIRO Anim Food & Hlth Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Machado, L (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	lorenna.machado@my.jcu.edu.au	Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012; Machado, Lorenna/I-1434-2015; Pavan, Fernando/F-6046-2010; Magnusson, Marie/D-8996-2012; Cardoso, Rosilene Fressatti/J-4796-2015	de Nys, Rocky/0000-0003-3869-4928; Machado, Lorenna/0000-0002-1554-6108; Pavan, Fernando/0000-0002-6969-3963; Magnusson, Marie/0000-0002-3141-8544; Paul, Nicholas/0000-0002-9275-1535; Cardoso, Rosilene Fressatti/0000-0001-6228-4780	Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program; Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program(Australian GovernmentDepartment of Agriculture and Water Resources); Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project is supported by funding from the Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program. The project is also supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AL, 2012, TROP ANIM HEALTH PRO, V44, P953, DOI 10.1007/s11250-011-9992-0; [Anonymous], 1970, AGR HDB; Arelovich HM, 2000, J ANIM SCI, V78, P2972; Bach SJ, 2008, ANIM FEED SCI TECH, V142, P17, DOI 10.1016/j.anifeedsci.2007.05.033; Beauchemin KA, 2008, AUST J EXP AGR, V48, P21, DOI 10.1071/EA07199; BIDLACK JE, 1992, CAN J PLANT SCI, V72, P809, DOI 10.4141/cjps92-097; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; Boyd RS, 2012, PLANT SCI, V195, P88, DOI 10.1016/j.plantsci.2012.06.012; Bozic AK, 2009, BIORESOURCE TECHNOL, V100, P4017, DOI 10.1016/j.biortech.2008.12.061; Breiman L., 1984, CLASSIFICATION REGRE; Bueno ICS, 2005, ANIM FEED SCI TECH, V123, P95, DOI 10.1016/j.anifeedsci.2005.05.003; Channiwala SA, 2002, FUEL, V81, P1051, DOI 10.1016/S0016-2361(01)00131-4; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chojnacka K, 2012, HANDBOOK OF MARINE MACROALGAE: BIOTECHNOLOGY AND APPLIED PHYCOLOGY, P478; CHOPIN T, 2009, SEAWEEDS THEIR MARIC, V3, P4477; Chowdhury S, 1995, AGR SCI BIOD SUST WO, P3; Cottle DJ, 2011, ANIM PROD SCI, V51, P491, DOI 10.1071/AN10163; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; del Val Antonio Gonzalez, 2001, International Microbiology, V4, P35; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genovese G, 2009, MAR DRUGS, V7, P361, DOI 10.3390/md7030361; Getachew G, 1998, ANIM FEED SCI TECH, V72, P261, DOI 10.1016/S0377-8401(97)00189-2; Goel G, 2012, TROP ANIM HEALTH PRO, V44, P729, DOI 10.1007/s11250-011-9966-2; Gorley C.K., 2006, GETTING STARTED PRIM; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Grainger C, 2008, AUST J EXP AGR, V48, P73, DOI 10.1071/EA07224; Grainger C, 2011, ANIM FEED SCI TECH, V166-67, P308, DOI 10.1016/j.anifeedsci.2011.04.021; Henry B, 2012, CROP PASTURE SCI, V63, P191, DOI 10.1071/CP11169; Jayanegara A, 2011, ANIM FEED SCI TECH, V163, P231, DOI 10.1016/j.anifeedsci.2010.11.009; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Ktita SR, 2010, SMALL RUMINANT RES, V91, P116, DOI 10.1016/j.smallrumres.2010.01.012; Lee HJ, 2003, ASIAN AUSTRAL J ANIM, V16, P1143, DOI 10.5713/ajas.2003.1143; Lourenco Sergio O., 2002, Phycological Research, V50, P233; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; Marin A, 2009, REV BIOL TROP, V57, P1271; McGinn SM, 2004, J ANIM SCI, V82, P3346; Meale SJ, 2012, ASIAN AUSTRAL J ANIM, V25, P86, DOI 10.5713/ajas.2011.11249; MOORE RE, 1977, ACCOUNTS CHEM RES, V10, P40, DOI 10.1021/ar50110a002; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Nagadi S, 2000, ANIM FEED SCI TECH, V87, P231, DOI 10.1016/S0377-8401(00)00197-8; O'Sullivan L, 2010, MAR DRUGS, V8, P2038, DOI 10.3390/md8072038; OTTENSTEIN DM, 1971, J CHROMATOGR SCI, V9, P673, DOI 10.1093/chromsci/9.11.673; Patra AK, 2006, ANIM FEED SCI TECH, V128, P276, DOI 10.1016/j.anifeedsci.2005.11.001; Patra AK, 2010, PHYTOCHEMISTRY, V71, P1198, DOI 10.1016/j.phytochem.2010.05.010; Patra AK, 2012, ENVIRON MONIT ASSESS, V184, P1929, DOI 10.1007/s10661-011-2090-y; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; PLAYNE MJ, 1985, J SCI FOOD AGR, V36, P638, DOI 10.1002/jsfa.2740360803; Reay D., 2010, METHANE CLIMATE CHAN, P1; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Sawidis T, 2001, ENVIRON INT, V27, P43, DOI 10.1016/S0160-4120(01)00052-6; Singh S, 2012, ANIM FEED SCI TECH, V178, P2, DOI 10.1016/j.anifeedsci.2012.08.019; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tavendale MH, 2005, ANIM FEED SCI TECH, V123, P403, DOI 10.1016/j.anifeedsci.2005.04.037; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wang Y, 2008, ANIM FEED SCI TECH, V145, P375, DOI 10.1016/j.anifeedsci.2007.03.013; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9	59	97	104	10	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85289	10.1371/journal.pone.0085289	http://dx.doi.org/10.1371/journal.pone.0085289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465524	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000330283100035
J	Li, SF; Gao, WJ; Zhao, XP; Dong, TY; Deng, CL; Lu, LD				Li, Shu-Fen; Gao, Wu-Jun; Zhao, Xin-Peng; Dong, Tian-Yu; Deng, Chuan-Liang; Lu, Long-Dou			Analysis of Transposable Elements in the Genome of Asparagus officinalis from High Coverage Sequence Data	PLOS ONE			English	Article							REPETITIVE SEQUENCES; SEX-CHROMOSOMES; SIZE VARIATION; RETROTRANSPOSONS	Asparagus officinalis is an economically and nutritionally important vegetable crop that is widely cultivated and is used as a model dioecious species to study plant sex determination and sex chromosome evolution. To improve our understanding of its genome composition, especially with respect to transposable elements (TEs), which make up the majority of the genome, we performed Illumina HiSeq2000 sequencing of both male and female asparagus genomes followed by bioinformatics analysis. We generated 17 Gb of sequence (126coverage) and assembled them into 163,406 scaffolds with a total cumulated length of 400 Mbp, which represent about 30% of asparagus genome. Overall, TEs masked about 53% of the A. officinalis assembly. Majority of the identified TEs belonged to LTR retrotransposons, which constitute about 28% of genomic DNA, with Ty1/copia elements being more diverse and accumulated to higher copy numbers than Ty3/gypsy. Compared with LTR retrotransposons, non-LTR retrotransposons and DNA transposons were relatively rare. In addition, comparison of the abundance of the TE groups between male and female genomes showed that the overall TE composition was highly similar, with only slight differences in the abundance of several TE groups, which is consistent with the relatively recent origin of asparagus sex chromosomes. This study greatly improves our knowledge of the repetitive sequence construction of asparagus, which facilitates the identification of TEs responsible for the early evolution of plant sex chromosomes and is helpful for further studies on this dioecious plant.	[Li, Shu-Fen; Gao, Wu-Jun; Zhao, Xin-Peng; Dong, Tian-Yu; Deng, Chuan-Liang; Lu, Long-Dou] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Li, Shu-Fen; Gao, Wu-Jun; Deng, Chuan-Liang; Lu, Long-Dou] Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang, Peoples R China	Henan Normal University	Gao, WJ (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.	gaowujun1@163.com	Fan, Huahao/AAR-8062-2021; Fan, Hang/AAA-8489-2022	Fan, Huahao/0000-0001-5007-2158; Fan, Hang/0000-0002-7927-1684; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [30970211, 31300202, 31000165]; Key Science and Technology Research Project of Henan Province [132102110195]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [13IRTSTHN009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Research Project of Henan Province; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by grants from the National Natural Science Foundation of China (30970211, 31300202 and 31000165), the Key Science and Technology Research Project of Henan Province (No. 132102110195) and the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (13IRTSTHN009). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du JC, 2012, PLANT CELL, V24, P21, DOI [10.1105/tpc.111.092759, 10.1105/tpc.112.103630]; Ellision JH, 1986, BREEDING VEGETABLE C, P521; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hertweck KL, 2013, GENOME, V56, P487, DOI 10.1139/gen-2013-0042; Hill P, 2005, MOL GENET GENOMICS, V273, P371, DOI 10.1007/s00438-005-1141-x; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumar Amar, 2000, Trends in Plant Science, V5, P509, DOI 10.1016/S1360-1385(00)01760-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lepesant JMJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r14; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Negrutiu I, 2001, PLANT PHYSIOL, V127, P1418, DOI 10.1104/pp.010711; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Reamon-Buttner SM, 1998, MOL BREEDING, V4, P91, DOI 10.1023/A:1009650221460; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rick CM, 1943, AM J BOT, V30, P711, DOI 10.2307/2437718; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Vitte C, 2013, ANN BOT-LONDON, V112, P881, DOI 10.1093/aob/mct155; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	42	179	185	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97189	10.1371/journal.pone.0097189	http://dx.doi.org/10.1371/journal.pone.0097189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24465717	Green Published, Green Submitted, gold			2022-12-27	WOS:000338213300131
J	Wang, X; Xu, Z; Miao, CH				Wang, Xin; Xu, Zheng; Miao, Chang-Hong			Current Clinical Evidence on the Effect of General Anesthesia on Neurodevelopment in Children: An Updated Systematic Review with Meta-Regression	PLOS ONE			English	Review							EARLY EXPOSURE; DEVELOPMENTAL DISORDERS; CHILDHOOD EXPOSURE; SURGERY	Background: Several epidemiological studies have been conducted to address the later effect of anesthesia on neurodevelopment in children. However, the results are still inconclusive. Methods: We here conducted a systematic review and meta-analysis to summarize the currently available clinical and epidemiologic evidence on the association of anesthesia/surgery with neurodevelopmental outcomes in children by searching PubMed, EMBASE, and Web of Science database (from January-1 2000 to February-1, 2013). The evaluation of neurodevelopment includes language and learning disabilities, cognition, behavioral development, and academic performance. Both retrospective and prospective studies were included. Data were abstracted from seven eligible studies. We estimated the synthesized hazard ratios (HR) and 95% confidence interval (CI) according to inter-study heterogeneity. Results: The pooled HR for the association of anesthesia/surgery with an adverse behavioral or developmental outcome was 1.25 (95% CI, 1.13-1.38, P, 0.001; random-effects model) in children undergoing the first anesthesia before the age of 4-year. Then we analyzed the factors for this association using meta-regression method. It showed that it was the number of times of exposure (HR = 1.75, 95% CI 1.31-2.33; P<0.001) rather than the time at exposure before 4-year (HR = 1.08, 95% CI 0.87-1.34 for the effect of per 1-year early exposure; P = 0.47) is a risk factor for neurodevelopmental impairment. Conclusion: The current clinical evidence suggests modestly elevated risk of adverse neurodevelopmental outcomes in children who were exposed to anesthesia/surgery during early childhood, especially for those with multiple times of exposure. Due to limitation of retrospective studies, prospective investigations are needed to determine whether anesthesia/surgery is causative.	[Wang, Xin] Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China.	xinwang79@gmail.com; miaochh@yahoo.com.cn	Cammeraat, Erik L.H./G-2863-2010; Kalbitz, Karsten/A-9641-2013	Cammeraat, Erik L.H./0000-0003-4398-206X; 				Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; DiMaggio C, 2012, J NEUROSURG ANESTH, V24, P376, DOI 10.1097/ANA.0b013e31826a038d; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guerra GG, 2011, PEDIATR ANESTH, V21, P932, DOI 10.1111/j.1460-9592.2011.03581.x; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; HATTORI R, 1991, LANCET, V337, P1357, DOI 10.1016/0140-6736(91)93045-B; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Roze JC, 2008, ARCH PEDIAT ADOL MED, V162, P728, DOI 10.1001/archpedi.162.8.728; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	21	236	240	16	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85760	10.1371/journal.pone.0085760	http://dx.doi.org/10.1371/journal.pone.0085760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465688	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500070
J	Dong, J; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Xu, R; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY				Dong, Jie; Han, Qing-Feng; Zhu, Tong-Ying; Ren, Ye-Ping; Chen, Jiang-Hua; Zhao, Hui-Ping; Chen, Meng-Hua; Xu, Rong; Wang, Yue; Hao, Chuan-Ming; Zhang, Rui; Zhang, Xiao-Hui; Wang, Mei; Tian, Na; Wang, Hai-Yan			The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; RENAL-FUNCTION DECLINE; HIGH BLOOD-PRESSURE; HEMODIALYSIS-PATIENTS; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROSIS RISK; LOWERING THERAPY; ARTERY-DISEASE	Aims: To investigate whether uric acid (UA) is an independent predictor of cardiovascular (CV) and all-cause mortality in peritoneal dialysis (PD) patients after controlling for recognized CV risk factors. Methods: A total of 2264 patients on chronic PD were collected from seven centers affiliated with the Socioeconomic Status on the Outcome of Peritoneal Dialysis (SSOP) Study. All demographic and laboratory data were recorded at baseline. Multivariate Cox regression was used to calculate the hazard ratio (HR) of CV and all-cause mortality with adjustments for recognized traditional and uremia-related CV factors. Results: There were no significant differences in baseline characteristics between patients with (n = 2193) and without (n = 71) UA measured. Each 1 mg/dL of increase in UA was associated with higher all-cause mortality with 1.05(1.00 similar to 1.10) of HR and higher CV mortality with 1.12 (1.05 similar to 1.20) of HR after adjusting for age, gender and center size. The highest gender-specific tertile of UA predicted higher all-cause mortality with 1.23(1.00 similar to 1.52) of HR and higher CV mortality with 1.69 (1.21 similar to 2.38) of HR after adjusting for age, gender and center size. The predictive value of UA was stronger in patients younger than 65 years without CV disease or diabetes at baseline. The prognostic value of UA as both continuous and categorical variable weakened or disappeared after further adjusted for uremia-related and traditional CV risk factors. Conclusions: The prognostic value of UA in CV and all-cause mortality was weak in PD patients generally, which was confounded by uremia-related and traditional CV risk factors.	[Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Educ, Key Lab Renal Dis, Beijing, Peoples R China; [Han, Qing-Feng; Wang, Yue] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Zhu, Tong-Ying] Fudan Univ, Dept Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Ren, Ye-Ping; Zhang, Rui] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhang, Xiao-Hui] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Mei] Peking Univ, Peoples Hosp, Dept Nephrol, Beijing 100871, Peoples R China; [Chen, Meng-Hua; Tian, Na] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Peking University; Peking University; Peking University; Fudan University; Harbin Medical University; Zhejiang University; Peking University; Ningxia Medical University	Dong, J (corresponding author), Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China.	dongjie@medmail.com.cn	tian, na/GVR-9226-2022; Dong, Jie/AFM-0048-2022; Dong, Jinwei/C-4949-2009	Biradar, Chandrashekhar/0000-0002-9532-9452; Xiao, Xiangming/0000-0003-0956-7428; Dong, Jinwei/0000-0001-5687-803X	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	This study is supported in part by New Century Excellent Talents from The Education Department, China, Baxer Clinical Research Award from Baxter Corp, China, and an ISN Research Award from the ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RW, 1994, NEW ENGL J MED, V331, P468, DOI 10.1056/NEJM199408183310709; Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Caravaca F, 2005, NEFROLOGIA, V25, P645; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chen YM, 2011, AM J NEPHROL, V33, P97, DOI 10.1159/000322966; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Iuliano L, 2001, LIPIDS, V36, pS41, DOI 10.1007/s11745-001-0680-1; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Jonasson T, 2005, CLIN CHEM LAB MED, V43, P628, DOI 10.1515/CCLM.2005.108; Jun M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008176.pub2; Kanbay M, 2012, AM J NEPHROL, V36, P324, DOI 10.1159/000342390; Kanbay M, 2011, AM J NEPHROL, V33, P298, DOI 10.1159/000324847; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Latif W, 2011, CLIN J AM SOC NEPHRO, V6, P2470, DOI 10.2215/CJN.00670111; Lee SMK, 2009, AM J NEPHROL, V29, P79, DOI 10.1159/000151292; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Melendez-Ramirez G, 2012, ENDOCR RES, V37, P1, DOI 10.3109/07435800.2011.566235; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Navaneethan SD, 2009, NEPHROL DIAL TRANSPL, V24, P1260, DOI 10.1093/ndt/gfn621; Navaneethan SD, 2009, COCHRANE DATABASE SY; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Pan Y, 2012, BRIT J NUTR, V108, P400, DOI 10.1017/S0007114511007033; Park JT, 2009, NEPHROL DIAL TRANSPL, V24, P3520, DOI 10.1093/ndt/gfp272; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Suzuki T, 2007, NITRIC OXIDE-BIOL CH, V16, P266, DOI 10.1016/j.niox.2006.10.008; Tangri N, 2010, AM J KIDNEY DIS, V56, P247, DOI 10.1053/j.ajkd.2010.06.004; Wang AYM, 2007, PERITON DIALYSIS INT, V27, pS228; Wannamethee SG, 1997, HEART, V78, P147, DOI 10.1136/hrt.78.2.147; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Zhang LX, 2012, NEPHROL DIAL TRANSPL, V27, P1836, DOI 10.1093/ndt/gfr597	43	62	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82342	10.1371/journal.pone.0082342	http://dx.doi.org/10.1371/journal.pone.0082342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24465714	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500015
J	Sanders, T; Cliff, DP; Lonsdale, C				Sanders, Taren; Cliff, Dylan P.; Lonsdale, Chris			Measuring Adolescent Boys' Physical Activity: Bout Length and the Influence of Accelerometer Epoch Length	PLOS ONE			English	Article							ACTIVITY PATTERNS; CHILDREN; HEALTH; LEVEL	Objectives: Accurate, objective measurement is important for understanding adolescents' physical activity (PA) behaviour. When using accelerometry to objectively measure PA, a decision must be made regarding how frequently data is recorded (i.e., epoch length). The purpose of this study was to examine i) PA bout length, and ii) the effect of variations in accelerometer epoch length on PA estimates during physical education (PE) and leisure time in adolescent boys. Design: Cross-sectional study. Methods: Year 9 boys (N = 133; mean age +/- SD = 14.36 +/- 0.48 years) wore accelerometers during two PE lessons, and for a period of seven consecutive days. Data were reintegrated from 1s into longer periods of 2, 5, 10, 30, and 60 seconds. ANOVAs were used to test for differences in PA estimates between epochs in leisure time and PE. Results: The mean length of vigorous PA (VPA) bouts was 3.5 +/- 2.0 seconds for PE and 2.5 +/- 1.7 seconds for leisure time, and mean length of moderate PA (MPA) bouts was 2.3 +/- 0.5 seconds for PE and 2.9 +/- 0.5 seconds for leisure time. During PE, estimates of MVPA, MPA, and light PA (LPA) increased as epoch increased from 1 second to 60 seconds, while VPA and sedentary behaviour estimates decreased. During leisure time, estimates of all PA intensities decreased as epoch increased from 1 second to 60 seconds, with the exception of sedentary behaviour, which increased as epoch length increased. Conclusion: The context in which PA occurs can influence PA bout length measurement and the effect of variations in epoch length on PA estimates. Researchers measuring PA with accelerometry should be conscious of the possible influence of context on PA estimates.	[Sanders, Taren; Lonsdale, Chris] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Cliff, Dylan P.] Univ Wollongong, Interdisciplinary Educ Res Inst, Sch Educ, Wollongong, NSW, Australia	Western Sydney University; University of Wollongong	Lonsdale, C (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	c.lonsdale@uws.edu.au	Coyle, David/P-3920-2019; Sanders, Caroline/G-8021-2014; Kessler, david/ABB-6489-2021; Bower, Peter/A-1508-2011; Bee, Penny E/O-8822-2014; Lonsdale, Chris/T-8710-2017; Gilbody, Simon/AAY-3720-2021; Sanders, Taren/N-9511-2018; Lovell, Karina S E/E-6410-2012	Coyle, David/0000-0002-5103-0379; Sanders, Caroline/0000-0002-0539-928X; Bower, Peter/0000-0001-9558-3349; Bee, Penny E/0000-0002-5600-0400; Lonsdale, Chris/0000-0002-2523-5565; Gilbody, Simon/0000-0002-8236-6983; Sanders, Taren/0000-0002-4504-6008; Lovell, Karina S E/0000-0001-8821-895X; Knowles, Sarah/0000-0002-0863-5866; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Kennedy, Catriona/0000-0003-3510-9113; Cliff, Dylan/0000-0001-6863-3996	University of Western Sydney; National Heart Foundation of Australia [PH 11S 6025]; Medical Research Council [G0401181] Funding Source: researchfish; National Institute for Health Research [SPCR-040, 06/43/05, 06/43/504] Funding Source: researchfish	University of Western Sydney; National Heart Foundation of Australia(National Heart Foundation of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the University of Western Sydney's support for Bachelor of Health Science (Honours) research projects. Dylan Cliff is funded by a National Heart Foundation of Australia Postdoctoral Research Fellowship (PH 11S 6025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph Software Department, 2012, ACT 6 US MAN; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Berman N, 1998, AM J HUM BIOL, V10, P289, DOI 10.1002/(SICI)1520-6300(1998)10:3<289::AID-AJHB4>3.0.CO;2-E; Blaes A, 2011, AM J HUM BIOL, V23, P353, DOI 10.1002/ajhb.21142; Carson V, 2014, INT J OBESITY, V38, P16, DOI 10.1038/ijo.2013.135; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dencker M, 2012, J SPORT MED PHYS FIT, V52, P115; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P.S., 1997, MED SCI SPORT EXER S, V29, P45, DOI DOI 10.1097/00005768-199705001-00256; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Gabriel KP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-53; Gutin B, 2008, OBESITY, V16, P2193, DOI 10.1038/oby.2008.348; Holman RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025733; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Obeid J, 2011, APPL PHYSIOL NUTR ME, V36, P291, DOI [10.1139/h11-002, 10.1139/H11-002]; Rowls AV., 2006, CITESEER, V4, P52; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sayers A, 2011, J CLIN ENDOCR METAB, V96, pE793, DOI 10.1210/jc.2010-2550; Sirard JR, 2009, J PHYS ACT HEALTH, V6, pS148, DOI 10.1123/jpah.6.s1.s148; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Vanhelst J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-26; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	37	143	148	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92040	10.1371/journal.pone.0092040	http://dx.doi.org/10.1371/journal.pone.0092040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643129	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900069
J	Wang, X; Cammeraat, ELH; Romeijn, P; Kalbitz, K				Wang, Xiang; Cammeraat, Erik L. H.; Romeijn, Paul; Kalbitz, Karsten			Soil Organic Carbon Redistribution by Water Erosion-The Role of CO2 Emissions for the Carbon Budget	PLOS ONE			English	Article							DIOXIDE EVOLUTION; VARIABLE RAINFALL; INTERRILL EROSION; ENRICHMENT RATIO; MATTER; RUNOFF; DEPOSITION; FRACTIONS; STABILITY; SEDIMENT	A better process understanding of how water erosion influences the redistribution of soil organic carbon (SOC) is sorely needed to unravel the role of soil erosion for the carbon (C) budget from local to global scales. The main objective of this study was to determine SOC redistribution and the complete C budget of a loess soil affected by water erosion. We measured fluxes of SOC, dissolved organic C (DOC) and CO2 in a pseudo-replicated rainfall-simulation experiment. We characterized different C fractions in soils and redistributed sediments using density fractionation and determined C enrichment ratios (CER) in the transported sediments. Erosion, transport and subsequent deposition resulted in significantly higher CER of the sediments exported ranging between 1.3 and 4.0. In the exported sediments, C contents (mg per g soil) of particulate organic C (POC, C not bound to soil minerals) and mineral-associated organic C (MOC) were both significantly higher than those of non-eroded soils indicating that water erosion resulted in losses of C-enriched material both in forms of POC and MOC. The averaged SOC fluxes as particles (4.7 g C m(-2) yr(-1)) were 18 times larger than DOC fluxes. Cumulative emission of soil CO2 slightly decreased at the erosion zone while increased by 56% and 27% at the transport and depositional zone, respectively, in comparison to non-eroded soil. Overall, CO2 emission is the predominant form of C loss contributing to about 90.5% of total erosion-induced C losses in our 4-month experiment, which were equal to 18 g C m(-2). Nevertheless, only 1.5% of the total redistributed C was mineralized to CO2 indicating a large stabilization after deposition. Our study also underlines the importance of C losses by particles and as DOC for understanding the effects of water erosion on the C balance at the interface of terrestrial and aquatic ecosystems.	[Wang, Xiang; Cammeraat, Erik L. H.; Romeijn, Paul; Kalbitz, Karsten] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Wang, X (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	X.Wang@uva.nl	Cammeraat, Erik L.H./G-2863-2010; Kalbitz, Karsten/A-9641-2013	Cammeraat, Erik L.H./0000-0003-4398-206X; 	China Scholarship Council (CSC); University of Amsterdam (UvA)	China Scholarship Council (CSC)(China Scholarship Council); University of Amsterdam (UvA)	This work was supported by China Scholarship Council (CSC) and University of Amsterdam (UvA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Berhe AA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001790; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Borselli L, 2001, EARTH SURF PROC LAND, V26, P329, DOI [10.1002/1096-9837(200103)26:3<329::AID-ESP177>3.0.CO;2-Y, 10.1002/1096-9837(200103)26:3&lt;329::AID-ESP177&gt;3.0.CO;2-Y]; Bremenfeld S, 2013, CATENA, V104, P14, DOI 10.1016/j.catena.2012.12.011; Buishand TA, 1980, EXTREME NEERSLAGHOEV, P104; Casals P, 2009, SOIL BIOL BIOCHEM, V41, P1915, DOI 10.1016/j.soilbio.2009.06.015; Cerli C, 2012, GEODERMA, V170, P403, DOI 10.1016/j.geoderma.2011.10.009; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Chen FS, 2010, APPL SOIL ECOL, V44, P42, DOI 10.1016/j.apsoil.2009.09.003; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Creed IF, 2013, BIOGEOCHEMISTRY, V112, P149, DOI 10.1007/s10533-012-9713-4; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P2145, DOI 10.1016/S0038-0717(01)00153-5; Doetterl S, 2012, GLOBAL CHANGE BIOL, V18, P2218, DOI 10.1111/j.1365-2486.2012.02680.x; Feng WT, 2014, SOIL BIOL BIOCHEM, V69, P398, DOI 10.1016/j.soilbio.2013.11.024; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Franzluebbers AJ, 1999, SOIL BIOL BIOCHEM, V31, P1083, DOI 10.1016/S0038-0717(99)00022-X; GHADIRI H, 1993, J ENVIRON MANAGE, V37, P37, DOI 10.1006/jema.1993.1003; GHADIRI H, 1991, J ENVIRON QUAL, V20, P634, DOI 10.2134/jeq1991.00472425002000030021x; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Gregorich EG, 1998, SOIL TILL RES, V47, P291, DOI 10.1016/S0167-1987(98)00117-2; Harden JW, 1999, GLOBAL BIOGEOCHEM CY, V13, P885, DOI 10.1029/1999GB900061; HEIMOVAARA TJ, 1990, WATER RESOUR RES, V26, P2311, DOI 10.1029/90WR01239; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Intergovernmental Panel on Climate Change (IPCC), 2014, INTERGOVERNMENTAL PA; IUSS Working Group, 2006, WORLD REF BAS SOIL R, DOI DOI 10.1017/S0014479706394902; Jacinthe PA, 2002, SOIL TILL RES, V66, P23, DOI 10.1016/S0167-1987(02)00010-7; Jacinthe PA, 2001, LAND DEGRAD DEV, V12, P329, DOI 10.1002/ldr.454; Kaiser K, 2003, EUR J SOIL SCI, V54, P219, DOI 10.1046/j.1365-2389.2003.00544.x; Kuhn NJ, 2007, EARTH SURF PROC LAND, V32, P794, DOI 10.1002/esp.1486; KWAAD FJPM, 1994, CATENA, V23, P253, DOI 10.1016/0341-8162(94)90071-X; Kwaad FJPM, 2006, SOIL EROSION EUROPE; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Nadeu E, 2012, BIOGEOSCIENCES, V9, P1099, DOI 10.5194/bg-9-1099-2012; Palis RG, 1997, AUST J SOIL RES, V35, P891, DOI 10.1071/S92060; Polyakov VO, 2008, GEODERMA, V143, P216, DOI 10.1016/j.geoderma.2007.11.005; Schiettecatte W, 2008, SOIL SCI SOC AM J, V72, P50, DOI 10.2136/sssaj2007.0201; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Smith SV, 2005, ECOL APPL, V15, P1929, DOI 10.1890/05-0073; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Strickland TC, 2005, J SOIL WATER CONSERV, V60, P142; Truman CC, 2007, J ENVIRON QUAL, V36, P1495, DOI 10.2134/jeq2006.0018; Van Hemelryck H, 2010, BIOGEOSCIENCES, V7, P3971, DOI 10.5194/bg-7-3971-2010; Van Hemelryck H, 2011, EARTH SURF PROC LAND, V36, P427, DOI 10.1002/esp.2055; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Wan Y, 1998, J ENVIRON QUAL, V27, P132, DOI 10.2134/jeq1998.00472425002700010019x; Wang X, 2013, EUR J SOIL SCI, V64, P219, DOI 10.1111/ejss.12018; Wang ZG, 2010, GEOMORPHOLOGY, V124, P65, DOI 10.1016/j.geomorph.2010.08.010; Zhang JH, 2006, GLOBAL CHANGE BIOL, V12, P1834, DOI 10.1111/j.1365-2486.2006.01206.x	53	236	240	16	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96299	10.1371/journal.pone.0096299	http://dx.doi.org/10.1371/journal.pone.0096299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24465688	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800051
J	Zhang, XJ; Bowles, AC; Semon, JA; Scruggs, BA; Zhang, SJ; Strong, AL; Gimble, JM; Bunnell, BA				Zhang, Xiujuan; Bowles, Annie C.; Semon, Julie A.; Scruggs, Brittni A.; Zhang, Shijia; Strong, Amy L.; Gimble, Jeffrey M.; Bunnell, Bruce A.			Transplantation of Autologous Adipose Stem Cells Lacks Therapeutic Efficacy in the Experimental Autoimmune Encephalomyelitis Model	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MULTIPLE-SCLEROSIS; BONE-MARROW; STROMAL CELLS; IMMUNE-RESPONSE; TISSUE; EXPRESSION; MCP-1; CCL2; METALLOPROTEINASES	Multiple sclerosis (MS), characterized by chronic inflammation, demyelination, and axonal damage, is a complicated neurological disease of the human central nervous system. Recent interest in adipose stromal/stem cell (ASCs) for the treatment of CNS diseases has promoted further investigation in order to identify the most suitable ASCs. To investigate whether MS affects the biologic properties of ASCs and whether autologous ASCs from MS-affected sources could serve as an effective source for stem cell therapy, cells were isolated from subcutaneous inguinal fat pads of mice with established experimental autoimmune encephalomyelitis (EAE), a murine model of MS. ASCs from EAE mice and their syngeneic wildtype mice were cultured, expanded, and characterized for their cell morphology, surface antigen expression, osteogenic and adipogenic differentiation, colony forming units, and inflammatory cytokine and chemokine levels in vitro. Furthermore, the therapeutic efficacy of the cells was assessed in vivo by transplantation into EAE mice. The results indicated that the ASCs from EAE mice displayed a normal phenotype, typical MSC surface antigen expression, and in vitro osteogenic and adipogenic differentiation capacity, while their osteogenic differentiation capacity was reduced in comparison with their unafflicted control mice. The ASCs from EAE mice also demonstrated increased expression of pro-inflammatory cytokines and chemokines, specifically an elevation in the expression of monocyte chemoattractant protein-1 and keratin chemoattractant. In vivo, infusion of wild type ASCs significantly ameliorate the disease course, autoimmune mediated demyelination and cell infiltration through the regulation of the inflammatory responses, however, mice treated with autologous ASCs showed no therapeutic improvement on the disease progression.	[Zhang, Xiujuan] Dalian Univ Technol, Sch Petr & Chem Engn, Panjin, Liaoning Provin, Peoples R China; [Zhang, Xiujuan; Bowles, Annie C.; Semon, Julie A.; Scruggs, Brittni A.; Zhang, Shijia; Strong, Amy L.; Bunnell, Bruce A.] Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70112 USA; [Bowles, Annie C.; Bunnell, Bruce A.] Tulane Univ, Dept Cell & Mol Biol, Sch Sci & Engn, New Orleans, LA 70118 USA; [Scruggs, Brittni A.; Zhang, Shijia] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Gimble, Jeffrey M.] Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA 70808 USA; [Bunnell, Bruce A.] Tulane Natl Primate Res Ctr, Div Regenerat Med, Covington, LA USA	Dalian University of Technology; Tulane University; Tulane University; Tulane University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Tulane University	Bunnell, BA (corresponding author), Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	bbunnell@tulane.edu		Bunnell, Bruce/0000-0001-6196-3722; Strong, Amy/0000-0002-2581-2481	Tulane University; Pennington Biomedical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	Tulane University; Pennington Biomedical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by Tulane University and the Pennington Biomedical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Baker D, 2007, ADV CLIN NEUROSCI RE, V6, P10; BONAB MM, 2007, IRAN J IMMUNOL, V4, P50; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fisher-Shoval Y, 2012, J MOL NEUROSCI; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Freedman SM, 2010, MULT SCLER, V16, P7; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Ge SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-171; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kieseier BC, 2007, CURR OPIN NEUROL, V20, P286, DOI 10.1097/WCO.0b013e3281568b80; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Lanz TV, 2010, STEM CELLS DEV, V19, P657, DOI 10.1089/scd.2009.0385; Liang J, 2009, MULT SCLER, V15, P2; Liu YL, 2011, STEM CELLS, V29, P1804, DOI 10.1002/stem.728; Luo Y, 2000, J IMMUNOL, V165, P4015, DOI 10.4049/jimmunol.165.7.4015; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mallam E, 2010, MULT SCLER J, V16, P909, DOI 10.1177/1352458510371959; Miller David H, 2004, NeuroRx, V1, P284, DOI 10.1602/neurorx.1.2.284; Niimi N, 2013, NEUROPATHOLOGY, V33, P612, DOI 10.1111/neup.12039; Payne N, 2012, CELL ADH MIGR, V6; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELA J, 1986, BIOMATER ARTIF CELL, V14, P227, DOI 10.3109/10731198609117544; Semon JA, 2013, STEM CELL TRANSL MED, V2, P789, DOI 10.5966/sctm.2013-0032; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; Uccelli A, 2012, MULT SCLER J, P1; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	49	199	202	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85007	10.1371/journal.pone.0085007	http://dx.doi.org/10.1371/journal.pone.0085007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465465	Green Published, gold			2022-12-27	WOS:000330244500026
J	Wu, FQ; Price, BW; Haider, W; Seufferheld, G; Nelson, R; Hanzawa, Y				Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Nelson, Randall; Hanzawa, Yoshie			Functional and Evolutionary Characterization of the CONSTANS Gene Family in Short-Day Photoperiodic Flowering in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; TIME GENE; LOCUS-T; ARABIDOPSIS; EXPRESSION; MATURITY; ORTHOLOG; SEQUENCE; NEOFUNCTIONALIZATION; DUPLICATION	CONSTANS (CO) plays a central role in photoperiodic flowering control of plants. However, much remains unknown about the function of the CO gene family in soybean and the molecular mechanisms underlying short-day photoperiodic flowering of soybean. We identified 26 CO homologs (GmCOLs) in the soybean genome, many of them previously unreported. Phylogenic analysis classified GmCOLs into three clades conserved among flowering plants. Two homeologous pairs in Clade I, GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b, showed the highest sequence similarity to Arabidopsis CO. The mRNA abundance of GmCOL1a and GmCOL1b exhibited a strong diurnal rhythm under flowering-inductive short days and peaked at dawn, which coincided with the rise of GmFT5a expression. In contrast, the mRNA abundance of GmCOL2a and GmCOL2b was extremely low. Our transgenic study demonstrated that GmCOL1a, GmCOL1b, GmCOL2a and GmCOL2b fully complemented the late flowering effect of the co-1 mutant in Arabidopsis. Together, these results indicate that GmCOL1a and GmCOL1b are potential inducers of flowering in soybean. Our data also indicate rapid regulatory divergence between GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b but conservation of their protein function. Dynamic evolution of GmCOL regulatory mechanisms may underlie the evolution of photoperiodic signaling in soybean.	[Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Hanzawa, Yoshie] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Nelson, Randall] Univ Illinois, Dept Crop Sci, USDA Agr Res Serv, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Hanzawa, Y (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	yhanzawa@illinois.edu	Haider, Waseem/AAD-6214-2019	Haider, Waseem/0000-0001-9200-6714; Hanzawa, Yoshie/0000-0003-4704-8872	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [USDA-NIFA2011-00078]; ARS [ARS-0424505] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is supported by the Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (USDA-NIFA2011-00078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Borthwick HA, 1939, BOT GAZ, V101, P341, DOI 10.1086/334874; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gonzalez-Schain ND, 2008, BIOL PLANTARUM, V52, P251, DOI 10.1007/s10535-008-0054-z; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Gu XF, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001649; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; He YH, 2012, TRENDS PLANT SCI, V17, P556, DOI 10.1016/j.tplants.2012.05.001; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; Hsu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045448; Imamura S, 1967, PHYSL FLOWERING PHAR; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kikuchi R, 2012, J EXP BOT, V63, P773, DOI 10.1093/jxb/err299; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Liu L, 2011, RUSS J PLANT PHYSL+, V58, P330, DOI 10.1134/S1021443711020105; Ma JinHua, 2009, Plant Physiology Communications, V46, P17; Martin J, 2004, PLANT MOL BIOL, V56, P159, DOI 10.1007/s11103-004-2647-z; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Molnar SJ, 2003, GENOME, V46, P1024, DOI [10.1139/g03-079, 10.1139/G03-079]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu F, 2014, HDB PLANT CROP PHYSL, P129; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang QingZhe, 2010, Acta Agronomica Sinica, V36, P539; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	59	97	105	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85754	10.1371/journal.pone.0085754	http://dx.doi.org/10.1371/journal.pone.0085754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24489881	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500105
J	Zhang, KX; Xu, HH; Gong, W; Jin, Y; Shi, YY; Yuan, TT; Li, J; Lu, YT				Zhang, Kun-Xiao; Xu, Heng-Hao; Gong, Wen; Jin, Yan; Shi, Ya-Ya; Yuan, Ting-Ting; Li, Juan; Lu, Ying-Tang			Proper PIN1 Distribution Is Needed for Root Negative Phototropism in Arabidopsis	PLOS ONE			English	Article							AUXIN EFFLUX CARRIER; SIGNAL TRANSDUCER; PLANT TROPISMS; TRANSPORT; LIGHT; GRAVITROPISM; PHOSPHORYLATION; POLARITY; PROTEIN; GROWTH	Plants can be adapted to the changing environments through tropic responses, such as light and gravity. One of them is root negative phototropism, which is needed for root growth and nutrient absorption. Here, we show that the auxin efflux carrier PIN-FORMED (PIN) 1 is involved in asymmetric auxin distribution and root negative phototropism. In darkness, PIN1 is internalized and localized to intracellular compartments; upon blue light illumination, PIN1 relocalize to basal plasma membrane in root stele cells. The shift of PIN1 localization induced by blue light is involved in asymmetric auxin distribution and root negative phototropic response. Both blue-light-induced PIN1 redistribution and root negative phototropism is mediated by a BFA-sensitive trafficking pathway and the activity of PID/PP2A. Our results demonstrate that blue-light-induced PIN1 redistribution participate in asymmetric auxin distribution and root negative phototropism.	[Zhang, Kun-Xiao; Xu, Heng-Hao; Gong, Wen; Jin, Yan; Yuan, Ting-Ting; Li, Juan; Lu, Ying-Tang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Shi, Ya-Ya] Hubei Acad Agr Sci, Inst Fruit & Tea, Wuhan, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences	Lu, YT (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yingtlu@whu.edu.cn	; Kitajima, Kaoru/M-8521-2018; Bagchi, Robert/F-1732-2011	Zhang, Kai/0000-0002-9641-8043; Harrison, Rhett/0000-0001-9055-3546; Kitajima, Kaoru/0000-0001-6822-8536; Goodale, Eben/0000-0003-3403-2847; Bagchi, Robert/0000-0003-4035-4105	National Natural Science Foundation of China [90917001]; Key Project of Chinese Ministry of Education [311026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (#90917001) and Key Project of Chinese Ministry of Education (#311026) to YT Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamins R, 2001, DEVELOPMENT, V128, P4057; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; Estelle M, 1996, CURR BIOL, V6, P1589, DOI 10.1016/S0960-9822(02)70780-X; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Haga K, 2012, PLANT PHYSIOL, V160, P763, DOI 10.1104/pp.112.202432; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Holland JJ, 2009, J EXP BOT, V60, P1969, DOI 10.1093/jxb/erp113; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Kutschera U, 2012, PLANTA, V235, P443, DOI 10.1007/s00425-012-1597-y; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sassi M, 2012, DEVELOPMENT, V139, P3402, DOI 10.1242/dev.078212; Shirakawa M, 2009, PLANT CELL PHYSIOL, V50, P1319, DOI 10.1093/pcp/pcp076; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Sukumar P, 2009, PLANT PHYSIOL, V150, P722, DOI 10.1104/pp.108.131607; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Wan YL, 2012, PLANT CELL, V24, P551, DOI 10.1105/tpc.111.094284; WENT FW, 1974, ANNU REV PLANT PHYS, V25, P1, DOI 10.1146/annurev.pp.25.060174.000245; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zhang KX, 2013, PLANT J	48	30	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85720	10.1371/journal.pone.0085720	http://dx.doi.org/10.1371/journal.pone.0085720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465665	Green Published, gold, Green Submitted			2022-12-27	WOS:000330244500097
J	Martin-Murphy, BV; You, Q; Wang, H; De La Houssaye, BA; Reilly, TP; Friedman, JE; Ju, C				Martin-Murphy, Brittany V.; You, Qiang; Wang, Hong; De La Houssaye, Becky A.; Reilly, Timothy P.; Friedman, Jacob E.; Ju, Cynthia			Mice Lacking Natural Killer T Cells Are More Susceptible to Metabolic Alterations following High Fat Diet Feeding	PLOS ONE			English	Article							INDUCED LIVER-INJURY; ADIPOSE-TISSUE; INSULIN-RESISTANCE; NKT CELLS; DEFICIENT MICE; NONALCOHOLIC STEATOHEPATITIS; MACROPHAGE POLARIZATION; GLUCOSE-INTOLERANCE; INDUCED OBESITY; BALB/C MICE	Current estimates suggest that over one-third of the adult population has metabolic syndrome and three-fourths of the obese population has non-alcoholic fatty liver disease (NAFLD). Inflammation in metabolic tissues has emerged as a universal feature of obesity and its co-morbidities, including NAFLD. Natural Killer T (NKT) cells are a subset of innate immune cells that abundantly reside within the liver and are readily activated by lipid antigens. There is general consensus that NKT cells are pivotal regulators of inflammation; however, disagreement exists as to whether NKT cells exert pathogenic or suppressive functions in obesity. Here we demonstrate that CD1d(-/-) mice, which lack NKT cells, were more susceptible to weight gain and fatty liver following high fat diet (HFD) feeding. Compared with their WT counterparts, CD1d(-/-) mice displayed increased adiposity and greater induction of inflammatory genes in the liver suggestive of the precursors of NAFLD. Calorimetry studies revealed a significant increase in food intake and trends toward decreased metabolic rate and activity in CD1d(-/-) mice compared with WT mice. Based on these findings, our results suggest that NKT cells play a regulatory role that helps to prevent diet-induced obesity and metabolic dysfunction and may play an important role in mechanisms governing cross-talk between metabolism and the immune system to regulate energy balance and liver health.	[You, Qiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Biotherapy, Nanjing, Jiangsu, Peoples R China; [You, Qiang; Ju, Cynthia] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Martin-Murphy, Brittany V.] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA; [Wang, Hong] Univ Colorado, Div Endocrinol Diabet & Metab, Aurora, CO USA; [De La Houssaye, Becky A.; Friedman, Jacob E.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Reilly, Timothy P.] Bristol Myers Squibb Co, Drug Safety Evaluat Res & Dev, Princeton, NJ USA	Nanjing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Bristol-Myers Squibb	Ju, C (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	Cynthia.ju@ucdenver.edu	Wang, Huaqing/A-9179-2017	Wang, Huaqing/0000-0001-5333-0829; Marteinsdottir, Bryndis/0000-0003-3779-7327	National Institute of Health [F31DK082269, RO1ES012914, R01-DK059767, P30DK048520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK059767, F31DK082269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012914] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants F31DK082269 (BVM), RO1ES012914 (CJ), R01-DK059767 (JEF) and P30DK048520 to the Colorado Nutrition and Obesity Research Center (NORC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bourdi M, 2007, CHEM RES TOXICOL, V20, P208, DOI 10.1021/tx060228l; BRENNER GJ, 1994, CELL IMMUNOL, V157, P510, DOI 10.1006/cimm.1994.1246; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; GUIDA JD, 1995, J VIROL, V69, P7674, DOI 10.1128/JVI.69.12.7674-7681.1995; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Jensen DR, 2001, J APPL PHYSIOL, V90, P912, DOI 10.1152/jappl.2001.90.3.912; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Li ZP, 2004, HEPATOLOGY, V40, P434, DOI 10.1002/hep.20320; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Miyagi T, 2010, J GASTROENTEROL, V45, P1247, DOI 10.1007/s00535-010-0272-y; Monroy-Ostria A, 1994, Arch Med Res, V25, P401; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; NIEWIESK S, 1993, J VIROL, V67, P75, DOI 10.1128/JVI.67.1.75-81.1993; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Novak J, 2007, INT REV IMMUNOL, V26, P49, DOI 10.1080/08830180601070229; Omar B, 2012, NUTRIENTS, V4, P1367, DOI 10.3390/nu4101367; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Sell H, 2012, NAT REV ENDOCRINOL, DOI [10.1038/nrendo.2012.114, DOI 10.1038/NRENDO.2012.114.]; Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Umetsu DT, 2012, CELL RES, V22, P1210, DOI 10.1038/cr.2012.65; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werner JM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-26; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603; You Q, 2006, HEPATOLOGY, V44, P1421, DOI 10.1002/hep.21425	61	87	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e80949	10.1371/journal.pone.0080949	http://dx.doi.org/10.1371/journal.pone.0080949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	25057815	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500002
J	Yang, YC; Huang, YT; Hsieh, CW; Yang, PM; Wung, BS				Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Yang, Po-Min; Wung, Being-Sun			Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM-STRESS; CO-RELEASING MOLECULES; THERAPEUTIC APPLICATIONS; GENE-EXPRESSION; UP-REGULATION; JNK PATHWAY; PHOSPHORYLATION; INHIBITION; APOPTOSIS	IL-6/STAT3 pathway is involved in a variety of biological responses, including cell proliferation, differentiation, apoptosis, and inflammation. In our present study, we found that CO releasing molecules (CORMs) suppress IL-6-induced STAT3 phosphorylation, nuclear translocation and transactivity in endothelial cells (ECs). CO is a byproduct of heme degradation mediated by heme oxygenase (HO-1). However, CORMs can induce HO-1 expression and then inhibit STAT3 phosphorylation. CO has been found to increase a low level ROS and which may induce protein glutathionylation. We hypothesized that CORMs increases protein glutathionylation and inhibits STAT3 activation. We found that CORMs increase the intracellular GSSG level and induce the glutathionylation of multiple proteins including STAT3. GSSG can inhibit STAT3 phosphorylation and increase STAT3 glutathionylation whereas the antioxidant enzyme catalase can suppress the glutathionylation. Furthermore, catalase blocks the inhibition of STAT3 phosphorylation by CORMs treatment. The inhibition of glutathione synthesis by BSO was also found to attenuate STAT3 glutathionylation and its inhibition of STAT3 phosphorylation. We further found that HO-1 increases STAT3 glutathionylation and that HO-1 siRNA attenuates CORM-induced STAT3 glutathionylation. Hence, the inhibition of STAT3 activation is likely to occur via a CO-mediated increase in the GSSG level, which augments protein glutathionylation, and CO-induced HO-1 expression, which may enhance and maintain its effects in IL-6-treated ECs.	[Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Wung, Being-Sun] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Yang, Po-Min] Chiayi Christian Hosp, Dept Ophthalmol, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital	Wung, BS (corresponding author), Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	bswung@mail.ncyu.edu.tw	; Herrup, Karl/C-5313-2014	Chen, Ji-hua/0000-0002-1151-0693; wung, being sun/0000-0002-9378-2798; Hsieh, Chia-Wen/0000-0003-1188-1934; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	National Science Council, Taiwan [102-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (102-2320-B-415-002-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh PY, 2014, FREE RADICAL BIO MED, V70, P1, DOI 10.1016/j.freeradbiomed.2014.01.042; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	112	121	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100677	10.1371/journal.pone.0100677	http://dx.doi.org/10.1371/journal.pone.0100677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	24498369	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600004
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-27	WOS:000330240500068
J	Wang, Y; Jin, S; Sonobe, Y; Cheng, Y; Horiuchi, H; Parajuli, B; Kawanokuchi, J; Mizuno, T; Takeuchi, H; Suzumura, A				Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-1 beta Induces Blood-Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; NEUROLOGICAL DISEASES; MOLECULAR-MECHANISMS; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; CNS	The blood-brain barrier (BBB) is composed of capillary endothelial cells, pericytes, and perivascular astrocytes, which regulate central nervous system homeostasis. Sonic hedgehog (SHH) released from astrocytes plays an important role in the maintenance of BBB integrity. BBB disruption and microglial activation are common pathological features of various neurologic diseases such as multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Interleukin-1 beta (IL-1 beta), a major pro-inflammatory cytokine released from activated microglia, increases BBB permeability. Here we show that IL-1 beta abolishes the protective effect of astrocytes on BBB integrity by suppressing astrocytic SHH production. Astrocyte conditioned media, SHH, or SHH signal agonist strengthened BBB integrity by upregulating tight junction proteins, whereas SHH signal inhibitor abrogated these effects. Moreover, IL-1 beta increased astrocytic production of pro-inflammatory chemokines such as CCL2, CCL20, and CXCL2, which induce immune cell migration and exacerbate BBB disruption and neuroinflammation. Our findings suggest that astrocytic SHH is a potential therapeutic target that could be used to restore disrupted BBB in patients with neurologic diseases.	[Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science and Technology of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Araujo GLL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00077; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Blamire AM, 2000, J NEUROSCI, V20, P8153; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Cheng Y, 2014, J NEUROIMMUNOL, V269, P38, DOI 10.1016/j.jneuroim.2014.02.001; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; FREQUIN STFM, 1992, J NEUROIMMUNOL, V40, P265, DOI 10.1016/0165-5728(92)90142-8; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; Glazner GW, 2000, J NEUROCHEM, V75, P101, DOI 10.1046/j.1471-4159.2000.0750101.x; Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; MARTINEY JA, 1990, AM J PATHOL, V137, P1411; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; Mastronardi FG, 2003, MULT SCLER, V9, P362, DOI 10.1191/1352458503ms924oa; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; SUZUMURA A, 1986, SCIENCE, V232, P991, DOI 10.1126/science.3010460; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110024	10.1371/journal.pone.0110024	http://dx.doi.org/10.1371/journal.pone.0110024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313834	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500094
J	Wang, YJ; Loghmanpour, N; Vandenberghe, S; Ferreira, A; Keller, B; Gorcsan, J; Antaki, J				Wang, Yajuan; Loghmanpour, Natasha; Vandenberghe, Stijn; Ferreira, Antonio; Keller, Bradley; Gorcsan, John; Antaki, James			Simulation of Dilated Heart Failure with Continuous Flow Circulatory Support	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; PRESSURE-VOLUME RELATIONS; TURBODYNAMIC BLOOD PUMPS; MYOCARDIAL RECOVERY; FILLING PRESSURES; RISK SCORE; IN-VIVO; EXERCISE; MODEL; REST	Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological descending limb of the Frank-Starling response of the overloaded ventricle. This study introduces a dilated heart failure model featuring a unimodal end systolic pressure-volume relationship (ESPVR) to address this critical shortcoming. The resulting hemodynamic response to mechanical circulatory support are illustrated through numerical simulations of a rotodynamic, continuous flow ventricular assist device (cfVAD) coupled to systemic and pulmonary circulations with baroreflex control. The model further incorporated septal interaction to capture the influence of left ventricular (LV) unloading on right ventricular function. Four heart failure conditions were simulated (LV and bi-ventricular failure with/without pulmonary hypertension) in addition to normal baseline. Several metrics of LV function, including cardiac output and stroke work, exhibited a unimodal response whereby initial unloading improved function, and further unloading depleted preload reserve thereby reducing ventricular output. The concept of extremal loading was introduced to reflect the loading condition in which the intrinsic LV stroke work is maximized. Simulation of bi-ventricular failure with pulmonary hypertension revealed inadequacy of LV support alone. These simulations	[Wang, Yajuan; Loghmanpour, Natasha; Ferreira, Antonio; Antaki, James] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Vandenberghe, Stijn] Univ Bern, Bern, Switzerland; [Ferreira, Antonio] Univ Fed Maranhao, Maranhao, Brazil; [Keller, Bradley] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Gorcsan, John] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA	Carnegie Mellon University; University of Bern; Universidade Federal do Maranhao; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Antaki, J (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	antaki@cmu.edu	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	NIH [1R01HL086918]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by NIH grant 1R01HL086918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHOFF D, 1987, AM J PHYSIOL, V252, pH1218, DOI 10.1152/ajpheart.1987.252.6.H1218; CAREY CF, 1998, WASHINGTON MANUAL ME; Choi S., 1998, THESIS U PITTSBURGH; Chung DC, 1997, AM J PHYSIOL-HEART C, V272, pH2942, DOI 10.1152/ajpheart.1997.272.6.H2942; Dang NC, 2006, J HEART LUNG TRANSPL, V25, P1, DOI 10.1016/j.healun.2005.07.008; EHRSAM RE, 1983, CLIN SCI, V65, P653, DOI 10.1042/cs0650653; FARRAR DJ, 1985, WORLD J SURG, V9, P89, DOI 10.1007/BF01656260; Ferreira A, 2007, P ANN INT IEEE EMBS, P3978, DOI 10.1109/IEMBS.2007.4353205; Ferreira A, 2009, IEEE T BIO-MED ENG, V56, P656, DOI 10.1109/TBME.2008.2005960; Fitzpatrick JR, 2009, J THORAC CARDIOV SUR, V137, P971, DOI 10.1016/j.jtcvs.2008.09.021; Fitzpatrick JR, 2008, J HEART LUNG TRANSPL, V27, P1286, DOI 10.1016/j.healun.2008.09.006; Gorcsan J, 2003, J HEART LUNG TRANSPL, V22, P1304, DOI 10.1016/S1053-2498(03)00056-1; Gwak KW, 2004, IEEE DECIS CONTR P, P1069, DOI 10.1109/CDC.2004.1428833; Gwak KW, 2007, ASAIO J, V53, P403, DOI 10.1097/MAT.0b013e31806ada0a; Gwak KW, 2011, ARTIF ORGANS, V35, P725, DOI 10.1111/j.1525-1594.2011.01230.x; Hall JE, 2010, GUYTON HALL TXB MED, P110; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Katz AM, 2008, CIRC-HEART FAIL, V1, P63, DOI 10.1161/CIRCHEARTFAILURE.108.772756; Kinoshita M, 1988, ASAIO Trans, V34, P208; KORMOS RL, 1990, ANN THORAC SURG, V49, P261, DOI 10.1016/0003-4975(90)90148-Y; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Lisy O, 2000, CIRCULATION, V102, P338; LITTLE WC, 1988, CIRCULATION, V78, P736, DOI 10.1161/01.CIR.78.3.736; Matthews JC, 2008, J AM COLL CARDIOL, V51, P2163, DOI 10.1016/j.jacc.2008.03.009; Maybaum S, 2011, CIRCULATION, V123, P355, DOI 10.1161/CIRCULATIONAHA.110.005199; Morley D, 2007, J THORAC CARDIOV SUR, V133, P21, DOI 10.1016/j.jtcvs.2006.07.037; Moscato F, 2010, ARTIF ORGANS, V34, P736, DOI 10.1111/j.1525-1594.2010.01066.x; Nair PK, 2010, J HEART LUNG TRANSPL, V29, P201, DOI 10.1016/j.healun.2009.09.013; Nakatani S, 1996, J AM COLL CARDIOL, V27, P894, DOI 10.1016/0735-1097(95)00555-2; NORDENFELT I, 1985, CLIN PHYSIOL, V5, P161, DOI 10.1111/j.1475-097X.1985.tb00592.x; Palardy M, 2009, CIRC-HEART FAIL, V2, P181, DOI 10.1161/CIRCHEARTFAILURE.108.822999; Rose AG, 2000, ANN THORAC SURG, V70, P1270, DOI 10.1016/S0003-4975(00)01929-9; ROSS J, 1964, CIRCULATION, V29, P739, DOI 10.1161/01.CIR.29.5.739; SARNOFF SJ, 1954, CIRCULATION, V9, P706, DOI 10.1161/01.CIR.9.5.706; Schima H, 2004, J THORAC CARDIOV SUR, V127, P1743, DOI 10.1016/j.jtcvs.2003.09.029; Shi YB, 2006, ARTIF ORGANS, V30, P929, DOI 10.1111/j.1525-1594.2006.00326.x; SHROFF SG, 1985, AM J PHYSIOL, V249, pH358, DOI 10.1152/ajpheart.1985.249.2.H358; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Soloff LA, 1999, CIRCULATION, V100, P1012, DOI 10.1161/circ.100.9.1011/-b; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON LW, 1986, CIRCULATION, V74, P1303, DOI 10.1161/01.CIR.74.6.1303; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; Ursino M, 1998, AM J PHYSIOL-HEART C, V275, pH1733, DOI 10.1152/ajpheart.1998.275.5.H1733; Vandenberghe S, 2003, ARTIF ORGANS, V27, P1094, DOI 10.1111/j.1525-1594.2003.07198.x; Vollkron M, 2002, ARTIF ORGANS, V26, P349, DOI 10.1046/j.1525-1594.2002.06870.x; ZARET BL, 1984, EUR HEART J, V5, P850, DOI 10.1093/oxfordjournals.eurheartj.a061576	49	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85234	10.1371/journal.pone.0085234	http://dx.doi.org/10.1371/journal.pone.0085234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	25313834	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000027
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24622390	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24622390	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	24622390	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800038
